PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sucharitakul, J; Tongsook, C; Pakotiprapha, D; van Berkel, WJH; Chaiyen, P				Sucharitakul, Jeerus; Tongsook, Chanakan; Pakotiprapha, Danaya; van Berkel, Willem J. H.; Chaiyen, Pimchai			The Reaction Kinetics of 3-Hydroxybenzoate 6-Hydroxylase from Rhodococcus jostii RHA1 Provide an Understanding of the para-Hydroxylation Enzyme Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Flavin; Flavoproteins; Hydroxylase	PARA-HYDROXYBENZOATE HYDROXYLASE; P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLIC ACID OXYGENASE; STEADY-STATE; ORNITHINE HYDROXYLASE; VIBRIO-CAMPBELLII; CRYSTAL-STRUCTURE; GENTISIC ACID; IN-VITRO; MECHANISM	Background: 3-Hydroxybenzoate 6-hydroxylase (3HB6H) is a flavoprotein hydroxylase catalyzing the para-hydroxylation of 3-hydroxybenzoate. Results: The oxidative half-reaction was studied using transient kinetics. The enzyme reaction mechanism was elucidated. Conclusion: The product release and the hydroxylation limit the turnovers and the enzyme shows characteristics different from the ortho-hydroxylation enzymes. Significance: This is the first report on the oxygenation mechanism of a para-hydroxylating flavoenzyme. 3-Hydroxybenzoate 6-hydroxylase (3HB6H) from Rhodococcus jostii RHA1 is an NADH-specific flavoprotein monooxygenase that catalyzes the para-hydroxylation of 3-hydroxybenzoate (3HB) to form 2,5-dihydroxybenzoate (2,5-DHB). Based on results from stopped-flow spectrophotometry, the reduced enzyme-3HB complex reacts with oxygen to form a C4a-peroxy flavin with a rate constant of 1.13 +/- 0.01 x 10(6) m(-1) s(-1) (pH 8.0, 4 degrees C). This intermediate is subsequently protonated to form a C4a-hydroperoxyflavin with a rate constant of 96 +/- 3 s(-1). This step shows a solvent kinetic isotope effect of 1.7. Based on rapid-quench measurements, the hydroxylation occurs with a rate constant of 36 +/- 2 s(-1). 3HB6H does not exhibit substrate inhibition on the flavin oxidation step, a common characteristic found in most ortho-hydroxylation enzymes. The apparent k(cat) at saturating concentrations of 3HB, NADH, and oxygen is 6.49 +/- 0.02 s(-1). Pre-steady state and steady-state kinetic data were used to construct the catalytic cycle of the reaction. The data indicate that the steps of product release (11.7 s(-1)) and hydroxylation (36 +/- 2 s(-1)) partially control the overall turnover.	[Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10330, Thailand; [Tongsook, Chanakan; Pakotiprapha, Danaya; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Tongsook, Chanakan; Pakotiprapha, Danaya; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [van Berkel, Willem J. H.] Wageningen Univ, Lab Biochem, NL-6703 HA Wageningen, Netherlands	Chulalongkorn University; Mahidol University; Mahidol University; Wageningen University & Research	Sucharitakul, J (corresponding author), Chulalongkorn Univ, Dept Biochem, Fac Dent, Henri Dunant Rd, Bangkok 10330, Thailand.	jeerus.s@chula.ac.th	van Berkel, Willem J.H./O-2431-2014; Pakotiprapha, Danaya/B-1032-2013; Chaiyen, Pimchai/R-5052-2019	van Berkel, Willem J.H./0000-0002-6551-2782; Pakotiprapha, Danaya/0000-0002-5017-8283; Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [RSA5580050, RTA5680001, MRG5680043]; National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund,; Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions; Faculty of Science, Mahidol University; Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme	Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund,; Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions; Faculty of Science, Mahidol University; Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme(Netherlands Organization for Scientific Research (NWO))	This work was supported by Thailand Research Fund Grants RSA5580050 (to J. S.), RTA5680001 (to P. C.), and MRG5680043 (to D. P.), and grants from the National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund, the Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions (to J. S.), the Faculty of Science, Mahidol University (to P. C.), and the Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme (to W. v. B.).	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Ashidate K, 2005, EUR J PHARMACOL, V513, P173, DOI 10.1016/j.ejphar.2005.03.012; Ballou DP, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P1; CHA S, 1968, J BIOL CHEM, V243, P820; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Joshi R, 2012, FREE RADICAL RES, V46, P11, DOI 10.3109/10715762.2011.633518; Kallio P, 2011, BIOCHEMISTRY-US, V50, P5535, DOI 10.1021/bi200600k; Keitaro H., 1979, KINETICS FAST ENZYME; Kuby S. A., 2000, STUDY ENZYMES HIST I; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; STEENNIS PJ, 1973, FEBS LETT, V36, P177, DOI 10.1016/0014-5793(73)80363-1; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2012, BIOCHEMISTRY-US, V51, P4309, DOI 10.1021/bi201823c; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Wang YL, 2002, FEMS MICROBIOL LETT, V208, P117, DOI 10.1016/S0378-1097(01)00591-2	41	24	24	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35210	35221		10.1074/jbc.M113.515205	http://dx.doi.org/10.1074/jbc.M113.515205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129570	Green Published, hybrid			2022-12-25	WOS:000329867600021
J	Chahdi, A; Raufman, JP				Chahdi, Ahmed; Raufman, Jean-Pierre			The Cdc42/Rac Nucleotide Exchange Factor Protein beta(1) Pix (Pak-interacting Exchange Factor) Modulates beta-Catenin Transcriptional Activity in Colon Cancer Cells EVIDENCE FOR DIRECT INTERACTION OF beta(1) PIX WITH beta-CATENIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta -Catenin; Cell Proliferation; Colon Cancer; Guanine Nucleotide Exchange Factor (GEF); Small GTPases	SUBCELLULAR-LOCALIZATION; ADHERENS JUNCTIONS; COLORECTAL-CANCER; RAC1 GTPASE; ACTIVATION; WNT; PATHWAY; COMPLEX; APC; BINDING	Wnt/beta-catenin signaling is highly regulated and critical for intestinal epithelial development and repair; aberrant -catenin signaling is strongly associated with colon cancer. The small GTPase Rac1 regulates -catenin nuclear translocation and signaling. Here we tested the hypothesis that (1)Pix, a Cdc42/Rac guanine nucleotide exchange factor (GEF), regulates -catenin-dependent transcriptional activity and cell function. We report the novel observations that (1)Pix binds directly to -catenin, an action requiring both the (1)Pix DH and dimerization domains but not (1)Pix GEF activity. In human colon cancer cells, activation of -catenin signaling with LiCl decreased (1)Pix/-catenin association in the cytosol and increased nuclear binding of -catenin to (1)Pix. Nuclear association of (1)Pix and -catenin was independent of Rac1 expression and activation; down- and up-regulating Rac1 expression levels did not alter nuclear (1)Pix/-catenin association. Ectopic (1)Pix expression enhanced LiCl-induced -catenin transcriptional activity. Conversely, siRNA knockdown of (1)Pix attenuated both LiCl-induced -catenin transcriptional activity and colon cancer cell proliferation. Ectopic expression of (1)Pix stimulated -catenin transcriptional activity, whereas (1)Pix(602-611), which is unable to bind -catenin, had no effect. Altogether, these findings suggest that (1)Pix functions as a transcriptional regulator of -catenin signaling through direct interaction with -catenin, an action that may be functionally relevant to colon cancer biology.	[Chahdi, Ahmed; Raufman, Jean-Pierre] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Baltimore, MD 21210 USA; [Raufman, Jean-Pierre] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21210 USA; [Raufman, Jean-Pierre] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Raufman, JP (corresponding author), Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, 22 South Greene St,N3W62, Baltimore, MD 21210 USA.	jraufman@medicine.umaryland.edu			NCI [CA-107345, CA-120407]; NIDDK, National Institutes of Health [DK-093406]; NATIONAL CANCER INSTITUTE [R01CA107345, R01CA120407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK093406] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Public Health Service Grants CA-107345 and CA-120407 from the NCI and Grant DK-093406 from the NIDDK, National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Cerbone A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040149; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chahdi A, 2010, BIOCHEM BIOPH RES CO, V391, P1330, DOI 10.1016/j.bbrc.2009.12.041; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mendoza-Catalan MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-116; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pinto D, 2005, BIOL CELL, V97, P185; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sparks AB, 1998, CANCER RES, V58, P1130; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zurawel RH, 1998, CANCER RES, V58, P896	55	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34019	34029		10.1074/jbc.M113.480103	http://dx.doi.org/10.1074/jbc.M113.480103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129564	hybrid, Green Published			2022-12-25	WOS:000327250200043
J	Breno, M; Bots, J; Van Dongen, S				Breno, Matteo; Bots, Jessica; Van Dongen, Stefan			Heritabilities of Directional Asymmetry in the Fore- and Hindlimbs of Rabbit Fetuses	PLOS ONE			English	Article							BILATERAL ASYMMETRY; DROSOPHILA-MELANOGASTER; FLUCTUATING ASYMMETRY; DEVELOPMENTAL INSTABILITY; ADAPTIVE ACCURACY; HAND DOMINANCE; SELECTION; HANDEDNESS; HUMANS; PREFERENCE	Directional asymmetry (DA), where at the population level symmetry differs from zero, has been reported in a wide range of traits and taxa, even for traits in which symmetry is expected to be the target of selection such as limbs or wings. In invertebrates, DA has been suggested to be non-adaptive. In vertebrates, there has been a wealth of research linking morphological asymmetry to behavioural lateralisation. On the other hand, the prenatal expression of DA and evidences for quantitative genetic variation for asymmetry may suggest it is not solely induced by differences in mechanic loading between sides. We estimate quantitative genetic variation of fetal limb asymmetry in a large dataset of rabbits. Our results showed a low but highly significant level of DA that is partially under genetic control for all traits, with forelimbs displaying higher levels of asymmetry. Genetic correlations were positive within limbs, but negative across bones of fore and hind limbs. Environmental correlations were positive for all, but smaller across fore and hind limbs. We discuss our results in light of the existence and maintenance of DA in locomotory traits.	[Breno, Matteo; Bots, Jessica; Van Dongen, Stefan] Univ Antwerp, Dept Biol, Evolutionary Biol Grp, B-2020 Antwerp, Belgium	University of Antwerp	Breno, M (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Biol Grp, B-2020 Antwerp, Belgium.	matteo.breno@ua.ac.be	breno, matteo/ABH-4494-2020	breno, matteo/0000-0003-1559-8730	University of Antwerp [BOF-KP 4382]; Fund for Scientific Research - Flanders (FWO)	University of Antwerp; Fund for Scientific Research - Flanders (FWO)(FWO)	This work benefited from a research grant from the University of Antwerp (BOF-KP 4382). MB holds a PhD Fellowship from the Fund for Scientific Research - Flanders (FWO). JB is a postdoctoral fellow with the Fund for Scientific Reserach - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2009, SEMIN CELL DEV BIOL, V20, P479, DOI 10.1016/j.semcdb.2008.10.011; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Beardmore J, 1965, S MUT PROC PRAG CZEC; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; Breno M, 2013, BIRTH DEF B IN PRESS; Carter Ashley J R, 2009, Int J Evol Biol, V2010, P759159, DOI 10.4061/2009/759159; Cassidy KM, 1998, ANGLE ORTHOD, V68, P445; COYNE JA, 1987, J HERED, V78, P119, DOI 10.1093/oxfordjournals.jhered.a110329; Faurie C, 2004, P ROY SOC B-BIOL SCI, V271, pS43, DOI 10.1098/rsbl.2003.0092; Galatius A, 2005, MAR MAMMAL SCI, V21, P401, DOI 10.1111/j.1748-7692.2005.tb01240.x; Garland T, 2005, EVOLUTION, V59, P1851, DOI 10.1111/j.0014-3820.2005.tb01832.x; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; Hughes TE, 2007, J DENT RES, V86, P1160, DOI 10.1177/154405910708601204; Kanchan Tanuj, 2008, J Forensic Leg Med, V15, P177, DOI 10.1016/j.jflm.2007.05.009; Kharlamova AV, 2010, J MORPHOL, V271, P1501, DOI 10.1002/jmor.10890; Klingenberg Christian Peter, 2003, P427; Kraak SBM, 1997, TRENDS ECOL EVOL, V12, P230, DOI 10.1016/S0169-5347(97)86959-5; KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; Leamy L, 1999, J EVOLUTION BIOL, V12, P146, DOI 10.1046/j.1420-9101.1999.00023.x; Leamy L, 1997, J HERED, V88, pCP2; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Palmer A. Richard, 2005, P359, DOI 10.1016/B978-012088777-4/50018-1; Pelabon C, 2008, EVOLUTION, V62, P2855, DOI 10.1111/j.1558-5646.2008.00495.x; Pettersson U, 2000, CALCIFIED TISSUE INT, V67, P199, DOI 10.1007/s002230001117; PLATO CC, 1980, AM J PHYS ANTHROPOL, V52, P27, DOI 10.1002/ajpa.1330520105; PURNELL DJ, 1973, HEREDITY, V31, P401, DOI 10.1038/hdy.1973.94; PURVES D, 1994, P NATL ACAD SCI USA, V91, P5030, DOI 10.1073/pnas.91.11.5030; R Development Core Team, 2011, R LANG ENV STAT COMP; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Razzetti E, 2007, ZOOMORPHOLOGY, V126, P31, DOI 10.1007/s00435-007-0028-2; Rego C, 2006, EVOLUTION, V60, P746, DOI 10.1111/j.0014-3820.2006.tb01153.x; Ribeiro AS, 2011, ANIM BEHAV, V81, P249, DOI 10.1016/j.anbehav.2010.10.014; ROY TA, 1994, AM J PHYS ANTHROPOL, V94, P203, DOI 10.1002/ajpa.1330940205; Sarringhaus LA, 2005, AM J PHYS ANTHROPOL, V128, P840, DOI 10.1002/ajpa.20190; Seligmann H, 2003, J ZOOL, V260, P129, DOI 10.1017/S0952836903003558; Seligmann H, 1998, J ZOOL, V245, P205, DOI 10.1017/S0952836998006086; Sengupta M, 2006, HUM BIOL, V78, P199, DOI 10.1353/hub.2006.0036; Sengupta M, 2007, AM J HUM BIOL, V19, P399, DOI 10.1002/ajhb.20601; Shaw CN, 2011, J HUM EVOL, V61, P480, DOI 10.1016/j.jhevol.2011.06.004; SINGH I, 1971, J ANAT, V109, P271; TUINSTRA EJ, 1990, P ROY SOC B-BIOL SCI, V241, P146, DOI 10.1098/rspb.1990.0078; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Dongen S, 2009, J EVOLUTION BIOL, V22, P612, DOI 10.1111/j.1420-9101.2008.01667.x; Van Dongen S, 2010, ANIM BIOL, V60, P169, DOI 10.1163/157075610X491716; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Windig JJ, 1999, P ROY SOC B-BIOL SCI, V266, P1413, DOI 10.1098/rspb.1999.0795; Woolf CM, 1997, GENETICA, V101, P199, DOI 10.1023/A:1018366122913; Yeo RA, 2002, ELSEVIER SCI, P329	52	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76358	10.1371/journal.pone.0076358	http://dx.doi.org/10.1371/journal.pone.0076358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130770	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200035
J	Herbst, S; Maucher, D; Schneider, M; Ihling, CH; Jahn, O; Sinz, A				Herbst, Sabine; Maucher, Daniel; Schneider, Marian; Ihling, Christian H.; Jahn, Olaf; Sinz, Andrea			Munc13-Like skMLCK Variants Cannot Mimic the Unique Calmodulin Binding Mode of Munc13 as Evidenced by Chemical Cross-Linking and Mass Spectrometry	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; PROTEIN-PROTEIN INTERACTIONS; SHORT-TERM PLASTICITY; PEPTIDE COMPLEX; ACTIVATION; SCATTERING; DOMAIN; MOTIF; NMR	Among the neuronal binding partners of calmodulin (CaM) are Munc13 proteins as essential presynaptic regulators that play a key role in synaptic vesicle priming and are crucial for presynaptic short-term plasticity. Recent NMR structural investigations of a CaM/Munc13-1 peptide complex have revealed an extended structure, which contrasts the compact structures of most classical CaM/target complexes. This unusual binding mode is thought to be related to the presence of an additional hydrophobic anchor residue at position 26 of the CaM binding motif of Munc13-1, resulting in a novel 1-5-8-26 motif. Here, we addressed the question whether the 1-5-8-26 CaM binding motif is a Munc13-related feature or whether it can be induced in other CaM targets by altering the motif's core residues. For this purpose, we chose skeletal muscle myosin light chain kinase (skMLCK) with a classical 1-5-8-14 CaM binding motif and constructed three skMLCK peptide variants mimicking Munc13-1, in which the hydrophobic anchor amino acid at position 14 was moved to position 26. Chemical cross-linking between CaM and skMLCK peptide variants combined with high-resolution mass spectrometry yielded insights into the peptides' binding modes. This structural comparison together with complementary binding data from surface plasmon resonance experiments revealed that skMLCK variants with an artificial 1-5-8-26 motif cannot mimic CaM binding of Munc13-1. Apparently, additional features apart from the spacing of the hydrophobic anchor residues are required to define the functional 1-5-8-26 motif of Munc13-1. We conclude that Munc13 proteins display a unique CaM binding behavior to fulfill their role as efficient presynaptic calcium sensors over broad range of Ca2+ concentrations.	[Herbst, Sabine; Maucher, Daniel; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany; [Schneider, Marian] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Res Grp Artificial Binding Prot, D-06108 Halle, Saale, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany.	andrea.sinz@pharmazie.uni-halle.de	Jahn, Olaf/AAD-8212-2020	Jahn, Olaf/0000-0002-3397-8924	DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg; region of Sachsen-Anhalt; BMBF; DFG	DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg; region of Sachsen-Anhalt; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	SH is funded by the DFG-Graduiertenkolleg 1026 "Conformational Transitions in Macromolecular Interactions'' at the Martin-Luther University Halle-Wittenberg. AS acknowledges financial support from the region of Sachsen-Anhalt, the BMBF, and the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bich C, 2010, ANAL CHEM, V82, P172, DOI 10.1021/ac901651r; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; Dimova K, 2009, BIOCHEMISTRY-US, V48, P5908, DOI 10.1021/bi900300r; Fabris D, 2010, J MASS SPECTROM, V45, P841, DOI 10.1002/jms.1762; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jahn O, 2004, ANAL BIOANAL CHEM, V378, P1031, DOI 10.1007/s00216-003-2353-8; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kalkhof S, 2005, ANAL CHEM, V77, P495, DOI 10.1021/ac0487294; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Krauth F, 2009, RAPID COMMUN MASS SP, V23, P2811, DOI 10.1002/rcm.4188; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P13997, DOI 10.1021/bi981311d; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P17810, DOI 10.1021/bi981656w; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipstein N, 2012, MOL CELL BIOL, V32, P4628, DOI 10.1128/MCB.00933-12; Persechini A, 2000, J BIOL CHEM, V275, P4199, DOI 10.1074/jbc.275.6.4199; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schaks S, 2011, BMMS, V2, P249; Schulz DM, 2004, BIOCHEMISTRY-US, V43, P4703, DOI 10.1021/bi036149f; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Sinz A, 2010, ANAL BIOANAL CHEM, V397, P3433, DOI 10.1007/s00216-009-3405-5; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75119	10.1371/journal.pone.0075119	http://dx.doi.org/10.1371/journal.pone.0075119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130683	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200003
J	Ruiz-Extremera, A; Munoz-Gamez, JA; Abril-Molina, A; Salmeron-Ruiz, MA; Munoz-de-Rueda, P; Pavon-Castillero, EJ; Quiles-Perez, R; Carazo, A; Gila, A; Jimenez-Ruiz, SM; Casado, J; Martin, AB; Sanjuan-Nunez, L; Ocete-Hita, E; Viota, JL; Leon, J; Salmeron, J				Ruiz-Extremera, Angeles; Antonio Munoz-Gamez, Jose; Abril-Molina, Ana; Angustias Salmeron-Ruiz, Maria; Munoz-de-Rueda, Paloma; Jose Pavon-Castillero, Esther; Quiles-Perez, Rosa; Carazo, Angel; Gila, Ana; Manuel Jimenez-Ruiz, Sergio; Casado, Jorge; Belen Martin, Ana; Sanjuan-Nunez, Laura; Ocete-Hita, Esther; Lopez Viota, Julian; Leon, Josefa; Salmeron, Javier			Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VERTICAL TRANSMISSION; NATURAL-HISTORY; LIVER FIBROSIS; INFECTION; INTERFERON; RISK; THERAPY; CHOLESTASIS; EXPRESSION	This study analyses the evolution of liver disease in women with chronic hepatitis C during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. Of the 122 mothers recruited to this study, 89 were HCV-RNA+ve/HIV-ve and 33 were HCV-RNA-ve/HIV-ve/HCVantibody+ve and all were tested during the third trimester of pregnancy, at delivery and post-delivery. The HCV-RNA+ve mothers were categorized as either Type-A (66%), with an increase in ALT levels in the post-partum period (>40 U/L; P<0.001) or as Type-B (34%), with no variation in ALT values. The Type-A mothers also presented a significant decrease in serum HCV-RNA levels in the post-delivery period (P<0.001) and this event was concomitant with an increase in Th1 cytokine levels (INF gamma, P=0.04; IL12, P=0.01 and IL2, P=0.01). On the other hand, the Type-B mothers and the HCV-RNA-ve women presented no variations in either of these parameters. However, they did present higher Th1 cytokine levels in the partum period (INF gamma and IL2, P<0.05) than both the Type-A and the HCV-RNA-ve women. Cytokine levels at the moment of delivery do not constitute a risk factor associated with HCV vertical transmission. It is concluded that differences in the ALT and HCV-RNA values observed in HCV-RNA+ve women in the postpartum period might be due to different ratios of Th1 cytokine production. In the Type-B women, the high partum levels of Th1 cytokines and the absence of post-partum variation in ALT and HCV-RNA levels may be related to permanent Th1 cytokine stimulation.	[Ruiz-Extremera, Angeles] San Cecilio Univ Hosp, Paediat Unit, Granada, Spain; [Ruiz-Extremera, Angeles; Munoz-de-Rueda, Paloma; Quiles-Perez, Rosa; Gila, Ana; Ocete-Hita, Esther; Leon, Josefa; Salmeron, Javier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Granada, Spain; [Ruiz-Extremera, Angeles; Ocete-Hita, Esther] Univ Granada, Paediat Unit, Granada, Spain; [Antonio Munoz-Gamez, Jose; Munoz-de-Rueda, Paloma; Jose Pavon-Castillero, Esther; Quiles-Perez, Rosa; Carazo, Angel; Gila, Ana; Manuel Jimenez-Ruiz, Sergio; Casado, Jorge; Belen Martin, Ana; Sanjuan-Nunez, Laura; Lopez Viota, Julian; Leon, Josefa; Salmeron, Javier] San Cecilio Univ Hosp, Clin Management Unit Digest Dis, Granada, Spain; [Abril-Molina, Ana; Ocete-Hita, Esther] Virgen de las Nieves Hosp, Paediat Unit, Granada, Spain; [Angustias Salmeron-Ruiz, Maria] La Paz Univ Hosp, Paediat Unit, Madrid, Spain; [Manuel Jimenez-Ruiz, Sergio; Sanjuan-Nunez, Laura; Salmeron, Javier] Univ Granada, Dept Med, Granada, Spain	Hospital Universitario San Cecilio; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; Hospital Universitario La Paz; University of Granada	Munoz-Gamez, JA (corresponding author), San Cecilio Univ Hosp, Clin Management Unit Digest Dis, Granada, Spain.	jamunozgamez@gmail.com	casado, Jorge/GVT-9383-2022; Leon, Pepi/K-8972-2014	Leon, Pepi/0000-0002-0543-4823; Ruiz-Extremera, Angeles o Angela/0000-0001-7978-1708; Quiles, Rosa/0000-0001-6089-6193; Lopez-Viota, Julian/0000-0003-3112-587X	Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III) [PI080704]; Consejeria de Salud (SAS); Junta de Andalucia [SAS111213]; Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III)	Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Consejeria de Salud (SAS); Junta de Andalucia(Junta de Andalucia); Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigaciones Sanitarias (FIS, Instituto de Salud Carlos III), [grant number PI080704]; Consejeria de Salud (SAS), Junta de Andalucia, [grant number SAS111213] and Ciberehd (Ciber de Enfermedades Hepaticas y Digestivas (Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 1998, RES VIROLOGY, V149, P229, DOI 10.1016/S0923-2516(98)80004-6; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Fallahi P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/468107; Floreani A, 1996, BRIT J OBSTET GYNAEC, V103, P325, DOI 10.1111/j.1471-0528.1996.tb09736.x; Gervais A, 2000, J HEPATOL, V32, P293, DOI 10.1016/S0168-8278(00)80075-6; Hattori Y, 2003, J MED VIROL, V71, P205, DOI 10.1002/jmv.10471; Hayashida A, 2007, J OBSTET GYNAECOL RE, V33, P417, DOI 10.1111/j.1447-0756.2007.00582.x; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; Hurtado CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012232; Indolfi G, 2006, J MED VIROL, V78, P911, DOI 10.1002/jmv.20640; Jabeen T, 2000, QJM-INT J MED, V93, P597, DOI 10.1093/qjmed/93.9.597; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Le Campion A, 2012, VIRUSES-BASEL, V4, P3531, DOI 10.3390/v4123531; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Lin HH, 2000, BRIT J OBSTET GYNAEC, V107, P1503, DOI 10.1111/j.1471-0528.2000.tb11675.x; Locatelli A, 1999, BRIT J OBSTET GYNAEC, V106, P498, DOI 10.1111/j.1471-0528.1999.tb08305.x; Mercalli A, 2013, IMMUNOLOGY; de Rueda PM, 2011, AM J GASTROENTEROL, V106, P1246, DOI 10.1038/ajg.2011.82; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Paternoster DM, 2008, J CLIN GASTROENTEROL, V42, P204, DOI 10.1097/01.mcg.0000247991.81591.2e; Paternoster DM, 2002, ACTA OBSTET GYN SCAN, V81, P99, DOI 10.1034/j.1600-0412.2002.810202.x; Paternoster DM, 2001, AM J GASTROENTEROL, V96, P2751, DOI 10.1111/j.1572-0241.2001.04135.x; Pergam SA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.052; Pol S, 2012, CONTRIB NEPHROL, V176, P1, DOI 10.1159/000332374; Ruiz-Extremera A, 2000, PEDIATR INFECT DIS J, V19, P511, DOI 10.1097/00006454-200006000-00004; Ruiz-Extremera A, 2005, AM J OBSTET GYNECOL, V193, P2010, DOI 10.1016/j.ajog.2005.04.045; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7; Salmeron J, 1998, REV ESP ENFERM DIG, V90, P846; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sbebl FM, 2009, J MED VIROL, V81, P1024, DOI 10.1002/jmv.21480; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416739; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Valladares G, 2010, ANN HEPATOL, V9, pS92, DOI 10.1016/S1665-2681(19)31731-4; Wan L, 2009, BIOCHEM BIOPH RES CO, V379, P855, DOI 10.1016/j.bbrc.2008.12.114	42	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75613	10.1371/journal.pone.0075613	http://dx.doi.org/10.1371/journal.pone.0075613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130726	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200018
J	Hasegawa, T; Shimada, S; Ishida, H; Nakashima, M				Hasegawa, Tatsuya; Shimada, Shoichiro; Ishida, Hitoshi; Nakashima, Masaya			Chafuroside B, an Oolong Tea Polyphenol, Ameliorates UVB-Induced DNA Damage and Generation of Photo-immunosuppression Related Mediators in Human Keratinocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ULTRAVIOLET-RADIATION; IMMUNE SUPPRESSION; CELL-MIGRATION; SKIN-CANCER; INTERLEUKIN-12; IL-12; CYTOKINE; INDUCTION; EXPOSURE	Chafuroside B was recently isolated as a new polyphenolic constituent of oolong tea leaves. However, the effects of chafuroside B on skin function have not been examined. In this study, we investigated the protective effects of chafuroside B against UVB-induced DNA damage, apoptosis and generation of photo-immunosuppression related mediators in cultured normal human epidermal keratinocytes (NHEK). Chafuroside B at 1 mu M attenuated both UVB-induced apoptosis, evaluated in terms of caspase-3/7 activity, and UVB-induced DNA damage, evaluated in terms of formation of cyclobutane pyrimidine dimers (CPD), in NHEK exposed to UVB (20 mJ/cm(2)). In addition, chafuroside B at 0.3 or 1 mu M suppressed the UVB-induced production of interleukin (IL)-10, tumor necrosis factor (TNF)-alpha, and prostaglandin E2 (PGE(2)), as determined by ELISA, and conversely enhanced IL-12 mRNA expression and production, as measured by RT-PCR and ELISA. Further, chafuroside B at 1 mu M also suppressed UVB-induced expression of receptor activator of nuclear factor kappa B ligand (RANKL) mRNA. These results indicate that chafuroside B promotes repair of UVB-induced DNA damage and ameliorates the generation of IL-10, TNF-alpha, PGE(2), and RANKL, all of which are UVB-induced immunosuppression related mediators. These effects of chafuroside B may be mediated at least in part through induction of IL-12 synthesis in human keratinocytes. Because chafuroside B might have practical value as a photoprotective agent, a further study of the in vivo effects of chafuroside B seems warranted.	[Hasegawa, Tatsuya; Shimada, Shoichiro; Nakashima, Masaya] Shiseido Res Ctr, Funct Food Res & Dev Ctr, Yokohama, Kanagawa, Japan; [Ishida, Hitoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Shiseido Company, Limited; University of Shizuoka	Hasegawa, T (corresponding author), Shiseido Res Ctr, Funct Food Res & Dev Ctr, Yokohama, Kanagawa, Japan.	tatsuya.hasegawa@to.shiseido.co.jp			Shiseido	Shiseido	Funding support for this research was provided entirely by Shiseido. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli RS, 2004, FEBS LETT, V559, P71, DOI 10.1016/S0014-5793(04)00026-2; ARAGANE Y, 1994, J IMMUNOL, V153, P5366; Asadullah K, 1998, J CLIN INVEST, V101, P783, DOI 10.1172/JCI1476; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; CHUNG HT, 1986, J IMMUNOL, V137, P2478; COOPER KD, 1992, P NATL ACAD SCI USA, V89, P8497, DOI 10.1073/pnas.89.18.8497; Cumberbatch M, 1999, BRIT J DERMATOL, V141, P192; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Gailani MR, 1996, J NATL CANCER I, V88, P349, DOI 10.1093/jnci/88.6.349; GREWE M, 1993, J INVEST DERMATOL, V101, P528, DOI 10.1111/1523-1747.ep12365904; Halliday GM, 2012, J DERMATOL SCI, V66, P176, DOI 10.1016/j.jdermsci.2011.12.009; Hanneman KK, 2006, DERMATOL CLIN, V24, P19, DOI 10.1016/j.det.2005.08.003; Ichihashi M, 2000, J DERMATOL SCI, V23, pS45, DOI 10.1016/S0923-1811(00)00083-9; Ishida H, 2009, J AGR FOOD CHEM, V57, P6779, DOI 10.1021/jf900032z; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kripke M L, 1996, Exp Dermatol, V5, P173, DOI 10.1111/j.1600-0625.1996.tb00113.x; KRIPKE ML, 1992, P NATL ACAD SCI USA, V89, P7516, DOI 10.1073/pnas.89.16.7516; Kupas V, 2011, J INVEST DERMATOL, V131, P944, DOI 10.1038/jid.2010.377; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Meeran SM, 2008, J INVEST DERMATOL, V128, P2716, DOI 10.1038/jid.2008.140; MOODYCLIFFE AM, 1994, IMMUNOLOGY, V81, P79; Moriwaki S, 2008, J DERMATOL SCI, V50, P169, DOI 10.1016/j.jdermsci.2007.08.011; MULLER G, 1995, J IMMUNOL, V155, P4661; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Nishigori C, 1996, P NATL ACAD SCI USA, V93, P10354, DOI 10.1073/pnas.93.19.10354; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Onoue S, 2012, EUR J PHARM SCI, V45, P184, DOI 10.1016/j.ejps.2011.11.003; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; RIVAS JM, 1992, J IMMUNOL, V149, P3865; RUZICKA T, 1983, J INVEST DERMATOL, V81, P300, DOI 10.1111/1523-1747.ep12519287; Schmitt DA, 2000, IMMUNOLOGY, V101, P90, DOI 10.1046/j.1365-2567.2000.00084.x; SCHMITT DA, 1995, J IMMUNOL, V154, P5114; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; Schwarz A, 1996, J INVEST DERMATOL, V106, P1187, DOI 10.1111/1523-1747.ep12347944; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Slominski A. T., 2013, J STEROID BIOCH MOL; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Toberer F, 2011, EXP DERMATOL, V20, P600, DOI 10.1111/j.1600-0625.2011.01303.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Verschooten L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1016, DOI 10.1562/2006-04-27-IR-884.1; Werth VP, 2003, J INVEST DERMATOL, V120, P116, DOI 10.1046/j.1523-1747.2003.12012.x; Wolf P, 2000, J INVEST DERMATOL, V114, P149, DOI 10.1046/j.1523-1747.2000.00839.x; Yoshiki R, 2009, J INVEST DERMATOL, V129, P705, DOI 10.1038/jid.2008.304	46	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77308	10.1371/journal.pone.0077308	http://dx.doi.org/10.1371/journal.pone.0077308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116222	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200113
J	Wrench, AP; Gardner, CL; Siegel, SD; Pagliai, FA; Malekiha, M; Gonzalez, CF; Lorca, GL				Wrench, Algevis P.; Gardner, Christopher L.; Siegel, Sara D.; Pagliai, Fernando A.; Malekiha, Mahsa; Gonzalez, Claudio F.; Lorca, Graciela L.			MglA/SspA Complex Interactions Are Modulated by Inorganic Polyphosphate	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI K-12; FRANCISELLA-TULARENSIS; PSEUDOMONAS-AERUGINOSA; RNA-POLYMERASE; KINASE PPK2; SURVIVAL; IDENTIFICATION; SALMONELLA; REGULATOR	The transcription factors MglA and SspA of Francisella tularensis form a heterodimer complex and interact with the RNA polymerase to regulate the expression of the Francisella pathogenicity island (FPI) genes. These genes are essential for this pathogen's virulence and survival within host cells. Our goal was to determine if an intracellular metabolite modulate these protein/protein interactions. In this study, we identified inorganic polyphosphate (polyP) as a signal molecule that promotes the interaction of MglA and SspA from F. tularensis SCHU S4. Analysis of the Mgla/SspA interaction was carried out using a two-hybrid system. The Escherichia coli reporter strain contained a deletion on the ppK-ppX operon, inhibiting polyP synthesis. The interaction between MglA and SspA was significantly impaired, as was the interaction between the MglA/SspA complex and the regulatory protein, FevR, indicating the stabilizing effect of polyP. In F. tularensis, chromatin immune precipitation studies revealed that in the absence of polyP, binding of the MglA/SspA complex to the promoter region of the pdpD, iglA, fevR and ppK genes is decreased. Isothermal titration calorimetry (ITC) indicated that polyP binds directly to the MglA/SspA complex with high affinity (K-D = 0.3 mu M). These observations directly correlated with results obtained from calorimetric scans (DSC), where a strong shift in the mid-transition temperature (Tm) of the MglA/SspA complex was observed in the presence of polyP.	[Wrench, Algevis P.; Gardner, Christopher L.; Siegel, Sara D.; Pagliai, Fernando A.; Malekiha, Mahsa; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019	Siegel, Sara/0000-0002-1412-0631; Pagliai, Fernando A./0000-0002-0434-4594; Gardner, Christopher/0000-0001-6416-8476	University of Florida Institute of Food and Agricultural Sciences; STEM Ladder Grant - Miami Dade College	University of Florida Institute of Food and Agricultural Sciences(University of Florida); STEM Ladder Grant - Miami Dade College	This study was partially supported by the University of Florida Institute of Food and Agricultural Sciences and a STEM Ladder Grant - Miami Dade College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; AHN KH, 1990, J BIOL CHEM, V265, P11734; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean RE, 2009, MICROBIOL-SGM, V155, P4104, DOI 10.1099/mic.0.031021-0; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Grillo-Puertas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050368; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; KULAEV IS, 1983, ADV MICROB PHYSIOL, V24, P83, DOI 10.1016/S0065-2911(08)60385-9; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuoppa K, 2001, FEMS MICROBIOL LETT, V205, P77, DOI 10.1111/j.1574-6968.2001.tb10928.x; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Li L, 2007, P NATL ACAD SCI USA, V104, P1794, DOI 10.1073/pnas.0610763104; Lindner SN, 2007, APPL ENVIRON MICROB, V73, P5026, DOI 10.1128/AEM.00600-07; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Richards MI, 2008, J MED MICROBIOL, V57, P1183, DOI 10.1099/jmm.0.2008/001826-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schellhorn HE, 1998, J BACTERIOL, V180, P6283; Schurig-Briccio LA, 2009, J BACTERIOL, V191, P4478, DOI 10.1128/JB.00082-09; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Whipple FW, 1998, NUCLEIC ACIDS RES, V26, P3700, DOI 10.1093/nar/26.16.3700; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315; Wrench AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054498; Yang ZX, 2010, MOL MICROBIOL, V77, P618, DOI 10.1111/j.1365-2958.2010.07233.x; Zhang HY, 2002, P NATL ACAD SCI USA, V99, P16678, DOI 10.1073/pnas.262655199; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	55	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76428	10.1371/journal.pone.0076428	http://dx.doi.org/10.1371/journal.pone.0076428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116108	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200055
J	Alborghetti, MR; Furlan, AD; da Silva, JC; Sforca, ML; Honorato, RV; Granato, DC; Migueleti, DLD; Neves, JL; de Oliveira, PSL; Paes-Leme, AF; Zeri, ACD; de Torriani, ICL; Kobarg, J				Alborghetti, Marcos Rodrigo; Furlan, Ariane da Silva; da Silva, Julio Cesar; Sforca, Mauricio Luis; Honorato, Rodrigo Vargas; Granato, Daniela Campos; dos Santos Migueleti, Deivid Lucas; Neves, Jorge L.; Lopes de Oliveira, Paulo Sergio; Paes-Leme, Adriana Franco; de Mattos Zeri, Ana Carolina; Linares de Torriani, Iris Concepcion; Kobarg, Joerg			Structural Analysis of Intermolecular Interactions in the Kinesin Adaptor Complex Fasciculation and Elongation Protein Zeta 1/Short Coiled-Coil Protein (FEZ1/SCOCO)	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEIN; X-RAY-SCATTERING; GLUTATHIONE TRANSFERASE; NEURITE OUTGROWTH; AXONAL-TRANSPORT; DIMER STABILITY; HUMAN FEZ1; CELLS; EXPRESSION; ACCURACY	Cytoskeleton and protein trafficking processes, including vesicle transport to synapses, are key processes in neuronal differentiation and axon outgrowth. The human protein FEZ1 (fasciculation and elongation protein zeta 1 / UNC-76, in C. elegans), SCOCO (short coiled-coil protein / UNC-69) and kinesins (e. g. kinesin heavy chain / UNC116) are involved in these processes. Exploiting the feature of FEZ1 protein as a bivalent adapter of transport mediated by kinesins and FEZ1 protein interaction with SCOCO (proteins involved in the same path of axonal growth), we investigated the structural aspects of intermolecular interactions involved in this complex formation by NMR (Nuclear Magnetic Resonance), cross-linking coupled with mass spectrometry (MS), SAXS (Small Angle X-ray Scattering) and molecular modelling. The topology of homodimerization was accessed through NMR (Nuclear Magnetic Resonance) studies of the region involved in this process, corresponding to FEZ1 (92-194). Through studies involving the protein in its monomeric configuration (reduced) and dimeric state, we propose that homodimerization occurs with FEZ1 chains oriented in an anti-parallel topology. We demonstrate that the interaction interface of FEZ1 and SCOCO defined by MS and computational modelling is in accordance with that previously demonstrated for UNC-76 and UNC-69. SAXS and literature data support a heterotetrameric complex model. These data provide details about the interaction interfaces probably involved in the transport machinery assembly and open perspectives to understand and interfere in this assembly and its involvement in neuronal differentiation and axon outgrowth.	[Alborghetti, Marcos Rodrigo; Furlan, Ariane da Silva; da Silva, Julio Cesar; Sforca, Mauricio Luis; Honorato, Rodrigo Vargas; Granato, Daniela Campos; dos Santos Migueleti, Deivid Lucas; Neves, Jorge L.; Lopes de Oliveira, Paulo Sergio; Paes-Leme, Adriana Franco; de Mattos Zeri, Ana Carolina; Kobarg, Joerg] CNPEM, LNBio, Campinas, SP, Brazil; [Furlan, Ariane da Silva; de Mattos Zeri, Ana Carolina; Kobarg, Joerg] Univ Estadual Campinas, Dept Bioquim, Programa Posgrad Biol Func & Mol, Inst Biol, Campinas, SP, Brazil; [dos Santos Migueleti, Deivid Lucas; Kobarg, Joerg] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Programa Posgrad Genet & Biol Mol, Inst Biol, Campinas, SP, Brazil; [Linares de Torriani, Iris Concepcion] Univ Estadual Campinas, Dept Condensed Matter Phys, Inst Fis Gleb Wataghin, UNICAMP, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Kobarg, J (corresponding author), CNPEM, LNBio, Campinas, SP, Brazil.	jorg.kobarg@lnbio.cnpem.br	Honorato, Rodrigo/H-9773-2013; Zeri, Ana/AAY-4799-2021; Neves, Jorge Luiz JL/F-8393-2010; Oliveira, Paulo S/K-5588-2013; Kobarg, Jörg/T-4736-2019; da Silva, Julio Cesar/A-5240-2011; NEVES, JORGE LUIZ/AAK-7723-2021; Honorato, Rodrigo Vargas/AAY-9375-2020; Leme, Adriana F Paes/C-9679-2012; Alborghetti, Marcos Rodrigo/K-7547-2012	Honorato, Rodrigo/0000-0001-5267-3002; Zeri, Ana/0000-0003-4169-4523; Neves, Jorge Luiz JL/0000-0003-3853-4529; Kobarg, Jörg/0000-0002-9419-0145; da Silva, Julio Cesar/0000-0001-8035-0550; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Leme, Adriana F Paes/0000-0001-7959-147X; Sforca, Mauricio/0000-0002-3395-1684; Alborghetti, Marcos Rodrigo/0000-0003-4517-5579	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento [471355/2010-0]; Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo (http://www.fapesp.br/), the Conselho Nacional de Pesquisa e Desenvolvimento (http://www.cnpq.br/; through a personal grant to JK: 471355/2010-0) and Centro Nacional de Pesquisa em Energia e Materiais / Laboratorio Nacional de Biociencias (http://www.lnbio.org.br/site/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborghetti MR, 2010, J PROTEOME RES, V9, P4595, DOI 10.1021/pr100314q; Alborghetti MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017426; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Alves CS, 2006, BIOCHEM J, V393, P523, DOI 10.1042/BJ20051066; Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Cavalcanti LP, 2004, REV SCI INSTRUM, V75, P4541, DOI 10.1063/1.1804956; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; de Oliveira JF, 2010, J MOL BIOL, V396, P1053, DOI 10.1016/j.jmb.2009.12.039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Guinier A., 1955, SMALL ANGLE SCATTERI; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; Huang J, 1996, CANCER LETT, V106, P29, DOI 10.1016/0304-3835(96)04293-0; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lanza DCF, 2008, EXP CELL RES, V314, P2028, DOI 10.1016/j.yexcr.2008.02.012; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; Lanza DCF, LOW RESOLUTION STRUC, P1; Li Cheng-yu, NEURON, V41, P257, DOI [10.1016/S0896-6273(02)00700-6, DOI 10.1016/S0896-6273(03)00629-9, 10.1016/S0896-6273(03)00847-X, DOI 10.1016/S0896-6273(02)00700-6]; Luo Shuo, 2006, J Biol, V5, P8, DOI 10.1186/jbiol41; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; McKnight NC, 2012, EMBO J, V31, P1, DOI [10.1038/emboj.2012.36, DOI 10.1038/EMB0J.2012.36.PUBMED:22354037]; Moncoq K, 2004, BIOPHYS J, V87, P4056, DOI 10.1529/biophysj.104.048645; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; Sato Y, 1998, J NEUROL SCI, V160, P92, DOI 10.1016/S0022-510X(98)00233-0; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; Su Cheng-Wen, 2006, J Biol, V5, P9, DOI 10.1186/jbiol39; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yu ZQ, 2011, BIPOLAR DISORD, V13, P486, DOI 10.1111/j.1399-5618.2011.00946.x	49	5	5	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76602	10.1371/journal.pone.0076602	http://dx.doi.org/10.1371/journal.pone.0076602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116125	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300071
J	D'Archivio, M; Scazzocchio, B; Giammarioli, S; Fiani, ML; Vari, R; Santangelo, C; Veneziani, A; Iacovelli, A; Giovannini, C; Gessani, S; Masella, R				D'Archivio, Massimo; Scazzocchio, Beatrice; Giammarioli, Stefania; Fiani, Maria L.; Vari, Rosaria; Santangelo, Carmela; Veneziani, Augusto; Iacovelli, Annunziata; Giovannini, Claudio; Gessani, Sandra; Masella, Roberta			omega 3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; FATTY-ACID-COMPOSITION; FACTOR-KAPPA-B; COLON-CANCER; PPAR-GAMMA; ADIPOSE-TISSUE; CELL-PROLIFERATION; METABOLIC SYNDROME; IMMUNE CELLS; OBESITY	Objective: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). Methods: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPAR gamma transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the omega 3 docosahexaenoic acid treatment on the balance between pro-and anti-inflammatory factors in adipocytes was also evaluated. Results: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPAR. and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased omega 3-/omega 6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPAR gamma. Conclusion: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies.	[D'Archivio, Massimo; Scazzocchio, Beatrice; Giammarioli, Stefania; Vari, Rosaria; Santangelo, Carmela; Giovannini, Claudio; Masella, Roberta] Dept Vet Publ Hlth & Food Safety, Rome, Italy; [Fiani, Maria L.; Gessani, Sandra] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Veneziani, Augusto] Univ Cattolica Sacro Cuore, Rome, Italy; [Iacovelli, Annunziata] Fabia Mater Hosp, Rome, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	D'Archivio, M (corresponding author), Dept Vet Publ Hlth & Food Safety, Rome, Italy.	maxdar@iss.it	Scazzocchio, Beatrice/AAH-1395-2021; GIAMMARIOLI, STEFANIA/C-2861-2015; D'Archivio, massimo/Z-4633-2019; VARI', ROSARIA/B-4111-2015; SANTANGELO, CARMELA/D-5726-2011; scazzocchio, beatrice/B-4110-2015; Masella, Roberta/B-4109-2015; Fiani, Maria Luisa/G-9369-2016; Giovannini, Claudio/A-9168-2013; Gessani, Sandra/K-5151-2016; D'ARCHIVIO, MASSIMO/B-4106-2015	Scazzocchio, Beatrice/0000-0002-5123-3897; SANTANGELO, CARMELA/0000-0002-4309-1745; Masella, Roberta/0000-0002-3173-1573; Fiani, Maria Luisa/0000-0003-2997-0767; Gessani, Sandra/0000-0002-8451-0758; D'Archivio, Massimo/0000-0001-8104-3421; Rosaria, Vari/0000-0003-0488-6702; Giammarioli, Stefania/0000-0002-8080-2331; Giovannini, Claudio/0000-0002-4228-1264				Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Aleksandrova K, 2011, CANCER PREV RES, V4, P1873, DOI 10.1158/1940-6207.CAPR-11-0218; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-36; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Cai QW, 2012, MOL MED REP, V5, P1438, DOI 10.3892/mmr.2012.849; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; Desreumaux P, 2006, ALIMENT PHARM THER, V24, P2, DOI 10.1111/j.1365-2036.2006.03069.x; Donohoe CL, 2010, BRIT J SURG, V97, P628, DOI 10.1002/bjs.7079; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Fenton JI, 2012, PROSTAGLANDINS LEUKO, V88, P219; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALANOS DS, 1965, BIOCHIM BIOPHYS ACTA, V98, P278, DOI 10.1016/0005-2760(65)90121-9; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Guri AJ, 2006, CLIN NUTR, V25, P871, DOI 10.1016/j.clnu.2006.08.006; Han S, 2007, ANTI-CANCER DRUG, V18, P237, DOI 10.1097/CAD.0b013e328011e67d; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard JM, 2010, BRIT J SURG, V97, P1020, DOI 10.1002/bjs.7072; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kant P, 2011, NAT REV GASTRO HEPAT, V8, P224, DOI 10.1038/nrgastro.2011.23; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kristensen K, 1999, BIOCHEM BIOPH RES CO, V259, P624, DOI 10.1006/bbrc.1999.0842; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Masella R, 2006, FEBS LETT, V580, P2421, DOI 10.1016/j.febslet.2006.03.068; Moon HS, 2011, DIABETES, V60, P1647, DOI 10.2337/db10-1791; Moon HS, 2011, DIABETES CARE, V34, P132, DOI 10.2337/dc10-0518; Moschen AR, 2012, CURR MED CHEM, V19, P5467; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Qiao L, 2008, CANCER LETT, V268, P260, DOI 10.1016/j.canlet.2008.04.003; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Romagnolo Donato F., 2010, Inflammation & Allergy Drug Targets, V9, P181; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Slagsvold JE, 2010, NUTR CANCER, V62, P611, DOI 10.1080/01635580903532366; Stubbins RE, 2012, NUTR REV, V70, P721, DOI 10.1111/j.1753-4887.2012.00522.x; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; Turner JJO, 2010, CLIN EXP IMMUNOL, V162, P487, DOI 10.1111/j.1365-2249.2010.04260.x; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Xu XT, 2011, J DIGEST DIS, V12, P234, DOI 10.1111/j.1751-2980.2011.00504.x; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2013, PROSTAGLANDINS LEUKO, DOI [10.1016/j.plefa.2013.02.005, DOI 10.1016/J.PLEFA.2013.02.005.PUBMED:23465412]	60	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77432	10.1371/journal.pone.0077432	http://dx.doi.org/10.1371/journal.pone.0077432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116229	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300121
J	Devilard, E; Xerri, L; Dubreuil, P; Lopez, M; Reymond, N				Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc; Reymond, Nicolas			Nectin-3 (CD113) Interacts with Nectin-2 (CD112) to Promote Lymphocyte Transendothelial Migration	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; CELL-CELL ADHESION; VE-CADHERIN; LEUKOCYTE EXTRAVASATION; BETA-CATENIN; N-CADHERIN; PECAM-1; PROTEIN; MEMBER; TRANSMIGRATION	Lymphocyte trafficking and migration through vascular endothelial cells (ECs) in secondary lymphoid tissues is critical for immune protection. In the present study, we investigate the role of nectin cell adhesion molecules for the migration of lymphocytes through ECs. Nectins are key players for the establishment of homotypic and heterotypic cell to cell contacts; they are required for cell to cell adherens junction formation and take part in the transendothelial migration of monocytes during the step of diapedesis, when monocytes migrate through EC junctions. We first show that Nectin-3 (CD113) is the only nectin expressed by T lymphocytes and since nectins are expressed on ECs we explored Nectin-3 potential functions in lymphocyte: EC interactions. We demonstrate that Nectin-2, expressed on ECs, is the major counter-receptor of Nectin-3. A soluble form of Nectin-3 binds to Nectin-2 localized at EC junctions and blocking Nectin-2 trans-interactions with monoclonal antibodies abolishes the binding of soluble Nectin-3 to ECs. Nectin-2 is expressed on High Endothelial venules (HEVs), where lymphocyte homing occurs in vivo. Finally, we show that Nectin-3 trans-interaction with Nectin-2 is essential for the process of lymphocyte transendothelial migration in vitro as targeting with blocking monoclonal antibodies either Nectin-3, expressed on lymphocytes, or Nectin-2, expressed on ECs, inhibits lymphocyte extravasation. The nectin family of CAMs is important for the regulation of endothelial barrier functions and transendothelial migration of immune cells. Our results demonstrate for the first time that Nectin-3 trans-interacts with Nectin-2 to promote lymphocyte and monocyte extravasation.	[Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc] Aix Marseille Univ, CRCM, Marseille, France; [Devilard, Elisabeth; Xerri, Luc; Dubreuil, Patrice; Lopez, Marc] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Dubreuil, Patrice] CNRS, INSERM, Lab Hematopoiese & Mecanisme Oncogenese, UMR7258,U1068, Marseille, France; [Lopez, Marc] CNRS, INSERM, Oncol Mol Lab, U1068,UMR7258, Marseille, France; [Reymond, Nicolas] CNRS, CRBM, UMR5237, Lab Tyrosine Kinases & Canc, F-34033 Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Reymond, N (corresponding author), CNRS, CRBM, UMR5237, Lab Tyrosine Kinases & Canc, BP 5051, F-34033 Montpellier, France.	nicolas.reymond@crbm.cnrs.fr	dubreuil, patrice/F-5346-2011; Dubreuil, Patrice/V-4816-2019	dubreuil, patrice/0000-0003-1155-1150; Dubreuil, Patrice/0000-0003-1155-1150	INSERM, Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC) (Label)	INSERM, Institut Paoli-Calmettes(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (LNCC) (Label)	This work was supported by INSERM, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (LNCC) (Label). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Biswas P, 2005, BIOCHEM BIOPH RES CO, V329, P1225, DOI 10.1016/j.bbrc.2005.02.095; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Ghislin S, 2011, PIGM CELL MELANOMA R, V24, P504, DOI 10.1111/j.1755-148X.2011.00856.x; Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012; Ilan N, 1999, J CELL SCI, V112, P3005; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; LOPEZ M, 1997, WHITE CELL DIFFER AN, P1081; Luscinskas FW, 2002, SEMIN IMMUNOL, V14, P105, DOI 10.1006/smim.2001.0347; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; Manes TD, 2011, J IMMUNOL, V186, P1763, DOI 10.4049/jimmunol.1002835; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Reymond N, 2005, FEBS LETT, V579, P2243, DOI 10.1016/j.febslet.2005.03.010; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sullivan DP, 2013, AM J PATHOL, V182, P1031, DOI 10.1016/j.ajpath.2012.11.037; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Weber C, 2003, J MOL MED, V81, P4, DOI 10.1007/s00109-002-0391-x; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2	51	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77424	10.1371/journal.pone.0077424	http://dx.doi.org/10.1371/journal.pone.0077424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116228	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300120
J	Peng, YH; Li, JJ; Xie, FW; Chen, JF; Yu, YH; Ouyang, XN; Liang, HJ				Peng, Yong-hai; Li, Jian-jun; Xie, Fang-wei; Chen, Jian-fang; Yu, Ying-hao; Ouyang, Xue-nong; Liang, Hou-jie			Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients	PLOS ONE			English	Article							PROTOONCOGENE PIM-1; COLORECTAL-CANCER; STEM-CELLS; KINASE; METASTASIS; APOPTOSIS; AMERICAN; GROWTH	Provirus integration site for Moloney murine leukemia virus (pim-1) is a proto-oncogene that is linked to the development and progression of several cancers. In this study, we evaluated pim-1 expression in tumors, tumor stroma and tumor-adjacent mucosa together as an independent prognostic factor for colon cancer patients. The study included 343 colon cancer patients. Immunohistochemical staining was used to detect pim-1. Multivariate cox regression for disease-free survival (DFS) were used to identify independent prognostic factors. Analytic hierarchy process (AHP) was used to calculate the weight of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa in order to obtain a Pim-1 total score (PTS) for recurrence and survival. Kaplan-Meier DFS curves and OS curves for patients with different pim-1 expression levels were compared using the log-rank test. In this study, four independent prognostic factors were identified for colon cancer patients: pim-1 expression in tumors, tumor stroma, tumor-adjacent mucosa, as well as tumor stage. It has been established that clinical stage is an important prognostic factor for colon cancer patients. However, PTS can identify the patients who are likely to recur not only in the whole radical excision group but also within each stage of this group. Based on the results of this study we can conclude that the PTS combined with clinical staging system may be a better predictor of colon cancer patients' prognosis than using the clinical stage system alone.	[Peng, Yong-hai; Li, Jian-jun; Chen, Jian-fang; Liang, Hou-jie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Xie, Fang-wei; Ouyang, Xue-nong] Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China; [Yu, Ying-hao] Fuzhou Gen Hosp, Dept Pathol, Fuzhou, Peoples R China	Army Medical University	Ouyang, XN (corresponding author), Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China.	oyxnong@163.com; lianghoujie@sina.com			Natural Science of Fujian Province [009J01184]	Natural Science of Fujian Province	Grant support was provided by Natural Science of Fujian Province (grant number 009J01184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Broussard EK, 2011, J CLIN ONCOL, V29, P601, DOI 10.1200/JCO.2010.32.9078; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chagpar R, 2012, J CLIN ONCOL, V30, P972, DOI 10.1200/JCO.2011.39.6937; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DOMEN J, 1993, J EXP MED, V178, P1665, DOI 10.1084/jem.178.5.1665; Donada M, 2011, J CANCER RES CLIN, V137, P201, DOI 10.1007/s00432-010-0872-1; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Jullumstro E, 2011, COLORECTAL DIS, V13, P512, DOI 10.1111/j.1463-1318.2010.02191.x; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Nakagoe T, 2003, ANN SURG ONCOL, V10, P163, DOI 10.1245/ASO.2003.05.027; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Warnecke-Eberz U, 2008, ONCOL REP, V20, P619, DOI 10.3892/or_00000050; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	37	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76693	10.1371/journal.pone.0076693	http://dx.doi.org/10.1371/journal.pone.0076693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116137	gold, Green Submitted, Green Published			2022-12-25	WOS:000325501300079
J	Ramsay, JD; Ueti, MW; Johnson, WC; Scoles, GA; Knowles, DP; Mealey, RH				Ramsay, Joshua D.; Ueti, Massaro W.; Johnson, Wendell C.; Scoles, Glen A.; Knowles, Donald P.; Mealey, Robert H.			Lymphocytes and Macrophages Are Infected by Theileria equi, but T Cells and B Cells Are Not Required to Establish Infection In Vivo	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BABESIA-EQUI; MONOCLONAL-ANTIBODIES; PROTOZOAN PARASITE; BOS-TAURUS; ANNULATA; HORSES; PARVA; EXPRESSION; RESISTANT	Theileria equi has a biphasic life cycle in horses, with a period of intraleukocyte development followed by patent erythrocytic parasitemia that causes acute and sometimes fatal hemolytic disease. Unlike Theileria spp. that infect cattle (Theileria parva and Theileria annulata), the intraleukocyte stage (schizont) of Theileria equi does not cause uncontrolled host cell proliferation or other significant pathology. Nevertheless, schizont-infected leukocytes are of interest because of their potential to alter host cell function and because immune responses directed against this stage could halt infection and prevent disease. Based on cellular morphology, Theileria equi has been reported to infect lymphocytes in vivo and in vitro, but the specific phenotype of schizont-infected cells has yet to be defined. To resolve this knowledge gap in Theileria equi pathogenesis, peripheral blood mononuclear cells were infected in vitro and the phenotype of infected cells determined using flow cytometry and immunofluorescence microscopy. These experiments demonstrated that the host cell range of Theileria equi was broader than initially reported and included B lymphocytes, T lymphocytes and monocyte/macrophages. To determine if B and T lymphocytes were required to establish infection in vivo, horses affected with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were inoculated with Theileria equi sporozoites. SCID horses developed patent erythrocytic parasitemia, indicating that B and T lymphocytes are not necessary to complete the Theileria equi life cycle in vivo. These findings suggest that the factors mediating Theileria equi leukocyte invasion and intracytoplasmic differentiation are common to several leukocyte subsets and are less restricted than for Theileria annulata and Theileria parva. These data will greatly facilitate future investigation into the relationships between Theileria equi leukocyte tropism and pathogenesis, breed susceptibility, and strain virulence.	[Ramsay, Joshua D.; Knowles, Donald P.; Mealey, Robert H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Ueti, Massaro W.; Johnson, Wendell C.; Scoles, Glen A.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; United States Department of Agriculture (USDA)	Ramsay, JD (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	jdr105@vetmed.wsu.edu	Mealey, Robert/H-1454-2016	Mealey, Robert/0000-0002-7571-1689	Grayson-Jockey Club Research Foundation; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2012-67011-19946]; USDA-ARS CRIS [5348-32000-028D]	Grayson-Jockey Club Research Foundation; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by the Grayson-Jockey Club Research Foundation (www.grayson-jockeyclub.org), the Agriculture and Food Research Initiative Competitive Grant No. 2012-67011-19946 from the USDA National Institute of Food and Agriculture (www.nifa.usda.gov), and USDA-ARS CRIS 5348-32000-028D (www.ars.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN CL, 1988, INFECT IMMUN, V56, P462, DOI 10.1128/IAI.56.2.462-467.1988; BARNETT SF, 1960, J INFECT DIS, V107, P253, DOI 10.1093/infdis/107.3.253; BLANCHARDCHANNELL M, 1994, IMMUNOLOGY, V82, P548; Boulter N, 2000, ADV PARASIT, V44, P41; CAMPBELL JD, 1994, PARASITE IMMUNOL, V16, P501, DOI 10.1111/j.1365-3024.1994.tb00378.x; Cantor GH, 2001, J VIROL, V75, P1689, DOI 10.1128/JVI.75.4.1689-1696.2001; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; CONRAD PA, 1989, PARASITOLOGY, V99, P205, DOI 10.1017/S0031182000058650; DEWAAL DT, 1992, BRIT VET J, V148, P6, DOI 10.1016/0007-1935(92)90061-5; EMERY DL, 1988, PARASITE IMMUNOL, V10, P379, DOI 10.1111/j.1365-3024.1988.tb00228.x; Forsyth LMG, 1999, J COMP PATHOL, V120, P39, DOI 10.1053/jcpa.1998.0256; Glass EJ, 2005, INT J PARASITOL, V35, P337, DOI 10.1016/j.ijpara.2004.12.006; GLASS EJ, 1989, VET IMMUNOL IMMUNOP, V22, P355, DOI 10.1016/0165-2427(89)90171-2; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P178, DOI 10.1016/j.vetimm.2012.03.006; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Jensen K, 2008, INT J PARASITOL, V38, P313, DOI 10.1016/j.ijpara.2007.08.007; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Kinnaird JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066833; KNOWLES DP, 1991, INFECT IMMUN, V59, P2412, DOI 10.1128/IAI.59.7.2412-2417.1991; KNOWLES DP, 1994, INFECT IMMUN, V62, P1909, DOI 10.1128/IAI.62.5.1909-1913.1994; KYDD J, 1994, VET IMMUNOL IMMUNOP, V42, P3, DOI 10.1016/0165-2427(94)90088-4; LUNN DP, 1995, IMMUNOLOGY, V84, P495; McGuire K, 2004, VET IMMUNOL IMMUNOP, V99, P87, DOI 10.1016/j.vetimm.2004.01.003; MCGUIRE TC, 1974, J AM VET MED ASSOC, V164, P70; MCGUIRE TC, 1983, AM J VET RES, V44, P1284; MCGUIRE TC, 1975, CLIN IMMUNOL IMMUNOP, V3, P555, DOI 10.1016/0090-1229(75)90080-X; Mealey RH, 2001, CLIN IMMUNOL, V101, P237, DOI 10.1006/clim.2001.5109; Mealey RH, 2008, VET IMMUNOL IMMUNOP, V121, P8, DOI 10.1016/j.vetimm.2007.07.011; Mealey RH, 2012, CLIN VACCINE IMMUNOL, V19, P100, DOI 10.1128/CVI.05301-11; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; MOLTMANN UG, 1983, J PARASITOL, V69, P111, DOI 10.2307/3281285; Morrison WI, 1996, INFECT IMMUN, V64, P557, DOI 10.1128/IAI.64.2.557-562.1996; MORRISON WI, 1981, EXP PARASITOL, V52, P248, DOI 10.1016/0014-4894(81)90080-1; Oliver RA, 1996, VET IMMUNOL IMMUNOP, V50, P173, DOI 10.1016/0165-2427(95)05487-1; Patton KM, 2004, INFECT IMMUN, V72, P7073, DOI 10.1128/IAI.72.12.7073-7083.2004; PERRYMAN LE, 1980, J AM VET MED ASSOC, V176, P1250; PERRYMAN LE, 1978, TRANSPLANTATION, V25, P50, DOI 10.1097/00007890-197802000-00002; PRESTON PM, 1992, RES VET SCI, V53, P230, DOI 10.1016/0034-5288(92)90115-I; REHBEIN G, 1982, Z PARASITENKD, V67, P125, DOI 10.1007/BF00929521; SCHEIN E, 1981, TROPENMED PARASITOL, V32, P223; Schein E., 1988, P197; Shaw MK, 1997, INT J PARASITOL, V27, P457, DOI 10.1016/S0020-7519(97)00015-5; SHAW MK, 1995, J CELL SCI, V108, P1587; Shin EK, 1997, J IMMUNOL, V158, P3565; SPOONER RL, 1989, IMMUNOLOGY, V66, P284; Taylor SD, 2010, J VIROL, V84, P6536, DOI 10.1128/JVI.00218-10; Tindih HS, 2012, INFECT IMMUN, V80, P1267, DOI 10.1128/IAI.05085-11; TUMAS DB, 1994, IMMUNOBIOLOGY, V192, P48, DOI 10.1016/S0171-2985(11)80407-9; Ueti MW, 2008, INFECT IMMUN, V76, P3525, DOI 10.1128/IAI.00251-08; Ueti MW, 2005, J CLIN MICROBIOL, V43, P3755, DOI 10.1128/JCM.43.8.3755-3759.2005; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; WILER R, 1995, P NATL ACAD SCI USA, V92, P11485, DOI 10.1073/pnas.92.25.11485	53	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76996	10.1371/journal.pone.0076996	http://dx.doi.org/10.1371/journal.pone.0076996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116194	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300111
J	Dort, J; Leblanc, N; Maltais-Giguere, J; Liaset, B; Cote, CH; Jacques, H				Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Liaset, Bjorn; Cote, Claude H.; Jacques, Helene			Beneficial Effects of Cod Protein on Inflammatory Cell Accumulation in Rat Skeletal Muscle after Injury Are Driven by Its High Levels of Arginine, Glycine, Taurine and Lysine	PLOS ONE			English	Article							NITRIC-OXIDE; INSULIN-RESISTANCE; MYOGENIC CELLS; AMINO-ACID; REGENERATION; MACROPHAGES; EXPRESSION; SUPPLEMENTATION; PATHWAY; FIBERS	We have shown that feeding cod protein, which is rich in anti-inflammatory arginine, glycine, and taurine, may beneficially modulate the inflammatory response during recovery following skeletal muscle injury; however it is unknown if these amino acids are responsible for this effect. This study was designed to assess whether supplementing casein with an amino acid mixture composed of arginine, glycine, taurine and lysine, matching their respective levels in cod protein, may account for the anti-inflammatory effect of cod protein. Male Wistar rats were fed isoenergetic diets containing either casein, cod protein, or casein supplemented with L-arginine (0.45%), glycine (0.43%), L-taurine (0.17%) and L-lysine (0.44%) (casein+). After 21 days of ad libitum feeding, one tibialis anterior muscle was injured with 200 mu l bupivacaine while the saline-injected contra-lateral tibialis anterior was served as sham. Cod protein and casein+ similarly modulated the inflammation as they decreased COX-2 level at day 2 post-injury (cod protein, p=0.014; casein(+), p=0.029) and ED1(+) macrophage density at days 2 (cod protein, p=0.012; casein(+), p<0.0001), 5 (cod protein, p=0.001; casein(+), p<0.0001) and 14 (cod protein, p<0.0001; casein(+), p<0.0001) post-injury, and increased ED2(+) macrophage density at days 5 (cod protein, p<0.0001; casein(+), p=0.006), 14 (cod protein, p=0.001; casein(+), p<0.002) and 28 (cod protein, p<0.009; casein(+), p<0.005) post-injury compared with casein. Furthermore, cod protein up-regulated (p=0.037) whereas casein(+) tended to up-regulate (p=0.062) myogenin expression at day 5 post-injury compared with casein. In the cod protein-fed group, these changes resulted in greater muscle mass at days 14 (p=0.002), and 28 (p=0.001) post-injury and larger myofiber cross-sectional area at day 28 post-injury compared with casein (p=0.012). No such effects were observed with casein(+). These data indicate that anti-inflammatory actions of cod protein, contrary to its effect on muscle mass recovery, are driven by its high levels of arginine, glycine, taurine and lysine.	[Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Jacques, Helene] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada; [Dort, Junio; Leblanc, Nadine; Maltais-Giguere, Julie; Jacques, Helene] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Cote, Claude H.] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [Cote, Claude H.] Univ Laval, Quebec Univ Hosp Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Jacques, H (corresponding author), Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ, Canada.	helene.jacques@fsaa.ulaval.ca		Liaset, Bjorn/0000-0002-8652-7801; Jacques, Helene/0000-0002-2755-6346	Natural Sciences and Engineering Research Council of Canada; Organization of American States	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Organization of American States	This study was supported by a grant to HJ from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), and by Summer Undergraduate Student Research Award from the Natural Sciences and Engineering Research Council of Canada to JMG. The first two years of the doctoral degree of JD was supported by an academic scholarship from the Organization of American States (http:// www.scholarships-bourses.gc.ca/scholarships-bourses/can/oas-oea.aspx?lang=fra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Aguilar FJ, 2008, EUR J PHARMACOL, V599, P152, DOI 10.1016/j.ejphar.2008.09.047; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Burns AR, 2007, AM J PHYSIOL-HEART C, V293, pH2904, DOI 10.1152/ajpheart.00871.2007; CANTINI M, 1994, BIOCHEM BIOPH RES CO, V202, P1688, DOI 10.1006/bbrc.1994.2129; Carlson Bruce M., 2008, V3, P163; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Clemmensen C, 2012, AMINO ACIDS, V43, P1265, DOI 10.1007/s00726-011-1199-1; Cote CH, 2008, MUSCLE NERVE, V37, P754, DOI 10.1002/mus.20998; Dort J, 2012, APPL PHYSIOL NUTR ME, V37, P489, DOI [10.1139/h2012-021, 10.1139/H2012-021]; El Mesallamy HO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-46; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gauglitz GG, 2008, J BURN CARE RES, V29, P683, DOI 10.1097/BCR.0b013e31818481ce; Gilani GS, 2006, BRIT J NUTR, V95, P443, DOI 10.1079/BJN20051712; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Gregorevic P, 2004, J PHYSIOL-LONDON, V558, P549, DOI 10.1113/jphysiol.2004.066217; HALLCRAGGS ECB, 1980, BRIT J EXP PATHOL, V61, P139; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Jacques H, 2010, BRIT J NUTR, V103, P1331, DOI 10.1017/S0007114509993278; Kim C, 2009, ADV EXP MED BIOL, V643, P463, DOI 10.1007/978-0-387-75681-3_48; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kyriakides C, 1999, AM J PHYSIOL-CELL PH, V277, pC1263, DOI 10.1152/ajpcell.1999.277.6.C1263; Lapointe BM, 2002, J APPL PHYSIOL, V92, P1995, DOI 10.1152/japplphysiol.00803.2001; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Liaset B, 2008, PROCESS BIOCHEM, V43, P42, DOI 10.1016/j.procbio.2007.10.007; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Luz MAM, 2002, BRAZ J MED BIOL RES, V35, P691, DOI 10.1590/S0100-879X2002000600009; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; PALMER RM, 1983, BIOCHEM J, V214, P1011, DOI 10.1042/bj2141011; Park E, 2002, CLIN IMMUNOL, V102, P179, DOI 10.1006/clim.2001.5160; Pilon G, 2011, METABOLISM, V60, P1122, DOI 10.1016/j.metabol.2010.12.005; Pizza FX, 2005, J PHYSIOL-LONDON, V562, P899, DOI 10.1113/jphysiol.2004.073965; Politi PK, 2006, ULTRASTRUCT PATHOL, V30, P461, DOI 10.1080/01913120600854434; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ross-Inta CM, 2009, AM J PHYSIOL-GASTR L, V296, pG1130, DOI 10.1152/ajpgi.90545.2008; Rudkowska I, 2010, PHYSIOL GENOMICS, V40, P189, DOI 10.1152/physiolgenomics.00120.2009; Schaefer N, 2008, TRANSPLANTATION, V85, P1300, DOI 10.1097/TP.0b013e31816c576f; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Sheridan BC, 1998, AM J PHYSIOL-LUNG C, V274, pL337, DOI 10.1152/ajplung.1998.274.3.L337; Silva LA, 2011, CELL BIOCHEM FUNCT, V29, P43, DOI 10.1002/cbf.1716; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stoffels B, 2011, NEUROGASTROENT MOTIL, V23, P76, DOI 10.1111/j.1365-2982.2010.01603.x; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Vos IHC, 2001, J AM SOC NEPHROL, V12, P361, DOI 10.1681/ASN.V122361; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	54	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77274	10.1371/journal.pone.0077274	http://dx.doi.org/10.1371/journal.pone.0077274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124612	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100169
J	Dworkin, MS; Peterson, CE; Gao, WH; Mayor, A; Hunter, R; Negron, E; Fleury, A; Besch, CL				Dworkin, Mark S.; Peterson, Caryn E.; Gao, Weihua; Mayor, Angel; Hunter, Robert; Negron, Edna; Fleury, Alison; Besch, C. Lynn			Efficacy of a Food Safety Comic Book on Knowledge and Self-Reported Behavior for Persons Living with AIDS	PLOS ONE			English	Article							HIV; MORTALITY; RISK; MENINGITIS; SALMONELLA; INFECTIONS; RECOVERY	Introduction: Persons living with AIDS are highly vulnerable to foodborne enteric infections with the potential for substantial morbidity and mortality. Educational materials about foodborne enteric infections intended for this immunocompromised population have not been assessed for their efficacy in improving knowledge or encouraging behavior change. Methods/Results: AIDS patients in four healthcare facilities in Chicago, New Orleans, and Puerto Rico were recruited using fliers and word of mouth to healthcare providers. Those who contacted research staff were interviewed to determine food safety knowledge gaps and risky behaviors. A food safety educational comic book that targeted knowledge gaps was created, piloted, and provided to these patients who were instructed to read it and return at least 2 weeks later for a follow-up interview. The overall food safety score was determined by the number of the 26 knowledge/belief/behavior questions from the survey answered correctly. Among 150 patients who participated in both the baseline and follow-up questionnaire, the intervention resulted in a substantial increase in the food safety score (baseline 59%, post-intervention 81%, p<0.001). The intervention produced a significant increase in all the food safety knowledge, belief, and behavior items that comprised the food safety score. Many of these increases were from baseline knowledge below 80 percent to well above 90%. Most (85%) of the patients stated they made a change to their behavior since receiving the educational booklet. Conclusion: This comic book format intervention to educate persons living with AIDS was highly effective. Future studies should examine to what extent long-term behavioral changes result.	[Dworkin, Mark S.; Peterson, Caryn E.] Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Gao, Weihua] Univ Illinois, Ctr Clin & Translat Sci, Chicago, IL USA; [Mayor, Angel; Hunter, Robert] Univ Cent Caribe, Sch Med, Hosp Univ Ramon Ruiz Arnau, Retrovirus Res Ctr,Internal Med Dept, Bayamon, PR USA; [Negron, Edna] Univ Puerto Rico, Food Sci & Technol Program, Mayaguez, PR USA; [Fleury, Alison; Besch, C. Lynn] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Puerto Rico; University of Puerto Rico Mayaguez; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Dworkin, MS (corresponding author), Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	mdworkin@uic.edu	Gao, Wei/GXH-0380-2022	Mayor, Angel M./0000-0002-7705-837X; Peterson, Caryn/0000-0002-9868-9576	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program [2009-51110-20173]; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by an award from the United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, National Integrated Food Safety Initiative Program (Award No. 2009-51110-20173). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2009, MMWR-MORBID MORTAL W, V58, P36; CDC, 1999, SAF FOODS WAT GUID P; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Cummings PL, 2010, FOODBORNE PATHOG DIS, V7, P1393, DOI 10.1089/fpd.2010.0588; Dworkin M. S., 2012, Food Protection Trends, V32, P564; Dworkin Mark S, 2013, Food Prot Trends, V33, P32; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Food U.S and Drug Administration Center for Food Safety and Applied Nutrition, 1992, EAT DEF FOOD SAF ADV; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; GRANT IH, 1990, AIDS, V4, P519, DOI 10.1097/00002030-199006000-00004; Guevara RE, 2009, CLIN INFECT DIS, V48, P1507, DOI 10.1086/598935; Heathcock R, 1998, AIDS CARE, V10, P237, DOI 10.1080/09540129850124497; Hoffman EW, 2005, J AM DIET ASSOC, V105, P1597, DOI 10.1016/j.jada.2005.07.035; James S, 2005, HEALTH PROMOT INT, V20, P157, DOI 10.1093/heapro/dah606; JURADO RL, 1993, CLIN INFECT DIS, V17, P224, DOI 10.1093/clinids/17.2.224; Larsen IK, 2011, SCAND J INFECT DIS, V43, P3, DOI 10.3109/00365548.2010.517780; Leonard MK, 2002, AM J MED SCI, V323, P266, DOI 10.1097/00000441-200205000-00007; Liebman Amy K, 2007, J Agromedicine, V12, P33, DOI 10.1300/J096v12n02_04; Meremo Alfred, 2012, Int Arch Med, V5, P28, DOI 10.1186/1755-7682-5-28; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e72874	10.1371/journal.pone.0072874	http://dx.doi.org/10.1371/journal.pone.0072874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124447	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100004
J	Laurance, SGW; Jones, D; Westcott, D; Mckeown, A; Harrington, G; Hilbert, DW				Laurance, Susan G. W.; Jones, Dean; Westcott, David; Mckeown, Adam; Harrington, Graham; Hilbert, David W.			Habitat Fragmentation and Ecological Traits Influence the Prevalence of Avian Blood Parasites in a Tropical Rainforest Landscape	PLOS ONE			English	Article							COMMUNITY COMPOSITION; WILD BIRD; BLUE TITS; MALARIA; DEFORESTATION; HOST; TRANSMISSION; BIODIVERSITY; EMERGENCE; DECAY	In the tropical rainforests of northern Australia, we investigated the effects of habitat fragmentation and ecological parameters on the prevalence of blood-borne parasites (Plasmodium and Haemoproteus) in bird communities. Using mist-nets on forest edges and interiors, we sampled bird communities across six study sites: 3 large fragments (20-85 ha) and 3 continuous-forest sites. From 335 mist-net captures, we recorded 28 bird species and screened 299 bird samples with PCR to amplify and detect target DNA. Of the 28 bird species sampled, 19 were infected with Plasmodium and/or Haemoproteus and 9 species were without infection. Over one third of screened birds (99 individuals) were positive for Haemoproteus and/or Plasmodium. In forest fragments, bird capture rates were significantly higher than in continuous forests, but bird species richness did not differ. Unexpectedly, we found that the prevalence of the dominant haemosporidian infection, Haemoproteus, was significantly higher in continuous forest than in habitat fragments. Further, we found that ecological traits such as diet, foraging height, habitat specialisation and distributional ranges were significantly associated with blood-borne infections.	[Laurance, Susan G. W.; Westcott, David; Hilbert, David W.] James Cook Univ, Ctr Trop Environm & Sustainabil Studies TESS, Cairns, Qld, Australia; [Laurance, Susan G. W.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Jones, Dean; Westcott, David; Mckeown, Adam; Harrington, Graham; Hilbert, David W.] CSIRO, Div Ecosyst Sci, Trop Forest Res Ctr, Atherton, Qld, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Laurance, SGW (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Studies TESS, Cairns, Qld, Australia.	susan.laurance@jcu.edu.au	Laurance, Susan/G-6021-2011; McKeown, Adam/D-3170-2011; Hilbert, David W/A-3796-2008; Westcott, David A/G-5559-2010	Laurance, Susan/0000-0002-2831-2933; 	Commonwealth Environment Research Facility MTSRF grant	Commonwealth Environment Research Facility MTSRF grant	This research was funded by a Commonwealth Environment Research Facility MTSRF grant to SL and DWH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kettle DS, 1982, MED VET ENTOMOLOGY; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 2002, J VEG SCI, V13, P595, DOI 10.1111/j.1654-1103.2002.tb02086.x; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lederberg J., 1992, I MED US COMMITTEE; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; LYNAM AJ, 1997, TROPICAL FOREST REMN; Martinez-de la Puente J, 2010, BIOL LETTERS, V6, P663, DOI 10.1098/rsbl.2010.0046; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; McCune B., 2011, PC ORD MULTIVARIATE; Mendes L, 2005, OIKOS, V109, P396, DOI 10.1111/j.0030-1299.2005.13509.x; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse Stephen S., 1993, P10; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pizzey G, 2007, FIELD GUIDE BIRDS AU; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Simpson K., 2010, FIELD GUIDE BIRDS AU, V8th edn; Steiger DM, 2012, J VECTOR ECOL, V37, P69, DOI 10.1111/j.1948-7134.2012.00201.x; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tracey JG, 1982, VEGETATION HUMID TRO; Valkiunas G, 2005, AVIAN MALARIA PARASI; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	56	37	37	3	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76227	10.1371/journal.pone.0076227	http://dx.doi.org/10.1371/journal.pone.0076227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124541	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000325489100098
J	Lee, IC; Huang, YH; Su, CW; Wang, YJ; Huo, TI; Lee, KC; Lin, HC				Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Wang, Yuan-Jen; Huo, Teh-Ia; Lee, Kuei-Chuan; Lin, Han-Chieh			CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study	PLOS ONE			English	Article							INDUCIBLE PROTEIN 10; INTERFERON TREATMENT; NATURAL-HISTORY; VIRUS INFECTION; VIRAL RESPONSE; C VIRUS; HBEAG; LAMIVUDINE; PREDICTS; IL28B	Background and Aims: There is lack of a practical biomarker to predict sustained virological response (SVR) in chronic hepatitis B (CHB) patients undergoing peginterferon alfa-2a (PEG-IFN). The aim of this pilot study was to identify immunological features associated with SVR. Methods: Consecutive 74 CHB patients receiving 24 weeks (for hepatitis B e antigen (HBeAg)-positive) or 48 weeks (for HBeAg-negative) PEG-IFN, were prospectively enrolled. Serum HBV viral loads, hepatitis B surface antigen (HBsAg), CXCL9, IFN-.-inducible protein 10 (IP-10), interferon-gamma (IFN-gamma) and transforming growth factor beta (TGF-beta) were measured at baseline and week 12. SVR was defined as HBeAg seroconversion combined with viral load <2000 IU/mL in HBeAg-positive (n=36), and viral load <2000 IU/mL in HBeAg-negative patients (n= 38) at 48 weeks after the end of treatment. Results: Nineteen patients (25.7%), 7 in HBeAg-positive and 12 in HBeAg-negative, achieved SVR. There were significant declines of HBV DNA, HBsAg, IP-10 and IFN-gamma levels at week 12. In multivariate analysis, pre-treatment CXCL9 >80 pg/mL, HBV DNA <2.5 x 10(7) IU/mL and on-treatment HBV viral load, HBsAg decline >10% at week 12 were predictors of SVR. The performance of CXCL9 in predicting SVR was good in patients with HBV DNA <2.5 x 107 IU/mL, particularly in HBeAg-negative CHB cases (positive predictive value, PPV=64.3%). Conclusions: Pre-treatment CXCL9 level has the potential to select CHB patients who can respond to PEG-IFN, especially in HBeAg-negative patients with low viral loads.	[Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Huo, Teh-Ia; Lee, Kuei-Chuan; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wang, Yuan-Jen] Taipei Vet Gen Hosp, Hlth Care Ctr, Taipei, Taiwan; [Lee, I-Cheng; Huang, Yi-Hsiang; Su, Chien-Wei; Lee, Kuei-Chuan] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, I-Cheng] Natl Yang Ming Univ Hosp, Dept Med, Ilan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Lee, I-Cheng/AAF-5650-2020; Su, Chien-Wei/C-1521-2012	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council [NSC 100-2314-B-010-024]; Taipei Veterans General Hospitals, Taipei, Taiwan [VGH100C-104, VGH101C-147, VGH102C-136]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospitals, Taipei, Taiwan	The study was supported by grants from the National Science Council (NSC 100-2314-B-010-024), and Taipei Veterans General Hospitals (VGH100C-104, VGH101C-147, VGH102C-136), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hong MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030360; Huang YH, 2006, J VIRAL HEPATITIS, V13, P336, DOI 10.1111/j.1365-2893.2005.00688.x; Huang YH, 2003, J VIRAL HEPATITIS, V10, P277, DOI 10.1046/j.1365-2893.2003.00428.x; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kurelac I, 2012, J INTERF CYTOK RES, V32, P386, DOI 10.1089/jir.2012.0006; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058071; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Liaw YF, 2011, HEPATOLOGY, V53, P2121, DOI 10.1002/hep.24364; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Peng CY, 2012, ALIMENT PHARM THER, V35, P458, DOI 10.1111/j.1365-2036.2011.04973.x; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Rijckborst V, 2010, HEPATOLOGY, V52, P454, DOI 10.1002/hep.23722; Sonneveld MJ, 2013, J HEPATOL, V58, P898, DOI 10.1016/j.jhep.2013.01.029; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Sung JJY, 2008, ALIMENT PHARM THER, V28, P1067, DOI 10.1111/j.1365-2036.2008.03816.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011; Xia YJ, 2012, J VIRAL HEPATITIS, V19, P509, DOI 10.1111/j.1365-2893.2011.01581.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	44	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76798	10.1371/journal.pone.0076798	http://dx.doi.org/10.1371/journal.pone.0076798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124595	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100152
J	Razavi, N; Jann, K; Koenig, T; Kottlow, M; Hauf, M; Strik, W; Dierks, T				Razavi, Nadja; Jann, Kay; Koenig, Thomas; Kottlow, Mara; Hauf, Martinus; Strik, Werner; Dierks, Thomas			Shifted Coupling of EEG Driving Frequencies and fMRI Resting State Networks in Schizophrenia Spectrum Disorders	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEFAULT MODE NETWORK; EVENT-RELATED FMRI; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; PHASE SYNCHRONIZATION; WORKING-MEMORY; LANGUAGE LATERALIZATION; AUDITORY HALLUCINATIONS; ELECTRODE IMPEDANCE	Introduction: The cerebral resting state in schizophrenia is altered, as has been demonstrated separately by electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) resting state networks (RSNs). Previous simultaneous EEG/fMRI findings in healthy controls suggest that a consistent spatiotemporal coupling between neural oscillations (EEG frequency correlates) and RSN activity is necessary to organize cognitive processes optimally. We hypothesized that this coupling is disorganized in schizophrenia and related psychotic disorders, in particular regarding higher cognitive RSNs such as the default-mode (DMN) and left-working-memory network (LWMN). Methods: Resting state was investigated in eleven patients with a schizophrenia spectrum disorder (n = 11) and matched healthy controls (n = 11) using simultaneous EEG/fMRI. The temporal association of each RSN to topographic spectral changes in the EEG was assessed by creating Covariance Maps. Group differences within, and group similarities across frequencies were estimated for the Covariance Maps. Results: The coupling of EEG frequency bands to the DMN and the LWMN respectively, displayed significant similarities that were shifted towards lower EEG frequencies in patients compared to healthy controls. Conclusions: By combining EEG and fMRI, each measuring different properties of the same pathophysiology, an aberrant relationship between EEG frequencies and altered RSNs was observed in patients. RSNs of patients were related to lower EEG frequencies, indicating functional alterations of the spatiotemporal coupling. Significance: The finding of a deviant and shifted coupling between RSNs and related EEG frequencies in patients with a schizophrenia spectrum disorder is significant, as it might indicate how failures in the processing of internal and external stimuli, as commonly seen during this symptomatology (i.e. thought disorders, hallucinations), arise.	[Razavi, Nadja; Jann, Kay; Koenig, Thomas; Kottlow, Mara; Strik, Werner; Dierks, Thomas] Univ Bern, Dept Psychiat Neurophysiol, Univ Hosp Psychiat, Bern, Switzerland; [Jann, Kay] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Hauf, Martinus] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Hauf, Martinus] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of California System; University of California Los Angeles; University of Bern; University Hospital of Bern; University of Bern	Razavi, N (corresponding author), Univ Bern, Dept Psychiat Neurophysiol, Univ Hosp Psychiat, Bern, Switzerland.	razavi@puk.unibe.ch	Koenig, Thomas/F-6454-2010; Koenig, Thomas/ABD-2278-2020; Jann, Kay/E-8343-2010; Jann, Kay/AAF-2154-2020; Strik, Werner Konrad/N-7807-2013; Dierks, Thomas/B-7092-2012	Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Strik, Werner Konrad/0000-0001-7108-1993; Dierks, Thomas/0000-0002-4173-5308; Jann, Kay/0000-0003-3574-0538				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Assaf M, 2009, BRAIN COGNITION, V70, P238, DOI 10.1016/j.bandc.2009.02.007; Bates AT, 2009, SCHIZOPHR RES, V115, P222, DOI 10.1016/j.schres.2009.09.036; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Diederen KMJ, 2010, BRAIN, V133, P3734, DOI 10.1093/brain/awq313; Dierks Th, 2009, EPILEPTOLOGIE, V26, P21; Douaud G, 2009, BRAIN, V132, P2437, DOI 10.1093/brain/awp126; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; GALDERISI S, 1991, SCHIZOPHR RES, V6, P15, DOI 10.1016/0920-9964(91)90016-K; Galderisi S, 2009, CLIN EEG NEUROSCI, V40, P62, DOI 10.1177/155005940904000206; Gallo A, 2012, NEUROLOGY, V79, P1458, DOI 10.1212/WNL.0b013e31826d5eea; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P921, DOI 10.1093/schbul/sbm045; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanslmayr S, 2012, HUM BRAIN M IN PRESS; Hayashi M, 1999, PERCEPT MOTOR SKILL, V88, P676, DOI 10.2466/pms.1999.88.2.676; Horn H, 2012, NEUROPSYCHOBIOLOGY, V66, P14, DOI 10.1159/000337133; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Ishii R, 2000, NEUROREPORT, V11, P3283, DOI 10.1097/00001756-200009280-00047; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kappenman ES, 2010, PSYCHOPHYSIOLOGY, V47, P888, DOI 10.1111/j.1469-8986.2010.01009.x; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Koch K, 2012, CORTEX IN PRESS; Koenig T, 2008, CLIN NEUROPHYSIOL, V119, P1262, DOI 10.1016/j.clinph.2007.12.023; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; Kottlow M, 2012, CLIN NEUROPHYSIOL, V123, P1536, DOI 10.1016/j.clinph.2011.12.019; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; Low MD, 1987, ELECTROENCEPHALOGRAP, P541; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Luchinger R, 2011, NEUROIMAGE, V56, P1493, DOI 10.1016/j.neuroimage.2011.02.050; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; Mandelkow H, 2006, NEUROIMAGE, V32, P1120, DOI 10.1016/j.neuroimage.2006.04.231; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McGuire PK, 1996, PSYCHOL MED, V26, P663, DOI 10.1017/S0033291700037673; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Mientus S, 2002, PSYCHIAT RES-NEUROIM, V116, P95, DOI 10.1016/S0925-4927(02)00043-4; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Miyauchi T, 1996, PSYCHIAT CLIN NEUROS, V50, P71, DOI 10.1111/j.1440-1819.1996.tb01666.x; Niedermeyer E., 1987, ELECTROENCEPHALOGRAP, V2nd, P97; Niedermeyer E, 1987, ELECTROENCEPHALOGRAP, P119; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Pascual-Marqui R. D., 2009, IMAGING ELECT NEURON, P49; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rotarska-Jagiela A, 2009, PSYCHIAT RES-NEUROIM, V174, P9, DOI 10.1016/j.pscychresns.2009.03.002; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Segalowitz SJ, 2010, BRAIN COGNITION, V72, P86, DOI 10.1016/j.bandc.2009.10.003; SHAM PC, 1994, ACTA PSYCHIAT SCAND, V89, P135, DOI 10.1111/j.1600-0447.1994.tb01501.x; Singer W, 2001, ANN NY ACAD SCI, V929, P123; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sommer IEC, 2001, SCHIZOPHR RES, V52, P57, DOI 10.1016/S0920-9964(00)00180-8; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Strijkstra AM, 2003, NEUROSCI LETT, V340, P17, DOI 10.1016/S0304-3940(03)00033-8; Strik WK, 1998, EVOKED POTENTIAL, V108, P406, DOI 10.1016/S0168-5597(98)00021-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka H, 1997, SLEEP, V20, P523, DOI 10.1093/sleep/20.7.523; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Venables NC, 2009, SCHIZOPHRENIA BULL, V35, P826, DOI 10.1093/schbul/sbn021; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WHO, 2012, ICD 10 CLASS MENT BE; Wolf ND, 2011, J PSYCHIATR NEUROSCI, V36, P366, DOI 10.1503/jpn.110008; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Yang CM, 2010, CONSCIOUS COGN, V19, P1084, DOI 10.1016/j.concog.2009.12.017; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	109	23	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76604	10.1371/journal.pone.0076604	http://dx.doi.org/10.1371/journal.pone.0076604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124576	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100133
J	Yuan, SL; Jiang, XL; Li, ZJ; He, K; Harada, M; Oshida, T; Lin, LK				Yuan, Shou-Li; Jiang, Xue-Long; Li, Zhen-Ji; He, Kai; Harada, Masashi; Oshida, Tatsuo; Lin, Liang-Kong			A Mitochondrial Phylogeny and Biogeographical Scenario for Asiatic Water Shrews of the Genus Chimarrogale: Implications for Taxonomy and Low-Latitude Migration Routes	PLOS ONE			English	Article							CYTOCHROME-B GENE; LATE-MIOCENE; TIBETAN PLATEAU; SPECIES DELIMITATION; CLIMATE-CHANGE; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; BAYESIAN ANALYSES; PLIOCENE; SEQUENCE	The six species and three subspecies in the genus Chimarrogale (Soricomorpha: Soricidae) are commonly referred to as Asiatic water shrews. The Chimarrogale are the most widely distributed group of Nectogaline shrews, extending throughout the Oriental region and Japan. Because of the limited numbers of specimens available for study, the phylogenetic relationships and biogeographical history of this genus have not been comprehensively discussed. We used mitochondrial cytochrome b gene sequences to estimate phylogenetic relationships and divergence times among four Chimarrogale species, including all three subspecies of Chimarrogale himalayica. We also conducted a species delimitation analysis and tested two alternative migration scenarios in Asia through species distribution modeling and a reconstruction of the ancestral distribution. Here, we present the first proposed hypothesis regarding the Asiatic water shrew phylogeny and reveal ten putative species within the four recognized species. Distinct phylogenetic statuses of Chimarrogale phaeura, Chimarrogale platycephala, and Chimarrogale styani were confirmed. Chimarrogale himalayica was strongly supported as paraphyletic. We suggest that three subspecies of Chimarrogale himalayica should be reconsidered as distinct species. However, these suggestions must be considered with caution because only a single locus of a mtDNA gene was used. Four additional putative species, possibly distributed in central southwestern China and Taiwan, are currently undescribed; therefore, comprehensive morphological analyses are warranted to test their taxonomic statuses. The estimated molecular divergence times indicated that rapid speciation occurred during the early Pliocene, and current distribution patterns may have been affected by global cooling during the Pliocene/Pleistocene boundary. Reconstruction of the ancestral distribution and species distribution modeling for Asiatic water shrews revealed a low-latitude migration route over which ancestral Chimarrogale migrated from Europe via Central Asia to their current distribution. Our results demonstrated that Asiatic water shrews could have evolved throughout the low-latitude migration route from Europe to East and Southeast Asia.	[Yuan, Shou-Li; Oshida, Tatsuo; Lin, Liang-Kong] Tunghai Univ, Dept Life Sci, Lab Wildlife Ecol, Taichung 40704, Taiwan; [Jiang, Xue-Long; He, Kai] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Li, Zhen-Ji] Xiamen Univ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China; [He, Kai] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Harada, Masashi] Osaka City Univ, Lab Anim Ctr, Grad Sch Med, Osaka 558, Japan	Tunghai University; Chinese Academy of Sciences; Kunming Institute of Zoology; Xiamen University; University of Manitoba; Osaka Metropolitan University	Lin, LK (corresponding author), Tunghai Univ, Dept Life Sci, Lab Wildlife Ecol, Taichung 40704, Taiwan.	lklin@thu.edu.tw	He, Kai/H-3164-2019	He, Kai/0000-0002-6234-2589				Abe H, 2003, MAMMALIAN SCI, V43, P51; Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Billups K, 2002, PALAEOGEOGR PALAEOCL, V185, P287, DOI 10.1016/S0031-0182(02)00340-1; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Choate JR, 1998, J MAMMAL, V79, P1416; Churchfield S, 1998, BEHAV ECOLOGY RIPARI, P49; Corbet GB, 1992, MAMMALS INDO MALAYAN; Cox CB, 2000, MEM I OSWALDO CRUZ, V95, P509, DOI 10.1590/S0074-02762000000400012; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; Dubey S, 2008, MOL PHYLOGENET EVOL, V48, P953, DOI 10.1016/j.ympev.2008.07.002; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gorog AJ, 2004, BIOL J LINN SOC, V81, P91, DOI 10.1111/j.1095-8312.2004.00281.x; GRAY J. E., 1842, ANN MAGAZINE NATURAL, V10, P255, DOI DOI 10.1080/03745484209445232; Guo ZT, 2004, GLOBAL PLANET CHANGE, V41, P135, DOI 10.1016/j.gloplacha.2004.01.002; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Haywood AM, 2009, PHILOS T R SOC A, V367, P3, DOI 10.1098/rsta.2008.0205; He K, 2010, MOL PHYLOGENET EVOL, V56, P734, DOI 10.1016/j.ympev.2010.03.039; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HOFFMANN R S, 1987, Acta Theriologica Sinica, V7, P100; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; Iwasa MA, 2006, ACTA THERIOL, V51, P29, DOI 10.1007/BF03192652; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; JONES GS, 1971, J MAMMAL, V52, P228, DOI 10.2307/1378458; Kawamura Y., 1989, Quaternary Research (Tokyo), V28, P317; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Lunde Darrin P., 2002, Mammal Study, V27, P137, DOI 10.3106/mammalstudy.27.137; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Marmi J, 2004, ZOOL SCR, V33, P481, DOI 10.1111/j.0300-3256.2004.00165.x; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Molnar P, 2005, PALAEONTOL ELECTRON, V8; Moss Steve J., 1998, P133; Motokawa M, 2006, ACTA THERIOL, V51, P215, DOI 10.1007/BF03192673; Ohdachi SD, 2006, J ZOOL, V270, P177, DOI 10.1111/j.1469-7998.2006.00125.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Qiu Zhuding, 2005, Scripta Geologica Special Issue, V5, P37; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Rubinoff D, 2006, CONSERV BIOL, V20, P1026, DOI 10.1111/j.1523-1739.2006.00372.x; Rzebik-Kowalska Barbara, 1998, P23; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Smith Andrew T., 2008, P1; Storch Gerhard, 1998, P93; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Thomas O, 1902, ANN MAG NAT HIST SER, V10, P163, DOI DOI 10.1080/00222930208678653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Dam JA, 2004, J PALEONTOL, V78, P741, DOI 10.1666/0022-3360(2004)078<0741:AMSFTM>2.0.CO;2; Wang L, 2006, PALAEOGEOGR PALAEOCL, V241, P118, DOI 10.1016/j.palaeo.2006.06.012; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X	77	12	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77156	10.1371/journal.pone.0077156	http://dx.doi.org/10.1371/journal.pone.0077156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124605	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100162
J	Hasse, D; Andersson, E; Carlsson, G; Masloboy, A; Hagemann, M; Bauwe, H; Andersson, I				Hasse, Dirk; Andersson, Evalena; Carlsson, Gunilla; Masloboy, Axel; Hagemann, Martin; Bauwe, Hermann; Andersson, Inger			Structure of the Homodimeric Glycine Decarboxylase P-protein from Synechocystis sp PCC 6803 Suggests a Mechanism for Redox Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Decarboxylase; Disulfide; Pyridoxal Phosphate; Redox Regulation; P-protein; Glycine Decarboxylase	CLEAVAGE SYSTEM; H-PROTEIN; T-PROTEIN; ANTISENSE REDUCTION; MULTIENZYME COMPLEX; CARBON METABOLISM; POTATO PLANTS; CLONING; CYANOBACTERIA; ENZYMES	Glycine decarboxylase, or P-protein, is a pyridoxal 5-phosphate (PLP)-dependent enzyme in one-carbon metabolism of all organisms, in the glycine and serine catabolism of vertebrates, and in the photorespiratory pathway of oxygenic phototrophs. P-protein from the cyanobacterium Synechocystis sp. PCC 6803 is an (2) homodimer with high homology to eukaryotic P-proteins. The crystal structure of the apoenzyme shows the C terminus locked in a closed conformation by a disulfide bond between Cys(972) in the C terminus and Cys(353) located in the active site. The presence of the disulfide bridge isolates the active site from solvent and hinders the binding of PLP and glycine in the active site. Variants produced by substitution of Cys(972) and Cys(353) by Ser using site-directed mutagenesis have distinctly lower specific activities, supporting the crucial role of these highly conserved redox-sensitive amino acid residues for P-protein activity. Reduction of the 353-972 disulfide releases the C terminus and allows access to the active site. PLP and the substrate glycine bind in the active site of this reduced enzyme and appear to cause further conformational changes involving a flexible surface loop. The observation of the disulfide bond that acts to stabilize the closed form suggests a molecular mechanism for the redox-dependent activation of glycine decarboxylase observed earlier.	[Hasse, Dirk; Carlsson, Gunilla; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Andersson, Evalena] Swedish Univ Agr Sci, Dept Mol Biol, S-75124 Uppsala, Sweden; [Masloboy, Axel; Hagemann, Martin; Bauwe, Hermann] Univ Rostock, Dept Plant Physiol, D-18051 Rostock, Germany	Uppsala University; Swedish University of Agricultural Sciences; University of Rostock	Andersson, I (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	inger@xray.bmc.uu.se		Hasse, Dirk/0000-0001-8710-327X	Deutscher Akademischer Austauschdienst; Landesgraduiertenstipendium Mecklenburg-Vorpommern; Swedish Research Council FORMAS	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Landesgraduiertenstipendium Mecklenburg-Vorpommern; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Deutscher Akademischer Austauschdienst and Landesgraduiertenstipendium Mecklenburg-Vorpommern and grants from the Swedish Research Council FORMAS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; BAUWE H, 1995, EUR J BIOCHEM, V234, P116, DOI 10.1111/j.1432-1033.1995.116_c.x; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Beffa T, 1996, APPL ENVIRON MICROB, V62, P1723, DOI 10.1128/AEM.62.5.1723-1727.1996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Bykova NV, 2005, PLANTA, V222, P130, DOI 10.1007/s00425-005-1505-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, FEMS MICROBIOL LETT, V277, P232, DOI 10.1111/j.1574-6968.2007.00960.x; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Faure M, 2000, EUR J BIOCHEM, V267, P2890, DOI 10.1046/j.1432-1033.2000.01330.x; FREUDENBERG W, 1989, J BACTERIOL, V171, P2209, DOI 10.1128/jb.171.4.2209-2215.1989; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guilhaudis L, 2000, BIOCHEMISTRY-US, V39, P4259, DOI 10.1021/bi992674w; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hasse D, 2007, FEBS LETT, V581, P1297, DOI 10.1016/j.febslet.2007.02.037; Hasse D, 2010, ACTA CRYSTALLOGR F, V66, P187, DOI 10.1107/S1744309109052828; Hasse D, 2009, FEBS J, V276, P6985, DOI 10.1111/j.1742-4658.2009.07406.x; Heineke D, 2001, PLANTA, V212, P880, DOI 10.1007/s004250000460; HIRAGA K, 1972, J BIOCHEM-TOKYO, V72, P1285, DOI 10.1093/oxfordjournals.jbchem.a130020; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorda J, 2011, ARCHAEA, V2011, DOI 10.1155/2011/409156; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanno J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043448; KAWASAKI H, 1966, BIOCHEM BIOPH RES CO, V23, P227, DOI 10.1016/0006-291X(66)90532-8; Kern R, 2011, PHOTOSYNTH RES, V109, P103, DOI 10.1007/s11120-010-9615-z; KIKUCHI G, 1982, MOL CELL BIOCHEM, V45, P137; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; KLEIN SM, 1967, J BIOL CHEM, V242, P297; KUME A, 1991, J BIOL CHEM, V266, P3323; Kure S, 1998, HUM GENET, V102, P430, DOI 10.1007/s004390050716; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; Li M, 2007, ARCH BIOCHEM BIOPHYS, V458, P220, DOI 10.1016/j.abb.2006.12.010; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lindahl M, 2009, J PROTEOMICS, V72, P416, DOI 10.1016/j.jprot.2009.01.003; Maaheimo H, 2001, EUR J BIOCHEM, V268, P2464, DOI 10.1046/j.1432-1327.2001.02126.x; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Marti MC, 2009, PLANT PHYSIOL, V150, P646, DOI 10.1104/pp.109.138073; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Nakai T, 2003, ACTA CRYSTALLOGR D, V59, P1610, DOI 10.1107/S0907444903014975; NEUBURGER M, 1986, FEBS LETT, V207, P18, DOI 10.1016/0014-5793(86)80005-9; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; OLIVER DJ, 1990, PLANT PHYSIOL, V94, P833, DOI 10.1104/pp.94.2.833; OLIVER DJ, 1994, ANNU REV PLANT PHYS, V45, P323, DOI 10.1146/annurev.pp.45.060194.001543; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASTERNACK LB, 1992, BIOCHEMISTRY-US, V31, P8713, DOI 10.1021/bi00152a005; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Timm S, 2012, FEBS LETT, V586, P3692, DOI 10.1016/j.febslet.2012.08.027; TURNER SR, 1992, J BIOL CHEM, V267, P5355; WALKER JL, 1986, J BIOL CHEM, V261, P2214; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037	70	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35333	35345		10.1074/jbc.M113.509976	http://dx.doi.org/10.1074/jbc.M113.509976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24121504	hybrid, Green Published			2022-12-25	WOS:000329867600031
J	Maeda, T; Lee, MJ; Palczewska, G; Marsili, S; Tesar, PJ; Palczewski, K; Takahashi, M; Maeda, A				Maeda, Tadao; Lee, Mee Jee; Palczewska, Grazyna; Marsili, Stefania; Tesar, Paul J.; Palczewski, Krzysztof; Takahashi, Masayo; Maeda, Akiko			Retinal Pigmented Epithelial Cells Obtained from Human Induced Pluripotent Stem Cells Possess Functional Visual Cycle Enzymes in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Induced Pluripotent Stem (iPS) Cell; Retinal Degeneration; Retinal Metabolism; Retinoid; Transplantation; LRAT; RPE; RPE65; Visual Cycle	LEBERS CONGENITAL AMAUROSIS; MACULAR DEGENERATION; RPE65; TRANSPLANTATION; EYE; DIFFERENTIATION; ACYLTRANSFERASE; EXPRESSION; MUTATIONS; INSIGHTS	Background: The visual (retinoid) cycle activity in human iPS-derived RPE (hiPS-RPE) cells has not been fully examined. Results: hiPS-RPE cells showed a functional visual cycle in both in vitro and in vivo. Conclusion: hiPS-RPE cell could provide potential treatment options for retinal degenerative diseases. Significance: hiPS-RPE cells with functional visual cycle proteins potentially could remedy certain degenerative retinal diseases. Differentiated retinal pigmented epithelial (RPE) cells have been obtained from human induced pluripotent stem (hiPS) cells. However, the visual (retinoid) cycle in hiPS-RPE cells has not been adequately examined. Here we determined the expression of functional visual cycle enzymes in hiPS-RPE cells compared with that of isolated wild-type mouse primary RPE (mpRPE) cells in vitro and in vivo. hiPS-RPE cells appeared morphologically similar to mpRPE cells. Notably, expression of certain visual cycle proteins was maintained during cell culture of hiPS-RPE cells, whereas expression of these same molecules rapidly decreased in mpRPE cells. Production of the visual chromophore, 11-cis-retinal, and retinosome formation also were documented in hiPS-RPE cells in vitro. When mpRPE cells with luciferase activity were transplanted into the subretinal space of mice, bioluminance intensity was preserved for >3 months. Additionally, transplantation of mpRPE into blind Lrat(-/-) and Rpe65(-/-) mice resulted in the recovery of visual function, including increased electrographic signaling and endogenous 11-cis-retinal production. Finally, when hiPS-RPE cells were transplanted into the subretinal space of Lrat(-/-) and Rpe65(-/-) mice, their vision improved as well. Moreover, histological analyses of these eyes displayed replacement of dysfunctional RPE cells by hiPS-RPE cells. Together, our results show that hiPS-RPE cells can exhibit a functional visual cycle in vitro and in vivo. These cells could provide potential treatment options for certain blinding retinal degenerative diseases.	[Maeda, Tadao; Lee, Mee Jee; Marsili, Stefania; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Tesar, Paul J.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Palczewska, Grazyna] Polgenix Inc, Cleveland, OH 44106 USA; [Takahashi, Masayo] RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; RIKEN	Maeda, T (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	txm88@case.edu; aam19@case.edu	Tesar, Paul J/C-9848-2014; marsili, stefania/AAY-9743-2020; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; marsili, stefania/0000-0003-0117-8874; Tesar, Paul/0000-0003-1532-3155	National Institutes of Health [K08EY019031, K08EY019880, R01EY022658, R01EY009339, R24EY021126, R44AG043645, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Midwest Eye Banks; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, K08EY019031, K08EY019880, R24EY021126, R01EY022658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG043645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Midwest Eye Banks; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, R01EY022658, R01EY009339, R24EY021126, R44AG043645, and P30EY011373. This work was also supported by the Research to Prevent Blindness Foundation, the Foundation Fighting Blindness, the Midwest Eye Banks, and the Ohio Lions Eye Research Foundation.	Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Carr AJF, 2013, TRENDS NEUROSCI, V36, P385, DOI 10.1016/j.tins.2013.03.006; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Engelhardt M, 2012, VISUAL NEUROSCI, V29, P83, DOI 10.1017/S0952523812000041; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Klein R, 2013, OPHTHALMOLOGY, V120, P1210, DOI 10.1016/j.ophtha.2012.11.041; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Stanzel BV, 2005, EXP EYE RES, V80, P103, DOI 10.1016/j.exer.2004.06.032; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tezel TH, 2007, AM J OPHTHALMOL, V143, P584, DOI 10.1016/j.ajo.2006.12.007; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	40	64	65	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34484	34493		10.1074/jbc.M113.518571	http://dx.doi.org/10.1074/jbc.M113.518571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129572	Green Published, hybrid			2022-12-25	WOS:000329812800018
J	Ramon-Garcia, S; Ng, C; Jensen, PR; Dosanjh, M; Burian, J; Morris, RP; Folcher, M; Eltis, LD; Grzesiek, S; Nguyen, L; Thompson, CJ				Ramon-Garcia, Santiago; Ng, Carol; Jensen, Pernille R.; Dosanjh, Manisha; Burian, Jan; Morris, Rowan P.; Folcher, Marc; Eltis, Lindsay D.; Grzesiek, Stephan; Liem Nguyen; Thompson, Charles J.			WhiB7, an Fe-S-dependent Transcription Factor That Activates Species-specific Repertoires of Drug Resistance Determinants in Actinobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actinobacteria; Antibiotic Resistance; Gene Regulation; Iron-Sulfur Protein; Transcription; AT-hook; Iron-Sulfur Cluster; Regulation	MYCOBACTERIUM-TUBERCULOSIS H37RV; IRON-SULFUR CLUSTER; SP STRAIN RHA1; ESCHERICHIA-COLI; 4FE-4S CLUSTER; ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; IN-VIVO; MOLECULAR-CLONING; BINDING PROTEIN	Background: WhiB7 is essential for antibiotic resistance in M. tuberculosis. Results: WhiB7 requires conserved residues, including a redox-sensitive center and DNA-binding motif, to coordinate transcription of species-specific drug resistance genes in diverse Actinobacteria. Conclusion: WhiB7 activates species-specific drug resistance genes in Actinobacteria. Significance: Understanding WhiB7 activity may allow the development of drugs that sensitize bacteria to antibiotics. WhiB-like (Wbl) proteins are well known for their diverse roles in actinobacterial morphogenesis, cell division, virulence, primary and secondary metabolism, and intrinsic antibiotic resistance. Gene disruption experiments showed that three different Actinobacteria (Mycobacterium smegmatis, Streptomyces lividans, and Rhodococcus jostii) each exhibited a different whiB7-dependent resistance profile. Heterologous expression of whiB7 genes showed these resistance profiles reflected the host's repertoire of endogenous whiB7-dependent genes. Transcriptional activation of two resistance genes in the whiB7 regulon, tap (a multidrug transporter) and erm(37) (a ribosomal methyltransferase), required interaction of WhiB7 with their promoters. Furthermore, heterologous expression of tap genes isolated from Mycobacterium species demonstrated that divergencies in drug specificity of homologous structural proteins contribute to the variation of WhiB7-dependent drug resistance. WhiB7 has a specific tryptophan/glycine-rich region and four conserved cysteine residues; it also has a peptide sequence (AT-hook) at its C terminus that binds AT-rich DNA sequence motifs upstream of the promoters it activates. Targeted mutagenesis showed that these motifs were required to provide antibiotic resistance in vivo. Anaerobically purified WhiB7 from S. lividans was dimeric and contained 2.1 +/- 0.3 and 2.2 +/- 0.3 mol of iron and sulfur, respectively, per protomer (consistent with the presence of a 2Fe-2S cluster). However, the properties of the dimer's absorption spectrum were most consistent with the presence of an oxygen-labile 4Fe-4S cluster, suggesting 50% occupancy. These data provide the first insights into WhiB7 iron-sulfur clusters as they exist in vivo, a major unresolved issue in studies of Wbl proteins.	[Ramon-Garcia, Santiago; Ng, Carol; Dosanjh, Manisha; Burian, Jan; Eltis, Lindsay D.; Thompson, Charles J.] Univ British Columbia, Dept Microbiol & Immunol, Ctr TB Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Jensen, Pernille R.; Folcher, Marc; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Morris, Rowan P.] Anim Hlth & Vet Labs Agcy, Starcross EX6 8PE, England; [Liem Nguyen] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	University of British Columbia; University of Basel; Case Western Reserve University	Nguyen, L (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	liem.nguyen@case.edu; charles.thompson@ubc.ca	Morris, Rowan/HGU-9105-2022; Jensen, Pernille Rose/J-8648-2016; Jensen, Pernille Rose/AAX-5696-2020; Eltis, Lindsay D/J-8272-2015; ramon, santi/C-6077-2013; Jensen, Pernille Rose/GQQ-6261-2022; Ramon Garcia, Santiago/V-8242-2017	Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Eltis, Lindsay D/0000-0002-6774-8158; ramon, santi/0000-0002-8480-0325; Jensen, Pernille Rose/0000-0003-4359-848X; Ramon Garcia, Santiago/0000-0002-8480-0325; Grzesiek, Stephan/0000-0003-1998-4225	National Institutes of Health [R01 AI087903]; Canadian Institute of Health Research [MOP-82855]; British Columbia Lung Association; Case Western Reserve University/University Hospitals Center for AIDS Research [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI087903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Case Western Reserve University/University Hospitals Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI087903 (to L. N.), Canadian Institute of Health Research Grant MOP-82855 (to C. J. T.), the British Columbia Lung Association (to C. J. T.), and Case Western Reserve University/University Hospitals Center for AIDS Research Grant P30 AI036219 (to L. N.).	Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8; Ainsa JA, 1998, J BACTERIOL, V180, P5836; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Burian J., 2013, NUCL ACIDS RES, DOI 10.1093/nar/gkt751; Burian J, 2012, EXPERT REV ANTI-INFE, V10, P1037, DOI [10.1586/eri.12.90, 10.1586/ERI.12.90]; Burian J, 2012, J BIOL CHEM, V287, P299, DOI 10.1074/jbc.M111.302588; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; EVANS JNS, 1995, INT J PEPT PROT RES, V45, P554; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Galbis-Martinez M, 2004, GENETICS, V167, P1585, DOI 10.1534/genetics.104.029207; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kazda J, 2009, ECOLOGY OF MYCOBACTERIA: IMPACT ON ANIMAL'S AND HUMAN'S HEALTH, 2ND EDITION, P1, DOI 10.1007/978-1-4020-9413-2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Konar M, 2012, FEBS J, V279, P2781, DOI 10.1111/j.1742-4658.2012.08662.x; Larsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037516; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032; LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Montoro E, 2005, J ANTIMICROB CHEMOTH, V55, P500, DOI 10.1093/jac/dki023; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; MURAKAMI T, 1986, MOL GEN GENET, V205, P42, DOI 10.1007/BF02428031; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Patrauchan MA, 2005, J BACTERIOL, V187, P4050, DOI 10.1128/JB.187.12.4050-4063.2005; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 1999, METHOD ENZYMOL, V304, P155; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Saini V, 2012, CURR OPIN CHEM BIOL, V16, P45, DOI 10.1016/j.cbpa.2012.03.004; Sambrook J, 2001, MOL CLONING LAB MANU; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Singh A., 2009, PLOS PATHOG, V5; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040407; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Stapleton MR, 2012, TUBERCULOSIS, V92, P328, DOI 10.1016/j.tube.2012.03.001; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; Warren R, 2004, J BACTERIOL, V186, P7783, DOI 10.1128/JB.186.22.7783-7795.2004; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	83	38	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34514	34528		10.1074/jbc.M113.516385	http://dx.doi.org/10.1074/jbc.M113.516385			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24126912	hybrid, Green Published			2022-12-25	WOS:000329812800021
J	Zoghbi, ME; Altenberg, GA				Zoghbi, Maria E.; Altenberg, Guillermo A.			Hydrolysis at One of the Two Nucleotide-binding Sites Drives the Dissociation of ATP-binding Cassette Nucleotide-binding Domain Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; ATPases; CFTR; Fluorescence; Kinetics; Multidrug Transporters; LRET; Luminescence Resonance Energy Transfer; Thermophile	ABC TRANSPORTER MSBA; P-GLYCOPROTEIN; CATALYTIC CYCLE; ASSOCIATION/DISSOCIATION; DIMERIZATION; RESIDUES	Background: Nucleotide-binding domains (NBDs) of ABC proteins bind two ATPs, but it is unknown whether dissociation follows hydrolysis of one or both ATPs. Results: NBD dimers with one or two sites capable of ATP hydrolysis dissociate at the same rate. Conclusion: NBD dimers dissociate following a single ATP hydrolysis event. Significance: Understanding ABC proteins will help develop strategies to modify their function in disease. The functional unit of ATP-binding cassette (ABC) transporters consists of two transmembrane domains and two nucleotide-binding domains (NBDs). ATP binding elicits association of the two NBDs, forming a dimer in a head-to-tail arrangement, with two nucleotides sandwiched at the dimer interface. Each of the two nucleotide-binding sites is formed by residues from the two NBDs. We recently found that the prototypical NBD MJ0796 from Methanocaldococcus jannaschii dimerizes in response to ATP binding and dissociates completely following ATP hydrolysis. However, it is still unknown whether dissociation of NBD dimers follows ATP hydrolysis at one or both nucleotide-binding sites. Here, we used luminescence resonance energy transfer to study heterodimers formed by one active (donor-labeled) and one catalytically defective (acceptor-labeled) NBD. Rapid mixing experiments in a stop-flow chamber showed that NBD heterodimers with one functional and one inactive site dissociated at a rate indistinguishable from that of dimers with two hydrolysis-competent sites. Comparison of the rates of NBD dimer dissociation and ATP hydrolysis indicated that dissociation followed hydrolysis of one ATP. We conclude that ATP hydrolysis at one nucleotide-binding site drives NBD dimer dissociation.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673; Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention and Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP101073.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Mittal A, 2012, J BIOL CHEM, V287, P20395, DOI 10.1074/jbc.M112.359794; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	33	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34259	34265		10.1074/jbc.M113.500371	http://dx.doi.org/10.1074/jbc.M113.500371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129575	Green Published, hybrid			2022-12-25	WOS:000327250200068
J	Grandjean, M; Sermeus, A; Branders, S; Defresne, F; Dieu, M; Dupont, P; Raes, M; De Ridder, M; Feron, O				Grandjean, Marie; Sermeus, Alexandra; Branders, Samuel; Defresne, Florence; Dieu, Marc; Dupont, Pierre; Raes, Martine; De Ridder, Mark; Feron, Olivier			Hypoxia Integration in the Serological Proteome Analysis Unmasks Tumor Antigens and Fosters the Identification of Anti-Phospho-eEF2 Antibodies as Potential Cancer Biomarkers	PLOS ONE			English	Article							AUTOANTIBODY SIGNATURES; BREAST-CANCER; ELONGATION-FACTOR-2; ANGIOGENESIS; ADAPTATION; ACTIVATION; IMPACT; MTOR	The expression by tumor cells of proteins with aberrant structure, expression or distribution accounts for the development of a humoral immune response. Autoantibodies (aAb) directed against tumor-associated antigens (TAA) may thus be particularly relevant for early detection of cancer. Serological proteome analysis (SERPA) aims to identify such circulating aAb through the immunoblotting of 2D-separated tumor cell proteins with cancer patient serum and the consecutive MS identification of proteins in reactive spots. This method has the advantage to use post-translationally modified proteins as a source of potential TAA. Here, we applied this strategy by using colorectal tumor cells pre-exposed to hypoxia in order to promote the expression of a pattern of TAA more likely to represent in vivo conditions. We used two human HCT116 and HT29 colorectal cancer cell lines exposed for 48 hours to 1% O-2. Spots positive after immunoblotting of 2D-separated lysates of hypoxic cells with the sera of tumor-bearing mice, were collected and analysed by MS for protein identification. Among the hypoxia-specific immunogenic proteins, we identified a phosphorylated form of eukaryotic translation elongation factor 2 (phospho-Thr56 eEF2). We confirmed the increased phosphorylation of this protein in hypoxic colorectal tumor cells as well as in mouse tumors. Using a specific immunoassay, we could detect the presence of corresponding anti-phospho -Thr56 eEF2 aAb in the serum of tumor-bearing mice (vs healthy mice). We further documented that the detection of these aAb preceded the detection of a palpable tumor mass in mice and validated the presence of anti-phospho-Thr56 eEF2 aAb in the serum of patients with adenomatous polyps and colorectal carcinoma. In conclusion, this study validates a phosphorylated form of eEF2 as a new TAA and more generally, provides evidence that integrating hypoxia upstream of SERPA offers a more relevant repertoire of TAA able to unmask the presence of circulating aAb.	[Grandjean, Marie; Defresne, Florence; Feron, Olivier] UCLouvain, IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium; [Sermeus, Alexandra; De Ridder, Mark] Vrije Univ Brussel, UZ Brussel, Brussels, Belgium; [Branders, Samuel; Dupont, Pierre] UCLouvain, Inst Informat & Commun Technol Elect & Appl Math, Machine Learning Grp, Louvain, Belgium; [Dieu, Marc; Raes, Martine] UNamur, Namur Res Inst Life Sci NARILIS, Res Unit Cell Biol URBC, Namur, Belgium	Universite Catholique Louvain; Vrije Universiteit Brussel; Universite Catholique Louvain	Feron, O (corresponding author), UCLouvain, IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium.	olivier.feron@uclouvain.be	FERON, Olivier/AAM-6395-2020; De Ridder, Mark/F-4794-2013	FERON, Olivier/0000-0001-5360-0286; De Ridder, Mark/0000-0003-4433-8807; Dieu, Marc/0000-0002-3902-542X; Sermeus, Alexandra/0000-0003-4759-5307	Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Scientifique Medicale (FRSM); Communaute francaise de Belgique [ARC 09/14-020]; Interuniversity Attraction Pole; J. Maisin Foundation; FNRS (Brussels, Belgium)	Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique(Australian Research Council); Interuniversity Attraction Pole(Belgian Federal Science Policy Office); J. Maisin Foundation; FNRS (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute francaise de Belgique (ARC 09/14-020), the Interuniversity Attraction Pole (IUAP program P7.03), and the J. Maisin Foundation. M. Grandjean is a FRIA (Fonds pour la formation a` la Recherche dans l'Industrie et dans l'Agriculture) Research Fellow. The MS facility of the URBC-NARILIS was supported by the FNRS (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Arora S, 2002, BIOCHEM BIOPH RES CO, V293, P1073, DOI 10.1016/S0006-291X(02)00324-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Daneau G, 2010, CLIN CANCER RES, V16, P410, DOI 10.1158/1078-0432.CCR-09-0583; Desmetz C, 2009, J PROTEOMICS, V72, P982, DOI 10.1016/j.jprot.2009.06.004; Desmetz C, 2009, EXPERT REV PROTEOMIC, V6, P377, DOI 10.1586/EPR.09.56; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gunawardana CG, 2007, CANCER LETT, V249, P110, DOI 10.1016/j.canlet.2007.01.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Kobold S, 2010, HUM IMMUNOL, V71, P643, DOI 10.1016/j.humimm.2010.03.015; Lacombe J, 2013, EXPERT REV PROTEOMIC, V10, P33, DOI [10.1586/EPR.12.68, 10.1586/epr.12.68]; Ladd JJ, 2013, CANCER RES, V73, P1502, DOI 10.1158/0008-5472.CAN-12-2560; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reuschenbach M, 2009, CANCER IMMUNOL IMMUN, V58, P1535, DOI 10.1007/s00262-009-0733-4; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Romero-Ruiz A, 2012, J BIOL CHEM, V287, P9651, DOI 10.1074/jbc.M111.299180; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Simiantonaki N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-320; Soussi T, 2000, CANCER RES, V60, P1777; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vincent KA, 2002, TRENDS CARDIOVAS MED, V12, P362, DOI 10.1016/S1050-1738(02)00186-X; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	36	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76508	10.1371/journal.pone.0076508	http://dx.doi.org/10.1371/journal.pone.0076508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130777	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200041
J	Petrova, K; Wentura, D; Bermeitinger, C				Petrova, Kalina; Wentura, Dirk; Bermeitinger, Christina			What Happens during the Stimulus Onset Asynchrony in the Dot-Probe Task? Exploring the Role of Eye Movements in the Assessment of Attentional Biases	PLOS ONE			English	Article							THREATENING FACIAL EXPRESSIONS; SELECTIVE ATTENTION; VISUAL-ATTENTION; FEARFUL FACES; SACCADES; ANXIETY; RESPONSES; PARADIGM	The dot-probe paradigm is one of the most often used paradigms to investigate attentional biases towards emotional information. However, a large number of the dot-probe studies so far used a long stimulus onset asynchrony allowing for eye movements to occur, which might increase the error variance. This study aimed at addressing this methodological issue by varying the instructions with regard to the gaze behavior and calculating the reaction time (RT) bias score (i.e., RTs for targets presented at the location of the emotional compared to the neutral stimulus) separately for trials with eye movements and trials without eye movements. Results of Experiment 1 (using typical instructions, i.e., instructions that are lenient with regard to eye movements) showed an RT bias, but only in the trials without eye movements The overall RT bias (calculated "blind" for eye movements) was non-significant. In Experiment 2, stricter instructions and small changes in the procedure led to a sharp decrease in the number of eye movements, such that both the RT bias in the trials without eye movements as well as the RT bias across all trials was significant.	[Petrova, Kalina; Wentura, Dirk] Univ Saarland, Dept Psychol, D-66123 Saarbrucken, Germany; [Bermeitinger, Christina] Univ Hildesheim, Dept Psychol, D-31141 Hildesheim, Germany	Saarland University; University of Hildesheim	Petrova, K (corresponding author), Univ Saarland, Dept Psychol, D-66123 Saarbrucken, Germany.	k.petrova@mx.uni-saarland.de		Wentura, Dirk/0000-0001-9907-498X	German Research Foundation [WE 2284/8-2, IRTG 1457]	German Research Foundation(German Research Foundation (DFG))	The research reported in this article was supported by the German Research Foundation (WE 2284/8-2 and IRTG 1457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEDEKER C, 1987, VISION RES, V27, P609, DOI 10.1016/0042-6989(87)90046-0; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Egloff B, 2003, PERS INDIV DIFFER, V35, P475, DOI 10.1016/S0191-8869(02)00265-9; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Gomez C, 1998, BIOL PSYCHOL, V47, P77, DOI 10.1016/S0301-0511(97)00022-7; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; IWASAKI S, 1990, ERGONOMICS, V33, P833, DOI 10.1080/00140139008927188; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Tukey J.W., 1977, EXPLORATORY DATA ANA, P1	28	19	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76335	10.1371/journal.pone.0076335	http://dx.doi.org/10.1371/journal.pone.0076335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236QM	24130768	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200033
J	Miyagawa, M; Nishio, S; Ikeda, T; Fukushima, K; Usami, S				Miyagawa, Maiko; Nishio, Shin-ya; Ikeda, Takuo; Fukushima, Kunihiro; Usami, Shin-ichi			Massively Parallel DNA Sequencing Successfully Identifies New Causative Mutations in Deafness Genes in Patients with Cochlear Implantation and EAS	PLOS ONE			English	Article							ELECTRIC-ACOUSTIC STIMULATION; HEARING-LOSS; TMPRSS3; PERFORMANCE; FAMILIES	Genetic factors, the most common etiology in severe to profound hearing loss, are one of the key determinants of Cochlear Implantation (CI) and Electric Acoustic Stimulation (EAS) outcomes. Satisfactory auditory performance after receiving a CI/EAS in patients with certain deafness gene mutations indicates that genetic testing would be helpful in predicting CI/EAS outcomes and deciding treatment choices. However, because of the extreme genetic heterogeneity of deafness, clinical application of genetic information still entails difficulties. Target exon sequencing using massively parallel DNA sequencing is a new powerful strategy to discover rare causative genes in Mendelian disorders such as deafness. We used massive sequencing of the exons of 58 target candidate genes to analyze 8 (4 early-onset, 4 late-onset) Japanese CI/EAS patients, who did not have mutations in commonly found genes including GJB2, SLC26A4, or mitochondrial 1555A>G or 3243A>G mutations. We successfully identified four rare causative mutations in the MYO15A, TECTA, TMPRSS3, and ACTG1 genes in four patients who showed relatively good auditory performance with CI including EAS, suggesting that genetic testing may be able to predict the performance after implantation.	[Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Ikeda, Takuo] Tsudumigaura Handicapped Childrens Hosp, Dept Otolaryngol, Shunan, Japan; [Fukushima, Kunihiro] Okayama Univ, Sch Med, Dept Otorhinolaryngol, Okayama 700, Japan	Shinshu University; Okayama University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Coninx F., 2003, LITTLEARS AUDITORY Q; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; MIYAGAWA M, 2013, PLOS ONE IN PRESS; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Usami S, 2010, AUDIOLOGICAL MED, V8, P28; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Usami S, 2012, ACTA OTO-LARYNGOL, V132, P377, DOI 10.3109/00016489.2011.649493; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zimmerman-Phillips S., 1997, INFANT TODDLER MEANI	22	71	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75793	10.1371/journal.pone.0075793	http://dx.doi.org/10.1371/journal.pone.0075793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130743	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900058
J	Rice, RH; Bradshaw, KM; Durbin-Johnson, BP; Rocke, DM; Eigenheer, RA; Phinney, BS; Schmuth, M; Gruber, R				Rice, Robert H.; Bradshaw, Katie M.; Durbin-Johnson, Blythe P.; Rocke, David M.; Eigenheer, Richard A.; Phinney, Brett S.; Schmuth, Matthias; Gruber, Robert			Distinguishing Ichthyoses by Protein Profiling	PLOS ONE			English	Article							RECESSIVE CONGENITAL ICHTHYOSIS; LAMELLAR ICHTHYOSIS; MOLECULAR ANALYSIS; STATISTICAL-MODEL; MUTATIONS; TRANSGLUTAMINASE-1; ABNORMALITIES; DISORDERS; FILAGGRIN	To explore the usefulness of protein profiling for characterization of ichthyoses, we here determined the profile of human epidermal stratum corneum by shotgun proteomics. Samples were analyzed after collection on tape circles from six anatomic sites (forearm, palm, lower leg, forehead, abdomen, upper back), demonstrating site-specific differences in profiles. Additional samples were collected from the forearms of subjects with ichthyosis vulgaris (filaggrin (FLG) deficiency), recessive X-linked ichthyosis (steroid sulfatase (STS) deficiency) and autosomal recessive congenital ichthyosis type lamellar ichthyosis (transglutaminase 1 (TGM1) deficiency). The ichthyosis protein expression patterns were readily distinguishable from each other and from phenotypically normal epidermis. In general, the degree of departure from normal was lower from ichthyosis vulgaris than from lamellar ichthyosis, parallel to the severity of the phenotype. Analysis of samples from families with ichthyosis vulgaris and concomitant modifying gene mutations (STS deficiency, GJB2 deficiency) permitted correlation of alterations in protein profile with more complex genetic constellations.	[Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Forens Sci Grad Program, Davis, CA 95616 USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Clin & Translat Sci Ctr,Biostat Core, Davis, CA 95616 USA; [Rocke, David M.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Eigenheer, Richard A.; Phinney, Brett S.] Univ Calif Davis, Prote Core Facil, Davis, CA 95616 USA; [Schmuth, Matthias; Gruber, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Medical University of Innsbruck	Gruber, R (corresponding author), Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria.	r.gruber@i-med.ac.at	Rice, Robert/AAP-7813-2021; Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Schmuth, Matthias/0000-0002-4064-1334	MFF Tirol [194]; National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences [2P42 ES04699]; NIH grant from the National Center for Advancing Translational Sciences [UL1TR0000002]; EU-FP7 COST Action [BM0903]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	MFF Tirol; National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences; NIH grant from the National Center for Advancing Translational Sciences; EU-FP7 COST Action; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by MFF Tirol grant number 194, National Institutes of Health (NIH) grant from the National Institute for Environmental Health Sciences (2P42 ES04699), NIH grant from the National Center for Advancing Translational Sciences (UL1TR0000002), and EU-FP7 COST Action BM0903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Akiyama M, 2011, DERM-ENDOCRINOL, V3, P107, DOI 10.4161/derm.3.2.15136; Aufenvenne K, 2012, J INVEST DERMATOL, V132, P1918, DOI 10.1038/jid.2012.65; Aufenvenne K, 2009, J INVEST DERMATOL, V129, P2068, DOI 10.1038/jid.2009.18; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Eckl KM, 2013, J INVEST DE IN PRESS; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Elias PM, 2002, EXP DERMATOL, V11, P248, DOI 10.1034/j.1600-0625.2001.110308.x; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.014555, DOI 10.1074/MCP.M1111.014555]; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Gruber R, 2010, J DERMATOL SCI, V58, P72, DOI 10.1016/j.jdermsci.2010.01.002; Herman ML, 2009, HUM MUTAT, V30, P537, DOI 10.1002/humu.20952; Hoppe T, 2012, BRIT J DERMATOL, V167, P514, DOI 10.1111/j.1365-2133.2012.10979.x; Israeli S, 2011, AM J HUM GENET, V88, P482, DOI 10.1016/j.ajhg.2011.02.011; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Lin TK, 2012, J INVEST DERMATOL, V132, P2430, DOI 10.1038/jid.2012.173; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Radner FP, 2013, PLOS GENETI IN PRESS; Ramesh R, 2011, J DERMATOL SCI, V64, P159, DOI 10.1016/j.jdermsci.2011.07.006; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Rice RH, 2005, ARCH DERMATOL RES, V297, P127, DOI 10.1007/s00403-005-0591-7; Rice RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051956; Schmuth Matthias, 2007, Adv Dermatol, V23, P231, DOI 10.1016/j.yadr.2007.07.011; Schmuth M, 2013, EUR J HUM GENET, V21, P123, DOI 10.1038/ejhg.2012.121; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	29	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75355	10.1371/journal.pone.0075355	http://dx.doi.org/10.1371/journal.pone.0075355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130705	gold, Green Published			2022-12-25	WOS:000325810900031
J	Buyyarapu, R; Kantety, RV; Yu, JZ; Xu, ZY; Kohel, RJ; Percy, RG; Macmil, S; Wiley, GB; Roe, BA; Sharma, GC				Buyyarapu, Ramesh; Kantety, Ramesh V.; Yu, John Z.; Xu, Zhanyou; Kohel, Russell J.; Percy, Richard G.; Macmil, Simone; Wiley, Graham B.; Roe, Bruce A.; Sharma, Govind C.			BAC-Pool Sequencing and Analysis of Large Segments of A12 and D12 Homoeologous Chromosomes in Upland Cotton	PLOS ONE			English	Article							X GOSSYPIUM-BARBADENSE; EVOLUTION; GENOME; MAP; ORGANIZATION; ARABIDOPSIS; ANNOTATION	Although new and emerging next-generation sequencing (NGS) technologies have reduced sequencing costs significantly, much work remains to implement them for de novo sequencing of complex and highly repetitive genomes such as the tetraploid genome of Upland cotton (Gossypium hirsutum L.). Herein we report the results from implementing a novel, hybrid Sanger/454-based BAC-pool sequencing strategy using minimum tiling path (MTP) BACs from Ctg-3301 and Ctg-465, two large genomic segments in A12 and D12 homoeologous chromosomes (Ctg). To enable generation of longer contig sequences in assembly, we implemented a hybrid assembly method to process similar to 35x data from 454 technology and 2.8-3x data from Sanger method. Hybrid assemblies offered higher sequence coverage and better sequence assemblies. Homology studies revealed the presence of retrotransposon regions like Copia and Gypsy elements in these contigs and also helped in identifying new genomic SSRs. Unigenes were anchored to the sequences in Ctg-3301 and Ctg-465 to support the physical map. Gene density, gene structure and protein sequence information derived from protein prediction programs were used to obtain the functional annotation of these genes. Comparative analysis of both contigs with Arabidopsis genome exhibited synteny and microcollinearity with a conserved gene order in both genomes. This study provides insight about use of MTP-based BAC-pool sequencing approach for sequencing complex polyploid genomes with limited constraints in generating better sequence assemblies to build reference scaffold sequences. Combining the utilities of MTP-based BAC-pool sequencing with current longer and short read NGS technologies in multiplexed format would provide a new direction to cost-effectively and precisely sequence complex plant genomes.	[Buyyarapu, Ramesh; Kantety, Ramesh V.; Sharma, Govind C.] Alabama A&M Univ, Dept Biol & Environm Sci, Ctr Mol Biol, Normal, AL 35762 USA; [Yu, John Z.; Xu, Zhanyou; Kohel, Russell J.; Percy, Richard G.] ARS, USDA, Southern Plains Agr Res Ctr, Crop Germplasm Res Unit, College Stn, TX USA; [Roe, Bruce A.] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Macmil, Simone] Univ Otago, Gene Struct & Funct Lab, Dunedin, New Zealand; [Wiley, Graham B.] Oklahoma Med Res Fdn, Arthrit & Immunol Dept, Oklahoma City, OK 73104 USA	Alabama A&M University; United States Department of Agriculture (USDA); University of Oklahoma System; University of Oklahoma - Norman; University of Otago; Oklahoma Medical Research Foundation	Buyyarapu, R (corresponding author), Dow AgroSci, Trait Genet & Technol, Indianapolis, IN USA.	rbuyyarapu@dow.com		Cree, Simone/0000-0002-7349-422X; Buyyarapu, Ramesh/0000-0002-5343-9960	USDA-CSREES [ALAX-011-706, ALAX-011-206]; NSF-PGRP [0703470]	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF-PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors would like to acknowledge the funding support for this work by USDA-CSREES grants ALAX-011-706 to RVK, ALAX-011-206 to GCS and NSF-PGRP grant 0703470 to RVK. The authors would like to acknowledge the support offered by Padmini Sripathi during data analysis and submissions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Brown CT, 2011, APPL ENV MICROBIOLOG; Buyyarapu R, 2009, BAC POOL 454 SEQUENC, pW121; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Green P, 1999, PHRAP SWAT CROSSMATC; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hawkins JS, 2008, GENOME, V51, P11, DOI [10.1139/G07-099, 10.1139/g07-099]; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Nautiyal S, 2010, P NATL ACAD SCI USA, V107, P12587, DOI 10.1073/pnas.1005173107; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; REINISCH AJ, 1994, GENETICS, V138, P829; Robinson AJ, 2004, BIOINFORMATICS, V20, P1475, DOI 10.1093/bioinformatics/bth104; Roe B, 2004, SHOTGUN LIB CONSTRUC, V255; ROE BA, 1996, DNA ISOLATION SEQUEN; Rong J, 2005, GENOME RES, V15, P1198, DOI 10.1101/gr.3907305; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shappley ZW, 1996, THEOR APPL GENET, V92, P915, DOI 10.1007/BF00224030; Shappley ZW, 1998, THEOR APPL GENET, V97, P756, DOI 10.1007/s001220050952; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Wiley G, 2009, METHODS GENERATING S; Wilkins T, 2013, PLANT ANIMAL GENOME; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Zhang MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033644	42	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76757	10.1371/journal.pone.0076757	http://dx.doi.org/10.1371/journal.pone.0076757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116150	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200065
J	Graham, MT; Abram, CL; Hu, YM; Lowell, CA				Graham, Michelle T.; Abram, Clare L.; Hu, Yongmei; Lowell, Clifford A.			Expression of the TEL-Syk Fusion Protein in Hematopoietic Stem Cells Leads to Rapidly Fatal Myelofibrosis in Mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MYELOPROLIFERATIVE NEOPLASMS; ACTIVATION; MUTATIONS; KINASE; GENE; LEUKEMOGENESIS; PATHOGENESIS; LYMPHOMA; TARGET	The TEL-Syk fusion protein was isolated from a patient with myelodysplasia with megakaryocyte blasts. Expression of TEL-Syk transforms interleukin-3 (IL-3)-dependent Ba/F3 cells in vitro by deregulating STAT5-mediated signal transduction pathways. In vivo, TEL-Syk expression in pre-B cells blocks B cell differentiation, leading to lymphoid leukemia. Here, we demonstrate that TEL-Syk introduced into fetal liver hematopoietic cells, which are then adoptively transferred into lethally irradiated recipients, leads to an aggressive myelodysplasia with myelofibrosis that is lethal in mice by 60-75 days. Expression of TEL-Syk induces a short-lived myeloexpansion that is rapidly followed by bone marrow failure and extreme splenic/hepatic fibrosis accompanied by extensive apoptosis. The disease is dependent on Syk kinase activity. Analysis of serum from TEL-Syk mice reveals an inflammatory cytokine signature reminiscent of that found in the sera from patients and mouse models of myeloproliferative neoplasms. TEL-Syk expressing cells showed constitutive STAT5 phosphorylation, which was resistant to JAK inhibition, consistent with deregulated cytokine signaling. These data indicate that expression of TEL-Syk in fetal liver hematopoietic cells results in JAK-independent STAT5 phosphorylation ultimately leading to a uniquely aggressive and lethal form of myelofibrosis.	[Graham, Michelle T.; Abram, Clare L.; Hu, Yongmei; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	clifford.lowell@ucsf.edu			US National Institutes of Health [AI65495, AI68150, AI078869]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078869, R01AI065495, R01AI068150] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (AI65495, AI68150 and AI078869 to C. A. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bisen A, 2013, ADV EXP MED BIOL, V779, P179, DOI 10.1007/978-1-4614-6176-0_8; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Holroyd A, 2011, LEUKEMIA RES, V35, P1279, DOI 10.1016/j.leukres.2011.05.037; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; Meester-Smoor MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023620; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; Pardanani A, 2012, LEUKEMIA, V26, P693, DOI 10.1038/leu.2011.251; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rigby S, 2009, J BIOL CHEM, V284, P26871, DOI 10.1074/jbc.M109.034272; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Takeda Y, 2011, BRIT J HAEMATOL, V153, P589, DOI 10.1111/j.1365-2141.2011.08663.x; Tanaka H, 2010, LEUKEMIA, V24, P197, DOI 10.1038/leu.2009.167; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Thiele J, 2005, SEMIN ONCOL, V32, P380, DOI 10.1053/j.seminoncol.2005.04.010; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381	31	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77542	10.1371/journal.pone.0077542	http://dx.doi.org/10.1371/journal.pone.0077542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116232	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200118
J	Wimuttisuk, W; Tobwor, P; Deenarn, P; Danwisetkanjana, K; Pinkaew, D; Kirtikara, K; Vichai, V				Wimuttisuk, Wananit; Tobwor, Punsa; Deenarn, Pacharawan; Danwisetkanjana, Kannawat; Pinkaew, Decha; Kirtikara, Kanyawim; Vichai, Vanicha			Insights into the Prostanoid Pathway in the Ovary Development of the Penaeid Shrimp Penaeus monodon	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE; UNSATURATED FATTY-ACIDS; LONE STAR TICK; EICOSANOID BIOSYNTHESIS; MOLECULAR-CLONING; ARACHIDONIC-ACID; IDENTIFICATION; 9-ALPHA,11-BETA-PROSTAGLANDIN-F2; VITELLOGENESIS; INVERTEBRATES	The prostanoid pathway converts polyunsaturated fatty acids (PUFAs) into bioactive lipid mediators, including prostaglandins, thromboxanes and prostacyclins, all of which play vital roles in the immune and reproductive systems in most animal phyla. In crustaceans, PUFAs and prostaglandins have been detected and often associated with female reproductive maturation. However, the presence of prostanoid biosynthesis genes remained in question in these species. In this study, we outlined the prostanoid pathway in the black tiger shrimp Penaeus monodon based on the amplification of nine prostanoid biosynthesis genes: cytosolic phospholipase A2, hematopoietic prostaglandin D synthase, glutathione-dependent prostaglandin D synthase, prostaglandin E synthase 1, prostaglandin E synthase 2, prostaglandin E synthase 3, prostaglandin F synthase, thromboxane A synthase and cyclooxygenase. TBLASTX analysis confirmed the identities of these genes with 51-99% sequence identities to their closest homologs. In addition, prostaglandin F-2 alpha (PGF(2 alpha)), which is a product of the prostaglandin F synthase enzyme, was detected for the first time in P. monodon ovaries along with the previously identified PUFAs and prostaglandin E-2 (PGE(2)) using RP-HPLC and mass-spectrometry. The prostaglandin synthase activity was also observed in shrimp ovary homogenates using in vitro activity assay. When prostaglandin biosynthesis was examined in different stages of shrimp ovaries, we found that the amounts of prostaglandin F synthase gene transcripts and PGF(2 alpha) decreased as the ovaries matured. These findings not only indicate the presence of a functional prostanoid pathway in penaeid shrimp, but also suggest a possible role of the PGF(2 alpha) biosynthesis in shrimp ovarian development.	[Wimuttisuk, Wananit; Tobwor, Punsa; Deenarn, Pacharawan; Danwisetkanjana, Kannawat; Pinkaew, Decha; Kirtikara, Kanyawim; Vichai, Vanicha] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Wimuttisuk, W (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand.	wananit.wim@biotec.or.th	vichai, vanicha/F-2122-2011; Pinkaew, Decha/AAD-3335-2022; Wimuttisuk, Wananit/F-5438-2018	vichai, vanicha/0000-0002-3778-2080; Pinkaew, Decha/0000-0001-8334-1545; Tobwor, Punsa/0000-0002-2274-1147; Wimuttisuk, Wananit/0000-0002-0897-506X	National Science and Technology Development Agency [BT-02-SG-BC-5105, BT-02-SG-BO-5203]	National Science and Technology Development Agency	This work has been supported by the National Science and Technology Development Agency (Grant number BT-02-SG-BC-5105 and BT-02-SG-BO-5203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOWMAN AS, 1995, INSECT BIOCHEM MOLEC, V25, P735, DOI 10.1016/0965-1748(95)00013-L; BRENNER RR, 1987, COMP BIOCHEM PHYS B, V87, P815, DOI 10.1016/0305-0491(87)90394-4; Campbell EM, 2009, PARASITOLOGY, V136, P867, DOI 10.1017/S0031182009990357; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GADELHAK GG, 1995, INSECT BIOCHEM MOLEC, V25, P743, DOI 10.1016/0965-1748(95)00014-M; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gonzalez-Felix ML, 2009, J WORLD AQUACULT SOC, V40, P194, DOI 10.1111/j.1749-7345.2009.00242.x; HAMPSON AJ, 1992, BIOCHIM BIOPHYS ACTA, V1124, P143, DOI 10.1016/0005-2760(92)90090-I; Heckmann LH, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-11; Huang JH, 2008, AQUAC RES, V39, P240, DOI 10.1111/j.1365-2109.2007.01868.x; Huang XQ, 2006, BIOORGAN MED CHEM, V14, P3553, DOI 10.1016/j.bmc.2006.01.010; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kashiwagi T, 2000, ACTA NEUROBIOL EXP, V60, P9; Kobayashi T, 2004, BIOCHEM J, V381, P59, DOI 10.1042/BJ20040118; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Kuley E, 2008, INT J FOOD SCI NUTR, V59, P573, DOI 10.1080/09637480701451201; Leelatanawit R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052677; LISTON TE, 1985, P NATL ACAD SCI USA, V82, P6030, DOI 10.1073/pnas.82.18.6030; LOHER W, 1981, P NATL ACAD SCI-BIOL, V78, P7835, DOI 10.1073/pnas.78.12.7835; McKillen DJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-34; Meunpol O, 2005, AQUAC RES, V36, P1216, DOI 10.1111/j.1365-2109.2005.01342.x; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; MURIANA FJG, 1995, BIOCHIMIE, V77, P190, DOI 10.1016/0300-9084(96)88124-7; PAGES M, 1986, PROSTAG OTH LIPID M, V32, P729, DOI 10.1016/0090-6980(86)90195-4; Parent J, 2005, PROSTAG OTH LIPID M, V78, P27, DOI 10.1016/j.prostaglandins.2005.02.005; PEDIBHOTLA VK, 1995, INSECT BIOCHEM MOLEC, V25, P1027, DOI 10.1016/0965-1748(95)00039-X; Preechaphol R, 2010, GENET MOL BIOL, V33, P676, DOI 10.1590/S1415-47572010000400014; RAGAB A, 1991, INSECT BIOCHEM, V21, P321, DOI 10.1016/0020-1790(91)90022-7; Ravid T, 1999, J EXP BIOL, V202, P1819; Reddy PS, 2004, GEN COMP ENDOCR, V135, P35, DOI 10.1016/j.ygcen.2003.08.002; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; SANDEE D, 2008, PROSTAG OTH LIPID M, V88, P111; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Spaziani EP, 1995, PROSTAGLANDINS, V50, P189, DOI 10.1016/0090-6980(95)00124-7; Spaziani EP, 1997, INVERTEBR REPROD DEV, V32, P21, DOI 10.1080/07924259.1997.9672600; Stanley D, 2006, ANNU REV ENTOMOL, V51, P25, DOI 10.1146/annurev.ento.51.110104.151021; Stanley DW, 1998, AM ZOOL, V38, P369; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varvas K, 2009, INSECT BIOCHEM MOLEC, V39, P851, DOI 10.1016/j.ibmb.2009.10.002; Waclawik A, 2006, ENDOCRINOLOGY, V147, P210, DOI 10.1210/en.2005-0880; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1985, J BIOL CHEM, V260, P7035; Watanabe K, 2003, BIOCHEM BIOPH RES CO, V306, P577, DOI 10.1016/S0006-291X(03)01025-8; XU XL, 1994, AQUACULTURE, V119, P359, DOI 10.1016/0044-8486(94)90300-X	55	43	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76934	10.1371/journal.pone.0076934	http://dx.doi.org/10.1371/journal.pone.0076934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116186	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200086
J	Laarakkers, CMM; Wiegerinck, ET; Klaver, S; Kolodziejczyk, M; Gille, H; Hohlbaum, AM; Tjalsma, H; Swinkels, DW				Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Kolodziejczyk, Maria; Gille, Hendrik; Hohlbaum, Andreas M.; Tjalsma, Harold; Swinkels, Dorine W.			Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform	PLOS ONE			English	Article							SERUM HEPCIDIN; LIQUID-CHROMATOGRAPHY; ROUND-ROBIN; QUANTIFICATION; FERROPORTIN; URINE; VARIABILITY; MUTATION	Mass spectrometry (MS)-based assays for the quantification of the iron regulatory hormone hepcidin are pivotal to discriminate between the bioactive 25-amino acid form that can effectively block the sole iron transporter ferroportin and other naturally occurring smaller isoforms without a known role in iron metabolism. Here we describe the design, validation and use of a novel stable hepcidin-25(+40) isotope as internal standard for quantification. Importantly, the relative large mass shift of 40 Da makes this isotope also suitable for easy-to-use medium resolution linear time-of-flight (TOF) platforms. As expected, implementation of hepcidin-25(+40) as internal standard in our weak cation exchange (WCX) TOF MS method yielded very low inter/intra run coefficients of variation. Surprisingly, however, in samples from kidney disease patients, we detected a novel peak (m/z 2673.9) with low intensity that could be identified as hepcidin-24 and had previously remained unnoticed due to peak interference with the formerly used internal standard. Using a cell-based bioassay it was shown that synthetic hepcidin-24 was, like the -22 and -20 isoforms, a significantly less potent inducer of ferroportin degradation than hepcidin-25. During prolonged storage of plasma at room temperature, we observed that a decrease in plasma hepcidin-25 was paralleled by an increase in the levels of the hepcidin-24, -22 and -20 isoforms. This provides first evidence that all determinants for the conversion of hepcidin-25 to smaller inactive isoforms are present in the circulation, which may contribute to the functional suppression of hepcidin-25, that is significantly elevated in patients with renal impairment. The present update of our hepcidin TOF MS assay together with improved insights in the source and preparation of the internal standard, and sample stability will further improve our understanding of circulating hepcidin and pave the way towards further optimization and standardization of plasma hepcidin assays.	[Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Tjalsma, Harold; Swinkels, Dorine W.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Laarakkers, Coby M. M.; Wiegerinck, Erwin T.; Klaver, Siem; Tjalsma, Harold; Swinkels, Dorine W.] Hepcidinanal Com, Nijmegen, Netherlands; [Kolodziejczyk, Maria; Gille, Hendrik; Hohlbaum, Andreas M.] Pieris AG, Freising Weihenstephan, Germany	Radboud University Nijmegen	Swinkels, DW (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands.	d.swinkels@labgk.umcn.nl	Swinkels, Dorine W./H-8098-2014; Girelli, Domenico/B-1183-2008	Swinkels, Dorine W./0000-0002-1040-9446; Girelli, Domenico/0000-0001-9684-1899	European Union [FP7-HEALTH-F4-2011-278408]	European Union(European Commission)	This work was in part funded by the European Union (grant agreement No. FP7-HEALTH-F4-2011-278408; http://www.eurocalin-fp7.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ambaglio I, 2013, HAEMATOLOGICA, V98, P420, DOI 10.3324/haematol.2012.077446; Anderson DS, 2011, ANAL CHEM, V83, P8357, DOI 10.1021/ac2020905; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Campostrini N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/329646; Campostrini N, 2012, J PROTEOMICS, V76, P28, DOI 10.1016/j.jprot.2012.08.006; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Hohlbaum AM, 2011, BLOOD, V118, P314, DOI 10.1182/blood.V118.21.687.687; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Itkonen O, 2012, CLIN CHIM ACTA, V413, P696, DOI 10.1016/j.cca.2011.12.015; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Kobold U, 2008, CLIN CHEM, V54, P1584, DOI 10.1373/clinchem.2008.107029; Kroot JJC, 2012, AM J HEMATOL, V87, P977, DOI 10.1002/ajh.23289; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Li Hongyan, 2009, Journal of Pharmacological and Toxicological Methods, V59, P171, DOI 10.1016/j.vascn.2009.02.004; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nemeth E, 2006, BLOOD, V107, P328, DOI 10.1182/blood-2005-05-2049; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peters HPE, 2012, NEPHROL DIAL TRANSPL, V27, P3923, DOI 10.1093/ndt/gfs164; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Santini V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023109; Schaap CCM, 2013, CLIN CHEM, V59, P527, DOI 10.1373/clinchem.2012.194977; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schranz M, 2009, BLOOD CELL MOL DIS, V43, P169, DOI 10.1016/j.bcmd.2009.03.008; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623; Ward DG, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-28	37	69	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75518	10.1371/journal.pone.0075518	http://dx.doi.org/10.1371/journal.pone.0075518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124495	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100052
J	Liong, S; Di Quinzio, MKW; Fleming, G; Permezel, M; Georgiou, HM				Liong, Stella; Di Quinzio, Megan K. W.; Fleming, Gabrielle; Permezel, Michael; Georgiou, Harry M.			Is Vitamin D Binding Protein a Novel Predictor of Labour?	PLOS ONE			English	Article							GROUP-SPECIFIC COMPONENT; COMPREHENSIVE PROTEOMIC ANALYSIS; GC-GLOBULIN; SERUM CONCENTRATION; FETAL FIBRONECTIN; PRETERM BIRTH; PLASMA; ACTIN; 25-HYDROXYVITAMIN-D; PHENOTYPE	Vitamin D binding protein (VDBP) has previously been identified in the amniotic fluid and cervicovaginal fluid (CVF) of pregnant women. The biological functions of VDBP include acting as a carrier protein for vitamin D metabolites, the clearance of actin that is released during tissue injury and the augmentation of the pro-inflammatory response. This longitudinal observational study was conducted on 221 healthy pregnant women who spontaneously laboured and delivered either at term or preterm. Serial CVF samples were collected and VDBP was measured by ELISA. Binary logistic regression analysis was performed to assess the utility of VDBP as a predictor of labour. VDBP in the CVF did not change between 20 and 35 weeks' gestation. VDBP measured in-labour was significantly increased 4.2 to 7.4-fold compared to 4-7, 8-14 and 15-28 days before labour (P<0.05). VDBP concentration was 4.3-fold significantly higher at 0-3 days compared to 15-28 days pre-labour (P<0.05). The efficacy of VDBP to predict spontaneous labour onset within 3 days provided a positive and negative predictive value of 82.8% and 95.3% respectively (area under receiver operator characteristic curve = 0.974). This longitudinal study of pregnant women suggests that VDBP in the CVF may be a useful predictor of labour.	[Liong, Stella; Di Quinzio, Megan K. W.; Permezel, Michael; Georgiou, Harry M.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Liong, Stella; Di Quinzio, Megan K. W.; Fleming, Gabrielle; Permezel, Michael; Georgiou, Harry M.] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Georgiou, HM (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	harrymg@unimelb.edu.au	Georgiou, A/Prof Harry/C-7143-2008; Liong, Stella/AAQ-5308-2021	Georgiou, A/Prof Harry/0000-0003-0553-9489; Liong, Stella/0000-0001-6131-858X; Di Quinzio, Megan/0000-0003-0220-857X	Medical Research Foundation for Women and Babies; Australian Postgraduate Award scholarship	Medical Research Foundation for Women and Babies; Australian Postgraduate Award scholarship	Financial support for this study was provided by the Medical Research Foundation for Women and Babies. SL is a recipient of an Australian Postgraduate Award scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNER R, 1995, AM J OBSTET GYNECOL, V172, P134, DOI 10.1016/0002-9378(95)90101-9; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Borges CR, 2008, J PROTEOME RES, V7, P4143, DOI 10.1021/pr8002936; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; CLEVE H, 1988, VOX SANG, V54, P215, DOI 10.1111/j.1423-0410.1988.tb03908.x; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Dasari S, 2007, J PROTEOME RES, V6, P1258, DOI 10.1021/pr0605419; Debruyne E, 2011, CLIN CHEM LAB MED, V49, P1855, DOI 10.1515/CCLM.2011.676; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; DiMartino SJ, 1999, J IMMUNOL, V163, P2135; EMERSON DL, 1985, AM J REPROD IM MIC, V7, P15; EMERSON DL, 1983, AM J REPROD IMMUNOL, V4, P185, DOI 10.1111/j.1600-0897.1983.tb00276.x; Ezura Y, 2003, J BONE MINER RES, V18, P1642, DOI 10.1359/jbmr.2003.18.9.1642; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GUHA C, 1995, HEPATOLOGY, V21, P1675; HADDAD JG, 1982, ARCH BIOCHEM BIOPHYS, V213, P538, DOI 10.1016/0003-9861(82)90581-1; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Heng YJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.011; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; HOLLIS BW, 1986, J CLIN ENDOCR METAB, V62, P41, DOI 10.1210/jcem-62-1-41; Ito I, 2004, CHEST, V125, P63, DOI 10.1378/chest.125.1.63; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Liong S, 2013, REPRODUCTION, V145, P137, DOI 10.1530/REP-12-0264; Malak TM, 1996, BRIT J OBSTET GYNAEC, V103, P648, DOI 10.1111/j.1471-0528.1996.tb09832.x; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; NESTLER JE, 1987, ENDOCRINOLOGY, V120, P1996, DOI 10.1210/endo-120-5-1996; Pereira L, 2007, J PROTEOME RES, V6, P1269, DOI 10.1021/pr0605421; PEREZ HD, 1994, INFLAMMATION, V18, P215, DOI 10.1007/BF01534562; PETERSON PA, 1971, J BIOL CHEM, V246, P7748; PETRINI M, 1984, CLIN IMMUNOL IMMUNOP, V31, P282, DOI 10.1016/0090-1229(84)90248-4; PIQUETTE CA, 1994, J LEUKOCYTE BIOL, V55, P349, DOI 10.1002/jlb.55.3.349; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Tang LJ, 2007, J PROTEOME RES, V6, P2874, DOI 10.1021/pr0700899; YAMAMOTO N, 1991, P NATL ACAD SCI USA, V88, P8539, DOI 10.1073/pnas.88.19.8539; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17	39	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76490	10.1371/journal.pone.0076490	http://dx.doi.org/10.1371/journal.pone.0076490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124566	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100123
J	MacArthur, CJ; Hausman, F; Kempton, JB; Choi, D; Trune, DR				MacArthur, Carol J.; Hausman, Fran; Kempton, J. Beth; Choi, Dongseok; Trune, Dennis R.			Otitis Media Impacts Hundreds of Mouse Middle and Inner Ear Genes	PLOS ONE			English	Article							ROUND WINDOW MEMBRANE; EXPRESSION PATTERN; UP-REGULATION; PROBE LEVEL; INTERLEUKIN-1-BETA; INFLAMMATION; ACTIVATION; FIBROCYTES; IL-1-BETA; PATHOLOGY	Objective: Otitis media is known to alter expression of cytokine and other genes in the mouse middle ear and inner ear. However, whole mouse genome studies of gene expression in otitis media have not previously been undertaken. Ninety-nine percent of mouse genes are shared in the human, so these studies are relevant to the human condition. Methods: To assess inflammation-driven processes in the mouse ear, gene chip analyses were conducted on mice treated with trans-tympanic heat-killed Hemophilus influenza using untreated mice as controls. Middle and inner ear tissues were separately harvested at 6 hours, RNA extracted, and samples for each treatment processed on the Affymetrix 430 2.0 Gene Chip for expression of its 34,000 genes. Results: Statistical analysis of gene expression compared to control mice showed significant alteration of gene expression in 2,355 genes, 11% of the genes tested and 8% of the mouse genome. Significant middle and inner ear upregulation (fold change >1.5, p<0.05) was seen in 1,081 and 599 genes respectively. Significant middle and inner ear downregulation (fold change <0.67, p<0.05) was seen in 978 and 287 genes respectively. While otitis media is widely believed to be an exclusively middle ear process with little impact on the inner ear, the inner ear changes noted in this study were numerous and discrete from the middle ear responses. This suggests that the inner ear does indeed respond to otitis media and that its response is a distinctive process. Numerous new genes, previously not studied, are found to be affected by inflammation in the ear. Conclusion: Whole genome analysis via gene chip allows simultaneous examination of expression of hundreds of gene families influenced by inflammation in the middle ear. Discovery of new gene families affected by inflammation may lead to new approaches to the study and treatment of otitis media.	[MacArthur, Carol J.; Trune, Dennis R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [MacArthur, Carol J.; Hausman, Fran; Kempton, J. Beth; Trune, Dennis R.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	MacArthur, CJ (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA.	macarthc@ohsu.edu		Choi, Dongseok/0000-0002-1552-4072	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) [R01 DC009455]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009455, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) grant R01 DC009455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basoglu MS, 2012, INT J PEDIATR OTORHI, V76, P64, DOI 10.1016/j.ijporl.2011.10.001; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Copeland NG, 2002, SCIENCE, V296, P1617, DOI 10.1126/science.1073127; Cureoglu S, 2005, ACTA OTO-LARYNGOL, V125, P9, DOI 10.1080/00016480410022534; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Faffe DS, 2005, AM J PHYSIOL-LUNG C, V288, pL1040, DOI 10.1152/ajplung.00333.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghaheri BA, 2007, OTOLARYNG HEAD NECK, V137, P332, DOI 10.1016/j.otohns.2007.03.020; Ghaheri BA, 2007, LARYNGOSCOPE, V117, P22, DOI 10.1097/01.mlg.0000240170.48584.73; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Juhn SK, 1997, ANN NY ACAD SCI, V830, P130, DOI 10.1111/j.1749-6632.1997.tb51885.x; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; MacArthur CJ, 2013, OTOL NEUROTOL, V34, P338, DOI 10.1097/MAO.0b013e31827b4d0a; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; MacArthur CJ, 2011, LARYNGOSCOPE, V121, P365, DOI 10.1002/lary.21349; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; MEYERHOFF WL, 1978, ANN OTO RHINOL LARYN, V87, P749, DOI 10.1177/000348947808700602; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; Morris LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039004; Oh S, 2012, J IMMUNOL, V188, P3496, DOI 10.4049/jimmunol.1103182; Page AV, 2011, INFECT DIS CLIN N AM, V25, P803, DOI 10.1016/j.idc.2011.07.007; PAPARELLA MM, 1984, ANN OTO RHINOL LARYN, V93, P623, DOI 10.1177/000348948409300616; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P911, DOI 10.1097/00006454-200009000-00034; Schachern P, 2008, ARCH OTOLARYNGOL, V134, P658, DOI 10.1001/archotol.134.6.658; Smirnova MG, 2002, EUR CYTOKINE NETW, V13, P161; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Woo JI, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-314; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang Q, 2010, ACTA OTO-LARYNGOL, V130, P68, DOI 10.3109/00016480902974183; Zhang Q, 2009, ORL-J OTO-RHIN-LARYN, V71, P70, DOI 10.1159/000182419	32	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75213	10.1371/journal.pone.0075213	http://dx.doi.org/10.1371/journal.pone.0075213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124478	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100035
J	Zhang, J; Ke, KF; Liu, Z; Qiu, YH; Peng, YP				Zhang, Jun; Ke, Kai-Fu; Liu, Zhan; Qiu, Yi-Hua; Peng, Yu-Ping			Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of A beta(1-42)-Induced Alzheimer's Disease Model Rats	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BRAIN-BARRIER DISRUPTION; T-CELLS; INFLAMMATION; EXPRESSION; PEPTIDE; FAS; LYMPHOCYTES; DEATH; IL-21	Neuroinflammation, especially innate immunocyte-mediated neuroinflammation, has been reported to participate in pathogenesis of Alzheimer's disease (AD). However, the involvement of adaptive immune cells, such as CD4(+) T lymphocytes, in pathogenesis of AD is not well clarified. Herein, we focus on T helper 17 (Th17) cells, a subpopulation of CD4(+) T cells with high proinflammation, and show the implication of the cells in neurodegeneration of AD. Amyloid beta(1-42) (A beta(1-42)) was bilaterally injected into hippocampus of rats to induce AD. On days 7 and 14 following the A beta(1-42) administration, escape latency of the rats in Morris water maze was increased, expression of amyloid precursor protein was upregulated, but expression of protein phosphatase 2A was downregulated in the hippocampus, and Nissl stain showed neuronal loss and gliosis in CA1 region. Infusion of FITC-linked albumin in blood circulation and combination with immunostaining of hippocampal sections for ROR gamma, a specific transcriptional factor of Th17 cells, demonstrated blood-brain barrier (BBB) disruption and Th17 cells' infiltration into brain parenchyma of AD rats. Expression of Th17 proinflammatory cytokines, interleukin (IL)-17 and IL-22, was increased in the hippocampus, and concentrations of the two cytokines were elevated in both the cerebrospinal fluid and the serum in AD occurrence and development. Compared with intact or saline-treated control rats, AD animals indicated an upregulated expression of Fas and FasL in the hippocampus. Further, the immunofluorescent histochemistry on AD hippocampal sections with NeuN, RORc, Fas and FasL displayed that Fas was principally expressed by neurons and FasL was predominantly expressed by Th17 cells, and that neuronal apoptosis shown by TUNEL and NeuN double-labeled cells increased. These results suggest that Th17 cells, which were infiltrated into AD brain parenchyma, participate in neuroinflammation and neurodegeneration of AD by release of proinflammatory cytokines and by direct action on neurons via Fas/FasL apoptotic pathway.	[Zhang, Jun; Liu, Zhan; Qiu, Yi-Hua; Peng, Yu-Ping] Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China; [Zhang, Jun; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Qiu, YH (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China.	yhqiu@ntu.edu.cn; yppeng@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [81271323]; Natural Science Foundation of Jiangsu Province of China [BK2010278, BK2011386]; Nantong Applied Research Program of China [BK2012014, BK2012015, CP12012003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Nantong Applied Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants 81271323 from the National Natural Science Foundation of China, BK2010278 and BK2011386 from the Natural Science Foundation of Jiangsu Province of China, BK2012014, BK2012015 and CP12012003 from the Nantong Applied Research Program of China, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Fang YJ, 2010, J LEUKOCYTE BIOL, V87, P1019, DOI 10.1189/jlb.0509352; Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696; GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5; Giuffrida ML, 2007, J NEUROSCI RES, V85, P623, DOI 10.1002/jnr.21135; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Higuchi M, 2010, INT J GERIATR PSYCH, V25, P604, DOI 10.1002/gps.2381; Iqbal Khalid, 2005, Current Alzheimer Research, V2, P335, DOI 10.2174/1567205054367810; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McLarnon JG, 2008, CURR ALZHEIMER RES, V5, P475, DOI 10.2174/156720508785908874; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Passos GF, 2010, BRAIN BEHAV IMMUN, V24, P493, DOI 10.1016/j.bbi.2009.12.003; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Saresella M, 2011, BRAIN BEHAV IMMUN, V25, P539, DOI 10.1016/j.bbi.2010.12.004; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735	30	54	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75786	10.1371/journal.pone.0075786	http://dx.doi.org/10.1371/journal.pone.0075786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124514	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100071
J	Ren, HB; Condit, R; Chen, B; Mi, XC; Cao, M; Ye, WH; Hao, ZQ; Ma, KP				Ren, Haibao; Condit, Richard; Chen, Bin; Mi, Xiangcheng; Cao, Min; Ye, Wanhui; Hao, Zhanqing; Ma, Keping			Geographical Range and Local Abundance of Tree Species in China	PLOS ONE			English	Article							SIZE RELATIONSHIPS; OCCUPANCY RELATIONSHIPS; SPATIAL VARIATION; BRITISH AVIFAUNA; LIFE-HISTORY; FOREST PLOT; PATTERNS; DISTRIBUTIONS; COMMUNITY; CONSERVATION	Most studies on the geographical distribution of species have utilized a few well-known taxa in Europe and North America, with little research in China and its wide range of climate and forest types. We assembled large datasets to quantify the geographic ranges of tree species in China and to test several biogeographic hypotheses: 1) whether locally abundant species tend to be geographically widespread; 2) whether species are more abundant towards their range-centers; and 3) how abundances are correlated between sites. Local abundances of 651 species were derived from four tree plots of 2025 ha where all individuals >= 1 cm in stem diameter were mapped and identified taxonomically. Range sizes of these species across China were then estimated from over 460,000 geo-referenced records; a Bayesian approach was used, allowing careful measures of error of each range estimate. The log-transformed range sizes had a bell-shaped distribution with a median of 703,000 km(2), and >90% of 651 species had ranges. 10(5) km(2). There was no relationship between local abundance and range size, and no evidence for species being more abundant towards their range-centers. Finally, species' abundances were positively correlated between sites. The widespread nature of most tree species in China suggests few are vulnerable to global extinction, and there is no indication of the double-peril that would result if rare species also had narrow ranges.	[Ren, Haibao; Chen, Bin; Mi, Xiangcheng; Ma, Keping] Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Condit, Richard] Smithsonian Trop Res Inst, Panama City, Panama; [Cao, Min] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Ye, Wanhui] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hao, Zhanqing] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Smithsonian Institution; Smithsonian Tropical Research Institute; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn			NSFC Project [30670311]; China National Program for R & D Infrastructure and Facility Development [2008BAC39B02]; CTFS-SiGEO workshop series; NSF [DEB-1046113]; Direct For Biological Sciences [1354741] Funding Source: National Science Foundation	NSFC Project(National Natural Science Foundation of China (NSFC)); China National Program for R & D Infrastructure and Facility Development; CTFS-SiGEO workshop series; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by NSFC Project (30670311), China National Program for R & D Infrastructure and Facility Development (2008BAC39B02), and the CTFS-SiGEO workshop series, funded by NSF Award DEB-1046113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ADV ECOL RES; [Anonymous], 2013, ADEHABITATHR HOME RA; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Blackburn TM, 1997, ECOGRAPHY, V20, P466, DOI 10.1111/j.1600-0587.1997.tb00414.x; Blackburn TM, 1998, ECOL LETT, V1, P47, DOI 10.1046/j.1461-0248.1998.00005.x; Blackburn TM, 2004, J BIOGEOGR, V31, P285, DOI 10.1046/j.0305-0270.2003.01018.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Condit R, 2001, BIOSCIENCE, V51, P389, DOI 10.1641/0006-3568(2001)051[0389:TSOTPC]2.0.CO;2; Condit R, 1998, TROPICAL FOREST CENS; Etherington TR, 2009, J BIOGEOGR, V36, P845, DOI 10.1111/j.1365-2699.2008.02041.x; Frost MT, 2004, ECOGRAPHY, V27, P643; Garcia-Barros E, 2010, ECOGRAPHY, V33, P392, DOI 10.1111/j.1600-0587.2010.06269.x; Gaston K.J., 1994, RARITY, P1; Gaston KJ, 1998, ECOL LETT, V1, P38, DOI 10.1046/j.1461-0248.1998.00004.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 1997, ECOGRAPHY, V20, P569, DOI 10.1111/j.1600-0587.1997.tb00425.x; GASTON KJ, 1990, OIKOS, V58, P329, DOI 10.2307/3545224; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1998, NATURE, V394, P229, DOI 10.1038/28288; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; HENGEVELD R, 1993, PROG PHYS GEOG, V17, P448, DOI 10.1177/030913339301700403; HENGEVELD R, 1982, J BIOGEOGR, V9, P303, DOI 10.2307/2844717; Hubbell Stephen P., 2001, V32, pi; Kenfack D, 2007, BIODIVERS CONSERV, V16, P2045, DOI 10.1007/s10531-006-9065-2; Kockemann B, 2009, J BIOGEOGR, V36, P854, DOI 10.1111/j.1365-2699.2008.02022.x; Kotze DJ, 2003, ECOGRAPHY, V26, P553, DOI 10.1034/j.1600-0587.2003.03488.x; Lan Guo-Yu, 2008, Zhiwu Shengtai Xuebao, V32, P287, DOI 10.3773/j.issn.1005-264x.2008.02.006; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Li Xi-Wen, 1994, Acta Botanica Yunnanica, V16, P221; Maurer BA, 1999, UNTANGLING ECOLOGICA; McGeoch MA, 2004, J ANIM ECOL, V73, P506, DOI 10.1111/j.0021-8790.2004.00825.x; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; Murphy HT, 2006, GLOBAL ECOL BIOGEOGR, V15, P63, DOI 10.1111/j.1466-822x.2006.00194.x; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poulin R, 2007, ECOGRAPHY, V30, P629, DOI 10.1111/j.2007.0906-7590.05139.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; R Core Team, 2012, R LANG ENV STAT COMP; Reif J, 2006, J BIOGEOGR, V33, P1959, DOI 10.1111/j.1365-2699.2006.01547.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; SPITZER K, 1988, OIKOS, V53, P31, DOI 10.2307/3565659; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stevens RD, 2004, J MAMMAL, V85, P698, DOI 10.1644/BWG-128; Stevenson MD, 2012, ECOGRAPHY, V35, P704, DOI 10.1111/j.1600-0587.2011.07292.x; Symonds MRE, 2006, GLOBAL ECOL BIOGEOGR, V15, P143, DOI 10.1111/j.1466-822x.2005.00198.x; Warren M, 2010, ECOGRAPHY, V33, P148, DOI 10.1111/j.1600-0587.2009.06041.x; Williams JN, 2010, J BIOGEOGR, V37, P951, DOI 10.1111/j.1365-2699.2009.02248.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wu Z.-Y., 1994, FLORA CHINA; Yang YM, 2004, BIODIVERS CONSERV, V13, P813, DOI 10.1023/B:BIOC.0000011728.46362.3c; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005	59	12	12	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76374	10.1371/journal.pone.0076374	http://dx.doi.org/10.1371/journal.pone.0076374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130772	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200037
J	Kobayashi, S; Suzuki, T; Igarashi, M; Orba, Y; Ohtake, N; Nagakawa, K; Niikura, K; Kimura, T; Kasamatsu, H; Sawa, H				Kobayashi, Shintaro; Suzuki, Tadaki; Igarashi, Manabu; Orba, Yasuko; Ohtake, Noriko; Nagakawa, Keita; Niikura, Kenichi; Kimura, Takashi; Kasamatsu, Harumi; Sawa, Hirofumi			Cysteine Residues in the Major Capsid Protein, Vp1, of the JC Virus Are Important for Protein Stability and Oligomer Formation	PLOS ONE			English	Article							SIMIAN VIRUS-40; CELLS; SIMIAN-VIRUS-40; RESOLUTION; BINDING; ROLES	The capsid of the human polyomavirus JC virus (JCV) consists of 72 pentameric capsomeres of a major structural protein, Vp1. The cysteine residues of the related Vp1 of SV40 are known to contribute to Vp1 folding, pentamer formation, pentamer-pentamer contacts, and capsid stabilization. In light of the presence of a slight structural difference between JCV Vp1 and SV40 counterpart, the way the former folds could be either different from or similar to the latter. We found a difference: an important contribution of Vp1 cysteines to the formation of infectious virions, unique in JCV and absent in SV40. Having introduced amino acid substitution at each of six cysteines (C42, C80, C97, C200, C247, and C260) in JCV Vp1, we found that, when expressed in HeLa cells, the Vp1 level was decreased in C80A and C247A mutants, and remained normal in the other mutants. Additionally, the C80A and C247A Vp1-expressing cell extracts did not show the hemagglutination activity characteristic of JCV particles. The C80A and C247A mutant Vp1s were found to be less stable than the wild-type Vp1 in HeLa cells. When produced in a reconstituted in vitro protein translation system, these two mutant proteins were stable, suggesting that some cellular factors were responsible for their degradation. As determined by their sucrose gradient sedimentation profiles, in vitro translated C247A Vp1 formed pentamers, but in vitro translated C80A Vp1 was entirely monomeric. When individually incorporated into the JCV genome, the C80A and C247A mutants, but not the other Vp1 cysteine residues mutants, interfered with JCV infectivity. Furthermore, the C80A, but not the C247A, mutation prevented the nuclear localization of Vp1 in JCV genome transfected cells. These findings suggest that C80 of JCV Vp1 is required for Vp1 stability and pentamer formation, and C247 is involved in capsid assembly in the nucleus.	[Kobayashi, Shintaro; Orba, Yasuko; Kimura, Takashi; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan; [Kobayashi, Shintaro; Sawa, Hirofumi] Hokkaido Univ, Global COE Program Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Igarashi, Manabu] Hokkaido Univ, Div Bioinfomat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Ohtake, Noriko; Nagakawa, Keita] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Niikura, Kenichi] Hokkaido Univ, RIES, Sapporo, Hokkaido, Japan; [Kasamatsu, Harumi] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Kasamatsu, Harumi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); Hokkaido University; Hokkaido University; Hokkaido University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sawa, H (corresponding author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan.	h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/AAW-8816-2021; Sawa, Hirofumi/F-6954-2012; Kobayashi, Shintaro/AFR-4313-2022; Igarashi, Manabu/F-6871-2012; Orba, Yasuko/F-6888-2012; Suzuki, Tadaki/ABH-2661-2020	Sawa, Hirofumi/0000-0003-2569-2755; Kobayashi, Shintaro/0000-0002-8735-5722; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Ministry of Health, Labor and Welfare, Japan; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan; University of California, USA	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of California, USA	This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Ministry of Health, Labor and Welfare, Japan; and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Japan; and gifts to H. K. from the University of California, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Chang DC, 1997, J GEN VIROL, V78, P1435, DOI 10.1099/0022-1317-78-6-1435; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Gasparovic ML, 2006, J VIROL, V80, P10858, DOI 10.1128/JVI.01298-06; Gee GV, 2004, J BIOL CHEM, V279, P49172, DOI 10.1074/jbc.M409326200; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Li, 2002, P NATL ACAD SCI USA, V99, P1353; Li, 2009, J VIROL, V83, P37; Li, 2005, J VIROL, V79, P3859; Li, 2000, J VIROL, V74, P11388; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Okada Y, 2000, J BIOL CHEM, V275, P17016, DOI 10.1074/jbc.275.22.17016; Orba Y, 2008, VIROLOGY, V370, P173, DOI 10.1016/j.virol.2007.08.034; Ou WC, 1999, J GEN VIROL, V80, P39, DOI 10.1099/0022-1317-80-1-39; Ou WC, 2001, J NEUROVIROL, V7, P298; Shen PS, 2011, VIROLOGY, V411, P142, DOI 10.1016/j.virol.2010.12.005; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; VACANTE DA, 1989, VIROLOGY, V170, P353, DOI 10.1016/0042-6822(89)90425-X	29	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76668	10.1371/journal.pone.0076668	http://dx.doi.org/10.1371/journal.pone.0076668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130786	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900080
J	Lee, H; Zhu, T; Patel, K; Zhang, YY; Truong, L; Hevener, KE; Gatuz, JL; Subramanya, G; Jeong, HY; Uprichard, SL; Johnson, ME				Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Zhang, Yan-Yan; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Subramanya, Gitanjali; Jeong, Hyun-Young; Uprichard, Susan L.; Johnson, Michael E.			High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; REPLICATION; PROTEIN; INTERFERON-ALPHA-2B; RIBAVIRIN; SYSTEM; DOMAIN; CLONE	Development of drug-resistant mutations has been a major problem with all currently developed Hepatitis C Virus (HCV) NS3/4A inhibitors, including the two FDA approved drugs, significantly reducing the efficacy of these inhibitors. The high incidence of drug-resistance mutations and the limited utility of these inhibitors against only genotype 1 highlight the need for novel, broad-spectrum HCV therapies. Here we used high-throughput screening (HTS) to identify low molecular weight inhibitors against NS3/4A from multiple genotypes. A total of 40,967 compounds from four structurally diverse molecular libraries were screened by HTS using fluorescence-based enzymatic assays, followed by an orthogonal binding analysis using surface plasmon resonance (SPR) to eliminate false positives. A novel small molecule compound was identified with an IC50 value of 2.2 mu M against the NS3/4A from genotype 1b. Mode of inhibition analysis subsequently confirmed this compound to be a competitive inhibitor with respect to the substrate, indicating direct binding to the protease active site, rather than to the allosteric binding pocket that was discovered to be the binding site of a few recently discovered small molecule inhibitors. This newly discovered inhibitor also showed promising inhibitory activity against the NS3/4As from three other HCV genotypes, as well as five common drug-resistant mutants of genotype 1b NS3/4A. The inhibitor was selective for NS3 from multiple HCV genotypes over two human serine proteases, and a whole cell lysate assay confirmed inhibitory activity in the cellular environment. This compound provides a lead for further development of potentially broader spectrum inhibitors.	[Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Johnson, Michael E.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Lee, Hyun; Zhu, Tian; Patel, Kavankumar; Truong, Lena; Hevener, Kirk E.; Gatuz, Joseph L.; Johnson, Michael E.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Zhang, Yan-Yan; Jeong, Hyun-Young] Univ Illinois, Dept Pharm Practice, Chicago, IL USA; [Subramanya, Gitanjali; Uprichard, Susan L.] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, ME (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA.	mjohnson@uic.edu	Johnson, Michael E/F-5141-2013; Hevener, Kirk/AAC-4828-2020	Johnson, Michael E/0000-0002-8246-4081; Hevener, Kirk/0000-0002-5584-3625; Gatuz, Joseph/0000-0002-8324-5892; ZHANG, YAN-YAN/0000-0002-4229-1470; Lee, Hyun/0000-0003-2570-8120	NIDCR, UIC College of Dentistry MOST program [5T32-DE018381]; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIDCR, UIC College of Dentistry MOST program; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.E.H. was supported during a portion of this work by NIDCR 5T32-DE018381, UIC College of Dentistry MOST program. ChemAxon, for a free academic license of their cheminformatics suite including JChem and JChem for excel, was used for HTS data analysis; and the UCSF RBVI for access to Chimera, supported by NIGMS P41-GM103311. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. The UIC Research Open Access Article Publishing (ROAAP) Fund was used to cover the open access publishing fee for this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaudhuri R, 2012, J CHEM INF MODEL, V52, P2245, DOI 10.1021/ci300177p; Cheng SJ, 2001, HEPATOLOGY, V33, P231, DOI 10.1053/jhep.2001.20675; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cicero DO, 1999, J MOL BIOL, V289, P385, DOI 10.1006/jmbi.1999.2746; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jeong H, 2006, XENOBIOTICA, V36, P1, DOI 10.1080/00498250500485115; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lee H, 2012, ANAL BIOCHEM, V423, P46, DOI 10.1016/j.ab.2012.01.006; Llinas-Brunet M, 1998, BIOORG MED CHEM LETT, V8, P1713, DOI 10.1016/S0960-894X(98)00299-6; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Malancona S, 2004, BIOORG MED CHEM LETT, V14, P4575, DOI 10.1016/j.bmcl.2004.05.093; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Melnikova I, 2008, NAT REV DRUG DISCOV, V7, P799, DOI 10.1038/nrd2661; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rishton GM, 2003, DRUG DISCOV TODAY, V8, P86, DOI 10.1016/S1359644602025722; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108; Schrodinger, 2011, LIGPREP VERS 2 5; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Tan SL, 2006, HEPATITIS C VIRUSES; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019; Zarkesh-Esfahani SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-69; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	37	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75144	10.1371/journal.pone.0075144	http://dx.doi.org/10.1371/journal.pone.0075144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130685	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900018
J	Luo, JF; Xiao, LH; Wu, CX; Zheng, Y; Zhao, NQ				Luo, Jianfeng; Xiao, Linhai; Wu, Chunxiao; Zheng, Ying; Zhao, Naiqing			The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004-2009	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; DUCTAL ADENOCARCINOMA; RESECTION; PANCREATICODUODENECTOMY; TRENDS; HEAD	Background: Pancreatic cancer is a devastating disease with dismal prognosis. Large population-based evidence on its survival rate and influence factors is lacking in China. Objective: This study aimed to depict the demographic factors, tumor characteristics, incidence rate and survival rate of pancreatic cancer cases in urban China. Methods: The demographic factors, tumor characteristics were collected for all the pancreatic cancer cases identified during 2004 to 2009 from the Shanghai Cancer Registry. The survival time was ascertained through linkage of the Shanghai Cancer Registry and the Shanghai Vital Statistics Registry. The deadline of death certificates was the end of December 2012. Kaplan-Meier method and Cox proportional-hazards regression model were used to explore the survival rate and influence factors. Results: 11,672 new pancreatic cancer cases were identified among Shanghai residency during 2004 to 2009. The crude incidence rate of pancreatic cancer was increasing from 12.80/100,000 in 2004 to 15.66/100,000 in 2009, while the standardized incidence rate was about 6.70/100,000 and didn't change a lot. The overall 5-year survival rate was 4.1% and the median survival time was 3.9 (95% Confidence Interval (CI) 3.8-4.0) months. Subjects had received surgical resection had improved survival (HR = 0.742, 95% CI: 0.634-0.868) than its counterparts. In adjusted multivariable Cox proportional-hazard models, factors associated with poor survival included older age at diagnosis (age >=70 years: hazard ratio (HR) = 1.827, 95% CI: 1.614-2.067), male sex (HR = 1.155, 95% CI: 1.041-1.281), distant disease at diagnosis (HR = 1.257, 95% CI: 1.061-1.488), positive lymph node (HR = 1.236, 95% CI: 1.085-1.408), tumor stage (Stage IV HR = 2.817, 95% CI: 2.029-3.909). Conclusion: The age-adjusted incidence rate was stable and overall survival rate was low among pancreatic cancer patients of Shanghai residency. Early detection and improved treatment strategies are needed to improve prognosis for this deadly disease.	[Luo, Jianfeng; Xiao, Linhai; Zhao, Naiqing] Fudan Univ, Sch Publ Hlth, Dept Hlth Stat & Social Med, Shanghai 200433, Peoples R China; [Wu, Chunxiao; Zheng, Ying] Shanghai Municipal Ctr Dis Prevent & Control, Dept Canc Control & Prevent, Shanghai, Peoples R China	Fudan University; Shanghai Center for Disease Control & Prevention	Zheng, Y (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hlth Stat & Social Med, Shanghai 200433, Peoples R China.	yzheng@scdc.sh.cn; nqzhao@fudan.edu.cn	Luo, jian/HGE-7331-2022		National Natural Science Foundation of China [30972551, 81273187, 81102183]; 12th Five-year Major New Drug Discovery Science and Technology [2012ZX09303013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Major New Drug Discovery Science and Technology	This research is supported by the projects 30972551, 81273187 and 81102183 from National Natural Science Foundation of China and the 12th Five-year Major New Drug Discovery Science and Technology, 2012ZX09303013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANN ICRP, V38, P1; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Chen WQ, 2012, CHINESE J CANCER RES, V24, P1, DOI 10.1007/s11670-012-0001-6; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Distler M, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-12; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; Dong M, 1998, ANTICANCER RES, V18, P4613; Eloubeidi MA, 2006, AM J SURG, V192, P322, DOI 10.1016/j.amjsurg.2006.02.017; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Garcea G, 2008, J PANCREAS, V9, P99; Gudjonsson B, 2002, J CLIN GASTROENTEROL, V35, P180, DOI 10.1097/00004836-200208000-00011; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuhlmann KFCD, 2004, EUR J CANCER, V40, P549, DOI 10.1016/j.ejca.2003.10.026; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Meyer W, 2000, SURG TODAY, V30, P582, DOI 10.1007/s005950070096; Ni Quan-Xing, 2002, Hepatobiliary Pancreat Dis Int, V1, P126; Ouyang HQ, 2011, PANCREAS, V40, P120, DOI 10.1097/MPA.0b013e3181e6e398; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x; Shaib Y, 2007, AM J GASTROENTEROL, V102, P1377, DOI 10.1111/j.1572-0241.2007.01202.x; Shen CM, 2012, PANCREATOLOGY, V12, P206, DOI 10.1016/j.pan.2012.04.002; Takai S, 2003, PANCREAS, V26, P243, DOI 10.1097/00006676-200304000-00007; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893; Zhang Qun-hua, 2004, Zhonghua Yi Xue Za Zhi, V84, P214; Zheng S, 2003, CHINESE J HEPATOBILI, V9, P134	28	61	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76052	10.1371/journal.pone.0076052	http://dx.doi.org/10.1371/journal.pone.0076052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130758	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900067
J	Zdzalik, M; Kalinska, M; Wysocka, M; Stec-Niemczyk, J; Cichon, P; Stach, N; Gruba, N; Stennicke, HR; Jabaiah, A; Markiewicz, M; Kedracka-Krok, S; Wladyka, B; Daugherty, PS; Lesner, A; Rolka, K; Dubin, A; Potempa, J; Dubin, G				Zdzalik, Michal; Kalinska, Magdalena; Wysocka, Magdalena; Stec-Niemczyk, Justyna; Cichon, Przemyslaw; Stach, Natalia; Gruba, Natalia; Stennicke, Henning R.; Jabaiah, Abeer; Markiewicz, Michal; Kedracka-Krok, Sylwia; Wladyka, Benedykt; Daugherty, Patrick S.; Lesner, Adam; Rolka, Krzysztof; Dubin, Adam; Potempa, Jan; Dubin, Grzegorz			Biochemical and Structural Characterization of SplD Protease from Staphylococcus aureus	PLOS ONE			English	Article							SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; EXTRACELLULAR PROTEASES; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURES; NASAL CARRIAGE; UNITED-STATES; PROTEINASES; CHYMOTRYPSIN; INFECTIONS	Staphylococcus aureus is a dangerous human pathogen. A number of the proteins secreted by this bacterium are implicated in its virulence, but many of the components of its secretome are poorly characterized. Strains of S. aureus can produce up to six homologous extracellular serine proteases grouped in a single spl operon. Although the SplA, SplB, and SplC proteases have been thoroughly characterized, the properties of the other three enzymes have not yet been investigated. Here, we describe the biochemical and structural characteristics of the SplD protease. The active enzyme was produced in an Escherichia coli recombinant system and purified to homogeneity. P1 substrate specificity was determined using a combinatorial library of synthetic peptide substrates showing exclusive preference for threonine, serine, leucine, isoleucine, alanine, and valine. To further determine the specificity of SplD, we used high-throughput synthetic peptide and cell surface protein display methods. The results not only confirmed SplD preference for a P1 residue, but also provided insight into the specificity of individual primed- and non-primed substrate-binding subsites. The analyses revealed a surprisingly narrow specificity of the protease, which recognized five consecutive residues (P4-P3-P2-P1-P1') with a consensus motif of R-(Y/W)-(P/L)-(T/L/I/V). S. To understand the molecular basis of the strict substrate specificity, we crystallized the enzyme in two different conditions, and refined the structures at resolutions of 1.56 angstrom and 2.1 angstrom. Molecular modeling and mutagenesis studies allowed us to define a consensus model of substrate binding, and illustrated the molecular mechanism of protease specificity.	[Zdzalik, Michal; Kalinska, Magdalena; Cichon, Przemyslaw; Stach, Natalia; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wysocka, Magdalena; Gruba, Natalia; Lesner, Adam; Rolka, Krzysztof] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Wladyka, Benedykt; Dubin, Adam] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Stennicke, Henning R.] Novo Nordisk AS, Haemophilia Biol, Malov, Denmark; [Jabaiah, Abeer; Daugherty, Patrick S.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Markiewicz, Michal] Jagiellonian Univ, Dept Computat Biophys & Bioinformat, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kedracka-Krok, Sylwia; Wladyka, Benedykt] Malopolska Ctr Biotechnol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA	Jagiellonian University; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Novo Nordisk; University of California System; University of California Santa Barbara; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Louisville	Dubin, G (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	grzegorz.dubin@uj.edu.pl	Dubin, Grzegorz/J-8168-2014; Władyka, Benedykt/T-7039-2019; Potempa, Jan/AAA-6850-2021; Lesner, Adam/M-2732-2019	Dubin, Grzegorz/0000-0002-5535-5760; Władyka, Benedykt/0000-0002-9075-3529; Rolka, Krzysztof/0000-0002-4537-700X; Lesner, Adam/0000-0001-8335-3431; Potempa, Jan/0000-0002-3600-7461; Gruba, Natalia/0000-0003-3281-9945; Wysocka, Magdalena/0000-0003-2216-5597	Polish Ministry of Science and Higher Education [N N301 032834]; National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland) [UMO-2011/01/D/NZ1/01169, UMO-2011/01/N/NZ1/00208]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08];  [538-8290-1036-12]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland); European Union(European Commission); 	This work was supported in part by grant N N301 032834 (to GD) from the Polish Ministry of Science and Higher Education; grants UMO-2011/01/D/NZ1/01169 (to GD) and UMO-2011/01/N/NZ1/00208 (to MZ) from the National Science Centre; institutional funds (DS9) from the Faculty of Biochemistry, Biophysics and Biotechnology (Jagiellonian University, Krakow, Poland); and a project contributed to the Development of Young Scientists and PhD students at University of Gdansk (Poland), grant 538-8290-1036-12 (to MW). The research was carried out with the equipment purchased thanks to the financial support of the European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Arvidson J, 2000, PEDIATR HEMAT ONCOL, V17, P285, DOI 10.1080/088800100276271; ARVIDSON S, 1973, BIOCHIM BIOPHYS ACTA, V302, P135, DOI 10.1016/0005-2744(73)90016-8; Avogadro, 2012, AVOGADRO OPEN SOURCE; Baron S., 1996, MED MICROBIOLOGY, V4th; Bateman KS, 2000, PROTEIN SCI, V9, P83; BERTHOLD H, 1992, BIOTECHNOL LETT, V14, P245, DOI 10.1007/BF01022318; Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dubin G, 2012, CURR PHARM DES; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P., 1997, NEWSLETT PROTEIN CRY, V33, P22; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalinska M, 2012, BIOCHIMIE, V94, P318, DOI 10.1016/j.biochi.2011.07.020; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lesk AM, 1996, J MOL BIOL, V258, P501, DOI 10.1006/jmbi.1996.0264; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V6; Lesner A, 2001, BIOCHEM BIOPH RES CO, V285, P1350, DOI 10.1006/bbrc.2001.5339; Lesner A, 2000, BIOCHEM BIOPH RES CO, V269, P81, DOI 10.1006/bbrc.2000.2257; MacKerell A. D., 1998, ENCY COMPUTATIONAL C; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Maeda H, 1996, BIOL CHEM H-S, V377, P217; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rieneck K, 1997, BBA-GENE STRUCT EXPR, V1350, P128, DOI 10.1016/S0167-4781(96)00216-3; Rudack C, 2009, J IMMUNOL, V183, P7592, DOI 10.4049/jimmunol.0803902; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Stec-Niemczyk J, 2009, BIOCHEM J, V419, P555, DOI 10.1042/BJ20081351; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wysocka M, 2007, COMB CHEM HIGH T SCR, V10, P171, DOI 10.2174/138620707780126714; Zdzalik M, 2012, FEMS IMMUNOL MED MIC, V66, P220, DOI 10.1111/j.1574-695X.2012.01005.x; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937	66	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76812	10.1371/journal.pone.0076812	http://dx.doi.org/10.1371/journal.pone.0076812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130791	gold, Green Published			2022-12-25	WOS:000325810900086
J	Zeng, YJ; Xu, JL; Wang, Y; Zhou, CF				Zeng, Yajie; Xu, Jiliang; Wang, Yong; Zhou, Chunfa			Habitat Association and Conservation Implications Endangered Francois' Langur (Trachypithecus francoisi)	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; NATURE-RESERVE; AVAILABILITY DATA; CHINA; GUANGXI; MODEL; GUIZHOU; DECLINE; WINTER; FUSUI	Francois' langur (Trachypithecus francoisi) is an endangered primate and endemic to the limestone forests of the tropical and subtropical zone of northern Vietnam and South-west China with a population of about 2,000 individuals. Conservation efforts are hampered by limited knowledge of habitat preference in its main distribution area. We surveyed the distribution of Francois' langur and modeled the relationship between the probability of use and habitat features in Mayanghe National Nature Reserve, Guizhou, China. The main objectives of this study were to provide quantitative information on habitat preference, estimating the availability of suitable habitat, and providing management guidelines for the effective conservation of this species. By comparing 92 used locations with habitat available in the reserve, we found that Francois' langur was mainly distributed along valleys and proportionally, used bamboo forests and mixed conifer-broadleaf forests more than their availability, whereas they tended to avoid shrubby areas and coniferous forests. The langur tended to occur at sites with lower elevation, steeper slope, higher tree canopy density, and a close distance to roads and water. The habitat occupancy probability was best modeled by vegetation type, vegetation coverage, elevation, slope degree, distances to nearest water, paved road, and farmland edge. The suitable habitat in this reserve concentrated in valleys and accounted for about 25% of the total reserve area. Our results showed that Francois' langur was not only restricted at the landscapes level at the regions with karst topography, limestone cliffs, and caves, but it also showed habitat preference at the local scale. Therefore, the protection and restoration of the langur preferred habitats such as mixed conifer-broadleaf forests are important and urgent for the conservation of this declining species.	[Zeng, Yajie; Xu, Jiliang] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Wang, Yong] Alabama A&M Univ, Sch Agr & Environm Sci, Ctr Forestry Ecol & Wildlife, Normal, AL 35762 USA; [Wang, Yong; Zhou, Chunfa] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing, Peoples R China; [Wang, Yong] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China	Beijing Forestry University; Alabama A&M University; Beijing Normal University; Nanjing Forestry University	Xu, JL (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	xujiliang@bjfu.edu.cn			Forestry Commonweal Programs [200904003]; Ministry of Science & Techenology of China [2008BADB0B01]; National Key Project of Scientific and Technical Supporting Programs	Forestry Commonweal Programs; Ministry of Science & Techenology of China; National Key Project of Scientific and Technical Supporting Programs	This work was supported by the Forestry Commonweal Programs (NO. 200904003) and the National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Techenology of China (NO. 2008BADB0B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BASKARAN N., 2010, J THREAT TAXA, V2, P753, DOI DOI 10.11609/J0TT.02101.753-9; Bennett Elizabeth L., 1994, P129; Bleisch William, 2004, P107; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2; Carpenter J, 2010, J WILDLIFE MANAGE, V74, P1806, DOI 10.2193/2009-368; Chen Z., 2001, GUIZHOU FOR SCI TECH, V29, P34; Cowlishaw G., 2000, PRIMATE CONSERVATION; Cramer J. S., 2003, LOGIT MODELS EC OTHE, P66; Durst P, 2000, INT C TIMB PLANT DEV; Garshelis DL, 2000, METH C CONS, P111; Guizhou Statistical Bureau, 2013, STAT YB GUIZH 2011; Guizhou Tourism Bureau, 2013, GUIZH EC CULT TOUR I; Hamer TE, 2008, J WILDLIFE MANAGE, V72, P983, DOI 10.2193/2006-565; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu CF, 2012, REPORT YANHE AUTONOM; Hu G, 2004, ORYX, V38, P48, DOI 10.1017/S0030605304000080; Hu Gang, 2011, Acta Theriologica Sinica, V31, P306; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Li Wen, 2010, Acta Theriologica Sinica, V30, P151; Li YB, 2007, ORYX, V41, P38, DOI 10.1017/S0030605307001500; Li ZY, 2004, INT J PRIMATOL, V25, P41, DOI 10.1023/B:IJOP.0000014644.36333.94; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luo Yang, 2000, Chinese Journal of Zoology, V35, P44; Luo Yang, 2007, Acta Ecologica Sinica, V27, P1715; Ministry of Environmental Protection, 2010, CHIN BIOD CONS STRAT; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Tabachnick B. G., 2013, USING MULTIVARIATE S; The Forestry Sector of Guizhou Province, 1994, REP SCI SURV RES MAY, P15; Wang DZ, 2005, PRIMATES, V46, P219, DOI 10.1007/s10329-004-0122-8; Wang S., 1998, CHINA RED DATA BOOK; Wang SL, 2011, PRIMATES, V52, P51, DOI 10.1007/s10329-010-0218-2; Wang Y, 2012, IBIS, V154, P273, DOI 10.1111/j.1474-919X.2012.01214.x; Wang YZ, 2004, J LIUPANSHUI TEACHER, V16, P1; Xu JL, 2012, ORYX, V46, P554, DOI 10.1017/S0030605311000810; Zar JH., 2010, BIOSTAT ANAL; Zhang Yongzu, 1992, Acta Theriologica Sinica, V12, P81; Zhou Qihai, 2007, Acta Theriologica Sinica, V27, P243	41	8	13	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75661	10.1371/journal.pone.0075661	http://dx.doi.org/10.1371/journal.pone.0075661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130730	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900049
J	Cardoso, AR; Kakimoto, PAHB; Kowaltowski, AJ				Cardoso, Ariel R.; Kakimoto, Pamela A. H. B.; Kowaltowski, Alicia J.			Diet-Sensitive Sources of Reactive Oxygen Species in Liver Mitochondria: Role of Very Long Chain Acyl-CoA Dehydrogenases	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; HIGH-FAT DIET; CALORIC RESTRICTION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COENZYME-A; SUPEROXIDE; GENERATION; STEATOHEPATITIS	High fat diets and accompanying hepatic steatosis are highly prevalent conditions. Previous work has shown that steatosis is accompanied by enhanced generation of reactive oxygen species (ROS), which may mediate further liver damage. Here we investigated mechanisms leading to enhanced ROS generation following high fat diets (HFD). We found that mitochondria from HFD livers present no differences in maximal respiratory rates and coupling, but generate more ROS specifically when fatty acids are used as substrates. Indeed, many acyl-CoA dehydrogenase isoforms were found to be more highly expressed in HFD livers, although only the very long chain acyl-CoA dehydrogenase (VLCAD) was more functionally active. Studies conducted with permeabilized mitochondria and different chain length acyl-CoA derivatives suggest that VLCAD is also a source of ROS production in mitochondria of HFD animals. This production is stimulated by the lack of NAD(+). Overall, our studies uncover VLCAD as a novel, diet-sensitive, source of mitochondrial ROS.	[Cardoso, Ariel R.; Kakimoto, Pamela A. H. B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Kowaltowski, AJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	Kowaltowski, Alicia J/H-8698-2012; Rodrigues Cardoso', Ariel/H-3561-2012	Rodrigues Cardoso', Ariel/0000-0002-8741-3734	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo; Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior; Conselho Nacional de Pesquisa e Desenvolvimento; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina; Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina	Supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo, Coordenadoria de Aperfeicoamento do Pessoal do Ensino Superior, Conselho Nacional de Pesquisa e Desenvolvimento, Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina and the Nucleo de Apoio a Pesquisa de Processos Redox em Biomedicina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; Cardoso AR, 2010, J BIOENERG BIOMEMBR, V42, P245, DOI 10.1007/s10863-010-9284-9; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; COOK GA, 1987, J BIOL CHEM, V262, P2050; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fridovich I., 1978, CIBA F SYMP, P77; Ge FX, 2010, EXP BIOL MED, V235, P1282, DOI 10.1258/ebm.2010.010095; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Jarmuszkiewicz W, 1998, J BIOL CHEM, V273, P34882, DOI 10.1074/jbc.273.52.34882; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1990, PROG CLIN BIOL RES, V321, P569; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Leite ACR, 2010, BBA-BIOENERGETICS, V1797, P1210, DOI 10.1016/j.bbabio.2010.01.034; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; MULLER F, 1978, FREE RADIC BIOL MED, V3, P215; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Rodrigues JV, 2012, FREE RADICAL BIO MED, V53, P12, DOI 10.1016/j.freeradbiomed.2012.04.016; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Schonfeld P, 2009, FREE RADICAL BIO MED, V47, P503, DOI 10.1016/j.freeradbiomed.2009.05.006; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; WILLIAMSON G, 1984, BIOCHEM J, V218, P521, DOI 10.1042/bj2180521; Zou YH, 2006, LIFE SCI, V79, P1100, DOI 10.1016/j.lfs.2006.03.021	53	42	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77088	10.1371/journal.pone.0077088	http://dx.doi.org/10.1371/journal.pone.0077088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116206	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300114
J	Li, XC; Zhang, XW; Zhou, JF; Ma, HY; Liu, ZD; Zhu, L; Yao, XJ; Li, LG; Fang, WH				Li, Xin-Cang; Zhang, Xiao-Wen; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong			Identification, Characterization, and Functional Analysis of Tube and Pelle Homologs in the Mud Crab Scylla paramamosain	PLOS ONE			English	Article							TOLL RECEPTOR; SHRIMP; COMPLEX; BINDING; RECOGNITION; CLONING; IRAK-4; FAMILY; GENE	Tube and Pelle are essential components in Drosophila Toll signaling pathway. In this study, we characterized a pair of crustacean homologs of Tube and Pelle in Scylla paramamosain, namely, SpTube and SpPelle, and analyzed their immune functions. The full-length cDNA of SpTube had 2052 bp with a 1578 bp open reading frame (ORF) encoding a protein with 525 aa. A death domain (DD) and a kinase domain were predicted in the deduced protein. The full-length cDNA of SpPelle had 3825 bp with a 3420 bp ORF encoding a protein with 1140 aa. The protein contained a DD and a kinase domain. Two conserved repeat motifs previously called Tube repeat motifs present only in insect Tube or Tube-like sequences were found between these two domains. Alignments and structure predictions demonstrated that SpTubeDD and SpPelleDD significantly differed in sequence and 3D structure. Similar to TubeDD, SpTubeDD contained three common conserved residues (R, K, and R) on one surface that may mediate SpMyD88 binding and two common residues (A and A) on the other surface that may contribute to Pelle binding. By contrast, SpPelleDD lacked similar conservative residues. SpTube, insect Tube-like kinases, and human IRAK4 were found to be RD kinases with an RD dipeptide in the kinase domain. SpPelle, Pelle, insect Pelle-like kinases, and human IRAK1 were found to be non-RD kinases lacking an RD dipeptide. Both SpTube and SpPelle were highly expressed in hemocytes, gills, and hepatopancreas. Upon challenge, SpTube and SpPele were significantly increased in hemocytes by Gram-negative or Gram-positive bacteria, whereas only SpPelle was elevated by White Spot Syndrome Virus. The pull-down assay showed that SpTube can bind to both SpMyD88 and SpPelle. These results suggest that SpTube, SpPelle, and SpMyD88 may form a trimeric complex involved in the immunity of mud crabs against both Gram-negative and Gram-positive bacteria.	[Li, Xin-Cang; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Li, Xin-Cang; Zhou, Jun-Fang; Ma, Hong-Yu; Liu, Zhi-Dong; Zhu, Lei; Yao, Xiao-Juan; Li, Lin-Gui; Fang, Wen-Hong] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Zhang, Xiao-Wen] Henan Normal Univ, Scholl Life Sci, Xinxiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Henan Normal University	Li, XC (corresponding author), Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China.	lixin8687@163.com; fwenhong@163.com			special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute) [2011M07]; National Natural Science Foundation of China [31101920, 31301883]; Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province [BY2012141]; Shanghai Municipal Natural Science Foundation [13ZR1449900]	special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province; Shanghai Municipal Natural Science Foundation	This work was supported by a special research grant for the National Nonprofit Institute (East China Sea Fisheries Research Institute) (No. 2011M07), the National Natural Science Foundation of China ((Nos. 31101920, 31301883), the Industry-Academia Cooperation Innovation Fund Projects of Jiangsu Province (No. BY2012141), and Shanghai Municipal Natural Science Foundation (No. 13ZR1449900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; Li XC, 2010, FISH SHELLFISH IMMUN, V28, P942, DOI 10.1016/j.fsi.2010.02.011; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Mekata T, 2008, FISH SHELLFISH IMMUN, V24, P122, DOI 10.1016/j.fsi.2007.10.006; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; O'Neill LA, 2013, NAT REV IMMUNOL; Shen BH, 2002, DEVELOPMENT, V129, P1925; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Yang CJ, 2008, FISH SHELLFISH IMMUN, V24, P564, DOI 10.1016/j.fsi.2007.12.012; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047038	37	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76728	10.1371/journal.pone.0076728	http://dx.doi.org/10.1371/journal.pone.0076728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116143	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300085
J	Rudel, D; Douglas, CD; Huffnagle, IM; Besser, JM; Ingersoll, CG				Rudel, David; Douglas, Chandler D.; Huffnagle, Ian M.; Besser, John M.; Ingersoll, Christopher G.			Assaying Environmental Nickel Toxicity Using Model Nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PRISTIONCHUS-PACIFICUS; EMERGING MODEL; RISK; SOIL; CARCINOGENESIS; GENETICS; MOTILITY; BEETLE	Although nickel exposure results in allergic reactions, respiratory conditions, and cancer in humans and rodents, the ramifications of excess nickel in the environment for animal and human health remain largely undescribed. Nickel and other cationic metals travel through waterways and bind to soils and sediments. To evaluate the potential toxic effects of nickel at environmental contaminant levels (8.9-7,600 mu g Ni/g dry weight of sediment and 50-800 mu g NiCl2/L of water), we conducted assays using two cosmopolitan nematodes, Caenorhabditis elegans and Pristionchus pacificus. We assayed the effects of both sediment-bound and aqueous nickel upon animal growth, developmental survival, lifespan, and fecundity. Uncontaminated sediments were collected from sites in the Midwestern United States and spiked with a range of nickel concentrations. We found that nickel-spiked sediment substantially impairs both survival from larval to adult stages and adult longevity in a concentration-dependent manner. Further, while aqueous nickel showed no adverse effects on either survivorship or longevity, we observed a significant decrease in fecundity, indicating that aqueous nickel could have a negative impact on nematode physiology. Intriguingly, C. elegans and P. pacificus exhibit similar, but not identical, responses to nickel exposure. Moreover, P. pacificus could be tested successfully in sediments inhospitable to C. elegans. Our results add to a growing body of literature documenting the impact of nickel on animal physiology, and suggest that environmental toxicological studies could gain an advantage by widening their repertoire of nematode species.	[Rudel, David; Douglas, Chandler D.; Huffnagle, Ian M.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Besser, John M.; Ingersoll, Christopher G.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA	University of North Carolina; East Carolina University; United States Department of the Interior; United States Geological Survey	Rudel, D (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	rudeld@ecu.edu			United States Geological Survey (USGS); East Carolina University	United States Geological Survey (USGS)(United States Geological Survey); East Carolina University	Funding was provided by the United States Geological Survey (USGS) and laboratory start up funds from East Carolina University. The USGS provided feedback on experimental design according to field and international monitoring standards. They also provided core resources and materials, i.e. sediments and test water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Ankley GT, 1996, ENVIRON TOXICOL CHEM, V15, P2056, DOI 10.1002/etc.5620151202; *ASTM, 2012, ASTM ANN BOOK STAND, V1106; ATSDR (Agency for Toxic Substances and Disease Registry), 2005, TOX PROF NICK; Baylis HA, 2007, BIOCHEM SOC T, V35, P129, DOI 10.1042/BST0350129; Besser J.M., 2011, TOXICITY NICKEL SPIK; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P1100, DOI 10.1897/1551-5028(2003)022&lt;1100:AOMTTN&gt;2.0.CO;2; BRENNER S, 1974, GENETICS, V77, P71; Brown Joanne, 2004, BIOS (Ocean Grove), V75, P95, DOI 10.1893/0005-3155(2004)075<0095:TDEONO>2.0.CO;2; Brueske-Hohlfeld Irene, 2009, V472, P3, DOI 10.1007/978-1-60327-492-0_1; Bruinsma JJ, 2008, GENETICS, V179, P811, DOI 10.1534/genetics.107.084384; Cai KZ, 2010, TOXICOL IND HEALTH, V26, P249, DOI 10.1177/0748233710364962; Chu DS, 2013, ADV EXP MED BIOL, V757, P171, DOI 10.1007/978-1-4614-4015-4_7; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Felix MA, 1999, P ROY SOC B-BIOL SCI, V266, P1617, DOI 10.1098/rspb.1999.0823; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fraire-Zamora JJ, 2010, MOL REPROD DEV, V77, P739, DOI 10.1002/mrd.21193; Franzen J, 2012, ECOTOXICOLOGY, V21, P557, DOI 10.1007/s10646-011-0816-9; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Goodman JE, 2011, CRIT REV TOXICOL, V41, P142, DOI 10.3109/10408444.2010.531460; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Hoss S, 2011, ENVIRON INT, V37, P940, DOI 10.1016/j.envint.2011.03.013; Hoss S, 2012, ENVIRON TOXICOL CHEM, V31, P1525, DOI 10.1002/etc.1843; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hubbard E.J.A., 2005, INTRO GERM LINE, P1; Hubbard EJA, 2013, ADV EXP MED BIOL, V757, P101, DOI 10.1007/978-1-4614-4015-4_5; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; ISO, 2010, WAT QUAL DET TOX EFF, P17; Jargar Jameel G., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P77, DOI 10.1515/jbcpp-2012-0013; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kasprzak KS, 2003, J ENVIRON MONITOR, V5, P183, DOI 10.1039/b210538c; Kim S, 2013, ADV EXP MED BIOL, V757, P277, DOI 10.1007/978-1-4614-4015-4_10; Kimble J., 2005, GERMLINE PROLIFERATI, P1; Kiontke Karin, 2005, P1; Ledon-Rettig CC, 2011, EVOL DEV, V13, P391, DOI 10.1111/j.1525-142X.2011.00494.x; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lombardi C, 2003, Eur Ann Allergy Clin Immunol, V35, P52; Lukac N, 2011, J APPL TOXICOL, V31, P144, DOI 10.1002/jat.1574; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Peate WF, 2002, AM FAM PHYSICIAN, V66, P1025; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; REGER RB, 1993, OCCUP MED, V8, P185; Robertson S, 2013, ADV EXP MED BIOL, V757, P351, DOI 10.1007/978-1-4614-4015-4_12; Rudel D, 2005, DEV BIOL, V277, P200, DOI 10.1016/j.ydbio.2004.09.021; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; SCHEDL T, 1988, GENETICS, V119, P43; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Sommer R.J., 2005, EVOLUTION DEV NEMATO, P1; Sommer RJ, 2011, CURR BIOL, V21, pR758, DOI 10.1016/j.cub.2011.06.034; Sommer Ralf J, 2006, WormBook, P1; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Thyssen JP, 2013, CONTACT DERMATITIS, V68, P3, DOI 10.1111/j.1600-0536.2012.02127.x; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; WHO, 2005, NICK DRINK WAT BACKG, P22; Zagury A, 2011, PEDIATR NEPHROL, V26, P915, DOI 10.1007/s00467-011-1825-x	60	12	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77079	10.1371/journal.pone.0077079	http://dx.doi.org/10.1371/journal.pone.0077079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116204	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300113
J	Wei, LJ; Diao, Y; Qi, J; Khokhlov, A; Feng, H; Yan, X; Li, Y				Wei, Lijun; Diao, Yan; Qi, Jing; Khokhlov, Alexander; Feng, Hui; Yan, Xing; Li, Yu			Effect of Change in Spindle Structure on Proliferation Inhibition of Osteosarcoma Cells and Osteoblast under Simulated Microgravity during Incubation in Rotating Bioreactor	PLOS ONE			English	Article							APOPTOSIS	In order to study the effect of microgravity on the proliferation of mammalian osteosarcoma cells and osteoblasts, the changes in cell proliferation, spindle structure, expression of MAD2 or BUB1, and effect of MAD2 or BUB1 on the inhibition of cell proliferation is investigated by keeping mammalian osteosarcoma cells and osteoblasts under simulated microgravity in a rotating wall vessel (2D-RWVS) bioreactor. Experimental results indicate that the effect of microgravity on proliferation inhibition, incidence of multipolar spindles, and expression of MAD2 or BUB1 increases with the extension of treatment time. And multipolar cells enter mitosis after MAD2 or BUB1 is knocked down, which leads to the decrease in DNA content, and decrease the accumulation of cells within multipolar spindles. It can therefore be concluded that simulated microgravity can alter the structure of spindle microtubules, and stimulate the formation of multipolar spindles together with multicentrosomes, which causes the overexpression of SAC proteins to block the abnormal cells in metaphase, thereby inhibiting cell proliferation. By clarifying the relationship between cell proliferation inhibition, spindle structure and SAC changes under simulated microgravity, the molecular mechanism and morphology basis of proliferation inhibition induced by microgravity is revealed, which will give experiment and theoretical evidence for the mechanism of space bone loss and some other space medicine problems.	[Wei, Lijun; Diao, Yan; Qi, Jing; Feng, Hui; Yan, Xing; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Khokhlov, Alexander] Moscow MV Lomonosov State Univ, Sch Biol, Moscow, Russia	Harbin Institute of Technology; Lomonosov Moscow State University	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn	Khokhlov, Alexander N/G-3905-2013; 黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022	Khokhlov, Alexander/0000-0001-7454-7023	National Science Foundation of China [30970686]; Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application [SMFA09K03]; Natural Science Foundation of Heilongjiang Province [D200879]; Natural Scientific Research Innovation Foundation of Harbin Institute of Technology [HIT.NSRIF.2008.14]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Innovation Foundation of Harbin Institute of Technology(Harbin Institute of Technology)	This work is funded by National Science Foundation of China (30970686), Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application (SMFA09K03), Natural Science Foundation of Heilongjiang Province (D200879), and Natural Scientific Research Innovation Foundation of Harbin Institute of Technology (HIT.NSRIF.2008.14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; GUIGNANDON A, 1995, CELL STRUCT FUNCT, V20, P369, DOI 10.1247/csf.20.369; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Kossmehl P, 2003, ENDOCRINOLOGY, V144, P4172, DOI 10.1210/en.2002-0171; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Lewis ML, 2004, J GRAVIT SPACE BIO B, V1, P3; Liedert A, 2004, BIOCHEM BIOPH RES CO, V319, P951, DOI 10.1016/j.bbrc.2004.05.087; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; RIJKEN PJ, 1991, J CELL SCI, V100, P491; RIJKEN PJ, 1991, AVIAT SPACE ENVIR MD, V62, P32; SiTu ZQ, 2004, CELL CULTURE, P163; Sun CR, 2006, J HARBIN MED U, V1, P70; [谭映军 Tan Yingjun], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P13; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Vassy J, 2003, ADV SPACE RES-SERIES, V32, P1595, DOI 10.1016/S0273-1177(03)90400-5; Wang SL, 2008, J PRACT MED, V6, P915; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu C, 2011, PLOS ONE, V7, P1; Xiong JH, 2003, ACTA ZOOL SINICA, V1, P98; [Zhang Shu 张舒], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P4530; Zhang XY, 2000, CHIN J AEROSPACE MED, V11, P432; [Zheng Hongxia 郑红霞], 2010, [航天医学与医学工程, Space Medicine & Medical Engineering], V23, P416; Zhong JJ, 2006, J XINJIANG MED U, V8, P669	27	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76710	10.1371/journal.pone.0076710	http://dx.doi.org/10.1371/journal.pone.0076710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116140	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300083
J	Armata, IA; Balaj, L; Kuster, JK; Zhang, X; Tsai, SL; Armatas, AA; Multhaupt-Buell, TJ; Soberman, R; Breakefield, XO; Ichinose, H; Sharma, N				Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Armatas, Andreas A.; Multhaupt-Buell, Trisha J.; Soberman, Roy; Breakefield, Xandra O.; Ichinose, Hiroshi; Sharma, Nutan			Dopa-Responsive Dystonia: Functional Analysis of Single Nucleotide Substitutions within the 5 ' Untranslated GCH1 Region	PLOS ONE			English	Article							GTP CYCLOHYDROLASE-I; HEREDITARY PROGRESSIVE DYSTONIA; MARKED DIURNAL FLUCTUATION; TRANSLATION INITIATION; GENE-EXPRESSION; MUTATION; TETRAHYDROBIOPTERIN; METABOLISM; MECHANISMS; DISORDERS	Background: Mutations in the GCH1 gene are associated with childhood onset, dopa-responsive dystonia (DRD). Correct diagnosis of DRD is crucial, given the potential for complete recovery once treated with L-dopa. The majority of DRD associated mutations lie within the coding region of the GCH1 gene, but three additional single nucleotide sequence substitutions have been reported within the 5' untranslated (5'UTR) region of the mRNA. The biologic significance of these 5' UTR GCH1 sequence substitutions has not been analyzed. Methodology/Principal Findings: Luciferase reporter assays, quantitative real time PCR and RNA decay assays, combined with bioinformatics, revealed a pathogenic 5' UTR GCH1 substitution. The +142C>T single nucleotide 5' UTR substitution that segregates with affected status in DRD patients, substantially attenuates translation without altering RNA expression levels or stability. The +142C>T substitution disrupts translation most likely by creating an upstream initiation start codon (uAUG) and an upstream open reading frame (uORF). Conclusions/Significance: This is the first GCH1 regulatory substitution reported to act at a post-transcriptional level, increasing the list of genetic diseases caused by abnormal translation and reaffirming the importance of investigating potential regulatory substitutions in genetic diseases.	[Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Multhaupt-Buell, Trisha J.; Breakefield, Xandra O.; Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurogenet, Boston, MA 02114 USA; [Armata, Ioanna A.; Balaj, Leonora; Kuster, John K.; Zhang, Xuan; Tsai, Shelun; Multhaupt-Buell, Trisha J.; Breakefield, Xandra O.; Sharma, Nutan] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Armatas, Andreas A.] Univ Patras, Dept Biol, Rion, Greece; [Soberman, Roy] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Patras; Harvard University; Massachusetts General Hospital; Tokyo Institute of Technology	Armata, IA (corresponding author), Massachusetts Gen Hosp, Dept Neurogenet, Boston, MA 02114 USA.	ionarm999@gmail.com	Armata, Ioanna A./T-7356-2019; Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Balaj, Leonora/0000-0003-0931-9715	NIH/NINDS [5P50NS037409]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS 5P50NS037409 (XOB and NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411; Bonafe L, 2001, CLIN CHEM, V47, P477; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Hagenah J, 2005, NEUROLOGY, V64, P908, DOI 10.1212/01.WNL.0000152839.50258.A2; Hirano M, 1997, BIOCHEM BIOPH RES CO, V234, P316, DOI 10.1006/bbrc.1997.6632; Hirayama K, 2001, J NEUROCHEM, V79, P576, DOI 10.1046/j.1471-4159.2001.00583.x; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; ICHINOSE H, 1995, J BIOL CHEM, V270, P10062, DOI 10.1074/jbc.270.17.10062; Ichinose H, 2000, BRAIN DEV-JPN, V22, pS107; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Ichinose H, 2008, CHEM REC, V8, P378, DOI 10.1002/tcr.20166; Inagaki H, 1999, BIOCHEM BIOPH RES CO, V260, P747, DOI 10.1006/bbrc.1999.0976; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Klein C, 2002, NEUROLOGY, V59, P1783, DOI 10.1212/01.WNL.0000035629.04791.3F; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Lukowski SW, 2011, HUM MUTAT, V32, pE2266, DOI 10.1002/humu.21545; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Nishiyama N, 2000, BRAIN DEV-JPN, V22, pS102; Nygaard T G, 1988, Adv Neurol, V50, P377; Segawa M, 1976, Adv Neurol, V14, P215; Segawa M, 2011, BRAIN DEV-JPN, V33, P195, DOI 10.1016/j.braindev.2010.10.015; Sharma N, 2011, MOVEMENT DISORD, V26, P2140, DOI 10.1002/mds.23786; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinberger D, 2007, NEUROGENETICS, V8, P51, DOI 10.1007/s10048-006-0069-6; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V293, P962, DOI 10.1016/S0006-291X(02)00343-1; Tachi N, 2011, EUR J NEUROL, V18, P1191, DOI 10.1111/j.1468-1331.2011.03354.x; Tassin J, 2000, BRAIN, V123, P1112, DOI 10.1093/brain/123.6.1112; Weber Y, 1997, NEUROGENETICS, V1, P125, DOI 10.1007/s100480050018; Witter K, 1996, GENE, V171, P285, DOI 10.1016/0378-1119(95)00886-1; Wu-Chou YH, 2010, AM J MED GENET B, V153B, P903, DOI 10.1002/ajmg.b.31058	33	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76975	10.1371/journal.pone.0076975	http://dx.doi.org/10.1371/journal.pone.0076975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124602	Green Published, gold			2022-12-25	WOS:000325489100159
J	Chang, CF; Li, CJ; Ko, CJ; Teng, TH; Lai, SC; Yang, MC; Chiu, CW; Chou, CC; Chang, CY; Yao, YC; Wu, LH; Wu, HP; Chen, WL; Lin, YR				Chang, Chin-Fu; Li, Chao-Jui; Ko, Chih-Jan; Teng, Tsung-Han; Lai, Shih-Chang; Yang, Mei-Chueh; Chiu, Chun-Wen; Chou, Chu-Chung; Chang, Chih-Yu; Yao, Yung-Chiao; Wu, Lan-Hsin; Wu, Han-Ping; Chen, Wen-Liang; Lin, Yan-Ren			The Post-Resuscitative Urinalysis Associate the Survival of Patients with Non-Traumatic Out-of-Hospital Cardiac Arrest	PLOS ONE			English	Article							BETA-TRACE PROTEIN; INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; SERUM CREATININE; SEPTIC SHOCK; CYSTATIN C; KIDNEY; POPULATION; STATEMENT	Objective: To analyze whether urine output and urinalysis results are predictive of survival and neurologic outcomes in patients with non-traumatic out-of-hospital cardiac arrest (OHCA). Methods: Information was obtained from 1,340 patients with non-traumatic OHCA who had achieved a sustained return of spontaneous circulation (ROSC). Factors that were associated with survival in the post-resuscitative period were evaluated. The association between urine output and fluid challenge in the early resuscitative period was analyzed and compared between the survivors and the non-survivors. The results of the initial urinalysis, including the presence of proteinuria and other findings, were used to evaluate the severity of vascular protein leakage and survival. The association between proteinuria and the neurologic outcomes of the survivors was also analyzed. The clinical features of capillary leakage were examined during the post-resuscitative period. Results: Of the 1,340 patients, 312 survived. A greater urine output was associated with a higher chance of survival. The initial urine output increased in proportion to the amount of fluid that was administered during early resuscitation in the emergency department for the survivors but not for the non-survivors (p<0.05). In the initial urinalysis, proteinuria was strongly associated with survival, and severe proteinuria indicated significantly poorer neurologic outcomes (p<0.05 for both comparisons). Proteinuria was associated with a risk of developing signs of capillary leakage, including body mass index gain and pitting edema (both p<0.001). Conclusion: The severity of proteinuria during the early post-resuscitative period was predictive of survival.	[Chang, Chin-Fu; Lai, Shih-Chang; Yang, Mei-Chueh; Chiu, Chun-Wen; Chou, Chu-Chung; Chang, Chih-Yu; Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Li, Chao-Jui] Chang Gung Univ, Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Ko, Chih-Jan] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Teng, Tsung-Han; Lai, Shih-Chang; Chang, Chih-Yu; Chen, Wen-Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Teng, Tsung-Han] Taichung Hosp, Dept Pathol, Dept Hlth, Taichung, Taiwan; [Chou, Chu-Chung; Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yao, Yung-Chiao; Wu, Lan-Hsin] Changhua Christian Hosp, Dept Nursing, Changhua, Taiwan; [Wu, Han-Ping] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Pediat, Taichung, Taiwan	Changhua Christian Hospital; Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Changhua Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Wu, HP (corresponding author), Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Pediat, Taichung, Taiwan.	arthur1226@gmail.com; wenurea@yahoo.com.tw; h6213.lac@gmail.com	Lin, Yan-Ren/AAU-4136-2020	Lin, Yan-Ren/0000-0002-9015-2678	Changhua Christian Hospital	Changhua Christian Hospital	The authors Changhua Christian Hospital for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Cokkinos Philip, 2009, Acute Card Care, V11, P131, DOI 10.1080/17482940903168209; Eppihimer MJ, 1997, SHOCK, V8, P16, DOI 10.1097/00024382-199707000-00004; Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008; Gando S, 1997, INTENS CARE MED, V23, P1245, DOI 10.1007/s001340050493; Hasper D, 2009, CRIT CARE, V13, DOI 10.1186/cc8144; Heradstveit BE, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-29; Hiratsuka M, 2009, INFLAMM RES, V58, P463, DOI 10.1007/s00011-009-0011-0; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Juraschek SP, 2013, CLIN J AM SOC NEPHRO, V8, P584, DOI 10.2215/CJN.08700812; Kagawa E, 2010, RESUSCITATION, V81, P968, DOI 10.1016/j.resuscitation.2010.03.037; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Lai S, 2013, J NEUROSCI NEUROENG, V2, P66; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Lin YR, 2010, RESUSCITATION, V81, P410, DOI 10.1016/j.resuscitation.2010.01.006; LIN YR, 2012, J NEUROSCI NEUROENG, V1, P213; Martin-Hernandez H, 2010, MED INTENSIVA, V34, P107, DOI 10.1016/j.medin.2009.09.001; Morimoto Y, 1996, CRIT CARE MED, V24, P1719, DOI 10.1097/00003246-199610000-00020; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Orenes-Pinero E, 2013, CLIN J AM SOC NEPHRO, V8, P873, DOI 10.2215/CJN.08870812; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Spanaus KS, 2010, CLIN CHEM, V56, P740, DOI 10.1373/clinchem.2009.138826; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; Temmesfeld-Wollbruck B, 2007, INTENS CARE MED, V33, P703, DOI 10.1007/s00134-007-0561-y; van Meurs M, 2009, AM J PHYSIOL-RENAL, V297, pF272, DOI 10.1152/ajprenal.00137.2009; Zacharia BE, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/124384	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75172	10.1371/journal.pone.0075172	http://dx.doi.org/10.1371/journal.pone.0075172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124472	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100029
J	Hung, MC; Hsieh, CL; Hwang, JS; Jeng, JS; Wang, JD				Hung, Mei-Chuan; Hsieh, Ching-Lin; Hwang, Jing-Shiang; Jeng, Jiann-Shing; Wang, Jung-Der			Estimation of the Long-Term Care Needs of Stroke Patients by Integrating Functional Disability and Survival	PLOS ONE			English	Article							1ST-EVER ISCHEMIC-STROKE; QUALITY-ADJUSTED SURVIVAL; BARTHEL INDEX; PSYCHOMETRIC CHARACTERISTICS; EXPECTED YEARS; YOUNG-ADULTS; RISK-FACTORS; LIFE LOST; AGED 15; SUBTYPES	Objectives: This study aimed to estimate the dynamic changes of different physical functional disabilities and life-time care needs for patients with stroke. Data Sources and Study Design: We examined a hospital-based cohort including 16,043 patients who had their first stroke during 1995-2010. The Barthel Index (BI) was used to measure disability levels in 1,162 consecutive patients, with a total of 1,294 measurements at the stroke clinics and the rehabilitation wards, and a cross-sectional design. Extraction Methods: The survival function was extrapolated to lifetime by a semi-parametric method and multiplied with proportions of different disabilities over time to obtain the long-term care needs for different stroke subtypes. Principal Findings: On average, stroke patients would suffer at least 0.86 years with mild disability, 1.24 years with moderate disability and 1.39 years with severe disability, as measured by the BI. Among these, patients with a cardio-embolic infarct or intracerebral hemorrhage (ICH) suffered more than 2 years of severe disability. Assistance in bathing was the most common need for care in stroke patients. Conclusions: Among different subtypes of stroke, cardio-embolic infarct and ICH lead to the longest durations of severe physical functional disability. The method presented in this work may also be applied to other chronic diseases and different functional disabilities.	[Hung, Mei-Chuan; Wang, Jung-Der] Natl Cheng Kung Univ Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hwang, Jing-Shiang] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Jeng, JS (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	jsjeng@ntu.edu.tw; jdwang121@gmail.com	Hwang, Jing-Shiang/AAP-2835-2021; Hsieh, Ching-Lin/G-6057-2011	Hwang, Jing-Shiang/0000-0002-5807-7583; Hsieh, Ching-Lin/0000-0001-9468-9969; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council of the Executive Yuan of Taiwan [NSC 102-2314-B-006-029-MY2, NSC 101-2314-B-006-077]	National Science Council of the Executive Yuan of Taiwan	This study is supported by the following two grants of the National Science Council of the Executive Yuan of Taiwan (NSC 102-2314-B-006-029-MY2 and NSC 101-2314-B-006-077). The funding agency has no role or interference in the hypothesis formation, study design, data analysis, inference, or conclusion.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2007, HLTH EXPECTANCY CALC; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x; Della Pietra GL, 2011, STROKE, V42, P2077, DOI 10.1161/STROKEAHA.111.613521; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; Hwang JS, 1996, STAT MED, V15, P93, DOI 10.1002/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2; Kimura K, 2004, CEREBROVASC DIS, V18, P47, DOI 10.1159/000078749; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lee ET, 2009, STAT METHODS SURVIVA, P64; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Liu PH, 2013, PREV MED, V56, P309, DOI 10.1016/j.ypmed.2013.02.003; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Shin SY, 2012, J GERONTOL NURS, V38, P33, DOI 10.3928/00989134-20120807-03; Spengos K, 2010, EUR J NEUROL, V17, P1358, DOI 10.1111/j.1468-1331.2010.03065.x; Turin TC, 2010, STROKE, V41, P1871, DOI 10.1161/STROKEAHA.110.581033; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Xie J., 2007, Morbidity and Mortality Weekly Report, V56, P504; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	28	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75605	10.1371/journal.pone.0075605	http://dx.doi.org/10.1371/journal.pone.0075605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124500	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100057
J	Ito, S; Tanaka, Y; Nishio, N; Thanasegaran, S; Isobe, KI				Ito, Sachiko; Tanaka, Yuriko; Nishio, Naomi; Thanasegaran, Suganya; Isobe, Ken-Ichi			Establishment of Self-Renewable GM-CSF-Dependent Immature Macrophages In Vitro from Murine Bone Marrow	PLOS ONE			English	Article							AORTIC ENDOTHELIUM; CELLS; LINEAGE; BLOOD; HEMATOPOIESIS; RECRUITMENT; PROGENITOR; ACTIVATION; EXPRESSION; MONOCYTES	Macrophages play a key role in the innate immune system. Macrophages are thought to originate from hematopoietic precursors or the yolk sac. Here, we describe the in vitro establishment of self-renewable GM-CSF-dependent immature macrophages (GM-IMs) from murine bone marrow (BM). GM-IMs grow continuously in vitro in conditioned medium containing GM-CSF. The immunophenotype of GM-IMs is F4/80(high) CD11b(high) CD11c(low) Ly6C(low). By comparing gene expression in GM-IMs and BM dendritic cells, we found that GM-IMs expressed lower levels of chemokines, cytokines and their receptors. GM-IMs are round in shape, attach loosely to non-coated culture dishes and have a marked phagocytic capacity. These results indicate that GM-IMs are macrophage precursor cells. Following stimulation with LPS, monocyte-like GM-IMs converted to flat macrophage-like cells that tightly adhered to non-coated culture dishes and produced pro-inflammatory cytokines TNF alpha, IL-6 and IL-1 beta. These results indicated that GM-IMs differentiated to M1 pro-inflammatory macrophages. This was confirmed by stimulation of GM-IMs with IFN gamma, an inducer of M1 markers. GM-IMs showed enhanced expression of M2 macrophage markers such as Arg1 and Retnla following stimulation by Th2 cytokines IL-4 and IL-13. When GM-IMs were injected into mice at sites of wounding, wound repair was enhanced. These results indicate that GM-IMs can differentiate to M2 macrophages. When GM-IMs were injected into clodronate-treated mice, they induced resident macrophage proliferation by producing M-CSF. In conclusion we have established self-renewable GM-CSF-dependent immature macrophages in vitro from murine BM, which differentiate to M1 or M2 macrophages.	[Ito, Sachiko; Tanaka, Yuriko; Nishio, Naomi; Thanasegaran, Suganya; Isobe, Ken-Ichi] Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Nagoya University	Isobe, KI (corresponding author), Nagoya Univ, Dept Immunol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	kisobe@med.nagoya-u.ac.jp	ito, Sachiko/M-4877-2014		Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76943	10.1371/journal.pone.0076943	http://dx.doi.org/10.1371/journal.pone.0076943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124601	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100158
J	Kamalam, BS; Medale, F; Larroquet, L; Corraze, G; Panserat, S				Kamalam, Biju Sam; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve; Panserat, Stephane			Metabolism and Fatty Acid Profile in Fat and Lean Rainbow Trout Lines Fed with Vegetable Oil: Effect of Carbohydrates	PLOS ONE			English	Article							DIETARY FISH-OIL; MUSCLE FAT; ONCORHYNCHUS-MYKISS; GENE-EXPRESSION; DESATURASE EXPRESSION; GLUCOSE-HOMEOSTASIS; TELEOST FISH; IN-VIVO; REPLACEMENT; SELECTION	The present study investigated the effect of dietary carbohydrates on metabolism, with special focus on fatty acid bioconversion and flesh lipid composition in two rainbow trout lines divergently selected for muscle lipid content and fed with vegetable oils. These lines were chosen based on previously demonstrated potential differences in LC-PUFA synthesis and carbohydrate utilization. Applying a factorial study design, juvenile trout from the lean (L) and the fat (F) line were fed vegetable oil based diets with or without gelatinised starch (17.1%) for 12 weeks. Blood, liver, muscle, intestine and adipose tissue were sampled after the last meal. Feed intake and growth was higher in the L line than the F line, irrespective of the diet. Moderate postprandial hyperglycemia, strong induction of hepatic glucokinase and repressed glucose-6-phosphatase transcripts confirmed the metabolic response of both lines to carbohydrate intake. Further at the transcriptional level, dietary carbohydrate in the presence of n-3 LC-PUFA deficient vegetable oils enhanced intestinal chylomicron assembly, disturbed hepatic lipid metabolism and importantly elicited a higher response of key desaturase and elongase enzymes in the liver and intestine that endorsed our hypothesis. PPAR gamma was identified as the factor mediating this dietary regulation of fatty acid bioconversion enzymes in the liver. However, these molecular changes were not sufficient to modify the fatty acid composition of muscle or liver. Concerning the genotype effect, there was no evidence of substantial genotypic difference in lipid metabolism, LC-PUFA synthesis and flesh fatty acid profile when fed with vegetable oils. The minor reduction in plasma glucose and triglyceride levels in the F line was linked to potentially higher glucose and lipid uptake in the muscle. Overall, these data emphasize the importance of dietary macro-nutrient interface in evolving fish nutrition strategies.	[Kamalam, Biju Sam; Medale, Francoise; Larroquet, Laurence; Corraze, Genevieve; Panserat, Stephane] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Panserat, S (corresponding author), INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France.	panserat@st-pee.inra.fr	Kamalam, Biju Sam/K-8876-2012	Kamalam, Biju Sam/0000-0003-1944-0244; Panserat, Stephane/0000-0002-4479-9868; Medale, Francoise/0000-0002-8083-1298	Indian Council of Agricultural Research (ICAR); Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France	Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR)); Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France	BS Kamalam was a recipient of the International doctoral fellowship provided by the Indian Council of Agricultural Research (ICAR). This study was supported by internal grants of the Nutrition, Metabolism and Aquaculture unit of the Institut National de la Recherche Agronomique (INRA), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NEW COMPREHENSIVE BI, DOI [DOI 10.1016/S0167-7306(02)36009-5, 10.1016/S0167-7306(02)36009-5]; Bell JG, 2010, AQUACULTURE, V306, P225, DOI 10.1016/j.aquaculture.2010.05.021; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; BERGOT F, 1979, AQUACULTURE, V18, P157, DOI 10.1016/0044-8486(79)90028-0; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geurden I, 2005, PHYSIOL BEHAV, V85, P107, DOI 10.1016/j.physbeh.2005.03.010; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Goetz F, 2010, MOL ECOL, V19, P176, DOI 10.1111/j.1365-294X.2009.04481.x; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hemre GI, 2002, AQUACULT NUTR, V8, P175, DOI 10.1046/j.1365-2095.2002.00200.x; Igarashi M, 2007, J LIPID RES, V48, P2463, DOI 10.1194/jlr.M700315-JLR200; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump D. B., 2002, Scandinavian Journal of Nutrition/Naringsforskning, V46, P59, DOI 10.1080/11026480213022; Kamalam BS, 2013, COMP BIOCHEM PHYS A, V164, P417, DOI 10.1016/j.cbpa.2012.11.020; Kamalam BS, 2012, J EXP BIOL, V215, P2567, DOI 10.1242/jeb.070581; Kirchner S, 2008, J COMP PHYSIOL B, V178, P429, DOI 10.1007/s00360-007-0235-7; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Kolditz CI, 2010, BRIT J NUTR, V103, P629, DOI 10.1017/S0007114509992340; Kolditz CI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-506; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Matsuzaka T, 2002, J LIPID RES, V43, P107; Menoyo D, 2005, J ANIM SCI, V83, P2853; Meyer A, 2004, J LIPID RES, V45, P1899, DOI 10.1194/jlr.M400181-JLR200; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; MOORE S, 1968, J BIOL CHEM, V243, P6281; Morais S., 2011, BR J NUTR, V1, P1; Morais S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-448; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Panserat S, 2009, AM J PHYSIOL-REG I, V297, pR707, DOI 10.1152/ajpregu.00120.2009; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; Panserat S, 2000, J NUTR BIOCHEM, V11, P22, DOI 10.1016/S0955-2863(99)00067-4; Panserat S, 2008, BRIT J NUTR, V100, P953, DOI 10.1017/S0007114508981411; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; POISSON JPG, 1991, J NUTR BIOCHEM, V2, P60, DOI 10.1016/0955-2863(91)90030-9; Polakof S, 2011, J ANIM SCI, V89, P3079, DOI 10.2527/jas.2010-3733; Quillet E, 2005, AQUACULTURE, V245, P49, DOI 10.1016/j.aquaculture.2004.12.014; Quillet E, 2007, AQUACULTURE, V269, P220, DOI 10.1016/j.aquaculture.2007.02.047; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Rollin X, 2003, COMP BIOCHEM PHYS B, V134, P349, DOI 10.1016/S1096-4959(02)00264-6; Sanchez-Gurmaches J, 2012, J EXP BIOL, V215, P1373, DOI 10.1242/jeb.061697; Sargent John R., 2002, P181; Seiliez I, 2001, COMP BIOCHEM PHYS B, V130, P83, DOI 10.1016/S1096-4959(01)00410-9; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Stubhaug I, 2005, BBA-MOL CELL BIOL L, V1734, P277, DOI 10.1016/j.bbalip.2005.04.003; SULLIVAN AC, 1971, J NUTR, V101, P265, DOI 10.1093/jn/101.2.265; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Torstensen B.E., 2010, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	69	46	48	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76570	10.1371/journal.pone.0076570	http://dx.doi.org/10.1371/journal.pone.0076570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124573	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100130
J	van der Wal, A; Tecon, R; Kreft, JU; Mooij, WM; Leveau, JHJ				van der Wal, Annemieke; Tecon, Robin; Kreft, Jan-Ulrich; Mooij, Wolf M.; Leveau, Johan H. J.			Explaining Bacterial Dispersion on Leaf Surfaces with an Individual-Based Model (PHYLLOSIM)	PLOS ONE			English	Article							PLANT-MICROBE INTERACTIONS; PSEUDOMONAS-SYRINGAE; BIOFILM FORMATION; WATER AVAILABILITY; GROWTH; DETACHMENT; DIFFUSION; MOTILITY; COLONIZATION; CUTICLES	We developed the individual-based model PHYLLOSIM to explain observed variation in the size of bacterial clusters on plant leaf surfaces (the phyllosphere). Specifically, we tested how different 'waterscapes' impacted the diffusion of nutrients from the leaf interior to the surface and the growth of individual bacteria on these nutrients. In the 'null' model or more complex 'patchy' models, the surface was covered with a continuous water film or with water drops of equal or different volumes, respectively. While these models predicted the growth of individual bacterial immigrants into clusters of variable sizes, they were unable to reproduce experimentally derived, previously published patterns of dispersion which were characterized by a much larger variation in cluster sizes and a disproportionate occurrence of clusters consisting of only one or two bacteria. The fit of model predictions to experimental data was about equally poor (<5%) regardless of whether the water films were continuous or patchy. Only by allowing individual bacteria to detach from developing clusters and re-attach elsewhere to start a new cluster, did PHYLLOSIM come much closer to reproducing experimental observations. The goodness of fit including detachment increased to about 70-80% for all waterscapes. Predictions of this 'detachment' model were further supported by the visualization and quantification of bacterial detachment and attachment events at an agarose-water interface. Thus, both model and experiment suggest that detachment of bacterial cells from clusters is an important mechanism underlying bacterial exploration of the phyllosphere.	[van der Wal, Annemieke; Tecon, Robin; Leveau, Johan H. J.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Tecon, Robin; Leveau, Johan H. J.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Tecon, Robin] Univ Birmingham, Sch Biosci, Ctr Syst Biol, Birmingham, W Midlands, England; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Mooij, Wolf M.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of California System; University of California Davis; University of Birmingham; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Leveau, JHJ (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	jleveau@ucdavis.edu	van der Wal, Annemieke/F-7411-2012; Leveau, Johan HJ/C-1096-2012; Tecon, Robin/B-2906-2011; Kreft, Jan-Ulrich/B-1234-2008; Mooij, Wolf M/C-2677-2008; KNAW, NIOO-KNAW/A-4320-2012	van der Wal, Annemieke/0000-0003-0261-1203; Leveau, Johan HJ/0000-0002-8376-4553; Tecon, Robin/0000-0002-5665-3073; Kreft, Jan-Ulrich/0000-0002-2351-224X; Mooij, Wolf M/0000-0001-5586-8200; KNAW, NIOO-KNAW/0000-0002-3835-159X	VIDI grant from The Netherlands Organisation for Scientific Research (NWO) [864.06.002]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation; National Centre for the Replacement [NC/K000683/1] Funding Source: researchfish	VIDI grant from The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Centre for the Replacement	This work was funded through VIDI grant 864.06.002 (LEVEAU) from The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell CA, 2002, APPL ENVIRON MICROB, V68, P4604, DOI 10.1128/AEM.68.9.4604-4612.2002; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Benedek GB, 2000, PHYS ILLUSTRATIVE EX; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; BUNSTER L, 1989, APPL ENVIRON MICROB, V55, P1340, DOI 10.1128/AEM.55.6.1340-1345.1989; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Elfwing A, 2004, APPL ENVIRON MICROB, V70, P675, DOI 10.1128/AEM.70.2.675-678.2004; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hirano SS, 1996, APPL ENVIRON MICROB, V62, P2560, DOI 10.1128/AEM.62.7.2560-2566.1996; Joyner DC, 2000, MICROBIOL-UK, V146, P2435, DOI 10.1099/00221287-146-10-2435; Knoll D, 2000, MICROB ECOL, V40, P33, DOI 10.1007/s002480000012; LEBEN C, 1970, PHYTOPATHOLOGY, V60, P677, DOI 10.1094/Phyto-60-677; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Leveau JHJ, 2006, ANNU PLANT REV, V23, P334; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LOHAUS G, 1995, BOT ACTA, V108, P270, DOI 10.1111/j.1438-8677.1995.tb00860.x; Monier J. M., 2006, Microbial ecology of aerial plant surfaces, P83, DOI 10.1079/9781845930615.0083; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Perez-Velazquez J, 2012, MATH BIOSCI, V239, P106, DOI 10.1016/j.mbs.2012.04.009; Picioreanu C, 2007, WATER SCI TECHNOL, V55, P337, DOI 10.2166/wst.2007.275; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Remus-Emsermann MNP, 2010, ISME J, V4, P215, DOI 10.1038/ismej.2009.110; Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; Sambrook J, 2001, MOL CLONING LAB MANU; Schonherr J, 1996, CUTICLE PERMEABILITY; Schreiber L, 2005, ANN BOT-LONDON, V95, P1069, DOI 10.1093/aob/mci122; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Stein W., 1990, CHANNELS CARRIERS PU; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Tecon R, 2012, ENVIRON MICROBIOL, V14, P1325, DOI 10.1111/j.1462-2920.2012.02715.x; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; TUKEY HB, 1966, B TORREY BOT CLUB, V93, P385, DOI 10.2307/2483411; van der Wal A, 2011, ENVIRON MICROBIOL, V13, P792, DOI 10.1111/j.1462-2920.2010.02382.x; Wang G, 2013, ISME J, V7, P395, DOI 10.1038/ismej.2012.115; Wilensky U, 1999, NETLOGO; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110	46	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75633	10.1371/journal.pone.0075633	http://dx.doi.org/10.1371/journal.pone.0075633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124501	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100058
J	Shiou, SR; Yu, YY; Guo, YE; Westerhoff, M; Lu, L; Petrof, EO; Sun, J; Claud, EC				Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; Westerhoff, Maria; Lu, Lei; Petrof, Elaine O.; Sun, Jun; Claud, Erika C.			Oral Administration of Transforming Growth Factor-beta 1 (TGF-beta 1) Protects the Immature Gut from Injury via Smad Protein-dependent Suppression of Epithelial Nuclear Factor kappa B (NF-kappa B) Signaling and Proinflammatory Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); Inflammation; Innate Immunity; Intestinal Epithelium; NF-kappa B (NF-KB); SMAD Transcription Factor; Transforming Growth Factor Beta (TGFbeta)	GROWTH-FACTOR-BETA; NEONATAL NECROTIZING ENTEROCOLITIS; TGF-BETA; INTERLEUKIN-6 GENE; HUMAN-MILK; CELL LINE; TNF-ALPHA; RAT MODEL; EXPRESSION; DISEASE	Background: Intestinal production of TGF- is decreased in neonatal necrotizing enterocolitis (NEC). Results: Oral administration of TGF- (TGF-1) inhibited inflammation in intestinal epithelium and systemic production of IL-6 and IFN- as well as NEC incidence in an animal model. Conclusion: Oral administration of TGF-1 can compensate for TGF-1 deficiency in gut diseases. Significance: TGF-1 can potentially be used to prevent and treat gut diseases. Inflammatory immune responses play an important role in mucosal homeostasis and gut diseases. Nuclear factor B (NF-B), central to the proinflammatory cascade, is activated in necrotizing enterocolitis (NEC), a devastating condition of intestinal injury with extensive inflammation in premature infants. TGF- is a strong immune suppressor and a factor in breast milk, which has been shown to be protective against NEC. In an NEC animal model, oral administration of the isoform TGF-1 activated the downstream effector Smad2 in intestine and significantly reduced NEC incidence. In addition, TGF-1 suppressed NF-B activation, maintained levels of the NF-B inhibitor IB in the intestinal epithelium, and systemically decreased serum levels of IL-6 and IFN-. The immature human fetal intestinal epithelial cell line H4 was used as a reductionistic model of the immature enterocyte to investigate mechanism. TGF-1 pretreatment inhibited the TNF--induced IB phosphorylation that targets the IB protein for degradation and inhibited NF-B activation. Chromatin immunoprecipitation (ChIP) assays demonstrated decreased NF-B binding to the promoters of IL-6, IL-8, and IB in response to TNF- with TGF-1 pretreatment. These TGF-1 effects appear to be mediated through the canonical Smad pathway as silencing of the TGF- central mediator Smad4 resulted in loss of the TGF-1 effects. Thus, TGF-1 is capable of eliciting anti-inflammatory effects by inhibiting NF-B specifically in the intestinal epithelium as well as by decreasing systemic IL-6 and IFN- levels. Oral administration of TGF-1 therefore can potentially be used to protect against gastrointestinal diseases.	[Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; Lu, Lei; Claud, Erika C.] Univ Chicago, Sect Neonatol, Dept Pediat, Chicago, IL 60637 USA; [Claud, Erika C.] Univ Chicago, Gastroenterol Sect, Dept Med, Chicago, IL 60637 USA; [Westerhoff, Maria] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98104 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; Queens University - Canada; Rush University	Claud, EC (corresponding author), Univ Chicago, Sect Neonatol, Dept Pediat, 5841 S Maryland Ave MC6060, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institutes of Health National Research Service Award (NRSA) F32 Fellowship [HD062144, HD059123]; Digestive Disease Research Core Center of the University of Chicago; National Institutes of Health [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059123, F32HD062144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award (NRSA) F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center of the University of Chicago(University of Chicago); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award (NRSA) F32 Fellowship Grants HD062144 (to S. S.) and HD059123 (to E. C. C.) and by the Digestive Disease Research Core Center of the University of Chicago (supported by National Institutes of Health Grant DK42086).	Azuma M, 1999, EXP CELL RES, V250, P213, DOI 10.1006/excr.1999.4503; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Cavin LG, 2003, HEPATOLOGY, V38, P1540, DOI 10.1016/j.hep.2003.09.019; Cho ML, 2006, IMMUNOL LETT, V105, P159, DOI 10.1016/j.imlet.2006.02.003; Chung HL, 2002, J ALLERGY CLIN IMMUN, V109, P150, DOI 10.1067/mai.2002.120562; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Kafetzis DA, 2003, CURR OPIN INFECT DIS, V16, P349, DOI 10.1097/00001432-200308000-00007; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Le YY, 2004, J IMMUNOL, V173, P962, DOI 10.4049/jimmunol.173.2.962; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Li DH, 2004, GENE, V342, P157, DOI 10.1016/j.gene.2004.07.034; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McKaig BC, 2002, AM J PHYSIOL-CELL PH, V282, pC172, DOI 10.1152/ajpcell.00048.2001; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Rautava S, 2012, J PEDIATR GASTR NUTR, V54, P630, DOI 10.1097/MPG.0b013e31823e7c29; Rupec RA, 1999, IMMUNOGENETICS, V49, P395, DOI 10.1007/s002510050512; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; SANDERSON IR, 1995, INT ARCH ALLERGY IMM, V107, P396, DOI 10.1159/000237051; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006	36	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34757	34766		10.1074/jbc.M113.503946	http://dx.doi.org/10.1074/jbc.M113.503946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129565	Green Published, hybrid			2022-12-25	WOS:000329812800044
J	Larsson, M; Vorrsjo, E; Talmud, P; Lookene, A; Olivecrona, G				Larsson, Mikael; Vorrsjo, Evelina; Talmud, Philippa; Lookene, Aivar; Olivecrona, Gunilla			Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Dyslipidemia; Lipolysis; Lipoprotein; Lipoprotein Metabolism; Triglyceride; Apolipoprotein C-I; Apolipoprotein C-III; Lipoprotein Lipase	TRIACYLGLYCEROL-RICH LIPOPROTEINS; DENSITY-LIPOPROTEINS; TRANSGENIC MICE; FATTY-ACIDS; APOC-III; A-I; BINDING; PLASMA; HYPERTRIGLYCERIDEMIA; RECEPTOR	Apolipoproteins (apo) C-I and C-III are known to inhibit lipoprotein lipase (LPL) activity, but the molecular mechanisms for this remain obscure. We present evidence that either apoC-I or apoC-III, when bound to triglyceride-rich lipoproteins, prevent binding of LPL to the lipid/water interface. This results in decreased lipolytic activity of the enzyme. Site-directed mutagenesis revealed that hydrophobic amino acid residues centrally located in the apoC-III molecule are critical for attachment to lipid emulsion particles and consequently inhibition of LPL activity. Triglyceride-rich lipoproteins stabilize LPL and protect the enzyme from inactivating factors such as angiopoietin-like protein 4 (angptl4). The addition of either apoC-I or apoC-III to triglyceride-rich particles severely diminished their protective effect on LPL and rendered the enzyme more susceptible to inactivation by angptl4. These observations were seen using chylomicrons as well as the synthetic lipid emulsion Intralipid. In the presence of the LPL activator protein apoC-II, more of apoC-I or apoC-III was needed for displacement of LPL from the lipid/water interface. In conclusion, we show that apoC-I and apoC-III inhibit lipolysis by displacing LPL from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL by factors such as angptl4.	[Larsson, Mikael; Vorrsjo, Evelina; Olivecrona, Gunilla] Umea Univ, Dept Med Biosciences Physiol Chem, SE-90187 Umea, Sweden; [Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Vorrsjo, Evelina; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Talmud, Philippa] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London WC1E 6JF, England	Umea University; Tallinn University of Technology; Umea University; University of London; University College London	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden.	gunilla.olivecrona@medbio.umu.se		Talmud, Philippa/0000-0002-5560-1933	Swedish Science Council [12203]; Swedish Heart and Lung Foundation; British Heart Foundation [RG08/014]	Swedish Science Council; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by Swedish Science Council Grant 12203, The Swedish Heart and Lung Foundation, and British Heart Foundation Grant RG08/014.	ASTRUP HN, 1982, COMP BIOCHEM PHYS B, V72, P487, DOI 10.1016/0305-0491(82)90494-1; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; ATTMAN PO, 1987, KIDNEY INT, V32, P368, DOI 10.1038/ki.1987.219; Baranowski T, 2011, HORM METAB RES, V43, P117, DOI 10.1055/s-0030-1267917; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BENGTSSON G, 1977, EUR J BIOCHEM, V79, P225, DOI 10.1111/j.1432-1033.1977.tb11800.x; BENGTSSON G, 1979, BIOCHIM BIOPHYS ACTA, V575, P471, DOI 10.1016/0005-2760(79)90118-8; Bengtsson-Olivecrona G., 1992, LIPOPROTEIN ANAL PRA, P169; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BENSADOU.A, 1974, J BIOL CHEM, V249, P2220; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; Cohn JS, 2002, J LIPID RES, V43, P1680, DOI 10.1194/jlr.M200055-JLR200; CRAWFORD GA, 1979, CLIN SCI, V57, P155, DOI 10.1042/cs0570155; DEMEL RA, 1984, BIOCHIM BIOPHYS ACTA, V793, P399, DOI 10.1016/0005-2760(84)90255-8; Ding YY, 2011, TRANSGENIC RES, V20, P867, DOI 10.1007/s11248-010-9467-5; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; FIELDING CJ, 1976, J LIPID RES, V17, P419; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; FORMISANO S, 1978, J BIOL CHEM, V253, P354; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Hansen JB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/271062; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; Hultin M, 1996, J LIPID RES, V37, P1022; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P203, DOI 10.1016/0005-2760(86)90169-4; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P211, DOI 10.1016/0005-2760(86)90170-0; JACKSON RL, 1979, BIOCHIM BIOPHYS ACTA, V556, P369, DOI 10.1016/0005-2736(79)90126-3; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KRAUSS RM, 1973, CIRC RES, V33, P403, DOI 10.1161/01.RES.33.4.403; KREBS KE, 1983, BIOCHIM BIOPHYS ACTA, V751, P470, DOI 10.1016/0005-2760(83)90308-9; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lambert DA, 1996, ATHEROSCLEROSIS, V127, P205, DOI 10.1016/S0021-9150(96)05955-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu HQ, 2000, J LIPID RES, V41, P1760; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; MAEDA N, 1994, J BIOL CHEM, V269, P23610; MASSEY JB, 1979, J BIOL CHEM, V254, P9359; Mattijssen F, 2012, BBA-MOL CELL BIOL L, V1821, P782, DOI 10.1016/j.bbalip.2011.10.010; Meyers NL, 2012, BIOCHEMISTRY-US, V51, P1238, DOI 10.1021/bi2015212; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; Olivecrona G, 1997, METHOD ENZYMOL, V286, P102; Olivecrona G, 2010, CURR OPIN LIPIDOL, V21, P409, DOI 10.1097/MOL.0b013e32833ded83; OSTLUNDLINDQVIST AM, 1975, BIOCHEM BIOPH RES CO, V65, P1447, DOI 10.1016/S0006-291X(75)80391-3; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Protter A. P., 1990, U.S. Patent, Patent No. [4,349,629, 4349629]; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shachter NS, 1996, J CLIN INVEST, V98, P846, DOI 10.1172/JCI118857; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; SPARROW JT, 1977, BIOCHEMISTRY-US, V16, P5427, DOI 10.1021/bi00644a004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; van der Hoogt CC, 2006, BBA-MOL CELL BIOL L, V1761, P213, DOI 10.1016/j.bbalip.2006.01.002; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang LB, 2003, J BIOL CHEM, V278, P37480, DOI 10.1074/jbc.M303133200; WASHINGTON C, 1988, INT J PHARM, V44, P169, DOI 10.1016/0378-5173(88)90113-5; Wei JY, 2012, FEBS J, V279, P91, DOI 10.1111/j.1742-4658.2011.08401.x; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102	74	108	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33997	34008		10.1074/jbc.M113.495366	http://dx.doi.org/10.1074/jbc.M113.495366			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121499	hybrid, Green Published			2022-12-25	WOS:000327250200041
J	Ameni, G; Tadesse, K; Hailu, E; Deresse, Y; Medhin, G; Aseffa, A; Hewinson, G; Vordermeier, M; Berg, S				Ameni, Gobena; Tadesse, Konjit; Hailu, Elena; Deresse, Yohannes; Medhin, Girmay; Aseffa, Abraham; Hewinson, Glyn; Vordermeier, Martin; Berg, Stefan			Transmission of Mycobacterium tuberculosis between Farmers and Cattle in Central Ethiopia	PLOS ONE			English	Article							CENTRAL-EUROPEAN COUNTRIES; BOVINE TUBERCULOSIS; HUMAN-POPULATIONS; DISEASE; IDENTIFICATION; EPIDEMIOLOGY; INFECTIONS; DIAGNOSIS; PULMONARY; PATHOLOGY	Background: Transmission of Mycobacterium tuberculosis (M. tuberculosis) complex could be possible between farmers and their cattle in Ethiopia. Methodology/Principal Findings: A study was conducted in mixed type multi-purposes cattle raising region of Ethiopia on 287 households (146 households with case of pulmonary tuberculosis (TB) and 141 free of TB) and 287 herds consisting of 2,033 cattle belonging to these households to evaluate transmission of TB between cattle and farmers. Interview, bacteriological examinations and molecular typing were used for human subjects while comparative intradermal tuberculin (CIDT) test, post mortem and bacteriological examinations, and molecular typing were used for animal studies. Herd prevalence of CIDT reactors was 9.4% and was higher (p<0.01) in herds owned by households with TB than in herds owned by TB free households. Animal prevalence was 1.8% and also higher (p<0.01) in cattle owned by households with TB case than in those owned by TB free households. All mycobacteria (141) isolated from farmers were M. tuberculosis, while only five of the 16 isolates from cattle were members of the M. tuberculosis complex (MTC) while the remaining 11 were members of non-tuberculosis mycobacteria (NTM). Further speciation of the five MTC isolates showed that three of the isolates were M. bovis (strain SB1176), while the remaining two were M. tuberculosis strains (SIT149 and SIT53). Pathology scoring method described by "Vordermeier et al. (2002)" was applied and the average severity of pathology in two cattle infected with M. bovis, in 11 infected with NTM and two infected with M. tuberculosis were 5.5, 2.1 and 0.5, respectively. Conclusions/Significance: The results showed that transmission of TB from farmers to cattle by the airborne route sensitizes the cows but rarely leads to TB. Similarly, low transmission of M. bovis between farmers and their cattle was found, suggesting requirement of ingestion of contaminated milk from cows with tuberculous mastitis.	[Ameni, Gobena; Tadesse, Konjit; Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Anim Hlth & Zoonot Res Unit, Addis Ababa, Ethiopia; [Ameni, Gobena; Hailu, Elena; Deresse, Yohannes; Aseffa, Abraham] Armauer Hansen Res Inst, TB Res Team, Addis Ababa, Ethiopia; [Hewinson, Glyn; Vordermeier, Martin; Berg, Stefan] Anim Hlth & Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England	Addis Ababa University; Veterinary Laboratories Agency	Ameni, G (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Anim Hlth & Zoonot Res Unit, Addis Ababa, Ethiopia.	gobenachimidi2009@yahoo.co.uk	Hewinson, Glyn/AAA-2364-2019; Hewinson, Glyn/J-1902-2014; Aseffa, Abraham/J-3248-2016; Vordermeier, H Martin/C-6936-2011; Berg, Stefan/AAU-6463-2020; Ameni, Gobena/AAR-4201-2020	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Ameni, Gobena/0000-0003-3987-0671; Medhin, Girmay/0000-0003-2146-4261; Hewinson, Glyn/0000-0002-5517-4281	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are grateful to the Wellcome Trust for financially supporting this project through the programme "Animal diseases in the developing world". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2001, ZOONOSES COMMUNICABL, VI, P283; Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Alexander KA, 2002, EMERG INFECT DIS, V8, P598, DOI 10.3201/eid0806.010358; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Boulahbal F, 1978, Arch Inst Pasteur Alger, V53, P155; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bruchfeld J, 2002, J CLIN MICROBIOL, V40, P1636, DOI 10.1128/JCM.40.5.1636-1643.2002; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; GRANGE JM, 1994, VET MICROBIOL, V40, P137, DOI 10.1016/0378-1135(94)90052-3; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kazwala RR, 1998, TROP ANIM HEALTH PRO, V30, P233, DOI 10.1023/A:1005075112393; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; MAGNUS K, 1966, B WORLD HEALTH ORGAN, V35, P483; Michalak K, 1998, EMERG INFECT DIS, V4, P283, DOI 10.3201/eid0402.980217; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Office de International Epidemiologues (OIE), 2009, TERR MAN BOV TUB, P1; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Pavlik I, 2005, VET MED-CZECH, V50, P291, DOI 10.17221/5626-VETMED; Pavlik I, 2003, VET MED-CZECH, V48, P83, DOI 10.17221/5754-VETMED; Radostits SM, 1994, VET MED TXB DIS CATT, P748; Regassa A, 2008, VET J, V178, P119, DOI 10.1016/j.tvjl.2007.06.019; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Sternberg S, 2002, J ZOO WILDLIFE MED, V33, P378, DOI 10.1638/1042-7260(2002)033[0378:SOTTIS]2.0.CO;2; Une Y, 2007, COMP IMMUNOL MICROB, V30, P415, DOI 10.1016/j.cimid.2007.05.002; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2008, GLOBAL TUBERCULOSIS; Wilton S, 1992, PCR Methods Appl, V1, P269; World Health Organization (WHO), 2009, WHOHTMTB2009426	37	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76891	10.1371/journal.pone.0076891	http://dx.doi.org/10.1371/journal.pone.0076891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130804	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200044
J	Du, QC; Zhang, DZ; Chen, XJ; Gui, LS; Wu, M; Xiao, WL				Du, Qi-cui; Zhang, Dai-zun; Chen, Xiu-juan; Gui Lan-Sun; Wu, Min; Xiao, Wen-lin			The Effect of p38MAPK on Cyclic Stretch in Human Facial Hypertrophic Scar Fibroblast Differentiation	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; P38 MAP KINASE; TGF-BETA; DERMAL FIBROBLASTS; IN-VITRO; SMAD; CELLS; EXPRESSION; PROLIFERATION; ACTIVATION	Hypertrophic scars (HTS), the excessive deposition of scar tissue by fibroblasts, is one of the most common skin disorders. Fibroblasts derived from surgical scar tissue produce high levels of alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-beta 1 (TGF-beta 1). However, the molecular mechanisms for this phenomenon is poorly understood. Thus, the purpose of this study was to evaluate the molecular mechanisms of HTS and their potential therapeutic implications. Fibroblasts derived from skin HTS were cultured and characterized in vitro. The fibroblasts were synchronized and randomly assigned to two groups: cyclic stretch and cyclic stretch pre-treated with SB203580 (a p38MAPK inhibitor). Cyclic stretch at 10% strain was applied at a loading frequency of 10 cycles per minute (i.e. 5 seconds of tension and 5 seconds of relaxation) for 0 h, 6 h and 12 h. Cyclic stretch on HTS fibroblasts led to an increase in the expression of alpha-SMA and TGF-beta 1 mRNA and protein and the phosphorylation of p38MAPK. SB203580 reversed these effects and caused a decrease in matrix contraction. Furthermore, HTS fibroblast growth was partially blocked by p38MAPK inhibition. Therefore, the mechanism of cyclic stretch involves p38 MAPK, and its inhibition is suggested as a novel therapeutic strategy for HTS.	[Du, Qi-cui; Chen, Xiu-juan; Gui Lan-Sun; Xiao, Wen-lin] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Stomatol, Qingdao 266071, Peoples R China; [Zhang, Dai-zun] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Paediat Dent, Qingdao 266071, Peoples R China; [Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA	Qingdao University; Qingdao University; University of North Dakota Grand Forks	Wu, M (corresponding author), Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	min.wu@med.und.edu; wenlinxiaocn@gmail.com		Wu, Min/0000-0003-1205-982X				Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; Guo L, 2012, MOL CELL BIOCHEM, V361, P161, DOI 10.1007/s11010-011-1100-2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Ishiguro S, 2009, WOUND REPAIR REGEN, V17, P617, DOI 10.1111/j.1524-475X.2009.00511.x; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawakita T, 2013, J CELL PHYSIOL, V228, P225, DOI 10.1002/jcp.24126; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Krane M, 2011, INT J CARDIOL, V149, P221, DOI 10.1016/j.ijcard.2010.02.003; Larjava H, 2011, J CAN DENT ASSOC, V77; Lee WL, 2012, FREE RADICAL BIO MED, V52, P1423, DOI 10.1016/j.freeradbiomed.2012.01.020; Li Zhe, 2009, Zhonghua Shao Shang Za Zhi, V25, P49; Lin ZW, 2012, BURNS, V38, P404, DOI 10.1016/j.burns.2011.08.013; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Nishimura K, 2007, WOUND REPAIR REGEN, V15, P646, DOI 10.1111/j.1524-475X.2007.00295.x; Nishimura K, 2009, J SURG RES, V155, P125, DOI 10.1016/j.jss.2008.07.029; Ochicha O, 2010, INDIAN J PATHOL MICR, V53, P262, DOI 10.4103/0377-4929.64341; Omori S, 2008, KIDNEY INT, V73, P1031, DOI 10.1038/ki.2008.3; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Stuart K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022139; Tan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009995; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varkey M, 2011, BIOMATERIALS, V32, P7581, DOI 10.1016/j.biomaterials.2011.06.070; Viera Martha H, 2010, J Clin Aesthet Dermatol, V3, P20; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	45	18	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75635	10.1371/journal.pone.0075635	http://dx.doi.org/10.1371/journal.pone.0075635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130728	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900047
J	Hakamata, Y; Iwase, M; Kato, T; Senda, K; Inada, T				Hakamata, Yuko; Iwase, Mikio; Kato, Takashi; Senda, Kohei; Inada, Toshiya			The Neural Correlates of Mindful Awareness: A Possible Buffering Effect on Anxiety-Related Reduction in Subgenual Anterior Cingulate Cortex Activity	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; PERSONALITY-TRAITS; FUNCTIONAL NEUROANATOMY; ORBITOFRONTAL CORTEX; SELF; METAANALYSIS; DISORDERS; HEALTH; DAMAGE; FEAR	Background: Human personality consists of two fundamental elements character and temperament. Character allays automatic and preconceptual emotional responses determined by temperament. However, the neurobiological basis of character and its interplay with temperament remain elusive. Here, we examined character-temperament interplay and explored the neural basis of character, with a particular focus on the subgenual anterior cingulate cortex extending to a ventromedial portion of the prefrontal cortex (sgACC/vmPFC). Methods: Resting brain glucose metabolism (GM) was measured using [(18) F] fluorodeoxyglucose positron emission tomography in 140 healthy adults. Personality traits were assessed using the Temperament and Character Inventory. Regions of interest (ROI) analysis and whole-brain analysis were performed to examine a combination effect of temperament and character on the sgACC/vmPFC and to explore the neural correlates of character, respectively. Results: Harm avoidance (HA), a temperament trait (i.e., depressive, anxious, vulnerable), showed a significant negative impact on the sgACC/vmPFC GM, whereas self-transcendence (ST), a character trait (i.e., intuitive, judicious, spiritual), exhibited a significant positive effect on GM in the same region (HA beta = -0.248, p = 0.003; ST: beta = 0.250, p = 0.003). In addition, when coupled with strong ST, individuals with strong HA maintained the sgACC/vmPFC GM level comparable to the level of those with low scores on both HA and ST. Furthermore, exploratory whole-brain analysis revealed a significant positive relationship between ST and sgACC/vmPFC GM (peak voxel at x = -8, y = 32, z = -8, k = 423, Z = 4.41, corrected p(FDR) = 0.030). Conclusion: The current findings indicate that the sgACC/vmPFC might play a critical role in mindful awareness to something beyond as well as in emotional regulation. Developing a sense of mindfulness may temper exaggerated emotional responses in individuals with a risk for or having anxiety and depressive disorders.	[Hakamata, Yuko] Kitasato Univ, Dept Clin Psychol, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Iwase, Mikio; Senda, Kohei] Koseikai Hosp, Diagnost Imaging Ctr, Toyohashi, Aichi, Japan; [Kato, Takashi] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Clin & Expt Neuroimaging, Obu, Aichi, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Shinjuku Ku, Tokyo, Japan	Kitasato University; National Center for Geriatrics & Gerontology	Hakamata, Y (corresponding author), Kitasato Univ, Dept Clin Psychol, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan.	hakamata@kitasato-u.ac.jp		Hakamata, Yuko/0000-0002-5717-8091; Inada, Toshiya/0000-0002-8427-5639	Japanese Society for the Promotion of Science [24683025]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Investigators A by the Japanese Society for the Promotion of Science (to Y.H., grant number: 24683025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cloninger CR, 2006, WORLD PSYCHIATRY, V5, P71; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M. B., 1997, STRUCTURED CLIN INTE; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gil S, 2005, J TRAUMA STRESS, V18, P563, DOI 10.1002/jts.20065; Gil S, 2006, PSYCHOSOM MED, V68, P904, DOI 10.1097/01.psy.0000242124.21796.f8; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Hakamata Y, 2006, NEUROSCI LETT, V396, P33, DOI 10.1016/j.neulet.2005.11.017; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Kaasinen V, 2002, NEUROSCI LETT, V332, P61, DOI 10.1016/S0304-3940(02)00929-1; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Karlsson H, 2011, MOL PSYCHIATR, V16, P282, DOI 10.1038/mp.2009.126; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuhn S., 2011, SCHIZOPHR B; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Mielke R, 1998, J NEURAL TRANSM, V105, P821, DOI 10.1007/s007020050097; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Tijssen MJA, 2010, ACTA PSYCHIAT SCAND, V122, P255, DOI 10.1111/j.1600-0447.2010.01539.x; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Youn T, 2002, BIOL PSYCHOL, V60, P109, DOI 10.1016/S0301-0511(02)00047-9	50	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75526	10.1371/journal.pone.0075526	http://dx.doi.org/10.1371/journal.pone.0075526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130715	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900039
J	Honda, M; Kuwano, Y; Katsuura-Kamano, S; Kamezaki, Y; Fujita, K; Akaike, Y; Kano, S; Nishida, K; Masuda, K; Rokutan, K				Honda, Manami; Kuwano, Yuki; Katsuura-Kamano, Sakurako; Kamezaki, Yoshiko; Fujita, Kinuyo; Akaike, Yoko; Kano, Shizuka; Nishida, Kensei; Masuda, Kiyoshi; Rokutan, Kazuhito			Chronic Academic Stress Increases a Group of microRNAs in Peripheral Blood	PLOS ONE			English	Article							EXPRESSION; MIR-16; SIGNATURE; RESPONSES; STATE	MicroRNAs (miRNAs) play key roles in regulation of cellular processes in response to changes in environment. In this study, we examined alterations in miRNA profiles in peripheral blood from 25 male medical students two months and two days before the National Examination for Medical Practitioners. Blood obtained one month after the examination were used as baseline controls. Levels of seven miRNAs (miR-16, -20b, -26b, -29a, -126, -144 and -144*) were significantly elevated during the pre-examination period in association with significant down-regulation of their target mRNAs (WNT4, CCM2, MAK, and FGFR1 mRNAs) two days before the examination. State anxiety assessed two months before the examination was positively and negatively correlated with miR-16 and its target WNT4 mRNA levels, respectively. Fold changes in miR-16 levels from two days before to one month after the examination were inversely correlated with those in WNT4 mRNA levels over the same time points. We also confirmed the interaction between miR-16 and WNT4 3'UTR in HEK293T cells overexpressing FLAG-tagged WNT4 3'UTR and miR-16. Thus, a distinct group of miRNAs in periheral blood may participate in the integrated response to chronic academic stress in healthy young men.	[Honda, Manami; Kuwano, Yuki; Katsuura-Kamano, Sakurako; Kamezaki, Yoshiko; Fujita, Kinuyo; Akaike, Yoko; Kano, Shizuka; Nishida, Kensei; Masuda, Kiyoshi; Rokutan, Kazuhito] Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University	Kuwano, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, Tokushima 770, Japan.	kuwanoy@tokushima-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Nishida, Kensei/0000-0003-2314-785X	Japan Society for the Promotion of Science [22390146, 22659142]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by grants from from Grants-in-Aid for Scientific Research B (22390146) and Grant-in-Aid for Challenging Exploratory Research (22659142) from the Japan Society for the Promotion of Science (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Cai ZG, 2012, CAN J PHYSIOL PHARM, V90, P37, DOI [10.1139/Y11-095, 10.1139/y11-095]; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Kawai T, 2007, BIOL PSYCHOL, V76, P147, DOI 10.1016/j.biopsycho.2007.07.008; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kurokawa K, 2011, STRESS, V14, P431, DOI 10.3109/10253890.2011.555930; Kuwano Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024723; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; SPIELBER.CD, 1966, J EXP PSYCHOL, V72, P589, DOI 10.1037/h0023769; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Weigelt K, 2013, BRAIN BEHAV IMMUN, V29, P147, DOI 10.1016/j.bbi.2012.12.018; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	34	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75960	10.1371/journal.pone.0075960	http://dx.doi.org/10.1371/journal.pone.0075960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130753	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900064
J	Arroyave, J; Denton, JSS; Stiassny, MLJ				Arroyave, Jairo; Denton, John S. S.; Stiassny, Melanie L. J.			Are characiform Fishes Gondwanan in Origin? Insights from a Time-Scaled Molecular Phylogeny of the Citharinoidei (Ostariophysi: Characiformes)	PLOS ONE			English	Article							MULTIPLE FOSSIL CALIBRATIONS; DIVERGENCE TIMES; EVOLUTIONARY TREES; BIOGEOGRAPHY; MODEL; MITOCHONDRIAL; TELEOSTEI; SEQUENCE; NUCLEAR; UNCERTAINTY	Fishes of the order Characiformes are a diverse and economically important teleost clade whose extant members are found exclusively in African and Neotropical freshwaters. Although their transatlantic distribution has been primarily attributed to the Early Cretaceous fragmentation of western Gondwana, vicariance has not been tested with temporal information beyond that contained in their fragmentary fossil record and a recent time-scaled phylogeny focused on the African family Alestidae. Because members of the suborder Citharinoidei constitute the sister lineage to the entire remaining Afro-Neotropical characiform radiation, we inferred a time-calibrated molecular phylogeny of citharinoids using a popular Bayesian approach to molecular dating in order to assess the adequacy of current vicariance hypotheses and shed light on the early biogeographic history of characiform fishes. Given that the only comprehensive phylogenetic treatment of the Citharinoidei has been a morphology-based analysis published over three decades ago, the present study also provided an opportunity to further investigate citharinoid relationships and update the evolutionary framework that has laid the foundations for the current classification of the group. The inferred chronogram is robust to changes in calibration priors and suggests that the origins of citharinoids date back to the Turonian (ca 90 Ma) of the Late Cretaceous. Most modern citharinoid genera, however, appear to have originated and diversified much more recently, mainly during the Miocene. By reconciling molecular-clock-with fossil-based estimates for the origins of the Characiformes, our results provide further support for the hypothesis that attributes the disjunct distribution of the order to the opening of the South Atlantic Ocean. The striking overlap in tempo of diversification and biogeographic patterns between citharinoids and the African-endemic family Alestidae suggests that their evolutionary histories could have been strongly and similarly influenced by Miocene geotectonic events that modified the landscape and produced the drainage pattern of Central Africa seen today.	[Arroyave, Jairo; Denton, John S. S.; Stiassny, Melanie L. J.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Arroyave, Jairo] CUNY, Grad Sch, Dept Biol, New York, NY USA; [Arroyave, Jairo] CUNY, Univ Ctr, New York, NY 10021 USA; [Denton, John S. S.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); City University of New York (CUNY) System; City University of New York (CUNY) System; American Museum of Natural History (AMNH)	Arroyave, J (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA.	jarroyave@amnh.org	Arroyave, Jairo/AAS-5895-2020	Arroyave, Jairo/0000-0002-5389-1789	AMNH Graduate Student Fellowship; CUNY Science Fellowship; AMNH-RGGS Student Fellowship; Axelrod Research Curatorship; NSF [DEB-0542540]	AMNH Graduate Student Fellowship; CUNY Science Fellowship; AMNH-RGGS Student Fellowship; Axelrod Research Curatorship; NSF(National Science Foundation (NSF))	This research was financially supported by an AMNH Graduate Student Fellowship and a CUNY Science Fellowship to JA, and by an AMNH-RGGS Student Fellowship to JSSD. Funding for supplies and field collections was provided by The Axelrod Research Curatorship and NSF grant DEB-0542540 to MLJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Arroyave J, 2011, MOL PHYLOGENET EVOL, V60, P385, DOI 10.1016/j.ympev.2011.04.016; Beadle L.C., 1974, INLAND WATERS TROPIC, DOI [10.4319/lo.1977.22.5.0972b, DOI 10.4319/LO.1977.22.5.0972B]; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Boulenger GA, 1915, CATALOGUE FRESH WATE; Brady Sean, 2011, American Entomologist, V57, P56; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; BRUNDIN L, 1965, EVOLUTION, V19, P496, DOI 10.2307/2406246; BUCKUP PA, 1991, THESIS U MICHIGAN; Buckup Paulo Andreas, 1998, P123; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; CAREY SW, 1959, TECTONIC APPROACH CO; Chakrabarty P, 2004, FISH FISH, V5, P97, DOI 10.1111/j.1467-2979.2004.00148.x; Chakrabarty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044083; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; COENEN E J, 1989, Cybium, V13, P311; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Daget J., 1960, Revue de Zoologie et de Botanique Africaines, V61, P35; Dahdul WM, 2010, SER TELEOST FISH BIO, P441; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Doucoure CM, 2003, J AFR EARTH SCI, V36, P371, DOI 10.1016/S0899-5362(03)00019-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUTHEIL DB, 1999, MESOZOIC FISHES, V2, P553; Eigenmann C.H., 1909, REPORTS PRINCETON U, V3(3), P225; ESCHMEYER WN, 2013, ATALOG FISHES CALIFO; Eschmeyer WN, 2013, SPECIES FAMILY SUBFA; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Feibel C.S., 2003, LOTHAGAM DAWN HUMANI, P17; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; George W., 1964, GEOBIOS; Gery Jacques, 2003, Zoologische Abhandlungen (Dresden), V53, P37; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goudie AS, 2005, GEOMORPHOLOGY, V67, P437, DOI 10.1016/j.geomorph.2004.11.008; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; GREGORY WILLIAM K., 1938, ZOOLOGICA [NEW YORK], V23, P319; Harrison T, 2001, T GEOBIOL, V18, P39; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Hennig W., 1966, P263; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEPICHON X, 1968, J GEOPHYS RES, V73, P3661, DOI 10.1029/JB073i012p03661; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Linder HP, 1995, CLADISTICS, V11, P5, DOI 10.1111/j.1096-0031.1995.tb00002.x; Lipscomb D., 1998, BASICS CLADISTIC ANA; Lloyd GT, 2012, SYST BIOL, V61, P80, DOI 10.1093/sysbio/syr076; Lovejoy NR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P405; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; MAISEY JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P435; Maisey JG, 2000, CRETACEOUS RES, V21, P281, DOI 10.1006/cres.1999.0195; Malbarba Maria Claudia, 2010, P317; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; McDougall I, 1999, J GEOL SOC LONDON, V156, P731, DOI 10.1144/gsjgs.156.4.0731; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Monod T., 1950, Bull Inst franY Afrique noire, V12, P1; Murray AM, 2003, J VERTEBR PALEONTOL, V23, P501, DOI 10.1671/1854; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; NELSON G, 1980, BIOSCIENCE, V30, P339, DOI 10.2307/1307856; Nelson G., 1981, SYSTEMATICS BIOGEORA; Nelson JS, 1984, FISHES WORLD; Nickum J. G., 2004, GUIDELINES USE FISHE; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; PAGE RDM, 1990, SYST ZOOL, V39, P205, DOI 10.2307/2992182; POLL M, 1963, REVISION GENRES NANN; Poll M., 1973, B MUS UM NATL DHISTO, V150, P113; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; REGAN CT, 1911, J NAT HIST, V8, P13; Roberts T.R., 1990, Ichthyological Exploration of Freshwaters, V1, P23; ROBERTS TR, 1967, BULLETIN, V18, P251; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruber L, 2004, MOL PHYLOGENET EVOL, V32, P1010, DOI 10.1016/j.ympev.2004.04.020; Runge J., 2008, LARGE RIVERS GEOMORP, P293; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schwarzer J, 2012, P ROY SOC B-BIOL SCI, V279, P4389, DOI 10.1098/rspb.2012.1667; SEBERG O, 1991, Australian Systematic Botany, V4, P127, DOI 10.1071/SB9910127; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; Stewart Kathlyn M., 2003, P75; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; STIASSNY MLJ, 2013, ZOOTAXA IN PRESS; Swofford David L., 1990, P411; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VARI R P, 1981, Proceedings of the Biological Society of Washington, V94, P1076; Vari R.P., 1979, Bulletin of the British Museum (Natural History) Zoology, V36, P261; Vari RP, 2004, P BIOL SOC WASH, V117, P551; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Weitzman S, 1998, ENCY FISHES, P101; Werner Christa, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P221; WILEY EO, 1988, ANNU REV ECOL SYST, V19, P513, DOI 10.1146/annurev.es.19.110188.002501; Wiley EO, 2011, PHYLOGENETICS THEORY; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	130	35	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77269	10.1371/journal.pone.0077269	http://dx.doi.org/10.1371/journal.pone.0077269			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116219	gold, Green Published			2022-12-25	WOS:000325552200111
J	Liang, FF; Liu, CP; Li, LX; Xue, MM; Xie, F; Guo, Y; Bai, L				Liang, Fen-Fen; Liu, Cui-Ping; Li, Li-Xuan; Xue, Min-Min; Xie, Fang; Guo, Yu; Bai, Lan			Activated Effects of Parathyroid Hormone-Related Protein on Human Hepatic Stellate Cells	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; POSTMENOPAUSAL OSTEOPOROSIS; TGF-BETA; FIBROSIS; ENDOTOXIN; FIBROGENESIS; INJURY; ROLES; PTH	Background & Aims: After years of experiments and clinical studies, parathyroid hormone-related protein(PTHrP) has been shown to be a bone formation promoter that elicits rapid effects with limited adverse reaction. Recently, PTHrP was reported to promote fibrosis in rat kidney in conjunction with transforming growth factor-beta1 (TGF-beta 1), which is also a fibrosis promoter in liver. However, the effect of PTHrP in liver has not been determined. In this study, the promoting actions of PTHrP were first investigated in human normal hepatic stellate cells (HSC) and LX-2 cell lines. Methods: TGF-beta 1, alpha-smooth muscle actin (alpha-SMA), matrix metalloproteinase 2 (MMP-2), and collagen I mRNA were quantified by real-time polymerase chain reaction (PCR) after HSCs or LX-2 cells were treated with PTHrP(1-36) or TGF-beta 1. Protein levels were also assessed by western-blot analysis. Alpha-SMA were also detected by immunofluorescence, and TGF-beta 1 secretion was measured with enzyme-linked immunosorbent assay (ELISA) of HSC cell culture media. Results: In cultured human HSCs, mRNA and protein levels of alpha-SMA, collagen I, MMP-2, and TGF-beta 1 were increased by PTHrP treatment. A similar increasing pattern was also observed in LX-2 cells. Moreover, PTHrP significantly increased TGF-beta 1 secretion in cultured media from HSCs. Conclusions: PTHrP activated HSCs and promoted the fibrosis process in LX-2 cells. These procedures were probably mediated via TGF-beta 1, highlighting the potential effects of PTHrP in the liver.	[Liang, Fen-Fen; Liu, Cui-Ping; Li, Li-Xuan; Xue, Min-Min; Xie, Fang] Southern Med Univ, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Guo, Yu; Bai, Lan] Southern Med Univ, Dept Huiqiao Bldg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Bai, L (corresponding author), Southern Med Univ, Dept Huiqiao Bldg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	bail42251@163.com			National Natural Scientific Foundation of China [81170354]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Scientific Foundation of China (#81170354) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Ardura JA, 2008, AM J PHYSIOL-RENAL, V295, pF415, DOI 10.1152/ajprenal.00018.2008; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bisello A, 2004, ENDOCRINOLOGY, V145, P3551, DOI 10.1210/en.2004-0509; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Collier JD, 2002, GUT, V50, P1; Fabrega E, 2000, DIGEST DIS SCI, V45, P703, DOI 10.1023/A:1005435424853; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Funk JL, 1996, MOL MED, V2, P204, DOI 10.1007/BF03401617; FUNK JL, 1993, J CLIN INVEST, V92, P2546, DOI 10.1172/JCI116864; Funk JL, 1997, ENDOCRINOLOGY, V138, P2665, DOI 10.1210/en.138.7.2665; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Henry JG, 1997, J CLIN ENDOCR METAB, V82, P900, DOI 10.1210/jc.82.3.900; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Horwitz MJ, 2010, J CLIN ENDOCR METAB, V95, P1279, DOI 10.1210/jc.2009-0233; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Liu CP, 2011, DIGEST DIS SCI, V56, P993, DOI 10.1007/s10620-010-1375-2; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; N JP, 1975, GASTROENTEROLOGY, V69, P1346; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; Wolzt M, 1997, J CLIN ENDOCR METAB, V82, P2548, DOI 10.1210/jc.82.8.2548; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	30	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76517	10.1371/journal.pone.0076517	http://dx.doi.org/10.1371/journal.pone.0076517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116114	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300061
J	Tambyah, PA; Sepramaniam, S; Ali, JM; Chai, SC; Swaminathan, P; Armugam, A; Jeyaseelan, K				Tambyah, Paul A.; Sepramaniam, Sugunavathi; Ali, Jaminah Mohamed; Chai, Siaw Ching; Swaminathan, Priyadharshini; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah			microRNAs in Circulation Are Altered in Response to Influenza A Virus Infection in Humans	PLOS ONE			English	Article							EXPRESSION; REPLICATION; CELLS; H1N1; PROTEINS; RNA	Changes in microRNA expression have been detected in vitro in influenza infected cells, yet little is known about them in patients. microRNA profiling was performed on whole blood of H1N1 patients to identify signature microRNAs to better understand the gene regulation involved and possibly improve diagnosis. Total RNA extracted from blood samples of influenza infected patients and healthy controls were subjected to microRNA microarray. Expression profiles of circulating microRNAs were altered and distinctly different in influenza patients. Expression of highly dysregulated microRNAs were validated using quantitative PCR. Fourteen highly dysregulated miRNAs, identified from the blood of influenza infected patients, provided a clear distinction between infected and healthy individuals. Of these, expression of miR-1260, -26a, -335*, -576-3p, -628-3p and -664 were consistently dysregulated in both whole blood and H1N1 infected cells. Potential host and viral gene targets were identified and the impact of microRNA dysregulation on the host proteome was studied. Consequences of their altered expression were extrapolated to changes in the host proteome expression. These highly dysregulated microRNAs may have crucial roles in influenza pathogenesis and are potential biomarkers of influenza.	[Tambyah, Paul A.; Ali, Jaminah Mohamed] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Med,Ctr Translat Med, Singapore 117595, Singapore; [Sepramaniam, Sugunavathi; Chai, Siaw Ching; Swaminathan, Priyadharshini; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Biochem,Ctr Translat Med, Singapore 117595, Singapore; [Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Biochem,Ctr Translat Med, Singapore 117595, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	Singapore National Medical Research Council [R-172-000-211-213]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work was supported and funded by the Singapore National Medical Research Council [R-172-000-211-213]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; Li Yaodong, 2009, Wei Sheng Wu Xue Bao, V49, P1081; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; Maeda K, 2012, INTERNAL MED, V51, P1931, DOI 10.2169/internalmedicine.51.7487; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Onnis A, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.29; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wright PF, 2007, PHILADELPHIA FIELDS, P1727; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	31	72	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76811	10.1371/journal.pone.0076811	http://dx.doi.org/10.1371/journal.pone.0076811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116168	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300099
J	Ballandras-Colas, A; Naraharisetty, H; Li, X; Serrao, E; Engelman, A				Ballandras-Colas, Allison; Naraharisetty, Hema; Li, Xiang; Serrao, Erik; Engelman, Alan			Biochemical Characterization of Novel Retroviral Integrase Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 DNA INTEGRATION; DERMAL SARCOMA-VIRUS; STRAND TRANSFER; NUCLEOTIDE-SEQUENCE; TARGET SITES; MECHANISM; CONSTRUCTION; REPLICATION; INHIBITION	Integrase is an essential retroviral enzyme, catalyzing the stable integration of reverse transcribed DNA into cellular DNA. Several aspects of the integration mechanism, including the length of host DNA sequence duplication flanking the integrated provirus, which can be from 4 to 6 bp, and the nucleotide preferences at the site of integration, are thought to cluster among the different retroviral genera. To date only the spumavirus prototype foamy virus integrase has provided diffractable crystals of integrase-DNA complexes, revealing unprecedented details on the molecular mechanisms of DNA integration. Here, we characterize five previously unstudied integrase proteins, including those derived from the alpharetrovirus lymphoproliferative disease virus (LPDV), betaretroviruses Jaagsiekte sheep retrovirus (JSRV), and mouse mammary tumor virus (MMTV), epsilonretrovirus walleye dermal sarcoma virus (WDSV), and gammaretrovirus reticuloendotheliosis virus strain A (Rev-A) to identify potential novel structural biology candidates. Integrase expressed in bacterial cells was analyzed for solubility, stability during purification, and, once purified, 3' processing and DNA strand transfer activities in vitro. We show that while we were unable to extract or purify accountable amounts of WDSV, JRSV, or LPDV integrase, purified MMTV and Rev-A integrase each preferentially support the concerted integration of two viral DNA ends into target DNA. The sequencing of concerted Rev-A integration products indicates high fidelity cleavage of target DNA strands separated by 5 bp during integration, which contrasts with the 4 bp duplication generated by a separate gammaretrovirus, the Moloney murine leukemia virus (MLV). By comparing Rev-A in vitro integration sites to those generated by MLV in cells, we concordantly conclude that the spacing of target DNA cleavage is more evolutionarily flexible than are the target DNA base contacts made by integrase during integration. Given their desirable concerted DNA integration profiles, Rev-A and MMTV integrase proteins have been earmarked for structural biology studies.	[Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	alan_engelman@dfci.harvard.edu		Ballandras-Colas, Allison/0000-0003-4735-4984	US National Institutes of Health [R01 AI070042, T32 AI007245]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042, T32AI007245] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants R01 AI070042 and T32 AI007245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, EUR J BIOCH, V150, P1; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Certo JL, 1998, J VIROL, V72, P5408, DOI 10.1128/JVI.72.7.5408-5413.1998; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; DOTAN I, 1995, J VIROL, V69, P456, DOI 10.1128/JVI.69.1.456-468.1995; ENGELMAN A, 1995, J VIROL, V69, P5908, DOI 10.1128/JVI.69.9.5908-5911.1995; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Faschinger A, 2008, J VIROL, V82, P1360, DOI 10.1128/JVI.02098-07; Fodor SK, 2002, J GEN VIROL, V83, P1361, DOI 10.1099/0022-1317-83-6-1361; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; HOLZSCHU DL, 1995, J VIROL, V69, P5320, DOI 10.1128/JVI.69.9.5320-5331.1995; King A.M., 2012, VIRUS TAXONOMY, V9; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Lairmore MD, 2000, P NATL ACAD SCI USA, V97, P6114, DOI 10.1073/pnas.110024497; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; SARID R, 1994, VIROLOGY, V204, P680, DOI 10.1006/viro.1994.1584; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; SHIMOTOHNO K, 1980, P NATL ACAD SCI-BIOL, V77, P7357, DOI 10.1073/pnas.77.12.7357; SHIMOTOHNO K, 1980, NATURE, V285, P550, DOI 10.1038/285550a0; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; VINK C, 1991, NUCLEIC ACIDS RES, V19, P6691, DOI 10.1093/nar/19.24.6691; WATANABE S, 1983, MOL CELL BIOL, V3, P2241, DOI 10.1128/MCB.3.12.2241; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; YORK DF, 1991, J VIROL, V65, P5061, DOI 10.1128/JVI.65.9.5061-5067.1991	37	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76638	10.1371/journal.pone.0076638	http://dx.doi.org/10.1371/journal.pone.0076638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124581	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100138
J	Baptista, IL; Silva, WJ; Artioli, GG; Guilherme, JPLF; Leal, ML; Aoki, MS; Miyabara, EH; Moriscot, AS				Baptista, Igor L.; Silva, Willian J.; Artioli, Guilherme G.; Guilherme, Joao Paulo L. F.; Leal, Marcelo L.; Aoki, Marcelo S.; Miyabara, Elen H.; Moriscot, Anselmo S.			Leucine and HMB Differentially Modulate Proteasome System in Skeletal Muscle under Different Sarcopenic Conditions	PLOS ONE			English	Article							HYDROXY-BETA-METHYLBUTYRATE; KAPPA-B ACTIVATION; RAT SOLEUS MUSCLE; PULMONARY INFLAMMATION; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; GENE-EXPRESSION; MESSENGER-RNAS; IMMOBILIZATION; ATROPHY	In the present study we have compared the effects of leucine supplementation and its metabolite beta-hydroxy-beta-methyl butyrate (HMB) on the ubiquitin-proteasome system and the PI3K/Akt pathway during two distinct atrophic conditions, hindlimb immobilization and dexamethasone treatment. Leucine supplementation was able to minimize the reduction in rat soleus mass driven by immobilization. On the other hand, leucine supplementation was unable to provide protection against soleus mass loss in dexamethasone treated rats. Interestingly, HMB supplementation was unable to provide protection against mass loss in all treatments. While solely fiber type I cross sectional area (CSA) was protected in immobilized soleus of leucine-supplemented rats, none of the fiber types were protected by leucine supplementation in rats under dexamethasone treatment. In addition and in line with muscle mass results, HMB treatment did not attenuate CSA decrease in all fiber types against either immobilization or dexamethasone treatment. While leucine supplementation was able to minimize increased expression of both Mafbx/Atrogin and MuRF1 in immobilized rats, leucine was only able to minimize Mafbx/Atrogin in dexamethasone treated rats. In contrast, HMB was unable to restrain the increase in those atrogenes in immobilized rats, but in dexamethasone treated rats, HMB minimized increased expression of Mafbx/Atrogin. The amount of ubiquitinated proteins, as expected, was increased in immobilized and dexamethasone treated rats and only leucine was able to block this increase in immobilized rats but not in dexamethasone treated rats. Leucine supplementation maintained soleus tetanic peak force in immobilized rats at normal level. On the other hand, HMB treatment failed to maintain tetanic peak force regardless of treatment. The present data suggested that the anti-atrophic effects of leucine are not mediated by its metabolite HMB.	[Baptista, Igor L.; Silva, Willian J.; Leal, Marcelo L.; Miyabara, Elen H.; Moriscot, Anselmo S.] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil; [Artioli, Guilherme G.; Guilherme, Joao Paulo L. F.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Aoki, Marcelo S.] Univ Sao Paulo, Sch Arts Sci & Humanities EACH, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Moriscot, AS (corresponding author), Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil.	moriscot@usp.br	Moriscot, Anselmo S./C-4506-2012; Baptista, Igor Luchini/N-6442-2016; Miyabara, Elen H/E-8143-2012; Guilherme, João Paulo L. F./C-3490-2017; Artioli, Guilherme Giannini/K-5925-2013; Aoki, Marcelo Saldanha/K-5423-2016; Baptista, Igor/ABC-1551-2021	Moriscot, Anselmo S./0000-0003-3098-4613; Baptista, Igor Luchini/0000-0001-5185-0185; Miyabara, Elen H/0000-0002-2325-9571; Guilherme, João Paulo L. F./0000-0001-9165-973X; Artioli, Guilherme Giannini/0000-0001-8463-2213; Aoki, Marcelo Saldanha/0000-0001-7803-6829; Baptista, Igor/0000-0001-5185-0185; Jose Silva, William/0000-0001-6969-3464	State of Sao Paulo Research Foundation, FAPESP [07/57613-3, 12/13071-0]; grant PQ 1D from CNPq; FAPESP [06/61523-7]	State of Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); grant PQ 1D from CNPq; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Igor L. Baptista is the recipient of a scholarship from, the State of Sao Paulo Research Foundation, FAPESP (grant #07/57613-3 and #12/13071-0). Anselmo Moriscot is the recipient of grant PQ 1D from CNPq. This work was funded by FAPESP (grant #06/61523-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSVED T, 1995, ACTA PHYSIOL SCAND, V154, P291, DOI 10.1111/j.1748-1716.1995.tb09913.x; Anthony JC, 2001, J NUTR, V131, p856S, DOI 10.1093/jn/131.3.856S; Aoki MS, 2004, CLIN NUTR, V23, P1176, DOI 10.1016/j.clnu.2004.03.004; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; BOOTH FW, 1982, J APPL PHYSIOL, V52, P1113; BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Pinheiro CHDJ, 2012, EUR J APPL PHYSIOL, V112, P2531, DOI 10.1007/s00421-011-2224-5; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Gerlinger-Romero F, 2011, GROWTH HORM IGF RES, V21, P57, DOI 10.1016/j.ghir.2010.12.006; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; GUTH L, 1969, EXP NEUROL, V25, P138, DOI 10.1016/0014-4886(69)90077-6; Haegens A, 2012, AM J PHYSIOL-LUNG C, V302, pL103, DOI 10.1152/ajplung.00084.2011; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; KAYALI AG, 1987, AM J PHYSIOL, V252, pE621, DOI 10.1152/ajpendo.1987.252.5.E621; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Langen RCJ, 2012, AM J RESP CELL MOL, V47, P288, DOI 10.1165/rcmb.2011-0119OC; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Liu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015607; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; Nagasawa T, 2002, J NUTR BIOCHEM, V13, P121, DOI 10.1016/S0955-2863(01)00209-1; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Pattison JS, 2003, J APPL PHYSIOL, V95, P2171, DOI 10.1152/japplphysiol.00500.2003; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Price SR, 1996, MINER ELECTROL METAB, V22, P72; Rowlands DS, 2009, J STRENGTH COND RES, V23, P836, DOI 10.1519/JSC.0b013e3181a00c80; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Smith HJ, 2005, CANCER RES, V65, P277; Soares AG, 2007, MUSCLE NERVE, V36, P685, DOI 10.1002/mus.20866; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Sugawara T, 2008, AMINO ACIDS, V34; Sugawara T, 2007, J NUTR SCI VITAMINOL, V53, P552, DOI 10.3177/jnsv.53.552; TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588; Urso ML, 2006, EUR J APPL PHYSIOL, V96, P564, DOI 10.1007/s00421-005-0109-1; Vary TC, 2007, AM J PHYSIOL-ENDOC M, V293, pE188, DOI 10.1152/ajpendo.00037.2007; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0; Zhang P, 2007, MED HYPOTHESES, V69, P310, DOI 10.1016/j.mehy.2006.11.043	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76752	10.1371/journal.pone.0076752	http://dx.doi.org/10.1371/journal.pone.0076752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124592	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100149
J	Garnett, JP; Gray, MA; Tarran, R; Brodlie, M; Ward, C; Baker, EH; Baines, DL				Garnett, James P.; Gray, Michael A.; Tarran, Robert; Brodlie, Malcolm; Ward, Christopher; Baker, Emma H.; Baines, Deborah L.			Elevated Paracellular Glucose Flux across Cystic Fibrosis Airway Epithelial Monolayers Is an Important Factor for Pseudomonas aeruginosa Growth	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TIGHT JUNCTIONS; SURFACE LIQUID; CELL CULTURE; PH; TRANSPORT; LUNG; HYPERGLYCEMIA; HOMEOSTASIS; SECRETION	People with cystic fibrosis (CF) who develop related diabetes (CFRD) have accelerated pulmonary decline, increased infection with antibiotic-resistant Pseudomonas aeruginosa and increased pulmonary exacerbations. We have previously shown that glucose concentrations are elevated in airway surface liquid (ASL) of people with CF, particularly in those with CFRD. We therefore explored the hypotheses that glucose homeostasis is altered in CF airway epithelia and that elevation of glucose flux into ASL drives increased bacterial growth, with an effect over and above other cystic fibrosis transmembrane conductance regulator (CFTR)-related ASL abnormalities. The aim of this study was to compare the mechanisms governing airway glucose homeostasis in CF and non-CF primary human bronchial epithelial (HBE) monolayers, under normal conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM or 15 mM basolateral glucose to investigate how changes in blood glucose, such as those seen in CFRD, affects luminal Ps. aeruginosa growth. Calu-3 cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired CFTR-dependent fluid secretions. We show that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions elicited more glucose flux across CF airway epithelial monolayers compared to non-CF monolayers which we propose increases glucose availability in ASL for bacterial growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above any CFTR-dependent effects and the presence or absence of mucus in Calu-3 airway epithelia-bacteria co-cultures. Together these studies highlight the importance of glucose as an additional factor in promoting Ps. aeruginosa growth and respiratory infection in CF disease.	[Garnett, James P.; Baker, Emma H.; Baines, Deborah L.] St Georges Univ London, Div Biomed Sci, London, England; [Gray, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Brodlie, Malcolm; Ward, Christopher] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	St Georges University London; Newcastle University - UK; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK	Garnett, JP (corresponding author), St Georges Univ London, Div Biomed Sci, London, England.	jgarnett@sgul.ac.uk	Garnett, James/O-7093-2014; Ward, Christopher/B-8175-2013	Garnett, James/0000-0002-4767-020X; Ward, Christopher/0000-0002-6954-9611; Baines, Deborah/0000-0001-7229-0244; Brodlie, Malcolm/0000-0003-4591-8299; Baker, Emma/0000-0002-0871-3721; GRAY, MICHAEL/0000-0002-6774-6283	Wellcome Trust [088304/Z/09/Z]; Medical Research Council [MR/K012770/1]; National Heart, Lung, and Blood Institute [R01 HL108927]; Academy of Medical Sciences (AMS) [AMS-SGCL6-Brodlie] Funding Source: researchfish; Medical Research Council [G0800419] Funding Source: researchfish; MRC [MR/K012770/1, G0800419] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust (Grant No: 088304/Z/09/Z), the Medical Research Council (Grant No: MR/K012770/1) and by the National Heart, Lung, and Blood Institute (R01 HL108927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EH, 2007, J APPL PHYSIOL, V102, P1969, DOI 10.1152/japplphysiol.01425.2006; Ballok AE, 2013, J BACTERIOL IN PRESS; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; Brodlie M, 2010, EXP LUNG RES, V36, P101, DOI 10.3109/01902140903165265; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Forrest IA, 2005, EUR RESPIR J, V26, P1080, DOI 10.1183/09031936.05.00141404; Garnett JP, 2013, THORAX, V68, P835, DOI 10.1136/thoraxjnl-2012-203178; Garnett JP, 2012, EUR RESPIR J, V40, P1269, DOI 10.1183/09031936.00052612; Garnett JP, 2012, J IMMUNOL, V189, P373, DOI 10.4049/jimmunol.1200718; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Jarad N A, 2008, Chron Respir Dis, V5, P29, DOI 10.1177/1479972307085635; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Kalsi KK, 2009, PFLUG ARCH EUR J PHY, V457, P1061, DOI 10.1007/s00424-008-0576-4; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; McIsaac SM, 2012, J LEUKOCYTE BIOL, V92, P977, DOI 10.1189/jlb.0811410; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pezzulo AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016166; Philips BJ, 2005, THORAX, V60, P761, DOI 10.1136/thx.2004.035766; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; SASAJIMA KI, 1979, BIOCHIM BIOPHYS ACTA, V571, P120, DOI 10.1016/0005-2744(79)90232-8; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	32	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76283	10.1371/journal.pone.0076283	http://dx.doi.org/10.1371/journal.pone.0076283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124542	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000325489100099
J	Kittur, FS; Bah, M; Archer-Hartmann, S; Hung, CY; Azadi, P; Ishihara, M; Sane, DC; Xie, JH				Kittur, Farooqahmed S.; Bah, Mamudou; Archer-Hartmann, Stephanie; Hung, Chiu-Yueh; Azadi, Parastoo; Ishihara, Mayumi; Sane, David C.; Xie, Jiahua			Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; IN-VITRO; PROTECTS; ASIALOERYTHROPOIETIN; BIOSYNTHESIS; EXPRESSION; PROTEINS; INJURY; NEUROPROTECTION; OVEREXPRESSION	Asialo-erythropoietin, a desialylated form of human erythropoietin (EPO) lacking hematopoietic activity, is receiving increased attention because of its broader protective effects in preclinical models of tissue injury. However, attempts to translate its protective effects into clinical practice is hampered by unavailability of suitable expression system and its costly and limit production from expensive mammalian cell-made EPO (rhuEPO(M)) by enzymatic desialylation. In the current study, we took advantage of a plant-based expression system lacking sialylating capacity but possessing an ability to synthesize complex N-glycans to produce cytoprotective recombinant human asialo-rhuEPO. Transgenic tobacco plants expressing asialo-rhuEPO were generated by stably co-expressing human EPO and beta 1,4-galactosyltransferase (GalT) genes under the control of double CaMV 35S and glyceraldehyde-3-phosphate gene (GapC) promoters, respectively. Plant-produced asialo-rhuEPO (asialo-rhuEPO(P)) was purified by immunoaffinity chromatography. Detailed N-glycan analysis using NSI-FTMS and MS/MS revealed that asialo-rhuEPO(P) bears paucimannosidic, high mannose-type and complex N-glycans. In vitro cytoprotection assays showed that the asialo-rhuEPO(P) (20 U/ml) provides 2-fold better cytoprotection (44%) to neuronal-like mouse neuroblastoma cells from staurosporine-induced cell death than rhuEPO(M) (21%). The cytoprotective effect of the asialo-rhuEPO(P) was found to be mediated by receptor-initiated phosphorylation of Janus kinase 2 (JAK2) and suppression of caspase 3 activation. Altogether, these findings demonstrate that plants are a suitable host for producing cytoprotective rhuEPO derivative. In addition, the general advantages of plant-based expression system can be exploited to address the cost and scalability issues related to its production.	[Kittur, Farooqahmed S.; Bah, Mamudou; Hung, Chiu-Yueh; Xie, Jiahua] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA; [Archer-Hartmann, Stephanie; Azadi, Parastoo; Ishihara, Mayumi] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Sane, David C.] Caril Clin, Roanoke, VA USA; [Sane, David C.] Virginia Tech, Caril Sch Med, Roanoke, VA USA	University of North Carolina; North Carolina Central University; University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University	Xie, JH (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA.	jxie@nccu.edu		Archer-Hartmann, Stephanie/0000-0001-8752-7363; Xie, Jiahua/0000-0003-2786-0281; Aoki, Mayumi/0000-0002-8368-8546	National Institute of General Medical Sciences [SC3GM088084]; NIH Integrated Biomedical Glycomics Center grant [8P41GM103490]; Startup Fund from Golden LEAF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, SC3GM088084] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Integrated Biomedical Glycomics Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup Fund from Golden LEAF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant (SC3GM088084) (http://www.nigms.nih.gov) to JHX, NIH Integrated Biomedical Glycomics Center grant (8P41GM103490) (www.nih.gov) to PA and a Startup Fund from Golden LEAF Foundation (www.goldenleaf.org) to BRITE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Castilho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054836; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Chargelegue D, 2000, TRANSGENIC RES, V9, P187, DOI 10.1023/A:1008976219939; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; Chill L, 2009, BIOTECHNOL BIOENG, V102, P828, DOI 10.1002/bit.22099; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Conley AJ, 2009, PLANT BIOTECHNOL J, V7, P183, DOI 10.1111/j.1467-7652.2008.00389.x; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; EGRIE JC, 1986, IMMUNOBIOLOGY, V172, P213, DOI 10.1016/S0171-2985(86)80101-2; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Goyal A, 2002, AM J RESP CELL MOL, V26, P224, DOI 10.1165/ajrcmb.26.2.4640; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hung CY, 2013, PLANT PHYSIOL, V161, P1049, DOI 10.1104/pp.112.209247; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jelkmann W, 2007, NEPHROL DIAL TRANSPL, V22, P2749, DOI 10.1093/ndt/gfm392; Jez J, 2013, BIOTECHNOL J, V8, P371, DOI 10.1002/biot.201200363; Jin C, 2008, GLYCOBIOLOGY, V18, P235, DOI 10.1093/glycob/cwm137; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kittur FS, 2012, PLANT CELL REP, V31, P1233, DOI 10.1007/s00299-012-1244-x; Kornfeld R, 1985, ANNU REV BIOCHEM, V54; KRANTZ SB, 1991, BLOOD, V77, P419; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; MAITI IB, 1993, P NATL ACAD SCI USA, V90, P6110, DOI 10.1073/pnas.90.13.6110; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; MATSUMOTO S, 1995, PLANT MOL BIOL, V27, P1163, DOI 10.1007/BF00020889; Mukherjee P, 2001, J NEUROCHEM, V77, P43, DOI 10.1046/j.1471-4159.2001.00167.x; Musa TA, 2009, PLANT BIOTECHNOL REP, V3, P157, DOI 10.1007/s11816-009-0086-7; Musiychuk K, 2013, STEM CELLS DEV, V22, P2326, DOI 10.1089/scd.2012.0489; NARHI LO, 1991, J BIOL CHEM, V266, P23022; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; Ogino A, 2010, J AM COLL CARDIOL, V56, P1949, DOI 10.1016/j.jacc.2010.04.068; Okada T, 2007, TRANSPLANTATION, V84, P504, DOI 10.1097/01.tp.0000277672.02783.33; Pankratova S, 2010, BRAIN, V133, P2281, DOI 10.1093/brain/awq101; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Parsons J, 2012, PLANT BIOTECHNOL J, V10, P851, DOI 10.1111/j.1467-7652.2012.00704.x; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; WASLEY LC, 1991, BLOOD, V77, P2624; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Weisner C., 2001, J CEREB BLOOD FLOW M, V21, P857; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Yokomaku Y, 2008, J AM SOC NEPHROL, V19, P321, DOI 10.1681/ASN.2007040481	69	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76468	10.1371/journal.pone.0076468	http://dx.doi.org/10.1371/journal.pone.0076468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124563	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100120
J	Li, L; Huang, YZ; Xiao, Y				Li, Lin; Huang, Yanzhao; Xiao, Yi			How to Use Not-Always-Reliable Binding Site Information in Protein-Protein Docking Prediction	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; SCORING FUNCTION; BIOLOGICAL INFORMATION; BACKBONE FLEXIBILITY; GEOMETRIC DOCKING; PAIR POTENTIALS; ENERGY FUNCTION; INTERFACES; SURFACE; CAPRI	In many protein-protein docking algorithms, binding site information is used to help predicting the protein complex structures. Using correct and accurate binding site information can increase protein-protein docking success rate significantly. On the other hand, using wrong binding sites information should lead to a failed prediction, or, at least decrease the success rate. Recently, various successful theoretical methods have been proposed to predict the binding sites of proteins. However, the predicted binding site information is not always reliable, sometimes wrong binding site information could be given. Hence there is a high risk to use the predicted binding site information in current docking algorithms. In this paper, a softly restricting method (SRM) is developed to solve this problem. By utilizing predicted binding site information in a proper way, the SRM algorithm is sensitive to the correct binding site information but insensitive to wrong information, which decreases the risk of using predicted binding site information. This SRM is tested on benchmark 3.0 using purely predicted binding site information. The result shows that when the predicted information is correct, SRM increases the success rate significantly; however, even if the predicted information is completely wrong, SRM only decreases success rate slightly, which indicates that the SRM is suitable for utilizing predicted binding site information.	[Li, Lin; Huang, Yanzhao; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China; [Li, Lin] Clemson Univ, Dept Phys, Clemson, SC 29631 USA	Huazhong University of Science & Technology; Clemson University	Huang, YZ (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China.	yzhuang@hust.edu.cn; yxiao@hust.edu.cn		Li, Lin/0000-0001-6447-2398	National Science Foundation of China [11174093, 11074084]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundation of China (www.nsfc.gov.cn) under Grant No. 11174093 and 11074084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Bordner AJ, 2005, PROTEINS, V60, P353, DOI 10.1002/prot.20433; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chung JL, 2006, PROTEINS, V62, P630, DOI 10.1002/prot.20741; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gottschalk KE, 2004, PROTEIN ENG DES SEL, V17, P183, DOI 10.1093/protein/gzh021; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; Huang B, 2008, GENE, V422, P14, DOI 10.1016/j.gene.2008.06.014; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2010, PROTEINS, V78, P3096, DOI 10.1002/prot.22797; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Law DS, 2003, PROTEINS, V52, P33, DOI 10.1002/prot.10395; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Li L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-36; Liang S, 2004, PROTEINS, V57, P548, DOI 10.1002/prot.20238; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liu SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-280; Liu SY, 2008, BIOINFORMATICS, V24, P2634, DOI 10.1093/bioinformatics/btn497; Lo Conte L, 1999, J MOL BIOL, V285, P2177; [罗丽 LUO Li], 2009, [生物物理学报, Acta Biophysica Sinica], V25, P282; Ma XH, 2005, PROTEINS, V60, P319, DOI 10.1002/prot.20577; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Qin S, 2007, PROTEINS, V69, P743, DOI 10.1002/prot.21752; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Vakser IA, 1997, PROTEINS, P226; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhang C, 2005, PROTEINS, V60, P314, DOI 10.1002/prot.20576; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099; Zhou HY, 2002, PROTEINS, V49, P483, DOI 10.1002/prot.10241	62	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75936	10.1371/journal.pone.0075936	http://dx.doi.org/10.1371/journal.pone.0075936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124522	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100079
J	Zhang, CQ; Chen, XX; Zou, RY; Zhou, K; Stephanopoulos, G; Too, HP				Zhang, Congqiang; Chen, Xixian; Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Too, Heng-Phon			Combining Genotype Improvement and Statistical Media Optimization for Isoprenoid Production in E. coli	PLOS ONE			English	Article							ENGINEERED ESCHERICHIA-COLI; HIGH-LEVEL PRODUCTION; LYCOPENE PRODUCTION; PLASMID DNA; PHOSPHOTRANSFERASE SYSTEM; AROMATIC-COMPOUNDS; PATHWAY; BIOSYNTHESIS; PRECURSOR; STRAINS	Isoprenoids are a large and diverse class of compounds that includes many high value natural products and are thus in great demand. To meet the increasing demand for isoprenoid compounds, metabolic engineering of microbes has been used to produce isoprenoids in an economical and sustainable manner. To achieve high isoprenoid yields using this technology, the availability of metabolic precursors feeding the deoxyxylulose phosphate (DXP) pathway, responsible for isoprenoid biosynthesis, has to be optimized. In this study, phosphoenolpyruvate, a vital DXP pathway precursor, was enriched by deleting the genes encoding the carbohydrate phosphotransferase system (PTS) in E. coli. Production of lycopene (a C40 isoprenoid) was maximized by optimizing growth medium and culture conditions. In optimized conditions, the lycopene yield from PTS mutant was seven fold higher than that obtained from the wild type strain. This resulted in the highest reported specific yield of lycopene produced from the DXP pathway in E. coli to date (20,000 mg/g dry cell weight). Both the copy number of the plasmid encoding the lycopene biosynthetic genes and the expression were found to be increased in the optimized media. Deletion of PTS together with a similar optimization strategy was also successful in enhancing the production of amorpha-1,4-diene, a distinct C15 isoprenoid, suggesting that the approaches developed herein can be generally applied to optimize production of other isoprenoids.	[Zhang, Congqiang; Chen, Xixian; Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Too, Heng-Phon] Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore; [Too, Heng-Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Too, HP (corresponding author), Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore.	heng-phon_too@nuhs.edu.sg	Chen, Xixian/AAO-3793-2020; Zhang, Congqiang/ABA-9058-2021; Zhou, Kang/AAI-9969-2021; Zhou, Kang/AAQ-5730-2021	Zhang, Congqiang/0000-0003-1070-8806; Zhou, Kang/0000-0003-0606-7030	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	This work was supported by a grant from Singapore-MIT Alliance (Chemical Pharmaceutical Engineering). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alper H, 2006, APPL MICROBIOL BIOT, V72, P968, DOI 10.1007/s00253-006-0357-y; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Baez-Viveros JL, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-30; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; Carnes AE, 2005, BIOPROCESS TECHNOL, P36; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; FREEDBERG WB, 1973, J BACTERIOL, V115, P816, DOI 10.1128/JB.115.3.816-823.1973; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HOFMANN KH, 1990, J BASIC MICROB, V30, P37, DOI 10.1002/jobm.3620300111; Islam RS, 2007, BIOTECHNOL PROGR, V23, P785, DOI 10.1021/bp070059a; Iyer PV, 2009, APPL BIOCHEM BIOTECH, V159, P233, DOI 10.1007/s12010-008-8522-7; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kolewe ME, 2008, MOL PHARMACEUT, V5, P243, DOI 10.1021/mp7001494; Mandenius CF, 2008, BIOTECHNOL PROGR, V24, P1191, DOI 10.1002/btpr.67; Martinez K, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-1; Mokhtari-Hosseini ZB, 2009, BIORESOURCE TECHNOL, V100, P2436, DOI 10.1016/j.biortech.2008.11.024; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; O'Kennedy RD, 2000, J BIOTECHNOL, V76, P175, DOI 10.1016/S0168-1656(99)00187-X; Prather KJ, 2003, ENZYME MICROB TECH, V33, P865, DOI 10.1016/S0141-0229(03)00205-9; Nguyen QT, 2012, FEBS LETT, V586, P2177, DOI 10.1016/j.febslet.2012.02.008; RIESENBERG D, 1991, J BIOTECHNOL, V20, P17, DOI 10.1016/0168-1656(91)90032-Q; RYAN W, 1991, BIOTECHNOL BIOENG, V37, P415, DOI 10.1002/bit.260370504; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Van Noorden R, 2010, NATURE, V466, P672, DOI [10.1038/466672a, 10.1038/467906a]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang X, 1998, J BACTERIOL, V180, P195, DOI 10.1128/JB.180.2.195-200.1998; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18; Zhou ZX, 2011, BIORESOURCE TECHNOL, V102, P9345, DOI 10.1016/j.biortech.2011.07.120	44	40	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75164	10.1371/journal.pone.0075164	http://dx.doi.org/10.1371/journal.pone.0075164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124471	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100028
J	Zhu, HB; Chen, LL; Zhou, W; Huang, ZT; Hu, JZ; Dai, S; Wang, XW; Huang, XF; He, C				Zhu, Hongbo; Chen, Linlin; Zhou, Wei; Huang, Zhongting; Hu, Jingzi; Dai, Sheng; Wang, Xiaowei; Huang, Xuefeng; He, Chao			Over-Expression of the ATP5J Gene Correlates with Cell Migration and 5-Fluorouracil Sensitivity in Colorectal Cancer	PLOS ONE			English	Article							BOVINE HEART-MITOCHONDRIA; COLON-CANCER; COUPLING FACTOR-6; BIOENERGETIC SIGNATURE; IN-VITRO; SYNTHASE; THERAPY; RESISTANCE; CARCINOMA; SURVIVAL	Recently we found that ATP5J was over-expressed in tissue samples from patients with colorectal cancer. However, the clinical significance and function of the over-expression of ATP5J in these patients remains unclear. We investigated these issues in the current study. Our results indicated that expression of ATP5J was significantly higher in colorectal cancer tissue than in adjacent tissue, and it was also significantly higher in metastatic lymph nodes than in primary cancer tissue (P<0.05). A correlation between ATP5J expression and tumor differentiation was detected, but no correlation with gender, age, T stage, lymph node metastasis, or survival status was observed. Down-regulation of ATP5J expression attenuated the ability of cell migration and increased the sensitivity to 5-fluorouracil (5-Fu) in cells of the DLD1 cell line. Inversely, up-regulation of ATP5J expression enhanced cell migration and decreased 5-Fu sensitivity, suggesting that the function of ATP5J in colorectal cancer might involve cell migration and 5-Fu sensitivity.	[Zhu, Hongbo; Chen, Linlin; Zhou, Wei; Dai, Sheng; Wang, Xiaowei; Huang, Xuefeng; He, Chao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Hongbo; Zhou, Wei; Huang, Zhongting] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Jingzi] Aviat Med Evaluat & Training Ctr Airforce Hangzho, Dept Internal Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, C (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou 310003, Zhejiang, Peoples R China.	drhechao@yahoo.com.cn	dai, sheng/AGQ-0059-2022		National Natural Science Foundation of China [30700970, 81272681]; Fundamental Research Funds for the Central Universities; Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Innovative Research Team in Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (30700970 and 81272681), the Fundamental Research Funds for the Central Universities and Program for Innovative Research Team in Zhejiang Province (2010R50046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2006, ANN SURG ONCOL, V13, P887, DOI 10.1245/ASO.2006.07.003; Bjerregaard H, 2011, DIAGN MOL PATHOL, V20, P212, DOI 10.1097/PDM.0b013e318212e0a9; Chang JK, 2003, REGUL PEPTIDES, V113, P63, DOI 10.1016/S0167-0115(02)00303-8; Chau I, 2002, BRIT MED BULL, V64, P159, DOI 10.1093/bmb/64.1.159; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Gu J, 2002, ONCOGENE, V21, P4757, DOI 10.1038/sj.onc.1205582; Huang X, 2002, GENE THER, V9, P1379, DOI 10.1038/sj.gt.3301810; JOSHI S, 1989, J BIOL CHEM, V264, P15548; Ju JH, 2007, INT J COLORECTAL DIS, V22, P855, DOI 10.1007/s00384-007-0293-z; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Osanai T, 2005, HYPERTENSION, V46, P1140, DOI 10.1161/01.HYP.0000186483.86750.85; Pathy S, 2012, DIS COLON RECTUM, V55, P900, DOI 10.1097/DCR.0b013e31825afc4e; Reddavide R, 2011, ANTICANCER RES, V31, P555; Rehman MU, 2009, ASIAN PAC J CANCER P, V10, P719; Shailubhai K, 2000, CANCER RES, V60, P5151; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Watts SW, 2005, HYPERTENSION, V46, P1100, DOI 10.1161/01.HYP.0000186476.62399.6c; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Zhang L, 2002, GENE THER, V9, P1262, DOI 10.1038/sj.gt.3301797; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; Zhu HB, 2007, INT J CANCER, V121, P1366, DOI 10.1002/ijc.22856	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76846	10.1371/journal.pone.0076846	http://dx.doi.org/10.1371/journal.pone.0076846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124598	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100155
J	Arsenault, PR; Pei, F; Lee, R; Kerestes, H; Percy, MJ; Keith, B; Simon, MC; Lappin, TRJ; Khurana, TS; Lee, FS				Arsenault, Patrick R.; Pei, Fei; Lee, Rebecca; Kerestes, Heddy; Percy, Melanie J.; Keith, Brian; Simon, M. Celeste; Lappin, Terence R. J.; Khurana, Tejvir S.; Lee, Frank S.			A Knock-in Mouse Model of Human PHD2 Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Erythropoeisis; Erythropoietin; Hypoxia; Hypoxia-inducible Factor; Hypoxia-inducible Factor (HIF); Prolyl Hydroxylase Domain Protein	HYDROXYLASE DOMAIN PROTEIN-2; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; LINDAU TUMOR-SUPPRESSOR; PULMONARY-HYPERTENSION; HIF-ALPHA; MUTATION; MICE; POLYCYTHEMIA; HIF-2-ALPHA; HIF-1-ALPHA	The central pathway for controlling red cell mass is the PHD (prolyl hydroxylase domain protein):hypoxia-inducible factor (HIF) pathway. HIF, which is negatively regulated by PHD, activates numerous genes, including ones involved in erythropoiesis, such as the ERYTHROPOIETIN (EPO) gene. Recent studies have implicated PHD2 as the key PHD isoform regulating red cell mass. Studies of humans have identified erythrocytosis-associated, heterozygous point mutations in the PHD2 gene. A key question concerns the mechanism by which human mutations lead to phenotypes. In the present report, we generated and characterized a mouse line in which a P294R knock-in mutation has been introduced into the mouse Phd2 locus to model the first reported human PHD2 mutation (P317R). Phd2(P294R/+) mice display a degree of erythrocytosis equivalent to that seen in Phd2(+/-) mice. The Phd2(P294R/+)-associated erythrocytosis is reversed in a Hif2a(+/-), but not a Hif1a(+/-) background. Additional studies using various conditional knock-outs of Phd2 reveal that erythrocytosis can be induced by homozygous and heterozygous knock-out of Phd2 in renal cortical interstitial cells using a Pax3-Cre transgene or by homozygous knock-out of Phd2 in hematopoietic progenitors driven by a Vav1-Cre transgene. These studies formally prove that a missense mutation in PHD2 is the cause of the erythrocytosis, show that this occurs through haploinsufficiency, and point to multifactorial control of red cell mass by PHD2.	[Arsenault, Patrick R.; Pei, Fei; Lee, Rebecca; Kerestes, Heddy; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Keith, Brian] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Keith, Brian; Simon, M. Celeste] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Percy, Melanie J.] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021; Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-CA153347]; NATIONAL CANCER INSTITUTE [R01CA153347, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA153347 (to F.S.L.).	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Degenhardt KR, 2010, DEV BIOL, V339, P519, DOI 10.1016/j.ydbio.2009.12.030; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Franke K, 2013, BLOOD, V121, P1436, DOI 10.1182/blood-2012-08-449181; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Mossuz P, 2004, HAEMATOLOGICA, V89, P1194; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Pappalardi MB, 2008, BIOCHEMISTRY-US, V47, P11165, DOI 10.1021/bi801624f; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; R Development Core Team, 2010, R ENV STAT COMP; Ryan HE, 2000, CANCER RES, V60, P4010; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Singh RP, 2013, BLOOD, V121, P5158, DOI 10.1182/blood-2012-12-471185; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	55	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33571	33584		10.1074/jbc.M113.482364	http://dx.doi.org/10.1074/jbc.M113.482364			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121508	hybrid, Green Published			2022-12-25	WOS:000327250200007
J	Chatterjee, R; Hoffman, M; Cliften, P; Seshan, S; Liapis, H; Jain, S				Chatterjee, Rajshekhar; Hoffman, Mary; Cliften, Paul; Seshan, Surya; Liapis, Helen; Jain, Sanjay			Targeted Exome Sequencing Integrated with Clinicopathological Information Reveals Novel and Rare Mutations in Atypical, Suspected and Unknown Cases of Alport Syndrome or Proteinuria	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BASEMENT-MEMBRANE NEPHROPATHY; GLOMERULAR-FILTRATION; NEPHROTIC SYNDROME; CHILDHOOD; HEMATURIA; REMISSION	We applied customized targeted next-generation exome sequencing (NGS) to determine if mutations in genes associated with renal malformations, Alport syndrome (AS) or nephrotic syndrome are a potential cause of renal abnormalities in patients with equivocal or atypical presentation. We first sequenced 4,041 exons representing 292 kidney disease genes in a Caucasian woman with a history of congenital vesicoureteral reflux (VUR), recurrent urinary tract infections and hydronephrosis who presented with nephrotic range proteinuria at the age of 45. Her biopsy was remarkable for focal segmental glomerulosclerosis (FSGS), a potential complication of longstanding VUR. She had no family history of renal disease. Her proteinuria improved initially, however, several years later she presented with worsening proteinuria and microhematuria. NGS analysis revealed two deleterious COL4A3 mutations, one novel and the other previously reported in AS, and a novel deleterious SALL2 mutation, a gene linked to renal malformations. Pedigree analysis confirmed that COL4A3 mutations were nonallelic and compound heterozygous. The genomic results in conjunction with subsequent abnormal electron microscopy, Collagen IV minor chain immunohistochemistry and progressive sensorineural hearing loss confirmed AS. We then modified our NGS approach to enable more efficient discovery of variants associated with AS or a subset of FSGS by multiplexing targeted exome sequencing of 19 genes associated with AS or FSGS in 14 patients. Using this approach, we found novel or known COL4A3 or COL4A5 mutations in a subset of patients with clinically diagnosed or suspected AS, APOL1 variants associated with FSGS in African Americans and novel mutations in genes associated with nephrotic syndrome. These studies demonstrate the successful application of targeted capture-based exome sequencing to simultaneously evaluate genetic variations in many genes in patients with complex renal phenotypes and provide insights into etiology of conditions with equivocal clinical and pathologic presentations.	[Chatterjee, Rajshekhar; Hoffman, Mary; Liapis, Helen; Jain, Sanjay] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Cliften, Paul] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Liapis, Helen; Jain, Sanjay] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Seshan, Surya] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cornell University	Jain, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA.	sjain22@wustl.edu		jain, sanjay/0000-0003-2804-127X	National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research [P30-DK079333]; Children Discovery Institute [MDII2009177]; renal division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research; Children Discovery Institute; renal division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) George M. O'Brien Center for Kidney Disease Research (P30-DK079333) to Washington University, Children Discovery Institute grant MDII2009177 (SJ) and renal division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Althaus K, 2009, SEMIN THROMB HEMOST, V35, P189, DOI 10.1055/s-0029-1220327; Alves Fatima Regina Abreu, 2008, Braz J Otorhinolaryngol, V74, P807, DOI 10.1016/S1808-8694(15)30140-3; Artuso R, 2012, EUR J HUM GENET, V20, P50, DOI 10.1038/ejhg.2011.164; Boyer O, 2010, J MED GENET, V47, P445, DOI 10.1136/jmg.2009.076166; Chatterjee R, 2012, HUM GENET, V131, P1725, DOI 10.1007/s00439-012-1181-3; Choi HJ, 2008, AM J KIDNEY DIS, V51, P834, DOI 10.1053/j.ajkd.2008.01.018; Cook C, 2008, AM J KIDNEY DIS, V51, pE25, DOI 10.1053/j.ajkd.2007.09.028; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; DISCHE FE, 1985, AM J NEPHROL, V5, P103, DOI 10.1159/000166914; Gipson DS, 2006, PEDIATR NEPHROL, V21, P344, DOI 10.1007/s00467-005-2097-0; GLEESON MJ, 1984, J LARYNGOL OTOL, V98, P449, DOI 10.1017/S0022215100146894; Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004; Kashtan CE, 2004, CURR OPIN PEDIATR, V16, P177, DOI 10.1097/00008480-200404000-00011; Koziell A, 2002, HUM MOL GENET, V11, P379, DOI 10.1093/hmg/11.4.379; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liapis H, 2012, PEDIAT NEPHROL; Mitsnefes M, 2005, AM J KIDNEY DIS, V45, P309, DOI 10.1053/j.ajkd.2004.11.006; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Savige J, 2003, KIDNEY INT, V64, P1169, DOI 10.1046/j.1523-1755.2003.00234.x; Troyanov S, 2005, J AM SOC NEPHROL, V16, P1061, DOI 10.1681/ASN.2004070593; VELOSA JA, 1983, MAYO CLIN PROC, V58, P568; Zhang Y, 2011, BLOOD, V119, P238	23	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76360	10.1371/journal.pone.0076360	http://dx.doi.org/10.1371/journal.pone.0076360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130771	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200036
J	Martin, BA; Kalata, W; Shaffer, N; Fischer, P; Luciano, M; Loth, F				Martin, Bryn A.; Kalata, Wojciech; Shaffer, Nicholas; Fischer, Paul; Luciano, Mark; Loth, Francis			Hydrodynamic and Longitudinal Impedance Analysis of Cerebrospinal Fluid Dynamics at the Craniovertebral Junction in Type I Chiari Malformation	PLOS ONE			English	Article							COMPUTATIONAL FLOW-ANALYSIS; FORAMEN MAGNUM; CSF FLOW; CRANIOCERVICAL DECOMPRESSION; MORPHOMETRIC-ANALYSIS; SYMPTOMATIC PATIENTS; OUTFLOW RESISTANCE; VEIN GRAFTS; MR; CHILDREN	Elevated or reduced velocity of cerebrospinal fluid (CSF) at the craniovertebral junction (CVJ) has been associated with type I Chiari malformation (CMI). Thus, quantification of hydrodynamic parameters that describe the CSF dynamics could help assess disease severity and surgical outcome. In this study, we describe the methodology to quantify CSF hydrodynamic parameters near the CVJ and upper cervical spine utilizing subject-specific computational fluid dynamics (CFD) simulations based on in vivo MRI measurements of flow and geometry. Hydrodynamic parameters were computed for a healthy subject and two CMI patients both pre- and post-decompression surgery to determine the differences between cases. For the first time, we present the methods to quantify longitudinal impedance (LI) to CSF motion, a subject-specific hydrodynamic parameter that may have value to help quantify the CSF flow blockage severity in CMI. In addition, the following hydrodynamic parameters were quantified for each case: maximum velocity in systole and diastole, Reynolds and Womersley number, and peak pressure drop during the CSF cardiac flow cycle. The following geometric parameters were quantified: cross-sectional area and hydraulic diameter of the spinal subarachnoid space (SAS). The mean values of the geometric parameters increased post-surgically for the CMI models, but remained smaller than the healthy volunteer. All hydrodynamic parameters, except pressure drop, decreased post-surgically for the CMI patients, but remained greater than in the healthy case. Peak pressure drop alterations were mixed. To our knowledge this study represents the first subject-specific CFD simulation of CMI decompression surgery and quantification of LI in the CSF space. Further study in a larger patient and control group is needed to determine if the presented geometric and/or hydrodynamic parameters are helpful for surgical planning.	[Martin, Bryn A.; Shaffer, Nicholas; Loth, Francis] Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA; [Martin, Bryn A.; Shaffer, Nicholas; Loth, Francis] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Kalata, Wojciech] Spraying Syst Inc, Wheaton, IL USA; [Fischer, Paul] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Luciano, Mark] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; United States Department of Energy (DOE); Argonne National Laboratory; Cleveland Clinic Foundation	Martin, BA (corresponding author), Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA.	director@chiari-research.org	Martin, Bryn A./N-6640-2016	Martin, Bryn A./0000-0003-1234-7880	Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program; Conquer Chiari; Labuda Family Foundation; American Syringomyelia Alliance Project; National Institutes for Health NINDS R15 Grant [1R15NS071455-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS071455] Funding Source: NIH RePORTER	Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program; Conquer Chiari; Labuda Family Foundation; American Syringomyelia Alliance Project; National Institutes for Health NINDS R15 Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Edward and Gayle Labuda Charitable Fund of the Vanguard Charitable Endowment Program, Conquer Chiari, the Labuda Family Foundation, the American Syringomyelia Alliance Project, and the National Institutes for Health NINDS R15 Grant No. 1R15NS071455-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; BORGESEN SE, 1992, ACTA NEUROCHIR, V119, P12, DOI 10.1007/BF01541775; Bunck A.C, 2012, EUROPEAN RADIOLOGY; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; Cousins J, 2009, AM J NEURORADIOL, V30, P1587, DOI 10.3174/ajnr.A1507; Curi MA, 2002, J SURG RES, V108, P191, DOI 10.1006/jsre.2002.6558; Dolar MT, 2004, AM J NEURORADIOL, V25, P142; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Haughton VM, 2003, AM J NEURORADIOL, V24, P169; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Lee S, 2000, P ANN INT IEEE EMBS, V22, P719, DOI 10.1109/IEMBS.2000.900848; Linge SO, 2011, AM J NEURORADIOL, V32, P1474, DOI 10.3174/ajnr.A2496; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; McGirt MJ, 2008, CHILD NERV SYST, V24, P833, DOI 10.1007/s00381-007-0569-1; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Meyerson SL, 2000, J VASC SURG, V31, P910, DOI 10.1067/mva.2000.105957; Meyerson SL, 2000, VASC ENDOVASC SURG, V34, P10; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Moawad J, 1999, EUR J VASC ENDOVASC, V17, P517, DOI 10.1053/ejvs.1999.0819; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Sakas DE, 2005, ACTA NEUROCHIR, V147, P1223, DOI 10.1007/s00701-005-0645-9; Schwartz LB, 1997, J VASC SURG, V25, P1033, DOI 10.1016/S0741-5214(97)70127-7; Sekula RF, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-11; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Skelly CL, 2001, ANN VASC SURG, V15, P110, DOI 10.1007/BF02693810; Tubbs RS, 2010, NEUROSURGERY, V66, P385, DOI 10.1227/01.NEU.0000363407.78399.BA; Tubbs RS, 2009, CHILD NERV SYST, V25, P689, DOI 10.1007/s00381-009-0810-1; Urbizu A, 2013, J NEUROIMAGING; Vardoulis O, 2011, IMPACT AORTIC UNPUB; Yedavalli RV, 2001, J BIOMECH ENG-T ASME, V123, P372, DOI 10.1115/1.1385845; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	34	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75335	10.1371/journal.pone.0075335	http://dx.doi.org/10.1371/journal.pone.0075335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130704	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200011
J	MacInnis, MJ; Carter, EA; Freeman, MG; Pandit, BP; Siwakoti, A; Subedi, A; Timalsina, U; Widmer, N; Thapa, GB; Koehle, MS; Rupert, JL				MacInnis, Martin J.; Carter, Eric A.; Freeman, Michael G.; Pandit, Bidur Prasad; Siwakoti, Ashmita; Subedi, Ankita; Timalsina, Utsav; Widmer, Nadia; Thapa, Ghan Bahadur; Koehle, Michael S.; Rupert, Jim L.			A Prospective Epidemiological Study of Acute Mountain Sickness in Nepalese Pilgrims Ascending to High Altitude (4380 m)	PLOS ONE			English	Article							RISK-FACTORS; PREVENTION; ACCLIMATIZATION; ACETAZOLAMIDE; PROPHYLAXIS; POPULATION; PREVALENCE; IBUPROFEN; TOURISTS; OXIMETRY	Background: Each year, thousands of pilgrims travel to the Janai Purnima festival in Gosainkunda, Nepal (4380 m), ascending rapidly and often without the aid of pharmaceutical prophylaxis. Methods: During the 2012 Janai Purnima festival, 538 subjects were recruited in Dhunche (1950 m) before ascending to Gosainkunda. Through interviews, subjects provided demographic information, ratings of AMS symptoms (Lake Louise Scores; LLS), ascent profiles, and strategies for prophylaxis. Results: In the 491 subjects (91% follow-up rate) who were assessed upon arrival at Gosainkunda, the incidence of AMS was 34.0%. AMS was more common in females than in males (RR = 1.57; 95% CI = 1.23, 2.00), and the AMS incidence was greater in subjects > 35 years compared to subjects <= 35 years (RR = 1.63; 95% CI = 1.36, 1.95). There was a greater incidence of AMS in subjects who chose to use garlic as a prophylactic compared to those who did not (RR = 1.69; 95% CI = 1.26, 2.28). Although the LLS of brothers had a moderate correlation (intraclass correlation = 0.40, p = 0.023), sibling AMS status was a weak predictor of AMS. Conclusions: The incidence of AMS upon reaching 4380 m was 34% in a large population of Nepalese pilgrims. Sex, age, and ascent rate were significant factors in the development of AMS, and traditional Nepalese remedies were ineffective in the prevention of AMS.	[MacInnis, Martin J.; Carter, Eric A.; Koehle, Michael S.; Rupert, Jim L.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Freeman, Michael G.] Univ Glasgow, Fac Med, Glasgow, Lanark, Scotland; [Pandit, Bidur Prasad; Siwakoti, Ashmita; Subedi, Ankita; Timalsina, Utsav; Thapa, Ghan Bahadur] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Widmer, Nadia; Koehle, Michael S.] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Glasgow; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of British Columbia	MacInnis, MJ (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	martin@alumni.ubc.ca	Koehle, Michael/C-7850-2013	Koehle, Michael/0000-0001-7026-8422; MacInnis, Martin/0000-0002-0377-5800	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC CGS Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) through Discovery grants to MS Koehle and JL Rupert. MM was funded by an NSERC CGS Scholarship (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basnyat B, 1999, AVIAT SPACE ENVIR MD, V70, P867; BASNYAT B, 1993, J WILDERNESS MED, V4, P286, DOI 10.1580/0953-9859-4.3.286; Basnyat B, 2000, WILD ENVIRON MED, V11, P89, DOI 10.1580/1080-6032(2000)011[0089:DAAPAE]2.3.CO;2; Baumgartner RW, 2007, HIGH ALT MED BIOL, V8, P108, DOI 10.1089/ham.2006.1070; Eichenberger U, 1996, AM J RESP CRIT CARE, V154, P1748, DOI 10.1164/ajrccm.154.6.8970365; Gaillard S, 2004, HIGH ALT MED BIOL, V5, P410, DOI 10.1089/ham.2004.5.410; Gertsch JH, 2012, WILD ENVIRON MED, V23, P307, DOI 10.1016/j.wem.2012.08.001; Gertsch JH, 2010, WILD ENVIRON MED, V21, P236, DOI 10.1016/j.wem.2010.06.009; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; KAYSER B, 1991, J WILDERNESS MED, V2, P110, DOI 10.1580/0953-9859-2.2.110; Kayser B, 2012, HIGH ALT MED BIOL, V13, P82, DOI 10.1089/ham.2011.1084; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; Li XX, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-740; Litch JA, 1996, WILD ENVIRON MED, V7, P232, DOI 10.1580/1080-6032(1996)007[0232:DIHPAA]2.3.CO;2; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; MacInnis MJ, 2011, J OCCUP ENVIRON MED, V53, P159, DOI 10.1097/JOM.0b013e318206b112; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Mairer K, 2010, HIGH ALT MED BIOL, V11, P343, DOI 10.1089/ham.2010.1039; Morris DM, 2013, APPL PHYSIOL NUTR ME, V38, P363, DOI 10.1139/apnm-2012-0210; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Nussbaumer-Ochsner Y, 2011, HIGH ALT MED BIOL, V12, P229, DOI 10.1089/ham.2010.1073; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Wang SH, 2010, HIGH ALT MED BIOL, V11, P43, DOI 10.1089/ham.2009.1063; West JB, 2009, HIGH ALT MED BIOL, V10, P1, DOI 10.1089/ham.2009.10101; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Windsor JS, 2012, WILD ENVIRON MED, V23, P112, DOI 10.1016/j.wem.2012.03.001; Wu TY, 2012, THORAX, V67, P914, DOI 10.1136/thoraxjnl-2011-200623; Wu TY, 2012, CHINESE MED J-PEKING, V125, P1393, DOI 10.3760/cma.j.issn.0366-6999.2012.08.006; You HY, 2012, WILD ENVIRON MED, V23, P316, DOI 10.1016/j.wem.2012.04.001	34	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75644	10.1371/journal.pone.0075644	http://dx.doi.org/10.1371/journal.pone.0075644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130729	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900048
J	Olsson, M; Tintle, L; Kierczak, M; Perloski, M; Tonomura, N; Lundquist, A; Muren, E; Fels, M; Tengvall, K; Pielberg, G; de Citres, CD; Dorso, L; Abadie, J; Hanson, J; Thomas, A; Leegwater, P; Hedhammar, A; Lindblad-Toh, K; Meadows, JRS				Olsson, Mia; Tintle, Linda; Kierczak, Marcin; Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Muren, Eva; Fels, Max; Tengvall, Katarina; Pielberg, Gerli; de Citres, Caroline Dufaure; Dorso, Laetitia; Abadie, Jerome; Hanson, Jeanette; Thomas, Anne; Leegwater, Peter; Hedhammar, Ake; Lindblad-Toh, Kerstin; Meadows, Jennifer R. S.			Thorough Investigation of a Canine Autoinflammatory Disease (AID) Confirms One Main Risk Locus and Suggests a Modifier Locus for Amyloidosis	PLOS ONE			English	Article							SHAR-PEI DOGS; INTERLEUKIN IL 1-BETA; RENAL AMYLOIDOSIS; HAPLOTYPE RECONSTRUCTION; CUTANEOUS MUCINOSIS; HYALURONIC-ACID; ALPHA; EXPRESSION; IL-1-BETA; INDUCTION	Autoinflammatory disease (AID) manifests from the dysregulation of the innate immune system and is characterised by systemic and persistent inflammation. Clinical heterogeneity leads to patients presenting with one or a spectrum of phenotypic signs, leading to difficult diagnoses in the absence of a clear genetic cause. We used separate genome-wide SNP analyses to investigate five signs of AID (recurrent fever, arthritis, breed specific secondary dermatitis, otitis and systemic reactive amyloidosis) in a canine comparative model, the pure bred Chinese Shar-Pei. Analysis of 255 DNA samples revealed a shared locus on chromosome 13 spanning two peaks of association. A three-marker haplotype based on the most significant SNP (p<2.6x10(-8)) from each analysis showed that one haplotypic pair (H13-11) was present in the majority of AID individuals, implicating this as a shared risk factor for all phenotypes. We also noted that a genetic signature (F-ST) distinguishing the phenotypic extremes of the breed specific Chinese Shar-Pei thick and wrinkled skin, flanked the chromosome 13 AID locus; suggesting that breed development and differentiation has played a parallel role in the genetics of breed fitness. Intriguingly, a potential modifier locus for amyloidosis was revealed on chromosome 14, and an investigation of candidate genes from both this and the chromosome 13 regions revealed significant (p<0.05) renal differential expression in four genes previously implicated in kidney or immune health (AOAH, ELMO1, HAS2 and IL6). These results illustrate that phenotypic heterogeneity need not be a reflection of genetic heterogeneity, and that genetic modifiers of disease could be masked if syndromes were not first considered as individual clinical signs and then as a sum of their component parts.	[Olsson, Mia; Muren, Eva; Tengvall, Katarina; Pielberg, Gerli; Lindblad-Toh, Kerstin; Meadows, Jennifer R. S.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Tintle, Linda] Wurtsboro Vet Clin, Wurtsboro, NY USA; [Kierczak, Marcin] Swedish Univ Agr Sci SLU, Dept Clin Sci, Computat Genet Sect, Uppsala, Sweden; [Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Lindblad-Toh, Kerstin] Broad Inst Harvard, Cambridge, MA USA; [Perloski, Michele; Tonomura, Noriko; Lundquist, Andrew; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02139 USA; [Tonomura, Noriko] Tufts Univ, Dept Clin Sci, Cummings Sch Vet Med, North Grafton, MA USA; [Fels, Max] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Dorso, Laetitia; Abadie, Jerome] LUNAM Univ, Oniris, AMaROC Unit, F-44307 Nantes, France; [Hanson, Jeanette; Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Leegwater, Peter] Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Uppsala University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Tufts University; Yeshiva University; Albert Einstein College of Medicine; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Swedish University of Agricultural Sciences; Utrecht University	Olsson, M (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	mia.olsson@imbim.uu.se; kersli@broadinstitute.org; jennifer.meadows@imbim.uu.se	Abadie, Jérôme/ABF-5089-2020; Tengvall, Katarina/L-1933-2019; Hanson, Jeanette/Q-9283-2018	Leegwater, Peter/0000-0002-4100-015X; Meadows, Jennifer/0000-0002-0850-230X; Hanson, Jeanette/0000-0001-5596-9538; Hedhammar, Ake/0000-0001-7048-3851; Dufaure de Citres, Caroline/0000-0001-6968-3864; Kierczak, Marcin/0000-0003-2629-5655; DORSO, Laetitia/0000-0001-7790-951X	Swedish Research Council, FORMAS [221-2009-1689]; Swedish Research Council, VR [521-2012-2826]; Swedish Foundation for Strategic Research; Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond; European Commission [GA-201370]; European Science Foundation	Swedish Research Council, FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council, VR(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond; European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Swedish Research Council, FORMAS (221-2009-1689); the Swedish Research Council, VR (521-2012-2826); the Swedish Foundation for Strategic Research; the Chinese Shar-Pei Charitable Trust; Agria och SKKs forkningsfond and the European Commission (FP7-LUPA, GA-201370). KL-T is the recipient of a EURYI award from the European Science Foundation. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Bjornerfeldt S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-28; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Galeazzi M, 2006, CLIN EXP RHEUMATOL, V24, pS79; Gattorno M, 2010, CURR OPIN PEDIATR, V22, P771, DOI 10.1097/MOP.0b013e3283404598; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Docampo MJ, 2011, VET DERMATOL, V22, P535, DOI 10.1111/j.1365-3164.2011.00986.x; Kijas JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041508; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Migita K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3849; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Ombrello MJ, 2011, NAT REV RHEUMATOL, V7, P82, DOI 10.1038/nrrheum.2010.229; Ozkurede VU, 2012, CLIN EXP IMMUNOL, V167, P382, DOI 10.1111/j.1365-2249.2011.04535.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Ramsden CA, 2000, J PEDIATR-US, V136, P62, DOI 10.1016/S0022-3476(00)90051-9; RIVAS AL, 1992, CLIN IMMUNOL IMMUNOP, V64, P36, DOI 10.1016/0090-1229(92)90057-U; SCOTT JE, 1995, J ANAT, V187, P259; Segev G, 2012, J VET INTERN MED, V26, P259, DOI 10.1111/j.1939-1676.2011.00878.x; Sen S, 2010, ARCH PATHOL LAB MED, V134, P532, DOI 10.1043/1543-2165-134.4.532; Shohat M, 2011, GENET MED, V13, P487, DOI 10.1097/GIM.0b013e3182060456; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Uhlar CM, 1997, J IMMUNOL METHODS, V203, P123, DOI 10.1016/S0022-1759(96)00220-7; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zanna G, 2008, VET DERMATOL, V19, P314, DOI 10.1111/j.1365-3164.2008.00703.x; Zanna G, 2009, VET DERMATOL, V20, P377, DOI 10.1111/j.1365-3164.2009.00799.x	46	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75242	10.1371/journal.pone.0075242	http://dx.doi.org/10.1371/journal.pone.0075242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130694	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900025
J	Rousselet, J; Imbert, CE; Dekri, A; Garcia, J; Goussard, F; Vincent, B; Denux, O; Robinet, C; Dorkeld, F; Roques, A; Rossi, JP				Rousselet, Jerome; Imbert, Charles-Edouard; Dekri, Anissa; Garcia, Jacques; Goussard, Francis; Vincent, Bruno; Denux, Olivier; Robinet, Christelle; Dorkeld, Franck; Roques, Alain; Rossi, Jean-Pierre			Assessing Species Distribution Using Google Street View: A Pilot Study with the Pine Processionary Moth	PLOS ONE			English	Article							THAUMETOPOEA-PITYOCAMPA DEN.; SCHIFF. LEP.; SAMPLE-SIZE; RANGE; PERFORMANCE; EXPANSION; POPULATIONS; IMPACTS; CLIMATE; SHIFTS	Mapping species spatial distribution using spatial inference and prediction requires a lot of data. Occurrence data are generally not easily available from the literature and are very time-consuming to collect in the field. For that reason, we designed a survey to explore to which extent large-scale databases such as Google maps and Google street view could be used to derive valid occurrence data. We worked with the Pine Processionary Moth (PPM) Thaumetopoea pityocampa because the larvae of that moth build silk nests that are easily visible. The presence of the species at one location can therefore be inferred from visual records derived from the panoramic views available from Google street view. We designed a standardized procedure allowing evaluating the presence of the PPM on a sampling grid covering the landscape under study. The outputs were compared to field data. We investigated two landscapes using grids of different extent and mesh size. Data derived from Google street view were highly similar to field data in the large-scale analysis based on a square grid with a mesh of 16 km (96% of matching records). Using a 2 km mesh size led to a strong divergence between field and Google-derived data (46% of matching records). We conclude that Google database might provide useful occurrence data for mapping the distribution of species which presence can be visually evaluated such as the PPM. However, the accuracy of the output strongly depends on the spatial scales considered and on the sampling grid used. Other factors such as the coverage of Google street view network with regards to sampling grid size and the spatial distribution of host trees with regards to road network may also be determinant.	[Dorkeld, Franck; Rossi, Jean-Pierre] Ctr Montpellier, Inst Natl Rech Agron, Unite Mixte Rech Ctr Biol Gest Populat 1062, Montpellier, France; [Rousselet, Jerome; Imbert, Charles-Edouard; Dekri, Anissa; Garcia, Jacques; Goussard, Francis; Vincent, Bruno; Denux, Olivier; Robinet, Christelle; Roques, Alain] INRA, Unite Rech Zool Forestiere 633, Ctr Orleans, Orleans, France	INRAE; INRAE	Rossi, JP (corresponding author), Ctr Montpellier, Inst Natl Rech Agron, Unite Mixte Rech Ctr Biol Gest Populat 1062, Montpellier, France.	rossi@supagro.inra.fr	Rousselet, Jérôme/AAI-9490-2020; ROUSSELET, Jérôme/H-9358-2013	Rousselet, Jérôme/0000-0001-9237-6096; ROUSSELET, Jérôme/0000-0001-9237-6096; Rossi, Jean-Pierre/0000-0002-8139-1116; Robinet, Christelle/0000-0002-4933-4656	French National Agency for Research (project URTICLIM); region Centre (project ADRIEN)	French National Agency for Research (project URTICLIM); region Centre (project ADRIEN)(Region Centre-Val de Loire)	Research was funded by the French National Agency for Research (project URTICLIM) and the region Centre (project ADRIEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguelov D, 2010, COMPUTER, V43, P32, DOI 10.1109/MC.2010.170; Arnaldo PS, 2005, FOREST ECOL MANAG, V210, P1, DOI 10.1016/j.foreco.2005.02.041; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bellehumeur C, 1997, PLANT ECOL, V130, P89, DOI 10.1023/A:1009763830908; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Chang AY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-49; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025008; Clay SA, 2011, GIS APPL AGR; DEMOLIN G, 1969, Annales des Sciences Forestieres (Paris), V26, P81; Fawcett T, 2006, PATTERN RECOGN, V27; Franklin J, 2009, MAPPING SPECIES DIST; Frome A, 2009, IEEE I CONF COMP VIS, P2373, DOI 10.1109/ICCV.2009.5459413; GERI C, 1985, ANN SCI FOREST, V42, P143, DOI 10.1051/forest:19850202; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Horn A, 2012, AGR FOREST ENTOMOL, V14, P358, DOI 10.1111/j.1461-9563.2012.00576.x; HUCHON H, 1970, Revue Forestiere Francaise (Nancy), V22, P220; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lockwood JL, 2007, INVASION ECOLOGY; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Carvalho LFR, 2012, PREV VET MED, V103, P74, DOI 10.1016/j.prevetmed.2011.08.006; Rey O, 2012, ECOL LETT, V15, P1266, DOI 10.1111/j.1461-0248.2012.01849.x; Robinet C, 2010, FORET WALLONNE, V108, P19; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Roques L, 2011, J THEOR BIOL, V274, P43, DOI 10.1016/j.jtbi.2011.01.006; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Saumel I, 2010, LANDSCAPE URBAN PLAN, V94, P244, DOI 10.1016/j.landurbplan.2009.10.009; Samalens JC, 2007, FOREST ECOL MANAG, V253, P177, DOI 10.1016/j.foreco.2007.07.015; Samalens JC, 2011, POPUL ECOL, V53, P287, DOI 10.1007/s10144-010-0227-4; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smith RM, 2007, AGR FOREST ENTOMOL, V9, P307, DOI 10.1111/j.1461-9563.2007.00349.x; Southwood TRE, 2000, ECOLOGICAL METHODS; Thomas CD, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P19; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	44	40	40	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74918	10.1371/journal.pone.0074918	http://dx.doi.org/10.1371/journal.pone.0074918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130675	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900010
J	Bombi, P; D'Amen, M; Luiselli, L				Bombi, Pierluigi; D'Amen, Manuela; Luiselli, Luca			From Continental Priorities to Local Conservation: A Multi-Level Analysis for African Tortoises	PLOS ONE			English	Article							SPECIES RICHNESS; SPATIAL SCALE; PROTECTED AREAS; NETWORK; IRREPLACEABILITY; DISTRIBUTIONS; RESOLUTION; SELECTION; PATTERNS; HOTSPOTS	Terrestrial tortoises are the most endangered group of vertebrates but they are still largely ignored for defining global conservation priorities. In this paper, we explored within a hierarchical framework the potential contribution of prioritization studies at the continental scale to the planning of local initiatives for the conservation of African tortoises at the regional level. First, we modeled the distribution of all the African tortoise species, we calculated three indicators of conservation priority (i.e. species richness, conservation value, and complementarity), and we carried out a gap analysis at continental scale. Second, we focused on the most important region for tortoise conservation and performed the same analyses at higher resolution. Finally, we compared the results from the two scales for understanding the degree to which they are complementary. Southern Africa emerged from the continental analysis as the most important region for tortoises. Within this area, the high-resolution analysis pointed out specific core sites for conservation. The relative degree of species protection was assessed similarly at the two different resolutions. Two species appeared particularly vulnerable at both scales. Priority indices calculated at high resolution were correlated to the values calculated for the corresponding cells at low resolution but the congruence was stronger for species richness. Our results suggest to integrate the calculation of conservation value and complementarity into a hierarchical framework driven by species richness. The advantages of large scale planning include its broad perspective on complementarity and the capability to identify regions with greatest conservation potential. In this light, continental analyses allow targeting fine scale studies toward regions with maximum priority. The regional analyses at fine scale allow planning conservation measure at a resolution similar to that required for the practical implementation, reducing the uncertainty associated with low resolution studies.	[Bombi, Pierluigi; D'Amen, Manuela] CNR, Inst Agroenvironm & Forest Biol, Monterotondo, Italy; [D'Amen, Manuela] Corpo Forestale Stato, Ctr Nazl Biodiversita Forestale Bosco Fontana, Verona, Italy; [Luiselli, Luca] Ctr Environm Studies Demetra Srl, Rome, Italy; [Luiselli, Luca] Eni Spa, Dept Environm, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Centre of Environmental Studies DEMETRA s.r.l.; Eni SpA	Bombi, P (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Monterotondo, Italy.	pierluigi.bombi@gmail.com	D'Amen, manuela/K-4170-2015; Luiselli, Luca/AAG-9098-2020; D'Amen, Manuela/L-8272-2016	D'Amen, Manuela/0000-0001-5910-4267; Bombi, Pierluigi/0000-0002-7322-5724				Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Bombi P, 2012, J BIOGEOGR, V39, P640, DOI 10.1111/j.1365-2699.2011.02627.x; Bombi P, 2011, DIVERS DISTRIB, V17, P581, DOI 10.1111/j.1472-4642.2011.00769.x; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Branch B., 2008, TORTOISES TERRAPINS; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Burgess Neil, 1997, Bulletin of the African Bird Club, V4, P93; Chirio L., 2007, ATLAS REPTILES CAMER; D'Amen M, 2013, ANIM CONSERV, V16, P370, DOI 10.1111/acv.12016; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Entsminger G.L., 2001, ECOSIM NULL MODELS S; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Groves C. R., 2003, CONSERVATIO IN PRESS; Hacker JE, 1998, BIOL CONSERV, V84, P251, DOI 10.1016/S0006-3207(97)00115-8; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber PR, 2010, LANDSCAPE ECOL, V25, P683, DOI 10.1007/s10980-010-9447-4; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN, 2019, IUCN RED LIST THREAT; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Iverson J.B., 1992, Smithsonian Herpetological Information Service, P1; IVERSON JB, 1992, HERPETOL J, V2, P77; Iverson JB, 2003, EMYSYSTEM WORLD TURT; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Larsen FW, 2003, BIODIVERS CONSERV, V12, P599, DOI 10.1023/A:1022448928753; Lehsten V, 2006, ECOGRAPHY, V29, P786, DOI 10.1111/j.0906-7590.2006.04626.x; Luiselli L, 2009, BIODIVERS CONSERV, V18, P1349, DOI 10.1007/s10531-008-9486-1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2009, C PLAN CONSERVATION; R Core Team, 2021, R LANG ENV STAT COMP; Rhodin AGJ, 2010, CHELONIANS RES MONOG, V5, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V3.2010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Shriner SA, 2006, ECOL APPL, V16, P1660, DOI 10.1890/1051-0761(2006)016[1660:RNBORH]2.0.CO;2; Thuiller W., 2009, BIOMOD SPECIES CLIMA; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Turtle Conservation Fund, 2002, GLOB ACT PLAN CONS T; Turtle Taxonomy Working Group, 2007, Chelonian Research Monographs, V4, P173	62	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77093	10.1371/journal.pone.0077093	http://dx.doi.org/10.1371/journal.pone.0077093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116208	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200102
J	Lampugnani, ER; Moller, IE; Cassin, A; Jones, DF; Koh, PL; Ratnayake, S; Beahan, CT; Wilson, SM; Bacic, A; Newbigin, E				Lampugnani, Edwin R.; Moller, Isabel E.; Cassin, Andrew; Jones, Daniel F.; Koh, Poh Ling; Ratnayake, Sunil; Beahan, Cherie T.; Wilson, Sarah M.; Bacic, Antony; Newbigin, Ed			In Vitro Grown Pollen Tubes of Nicotiana alata Actively Synthesise a Fucosylated Xyloglucan	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDES; CALLOSE SYNTHASE; ARABINOGALACTAN PROTEINS; MONOCLONAL-ANTIBODY; CELLULOSE SYNTHASE; GENE FAMILY; ARABIDOPSIS; GENERATION; EXPRESSION; ENCODES	Nicotiana alata pollen tubes are a widely used model for studies of polarized tip growth and cell wall synthesis in plants. To better understand these processes, RNA-Seq and de novo assembly methods were used to produce a transcriptome of N. alata pollen grains. Notable in the reconstructed transcriptome were sequences encoding proteins that are involved in the synthesis and remodelling of xyloglucan, a cell wall polysaccharide previously not thought to be deposited in Nicotiana pollen tube walls. Expression of several xyloglucan-related genes in actively growing pollen tubes was confirmed and xyloglucan epitopes were detected in the wall with carbohydrate-specific antibodies: the major xyloglucan oligosaccharides found in N. alata pollen grains and tubes were fucosylated, an unusual structure for the Solanaceae, the family to which Nicotiana belongs. Finally, carbohydrate linkages consistent with xyloglucan were identified chemically in the walls of N. alata pollen grains and pollen tubes grown in culture. The presence of a fucosylated xyloglucan in Nicotiana pollen tube walls was thus confirmed. The consequences of this discovery to models of pollen tube growth dynamics and more generally to polarised tip-growing cells in plants are discussed.	[Lampugnani, Edwin R.; Koh, Poh Ling; Ratnayake, Sunil; Newbigin, Ed] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Moller, Isabel E.; Cassin, Andrew; Beahan, Cherie T.; Wilson, Sarah M.] Univ Melbourne, Australian Res Council Ctr Excellence Plant Cell, Sch Bot, Melbourne, Vic, Australia; [Bacic, Antony] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne, Vic, Australia; [Jones, Daniel F.] La Trobe Univ, Dept Bot, Bundoora, Vic 3083, Australia	University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University	Newbigin, E (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	edwardjn@unimelb.edu.au	Lampugnani, Edwin/AAF-4238-2019	Lampugnani, Edwin/0000-0002-3666-7240; Newbigin, Ed/0000-0002-9644-302X; Bacic, Tony/0000-0001-7483-8605	Australian Research Council	Australian Research Council(Australian Research Council)	Funding provided by Australian Research Council (http://arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Brennan M, 2011, MOL PLANT, V4, P144, DOI 10.1093/mp/ssq067; Brownfield L, 2008, BIOCHEM J, V414, P43, DOI 10.1042/BJ20080693; Brownfield L, 2007, PLANT J, V52, P147, DOI 10.1111/j.1365-313X.2007.03219.x; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chou YH, 2012, PLANT PHYSIOL, V159, P1355, DOI 10.1104/pp.112.199356; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dardelle F, 2010, PLANT PHYSIOL, V153, P1563, DOI 10.1104/pp.110.158881; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Derksen J, 2011, PLANT J, V68, P495, DOI 10.1111/j.1365-313X.2011.04703.x; Doblin MS, 2001, PLANT PHYSIOL, V125, P2040, DOI 10.1104/pp.125.4.2040; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Ferguson C, 1998, PLANTA, V206, P452, DOI 10.1007/s004250050421; Ferguson C, 1999, PROTOPLASMA, V206, P105, DOI 10.1007/BF01279257; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris P. J., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P201, DOI 10.1079/9780851999043.0201; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Kroeger J, 2012, CURR OPIN PLANT BIOL, V15, P618, DOI 10.1016/j.pbi.2012.09.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Li HJ, 1999, PLANTA, V208, P528, DOI 10.1007/s004250050590; Li HJ, 1997, PLANT PHYSIOL, V114, P1255, DOI 10.1104/pp.114.4.1255; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mollet Jean-Claude, 2013, Plants (Basel), V2, P107, DOI 10.3390/plants2010107; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Park YB, 2012, PLANT PHYSIOL, V158, P465, DOI 10.1104/pp.111.189779; Perrin RM, 2003, PLANT PHYSIOL, V132, P768, DOI 10.1104/pp.102.016642; PUHLMANN J, 1994, PLANT PHYSIOL, V104, P699, DOI 10.1104/pp.104.2.699; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; SCHLUPMANN H, 1994, PLANT PHYSIOL, V105, P659, DOI 10.1104/pp.105.2.659; Sims IM, 1996, CARBOHYD RES, V293, P147, DOI 10.1016/0008-6215(96)00142-5; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061; Walker M, 2011, PLANT PHYSIOL, V156, P46, DOI 10.1104/pp.111.172692; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P1025, DOI 10.1093/pcp/pce154; York WS, 1996, CARBOHYD RES, V285, P99, DOI 10.1016/0008-6215(96)00029-8; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zabotina OA, 2012, PLANT PHYSIOL, V159, P1367, DOI 10.1104/pp.112.198119	56	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77140	10.1371/journal.pone.0077140	http://dx.doi.org/10.1371/journal.pone.0077140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116212	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200105
J	Liu, GF; Xie, XF; Ye, D; Ye, XH; Tuvshintogtokh, I; Mandakh, B; Huang, ZY; Dong, M				Liu, Guofang; Xie, Xiufang; Ye, Duo; Ye, Xuehua; Tuvshintogtokh, Indree; Mandakh, Bayart; Huang, Zhenying; Dong, Ming			Plant Functional Diversity and Species Diversity in the Mongolian Steppe	PLOS ONE			English	Article							CLIMATE-DRIVEN CHANGES; BIODIVERSITY LOSS; GRASSLAND; HETEROGENEITY; VEGETATION; DOMINANCE; RICHNESS; EVENNESS; DENSITY; BIOMASS	Background: The Mongolian steppe is one of the most important grasslands in the world but suffers from aridization and damage from anthropogenic activities. Understanding structure and function of this community is important for the ecological conservation, but has seldom been investigated. Methodology/Principal Findings: In this study, a total of 324 quadrats located on the three main types of Mongolian steppes were surveyed. Early-season perennial forbs (37% of total importance value), late-season annual forbs (33%) and late-season perennial forbs (44%) were dominant in meadow, typical and desert steppes, respectively. Species richness, diversity and plant functional type (PFT) richness decreased from the meadow, via typical to desert steppes, but evenness increased; PFT diversity in the desert and meadow steppes was higher than that in typical steppe. However, above-ground net primary productivity (ANPP) was far lower in desert steppe than in the other two steppes. In addition, the slope of the relationship between species richness and PFT richness increased from the meadow, via typical to desert steppes. Similarly, with an increase in species diversity, PFT diversity increased more quickly in both the desert and typical steppes than that in meadow steppe. Random resampling suggested that this coordination was partly due to a sampling effect of diversity. Conclusions/Significance: These results indicate that desert steppe should be strictly protected because of its limited functional redundancy, which its ecological functioning is sensitive to species loss. In contrast, despite high potential forage production shared by the meadow and typical steppes, management of these two types of steppes should be different: meadow steppe should be preserved due to its higher conservation value characterized by more species redundancy and higher spatial heterogeneity, while typical steppe could be utilized moderately because its dominant grass genus Stipa is resistant to herbivory and drought.	[Liu, Guofang; Xie, Xiufang; Ye, Duo; Ye, Xuehua; Huang, Zhenying; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Tuvshintogtokh, Indree; Mandakh, Bayart] Mongolian Acad Sci, Inst Bot, Ulaanbaatar, Mongolia; [Xie, Xiufang; Ye, Duo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Hangzhou Normal University; Mongolian Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	yexuehua@ibcas.ac.cn	Ye, Xuehua/I-3116-2013	Ye, Xuehua/0000-0002-5625-9877; Indree, Tuvshintogtokh/0000-0002-3801-3806	External Cooperation Program of the Chinese Academy of Sciences [GJHZ1006]	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This international cooperative work was supported by the External Cooperation Program of the Chinese Academy of Sciences, Grant No. GJHZ1006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白永飞 Bai Yongfei], 2002, [生态学报, Acta Ecologica Sinica], V22, P1215; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Box EO, 1996, J VEG SCI, V7, P309, DOI 10.2307/3236274; Buxbaum CAZ, 2007, J ARID ENVIRON, V69, P617, DOI 10.1016/j.jaridenv.2006.11.017; Camargo JA, 1995, OIKOS, V74, P538, DOI 10.2307/3546000; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; CHANETON EJ, 1991, VEGETATIO, V93, P143, DOI 10.1007/BF00033208; Cheng Yunxiang, 2008, Grassland Science, V54, P107, DOI 10.1111/j.1744-697X.2008.00112.x; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; DeLucia EH, 2000, GLOBAL CHANGE BIOL, V6, P587, DOI 10.1046/j.1365-2486.2000.00338.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S., 2007, FUNCTIONAL DIVERSITY, P81; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Elmqvist T., 2010, EC ECOSYSTEMS BIODIV; Fernandez-Gimenez M, 2001, PLANT ECOL, V157, P101, DOI 10.1023/A:1014519206041; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Ho P, 2010, ENVIRON RES, V110, P302, DOI 10.1016/j.envres.2009.12.007; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; IPCC, 2007, CLIM CHANG PHYS SCI; LAJTHA K, 1989, OECOLOGIA, V80, P341, DOI 10.1007/BF00379035; Li B, 1990, STEPPE CHINA; Lockwood Julie L., 2004, P55; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Naeem S., 2009, BIODIVERSITY ECOSYST; Nakano T, 2008, AGR FOREST METEOROL, V148, P1456, DOI 10.1016/j.agrformet.2008.04.011; Perrings Charles, 1995, P190; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Politis DN, 1999, STAT SINICA, V11, P1105; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Qiao JJ, 2012, J PLANT ECOL, V5, P313, DOI 10.1093/jpe/rtr032; R Development Core Team, 2012, R LANG ENV STAT COMP; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shi Y, 2013, CHINESE SCI BULL, P1; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Sokal R. R., 2012, BIOMETRY; Souto C. P., 2004, Phyton (Buenos Aires), V2004, P39; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Sugita M, 2007, J HYDROL, V333, P3, DOI 10.1016/j.jhydrol.2006.07.032; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wang RZ, 2003, GLOBAL ECOL BIOGEOGR, V12, P249, DOI 10.1046/j.1466-822X.2003.00027.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Westerman RL, 1990, SOIL TESTING PLANT A, P3; Wood A, 2013, ROOT CAUSES BIODIVER, DOI [10.4324/9781315071688, DOI 10.4324/9781315071688]	51	18	23	5	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77565	10.1371/journal.pone.0077565	http://dx.doi.org/10.1371/journal.pone.0077565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116233	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200119
J	Sun, H; Weng, J; Yu, GC; Massawe, RH				Sun, Heng; Weng, Jian; Yu, Guangchuang; Massawe, Richard H.			A DNA-Based Semantic Fusion Model for Remote Sensing Data	PLOS ONE			English	Article							BIG DATA; ONTOLOGY; INFORMATION; SCIENCE; STORAGE; GENE; XML; WEB	Semantic technology plays a key role in various domains, from conversation understanding to algorithm analysis. As the most efficient semantic tool, ontology can represent, process and manage the widespread knowledge. Nowadays, many researchers use ontology to collect and organize data's semantic information in order to maximize research productivity. In this paper, we firstly describe our work on the development of a remote sensing data ontology, with a primary focus on semantic fusion-driven research for big data. Our ontology is made up of 1,264 concepts and 2,030 semantic relationships. However, the growth of big data is straining the capacities of current semantic fusion and reasoning practices. Considering the massive parallelism of DNA strands, we propose a novel DNA-based semantic fusion model. In this model, a parallel strategy is developed to encode the semantic information in DNA for a large volume of remote sensing data. The semantic information is read in a parallel and bit-wise manner and an individual bit is converted to a base. By doing so, a considerable amount of conversion time can be saved, i.e., the cluster-based multi-processes program can reduce the conversion time from 81,536 seconds to 4,937 seconds for 4.34 GB source data files. Moreover, the size of result file recording DNA sequences is 54.51 GB for parallel C program compared with 57.89 GB for sequential Perl. This shows that our parallel method can also reduce the DNA synthesis cost. In addition, data types are encoded in our model, which is a basis for building type system in our future DNA computer. Finally, we describe theoretically an algorithm for DNA-based semantic fusion. This algorithm enables the process of integration of the knowledge from disparate remote sensing data sources into a consistent, accurate, and complete representation. This process depends solely on ligation reaction and screening operations instead of the ontology.	[Sun, Heng; Weng, Jian] Jinan Univ, Coll Informat Sci & Technol, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China; [Yu, Guangchuang] Jinan Univ, Coll Life Sci & Technol, Key Lab Funct Prot Res, Guangdong Higher Educ Inst,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Massawe, Richard H.] Jinan Univ, Int Sch, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Sun, H (corresponding author), Jinan Univ, Coll Informat Sci & Technol, Dept Comp Sci, Guangzhou, Guangdong, Peoples R China.	tsunheng@jnu.edu.cn	Yu, Guangchuang/H-4685-2014; YU, Guangchuang/V-7134-2019; Yu, Guangchuang/G-1015-2017; Yu, Guangchuang/GQI-1922-2022	Yu, Guangchuang/0000-0002-6485-8781; Yu, Guangchuang/0000-0002-6485-8781	Natural Science Foundation of China [61272413, 60903178, 61272073]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (Grant No. 61272413, No. 60903178, and No. 61272073) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Afek Y, 2011, SCIENCE, V331, P183, DOI 10.1126/science.1193210; Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancroft C, 2001, SCIENCE, V293, P1763; Batcheller JK, 2010, COMPUT ENVIRON URBAN, V34, P333, DOI 10.1016/j.compenvurbsys.2010.02.008; Blu-ray Disc Association, 2010, WHIT PAP BLUR DISC F; Borresen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048498; Brovko OO, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704181; Bryant B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035703; Calvanese D., 2005, P AAAI 2005, P602; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cyganiak R, 2012, N QUADS EXTENDING N; Figuera JDL, 1993, PHYS REV B, V47, P13043; Fox A, 2011, SCIENCE, V331, P406, DOI 10.1126/science.1198981; Geneves P, 2011, ACM T INTERNET TECHN, V11, DOI 10.1145/1993083.1993087; Gerstein M, 2012, NATURE, V489, P208, DOI 10.1038/489208b; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glimm B, 2008, J ARTIF INTELL RES, V31, P157, DOI 10.1613/jair.2372; Halvorsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044212; Hastings J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025513; Hendler J, 2003, SCIENCE, V299, P520, DOI 10.1126/science.1078874; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; Hussain S, 2013, PROC SPIE, V8639, DOI 10.1117/12.2002782; Imai H, 1982, STEREO REV, V12, P63; Iribarne L, 2011, IEEE T SYST MAN CY A, V41, P730, DOI 10.1109/TSMCA.2011.2132706; Janowicz K, 2012, T GIS, V16, P351, DOI 10.1111/j.1467-9671.2012.01342.x; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kingston, 2013, KINGST DIG SHIPS ITS; Kneuer C, 2000, BIOCONJUGATE CHEM, V11, P926, DOI 10.1021/bc0000637; Konrath M, 2012, J WEB SEMANT, V16, P52, DOI 10.1016/j.websem.2012.06.002; Lattanzio A, 2013, B AM METEOROL SOC, V94, P205, DOI 10.1175/BAMS-D-11-00230.1; Leida M, 2012, J AMBINET INTELL HUM; Lewis JJ, 2007, INFORM FUSION, V8, P119, DOI 10.1016/j.inffus.2005.09.006; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; Ma XG, 2012, COMPUT GEOSCI-UK, V40, P107, DOI 10.1016/j.cageo.2011.07.018; Mervis J, 2012, SCIENCE, V336, P22, DOI 10.1126/science.336.6077.22; Mimura H, 1997, P IEEE COMPCON 97 SA, P291; Oka H, 2010, SCIENCE, V327, P843, DOI 10.1126/science.1183224; Paun G., 1998, DNA COMPUTING NEW CO, DOI DOI 10.1007/978-3-662-03563-4; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Rivera R, 2012, IBM SYSTEM STORAGE L; Schneider T, 2012, APPL ONTOL, V7, P357, DOI 10.3233/AO-2012-0111; Sun H, 2005, IEEE GEOSCI REMOTE S, V2, P440, DOI 10.1109/LGRS.2005.853573; Tsou M-H., 2004, J GEOGRAPHICAL SYSTE, V6, P155, DOI [10.1007/s10109-004-0131-6, DOI 10.1007/s10109-004-0131-6]; Tsuboi Y, 2005, INT J INNOV COMPUT I, V1, P755; Wang XS, 2005, NAT BIOTECHNOL, V23, P1099, DOI 10.1038/nbt1139; Wei YX, 2007, COMPUT GEOSCI-UK, V33, P238, DOI 10.1016/j.cageo.2006.06.006; Williams GT, 2010, J WEB SEMANT, V8, P365, DOI 10.1016/j.websem.2010.08.002; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Xu J, 2011, IEEE T NANOBIOSCI, V10, P94, DOI 10.1109/TNB.2011.2160996; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	55	2	2	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77090	10.1371/journal.pone.0077090	http://dx.doi.org/10.1371/journal.pone.0077090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116207	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200101
J	Yang, D; Chariyalertsak, C; Wongthanee, A; Kawichai, S; Yotruean, K; Saokhieo, P; Guadamuz, T; Suwanvanichkij, V; Beyrer, C; Chariyalertsak, S				Yang, Daniel; Chariyalertsak, Chonlisa; Wongthanee, Antika; Kawichai, Surinda; Yotruean, Kriengkrai; Saokhieo, Pongpun; Guadamuz, Thomas; Suwanvanichkij, Voravit; Beyrer, Chris; Chariyalertsak, Suwat			Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand	PLOS ONE			English	Article							GAY PRIDE EVENTS; HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; POSTEXPOSURE PROPHYLAXIS; LIMITED KNOWLEDGE; RISK; ATTENDEES; ATTITUDES; INFECTION; BARRIERS	Background: Northern Thailand has a high burden HIV epidemic among MSM and TG. Oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine has demonstrated efficacy in preventing HIV among MSM and TG in Chiang Mai, Thailand. Determinants of PrEP acceptability are needed to gauge the potential uptake of this prevention strategy. Methods: From January to February 2012, 238 MSM and TG participants, who self-reported as HIV-uninfected or of unknown status, completed a self-administered survey on hand-held computers. Participants were recruited by venue-day-time sampling and asked to rate their likelihood of using oral PrEP for HIV prevention with an efficacy of 50%. PrEP acceptability was defined as being "very likely" to use PrEP. Odds ratios and 95% CIs were calculated to identify correlates of acceptability. Results: 131 MSM and 107 TG responded, with mean ages of 23.7 and 21.8, respectively. 24% of MSM engaged primarily in receptive anal sex vs. 74% of TG. 21% of MSM and 44% of TG reported regular medication use. Prior awareness of PrEP was high at 66% among both MSM and TG respondents. 41% of MSM and 37% of TG were "very likely" to use PrEP. Among MSM, factors associated with PrEP acceptability included a prior history of STIs (AOR 4.6; 95% CIs 1.7-12.6), previous HIV testing (AOR 2.4 95% CIs 1.1-5.3), regularly planned sex (AOR 2.8 95% CIs 1.1-7.2), and infrequent sex (AOR 2.9 95% CIs 1.3-6.3). Among TG, factors associated with acceptability included prior awareness of PrEP (AOR 3.3; 95% CIs 1.2-9.0) and having private insurance (AOR 5.0; 95% CIs 1.3-19.0). Conclusion: MSM and TG in Northern Thailand are distinct groups in terms of sexual behaviors, patterns of medication use, and correlates of PrEP acceptability. Efforts to maximize PrEP uptake should include expanded HIV testing services and the provision of financial subsidies to reduce the cost of PrEP.	[Yang, Daniel] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yang, Daniel; Kawichai, Surinda; Suwanvanichkij, Voravit; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wongthanee, Antika; Kawichai, Surinda; Saokhieo, Pongpun; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Chariyalertsak, Chonlisa; Yotruean, Kriengkrai] Thailand Minist Publ Hlth, Chiang Mai Prov Publ Hlth Off, Chiang Mai, Thailand; [Guadamuz, Thomas] Mahidol Univ, Fac Social Sci & Humanities, Ctr Hlth Policy Studies, Nakhon Pathom, Thailand; [Guadamuz, Thomas] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chiang Mai University; Ministry of Public Health - Thailand; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chiang Mai University	Yang, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Daniel.Yang@ucsf.edu		Kawichai, Surinda/0000-0003-0189-4125	National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; Johns Hopkins Fogarty AIDS International Training and Research Program [D43 TW00010-22]; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH085567] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; Johns Hopkins Fogarty AIDS International Training and Research Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. The research was also supported, in part, by the Johns Hopkins Fogarty AIDS International Training and Research Program (D43 TW00010-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant R, 2011, ABSTR COMPL OBS RAND; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Kellerman SE, 2006, JAIDS-J ACQ IMM DEF, V43, P376, DOI 10.1097/01.qai.0000234085.18914.d5; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Mansergh G, 2006, FIELD METHOD, V18, P135, DOI 10.1177/1525822X05282267; Mayer KH, 2010, JAIDS-J ACQ IMM DEF, V55, pS122, DOI 10.1097/QAI.0b013e3181fbcb4c; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Schneider JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011922; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2011, UNAIDS REP GLOB AIDS; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; van Griensven F., 2006, Morbidity and Mortality Weekly Report, V55, P844; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-13; Voetsch AC, 2007, JAIDS-J ACQ IMM DEF, V46, P378, DOI 10.1097/QAI.0b013e3181576874; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	34	17	20	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76650	10.1371/journal.pone.0076650	http://dx.doi.org/10.1371/journal.pone.0076650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116132	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200060
J	Bompard, A; Amat, I; Fauvergue, X; Spataro, T				Bompard, Anais; Amat, Isabelle; Fauvergue, Xavier; Spataro, Thierry			Host-Parasitoid Dynamics and the Success of Biological Control When Parasitoids Are Prone to Allee Effects	PLOS ONE			English	Article							SEX-RATIO; CONSTRAINED OVIPOSITION; DENSITY-DEPENDENCE; POPULATIONS; PREDATOR; COMPETITION; BEHAVIOR; MODELS; MOTH; CONSEQUENCES	In sexual organisms, low population density can result in mating failures and subsequently yields a low population growth rate and high chance of extinction. For species that are in tight interaction, as in host-parasitoid systems, population dynamics are primarily constrained by demographic interdependences, so that mating failures may have much more intricate consequences. Our main objective is to study the demographic consequences of parasitoid mating failures at low density and its consequences on the success of biological control. For this, we developed a deterministic host-parasitoid model with a mate-finding Allee effect, allowing to tackle interactions between the Allee effect and key determinants of host-parasitoid demography such as the distribution of parasitoid attacks and host competition. Our study shows that parasitoid mating failures at low density result in an extinction threshold and increase the domain of parasitoid deterministic extinction. When proned to mate finding difficulties, parasitoids with cyclic dynamics or low searching efficiency go extinct; parasitoids with high searching efficiency may either persist or go extinct, depending on host intraspecific competition. We show that parasitoids suitable as biocontrol agents for their ability to reduce host populations are particularly likely to suffer from mate-finding Allee effects. This study highlights novel perspectives for understanding of the dynamics observed in natural host-parasitoid systems and improving the success of parasitoid introductions.	[Bompard, Anais; Spataro, Thierry] Univ Paris 06, CNRS, ENS, UMR Ecol & Evolut 7625, Paris, France; [Bompard, Anais; Spataro, Thierry] INRA, USC Ecol Populat & Communautes 2031, Paris, France; [Amat, Isabelle] Univ Lyon 1, CNRS, UMR Lab Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France; [Fauvergue, Xavier] Univ Nice Sophia Antipolis, CNRS, INRA, UMR 1355,Inst Sophia Agrobiotech 7254, Sophia Antipolis, France; [Spataro, Thierry] AgroParisTech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; AgroParisTech	Bompard, A (corresponding author), Univ Paris 06, CNRS, ENS, UMR Ecol & Evolut 7625, Paris, France.	anais.bompard@gmail.com	fauvergue, xavier/B-9108-2012	fauvergue, xavier/0000-0002-3579-7721; Spataro, Thierry/0000-0003-3373-6527	 [ANR-2010-BLAN-1717]		This work was supported by ANR-2010-BLAN-1717 "Sextinction" (http://www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDDINGTON JR, 1978, NATURE, V273, P513, DOI 10.1038/273513a0; BEDDINGTON JR, 1976, J ANIM ECOL, V45, P791, DOI 10.2307/3581; BEDDINGTON JR, 1982, ECOL MODEL, V14, P155, DOI 10.1016/0304-3800(82)90016-3; Bellows TS, 2001, BIOL CONTROL, V21, P199, DOI 10.1006/bcon.2001.0936; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; Bernstein C, 2000, PARASITOID POPULATION BIOLOGY, P41; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Blackwood JC, 2012, P ROY SOC B-BIOL SCI, V279, P2807, DOI 10.1098/rspb.2012.0255; Boukal DS, 2009, POPUL ECOL, V51, P445, DOI 10.1007/s10144-009-0154-4; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; BRIGGS CJ, 1993, AM NAT, V141, P372, DOI 10.1086/285479; Briggs CJ, 2001, THEOR POPUL BIOL, V60, P33, DOI 10.1006/tpbi.2001.1529; Collier TR, 2001, OECOLOGIA, V129, P147, DOI 10.1007/s004420100706; COMINS HN, 1985, J ANIM ECOL, V54, P583, DOI 10.2307/4500; Contarini M, 2009, ENTOMOL EXP APPL, V133, P307, DOI 10.1111/j.1570-7458.2009.00930.x; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cronin JT, 2009, ECOLOGY, V90, P196, DOI 10.1890/08-0208.1; Dennis B., 1989, Natural Resource Modeling, V3, P481; Deredec A, 2006, OIKOS, V112, P667, DOI 10.1111/j.0030-1299.2006.14243.x; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; EMBREE DG, 1966, CAN ENTOMOL, V98, P1159, DOI 10.4039/Ent981159-11; Engelkes T, 2011, BIOCONTROL, V56, P383, DOI 10.1007/s10526-011-9377-3; Fauvergue X, 1998, J EVOLUTION BIOL, V11, P611, DOI 10.1007/s000360050109; FAUVERGUE X, 1995, P NATL ACAD SCI USA, V92, P900, DOI 10.1073/pnas.92.3.900; Fauvergue X, 2008, OECOLOGIA, V156, P913, DOI 10.1007/s00442-008-1037-7; Fauvergue X, 2007, ECOLOGY, V88, P2392, DOI 10.1890/06-1238.1; Fauvergue X, 2013, ENTOMOL EXP APPL, V146, P79, DOI 10.1111/eea.12021; Fauvergue X, 2009, POPUL ECOL, V51, P385, DOI 10.1007/s10144-009-0147-3; Gascoigne J, 2009, POPUL ECOL, V51, P355, DOI 10.1007/s10144-009-0146-4; GODFRAY HCJ, 1988, ECOL ENTOMOL, V13, P283, DOI 10.1111/j.1365-2311.1988.tb00358.x; Grevstad Fritzi S., 1999, Biological Invasions, V1, P313, DOI 10.1023/A:1010037912369; Hall R.W., 1979, Bulletin of the Entomological Society of America, V25, P280; Hardy ICW, 1999, ETHOLOGY, V105, P57, DOI 10.1111/j.1439-0310.1999.tb01220.x; Hardy ICW, 1998, TRENDS ECOL EVOL, V13, P431, DOI 10.1016/S0169-5347(97)01298-6; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASSELL MP, 1983, J ANIM ECOL, V52, P889, DOI 10.2307/4462; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Henne DC, 2010, BIOL CONTROL, V55, P63, DOI 10.1016/j.biocontrol.2010.07.001; HOPPER KR, 1993, ECOL ENTOMOL, V18, P321, DOI 10.1111/j.1365-2311.1993.tb01108.x; Jang SRJ, 2006, J DIFFER EQU APPL, V12, P165, DOI 10.1080/10236190500539238; Kapranas A, 2011, J ANIM ECOL, V80, P192, DOI 10.1111/j.1365-2656.2010.01767.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Li J, 2012, FLA ENTOMOL, V95, P128, DOI 10.1653/024.095.0120; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu H, 2009, ECOL COMPLEX, V6, P337, DOI 10.1016/j.ecocom.2009.01.003; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MAY RM, 1981, J ANIM ECOL, V50, P855, DOI 10.2307/4142; Metzger M, 2008, ECOL ENTOMOL, V33, P167, DOI 10.1111/j.1365-2311.2007.00953.x; Metzger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013505; Meunier J, 2002, ECOL MODEL, V152, P77, DOI 10.1016/S0304-3800(01)00491-4; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Ode PJ, 1997, OECOLOGIA, V109, P547, DOI 10.1007/s004420050115; Pareja M, 2008, BASIC APPL ECOL, V9, P701, DOI 10.1016/j.baae.2007.10.008; Perez-Lachaud G, 2010, ENTOMOL EXP APPL, V137, P62, DOI 10.1111/j.1570-7458.2010.01037.x; Rusch A, 2011, LANDSCAPE ECOL, V26, P473, DOI 10.1007/s10980-011-9573-7; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STILING P, 1990, American Entomologist, V36, P225; Stiling Peter, 1993, American Entomologist, V39, P31; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Tobin PC, 2013, ENTOMOL EXP APPL, V146, P103, DOI 10.1111/j.1570-7458.2012.01299.x; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Tobin PC, 2009, POPUL ECOL, V51, P373, DOI 10.1007/s10144-009-0144-6; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; VANLENTEREN JC, 1983, AGR ECOSYST ENVIRON, V10, P143, DOI 10.1016/0167-8809(83)90059-2; Verdy A, 2010, ECOL MODEL, V221, P1098, DOI 10.1016/j.ecolmodel.2010.01.005; Wogin MJ, 2013, ENTOMOL EXP APPL, V146, P165, DOI 10.1111/eea.12009; Zhou SR, 2005, THEOR POPUL BIOL, V67, P23, DOI 10.1016/j.tpb.2004.06.007	72	21	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76768	10.1371/journal.pone.0076768	http://dx.doi.org/10.1371/journal.pone.0076768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116153	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300093
J	Kinoshita, R; Nam, JM; Ito, YM; Hatanaka, KC; Hashimoto, A; Handa, H; Otsuka, Y; Hashimoto, S; Onodera, Y; Hosoda, M; Onodera, S; Shimizu, S; Tanaka, S; Shirato, H; Tanino, M; Sabe, H				Kinoshita, Rumiko; Nam, Jin-Min; Ito, Yoichi M.; Hatanaka, Kanako C.; Hashimoto, Ari; Handa, Haruka; Otsuka, Yutaro; Hashimoto, Shigeru; Onodera, Yasuhito; Hosoda, Mitsuchika; Onodera, Shunsuke; Shimizu, Shinichi; Tanaka, Shinya; Shirato, Hiroki; Tanino, Mishie; Sabe, Hisataka			Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy	PLOS ONE			English	Article							20-YEAR FOLLOW-UP; CONSERVING THERAPY; RISK-FACTORS; LARGE SERIES; CANCER; EXPRESSION; MASTECTOMY; BETA-1-INTEGRIN; SIGNATURE; SURVIVAL	A major problem of current cancer research and therapy is prediction of tumor recurrence after initial treatment, rather than the simple biological characterization of the malignancy and proliferative properties of tumors. Breast conservation therapy (BCT) is a well-approved, standard treatment for patients with early stages of breast cancer, which consists of lumpectomy and whole-breast irradiation. In spite of extensive studies, only 'age' and 'Ki-67 positivity' have been identified to be well correlated with local recurrence after BCT. An Arf6 pathway, activated by GEP100 under receptor tyrosine kinases (RTKs) and employs AMAP1 as its effector, is crucial for invasion and metastasis of some breast cancer cells. This pathway activates beta 1 integrins and perturbs E-cadherin-based adhesions, hence appears to be integral for epithelial-mesenchymal transdifferentiation (EMT). We here show that expression of the Arf6 pathway components statistically correlates with rapid local recurrence after BCT. We retrospectively analyzed four hundred seventy-nine patients who received BCT in Hokkaido University Hospital, and found 20 patients had local recurrence. We then analyzed pathological samples of patients who experienced local recurrence by use of Kaplan-Meier analysis, Stepwise regression analysis and the t-test, coupled with immunostaining, and found that co-overexpression of GEP100 and AMAP1 correlates with rapidity of the local recurrence. Their margin-status, node-positivity, and estrogen receptor (ER)-or progesterone receptor (PgR)positivity did not correlated with the rapidity. This study is the first to show that expression of a certain set of proteins correlates with the rapidity of local recurrence. Our results are useful not only for prediction, but highlight the possibility of developing novel strategies to block local recurrence. We also discuss why mRNAs encoding these proteins have not been identified to correlate with local recurrence by previous conventional gene expression profiling analyses.	[Kinoshita, Rumiko; Nam, Jin-Min; Onodera, Shunsuke; Shimizu, Shinichi; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Hashimoto, Ari; Handa, Haruka; Otsuka, Yutaro; Hashimoto, Shigeru; Onodera, Yasuhito; Sabe, Hisataka] Hokkaido Univ, Grad Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Hosoda, Mitsuchika] Hokkaido Univ Hosp, Dept Breast & Endocrine Surg, Sapporo, Hokkaido 060, Japan; [Tanaka, Shinya; Tanino, Mishie] Hokkaido Univ, Grad Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Tanino, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Canc Res Lab, Sapporo, Hokkaido, Japan.	tanino@med.hokudai.ac.jp; sabe@med.hokudai.ac.jp	Onodera, Yasuhito/D-7108-2012; Tanaka, Shinya/D-3586-2011; Shirato, Hiroki/A-7068-2010; Kinoshita, Rumiko/ABG-3864-2021; Shimizu, Shinichi/G-4477-2010; Nam, Jin-Min/D-6468-2012; Sabe, Hisataka/GPF-4385-2022	Shimizu, Shinichi/0000-0003-3143-0479; Ito, Yoichi M./0000-0001-5073-0827; Handa, Haruka/0000-0002-8557-7479; Onodera, Yasuhito/0000-0002-0064-9016	Ministry of Education, Science, Sports and Culture of Japan; Mitsubishi Foundation for Natural Sciences; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [24791259]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research [23590323, 24590406] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation for Natural Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, Mitsubishi Foundation for Natural Sciences, Takeda Science Foundation to H. Sabe, The Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST program http://www.jsps.go.jp/j-first/gaiyou.html) to H. Shirato, and Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government http://www.jsps.go.jp/j-grantsinaid/square) (No. 24791259) to R. Kinoshita. J.-M. Nam was supported by a grant from the Matching Program for Innovations in Future Drug Discovery and Medical Care from the) square Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manusclipt	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; Elkhuizen PHM, 1999, INT J RADIAT ONCOL, V45, P73, DOI 10.1016/S0360-3016(99)00158-3; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hay ED, 1995, ACTA ANAT, V154, P8; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; InstituteSas IS, 2012, JMP 10 MOD MULT METH; Jones HA, 2009, J CLIN ONCOL, V27, P4939, DOI 10.1200/JCO.2008.21.5764; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kreike B, 2009, CLIN CANCER RES, V15, P4181, DOI 10.1158/1078-0432.CCR-08-2644; Kunkler IH, 2012, INT J RADIAT ONCOL, V83, P829, DOI 10.1016/j.ijrobp.2011.08.018; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miyata M, 2008, CELL CYCLE, V7, P3273, DOI 10.4161/cc.7.20.6883; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76791	10.1371/journal.pone.0076791	http://dx.doi.org/10.1371/journal.pone.0076791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116160	Green Published, gold			2022-12-25	WOS:000325501300096
J	Martens, B; Amman, F; Manoharadas, S; Zeichen, L; Orell, A; Albers, SV; Hofacker, I; Blasi, U				Maertens, Birgit; Amman, Fabian; Manoharadas, Salim; Zeichen, Lukas; Orell, Alvaro; Albers, Sonja-Verena; Hofacker, Ivo; Blaesi, Udo			Alterations of the Transcriptome of Sulfolobus acidocaldarius by Exoribonuclease aCPSF2	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTOR; MESSENGER-RNA DEGRADATION; BETA-CASP RIBONUCLEASES; ESCHERICHIA-COLI; SOLFATARICUS; MATURATION; COMPLEX; DECAY; CRENARCHAEOTA; EXPRESSION	Recent studies identified a 5' to 3' exoribonuclease termed Sso-RNase J in the crenarchaeon Sulfolobus solfataricus (Sso), which has been reclassified to the aCPSF2 (archaeal cleavage and polyadenylation specificity factor 2) group of beta-CASP proteins. In this study, the Sso-aCPSF2 orthologue of Sulfolobus acidocaldarius (Saci-aCPSF2) was functionally characterized. Like Sso-aCPSF2, Saci-aCPSF2 degrades RNA with 5' to 3' directionality in vitro. To address the biological significance of Saci-aCPSF2, a deletion mutant was constructed, and the influence of Saci-aCPSF2 on the transcriptome profile was assessed employing high throughput RNA sequencing. This analysis revealed 560 genes with differential transcript abundance, suggesting a considerable role of this enzyme in RNA metabolism. In addition, bioinformatic analyses revealed several transcripts that are preferentially degraded at the 5' end. This was exemplarily verified for two transcripts by Northern-blot analyses, showing for the first time that aCPSF2 proteins play a role in 5' to 3' directional mRNA decay in the crenarchaeal clade of Archaea.	[Maertens, Birgit; Manoharadas, Salim; Zeichen, Lukas; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Vienna, Austria; [Amman, Fabian; Hofacker, Ivo] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Orell, Alvaro; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Amman, Fabian] Univ Leipzig, Dept Comp Sci, D-04109 Leipzig, Germany; [Amman, Fabian] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; Max Planck Society; Leipzig University; Leipzig University	Blasi, U (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Vienna, Austria.	udo.blaesi@univie.ac.at	MANOHARADAS, SALIM/ABC-6986-2020; Hofacker, Ivo L/A-2378-2013; Albers, Sonja-Verena/H-8689-2019	MANOHARADAS, SALIM/0000-0002-1875-5976; Hofacker, Ivo L/0000-0001-7132-0800; Albers, Sonja-Verena/0000-0003-2459-2226; Amman, Fabian/0000-0002-8646-859X	Austrian Science Fund [P21560]; Max Planck Society; FWF project [SFB F43]; Austrian Science Fund (FWF) [P 21560] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck Society); FWF project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grant P21560 from the Austrian Science Fund to UB. AO and SVA were supported by intramural funds of the Max Planck Society. FA and IH were supported by the FWF project SFB F43 "RNA regulation of the transcriptome".	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berkner S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm449; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Clout d Orval B, 2010, J BIOL CHEM, V285, P17574; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Franzetti B, 1997, J BACTERIOL, V179, P1180, DOI 10.1128/jb.179.4.1180-1185.1997; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hasenohrl D, 2011, RNA, V17, P99, DOI 10.1261/rna.2418211; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pedulla N, 2005, NUCLEIC ACIDS RES, V33, P1804, DOI 10.1093/nar/gki321; Phung DK, 2013, NUCLEIC ACIDS RES, V41, P1091, DOI 10.1093/nar/gks1237; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taverniti V, 2011, MOL MICROBIOL, V82, P1260, DOI 10.1111/j.1365-2958.2011.07888.x; Tourriere H, 2002, BIOCHIMIE, V84, P821, DOI 10.1016/S0300-9084(02)01445-1; Wagner M, 2009, BIOCHEM SOC T, V37, P97, DOI 10.1042/BST0370097	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76569	10.1371/journal.pone.0076569	http://dx.doi.org/10.1371/journal.pone.0076569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116119	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300066
J	Brands, J; Kliner, D; Lipowsky, HH; Kameneva, MV; Villanueva, FS; Pacella, JJ				Brands, Judith; Kliner, Dustin; Lipowsky, Herbert H.; Kameneva, Marina V.; Villanueva, Flordeliza S.; Pacella, John J.			New Insights into the Microvascular Mechanisms of Drag Reducing Polymers: Effect on the Cell-Free Layer	PLOS ONE			English	Article							BLOOD-FLOW; SPATIOTEMPORAL VARIATIONS; ERYTHROCYTE AGGREGATION; HEMORRHAGIC-SHOCK; RAT MODEL; MODULATION; SURVIVAL; WIDTH; LEUKOCYTES; VISCOSITY	Drag-reducing polymers (DRPs) significantly increase blood flow, tissue perfusion, and tissue oxygenation in various animal models. In rectangular channel microfluidic systems, DRPs were found to significantly reduce the near-wall cell-free layer (CFL) as well as modify traffic of red blood cells (RBC) into microchannel branches. In the current study we further investigated the mechanism by which DRP enhances microvascular perfusion. We studied the effect of various concentrations of DRP on RBC distribution in more relevant round microchannels and the effect of DRP on CFL in the rat cremaster muscle in vivo. In round microchannels hematocrit was measured in parent and daughter branch at baseline and after addition of DRP. At DRP concentrations of 5 and 10 ppm, the plasma skimming effect in the daughter branch was eliminated, as parent and daughter branch hematocrit were equivalent, compared to a significantly lowered hematocrit in the daughter branch without DRPs. In anesthetized rats (N=11) CFL was measured in the cremaster muscle tissue in arterioles with a diameter of 32.6 +/- 1.7 mu m. In the control group (saline, N=6) there was a significant increase in CFL in time compared to corresponding baseline. Addition of DRP at 1 ppm (N=5) reduced CFL significantly compared to corresponding baseline and the control group. After DRP administration the CFL reduced to about 85% of baseline at 5, 15, 25 and 35 minutes after DRP infusion was complete. These in vivo and in vitro findings demonstrate that DRPs induce a reduction in CFL width and plasma skimming in the microvasculature. This may lead to an increase of RBC flux into the capillary bed, and thus explain previous observations of a DRP mediated enhancement of capillary perfusion.	[Brands, Judith; Kliner, Dustin; Villanueva, Flordeliza S.; Pacella, John J.] Univ Pittsburgh, Sch Med, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15213 USA; [Lipowsky, Herbert H.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Kameneva, Marina V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pacella, JJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15213 USA.	pacellajj@upmc.edu	Brands, Judith/AAG-3037-2020	Brands, Judith/0000-0002-2302-5345	American Heart Association [AHA 12POST9400001]; National Institute of Health [NIH K08 1 K08 HL086730-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086730] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (grant AHA 12POST9400001) and National Institute of Health (grant NIH K08 1 K08 HL086730-01). (url: http://my.americanheart.org/professional/index.jsp, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Chen XH, 2011, INT J CARDIOL, V147, P112, DOI 10.1016/j.ijcard.2010.09.008; COLEMAN PB, 1987, CIRC RES, V61, P787, DOI 10.1161/01.RES.61.6.787; Cotoia A, 2009, SHOCK, V31, P258, DOI 10.1097/SHK.0b013e31817fc434; ELLIS CG, 1994, CIRC RES, V75, P357, DOI 10.1161/01.RES.75.2.357; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; FARUQUI FI, 1987, CIRCULATION, V75, P627, DOI 10.1161/01.CIR.75.3.627; FENTON BM, 1985, MICROVASC RES, V29, P103, DOI 10.1016/0026-2862(85)90010-X; Fung YC, 1993, BIOMECHANICS MECH PR, pxviii; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; GRETZ JE, 1995, MICROVASC RES, V49, P134, DOI 10.1006/mvre.1995.1011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; HOUSE SD, 1987, AM J PHYSIOL, V252, pH211, DOI 10.1152/ajpheart.1987.252.1.H211; Johnson L, 2009, PACE, V32, P224, DOI 10.1111/j.1540-8159.2008.02206.x; JONES CJH, 1995, CARDIOVASC RES, V29, P585; Kameneva MV, 2004, BIORHEOLOGY, V41, P53; KAMENEVA MV, 1991, FLUID DYNAM, V25, P956, DOI DOI 10.1007/BF01049712; Kim S, 2006, MICROCIRCULATION, V13, P199, DOI 10.1080/10739680600556878; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim S, 2009, BIORHEOLOGY, V46, P181, DOI 10.3233/BIR-2009-0530; KUO L, 1992, NEWS PHYSIOL SCI, V7, P5; LIPOWSKY HH, 1978, CIRC RES, V43, P738, DOI 10.1161/01.RES.43.5.738; Macias CA, 2004, SHOCK, V22, P151, DOI 10.1097/01.shk.0000131489.83194.1a; Marhefka JN, 2009, BIORHEOLOGY, V46, P281, DOI 10.3233/BIR-2009-0543; Marhefka JN, 2008, BIORHEOLOGY, V45, P599, DOI 10.3233/BIR-2008-0511; MOSTARDI RA, 1978, BIORHEOLOGY, V15, P1; Ong PK, 2011, PHYSIOL MEAS, V32, pN1, DOI 10.1088/0967-3334/32/3/N01; Ong PK, 2013, MICROCIRCULATION, V20, P440, DOI 10.1111/micc.12045; Ong PK, 2012, MICROVASC RES, V83, P118, DOI 10.1016/j.mvr.2011.11.003; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Pacella JJ, 2006, EUR HEART J, V27, P2362, DOI 10.1093/eurheartj/ehl165; Pacella JJ, 2012, MICROCIRCULATION, V19, P580, DOI 10.1111/j.1549-8719.2012.00190.x; Pacella JJ, 2009, BIORHEOLOGY, V46, P365, DOI 10.3233/BIR-2009-0548; Pacella JJ, 2009, BIORHEOLOGY, V46, P293, DOI 10.3233/BIR-2009-0547; Pappu V, 2007, BIORHEOLOGY, V44, P191; POLIMENI PI, 1985, J MOL CELL CARDIOL, V17, P721, DOI 10.1016/S0022-2828(85)80072-9; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1986, AM J PHYSIOL, V251, pH1324, DOI 10.1152/ajpheart.1986.251.6.H1324; Sakai T, 2007, BRIT J ANAESTH, V98, P23, DOI 10.1093/bja/ael307; Sharan M, 2001, BIORHEOLOGY, V38, P415; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SOUTANI M, 1995, AM J PHYSIOL-HEART C, V268, pH1959, DOI 10.1152/ajpheart.1995.268.5.H1959; Toms B., 1949, P 1 INT C RHEOL N HO, VII, P135, DOI DOI 10.1155/2011/367042; Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; YAN ZY, 1991, MICROVASC RES, V42, P17, DOI 10.1016/0026-2862(91)90072-J	48	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77252	10.1371/journal.pone.0077252	http://dx.doi.org/10.1371/journal.pone.0077252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124610	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100167
J	Chen, YC; Chang, SC; Pu, C; Tang, GJ				Chen, Yu-Chun; Chang, Shih-Chieh; Pu, Christy; Tang, Gau-Jun			The Impact of Nationwide Education Program on Clinical Practice in Sepsis Care and Mortality of Severe Sepsis: A Population-Based Study in Taiwan	PLOS ONE			English	Article							GOAL-DIRECTED THERAPY; INSURANCE RESEARCH DATABASE; SURVIVING SEPSIS; RESUSCITATION BUNDLE; UNITED-STATES; SEPTIC SHOCK; MANAGEMENT; IMPLEMENTATION; GUIDELINE; TREND	Objectives: We investigated the effect of a nationwide educational program following surviving sepsis campaign (SSC) guidelines. Physicians' clinical practice in sepsis care and patient mortality rate for severe sepsis were analyzed using a nationally representative cohort. Methods: Hospitalizations for severe sepsis with organ failure from 1997 to 2008 were extracted from Taiwan's National Health Insurance Research Database (NHIRD), and trends in sepsis incidence and mortality rates were analyzed. A before-and-after study design was used to evaluate changes in the utilization rates of SSC items and changes in severe sepsis mortality rates occurred after a national education program conducted by the Joint Taiwan Critical Care Medicine Committee since 2004. A total of 39,706 hospitalizations were analyzed, which consisted of a pre-intervention cohort of 14,848 individuals (2000-2003) and a post-intervention cohort of 24,858 individuals (2005-2008). Results: The incidence rate of severe sepsis increased from 1.88 per 1,000 individuals in 1997 to 5.07 per 1,000 individuals in 2008. The cumulative mortality rate decreased slightly from 48.2% for the pre-intervention cohort to 45.9% for the post-intervention cohort. The utilization rates of almost all SSC items changed significantly between the pre-intervention and post-intervention cohorts. These changes of utilization rates were found to be associated with mild reduction in mortality rate. Conclusion: The nationwide education program through a national professional society has a significant impact on physicians' clinical practice and resulted in a slight but significant reduction of severe sepsis mortality rate.	[Chen, Yu-Chun; Tang, Gau-Jun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yilan, Taiwan; [Chen, Yu-Chun; Pu, Christy; Tang, Gau-Jun] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chang, Shih-Chieh] Natl Yang Ming Univ Hosp, Dept Internal Med, Div Chest Med, Yilan, Taiwan; [Chang, Shih-Chieh] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tang, GJ (corresponding author), Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yilan, Taiwan.	gaujuntang02@gmail.com	Chen, Yu Chun/K-6635-2019; Chen, Yu-Chun/B-1227-2012; Chen, YuChun/L-1052-2019	Chen, Yu-Chun/0000-0002-4124-1949; Chen, YuChun/0000-0002-4124-1949				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Coopersmith CM, 2002, CRIT CARE MED, V30, P59, DOI 10.1097/00003246-200201000-00009; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Havel C, 2011, COCHRANE DB SYST REV, V5, DOI CD003709; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kortgen A, 2006, CRIT CARE MED, V34, P943, DOI 10.1097/01.CCM.0000206112.32673.D4; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Micek ST, 2006, CRIT CARE MED, V34, P2707, DOI 10.1097/01.CCM.0000241151.25426.D7; Na S, 2012, INT J QUAL HEALTH C, V24, P452, DOI 10.1093/intqhc/mzs045; Nguyen HB, 2011, CRIT CARE, V15, DOI 10.1186/cc10469; Nguyen HM, 2012, INT J CLIN PRACT, V66, P705, DOI 10.1111/j.1742-1241.2012.02939.x; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Phua Jason, 2011, BMJ, V342, pd3245, DOI 10.1136/bmj.d3245; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Vasu Tajender S, 2012, J Intensive Care Med, V27, P172, DOI 10.1177/0885066610396312	28	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77414	10.1371/journal.pone.0077414	http://dx.doi.org/10.1371/journal.pone.0077414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124616	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100173
J	El Alaoui, MA; Melloul, M; Amine, SA; Stambouli, H; El Bouri, A; Soulaymani, A; El Fahime, E				El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Amine, Sanaa Alaoui; Stambouli, Hamid; El Bouri, Aziz; Soulaymani, Abdelmajid; El Fahime, Elmostafa			Extraction of High Quality DNA from Seized Moroccan Cannabis Resin (Hashish)	PLOS ONE			English	Article							THCA SYNTHASE GENE; RAPID ISOLATION; POLYSACCHARIDE; POLYMORPHISMS; PROTOCOL; SATIVA; PLANTS	The extraction and purification of nucleic acids is the first step in most molecular biology analysis techniques. The objective of this work is to obtain highly purified nucleic acids derived from Cannabis sativa resin seizure in order to conduct a DNA typing method for the individualization of cannabis resin samples. To obtain highly purified nucleic acids from cannabis resin (Hashish) free from contaminants that cause inhibition of PCR reaction, we have tested two protocols: the CTAB protocol of Wagner and a CTAB protocol described by Somma (2004) adapted for difficult matrix. We obtained high quality genomic DNA from 8 cannabis resin seizures using the adapted protocol. DNA extracted by the Wagner CTAB protocol failed to give polymerase chain reaction (PCR) amplification of tetrahydrocannabinolic acid (THCA) synthase coding gene. However, the extracted DNA by the second protocol permits amplification of THCA synthase coding gene using different sets of primers as assessed by PCR. We describe here for the first time the possibility of DNA extraction from (Hashish) resin derived from Cannabis sativa. This allows the use of DNA molecular tests under special forensic circumstances.	[El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Amine, Sanaa Alaoui; El Fahime, Elmostafa] Ctr Sci & Tech Res CNRST, UATRS, Rabat, Morocco; [Stambouli, Hamid; El Bouri, Aziz] Lab Forens Sci Moroccan Gendarmerie Royale LARATE, Rabat, Morocco; [El Alaoui, Moulay Abdelaziz; Soulaymani, Abdelmajid] Univ Ibn Tofail, Fac Sci, Dept Biol, Lab Genet & Biometrie, Kenitra, Morocco	Centre National de la Recherche Scientifique & Technologique (CNRST); Ibn Tofail University of Kenitra	El Alaoui, MA (corresponding author), Ctr Sci & Tech Res CNRST, UATRS, Rabat, Morocco.	elalaoui@cnrst.ma	SOULAYMANI, Abdelmajid a/H-4382-2011; FAHIME, Elmostafa EL/AAC-2146-2020	SOULAYMANI, Abdelmajid a/0000-0002-0964-1029; el fahime, elmostafa/0000-0001-7812-0641; El Alaoui, My Abdelaziz/0000-0002-1555-5194; Melloul, Marouane/0000-0002-1821-7537	Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST)	Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST)	This work was supported by the Functional Genomic Platform; (UATRS) at the Moroccan Centre for Scientific and Technical Research (CNRST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1999, PLANT MOL BIOL REP, V17, P281, DOI 10.1023/A:1007692929505; Angeles J. G. C., 2005, Plant Molecular Biology Reporter, V23, P297, DOI 10.1007/BF02772760; Carson DR, 2001, HASHISH ENCY DRUGS A, V2; Cascini F, 2012, FORENSIC SCI INT, V217, P134, DOI 10.1016/j.forsciint.2011.10.041; Coyle HM, 2003, CROAT MED J, V44, P315; Coyle HM, 2003, FORENSIC SCI, V48, P207; Demeke T, 2009, J AOAC INT, V92, P1136; DNA Baser Sequence Assembler v3.x, 2012, HER BIOSOFT SRL ROM; Gilmore S, 2003, FORENSIC SCI INT, V131, P65, DOI 10.1016/S0379-0738(02)00397-3; Horne E. C., 2004, Plant Molecular Biology Reporter, V22, P83, DOI 10.1007/BF02773352; Howard C, 2008, NATL DRUG LAW ENFORC, V29, P1; International Organization for Standardization, 2005, ISO215712005; Jaakola L, 2001, PLANT MOL BIOL REP, V19, P125, DOI 10.1007/BF02772901; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Kojoma M, 2006, FORENSIC SCI INT, V159, P132, DOI 10.1016/j.forsciint.2005.07.005; Lamitina Lab Protocols, 2007, ETH PREC DNA; Linacre A, 1998, FORENSIC SCI INT, V91, P71, DOI 10.1016/S0379-0738(97)00173-4; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NanoDrop, 2007, NANODROP TECHNICAL S, VT009; Office des Nations Unies contre la drogue et le crime, 2006, B STUP BIL SIT MOND, VLVIII, P1; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Sablok G, 2009, PLANT OMICS, V2, P103; Stambouli H., 2005, ANN TOXICOL ANAL, V17, P79; Terry CF, 2002, J AOAC INT, V85, P768; WAGNER DB, 1987, P NATL ACAD SCI USA, V84, P2097, DOI 10.1073/pnas.84.7.2097	25	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74714	10.1371/journal.pone.0074714	http://dx.doi.org/10.1371/journal.pone.0074714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124454	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100011
J	Li, YQ; Liu, FF; Zhang, XM; Guo, XJ; Ren, MJ; Fu, L				Li, Ya-Qing; Liu, Fang-Fang; Zhang, Xin-Min; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li			Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; TGF-BETA; PERIPHERAL-BLOOD; OVARIAN-CANCER; CARCINOMA; MICROENVIRONMENT; PROGRESSION; RECRUITMENT; IMMUNOTHERAPY	It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients. However, the cytokines activating the Treg infiltration are not known. This study was undertaken to evaluate the role of CCL22 and TGF-beta 1 in this cascade and their prognostic significance for BC patients. 417 cases of invasive breast cancer were selected from the prior study cohort and the expressions of CCL22 and TGF-beta 1 were assessed by immunohistochemistry. It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056). Moreover, CCL22 expression was found to be associated with the tumor histological features known to be related with unfavorable prognosis of patients, including high histological grade (P<0.0001), negative ER (P<0.0001), negative PR (P=0.001), and HER2 amplification (P=0.028). Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001). Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively). In contrast, although TGF-beta 1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients. Our study indicates that both CCL22 and TGF-beta 1 are candidate chemoattractants for intratumoral Foxp3 (+)Tregs infiltration; however, unlike the later, CCL22 is an independent prognostic predictor of BC patients, and it therefore may have the potential to serve as a target for immunotherapeutic strategy of BC.	[Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Li, Ya-Qing; Liu, Fang-Fang; Guo, Xiao-Jing; Ren, Mei-Jing; Fu, Li] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Xin-Min] Temple Univ Hosp & Med Sch, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Fu, Li] 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fu, L (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc Pathol & Res Lab, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.	fuli@tijmu.edu.cn			National Natural Science Foundation of China [30930038, 81202101, 81172531]; Program for Changjiang Scholars and Innovative Research Team [IRT0743]; Tianjin Medical University; third phase of the 211 Project for Higher Education [2010GSI07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Tianjin Medical University; third phase of the 211 Project for Higher Education	This work was supported by National Natural Science Foundation of China (Grant No. 30930038), Program for Changjiang Scholars and Innovative Research Team (Grant No. IRT0743) to Li Fu, National Natural Science Foundation of China (Grant No. 81202101) to Fang-Fang Liu, National Natural Science Foundation of China (Grant No. 81172531) to Xiao-Jing Guo, as well as Innovation Funding for graduate of Tianjin Medical University, third phase of the 211 Project for Higher Education (Grant No. 2010GSI07) to Ya-Qing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our study has not been published, in whole or in part, elsewhere in the peer-reviewed literature.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Faget J, 2012, CANCER RES, V72, P6130, DOI 10.1158/0008-5472.CAN-12-2409; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Herrera ACSA, 2012, CANCER IMMUNOL IMMUN, V61, P2193, DOI 10.1007/s00262-012-1283-8; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Levano KS, 2011, BIOCHEM BIOPH RES CO, V411, P107, DOI 10.1016/j.bbrc.2011.06.102; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Maruyama T, 2010, DIS ESOPHAGUS, V23, P422, DOI 10.1111/j.1442-2050.2009.01029.x; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Qin XJ, 2009, CLIN CANCER RES, V15, P2231, DOI 10.1158/1078-0432.CCR-08-2641; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Thomachot MC, 2004, INT J CANCER, V110, P710, DOI 10.1002/ijc.20146; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Wang SE, 2011, SIGNAL TRANSDUCT, V2011; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	37	24	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76379	10.1371/journal.pone.0076379	http://dx.doi.org/10.1371/journal.pone.0076379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124553	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100110
J	Miklos, AC; Sumpter, M; Zhou, HX				Miklos, Andrew C.; Sumpter, Matthew; Zhou, Huan-Xiang			Competitive Interactions of Ligands and Macromolecular Crowders with Maltose Binding Protein	PLOS ONE			English	Article							LAMBDA-RECEPTOR PROTEIN; ESCHERICHIA-COLI; MALTODEXTRIN TRANSPORT; HIV-1 PROTEASE; STABILITY; NMR; DIFFUSION; AFFINITY; CONSEQUENCES; SPECTROSCOPY	Cellular signaling involves a cascade of recognition events occurring in a complex environment with high concentrations of proteins, polysaccharides, and other macromolecules. The influence of macromolecular crowders on protein binding affinity through hard-core repulsion is well studied, and possible contributions of protein-crowder soft attraction have been implicated recently. Here we present direct evidence for weak association of maltose binding protein (MBP) with a polysaccharide crowder Ficoll, and that this association effectively competes with the binding of the natural ligand, maltose. Titration data over wide ranges of maltose and Ficoll concentrations fit well with a three-state competitive binding model. Broadening of MBP H-1-N-15 TROSY spectra by the addition of Ficoll indicates weak protein-crowder association, and subsequent recovery of sharp NMR peaks upon addition of maltose indicates that the interactions of the crowder and the ligand with MBP are competitive. We hypothesize that, in the Escherichia coli periplasm, the competitive interactions of polysaccharides and maltose with MBP could allow MBP to shuttle between the peptidoglycan attached to the outer membrane and the ATP-binding cassette transporter in the inner membrane.	[Miklos, Andrew C.; Sumpter, Matthew; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhou, HX (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu	Zhou, Huan-Xiang/AAH-9836-2020; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Zhou, Huan-Xiang/0000-0001-9020-0302; Zhou, Huan-Xiang/0000-0001-9020-0302; Sumpter, Matthew/0000-0001-5854-9686; Miklos, Andrew/0000-0002-1918-8352	National Institutes of Health [R01 GM88187, F32 GM103217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103217, R01GM088187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grants R01 GM88187 and F32 GM103217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends SJR, 2010, J BACTERIOL, V192, P242, DOI 10.1128/JB.01244-09; BAVOIL P, 1981, J BIOL CHEM, V256, P1385; BAVOIL P, 1983, J BACTERIOL, V155, P919, DOI 10.1128/JB.155.2.919-921.1983; Benton LA, 2012, BIOCHEMISTRY-US, V51, P9773, DOI 10.1021/bi300909q; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; BRASS JM, 1986, J BACTERIOL, V165, P787, DOI 10.1128/jb.165.3.787-795.1986; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; Charlton LM, 2008, J AM CHEM SOC, V130, P6826, DOI 10.1021/ja8005995; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dong H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000833; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; Hulsmann A, 2000, J BACTERIOL, V182, P6292, DOI 10.1128/JB.182.22.6292-6301.2000; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Minh DDL, 2006, J AM CHEM SOC, V128, P6006, DOI 10.1021/ja060483s; Nagarajan S, 2011, BIOPHYS J, V100, P2991, DOI 10.1016/j.bpj.2011.03.065; Qin SB, 2010, J PHYS CHEM LETT, V1, P107, DOI 10.1021/jz900023w; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Walker IH, 2010, APPL MICROBIOL BIOT, V88, P187, DOI 10.1007/s00253-010-2696-y; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Zhang DL, 2012, ACTA BIOCH BIOPH SIN, V44, P703, DOI 10.1093/abbs/gms052; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064; Zhou HX, 2013, FEBS LETT, V587, P394, DOI 10.1016/j.febslet.2013.01.030	43	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74969	10.1371/journal.pone.0074969	http://dx.doi.org/10.1371/journal.pone.0074969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124463	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100020
J	Ortuno, VM; Gilgado, JD; Jimenez-Valverde, A; Sendra, A; Perez-Suarez, G; Herrero-Borgonon, JJ				Ortuno, Vicente M.; Gilgado, Jose D.; Jimenez-Valverde, Alberto; Sendra, Alberto; Perez-Suarez, Gonzalo; Herrero-Borgonon, Juan J.			The "Alluvial Mesovoid Shallow Substratum", a New Subterranean Habitat	PLOS ONE			English	Article							COLEOPTERA; DIVERSITY; ECOLOGY; ARANEAE	In this paper we describe a new type of subterranean habitat associated with dry watercourses in the Eastern Iberian Peninsula, the "Alluvial Mesovoid Shallow Substratum" (alluvial MSS). Historical observations and data from field sampling specially designed to study MSS fauna in the streambeds of temporary watercourses support the description of this new habitat. To conduct the sampling, 16 subterranean sampling devices were placed in a region of Eastern Spain. The traps were operated for 12 months and temperature and relative humidity data were recorded to characterise the habitat. A large number of species was captured, many of which belonged to the arthropod group, with marked hygrophilous, geophilic, lucifugous and mesothermal habits. In addition, there was also a substantial number of species showing markedly ripicolous traits. The results confirm that the network of spaces which forms in alluvial deposits of temporary watercourses merits the category of habitat, and here we propose the name of "alluvial MSS". The "alluvial MSS" may be covered or not by a layer of soil, is extremely damp, provides a buffer against above ground temperatures and is aphotic. In addition, compared to other types of MSS, it is a very unstable habitat. It is possible that the "alluvial MSS" may be found in other areas of the world with strongly seasonal climatic regimes, and could play an important role as a biogeographic corridor and as a refuge from climatic changes.	[Ortuno, Vicente M.; Gilgado, Jose D.; Sendra, Alberto; Perez-Suarez, Gonzalo] Univ Alcala De Henares, Dept Ciencias Vida, Fac Biol Ciencias Ambientales & Quim, Madrid, Spain; [Jimenez-Valverde, Alberto] Univ Malaga, Fac Ciencias, Dept Biol Anim, E-29071 Malaga, Spain; [Herrero-Borgonon, Juan J.] Univ Valencia, Fac Ciencias Biol, Dept Bot, Valencia, Spain; [Jimenez-Valverde, Alberto] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Cambio Global, E-28006 Madrid, Spain	Universidad de Alcala; Universidad de Malaga; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Ortuno, VM (corresponding author), Univ Alcala De Henares, Dept Ciencias Vida, Fac Biol Ciencias Ambientales & Quim, Madrid, Spain.	vicente.ortuno@uah.es	Jimenez-Valverde, Alberto/L-2755-2014	Jimenez-Valverde, Alberto/0000-0001-9962-2106; Sendra, Alberto/0000-0003-1035-3638; Gilgado, Jose D./0000-0003-0484-4000	Spanish Ministry of Science and Innovation [CGL2010-19924]; Ministry of Education and Science programme "Juan de la Cierva"	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Education and Science programme "Juan de la Cierva"	The Spanish Ministry of Science and Innovation for funded this research project (CGL2010-19924) and the Ministry of Education and Science programme "Juan de la Cierva". This research Project (CGL2010-19924) was funded by the Spanish Ministry of Science and Innovation. The Ministry of Education and Science programme "Juan de la Cierva" funded the research activity of one of the authors (A.J-V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Jose Ramon Guzman, 2011, Lampyrid, V1, P22; [Anonymous], 2010, GOOGL EARTH VERS 5 2; Barranco P., 2004, Graellsia, V60, P81; Bates AJ, 2007, EUR J ENTOMOL, V104, P479, DOI 10.14411/eje.2007.068; Bates AJ, 2005, 668 CCW; Belles X., 1987, FAUNA CAVERNICOLA IN; Brolemann HW, 1935, FAUNE FRANCE, V29, P368; Bucciarelli I., 1960, B SOC ENTOMOLOGICA I, V90, P170; Camarasa AM, 2006, NATURALES DESARROLLO, p[167, 10]; Camarasa AM, 2001, ESTUD GEOGRAFICOS, V52, P649; Campbell GS., 1998, INTRO ENV BIOPHYSICS, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Delay B., 1981, Memoires de Biospeologie, V8, P45; Dresch J, 1982, GEOGRAPHIE REGIONS A; ESPANOL F., 1965, PUBLICACIONES INST BIOL A PL, V38, P123; ESPANOL F, 1977, Graellsia, V33, P107; ESPANOL F., 1966, PUBL INST BIOL APL, V41, P49; Fresneda Javier, 2007, Boletin de la Asociacion Espanola de Entomologia, V31, P187; Galan Carlos, 1993, Munibe (Ciencias Naturales - Natur Zientziak), V45, P3; Geisthardt M., 2008, Heteropterus Revista de Entomologia, V8, P147; Gers C, 1998, ACTA OECOL, V19, P205, DOI 10.1016/S1146-609X(98)80025-8; Gers C., 1992, THESIS U TOULOUSE 3; Giachino PM, 2010, HYPOGEAN LIFE CONCEP, V132; Ginet R, 1977, INITIATION BIOL ECOL, P345; Hess WN, 1920, BIOL BULL-US, V38, P39, DOI 10.2307/1536232; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; IDE, 2010, JUC VIS INFR DAT ESP; IGME, 1989, AG SUBT COM VAL US C; Jeanne C., 1976, Bulletin Soc linn Bordeaux, V6, P27; Jeannel R, 1943, AVENIR SCI, V1; Jeannel R, 1926, ABEILLE, V32, P221; Jeannel R, 1926, LECHEVALIER PARIS, V7, P334; Juberthie C., 1980, Memoires de Biospeologie, V7, P19; Juberthie C, 2000, ECOSY WORLD, V30, P17; Juberthie C., 1981, Memoires de Biospeologie, V8, P77; Juberthie C, 1994, C JUBERTHIEV DECU EN, P5; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Krantz G., 2009, MANUAL ACAROLOGY; Llobera F, 1989, LITORAL MEDITERRANEO, P378; Lopez Heriberto, 2010, Speleobiology Notes, V2, P7; Margalef R, 1983, LIMNOLOGIA BARCELONA; Martin JP, 2009, INGENIERIA RIOS; Milhous R.T., 1982, GRAVEL BED RIVERS, P819; Morla C, 2003, MONOGRAFIAS JARDIN B, V11, P75; Orghidan T, 1955, ROMANIA, V7, P657; Oromi P., 1986, ACT 9 C INT ESP CAT, V2, P147; Oromi P, 2010, VOLCANES MENSAJEROS, P63; Ortega M., 1991, Limnetica, V7, P11; Ortuno V. M., 1996, Boletin de la Asociacion Espanola de Entomologia, V20, P193; Ortuno Vicente M., 2010, Entomologische Blaetter fuer Biologie und Systematik der Kaefer, V106, P233; Ortuno VM, 2011, J NAT HIST, V45, P1233, DOI 10.1080/00222933.2011.566944; Ortuno VM, 2005, J NAT HIST, V39, P3483, DOI 10.1080/00222930500393046; Ortuno VM, 2007, INVERTEBRADOS ENDEMI, P138; Ortuno VM, 2005, CARABIDAE PENINSULA, V1, P455; Owen J. A., 1995, Entomologist's Record and Journal of Variation, V107, P225; Palmen E, 1969, ATMOSPHERIC CIRCULAT, P603; Palmen E., 1955, TELLUS, V1, P22, DOI [10.1111/j.2153-3490.1949.tb01925.x, DOI 10.1111/J.2153-3490.1949.TB01925.X]; Perez Cueva AJ, 1986, CUADERNOS GEOGRAFIA, V38, P61; Perez-Cueva A, 1983, AGR SOC, V28, P189; Pipan T, 2011, J NAT HIST, V45, P253, DOI 10.1080/00222933.2010.523797; Prieto C, 2011, B SOC ENTOMOLOGICA A, V49, P365; PULIDO A., 1993, REGENERACION CUBIERT, P131; Racovitza E.G., 1907, ARCH ZOOLOGIE EXPT G, V6, P371; Renard KG, 1966, J HYDRAULICS DIVISIO, V92, P33; Rezac M, 2007, J ARACHNOL, V35, P432; Ribera C, 1986, PUBLICACIONES DEP ZO, P51; Ribera C, 2006, INVERTEBRADOS ENDEMI, P91; Ribera C, 1981, ARXIUS CTR EXCURSION, V8, P283; Ribera-Almerje C., 1981, Treballs de la Institucio Catalana d'Historia Natural, V9, P157; Roberts M.J., 1995, COLLINS FIELD GUIDE; Robertson AL, 2010, FUND APPL LIMNOL, V176, P279, DOI 10.1127/1863-9135/2010/0176-0279; RUZICKA V, 1995, PEDOBIOLOGIA, V39, P42; Ruzicka V, 1999, J NAT HIST, V33, P255, DOI 10.1080/002229399300407; Sadler J.P., 2007, HYDROECOLOGY ECOHYDR, P37, DOI DOI 10.1002/9780470010198.CH3; Salgado JM, 2008, FAUNA IBERICA, V31, P799; Salgado JM, 2007, INVERTEBRADOS ENDEMI, P184; Segura FS, 1990, THESIS U VALENCIA VA; Sigpac, 2010, SIST INF GEOGR ID PA; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Smith DI, 1975, PROCESSES PHYS HUMAN, P130; Suarez ML, 1986, THESIS U MURCIA MURC; Tongiorgi P., 1966, Bulletin of the Museum of Comparative Zoology, V134, P275; Ueno S.-I., 1981, Journal of the Speleological Society of Japan, V6, P11; UENO S-I, 1980, Bulletin of the National Science Museum Series A (Zoology), V6, P195; UENO SI, 1987, ZOOL SCI, V4, P593; Uzquiano Paloma, 1997, Anales del Jardin Botanico de Madrid, V55, P125; Vandel A, 1964, BIOSPEOLOGIE BIOL AN; Velasco J., 1993, Limnetica, V9, P73; Vidal-Abarca M.R., 1992, Limnetica, V8, P151; Vidal-Abarca MR, 1990, SCI GERUNDENSIS, V16, P219; Vila Valenti J, 1961, MEDITERRANEE, V2, P18; Ward RC, 1978, FLOODS GEOGRAPHICAL; Williams D. D., 1987, ECOLOGY TEMPORARY WA; Williams DD, 1996, J N AM BENTHOL SOC, V15, P634, DOI 10.2307/1467813; Zacharda M, 2007, PERMAFROST PERIGLAC, V18, P301, DOI 10.1002/ppp.598; Zaragoza J. A., 1990, DIPUTACION PROVINCIA, V1, P45; Zaragoza J.A., 1988, FAUNA FLORA CIENCIAS, V3, P11; Zaragoza Juan A., 2007, Revista Iberica de Aracnologia, V13, P3	97	53	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76311	10.1371/journal.pone.0076311	http://dx.doi.org/10.1371/journal.pone.0076311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124544	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100101
J	Roca, H; Hernandez, J; Weidner, S; McEachin, RC; Fuller, D; Sud, S; Schumann, T; Wilkinson, JE; Zaslavsky, A; Li, HW; Maher, CA; Daignault-Newton, S; Healy, PN; Pienta, KJ				Roca, Hernan; Hernandez, James; Weidner, Savannah; McEachin, Richard C.; Fuller, David; Sud, Sudha; Schumann, Taibriana; Wilkinson, John E.; Zaslavsky, Alexander; Li, Hangwen; Maher, Christopher A.; Daignault-Newton, Stephanie; Healy, Patrick N.; Pienta, Kenneth J.			Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer	PLOS ONE			English	Article							MIR-200 FAMILY; TUMOR-METASTASIS; RNA-SEQ; GENE; EXPRESSION; CELLS; ZEB1; MACROPHAGES; PATHWAYS; INVASION	Cell plasticity regulated by the balance between the mesenchymal to epithelial transition (MET) and the opposite program, EMT, is critical in the metastatic cascade. Several transcription factors (TFs) are known to regulate EMT, though the mechanisms of MET remain unclear. We demonstrate a novel function of two TFs, OVOL1 and OVOL2, as critical inducers of MET in human cancers. Our findings indicate that the OVOL-TFs control MET through a regulatory feedback loop with EMT-inducing TF ZEB1, and the regulation of mRNA splicing by inducing Epithelial Splicing Regulatory Protein 1 (ESRP1). Using mouse prostate tumor models we show that expression of OVOL-TFs in mesenchymal prostate cancer cells attenuates their metastatic potential. The role of OVOL-TFs as inducers of MET is further supported by expression analyses in 917 cancer cell lines, suggesting their role as crucial regulators of epithelial-mesenchymal cell plasticity in cancer.	[Roca, Hernan; Zaslavsky, Alexander; Li, Hangwen; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Hernandez, James; Weidner, Savannah; Fuller, David; Sud, Sudha; Schumann, Taibriana; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [McEachin, Richard C.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Daignault-Newton, Stephanie; Healy, Patrick N.] Univ Michigan, Sch Med, Div Biostat, Ctr Comprehens Canc, Ann Arbor, MI USA; [Maher, Christopher A.] Washington Univ, Sch Med, Dept Med, Genome Inst,Div Oncol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL)	Roca, H (corresponding author), Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA.	rocach@umich.edu			National Institutes of Health [U54-CA163124, U01-CA143055, P50-CA69568, PO1-CA093900]; University of Michigan; NATIONAL CANCER INSTITUTE [P01CA093900, P50CA069568, U54CA163124, T32CA083654, U01CA143055, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U54-CA163124, U01-CA143055, P50-CA69568 and PO1-CA093900 from the National Institutes of Health. KJP is supported as an American Cancer Society Clinical Research Professor and as a Taubman Research Scholar of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng YS, 2012, J CELL BIOCHEM, V113, P1714, DOI 10.1002/jcb.24041; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; SPREMULLI EN, 1983, J CLIN ONCOL, V1, P496, DOI 10.1200/JCO.1983.1.8.496; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	37	158	166	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76773	10.1371/journal.pone.0076773	http://dx.doi.org/10.1371/journal.pone.0076773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124593	Green Published, gold			2022-12-25	WOS:000325489100150
J	Shen, J; Wei, J; Wang, H; Yang, Y; Yue, GF; Wang, L; Yu, LX; Xie, L; Sun, X; Bian, XY; Zou, ZY; Qian, XP; Guan, WX; Liu, BR				Shen, Jie; Wei, Jia; Wang, Hao; Yang, Yang; Yue, Guofeng; Wang, Lin; Yu, Lixia; Xie, Li; Sun, Xia; Bian, Xinyu; Zou, Zhengyun; Qian, Xiaoping; Guan, Wenxian; Liu, Baorui			SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; HEPARAN-SULFATE; TUMOR-CELLS; BINDING; GROWTH; SURVIVAL; ERCC1; CHEMOTHERAPY; TARGET	Objective: Biomarkers capable of discriminating the patients who are likely to respond to certain chemotherapeutic agents could improve the clinical efficiency. The sulfatases(SULFs) play a critical role in the pathogenesis of a variety of human cancers. Here, we focused our investigation on the prognostic and predictive impact of SULF2 methylation in gastric cancer. Methods: Promoter CpG island methylation of SULF2 was analyzed in 100 gastric cancer samples. The in vitro sensitivity to cisplatin, docetaxel, gemcitabine, irinotecan and pemetrexed were determined by histoculture drug response assay(HDRA). Additionally, 56 gastric cancer patients treated with a modified FOLFOX regimen(biweekly oxaliplatin plus 5-FU and folinic acid) were retrospectively analyzed to further evaluate the prognostic and predictive impact of SULF2 methylation in gastric cancer. Results: Methylated SULF2(SULF2M) was detected in 28 patients, while the remaining 72 patients showed unmethylated SULF2(SULF2U, methylation rate: 28%). Samples with SULF2U were more sensitive to cisplatin than those with SULF2M(inhibition rate: 48.80% vs. 38.15%, P = 0.02), while samples with SULF2M were more sensitive to irinotecan than SULF2U(inhibition rate: 53.61% vs. 40.92%, P = 0.01). There were no association between SULF2 methylation and in vitro sensitivity to docetaxel, gemcitabine and pemetrexed. SULF2 methylation was found to have a significant association with cisplatin efficacy(SULF2M: 57.14%, SULF2U: 80.56%, P = 0.02) and irinotecan efficacy(SULF2M: 89.29%, SULF2U: 62.50%, P = 0.01). Among the 56 patients receiving the modified FOLFOX regimen, a significant association was observed between survival and SULF2 methylation status(SULF2M: 309 days, 95% CI = 236 to 382 days; SULF2U: 481 days, 95% CI = 418 to 490 days; P = 0.02). Multivariate analysis revealed that SULF2 methylation was an independent prognostic factor of overall survival in gastric cancer patients treated with platinum-based chemotherapy. Conclusion: SULF2 methylation is negatively associated with cisplatin sensitivity in vitro. SULF2 methylation may be a novel prognostic biomarker for gastric cancer patients treated with platinum-based chemotherapy.	[Shen, Jie; Wei, Jia; Yang, Yang; Wang, Lin; Yu, Lixia; Xie, Li; Sun, Xia; Bian, Xinyu; Zou, Zhengyun; Qian, Xiaoping; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Ctr Comprehens Canc, Drum Tower Hosp,Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Hao; Guan, Wenxian] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China; [Yue, Guofeng] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Guan, WX (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	guanwenxiannj@163.com; baoruiliu@nju.edu.cn	Wei, Jia/AAE-9973-2020		National Natural Science Foundation of China [81220108023, 81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province	This work was funded by grants from the National Natural Science Foundation of China (Grant No. 81220108023 and 81172094) and Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Chen CY, 2011, LUNG CANCER, V74, P132, DOI 10.1016/j.lungcan.2011.01.024; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Hanauske AR, 2007, INVEST NEW DRUG, V25, P417, DOI 10.1007/s10637-007-9060-9; Hayashi Y, 2009, INTERNAL MED, V48, P203, DOI 10.2169/internalmedicine.48.1659; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kudo K, 2012, ONCOGENE, V31, P4718, DOI 10.1038/onc.2011.610; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Mutze K, 2011, EUR J CANCER, V47, P1817, DOI 10.1016/j.ejca.2011.02.024; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Rosell R, 2010, EXPERT OPIN PHARMACO, V11, P1683, DOI 10.1517/14656566.2010.482101; Shim HJ, 2010, CANCER SCI, V101, P1247, DOI 10.1111/j.1349-7006.2010.01514.x; Tessema M, 2012, ONCOGENE, V31, P4107, DOI 10.1038/onc.2011.577; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Wei J, 2008, BRIT J CANCER, V98, P1398, DOI 10.1038/sj.bjc.6604317; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Wesolowski R, 2009, LANCET ONCOL, V10, P903, DOI 10.1016/S1470-2045(09)70136-6	32	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75564	10.1371/journal.pone.0075564	http://dx.doi.org/10.1371/journal.pone.0075564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124496	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100053
J	Shi, SJ; Wang, LJ; Wang, GD; Guo, ZY; Wei, M; Meng, YL; Yang, AG; Wen, WH				Shi, Sheng-Jia; Wang, Li-Juan; Wang, Guo-Dong; Guo, Zhang-Yan; Wei, Ming; Meng, Yan-Ling; Yang, An-Gang; Wen, Wei-Hong			B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							T-CELLS; POTENTIAL MECHANISM; IMMUNE SUPPRESSION; TUMOR; PD-L1; DEATH; IMMUNOTHERAPY; LYMPHOCYTES; SENSITIVITY; INVOLVEMENT	Background And Objective: The investigation concerning the B7-H1 expression in colorectal cancer cells is at an early stage. It is unclear whether B7-H1 expression may have diagnostic or prognostic value in colorectal carcinoma. Additionally, how B7-H1 is associated with the clinical features of colorectal carcinoma is not known. In order to investigate the relationship between B7-H1 and colorectal cancer, we analyzed B7-H1 expression and its effect in clinical specimens and HCT116 cells. Methods: Paraffin-embedded specimens from 143 eligible patients were used to investigate the expression of CD274 by immunohistochemistry. We also examined whether B7-H1 itself may be related to cell proliferation, apoptosis, migration and invasion in colon cancer HCT116 cells. Results: Our results show that B7-H1 was highly expressed in colorectal carcinoma and was significantly associated with cell differentiation status and TNM (Tumor Node Metastasis) stage. Patients with positive B7-H1 expression showed a trend of shorter survival time. Using multivariate analysis, we demonstrate that positive B7-H1 expression is an independent predictor of colorectal carcinoma prognosis. Our results indicate that B7-H1 silencing with siRNA inhibits cell proliferation, migration and invasion. Furthermore, cell apoptosis was also increased by B7-H1 inhibition. Conclusions: Positive B7-H1 expression is an independent predictor for colorectal carcinoma prognosis. Moreover, knockdown of B7-H1 can inhibit cell proliferation, migration and invasion.	[Shi, Sheng-Jia; Guo, Zhang-Yan; Meng, Yan-Ling; Yang, An-Gang; Wen, Wei-Hong] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Wang, Li-Juan] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Xian 710049, Peoples R China; [Wang, Guo-Dong; Wei, Ming] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Guo-Dong] Chinese Peoples Liberat Army, Hosp 323, Dept Comprehens Med, Xian, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	Yang, AG (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn; wenweihongfmmu@126.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022; 温, 家琦/GYV-3177-2022		National Natural Science Foundation of China [30873004, 30973000, 81171924]; Natural Science Foundation of Shan xi Province [2011JM4006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shan xi Province(Natural Science Foundation of Shanxi Province)	This work was supported by the National Natural Science Foundation of China (No.30873004, 30973000 and 81171924) and Natural Science Foundation of Shan xi Province (No.2011JM4006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awwad RA, 2003, CANCER RES, V63, P4731; Betts G, 2012, GUT, V61, P1163, DOI 10.1136/gutjnl-2011-300970; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Deng LF, 2010, CLIN CANCER RES, V16, P4105, DOI 10.1158/1078-0432.CCR-10-1073; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DROESER RA, 2013, EUR J CANCER; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghebeh H, 2007, INT J CANCER, V121, P751, DOI 10.1002/ijc.22703; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Haile ST, 2011, J IMMUNOL, V186, P6822, DOI 10.4049/jimmunol.1003682; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hatam LJ, 2012, CLIN CANCER RES, V18, P1925, DOI 10.1158/1078-0432.CCR-11-2941; Hirano F, 2005, CANCER RES, V65, P1089; Hornung M, 2006, EUR J IMMUNOL, V36, P1210, DOI 10.1002/eji.200535332; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Sawhney RS, 2002, J BIOL CHEM, V277, P75, DOI 10.1074/jbc.M103268200; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Strome SE, 2003, CANCER RES, V63, P6501; Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wintterle S, 2003, CANCER RES, V63, P7462; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yao Y, 2009, NEURO-ONCOLOGY, V11, P757, DOI 10.1215/15228517-2009-014; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	38	133	148	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76012	10.1371/journal.pone.0076012	http://dx.doi.org/10.1371/journal.pone.0076012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124529	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100086
J	Zhao, L; Ye, P; Gonda, TJ				Zhao, L.; Ye, P.; Gonda, T. J.			The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1	ONCOGENE			English	Article						U937; MYB; GFI1; monocytic differentiation; target gene	HUMAN HEMATOPOIETIC-CELLS; FINGER PROTEIN GFI-1; C-MYB; INSERTIONAL MUTAGENESIS; CONSTITUTIVE EXPRESSION; LYMPHOBLASTIC-LEUKEMIA; HUMAN NEUTROPENIA; REPRESSOR GFI-1; STEM-CELLS; T-ALL	The MYB gene is a master regulator of hematopoiesis and contributes to leukemogenesis in several species including humans. Although it is clear that MYB can promote proliferation, suppress apoptosis and block differentiation, the identities of the MYB target genes that mediate these effects have only been partially elucidated. Several studies, including our own, have collectively identified substantial numbers of MYB target genes, including candidates for each of these activities; however, functional validation, particularly in the case of differentiation suppression, has lagged well behind. Here we show that GFI1, which encodes an important regulator of hematopoietic stem cell (HSC) function and granulocytic differentiation, is a direct target of MYB in myeloid leukemia cells. Chromatin immunoprecipitation and reporter studies identified a functional MYB-binding site in the promoter region of GFI, whereas ectopic expression and small hairpin RNA-mediated knockdown of MYB resulted in concomitant increases and decreases, respectively, in GFI1 expression. We also demonstrate that GFI1, like MYB, can block the induced monocytic differentiation of a human acute myeloid leukemia cell line, and most importantly, that GFI1 is essential for MYB's ability to block monocytic differentiation. Thus, we have identified a target of MYB that is a likely mediator of its myeloid differentiation-blocking activity, and which may also be involved in MYB's activities in regulating normal HSC function and myeloid differentiation.	[Zhao, L.; Ye, P.; Gonda, T. J.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Ye, P.; Gonda, T. J.] Univ Queensland, Sch Pharm, Pharm Australia Ctr Excellence, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Gonda, TJ (corresponding author), Univ Queensland, Pharm Australia Ctr Excellence, Sch Pharm, Level 4,20 Cornwall St, Woolloongabba, Qld 4102, Australia.	t.gonda@uq.edu.au	Zhao, Liang/K-1484-2014	Zhao, Liang/0000-0002-3489-7421; Gonda, Thomas/0000-0002-8792-3021	National Health and Medical Research Council of Australia; University of Queensland Postdoctoral Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Postdoctoral Fellowship(University of Queensland)	This work was supported in part by a grant from the National Health and Medical Research Council of Australia (to TJG) and a University of Queensland Postdoctoral Fellowship (to PY).	Adati Naoki, 2009, BMC Res Notes, V2, P153, DOI 10.1186/1756-0500-2-153; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Belloni E, 2011, LEUKEMIA, V25, P733, DOI 10.1038/leu.2010.317; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Bonadies N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016330; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; CASTANEDA VL, 1991, LEUKEMIA, V5, P142; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Drabsch Y, 2007, P NATL ACAD SCI USA; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Fu SL, 1997, CELL GROWTH DIFFER, V8, P35; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hogg A, 1997, ONCOGENE, V15, P2885, DOI 10.1038/sj.onc.1201472; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Huang M, 2010, ACTA HAEMATOL-BASEL, V123, P1, DOI 10.1159/000253856; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Knopfova L, 2008, NEOPLASMA, V55, P286; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Lidonnici MR, 2010, CANCER RES, V70, P7949, DOI 10.1158/0008-5472.CAN-10-1667; MOSCOVICI C, 1981, VIROLOGY, V113, P765, DOI 10.1016/0042-6822(81)90205-1; Murati A, 2009, LEUKEMIA, V23, P85, DOI 10.1038/leu.2008.257; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; O'Neil J, 2007, J EXP MED, V204, P3059, DOI 10.1084/jem.20071637; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pattabiraman DR, 2013, LEUKEMIA, V27, P269, DOI 10.1038/leu.2012.225; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Phelan J, 2010, NARRATIVE, V18, P1; Quelen C, 2011, BLOOD, V117, P5719, DOI 10.1182/blood-2011-01-333013; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; Ramsay RG, 2005, INT J BIOCHEM CELL B, V37, P1254, DOI 10.1016/j.biocel.2004.12.011; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; SELVAKUMARAN M, 1992, MOL CELL BIOL, V12, P2493, DOI 10.1128/MCB.12.6.2493; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2012, AM J BLOOD RES, V2, P228; Wang Tian-Tian, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P834; Wei W, 2008, CELL RES, V18, P677, DOI 10.1038/cr.2008.60; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; Wolff L, 1996, CURR TOP MICROBIOL, V211, P191; Wolff L, 2001, BLOOD CELL MOL DIS, V27, P483, DOI 10.1006/bcmd.2001.0409; Ye P, 2013, LEUKEMIA RES, V37, P595, DOI 10.1016/j.leukres.2013.01.012; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhan Rong, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P849; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zornig M, 1996, ONCOGENE, V12, P1789	57	21	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4442	4449		10.1038/onc.2013.419	http://dx.doi.org/10.1038/onc.2013.419			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24121275				2022-12-25	WOS:000341157800009
J	Vardy, E; Mosier, PD; Frankowski, KJ; Wu, HX; Katritch, V; Westkaemper, RB; Aube, J; Stevens, RC; Roth, BL				Vardy, Eyal; Mosier, Philip D.; Frankowski, Kevin J.; Wu, Huixian; Katritch, Vsevolod; Westkaemper, Richard B.; Aube, Jeffrey; Stevens, Raymond C.; Roth, Bryan L.			Chemotype-selective Modes of Action of kappa-Opioid Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Mutagenesis Site-specific; Opiate Opioid; Pharmacology; Receptor Structure-Function	PROTEIN-COUPLED RECEPTOR; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; ADRENERGIC-RECEPTOR; SEROTONIN RECEPTORS; SALVINORIN-A; FQ RECEPTOR; ANTAGONIST; LIGANDS	Background: The -opioid receptor can be activated by structurally diverse agonists. Results: Four structurally diverse agonists differentially bound to and activated wild type and mutant -opioid receptors. Conclusion: The structural features of the agonists dictate how they interact with and stabilize G(i)-signaling receptor conformations. Significance: The results provide insights into the structural basis of opioid receptor ligand recognition and activation. The crystal structures of opioid receptors provide a novel platform for inquiry into opioid receptor function. The molecular determinants for activation of the -opioid receptor (KOR) were studied using a combination of agonist docking, functional assays, and site-directed mutagenesis. Eighteen positions in the putative agonist binding site of KOR were selected and evaluated for their effects on receptor binding and activation by ligands representing four distinct chemotypes: the peptide dynorphin A(1-17), the arylacetamide U-69593, and the non-charged ligands salvinorin A and the octahydroisoquinolinone carboxamide 1xx. Minimally biased docking of the tested ligands into the antagonist-bound KOR structure generated distinct binding modes, which were then evaluated biochemically and pharmacologically. Our analysis identified two types of mutations: those that affect receptor function primarily via ligand binding and those that primarily affect function. The shared and differential mechanisms of agonist binding and activation in KOR are further discussed. Usually, mutations affecting function more than binding were located at the periphery of the binding site and did not interact strongly with the various ligands. Analysis of the crystal structure along with the present results provide fundamental insights into the activation mechanism of the KOR and suggest that functional residues, along with water molecules detected in the crystal structure, may be directly involved in transduction of the agonist binding event into structural changes at the conserved rotamer switches, thus leading to receptor activation.	[Vardy, Eyal; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Mosier, Philip D.; Westkaemper, Richard B.] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA; [Frankowski, Kevin J.; Aube, Jeffrey] Univ Kansas, Sch Pharm, Dept Med Chem, Lawrence, KS 66047 USA; [Wu, Huixian; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University; University of Kansas; Scripps Research Institute	Roth, BL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Katritch, Vsevolod/Y-2721-2019; Roth, Bryan L/F-3928-2010; Wu, Huixian/N-6353-2014; Roth, Bryan/ABE-7032-2020; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016	Wu, Huixian/0000-0003-1357-9747; Roth, Bryan/0000-0002-0561-6520; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Aube, Jeffrey/0000-0003-1049-5767	National Institutes of Health (NIH) [R01 DA017204]; NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill); NIH PSI:Biology Grant [U54 GM094618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill); NIH PSI:Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01 DA017204 (to B. L R.); the NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill) (to B. L R.); and NIH PSI:Biology Grant U54 GM094618 (to V. K. and R. C. S.).	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Ferguson DM, 2000, J MED CHEM, V43, P1251, DOI 10.1021/jm990583r; Filizola M, 2012, NATURE, V485, P314, DOI 10.1038/485314a; Frankowski KJ, 2010, ACS MED CHEM LETT, V1, P189, DOI 10.1021/ml100040t; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hjorth SA, 1996, MOL PHARMACOL, V50, P977; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Kane BE, 2008, J MED CHEM, V51, P1824, DOI 10.1021/jm701040v; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Katritch V, 2011, TRENDS PHARMACOL SCI, V32, P637, DOI 10.1016/j.tips.2011.08.001; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; KONG HY, 1994, REGUL PEPTIDES, V54, P155; Kristiansen K, 2000, J PHARMACOL EXP THER, V293, P735; Larson DL, 2000, J MED CHEM, V43, P1573, DOI 10.1021/jm000059g; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Metzger TG, 2001, J MED CHEM, V44, P857, DOI 10.1021/jm000381r; Naqvi T, 1998, PEPTIDES, V19, P1277, DOI 10.1016/S0196-9781(98)00042-4; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; OHTA K, 1994, BIOCHEM BIOPH RES CO, V203, P1096, DOI 10.1006/bbrc.1994.2295; Owens CE, 2002, J PHARMACOL EXP THER, V300, P992, DOI 10.1124/jpet.300.3.992; Patkar KA, 2009, J MED CHEM, V52, P6814, DOI 10.1021/jm900715m; PORTOGHESE PS, 1989, TRENDS PHARMACOL SCI, V10, P230, DOI 10.1016/0165-6147(89)90267-8; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; Stevens CW, 2007, NEUROSCI LETT, V419, P189, DOI 10.1016/j.neulet.2007.04.014; STRADER CD, 1988, J BIOL CHEM, V263, P10267; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vardy E, 2013, CELL, V152, P385, DOI 10.1016/j.cell.2013.01.025; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; WANG JB, 1994, J BIOL CHEM, V269, P25966; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; Westkaemper RB, 1999, EUR J PHARMACOL, V380, pR5, DOI 10.1016/S0014-2999(99)00525-7; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yan F, 2005, BIOCHEMISTRY-US, V44, P8643, DOI 10.1021/bi050490d; Yan F, 2009, BIOCHEMISTRY-US, V48, P6898, DOI 10.1021/bi900605n	47	44	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34470	34483		10.1074/jbc.M113.515668	http://dx.doi.org/10.1074/jbc.M113.515668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121503	hybrid, Green Published			2022-12-25	WOS:000329812800017
J	Azushima, K; Tamura, K; Wakui, H; Maeda, A; Ohsawa, M; Uneda, K; Kobayashi, R; Kanaoka, T; Dejima, T; Fujikawa, T; Yamashita, A; Toya, Y; Umemura, S				Azushima, Kengo; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Kanaoka, Tomohiko; Dejima, Toru; Fujikawa, Tetsuya; Yamashita, Akio; Toya, Yoshiyuki; Umemura, Satoshi			Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED PROTEIN; CARDIAC-HYPERTROPHY; LIVER LIPIDS; PPAR-GAMMA; ADIPONECTIN; GHRELIN; PEPTIDE; WEIGHT; TYPE-1; SAN	Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system.	[Azushima, Kengo; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Uneda, Kazushi; Kobayashi, Ryu; Kanaoka, Tomohiko; Dejima, Toru; Fujikawa, Tetsuya; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Yamashita, Akio] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Tamura, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan.	tamukou@med.yokohama-cu.ac.jp	Fujikawa, Tetsuya/N-6520-2014	Fujikawa, Tetsuya/0000-0002-0533-3061; Azushima, Kengo/0000-0002-5136-0730	Health and Labor Sciences Research grant; Japanese Ministry of Education, Science, Sports and Culture; Salt Science Research Foundation [1134]; Yokohama Foundation for Advancement of Medical Science; Kidney Foundation, Japan [JKFB13-17]; Novartis Foundation for Gerontological Research; Grants-in-Aid for Scientific Research [25460906] Funding Source: KAKEN	Health and Labor Sciences Research grant(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Yokohama Foundation for Advancement of Medical Science; Kidney Foundation, Japan(Kidney Foundation, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Health and Labor Sciences Research grant and by grants from the Japanese Ministry of Education, Science, Sports and Culture, the Salt Science Research Foundation (number 1134), the Yokohama Foundation for Advancement of Medical Science, the Kidney Foundation, Japan (JKFB13-17) and the Novartis Foundation for Gerontological Research (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P158, DOI 10.3164/jcbn.2008023; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dietrich MO, 2012, NAT REV DRUG DISCOV, V11, P675, DOI 10.1038/nrd3739; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Horvath K, 2008, ARCH INTERN MED, V168, P571, DOI 10.1001/archinte.168.6.571; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maggs Fenella G, 2012, Acute Med, V11, P107; Matsuda M, 2011, PHYSIOL GENOMICS, V43, P884, DOI 10.1152/physiolgenomics.00005.2011; Morimoto Y, 2002, YAKUGAKU ZASSHI, V122, P163, DOI 10.1248/yakushi.122.163; Morimoto Yasuo, 2001, Folia Pharmacologica Japonica, V117, P77, DOI 10.1254/fpj.117.77; Nakayama T, 2007, J ETHNOPHARMACOL, V109, P236, DOI 10.1016/j.jep.2006.07.041; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sakamoto S, 2005, IN VIVO, V19, P1029; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tsurumi Y, 2006, KIDNEY INT, V69, P488, DOI 10.1038/sj.ki.5000130; Uno K, 2012, EUR HEART J, V33, P1279, DOI 10.1093/eurheartj/ehr265; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wakui H, 2010, AM J PHYSIOL-RENAL, V299, pF991, DOI 10.1152/ajprenal.00738.2009; Wakui H, 2010, HYPERTENSION, V55, P1157, DOI 10.1161/HYPERTENSIONAHA.109.147207; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yiannikouris F, 2010, CURR OPIN NEPHROL HY, V19, P195, DOI 10.1097/MNH.0b013e3283366cd0; YOSHIDA T, 1995, INT J OBESITY, V19, P717; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	40	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75560	10.1371/journal.pone.0075560	http://dx.doi.org/10.1371/journal.pone.0075560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130717	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900040
J	Mattoo, AR; Pastan, I; FitzGerald, D				Mattoo, Abid R.; Pastan, Ira; FitzGerald, David			Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACUTE LYMPHOBLASTIC-LEUKEMIA; LUNG-CANCER CELLS; PSEUDOMONAS EXOTOXIN; RECOMBINANT IMMUNOTOXIN; PHASE-I; HEMATOLOGIC MALIGNANCIES; MONOCLONAL-ANTIBODIES; THERAPEUTIC TARGET; IMMUNOGENICITY	Activated protein kinase C (PKC) contributes to tumor survival and proliferation, provoking the development of inhibitory agents as potential cancer therapeutics. Immunotoxins are antibody-based recombinant proteins that employ antibody fragments for cancer targeting and bacterial toxins as the cytotoxic agent. Pseudomonas exotoxin-based immunotoxins act via the ADP-ribosylation of EF2 leading to the enzymatic inhibition of protein synthesis. Combining PKC inhibitors with the immunotoxin SS1P, targeted to surface mesothelin, was undertaken to explore possible therapeutic strategies. Enzastaurin but not two other PKC inhibitors combined with SS1P to produce synergistic cell death via apoptosis. Mechanistic insights of the synergistic killing centered on the complete loss of the prosurvival Bcl2 protein, Mcl-1, the loss of AKT and the activation of caspase 3/7. Synergy was most evident when cells exhibited resistance to the immunotoxin alone. Further, because PKC inhibition by itself was not sufficient to enhance SS1P action, enzastaurin must target other kinases that are involved in the immunotoxin pathway.	[Mattoo, Abid R.; Pastan, Ira; FitzGerald, David] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	FitzGerald, D (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	fitzgerd@helix.nih.gov	pastan, ira/P-9319-2019; MATTOO, ABID/AGI-4855-2022	pastan, ira/0000-0002-9223-0270; MATTOO, ABID/0000-0002-4947-0113	National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by funding from the Intramural Research Program, National Cancer Institute, Center for Cancer Research at the National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Barger JF, 2013, ONCOGENE, V32, P453, DOI 10.1038/onc.2012.70; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Du X, 2011, CLIN CANCER RES, V17, P5926, DOI 10.1158/1078-0432.CCR-11-1235; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Fitzgerald DJ, 2011, LEUKEMIA LYMPHOMA, V52, P79, DOI 10.3109/10428194.2011.569961; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Hansen JK, 2010, J IMMUNOTHER, V33, P297, DOI 10.1097/CJI.0b013e3181cd1164; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Herrera L, 2009, J PEDIAT HEMATOL ONC, V31, P936, DOI 10.1097/MPH.0b013e3181bdf211; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kuo WL, 2010, MOL CANCER THER, V9, P2814, DOI 10.1158/1535-7163.MCT-10-0352; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Liu XF, 2013, CANCER RES, V73, P2281, DOI 10.1158/0008-5472.CAN-12-3436; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mattoo AR, 2013, INT J CANCER, V132, P978, DOI 10.1002/ijc.27732; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Onda M, 2011, P NATL ACAD SCI USA, V108, P5742, DOI 10.1073/pnas.1102746108; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pastan I, 2011, LEUKEMIA LYMPHOMA, V52, P87, DOI 10.3109/10428194.2011.573039; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Schindler J, 2011, BRIT J HAEMATOL, V154, P471, DOI 10.1111/j.1365-2141.2011.08762.x; Steinbach D, 2007, EUR J HAEMATOL, V79, P281, DOI 10.1111/j.1600-0609.2007.00928.x; Traini R, 2010, MOL CANCER THER, V9, P2007, DOI 10.1158/1535-7163.MCT-10-0257; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Wu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029622; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2011, CANCER RES, V71, P5915, DOI 10.1158/0008-5472.CAN-11-0466	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75576	10.1371/journal.pone.0075576	http://dx.doi.org/10.1371/journal.pone.0075576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130723	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900044
J	Park, MH; Park, JY; Lee, HJ; Kim, DH; Chung, KW; Park, D; Jeong, HO; Kim, HR; Park, CH; Kim, SR; Chun, P; Byun, Y; Moon, HR; Chung, HY				Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Kim, Hye Rim; Park, Chan Hum; Kim, So Ra; Chun, Pusoon; Byun, Youngjoo; Moon, Hyung Ryong; Chung, Hae Young			The Novel PPAR alpha/gamma Dual Agonist MHY 966 Modulates UVB-Induced Skin Inflammation by Inhibiting NF-kappa B Activity	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NITRIC-OXIDE; PEROXYNITRITE; SUPEROXIDE; CHEMISTRY; APOPTOSIS; FUTURE; CELLS; MODEL	Ultraviolet B (UVB; 290 similar to 320nm) irradiation-induced lipid peroxidation induces inflammatory responses that lead to skin wrinkle formation and epidermal thickening. Peroxisome proliferator-activated receptor (PPAR) alpha/gamma dual agonists have the potential to be used as anti-wrinkle agents because they inhibit inflammatory response and lipid peroxidation. In this study, we evaluated the function of 2-bromo-4-(5-chloro-benzo[d]thiazol-2-yl) phenol (MHY 966), a novel synthetic PPAR alpha/gamma dual agonist, and investigated its anti-inflammatory and anti-lipid peroxidation effects. The action of MHY 966 as a PPAR alpha/gamma dual agonist was also determined in vitro by reporter gene assay. Additionally, 8-week-old melanin-possessing hairless mice 2 (HRM2) were exposed to 150 mJ/cm(2) UVB every other day for 17 days and MHY 966 was simultaneously pre-treated every day for 17 days to investigate the molecular mechanisms involved. MHY 966 was found to stimulate the transcriptional activities of both PPAR alpha and gamma. In HRM2 mice, we found that the skins of mice exposed to UVB showed significantly increased pro-inflammatory mediator levels (NF-kappa B, iNOS, and COX-2) and increased lipid peroxidation, whereas MHY 966 co-treatment down-regulated these effects of UVB by activating PPAR alpha and gamma. Thus, the present study shows that MHY 966 exhibits beneficial effects on inflammatory responses and lipid peroxidation by simultaneously activating PPAR alpha and gamma. The major finding of this study is that MHY 966 demonstrates potential as an agent against wrinkle formation associated with chronic UVB exposure.	[Park, Min Hi; Park, Ji Young; Lee, Hye Jin; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Kim, So Ra; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea; [Park, Min Hi; Kim, Dae Hyun; Chung, Ki Wung; Park, Daeui; Jeong, Hyoung Oh; Park, Chan Hum; Kim, So Ra; Chung, Hae Young] Pusan Natl Univ, Biochem Lab, Busan, South Korea; [Park, Ji Young; Lee, Hye Jin; Kim, Hye Rim; Moon, Hyung Ryong] Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan, South Korea; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea; [Byun, Youngjoo] Korea Univ, Coll Pharm, Chungnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Inje University; Korea University	Moon, HR (corresponding author), Pusan Natl Univ, Coll Pharm, Med Chem Lab, Busan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020	Park, Daeui/0000-0002-9452-5849; , Youngjoo/0000-0002-0297-7734	National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, no. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar Mohammad, 2002, Indian Journal of Experimental Biology, V40, P656; Bae JY, 2008, FOOD CHEM TOXICOL, V46, P1298, DOI 10.1016/j.fct.2007.09.112; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Cho HS, 2007, PHOTODERMATOL PHOTO, V23, P155, DOI 10.1111/j.1600-0781.2007.00298.x; Choi YJ, 2012, J DERMATOL SCI, V68, P164, DOI 10.1016/j.jdermsci.2012.09.014; Davidson SM, 2006, CELL CALCIUM, V40, P561, DOI 10.1016/j.ceca.2006.08.017; DEGRUIJL FR, 1994, HEALTH PHYS, V67, P319, DOI 10.1097/00004032-199410000-00001; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Giacomoni PU, 2004, MICRON, V35, P179, DOI 10.1016/j.micron.2003.11.004; Hanley K, 1998, J INVEST DERMATOL, V111, P440, DOI 10.1046/j.1523-1747.1998.00303.x; Hitoshi Y, 2010, INT J HEMATOL, V91, P189, DOI 10.1007/s12185-010-0531-y; Katiyar SK, 2001, TOXICOL APPL PHARM, V176, P110, DOI 10.1006/taap.2001.9276; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Olesen H, 1998, CLIN CHIM ACTA, V271, pS5, DOI 10.1016/S0009-8981(97)00214-3; Oplander C, 2007, FREE RADICAL BIO MED, V43, P818, DOI 10.1016/j.freeradbiomed.2007.05.030; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; RADI R, 1991, J BIOL CHEM, V266, P4244; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Seber S, 2006, DIABETES RES CLIN PR, V71, P52, DOI 10.1016/j.diabres.2005.05.009; Suschek CV, 2001, CELL DEATH DIFFER, V8, P515, DOI 10.1038/sj.cdd.4400839; Suschek CV, 1999, J BIOL CHEM, V274, P6130, DOI 10.1074/jbc.274.10.6130; Thuillier P, 2002, BIOCHEM J, V366, P901, DOI 10.1042/BJ20020377; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66	33	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76820	10.1371/journal.pone.0076820	http://dx.doi.org/10.1371/journal.pone.0076820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130794	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900089
J	Sevilla, CA; Dalecki, D; Hocking, DC				Sevilla, Carlos A.; Dalecki, Diane; Hocking, Denise C.			Regional Fibronectin and Collagen Fibril Co-Assembly Directs Cell Proliferation and Microtissue Morphology	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; POLYMERIZATION; MORPHOGENESIS; MICROSCOPY; REGULATOR; ADHESION; BINDING	The extracellular matrix protein, fibronectin stimulates cells to self-assemble into three-dimensional multicellular structures by a mechanism that requires the cell-dependent conversion of soluble fibronectin molecules into insoluble fibrils. Fibronectin also binds to collagen type I and mediates the co-assembly of collagen fibrils into the extracellular matrix. Here, the role of collagen-fibronectin binding in fibronectin-induced cellular self-assembly was investigated using fibronectin-null fibroblasts in an in vitro model of tissue formation. High resolution, two-photon immunofluorescence microscopy was combined with second harmonic generation imaging to examine spatial and temporal relationships among fibronectin and collagen fibrils, actin organization, cell proliferation, and microtissue morphology. Time course studies coupled with simultaneous 4-channel multiphoton imaging identified regional differences in fibronectin fibril conformation, collagen fibril remodeling, actin organization, and cell proliferation during three-dimensional cellular self-assembly. Regional differences in cell proliferation and fibronectin structure were dependent on both soluble fibronectin concentration and fibronectin-collagen interactions. Fibronectin-collagen binding was not necessary for either fibronectin matrix formation or intercellular cohesion. However, inhibiting fibronectin binding to collagen reduced collagen fibril remodeling, decreased fibronectin fibril extension, blocked fibronectin-induced cell proliferation, and altered microtissue morphology. Furthermore, continual fibronectin-collagen binding was necessary to maintain both cell proliferation and microtissue morphology. Collectively, these data suggest that the complex changes in extracellular matrix and cytoskeletal remodeling that mediate tissue assembly are driven, in part, by regional variations in cell-mediated fibronectin-collagen co-assembly.	[Sevilla, Carlos A.; Dalecki, Diane; Hocking, Denise C.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Hocking, Denise C.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Hocking, DC (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	denise_hocking@urmc.rochester.edu	Hocking, Denise/H-7903-2012	Hocking, Denise/0000-0003-2337-0357; Dalecki, Diane/0000-0001-7114-9732	National Institutes of Health [EB008368, EB008996, GM081513, F31AR057675]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR057675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008368, R01EB008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants EB008368, EB008996 and GM081513 from the National Institutes of Health. C. S. was supported by NIH predoctoral fellowship F31AR057675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; AKIYAMA S, 2001, URIF FIBRONECTIN CUR, P13; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P546, DOI 10.1016/j.yexcr.2012.10.005; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gildner CD, 2004, AM J PHYSIOL-HEART C, V287, pH46, DOI 10.1152/ajpheart.00859.2003; Gui LQ, 2006, J BIOL CHEM, V281, P34816, DOI 10.1074/jbc.M608611200; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hansen AE, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-89; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hocking DC, 2008, CIRC RES, V102, P372, DOI 10.1161/CIRCRESAHA.107.158501; Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Nogawa H, 1998, DEV DYNAM, V213, P228, DOI 10.1002/(SICI)1097-0177(199810)213:2<228::AID-AJA8>3.0.CO;2-I; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pereira M, 2002, J CELL SCI, V115, P609; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Rebres RA, 1995, AM J PHYSIOL-GASTR L, V269, pG902, DOI 10.1152/ajpgi.1995.269.6.G902; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; ROSSOMANDO E, 1992, MORPHOGENESIS ANAL D; Roy DC, 2013, TISSUE ENG PT A, V19, P558, DOI [10.1089/ten.tea.2012.0257, 10.1089/ten.TEA.2012.0257]; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Sevilla CA, 2010, TISSUE ENG PT A, V16, P3805, DOI [10.1089/ten.tea.2010.0316, 10.1089/ten.TEA.2010.0316]; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; SHIRAISHI I, 1995, ANAT EMBRYOL, V191, P183; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; VANDELEST CHA, 1995, J HISTOCHEM CYTOCHEM, V43, P727, DOI 10.1177/43.7.7608528; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	46	31	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77316	10.1371/journal.pone.0077316	http://dx.doi.org/10.1371/journal.pone.0077316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116223	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200114
J	Akhras, MS; Pettersson, E; Diamond, L; Unemo, M; Okamoto, J; Davis, RW; Pourmand, N				Akhras, Michael S.; Pettersson, Erik; Diamond, Lisa; Unemo, Magnus; Okamoto, Jennifer; Davis, Ronald W.; Pourmand, Nader			The Sequencing Bead Array (SBA), a Next-Generation Digital Suspension Array	PLOS ONE			English	Article							DIRECT ELECTRICAL DETECTION; PADLOCK PROBES; IN-SITU; DNA; AMPLIFICATION; TECHNOLOGY; ASSAY; CLASSIFICATION; MOLECULES; PRIMERS	Here we describe the novel Sequencing Bead Array (SBA), a complete assay for molecular diagnostics and typing applications. SBA is a digital suspension array using Next-Generation Sequencing (NGS), to replace conventional optical readout platforms. The technology allows for reducing the number of instruments required in a laboratory setting, where the same NGS instrument could be employed from whole-genome and targeted sequencing to SBA broad-range biomarker detection and genotyping. As proof-of-concept, a model assay was designed that could distinguish ten Human Papillomavirus (HPV) genotypes associated with cervical cancer progression. SBA was used to genotype 20 cervical tumor samples and, when compared with amplicon pyrosequencing, was able to detect two additional co-infections due to increased sensitivity. We also introduce in-house software Sphix, enabling easy accessibility and interpretation of results. The technology offers a multi-parallel, rapid, robust, and scalable system that is readily adaptable for a multitude of microarray diagnostic and typing applications, e. g. genetic signatures, single nucleotide polymorphisms (SNPs), structural variations, and immunoassays. SBA has the potential to dramatically change the way we perform probe-based applications, and allow for a smooth transition towards the technology offered by genomic sequencing.	[Akhras, Michael S.; Pettersson, Erik; Diamond, Lisa; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Unemo, Magnus] Orebro Univ Hosp, World Hlth Org Collaborating Ctr Gonorrhoea & Oth, Swedish Reference Lab Pathogen Neisseria, Dept Lab Med, Orebro, Sweden; [Okamoto, Jennifer] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Okamoto, Jennifer] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Pourmand, Nader] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Stanford University; Orebro University; World Health Organization; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Santa Cruz	Pourmand, N (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	pourmand@soe.ucsc.edu	Unemo, Magnus/ABD-6653-2021	Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [P01-35HG000205]; Carl Tryggers Foundation [CTS 11:5, CTS 12:5]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Tryggers Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this research was provided in part by the National Institutes of Health [P01-35HG000205] and the Carl Tryggers Foundation [CTS 11:5, CTS 12:5] to MSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000915; Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson EP, 2008, SENSOR ACTUAT B-CHEM, V129, P79, DOI 10.1016/j.snb.2007.07.105; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gharizadeh B, 2006, MOL CELL PROBE, V20, P230, DOI 10.1016/j.mcp.2006.01.002; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Jensen MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034373; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Landegren U, 2003, COMP FUNCT GENOM, V4, P525, DOI 10.1002/cfg.326; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Natsume T, 2007, CHEM PHYS LETT, V434, P133, DOI 10.1016/j.cplett.2006.12.017; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Nyren Pal, 2007, V373, P1; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pettersson E, 2008, HUM MUTAT, V29, P323, DOI 10.1002/humu.20655; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Pourmand N, 2007, P NATL ACAD SCI USA, V104, P6146, DOI 10.1073/pnas.0700921104; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sims PA, 2011, NAT METHODS, V8, P575, DOI [10.1038/NMETH.1629, 10.1038/nmeth.1629]; Stahl PL, 2012, ANNU REV BIOCHEM, V81, P359, DOI 10.1146/annurev-biochem-060410-094158; Weibrecht I, 2013, NAT PROTOC, V8, P355, DOI 10.1038/nprot.2013.006; Zhang K, 2012, J AM CHEM SOC, V134, P16488, DOI 10.1021/ja306854d; Zieba A, 2012, NEW BIOTECHNOL, V29, P634, DOI 10.1016/j.nbt.2012.05.004	44	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76696	10.1371/journal.pone.0076696	http://dx.doi.org/10.1371/journal.pone.0076696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116138	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300080
J	Bertelsmeier, C; Guenard, B; Courchamp, F				Bertelsmeier, Cleo; Guenard, Benoit; Courchamp, Franck			Climate Change May Boost the Invasion of the Asian Needle Ant	PLOS ONE			English	Article							LINEPITHEMA-HUMILE MAYR; ARGENTINE ANT; SPECIES DISTRIBUTION; SOLENOPSIS-INVICTA; NICHE; TEMPERATURE; DYNAMICS; CONSEQUENCES; INVASIBILITY; HYMENOPTERA	Following its introduction from Asia to the USA, the Asian needle ant (Pachycondyla chinensis) is rapidly spreading into a wide range of habitats with great negative ecological affects. In addition, the species is a concern for human health because of its powerful, sometimes deadly, sting. Here, we assessed the potential of P. chinensis to spread further and to invade entirely new regions. We used species distribution models to assess suitable areas under current climatic conditions and in 2020, 2050 and 2080. With a consensus model, combining five different modelling techniques, three Global Circulation (climatic) Models and two CO2 emission scenarios, we generated world maps with suitable climatic conditions. Our models suggest that the species currently has a far greater potential distribution than its current exotic range, including large parts of the world landmass, including Northeast America, Southeast Asia and Southeast America. Climate change is predicted to greatly exacerbate the risk of P. chinensis invasion by increasing the suitable landmass by 64.9% worldwide, with large increases in Europe (+210.1%), Oceania (+75.1%), North America (+74.9%) and Asia (+62.7%). The results of our study suggest P. chinensis deserves increased attention, especially in the light of on-going climate change.	[Bertelsmeier, Cleo; Courchamp, Franck] Univ Paris 11, Orsay, France; [Guenard, Benoit] Okinawa Inst Sci & Technol, Biodivers & Biocomplex Unit, Okinawa, Japan	UDICE-French Research Universities; Universite Paris Saclay; Okinawa Institute of Science & Technology Graduate University	Bertelsmeier, C (corresponding author), Univ Paris 11, Orsay, France.	cleo.bertelsmeier@u-psud.fr	Courchamp, Franck/ABE-7204-2020	Courchamp, Franck/0000-0001-7605-4548; Guenard, Benoit/0000-0002-7144-1175; /0000-0001-6782-917X; Bertelsmeier, Cleo/0000-0003-3624-1300	Region Ile-de-France [03-2010/GV-DIM ASTREA]; ANR [2009 PEXT 010 01]	Region Ile-de-France(Region Ile-de-France); ANR(French National Research Agency (ANR))	This paper was supported by Region Ile-de-France (03-2010/GV-DIM ASTREA) and ANR (2009 PEXT 010 01) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2008, J INSECT PHYSIOL, V54, P265, DOI 10.1016/j.jinsphys.2007.09.009; Abril S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9701; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bertelsmeier C, 2013, CONSERVATIO IN PRESS, DOI [10.1111/cobi.12093, DOI 10.1111/C0BI.12093]; Bertelsmeier C, 2013, BIOL INVASIONS, V15, P1561, DOI 10.1007/s10530-012-0390-y; BOLTON B., 2007, BOLTONS CATALOGUE AN; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brightwell RJ, 2010, ENVIRON ENTOMOL, V39, P1659, DOI 10.1603/EN09345; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Cristianini N, 2002, AI MAG, V23, P31; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Emery C., 1895, Annali del Museo Genova, Vxxxiv, P450; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzgerald K, 2012, CONSERV BIOL, V26, P525, DOI 10.1111/j.1523-1739.2012.01836.x; Franklin J, 2009, MAPPING SPECIES DIST; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann BD, 2010, ANT ECOLOGY, P287; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; IPCC, 2007, BIL 2007 CHANG CLIM, V446; IUCN (International Union for Conservation of Nature) SSC (Species Survival Commission) Invasive Species Specialist Group, 2012, GLOB INV SPEC DAT; Jenkins C.N., 2011, DIVERS DISTRIB, V2011, P1; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kaiser BA, 2010, RESOUR ENERGY ECON, V32, P566, DOI 10.1016/j.reseneeco.2010.04.007; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Lach L, 2010, ANT ECOLOGY, P261; Lessard JP, 2009, INSECT SOC, V56, P149, DOI 10.1007/s00040-009-0006-4; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Lowe S., 2000, ENCY BIOL INVASIONS; Maravelias CD, 2003, MAR ECOL PROG SER, V255, P249, DOI 10.3354/meps255249; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; O'Donnell JA, 2011, GLOBAL CHANGE BIOL, V17, P1461, DOI 10.1111/j.1365-2486.2010.02358.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rabitsch W, 2011, BIOCONTROL, V56, P551, DOI 10.1007/s10526-011-9370-x; Rice ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056281; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Sloggett JJ, 2012, ENTOMOL SCI, V15, P261, DOI 10.1111/j.1479-8298.2012.00519.x; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Suarez AV, 2010, ANT ECOLOGY, P233; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walters AC, 2004, ANN ENTOMOL SOC AM, V97, P971, DOI 10.1603/0013-8746(2004)097[0971:COUTTB]2.0.CO;2; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Yashiro T, 2010, ZOOTAXA, P39	80	28	29	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75438	10.1371/journal.pone.0075438	http://dx.doi.org/10.1371/journal.pone.0075438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124489	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100046
J	Crepey, P; Pivette, M; Desvarieux, M				Crepey, Pascal; Pivette, Mathilde; Desvarieux, Moise			Potential Impact of Influenza A/H1N1 Pandemic and Hand-Gels on Acute Diarrhea Epidemic in France	PLOS ONE			English	Article							COMMUNICABLE DISEASES; SURVEILLANCE; STRATEGIES	Background: The 2009 A/H1N1 influenza pandemic has received a great deal of attention from public health authorities. Our study examines whether this pandemic and the resulting public health measures could have impacted acute diarrhea, a prevalent, highly transmissible and historically monitored disease. Methods: Using augmentation procedures of national data for the previous five years (2004-2009), we estimated the expected timing and incidence of acute diarrhea in France in 2009-2010 and evaluated differences with the observed. We also reviewed national hand gels for the same period. Findings: Number of episodes of acute diarrhea in France in 2009-2010 was significantly lower than expected until the third week of December (224%, 95% CI [-36%; -9%]), then significantly higher (+40%, 95% CI [22%; 62%]), leading to a surplus of 574,440 episodes. The epidemic was delayed by 5 weeks with a peak 1.3 times higher than expected. Hand-gels sales inversely correlated with incidence of both influenza-like illness and acute diarrheal disease. Among individuals >65 yo, no excess cases of influenza and no excess rebound in acute diarrhea were observed, despite similar delay in the onset of the seasonal diarrheal epidemic. Interpretation: Our results suggest that at least one endemic disease had an unexpected behavior in 2009-2010. Acute diarrhea seems to have been controlled during the beginning of the pandemic in all age groups, but later peaked higher than expected in the younger population. The all-age delay in seasonal onset seems partly attributable to hand-gels use, while the differential magnitude of the seasonal epidemic between young and old, concurrent for both influenza and acute diarrhea, is compatible with disease interaction.	[Crepey, Pascal; Pivette, Mathilde; Desvarieux, Moise] Ecole Hautes Etud Sante Publ Rennes, Sorbonne Paris Cite, Paris, France; [Crepey, Pascal] Aix Marseille Univ, UMR EPV Emergence Pathol Virales 190, Marseille, France; [Pivette, Mathilde] Univ Paris 05, MAP5, Paris, France; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Desvarieux, Moise] INSERM, U738, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crepey, P (corresponding author), Ecole Hautes Etud Sante Publ Rennes, Sorbonne Paris Cite, Paris, France.	pascal.crepey@ehesp.fr	Crépey, Pascal/G-5422-2011; Desvarieux, Moise/C-4991-2019	Crépey, Pascal/0000-0003-1852-0752; 	Ecole des Hautes Etudes en Sante Publique	Ecole des Hautes Etudes en Sante Publique	This study was funded by Ecole des Hautes Etudes en Sante Publique. No external funding used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; [Anonymous], WHO REC PAND H1N1 20; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Garenne M, 2008, CAHIERS SOCIOLOGIE D; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; GRMEK MD, 1969, ANN ESC, V24, P1473; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kish JL, 1965, SURVEY SAMPLING; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Longini IM, 2005, POPULATION; McNeill Alfred, 2003, COLUMBIAN EXCHANGE B, P13; McNeill WilliamH., 1998, PLAGUES PEOPLES; Noymer A, 2000, POPULATION DEV REV; Noymer A, 2010, PLAGUES EPIDEMICS IN, P137; Secretariat General de la Defense Nationale, 2009, PLAN NAT PREV LUTT P; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; US Department of Health and Human Services, 2005, HHS PAND INFL PLAN; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Weil-Olivier Catherine, 2010, Rev Prat, V60, P1388; WHO, 2009, PAND H1N1 2009 UPD; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2010, EMERG INFECT DIS, V16, P10	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75226	10.1371/journal.pone.0075226	http://dx.doi.org/10.1371/journal.pone.0075226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124479	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100036
J	Ho, CL; Lin, CY; Ka, SM; Chen, A; Tasi, YL; Liu, ML; Chiu, YC; Hua, KF				Ho, Chen-Lung; Lin, Chai-Yi; Ka, Shuk-Man; Chen, Ann; Tasi, Yu-Ling; Liu, May-Lan; Chiu, Yi-Chich; Hua, Kuo-Feng			Bamboo Vinegar Decreases Inflammatory Mediator Expression and NLRP3 Inflammasome Activation by Inhibiting Reactive Oxygen Species Generation and Protein Kinase C-alpha/delta Activation	PLOS ONE			English	Article							NF-KAPPA-B; PHENOLIC ANTIDIARRHEIC INGREDIENTS; SIGNAL-TRANSDUCTION; WOOD CREOSOTE; SECRETION; ACID; INTERLEUKIN-1-BETA; COMPOUND; MEDICINE; IMMUNITY	Bamboo vinegar (BV), a natural liquid derived from the condensation produced during bamboo charcoal production, has been used in agriculture and as a food additive, but its application to immune modulation has not been reported. Here, we demonstrated that BV has anti-inflammatory activities both in vitro and in vivo. BV reduced inducible nitric oxide synthase expression and nitric oxide levels in, and interleukin-6 secretion by, lipopolysaccharide-activated macrophages without affecting tumor necrosis factor-a secretion and cyclooxygenase-2 expression. The mechanism for the anti-inflammatory effect of BV involved decreased reactive oxygen species production and protein kinase C-alpha/delta activation. Furthermore, creosol (2-methoxy-4-methylphenol) was indentified as the major anti-inflammatory compound in BV. Impaired cytokine expression and NLR family, pyrin domain-containing 3 (NLRP3) inflammasome activation was seen in mice treated with creosol. These findings provide insights into how BV regulates inflammation and suggest that it may be a new source for the development of anti-inflammatory agents or a healthy supplement for preventing and ameliorating inflammation-and NLRP3 inflammasome-related diseases, including metabolic syndrome.	[Ho, Chen-Lung] Taiwan Forestry Res Inst, Div Wood Cellulose, Taipei, Taiwan; [Lin, Chai-Yi; Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Chen, Ann] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Tasi, Yu-Ling] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, May-Lan] Toko Univ, Dept Nutr Sci, Chiayi, Taiwan; [Chiu, Yi-Chich] Natl Ilan Univ, Dept Biomechatron Engn, Ilan, Taiwan	National Ilan University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Ilan University	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.	kuofenghua@gmail.com			National Science Council, Taiwan [NSC 102-2628-B-197-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by National Science Council, Taiwan (contract grant number NSC 102-2628-B-197-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakabe Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2797, DOI 10.1271/bbb.60317; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chao LK, 2008, FOOD CHEM TOXICOL, V46, P220, DOI 10.1016/j.fct.2007.07.016; Chen YX, 2010, CHEMOSPHERE, V78, P1177, DOI 10.1016/j.chemosphere.2009.12.029; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandez AP, 2010, CURR PHARM DESIGN, V16, P2837; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Higa JK, 2011, BRIT J NUTR, V106, P1810, DOI 10.1017/S0007114511002157; Higa JK, 2011, CYTOKINE, V55, P18, DOI 10.1016/j.cyto.2011.02.019; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Huang TT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01374; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Jeong HJ, 2011, J MED FOOD, V14, P53, DOI 10.1089/jmf.2010.1232; Jiao JJ, 2007, J AGR FOOD CHEM, V55, P10086, DOI 10.1021/jf0716533; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; JODAI S, 1989, MOKUZAI GAKKAISHI, V35, P555; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kimura Y, 2002, BIOL PHARM BULL, V25, P1026, DOI 10.1248/bpb.25.1026; Kuge T, 2003, PHARMACOTHERAPY, V23, P1391, DOI 10.1592/phco.23.14.1391.31940; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lin HC, 2006, J FAC AGR KYUSHU U, V51, P5; Lin HC, 2006, Q J FOREST RES TAIWA, V28, P51; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marumoto S, 2012, J AGR FOOD CHEM, V60, P9106, DOI 10.1021/jf3021317; Matsushima N, 2007, EUR J PHARMACOL, V567, P59, DOI 10.1016/j.ejphar.2007.03.034; McLafferty F.W., 1989, WILEY NBS REGISTRY M, V1; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Momose T, 1997, ORGANIC ANAL, P147; Moriguchi N, 2007, BIOCHEM PHARMACOL, V73, P385, DOI 10.1016/j.bcp.2006.09.025; Nakamichi N, 2010, J NEUROSCI RES, V88, P2483, DOI 10.1002/jnr.22399; OGATA N, 1995, PHARMACOLOGY, V51, P195, DOI 10.1159/000139335; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Perez-Prieto LJ, 2003, J AGR FOOD CHEM, V51, P5444, DOI 10.1021/jf0345292; Ruttanavut J, 2012, HISTOL HISTOPATHOL, V27, P1333, DOI 10.14670/HH-27.1333; Said SN, 2010, PLOS ONE, V5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shiah T.C., 2006, J AGR, V3, P1; Shin HY, 2003, IMMUNOPHARM IMMUNOT, V25, P377, DOI 10.1081/IPH-120024505; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uchimura T., 2000, ISSUES BAMBOO CHARCO, P138; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024	58	32	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75738	10.1371/journal.pone.0075738	http://dx.doi.org/10.1371/journal.pone.0075738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124509	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100066
J	Taibi, AV; Lighthouse, JK; Grady, RC; Shroyer, KR; Holdener, BC				Taibi, Andrew V.; Lighthouse, Janet K.; Grady, Richard C.; Shroyer, Kenneth R.; Holdener, Bernadette C.			Development of a Conditional Mesd (Mesoderm Development) Allele for Functional Analysis of the Low-Density Lipoprotein Receptor-Related Family in Defined Tissues	PLOS ONE			English	Article							CRE RECOMBINASE; MICE	The Low-density lipoprotein receptor-Related Protein (LRP) family members are essential for diverse processes ranging from the regulation of gastrulation to the modulation of lipid homeostasis. Receptors in this family bind and internalize a diverse array of ligands in the extracellular matrix (ECM). As a consequence, LRPs regulate a wide variety of cellular functions including, but not limited to lipid metabolism, membrane composition, cell motility, and cell signaling. Not surprisingly, mutations in single human LRPs are associated with defects in cholesterol metabolism and development of atherosclerosis, abnormalities in bone density, or aberrant eye vasculature, and may be a contributing factor in development of Alzheimer's disease. Often, members of this diverse family of receptors perform overlapping roles in the same tissues, complicating the analysis of their function through conventional targeted mutagenesis. Here, we describe development of a mouse Mesd (Mesoderm Development) conditional knockout allele, and demonstrate that ubiquitous deletion of Mesd using Cre-recombinase blocks gastrulation, as observed in the traditional knockout and albino-deletion phenotypes. This conditional allele will serve as an excellent tool for future characterization of the cumulative contribution of LRP members in defined tissues.	[Taibi, Andrew V.; Lighthouse, Janet K.; Grady, Richard C.; Holdener, Bernadette C.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Holdener, BC (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	bernadette.holdener@stonybrook.edu	Lighthouse, Janet/Q-2026-2019	Lighthouse, Janet/0000-0001-9838-6113	National Institutes of Health [GM53964, CA123071]; NYSTEM [C026716]; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported in part by National Institutes of Health grant to BCH (GM53964) and to Drs. Robert Haltiwanger and BCH (CA123071). Adenovirus was produced by the Stony Brook University Stem Cell Core Facility funded by NYSTEM (C026716). No additional external funding was received for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Kohler C, 2011, STRUCTURE, V19, P337, DOI 10.1016/j.str.2010.12.022; Lighthouse JK, 2011, DEV DYNAM, V240, P577, DOI 10.1002/dvdy.22477; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75782	10.1371/journal.pone.0075782	http://dx.doi.org/10.1371/journal.pone.0075782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124512	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100069
J	Saiz-Ladera, C; Lara, MF; Garin, M; Ruiz, S; Santos, M; Lorz, C; Garcia-Escudero, R; Martinez-Fernandez, M; Bravo, A; Fernandez-Capetillo, O; Segrelles, C; Paramio, JM				Saiz-Ladera, C.; Lara, M. F.; Garin, M.; Ruiz, S.; Santos, M.; Lorz, C.; Garcia-Escudero, R.; Martinez-Fernandez, M.; Bravo, A.; Fernandez-Capetillo, O.; Segrelles, C.; Paramio, J. M.			p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia	ONCOGENE			English	Article						pRb; p21; skin; differentiation; inflammation; tumorigenesis	SQUAMOUS-CELL CARCINOMA; MOUSE SKIN CARCINOGENESIS; EPIDERMAL KERATINOCYTE DIFFERENTIATION; GENE-EXPRESSION PROFILES; KINASE INHIBITOR P21; NF-KAPPA-B; NECK-CANCER; TUMOR-SUPPRESSOR; DNA-DAMAGE; RETINOBLASTOMA PROTEIN	The retinoblastoma gene product (pRb) controls proliferation and differentiation processes in stratified epithelia. Importantly, and in contrast to other tissues, Rb deficiency does not lead to spontaneous skin tumor formation. As the cyclin-dependent kinase inhibitor p21 regulates proliferation and differentiation in the absence of pRb, we analyzed the consequences of deleting p21 in pRb-ablated stratified epithelia (hereafter pRb(Delta Epi); p21 - / -). These mice display an enhancement of the phenotypic abnormalities observed in pRb(Delta Epi) animals, indicating that p21 partially compensates pRb absence. Remarkably, pRb(Delta Epi); p21 - / - mice show an acute skin inflammatory phenotype and develop spontaneous epithelial tumors, particularly affecting tongue and oral tissues. Biochemical analyses and transcriptome studies reveal changes affecting multiple pathways, including DNA damage and p53-dependent signaling responses. Comparative metagenomic analyses, together with the histopathological profiles, indicate that these mice constitute a faithful model for human head and neck squamous cell carcinomas. Collectively, our findings demonstrate that p21, in conjunction with pRb, has a central role in regulating multiple epithelial processes and orchestrating specific tumor suppressor functions.	[Saiz-Ladera, C.; Lara, M. F.; Santos, M.; Lorz, C.; Garcia-Escudero, R.; Martinez-Fernandez, M.; Segrelles, C.; Paramio, J. M.] CIEMAT, Ctr Invest Energet Medioambientales & Tecnol, Mol Oncol Unit ed70A, Div Biomed, E-28040 Madrid, Spain; [Garin, M.] CIEMAT, Ctr Invest Energet Medioambientales & Tecnol, Ctr Invest Biomed Red Enfermedades Raras, Div Hematopoiet Innovat Therapies HIT, E-28040 Madrid, Spain; [Ruiz, S.; Fernandez-Capetillo, O.] Spanish Natl Canc Res Ctr, Genom Instabil Grp, Madrid, Spain; [Bravo, A.] Univ Santiago de Compostela, Dept Vet Clin Sci, Lugo, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); Universidade de Santiago de Compostela	Segrelles, C (corresponding author), CIEMAT, Ctr Invest Energet Medioambientales & Tecnol, Mol Oncol Unit ed70A, Ave Complutense 40, E-28040 Madrid, Spain.	carmen.segrelles@ciemat.es; jesusm.paramio@ciemat.es	Fernandez-Capetillo, Oscar/H-3508-2015; Garcia-Escudero, Ramon/A-2735-2012; Ruiz, Sergio/G-1561-2016; Paramio, Jesus M/M-8482-2014; Moral, Ana María Bravo/AAD-3339-2021; Santos, Mirentxu/AAA-1727-2020; Cabanás, María Lara/AAH-3621-2019; Garin, Marina I/C-5094-2014; Lorz, Corina/E-3651-2016; Segrelles, Carmen/E-3655-2016	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Garcia-Escudero, Ramon/0000-0001-5640-6542; Ruiz, Sergio/0000-0002-0177-6965; Paramio, Jesus M/0000-0001-7520-3177; Moral, Ana María Bravo/0000-0002-5282-8921; Garin, Marina I/0000-0001-7956-6792; Lorz, Corina/0000-0001-8214-9076; Segrelles, Carmen/0000-0001-9340-2102; Saiz Ladera, Cristina/0000-0001-8094-5992	MINECO [SAF2011-26122-C02-01, SAF2012-34378]; CAM Oncocycle Program [S2010/BMD-2470]; ISCIII-RETIC [RD06/0020/0029, RD12/0036/0009]; REGENER-AR; ISCIII [PI12/01959]; 'Juan de la Cierva' research fellowship from MICINN [JCI-2010-06167]; 'Ramon y Cajal' research fellowship from MICINN [11-866-25-04]; Spanish Ministry of Science [SAF2011-23753]; Association for International Cancer Research [12-0229]; Howard Hughes Medical Institute; European Research Council [ERC-210520]; EU [FP7-HEALTH-279174]; Worldwide Cancer Research [12-0229] Funding Source: researchfish	MINECO(Spanish Government); CAM Oncocycle Program; ISCIII-RETIC(Instituto de Salud Carlos III); REGENER-AR; ISCIII(Instituto de Salud Carlos III); 'Juan de la Cierva' research fellowship from MICINN; 'Ramon y Cajal' research fellowship from MICINN; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association for International Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Worldwide Cancer Research	We thank Pilar Hernandez for her excellent technical support on histology preparations and sectioning. The technical support by the personnel of the CIEMAT Animal Facility is specially acknowledged. Grant support: MINECO grants SAF2011-26122-C02-01 and SAF2012-34378, CAM Oncocycle Program Grants S2010/BMD-2470, ISCIII-RETIC grants RD06/0020/0029 and RD12/0036/0009 to JMP. EU FP7-HEALTH-279174, REGENER-AR to MG. ISCIII grant PI12/01959 to MS. MMF is funded by a 'Juan de la Cierva' research fellowship (JCI-2010-06167) from MICINN. SR is funded by a 'Ramon y Cajal' research fellowship (11-866-25-04) from MICINN. Work in the laboratory of OF is supported by grants from the Spanish Ministry of Science (SAF2011-23753), the Association for International Cancer Research (12-0229), the Howard Hughes Medical Institute and the European Research Council (ERC-210520).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Balsitis SJ, 2003, MOL CELL BIOL, V23, P9094, DOI 10.1128/MCB.23.24.9094-9103.2003; Martinez-Cruz AB, 2010, METHODS MOL BIOL, V585, P361, DOI 10.1007/978-1-60761-380-0_25; Martinez-Cruz AB, 2009, ANTICANCER RES, V29, P3035; Bornachea O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00434; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Costa C, 2013, ONCOGENE, V32, P2937, DOI 10.1038/onc.2012.316; Costa C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00828; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; D'Souza SJA, 2001, J BIOL CHEM, V276, P23531, DOI 10.1074/jbc.M100780200; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; De la Cueva E, 2006, ONCOGENE, V25, P4128, DOI 10.1038/sj.onc.1209432; de Marval PLM, 2004, ONCOGENE, V23, P1863, DOI 10.1038/sj.onc.1207309; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Duenas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042494; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Garcia-Escudero R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-193; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARPER JW, 1993, CELL, V75, P805; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kyng KJ, 2005, ONCOGENE, V24, P5026, DOI 10.1038/sj.onc.1208692; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Lara MF, 2008, MOL CARCINOGEN, V47, P105, DOI 10.1002/mc.20367; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin-Caballero J, 2004, ONCOGENE, V23, P8231, DOI 10.1038/sj.onc.1207863; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; PAK AS, 1995, CLIN CANCER RES, V1, P95; Paramio JM, 2001, J BIOL CHEM, V276, P44203, DOI 10.1074/jbc.M105650200; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Riley DJ, 1996, NAT MED, V2, P1316, DOI 10.1038/nm1296-1316; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rodriguez-Puebla ML, 2002, AM J PATHOL, V161, P405, DOI 10.1016/S0002-9440(10)64196-X; Ruiz S, 2005, CANCER RES, V65, P9678, DOI 10.1158/0008-5472.CAN-05-1853; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Ruiz S, 2004, DEV DYNAM, V230, P410, DOI 10.1002/dvdy.20065; Ruiz S, 2003, DEVELOPMENT, V130, P2341, DOI 10.1242/dev.00453; Ruiz S, 2006, CELL CYCLE, V5, P625, DOI 10.4161/cc.5.6.2580; Santos M, 2003, J BIOL CHEM, V278, P13422, DOI 10.1074/jbc.M208170200; Santos M, 2008, MOL CARCINOGEN, V47, P815, DOI 10.1002/mc.20426; Serefoglou Z, 2008, ORAL ONCOL, V44, P1093, DOI 10.1016/j.oraloncology.2008.02.012; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin MK, 2009, CANCER RES, V69, P5656, DOI 10.1158/0008-5472.CAN-08-3711; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wang DW, 2001, MOL CARCINOGEN, V31, P90, DOI 10.1002/mc.1044; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Weinberg WC, 1999, CANCER RES, V59, P2050; Woods KV, 1998, CANCER RES, V58, P3132; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	105	12	12	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4599	4612		10.1038/onc.2013.417	http://dx.doi.org/10.1038/onc.2013.417			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24121270	Green Accepted			2022-12-25	WOS:000342004800007
J	Xia, WX; Ye, YF; Lu, X; Wang, L; Ke, LR; Zhang, HB; Roycik, MD; Yang, J; Shi, JL; Cao, KJ; Guo, X; Xiang, YQ				Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Roycik, Mark D.; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun			The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; BARR-VIRUS DNA; TUMOR; SCORE; SURVIVAL; EXPRESSION; MANAGEMENT; UPDATE	Background: The aim of this study was to determine whether baseline C-reactive protein (CRP) levels and CRP kinetics predict the overall survival in metastatic nasopharyngeal carcinoma (mNPC) patients. Methods: A total of 116 mNPC patients from January 2006 to July 2011 were retrospectively reviewed. Serum CRP level was measured at baseline and thereafter at the start of each palliative chemotherapy cycle for all patients. Results: Patients with higher values of baseline CRP (>= 3.4 mg/L) had significantly worse survival than those with lower baseline CRP values (< 3.4 mg/L). Patients were divided into four groups according to baseline CRP and CRP kinetics: (1) patients whose CRP < 3.4 mg/L and never elevated during treatment; (2) patients whose CRP < 3.4 mg/L and elevated at least one time during treatment; (3) patients whose CRP >= 3.4 mg/L and normalized at least one time during treatment; and (4) patients whose CRP >= 3.4 mg/L and never normalized during treatment. The patients were further assigned to non-elevated, elevated, normalized, and non-normalized CRP groups. Overall survival rates were significantly different among the four groups, with three-year survival rates of 68%, 41%, 33%, and 0.03% for non-elevated, elevated, normalized, and non-normalized CRP groups respectively. When compared with the non-elevated group, hazard ratios of death were 1.69, 2.57, and 10.34 in the normalized, elevated, and non-normalized groups (P < 0.001). Conclusions: Baseline CRP and CRP kinetics may be useful to predict the prognosis of metastatic NPC patients treated with palliative chemotherapy and facilitate individualized treatment. A prospective study to validate this prognostic model is still needed however.	[Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Wei-Xiong; Ye, Yan-Fang; Lu, Xing; Wang, Lin; Ke, Liang-Ru; Zhang, Hai-Bo; Yang, Jing; Shi, Jun-Li; Cao, Ka-Jia; Guo, Xiang; Xiang, Yan-Qun] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Ye, Yan-Fang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Roycik, Mark D.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Roycik, Mark D.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Guo, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China.	guoxiang@sysucc.org.cn; xiangyq@sysucc.org.cn			National Natural Science Foundation of China [81172041]; Natural Science Foundation of Guangdong Province, China [S2011010005312]; Science and Technology Planning Project of Guangdong Province, China [B031500037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	Supported by National Natural Science Foundation of China (No. 81172041), Natural Science Foundation of Guangdong Province, China (S2011010005312) and Science and Technology Planning Project of Guangdong Province, China (No. B031500037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRES RB, 1987, MOL IMMUNOL, V24, P479, DOI 10.1016/0161-5890(87)90022-8; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Bidart JM, 1999, CLIN CHEM, V45, P1695; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; FALCONER JS, 1994, ANN SURG, V219, P325, DOI 10.1097/00000658-199404000-00001; Fandi A, 2000, J CLIN ONCOL, V18, P1324, DOI 10.1200/JCO.2000.18.6.1324; Gioulbasanis I, 2012, LUNG CANCER, V77, P383, DOI 10.1016/j.lungcan.2012.04.008; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Huang YT, 1999, CANCER RES, V59, P1599; Hui EP, 2004, CANCER-AM CANCER SOC, V101, P300, DOI 10.1002/cncr.20358; Iwanicki-Caron I, 2008, J CLIN ONCOL, V26, P3681, DOI 10.1200/JCO.2007.15.0904; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; KWONG D, 1994, INT J RADIAT ONCOL, V30, P1029, DOI 10.1016/0360-3016(94)90306-9; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lo YMD, 1999, CANCER RES, V59, P5452; Loong HH, 2008, HEMATOL ONCOL CLIN N, V22, P1267, DOI 10.1016/j.hoc.2008.08.012; Lu X, 2011, EUR J CANCER, V47, P339, DOI 10.1016/j.ejca.2010.09.025; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Saito K, 2012, BJU INT, V110, P1478, DOI 10.1111/j.1464-410X.2012.11153.x; Saito K, 2009, EUR UROL, V55, P1145, DOI 10.1016/j.eururo.2008.10.012; Scott HR, 2001, LUNG CANCER, V32, P307, DOI 10.1016/S0169-5002(00)00244-0; Shimoda M, 2010, CHEMOTHERAPY, V56, P501, DOI 10.1159/000321014; Srimuninnimit Vichien, 2012, J Med Assoc Thai, V95 Suppl 2, pS199; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wo JY, 2009, J CLIN ONCOL, V27, P6000, DOI 10.1200/JCO.2009.23.6067; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Xia WX, 2013, EUR J CANC, P00188; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	40	22	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76958	10.1371/journal.pone.0076958	http://dx.doi.org/10.1371/journal.pone.0076958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130817	gold, Green Submitted, Green Published			2022-12-25	WOS:000325814200045
J	Rios, FJO; Ferracini, M; Pecenin, M; Koga, MM; Wang, YJ; Ketelhuth, DFJ; Jancar, S				Rios, Francisco J. O.; Ferracini, Matheus; Pecenin, Mateus; Koga, Marianna M.; Wang, Yajuan; Ketelhuth, Daniel F. J.; Jancar, S.			Uptake of oxLDL and IL-10 Production by Macrophages Requires PAFR and CD36 Recruitment into the Same Lipid Rafts	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACTIVATING-FACTOR RECEPTOR; OXIDIZED PHOSPHOLIPIDS; PPAR-GAMMA; EXPRESSION; OXIDATION; MEMBRANE; LDL; ATHEROSCLEROSIS; RECOGNITION	Macrophage interaction with oxidized low-density lipoprotein (oxLDL) leads to its differentiation into foam cells and cytokine production, contributing to atherosclerosis development. In a previous study, we showed that CD36 and the receptor for platelet-activating factor (PAFR) are required for oxLDL to activate gene transcription for cytokines and CD36. Here, we investigated the localization and physical interaction of CD36 and PAFR in macrophages stimulated with oxLDL. We found that blocking CD36 or PAFR decreases oxLDL uptake and IL-10 production. OxLDL induces IL-10 mRNA expression only in HEK293T expressing both receptors (PAFR and CD36). OxLDL does not induce IL-12 production. The lipid rafts disruption by treatment with beta CD reduces the oxLDL uptake and IL-10 production. OxLDL induces co-immunoprecipitation of PAFR and CD36 with the constitutive raft protein flotillin-1, and colocalization with the lipid raft-marker GM1-ganglioside. Finally, we found colocalization of PAFR and CD36 in macrophages from human atherosclerotic plaques. Our results show that oxLDL induces the recruitment of PAFR and CD36 into the same lipid rafts, which is important for oxLDL uptake and IL-10 production. This study provided new insights into how oxLDL interact with macrophages and contributing to atherosclerosis development.	[Rios, Francisco J. O.; Ferracini, Matheus; Pecenin, Mateus; Koga, Marianna M.; Jancar, S.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Rios, Francisco J. O.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Wang, Yajuan; Ketelhuth, Daniel F. J.] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden	Universidade de Sao Paulo; University of Glasgow; Karolinska Institutet	Rios, FJO (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	fjorios@usp.br	Rios, Francisco J./C-6059-2012; Ferracini, Matheus/E-3820-2010; Jancar, Sonia/C-5153-2012; Fila Pecenin, Mateus/O-5433-2018; Ketelhuth, Daniel/F-6580-2012	Ferracini, Matheus/0000-0003-1523-6457; Jancar, Sonia/0000-0001-7983-3459; Fila Pecenin, Mateus/0000-0001-5799-012X; Ketelhuth, Daniel/0000-0002-0087-116X; Koga, Marianna/0000-0003-3244-9059; Rios, Francisco/0000-0002-8194-0787	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/03982-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant 2006/03982-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brocheriou I, 2000, CIRCULATION, V102, P2569; Chatterjee S, 2003, GLYCOCONJUGATE J, V20, P331, DOI 10.1023/B:GLYC.0000033629.54962.68; Davies John Q, 2005, Methods Mol Biol, V290, P91; de Oliveira SI, 2006, PROSTAG OTH LIPID M, V80, P62, DOI 10.1016/j.prostaglandins.2006.04.002; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Gaut JP, 2001, TRENDS CARDIOVAS MED, V11, P103, DOI 10.1016/S1050-1738(01)00101-3; GREENWALT DE, 1992, BLOOD, V80, P1105; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Itabe H, 1998, PROG LIPID RES, V37, P181, DOI 10.1016/S0163-7827(98)00009-5; Kazerounian S, 2011, BLOOD, V117, P4658, DOI 10.1182/blood-2010-09-305284; Ketelhuth DFJ, 2011, CIRCULATION, V124, P2433, DOI 10.1161/CIRCULATIONAHA.111.051599; Ketelhuth DFJ, 2011, THROMB HAEMOSTASIS, V106, P779, DOI 10.1160/TH11-05-0321; Kiyanagi T, 2011, ATHEROSCLEROSIS, V215, P60, DOI 10.1016/j.atherosclerosis.2010.10.019; Lemaire-Ewing S, 2012, ATHEROSCLEROSIS, V221, P303, DOI 10.1016/j.atherosclerosis.2011.10.016; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Pegorier S, 2006, ATHEROSCLEROSIS, V188, P433, DOI 10.1016/j.atherosclerosis.2005.11.015; Poisson C, 2009, J IMMUNOL, V183, P2747, DOI 10.4049/jimmunol.0802651; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Rios FJO, 2008, CELL PHYSIOL BIOCHEM, V22, P549, DOI 10.1159/000185539; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; SAKAI H, 1982, AM J CLIN PATHOL, V78, P58, DOI 10.1093/ajcp/78.1.58; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shin SH, 2010, CELL PHYSIOL BIOCHEM, V26, P689, DOI 10.1159/000322336; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Carvalho MDT, 2010, J ATHEROSCLER THROMB, V17, P844, DOI 10.5551/jat.3905; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verouti SN, 2011, ATHEROSCLEROSIS, V219, P519, DOI 10.1016/j.atherosclerosis.2011.07.123; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603	43	30	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76893	10.1371/journal.pone.0076893	http://dx.doi.org/10.1371/journal.pone.0076893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130805	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325810900099
J	Zeng, R; Xiong, Y; Zhu, FM; Ma, ZF; Liao, WH; He, Y; He, JS; Li, W; Yang, J; Lu, Q; Xu, G; Yao, Y				Zeng, Rui; Xiong, Yan; Zhu, Fengming; Ma, Zufu; Liao, Wenhui; He, Yong; He, JinSeng; Li, Wei; Yang, Juan; Lu, Qian; Xu, Gang; Yao, Ying			Fenofibrate Attenuated Glucose-Induced Mesangial Cells Proliferation and Extracellular Matrix Synthesis via PI3K/AKT and ERK1/2	PLOS ONE			English	Article							PPAR-ALPHA; DIABETIC-NEPHROPATHY; ACTIVATION; ARREST	Excess mesangial extracellular matrix (ECM) and mesangial cell proliferation is the major pathologic feature of diabetic nephropathy (DN). Fenofibrate, a PPAR alpha agonist, has been shown to attenuate extracellular matrix formation in diabetic nephropathy. However, the mechanisms underlying this effect remain to be elucidated. In this study, the effect of fenofibrate on high-glucose induced cell proliferation and extracellular matrix exertion and its mechanisms were investigated in cultured rat mesangial cells by the methylthiazoletetrazolium (MTT) assay, flow cytometry and western blot. The results showed that treatment of mesangial cells (MCs) with fenofibrate repressed high-glucose induced up-regulation of extracellular matrix Collagen-IV, and inhibited entry of cell cycle into the S phase. This G1 arrest and ECM inhibition was caused by the reduction of phosphorylation and activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and AKT. On the contrary, PPAR alpha siRNA accelerated high glucose-induced cell cycle progression by ERK1/2 and AKT activation. Taken together, fenofibrate ameliorated glucose-induced mesangial cell proliferation and matrix production via its inhibition of PI3K/AKT and ERK1/2 signaling pathways. Such mechanisms may contribute to the favorable effects of treatment using fenofibrate in diabetic nephropathy.	[Zeng, Rui; Xiong, Yan; Zhu, Fengming; Ma, Zufu; He, Yong; He, JinSeng; Li, Wei; Yang, Juan; Lu, Qian; Xu, Gang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol, Wuhan 430074, Hubei, Peoples R China; [Xiong, Yan] Wuhan 4 Hosp, Div Nephrol, Wuhan, Hubei, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Geriatr, Wuhan 430074, Hubei, Peoples R China; [He, Yong] Wuhan 5 Hosp, Div Nephrol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol, Wuhan 430074, Hubei, Peoples R China.	xugang@tjh.tjmu.edu.cn; yaoyingkk@126.com	Zeng, Rui/GRY-0646-2022; Yang, Juan/ABF-4433-2021	Zeng, Rui/0000-0003-1188-3198; 	National Nature Science Foundation of China (NSFC) [81170686, 81270771]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (NSFC) (numbers 81170686 and 81270771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Heljic Mediha, 2011, Front Biosci (Schol Ed), V3, P98, DOI 10.2741/s135; Hirasawa Y, 2011, EUR J PHARMACOL, V672, P159, DOI 10.1016/j.ejphar.2011.09.185; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Ingram AJ, 1999, KIDNEY INT, V56, P1721, DOI 10.1046/j.1523-1755.1999.00743.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; Kim YH, 2006, J CELL PHYSIOL, V209, P94, DOI 10.1002/jcp.20706; Kono K, 2009, AM J PHYSIOL-RENAL, V296, pF328, DOI 10.1152/ajprenal.00484.2007; Lee JJ, 2011, EUR J PHARMACOL, V650, P342, DOI 10.1016/j.ejphar.2010.10.046; Lee Sungchun, 2004, Curr Rheumatol Rep, V6, P141, DOI 10.1007/s11926-004-0059-3; Marks JB, 1998, MED CLIN N AM, V82, P877, DOI 10.1016/S0025-7125(05)70028-6; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Ohashi N, 2010, HYPERTENS RES, V33, P1174, DOI 10.1038/hr.2010.143; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Yoo KD, 2012, J PHARMACOL SCI, V118, P171, DOI 10.1254/jphs.11159FP	23	30	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76836	10.1371/journal.pone.0076836	http://dx.doi.org/10.1371/journal.pone.0076836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130796	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900091
J	Lane, MA; Kimber, M; Khokha, MK				Lane, Maura A.; Kimber, Megan; Khokha, Mustafa K.			Breeding Based Remobilization of Tol2 Transposon in Xenopus tropicalis	PLOS ONE			English	Article							MEDAKA FISH; GENE-TRAP; TRANSGENIC LINES; DNA TRANSPOSONS; ELEMENT; IDENTIFICATION; EXPRESSION; GENOME	Xenopus is a powerful model for studying a diverse array of biological processes. However, despite multiple methods for transgenesis, relatively few transgenic reporter lines are available and commonly used. Previous work has demonstrated that transposon based strategies are effective for generating transgenic lines in both invertebrate and vertebrate systems. Here we show that the Tol2 transposon can be remobilized in the genome of X. tropicalis and passed through the germline via a simple breeding strategy of crossing transposase expressing and transposon lines. This remobilization system provides another tool to exploit transgenesis and opens new opportunities for gene trap and enhancer trap strategies.	[Lane, Maura A.; Kimber, Megan; Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06511 USA	Yale University	Khokha, MK (corresponding author), Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06511 USA.	mustafa.khokha@yale.edu			NIH/NCRR [1R21RR025168]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025168] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	NIH/NCRR 1R21RR025168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Doherty JR, 2007, DEV DYNAM, V236, P2808, DOI 10.1002/dvdy.21321; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Hirsch N, 2002, DEV DYNAM, V225, P522, DOI 10.1002/dvdy.10188; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Koga A, 2004, ADV BIOPHYS, V38, P161, DOI 10.1016/S0065-227X(04)80151-5; Koga A, 1996, NATURE, V383, P30, DOI 10.1038/383030a0; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Offield MF, 2000, DEVELOPMENT, V127, P1789; Ogino H, 2006, MECH DEVELOP, V123, P103, DOI 10.1016/j.mod.2005.11.006; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Wallingford JB, 2010, CURR BIOL, V20, pR263, DOI 10.1016/j.cub.2010.01.012; Yergeau DA, 2007, NAT PROTOC, V2, P2975, DOI 10.1038/nprot.2007.428; Yergeau Donald A, 2012, Methods Mol Biol, V917, P111, DOI 10.1007/978-1-61779-992-1_6; Yergeau DA, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-15; Yergeau DA, 2010, METHODS, V51, P92, DOI 10.1016/j.ymeth.2010.03.001; Yergeau DA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-11; Yergeau DA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S11	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76807	10.1371/journal.pone.0076807	http://dx.doi.org/10.1371/journal.pone.0076807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116167	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200074
J	Maity, A; Yadav, S; Verma, CS; Dastidar, SG				Maity, Atanu; Yadav, Seema; Verma, Chandra S.; Dastidar, Shubhra Ghosh			Dynamics of Bcl-xL in Water and Membrane: Molecular Simulations	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; GENERALIZED BORN; PEPTIDE COMPLEX; CELL-DEATH; FAMILY PROTEINS; LIGAND-BINDING; FORCE-FIELDS; BCL-X(L); INHIBITOR; APOPTOSIS	The Bcl2 family of proteins is capable of switching the apoptotic machinery by directly controlling the release of apoptotic factors from the mitochondrial outer membrane. They have 'pro' and 'anti'-apoptotic subgroups of proteins which antagonize each other's function; however a detailed atomistic understanding of their mechanisms based on the dynamical events, particularly in the membrane, is lacking. Using molecular dynamics simulations totaling 1.6 mu s we outline the major differences between the conformational dynamics in water and in membrane. Using implicit models of solvent and membrane, the simulated results reveal a picture that is in agreement with the 'hit- and run' concept which states that BH3-only peptides displace the tail (which acts as a pseudo substrate of the protein itself) from its binding pocket; this helps the membrane association of the protein after which the BH3 peptide becomes free. From simulations, Bcl-xL appears to be auto-inhibited by its C-terminal tail that embeds into and covers the hydrophobic binding pocket. However the tail is unable to energetically compete with BH3-peptides in water. In contrast, in the membrane, neither the tail nor the BH3-peptides are stable in the binding pocket and appear to be easily dissociated off as the pocket expands in response to the hydrophobic environment. This renders the binding pocket large and open, thus receptive to interactions with other protein partners. Principal components of the motions are dramatically different in the aqueous and in the membrane environments and provide clues regarding the conformational transitions that Bcl-xL undergoes in the membrane, in agreement with the biochemical data.	[Maity, Atanu; Yadav, Seema; Dastidar, Shubhra Ghosh] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India; [Verma, Chandra S.] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Department of Science & Technology (India); Bose Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Dastidar, SG (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	sgd@jcbose.ac.in		Maity, Atanu/0000-0002-7795-692X	Department of Biotechnology, Government of India [BT/PR793/BID/7/370/2011]; CSIR, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This project (BT/PR793/BID/7/370/2011) is supported by the funding from the Department of Biotechnology, Government of India. AM receives funding from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bhat V, 2012, J MOL BIOL, V416, P57, DOI 10.1016/j.jmb.2011.12.015; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dastidar SG, 2011, CELL CYCLE, V10, P82, DOI 10.4161/cc.10.1.14345; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gemperli AC, 2005, J AM CHEM SOC, V127, P1596, DOI 10.1021/ja0441211; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Im W, 2005, P NATL ACAD SCI USA, V102, P6771, DOI 10.1073/pnas.0408135102; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; Kaufmann T, 2004, TRENDS CELL BIOL, V14, P8, DOI 10.1016/j.tcb.2003.11.005; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015; Li MY, 2008, J MOL MODEL, V14, P957, DOI 10.1007/s00894-008-0342-8; Ling BP, 2012, J MOL GRAPH MODEL, V35, P1, DOI 10.1016/j.jmgm.2012.01.005; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lugovskoy AA, 2002, J AM CHEM SOC, V124, P1234, DOI 10.1021/ja011239y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Wolf A, 2013, J MOL MODEL, V19, P539, DOI 10.1007/s00894-012-1563-4; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	62	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76837	10.1371/journal.pone.0076837	http://dx.doi.org/10.1371/journal.pone.0076837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116174	Green Published, gold			2022-12-25	WOS:000325552200078
J	Secher, T; Samba-Louaka, A; Oswald, E; Nougayrede, JP				Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe			Escherichia coli Producing Colibactin Triggers Premature and Transmissible Senescence in Mammalian Cells	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; PERSISTENT DNA-DAMAGE; CELLULAR SENESCENCE; OXIDATIVE STRESS; CANCER; FIBROBLASTS; EXPRESSION; PML; P53; INFLAMMATION	Cellular senescence is an irreversible state of proliferation arrest evoked by a myriad of stresses including oncogene activation, telomere shortening/dysfunction and genotoxic insults. It has been associated with tumor activation, immune suppression and aging, owing to the secretion of proinflammatory mediators. The bacterial genotoxin colibactin, encoded by the pks genomic island is frequently harboured by Escherichia coli strains of the B2 phylogenetic group. Mammalian cells exposed to live pks+ bacteria exhibit DNA-double strand breaks (DSB) and undergo cell-cycle arrest and death. Here we show that cells that survive the acute bacterial infection with pks+ E. coli display hallmarks of cellular senescence: chronic DSB, prolonged cell-cycle arrest, enhanced senescence-associated beta-galactosidase (SA-beta-Gal) activity, expansion of promyelocytic leukemia nuclear foci and senescence-associated heterochromatin foci. This was accompanied by reactive oxygen species production and pro-inflammatory cytokines, chemokines and proteases secretion. These mediators were able to trigger DSB and enhanced SA-beta-Gal activity in bystander recipient cells treated with conditioned medium from senescent cells. Furthermore, these senescent cells promoted the growth of human tumor cells. In conclusion, the present data demonstrated that the E. coli genotoxin colibactin induces cellular senescence and subsequently propel bystander genotoxic and oncogenic effects.	[Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] INRA, USC 1360, F-31931 Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Fac Med Toulouse, INSERM, UMR 1043, F-31073 Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] CNRS, UMR 5282, Toulouse, France; [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Univ Toulouse, UPS, CPTP, Toulouse, France; [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Nougayrede, JP (corresponding author), INRA, USC 1360, F-31931 Toulouse, France.	jean-philippe.nougayrede@toulouse.inra.fr	SECHER, Thomas/P-4795-2016; Nougayrede, Jean-Philippe/I-6362-2019; Samba-Louaka, Ascel/H-7073-2016	Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; Samba-Louaka, Ascel/0000-0003-4417-6254	French fondation ARC pour la recherche sur le cancer [SFI20101201751]; Agence Nationale de la Recherche [ANR-10-CESA-0011, ANR-09-MIE-005]; INRA [AO-blanc-2010]; conseil regional de Midi-Pyrenees [12050986]	French fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; conseil regional de Midi-Pyrenees(Region Occitanie)	This work was made possible by financial support SFI20101201751 from the French fondation ARC pour la recherche sur le cancer, by the Agence Nationale de la Recherche (ANR-10-CESA-0011) and grant AO-blanc-2010 from INRA. Thomas Secher was supported by the Agence Nationale de la Recherche (ANR-09-MIE-005) and by the conseil regional de Midi-Pyrenees (12050986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chen QM, 2000, J CELL SCI, V113, P4087; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frippiat C, 2000, EXP GERONTOL, V35, P733, DOI 10.1016/S0531-5565(00)00167-4; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Ohtani S, 2004, MOL CANCER THER, V3, P93; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; WANG X, 2013, CANCER PREV RES, V6, P971; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2012, GASTROENTEROLOGY, V142, P543, DOI 10.1053/j.gastro.2011.11.020; Yang YH, 2012, CANCER RES, V72, P5219, DOI 10.1158/0008-5472.CAN-12-1463; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	69	76	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77157	10.1371/journal.pone.0077157	http://dx.doi.org/10.1371/journal.pone.0077157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116215	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200107
J	Tan, A; Goh, D; Farhatnia, Y; Natasha, G; Lim, J; Teoh, SH; Rajadas, J; Alavijeh, MS; Seifalian, AM				Tan, Aaron; Goh, Debbie; Farhatnia, Yasmin; Natasha, G.; Lim, Jing; Teoh, Swee-Hin; Rajadas, Jayakumar; Alavijeh, Mohammad S.; Seifalian, Alexander M.			An Anti-CD34 Antibody-Functionalized Clinical-Grade POSS-PCU Nanocomposite Polymer for Cardiovascular Stent Coating Applications: A Preliminary Assessment of Endothelial Progenitor Cell Capture and Hemocompatibility	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; IN-SITU ENDOTHELIALIZATION; INFRAINGUINAL EPTFE GRAFTS; SIROLIMUS-ELUTING STENTS; HUMAN PERIPHERAL-BLOOD; BYPASS GRAFT; VITRO ENDOTHELIALIZATION; REGENERATIVE MEDICINE; PLATELET-ADHESION; VIVO	In situ endothelialization of cardiovascular implants has emerged in recent years as an attractive means of targeting the persistent problems of thrombosis and intimal hyperplasia. This study aimed to investigate the efficacy of immobilizing anti-CD34 antibodies onto a POSS-PCU nanocomposite polymer surface to sequester endothelial progenitor cells (EPCs) from human blood, and to characterize the surface properties and hemocompatibility of this surface. Amine-functionalized fumed silica was used to covalently conjugate anti-CD34 to the polymer surface. Water contact angle, fluorescence microscopy, and scanning electron microscopy were used for surface characterization. Peripheral blood mononuclear cells (PBMCs) were seeded on modified and pristine POSS-PCU polymer films. After 7 days, adhered cells were immunostained for the expression of EPC and endothelial cell markers, and assessed for the formation of EPC colonies. Hemocompatibility was assessed by thromboelastography, and platelet activation and adhesion assays. The number of EPC colonies formed on anti-CD34-coated POSS-PCU surfaces was not significantly higher than that of POSS-PCU (5.0+/-1.0 vs. 1.7+/-0.6, p>0.05). However, antibody conjugation significantly improved hemocompatibility, as seen from the prolonged reaction and clotting times, decreased angle and maximum amplitude (p<0.05), as well as decreased platelet adhesion (76.8+/-7.8 vs. 8.4+/-0.7, p<0.05) and activation. Here, we demonstrate that POSS-PCU surface immobilized anti-CD34 antibodies selectively captured CD34(+) cells from peripheral blood, although only a minority of these were EPCs. Nevertheless, antibody conjugation significantly improves the hemocompatibility of POSS-PCU, and should therefore continue to be explored in combination with other strategies to improve the specificity of EPC capture to promote in situ endothelialization.	[Tan, Aaron; Goh, Debbie; Farhatnia, Yasmin; Natasha, G.; Seifalian, Alexander M.] UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England; [Tan, Aaron; Goh, Debbie; Natasha, G.] UCL, UCL Med Sch, London, England; [Lim, Jing; Teoh, Swee-Hin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 639798, Singapore; [Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Sch Med, Stanford, CA 94305 USA; [Alavijeh, Mohammad S.] Pharmidex Pharmaceut Serv Ltd, London, England; [Seifalian, Alexander M.] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; University of London; University College London; Royal Free London NHS Foundation Trust	Seifalian, AM (corresponding author), UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England.	a.seifalian@ucl.ac.uk	Seifalian, Alexander M/I-6028-2013; Rajadas, Jayakumar/AHC-0630-2022; Alavijeh, Mo/AFU-7249-2022	Seifalian, Alexander M/0000-0002-1180-3322; G, Natasha/0000-0002-9262-4595; Rajadas, Jayakumar/0000-0001-6520-3923; Tan, Aaron/0000-0002-8935-0773; seifalian, Alexander/0000-0002-8334-9376; Alavijeh, Mo/0000-0002-2136-8344	Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE	Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE	This research was supported by funding from the Engineering and Physical Sciences Research Council (EPSRC) - Industrial CASE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED M., 2011, THESIS; Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051; Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034; Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13; Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Brito LA, 2010, J BIOMED MATER RES A, V93A, P325, DOI 10.1002/jbm.a.32488; Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056; Chong MSK, 2010, TISSUE ENG PT A, V16, P2485, DOI [10.1089/ten.tea.2009.0680, 10.1089/ten.TEA.2009.0680]; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dambisya YM, 1996, BLOOD COAGUL FIBRIN, V7, P678, DOI 10.1097/00001721-199610000-00003; de Mel A, 2011, THESIS; de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597; Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1016/S0039-6060(99)70025-5; Duckers Henricus J, 2007, EuroIntervention, V3, P67; Duckers Henricus J, 2007, EuroIntervention, V3, P350; EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x; Eunju O, 2011, FASEB J, V25, P159, DOI 10.1096/fj.10-162040; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Ghanbari Alanagh H, 2011, THESIS; Ghanbari H, 2010, ACTA BIOMATER, V6, P4249, DOI 10.1016/j.actbio.2010.06.015; Goh D, 2013, MOL PHARMACEUT, V10, P1279, DOI 10.1021/mp3006616; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; Greenhalgh J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004587.pub2; Heyligers J, 2006, NOVEL STRATEGIES IMP, P53; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z; Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006; Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b; Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025; KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.3.CO;2-F; Markway BD, 2008, TISSUE ENG PART C-ME, V14, P97, DOI 10.1089/ten.tec.2007.0300; Marois Y., 2000, BIOCOMPATIBILITY POL; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3; Melchiorri AJ, 2013, TISSUE ENG PART B-RE, V19, P292, DOI [10.1089/ten.TEB.2012.0577, 10.1089/ten.teb.2012.0577]; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Niccoli G, 2010, J AM COLL CARDIOL, V56, P1783, DOI 10.1016/j.jacc.2010.06.045; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Punshon G, 2008, CELL PROLIFERAT, V41, P321, DOI 10.1111/j.1365-2184.2008.00523.x; Punshon G, 2011, BIOTECHNOL APPL BIOC, V58, P328, DOI 10.1002/bab.47; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Scott EA, 2008, BIOMATERIALS, V29, P4481, DOI 10.1016/j.biomaterials.2008.08.003; Silber S, 2011, EUROINTERVENTION, V6, P819, DOI 10.4244/EIJV6I7A141; Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042; Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A; Tan A, 2013, J BIOTECHNOL, V164, P151, DOI 10.1016/j.jbiotec.2013.01.020; Tan A, 2010, CURR PHARM DESIGN, V16, P3848, DOI 10.2174/138161210794455058; Tang Y, 2009, POLYM ADVAN TECHNOL, V20, P1, DOI 10.1002/pat.1229; Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI [10.1089/ten.teb.2009.0527, 10.1089/ten.TEB.2009.0527]; Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020; Yazdani S. K., 2012, J INTERV CARDIOL, V4, P169, DOI DOI 10.2217/ICA.11.99	69	36	37	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77112	10.1371/journal.pone.0077112	http://dx.doi.org/10.1371/journal.pone.0077112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116210	Green Published, gold			2022-12-25	WOS:000325552200103
J	Chu, ZT; Abu-Baker, S; Palascak, MB; Ahmad, SA; Franco, RS; Qi, XY				Chu, Zhengtao; Abu-Baker, Shadi; Palascak, Mary B.; Ahmad, Syed A.; Franco, Robert S.; Qi, Xiaoyang			Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer	PLOS ONE			English	Article							SPHINGOLIPID ACTIVATOR PROTEINS; ACID BETA-GLUCOSIDASE; SAPOSIN-C; MEMBRANE INTERACTIONS; CELL-LINES; PHOSPHATIDYLSERINE; CERAMIDE; BINDING; DESTABILIZATION; EXPRESSION	Only a small number of promising drugs target pancreatic cancer, which is the fourth leading cause of cancer deaths with a 5-year survival of less than 5%. Our goal is to develop a new biotherapeutic agent in which a lysosomal protein (saposin C, SapC) and a phospholipid (dioleoylphosphatidylserine, DOPS) are assembled into nanovesicles (SapC-DOPS) for treating pancreatic cancer. A distinguishing feature of SapC-DOPS nanovesicles is their high affinity for phosphatidylserine (PS) rich microdomains, which are abnormally exposed on the membrane surface of human pancreatic tumor cells. To evaluate the role of external cell PS, in vitro assays were used to correlate PS exposure and the cytotoxic effect of SapC-DOPS in human tumor and nontumorigenic pancreatic cells. Next, pancreatic tumor xenografts (orthotopic and subcutaneous models) were used for tumor targeting and therapeutic efficacy studies with systemic SapC-DOPS treatment. We observed that the nanovesicles selectively killed human pancreatic cancer cells in vitro by inducing apoptotic death, whereas untransformed cells remained unaffected. This in vitro cytotoxic effect correlated to the surface exposure level of PS on the tumor cells. Using xenografts, animals treated with SapC-DOPS showed clear survival benefits and their tumors shrank or disappeared. Furthermore, using a double-tracking method in live mice, we showed that the nanovesicles were specifically targeted to orthotopically-implanted, bioluminescent pancreatic tumors. These data suggest that the acidic phospholipid PS is a biomarker for pancreatic cancer that can be effectively targeted for therapy utilizing cancer-selective SapC-DOPS nanovesicles. This study provides convincing evidence in support of developing a new therapeutic approach to pancreatic cancer.	[Chu, Zhengtao; Abu-Baker, Shadi; Palascak, Mary B.; Franco, Robert S.; Qi, Xiaoyang] Univ Cincinnati Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA; [Ahmad, Syed A.] Univ Cincinnati Coll Med, Dept Surg, Cincinnati, OH USA; [Qi, Xiaoyang] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Qi, XY (corresponding author), Univ Cincinnati Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA.	xiaoyang.qi@uc.edu			NIH/NCI [1R01CA158372-01, 1R43CA117283-01]; New Drug State Key Project [009ZX09102-205]; NATIONAL CANCER INSTITUTE [R01CA158372] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New Drug State Key Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH/NCI Grants Number 1R01CA158372-01 (to Qi), 1R43CA117283-01(to Qi and Xu), and New Drug State Key Project Grant Number 009ZX09102-205 (to Qi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Baker Shadi, 2012, J Cancer Ther, V3, P321; Allison A C, 1974, J Clin Pathol Suppl (R Coll Pathol), V7, P43; [Anonymous], 2000, METABOLIC MOL BASES; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; BOYER MJ, 1993, ADV CANCER RES, V60, P269; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chua ZT, 2005, ANN NY ACAD SCI, V1053, P237, DOI 10.1196/annals.1344.021; Ditaranto-Desimone K, 2003, BRAIN RES BULL, V59, P523, DOI 10.1016/S0361-9230(02)00948-6; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Harzer K, 1997, FEBS LETT, V417, P270, DOI 10.1016/S0014-5793(97)01302-1; Hendrich AB, 2003, CURR DRUG TARGETS, V4, P23, DOI 10.2174/1389450033347172; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; HIRAIWA M, 1993, ARCH BIOCHEM BIOPHYS, V303, P326, DOI 10.1006/abbi.1993.1291; HOELZL DF, 1969, NEW ENGL J MED, V280, P761, DOI 10.1056/NEJM196904032801406; Hoffmann D, 2006, MOL CANCER THER, V5, P2013, DOI 10.1158/1535-7163.MCT-06-0128; Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341; Kaimal V, 2011, MOL IMAGING BIOL, V13, P886, DOI 10.1007/s11307-010-0417-7; Kang R, 2012, AM J CANCER RES, V2, P383; Kilkus J, 2003, J NEUROSCI RES, V72, P65, DOI 10.1002/jnr.10549; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; MORIMOTO S, 1990, P NATL ACAD SCI USA, V87, P3493, DOI 10.1073/pnas.87.9.3493; Qi XY, 2009, CLIN CANCER RES, V15, P5840, DOI 10.1158/1078-0432.CCR-08-3285; Qi XY, 2004, ARCH BIOCHEM BIOPHYS, V424, P210, DOI 10.1016/j.abb.2004.02.023; QI XY, 1994, J BIOL CHEM, V269, P16746; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Unger C, 1996, J CANCER RES CLIN, V122, P189, DOI 10.1007/BF01209645; UTSUGI T, 1991, CANCER RES, V51, P3062; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallach D F, 1969, Curr Top Microbiol Immunol, V47, P152; Wallach D F, 1978, Pathobiol Annu, V8, P189; Wang Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P43, DOI 10.1016/S0003-9861(03)00219-4; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; You HX, 2003, BIOPHYS J, V84, P2043, DOI 10.1016/S0006-3495(03)75012-7; You HX, 2001, FEBS LETT, V503, P97, DOI 10.1016/S0014-5793(01)02700-4	42	32	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75507	10.1371/journal.pone.0075507	http://dx.doi.org/10.1371/journal.pone.0075507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124494	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100051
J	Goatley, CHR; Bellwood, DR				Goatley, Christopher H. R.; Bellwood, David R.			Ecological Consequences of Sediment on High-Energy Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COMMUNITY STRUCTURE; EPILITHIC ALGAL; CLIMATE-CHANGE; HERBIVOROUS FISH; RESILIENCE; SHELF; DIVERSITY; MORTALITY; PATTERNS	Sediments are widely accepted as a threat to coral reefs but our understanding of their ecological impacts is limited. Evidence has suggested that benthic sediments bound within the epilithic algal matrix (EAM) suppress reef fish herbivory, a key ecological process maintaining reef resilience. An experimental combination of caging and sediment addition treatments were used to investigate the effects of sediment pulses on herbivory and EAMs and to determine whether sediment addition could trigger a positive-feedback loop, leading to deep, sediment-rich turfs. A 1-week pulsed sediment addition resulted in rapid increases in algal turf length with effects comparable to those seen in herbivore exclusion cages. Contrary to the hypothesised positive-feedback mechanism, benthic sediment loads returned to natural levels within 3 weeks, however, the EAM turfs remained almost 60% longer for at least 3 months. While reduced herbivore density is widely understood to be a major threat to reefs, we show that acute disturbances to reef sediments elicit similar ecological responses in the EAM. With reefs increasingly threatened by both reductions in herbivore biomass and altered sediment fluxes, the development of longer turfs may become more common on coral reefs.	[Goatley, Christopher H. R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	christopher.goatley@my.jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	Lizard Island Reef Research Foundation; Australian Museum through a Lizard Island Doctoral Fellowship; Australian Research Council	Lizard Island Reef Research Foundation; Australian Museum through a Lizard Island Doctoral Fellowship; Australian Research Council(Australian Research Council)	This study was funded by the Lizard Island Reef Research Foundation and the Australian Museum, through a Lizard Island Doctoral Fellowship (C.H.R.G.), and the Australian Research Council (D.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; CARPENTER RC, 1993, LIMNOL OCEANOGR, V38, P687, DOI 10.4319/lo.1993.38.3.0687; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Downie RA, 2013, MAR ECOL PROG SER, V482, P217, DOI 10.3354/meps10250; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; ENTSCH B, 1983, LIMNOL OCEANOGR, V28, P465, DOI 10.4319/lo.1983.28.3.0465; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Esslemont G, 2004, J MARINE SYST, V52, P51, DOI 10.1016/j.jmarsys.2004.01.005; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2007, CORAL REEFS, V26, P69, DOI 10.1007/s00338-006-0171-0; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fox RJ, 2013, CORAL REEFS, V32, P13, DOI 10.1007/s00338-012-0945-5; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; GAGAN MK, 1988, J SEDIMENT PETROL, V58, P845; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; Goatley CHR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027307; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kench PS, 2006, J COASTAL RES, V22, P209, DOI 10.2112/05A-0016.1; Kench PS, 1998, MAR GEOL, V145, P197, DOI 10.1016/S0025-3227(97)00101-1; Kramer MJ, 2013, MAR FRESHWATER RES, V64, P687, DOI 10.1071/MF12284; Kramer MJ, 2012, CORAL REEFS, V31, P1007, DOI 10.1007/s00338-012-0924-x; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Mallela J, 2007, J FISH BIOL, V70, P523, DOI 10.1111/j.1095-8649.2007.01323.x; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Prathep A, 2003, MAR BIOL, V142, P381, DOI 10.1007/s00227-002-0940-4; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Purcell SW, 2000, B MAR SCI, V66, P199; Purcell SW, 1996, CORAL REEFS, V15, P211, DOI 10.1007/BF01787453; SCOFFIN TP, 1992, CORAL REEFS, V11, P57, DOI 10.1007/BF00357423; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; Verges A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045543; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vroom PS, 2011, MAR BIOL; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson S, 2002, J EXP MAR BIOL ECOL, V271, P155, DOI 10.1016/S0022-0981(02)00035-7; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; WOLANSKI E, 1992, WATER ENVIRON RES, V64, P910, DOI 10.2175/WER.64.7.9	63	51	51	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77737	10.1371/journal.pone.0077737	http://dx.doi.org/10.1371/journal.pone.0077737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124619	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000325489100177
J	Gupta, S; Utoft, R; Hasseldam, H; Schmidt-Christensen, A; Hannibal, TD; Hansen, L; Fransen-Pettersson, N; Agarwal-Gupta, N; Rozell, B; Andersson, A; Holmberg, D				Gupta, Shashank; Utoft, Regine; Hasseldam, Henrik; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Agarwal-Gupta, Noopur; Rozell, Bjorn; Andersson, Asa; Holmberg, Dan			Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; TIME-COURSE; MRI; EXPRESSION; QUANTIFICATION; INFLAMMATION; PEPTIDE; MICE; VISUALIZATION	Multiple Sclerosis (MS) is a progressive autoimmune inflammatory and demyelinating disease of the central nervous system (CNS). T cells play a key role in the progression of neuroinflammation in MS and also in the experimental autoimmune encephalomyelitis (EAE) animal models for the disease. A technology for quantitative and 3 dimensional (3D) spatial assessment of inflammation in this and other CNS inflammatory conditions is much needed. Here we present a procedure for 3D spatial assessment and global quantification of the development of neuroinflammation based on Optical Projection Tomography (OPT). Applying this approach to the analysis of rodent models of MS, we provide global quantitative data of the major inflammatory component as a function of the clinical course. Our data demonstrates a strong correlation between the development and progression of neuroinflammation and clinical disease in several mouse and a rat model of MS refining the information regarding the spatial dynamics of the inflammatory component in EAE. This method provides a powerful tool to investigate the effect of environmental and genetic forces and for assessing the therapeutic effects of drug therapy in animal models of MS and other neuroinflammatory/neurodegenerative disorders.	[Gupta, Shashank; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Holmberg, Dan] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Gupta, Shashank; Schmidt-Christensen, Anja; Hannibal, Tine Dahlbaek; Hansen, Lisbeth; Fransen-Pettersson, Nina; Holmberg, Dan] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Gupta, Shashank; Rozell, Bjorn; Holmberg, Dan] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Utoft, Regine; Andersson, Asa] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Hasseldam, Henrik; Agarwal-Gupta, Noopur] Univ Copenhagen, Dept Biomed Sci, BRIC, Copenhagen, Denmark; [Agarwal-Gupta, Noopur] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen; Lund University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Holmberg, D (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	dan.holmberg@med.lu.se	Hasseldam, Henrik/G-8810-2017; Schmidt-Christensen, Anja/L-6284-2016	Schmidt-Christensen, Anja/0000-0001-5813-9118; /0000-0003-4360-7710; Fransen Pettersson, Nina/0000-0002-5049-1544; Hasseldam, Henrik/0000-0002-4515-5343; Hannibal, Tine/0000-0001-8036-6704	Lundbeck foundation; Skleroseforeningen; Swedish research council; Danish Research Council	Lundbeck foundation(Lundbeckfonden); Skleroseforeningen; Swedish research council(Swedish Research CouncilEuropean Commission); Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by grants from The Lundbeck foundation, Skleroseforeningen, The Swedish research council and the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2013, EXP NEUROL, V240, P130, DOI 10.1016/j.expneurol.2012.11.004; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; Baeten K, 2008, J NEUROIMMUNOL, V195, P1, DOI 10.1016/j.jneuroim.2007.11.008; Barkhof F, 2012, NAT REV NEUROL, V8, P13, DOI 10.1038/nrneurol.2011.190; Begolka WS, 1998, J IMMUNOL, V161, P4437; Boretius S, 2006, NMR BIOMED, V19, P41, DOI 10.1002/nbm.999; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Espejo C, 2005, NEUROSCIENCE, V132, P1135, DOI 10.1016/j.neuroscience.2005.01.057; Filippi M, 1996, BRAIN, V119, P1349, DOI 10.1093/brain/119.4.1349; Gareau PJ, 2002, J MAGN RESON IMAGING, V16, P28, DOI 10.1002/jmri.10136; JANSSON L, 1991, EUR J IMMUNOL, V21, P693, DOI 10.1002/eji.1830210323; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Lycklama G, 2003, LANCET NEUROL, V2, P555, DOI 10.1016/S1474-4422(03)00504-0; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Morrissey SP, 1996, BRAIN, V119, P239, DOI 10.1093/brain/119.1.239; Muller YD, 2013, AM J TRANSPLANT, V13, P1093, DOI 10.1111/ajt.12138; Nessler S, 2007, BRAIN, V130, P2186, DOI 10.1093/brain/awm105; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Recks MS, 2011, NEUROSCI LETT, V494, P227, DOI 10.1016/j.neulet.2011.03.021; Robinson KM, 2010, MOL IMAGING BIOL, V12, P240, DOI 10.1007/s11307-009-0272-6; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Skundric DS, 2005, CURR NEUROVASC RES, V2, P349, DOI 10.2174/156720205774322601; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Stosic-Grujicic S, 2004, CLIN EXP IMMUNOL, V136, P49, DOI 10.1111/j.1365-2249.2004.02418.x; Traboulsee Anthony L, 2006, Adv Neurol, V98, P125; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P774, DOI 10.1002/jmri.21678; Zargari M, 2007, NEUROSCI LETT, V412, P24, DOI 10.1016/j.neulet.2006.08.033	33	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76330	10.1371/journal.pone.0076330	http://dx.doi.org/10.1371/journal.pone.0076330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124545	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100102
J	Lunn, D; Gaddipati, SR; Tucker, GA; Lycett, GW				Lunn, Daniel; Gaddipati, Sanyasi R.; Tucker, Gregory A.; Lycett, Grantley W.			Null Mutants of Individual RABA Genes Impact the Proportion of Different Cell Wall Components in Stem Tissue of Arabidopsis thaliana	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; MEMBRANE TRAFFICKING; VESICLE TRAFFICKING; GOLGI BODIES; BREFELDIN-A; ROOT-CELLS; POLYSACCHARIDES; PROTEINS; GTPASES; PLANTS	In Arabidopsis, and other plants, the RABA GTPases (orthologous to the Rab11a of mammals) have expanded in number and diversity and have been shown to belong to eight sub clades, some of which have been implicated in controlling vesicles that traffic cell wall polymers and enzymes that synthesise or modify them to the cell wall. In order to investigate this, we have investigated whether T-DNA insertion knockouts of individual RABA genes belonging to different sub clades, impact on the composition of the plant cell wall. Single gene knockouts of the RABA1, RABA2 and RABA4 sub clades primarily affected the percentage composition of pectin, cellulose and hemicellulose within the cell wall, respectively, despite having no obvious phenotype in the whole plant. We hypothesise that vesicles carrying specific types of cargoes from the Golgi to the cell surface may be regulated by particular sub types of RABA proteins, a finding that could have wider implications for how trafficking systems work and could be a useful tool in cell wall research and other fields of plant biology.	[Lunn, Daniel; Gaddipati, Sanyasi R.; Tucker, Gregory A.; Lycett, Grantley W.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Nottingham	Lycett, GW (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	grantley.lycett@nottingham.ac.uk	Lycett, Grantley/B-1553-2008	Lycett, Grantley/0000-0001-6283-9440; Tejeda-Lunn, Daniel/0000-0002-9386-1568; Tucker, Gregory/0000-0002-3377-9132	Targetted Priority Studentship in Bioenergy from BBSRC [BB/G017964/1]; BBSRC [BB/G01616X/1]; Biotechnology and Biological Sciences Research Council [BB/G01616X/1] Funding Source: researchfish	Targetted Priority Studentship in Bioenergy from BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DL was supported by a Targetted Priority Studentship in Bioenergy (number BB/G017964/1) from BBSRC (http://www.bbsrc.ac.uk). SRG, as a part of LACE (Lignocellulose agricultural waste to ethanol), was also supported by a BBSRC grant (number BB/G01616X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Baluska F, 2005, PROTOPLASMA, V225, P141, DOI 10.1007/s00709-005-0095-5; binZainal Z, 1996, BBA-MOL CELL RES, V1314, P187, DOI 10.1016/S0167-4889(96)00133-4; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chen LM, 1998, PLANT J, V16, P385, DOI 10.1046/j.1365-313x.1998.00301.x; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; De Caroli M, 2011, PLANT J, V65, P295, DOI 10.1111/j.1365-313X.2010.04421.x; de Graaf BHJ, 2005, PLANT CELL, V17, P2564, DOI 10.1105/tpc.105.033183; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Lanubile R, 1997, J EXP BOT, V48, P1925, DOI 10.1093/jexbot/48.316.1925; Leucci MR, 2007, PLANTA, V225, P1001, DOI 10.1007/s00425-006-0407-9; Lu CG, 2001, PLANT CELL, V13, P1819, DOI 10.1105/tpc.13.8.1819; Lunn D, 2013, PLANT PHYSIOL BIOCH, V66, P91, DOI 10.1016/j.plaphy.2013.02.005; Lycett G, 2008, J EXP BOT, V59, P4061, DOI 10.1093/jxb/ern255; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MOORE PJ, 1991, J CELL BIOL, V112, P589, DOI 10.1083/jcb.112.4.589; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rehman RU, 2008, PLANT CELL PHYSIOL, V49, P751, DOI 10.1093/pcp/pcn051; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Toyooka K, 2009, PLANT CELL, V21, P1212, DOI 10.1105/tpc.108.058933; Wightman R, 2010, PLANT PHYSIOL, V153, P427, DOI 10.1104/pp.110.154666; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Zeef LAH, 2006, MEXP 265 TRANSCRIPTI	39	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75724	10.1371/journal.pone.0075724	http://dx.doi.org/10.1371/journal.pone.0075724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124508	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100065
J	Mirza, M; Volz, C; Karlstetter, M; Langiu, M; Somogyi, A; Ruonala, MO; Tamm, ER; Jagle, H; Langmann, T				Mirza, Myriam; Volz, Cornelia; Karlstetter, Marcus; Langiu, Monica; Somogyi, Aleksandra; Ruonala, Mika O.; Tamm, Ernst R.; Jaegle, Herbert; Langmann, Thomas			Progressive Retinal Degeneration and Glial Activation in the CLN6(nclf) Mouse Model of Neuronal Ceroid Lipofuscinosis: A Beneficial Effect of DHA and Curcumin Supplementation	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN; DISEASE; CLN6; MUTATIONS; MICROGLIA; CELLS; MICE; GENE; NEUROPATHOLOGY; SURVIVAL	Neuronal ceroid lipofuscinosis (NCL) is a group of neurodegenerative lysosomal storage disorders characterized by vision loss, mental and motor deficits, and spontaneous seizures. Neuropathological analyses of autopsy material from NCL patients and animal models revealed brain atrophy closely associated with glial activity. Earlier reports also noticed loss of retinal cells and reactive gliosis in some forms of NCL. To study this phenomenon in detail, we analyzed the ocular phenotype of CLN6(nclf) mice, an established mouse model for variant-late infantile NCL. Retinal morphometry, immunohistochemistry, optokinetic tracking, electroretinography, and mRNA expression were used to characterize retinal morphology and function as well as the responses of Muller cells and microglia. Our histological data showed a severe and progressive degeneration in the CLN6(nclf) retina co-inciding with reactive Muller glia. Furthermore, a prominent phenotypic transformation of ramified microglia to phagocytic, bloated, and mislocalized microglial cells was identified in CLN6(nclf) retinas. These events overlapped with a rapid loss of visual perception and retinal function. Based on the strong microglia reactivity we hypothesized that dietary supplementation with immuno-regulatory compounds, curcumin and docosahexaenoic acid (DHA), could ameliorate microgliosis and reduce retinal degeneration. Our analyses showed that treatment of three-week-old CLN6(nclf) mice with either 5% DHA or 0.6% curcumin for 30 weeks resulted in a reduced number of amoeboid reactive microglia and partially improved retinal function. DHA-treatment also improved the morphology of CLN6(nclf) retinas with a preserved thickness of the photoreceptor layer in most regions of the retina. Our results suggest that microglial reactivity closely accompanies disease progression in the CLN6(nclf) retina and both processes can be attenuated with dietary supplemented immuno-modulating compounds.	[Mirza, Myriam] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Mirza, Myriam; Karlstetter, Marcus; Jaegle, Herbert] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Volz, Cornelia; Langmann, Thomas] Univ Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany; [Langiu, Monica; Somogyi, Aleksandra; Ruonala, Mika O.] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany; [Tamm, Ernst R.] Univ Regensburg, Inst Human Anat & Embryol, D-93053 Regensburg, Germany	University of Regensburg; University of Cologne; University of Regensburg; Goethe University Frankfurt; University of Regensburg	Langmann, T (corresponding author), Univ Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany.	thomas.langmann@uk-koeln.de	Langmann, Thomas/HHZ-9814-2022; Volz, Cornelia/ABB-4451-2021; Tamm, Ernst/AAB-9772-2019; Somogyi, Aleksandra/P-5267-2018; Jägle, Herbert/GPP-2945-2022	Langmann, Thomas/0000-0001-6826-529X; Tamm, Ernst/0000-0002-6679-8743; Langiu, Monica/0000-0003-0719-8999; Somogyi, Aleksandra/0000-0003-3079-2849	NCL foundation; Auerbach foundation; NCL group Germany; Stock foundation; DFG [LA1203/6-2, 8-1]	NCL foundation; Auerbach foundation; NCL group Germany; Stock foundation; DFG(German Research Foundation (DFG))	This study was supported by the NCL foundation, the Auerbach foundation, the NCL group Germany, the Stock foundation, and the DFG (LA1203/6-2 and 8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2012, J NEUROSCI RES, V90, P575, DOI 10.1002/jnr.22783; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Goebel HH, 1999, MOL GENET METAB, V66, P367, DOI 10.1006/mgme.1999.2808; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Groh J, 2013, BRAIN, V136, P1083, DOI 10.1093/brain/awt020; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; He LF, 2010, BRAIN RES, V1339, P60, DOI 10.1016/j.brainres.2010.04.014; Hlawatsch J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060633; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jang S, 2010, NUTR REV, V68, P719, DOI 10.1111/j.1753-4887.2010.00336.x; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P299, DOI 10.1007/BF00710270; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Lei B, 2006, J NEUROSCI RES, V84, P1139, DOI 10.1002/jnr.21008; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Martin RE, 2004, MOL VIS, V10, P199; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGill TJ, 2012, INVEST OPHTH VIS SCI, V53, P6232, DOI 10.1167/iovs.12-9569; Miller JN, 2013, HUM MOL GENET, V22, P2723, DOI 10.1093/hmg/ddt120; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Seehafer SS, 2011, J NEUROIMMUNOL, V230, P169, DOI 10.1016/j.jneuroim.2010.08.024; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Staropoli JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038310; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; TARKKANEN A, 1977, J PEDIATR OPHTHALMOL, V14, P235; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Thelen M, 2012, J NEUROSCI RES, V90, P568, DOI 10.1002/jnr.22773; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708	43	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75963	10.1371/journal.pone.0075963	http://dx.doi.org/10.1371/journal.pone.0075963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124525	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100082
J	Phetsouphanh, C; Xu, Y; Amin, J; Seddiki, N; Procopio, F; Sekaly, RP; Zaunders, JJ; Kelleher, AD				Phetsouphanh, Chansavath; Xu, Yin; Amin, Janaki; Seddiki, Nabila; Procopio, Francesco; Sekaly, Rafick Pierre; Zaunders, John J.; Kelleher, Anthony D.			Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+T Cells Using Qualitative Multiplex Single-Cell RT-PCR	PLOS ONE			English	Article							CD4(+) T-CELLS; GENE-EXPRESSION; CYTOKINE PRODUCTION; QUANTIFICATION; COEXPRESSION; DIFFERENTIATION; ASSAY; CD25	Current research on antigen specific CD4+ T cells indicates that there is functional and phenotypic heterogeneity within these populations, but the extent of this heterogeneity is poorly described. The CD134/CD25 assay allows live isolation of antigen specific cells in vitro for down-stream molecular analysis. Antigen specific CD4+ T cells were examined at the molecular level by lineage specific transcription factor profiling using qualitative multiplex single cell RT-PCR and Lock Nucleic Acid (LNA) probes allowed unbiased amplification and delineation of expression of Tbx21, Gata3, Rorc, Foxp3 and Bcl-6. It overcomes the limitations of previous assays by allowing identification of transcription factor mRNA in single antigen specific cells with high sensitivity (down to 10 femtograms) and specificity. Patterns of responses can be robustly characterized using,200 cells based on exact binomial calculations. These results are reproducible with a CV of approximate to 6%. The patterns of heterogeneity are stable within an individual antigen specific response but vary between responses to different antigens. Responses to CMV have a Th1 predominant profile (35.6% of responding cells expressing tbx21) whereas responses to Tetanus Toxoid have a Th2 biased profile (22% of responding cells expressing gata3), with unexpectedly high levels of Treg cells found in both populations. Here we describe a methodology that allows live isolation of Ag specific cells and transcription factor profiling at a single cell level to robustly delineate the different CD4+ T cell subsets within this population. This novel method is a powerful tool that can be used to study CD4+ T cell heterogeneity within extremely small populations of cells and where cell numbers are limited.	[Phetsouphanh, Chansavath; Xu, Yin; Amin, Janaki; Seddiki, Nabila; Zaunders, John J.; Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Phetsouphanh, Chansavath; Xu, Yin; Seddiki, Nabila; Zaunders, John J.; Kelleher, Anthony D.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Procopio, Francesco; Sekaly, Rafick Pierre] VGTI, Port St Lucie, FL USA	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Vaccine & Gene Therapy Institute of Florida	Phetsouphanh, C (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	c.phetsouphanh@amr.org.au	Phetsouphanh, Chansavath/AAS-4832-2020; Zaunders, John/J-6553-2012; Procopio, Francesco/ABD-8065-2021	Zaunders, John/0000-0002-5912-5989; Amin, Janaki/0000-0003-2161-9366; Phetsouphanh, Chansavath/0000-0001-6617-5995; Seddiki, Nabila/0000-0002-0379-8527	NHMRC [510488]; Australian Government Department of Health and Ageing	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was funded by NHMRC-Program grant 510488. AK was supported by an NHMRC Practitioner Fellowship. The Kirby Institute receives funding through the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection, analysis, decision to publish or preparation of manuscript.	Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cossman J, 2001, J HISTOCHEM CYTOCHEM, V49, P799, DOI 10.1177/002215540104900617; Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Garba ML, 2001, J IMMUNOL METHODS, V258, P193, DOI 10.1016/S0022-1759(01)00491-4; Gentile D, 2006, ALLERGY ASTHMA PROC, V27, P197, DOI 10.2500/aap.2006.27.2857; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Jena PK, 1996, J IMMUNOL METHODS, V190, P199, DOI 10.1016/0022-1759(95)00277-4; Keoshkerian E, 2012, J IMMUNOL METHODS, V375, P148, DOI 10.1016/j.jim.2011.10.004; Krishna S, 2005, P NATL ACAD SCI USA, V102, P4771, DOI 10.1073/pnas.0406415102; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Mackay John, 2007, Methods Mol Biol, V353, P237; Modlin RL, 1993, J INVEST DERMATOL, V102, P828; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Phillips JK, 2000, AUTON NEUROSCI-BASIC, V86, P1, DOI 10.1016/S1566-0702(00)00245-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Tamura Toshiki, 2009, Nihon Hansenbyo Gakkai Zasshi, V78, P271; Todd R, 2002, TRENDS MOL MED, V8, P254, DOI 10.1016/S1471-4914(02)02350-X; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Walter U, 2000, EUR J IMMUNOL, V30, P1224, DOI 10.1002/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zaunders JJ, 2009, J IMMUNOL, V183, P2827, DOI 10.4049/jimmunol.0803548; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	33	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74946	10.1371/journal.pone.0074946	http://dx.doi.org/10.1371/journal.pone.0074946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124462	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100019
J	Scharff-Poulsen, P; Pedersen, PA				Scharff-Poulsen, Peter; Pedersen, Per Amstrup			Saccharomyces cerevisiae-Based Platform for Rapid Production and Evaluation of Eukaryotic Nutrient Transporters and Transceptors for Biochemical Studies and Crystallography	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; KINASE-A PATHWAY; PLASMA-MEMBRANE; YEAST; EXPRESSION; MECHANISM; GLUCOSE; PURIFICATION; ACTIVATION; PROTEINS	To produce large quantities of high quality eukaryotic membrane proteins in Saccharomyces cerevisiae, we modified a high-copy vector to express membrane proteins C-terminally-fused to a Tobacco Etch Virus (TEV) protease detachable Green Fluorescent Protein (GFP)-8His tag, which facilitates localization, quantification, quality control, and purification. Using this expression system we examined the production of a human glucose transceptor and 11 nutrient transporters and transceptors from S. cerevisiae that have not previously been overexpressed in S. cerevisiae and purified. Whole-cell GFP-fluorescence showed that induction of GFP-fusion synthesis from a galactose-inducible promoter at 15 degrees C resulted in stable accumulation of the fusions in the plasma membrane and in intracellular membranes. Expression levels of the 12 fusions estimated by GFP-fluorescence were in the range of 0.4 mg to 1.7 mg transporter pr. liter cell culture. A detergent screen showed that n-dodecyl-beta-D-maltopyranoside (DDM) is acceptable for solubilization of the membrane-integrated fusions. Extracts of solubilized membranes were prepared with this detergent and used for purifications by Ni-NTA affinity chromatography, which yielded partially purified full-length fusions. Most of the fusions were readily cleaved at a TEV protease site between the membrane protein and the GFP-8His tag. Using the yeast oligopeptide transporter Ptr2 as an example, we further demonstrate that almost pure transporters, free of the GFP-8His tag, can be achieved by TEV protease cleavage followed by reverse immobilized metal-affinity chromatography. The quality of the GFP-fusions was analysed by fluorescence size-exclusion chromatography. Membranes solubilized in DDM resulted in preparations containing aggregated fusions. However, 9 of the fusions solubilized in DDM in presence of cholesteryl hemisuccinate and specific substrates, yielded monodisperse preparations with only minor amounts of aggregated membrane proteins. In conclusion, we developed a new effective S. cerevisiae expression system that may be used for production of high-quality eukaryotic membrane proteins for functional and structural analysis.	[Scharff-Poulsen, Peter; Pedersen, Per Amstrup] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Scharff-Poulsen, Peter] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Scharff-Poulsen, P (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	PSPoulsen@bio.ku.dk; PAPedersen@bio.ku.dk	Scharff-Poulsen, Peter/A-3556-2014; Pedersen, Per Amstrup/M-4592-2014	Scharff-Poulsen, Peter/0000-0002-5332-9331; Pedersen, Per Amstrup/0000-0001-8648-9748	Danish Research Council for Technology and Production; Danish National Advanced Technology Foundation (IBISS)	Danish Research Council for Technology and Production; Danish National Advanced Technology Foundation (IBISS)	This study was supported by grants from the Danish Research Council for Technology and Production to Morten Kielland-Brandt (IVC) and to Per Amstrup Pedersen and a grant from the Danish National Advanced Technology Foundation (IBISS) to Per Amstrup Pedersen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bomholt J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056431; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew David, 2012, Methods Mol Biol, V866, P191, DOI 10.1007/978-1-61779-770-5_16; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jorgensen JR, 2001, BIOCHEMISTRY-US, V40, P7301, DOI 10.1021/bi0029503; Karhumaa K, 2010, J CELL BIOCHEM, V110, P920, DOI 10.1002/jcb.22605; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lamb RF, 2012, FEBS J, V279, P2624, DOI 10.1111/j.1742-4658.2012.08659.x; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Newstead S, 2011, BIOCHEM SOC T, V39, P1353, DOI 10.1042/BST0391353; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Poulsen P, 2008, MOL MEMBR BIOL, V25, P164, DOI 10.1080/09687680701771917; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shiroishi M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-78; Shiroishi M, 2011, METHODS, V55, P281, DOI 10.1016/j.ymeth.2011.08.015; Sonoda Y, 2010, FEBS LETT, V584, P2539, DOI 10.1016/j.febslet.2010.04.015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Wickersham LJ, 1951, USDA TECH B, V1029; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	50	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76851	10.1371/journal.pone.0076851	http://dx.doi.org/10.1371/journal.pone.0076851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124599	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100156
J	Dong, L; Jin, L; Tseng, HY; Wang, CY; Wilmott, JS; Yosufi, B; Yan, XG; Jiang, CC; Scolyer, RA; Zhang, XD; Guo, ST				Dong, L.; Jin, L.; Tseng, H-Y; Wang, C. Y.; Wilmott, J. S.; Yosufi, B.; Yan, X. G.; Jiang, C. C.; Scolyer, R. A.; Zhang, X. D.; Guo, S. T.			Oncogenic suppression of PHLPP1 in human melanoma	ONCOGENE			English	Article						PHLPP1; Akt; melanoma; DNA methylation	TUMOR-SUPPRESSOR; SIGNALING PATHWAYS; PHOSPHATASE PHLPP; CPG METHYLATION; PH DOMAIN; PROTEIN; AKT; PTEN; ACTIVATION; PI3K	Akt is constitutively activated in up to 70% of human melanomas and has an important role in the pathogenesis of the disease. However, little is known about protein phosphatases that dephosphorylate and thereby inactivate it in melanoma cells. Here we report that suppression of pleckstrin homology domain and leucine-rich repeat Ser/Thr protein phosphatase 1 (PHLPP1) by DNA methylation promotes Akt activation and has an oncogenic role in melanoma. While it is commonly downregulated, overexpression of PHLPP1 reduces Akt activation and inhibits melanoma cell proliferation in vitro, and retards melanoma growth in a xenograft model. In contrast, knockdown of PHLPP1 increases Akt activation, enhances melanoma cell and melanocyte proliferation, and results in anchorage-independent growth of melanocytes. Suppression of PHLPP1 involves blockade of binding of the transcription factor Sp1 to the PHLPP1 promoter. Collectively, these results suggest that suppression of PHLPP1 by DNA methylation contributes to melanoma development and progression.	[Dong, L.; Jin, L.; Tseng, H-Y; Yan, X. G.; Jiang, C. C.; Zhang, X. D.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia; [Wang, C. Y.; Guo, S. T.] Shanxi Med Univ, Shanxi Canc Hosp & Inst, Dept Mol Biol, Affiliated Hosp, Taiyuan, Peoples R China; [Wilmott, J. S.; Yosufi, B.; Scolyer, R. A.] Melanoma Inst Australia, Sydney, NSW, Australia; [Wilmott, J. S.; Scolyer, R. A.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Scolyer, R. A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Newcastle; Shanxi Medical University; Melanoma Institute Australia; University of Sydney; University of Sydney	Zhang, XD (corresponding author), Univ Newcastle, Prior Res Ctr Canc Res, Sch Med & Publ Hlth, LS3-49,Life Sci Bldg, Newcastle, NSW 2308, Australia.	Xu.Zhang@newcastle.edu.au; gsutang@gmail.com	Tseng, Cindy Hsin-Yi/AAB-8958-2022; Wilmott, James/AGA-8227-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Jin, Lei/J-1896-2019; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; Jin, Lei/K-2315-2019; Scolyer, Richard/AAE-8511-2019	Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; Wilmott, James/0000-0002-6750-5244; Jin, Lei/0000-0001-7187-9671; Scolyer, Richard/0000-0002-8991-0013; Zhang, Xu Dong/0000-0001-9457-8003	National Health and Medical Research Council (NHMRC); Cancer Council NSW; Cancer Institute NSW; Hunter Medical Research Institute, Australia; National Natural Science Foundation of China; NHMRC; Cancer Institute NSW Fellowship Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Hunter Medical Research Institute, Australia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Fellowship Program	This work was supported by the National Health and Medical Research Council (NHMRC), the Cancer Council NSW, Cancer Institute NSW and Hunter Medical Research Institute, Australia; and National Natural Science Foundation of China. XDZ is supported by senior research fellowships of NHMRC. RAS is supported by the Cancer Institute NSW Fellowship Program. We thank Dr Tianyan Gao (Markey Cancer Center, University of Kentucky) for the pcDNA3-PHLPP1-HA constructs.	Beezhold K, 2011, TOXICOL SCI, V123, P411, DOI 10.1093/toxsci/kfr188; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Cheung M, 2008, CANCER RES, V68, P3429, DOI 10.1158/0008-5472.CAN-07-5867; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Curtin JA, 2006, J INVEST DERMATOL, V126, P1660, DOI 10.1038/sj.jid.5700311; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gillespie S, 2005, MOL CANCER THER, V4, P668, DOI 10.1158/1535-7163.MCT-04-0332; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Houslay MD, 2011, CANCER CELL, V19, P3, DOI 10.1016/j.ccr.2011.01.004; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang CC, 2011, CLIN CANCER RES, V17, P721, DOI 10.1158/1078-0432.CCR-10-2225; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; O'Hayre M, 2012, LEUKEMIA, V26, P1689, DOI 10.1038/leu.2012.6; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Saavedra A, 2010, CELL DEATH DIFFER, V17, P324, DOI 10.1038/cdd.2009.127; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Tay KH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.79; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Ye Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2489; Zhuang LQ, 2009, HISTOPATHOLOGY, V54, P462, DOI 10.1111/j.1365-2559.2009.03242.x	60	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4756	4766		10.1038/onc.2013.420	http://dx.doi.org/10.1038/onc.2013.420			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24121273	Green Submitted			2022-12-25	WOS:000343239500006
J	Kubota, T; Arita, M; Isobe, Y; Iwamoto, R; Goto, T; Yoshioka, T; Urabe, D; Inoue, M; Arai, H				Kubota, Tadafumi; Arita, Makoto; Isobe, Yosuke; Iwamoto, Ryo; Goto, Tomomi; Yoshioka, Takeshi; Urabe, Daisuke; Inoue, Masayuki; Arai, Hiroyuki			Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid	FASEB JOURNAL			English	Article						bioactive lipid; metabolomics	POLYUNSATURATED FATTY-ACIDS; INFLAMMATION; OMEGA-3-FATTY-ACIDS; IDENTIFICATION; NEUTROPHIL; RESOLUTION	Eicosapentaenoic acid (EPA) has beneficial effects in many inflammatory disorders. In this study, dietary EPA was converted to 17,18-epoxyeicosatetraenoic acid (17,18-EpETE) by -3 epoxygenation in the mouse peritoneal cavity. Mediator lipidomics revealed a series of novel oxygenated metabolites of 17,18-EpETE, and one of the major metabolites, 12-hydroxy-17,18-epoxyeicosatetraenoic acid (12-OH-17,18-EpETE), displayed a potent anti-inflammatory action by limiting neutrophil infiltration in murine zymosan-induced peritonitis. 12-OH-17,18-EpETE inhibited leukotriene B-4-induced neutrophil chemotaxis and polarization in vitro in a low nanomolar range (EC50 0.6 nM). The complete structures of two natural isomers were assigned as 12S-OH-17R,18S-EpETE and 12S-OH-17S,18R-EpETE, using chemically synthesized stereoisomers. These natural isomers displayed potent anti-inflammatory action, whereas the unnatural stereoisomers were essentially devoid of activity. These results demonstrate that 17,18-EpETE derived from dietary EPA is converted to a potent bioactive metabolite 12-OH-17,18-EpETE, which may generate an endogenous anti-inflammatory metabolic pathway.Kubota, T., Arita, M., Isobe, Y., Iwamoto, R., Goto, T., Yoshioka, T., Urabe, D., Inoue, M., Arai, H. Eicosapentaenoic acid is converted via -3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid.	[Kubota, Tadafumi; Arita, Makoto; Isobe, Yosuke; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 1130033, Japan; [Isobe, Yosuke; Iwamoto, Ryo; Goto, Tomomi; Yoshioka, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Business Acad Collaborat Lab, Tokyo 1130033, Japan; [Goto, Tomomi; Urabe, Daisuke; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Integral Analyt Chem, Tokyo 1130033, Japan; [Arita, Makoto] Japanese Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Goto, Tomomi; Yoshioka, Takeshi] Shionogi & Co Ltd, Shionogi Res Labs, Osaka 553, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Shionogi & Company Limited	Arita, M (corresponding author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	marita@mol.f.u-tokyo.ac.jp		Arita, Makoto/0000-0001-9902-0463; Yoshioka, Takeshi/0000-0002-8658-8081	Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Michiko Kamio and Mie Honda for skillful technical assistance. This study was supported by the Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO; to M.A.), a Grant in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.A.), and the program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry (to H.A.).	Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Capdevila JH, 1996, J BIOL CHEM, V271, P22663, DOI 10.1074/jbc.271.37.22663; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lucas D, 2010, J LIPID RES, V51, P1125, DOI 10.1194/jlr.M003061; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Yoshimoto T, 2002, PROSTAG OTH LIPID M, V68-9, P245, DOI 10.1016/S0163-7827(97)00002-7	25	34	35	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					586	593		10.1096/fj.13-236224	http://dx.doi.org/10.1096/fj.13-236224			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24128889				2022-12-25	WOS:000331072200007
J	Tumer, E; Broer, A; Balkrishna, S; Julich, T; Broer, S				Tuemer, Emrah; Broeer, Angelika; Balkrishna, Sarojini; Juelich, Torsten; Broeer, Stefan			Enterocyte-specific Regulation of the Apical Nutrient Transporter SLC6A19 (B(0)AT1) by Transcriptional and Epigenetic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; DNA Methylation; Epithelial Cell; Histone Modification; HNF-4; Promoters; Transcription Regulation	HEPATOCYTE NUCLEAR FACTOR-1; INTESTINAL EPITHELIAL-CELLS; AMINO-ACID-TRANSPORT; GENE-EXPRESSION; DNA DEMETHYLATION; HARTNUP DISORDER; SELF-RENEWAL; ALPHA-GENE; DIFFERENTIATION; MUTATIONS	Enterocytes are specialized to absorb nutrients from the lumen of the small intestine by expressing a select set of genes to maximize the uptake of nutrients. They develop from stem cells in the crypt and differentiate into mature enterocytes while moving along the crypt-villus axis. Using the Slc6a19 gene as an example, encoding the neutral amino acid transporter B(0)AT1, we studied regulation of the gene by transcription factors and epigenetic factors in the intestine. To investigate this question, we used a fractionation method to separate mature enterocytes from crypt cells and analyzed gene expression. Transcription factors HNF1a and HNF4a activate transcription of the Slc6a19 gene in villus enterocytes, whereas high levels of SOX9 repress expression in the crypts. CpG dinucleotides in the proximal promoter were highly methylated in the crypt and fully de-methylated in the villus. Furthermore, histone modification H3K27Ac, indicating an active promoter, was prevalent in villus cells but barely detectable in crypt cells. The results suggest that Slc6a19 expression in the intestine is regulated at three different levels involving promoter methylation, histone modification, and opposing transcription factors.	[Tuemer, Emrah; Broeer, Angelika; Balkrishna, Sarojini; Juelich, Torsten; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	Stefan.broeer@anu.edu.au	Broer, Stefan/A-1286-2008	Broer, Stefan/0000-0002-8040-1634	National Health and Medical Research Council [525415]; Australian Research Council [DP0877897]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant 525415 and Australian Research Council Grant DP0877897 (to S.B.).	BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Carey N, 2011, DRUG DISCOV TODAY, V16, P683, DOI 10.1016/j.drudis.2011.05.004; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; ENCODE Project Consortium, 2011, PLOS BIOL, V9; Fairweather S. J., 2012, BIOCH J; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gracz AD, 2011, AM J PHYSIOL-GASTR L, V300, pG503, DOI 10.1152/ajpgi.00489.2010; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Richmond CA, 2010, PROG MOL BIOL TRANSL, V96, P207, DOI 10.1016/S1877-1173(10)96009-2; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Suzuki T, 2008, BIOCHEM BIOPH RES CO, V369, P788, DOI 10.1016/j.bbrc.2008.02.101; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Weaver R. F., 2012, MOL BIOL, P259; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	45	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33813	33823		10.1074/jbc.M113.482760	http://dx.doi.org/10.1074/jbc.M113.482760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121511	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000327250200026
J	Xu, X; Hu, JJ; McGrath, BC; Cavener, DR				Xu, Xu; Hu, Jingjie; McGrath, Barbara C.; Cavener, Douglas R.			GCN2 in the Brain Programs PPAR gamma 2 and Triglyceride Storage in the Liver during Perinatal Development in Response to Maternal Dietary Fat	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; LEPTIN-DEFICIENT MICE; PPAR-GAMMA; EIF2-ALPHA KINASE; TRANSFER-RNA; TRANSLATIONAL CONTROL; LIPID-ACCUMULATION; HEPATIC STEATOSIS; ACID HOMEOSTASIS; GENE-EXPRESSION	The liver plays a central role in regulating lipid metabolism and facilitates efficient lipid utilization and storage. We discovered that a modest increase in maternal dietary fat in mice programs triglyceride storage in the liver of their developing offspring. The activation of this programming is not apparent, however, until several months later at the adult stage. We found that the perinatal programming of adult hepatic triglyceride storage was controlled by the eIF2 alpha kinase GCN2 (EIF2AK4) in the brain of the offspring, which stimulates epigenetic modification of the Ppar gamma 2 gene in the neonatal liver. Genetic ablation of Gcn2 in the offspring exhibited reduced hepatic triglyceride storage and repressed expression of the peroxisome proliferator-activated receptor gamma 2 (Ppar gamma 2) and two lipid droplet protein genes, Fsp27 and Cidea. Brain-specific, but not liver-specific, Gcn2 KO mice exhibit these same defects demonstrating that GCN2 in the developing brain programs hepatic triglyceride storage. GCN2 and nutrition-dependent programming of Ppar gamma 2 is correlated with trimethylation of lysine 4 of histone 3 (H3K4me3) in the Ppar gamma 2 promoter region during neonatal development. In addition to regulating hepatic triglyceride in response to modest changes in dietary fat, Gcn2 deficiency profoundly impacts the severity of the obese-diabetic phenotype of the leptin receptor mutant (db/db) mouse, by reducing hepatic steatosis and obesity but exacerbating the diabetic phenotype. We suggest that GCN2-dependent perinatal programming of hepatic triglyceride storage is an adaptation to couple early nutrition to anticipated needs for hepatic triglyceride storage in adults. However, increasing the hepatic triglyceride set point during perinatal development may predispose individuals to hepatosteatosis, while reducing circulating fatty acid levels that promote insulin resistance.	[Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu	wang, meng/GWZ-9558-2022		National Institutes of Health (NIH) [R01 DK088140, R56 GM056857]; Ajinomoto Research Foundation (3ARP) grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056857] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Research Foundation (3ARP) grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health (NIH) grants R01 DK088140 and R56 GM056857 and an Ajinomoto Research Foundation (3ARP) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; Bocher V, 2002, ANN NY ACAD SCI, V967, P7; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2011, WORLD J DIABETES, V2, P164, DOI 10.4239/wjd.v2.i10.164; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Hyatt MA, 2011, REPRODUCTION, V141, P119, DOI 10.1530/REP-10-0325; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lazarow P B, 1981, Methods Enzymol, V72, P315; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levin BE, 2009, INT J OBESITY, V33, pS53, DOI 10.1038/ijo.2009.18; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Levin BE, 2000, NUTRITION, V16, P909, DOI 10.1016/S0899-9007(00)00408-1; Levin BE, 2000, OBES RES, V8, P342, DOI 10.1038/oby.2000.41; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; McMillen IC, 2006, REPRODUCTION, V131, P415, DOI 10.1530/rep.1.00303; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Uno K, 2011, EUR HEART J; Uno K, 2012, EUR HEART J, V33, P1279, DOI 10.1093/eurheartj/ehr265; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	65	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75917	10.1371/journal.pone.0075917	http://dx.doi.org/10.1371/journal.pone.0075917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130751	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200025
J	Vivant, AL; Garmyn, D; Maron, PA; Nowak, V; Piveteau, P				Vivant, Anne-Laure; Garmyn, Dominique; Maron, Pierre-Alain; Nowak, Virginie; Piveteau, Pascal			Microbial Diversity and Structure Are Drivers of the Biological Barrier Effect against Listeria monocytogenes in Soil	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MILKING EQUIPMENT; COMMUNITY; SURVIVAL; CONTAMINATION; INVASION; BIODIVERSITY; PREVALENCE; BACTERIA; BIOFILM	Understanding the ecology of pathogenic organisms is important in order to monitor their transmission in the environment and the related health hazards. We investigated the relationship between soil microbial diversity and the barrier effect against Listeria monocytogenes invasion. By using a dilution-to-extinction approach, we analysed the consequence of eroding microbial diversity on L. monocytogenes population dynamics under standardised conditions of abiotic parameters and microbial abundance in soil microcosms. We demonstrated that highly diverse soil microbial communities act as a biological barrier against L. monocytogenes invasion and that phylogenetic composition of the community also has to be considered. This suggests that erosion of diversity may have damaging effects regarding circulation of pathogenic microorganisms in the environment.	[Vivant, Anne-Laure; Garmyn, Dominique; Piveteau, Pascal] Univ Bourgogne, Agroecol UMR1347, Dijon, France; [Vivant, Anne-Laure; Garmyn, Dominique; Maron, Pierre-Alain; Nowak, Virginie; Piveteau, Pascal] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Maron, Pierre-Alain; Nowak, Virginie] INRA, Agroecol UMR1347, Plateforme GenoSol, F-21034 Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Piveteau, P (corresponding author), Univ Bourgogne, Agroecol UMR1347, Dijon, France.	piveteau@u-bourgogne.fr		Garmyn, Dominique/0000-0003-4693-6026	French state through the National Agency for Research [ANR-11-INBS-0001]; Regional Council of Burgundy [PARI AGRALE 11]	French state through the National Agency for Research; Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work, through the involvement of technical facilities of the GenoSol platform of the infrastructure ANAEE-Services, received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as a grant from the Regional Council of Burgundy (reference PARI AGRALE 11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Baumann K, 2013, BIOGEOCHEMISTRY, V114, P201, DOI 10.1007/s10533-012-9800-6; Beuchat LR, 1996, FOOD CONTROL, V7, P223, DOI 10.1016/S0956-7135(96)00039-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; De Luca G, 1998, ZBL HYG UMWELTMED, V201, P269; Dowe MJ, 1997, J FOOD PROTECT, V60, P1201, DOI 10.4315/0362-028X-60.10.1201; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; Forslund A, 2012, WATER RES, V46, P5917, DOI 10.1016/j.watres.2012.08.011; Franklin RB, 2006, MICROB ECOL, V52, P280, DOI 10.1007/s00248-006-9033-0; Garland JL, 1999, FEMS MICROBIOL ECOL, V30, P333, DOI 10.1111/j.1574-6941.1999.tb00661.x; Garrec N, 2003, FEMS IMMUNOL MED MIC, V35, P275, DOI 10.1016/S0928-8244(02)00443-1; Garrido V, 2009, FOOD CONTROL, V20, P986, DOI 10.1016/j.foodcont.2008.11.013; Goulet V, 1998, J INFECT DIS, V177, P155, DOI 10.1086/513814; Griffiths BS, 2008, BIOL FERT SOILS, V44, P745, DOI 10.1007/s00374-007-0257-z; Grolleau E., 2004, ETUDE GESTION SOLS, V11, P255; Hallin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051962; Ho AJ, 2007, PREV VET MED, V80, P287, DOI 10.1016/j.prevetmed.2007.03.005; IIDA T, 1991, J VET MED SCI, V53, P873, DOI 10.1292/jvms.53.873; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; Latorre AA, 2009, APPL ENVIRON MICROB, V75, P1315, DOI 10.1128/AEM.01826-08; Lemunier M, 2005, APPL ENVIRON MICROB, V71, P5779, DOI 10.1128/AEM.71.10.5779-5786.2005; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma JC, 2012, ENVIRON SCI TECHNOL, V46, P12154, DOI 10.1021/es302738z; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Maron PA, 2011, CR BIOL, V334, P403, DOI 10.1016/j.crvi.2010.12.003; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; McLaughlin HP, 2011, ARCH MICROBIOL, V193, P775, DOI 10.1007/s00203-011-0716-7; Morales A, 1996, FEMS MICROBIOL ECOL, V20, P155, DOI 10.1016/0168-6496(96)00020-7; Moshtaghi H., 2009, Indian Journal of Veterinary Research, V18, P1; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Nonaka L, 2010, ENV MICROBIOL REP, V2, P465, DOI 10.1111/j.1758-2229.2010.00178.x; Oliveros JC, 2007, VENNY INTERACTIVE TO; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Voidarou C, 2011, ANAEROBE, V17, P320, DOI 10.1016/j.anaerobe.2011.05.004; Xiuping Jiang, 2004, Journal of Food Protection, V67, P1676	56	69	72	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76991	10.1371/journal.pone.0076991	http://dx.doi.org/10.1371/journal.pone.0076991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116193	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200091
J	McDonough, CW; Gillis, NK; Alsultan, A; Chang, SW; Kawaguchi-Suzuki, M; Lang, JE; Shahin, MHA; Buford, TW; El Rouby, NM; Sa, ACC; Langaee, TY; Gums, JG; Chapman, AB; Cooper-DeHoff, RM; Turner, ST; Gong, Y; Johnson, JA				McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Lang, Jason E.; Shahin, Mohamed Hossam A.; Buford, Thomas W.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Chapman, Arlene B.; Cooper-DeHoff, Rhonda M.; Turner, Stephen T.; Gong, Yan; Johnson, Julie A.			Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; GENE-CENTRIC METAANALYSIS; CHOLESTEROL; ASSOCIATION; VISUALIZATION; ANNOTATION; EXPRESSION; HAPLOTYPE; THERAPY; ABCB1	We sought to identify novel pharmacogenomic markers for HDL-C response to atenolol in participants with mild to moderate hypertension. We genotyped 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study on the Illumina HumanCVD Beadchip. During PEAR, participants were randomized to receive atenolol or hydrochlorothiazide. Blood pressure and cholesterol levels were evaluated at baseline and after treatment. This study focused on participants treated with atenolol monotherapy. Association with atenolol induced HDL-C change was evaluated in 232 whites and 152 African Americans using linear regression. No SNPs achieved a Bonferroni corrected P-value. However, we identified 13 regions with consistent association across whites and African Americans. The most interesting of these regions were seven with prior associations with HDL-C, other metabolic traits, or functional implications in the lipid pathway: GALNT2, FTO, ABCB1, LRP5, STARD3NL, ESR1, and LIPC. Examples are rs2144300 in GALNT2 in whites (P=2.29x10(-4), beta=-1.85 mg/dL) and rs12595985 in FTO in African Americans (P=2.90x10(-4), beta=4.52 mg/dL), both with consistent regional association (P<0.05) in the other race group. Additionally, baseline GALNT2 expression differed by rs2144300 genotype in whites (P=0.0279). In conclusion, we identified multiple gene regions associated with atenolol induced HDL-C change that were consistent across race groups, several with functional implications or prior associations with HDL-C.	[McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Shahin, Mohamed Hossam A.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Cooper-DeHoff, Rhonda M.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [McDonough, Caitrin W.; Gillis, Nancy K.; Alsultan, Abdullah; Chang, Shin-Wen; Kawaguchi-Suzuki, Marina; Shahin, Mohamed Hossam A.; El Rouby, Nihal M.; Sa, Ana C. C.; Langaee, Taimour Y.; Gums, John G.; Cooper-DeHoff, Rhonda M.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Lang, Jason E.] Nemours Childrens Hosp, Div Pulm & Sleep Med, Orlando, FL USA; [Lang, Jason E.] Nemours Childrens Hosp, Ctr Pharmacogen & Translat Res, Orlando, FL USA; [Buford, Thomas W.] Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL USA; [Gums, John G.] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL USA; [Chapman, Arlene B.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; State University System of Florida; University of Florida; Mayo Clinic	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA.	Johnson@cop.ufl.edu	Buford, Thomas W/B-1111-2011; Gillis, Nancy/N-4860-2017; Shahin, Mohamed/Q-2874-2019; Turner, Stephen/GXM-4654-2022; Alsultan, Abdullah/K-1751-2019	Buford, Thomas W/0000-0002-9541-4358; Gillis, Nancy/0000-0002-7744-8490; Alsultan, Abdullah/0000-0002-7013-8369; McDonough, Caitrin/0000-0001-6393-7288; , Marina/0000-0003-0901-8381	National Institute of Health Pharmacogenetics Research Network grant [U01-GM074492]; National Center for Advancing Translational Sciences [UL1 TR000064, UL1 TR000454, UL1 TR000135]; Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR000454, UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of Health Pharmacogenetics Research Network grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	PEAR was supported by the National Institute of Health Pharmacogenetics Research Network grant U01-GM074492 and the National Center for Advancing Translational Sciences under the award number UL1 TR000064 (University of Florida); UL1 TR000454 (Emory University) and UL1 TR000135 (Mayo Clinic). PEAR efforts at the Mayo Clinic were also supported by funds from the Mayo Foundation. http://www.nih.gov/ http://www.mayoclinic.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2006, BIOCHEM SOC T, V34, P343, DOI 10.1042/BST0340343; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Jafri H, 2010, ANN INTERN MED, V153, P800, DOI 10.7326/0003-4819-153-12-201012210-00006; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Kajinami K, 2005, ATHEROSCLEROSIS, V178, P331, DOI 10.1016/j.atherosclerosis.2004.08.034; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Keene KL, 2008, HUM GENET, V123, P333, DOI 10.1007/s00439-008-0482-z; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; LEHTONEN A, 1984, ATHEROSCLEROSIS, V51, P335, DOI 10.1016/0021-9150(84)90181-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Mahungu TW, 2009, CLIN PHARMACOL THER, V86, P204, DOI 10.1038/clpt.2009.78; Messerli FH, 2008, CIRCULATION, V117, P2706, DOI 10.1161/CIRCULATIONAHA.107.695007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schmitz G, 2009, ARTERIOSCL THROM VAS, V29, P1718, DOI 10.1161/ATVBAHA.108.179507; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	34	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76984	10.1371/journal.pone.0076984	http://dx.doi.org/10.1371/journal.pone.0076984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116192	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300110
J	Geran, L; Travers, S				Geran, Laura; Travers, Susan			Temporal Characteristics of Gustatory Responses in Rat Parabrachial Neurons Vary by Stimulus and Chemosensitive Neuron Type	PLOS ONE			English	Article							SOLITARY TRACT; CORTICAL-NEURONS; TASTE STIMULI; NUCLEUS; CORTEX; TIME; QUALITY; LICKING; VARIABILITY; MODULATION	It has been demonstrated that temporal features of spike trains can increase the amount of information available for gustatory processing. However, the nature of these temporal characteristics and their relationship to different taste qualities and neuron types are not well-defined. The present study analyzed the time course of taste responses from parabrachial (PBN) neurons elicited by multiple applications of "sweet" (sucrose), "salty" (NaCl), "sour" (citric acid), and "bitter" (quinine and cycloheximide) stimuli in an acute preparation. Time course varied significantly by taste stimulus and best-stimulus classification. Across neurons, the ensemble code for the three electrolytes was similar initially but quinine diverged from NaCl and acid during the second 500ms of stimulation and all four qualities became distinct just after 1s. This temporal evolution was reflected in significantly broader tuning during the initial response. Metric space analyses of quality discrimination by individual neurons showed that increases in information (H) afforded by temporal factors was usually explained by differences in rate envelope, which had a greater impact during the initial 2s (22.5% increase in H) compared to the later response (9.5%). Moreover, timing had a differential impact according to cell type, with between-quality discrimination in neurons activated maximally by NaCl or citric acid most affected. Timing was also found to dramatically improve within-quality discrimination (80% increase in H) in neurons that responded optimally to bitter stimuli (B-best). Spikes from B-best neurons were also more likely to occur in bursts. These findings suggest that among PBN taste neurons, time-dependent increases in mutual information can arise from stimulus-and neuron-specific differences in response envelope during the initial dynamic period. A stable rate code predominates in later epochs.	[Geran, Laura; Travers, Susan] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Travers, S (corresponding author), Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA.	travers.3@osu.edu			NIH [RO1-DC726315, RO3-DC008678]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH RO1-DC726315 (SPT) and RO3-DC008678 (LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIDLER LM, 1953, J NEUROPHYSIOL, V16, P595, DOI 10.1152/jn.1953.16.6.595; BOUDREAU JC, 1987, CHEM SENSES, V12, P437, DOI 10.1093/chemse/12.3.437; Breza JM, 2010, J NEUROPHYSIOL, V103, P1771, DOI 10.1152/jn.00785.2009; BUJAS Z, 1989, PERCEPT PSYCHOPHYS, V45, P385, DOI 10.3758/BF03210710; Chen JY, 2008, J NEUROPHYSIOL, V99, P2144, DOI 10.1152/jn.01020.2007; Chen JY, 2011, J NEUROPHYSIOL, V105, P697, DOI 10.1152/jn.00539.2010; CROSS BA, 1970, J ENDOCRINOL, V48, P475, DOI 10.1677/joe.0.0480475; Cubero-Castillo E, 2001, CHEM SENSES, V26, P419, DOI 10.1093/chemse/26.4.419; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Di Lorenzo PM, 2003, BEHAV NEUROSCI, V117, P1423, DOI 10.1037/0735-7044.117.6.1423; Di Lorenzo PM, 2003, J NEUROPHYSIOL, V90, P1418, DOI 10.1152/jn.00177.2003; FISHMAN IY, 1957, J CELL COMPAR PHYSL, V49, P319, DOI 10.1002/jcp.1030490213; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Frank ME, 2005, BRAIN RES BULL, V66, P70, DOI 10.1016/j.brainresbull.2005.04.004; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Geran LC, 2006, J NEUROPHYSIOL, V96, P2513, DOI 10.1152/jn.00607.2006; Geran LC, 2009, J NEUROPHYSIOL, V101, P1598, DOI 10.1152/jn.91168.2008; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; HALPERN BP, 1971, SCIENCE, V171, P1256, DOI 10.1126/science.171.3977.1256; Halsell CB, 1997, J NEUROPHYSIOL, V78, P920, DOI 10.1152/jn.1997.78.2.920; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Khosravi-Hashemi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040339; Khosravi-Hashemi N, 2011, J NEUROPHYSIOL, V106, P1954, DOI 10.1152/jn.00116.2011; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; LARSONPOWERS N, 1978, J FOOD SCI, V43, P41, DOI 10.1111/j.1365-2621.1978.tb09732.x; Laviolette SR, 2005, J NEUROSCI, V25, P6066, DOI 10.1523/JNEUROSCI.1168-05.2005; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lestienne R, 1998, NEUROSCIENCE, V82, P315; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; Lundy RF, 1999, J NEUROPHYSIOL, V82, P2970, DOI 10.1152/jn.1999.82.6.2970; Mistretta CM, 1972, OLFACTION TASTE, P294; NISHIJO H, 1991, J NEUROPHYSIOL, V66, P974, DOI 10.1152/jn.1991.66.3.974; NORGREN R, 1973, J COMP NEUROL, V150, P217, DOI 10.1002/cne.901500208; OGAWA H, 1987, EXP BRAIN RES, V68, P449; OGAWA H, 1969, J PHYSIOL-LONDON, V204, P311, DOI 10.1113/jphysiol.1969.sp008915; Pangborn RM, 1983, J I BREW, V89; Pfaffmann C, 1941, J CELL COMPAR PHYSL, V17, P243, DOI 10.1002/jcp.1030170209; Rosen AM, 2011, J NEUROPHYSIOL, V105, P1889, DOI 10.1152/jn.00836.2010; Roussin AT, 2008, J NEUROPHYSIOL, V99, P644, DOI 10.1152/jn.00920.2007; Roussin AT, 2012, J NEUROSCI, V32, P10494, DOI 10.1523/JNEUROSCI.1856-12.2012; SACHDEV RNS, 1991, BRAIN RES, V549, P194, DOI 10.1016/0006-8993(91)90458-8; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; SCOTT TR, 1974, PHYSIOL BEHAV, V12, P413, DOI 10.1016/0031-9384(74)90118-8; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; TRAVERS JB, 1987, ANNU REV NEUROSCI, V10, P595, DOI 10.1146/annurev.ne.10.030187.003115; TRAVERS SP, 1989, CHEM SENSES, V14, P55, DOI 10.1093/chemse/14.1.55; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Villars Penelope S, 2004, AANA J, V72, P197; Weiss MS, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00027	59	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76828	10.1371/journal.pone.0076828	http://dx.doi.org/10.1371/journal.pone.0076828			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124597	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100154
J	Jun, DW; Hwang, M; Kim, HJ; Hwang, SK; Kim, S; Lee, CH				Jun, Dong Wha; Hwang, Mihwa; Kim, Hyun Jung; Hwang, Soo Kyung; Kim, Sunshin; Lee, Chang-Hun			Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents	PLOS ONE			English	Article							CANCER CELLS; TUMOR-CELLS; REPAIR; DRUG; RESISTANCE; CISPLATIN; PROTEIN; NA,K-ATPASE; MELPHALAN; ENZYME	Modulation of the DNA repair pathway is an emerging target for the development of anticancer drugs. DNA interstrand cross-links (ICLs), one of the most severe forms of DNA damage caused by anticancer drugs such as cisplatin and mitomycin C (MMC), activates the Fanconi anemia (FA)/BRCA DNA repair pathway. Inhibition of the FA/BRCA pathway can enhance the cytotoxic effects of ICL-inducing anticancer drugs and can reduce anticancer drug resistance. To find FA/BRCA pathway inhibitory small molecules, we established a cell-based high-content screening method for quantitating the activation of the FA/BRCA pathway by measuring FANCD2 foci on DNA lesions and then applied our method to chemical screening. Using commercial LOPAC1280 chemical library screening, ouabain was identified as a competent FA/BRCA pathway inhibitory compound. Ouabain, a member of the cardiac glycoside family, binds to and inhibits Na+/K+-ATPase and has been used to treat heart disease for many years. We observed that ouabain, as well as other cardiac glycoside family members-digitoxin and digoxin-down-regulated FANCD2 and FANCI mRNA levels, reduced monoubiquitination of FANCD2, inhibited FANCD2 foci formation on DNA lesions, and abrogated cell cycle arrest induced by MMC treatment. These inhibitory activities of ouabain required p38 MAPK and were independent of cellular Ca2+ ion increase or the drug uptake-inhibition effect of ouabain. Furthermore, we found that ouabain potentiated the cytotoxic effects of MMC in tumor cells. Taken together, we identified an additional effect of ouabain as a FA/BRCA pathway-inhibiting chemosensitization compound. The results of this study suggest that ouabain may serve as a chemosensitizer to ICL-inducing anticancer drugs.	[Jun, Dong Wha; Hwang, Mihwa; Kim, Hyun Jung; Kim, Sunshin] Natl Canc Ctr, New Expt Therapeut Branch, Div Convergence Technol, Goyang, Gyeonggi, South Korea; [Hwang, Soo Kyung; Lee, Chang-Hun] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Goyang, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, S (corresponding author), Natl Canc Ctr, New Expt Therapeut Branch, Div Convergence Technol, Goyang, Gyeonggi, South Korea.	ksunshin@ncc.re.kr; chlee@ncc.re.kr			National Cancer Center [1110031, 1110032]	National Cancer Center	This work was supported by the National Cancer Center Grants 1110031 and 1110032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Surrah AS, 2006, CURR MED CHEM, V13, P1337, DOI 10.2174/092986706776872970; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Brouillard F, 2001, CANCER RES, V61, P1693; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hiyoshi H, 2012, BRIT J CANCER, V106, P1807, DOI 10.1038/bjc.2012.159; Jun DW, 2012, BRIT J PHARMACOL, V167, P141, DOI 10.1111/j.1476-5381.2012.01977.x; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; Kim S, 2011, J BIOMOL SCREEN, V16, P259, DOI 10.1177/1087057110392993; Landais I, 2009, INT J CANCER, V124, P783, DOI 10.1002/ijc.24039; LAWRENCE TS, 1988, INT J RADIAT ONCOL, V15, P953, DOI 10.1016/0360-3016(88)90132-0; Li YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044254; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Musto P, 2007, EXPERT OPIN INV DRUG, V16, P1467, DOI 10.1517/13543784.16.9.1467; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Saadatzadeh MR, 2009, BLOOD, V113, P2655, DOI 10.1182/blood-2008-09-181420; SMITH IE, 1992, BRIT J CANCER, V65, P787, DOI 10.1038/bjc.1992.169; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LS, 2012, J CLIN ENDOCR METAB, V97, pE319, DOI 10.1210/jc.2011-2671	38	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75905	10.1371/journal.pone.0075905	http://dx.doi.org/10.1371/journal.pone.0075905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124520	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100077
J	Cordero-Maldonado, ML; Siverio-Mota, D; Vicet-Muro, L; Wilches-Arizabala, IM; Esguerra, CV; de Witte, PAM; Crawford, AD				Lorena Cordero-Maldonado, Maria; Siverio-Mota, Dany; Vicet-Muro, Liliana; Maria Wilches-Arizabala, Isabel; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.			Optimization and Pharmacological Validation of a Leukocyte Migration Assay in Zebrafish Larvae for the Rapid In Vivo Bioactivity Analysis of Anti-Inflammatory Secondary Metabolites	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; CAFFEIC ACID; EXPRESSION ANALYSIS; EARLY MACROPHAGES; CAPRARIA-BIFLORA; GENE-EXPRESSION; ELLAGIC ACID; INFLAMMATION; DISCOVERY	Over the past decade, zebrafish (Danio rerio) have emerged as an attractive model for in vivo drug discovery. In this study, we explore the suitability of zebrafish larvae to rapidly evaluate the anti-inflammatory activity of natural products (NPs) and medicinal plants used in traditional medicine for the treatment of inflammatory disorders. First, we optimized a zebrafish assay for leukocyte migration. Inflammation was induced in four days post-fertilization (dpf) zebrafish larvae by tail transection and co-incubation with bacterial lipopolysaccharides (LPS), resulting in a robust recruitment of leukocytes to the zone of injury. Migrating zebrafish leukocytes were detected in situ by myeloperoxidase (MPO) staining, and anti-inflammatory activity was semi-quantitatively scored using a standardized scale of relative leukocyte migration (RLM). Pharmacological validation of this optimized assay was performed with a panel of anti-inflammatory drugs, demonstrating a concentration-responsive inhibition of leukocyte migration for both steroidal and non-steroidal anti-inflammatory drugs (SAIDs and NSAIDs). Subsequently, we evaluated the bioactivity of structurally diverse NPs with well-documented anti-inflammatory properties. Finally, we further used this zebrafish-based assay to quantify the anti-inflammatory activity in the aqueous and methanolic extracts of several medicinal plants. Our results indicate the suitability of this LPS-enhanced leukocyte migration assay in zebrafish larvae as a front-line screening platform in NP discovery, including for the bioassay-guided isolation of anti-inflammatory secondary metabolites from complex NP extracts.	[Lorena Cordero-Maldonado, Maria; Siverio-Mota, Dany; Vicet-Muro, Liliana; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Lorena Cordero-Maldonado, Maria; Maria Wilches-Arizabala, Isabel] Univ Cuenca, Sch Biochem & Pharm, Fac Chem Sci, Cuenca, Ecuador; [Siverio-Mota, Dany; Vicet-Muro, Liliana] Cent Univ Marta Abreu Las Villas, Fac Chem Pharm, Dept Pharm, Santa Clara, Cuba; [Lorena Cordero-Maldonado, Maria; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	KU Leuven; Universidad de Cuenca; Universidad Central "Marta Abreu" de Las Villas; University of Luxembourg	Crawford, AD (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	alexander.crawford@pharm.kuleuven.be	Esguerra, Camila/D-7657-2014; Esguerra, Camila/N-6159-2015	Esguerra, Camila/0000-0001-7891-1427; Esguerra, Camila/0000-0002-2271-8094; de Witte, Peter/0000-0002-9989-9567	Vlaamse Interuniversitaire Raad (VLIR); Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	Vlaamse Interuniversitaire Raad (VLIR); Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	MLCM was funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador''. DSM and LVM were funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta Sulay Loy, 2003, Acta Farmaceutica Bonaerense, V22, P53; Bohni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064006; Challal S, 2012, CHIMIA, V66, P229, DOI 10.2533/chimia.2012.229; Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Collins DO, 2000, J NAT PROD, V63, P1515, DOI 10.1021/np000280w; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Dimitrova P, 2012, CENTRAL EUROPEAN J B, V8, P186; ELIAS JM, 1980, AM J CLIN PATHOL, V73, P797; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Flemming A, 2007, NC3RS, V10, P1; Fonseca AM, 2006, J ESSENT OIL RES, V18, P158, DOI 10.1080/10412905.2006.9699052; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Gunther M, 2006, PHYTOCHEM ANALYSIS, V17, P1, DOI 10.1002/pca.822; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255; KAPLOW LS, 1965, BLOOD-J HEMATOL, V26, P215, DOI 10.1182/blood.V26.2.215.215; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kim S, 2011, FOOD CHEM TOXICOL, V49, P2580, DOI 10.1016/j.fct.2011.06.076; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lister JA, 1999, DEVELOPMENT, V126, P3757; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Marrero-Ponce Y, 2011, EUR J MED CHEM, V46, P5736, DOI 10.1016/j.ejmech.2011.07.053; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; McGregor Gerard, 2005, Phytochemistry Reviews, V4, P47, DOI 10.1007/s11101-004-2374-8; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Rocha NFM, 2011, N-S ARCH PHARMACOL, V384, P525, DOI 10.1007/s00210-011-0679-x; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Odontuya G, 2005, PHYTOTHER RES, V19, P782, DOI 10.1002/ptr.1723; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Quan LD, 2008, EXPERT OPIN THER PAT, V18, P723, DOI 10.1517/13543776.18.7.723; Rainsford K. D., 2007, V42, P3; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Sarah B, 2006, J ALTERN COMPLEM MED, V12, P981, DOI 10.1089/acm.2006.12.981; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Srivastava JK, 2010, MOL MED REP, V3, P895, DOI 10.3892/mmr.2010.377; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Watzke J, 2007, FISH SHELLFISH IMMUN, V23, P901, DOI 10.1016/j.fsi.2007.03.004; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yazawa R, 2005, MAR BIOTECHNOL, V7, P231, DOI 10.1007/s10126-004-0403-7	60	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75404	10.1371/journal.pone.0075404	http://dx.doi.org/10.1371/journal.pone.0075404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124487	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100044
J	Pizon, V; Rybina, S; Gerbal, F; Delort, F; Vicart, P; Baldacci, G; Karsenti, E				Pizon, Veronique; Rybina, Sofia; Gerbal, Fabien; Delort, Florence; Vicart, Patrick; Baldacci, Giuseppe; Karsenti, Eric			MURF2B, a Novel LC3-Binding Protein, Participates with MURF2A in the Switch between Autophagy and Ubiquitin Proteasome System during Differentiation of C2C12 Muscle Cells	PLOS ONE			English	Article							RING FINGER PROTEINS; MYOFIBRILLAR PROTEINS; DEGRADATION; EXPRESSION; MICROTUBULE; TITIN; INHIBITION; DOMAIN; LC3; IDENTIFICATION	The ubiquitin proteasome system and macroautophagy are proteolytic pathways essential in the maintenance of cellular homeostasis during differentiation and remodelling of skeletal muscle. In both pathways, proteins to be degraded are tagged with polyubiquitin. In skeletal muscles, the MURF2 proteins display E3 ubiquitin ligase structure suggesting that they may covalently attach ubiquitin polypeptides to still unknown target proteins. So far only MURF2A isoforms were studied and shown to interact with p62/SQSTM1, a protein implicated in macroautophagic and ubiquitin proteasome system degradations. Here, we analyzed the MURF2B and MURF2A proteins and show that the ratio of the isoforms changes during differentiation of muscle C2C12 cells and that the shift of the isoforms expression follows the sequential activation of autophagic or proteasomal degradation. We also show that MURF2B has a functional domain needed for its interaction with LC3, a protein needed for autophagic vesicles formation. Using specific MURF2 RNAi cells we observed that MURF2A and MURF2B are both needed for the formation of autophagosomes and that in the absence of MURF2B, the cells expressing MURF2A display an activated ubiquitin proteasome system implicated in the degradation of p62/SQSTM1 by UPS. Altogether, our results indicate that MURF2A and MURF2B proteins could participate in the molecular switch between the two ubiquitin degradative pathways.	[Pizon, Veronique; Delort, Florence; Vicart, Patrick] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS,EAC4413, Paris, France; [Rybina, Sofia; Karsenti, Eric] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Gerbal, Fabien] Univ Paris Diderot, CNRS, UMR 7057, Paris, France; [Baldacci, Giuseppe] Univ Paris Diderot, Inst Jacques Monod, CNRS, Paris, France; [Gerbal, Fabien] Univ Paris 06, Dept Phys, UFR925, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Pizon, V (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS,EAC4413, Paris, France.	veronique.pizon@univ-paris-diderot.fr	Pizon, Veronique/M-5590-2018	Pizon, Veronique/0000-0003-3596-8313				Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Faller EM, 2009, MOL CELL NEUROSCI, V41, P85, DOI 10.1016/j.mcn.2009.02.001; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gregorio CC, 2005, J MUSCLE RES CELL M, V26, P389, DOI 10.1007/s10974-005-9021-x; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; IAKOVENKO A, 2000, J MUSCLE RES CELL M, V21, P833; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kachaeva EV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493618; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perera S, 2012, J MUSCLE RES CELL M, V33, P107, DOI 10.1007/s10974-012-9288-7; Perera S, 2011, DEV BIOL, V351, P46, DOI 10.1016/j.ydbio.2010.12.024; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Purintrapiban J, 2003, COMP BIOCHEM PHYS B, V136, P393, DOI 10.1016/S1096-4959(03)00201-X; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Taillandier D, 2004, P NUTR SOC, V63, P357, DOI 10.1079/PAR2004358; TERJE J, 2010, AUTOPHAGY, V7, P279; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	56	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76140	10.1371/journal.pone.0076140	http://dx.doi.org/10.1371/journal.pone.0076140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124537	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100094
J	Venghateri, JB; Gupta, TK; Verma, PJ; Kunwar, A; Panda, D				Venghateri, Jubina B.; Gupta, Tilak Kumar; Verma, Paul J.; Kunwar, Ambarish; Panda, Dulal			Ansamitocin P3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; KINETIC STABILIZATION; TUMOR INHIBITORS; DYNAMIC INSTABILITY; MAYTANSINE-BINDING; SULFHYDRYL-GROUPS; ANTITUMOR AGENTS; MITOTIC ARREST; BLIND DOCKING; HALOGEN BONDS	Maytansinoid conjugates are currently under different phases of clinical trials and have been showing promising activity for various types of cancers. In this study, we have elucidated the mechanism of action of ansamitocin P3, a structural analogue of maytansine for its anticancer activity. Ansamitocin P3 potently inhibited the proliferation of MCF-7, HeLa, EMT-6/AR1 and MDA-MB-231 cells in culture with a half-maximal inhibitory concentration of 20 +/- 3, 50 +/- 0.5, 140 +/- 17, and 150 +/- 1.1 pM, respectively. Ansamitocin P3 strongly depolymerized both interphase and mitotic microtubules and perturbed chromosome segregation at its proliferation inhibitory concentration range. Treatment of ansamitocin P3 activated spindle checkpoint surveillance proteins, Mad2 and BubR1 and blocked the cells in mitotic phase of the cell cycle. Subsequently, cells underwent apoptosis via p53 mediated apoptotic pathway. Further, ansamitocin P3 was found to bind to purified tubulin in vitro with a dissociation constant (K-d) of 1.3 +/- 0.7 mu M. The binding of ansamitocin P3 induced conformational changes in tubulin. A docking analysis suggested that ansamitocin P3 may bind partially to vinblastine binding site on tubulin in two different positions. The analysis indicated that the binding of ansamitocin P3 to tubulin is stabilized by hydrogen bonds. In addition, weak interactions such as halogen-oxygen interactions may also contribute to the binding of ansamitocin P3 to tubulin. The study provided a significant insight in understanding the antiproliferative mechanism of action of ansamitocin P3.	[Venghateri, Jubina B.] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India; [Gupta, Tilak Kumar; Kunwar, Ambarish; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Verma, Paul J.] Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Verma, Paul/AAQ-4657-2021; Venghateri, Jubina Balan/AFX-6954-2022; Kunwar, Ambarish/AAD-3618-2022	Venghateri, Jubina Balan/0000-0001-5158-661X; Kunwar, Ambarish/0000-0002-8671-7816	IITB-Monash Research Academy; DAE-SRC fellowship, Department of Atomic energy; Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay; IITB Monash Research Academy	IITB-Monash Research Academy; DAE-SRC fellowship, Department of Atomic energy; Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay; IITB Monash Research Academy	The work is partly supported by funding from IITB-Monash Research Academy. D.P. is supported by a DAE-SRC fellowship, Department of Atomic energy. A.K. is supported by Wadhwani Research Centre in Biosciences and Bioengineering at Indian Institute of Technology Bombay. P.J.V. is by Monash Institute of Medical Research. J.B.V is supported by fellowship from IITB Monash Research Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; BHATTACHARYYA B, 1976, P NATL ACAD SCI USA, V73, P2375, DOI 10.1073/pnas.73.7.2375; BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassady JM, 2004, CHEM PHARM BULL, V52, P1, DOI 10.1248/cpb.52.1; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Daly E. M., 2009, CURR CHEM BIOL, V3, P367; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gajula PK, 2013, J MED CHEM, V56, P2235, DOI 10.1021/jm3009629; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1992, PHARMACOL THERAPEUT, V55, P31, DOI 10.1016/0163-7258(92)90028-X; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; HIGASHIDE E, 1977, NATURE, V270, P721, DOI 10.1038/270721a0; HUANG AB, 1985, BIOCHEM BIOPH RES CO, V128, P1239, DOI 10.1016/0006-291X(85)91073-3; Hubbard S., 1996, NACCESS COMPUTER PRO; IKEYAMA S, 1981, BIOCHEM PHARMACOL, V30, P2421, DOI 10.1016/0006-2952(81)90336-1; Iorga B, 2006, J MOL MODEL, V12, P366, DOI 10.1007/s00894-005-0057-z; ISSELL BF, 1978, CANCER TREAT REV, V5, P199, DOI 10.1016/S0305-7372(78)80014-0; Kaur Harpreet, 2006, In Silico Biology, V6, P111; Kukol A., 2008, MOL MODELING PROTEIN; KUPCHAN SM, 1977, J ORG CHEM, V42, P2349, DOI 10.1021/jo00434a001; KUPCHAN SM, 1978, J MED CHEM, V21, P31, DOI 10.1021/jm00199a006; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P1354, DOI 10.1021/ja00759a054; LI Y, 1992, BIOCHEM BIOPH RES CO, V187, P722, DOI 10.1016/0006-291X(92)91255-O; Liu C, 1997, Expert Opin Investig Drugs, V6, P169, DOI 10.1517/13543784.6.2.169; LOBERT S, 1995, BIOCHEMISTRY-US, V34, P8050, DOI 10.1021/bi00025a011; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; MANDELBAUMSHAVIT F, 1976, BIOCHEM BIOPH RES CO, V72, P47, DOI 10.1016/0006-291X(76)90958-X; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; Panda D, 2000, BIOCHEMISTRY-US, V39, P14121, DOI 10.1021/bi0010827; Panda D, 1998, P NATL ACAD SCI USA, V95, P9313, DOI 10.1073/pnas.95.16.9313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Rai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044311; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; REMILLARD S, 1975, SCIENCE, V189, P1002, DOI 10.1126/science.1241159; Riley KE, 2011, CRYST GROWTH DES, V11, P4272, DOI 10.1021/cg200882f; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sertel S, 2011, BIOCHEM PHARMACOL, V81, P723, DOI 10.1016/j.bcp.2010.12.026; Sieber S M, 1975, Bibl Haematol, P495; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Suezawa H, 2004, EUR J ORG CHEM, V2004, P4816, DOI 10.1002/ejoc.20040373; Taft F, 2012, CHEM-EUR J, V18, P880, DOI 10.1002/chem.201101640; TAKAHASHI M, 1987, BIOCHIM BIOPHYS ACTA, V926, P215, DOI 10.1016/0304-4165(87)90206-6; TANIDA S, 1980, J ANTIBIOT, V33, P192, DOI 10.7164/antibiotics.33.192	54	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75182	10.1371/journal.pone.0075182	http://dx.doi.org/10.1371/journal.pone.0075182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124473	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100030
J	Zeituni, AE; Miura, K; Diakite, M; Doumbia, S; Moretz, SE; Diouf, A; Tullo, G; Lopera-Mesa, TM; Bess, CD; Mita-Mendoza, NK; Anderson, JM; Fairhurst, RM; Long, CA				Zeituni, Amir E.; Miura, Kazutoyo; Diakite, Mahamadou; Doumbia, Saibou; Moretz, Samuel E.; Diouf, Ababacar; Tullo, Gregory; Lopera-Mesa, Tatiana M.; Bess, Cameron D.; Mita-Mendoza, Neida K.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.			Effects of Age, Hemoglobin Type and Parasite Strain on IgG Recognition of Plasmodium falciparum-Infected Erythrocytes in Malian Children	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; SICKLE-CELL TRAIT; APICAL MEMBRANE ANTIGEN-1; IN-VITRO; FLUORESCENT ANTIBODY; ACQUIRED-IMMUNITY; HUMAN MALARIA; PROTECTIVE ANTIBODIES; HEME OXYGENASE-1; AGGLUTINATION	Background: Naturally-acquired antibody responses to antigens on the surface of Plasmodium falciparum-infected red blood cells (iRBCs) have been implicated in antimalarial immunity. To profile the development of this immunity, we have been studying a cohort of Malian children living in an area with intense seasonal malaria transmission. Methodology/Principal Findings: We collected plasma from a sub-cohort of 176 Malian children aged 3-11 years, before (May) and after (December) the 2009 transmission season. To measure the effect of hemoglobin (Hb) type on antibody responses, we enrolled age-matched HbAA, HbAS and HbAC children. To quantify antibody recognition of iRBCs, we designed a high-throughput flow cytometry assay to rapidly test numerous plasma samples against multiple parasite strains. We evaluated antibody reactivity of each plasma sample to 3 laboratory-adapted parasite lines (FCR3, D10, PC26) and 4 short-term-cultured parasite isolates (2 Malian and 2 Cambodian). 97% of children recognized >= 1 parasite strain and the proportion of IgG responders increased significantly during the transmission season for most parasite strains. Both strain-specific and strain-transcending IgG responses were detected, and varied by age, Hb type and parasite strain. In addition, the breadth of IgG responses to parasite strains increased with age in HbAA, but not in HbAS or HbAC, children. Conclusions/Significance: Our assay detects both strain-specific and strain-transcending IgG responses to iRBCs. The magnitude and breadth of these responses varied not only by age, but also by Hb type and parasite strain used. These findings indicate that studies of acquired humoral immunity should account for Hb type and test large numbers of diverse parasite strains.	[Zeituni, Amir E.; Miura, Kazutoyo; Moretz, Samuel E.; Diouf, Ababacar; Tullo, Gregory; Lopera-Mesa, Tatiana M.; Bess, Cameron D.; Mita-Mendoza, Neida K.; Anderson, Jennifer M.; Fairhurst, Rick M.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Diakite, Mahamadou; Doumbia, Saibou] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Mita-Mendoza, Neida K.] Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Long, CA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	clong@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, ZIAAI001062, ZIAAI001000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUIAR JC, 1992, AM J TROP MED HYG, V47, P621; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; ANDERS RF, 1983, P NATL ACAD SCI-BIOL, V80, P6652, DOI 10.1073/pnas.80.21.6652; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BROWN IN, 1968, IMMUNOLOGY, V14, P127; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cabrera G, 2004, INFECT IMMUN, V72, P284, DOI 10.1128/IAI.72.1.284-294.2004; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; CHULAY JD, 1985, B WORLD HEALTH ORGAN, V63, P317; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLLINS WE, 1964, AM J TROP MED HYG, V13, P1; COLLINS WE, 1964, AM J TROP MED HYG, V13, P777, DOI 10.4269/ajtmh.1964.13.777; COLLINS WE, 1964, AM J TROP MED HYG, V13, P256, DOI 10.4269/ajtmh.1964.13.256; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Eaton MD, 1938, J EXP MED, V67, P857, DOI 10.1084/jem.67.6.857; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FANDEUR T, 1984, J IMMUNOL, V132, P432; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fu Y, 2010, CYTOM PART A, V77A, P253, DOI 10.1002/cyto.a.20856; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Giha HA, 1998, AM J TROP MED HYG, V58, P399, DOI 10.4269/ajtmh.1998.58.399; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; GYSIN J, 1982, PARASITE IMMUNOL, V4, P421, DOI 10.1111/j.1365-3024.1982.tb00453.x; GYSIN J, 1987, ANN INST PASTEUR IMM, V138, P829, DOI 10.1016/S0769-2625(87)80003-X; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; JENSEN JB, 1978, AM J TROP MED HYG, V27, P743, DOI 10.4269/ajtmh.1978.27.743; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; MARSH K, 1986, J IMMUNOL METHODS, V91, P107, DOI 10.1016/0022-1759(86)90108-0; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060182; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; OTOO LN, 1988, T ROY SOC TROP MED H, V82, P59, DOI 10.1016/0035-9203(88)90263-5; Piper KP, 1999, EXP PARASITOL, V91, P161, DOI 10.1006/expr.1998.4368; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SOUTHWELL BR, 1989, T ROY SOC TROP MED H, V83, P464, DOI 10.1016/0035-9203(89)90248-4; Staalso T, 1998, IMMUNOL LETT, V60, P121, DOI 10.1016/S0165-2478(97)00143-0; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tan XL, 2011, J INFECT DIS, V204, P1750, DOI 10.1093/infdis/jir638; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; VOLLER A, 1975, BRIT MED J, V1, P659, DOI 10.1136/bmj.1.5959.659; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088	77	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76734	10.1371/journal.pone.0076734	http://dx.doi.org/10.1371/journal.pone.0076734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124591	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100148
J	Goodson, JM; Tavares, M; Wang, XS; Niederman, R; Cugini, M; Hasturk, H; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K				Goodson, J. Max; Tavares, Mary; Wang, Xiaoshan; Niederman, Richard; Cugini, Maryann; Hasturk, Hatice; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem			Obesity and Dental Decay: Inference on the Role of Dietary Sugar	PLOS ONE			English	Article							NUTRITIONAL-STATUS; KUWAITI CHILDREN; US CHILDREN; CARIES; ASSOCIATION; SCHOOLCHILDREN; ADOLESCENTS; OVERWEIGHT; RATES	Objective: To evaluate the relationship of children's obesity and dental decay. Methods: We measured parameters related to obesity and dental decay in 8,275 4th and 5th grade Kuwaiti children (average age=11.36 years) in a cross-sectional study. First to determine body weight, height, age for computation of BMI. Second, to determine numbers of teeth, numbers of fillings and numbers of untreated decayed teeth to determine extent and severity of dental disease. From these measurements, we computed measures of dental decay in children from four body weight categories; obese, overweight, normal healthy weight and underweight children. Results: The percentage of children with decayed or filled teeth varied inversely with the body weight category. The percentage of decayed or filled teeth decreased from 15.61% (n=193) in underweight children, to 13.03% (n=4,094) in normal healthy weight children, to 9.73% (n=1,786) in overweight children to 7.87% (n=2,202) in obese children. Differences between all groups were statistically significant. Male children in this population had more dental decay than female children but the reduction of tooth decay as a function of BMI was greater in male children. Conclusions: The finding of an inverse obesity-dental decay relationship contradicts the obesity-sugar and the obesity-dental decay relationship hypotheses. Sugar is well recognized as necessary and sufficient for dental decay. Sugar is also hypothesized to be a leading co-factor in obesity. If the later hypothesis is true, one would expect dental decay to increase with obesity. This was not found. The reasons for this inverse relationship are not currently clear.	[Goodson, J. Max; Tavares, Mary; Wang, Xiaoshan; Niederman, Richard; Cugini, Maryann; Hasturk, Hatice; Soparkar, Pramod] Forsyth Inst, Cambridge, MA USA; [Barake, Roula] Dasman Diabet Inst, Nutr Serv, Kuwait, Kuwait; [Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha] Minist Hlth, Kuwait, Kuwait; [Ariga, Jitendra] Minist Hlth, Sch Oral Hlth Program, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait	Harvard University; Forsyth Institute; Kuwait University	Goodson, JM (corresponding author), Forsyth Inst, Cambridge, MA USA.	mgoodson@forsyth.org	Wang, Xiaoshan/D-6292-2014	Wang, Xiaoshan/0000-0002-6760-5456; Barake, Roula/0000-0002-9461-2897; Tavares, Mary/0000-0003-4705-1238; niederman, richard/0000-0001-6674-1774	Dasman Institute, Kuwait	Dasman Institute, Kuwait	This work was funded by the Dasman Institute, Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuZeid K, 2007, AR WAT HLTH C EG CAI; Al-Isa AN, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/459261; Al-Mutawa SA, 2006, COMMUNITY DENT HLTH, V23, P31; BAYOUMI A, 1985, INT J EPIDEMIOL, V14, P415, DOI 10.1093/ije/14.3.415; Behbehani JM, 2002, MED PRIN PRACT, V11, P36, DOI 10.1159/000057777; Burt B A, 2001, J Dent Educ, V65, P1017; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Hettmansperger TP, 2012, ROBUST NONPARAMETRIC; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Jackson RT, 2011, PUBLIC HEALTH NUTR, V14, P70, DOI 10.1017/S1368980010002600; Kopycka-Kedzierawski DT, 2008, COMMUNITY DENT ORAL, V36, P157, DOI 10.1111/j.1600-0528.2007.00384.x; Macek MD, 2006, PEDIATR DENT, V28, P375; MOORE WJ, 1972, CARIES RES, V7, P139, DOI 10.1159/000259838; Narksawat K, 2009, SE ASIAN J TROP MED, V40, P338; *NRC, 1989, DIET HLTH IMPL RED C; Oliveira LB, 2008, EUR J ORAL SCI, V116, P37, DOI 10.1111/j.1600-0722.2007.00507.x; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Te Morenga L, 2013, BR MED J CLIN RES ED	20	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e74461	10.1371/journal.pone.0074461	http://dx.doi.org/10.1371/journal.pone.0074461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130667	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200001
J	Bode, NWF; Delcourt, J				Bode, Nikolai W. F.; Delcourt, Johann			Individual-to-Resource Landscape Interaction Strength Can Explain Different Collective Feeding Behaviours	PLOS ONE			English	Article							ECOLOGY	Taking in sufficient quantities of nutrients is vital for all living beings and in doing so, individuals interact with the local resource environment. Here, we focus explicitly on the interactions between feeding individuals and the resource landscape. In particular, we are interested in the emergent movement dynamics resulting from these interactions. We present an individual-based simulation model for the movement of populations in a resource landscape that allows us to vary the strength of the interactions mentioned above. The key assumption and novelty of our model is that individuals can cause the release of additional nutrients, as well as consuming them. Our model produces clear predictions. For example, we expect more tortuous individual movement paths and higher levels of aggregation in populations occupying homogeneous environments where individual movement makes more nutrients available. We also show how observed movement dynamics could change when local nutrient sources are depleted or when the population density increases. Our predictions are testable and qualitatively reproduce the different feeding behaviours observed in filter-feeding ducks, for example. We suggest that considering two-way interactions between feeding individuals and resource landscapes could help to explain fine-scale movement dynamics.	[Bode, Nikolai W. F.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Delcourt, Johann] Univ Liege, Behav Biol Unit Ethol & Anim Psychol, Lab Fish & Amphibian Ethol, Dept Environm Sci & Management,Fac Sci,Inst Zool, Liege, Belgium	University of Essex; University of Liege	Delcourt, J (corresponding author), Univ Liege, Behav Biol Unit Ethol & Anim Psychol, Lab Fish & Amphibian Ethol, Dept Environm Sci & Management,Fac Sci,Inst Zool, Liege, Belgium.	johann.delcourt@ulg.ac.be		Delcourt, Johann/0000-0001-5036-8450	AXA research fellowship; F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC) [2.4.617.08F]	AXA research fellowship(AXA Research Fund); F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC)(Fonds de la Recherche Scientifique - FNRS)	NWFB is supported by an AXA research fellowship and JD is supported by the F.R.S.-FNRS (Fonds de la Recherche Scientifique, Belgium, FRFC grant 2.4.617.08F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bazazi S, 2012, BEHAV ECOL SOCIOBIOL, V66, P879, DOI 10.1007/s00265-012-1336-1; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; BenJacob E, 1997, PHYSICA A, V238, P181, DOI 10.1016/S0378-4371(96)00457-8; Bragg AN, 1965, GNOMES NIGHT SPADEFO; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Caro Tim, 2005, pXIII; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CROME FHJ, 1985, AUST J ZOOL, V33, P849, DOI 10.1071/ZO9850849; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; Delcourt J, 2012, REV FISH BIOL FISHER, V22, P595, DOI 10.1007/s11160-012-9260-z; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; DiGiacomo PM, 2002, J MARINE SYST, V37, P199, DOI 10.1016/S0924-7963(02)00202-6; Geroudet P, 1999, PALMIPEDES EUROPE; Gooders J, 1986, DUCKS N AM NO HEMISP; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Guillemain M, 2000, WATERBIRDS, V23, P353, DOI 10.2307/1522173; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Johnsgard PA, 1965, HDB WATERFOWL BEHAV; KATZ LC, 1981, ANIM BEHAV, V29, P20, DOI 10.1016/S0003-3472(81)80148-0; Kils U., 1992, Advances in Limnology, V36, P83; Krause J, 2002, LIVING GROUPS; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; Mach R, 2007, B MATH BIOL, V69, P539, DOI 10.1007/s11538-006-9135-3; Obst BS, 1996, NATURE, V384, P121, DOI 10.1038/384121a0; Oom SP, 2004, ECOL COMPLEX, V1, P299, DOI 10.1016/j.ecocom.2004.06.003; PARTRIDGE BL, 1983, ENVIRON BIOL FISH, V9, P253, DOI 10.1007/BF00692374; Perna A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002592; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Tania N, 2012, P NATL ACAD SCI USA, V109, P11228, DOI 10.1073/pnas.1201739109; THOMAS GJ, 1982, J ZOOL, V197, P131, DOI 10.1111/jzo.1982.197.1.131; Tietje WD, 1996, J WILDLIFE MANAGE, V60, P843, DOI 10.2307/3802385; Todd F, 1979, WATERFOWL DUCKS GEES; Torney CJ, 2010, P NATL ACAD SCI USA, V107, P20394, DOI 10.1073/pnas.1014316107	42	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75879	10.1371/journal.pone.0075879	http://dx.doi.org/10.1371/journal.pone.0075879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130748	gold, Green Published			2022-12-25	WOS:000325810900061
J	Hamsher, SE; LeGresley, MM; Martin, JL; Saunders, GW				Hamsher, Sarah E.; LeGresley, Murielle M.; Martin, Jennifer L.; Saunders, Gary W.			A Comparison of Morphological and Molecular-Based Surveys to Estimate the Species Richness of Chaetoceros and Thalassiosira (Bacillariophyta), in the Bay of Fundy	PLOS ONE			English	Article							BARCODING DIATOMS; DIVERSITY; RDNA; IDENTIFICATION; TAXONOMY; PRIMERS; COX1; RBCL; DNA	The goal of this study was to compare the ability of morphology and molecular-based surveys to estimate species richness for two species-rich diatom genera, Chaetoceros Ehrenb. and Thalassiosira Cleve, in the Bay of Fundy. Phytoplankton tows were collected from two sites at intervals over two years and subsampled for morphology-based surveys (2010, 2011), a culture-based DNA reference library (DRL; 2010), and a molecular-based survey (2011). The DRL and molecular-based survey utilized the 39 end of the RUBISCO large subunit (rbcL-3P) to identify genetic species groups (based on 0.1% divergence in rbcL-3P), which were subsequently identified morphologically to allow comparisons to the morphology-based survey. Comparisons were compiled for the year (2011) by site (n = 2) and by season (n = 3). Of the 34 taxa included in the comparisons, 50% of taxa were common to both methods, 35% were unique to the molecular-based survey, and 12% were unique to the morphology-based survey, while the remaining 3% of taxa were unidentified genetic species groups. The morphology-based survey excelled at identifying rare taxa in individual tow subsamples, which were occasionally missed with the molecular approach used here, while the molecular methods (the DRL and molecular-based survey), uncovered nine cryptic species pairs and four previously overlooked species. The last mentioned were typically difficult to identify and were generically assigned to Thalassiosira spp. during the morphology-based survey. Therefore, for now we suggest a combined approach encompassing routine morphology-based surveys accompanied by periodic molecular-based surveys to monitor for cryptic and difficult to identify taxa. As sequencing technologies improve, molecular-based surveys should become routine, leading to a more accurate representation of species composition and richness in monitoring programs.	[Hamsher, Sarah E.; Saunders, Gary W.] Univ New Brunswick, Fredericton, NB, Canada; [LeGresley, Murielle M.; Martin, Jennifer L.] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada	University of New Brunswick; Fisheries & Oceans Canada	Hamsher, SE (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	sarah.hamsher@colorado.edu	Saunders, Gary W/D-8767-2014	Saunders, Gary W/0000-0003-4813-6831	Genome Canada (through the Ontario Genomics Institute); National Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canada Research Chair Program; Department of Fisheries and Oceans	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Department of Fisheries and Oceans	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute), National Sciences and Engineering Research Council of Canada (NSERC), and other sponsors listed at www.BOLNET.ca. Additional funding was provided by NSERC and the Canada Research Chair Program to GWS, as well as infrastructure support from the Canada Foundation for Innovation and the New Brunswick Foundation for Innovation. Additional support was provided by the Department of Fisheries and Oceans. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; [Anonymous], OC GEN LEG OC GEN RE; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Berard-Therriault L, 1999, GUIDE IDENTIFICATION, V128; Berlyn G.P., 1976, BOT MICROTECHNIQUE C, DOI [10.2307/2418781, DOI 10.2307/2418781]; Drummond A., 2011, GENEIOUS V 5 4; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Guiry MD, 2012, ALGAEBASE; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; HASLE GR, 1976, DEEP-SEA RES, V23, P319; Helsinki Commission (HELCOM), 2006, MAN MAR MON COMBINE; Hoppenrath M., 2009, SCHWEIZERBART SCHE V; Horner R.A, 2002, TAXONOMIC GUIDE SOME; Jensen K.G., 1998, OPERA BOT, V133, P5, DOI [10.1111/j.1756-1051.1998.tb01103.x, DOI 10.1111/J.1756-1051.1998.TB01103.X]; Kaczmarska I, 2008, BOTANY, V86, P763, DOI 10.1139/B08-046; Kraberg A.C., 2010, COASTAL PHYTOPLANKTO; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; MADDISON WP, 2003, MACCLADE VERSION 4 0; Mann DG, 2010, CRYPTOGAMIE ALGOL, V31, P557; Martin JL, 2009, J SEA RES, V61, P76, DOI 10.1016/j.seares.2008.05.011; Martin JL, 2001, CAN TECH REP FISH AQ, V2349; Martin JL, 1999, CAN TECH REP FISH AQ, V2265; Martin JL, 1995, CAN MANUSCR REP FISH, V2277; Martin JL, 2006, CAN TECH REP FISH AQ, V2629; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Richlen ML, 2005, MOL ECOL NOTES, V5, P688, DOI 10.1111/j.1471-8286.2005.01032.x; RINES JEB, 1987, J PLANKTON RES, V9, P917, DOI 10.1093/plankt/9.5.917; Rines JEB, 1988, BIOBLIOTHECA PHYCOLO, V79; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Saunders Gary W, 2012, Methods Mol Biol, V858, P207, DOI 10.1007/978-1-61779-591-6_10; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; Throndsen J., 2007, PHYTOPLANKTON NORWEG; Tomas CR, 1993, IDENTIFYING MARINE P; Trobajo R, 2010, EUR J PHYCOL, V45, P413, DOI 10.1080/09670262.2010.498586; Trobajo R, 2009, PHYCOLOGIA, V48, P443, DOI 10.2216/08-69.1; Wildish DJ, 1990, CAN TECH REP FISH AQ, V1760; Wildish DJ, 1988, CAN TECH REP FISH AQ, V1648; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	49	18	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e73521	10.1371/journal.pone.0073521	http://dx.doi.org/10.1371/journal.pone.0073521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130665	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900002
J	Hayek, LAC; Wilson, B				Hayek, Lee-Ann C.; Wilson, Brent			Quantifying Assemblage Turnover and Species Contributions at Ecologic Boundaries	PLOS ONE			English	Article							QUATERNARY BENTHIC FORAMINIFERA; SEQUENCE STRATIGRAPHY; BLAKE RIDGE; SEA-LEVEL; DIVERSITY; SLOPE; RISE; PRODUCTIVITY; PATTERNS; CHANNEL	Not all boundaries, whether stratigraphical or geographical, are marked by species-level changes in community composition. For example, paleodata for some sites do not show readily discernible glacial-interglacial contrasts. Rather, the proportional abundances of species can vary subtly between glacials and interglacials. This paper presents a simple quantitative measure of assemblage turnover (assemblage turnover index, ATI) that uses changes in species' proportional abundances to identify intervals of community change. A second, functionally-related index (conditioned-on-boundary index, CoBI) identifies species contributions to the total assemblage turnover. With these measures we examine benthonic foraminiferal assemblages to assess glacial/interglacial contrasts at abyssal depths. Our results indicate that these measures, ATI and CoBI, have potential as sequence stratigraphic tools in abyssal depth deposits. Many peaks in the set of values of ATI coincide with terminations at the end of glaciations and delineate peak-bounded ATI intervals (PATIs) separated by boundaries that approximate to glacial terminations and to transgressions at neritic depths. These measures, however, can be used to evaluate the assemblage turnover and composition at any defined ecological or paleoecological boundary. The section used is from Ocean Drilling Program (OPD) Hole 994C, drilled on the Blake Ridge, offshore SE USA.	[Hayek, Lee-Ann C.] Smithsonian Inst Math & Stat NMNH MRC 121, Washington, DC USA; [Wilson, Brent] Univ W Indies, Petr Geosci Programme, Dept Chem Engn, St Augustine, Trinidad Tobago	Smithsonian Institution; University West Indies Mona Jamaica; University West Indies Saint Augustine	Wilson, B (corresponding author), Univ W Indies, Petr Geosci Programme, Dept Chem Engn, St Augustine, Trinidad Tobago.	brent.wilson@sta.uwi.edu			U.S. National Science Foundation (NSF); Joint Oceanographic Institutions (JOI), Inc.	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Joint Oceanographic Institutions (JOI), Inc.	This research used samples provided by the Ocean Drilling Program (ODP) that is sponsored by the U.S. National Science Foundation (NSF) and participating countries under management of Joint Oceanographic Institutions (JOI), Inc. Thanks are due to two anonymous reviewers, whose suggestions improved this paper markedly.	Altenbach AV, 1999, J FORAMIN RES, V29, P173; Armentrout John M., 1996, Geological Society Special Publication, V104, P65, DOI 10.1144/GSL.SP.1996.104.01.06; Astorga G, 2011, GEOL ACTA, V9, P45, DOI 10.1344/105.000001649; Baden-Powell D. F. W., 1956, Proceedings of the Geologists' Association London, V66, P271; BANDY OL, 1960, J PALEONTOL, V34, P671; Berger W. H., 2012, MIKLANKOVITCH THEORY, P1; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Bhaumik AK, 2007, CURR SCI INDIA, V92, P192; Bhaumik AK, 2005, CURR SCI INDIA, V88, P1969; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Bocher J, 2012, BOREAS, V41, P644, DOI 10.1111/j.1502-3885.2012.00251.x; Bolli H.M., 1985, P155; Bornmalm Lennart, 1997, Fossils and Strata, V41, P1; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; Catuneanu O., 2006, PRINCIPLES SEQUENCE, V1, DOI DOI 10.1016/C2009-0-19362-5; Catuneanu O, 2011, NEWSL STRATIGR, V44, P173, DOI 10.1127/0078-0421/2011/0011; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Cushman J. A., 1922, Bulletin United States National Museum, V104, P1; Cushman J. A., 1923, Bulletin United States National Museum, V104, P1; Cushman J. A., 1924, Bulletin United States National Museum, V104, P1; Cushman J. A., 1930, B US NAT MUS, V104, P1; Cushman J. A., 1931, US NATL MUSEUM B, V104, P1; Cushman J. A., 1920, US NATL MUSEUM B, V104, P1; Cushman J. A., 1940, US GEOLOGICAL SURV A, P35; CUSHMAN JOSEPH A., 1929, U S NATION MUS BULL, V104, P1; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; den Dulk M, 1998, MAR MICROPALEONTOL, V35, P43, DOI 10.1016/S0377-8398(98)00015-2; Dillon W. P., 1996, P ODP INIT REPTS, V164, P47; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; GABY ML, 1985, MAR GEOL, V68, P125, DOI 10.1016/0025-3227(85)90008-8; Geikie J., 1874, GREAT ICE AGE ITS RE; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Gooday AJ, 2000, DEEP-SEA RES PT II, V47, P25, DOI 10.1016/S0967-0645(99)00099-5; GUPTA AK, 1993, MICROPALEONTOLOGY, V39, P47, DOI 10.2307/1485973; Hayek LAC, 2013, J FORAMIN RES, V43, P305, DOI 10.2113/gsjfr.43.3.305; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HEEZEN BC, 1966, SCIENCE, V152, P502, DOI 10.1126/science.152.3721.502; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; KAIHO K, 1994, GEOLOGY, V22, P719, DOI 10.1130/0091-7613(1994)022<0719:BFDOIA>2.3.CO;2; Lewis FJ, 1906, SCOT GEOGR MAG, V22, P241, DOI 10.1080/14702540608554658; LINKE P, 1993, MAR MICROPALEONTOL, V20, P215, DOI 10.1016/0377-8398(93)90034-U; Luning S, 1998, J FORAMIN RES, V28, P19; Mackensen A, 1995, MICROPALEONTOLOGY, V41, P342, DOI 10.2307/1485808; Mohan K, 2011, J MICROPALAEONTOL, V30, P33, DOI 10.1144/0262-821X10-008; Murray JW, 2013, J MICROPALAEONTOL, V32, P1, DOI 10.1144/jmpaleo2012-010; MURRAY JW, 1992, J FORAMIN RES, V22, P114, DOI 10.2113/gsjfr.22.2.114; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Nagy J, 2001, J FORAMIN RES, V31, P324, DOI 10.2113/0310324; Oba T, 2000, P OCEAN DRILLING PRO; Okada Hisatake, 2000, Proceedings of the Ocean Drilling Program Scientific Results, V164, P331; Parker F. L., 1954, B MUS COMP ZOOL HARV, V111, P454; Paull CK, 1996, P OCEAN DRILLING PRO, P99; Pekar SF, 2001, J SEDIMENT RES, V71, P608, DOI 10.1306/100600710608; Pflum C.E., 1976, Special Publs Cushman Fdn, VNo. 14, P1; Phleger F. B., 1953, Report of the Swedish Deep-Sea Expedition (1947-1948), V7, P1; Phleger F. B., 1951, ECOLOGY FORAMINIFERA, V46, P1; Poag C.W., 1976, Geol Socs, V26, P185; QVALE G, 1985, MAR MICROPALEONTOL, V9, P469, DOI 10.1016/0377-8398(85)90014-3; Rai AK, 2012, OCEANOLOGIA, V54, P449, DOI 10.5697/oc.54-3.449; Schafer CT, 1978, GEOLOGICAL SURVEY CA, P1; SCHNITKER D, 1974, NATURE, V248, P385, DOI 10.1038/248385a0; Schonfeld J, 2005, MAR MICROPALEONTOL, V57, P1, DOI 10.1016/j.marmicro.2005.05.004; Schonfeld J, 2001, J FORAMIN RES, V31, P86, DOI 10.2113/0310086; SCHOTT W, 1935, RECENT MARINE SEDIME, V4, P396; SEIGLIE G A, 1968, AM ASSOC PET GEOL BULL, V52, P2231; SENGUPTA BK, 1982, MAR MICROPALEONTOL, V7, P297, DOI 10.1016/0377-8398(82)90007-X; SENGUPTA BK, 1982, GEOL SOC AM BULL, V93, P218, DOI 10.1130/0016-7606(1982)93<218:LBFOTF>2.0.CO;2; SenGupta BK, 1996, GEOLOGY, V24, P227, DOI 10.1130/0091-7613(1996)024<0227:SODICS>2.3.CO;2; Smart CW, 2006, J FORAMIN RES, V36, P34, DOI 10.2113/36.1.34; Smart CW, 2002, QUATERNARY ENVIRONMENTAL MICROPALAEONTOLOGY, P14; SMART CW, 1994, MAR MICROPALEONTOL, V23, P89, DOI 10.1016/0377-8398(94)90002-7; STREETER SS, 1982, GEOL SOC AM BULL, V93, P190, DOI 10.1130/0016-7606(1982)93<190:HALGBF>2.0.CO;2; Streeter SS, 1973, QUATERNARY RES, V3, P141; Sun HJ, 2011, CHINESE SCI BULL, V56, P2732, DOI 10.1007/s11434-011-4603-z; Taldenkova E, 2012, MAR MICROPALEONTOL, V96-97, P13, DOI 10.1016/j.marmicro.2012.06.007; THOMAS E, 1995, PALEOCEANOGRAPHY, V10, P545, DOI 10.1029/94PA03056; Torrens HS, 2002, GEOL SOC SPEC PUBL, V192, P251, DOI 10.1144/GSL.SP.2002.192.01.14; Tucholke B.E., 2002, MEMOIRS, V22, P39, DOI DOI 10.1144/GSL.MEM.2002.022.01.04; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wilson B, 2003, CARIBB J SCI, V39, P209; Wilson B., 2011, J FORAMIN RES, V41, P40; Wilson B, J FORAMINIF IN PRESS; Wilson B, 2013, J FORAMIN RES, V43, P143, DOI 10.2113/gsjfr.43.2.143; Wilson B, 2008, J MICROPALAEONTOL, V27, P177, DOI 10.1144/jm.27.2.177; WOODS J, 1993, J PLANKTON RES, V15, P1053, DOI 10.1093/plankt/15.9.1053; Wright R., 1978, Initial Reports of the Deep Sea Drilling Project, V42, P837	88	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74999	10.1371/journal.pone.0074999	http://dx.doi.org/10.1371/journal.pone.0074999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130679	Green Submitted, gold, Green Published			2022-12-25	WOS:000325810900014
J	Hertlein, E; Beckwith, KA; Lozanski, G; Chen, TL; Towns, WH; Johnson, AJ; Lehman, A; Ruppert, AS; Bolon, B; Andritsos, L; Lozanski, A; Rassenti, L; Zhao, WQ; Jarvinen, TM; Senter, L; Croce, CM; Symer, DE; de la Chapelle, A; Heerema, NA; Byrd, JC				Hertlein, Erin; Beckwith, Kyle A.; Lozanski, Gerard; Chen, Timothy L.; Towns, William H.; Johnson, Amy J.; Lehman, Amy; Ruppert, Amy S.; Bolon, Brad; Andritsos, Leslie; Lozanski, Arletta; Rassenti, Laura; Zhao, Weiqiang; Jarvinen, Tiina M.; Senter, Leigha; Croce, Carlo M.; Symer, David E.; de la Chapelle, Albert; Heerema, Nyla A.; Byrd, John C.			Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; B-CLL CELLS; CLONAL EVOLUTION; HIGH-RISK; GENE-EXPRESSION; GENOMIC ABERRATIONS; SITU HYBRIDIZATION; SURVIVAL; MUTATIONS; NUDE	Studies of chronic lymphocytic leukemia (CLL) have yielded substantial progress, however a lack of immortalized cell lines representative of the primary disease has hampered a full understanding of disease pathogenesis and development of new treatments. Here we describe a novel CLL cell line (OSU-CLL) generated by EBV transformation, which displays a similar cytogenetic and immunophenotype observed in the patient's CLL (CD5 positive with trisomy 12 and 19). A companion cell line was also generated from the same patient (OSU-NB). This cell line lacked typical CLL characteristics, and is likely derived from the patient's normal B cells. In vitro migration assays demonstrated that OSU-CLL exhibits migratory properties similar to primary CLL cells whereas OSU-NB has significantly reduced ability to migrate spontaneously or towards chemokine. Microarray analysis demonstrated distinct gene expression patterns in the two cell lines, including genes on chromosomes 12 and 19, which is consistent with the cytogenetic profile in this cell line. Finally, OSU-CLL was readily transplantable into NOG mice, producing uniform engraftment by three weeks with leukemic cells detectable in the peripheral blood spleen and bone marrow. These studies describe a new CLL cell line that extends currently available models to study gene function in this disease.	[Hertlein, Erin; Beckwith, Kyle A.; Chen, Timothy L.; Towns, William H.; Johnson, Amy J.; Ruppert, Amy S.; Andritsos, Leslie; Lozanski, Arletta; Symer, David E.; Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lozanski, Gerard; Zhao, Weiqiang; Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Lehman, Amy] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Bolon, Brad] Ohio State Univ, Dept Vet Biosci & Comparat Pathol & Mouse Phenoty, Columbus, OH 43210 USA; [Rassenti, Laura] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; [Jarvinen, Tiina M.; Senter, Leigha; Croce, Carlo M.; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Byrd, JC (corresponding author), Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Young, Richard A/F-6495-2012; Zhao, Weiqiang/E-4368-2011	Young, Richard A/0000-0001-8855-8647; Beckwith, Kyle/0000-0001-8025-2512	National Cancer Institute [P01 CA95426, P50CA140158]; CLL Research Consortium [P01 CA81534-02]; Leukemia and Lymphoma Society; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA151319, P50CA140158, P01CA081534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLL Research Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (P01 CA95426 and P50CA140158); CLL Research Consortium (P01 CA81534-02), The Leukemia and Lymphoma Society (special scholar grant to EH) and The D. Warren Brown Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Berkova A, 2009, NEOPLASMA, V56, P455, DOI 10.4149/neo_2009_05_455; Bertilaccio MTS, 2010, BLOOD, V115, P1605, DOI 10.1182/blood-2009-05-223586; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Capello D, 2004, LEUKEMIA, V18, P1941, DOI 10.1038/sj.leu.2403537; Cavazzini F, 2012, LEUKEMIA LYMPHOMA, V53, P83, DOI 10.3109/10428194.2011.606384; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Ghia EM, 2008, BLOOD, V111, P5101, DOI 10.1182/blood-2007-12-130229; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Hwang KK, 2012, BLOOD, V119, pE35, DOI 10.1182/blood-2011-08-371203; Janssens A, 2012, EUR J HAEMATOL, V89, P72, DOI 10.1111/j.1600-0609.2012.01790.x; Joshi AD, 2007, CLIN CANCER RES, V13, P5295, DOI 10.1158/1078-0432.CCR-07-0283; Kardava L, 2011, INT IMMUNOL, V23, P375, DOI 10.1093/intimm/dxr027; KAWATA A, 1993, LEUKEMIA RES, V17, P883, DOI 10.1016/0145-2126(93)90154-D; Khartan-Dabaja MA, 2008, CANCER-AM CANCER SOC, V113, P897, DOI 10.1002/cncr.23671; Khinkis Leonid A, 2003, Nonlinearity Biol Toxicol Med, V1, P363, DOI 10.1080/15401420390249925; Lacerda JF, 1996, TRANSPLANTATION, V61, P492, DOI 10.1097/00007890-199602150-00030; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; LEE CLY, 1986, CANCER RES, V46, P2497; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Loisel S, 2005, LEUKEMIA RES, V29, P1347, DOI 10.1016/j.leukres.2005.04.017; Loscertales J, 2010, LEUKEMIA LYMPHOMA, V51, P1142, DOI 10.3109/10428191003793374; Lozanski G, 2012, LEUKEMIA LYMPHOMA, V53, P1743, DOI 10.3109/10428194.2012.668683; Mittal AK, 2007, INT J MOL MED, V20, P461; Muthusamy N, 2011, CANCER GENET-NY, V204, P77, DOI 10.1016/j.cancergen.2010.12.006; MYHRINDER AL, 2013, MOL CHARACTERIZATION, P23168; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Porpaczy E, 2009, EUR J CLIN INVEST, V39, P568, DOI 10.1111/j.1365-2362.2009.02146.x; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Shanafelt TD, 2008, J CLIN ONCOL, V26, pE5, DOI 10.1200/JCO.2008.16.7874; Shanafelt TD, 2006, J CLIN ONCOL, V24, P4634, DOI 10.1200/JCO.2006.06.9492; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stilgenbauer S, 2007, HAEMATOLOGICA, V92, P1242, DOI 10.3324/haematol.10720; TAKADA K, 1980, INTERVIROLOGY, V13, P223, DOI 10.1159/000149129; Villamor N, 2013, LEUKEMIA, V27, P1100, DOI 10.1038/leu.2012.357; WALLS EV, 1989, INT J CANCER, V44, P846, DOI 10.1002/ijc.2910440517; Wang J, 2004, BIOINFORMATICS, V20, P3166, DOI 10.1093/bioinformatics/bth381; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476	47	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76607	10.1371/journal.pone.0076607	http://dx.doi.org/10.1371/journal.pone.0076607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130782	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900078
J	Hou, Y; Mattson, MP; Cheng, AW				Hou, Yan; Mattson, Mark P.; Cheng, Aiwu			Permeability Transition Pore-Mediated Mitochondrial Superoxide Flashes Regulate Cortical Neural Progenitor Differentiation	PLOS ONE			English	Article							CYCLOSPORINE-A; NEURONAL DIFFERENTIATION; NEGATIVE REGULATOR; OXIDATIVE-STRESS; STEM-CELLS; PROLIFERATION; NEUROGENESIS; PRECURSOR; FATE	In the process of neurogenesis, neural progenitor cells (NPCs) cease dividing and differentiate into postmitotic neurons that grow dendrites and an axon, become excitable, and establish synapses with other neurons. Mitochondrial biogenesis and aerobic metabolism provide energy substrates required to support the differentiation, growth and synaptic activity of neurons. Mitochondria may also serve signaling functions and, in this regard, it was recently reported that mitochondria can generate rapid bursts of superoxide (superoxide flashes), the frequency of which changes in response to environmental conditions and signals including oxygen levels and Ca2+ fluxes. Here we show that the frequency of mitochondrial superoxide flashes increases as embryonic cerebral cortical neurons differentiate from NPCs, and provide evidence that the superoxide flashes serve a signaling function that is critical for the differentiation process. The superoxide flashes are mediated by mitochondrial permeability transition pore (mPTP) opening, and pharmacological inhibition of the mPTP suppresses neuronal differentiation. Moreover, superoxide flashes and neuronal differentiation are inhibited by scavenging of mitochondrial superoxide. Conversely, manipulations that increase superoxide flash frequency accelerate neuronal differentiation. Our findings reveal a regulatory role for mitochondrial superoxide flashes, mediated by mPTP opening, in neuronal differentiation.	[Hou, Yan; Mattson, Mark P.; Cheng, Aiwu] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov; chengai@mail.nih.gov			National Institute on Aging	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LW, 2000, J IMMUNOL, V164, P2924, DOI 10.4049/jimmunol.164.6.2924; Candelario KM, 2013, J NEUROCHEM, V125, P420, DOI 10.1111/jnc.12204; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; CORDEAULOSSOUARN L, 1991, BIOL CELL, V71, P57, DOI 10.1016/0248-4900(91)90051-N; Davies WR, 2005, J HEART LUNG TRANSPL, V24, P1868, DOI 10.1016/j.healun.2005.04.004; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hou TT, 2013, J BIOL CHEM, V288, P4602, DOI [10.1074/jbc.M112.398297, 10.1074/jbc.M113.527770]; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; Hunt J, 2010, J NEUROSCI, V30, P2888, DOI 10.1523/JNEUROSCI.5991-09.2010; KOSUGI A, 1991, J IMMUNOL, V146, P1416; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Siggins RW, 2008, INT J CLIN EXP MED, V1, P2; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang B, 2009, NEUROSCI LETT, V461, P252, DOI 10.1016/j.neulet.2009.06.020; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364	36	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76721	10.1371/journal.pone.0076721	http://dx.doi.org/10.1371/journal.pone.0076721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116142	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200063
J	Mandrup, OA; Friis, NA; Lykkemark, S; Just, J; Kristensen, P				Mandrup, Ole Aalund; Friis, Niels Anton; Lykkemark, Simon; Just, Jesper; Kristensen, Peter			A Novel Heavy Domain Antibody Library with Functionally Optimized Complementarity Determining Regions	PLOS ONE			English	Article							PHAGE-DISPLAYED LIBRARIES; VARIABLE DOMAINS; HIGH-AFFINITY; BIOPHYSICAL PROPERTIES; MOLECULAR RECOGNITION; FILAMENTOUS PHAGE; COMBINING SITE; VH DOMAINS; AGGREGATION; SELECTION	Today a number of synthetic antibody libraries of different formats have been created and used for the selection of a large number of recombinant antibodies. One of the determining factors for successful isolation of recombinant antibodies from libraries lies in the quality of the libraries i.e. the number of correctly folded, functional antibodies contained in the library. Here, we describe the construction of a novel, high quality, synthetic single domain antibody library dubbed Predator. The library is based on the HEL4 domain antibody with the addition of recently reported mutations concerning the amino acid composition at positions critical for the folding characteristics and aggregation propensities of domain antibodies. As a unique feature, the CDR3 of the library was designed to mimic the natural human immune response by designating amino acids known to be prevalent in functional antibodies to the diversity in CDR3. CDR randomizations were performed using trinucleotide synthesis to avoid the presence of stop codons. Furthermore a novel cycle free elongation method was used for the conversion of the synthesized single stranded DNA containing the randomized CDRs into double stranded DNA of the library. In addition a modular approach has been adopted for the scaffold in which each CDR region is flanked by unique restrictions sites, allowing easy affinity maturation of selected clones by CDR shuffling. To validate the quality of the library, one round phage display selections were performed on purified antigens and highly complex antigen mixtures such as cultured eukaryotic cells resulting in several specific binders. The further characterization of some of the selected clones, however, indicates a reduction in thermodynamic stability caused by the inclusion the additional mutations to the HEL4 scaffold.	[Mandrup, Ole Aalund; Kristensen, Peter] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Friis, Niels Anton; Just, Jesper] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Lykkemark, Simon] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Lykkemark, Simon] Sino Danish Ctr Educ & Res, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, P (corresponding author), Aarhus Univ, Dept Engn, Aarhus, Denmark.	pk@mb.au.dk	Kristensen, Peter/T-6684-2018	Kristensen, Peter/0000-0001-7205-6853; Just, Jesper/0000-0002-3825-0000; Lykkemark, Simon/0000-0001-8920-6926; Mandrup, Ole Aalund/0000-0002-9700-4328	Danish Council for Independent Research \ Technology and Production Sciences [09-065063, 10-081681]; EU FP6 integrated project PROTEOMAGE [518230]; Bioneer A/S	Danish Council for Independent Research \ Technology and Production Sciences(Det Frie Forskningsrad (DFF)); EU FP6 integrated project PROTEOMAGE; Bioneer A/S	The study has been supported by grants from the The Danish Council for Independent Research vertical bar Technology and Production Sciences, grant number 09-065063 and 10-081681. Furthermore the EU FP6 integrated project PROTEOMAGE, grant number 518230, supported part of the study. OAM was supported by a grant from Bioneer A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 2003, CURRENT PROTOCOLS MO; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bond CJ, 2005, J MOL BIOL, V348, P699, DOI 10.1016/j.jmb.2005.02.063; Brockmann EC, 2011, PROTEIN ENG DES SEL, V24, P691, DOI 10.1093/protein/gzr023; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Dudgeon K, 2009, PROTEIN ENG DES SEL, V22, P217, DOI 10.1093/protein/gzn059; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Marks James D, 2004, Methods Mol Biol, V248, P161; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Ramsland PA, 2001, EXP CLIN IMMUNOGENET, V18, P176, DOI 10.1159/000049197; Rattan SIS, 2005, REJUV RES, V8, P46, DOI 10.1089/rej.2005.8.46; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schultz K, 2005, METABOLISM, V54, P287, DOI 10.1016/j.metabol.2004.09.007; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Thomas BR, 1996, ACTA CRYSTALLOGR D, V52, P776, DOI 10.1107/S090744499600279X; WADA KN, 1992, NUCLEIC ACIDS RES, V20, P2111, DOI 10.1093/nar/20.suppl.2111; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	47	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76834	10.1371/journal.pone.0076834	http://dx.doi.org/10.1371/journal.pone.0076834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116173	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200077
J	Spathe, A; Reinecke, A; Haverkamp, A; Hansson, BS; Knaden, M				Spaethe, Anna; Reinecke, Andreas; Haverkamp, Alexander; Hansson, Bill S.; Knaden, Markus			Host Plant Odors Represent Immiscible Information Entities - Blend Composition and Concentration Matter in Hawkmoths	PLOS ONE			English	Article							OVIPOSITION BEHAVIOR; FLORAL CO2; INSECTS; PERCEPTION; VOLATILES; LOCATION; BEETLE	Host plant choice is of vital importance for egg laying herbivorous insects that do not exhibit brood care. Several aspects, including palatability, nutritional quality and predation risk, have been found to modulate host preference. Olfactory cues are thought to enable host location. However, experimental data on odor features that allow choosing among alternative hosts while still in flight are not available. It has previously been shown that M. sexta females prefer Datura wrightii compared to Nicotiana attenuata. The bouquet of the latter is more intense and contains compounds typically emitted by plants after feeding-damage to attract the herbivore's enemies. In this wind tunnel study, we offered female gravid hawkmoths (Manduca sexta) odors from these two ecologically relevant, attractive, non-flowering host species. M. sexta females preferred surrogate leaves scented with vegetative odors form both host species to unscented control leaves. Given a choice between species, females preferred the odor bouquet emitted by D. wrightii to that of N. attenuata. Harmonizing, i.e. adjusting, volatile intensity to similar levels did not abolish but significantly weakened this preference. Superimposing, i.e. mixing, the highly attractive headspaces of both species, however, abolished discrimination between scented and non-scented surrogate leaves. Beyond ascertaining the role of blend composition in host plant choice, our results raise the following hypotheses. (i) The odor of a host species is perceived as a discrete odor 'Gestalt', and its core properties are lost upon mixing two attractive scents (ii). Stimulus intensity is a secondary feature affecting olfactory-based host choice (iii). Constitutively smelling like a plant that is attracting herbivore enemies may be part of a plant's strategy to avoid herbivory where alternative hosts are available to the herbivore.	[Spaethe, Anna; Reinecke, Andreas; Haverkamp, Alexander; Hansson, Bill S.; Knaden, Markus] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Max Planck Society	Hansson, BS (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	hansson@ice.mpg.de; mknaden@ice.mpg.de	Knaden, Markus/E-2151-2015; Hansson, Bill S/G-2774-2013	Knaden, Markus/0000-0002-6710-1071; Hansson, Bill S/0000-0002-4811-1223; Reinecke, Andreas/0000-0002-9336-7324; Haverkamp, Alexander/0000-0003-3512-9659	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrell L, 2005, GLOBAL CHANGE BIOL, V11, P1272, DOI 10.1111/j.1365-2486.2005.00989.x; Adler LS, 2004, ECOLOGY, V85, P1519, DOI 10.1890/03-0409; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Guerenstein PG, 2004, J COMP PHYSIOL A, V190, P707, DOI 10.1007/s00359-004-0529-0; Kariyat RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0020; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler D, 2012, ENTOMOL EXP APPL, V144, P112, DOI 10.1111/j.1570-7458.2012.01270.x; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Stange G, 1999, NATURWISSENSCHAFTEN, V86, P190, DOI 10.1007/s001140050595; THIERY D, 1987, J CHEM ECOL, V13, P1139, DOI 10.1007/BF01020544; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503	29	19	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77135	10.1371/journal.pone.0077135	http://dx.doi.org/10.1371/journal.pone.0077135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116211	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200104
J	Zhang, L; Zhang, D; Chen, W; Zou, X; Ling, L				Zhang, Lei; Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li			High Prevalence of HIV, HCV and Tuberculosis and Associated Risk Behaviours among New Entrants of Methadone Maintenance Treatment Clinics in Guangdong Province, China	PLOS ONE			English	Article							INJECTION-DRUG USERS; FEMALE SEX WORKERS; HEPATITIS-C VIRUS; MENTAL-HEALTH; GENDER-DIFFERENCES; INFECTION; EPIDEMIOLOGY; SICHUAN; AIDS; TRANSITION	Background: Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006. This study aims to estimate the prevalence levels of HIV, Hepatitis C (HCV), Tuberculosis (TB) and their co-infections and associated demographic and risk behaviours among MMT entrants. Method: A total of 2296 drug users at the time of their MMT enrolment were recruited from four clinics during 2006-2011. Participants' demographic characteristics, infection status and self-reported high-risk drug-use and sexual behaviours were surveyed. Log-linear contingency analysis was employed to investigate the demographic and behavioural differences between gender and drug-user type, while multivariate regression analysis was used to identify the associated factors of HIV, HCV and TB infections. Results: Female drug users demonstrate significantly higher frequency of daily drug consumption (Log-linear contingency analysis, G(2)=10.86, p=0.013) and higher proportion of having had sex in the past three months (G(2)=30.22, p<0.001) than their male counterparts. Among injecting drug users, females also inject (chi(2)=16.15, p=0.001) and share syringes (chi(2)=13.24, p=0.004) more frequently than males. Prevalence of HIV, HCV and TB among MMT entrants are 6.3%, 78.7% and 4.4% respectively. Co-infections of HIV/HCV, HIV/TB, HCV/TB and HIV/HCV/TB reportedly infect 5.6%, 0.5%, 3.8% and 0.3% of study participants. Infection risks of HIV, HCV and TB are consistently associated with increasing length of drug use, injecting drugs, financial dependence and reduced sexual activities. Conclusion: Injecting drug use is the major contributing factor in prevalence levels of HIV, HCV and TB among MMT entrants. Female drug users are more disadvantaged in their social status and risk-taking in their drug use behaviours than males.	[Zhang, Lei; Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Di; Chen, Wen; Zou, Xia; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Zhang, Di] Sun Yat Sen Univ, Off Med Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of New South Wales Sydney; Kirby Institute; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Zou, Xia/U-2205-2019; Zhang, Lei/D-4039-2011	Zhang, Lei/0000-0003-2343-084X	Natural Science Foundation of China [71173245, 30972552]; Globe Fund of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Globe Fund of China	This project supported by Natural Science Foundation of China (number 71173245) (http://www.nsfc.gov.cn/Portal0/default152.htm), Natural Science Foundation of China (number 30972552), Globe Fund of China of 2012 (http://ncaids.chinacdc.cn/gjhz/hdjz8/201208/t20120802_1820489.htm). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; Anderson T.L., 2001, ENCY CRIMINOLOGY DEV, V4, P286; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Barclay D M 3rd, 1995, Arch Fam Med, V4, P541, DOI 10.1001/archfami.4.6.541; Bloor R, 2006, AM J ADDICTION, V15, P201, DOI 10.1080/10550490600625269; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Bruce RD, 2010, INT J DRUG POLICY, V21, P122, DOI 10.1016/j.drugpo.2009.10.004; Chen W, 2012, J ADDICT MED, V6, P212, DOI 10.1097/ADM.0b013e318259b2c4; *CHIN MOHOTPSRO, 2008, CRIT DIAGN TUB; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Corsi KF, 2009, J SUBST ABUSE TREAT, V37, P120, DOI 10.1016/j.jsat.2008.11.004; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Dembo R, 2010, J CHILD ADOLES SUBST, V19, P424, DOI 10.1080/1067828X.2010.515886; DESJARLAIS DC, 1992, BRIT J ADDICT, V87, P493; Drobniewski FA, 2005, EUR RESPIR J, V26, P298, DOI 10.1183/09031936.05.00136004; Elifson KW, 2007, AIDS BEHAV, V11, pS45, DOI 10.1007/s10461-007-9306-8; Forsythe L, 2009, TRENDS ISS CRIME CRI, P1; Garfein RS, 2009, INT J TUBERC LUNG D, V13, P626; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gilchrist G, 2011, AIDS BEHAV, V15, P1834, DOI 10.1007/s10461-011-9991-1; Gu J, 2010, WOMEN HEALTH, V50, P20, DOI 10.1080/03630241003601137; HAAS K, 2004, ANN REV UNDERGRADUAT, V3, P92; Hartel DM, 2006, CLIN INFECT DIS, V43, P525, DOI 10.1086/505978; Irwin KL, 1996, DRUG ALCOHOL DEPEN, V42, P85, DOI 10.1016/0376-8716(96)01262-8; James S, 2013, ADDICT BEHAV, V38, P1804, DOI 10.1016/j.addbeh.2012.09.002; Johnson H, 2006, AUST NZ J CRIMINOL, V39, P190, DOI 10.1375/acri.39.2.190; Jones DL, 2010, AIDS CARE, V22, P152, DOI 10.1080/09540120903039851; KU HH, 1974, AM STAT, V28, P115, DOI 10.2307/2683334; Lau JTF, 2011, AIDS BEHAV, V15, P86, DOI 10.1007/s10461-010-9754-4; Lau JTF, 2009, AIDS CARE, V21, P909, DOI 10.1080/09540120802612790; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; *MIN HLTH CHIN, 2006, NAT GUID COMM BAS ME; *MIN HLTH CHIN, 2011, EST HIV AIDS EP CHIN; Neale J, 2004, BRIT J SOC WORK, V34, P851, DOI 10.1093/bjsw/bch105; NELDER JA, 1974, ROY STAT SOC C-APP, V23, P323; Niveau G, 2006, PUBLIC HEALTH, V120, P33, DOI 10.1016/j.puhe.2005.03.017; Nolte S, 2013, QUAL LIFE RES, V22; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Peng EYC, 2011, J FORMOS MED ASSOC, V110, P446, DOI 10.1016/S0929-6646(11)60066-1; Perlman DC, 1999, SOC SCI MED, V48, P1441, DOI 10.1016/S0277-9536(98)00448-1; Powis B, 1996, SUBST USE MISUSE, V31, P529, DOI 10.3109/10826089609045825; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Tran TMT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-248; *UN OFF DRUGS CRIN, 2012, WORLD DRUG REP; VANAMEIJDEN EJC, 1994, AM J EPIDEMIOL, V139, P1153, DOI 10.1093/oxfordjournals.aje.a116962; Vega WA, 1998, ADDICTION, V93, P1839, DOI 10.1046/j.1360-0443.1998.931218399.x; VU TTM, 2010, KHAN HOA PROVINCE VI; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045632; Wei Z., 2003, TRENDS ISSUES CRIME, V278; *WHO UNICEF, 2011, PROGR REP 2011 GLOB; World Health Organization, 2006, STOP TB STRAT BUILD; Wu F, 2013, J PUBLIC HEALTH-UK, V35, P206, DOI 10.1093/pubmed/fds079; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia YH, 2013, PSYCHOL HEALTH MED, V18, P321, DOI 10.1080/13548506.2012.729845; Xu JJ, 2012, INT J STD AIDS, V23, P670, DOI 10.1258/ijsa.2009.009128; YIN W, 2009, CHIN J INFECT CONTRO, V8, P384; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang, 2010, CHIN J DIS CONTROL P, V14, P300; Zhao L, 2012, AIDS CARE, V24, P195, DOI 10.1080/09540121.2011.596520; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	70	19	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76931	10.1371/journal.pone.0076931	http://dx.doi.org/10.1371/journal.pone.0076931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116185	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200085
J	Farmer, DT; Shariat, N; Park, CY; Liu, HJ; Mavropoulos, A; McManus, MT				Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; Mavropoulos, Anastasia; McManus, Michael T.			Partially Penetrant Postnatal Lethality of an Epithelial Specific MicroRNA in a Mouse Knockout	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; MIR-205; CANCER; P63; MORPHOGENESIS; BIOGENESIS; DISEASE; LIMB	MicroRNAs are small noncoding RNAs thought to have pivotal roles in numerous diseases and developmental processes. However, a growing body of literature indicates that in vivo elimination of these tiny RNAs usually has little to no observable consequence, suggesting functional redundancy with other microRNAs or cellular pathways. We provide an in-depth analysis of miR-205 expression and define miR-205 as an epithelial-specific microRNA, and for the first time show that ablation of this microRNA knockout exhibits partially penetrant lethality in a constitutive mouse knockout model. Given the role of this microRNA in cancer and development, this mouse model will be an incredible reagent to study the function and mechanisms of miR-205 in epithelial tissue development and disease.	[Farmer, D'Juan T.; Shariat, Nikki; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Mavropoulos, Anastasia] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; Mavropoulos, Anastasia; McManus, Michael T.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Farmer, D'Juan T.; Shariat, Nikki; Park, Chong Yon; Liu, Huey Jiin; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McManus, MT (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	michael.mcmanus@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Shariat, Nikki/0000-0003-3943-4829	National Institute of General Medical Sciences (NIGMS) IMSD Fellowship; WM Keck Foundation; National Institutes of Health (NIH) [DK063720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER; Direct For Education and Human Resources [1011717] Funding Source: National Science Foundation	National Institute of General Medical Sciences (NIGMS) IMSD Fellowship; WM Keck Foundation(W.M. Keck Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by a National Institute of General Medical Sciences (NIGMS) IMSD Fellowship to DF and the WM Keck Foundation and National Institutes of Health (NIH) DK063720 to MTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Ryan D, 2006, MOL VIS, V12, P1175; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Xie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046990; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76634	10.1371/journal.pone.0076634	http://dx.doi.org/10.1371/journal.pone.0076634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116130	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300076
J	Kato, K; Ishii, R; Goto, E; Ishitani, R; Tokunaga, F; Nureki, O				Kato, Kazuki; Ishii, Ryohei; Goto, Eiji; Ishitani, Ryuichiro; Tokunaga, Fuminori; Nureki, Osamu			Structural and Functional Analyses of DNA-Sensing and Immune Activation by Human cGAS	PLOS ONE			English	Article							CYCLIC GMP-AMP; CYTOSOLIC DNA; 2ND-MESSENGER; SENSOR; RECOGNITION; UBIQUITINATION; INFLAMMASOME; DINUCLEOTIDE; HELICASE; ADAPTER	The detection of cytosolic DNA, derived from pathogens or host cells, by cytosolic receptors is essential for appropriate host immune responses. Cyclic GMP-AMP synthase (cGAS) is a newly identified cytosolic DNA receptor that produces cyclic GMP-AMP, which activates stimulator of interferon genes (STING), resulting in TBK1-IRF3 pathway activation followed by the production of type I interferons. Here we report the crystal structure of human cGAS. The structure revealed that a cluster of lysine and arginine residues forms the positively charged DNA binding surface of human cGAS, which is important for the STING-dependent immune activation. A structural comparison with other previously determined cGASs and our functional analyses suggested that a conserved zinc finger motif and a leucine residue on the DNA binding surface are crucial for the DNA-specific immune response of human cGAS, consistent with previous work. These structural features properly orient the DNA binding to cGAS, which is critical for DNA-induced cGAS activation and STING-dependent immune activation. Furthermore, we showed that the cGAS-induced activation of STING also involves the activation of the NF-kappa B and IRF3 pathways. Our results indicated that cGAS is a DNA sensor that efficiently activates the host immune system by inducing two distinct pathways.	[Kato, Kazuki; Ishii, Ryohei; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Kato, Kazuki; Ishii, Ryohei; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama, Japan; [Goto, Eiji; Tokunaga, Fuminori] Gunma Univ, Mol Cell Biol Lab, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan	University of Tokyo; RIKEN; Gunma University	Tokunaga, F (corresponding author), Gunma Univ, Mol Cell Biol Lab, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ftokunaga@gunma-u.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014	Tokunaga, Fuminori/0000-0003-3626-9119; Ishii, Ryohei/0000-0003-2486-1393	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22117006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS), through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)", to O.N., by the Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST) to F. T. and O.N., by a grant for the National Project on Protein Structural and Functional Analyses and Platform for Drug Discovery, Informatics, and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), to O.N., by a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT to F. T., R. I., and O.N., and by a grant from Takeda Science Foundation to F. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Tokunaga F, 2012, MICROBES INFECT, V14, P563, DOI 10.1016/j.micinf.2012.01.011; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	34	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76983	10.1371/journal.pone.0076983	http://dx.doi.org/10.1371/journal.pone.0076983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116191	gold, Green Submitted, Green Published			2022-12-25	WOS:000325501300109
J	Carlsson, M; Gustavsson, M; Hu, GZ; Muren, E; Ronne, H				Carlsson, Mattias; Gustavsson, Marie; Hu, Guo-Zhen; Muren, Eva; Ronne, Hans			A Ham1p-Dependent Mechanism and Modulation of the Pyrimidine Biosynthetic Pathway can both Confer Resistance to 5-Fluorouracil in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CARBAMOYL-PHOSPHATE; ARGININE METABOLISM; CANCER-CELLS; EXPRESSION; PROTEINS; ENZYMES; GENOME; MUTANT; GENES	5-Fluorouracil (5-FU) is an anticancer drug and pyrimidine analogue. A problem in 5-FU therapy is acquired resistance to the drug. To find out more about the mechanisms of resistance, we screened a plasmid library in yeast for genes that confer 5-FU resistance when overexpressed. We cloned five genes: CPA1, CPA2, HMS1, YAE1 and YJL055W. CPA1 and CPA2 encode a carbamoyl phosphate synthase involved in arginine biosynthesis and HMS1 a helix-loop-helix transcription factor. Our results suggest that CPA1, CPA2, and HMS1 confer 5-FU resistance by stimulating pyrimidine biosynthesis. Thus, they are unable to confer 5-FU resistance in a ura2 mutant, and inhibit the uptake and incorporation into RNA of both uracil and 5-FU. In contrast, YAE1 and YJL055W confer 5-FU resistance in a ura2 mutant, and selectively inhibit incorporation into RNA of 5-FU but not uracil. YAE1 is the strongest resistance gene, but it partially depends on YJL055W for its function. This suggests that YAE1 and YJL055W function together in a novel mechanism for detoxification of 5-FU and other pyrimidine analogs. Yae1p belongs to a small protein family with only two members, which are conserved in all eukaryotes examined. One of the human homologs, TAOS1, is overexpressed in oral carcinomas.	[Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Gustavsson, Marie; Muren, Eva] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden.	Hans.Ronne@slu.se		Ronne, Hans/0000-0002-1645-6091	Swedish Cancer Society; Swedish Research School in Genomics and Bioinformatics; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research School in Genomics and Bioinformatics; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research School in Genomics and Bioinformatics and the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI T, 1981, SCIENCE, V212, P463, DOI 10.1126/science.7209543; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Benoist P, 2000, YEAST, V16, P1299, DOI 10.1002/1097-0061(200010)16:14<1299::AID-YEA593>3.0.CO;2-6; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Davies O, 2012, BMB REP, V45, P259, DOI 10.5483/BMBRep.2012.45.4.259; Dengg M, 2006, EMBO REP, V7, P1046, DOI 10.1038/sj.embor.7400782; ELHAJJ HH, 1992, J BACTERIOL, V174, P4450, DOI 10.1128/JB.174.13.4450-4456.1992; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Jaques S, 1981, PLANT PHYSIOL, V67, P287; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; JENSEN KF, 1982, EMBO J, V1, P69, DOI 10.1002/j.1460-2075.1982.tb01126.x; JUND R, 1970, J BACTERIOL, V102, P607, DOI 10.1128/JB.102.3.607-615.1970; KAMENS J, 1991, NEW BIOL, V3, P1005; Keniry ME, 2004, GENETICS, V166, P1177, DOI 10.1534/genetics.166.3.1177; Ko N, 2008, YEAST, V25, P155, DOI 10.1002/yea.1554; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LACROUTE F, 1965, J GEN MICROBIOL, V40, P127, DOI 10.1099/00221287-40-1-127; Longley DB, 2006, BBA-REV CANCER, V1766, P184, DOI 10.1016/j.bbcan.2006.08.001; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lorenz MC, 1998, GENETICS, V150, P1443; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; PALMER LM, 1975, MOL GEN GENET, V140, P165, DOI 10.1007/BF00329784; PETERS GJ, 1991, ANN ONCOL, V2, P469, DOI 10.1093/oxfordjournals.annonc.a057994; PIERARD A, 1978, J BACTERIOL, V134, P167; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Schmidt WM, 2004, INT J CANCER, V112, P200, DOI 10.1002/ijc.20401; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; Stepchenkova EI, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-31; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0	41	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e52094	10.1371/journal.pone.0052094	http://dx.doi.org/10.1371/journal.pone.0052094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124444	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100001
J	Larocca, RA; Moraes-Vieira, PM; Bassi, EJ; Semedo, P; de Almeida, DC; da Silva, MB; Thornley, T; Pacheco-Silva, A; Camara, NOS				Larocca, Rafael Assumpcao; Moraes-Vieira, Pedro Manoel; Bassi, Enio Jose; Semedo, Patricia; de Almeida, Danilo Candido; da Silva, Marina Burgos; Thornley, Thomas; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen			Adipose Tissue-Derived Mesenchymal Stem Cells Increase Skin Allograft Survival and Inhibit Th-17 Immune Response	PLOS ONE			English	Article							REGULATORY T-CELLS; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; IFN-GAMMA; TRANSPLANTATION TOLERANCE; LYMPHOCYTE-PROLIFERATION; INTERFERON-GAMMA; DENDRITIC CELLS; NITRIC-OXIDE; MOUSE MODEL	Adipose tissue-derived mesenchymal stem cells (ADSC) exhibit immunosuppressive capabilities both in vitro and in vivo. Their use for therapy in the transplant field is attractive as they could render the use of immunosuppressive drugs unnecessary. The aim of this study was to investigate the effect of ADSC therapy on prolonging skin allograft survival. Animals that were treated with a single injection of donor allogeneic ADSC one day after transplantation showed an increase in donor skin graft survival by approximately one week. This improvement was associated with preserved histological morphology, an expansion of CD4(+) regulatory T cells (Treg) in draining lymph nodes, as well as heightened IL-10 expression and down-regulated IL-17 expression. In vitro, ADSC inhibit naive CD4(+) T cell proliferation and constrain Th-1 and Th-17 polarization. In summary, infusion of ADSC one day post-transplantation dramatically increases skin allograft survival by inhibiting the Th-17 pathogenic immune response and enhancing the protective Treg immune response. Finally, these data suggest that ADSC therapy will open new opportunities for promoting drug-free allograft survival in clinical transplantation.	[Larocca, Rafael Assumpcao; Moraes-Vieira, Pedro Manoel; Bassi, Enio Jose; da Silva, Marina Burgos; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Lab Transplantat Immunobiol, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Semedo, Patricia; de Almeida, Danilo Candido; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Lab Clin & Expt Immunol, Div Nephrol, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Albert Einstein Hosp, Inst Israelita Ensino & Pesquisa, Renal Transplantat Div, Sao Paulo, Brazil; [Larocca, Rafael Assumpcao; Thornley, Thomas] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Moraes-Vieira, Pedro Manoel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02215 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Larocca, RA (corresponding author), Univ Sao Paulo, Lab Transplantat Immunobiol, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	rlarocca@bidmc.harvard.edu	Moraes-Vieira, Pedro/C-8701-2014; Assumpcao Larocca, Rafael/H-1655-2015; Semedo-Kuriki, Patricia/D-2429-2010; Bassi, Ênio José/P-9937-2019; camara, niels olsen saraiva/AAX-3269-2020; da Silva, Marina Burgos/C-3026-2012; da Silva, Marina Burgos/AAR-5639-2020; de Almeida, Danilo Candido/R-2646-2019; de Almeida, Danilo/AAK-2399-2021; Bassi, Ênio José/I-3616-2016; Camara, Niels OS/G-8336-2011	Moraes-Vieira, Pedro/0000-0002-8263-786X; Assumpcao Larocca, Rafael/0000-0002-9995-1804; Bassi, Ênio José/0000-0002-7956-5746; camara, niels olsen saraiva/0000-0001-5436-1248; da Silva, Marina Burgos/0000-0001-8630-7211; de Almeida, Danilo Candido/0000-0003-3661-2124; Bassi, Ênio José/0000-0002-7956-5746; Camara, Niels OS/0000-0001-5436-1248; Thornley, Thomas/0000-0001-5296-6825; Semedo-Kuriki, Patricia/0000-0002-2136-3308	State of Sao Paulo Foundation for Research Support (FAPESP) [07/07139-3, 06/55326-4, 10/52180-4, 12/02270-2]; Brazilian Council of Scientific and Technologic Development [470533/2007-2, CNPq/DECIT/MS]; Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel [CAPES Bex-2236/09-5]	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technologic Development; Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel	This study was supported by grants 07/07139-3, 06/55326-4, 10/52180-4 and 12/02270-2 from the State of Sao Paulo Foundation for Research Support (FAPESP), Brazilian Council of Scientific and Technologic Development (470533/2007-2, CNPq/DECIT/MS) and Complex Fluids INCT, Coordination of Improvement of Higher Education Personnel (CAPES Bex-2236/09-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asavaroengchai W, 2007, BIOL BLOOD MARROW TR, V13, P46, DOI 10.1016/j.bbmt.2006.09.014; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; BRENNAN DC, 1995, AM J KIDNEY DIS, V26, P701, DOI 10.1016/0272-6386(95)90432-8; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; Feng G, 2008, EUR J IMMUNOL, V38, P2512, DOI 10.1002/eji.200838411; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Hidalgo LG, 2002, CRIT REV IMMUNOL, V22, P317; Hirayama S, 2006, MOL MED, V12, P208, DOI 10.2119/2006-00036.Hirayama; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Kang SM, 2007, AM J TRANSPLANT, V7, P1457, DOI 10.1111/j.1600-6143.2007.01829.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Klimczak Aleksandra, 2007, Semin Plast Surg, V21, P226, DOI 10.1055/s-2007-991192; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Larocca R, 2008, INFLAMM RES, V57, P171, DOI 10.1007/s00011-007-7140-0; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; MacLeod M, 2006, J EXP MED, V203, P897, DOI 10.1084/jem.20050711; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Lopez MM, 2006, TRANSPL IMMUNOL, V17, P31, DOI 10.1016/j.trim.2006.09.018; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; MURRAY JE, 1971, PLAST RECONSTR SURG, V47, P425, DOI 10.1097/00006534-197105000-00003; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Renner P, 2009, TRANSPL P, V41, P2607, DOI 10.1016/j.transproceed.2009.06.119; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Surquin Murielle, 2005, Nephrol Ther, V1, P161, DOI 10.1016/j.nephro.2005.05.004; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhang Zhi-gang, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P305; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	63	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76396	10.1371/journal.pone.0076396	http://dx.doi.org/10.1371/journal.pone.0076396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124557	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100114
J	Nguyen, TH; Ranwez, V; Berry, V; Scornavacca, C				Thi-Hau Nguyen; Ranwez, Vincent; Berry, Vincent; Scornavacca, Celine			Support Measures to Estimate the Reliability of Evolutionary Events Predicted by Reconciliation Methods	PLOS ONE			English	Article							TREE RECONCILIATION; GENE DUPLICATION; ALGORITHMS; LINEAGE; ERROR	The genome content of extant species is derived from that of ancestral genomes, distorted by evolutionary events such as gene duplications, transfers and losses. Reconciliation methods aim at recovering such events and at localizing them in the species history, by comparing gene family trees to species trees. These methods play an important role in studying genome evolution as well as in inferring orthology relationships. A major issue with reconciliation methods is that the reliability of predicted evolutionary events may be questioned for various reasons: Firstly, there may be multiple equally optimal reconciliations for a given species tree-gene tree pair. Secondly, reconciliation methods can be misled by inaccurate gene or species trees. Thirdly, predicted events may fluctuate with method parameters such as the cost or rate of elementary events. For all of these reasons, confidence values for predicted evolutionary events are sorely needed. It was recently suggested that the frequency of each event in the set of all optimal reconciliations could be used as a support measure. We put this proposition to the test here and also consider a variant where the support measure is obtained by additionally accounting for suboptimal reconciliations. Experiments on simulated data show the relevance of event supports computed by both methods, while resorting to suboptimal sampling was shown to be more effective. Unfortunately, we also show that, unlike the majority-rule consensus tree for phylogenies, there is no guarantee that a single reconciliation can contain all events having above 50% support. In this paper, we detail how to rely on the reconciliation graph to efficiently identify the median reconciliation. Such median reconciliation can be found in polynomial time within the potentially exponential set of most parsimonious reconciliations.	[Thi-Hau Nguyen; Berry, Vincent] Univ Montpellier 2, Ctr Natl Rech Sci, Lab Informat Robot & Microelect Montpellier, Montpellier, France; [Thi-Hau Nguyen; Ranwez, Vincent] Montpellier SupAgro, Unite Mixte Rech AGAP, Montpellier, France; [Scornavacca, Celine] Univ Montpellier 2, Unite Mixte Rech 5554, Inst Sci Evolut Montpellier, Montpellier, France; [Thi-Hau Nguyen; Ranwez, Vincent; Berry, Vincent; Scornavacca, Celine] Inst Biol Computat, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Scornavacca, C (corresponding author), Univ Montpellier 2, Unite Mixte Rech 5554, Inst Sci Evolut Montpellier, Montpellier, France.	celine.scornavacca@univ-montp2.fr	ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541; Berry, Vincent/0000-0001-7271-4027	Languedoc-Roussillon Chercheur d'Avenir program; French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique [ANR-10-BINF-01-02, ANR-09-PEXT- 000]; Institut de Biologie Computationnelle	Languedoc-Roussillon Chercheur d'Avenir program(Region Occitanie); French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique(French National Research Agency (ANR)); Institut de Biologie Computationnelle	This work was funded by the Languedoc-Roussillon Chercheur d'Avenir program, by the French Agence Nationale de la Recherche: Investissements d'avenir/Bioinformatique (ANR-10-BINF-01-02, Ancestrome), Programme 6\e'me Extinction (ANR-09-PEXT- 000, Phylospace), and by the Institut de Biologie Computationnelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvestad L, 2009, J ACM, V56, DOI 10.1145/1502793.1502796; Bansal MS, 2012, BIOINFORMATICS, V28, pI283, DOI 10.1093/bioinformatics/bts225; BARTHELEMY JP, 1986, J CLASSIF, V3, P329, DOI 10.1007/BF01894194; Berry V, 1996, MOL BIOL EVOL, V13, P999, DOI 10.1093/molbev/13.7.999; Bryant D., 2003, Bioconsensus. DIMACS Working Group Meetings on Bioconsensus, P163; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaudhary R, 2011, LECT N BIOINFORMAT, V6674, P227, DOI 10.1007/978-3-642-21260-4_23; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Doyon JP, 2011, BRIEF BIOINFORM, V12, P392, DOI 10.1093/bib/bbr045; Doyon JP, 2010, LECT N BIOINFORMAT, V6398, P93, DOI 10.1007/978-3-642-16181-0_9; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gorecki P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S14; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Nakhleh L, 2005, J COMPUT BIOL, V12, P796, DOI 10.1089/cmb.2005.12.796; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Park HJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-131; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Scornavacca C, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720012500254; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stolzer M, 2012, BIOINFORMATICS, V28, pI409, DOI 10.1093/bioinformatics/bts386; Szollosi GJ, 2012, METHODS MOL BIOL, V856, P29, DOI 10.1007/978-1-61779-585-5_2; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Than C, 2007, J COMPUT BIOL, V14, P517, DOI 10.1089/cmb.2007.A010; Nguyen TH, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-12; Thi Hau Nguyen, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P123, DOI 10.1007/978-3-642-33122-0_10; Tofigh A., 2009, THESIS KTH SCH COMP; Tofigh A, 2011, IEEE ACM T COMPUT BI, V8, P517, DOI 10.1109/TCBB.2010.14	35	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e73667	10.1371/journal.pone.0073667	http://dx.doi.org/10.1371/journal.pone.0073667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124449	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100006
J	Piontek, K; Strittmatter, E; Ullrich, R; Grobe, G; Pecyna, MJ; Kluge, M; Scheibner, K; Hofrichter, M; Plattner, DA				Piontek, Klaus; Strittmatter, Eric; Ullrich, Rene; Groebe, Glenn; Pecyna, Marek J.; Kluge, Martin; Scheibner, Katrin; Hofrichter, Martin; Plattner, Dietmar A.			Structural Basis of Substrate Conversion in a New Aromatic Peroxygenase CYTOCHROME P450 FUNCTIONALITY WITH BENEFITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Fungi; Glycoprotein; Heme; Magnesium; Oxyfunctionalization; Peroxygenase; Polycyclic Aromatic Hydrocarbons	CRYSTAL-STRUCTURE; PEROXIDASE; CYTOCHROME-P450; CHLOROPEROXIDASE; RESOLUTION; OXYFUNCTIONALIZATION; REFINEMENT; ACTIVATION; ENZYMES; BINDING	Background: Aromatic peroxygenases (APOs) are the missing link between heme peroxidases and P450-monooxygenases. Results: Based on two crystal structures the substrate conversion of APOs is elucidated. Conclusion: The specific design of the heme cavity and the distal heme access channel govern substrate specificity. Significance: APOs can be utilized in biotechnology and organic synthesis having significant advantages when compared with cytochrome P450 enzymes. Aromatic peroxygenases (APOs) represent a unique oxidoreductase sub-subclass of heme proteins with peroxygenase and peroxidase activity and were thus recently assigned a distinct EC classification (EC 1.11.2.1). They catalyze, inter alia, oxyfunctionalization reactions of aromatic and aliphatic hydrocarbons with remarkable regio- and stereoselectivities. When compared with cytochrome P450, APOs appear to be the choice enzymes for oxyfunctionalizations in organic synthesis due to their independence from a cellular environment and their greater chemical versatility. Here, the first two crystal structures of a heavily glycosylated fungal aromatic peroxygenase (AaeAPO) are described. They reveal different pH-dependent ligand binding modes. We model the fitting of various substrates in AaeAPO, illustrating the way the enzyme oxygenates polycyclic aromatic hydrocarbons. Spatial restrictions by a phenylalanine pentad in the active-site environment govern substrate specificity in AaeAPO.	[Piontek, Klaus; Strittmatter, Eric; Plattner, Dietmar A.] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Ullrich, Rene; Pecyna, Marek J.; Kluge, Martin; Hofrichter, Martin] Int Grad Sch Zittau, Dept Bio & Environm Sci, D-02763 Zittau, Germany; [Groebe, Glenn; Scheibner, Katrin] Lausitz Univ Appl Sci, Dept Biotechnol, Fac Nat Sci, D-01968 Senftenberg, Germany	University of Freiburg; Technische Universitat Dresden; Brandenburg University of Technology Cottbus	Piontek, K (corresponding author), Univ Freiburg, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany.	Klaus.Piontek@ocbc.uni-freiburg.de; Dietmar.Plattner@chemie.uni-freiburg.de		Hofrichter, Martin/0000-0001-5174-7604	Commission of the European Communities [NMP2-CT-2006-026456]; 7th European Framework Programme (PEROXICATS) [KBBE-2010-4-265397]; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021" [0315877]; International Research Training Group (IRTG) "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) [1038]	Commission of the European Communities(European Commission); 7th European Framework Programme (PEROXICATS); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021"(Federal Ministry of Education & Research (BMBF)); International Research Training Group (IRTG) "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Commission of the European Communities (to K. P. and M. H.), within a project of the 6th European Framework Programme (BIORENEW Contract NMP2-CT-2006-026456) and a grant through the 7th European Framework Programme (PEROXICATS Contract KBBE-2010-4-265397) (to M. H.). This work was also supported by the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021" (Project 0315877 to K. P., K. S., M. H., and D. A. P.).; Supported by the International Research Training Group (IRTG) 1038 "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aranda E, 2010, BIODEGRADATION, V21, P267, DOI 10.1007/s10532-009-9299-2; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P91, DOI 10.1021/ar00051a001; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bordeaux M, 2012, ANGEW CHEM INT EDIT, V51, P10712, DOI 10.1002/anie.201203280; Casal S, 2002, J CHROMATOGR A, V976, P285, DOI 10.1016/S0021-9673(02)01154-8; Chan PC, 2008, ARCH TOXICOL, V82, P45, DOI 10.1007/s00204-007-0222-5; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Churakova E, 2011, ANGEW CHEM INT EDIT, V50, P10716, DOI 10.1002/anie.201105308; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Grobe G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-31; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Gutierrez A, 2011, ARCH BIOCHEM BIOPHYS, V514, P33, DOI 10.1016/j.abb.2011.08.001; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakiuchi F, 2003, ADV SYNTH CATAL, V345, P1077, DOI 10.1002/adsc.200303094; Kastner M, 1999, APPL ENVIRON MICROB, V65, P1834; Kinne M, 2009, J BIOL CHEM, V284, P29343, DOI 10.1074/jbc.M109.040857; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuhnel K, 2006, J BIOL CHEM, V281, P23990, DOI 10.1074/jbc.M603166200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moon JK, 2011, J AGR FOOD CHEM, V59, P615, DOI 10.1021/jf104098a; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Peter S, 2011, FEBS J, V278, P3667, DOI 10.1111/j.1742-4658.2011.08285.x; Piontek K, 2010, ACTA CRYSTALLOGR F, V66, P693, DOI 10.1107/S1744309110013515; Poraj-Kobielska M, 2011, BIOCHEM PHARMACOL, V82, P789, DOI 10.1016/j.bcp.2011.06.020; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Sakaki T, 2012, BIOL PHARM BULL, V35, P844, DOI 10.1248/bpb.35.844; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; SONO M, 1986, BIOCHEMISTRY-US, V25, P347, DOI 10.1021/bi00350a011; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; Verras A, 2006, PROTEIN ENG DES SEL, V19, P491, DOI 10.1093/protein/gzl035; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XS, 2012, J AM CHEM SOC, V134, P12897, DOI 10.1021/ja3049223	51	90	90	9	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34767	34776		10.1074/jbc.M113.514521	http://dx.doi.org/10.1074/jbc.M113.514521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24126915	Green Published, hybrid			2022-12-25	WOS:000329812800045
J	Kim, HJ; Kim, J; Cho, H; Ye, BS; Yoon, CW; Noh, Y; Kim, GH; Lee, JH; Kim, JS; Choe, YS; Lee, KH; Kim, CH; Seo, SW; Weiner, MW; Na, DL; Seong, JK				Kim, Hee Jin; Kim, Jeonghun; Cho, Hanna; Ye, Byoung Seok; Yoon, Cindy W.; Noh, Young; Kim, Geon Ha; Lee, Jae Hong; Kim, Jae Seung; Choe, Yearn Seong; Lee, Kyung-Han; Kim, Chang-Hun; Seo, Sang Won; Weiner, Michael W.; Na, Duk L.; Seong, Joon-Kyung			Individual Subject Classification of Mixed Dementia from Pure Subcortical Vascular Dementia Based on Subcortical Shape Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PERMUTATION TESTS; HIPPOCAMPAL; AMYGDALA; ATROPHY; VOLUME; MRI; AD	Subcortical vascular dementia (SVaD), one of common causes of dementia, has concomitant Alzheimer's disease (AD) pathology in over 30%, termed "mixed dementia''. Identifying mixed dementia from SVaD is important because potential amyloid-targeted therapies may be effective for treatment in mixed dementia. The purpose of this study was to discriminate mixed dementia from pure SVaD using magnetic resonance imaging (MRI). We measured brain amyloid deposition using the 11C-Pittsburgh compound B positron emission tomography (PiB-PET) in 68 patients with SVaD. A PiB retention ratio greater than 1.5 was considered PiB(+). Hippocampal and amygdalar shape were used in the incremental learning method to discriminate mixed dementia from pure SVaD because these structures are known to be prominently involved by AD pathologies. Among 68 patients, 23 (33.8%) patients were positive for PiB binding. With use of hippocampal shape analysis alone, PiB(+) SVaD could be discriminated from PiB(-) SVaD with 77.9% accuracy (95.7% sensitivity and 68.9% specificity). With use of amygdalar shape, the discrimination accuracy was 75.0% (87.0% sensitivity and 68.9% specificity). When hippocampal and amygdalar shape were analyzed together, accuracy increased to 82.4% (95.7% sensitivity and 75.6% specificity). An incremental learning method using hippocampal and amygdalar shape distinguishes mixed dementia from pure SVaD. Furthermore, our results suggest that amyloid pathology and vascular pathology have different effects on the shape of the hippocampus and amygdala.	[Kim, Hee Jin; Cho, Hanna; Ye, Byoung Seok; Seo, Sang Won; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Jeonghun; Kim, Chang-Hun] Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea; [Yoon, Cindy W.] Inha Univ, Coll Med, Dept Neurol, Inchon, South Korea; [Noh, Young] Gachon Univ, Gil Med Ctr, Dept Neurol, Inchon, South Korea; [Kim, Geon Ha] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Lee, Jae Hong] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Jae Seung] Univ Ulsan, Coll Med, Dept Nucl Med, Seoul, South Korea; [Choe, Yearn Seong; Lee, Kyung-Han] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea; [Weiner, Michael W.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Weiner, Michael W.] Dept Vet Affairs Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Inha University; Gachon University; Ewha Womans University; University of Ulsan; Asan Medical Center; University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California San Francisco; Korea University	Seo, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	sangwonseo@empal.com; jkseong@korea.ac.kr	Na, Duk Lyul/C-9598-2011; Yoon, Cindy/HCJ-0079-2022	Yoon, Cindy/0000-0002-4697-6610	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065, A120798]; Samsung Medical Center Clinical Research Development Program grant [CRL-108011, CRS 110-14-1]; Converging Research Center Program through the Ministry of Education, Science and Technology [2010K001054]; National Research Foundation of Korea (NRF); Korea government (MEST) [2013-00009999]; NRF; Korea government (MSIP) [2010-0028631]; Basic Science Research Program through the NRF; Ministry of Education [2012-004157]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Samsung Medical Center Clinical Research Development Program grant(Samsung); Converging Research Center Program through the Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NRF; Korea government (MSIP); Basic Science Research Program through the NRF; Ministry of Education	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (No. A102065, A120798), a Samsung Medical Center Clinical Research Development Program grant (CRL-108011 and CRS 110-14-1), the Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001054), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013-00009999), the NRF grant funded by the Korea government (MSIP) (No. 2010-0028631), and Basic Science Research Program through the NRF funded by the Ministry of Education (No. 2012-004157). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2006, PSYCHIAT RES-NEUROIM, V146, P251, DOI 10.1016/j.pscychresns.2006.01.007; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavedo E, 2011, NEUROLOGY, V76, P727, DOI 10.1212/WNL.0b013e31820d62d9; Cho Y, 2012, NEUROIMAGE, V59, P2217, DOI 10.1016/j.neuroimage.2011.09.085; Cho Y, 2011, NEUROIMAGE, V57, P1376, DOI 10.1016/j.neuroimage.2011.05.066; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; de Leeuw FE, 2006, STROKE, V37, P2248, DOI 10.1161/01.STR.0000236555.87674.e1; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Horinek D, 2007, CURR OPIN PSYCHIATR, V20, P273; Jae-il Kim, 2012, Journal of Computing Science and Engineering, V6, P219, DOI 10.5626/JCSE.2012.6.3.219; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Kim GH, 2012, ALZHEIMERS DEMENT S, V8, pP158; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Liu CJ, 2000, IEEE T IMAGE PROCESS, V9, P132, DOI 10.1109/83.817604; Marrocco C, 2008, PATTERN RECOGN, V41, P1961, DOI 10.1016/j.patcog.2007.11.017; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pieper S, 2006, P ISBI NAN MACR; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Shi J, 2013, NEUROIMAGE, V78, P111, DOI 10.1016/j.neuroimage.2013.04.018; Sorkine O, 2006, COMPUT GRAPH FORUM, V25, P789, DOI 10.1111/j.1467-8659.2006.00999.x; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; van de Pol L, 2011, NEURODEGENER DIS, V8, P465, DOI 10.1159/000326695; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Yu H, 2001, PATTERN RECOGN, V34, P2067, DOI 10.1016/S0031-3203(00)00162-X; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75602	10.1371/journal.pone.0075602	http://dx.doi.org/10.1371/journal.pone.0075602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130724	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200017
J	Knight, EJ; Klepac, KM; Kralik, JD				Knight, Emily J.; Klepac, Kristen M.; Kralik, Jerald D.			Too Good to Be True: Rhesus Monkeys React Negatively to Better-than-Expected Offers	PLOS ONE			English	Article							LEARNED HELPLESSNESS; COGNITIVE-DISSONANCE; EMOTIONAL RESPONSES; GREAT APES; DECISION; QUANTITY; CORTEX; REINFORCEMENT; CONSEQUENCES; FOUNDATIONS	To succeed in a dynamically changing world, animals need to predict their environments. Humans, in fact, exhibit such a strong desire for consistency that one of the most well-established findings in social psychology is the effort people make to maintain consistency among their beliefs, attitudes, and behavior. However, displeasure with unpredictability leads to a potential paradox, because a positive outcome that exceeds one's expectations often leads to increased subjective value and positive affect, not the opposite. We tested the hypothesis that two evolutionarily-conserved evaluation processes underlie goal-directed behavior: (1) consistency, concerned with prediction errors, and (2) valuation, concerned with outcome utility. Rhesus monkeys (Macaca mulatta) viewed a food item and then were offered an identical, better, or worse food, which they could accept or reject. The monkeys ultimately accepted all offers, attesting to the influence of the valuation process. However, they were slower to accept the unexpected offers, and they exhibited aversive reactions, especially to the better-than-expected offers, repeatedly turning their heads and looking away before accepting the food item. Our findings (a) provide evidence for two separable evaluation processes in primates, consistency and value assessment, (b) reveal a direct relationship between consistency assessment and emotional processes, and (c) show that our wariness with events that are much better than expected is shared with other social primates.	[Knight, Emily J.; Klepac, Kristen M.; Kralik, Jerald D.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Kralik, JD (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Jerald.D.Kralik@Dartmouth.edu		Knight, Emily/0000-0002-6971-1148	NIMH [1 K22 MH071756-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [K22MH071756] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by NIMH 1 K22 MH071756-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R.P., 1968, THEORIES COGNITIVE C; ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; AMSEL A, 1994, PSYCHON B REV, V1, P280, DOI 10.3758/BF03213968; ARONSON E, 1968, ADV EXPT SOCIAL PSYC, P1; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; CARLSMITH JM, 1963, J ABNORM PSYCHOL, V66, P151, DOI 10.1037/h0042692; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chen MK, 2009, J EXP SOC PSYCHOL, V45, P425, DOI 10.1016/j.jesp.2008.08.026; Chen YH, 2009, J AUTISM DEV DISORD, V39, P635, DOI 10.1007/s10803-008-0663-6; Chu S, 2007, PERS INDIV DIFFER, V42, P1291, DOI 10.1016/j.paid.2006.10.007; Cooper J, 2007, COGNITIVE DISSONANCE; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; Coughlan R, 2001, ORGAN BEHAV HUM DEC, V85, P211, DOI 10.1006/obhd.2000.2939; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P267, DOI 10.1111/j.1749-6632.1990.tb48900.x; Dickinson A., 1994, ANIMAL LEARNING COGN; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014; Eilam D, 2006, NEUROSCI BIOBEHAV R, V30, P456, DOI 10.1016/j.neubiorev.2005.08.003; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Gazzaniga M. S., 2008, COGNITIVE NEUROSCIEN; Goswami U., 2008, COGNITIVE DEV; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; HALL G, 1979, J EXP PSYCHOL ANIM B, V5, P31, DOI 10.1037/0097-7403.5.1.31; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Hassin R. R., 2010, SELF CONTROL SOC MIN; Hastie R., 2001, RATIONAL CHOICE UNCE; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HOGG RV, 1974, J AM STAT ASSOC, V69, P909, DOI 10.2307/2286160; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1982, JUDGEMENT UNCERTAINT; KANNER L, 1968, ACTA PAEDOPSYCHIATR, V35, P100; Kobayashi R, 1998, PSYCHIAT CLIN NEUROS, V52, P383, DOI 10.1046/j.1440-1819.1998.00415.x; Kralik JD, 2005, J COMP PSYCHOL, V119, P78, DOI 10.1037/0735-7036.119.1.78; KRALIK JD, 2011, BEHAV CONTROL PRIMAT; KRALIK JD, PUBLIC LIB IN PRESS; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Kralik JD, 2012, BEHAV PROCESS, V89, P197, DOI 10.1016/j.beproc.2011.09.010; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Marticorena DCW, 2011, DEVELOPMENTAL SCI, V14, P1406, DOI 10.1111/j.1467-7687.2011.01085.x; Mazur JE, 2005, LEARNING BEHAV; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meunier M, 1999, EUR J NEUROSCI, V11, P4403, DOI 10.1046/j.1460-9568.1999.00854.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINEKA S, 1978, J ABNORM PSYCHOL, V87, P256, DOI 10.1037/0021-843X.87.2.256; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; O'Reilly RC, 2010, CURR OPIN NEUROBIOL, V20, P257, DOI 10.1016/j.conb.2010.01.008; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt M. L., 2010, PRIMATE NEUROETHOLOG; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rescorla R. A., 1972, CLASSICAL CONDITIONI; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shepperd JA, 2002, PSYCHOL SCI, V13, P85, DOI 10.1111/1467-9280.00416; Shifferman EM, 2009, ANIM COGN, V12, P547, DOI 10.1007/s10071-009-0215-2; Silberberg A, 1998, J EXP PSYCHOL ANIM B, V24, P215, DOI 10.1037/0097-7403.24.2.215; Silberberg A, 2009, ANIM COGN, V12, P505, DOI 10.1007/s10071-009-0211-6; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; STADDON JER, 1970, LEARN MOTIV, V1, P227, DOI 10.1016/0023-9690(70)90148-7; Stout SC, 2003, LEARN MOTIV, V34, P437, DOI 10.1016/S0023-9690(03)00038-9; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teigen KH, 2003, COGNITION, V87, P55, DOI 10.1016/S0010-0277(02)00201-9; Thierry B., 2004, MACAQUE SOC MODEL ST; Thorsteinson TJ, 2004, J BUS PSYCHOL, V19, P125, DOI 10.1023/B:JOBU.0000040276.75748.b9; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; WEISS JM, 1970, PSYCHOSOM MED, V32, P397, DOI 10.1097/00006842-197007000-00008; Williams BA, 2002, ANIM LEARN BEHAV, V30, P1, DOI 10.3758/BF03192905; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Winer B.J., 1991, STAT PRINCIPLES EXPT; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Zentall TR, 2007, J EXP ANAL BEHAV, V88, P131, DOI 10.1901/jeab.2007.27-06	109	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75768	10.1371/journal.pone.0075768	http://dx.doi.org/10.1371/journal.pone.0075768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130742	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900057
J	Ryan, M; Suaya, JA; Chapman, JD; Stason, WB; Shepard, DS; Thomas, CP				Ryan, Marian; Suaya, Jose A.; Chapman, John D.; Stason, William B.; Shepard, Donald S.; Thomas, Cindy Parks			Incidence and Cost of Pneumonia in Older Adults with COPD in the United States	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; HEART-FAILURE; INHALED CORTICOSTEROIDS; ECONOMIC BURDEN; RISK; HOSPITALIZATION; PREVALENCE; PROGNOSIS; DIAGNOSIS	Objectives: To estimate the incidence of pneumonia by COPD status and the excess cost of inpatient primary pneumonia in elders with COPD. Study Design: A retrospective, longitudinal study using claims linked to eligibility/demographic data for a 5% sample of fee-for-service Medicare beneficiaries from 2005 through 2007. Methods: Incidence rates of pneumonia were calculated for elders with and without COPD and for elders with COPD and coexistent congestive heart failure (CHF). Propensity-score matching with multivariate generalized linear regression was used to estimate the excess direct medical cost of inpatient primary pneumonia in elders with COPD as compared with elders with COPD but without a pneumonia hospitalization. Results: Elders with COPD had nearly six-times the incidence of pneumonia compared with elders without COPD (167.6/1000 person-years versus 29.5/1000 person-years; RR=5.7, p <0. 01); RR increased to 8.1 for elders with COPD and CHF compared with elders without COPD. The incidence of inpatient primary pneumonia among elders with COPD was 54.2/1000 person-years compared with 7/1000 person-years for elders without COPD; RR=7.7, p<0.01); RR increased to 11.0 for elders with COPD and CHF compared with elders without COPD. The one-year excess direct medical cost of inpatient pneumonia in COPD patients was $ 22,697 ($ 45,456 in cases vs. $ 22,759 in controls (p <0.01)); 70.2% of this cost was accrued during the quarter of the index hospitalization. During months 13 through 24 following the index hospitalization, the excess direct medical cost was $ 5,941 ($ 23,215 in cases vs. $ 17,274 in controls, p<0.01). Conclusions: Pneumonia occurs more frequently in elders with COPD than without COPD. The excess direct medical cost in elders with inpatient pneumonia extends up to 24 months following the index hospitalization and represents $ 28,638 in 2010 dollars.	[Ryan, Marian; Chapman, John D.; Stason, William B.; Shepard, Donald S.; Thomas, Cindy Parks] Brandeis Univ, Heller Sch, Schneider Inst Healthcare Syst, Waltham, MA 02254 USA; [Suaya, Jose A.] GlaxoSmithKline Vaccines, Philadelphia, PA USA	Brandeis University; GlaxoSmithKline	Ryan, M (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Healthcare Syst, Waltham, MA 02254 USA.	mryan@brandeis.edu	Thomas, Cindy Parks/L-3204-2015	Thomas, Cindy Parks/0000-0001-5855-1196	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This research has been funded by GlaxoSmithKline. Decisions on study design, data collection and analysis, decision where to publish, and preparation of the manuscript were done solely and collectively by the authors. Authors adhere to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Akazawa M, 2008, CLIN THER, V30, P1003, DOI 10.1016/j.clinthera.2008.05.020; Andersson F, 2002, RESP MED, V96, P700, DOI 10.1053/rmed.2002.1334; *ATS, 2005, AM J RESP CRIT CARE, V171, P1143; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Blanchette CM, 2008, J MANAGE CARE PHARM, V14, P176, DOI 10.18553/jmcp.2008.14.2.176; Bohannon Richard W, 2003, Conn Med, V67, P599; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; Bratzler Dale W, 2004, J Okla State Med Assoc, V97, P227; Briggs Dick D Jr, 2004, J Manag Care Pharm, V10, pS3; *BUCC, 2009, HRON COND WAR US MAN, P23; BURGE S, 2003, EUR RESPIR J, V41, P46, DOI DOI 10.1183/09031936.03.00078002; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Crespo A, 2013, EUR RESPIR J, V42; Dodd S, 2006, J EVAL CLIN PRACT, V12, P76, DOI 10.1111/j.1365-2753.2006.00610.x; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Faulkner Michele A, 2002, Expert Opin Pharmacother, V3, P219; Franciosi LG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-74; Fromer L, 2008, INT J CLIN PRACT, V62, P1219, DOI 10.1111/j.1742-1241.2008.01807.x; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; *IN GLOB CHRON OBS, 2011, LOB STRAT DIAGN MAN; *IN GLOB CHRON OBS, 2010, LOB STRAT DIAGN MAN; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kaysar M, 2008, GERIATR GERONTOL INT, V8, P227, DOI 10.1111/j.1447-0594.2008.00480.x; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Krumholz HM., 2008, HOSP 30 DAY PNEUMONI; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Macchia A, 2012, EUR RESPIR J, V39, P51, DOI 10.1183/09031936.00044411; Mannino DM, 2009, RESP MED, V103, P224, DOI 10.1016/j.rmed.2008.09.005; *MED, 2006, FED REGISTER, V71, P65883; *MEDPAC, 2008, MED PAYM POL; Menzin J, 2008, RESP MED, V102, P1248, DOI 10.1016/j.rmed.2008.04.009; Minkoff NB., 2005, J MANAG CARE PHAR SA, V11, pS20; Mor A, 2013, EUR J INTERN MED, V24, P349, DOI 10.1016/j.ejim.2013.02.013; Moran JL, 2007, J EVAL CLIN PRACT, V13, P381, DOI 10.1111/j.1365-2753.2006.00711.x; *NHLBI, 2007, MORB MORT 2007 CHART; Omachi TA, 2008, COPD, V5, P339, DOI 10.1080/15412550802522700; Padeletti M, 2008, INT J CARDIOL, V125, P209, DOI 10.1016/j.ijcard.2007.12.001; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Ruchlin HS, 2001, PHARMACOECONOMICS, V19, P623, DOI 10.2165/00019053-200119060-00002; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Thomas CP, 2012, CHEST, V142, P973, DOI 10.1378/chest.11-1160; Tinkelman D, 2003, AM J MANAG CARE, V9, P767; Tinkelman David G, 2007, Prim Care Respir J, V16, P41, DOI 10.3132/pcrj.2007.00009; Vestbo J, 2006, THORAX, V61, P86, DOI 10.1136/thx.2005.046227; Ward MM, 2000, RESP MED, V94, P1123, DOI 10.1053/rmed.2000.0933; Zeng QJ, 2012, J THORAC DIS, V4, P310, DOI 10.3978/j.issn.2072-1439.2012.01.09	59	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75887	10.1371/journal.pone.0075887	http://dx.doi.org/10.1371/journal.pone.0075887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130749	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900062
J	Traber, PG; Chou, H; Zomer, E; Hong, F; Klyosov, A; Fiel, MI; Friedman, SL				Traber, Peter G.; Chou, Hsin; Zomer, Eliezer; Hong, Feng; Klyosov, Anatole; Fiel, Maria-Isabel; Friedman, Scott L.			Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; BINDING; INFLAMMATION; EXPRESSION; ANTIGEN; DOMAIN; CELLS	Galectin-3 protein is critical to the development of liver fibrosis because galectin-3 null mice have attenuated fibrosis after liver injury. Therefore, we examined the ability of novel complex carbohydrate galectin inhibitors to treat toxin-induced fibrosis and cirrhosis. Fibrosis was induced in rats by intraperitoneal injections with thioacetamide (TAA) and groups were treated with vehicle, GR-MD-02 (galactoarabino-rhamnogalaturonan) or GM-CT-01 (galactomannan). In initial experiments, 4 weeks of treatment with GR-MD-02 following completion of 8 weeks of TAA significantly reduced collagen content by almost 50% based on Sirius red staining. Rats were then exposed to more intense and longer TAA treatment, which included either GR-MD-02 or GM-CT-01 during weeks 8 through 11. TAA rats treated with vehicle developed extensive fibrosis and pathological stage 6 Ishak fibrosis, or cirrhosis. Treatment with either GR-MD-02 (90 mg/kg ip) or GM-CT-01 (180 mg/kg ip) given once weekly during weeks 8-11 led to marked reduction in fibrosis with reduction in portal and septal galectin-3 positive macrophages and reduction in portal pressure. Vehicle-treated animals had cirrhosis whereas in the treated animals the fibrosis stage was significantly reduced, with evidence of resolved or resolving cirrhosis and reduced portal inflammation and ballooning. In this model of toxin-induced liver fibrosis, treatment with two galectin protein inhibitors with different chemical compositions significantly reduced fibrosis, reversed cirrhosis, reduced galectin-3 expressing portal and septal macrophages, and reduced portal pressure. These findings suggest a potential role of these drugs in human liver fibrosis and cirrhosis.	[Traber, Peter G.; Zomer, Eliezer; Klyosov, Anatole] Galectin Therapeut Inc, Norcross, GA USA; [Traber, Peter G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Chou, Hsin; Hong, Feng; Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY USA; [Fiel, Maria-Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA	Emory University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Traber, PG (corresponding author), Galectin Therapeut Inc, Norcross, GA USA.	traber@galectintherapeutics.com			Galectin Therapeutics	Galectin Therapeutics	Three of the authors (PGT, EZ, AK), including the corresponding author (PGT) were employees of Galectin Therapeutics, which funded the studies. Hence, employees of the funder had a direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Bonis PAL, 2001, NEW ENGL J MED, V344, P452, DOI 10.1056/NEJM200102083440610; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Forsman H, 2011, ARTHRITIS RHEUM-US, V63, P445, DOI 10.1002/art.30118; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P2281; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200; Maeda Naoto, 2004, Comp Hepatol, V3 Suppl 1, pS10, DOI 10.1186/1476-5926-2-S1-S10; Miller MC, 2012, GLYCOBIOLOGY, V22, P543, DOI 10.1093/glycob/cwr173; Miller MC, 2011, GLYCOBIOLOGY, V21, P1627, DOI 10.1093/glycob/cwr083; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Oberg CT, 2011, CHIMIA, V65, P18, DOI 10.2533/chimia.2011.18; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Papaspyridonos M, 2008, ARTERIOSCL THROM VAS, V28, P433, DOI 10.1161/ATVBAHA.107.159160; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; SATO S, 1992, J GEN MICROBIOL, V138, P1992, DOI 10.1099/00221287-138-9-1992; Schuppan D, 2010, LIVER INT, V30, P795, DOI 10.1111/j.1478-3231.2010.02264.x; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	43	134	140	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75361	10.1371/journal.pone.0075361	http://dx.doi.org/10.1371/journal.pone.0075361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130706	Green Published, gold			2022-12-25	WOS:000325810900032
J	Gao, W; Baars, JJP; Dolstra, O; Visser, RGF; Sonnenberg, ASM				Gao, Wei; Baars, Johan J. P.; Dolstra, Oene; Visser, Richard G. F.; Sonnenberg, Anton S. M.			Genetic Variation and Combining Ability Analysis of Bruising Sensitivity in Agaricus bisporus	PLOS ONE			English	Article							SCHIZOPHYLLUM-COMMUNE; GROWTH-RATE; INHERITANCE; POPULATIONS; IMPROVEMENT; SELECTION; MUSHROOM; YIELD	Advanced button mushroom cultivars that are less sensitive to mechanical bruising are required by the mushroom industry, where automated harvesting still cannot be used for the fresh mushroom market. The genetic variation in bruising sensitivity (BS) of Agaricus bisporus was studied through an incomplete set of diallel crosses to get insight in the heritability of BS and the combining ability of the parental lines used and, in this way, to estimate their breeding value. To this end nineteen homokaryotic lines recovered from wild strains and cultivars were inter-crossed in a diallel scheme. Fifty-one successful hybrids were grown under controlled conditions, and the BS of these hybrids was assessed. BS was shown to be a trait with a very high heritability. The results also showed that brown hybrids were generally less sensitive to bruising than white hybrids. The diallel scheme allowed to estimate the general combining ability (GCA) for each homokaryotic parental line and to estimate the specific combining ability (SCA) of each hybrid. The line with the lowest GCA is seen as the most attractive donor for improving resistance to bruising. The line gave rise to hybrids sensitive to bruising having the highest GCA value. The highest negative SCA possibly indicates heterosis effects for resistance to bruising. This study provides a foundation for estimating breeding value of parental lines to further study the genetic factors underlying bruising sensitivity and other quality-related traits, and to select potential parental lines for further heterosis breeding. The approach of studying combining ability in a diallel scheme was used for the first time in button mushroom breeding.	[Gao, Wei; Baars, Johan J. P.; Dolstra, Oene; Visser, Richard G. F.; Sonnenberg, Anton S. M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Gao, Wei] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Wageningen University & Research; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Sonnenberg, ASM (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	anton.sonnenberg@wur.nl	Sonnenberg, Anton/GRJ-0442-2022; Visser, Richard GF/B-3423-2012	Sonnenberg, Anton/0000-0002-1699-1481; Visser, Richard GF/0000-0002-0213-4016; Baars, Johan/0000-0002-0692-7371	TTI Green genetics [TTI06201]; Wageningen UR-Plant Breeding; Bromyc; Sylvan; Product Board for Horticulture; Greenery; Banken Champignons; Lutece; WeBe Engineering	TTI Green genetics; Wageningen UR-Plant Breeding; Bromyc; Sylvan; Product Board for Horticulture; Greenery; Banken Champignons; Lutece; WeBe Engineering	This study was funded by TTI Green genetics (TTI06201), Wageningen UR-Plant Breeding, Bromyc, Sylvan, Product Board for Horticulture, Greenery, Banken Champignons, Lutece and WeBe Engineering. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders have no objections to publishing this manuscript.	Acquaah G, 2012, PRINCIPLES PLANT GEN, P139; Adebambo AO, 2011, TROP ANIM HEALTH PRO, V43, P1465, DOI 10.1007/s11250-011-9844-y; [Anonymous], 1966, GENETICS SEXUALITY H; Bahari M, 2012, SCI WORLD J, P1, DOI 10.1100/2012/543158; CALLAC P, 1993, MYCOLOGIA, V85, P835, DOI 10.2307/3760617; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; da Cruz RP, 2010, SCI AGR, V67, P669, DOI 10.1590/S0103-90162010000600008; Deglene L, 1999, PLANT PATHOL, V48, P559, DOI 10.1046/j.1365-3059.1999.00375.x; Elliott T.J., 1972, MUSH SCI, V8, P11; Esquerre C, 2009, J AGR FOOD CHEM, V57, P1903, DOI 10.1021/jf803090c; Foulongne-Oriol M, 2012, APPL MICROBIOL BIOT, V95, P891, DOI 10.1007/s00253-012-4228-4; Foulongne-Oriol M, 2012, APPL ENVIRON MICROB, V78, P2422, DOI 10.1128/AEM.07516-11; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Jolivet S, 1998, MYCOL RES, V102, P1459, DOI 10.1017/S0953756298006248; KARLIN S, 1979, THEOR POPUL BIOL, V16, P81, DOI 10.1016/0040-5809(79)90007-8; KERRIGAN RW, 1993, GENETICS, V133, P225; Kothe E, 2001, APPL MICROBIOL BIOT, V56, P602, DOI 10.1007/s002530100763; Lynch M, 1998, GENETICS ANAL QUANTI, P353; NASPOLINI V, 1981, REV BRAS GENET, V4, P571; Noh A, 2012, SCI WORLD J, DOI 10.1100/2012/792601; Qu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028463; ROJAS BA, 1952, AGRON J, V44, P462, DOI 10.2134/agronj1952.00021962004400090002x; SIMCHEN G, 1964, HEREDITY, V19, P629, DOI 10.1038/hdy.1964.75; SIMCHEN G, 1966, GENETICS, V53, P1151; SIMCHEN G, 1966, HEREDITY, V21, P241, DOI 10.1038/hdy.1966.21; Sonnenberg A. S. M., 2011, Mushroom biology and mushroom products. Proceedings of the 7th International Conference on Mushroom Biology and Mushroom Products, Arcachon, France, 4-7 October, 2011. Volume 1. Oral presentations, P7; Sonnenberg ASM, 1996, APPL ENVIRON MICROB, V62, P4542, DOI 10.1128/AEM.62.12.4542-4547.1996; SONNENBERG ASM, 2005, ACTA EDULIS FUNGI S, V12, P163, DOI DOI 10.1007/978-3-642-36821-9_; SUMMERBELL RC, 1989, GENETICS, V123, P293; Viana JMS, 2003, GENET MOL BIOL, V26, P465, DOI 10.1590/S1415-47572003000400010; WALEJKO RN, 1977, CROP SCI, V17, P647, DOI 10.2135/cropsci1977.0011183X001700040043x; WANG SS, 1972, MYCOLOGIA, V64, P521, DOI 10.2307/3757869; Weijn A, 2013, FUNGAL GENET BIOL, V55, P42, DOI 10.1016/j.fgb.2012.10.004; Weijn A, 2012, LWT-FOOD SCI TECHNOL, V47, P308, DOI 10.1016/j.lwt.2012.01.024; WILLIAMS S, 1976, HEREDITY, V37, P365, DOI 10.1038/hdy.1976.101	35	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76826	10.1371/journal.pone.0076826	http://dx.doi.org/10.1371/journal.pone.0076826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116171	gold, Green Published			2022-12-25	WOS:000325552200075
J	Modvig, S; Degn, M; Horwitz, H; Cramer, SP; Larsson, HBW; Wanscher, B; Sellebjerg, F; Frederiksen, JL				Modvig, Signe; Degn, Matilda; Horwitz, Henrik; Cramer, Stig P.; Larsson, Henrik B. W.; Wanscher, Benedikte; Sellebjerg, Finn; Frederiksen, Jette L.			Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OSTEOPONTIN LEVELS; DISEASE-ACTIVITY; N-ACETYLASPARTATE; CSF; NEUROFILAMENT; MATRIX-METALLOPROTEINASE-9; NATALIZUMAB; CHEMOKINES; CONVERSION	Background: Various inflammatory biomarkers show prognostic potential for multiple sclerosis (MS)-risk after clinically isolated syndromes. However, biomarkers are often examined singly and their interrelation and precise aspects of their associated pathological processes remain unclear. Clarification of these relationships could aid the appropriate implementation of prognostic biomarkers in clinical practice. Objective: To investigate the interrelation between biomarkers of inflammation, demyelination and neurodegeneration in acute optic neuritis and to assess their association to measures of MS risk. Material and Methods: A prospective study at a tertiary referral centre from June 2011 to December 2012 of 56 patients with optic neuritis as a first demyelinating symptom and 27 healthy volunteers. Lumbar puncture was performed within 28 (median 16) days of onset. CSF levels of CXCL13, matrix metalloproteinase (MMP)-9, CXCL10, CCL-2, osteopontin and chitinase-3-like-1, myelin basic protein (MBP) and neurofilament light-chain (NF-L) were determined. MS-risk outcome measures were dissemination in space (DIS) of white matter lesions on cerebral MRI, CSF oligoclonal bands and elevated IgG-index. Results: In the interrelation analysis the biomarkers showed close correlations within two distinct groups: Biomarkers of leukocyte infiltration (CXCL13, MMP-9 and CXCL10) were strongly associated (p<0.0001 for all). Osteopontin and chitinase-3-like-1 were also tightly associated (p<0.0001) and correlated strongly to tissue damage markers (NF-L and MBP). The biomarkers of leukocyte infiltration all associated strongly with MS-risk parameters, whereas CHI3L1 and MBP correlated with MRI DIS, but not with CSF MS-risk parameters and osteopontin and NF-L did not correlate with any MS-risk parameters. Conclusions: Our findings suggest two distinct inflammatory processes: one of leukocyte infiltration, represented by CXCL13, CXCL10 and MMP-9, strongly associated with and potentially predicting MS-risk; the other represented by osteopontin and CHI3L1, suggesting tissue damage-related inflammation, potentially predicting residual disabilities after attack and perhaps cumulative damage over time. These hypotheses should be further addressed in follow-up studies.	[Modvig, Signe; Degn, Matilda; Horwitz, Henrik; Cramer, Stig P.; Frederiksen, Jette L.] Copenhagen Univ Hosp Glostrup, MS Clin, Dept Neurol, Glostrup, Denmark; [Cramer, Stig P.; Larsson, Henrik B. W.] Copenhagen Univ Hosp, Dept Diagnost, Funct Imaging Unit, Glostrup, Denmark; [Wanscher, Benedikte] Copenhagen Univ Hosp Glostrup, Dept Clin Neurophysiol, Glostrup, Denmark; [Sellebjerg, Finn] Copenhagen Univ Hosp Rigshosp, Dept Neurol, Danish MS Res Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Modvig, S (corresponding author), Copenhagen Univ Hosp Glostrup, MS Clin, Dept Neurol, Glostrup, Denmark.	simoni01@regionh.dk	Cramer, Stig P./H-5007-2019	Degn, Matilda/0000-0003-3093-3525; frederiksen, jette/0000-0003-1661-7438; Sellebjerg, Finn/0000-0002-1333-9623; Praestekjaer Cramer, Stig/0000-0003-2959-2161	Danish Council for Strategic Research; Danish Multiple Sclerosis Society; Karen A. Tholstrup foundation; Bdr. Hartmanns foundation; Lykfeldts Legat foundation; Hestehandler Ole Jacobsen Memorial foundation; Danish Research foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Multiple Sclerosis Society; Karen A. Tholstrup foundation; Bdr. Hartmanns foundation; Lykfeldts Legat foundation; Hestehandler Ole Jacobsen Memorial foundation; Danish Research foundation	This research was supported by grants from the Danish Council for Strategic Research (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-strategiske-forskningsrad), the Danish Multiple Sclerosis Society (http://scleroseforeningen.dk/), the Karen A. Tholstrup foundation (http://www.brammeradvokater.dk/fonde/), the Bdr. Hartmanns foundation (http://www.hartmannfonden.dk/), the Lykfeldts Legat foundation (no website), the Hestehandler Ole Jacobsen Memorial foundation (no website) and the Danish Research foundation (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chowdhury SA, 2008, ARCH NEUROL-CHICAGO, V65, P232, DOI 10.1001/archneurol.2007.33; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Horwitz H, 2012, J NEUROL, V259, P2616, DOI 10.1007/s00415-012-6551-1; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Johansen JS, 2001, SCAND J RHEUMATOL, V30, P297; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Khalil M, 2013, MULT SCLER J, V19, P436, DOI 10.1177/1352458512458010; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lim ET, 2005, MULT SCLER J, V11, P532, DOI 10.1191/1352458505ms1218oa; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Sellebjerg F, 1998, MULT SCLER, V4, P475, DOI 10.1177/135245859800400603; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Soderstrom M, 1998, NEUROLOGY, V50, P708, DOI 10.1212/WNL.50.3.708; Sorensen TL, 2002, J NEUROIMMUNOL, V127, P59, DOI 10.1016/S0165-5728(02)00097-8; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007	37	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77163	10.1371/journal.pone.0077163	http://dx.doi.org/10.1371/journal.pone.0077163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116216	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200108
J	Jacewicz, A; Trzemecka, A; Guja, KE; Plochocka, D; Yakubovskaya, E; Bebenek, A; Garcia-Diaz, M				Jacewicz, Agata; Trzemecka, Anna; Guja, Kip E.; Plochocka, Danuta; Yakubovskaya, Elena; Bebenek, Anna; Garcia-Diaz, Miguel			A Remote Palm Domain Residue of RB69 DNA Polymerase Is Critical for Enzyme Activity and Influences the Conformation of the Active Site	PLOS ONE			English	Article							MISPAIRED PRIMER TERMINI; MUTATOR MUTANT; BINDING POCKET; HINGE RESIDUE; FIDELITY; BETA; PROTEIN; SUBSTITUTION; ALIGNMENT; KINETICS	Non-conserved amino acids that are far removed from the active site can sometimes have an unexpected effect on enzyme catalysis. We have investigated the effects of alanine replacement of residues distant from the active site of the replicative RB69 DNA polymerase, and identified a substitution in a weakly conserved palm residue (D714A), that renders the enzyme incapable of sustaining phage replication in vivo. D714, located several angstroms away from the active site, does not contact the DNA or the incoming dNTP, and our apoenzyme and ternary crystal structures of the PolD714A mutant demonstrate that D714A does not affect the overall structure of the protein. The structures reveal a conformational change of several amino acid side chains, which cascade out from the site of the substitution towards the catalytic center, substantially perturbing the geometry of the active site. Consistent with these structural observations, the mutant has a significantly reduced kpol for correct incorporation. We propose that the observed structural changes underlie the severe polymerization defect and thus D714 is a remote, non-catalytic residue that is nevertheless critical for maintaining an optimal active site conformation. This represents a striking example of an action-at-a-distance interaction.	[Jacewicz, Agata; Trzemecka, Anna; Bebenek, Anna] Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland; [Plochocka, Danuta] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland; [Guja, Kip E.; Yakubovskaya, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bebenek, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland.	aniab@ibb.waw.pl; miguel.garcia-diaz@stonybrook.edu	Guja, Kip/AAU-1039-2020	Guja, Kip/0000-0002-9549-7085; Lada, Agnieszka/0000-0002-5100-7638; Bebenek, Anna/0000-0001-5374-8205	National Institutes of Health [R00 ES015421]; Polish Ministry of Science and Higher Education [N N301 787840]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES022930, R00ES015421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, R01GM100021, T32GM008444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R00 ES015421 to MGD from National Institutes of Health and by grant N N301 787840 to AB from the Polish Ministry of Science and Higher Education. Support for the National Synchrotron Light Source beamline X12C comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bebenek A, 2002, GENETICS, V162, P1003; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dalal S, 2004, J BIOL CHEM, V279, P577, DOI 10.1074/jbc.M309607200; Dalal S, 2008, BIOCHEMISTRY-US, V47, P12118, DOI 10.1021/bi8011548; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Ghadessy FJ, 2004, NAT BIOTECHNOL, V22, P755, DOI 10.1038/nbt974; Hogg M, 2006, NUCLEIC ACIDS RES, V34, P2528, DOI 10.1093/nar/gkl300; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; Jacewicz A, 2007, J MOL BIOL, V368, P18, DOI 10.1016/j.jmb.2007.01.067; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Langkilde A, 2008, ACTA CRYSTALLOGR D, V64, P851, DOI 10.1107/S0907444908017083; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrov VM, 2002, J BIOL CHEM, V277, P33041, DOI 10.1074/jbc.M204754200; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Starcevic D, 2005, J BIOL CHEM, V280, P28388, DOI 10.1074/jbc.M502178200; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Trzemecka A, 2010, J MOL BIOL, V404, P778, DOI 10.1016/j.jmb.2010.09.058; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Xia SL, 2011, J MOL BIOL, V406, P558, DOI 10.1016/j.jmb.2010.12.033; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhang H, 2006, BIOCHEMISTRY-US, V45, P2211, DOI 10.1021/bi052099y; Zhang H, 2009, BIOCHEMISTRY-US, V48, P6940, DOI 10.1021/bi900422b	48	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76700	10.1371/journal.pone.0076700	http://dx.doi.org/10.1371/journal.pone.0076700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116139	gold, Green Published			2022-12-25	WOS:000325501300081
J	Vavrova, A; Jansova, H; Mackova, E; Machacek, M; Haskova, P; Tichotova, L; Sterba, M; Simunek, T				Vavrova, Anna; Jansova, Hana; Mackova, Eliska; Machacek, Miloslav; Haskova, Pavlina; Tichotova, Lucie; Sterba, Martin; Simunek, Tomas			Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; DEXRAZOXANE ICRF-187; OXIDATIVE STRESS; IRON CHELATORS; LABILE IRON; DOXORUBICIN; DRUG; BETA; BIS(2,6-DIOXOPIPERAZINE); CYTOTOXICITY	Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is hampered by the risk of irreversible cardiotoxicity. Dexrazoxane (ICRF-187) is the only clinically approved cardioprotective agent against anthracycline cardiotoxicity. Its activity has traditionally been attributed to the iron-chelating effects of its metabolite with subsequent protection from oxidative stress. However, dexrazoxane is also a catalytic inhibitor of topoisomerase II (TOP2). Therefore, we examined whether dexrazoxane and two other TOP2 catalytic inhibitors, namely sobuzoxane (MST-16) and merbarone, protect cardiomyocytes from anthracycline toxicity and assessed their effects on anthracycline antineoplastic efficacy. Dexrazoxane and two other TOP2 inhibitors protected isolated neonatal rat cardiomyocytes against toxicity induced by both doxorubicin and daunorubicin. However, none of the TOP2 inhibitors significantly protected cardiomyocytes in a model of hydrogen peroxide-induced oxidative injury. In contrast, the catalytic inhibitors did not compromise the antiproliferative effects of the anthracyclines in the HL-60 leukemic cell line; instead, synergistic interactions were mostly observed. Additionally, anthracycline-induced caspase activation was differentially modulated by the TOP2 inhibitors in cardiac and cancer cells. Whereas dexrazoxane was upon hydrolysis able to significantly chelate intracellular labile iron ions, no such effect was noted for either sobuzoxane or merbarone. In conclusion, our data indicate that dexrazoxane may protect cardiomyocytes via its catalytic TOP2 inhibitory activity rather than iron-chelation activity. The differential expression and/or regulation of TOP2 isoforms in cardiac and cancer cells by catalytic inhibitors may be responsible for the selective modulation of anthracycline action observed.	[Vavrova, Anna; Jansova, Hana; Mackova, Eliska; Machacek, Miloslav; Haskova, Pavlina; Tichotova, Lucie; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic; [Sterba, Martin] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Hradec Kralove	Simunek, T (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic.	Tomas.Simunek@faf.cuni.cz	Jansova, Hana/S-5847-2017; Simunek, Tomas/A-3938-2008; Hašková, Pavlína/ABC-6019-2021; Jirkovska, Anna/E-8419-2012; Machacek, Miloslav/T-3378-2017; Sterba, Martin/E-8123-2017	Jansova, Hana/0000-0002-5377-518X; Simunek, Tomas/0000-0001-5464-4176; Jirkovska, Anna/0000-0002-0131-6010; Machacek, Miloslav/0000-0001-7221-5914; Haskova, Pavlina/0000-0002-1179-8885	Czech Science Foundation [13-15008S]; Charles University in Prague [SVV 267 004]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0022]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University in Prague; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This study was supported by the Czech Science Foundation (project 13-15008S; www.gacr.cz), Charles University in Prague (project SVV 267 004; www.cuni.cz) and co-financed by the European Social Fund and the state budget of the Czech Republic (project no. CZ.1.07/2.3.00/30.0022; www.msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcova M, 2007, TOXICOLOGY, V237, P218, DOI 10.1016/j.tox.2007.05.016; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bendova P, 2010, CHEM RES TOXICOL, V23, P1105, DOI 10.1021/tx100125t; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; COONEY DA, 1985, BIOCHEM PHARMACOL, V34, P3395, DOI 10.1016/0006-2952(85)90368-5; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Fujiwara Y, 1999, J CLIN ONCOL, V17, P3362, DOI 10.1200/JCO.1999.17.10.3362; GALLAGHER R, 1979, BLOOD, V54, P713; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; Hasinoff BB, 1998, CURR MED CHEM, V5, P1; Hasinoff BB, 2003, MOL PHARMACOL, V64, P670, DOI 10.1124/mol.64.3.670; Hasinoff BB, 1996, ANTI-CANCER DRUG, V7, P558, DOI 10.1097/00001813-199607000-00011; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P140, DOI 10.1007/s12012-007-0023-3; Hasinoff Brian B, 2003, Cardiovasc Toxicol, V3, P89, DOI 10.1385/CT:3:2:89; Inutsuka S, 1998, CANCER CHEMOTH PHARM, V42, P194, DOI 10.1007/s002800050805; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; Lu Da Yong, 2005, BMC Pharmacology, V5, P11, DOI 10.1186/1471-2210-5-11; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; MALISZA KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P680, DOI 10.1006/abbi.1995.1091; Martin E, 2009, TOXICOLOGY, V255, P72, DOI 10.1016/j.tox.2008.10.011; MINDERMAN H, 1993, ANTICANCER RES, V13, P1161; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Popelova O, 2009, BRIT J CANCER, V101, P792, DOI 10.1038/sj.bjc.6605192; Sawyer DB, 2013, NEW ENGL J MED, V368, P1154, DOI 10.1056/NEJMcibr1214975; Schroeder PE, 2003, CANCER CHEMOTH PHARM, V52, P167, DOI 10.1007/s00280-003-0619-7; Simunek T, 2009, PHARMACOL REP, V61, P154; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Swain SM, 2004, J CANCER RES CLIN, V130, P1, DOI 10.1007/s00432-003-0498-7; TANABE K, 1991, CANCER RES, V51, P4903; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; van Dalen EC, 2011, COCHRANE DATABASE SY, V71; Vavrova A, 2012, INT J BIOCHEM CELL B, V44, P834, DOI 10.1016/j.biocel.2012.03.005; Vavrova A, 2011, ARCH TOXICOL, V85, P525, DOI 10.1007/s00204-010-0615-8; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	41	50	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76676	10.1371/journal.pone.0076676	http://dx.doi.org/10.1371/journal.pone.0076676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116135	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300077
J	Dumont, BL; Eichler, EE				Dumont, Beth L.; Eichler, Evan E.			Signals of Historical Interlocus Gene Conversion in Human Segmental Duplications	PLOS ONE			English	Article							COPY NUMBER VARIATION; HUMAN GENOME; PRIMATE EVOLUTION; RECOMBINATION RATES; POSITIVE SELECTION; RAPID EVOLUTION; DNA-SEQUENCES; DISEASE RISK; HOT-SPOTS; FAMILY	Standard methods of DNA sequence analysis assume that sequences evolve independently, yet this assumption may not be appropriate for segmental duplications that exchange variants via interlocus gene conversion (IGC). Here, we use high quality multiple sequence alignments from well-annotated segmental duplications to systematically identify IGC signals in the human reference genome. Our analysis combines two complementary methods: (i) a paralog quartet method that uses DNA sequence simulations to identify a statistical excess of sites consistent with inter-paralog exchange, and (ii) the alignment-based method implemented in the GENECONV program. One-quarter (25.4%) of the paralog families in our analysis harbor clear IGC signals by the quartet approach. Using GENECONV, we identify 1477 gene conversion tracks that cumulatively span 1.54 Mb of the genome. Our analyses confirm the previously reported high rates of IGC in subtelomeric regions and Y-chromosome palindromes, and identify multiple novel IGC hotspots, including the pregnancy specific glycoproteins and the neuroblastoma breakpoint gene families. Although the duplication history of a paralog family is described by a single tree, we show that IGC has introduced incredible site-to-site variation in the evolutionary relationships among paralogs in the human genome. Our findings indicate that IGC has left significant footprints in patterns of sequence diversity across segmental duplications in the human genome, out-pacing the contributions of single base mutation by orders of magnitude. Collectively, the IGC signals we report comprise a catalog that will provide a critical reference for interpreting observed patterns of DNA sequence variation across duplicated genomic regions, including targets of recent adaptive evolution in humans.	[Dumont, Beth L.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Dumont, BL (corresponding author), N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA.	bldumont@ncsu.edu			NIH [HG002385, 5T32HG000035-17]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG002385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded, in part, by NIH Grant HG002385 to EEE. BLD was funded by a NIH Training Grant awarded to the Department of Genome Sciences at the University of Washington (5T32HG000035-17). EEE is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beyond the sources of funding listed in the acknowledgements, no external funding was received for this study.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Avent ND, 1997, BLOOD, V89, P1779, DOI 10.1182/blood.V89.5.1779.1779_1779_1786; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benovoy D, 2009, GENOMICS, V93, P27, DOI 10.1016/j.ygeno.2008.09.007; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Casola C, 2012, GENOME RES, V22, P429, DOI 10.1101/gr.127738.111; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Drouin G, 2002, J MOL EVOL, V55, P14, DOI 10.1007/s00239-001-0085-y; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Ezawa K, 2006, MOL BIOL EVOL, V23, P927, DOI 10.1093/molbev/msj093; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta PK, 2005, BRIT J HAEMATOL, V130, P752, DOI 10.1111/j.1365-2141.2005.05660.x; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Innan H, 2002, GENETICS, V161, P865; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jackson MS, 2005, AM J HUM GENET, V77, P824, DOI 10.1086/497704; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kitano T, 1999, J MOL EVOL, V49, P615, DOI 10.1007/PL00006583; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lukacsovich T, 1999, GENETICS, V151, P1559; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mansai SP, 2010, GENETICS, V184, P517, DOI 10.1534/genetics.109.111161; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McGrath CL, 2009, GENETICS, V182, P615, DOI 10.1534/genetics.109.101428; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Ohta T, 1997, HEREDITAS, V127, P97, DOI 10.1111/j.1601-5223.1997.00097.x; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; SIEGEL S., 1956, NONPARAMETRIC STAT B; St Charles J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003434; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; TAJIMA F, 1993, GENETICS, V135, P599; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Talbert PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000326; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang SH, 2012, P NATL ACAD SCI USA, V109, P20992, DOI 10.1073/pnas.1211827110	93	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75949	10.1371/journal.pone.0075949	http://dx.doi.org/10.1371/journal.pone.0075949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124524	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100081
J	Yang, XW; He, Y; Xu, J; Xiao, X; Wang, FP				Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping			The Regulatory Role of Ferric Uptake Regulator (Fur) during Anaerobic Respiration of Shewanella piezotolerans WP3	PLOS ONE			English	Article							C-TYPE CYTOCHROMES; ESCHERICHIA-COLI; ONEIDENSIS MR-1; IRON-METABOLISM; GENE-EXPRESSION; SMALL RNA; TRANSCRIPTIONAL REGULATION; SALMONELLA-ENTERICA; ELECTRON-ACCEPTORS; HEME-BIOSYNTHESIS	Ferric uptake regulator (Fur) is a global regulator that controls bacterial iron homeostasis. In this study, a fur deletion mutant of the deep-sea bacterium Shewanella piezotolerans WP3 was constructed. Physiological studies revealed that the growth rate of this mutant under aerobic conditions was only slightly lower than that of wild type (WT), but severe growth defects were observed under anaerobic conditions when different electron acceptors (EAs) were provided. Comparative transcriptomic analysis demonstrated that Fur is involved not only in classical iron homeostasis but also in anaerobic respiration. Fur exerted pleiotropic effects on the regulation of anaerobic respiration by controlling anaerobic electron transport, the heme biosynthesis system, and the cytochrome c maturation system. Biochemical assays demonstrated that levels of c-type cytochromes were lower in the fur mutant, consistent with the transcriptional profiling. Transcriptomic analysis and electrophoretic mobility shift assays revealed a primary regulation network for Fur in WP3. These results suggest that Fur may act as a sensor for anoxic conditions to trigger and influence the anaerobic respiratory system.	[Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yang, Xin-Wei; He, Ying; Xu, Jun; Xiao, Xiang; Wang, Feng-Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Wang, Feng-Ping] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, FP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	fengpingw@sjtu.edu.cn	xiao, xiang/GWU-6035-2022	Yang, Xinwei/0000-0003-0776-8269	National Science Foundation of China [31290232, 41076078]; National Basic Research Program of China [2011CB808800]; China Ocean Mineral Resources R D Association [DY125-15-T-04]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Ocean Mineral Resources R D Association; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	This work was supported by National Science Foundation of China (Grant No. 31290232, 41076078), National Basic Research Program of China (Grant No. 2011CB808800), China Ocean Mineral Resources R & D Association (Grant No. DY125-15-T-04), "ShuGuang" Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Cavallaro G, 2008, J PROTEOME RES, V7, P4946, DOI 10.1021/pr8004309; Chen S.-Y., 1996, J OCEANOGR, V52, P705; Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Craig SA, 2011, J BACTERIOL, V193, P6505, DOI 10.1128/JB.05681-11; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Evans MR, 2011, BMC MICROBIOL, V21, P11; Fennessey CM, 2010, APPL ENVIRON MICROB, V76, P2425, DOI 10.1128/AEM.03066-09; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kuehl CJ, 2010, FUTURE MICROBIOL, V5, P1403, DOI 10.2217/FMB.10.90; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Miles S, 2010, J MICROBIOL, V48, P378, DOI 10.1007/s12275-010-0022-0; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Parker D, 2005, J BACTERIOL, V187, P366, DOI 10.1128/JB.187.1.366-375.2005; Paustian ML, 2001, INFECT IMMUN, V69, P4109, DOI 10.1128/IAI.69.6.4109-4115.2001; Pellicer S, 2012, FEBS J, V279, P2231, DOI 10.1111/j.1742-4658.2012.08606.x; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Shroff NP, 2010, J BACTERIOL, V192, P3227, DOI 10.1128/JB.01695-09; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wang FP, 2004, EXTREMOPHILES, V8, P165, DOI 10.1007/s00792-003-0365-0; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang LY, 1997, J BACTERIOL, V179, P2907, DOI 10.1128/jb.179.9.2907-2914.1997; Wu WF, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001728; Xiao X, 2007, INT J SYST EVOL MICR, V57, P60, DOI 10.1099/ijs.0.64500-0; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131; Yuan J, 2012, PROTEOMICS, V12, P1957, DOI 10.1002/pmic.201100651	70	146	149	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75588	10.1371/journal.pone.0075588	http://dx.doi.org/10.1371/journal.pone.0075588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124499	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100056
J	Wertheimer, E; Krapf, D; de la Vega-Beltran, JL; Sanchez-Cardenas, C; Navarrete, F; Haddad, D; Escoffier, J; Salicioni, AM; Levin, LR; Buck, J; Mager, J; Darszon, A; Visconti, PE				Wertheimer, Eva; Krapf, Dario; de la Vega-Beltran, Jose L.; Sanchez-Cardenas, Claudia; Navarrete, Felipe; Haddad, Douglas; Escoffier, Jessica; Salicioni, Ana M.; Levin, Lonny R.; Buck, Jochen; Mager, Jesse; Darszon, Alberto; Visconti, Pablo E.			Compartmentalization of Distinct cAMP Signaling Pathways in Mammalian Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Calcium Imaging; Cell Signaling; Cyclic AMP (cAMP); Heterotrimeric G Proteins; Protein Kinase A (PKA); Signal Transduction; Acrosome Reaction; Forskolin; Sperm Capacitation	SOLUBLE ADENYLYL-CYCLASE; CYCLIC ADENINE RIBONUCLEOTIDE; MOUSE SPERM; G-PROTEINS; TYROSINE PHOSPHORYLATION; REGULATORY PROTEIN; HUMAN SPERMATOZOA; TISSUE PARTICLES; PERTUSSIS TOXIN; CATSPER CHANNEL	Fertilization competence is acquired in the female tract in a process known as capacitation. Capacitation is needed for the activation of motility (e.g. hyperactivation) and to prepare the sperm for an exocytotic process known as acrosome reaction. Although the HCO3--dependent soluble adenylyl cyclase Adcy10 plays a role in motility, less is known about the source of cAMP in the sperm head. Transmembrane adenylyl cyclases (tmACs) are another possible source of cAMP. These enzymes are regulated by stimulatory heterotrimeric G(s) proteins; however, the presence of G(s) or tmACs in mammalian sperm has been controversial. In this study, we used Western blotting and cholera toxin-dependent ADP-ribosylation to show the G(s) presence in the sperm head. Also, we showed that forskolin, a tmAC-specific activator, induces cAMP accumulation in sperm from both WT and Adcy10-null mice. This increase is blocked by the tmAC inhibitor SQ22536 but not by the Adcy10 inhibitor KH7. Although G(s) immunoreactivity and tmAC activity are detected in the sperm head, PKA is only found in the tail, where Adcy10 was previously shown to reside. Consistent with an acrosomal localization, G(s) reactivity is lost in acrosome-reacted sperm, and forskolin is able to increase intracellular Ca2+ and induce the acrosome reaction. Altogether, these data suggest that cAMP pathways are compartmentalized in sperm, with G(s) and tmAC in the head and Adcy10 and PKA in the flagellum.	[Wertheimer, Eva; Krapf, Dario; Navarrete, Felipe; Haddad, Douglas; Escoffier, Jessica; Salicioni, Ana M.; Mager, Jesse; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Wertheimer, Eva] Univ Buenos Aires, Ctr Estudios Farmacol & Bot, Fac Med, Consejo Nacl Invest Cient & Tecn, RA-1053 Buenos Aires, DF, Argentina; [Krapf, Dario] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut, Inst Biol Celular & Mol Rosario, RA-2000 Rosario, Santa Fe, Argentina; [de la Vega-Beltran, Jose L.; Sanchez-Cardenas, Claudia; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Levin, Lonny R.; Buck, Jochen] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA	University of Massachusetts System; University of Massachusetts Amherst; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad Nacional Autonoma de Mexico; Cornell University	Darszon, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico.	darszon@ibt.unam.mx; pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021; Escoffier, jessica/E-9498-2017; Escoffier, jessica/T-9857-2019; Levin, Lonny R/A-7215-2011	Salicioni, Ana Maria/0000-0002-8951-3587; Escoffier, jessica/0000-0001-8166-5845; Levin, Lonny/0000-0002-5204-6356; Darszon, Alberto/0000-0002-2502-0505; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [HD38082, HD44044, HD059913, GM62328]; CONACyT-Mexico Grant [49113]; DGAPA/UNAM Grants [IN211809, IN225406]; PICT-ANPCyT-Argentina Grant [2011-0540]; National Council of Science and Technology [2012-2263]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082, R01HD059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT-Mexico Grant; DGAPA/UNAM Grants; PICT-ANPCyT-Argentina Grant; National Council of Science and Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P. E. V.) and Grants HD059913 and GM62328 (to J. B. and L R. L). This work was also supported by CONACyT-Mexico Grant 49113 (to A. D.), DGAPA/UNAM Grants IN211809 and IN225406 (to A. D.), PICT-ANPCyT-Argentina Grant 2011-0540 (to D. K.), and Postdoctoral Fellowship 2012-2263 from the National Council of Science and Technology (to E. W.). Drs. Levin and Buck own equity interest in CEP Biotech, which has licensed commercialization of a panel of monoclonal antibodies directed against sAC.	AITKEN RJ, 1986, J REPROD FERTIL, V78, P515; Alfano M, 2005, CURR PHARM DESIGN, V11, P2909, DOI 10.2174/1381612054546725; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Baxendale RW, 2003, MOL REPROD DEV, V66, P181, DOI 10.1002/mrd.10344; Baxendale RW, 2003, MOL REPROD DEV, V65, P104, DOI 10.1002/mrd.10295; BENTLEY JK, 1986, BIOCHEM BIOPH RES CO, V138, P728, DOI 10.1016/S0006-291X(86)80557-5; Bitterman J. L., 2013, J PHARM EXP THER, DOI 10.1124/jpet.113.208496; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CHENG CY, 1979, BIOCHEM BIOPH RES CO, V91, P1, DOI 10.1016/0006-291X(79)90574-6; DALY JW, 1984, ADV CYCLIC NUCL PROT, V17, P81; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; FORTE LR, 1983, MOL PHARMACOL, V24, P42; FRASER LR, 1993, J REPROD FERTIL, V98, P187; Fraser LR, 1999, BIOESSAYS, V21, P304, DOI 10.1002/(SICI)1521-1878(199904)21:4<304::AID-BIES6>3.0.CO;2-H; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HANSKI E, 1983, FEBS LETT, V162, P447, DOI 10.1016/0014-5793(83)80805-9; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Helsel DR, 2006, CHEMOSPHERE, V65, P2434, DOI 10.1016/j.chemosphere.2006.04.051; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HILDEBRANDT JD, 1985, ENDOCRINOLOGY, V116, P1357, DOI 10.1210/endo-116-4-1357; Huston E, 2006, BIOCHEM SOC T, V34, P504, DOI 10.1042/BST0340504; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; KALAB P, 1994, J BIOL CHEM, V269, P3810; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kim M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002084; KOPF GS, 1986, J BIOL CHEM, V261, P7327; Leclerc P, 1999, J ANDROL, V20, P126; LECLERC P, 1995, BIOL REPROD, V52, P1227, DOI 10.1095/biolreprod52.6.1227; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Lynch MJ, 2006, CURR TOP DEV BIOL, V75, P225, DOI 10.1016/S0070-2153(06)75007-4; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Merlet F, 1999, MOL HUM REPROD, V5, P38, DOI 10.1093/molehr/5.1.38; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; MONKS NJ, 1986, INT J ANDROL, V9, P67, DOI 10.1111/j.1365-2605.1986.tb00868.x; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; RALL TW, 1958, J BIOL CHEM, V232, P1065; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; ROJAS FJ, 1992, HUM REPROD, V7, P1126, DOI 10.1093/oxfordjournals.humrep.a137806; SEAMON K, 1981, J BIOL CHEM, V256, P9799; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1998, J ANDROL, V19, P242; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; ZIGMAN JM, 1993, ENDOCRINOLOGY, V133, P2508, DOI 10.1210/en.133.6.2508	74	76	76	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35307	35320		10.1074/jbc.M113.489476	http://dx.doi.org/10.1074/jbc.M113.489476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129574	Green Published, hybrid			2022-12-25	WOS:000329867600029
J	Ziemba, A; Hill, S; Sandoval, D; Webb, K; Bennett, EJ; Kleiger, G				Ziemba, Amy; Hill, Spencer; Sandoval, Danielle; Webb, Kristofor; Bennett, Eric J.; Kleiger, Gary			Multimodal Mechanism of Action for the Cdc34 Acidic Loop A CASE STUDY FOR WHY UBIQUITIN-CONJUGATING ENZYMES HAVE LOOPS AND TAILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetics; Ubiquitin-conjugating Enzyme (Ubc); Ubiquitin Ligase; Ubiquitination; Yeast Genetics	POLYUBIQUITIN CHAINS; S-TRANSITION; LIGASE; DOMAIN; UBC3; PHOSPHORYLATION; COMPLEX; LYSINE; SCF; RECOGNITION	Background: Ubiquitin-mediated proteolysis is the principal mechanism for regulating protein half-lives in cells. Results: Cdc34 promotes ubiquitin chain assembly onto protein substrates and contains an essential acidic loop near the active site. Conclusion: The Cdc34 acidic loop promotes both protein-protein interactions and catalysis of ubiquitin chain formation. Significance: These results uncover specific biochemical activities for the Cdc34 acidic loop. Together with ubiquitin ligases (E3), ubiquitin-conjugating enzymes (E2) are charged with the essential task of synthesizing ubiquitin chains onto protein substrates. Some 75% of the known E2s in the human proteome contain unique insertions in their primary sequences, yet it is largely unclear what effect these insertions impart on the ubiquitination reaction. Cdc34 is an important E2 with prominent roles in cell cycle regulation and signal transduction. The amino acid sequence of Cdc34 contains an insertion distal to the active site that is absent in most other E2s, yet this acidic loop (named for its four invariably conserved acidic residues) is critical for Cdc34 function both in vitro and in vivo. Here we have investigated how the acidic loop in human Cdc34 promotes ubiquitination, identifying two key molecular events during which the acidic loop exerts its influence. First, the acidic loop promotes the interaction between Cdc34 and its ubiquitin ligase partner, SCF. Second, two glutamic acid residues located on the distal side of the loop collaborate with an invariably conserved histidine on the proximal side of the loop to suppress the pK(a) of an ionizing species on ubiquitin or Cdc34 which greatly contributes to Cdc34 catalysis. These results demonstrate that insertions can guide E2s to their physiologically relevant ubiquitin ligases as well as provide essential modalities that promote catalysis.	[Ziemba, Amy; Hill, Spencer; Sandoval, Danielle; Kleiger, Gary] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA; [Webb, Kristofor; Bennett, Eric J.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	Kleiger, G (corresponding author), Univ Nevada, Dept Chem, 4505 S Maryland Pkwy,Box 454003, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu		Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health from NCRR [5P20RR016464-11]; National Institutes of Health from NIGMS [8P20GM103440-11]; Ellison Medical Foundation; Sidney Kimmel Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); Sidney Kimmel Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR016464-11 from NCRR and 8P20GM103440-11 from NIGMS (to A.Z. and G.K.). This work was also supported by the Ellison Medical Foundation and the Sidney Kimmel Cancer Research Foundation (both to E.J.B.).	Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Deshaies RJ, 2009, NATURE, V458, P709, DOI 10.1038/458709a; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Fersht A., 1985, ENZYME STRUCTURE MEC, P157; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang H., 2013, NAT CHEM BI IN PRESS; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ju T., PROTEINS, V78, P1291; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040786; Papaleo E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002056; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	49	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34882	34896		10.1074/jbc.M113.509190	http://dx.doi.org/10.1074/jbc.M113.509190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129577	Green Published, hybrid			2022-12-25	WOS:000329812800055
J	Mowry, EM; Carey, RF; Blasco, MR; Pelletier, J; Duquette, P; Villoslada, P; Malikova, I; Roger, E; Kinkel, RP; McDonald, J; Bacchetti, P; Waubant, E				Mowry, Ellen M.; Carey, Robert F.; Blasco, Maria R.; Pelletier, Jean; Duquette, Pierre; Villoslada, Pablo; Malikova, Irina; Roger, Elaine; Kinkel, R. Phillip; McDonald, Jamie; Bacchetti, Peter; Waubant, Emmanuelle			Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS	PLOS ONE			English	Article							INTERFERON BETA-1A; CONTROLLED-TRIAL; CD4(+) T; REPLICATION; RECEPTOR; RISK; CD58; CD6	Objective: The anatomic location of subsequent relapses in early multiple sclerosis (MS) appears to be predicted by the first attack location. We sought to determine if genetic polymorphisms associated with MS susceptibility are associated with attack location. Methods: 17 genome-wide association study-identified MS susceptibility polymorphisms were genotyped in 503 white, non-Hispanic patients seen within a year of MS onset. Their association with the CNS location of the first two MS attacks was assessed in multivariate repeated measures analyses (generalized estimating equations with robust standard errors). Results: The IL12A polymorphism was independently associated with increased odds of attacks involving the spinal cord (OR = 1.52, 95% CI 1.11, 2.07, p = 0.009), as was the IRF8 polymorphism (OR = 2.40, 95% CI [1.04, 5.50], p = 0.040). The IL7R polymorphism was associated with reduced odds of attacks involving the brainstem/cerebellum (OR = 0.46, 95% CI 0.22, 0.97, p = 0.041), as were the TNFRSF1A and IL12A polymorphisms. The CD6 polymorphism conferred reduced odds of optic neuritis as an attack location (OR = 0.69, 95% CI [0.49, 0.97], p = 0.034). Several other genes showed trends for association with attack location. Conclusions: Some of the MS susceptibility genes may be associated with MS attack location. The IL12A polymorphism is of particular interest given that interferon beta therapy appears to influence IL12 levels. These findings may lead to improved understanding of MS pathogenesis and treatment.	[Mowry, Ellen M.] Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA; [Carey, Robert F.; McDonald, Jamie; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Blasco, Maria R.] Hosp Univ Puerta Hierro, Dept Neurol, Madrid, Spain; [Pelletier, Jean; Malikova, Irina] Aix Marseille Univ, Ctr Hosp Univ Timone, Ctr Resonance Magnet Biol & Med, Pole Neurosci Clin,Serv Neurol, Marseille, France; [Duquette, Pierre; Roger, Elaine] Univ Montreal, Ctr Hosp, Multiple Sclerosis Clin, Montreal, PQ, Canada; [Villoslada, Pablo] Inst Biomed Res August Pi Sunyer, Hosp Clin, Ctr Neuroimmunol, Barcelona, Spain; [Kinkel, R. Phillip] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; University of California System; University of California San Francisco; Hospital Puerta de Hierro-Majadahonda; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Mowry, EM (corresponding author), Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA.	emowry1@jhmi.edu	Villoslada, Pablo/AAF-9547-2019	Mowry, Ellen/0000-0003-0623-5188; Blasco Quilez, Maria Rosario/0000-0003-2719-4629; Villoslada, Pablo/0000-0002-8735-6119	National Multiple Sclerosis Society [RG-3692A]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was supported by a National Multiple Sclerosis Society research grant (www.nmss.org; RG-3692A; PI E. Waubant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Beck RW, 2002, ANN NEUROL, V51, P481, DOI 10.1002/ana.10148; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; CONFAVREUX C, 1994, ANN NEUROL, V36, pS136, DOI 10.1002/ana.410360733; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Deen S, 2008, J NEUROL NEUROSUR PS, V79, P1190, DOI 10.1136/jnnp.2007.136440; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Kress-Bennett JM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-155; Marcus JF, 2010, MULT SCLER J, V16, P1004; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P400, DOI 10.1136/jnnp.2008.157305; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Waubant E, 2012, NEUROLOGY, V78, P1171, DOI 10.1212/WNL.0b013e31824f7fdd	27	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75565	10.1371/journal.pone.0075565	http://dx.doi.org/10.1371/journal.pone.0075565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130718	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200015
J	Beygo, J; Ammerpohl, O; Gritzan, D; Heitmann, M; Rademacher, K; Richter, J; Caliebe, A; Siebert, R; Horsthemke, B; Buiting, K				Beygo, Jasmin; Ammerpohl, Ole; Gritzan, Daniela; Heitmann, Melanie; Rademacher, Katrin; Richter, Julia; Caliebe, Almuth; Siebert, Reiner; Horsthemke, Bernhard; Buiting, Karin			Deep Bisulfite Sequencing of Aberrantly Methylated Loci in a Patient with Multiple Methylation Defects	PLOS ONE			English	Article							RECURRENT HYDATIDIFORM MOLE; DNA METHYLATION; CPG ISLANDS; REPRODUCTIVE WASTAGE; MUTATIONS; NLRP7; PHENOTYPE; GENE; IDENTIFICATION; GENOTYPE	NLRP7 is a maternal effect gene as maternal mutations in this gene cause recurrent hydatidiform moles, spontaneous abortions and stillbirths, whereas live births are very rare. We have studied a patient with multiple anomalies born to a mother with a heterozygous NLRP7 mutation. By array-based CpG methylation analysis of blood DNA from the patient, his parents and 18 normal controls on Illumina Infinium HumanMethylation27 BeadChips we found that the patient had methylation changes (delta beta >= 0.3) at many imprinted loci as well as at 87 CpGs associated with 85 genes of unknown imprinting status. Using a pseudoproband (permutation) approach, we found methylation changes at only 7-24 CpGs (mean 15; standard deviation 4.84) in the controls. Thus, the number of abberantly methylated CpGs in the patient is more than 14 standard deviations higher. In order to identify novel imprinted genes among the 85 conspicuous genes in the patient, we selected 19 (mainly hypomethylated) genes for deep bisulfite amplicon sequencing on the ROCHE/454 Genome Sequencer in the patient and at least two additional controls. These controls had not been included in the array analysis and were heterozygous for a single nucleotide polymorphism at the test locus, so that allele-specific DNA methylation patterns could be determined. Apart from FAM50B, which we proved to be imprinted in blood, we did not observe allele-specific DNA methylation at the other 18 loci. We conclude that the patient does not only have methylation defects at imprinted loci but (at least in blood) also an excess of methylation changes at apparently non-imprinted loci.	[Beygo, Jasmin; Gritzan, Daniela; Heitmann, Melanie; Rademacher, Katrin; Horsthemke, Bernhard; Buiting, Karin] Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, Essen, Germany; [Ammerpohl, Ole; Richter, Julia; Caliebe, Almuth; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Ammerpohl, Ole; Richter, Julia; Caliebe, Almuth; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany	University of Duisburg Essen; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Horsthemke, B (corresponding author), Univ Duisburg Essen, Inst Humangenet, Univ Klinikum Essen, Essen, Germany.	bernhard.horsthemke@uni-due.de	Caliebe, Almuth/G-1248-2018; Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010	Caliebe, Almuth/0000-0003-2157-425X; 	Bundesministerium fur Bildung und Forschung (Network imprinting diseases) [01GM1114]	Bundesministerium fur Bildung und Forschung (Network imprinting diseases)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (Network imprinting diseases, 01GM1114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Beygo J, 2011, MOL SYNDROMOL, V2, P53, DOI 10.1159/000335545; Beygo J, 2013, HUM MOL GENET, V22, P544, DOI 10.1093/hmg/dds465; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Davison AC, 1997, BOOTSTRAP METHODS TH, Vx, P582; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dixon PH, 2012, J MED GENET, V49, P206, DOI 10.1136/jmedgenet-2011-100602; Djuric U, 2006, HUM GENET, V120, P390, DOI 10.1007/s00439-006-0192-3; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Fallahian M, 2013, HUM MUTAT, V34, P301, DOI 10.1002/humu.22228; Fisher RA, 2004, J REPROD MED, V49, P595; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035789; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Martin-Trujillo A, 2011, EPIGENETICS-US, V6, P1236, DOI 10.4161/epi.6.10.17654; Messaed C, 2011, J MED GENET, V48, P540, DOI 10.1136/jmg.2011.089144; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nakabayashi K, 2011, HUM MOL GENET, V20, P3188, DOI 10.1093/hmg/ddr224; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Prickett AR, 2012, MOL GENET GENOMICS, V287, P621, DOI 10.1007/s00438-012-0708-6; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Turan N, 2010, EPIGENETICS-US, V5, P16, DOI 10.4161/epi.5.1.10557; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Williams D, 2010, EUR J OBSTET GYN R B, V150, P3, DOI 10.1016/j.ejogrb.2010.01.003; Zeschnigk M, 2009, HUM MOL GENET, V18, P1439, DOI 10.1093/hmg/ddp054; Zhang AP, 2011, NUCLEIC ACIDS RES, V39, P5388, DOI 10.1093/nar/gkr108; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	50	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76953	10.1371/journal.pone.0076953	http://dx.doi.org/10.1371/journal.pone.0076953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130816	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900110
J	Fuentes, CT; Runa, C; Blanco, XA; Orvalho, V; Haggard, P				Fuentes, Christina T.; Runa, Catarina; Blanco, Xenxo Alvarez; Orvalho, Veronica; Haggard, Patrick			Does My Face FIT?: A Face Image Task Reveals Structure and Distortions of Facial Feature Representation	PLOS ONE			English	Article							SELF-FACE; OWN FACE; BODY; PERCEPTION; HEAD; RECOGNITION; HEMISPHERE; BRAIN; SIZE	Despite extensive research on face perception, few studies have investigated individuals' knowledge about the physical features of their own face. In this study, 50 participants indicated the location of key features of their own face, relative to an anchor point corresponding to the tip of the nose, and the results were compared to the true location of the same individual's features from a standardised photograph. Horizontal and vertical errors were analysed separately. An overall bias to underestimate vertical distances revealed a distorted face representation, with reduced face height. Factor analyses were used to identify separable subconfigurations of facial features with correlated localisation errors. Independent representations of upper and lower facial features emerged from the data pattern. The major source of variation across individuals was in representation of face shape, with a spectrum from tall/thin to short/wide representation. Visual identification of one's own face is excellent, and facial features are routinely used for establishing personal identity. However, our results show that spatial knowledge of one's own face is remarkably poor, suggesting that face representation may not contribute strongly to self-awareness.	[Fuentes, Christina T.; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Runa, Catarina; Blanco, Xenxo Alvarez; Orvalho, Veronica] Univ Porto, Inst Telecomunicacoes, Porto Interact Ctr, P-4100 Porto, Portugal	University of London; University College London; Instituto de Telecomunicacoes; Universidade do Porto	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, London, England.	haggard@ucl.ac.uk		Haggard, Patrick/0000-0001-7798-793X; Runa Miranda, Catarina/0000-0002-6018-1160; orvalho, veronica/0000-0002-7150-6098	EU FP7 project [VERE 257696]; ESRC	EU FP7 project(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by EU FP7 project VERE 257696, work package 1. PH was further supported by an ESRC Professorial Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY GC, 1969, J EXP PSYCHOL, V81, P376, DOI 10.1037/h0027737; Bianchi I, 2008, BRIT J PSYCHOL, V99, P513, DOI 10.1348/000712608X304469; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; Casey SJ, 2005, EXP BRAIN RES, V166, P583, DOI 10.1007/s00221-005-2398-3; Chamberlain R, 2013, Q J EXP PSYCHOL, V66, P1448, DOI 10.1080/17470218.2012.750678; Collishaw SM, 2005, PERCEPTION, V34, P163, DOI 10.1068/p5216; Corradi-Dell'Acqua C, 2008, CEREB CORTEX, V18, P2879, DOI 10.1093/cercor/bhn046; Costa M, 2001, J NONVERBAL BEHAV, V25, P63, DOI 10.1023/A:1006737224617; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Greenberg SN, 2009, J EXP PSYCHOL LEARN, V35, P499, DOI 10.1037/a0014640; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keyes H, 2010, Q J EXP PSYCHOL, V63, P840, DOI 10.1080/17470211003611264; Little AC, 2007, BIOL PSYCHOL, V76, P209, DOI 10.1016/j.biopsycho.2007.08.003; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Metzinger T., 2004, BEING NO ONE SELF MO; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Ramon M, 2012, BRAIN COGNITION, V78, P7, DOI 10.1016/j.bandc.2011.10.009; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rooney B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00066; SAVARDI U, 2006, DIPAV QUADERNI, V15, P59; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; TANAKA JW, 2011, OXFORD HDB FACE PERC; Thomas R, 2006, ACTA PSYCHOL, V121, P317, DOI 10.1016/j.actpsy.2005.08.002; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Zhou GM, 2012, PSYCHON B REV, V19, P157, DOI 10.3758/s13423-011-0174-x	36	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76805	10.1371/journal.pone.0076805	http://dx.doi.org/10.1371/journal.pone.0076805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130790	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900085
J	Hsing, CH; Kwok, FA; Cheng, HC; Li, CF; Chang, MS				Hsing, Chung-Hsi; Kwok, Franky Antonius; Cheng, Hung-Chi; Li, Chien-Feng; Chang, Ming-Shi			Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression	PLOS ONE			English	Article							CANCER-PATIENTS; TH2 CYTOKINES; MESSENGER-RNA; TUMOR-CELL; IL-19; EXPRESSION; METASTASIS; RECEPTORS; FAMILY; CXCR4	Background: IL-19 is expressed in esophageal squamous cell carcinoma (SCC), but its biological effect on esophageal cancer remains unclear. We determined the correlation between IL-19 expression levels and clinicopathological variables and explored the effects of IL-19 on the esophageal SCC in vivo and in vitro. Methodology/Principal Findings: We determined the expression levels of esophageal SCC tissues from 60 patients using immunohistochemistry. We examined the effects of IL-19 on intracellular signaling, cytokines production as well as proliferation, colonization, and migration in the human esophageal SCC cell line CE81T. Monoclonal antibodies (mAbs) against IL-19 (1BB1) and its receptor IL-20R1 (51D) were used to antagonize the effects of IL-19. We injected SCID mice with CE81T cells and then treated them with anti-IL-19 mAb or control IgG every 3 days and determined tumor growth for 32 days. Of the 60 esophageal SCC patients, 36 patients (60%) were IL-19 strongly stained, which was associated with advanced tumor stage. CE81T cells expressed IL-19 and its receptors. IL-19 induced phosphorylation of STAT3, P38, JNK, ERK1/2, Akt, and NF-kappa B in CE81T cells. IL-19 promoted the proliferation, colonization, and migration of CE81T cells, which were antagonized by 1BB1 and 51D. IL-19 also induced expression of the transcripts of TGF-beta, cyclin B1, CXCR4, and MMP-1 in CE81T cells. In CE81T tumor-bearing mice, 1BB1 reduced tumor growth and downregulated TGF-beta, cyclin B1, MMP-1, and CXCR4 expression in tumors. Conclusions/Significance: IL-19 affects the pathogenesis of esophageal cancer. IL-19 mAb (1BB1) is potentially a potent drug for esophageal cancer therapy.	[Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Kwok, Franky Antonius; Cheng, Hung-Chi; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Inst Biochem & Mol Biol, Tainan 70101, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan	Chi Mei Hospital; Taipei Medical University; National Cheng Kung University; Chi Mei Hospital	Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Biochem & Mol Biol, Tainan 70101, Taiwan.	mschang@mail.ncku.edu.tw		Li, Chien-Feng/0000-0002-9527-7576	National Science Council, Taiwan [NSC 101-2314-B-384-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 101-2314-B-384-003-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2009, CURR OPIN PHARMACOL, V9, P396, DOI 10.1016/j.coph.2009.06.010; Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Department of Health (DOH) RoCR, 2007, HLTH STAT; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2007, NEPHROL DIAL TRANSPL, V22, P2230, DOI 10.1093/ndt/gfm179; Hsing CH, 2006, CYTOKINE, V35, P44, DOI 10.1016/j.cyto.2006.07.006; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsing CH, 2012, CLIN CANCER RES, V18, P713, DOI 10.1158/1078-0432.CCR-11-1532; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; HU CP, 1984, J NATL CANCER I, V72, P577; Jaiswal K, 2006, AM J PHYSIOL-GASTR L, V290, pG335, DOI 10.1152/ajpgi.00167.2005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kan T, 2001, BIOCHEM BIOPH RES CO, V286, P792, DOI 10.1006/bbrc.2001.5400; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.biochem.55.1.1037; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; MCCLELLAND RA, 1990, CANCER RES, V50, P3545; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Paduch R, 2005, CELL BIOL INT, V29, P497, DOI 10.1016/j.cellbi.2005.01.007; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Ries LAG, SEER CANC STAT REV 1; Rikiishi H, 1993, Hum Cell, V6, P21; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sabbioni MEE, 2000, BREAST CANCER RES TR, V59, P279, DOI 10.1023/A:1006379925343; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Sasaki K, 2008, J SURG ONCOL, V97, P433, DOI 10.1002/jso.20976; Sigmundsdottir H, 2001, CLIN EXP IMMUNOL, V126, P365, DOI 10.1046/j.1365-2249.2001.01688.x; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; Takahashi S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-103; Wang JS, 2008, WORLD J GASTROENTERO, V14, P3982, DOI 10.3748/wjg.14.3982; Wei L, 2010, INT J CANC; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973	54	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75254	10.1371/journal.pone.0075254	http://dx.doi.org/10.1371/journal.pone.0075254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130695	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900026
J	Armitage, AR; Ho, CK; Quigg, A				Armitage, Anna R.; Ho, Chuan-Kai; Quigg, Antonietta			The Interactive Effects of Pulsed Grazing Disturbance and Patch Size Vary among Wetland Arthropod Guilds	PLOS ONE			English	Article							TROPHIC-LEVEL INTERACTIONS; PLANT COMMUNITY STRUCTURE; BOTTOM-UP FORCES; SALT-MARSH; TOP-DOWN; SPARTINA-ALTERNIFLORA; VERTEBRATE HERBIVORES; INSECT COMMUNITIES; TEMPORAL PATTERNS; BAY	Pulse disturbances and habitat patch size can determine community composition independently or in concert, and may be particularly influential on small spatial scales for organisms with low mobility. In a field experiment, we investigated whether the effects of a pulsed disturbance that simulated a grazing event varied with habitat patch size. We focused on the short-term responses of multiple co-occurring emergent salt marsh arthropods with differing levels of mobility and dispersal potential. As part of a marsh restoration project, two types of emergent marsh structures were created: small circular mounds (0.5 m diameter) separated by several meters of aquatic habitat, and larger, elongated terraces (. 50 m long). Study plots (0.25 m(2)) were established on both structures; in a subset of plots, we simulated a pulsed grazing disturbance event by clipping the aboveground tissue of emergent plants, primarily Spartina alterniflora. At the end of the two-month recovery period, Ischnodemus (Hemiptera: Blissidae) density was over 50% lower in disturbed treatments within both large (terrace) and small (mound) patches. Predatory spider treatment responses were similar to Ischnodemus responses, suggesting a trophic relationship between those two arthropod groups. Alternatively, spiders may have been directly affected by the loss of shelter in the disturbed plots. Prokelisia (Homoptera: Delphacidae), which are generally more mobile than Ischnodemus, were not affected by disturbance treatment or by patch size, suggesting the potential for rapid recolonization following disturbance. Larval stem borers decreased by an order of magnitude in disturbed plots, but only in the large patches. In general, the disturbance effects of vegetation removal on arthropod density and community composition were stronger than patch size effects, and there were few interactions between pulsed disturbance and patch size. Rather, emergent marsh arthropod responses to disturbance and habitat area treatments were linked to the dispersal potential and mobility of each individual taxon.	[Armitage, Anna R.; Ho, Chuan-Kai; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Ho, Chuan-Kai] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; National Taiwan University; Texas A&M University System; Texas A&M University College Station	Armitage, AR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	armitaga@tamug.edu	Armitage, Anna/X-2773-2019	Armitage, Anna/0000-0003-1563-8026; HO, CHUAN-KAI/0000-0002-6437-0073	Texas General Land Office Oil Spill Prevention and Response Division [09-060-000-3396]	Texas General Land Office Oil Spill Prevention and Response Division	This material is based in part upon work supported by the Research and Development program of the Texas General Land Office Oil Spill Prevention and Response Division under Grant No. 09-060-000-3396 (http://www.glo.texas.gov/what-we-do/caring-for-the-coast/oil-spills/research-development.html). While employed under this grant, Amanda Thronson made substantial contributions to the data collection for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PFE, 2008, J EXP MAR BIOL ECOL, V364, P19, DOI 10.1016/j.jembe.2008.06.020; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; Brown SC, 1997, ENVIRON ENTOMOL, V26, P1016, DOI 10.1093/ee/26.5.1016; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denno RF, 1996, ECOL MONOGR, V66, P389, DOI 10.2307/2963487; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; DENNO RF, 1979, ECOLOGY, V60, P221, DOI 10.2307/1936482; Denno Robert F., 2000, American Entomologist, V46, P95; Diaz R, 2008, ANN ENTOMOL SOC AM, V101, P604, DOI 10.1603/0013-8746(2008)101[604:TDSAPD]2.0.CO;2; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Evers DE, 1998, ESTUARIES, V21, P1, DOI 10.2307/1352543; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Ford H, 2013, INSECT CONSERV DIVER, V6, P189, DOI 10.1111/j.1752-4598.2012.00202.x; Ford MA, 1998, J ECOL, V86, P974, DOI 10.1046/j.1365-2745.1998.00314.x; FURBISH CE, 1994, ECOLOGY, V75, P1015, DOI 10.2307/1939425; Gough L, 1998, OECOLOGIA, V117, P527, DOI 10.1007/s004420050689; Gratton C, 2003, ECOLOGY, V84, P2692, DOI 10.1890/02-0666; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Halaj J, 2000, ENVIRON ENTOMOL, V29, P383, DOI 10.1603/0046-225X(2000)029[0383:MHREGP]2.0.CO;2; Hartzell D, 2007, WETLANDS, V27, P794, DOI 10.1672/0277-5212(2007)27[794:ACONAC]2.0.CO;2; Ho CK, 2008, ECOLOGY, V89, P1714, DOI 10.1890/07-1069.1; Jefferies RL, 1999, HERBIVORES NUTR TROP; Johnson LA, 1997, AQUAT BOT, V59, P17, DOI 10.1016/S0304-3770(97)00031-4; Kettenring KM, 2010, ESTUAR COAST, V33, P118, DOI 10.1007/s12237-009-9241-1; Kotanen PM, 2013, PLANT ECOL, V214, P409, DOI 10.1007/s11258-013-0178-x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; MacKenzie RA, 2005, AM MIDL NAT, V153, P257, DOI 10.1674/0003-0031(2005)153[0257:SATPII]2.0.CO;2; Martinson HM, 2012, ECOLOGY, V93, P1779, DOI 10.1890/11-1497.1; McFalls TB, 2010, J COASTAL RES, V26, P901, DOI 10.2112/JCOASTRES-D-09-00037.1; Mills VS, 2009, ESTUAR COAST SHELF S, V81, P123, DOI 10.1016/j.ecss.2008.10.005; Moon DC, 2005, ECOL ENTOMOL, V30, P642, DOI 10.1111/j.0307-6946.2005.00733.x; Moon DC, 2004, ECOLOGY, V85, P2709, DOI 10.1890/03-4099; Moon DC, 2002, OECOLOGIA, V133, P243, DOI 10.1007/s00442-002-1013-6; Moon DC, 2002, OIKOS, V98, P480, DOI 10.1034/j.1600-0706.2002.980312.x; Murphy SM, 2012, PLOS ONE, V7; Olofsson J, 2008, OECOLOGIA, V156, P825, DOI 10.1007/s00442-008-1038-6; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Rand TA, 2002, OECOLOGIA, V132, P549, DOI 10.1007/s00442-002-0989-2; Randall LAJ, 2005, WETLANDS, V25, P38; Richardson BA, 2010, ECOSYSTEMS, V13, P286, DOI 10.1007/s10021-010-9317-6; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Rose CD, 1999, MAR ECOL PROG SER, V190, P211, DOI 10.3354/meps190211; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Slater JA, 1990, LYGAEIDAE FLORIDA HE; Stagliano DM, 1998, J N AM BENTHOL SOC, V17, P37, DOI 10.2307/1468050; Steinly BA, 2004, P ENTOMOL SOC WASH, V106, P460; Stevenson JC, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P709; STILING P, 1991, FLA ENTOMOL, V74, P88, DOI 10.2307/3495244; STILING PD, 1983, ECOLOGY, V64, P770, DOI 10.2307/1937200; STILING PD, 1984, ECOLOGY, V65, P660, DOI 10.2307/1941431; Stoner KJL, 2004, ECOL APPL, V14, P1306, DOI 10.1890/03-5112; STRONG DR, 1989, J ANIM ECOL, V58, P1065, DOI 10.2307/5142; TURNER MG, 1987, ESTUARIES, V10, P54, DOI 10.2307/1352025; Watts CH, 2006, OECOLOGIA, V148, P61, DOI 10.1007/s00442-005-0344-5; Weyer J, 2012, J INSECT CONSERV, V16, P379, DOI 10.1007/s10841-011-9423-6; White WH, 2005, 46 USDA SYST ENT LAB; With KA, 2011, LANDSCAPE ECOL, V26, P1035, DOI 10.1007/s10980-011-9627-x	62	10	10	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76672	10.1371/journal.pone.0076672	http://dx.doi.org/10.1371/journal.pone.0076672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116133	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200061
J	Majchrzak, K; Lo Re, D; Gajewska, M; Bulkowska, M; Homa, A; Pawlowski, K; Motyl, T; Murphy, PV; Krol, M				Majchrzak, Kinga; Lo Re, Daniele; Gajewska, Malgorzata; Bulkowska, Malgorzata; Homa, Agata; Pawlowski, Karol; Motyl, Tomasz; Murphy, Paul V.; Krol, Magdalena			Migrastatin Analogues Inhibit Canine Mammary Cancer Cell Migration and Invasion	PLOS ONE			English	Article							TUMOR-METASTASIS; BREAST-CANCER; DORRIGOCIN; EXPRESSION; DISCOVERY; CONGENERS; LACTONE; FASCIN; LINES; MODEL	Background: Cancer spread to other organs is the main cause of death of oncological patients. Migration of cancer cells from a primary tumour is the crucial step in the complex process of metastasis, therefore blocking this process is currently the main treatment strategy. Metastasis inhibitors derived from natural products, such as, migrastatin, are very promising anticancer agents. Thus, the aim of our study was to investigate the effect of six migrastatin analogues (MGSTA-1 to 6) on migration and invasion of canine mammary adenocarcinoma cell lines isolated from primary tumours and their metastases to the lungs. Canine mammary tumours constitute a valuable tool for studying multiple aspect of human cancer. Results: Our results showed that two of six fully synthetic analogues of migrastatin: MGSTA-5 and MGSTA-6 were potent inhibitors of canine mammary cancer cells migration and invasion. These data were obtained using the wound healing test, as well as trans-well migration and invasion assays. Furthermore, the treatment of cancer cells with the most effective compound (MGSTA-6) disturbed binding between filamentous F-actin and fascin1. Confocal microscopy analyses revealed that treatment with MGSTA-6 increased the presence of unbound fascin1 and reduced co-localization of F-actin and fascin1 in canine cancer cells. Most likely, actin filaments were not cross-linked by fascin1 and did not generate the typical filopodial architecture of actin filaments in response to the activity of MGSTA-6. Thus, administration of MGSTA-6 results in decreased formation of filopodia protrusions and stress fibres in canine mammary cancer cells, causing inhibition of cancer migration and invasion. Conclusion: Two synthetic migrastatin analogues (MGSTA-5 and MGSTA-6) were shown to be promising compounds for inhibition of cancer metastasis. They may have beneficial therapeutic effects in cancer therapy in dogs, especially in combination with other anticancer drugs. However, further in vivo studies are required to verify this hypothesis.	[Majchrzak, Kinga; Gajewska, Malgorzata; Bulkowska, Malgorzata; Homa, Agata; Motyl, Tomasz; Krol, Magdalena] Warsaw Univ Life Sci, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland; [Majchrzak, Kinga] Warsaw Univ Life Sci, Fac Anim Sci, Dept Anim Environm Biol, Warsaw, Poland; [Lo Re, Daniele; Murphy, Paul V.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Pawlowski, Karol] Warsaw Univ Life Sci, Dept Large Anim Dis Clin, Fac Vet Med, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Ollscoil na Gaillimhe-University of Galway; Warsaw University of Life Sciences	Krol, M (corresponding author), Warsaw Univ Life Sci, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland.	magdalena_krol@sggw.pl	lo re, Daniele/F-2295-2016; Murphy, Paul V/F-7655-2010; Krol, Magdalena/A-5554-2019	lo re, Daniele/0000-0002-6068-5975; Pawlowski, Karol/0000-0003-4565-2873; Murphy, Paul/0000-0002-1529-6540; Krol, Magdalena/0000-0003-0421-5167; Motyl, Tomasz/0000-0002-3470-3324; Rybicka, Agata/0000-0002-7749-8850; Majchrzak-Kuligowska, Kinga/0000-0002-9504-4588; Gajewska, Malgorzata/0000-0001-7249-8627	Ministry of Sciences and Higher Education of Poland [N N308 574940]; Science Foundation Ireland [07/IN.1/B966]; European Union under REA [PIEF-GA-2011-299042]; COST Action [CM1106]	Ministry of Sciences and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union under REA; COST Action(European Cooperation in Science and Technology (COST))	This work was supported by grant number N N308 574940 from the Ministry of Sciences and Higher Education of Poland and Science Foundation Ireland (grant number 07/IN.1/B966). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement number PIEF-GA-2011-299042. This work was supported by COST Action CM1106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Anquetin G, 2008, CHEM-EUR J, V14, P1592, DOI 10.1002/chem.200701033; Anquetin G, 2008, EUR J ORG CHEM, V2008, P1953, DOI 10.1002/ejoc.200701192; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dias LC, 2010, EUR J ORG CHEM, V2010, P6748, DOI 10.1002/ejoc.201001097; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Gaul C, 2003, J AM CHEM SOC, V125, P6042, DOI 10.1021/ja0349103; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Krol M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-16; Lecomte N, 2011, P NATL ACAD SCI USA, V108, P15074, DOI 10.1073/pnas.1015247108; Majchrzak K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-170; Manuali E, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-86; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nakae K, 2000, J ANTIBIOT, V53, P1130, DOI 10.7164/antibiotics.53.1130; Nakae K, 2000, J ANTIBIOT, V53, P1228, DOI 10.7164/antibiotics.53.1228; Nakamura H, 2002, J ANTIBIOT, V55, P442, DOI 10.7164/antibiotics.55.442; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Oskarsson T, 2010, J AM CHEM SOC, V132, P3224, DOI 10.1021/ja9101503; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Queiroga FL, 2011, IN VIVO, V25, P455; Rao Y, 2009, TETRAHEDRON LETT, V50, P6684, DOI 10.1016/j.tetlet.2009.09.080; Rodriguez Luis G., 2004, V294, P23; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schirmer A, 2006, P NATL ACAD SCI USA, V103, P4234, DOI 10.1073/pnas.0600445103; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Zhou Y, 2010, TETRAHEDRON LETT, V51, P5262, DOI 10.1016/j.tetlet.2010.07.141	35	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76789	10.1371/journal.pone.0076789	http://dx.doi.org/10.1371/journal.pone.0076789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116159	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200069
J	Rothfels, CJ; Larsson, A; Li, FW; Sigel, EM; Huiet, L; Burge, DO; Ruhsam, M; Graham, SW; Stevenson, DW; Wong, GKS; Korall, P; Pryer, KM				Rothfels, Carl J.; Larsson, Anders; Li, Fay-Wei; Sigel, Erin M.; Huiet, Layne; Burge, Dylan O.; Ruhsam, Markus; Graham, Sean W.; Stevenson, Dennis W.; Wong, Gane Ka-Shu; Korall, Petra; Pryer, Kathleen M.			Transcriptome-Mining for Single-Copy Nuclear Markers in Ferns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC-RELATIONSHIPS; CHLOROPLAST DNA; MOLECULAR PHYLOGENY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; EVOLUTIONARY LINEAGES; MATERNAL INHERITANCE; RETICULATE EVOLUTION; NUCLEOTIDE-SEQUENCES; SOMATIC CYTOKINESIS	Background: Molecular phylogenetic investigations have revolutionized our understanding of the evolutionary history of ferns-the second-most species-rich major group of vascular plants, and the sister clade to seed plants. The general absence of genomic resources available for this important group of plants, however, has resulted in the strong dependence of these studies on plastid data; nuclear or mitochondrial data have been rarely used. In this study, we utilize transcriptome data to design primers for nuclear markers for use in studies of fern evolutionary biology, and demonstrate the utility of these markers across the largest order of ferns, the Polypodiales. Principal Findings: We present 20 novel single-copy nuclear regions, across 10 distinct protein-coding genes: ApPEFP_C, cryptochrome 2, cryptochrome 4, DET1, gapCpSh, IBR3, pgiC, SQD1, TPLATE, and transducin. These loci, individually and in combination, show strong resolving power across the Polypodiales phylogeny, and are readily amplified and sequenced from our genomic DNA test set (from 15 diploid Polypodiales species). For each region, we also present transcriptome alignments of the focal locus and related paralogs-curated broadly across ferns-that will allow researchers to develop their own primer sets for fern taxa outside of the Polypodiales. Analyses of sequence data generated from our genomic DNA test set reveal strong effects of partitioning schemes on support levels and, to a much lesser extent, on topology. A model partitioned by codon position is strongly favored, and analyses of the combined data yield a Polypodiales phylogeny that is well-supported and consistent with earlier studies of this group. Conclusions: The 20 single-copy regions presented here more than triple the single-copy nuclear regions available for use in ferns. They provide a much-needed opportunity to assess plastid-derived hypotheses of relationships within the ferns, and increase our capacity to explore aspects of fern evolution previously unavailable to scientific investigation.	[Rothfels, Carl J.; Li, Fay-Wei; Sigel, Erin M.; Huiet, Layne; Pryer, Kathleen M.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Rothfels, Carl J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Larsson, Anders; Korall, Petra] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Burge, Dylan O.; Graham, Sean W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ruhsam, Markus] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Stevenson, Dennis W.] New York Bot Garden, Bronx, NY 10458 USA; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] BGI Shenzhen, Shenzhen, Peoples R China	Duke University; University of British Columbia; Uppsala University; University of British Columbia; New York Botanical Garden; University of Alberta; Beijing Genomics Institute (BGI)	Rothfels, CJ (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	crothfels@yahoo.ca	Ruhsam, Markus/B-3608-2010; WONG, Gane Ka-Shu/G-5784-2013; Graham, Sean W/L-3944-2014; Pryer, Kathleen M./ABF-4908-2020; Ruhsam, Markus/N-6820-2019; Pryer, Kathleen/X-4635-2019	WONG, Gane Ka-Shu/0000-0001-6108-5560; Graham, Sean W/0000-0001-8209-5231; Pryer, Kathleen M./0000-0002-9776-6736; Ruhsam, Markus/0000-0002-8457-345X; Rothfels, Carl/0000-0002-6605-1770; Larsson, Anders/0000-0002-2096-8102; Li, Fay-Wei/0000-0002-0076-0152	National Science Foundation [DDIG DEB-1110767, DDIG DEB-1110775, DEB-1145614]; Natural Science and Engineering Research Council (Canada); Discovery grant; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2006-429, 2010-585]; Alberta Enterprise and Advanced Education; Genome Alberta; Alberta Innovates Technology Futures iCORE; Musea Ventures; BGI-Shenzhen; Division Of Environmental Biology [1110652] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery grant; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Alberta Enterprise and Advanced Education; Genome Alberta; Alberta Innovates Technology Futures iCORE; Musea Ventures; BGI-Shenzhen; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funds from the National Science Foundation (www.nsf.gov) DDIG DEB-1110767 to KMP and CJR (co-authors), DDIG DEB-1110775 to KMP and EMS (co-authors), and DEB-1145614 to KMP and LH; a Natural Science and Engineering Research Council (Canada) Postgraduate Scholarship - Doctoral of NSERC (Natural Sciences and Engineering Research Council) to CJR and Discovery grant to SWG; grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) to PK (2006-429 and 2010-585); GKSW acknowledges the support of Alberta Enterprise and Advanced Education, Genome Alberta, Alberta Innovates Technology Futures iCORE, Musea Ventures, and BGI-Shenzhen. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjie B, 2007, J PLANT RES, V120, P129, DOI 10.1007/s10265-006-0032-5; Adjie Bayu, 2008, Acta Phytotaxonomica et Geobotanica, V59, P79; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barker MS, 2010, BIOSCIENCE, V60, P177, DOI 10.1525/bio.2010.60.3.4; Beck JB, 2010, SYST BOT, V35, P223, DOI 10.1600/036364410791638388; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BRINKMANN H, 1987, J MOL EVOL, V26, P320, DOI 10.1007/BF02101150; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown JWS, 1996, PLANT MOL BIOL, V32, P531, DOI 10.1007/BF00019105; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang HM, 2009, AM FERN J, V99, P61, DOI 10.1640/0002-8444-99.2.61; CHANG Y, 2013, TAXON IN PRESS; Chao YS, 2012, INT J MOL SCI, V13, P4523, DOI 10.3390/ijms13044523; Charlesworth D, 1998, HEREDITY, V81, P453, DOI 10.1046/j.1365-2540.1998.00415.x; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Cranfill R, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P25; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Des Marais DL, 2003, INT J PLANT SCI, V164, P737, DOI 10.1086/376817; Dubuisson JY, 2003, INT J PLANT SCI, V164, P753, DOI 10.1086/377059; Dyer RJ, 2012, ANN BOT-LONDON, V110, P1515, DOI 10.1093/aob/mcs202; Ebihara A, 2005, AM J BOT, V92, P1535, DOI 10.3732/ajb.92.9.1535; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Ford VS, 2006, AM J BOT, V93, P480, DOI 10.3732/ajb.93.3.480; Gao L, 2013, GENOME BIOL EVOL, V5, P1403, DOI 10.1093/gbe/evt099; Gastony Gerald J., 1998, Aliso, V17, P131; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; Guillon JM, 2000, CURR GENET, V37, P53, DOI 10.1007/s002940050008; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Haufler CH, 1995, AM FERN J, V85, P361, DOI 10.2307/1547815; He LJ, 2012, MOL PHYLOGENET EVOL, V65, P757, DOI 10.1016/j.ympev.2012.07.021; Hennequin S, 2010, BOT J LINN SOC, V164, P113, DOI 10.1111/j.1095-8339.2010.01076.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Juslen A, 2011, TAXON, V60, P1284, DOI 10.1002/tax.605005; Kamiya K, 2005, AM J BOT, V92, P775, DOI 10.3732/ajb.92.5.775; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korall P, 2006, MOL PHYLOGENET EVOL, V39, P830, DOI 10.1016/j.ympev.2006.01.001; Kranz HD, 1996, PLANT SYST EVOL, V202, P1, DOI 10.1007/BF00985814; Kreier HP, 2006, AM J BOT, V93, P217, DOI 10.3732/ajb.93.2.217; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Labiak PH, 2010, TAXON, V59, P911, DOI 10.1002/tax.593019; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LARSSON A, 2013, IASSEBLASTE; LARSSON A, 2013, PHYLOGENY WOOD UNPUB; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee SJ, 2013, BIOCHEM SYST ECOL, V50, P371, DOI 10.1016/j.bse.2013.05.008; Lehtonen S, 2012, BOT J LINN SOC, V170, P489, DOI 10.1111/j.1095-8339.2012.01312.x; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li FW, 2012, SYST BOT, V37, P845, DOI 10.1600/036364412X656626; LI FW, 2013, BLUE DEVIL BLAST UTI; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liu YC, 2011, TAXON, V60, P824, DOI 10.1002/tax.603014; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maddison, 2019, MESQUITE MODULAR SYS; Maggini F, 1998, PLANT SYST EVOL, V213, P199, DOI 10.1007/BF00985200; MARTIN W, 1986, EUR J BIOCHEM, V159, P323, DOI 10.1111/j.1432-1033.1986.tb09871.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McKeown M, 2012, PHYTOKEYS, V14, P43, DOI 10.3897/phytokeys.14.3446; Metzgar JS, 2008, SYST BOT, V33, P31, DOI 10.1600/036364408783887528; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moummou H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-219; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; Nagalingum NS, 2007, SYST BOT, V32, P16, DOI 10.1600/036364407780360256; Nakazato T, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P175, DOI 10.1017/CBO9780511541827.008; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nitta JH, 2011, AM J BOT, V98, P1782, DOI 10.3732/ajb.1000484; Petersen J, 2003, J MOL EVOL, V57, P16, DOI 10.1007/s00239-002-2441-y; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2002, TRENDS PLANT SCI, V7, P550, DOI 10.1016/S1360-1385(02)02375-0; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rai HS, 2010, AM J BOT, V97, P1444, DOI 10.3732/ajb.0900305; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Reid JD, 2006, INT J PLANT SCI, V167, P529, DOI 10.1086/501071; Roper JM, 2007, AM FERN J, V97, P95, DOI 10.1640/0002-8444(2007)97[95:TCPGSO]2.0.CO;2; Rothfels CJ, 2008, TAXON, V57, P712, DOI 10.1002/tax.573005; Rothfels CJ, 2013, SYST BOT, V38, P295, DOI 10.1600/036364413X666787; Rothfels CJ, 2012, TAXON, V61, P515, DOI 10.1002/tax.613003; Rothfels CJ, 2012, SYST BIOL, V61, P490, DOI 10.1093/sysbio/sys001; ROTHFELS CJ, 2013, SYST BIOL IN PRESS; Salmi ML, 2005, PLANT PHYSIOL, V138, P1734, DOI 10.1104/pp.105.062851; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; Sato N, 2003, DNA RES, V10, P229, DOI 10.1093/dnares/10.6.229; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schneider H, 2004, SYST BOT, V29, P260, DOI 10.1600/036364404774195476; Schneider H, 2013, J SYST EVOL, V51, P142, DOI 10.1111/j.1759-6831.2012.00226.x; Schuettpelz E, 2008, SYST BOT, V33, P621, DOI 10.1600/036364408786500127; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Schuettpelz E, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P395, DOI 10.1017/CBO9780511541827.016; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Sessa EB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-104; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V49, P240, DOI 10.1016/j.ympev.2008.06.015; Sigel EM, 2011, SYST BOT, V36, P554, DOI 10.1600/036364411X583547; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith AR, 2002, AM FERN J, V92, P131, DOI 10.1640/0002-8444(2002)092[0131:IROTTF]2.0.CO;2; STEIN DB, 1990, ANN MO BOT GARD, V77, P334, DOI 10.2307/2399548; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Sundue MA, 2010, BRITTONIA, V62, P357, DOI 10.1007/s12228-009-9108-6; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thiers B., INDEX HERBARIORUM GL; van Damme D, 2006, PLANT CELL, V18, P3502, DOI 10.1105/tpc.106.040923; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; Vangerow S, 1999, PLANT BIOLOGY, V1, P235, DOI 10.1055/s-2007-978512; Vogel JC, 1998, BOT ACTA, V111, P247, DOI 10.1111/j.1438-8677.1998.tb00704.x; Wang L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-158; Wang ML, 2002, ACTA PHYTOTAXON SIN, V41, P416; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wikstrom N, 2005, MOL PHYLOGENET EVOL, V36, P484, DOI 10.1016/j.ympev.2005.04.008; Windham MD, 2009, AM FERN J, V99, P128; WITTER MS, 1990, ANN MO BOT GARD, V77, P110, DOI 10.2307/2399630; Wolf P.G., 2012, GENOMICS CHLOROPLAST, P89, DOI DOI 10.1007/978-94-007-2920-9_; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 1997, AM J BOT, V84, P1429, DOI 10.2307/2446141; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; Wolf PG, 1995, AM FERN J, V85, P306, DOI 10.2307/1547812; WOLF PG, 1996, PTERIDOLOGY PERSPECT, P203; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Yamauchi D, 2005, J PLANT RES, V118, P223, DOI 10.1007/s10265-005-0209-3; Zhang LB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-180; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	145	56	59	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76957	10.1371/journal.pone.0076957	http://dx.doi.org/10.1371/journal.pone.0076957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116189	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200089
J	Harada, K; Mikuni, S; Beppu, H; Niimi, H; Abe, S; Hano, N; Yamagata, K; Kinjo, M; Kitajima, I				Harada, Kenu; Mikuni, Shintaro; Beppu, Hideyuki; Niimi, Hideki; Abe, Shigeki; Hano, Nobuko; Yamagata, Koichi; Kinjo, Masataka; Kitajima, Isao			A Rapid and High-Throughput Quantitation Assay of the Nuclear Factor kappa B Activity Using Fluorescence Correlation Spectroscopy in the Setting of Clinical Laboratories	PLOS ONE			English	Article							DNA-BINDING PROTEINS; SINGLE-MOLECULE DETECTION; SEPSIS; PROBE	Background: Transcription factor nuclear factor-kappa B (NF-kappa B) plays a key role in the regulation of immune responses to inflammation. However, convenient assay systems to quantitate the NF-kappa B activity level in a timely manner are not available in the setting of clinical laboratories. Therefore, we developed a novel and high-throughput quantitative assay based on fluorescence correlation spectroscopy (FCS) to detect the NF-kappa B activity level in cellular nuclear extracts and evaluated the performance of this method. The basic principle of this assay is to calculate the binding fraction of NF-kappa B to fluorescent-labeled DNA probes, which contain NF-kappa B binding sites. Methods: Non-fluorescent competitive probes are employed to normalize the influence of the viscosity of the nuclear extracts between samples and to eliminate the influence of nonspecific binding of the fluorescent probes. To confirm accurate quantitation, human recombinant NF-kappa B p50 was mixed into U937 cell nuclear extracts, and the binding fraction of the fluorescent probes to NF-kappa B in the mixture was calculated for quantitation. To evaluate whether this method can be applied to measure the NF-kappa B activity in human lymphocytes, the NF-kappa B activity levels of systemic inflammatory response syndrome patients during perioperative periods were measured. Results: The percentage recovery was 88.9%. The coefficients of variation of the intra-assay were approximately 10%. NF-kappa B activity levels during the perioperative period can were successfully measured. The assay time for the FCS measurement was within 20 minutes. Conclusions: This assay system can be used to quantitate NF-kappa B activity levels in a timely manner in the setting of hospital laboratories.	[Harada, Kenu; Beppu, Hideyuki; Niimi, Hideki; Kitajima, Isao] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Lab & Mol Pathol, Toyama 930, Japan; [Mikuni, Shintaro] Hokkaido Univ, Graduated Sch Med, Res Ctr Cooperat Projects, Dept Adv Opt Imaging Res, Sapporo, Hokkaido, Japan; [Mikuni, Shintaro; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan; [Abe, Shigeki; Hano, Nobuko; Yamagata, Koichi] Sysmex Corp BMA Lab, Kobe, Hyogo, Japan	University of Toyama; Hokkaido University; Hokkaido University; Sysmex Corporation	Kitajima, I (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Lab & Mol Pathol, Toyama 930, Japan.	kitajima@med.u-toyama.ac.jp	Yamagata, Koichi/AAV-7222-2021; Kinjo, Masataka/F-5267-2011	Yamagata, Koichi/0000-0003-1277-3468; Kinjo, Masataka/0000-0001-8889-8369	Ministry of Education, Culture, Sports, Science and Technology of Japan [23659294, 25670268]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for challenging Exploratory Research (#23659294 and #25670268) to I. Kitajima from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt D, 2009, ORG BIOMOL CHEM, V7, P3934, DOI 10.1039/b906447h; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Benotmane AM, 1997, ANAL BIOCHEM, V250, P181, DOI 10.1006/abio.1997.2231; Bhattacharya N, 2010, INT J CANCER, V127, P404, DOI 10.1002/ijc.25054; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen ZZ, 2006, BIOCHEM BIOPH RES CO, V345, P1254, DOI 10.1016/j.bbrc.2006.05.012; Eydeler K, 2009, BIOPHYS J, V96, P3703, DOI 10.1016/j.bpj.2009.01.041; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GUBLER ML, 1995, BIOTECHNIQUES, V18, P1008; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He HJ, 2007, BIOTECHNIQUES, V43, P93, DOI 10.2144/000112475; Jin S, 2005, J BIOCHEM BIOPH METH, V65, P20, DOI 10.1016/j.jbbm.2005.08.006; Kinjo M, 1998, ANAL BIOCHEM, V260, P166, DOI 10.1006/abio.1998.2652; KINJO M, 1995, NUCLEIC ACIDS RES, V23, P1795, DOI 10.1093/nar/23.10.1795; Kobayashi T, 2004, ANAL BIOCHEM, V332, P58, DOI 10.1016/j.ab.2004.05.053; Kobayashi T, 2009, BIOORGAN MED CHEM, V17, P5293, DOI 10.1016/j.bmc.2009.05.030; Korn K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng089; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mikuni S, 2007, FEBS LETT, V581, P389, DOI 10.1016/j.febslet.2006.12.038; Mokart D, 2005, BRIT J ANAESTH, V94, P767, DOI 10.1093/bja/aei143; Nomura Y, 2007, CURR PHARM BIOTECHNO, V8, P286, DOI 10.2174/138920107782109958; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; RIGLER R, 1995, J BIOTECHNOL, V41, P177, DOI 10.1016/0168-1656(95)00054-T; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Wang JK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni021; Wolcke J, 2003, J BIOL CHEM, V278, P32587, DOI 10.1074/jbc.M303615200	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75579	10.1371/journal.pone.0075579	http://dx.doi.org/10.1371/journal.pone.0075579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124497	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100054
J	Lassale, C; Galan, P; Julia, C; Fezeu, L; Hercberg, S; Kesse-Guyot, E				Lassale, Camille; Galan, Pilar; Julia, Chantal; Fezeu, Leopold; Hercberg, Serge; Kesse-Guyot, Emmanuelle			Association between Adherence to Nutritional Guidelines, the Metabolic Syndrome and Adiposity Markers in a French Adult General Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CARDIOVASCULAR RISK-FACTORS; MEDITERRANEAN DIET; NATIONAL NUTRITION; WEIGHT CHANGE; BODY-FAT; METAANALYSIS; QUALITY; OBESITY; HEALTH	Introduction: Few studies have focused on the association between diet quality scores and the Metabolic Syndrome (MetS), a multi-component condition predictive of cardiovascular diseases (CVD) and death. The present study aims at investigating, in a cross-sectional design, the association between adherence to the French dietary guidelines through an a priori score - the French Nutrition and Health Program-Guideline Score (PNNS-GS) - and cardiovascular risk factors (CVRF) including the MetS and adiposity markers. Methods: 7902 French adults participating in the NutriNet-Sante study (an on-going web-based cohort study) attended a clinical and biological examination between January 2011 and November 2012: a fasting blood sample was drawn, blood pressure and body composition (bio-impedance) were measured. Multivariate linear and logistic regression models were used to assess the association between PNNS-GS and CVRF or the MetS. Results: An increase of PNNS-GS was significantly negatively associated with waist circumference (WC), systolic and diastolic blood pressure (SBP and DBP) and serum triglycerides concentrations. From bottom to top quartile of PNNS-GS, SBP decreased from 129.9 to 128.8 mm Hg, DBP from 76.7 to 75.9 mm Hg, serum triglycerides concentrations from 110.8 to 104.6 mg/dL and WC from 94.8 to 90.1 cm for men and 81.3 to 78.9 cm for women. All adiposity markers (waist and hip circumference, % body fat, % trunk fat, % leg fat) were markedly reduced across quartiles of PNNS-GS and linearly. Individuals with a better PNNS-GS (quartile 4 vs quartile 1) were less likely to have the MetS (OR=0.71, 95% CI: 0.56-0.89). Conclusion: The negative association between a higher adherence to the French dietary guidelines and a number of CVRF, the MetS prevalence and regional adiposity supports the importance of promoting the PNNS dietary guidelines in the population for the prevention of cardiometabolic abnormalities and hence, cardiovascular diseases.	[Lassale, Camille; Galan, Pilar; Julia, Chantal; Fezeu, Leopold; Hercberg, Serge; Kesse-Guyot, Emmanuelle] Univ Paris 13, Sorbonne Paris Cite, Nutr Epidemiol Res Unit, CNAM,INSERM INRA U1125 U557, Bobigny, France; [Julia, Chantal; Hercberg, Serge] Univ Paris 13, Hop Avicenne, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Lassale, C (corresponding author), Univ Paris 13, Sorbonne Paris Cite, Nutr Epidemiol Res Unit, CNAM,INSERM INRA U1125 U557, Bobigny, France.	c.lassale@uren.smbh.univ-paris13.fr	Pilar, Galan/F-2908-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/F-2692-2017; Chantal, Julia/F-2805-2017; Fezeu, Leopold/F-2804-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Serge, Hercberg/F-3038-2017; Lassale, Camille/ABE-7813-2020	Pilar, Galan/0000-0003-1706-3107; HERCBERG, Serge/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Chantal, Julia/0000-0003-2006-5269; Fezeu, Leopold/0000-0002-7589-3179; Serge, Hercberg/0000-0002-3168-1350; Lassale, Camille/0000-0002-9340-2708	Region Ile de France (CORDDIM); Fondation Coeur et Arteres; Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	Region Ile de France (CORDDIM)(Region Ile-de-France); Fondation Coeur et Arteres; Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by grants from the Region Ile de France (CORDDIM) and Fondation Coeur et Arteres. The NutriNet-Sante study is being supported and granted by the following institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouRjaili G, 2010, METABOLISM, V59, P1210, DOI 10.1016/j.metabol.2009.11.014; Ahluwalia N, 2013, DIABETES METAB, V39, P99, DOI 10.1016/j.diabet.2012.08.007; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], APPORTS NUTR CONSEIL; Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Boghossian NS, 2013, EUR J CLIN NUTR, V67, P289, DOI 10.1038/ejcn.2013.4; Bozkirli E, 2007, ASIA PAC J CLIN NUTR, V16, P443; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Drewnowski A, 2009, J AM COLL NUTR, V28, P22, DOI 10.1080/07315724.2009.10719757; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193, DOI 10.1093/ajcn/86.4.1193; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frisoli TM, 2011, EUR HEART J, V32, P3081, DOI 10.1093/eurheartj/ehr379; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Hosseini-Esfahani F, 2010, METABOLISM, V59, P1833, DOI 10.1016/j.metabol.2010.06.013; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Julia C, 2010, PREV MED, V51, P488, DOI 10.1016/j.ypmed.2010.09.009; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kesse-Guyot E, 2011, J NUTR, V141, P1134, DOI 10.3945/jn.110.136317; Kesse-Guyot E, 2009, AM J EPIDEMIOL, V170, P757, DOI 10.1093/aje/kwp174; Kimokoti RW, 2012, J NUTR, V142, P1720, DOI 10.3945/jn.112.162479; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Lassale C, 2012, INT J OBESITY, V36, P1455, DOI 10.1038/ijo.2011.264; Le Moullec N, 1996, VALIDATION PHOTO MAN; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Nettleton JA, 2013, AM J EPIDEMIOL, V177, P103, DOI 10.1093/aje/kws297; Nicklas TA, 2012, J NUTR, V142, P2112, DOI 10.3945/jn.112.164889; NutriNet-Sante coordination, 2013, TABL COMP AL; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Siri-Tarino PW, 2011, CURR ATHEROSCLER REP, V13, P453, DOI 10.1007/s11883-011-0207-y; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO, 2009, GLOB HLTH RISKS TECH; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	53	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76349	10.1371/journal.pone.0076349	http://dx.doi.org/10.1371/journal.pone.0076349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124548	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100105
J	Iglesias, JM; Beloqui, I; Garcia-Garcia, F; Leis, O; Vazquez-Martin, A; Eguiara, A; Cufi, S; Pavon, A; Menendez, JA; Dopazo, J; Martin, AG				Manuel Iglesias, Juan; Beloqui, Izaskun; Garcia-Garcia, Francisco; Leis, Olatz; Vazquez-Martin, Alejandro; Eguiara, Arrate; Cufi, Silvia; Pavon, Andres; Menendez, Javier A.; Dopazo, Joaquin; Martin, Angel G.			Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; FALSE DISCOVERY RATE; SOLID TUMORS; IDENTIFICATION; ASSAY	Tumors are heterogeneous at the cellular level where the ability to maintain tumor growth resides in discrete cell populations. Floating sphere-forming assays are broadly used to test stem cell activity in tissues, tumors and cell lines. Spheroids are originated from a small population of cells with stem cell features able to grow in suspension culture and behaving as tumorigenic in mice. We tested the ability of eleven common breast cancer cell lines representing the major breast cancer subtypes to grow as mammospheres, measuring the ability to maintain cell viability upon serial non-adherent passage. Only MCF7, T47D, BT474, MDA-MB-436 and JIMT1 were successfully propagated as long-term mammosphere cultures, measured as the increase in the number of viable cells upon serial non-adherent passages. Other cell lines tested (SKBR3, MDA-MB-231, MDA-MB-468 and MDA-MB-435) formed cell clumps that can be disaggregated mechanically, but cell viability drops dramatically on their second passage. HCC1937 and HCC1569 cells formed typical mammospheres, although they could not be propagated as long-term mammosphere cultures. All the sphere forming lines but MDA-MB-436 express E-cadherin on their surface. Knock down of E-cadherin expression in MCF-7 cells abrogated its ability to grow as mammospheres, while re-expression of E-cadherin in SKBR3 cells allow them to form mammospheres. Therefore, the mammosphere assay is suitable to reveal stem like features in breast cancer cell lines that express E-cadherin.	[Manuel Iglesias, Juan; Beloqui, Izaskun; Leis, Olatz; Eguiara, Arrate; Pavon, Andres; Martin, Angel G.] Fdn Inbiomed, Regulat Cell Growth Lab, San Sebastian, Gipuzkoa, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, Computat Genom Inst, Valencia, Spain; [Garcia-Garcia, Francisco; Dopazo, Joaquin] CIPF, INB, Valencia, Spain; [Vazquez-Martin, Alejandro; Cufi, Silvia; Menendez, Javier A.] ICO, Translat Res Lab, Girona, Spain; [Vazquez-Martin, Alejandro; Cufi, Silvia; Menendez, Javier A.] Girona Biomed Res Inst IDIBGi, Girona, Spain; [Dopazo, Joaquin] CIBERER, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martin, AG (corresponding author), Fdn Inbiomed, Regulat Cell Growth Lab, San Sebastian, Gipuzkoa, Spain.	kelfox@me.com	García-García, Francisco/N-2263-2019; MENENDEZ, JAVIER A/C-6148-2016; García-García, Francisco/B-1929-2014; Dopazo, Joaquin/A-9270-2014	García-García, Francisco/0000-0001-8354-5636; MENENDEZ, JAVIER A/0000-0001-8733-4561; García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Garcia Martin, Angel/0000-0002-3831-2769; Cufi, Silvia/0000-0002-2476-748X	Obra Social Kutxa; Fundacion Medica Mutua Madrilena; Gobierno Vasco (Saiotek program); Gobierno Vasco (Consejeria de Educacion) [PI2010-25]; Instituto de Salud Carlos III Accion Estrategica en Salud [PI2010-01035]; MICINN; GVA-FEDER [PROMETEO/2010/001]; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain [CD08/00283]; Ministerio de Ciencia e Innovacion (MICINN, Spain) [SAF2009-11579];  [BIO2011-27069]	Obra Social Kutxa; Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); Gobierno Vasco (Saiotek program); Gobierno Vasco (Consejeria de Educacion); Instituto de Salud Carlos III Accion Estrategica en Salud; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); GVA-FEDER; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	The Regulation of Cell Growth Laboratory is supported by grants from Obra Social Kutxa, Fundacion Medica Mutua Madrilena, Gobierno Vasco (Saiotek program and Consejeria de Educacion PI2010-25) and Instituto de Salud Carlos III Accion Estrategica en Salud (PI2010-01035). This work is partly supported by grant BIO2011-27069, MICINN and PROMETEO/2010/001 from the GVA-FEDER to J. Dopazo. Alejandro Vazquez-Martin received the Sara Borrell post-doctoral contract (CD08/00283, Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria [FIS], Spain). Silvia Cufi received a Research Fellowship (Formacion de Personal Investigador [FPI]; SAF2009-11579) from the Ministerio de Ciencia e Innovacion (MICINN, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borgna S, 2012, CELL CYCLE, V11, P4242, DOI 10.4161/cc.22543; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Diaz-Guerra E, 2012, FASEB J, V26, P3844, DOI 10.1096/fj.11-200782; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hiraguri S, 1998, CANCER RES, V58, P1972; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Piggott L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2945; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricardo S, 2011, J CLIN PATHOL, V51, P1659; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Serrano M, 2000, CARCINOGENESIS, V21, P865, DOI 10.1093/carcin/21.5.865; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499	44	130	131	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77281	10.1371/journal.pone.0077281	http://dx.doi.org/10.1371/journal.pone.0077281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124614	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100171
J	Morozumi, Y; Ino, R; Ikawa, S; Mimida, N; Shimizu, T; Toki, S; Ichikawa, H; Shibata, T; Kurumizaka, H				Morozumi, Yuichi; Ino, Ryohei; Ikawa, Shukuko; Mimida, Naozumi; Shimizu, Takeshi; Toki, Seiichi; Ichikawa, Hiroaki; Shibata, Takehiko; Kurumizaka, Hitoshi			Homologous Pairing Activities of Two Rice RAD51 Proteins, RAD51A1 and RAD51A2	PLOS ONE			English	Article							DNA STRAND EXCHANGE; RECOMBINATION PROTEIN; SACCHAROMYCES-CEREVISIAE; RECA PROTEIN; DMC1; GENE; SEQUENCE; DAMAGE; MOUSE; FILAMENT	In higher eukaryotes, RAD51 functions as an essential protein in homologous recombination and recombinational repair of DNA double strand breaks. During these processes, RAD51 catalyzes homologous pairing between single-stranded DNA and double-stranded DNA. Japonica cultivars of rice (Oryza sativa) encode two RAD51 proteins, RAD51A1 and RAD51A2, whereas only one RAD51 exists in yeast and mammals. However, the functional differences between RAD51A1 and RAD51A2 have not been elucidated, because their biochemical properties have not been characterized. In the present study, we purified RAD51A1 and RAD51A2, and found that RAD51A2 robustly promotes homologous pairing in vitro. RAD51A1 also possesses homologous-pairing activity, but it is only about 10% of the RAD51A2 activity. Both RAD51A1 and RAD51A2 bind to ssDNA and dsDNA, and their DNA binding strictly requires ATP, which modulates the polymer formation activities of RAD51A1 and RAD51A2. These findings suggest that although both RAD51A1 and RAD51A2 have the potential to catalyze homologous pairing, RAD51A2 may be the major recombinase in rice.	[Morozumi, Yuichi; Ino, Ryohei; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo, Japan; [Ikawa, Shukuko; Shibata, Takehiko] RIKEN, Wako, Saitama, Japan; [Mimida, Naozumi; Shimizu, Takeshi; Toki, Seiichi; Ichikawa, Hiroaki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Waseda University; RIKEN; National Institute of Agrobiological Sciences - Japan	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo, Japan.	kurumizaka@waseda.jp	Toki, Seiichi/AAR-1889-2021; Ichikawa, Hiroaki/AAB-3127-2019; Shimizu, Takeshi/ABE-6503-2020	Kurumizaka, Hitoshi/0000-0001-7412-3722; Ichikawa, Hiroaki/0000-0002-1898-8235	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo; Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [22247002] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo; Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and from the Bio-Oriented Technology Research Advancement Institution (BRAIN) in Tokyo to TS and HK, and to HI and ST, respectively. This work was also supported in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Devisetty Upendra Kumar, 2010, BMC Res Notes, V3, P245, DOI 10.1186/1756-0500-3-245; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Endo M, 2012, PLANT J, V69, P967, DOI 10.1111/j.1365-313X.2011.04847.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Franklin AE, 2003, CHROMOSOMA, V112, P17, DOI 10.1007/s00412-003-0242-8; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Habu T, 1996, NUCLEIC ACIDS RES, V24, P470, DOI 10.1093/nar/24.3.470; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Ishida T, 2008, GENES CELLS, V13, P91, DOI 10.1111/j.1365-2443.2007.01143.x; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Maeshima K, 1996, GENES CELLS, V1, P1057, DOI 10.1046/j.1365-2443.1996.d01-224.x; Markmann-Mulisch U, 2002, P NATL ACAD SCI USA, V99, P2959, DOI 10.1073/pnas.032668199; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Matsuo Y, 2006, FEBS J, V273, P3148, DOI 10.1111/j.1742-4658.2006.05323.x; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pawlowski WP, 2003, PLANT CELL, V15, P1807, DOI 10.1105/tpc.012898; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Rajanikant C, 2008, PLANT MOL BIOL, V68, P479, DOI 10.1007/s11103-008-9385-6; Sakane I, 2008, NUCLEIC ACIDS RES, V36, P4266, DOI 10.1093/nar/gkn405; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITAKER SJ, 1992, EUR J CANCER, V28A, P273, DOI 10.1016/0959-8049(92)90432-2; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Yang ZY, 2010, MUTAT RES-FUND MOL M, V691, P55, DOI 10.1016/j.mrfmmm.2010.07.005	50	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75451	10.1371/journal.pone.0075451	http://dx.doi.org/10.1371/journal.pone.0075451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124491	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100048
J	Mukhopadhyay, C; Zhao, XS; Maroni, D; Band, V; Naramura, M				Mukhopadhyay, Chandrani; Zhao, Xiangshan; Maroni, Dulce; Band, Vimla; Naramura, Mayumi			Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN-BREAST-CANCER; BASAL-LIKE SUBTYPE; ADULT HUMAN BREAST; GLAND DEVELOPMENT; GENE-EXPRESSION; FACTOR RECEPTOR; FACTOR-ALPHA; STEM-CELLS; SUSTAINED ACTIVATION	Based on gene expression patterns, breast cancers can be divided into subtypes that closely resemble various developmental stages of normal mammary epithelial cells (MECs). Thus, understanding molecular mechanisms of MEC development is expected to provide critical insights into initiation and progression of breast cancer. Epidermal growth factor receptor (EGFR) and its ligands play essential roles in normal and pathological mammary gland. Signals through EGFR is required for normal mammary gland development. Ligands for EGFR are over-expressed in a significant proportion of breast cancers, and elevated expression of EGFR is associated with poorer clinical outcome. In the present study, we examined the effect of signals through EGFR on MEC differentiation using the human telomerase reverse transcriptase (hTERT)-immortalized human stem/progenitor MECs which express cytokeratin 5 but lack cytokeratin 19 (K5(+)K19(-) hMECs). As reported previously, these cells can be induced to differentiate into luminal and myoepithelial cells under appropriate culture conditions. K5(+)K19(-) hMECs acquired distinct cell fates in response to EGFR ligands epidermal growth factor (EGF), amphiregulin (AREG) and transforming growth factor alpha (TGF alpha) in differentiation-promoting MEGM medium. Specifically, presence of EGF during in vitro differentiation supported development into both luminal and myoepithelial lineages, whereas cells differentiated only towards luminal lineage when EGF was replaced with AREG. In contrast, substitution with TGF alpha led to differentiation only into myoepithelial lineage. Chemical inhibition of the MEK-Erk pathway, but not the phosphatidylinositol 3-kinase (PI3K)-AKT pathway, interfered with K5(+)K19(-) hMEC differentiation. The present data validate the utility of the K5(+)K19(-) hMEC cells for modeling key features of human MEC differentiation. This system should be useful in studying molecular/biochemical mechanisms of human MEC differentiation.	[Mukhopadhyay, Chandrani; Maroni, Dulce; Band, Vimla; Naramura, Mayumi] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Zhao, Xiangshan; Band, Vimla; Naramura, Mayumi] Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naramura, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	mnaramura@unmc.edu		Naramura, Mayumi/0000-0003-3658-0767	Department of Defense [W81 XWH-10-1-0740, W81XWH-07-1-0351, W81XWH-11-1-0171]; Nebraska Stem Cell Grant [2011-06]; NIH [CA96844, CA144027]; Department of Defense; University of Nebraska; NATIONAL CANCER INSTITUTE [R01CA096844, R01CA144027] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Nebraska Stem Cell Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Nebraska; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Department of Defense W81 XWH-10-1-0740 and Nebraska Stem Cell Grant 2011-06 to MN and the NIH grants CA96844 and CA144027 and Department of Defense grants W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB. UNMC Core Facilities are in part supported by the NCI Core Support Grant to UNMC-Eppley Cancer Center. C. M. is supported by the Skala Scholarship from University of Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DERYNCK R, 1987, CANCER RES, V47, P707; DOTZLAW H, 1990, CANCER RES, V50, P4204; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LEJEUNE S, 1993, CANCER RES, V53, P3597; Li G, 2002, DEVELOPMENT, V129, P4159; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; QI CF, 1994, BRIT J CANCER, V69, P903, DOI 10.1038/bjc.1994.174; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sternlicht MD, 2008, J MAMMARY GLAND BIOL, V13, P181, DOI 10.1007/s10911-008-9084-6; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Venere M, 2013, CANCER CELL, V23, P135, DOI 10.1016/j.ccr.2013.01.020; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	46	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75907	10.1371/journal.pone.0075907	http://dx.doi.org/10.1371/journal.pone.0075907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124521	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100078
J	Schroder, A				Schroeder, Arne			Density- and Size-Dependent Winter Mortality and Growth of Late Chaoborus flavicans Larvae	PLOS ONE			English	Article							FISH PREDATION; BODY-SIZE; INVERTEBRATE PREDATORS; ZOOPLANKTON COMMUNITY; CLIMATE-CHANGE; DYNAMICS; LAKE; ABUNDANCE; SELECTION; DIPTERA	Winter processes such as overwinter survival and growth of individuals can have wide-ranging consequences for population dynamics and communities within and across seasons. In freshwater organisms winter processes have been mainly studied in fish despite that invertebrates also have substantial impacts on lake and pond food webs. One of the major invertebrate consumers in lake and ponds is the planktonic larvae of the dipteran insect Chaoborus spec. However, while much is known about Chaoborus feeding ecology, behaviour and structuring role in food webs, its winter ecology and how it affects its populations are poorly understood. Here size-and density-dependent winter mortality and body growth of late Chaoborus flavicans larvae were quantified over naturally occurring size and density ranges in autumn and under natural winter conditions using two field enclosure experiments. Winter mortality increased with autumn density but decreased with autumn body size while winter growth rates decreased with autumn density and body sizes. There was also a density-and size-independent background mortality component. The proportion of pupae found in spring decreased strongly and exponentially with autumn density. These results may explain the commonly observed univoltine life cycle and multi-annual density fluctuations in northern Chaoborus populations. They further demonstrate the relevance of winter processes and conditions for freshwater invertebrates and ecosystems.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Schroder, A (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	a.schroder@sheffield.ac.uk			European Science Foundation [3873]	European Science Foundation(European Science Foundation (ESF)European Commission)	Part of the research was supported by a Short Visit Grant No 3873 from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARNOTT SE, 1993, ECOLOGY, V74, P2361, DOI 10.2307/1939588; Balayla D, 2010, HYDROBIOLOGIA, V646, P159, DOI 10.1007/s10750-010-0164-4; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Davison AC, 1997, BOOTSTRAP METHODS TH; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; FEDORENKO AY, 1975, LIMNOL OCEANOGR, V20, P238; Fischer JM, 1997, CAN J FISH AQUAT SCI, V54, P637, DOI 10.1139/cjfas-54-3-637; Foster SE, 2009, LIMNOL OCEANOGR, V54, P757, DOI 10.4319/lo.2009.54.3.0757; Garcia EA, 2008, ECOLOGY, V89, P1703, DOI 10.1890/07-0737.1; Gliwicz ZM, 2000, ARCH HYDROBIOL, V149, P193; HANAZATO T, 1989, OECOLOGIA, V81, P450, DOI 10.1007/BF00378951; HANAZATO T, 1989, ARCH HYDROBIOL, V114, P497; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Huss M, 2008, CAN J FISH AQUAT SCI, V65, P2149, DOI 10.1139/F08-115; Jackson LJ, 2007, FRESHWATER BIOL, V52, P1782, DOI 10.1111/j.1365-2427.2007.01809.x; Jager IS, 2011, INT REV HYDROBIOL, V96, P191, DOI 10.1002/iroh.201011253; Jager IS, 2003, J PLANKTON RES, V25, P255, DOI 10.1093/plankt/25.3.255; Lagergren R, 2008, LIMNOL OCEANOGR, V53, P1083, DOI 10.4319/lo.2008.53.3.1083; Liljendahl-Nurminen A, 2003, ARCH HYDROBIOL, V158, P75, DOI 10.1127/0003-9136/2003/0158-0075; MOORE MV, 1988, FRESHWATER BIOL, V19, P249, DOI 10.1111/j.1365-2427.1988.tb00346.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; NEILL W E, 1988, P31; Neill W.E., 1988, P236; Neill W.E., 1985, Advances in Limnology, V21, P483; NEILL WE, 1981, OECOLOGIA, V48, P164, DOI 10.1007/BF00347959; Ouimet C, 2001, FRESHWATER BIOL, V46, P1169, DOI 10.1046/j.1365-2427.2001.00738.x; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Persaud AD, 2010, J PLANKTON RES, V32, P57, DOI 10.1093/plankt/fbp099; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; Post JT, 1998, CANADIAN J FISHERIES, V55, P2588; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramcharan C. W., 2001, Ergebnisse der Limnologie, P81; Saether OA, 1997, TAXONOMIC HDB, V2, P149; SARDELLA LC, 1983, HYDROBIOLOGIA, V107, P155, DOI 10.1007/BF00017430; Schroder A, 2012, OIKOS, V121, P417, DOI 10.1111/j.1600-0706.2011.19764.x; Shuter BJ, 2012, AQUAT SCI, V74, P637, DOI 10.1007/s00027-012-0274-3; Skov C, 2011, P ROY SOC B-BIOL SCI, V278, P1414, DOI 10.1098/rspb.2010.2035; Soranno Patricia A., 1993, P103, DOI 10.1017/CBO9780511525513.008; Sutor M, 2001, HYDROBIOLOGIA, V464, P121, DOI 10.1023/A:1013939201391; van de Wolfshaar KE, 2008, ECOLOGY, V89, P259, DOI 10.1890/06-2058.1; VONENDE CN, 1979, ECOLOGY, V60, P119, DOI 10.2307/1936474; Wahlstrom E, 1999, CAN J FISH AQUAT SCI, V56, P1865, DOI 10.1139/cjfas-56-10-1865; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wissel B, 2003, FRESHWATER BIOL, V48, P1421, DOI 10.1046/j.1365-2427.2003.01100.x; WRIGHT RT, 1964, LIMNOL OCEANOGR, V9, P163, DOI 10.4319/lo.1964.9.2.0163; Xie P, 1998, HYDROBIOLOGIA, V368, P83, DOI 10.1023/A:1003217325236; ZARET TM, 1975, ECOLOGY, V56, P232, DOI 10.2307/1935317	50	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75839	10.1371/journal.pone.0075839	http://dx.doi.org/10.1371/journal.pone.0075839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124517	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100074
J	Tsugita, M; Yamada, N; Noguchi, S; Yamada, K; Moritake, H; Shimizu, K; Akao, Y; Ohno, T				Tsugita, Masanori; Yamada, Nami; Noguchi, Shunsuke; Yamada, Kazunari; Moritake, Hiroshi; Shimizu, Katsuji; Akao, Yukihiro; Ohno, Takatoshi			Ewing Sarcoma Cells Secrete EWS/Fli-1 Fusion mRNA via Microvesicles	PLOS ONE			English	Article							MALIGNANT-MELANOMA; PROSTATE-CANCER; DOWN-REGULATION; SOFT PARTS; PROTEIN; GROWTH; EWS-FLI1; TUMORS; INHIBITION; EXPRESSION	Tumours defined as Ewing sarcoma (ES) constitute a group of highly malignant neoplasms that most often affect children and young adults in the first 2 decades of life. The EWS/Fli-1 fusion gene, a product of the translocation t(11;22) (q24;12), is detected in 95% of ES patients. Recently, it was validated that cells emit a heterogeneous mixture of vesicular, organelle-like structures (microvesicles, MVs) into their surroundings including blood and body fluids, and that these MVs contain a selected set of tumor-related proteins and high levels of mRNAs and miRNAs. In this present study, we detected the Ewing sarcoma-specific EWS/Fli-1 mRNA in MVs from the culture medium of ES cell lines carrying t(11;22) (q24;12). Also, we detected this fusion gene in approximately 40% of the blood samples from mice inoculated with xenografts of TC135 or A673 cells. These findings indicate the EWS/Fli-1 mRNA in MVs might be a new non-invasive diagnostic marker for specific cases of Ewing sarcoma.	[Tsugita, Masanori; Yamada, Kazunari; Shimizu, Katsuji; Ohno, Takatoshi] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan; [Tsugita, Masanori; Yamada, Nami; Noguchi, Shunsuke; Akao, Yukihiro] United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Yamada, Nami] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Moritake, Hiroshi] Miyazaki Univ, Fac Med, Dept Reprod & Dev Med, Div Pediat, Miyazaki, Japan	Gifu University; Gifu University; University of Miyazaki	Ohno, T (corresponding author), Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan.	takaohno@gifu-u.ac.jp		Yamada, Nami/0000-0002-1220-0814	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Camussi G, 2011, AM J CANCER RES, V1, P98; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Dohjima T, 2000, BRIT J CANCER, V82, P16, DOI 10.1054/bjoc.1998.0870; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Itoh T, 2012, J MOL HISTOL, V43, P509, DOI 10.1007/s10735-012-9415-1; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Lin PP, 1999, CANCER RES, V59, P1428; Matsuhashi A, 2012, CURR CANCER DRUG TAR, V12, P625, DOI 10.2174/156800912801784839; Miller IV, 2013, BIOL CELL, V105, P289, DOI 10.1111/boc.201200086; Moritake H, 2002, CANCER GENET CYTOGEN, V135, P48, DOI 10.1016/S0165-4608(01)00641-0; Nagano A, 2010, INT J CANCER, V126, P2790, DOI 10.1002/ijc.24781; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; OHNO T, 1994, ONCOGENE, V9, P3087; OHNO T, 1993, CANCER RES, V53, P5859; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Takigami I, 2011, INT J CANCER, V128, P216, DOI 10.1002/ijc.25564; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; van Maldegem AM, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-7; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Yamamoto T, 2009, J CANCER RES CLIN, V135, P1125, DOI 10.1007/s00432-009-0554-z; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77416	10.1371/journal.pone.0077416	http://dx.doi.org/10.1371/journal.pone.0077416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124617	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100174
J	Tsai, CH; Teng, CH; Tu, YT; Cheng, TS; Wu, SR; Ko, CJ; Shyu, HY; Lan, SW; Huang, HP; Tzeng, SF; Johnson, MD; Lin, CY; Hsiao, PW; Lee, MS				Tsai, C-H; Teng, C-H; Tu, Y-T; Cheng, T-S; Wu, S-R; Ko, C-J; Shyu, H-Y; Lan, S-W; Huang, H-P; Tzeng, S-F; Johnson, M. D.; Lin, C-Y; Hsiao, P-W; Lee, M-S			HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase	ONCOGENE			English	Article						prostate cancer; hepatocyte growth factor activator inhibitor-2; cancer cell invasion; tumorigenicity; metastasis	SERINE-PROTEASE INHIBITOR; FACTOR ACTIVATOR INHIBITOR-1; HUMAN BREAST-CANCER; CELL-SURFACE; PLACENTAL DEVELOPMENT; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; TUMOR-GROWTH; IN-VITRO; HEPATOCYTE	Dysregulation of cell surface proteolysis has been strongly implicated in tumorigenicity and metastasis. In this study, we delineated the role of hepatocyte growth factor activator inhibitor-2 (HAI-2) in prostate cancer (PCa) cell migration, invasion, tumorigenicity and metastasis using a human PCa progression model (103E, N1, and N2 cells) and xenograft models. N1 and N2 cells were established through serial intraprostatic propagation of 103E human PCa cells and isolation of the metastatic cells from nearby lymph nodes. The invasion capability of these cells was revealed to gradually increase throughout the serial isolations (103E < N1 < N2). In this series of cells, the expression of HAI-2 but not HAI-1 was significantly decreased throughout the progression and occurred in parallel with increased activation of matriptase. The expression level and activity of matriptase increased whereas the HAI-2 protein level decreased over the course of orthotopic tumor growth in mice, which was consistent with the immunohistochemical profiles of matriptase and HAI-2 in archival PCa specimens. Knockdown of matriptase reduced the PCa cell invasion induced by HAI-2 knockdown. HAI-2 overexpression or matriptase silencing in N2 cells downregulated matriptase activity and significantly decreased tumorigenicity and metastatic capability in orthotopically xenografted mice. These results suggest that during the progression of human PCa, matriptase activity is primarily controlled by HAI-2 expression. The imbalance between HAI-2 and matriptase expression led to matriptase activation, thereby increasing cell migration, invasion, tumorigenicity and metastasis.	[Tsai, C-H; Tzeng, S-F; Hsiao, P-W] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Teng, C-H; Tu, Y-T; Cheng, T-S; Wu, S-R; Ko, C-J; Shyu, H-Y; Lan, S-W; Lee, M-S] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan; [Shyu, H-Y] Minist Justice, Invest Bur, Taipei, Taiwan; [Huang, H-P] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Johnson, M. D.; Lin, C-Y] Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Georgetown University	Hsiao, PW (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	pwhsiao@gate.sinica.edu.tw; mslee2006@ntu.edu.tw	Ko, Chun-Jung/AAA-6187-2022; Hsiao, Pei-Wen/V-5653-2018	johnson, Michael/0000-0001-6260-7586; LEE, MING-SHYUE/0000-0002-8673-5088; LEE, MING-SHYUE/0000-0002-5884-4535; HUANG, HSIANG-PO/0000-0002-3382-305X; Hsiao, Pei-Wen/0000-0002-3589-6754; Ko, Chun-Jung/0000-0001-6565-7060	Taiwan National Health Research Institutes [NHRI-EX101-9909BC, NHRI-EX102-9909BC]; Taiwan National Science Council [NSC 97-2320-B-002-052-MY3, NSC 100-2628-B-002-004-MY4, NSC 101-2324-B-002-015, NSC 98-2320-B-001-018-MY3]; National Taiwan University [98R0305]; National Taiwan University Cutting-Edge Steering Research Project [10R71602C4]; Postdoctoral Fellowship from the Aim for Top University Program, National Taiwan University; Agricultural Biotechnology Research Center and Academia Sinica; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	Taiwan National Health Research Institutes; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Taiwan University Cutting-Edge Steering Research Project; Postdoctoral Fellowship from the Aim for Top University Program, National Taiwan University; Agricultural Biotechnology Research Center and Academia Sinica; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by Taiwan National Health Research Institutes Grants NHRI-EX101-9909BC and NHRI-EX102-9909BC, Taiwan National Science Council Grants NSC 97-2320-B-002-052-MY3, NSC 100-2628-B-002-004-MY4 and NSC 101-2324-B-002-015, the Frontier and Innovative Research Grant of National Taiwan University 98R0305 and National Taiwan University Cutting-Edge Steering Research Project 10R71602C4 to M-S Lee; Postdoctoral Fellowship from the Aim for Top University Program, National Taiwan University, to T-S Cheng; and grants from the National Science Council, Taiwan (NSC 98-2320-B-001-018-MY3), financial and instrumental support from the Agricultural Biotechnology Research Center and Academia Sinica awarded to P-W Hsiao. We are also grateful to Miranda Loney (Editor, ABRC) for critical suggestions editing this article.	Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fukai K, 2003, CANCER RES, V63, P8674; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; Huang HP, 2012, HEPATOLOGY, V55, P161, DOI 10.1002/hep.24657; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Kang JY, 2003, CANCER RES, V63, P1101; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee MS, 2006, J CANC MOL, V2, P183; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Nagakawa O, 2005, EUR UROL, V48, P686, DOI 10.1016/j.eururo.2005.05.020; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; SHI YE, 1993, CANCER RES, V53, P1409; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tsai CH, 2009, CLIN CANCER RES, V15, P5435, DOI 10.1158/1078-0432.CCR-09-0298; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Weiss L, 2000, Cancer Metastasis Rev, V19, pI; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228	46	38	39	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4643	4652		10.1038/onc.2013.412	http://dx.doi.org/10.1038/onc.2013.412			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24121274	Green Accepted			2022-12-25	WOS:000342007200003
J	Lu, Y; Liu, XJ; Zhou, JF; Huang, AJ; Zhou, JZ; He, C				Lu, Yan; Liu, Xiujie; Zhou, Jianfeng; Huang, Aijun; Zhou, Jiazhen; He, Cheng			TROY Interacts with Rho Guanine Nucleotide Dissociation Inhibitor alpha (RhoGDI alpha) to Mediate Nogo-induced Inhibition of Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Neurite Outgrowth; Neurons; RhoA; Signaling	FACTOR RECEPTOR SUPERFAMILY; FAMILY-MEMBER; GTPASES; CELLS; EXPRESSION; REGENERATION; CORECEPTOR; MORPHOLOGY; ADHESION; TAJ/TROY	Background: TROY, together with the Nogo receptor, mediates Nogo-66 induced neurite outgrowth inhibition. Results: TROY binds to RhoGDI to activate RhoA and inhibit neurite outgrowth after Nogo-66 stimulation in cerebellar granule neurons. Conclusion: TROY/RhoGDI interaction transduces the inhibitory effects of Nogo-66 on neurite extension by activating RhoA. Significance: TROY/RhoGDI interaction plays a key role in RhoA activation and neurite outgrowth inhibition by Nogo-66. TROY can functionally substitute p75 to comprise the Nogo receptor complex, which transduces the inhibitory signal of myelin-associated inhibitory factors on axon regeneration following CNS injury. The inhibition of neurite extension relies on TROY-dependent RhoA activation, but how TROY activates RhoA remains unclear. Here, we firstly identified Rho guanine nucleotide dissociation inhibitor (RhoGDI) as a binding partner of TROY using GST pull-down combined with two-dimensional gel electrophoresis and mass spectra analysis. The interaction was further confirmed by coimmunoprecipitation in vitro and in vivo. Deletion mutagenesis revealed that two regions of the TROY intracellular domain (amino acids 234-256 and 321-350) were essential for the interaction with RhoGDI. Secondly, TROY and RhoGDI were coexpressed in postnatal dorsal root ganglion neurons, cortex neurons, and cerebellar granule neurons (CGNs). Thirdly, TROY/RhoGDI association was potentiated by Nogo-66 and was independent of p75/RhoGDI interaction. Fourthly, TROY/RhoGDI interaction was still able to activate RhoA when p75 was deficient. Furthermore, RhoA activation was decreased dramatically when TROY was knocked down in p75-deficient CGNs cells. Finally, RhoGDI overexpression abolished RhoA activation and following neurite outgrowth inhibition by Nogo-66 in both wild-type and p75-deficient CGNs. These results showed that the association of RhoGDI with TROY contributed to TROY-dependent RhoA activation and neurite outgrowth inhibition after Nogo-66 stimulation.	Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn			National Key Basic Research Program [2011CB504401]; National Natural Science Foundation of China [31070922, 31130024]; Natural Science Foundation of Shanghai City [13ZR1448500]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai City(Natural Science Foundation of Shanghai)	This work was supported by National Key Basic Research Program Grant 2011CB504401, by National Natural Science Foundation of China Grants 31070922 and 31130024, and by Natural Science Foundation of Shanghai City Grant 13ZR1448500.	Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boulter Etienne, 2010, Small GTPases, V1, P65; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chumbalkar VC, 2005, PROTEOMICS, V5, P1167, DOI 10.1002/pmic.200401202; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hisaoka T, 2006, BRAIN RES, V1110, P81, DOI 10.1016/j.brainres.2006.06.068; Hisaoka T, 2006, EUR J NEUROSCI, V23, P3149, DOI 10.1111/j.1460-9568.2006.04851.x; Jacobs VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037955; Jiao L, 2011, CELL RES, V21, P327, DOI 10.1038/cr.2010.139; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li X, 2012, ONCOGENE, V31, P595, DOI 10.1038/onc.2011.256; Liu XJ, 2012, J BIOL CHEM, V287, P17503, DOI 10.1074/jbc.M111.317610; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mandemakers WJ, 2005, CURR BIOL, V15, pR302, DOI 10.1016/j.cub.2005.04.002; McDonald CL, 2011, CURR MED CHEM, V18, P234; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Morikawa Y, 2008, ANN NY ACAD SCI, V1126, pA1, DOI 10.1196/annals.1366.036; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Schwab JM, 2006, TRENDS MOL MED, V12, P293, DOI 10.1016/j.molmed.2006.05.001; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072; Zhang Y, 2009, J BIOL CHEM, V284, P12469, DOI 10.1074/jbc.M809214200	49	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34276	34286		10.1074/jbc.M113.519744	http://dx.doi.org/10.1074/jbc.M113.519744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129566	hybrid, Green Published			2022-12-25	WOS:000327250200070
J	Uotila, LM; Aatonen, M; Gahmberg, CG				Uotila, Liisa M.; Aatonen, Maria; Gahmberg, Carl G.			Integrin CD11c/CD18 alpha-Chain Phosphorylation Is Functionally Important	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Integrins; Leukocyte; Phagocytosis; Phosphorylation	LEUKOCYTE ADHESION; BLOOD MONOCYTES; BETA-SUBUNIT; ACTIVATION; RECEPTOR; RECOGNITION; BINDING; LIGAND; DOMAIN; MAC-1	CD11c/CD18 ((X2), p150/95, or complement receptor 4, CR4) is a monocyte/macrophage-enriched integrin that has been reported to bind to a variety of ligands. These include cell surface proteins, extracellular matrix proteins, and soluble ligands. The regulation of ligand binding to CD11c/CD18 has remained poorly understood. Previous work has shown that both -chain and -chain phosphorylations of CD11a/CD18 and CD11b/CD18 are needed for activity, but no corresponding studies on CD11c/CD18 have been performed. In this study, we have identified the phosphorylation site of CD11c as Ser-1158 and show that it is pivotal for adherence and phagocytosis.	[Uotila, Liisa M.; Aatonen, Maria; Gahmberg, Carl G.] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Gahmberg, CG (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Div Biochem & Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	Carl.Gahmberg@Helsinki.Fi	Gahmberg, Carl/AAE-1876-2019	Aatonen, Maria/0000-0002-4819-6722; Uotila, Liisa/0000-0003-4743-9013; Gahmberg, Carl/0000-0001-9892-9296	Academy of Finland; Sigrid Juselius Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Wilhelm and Else Stockmann Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Wilhelm and Else Stockmann Foundation	This work was supported in part by grants from the Academy of Finland, the Sigrid Juselius Foundation, the Finska Lakaresallskapet, the Liv och Halsa Foundation, the Magnus Ehrnrooth Foundation, and the Wilhelm and Else Stockmann Foundation.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; BILSLAND CAG, 1994, J IMMUNOL, V152, P4582; Blackford J, 1996, EUR J IMMUNOL, V26, P525, DOI 10.1002/eji.1830260304; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BUYON JP, 1990, J IMMUNOL, V144, P191; Castro FVV, 2008, EUR J IMMUNOL, V38, P2263, DOI 10.1002/eji.200838302; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Faham A, 2011, INT J CANCER, V129, P1391, DOI 10.1002/ijc.25810; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Garnotel R, 2000, J IMMUNOL, V164, P5928, DOI 10.4049/jimmunol.164.11.5928; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; SUTHERLAND JA, 1986, J BIOL RESP MODIF, V5, P250; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Vorup-Jensen T, 2007, J BIOL CHEM, V282, P30869, DOI 10.1074/jbc.M706114200; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	42	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33494	33499		10.1074/jbc.C113.497446	http://dx.doi.org/10.1074/jbc.C113.497446			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24129562	Green Published, hybrid			2022-12-25	WOS:000328841700061
J	Bagheri, M; Rezakhani, A; Nystrom, S; Turkina, MV; Roghani, M; Hammarstrom, P; Mohseni, S				Bagheri, Maryam; Rezakhani, Arjang; Nystrom, Sofie; Turkina, Maria V.; Roghani, Mehrdad; Hammarstrom, Per; Mohseni, Simin			Amyloid Beta(1-40)-Induced Astrogliosis and the Effect of Genistein Treatment in Rat: A Three-Dimensional Confocal Morphometric and Proteomic Study	PLOS ONE			English	Article							KAPPA-B ACTIVATION; TYROSINE KINASE INHIBITOR; CEREBRAL-CORTEX; ASTROCYTE MORPHOLOGY; ALZHEIMERS-DISEASE; RENAL INFLAMMATION; SANFILIPPO DISEASE; GENE-EXPRESSION; BRAIN; HIPPOCAMPUS	Astrocytes are highly involved in regulation and homeostasis of the extracellular environment in the healthy brain. In pathological conditions, these cells play a major role in the inflammatory response seen in CNS tissues, which is called reactive astrogliosis and includes hypertrophy and proliferation of astrocytes. Here, we performed 3D confocal microscopy to evaluate the morphological response of reactive astrocytes positive for glial fibrillary acidic protein (GFAP) in rats, to the presence of A beta(1-40) in the rat brain before and after treatment with genistein. In 50 astrocytes per animal, we measured the volume and surface area for the nucleus, cell body, the entire cell, the tissue covered by single astrocytes and quantified the number and length of branches, the density of the astrocytes and the intensity of GFAP immunoreactivity. Injecting A beta(1-40) into the brain of rats caused astrogliosis indicated by increased values for all measured parameters. Mass spectrometric analysis of hippocampal tissue in A beta(1-40)-injected brain showed decreased amounts of tubulins, enolases and myelin basic protein, and increased amounts of dihydropyrimidinase-related protein 2. In A beta(1-40)-injected rats pretreated with genistein, GFAP intensity was decreased to the sham-operated group level, and A beta(1-40)-induced astrogliosis was significantly ameliorated.	[Bagheri, Maryam] Ilam Univ Med Sci, Fac Med, Dept Physiol, Ilam, Iran; [Rezakhani, Arjang; Turkina, Maria V.; Mohseni, Simin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Nystrom, Sofie; Hammarstrom, Per] Linkoping Univ, IFM Dept Chem, Linkoping, Sweden; [Roghani, Mehrdad] Shahed Univ, Neurophysiol Res Grp, Dept Physiol, Tehran, Iran	Linkoping University; Linkoping University; Shahed University	Mohseni, S (corresponding author), Ilam Univ Med Sci, Fac Med, Dept Physiol, Ilam, Iran.	Simin.Mohseni@liu.se	bagheri, Maryam/F-6865-2017	bagheri, Maryam/0000-0002-4188-6288; Nystrom, Sofie/0000-0002-4303-4783; Roghani, Mehrdad/0000-0002-9209-8484	County Council of Ostergotland (Sweden); Linkoping University; Cellular and Molecular Research Center; Tehran University of Medical Sciences (Tehran, Iran)	County Council of Ostergotland (Sweden); Linkoping University; Cellular and Molecular Research Center; Tehran University of Medical Sciences (Tehran, Iran)(Tehran University of Medical Sciences)	This project was supported by grants from the County Council of Ostergotland (Sweden), Linkoping University, and the Cellular and Molecular Research Center affiliated with Tehran University of Medical Sciences (Tehran, Iran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Caccamo D, 2005, NEUROTOXICOLOGY, V26, P915, DOI 10.1016/j.neuro.2005.01.010; Cashion AB, 2003, ENDOCRINOLOGY, V144, P274, DOI 10.1210/en.2002-220711; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; de Ruijter J, 2012, ANN NEUROL, V71, P110, DOI 10.1002/ana.22643; Duan W, 2003, AM J RESP CRIT CARE, V167, P185, DOI 10.1164/rccm.200205-420OC; Elmarakby AA, 2011, VASC PHARMACOL, V55, P149, DOI 10.1016/j.vph.2011.07.007; GARWOOD CJ, 2011, DROSOPHILA INF SERV, V2, pE167; Garwood Claire J, 2010, Front Psychiatry, V1, P136, DOI 10.3389/fpsyt.2010.00136; Girardi E, 2004, NEUROCHEM RES, V29, P371, DOI 10.1023/B:NERE.0000013739.15160.a8; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Hama K, 2004, J NEUROCYTOL, V33, P277, DOI 10.1023/B:NEUR.0000044189.08240.a2; Hamalainen M, 2011, PLANTA MED, V77, P1504, DOI 10.1055/s-0030-1270762; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Ibrahim AS, 2010, MOL VIS, V16, P2033; JATURAPATPORN D, 2012, SPIRIN STEROIDAL NON, V2, P6378; Ji GY, 2011, INT IMMUNOPHARMACOL, V11, P762, DOI 10.1016/j.intimp.2011.01.036; Kim DJ, 2009, TOXICOL MECH METHOD, V19, P251, DOI 10.1080/15376510802563330; Kim JM, 2011, BIOGERONTOLOGY, V12, P537, DOI 10.1007/s10522-011-9345-4; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; Malinova V, 2012, JIMD REP, V5, P21, DOI 10.1007/8904_2011_87; Moran J, 2013, EXP GERONTOL, V48, P414, DOI 10.1016/j.exger.2013.02.010; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; Palanisamy N, 2011, EUR J PHARMACOL, V667, P355, DOI 10.1016/j.ejphar.2011.06.011; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Persichini T, 2010, NEUROSCI LETT, V484, P133, DOI 10.1016/j.neulet.2010.08.034; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sadowska-Krowicka H, 1998, P SOC EXP BIOL MED, V217, P351; Safavi-Abbasi S, 2001, GLIA, V36, P102, DOI 10.1002/glia.1099; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sullivan SM, 2010, GLIA, V58, P181, DOI 10.1002/glia.20911; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; WEIS S, 1993, NEUROPATH APPL NEURO, V19, P329, DOI 10.1111/j.1365-2990.1993.tb00448.x; Zhang YJ, 2012, INFLAMMATION, V35, P377, DOI 10.1007/s10753-011-9365-x	56	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76526	10.1371/journal.pone.0076526	http://dx.doi.org/10.1371/journal.pone.0076526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130779	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900075
J	Kang, TH; Park, Y; Bader, JS; Friedmann, T				Kang, Tae Hyuk; Park, Yongjin; Bader, Joel S.; Friedmann, Theodore			The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation	PLOS ONE			English	Article							LESCH-NYHAN-DISEASE; DOPAMINERGIC-NEURONS; MICROGLIAL ACTIVATION; TYROSINE-PHOSPHATASE; BASAL GANGLIA; KNOCKOUT MICE; RNA-SEQ; EXPRESSION; SOX2; INHIBITION	The mechanisms by which mutations of the purinergic housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) cause the severe neurodevelopmental Lesch Nyhan Disease (LND) are poorly understood. The best recognized neural consequences of HPRT deficiency are defective basal ganglia expression of the neurotransmitter dopamine (DA) and aberrant DA neuronal function. We have reported that HPRT deficiency leads to dysregulated expression of multiple DA-related developmental functions and cellular signaling defects in a variety of HPRT-deficient cells, including human induced pluripotent stem (iPS) cells. We now describe results of gene expression studies during neuronal differentiation of HPRT-deficient murine ESD3 embryonic stem cells and report that HPRT knockdown causes a marked switch from neuronal to glial gene expression and dysregulates expression of Sox2 and its regulator, genes vital for stem cell pluripotency and for the neuronal/glial cell fate decision. In addition, HPRT deficiency dysregulates many cellular functions controlling cell cycle and proliferation mechanisms, RNA metabolism, DNA replication and repair, replication stress, lysosome function, membrane trafficking, signaling pathway for platelet activation (SPPA) multiple neurotransmission systems and sphingolipid, sulfur and glycan metabolism. We propose that the neural aberrations of HPRT deficiency result from combinatorial effects of these multi-system metabolic errors. Since some of these aberrations are also found in forms of Alzheimer's and Huntington's disease, we predict that some of these systems defects play similar neuropathogenic roles in diverse neurodevelopmental and neurodegenerative diseases in common and may therefore provide new experimental opportunities for clarifying pathogenesis and for devising new potential therapeutic targets in developmental and genetic disease.	[Kang, Tae Hyuk; Friedmann, Theodore] UCSD Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Kang, Tae Hyuk; Friedmann, Theodore] UCSD Sch Med, Rady Childrens Hosp San Diego, La Jolla, CA USA; [Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, High Throughput Biol Ctr, Baltimore, MD USA; [Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	Friedmann, T (corresponding author), UCSD Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	tfriedmann@ucsd.edu			National Institutes of Health [DK082840]; Lesch Nyhan Disease Children's Research Foundation; UCSD Department of Pediatrics; UCSD Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lesch Nyhan Disease Children's Research Foundation; UCSD Department of Pediatrics; UCSD Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants from the National Institutes of Health (DK082840), the Lesch Nyhan Disease Children's Research Foundation, the UCSD Department of Pediatrics and the UCSD Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bertelli M, 2006, CLIN CHIM ACTA, V373, P104, DOI 10.1016/j.cca.2006.05.013; Bertelli M, 2009, J CLIN NEUROSCI, V16, P1061, DOI 10.1016/j.jocn.2008.12.011; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Deutsch SI, 2005, CLIN NEUROPHARMACOL, V28, P28, DOI 10.1097/01.wnf.0000152043.36198.25; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egami K, 2007, NEUROBIOL DIS, V26, P396, DOI 10.1016/j.nbd.2007.01.010; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Esposito G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028668; Evsen L, 2013, J NEUROSCI, V33, P3879, DOI 10.1523/JNEUROSCI.4030-12.2013; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Garcia MG, 2012, J INHERIT METAB DIS, V35, P1129, DOI 10.1007/s10545-012-9470-5; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; JINNAH HA, 1994, J NEUROSCI, V14, P1164; Jinnah HA, 2000, LESCH NYHAN DIS ITS, P2537; Kang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016572; Krady JK, 2002, GLIA, V40, P11, DOI 10.1002/glia.10101; Laszlo A, 2009, IDEGGYOGY SZEMLE, V62, P413; Li HL, 2009, NAT NEUROSCI, V12, P815, DOI 10.1038/nn0709-815; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Makoukji J, 2011, J NEUROSCI, V31, P9620, DOI 10.1523/JNEUROSCI.0761-11.2011; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pinto CS, 2006, J NEUROCHEM, V96, P454, DOI 10.1111/j.1471-4159.2005.03570.x; Pinto CS, 2005, J NEUROCHEM, V93, P1579, DOI 10.1111/j.1471-4159.2005.03151.x; Sadeghian M, 2012, J NEUROIMMUNOL, V246, P69, DOI 10.1016/j.jneuroim.2012.03.010; Saito Y, 2000, BRAIN DEV-JPN, V22, pS122; Sandhoff K, 1998, ACTA BIOCHIM POL, V45, P373, DOI 10.18388/abp.1998_4232; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schebesta M, 2009, DEV DYNAM, V238, P887, DOI 10.1002/dvdy.21909; Smith DW, 2000, MOL THER, V1, P486, DOI 10.1006/mthe.2000.0057; Suh HS, 2005, J IMMUNOL, V174, P2712, DOI 10.4049/jimmunol.174.5.2712; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Yeh J, 1998, J NEUROSCI RES, V53, P78, DOI 10.1002/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G	54	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74967	10.1371/journal.pone.0074967	http://dx.doi.org/10.1371/journal.pone.0074967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130677	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900012
J	Barrett, RD; McLellan, TL; McKinlay, A				Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey			Self versus Family Ratings of the Frontal Systems Behaviour Scale and Measured Executive Functions: Adult Outcomes following Childhood Traumatic Brain Injury	PLOS ONE			English	Article							WORKING-MEMORY; SHORT-TERM; AWARENESS; RELIABILITY; CONCORDANCE; DEFICITS; PREVALENCE; AGREEMENT; CHILDREN; VALIDITY	Traumatic brain injury (TBI) frequently occurs during childhood and adolescence with long-term neuropsychological and behavioral effects. Greater personal awareness of injury is associated with better outcomes. However, personal awareness is often assessed using ratings obtained from family members or significant others. Surprisingly, the accuracy of family-ratings compared with self-ratings has not been well studied in the TBI population. Thus, the purpose of this study was to examine self versus family-ratings of frontal dysfunction and secondly, the association between self/family reported frontal dysfunction and measured executive function outcomes. A total of 60 participants, approximately 10 years post-TBI, comprised 3 groups including; moderate/severe TBI (N=26; mean age 22.9, SD=3.0), mild TBI (N=20; mean age, 21.7, SD=2.7), and control (N=14: mean age, 21.6, SD=3.7). Neuropsychological testing was used to obtain domain scores for executive function and working memory/attention for each participant, and nominated family members and participants with TBI were asked to complete the Frontal Systems Behaviour Scale (FrSBe), consisting of three sub-scales; apathy, disinhibition, and executive dysfunction. Using the FrSBe there was no significant difference between the groups in executive function score, but the moderate/severe and mild groups had significantly lower working memory/attention scores compared with the control group (p<0.05). Repeated measures analysis of variance showed higher self-ratings on all sub-scales compared with family in each group (p<0.05). Scores on executive function and working memory/attention domains correlated with self, but not family reported executive dysfunction. Self-rated executive dysfunction explained 36% of the variance in executive function (p<0.001). While agreement between self-rated and family-rated total FrSBe scores was significant in all groups (p<0.001), our results showed that self-ratings were of higher predictive utility for executive functioning compared with family ratings. Further, at 10 years post-TBI, patients show greater awareness of deficits compared with family who rate consistently closer to the normal functioning range.	[Barrett, Robert D.; McLellan, Tracey L.; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia	University of Canterbury; Monash University	McKinlay, A (corresponding author), Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand.	Audrey.mckinlay@monash.edu		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council; Accident Compensation Corporation of New Zealand	Health Research Council; Accident Compensation Corporation of New Zealand	Dr. McKinlay was supported by a post-doctoral fellowship from the Health Research Council and the Accident Compensation Corporation of New Zealand (www.hrc.govt.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.acc.co.nz	Amminger GP, 2002, SCHIZOPHR RES, V54, P223, DOI 10.1016/S0920-9964(01)00278-X; Cabaret J, 2009, VET PARASITOL, V164, P21, DOI 10.1016/j.vetpar.2009.04.018; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jonge JM, 2005, BEHAV COGN PSYCHOTH, V33, P285, DOI 10.1017/S1352465804001948; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Gasquoine, 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grace J., 2001, PSYCHOL ASSESSMENT R; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Green S. M., 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; MUGNAI L, 1989, MYCOL RES, V92, P199, DOI 10.1016/S0953-7562(89)80012-7; Nelson HE., 1982, NATL ADULT READING T; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, 1996, J INT NEUROPSYCH SOC, V2, P17; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wechsler D., 1999, WECHSLER ABBREVIATED; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	43	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76916	10.1371/journal.pone.0076916	http://dx.doi.org/10.1371/journal.pone.0076916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116182	gold, Green Published			2022-12-25	WOS:000325552200083
J	Mariappan, V; Vellasamy, KM; Thimma, J; Hashim, OH; Vadivelu, J				Mariappan, Vanitha; Vellasamy, Kumutha Malar; Thimma, Jaikumar; Hashim, Onn Haji; Vadivelu, Jamuna			Infection of Burkholderia cepacia Induces Homeostatic Responses in the Host for Their Prolonged Survival: The Microarray Perspective	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PSEUDOMONAS-CEPACIA; EPITHELIAL-CELLS; IN-VITRO; INVASION; INHIBITION; BLOOD; PURIFICATION; MULTIVORANS; CENOCEPACIA	Burkholderia cepacia is an opportunistic human pathogen associated with life-threatening pulmonary infections in immunocompromised individuals. Pathogenesis of B. cepacia infection involves adherence, colonisation, invasion, survival and persistence in the host. In addition, B. cepacia are also known to secrete factors, which are associated with virulence in the pathogenesis of the infection. In this study, the host factor that may be the cause of the infection was elucidated in human epithelial cell line, A549, that was exposed to live B. cepacia (mid-log phase) and its secretory proteins (mid-log and early-stationary phases) using the Illumina Human Ref-8 microarray platform. The non-infection A549 cells were used as a control. Expression of the host genes that are related to apoptosis, inflammation and cell cycle as well as metabolic pathways were differentially regulated during the infection. Apoptosis of the host cells and secretion of pro-inflammatory cytokines were found to be inhibited by both live B. cepacia and its secretory proteins. In contrast, the host cell cycle and metabolic processes, particularly glycolysis/glycogenesis and fatty acid metabolism were transcriptionally up-regulated during the infection. Our microarray analysis provided preliminary insights into mechanisms of B. cepacia pathogenesis. The understanding of host response to an infection would provide novel therapeutic targets both for enhancing the host's defences and repressing detrimental responses induced by the invading pathogen.	[Mariappan, Vanitha; Vellasamy, Kumutha Malar; Thimma, Jaikumar; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, UMCPR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	jamuna@um.edu.my	Mariappan, Vanitha/I-4769-2013; VADIVELU, JAMUNARANI S/B-8696-2010; Hashim, Onn H/B-9459-2010; Vellasamy, Kumutha Malar/CAF-0007-2022; Vellasamy, Kumutha Malar/A-6592-2017; Mariappan, Vanitha/ABD-4066-2020	Mariappan, Vanitha/0000-0002-2351-1597; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Hashim, Onn H/0000-0002-0196-6793; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Mariappan, Vanitha/0000-0002-2351-1597	Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project [E000013-20001]; Ministry of Science, Innovation and Technology (MOSTI), Malaysia [55-02-03-1002]	Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project; Ministry of Science, Innovation and Technology (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported by Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project (E000013-20001) and Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund (55-02-03-1002). The funders had no role in the study design, data collection and analysis or the decision to publish or preparation of the manuscript.	ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Caraher E, 2007, J CYST FIBROS, V6, P49, DOI 10.1016/j.jcf.2006.05.007; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Chiu CH, 2001, MICROBIOL-SGM, V147, P2651, DOI 10.1099/00221287-147-10-2651; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177; DOMENECH CE, 1992, FEBS LETT, V299, P96, DOI 10.1016/0014-5793(92)80108-S; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; Govan JRW, 1998, MICROBIOL-SGM, V144, P2373, DOI 10.1099/00221287-144-9-2373; Govan JRW, 1996, J MED MICROBIOL, V45, P395, DOI 10.1099/00222615-45-6-395; GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637; Holt J., 1994, BERGEYS MANUAL DETER; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; LONON MK, 1988, J CLIN MICROBIOL, V26, P979, DOI 10.1128/JCM.26.5.979-984.1988; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mariappan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026518; Mariappan V, 2010, VACCINE, V28, P1318, DOI 10.1016/j.vaccine.2009.11.027; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; MCKEVITT AI, 1989, INFECT IMMUN, V57, P771, DOI 10.1128/IAI.57.3.771-778.1989; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; PINE L, 1984, J CLIN MICROBIOL, V19, P286, DOI 10.1128/JCM.19.2.286-290.1984; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walduck A, 2004, FASEB J, V18, P1955, DOI 10.1096/fj.04-2321fje; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; Wongprompitak P, 2008, ASIAN PAC J ALLERGY, V26, P59; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983	38	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77418	10.1371/journal.pone.0077418	http://dx.doi.org/10.1371/journal.pone.0077418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116227	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325501300119
J	Sladek, M; Sumova, A				Sladek, Martin; Sumova, Alena			Entrainment of Spontaneously Hypertensive Rat Fibroblasts by Temperature Cycles	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; HEAT-SHOCK FACTOR-1; SUPRACHIASMATIC NUCLEUS; BODY-TEMPERATURE; PERIPHERAL-TISSUES; IN-VITRO; RHYTHMS; LIGHT; MICE; TRANSCRIPTION	The functional state of the circadian system of spontaneously hypertensive rats (SHR) differs in several characteristics from the functional state of normotensive Wistar rats. Some of these changes might be due to the compromised ability of the central pacemaker to entrain the peripheral clocks. Daily body temperature cycles represent one of the important cues responsible for the integrity of the circadian system, because these cycles are driven by the central pacemaker and are able to entrain the peripheral clocks. This study tested the hypothesis that the aberrant peripheral clock entrainment of SHR results from a compromised peripheral clock sensitivity to the daily temperature cycle resetting. Using cultured Wistar rat and SHR fibroblasts transfected with the circadian luminescence reporter Bmal1-dLuc, we demonstrated that two consecutive square-wave temperature cycles with amplitudes of 2.5 degrees C are necessary and sufficient to restart the dampened oscillations and entrain the circadian clocks in both Wistar rat and SHR fibroblasts. We also generated a phase response curve to temperature cycles for fibroblasts of both rat strains. Although some of the data suggested a slight resistance of SHR fibroblasts to temperature entrainment, we concluded that the overall effect it too weak to be responsible for the differences between the SHR and Wistar in vivo circadian phenotype.	[Sladek, Martin; Sumova, Alena] Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sladek, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic.	sladek@biomed.cas.cz	Sumova, Alena/C-3390-2012; Sládek, Martin/C-3383-2012	Sumova, Alena/0000-0003-4126-5470; Sládek, Martin/0000-0002-9744-9386	Czech Science Foundation [P30510P244, P303110668];  [RVO 67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); 	This work was supported by the Czech Science Foundation grant No. P30510P244, Research Project RVO 67985823 and a minor part of the project was also supported by the Czech Science Foundation grant No. P303110668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BARRETT RK, 1995, J NEUROSCI, V15, P5681; BERKEY DL, 1990, AM J PHYSIOL, V258, pR743, DOI 10.1152/ajpregu.1990.258.3.R743; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; ERKERT HG, 1981, COMP BIOCHEM PHYS A, V68, P383, DOI 10.1016/0300-9629(81)90065-7; FRANCIS AJP, 1988, PHYSIOL BEHAV, V43, P471, DOI 10.1016/0031-9384(88)90121-7; FRANCIS CD, 1979, PLANT PHYSIOL, V64, P1000, DOI 10.1104/pp.64.6.1000; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; MILLS JN, 1978, J PHYSIOL-LONDON, V285, P455, DOI 10.1113/jphysiol.1978.sp012582; Morf J, 2013, CELL CYCLE, V12, P539, DOI 10.4161/cc.23670; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nishide S, 2008, EUR J NEUROSCI, V27, P2686, DOI 10.1111/j.1460-9568.2008.06231.x; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Pohl H, 1998, BIOL RHYTHM RES, V29, P311, DOI 10.1076/brhm.29.3.311.1436; Pravenec M, 2004, PHYSIOL RES, V53, pS15; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Ruby NF, 1999, J NEUROSCI, V19, P8630; Ruby NF, 2011, J BIOL RHYTHM, V26, P368, DOI 10.1177/0748730411411678; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sladek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046951; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; SWEENEY BM, 1960, COLD SPRING HARB SYM, V25, P87, DOI 10.1101/SQB.1960.025.01.009; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; TOKURA H, 1983, AM J PHYSIOL, V245, pR800, DOI 10.1152/ajpregu.1983.245.6.R800; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WILKINS MB, 1983, PLANTA, V157, P471, DOI 10.1007/BF00397205; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106; Yoshikawa T, 2013, EUR J NEUROSCI, V37, P491, DOI 10.1111/ejn.12052; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77010	10.1371/journal.pone.0077010	http://dx.doi.org/10.1371/journal.pone.0077010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116198	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300112
J	Brittain, EL; Pugh, ME; Wang, L; Newman, AL; Robbins, IM; Newman, JH; Hemnes, AR				Brittain, Evan L.; Pugh, Meredith E.; Wang, Li; Newman, Alex L.; Robbins, Ivan M.; Newman, John H.; Hemnes, Anna R.			Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; OF-CARDIOLOGY FOUNDATION; PRESSURE-GRADIENT; ASSOCIATION; DIAGNOSIS; ECHOCARDIOGRAPHY; STATEMENT; COUNCIL; SOCIETY; DISEASE	Background: Differentiation of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH) often requires right heart catheterization (RHC). We sought to determine whether a combination of clinical and echocardiographic variables could predict the pulmonary diastolic to wedge (PAd-PWP) gradient and thus differentiate patients with PAH and PVH. Methods: We prospectively enrolled 108 patients presenting for PH evaluation. We developed a multivariate model to predict PAd-PWP gradient and validated this model using bootstrapping technique. Results: PAH patients had worse hemodynamics and were more likely to have evidence of right ventricular dilation and dysfunction whereas patients with PVH were older and more likely to have features of the metabolic syndrome. PAd-PWP gradient of >= 6mmHg accurately discriminated patients with PAH compared to PVH. Our model including clinical and echocardiographic variables was highly accurate for the prediction of PAd-PWP gradient with a slope 0.89 (slope of 1 represents perfect prediction). Conclusions: In this prospective study of patients referred for PH evaluation, a model of readily available clinical parameters and simple echocardiographic measurements accurately predicted the PAd-PWP gradient, allowing discrimination of patients with PAH and PVH. This model requires validation in a larger cohort, but may afford clinicians more parsimony with referral for invasive testing in the evaluation of PH.	[Brittain, Evan L.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37212 USA; [Pugh, Meredith E.; Newman, Alex L.; Robbins, Ivan M.; Newman, John H.; Hemnes, Anna R.] Vanderbilt Univ, Med Ctr, Div Pulm & Crit Care Med, Nashville, TN USA; [Wang, Li] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Brittain, EL (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37212 USA.	evan.brittain@vanderbilt.edu		Brittain, Evan/0000-0001-5843-3392	CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087738, T32HL007411, P01HL108800] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by CTSA award number UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health; 1 P01 HL 108800-01A1 (Hemnes, Robbins, Pugh). The study was also supported by American College of Cardiology Foundation/Merck Fellowship in Cardiometabolic Disorders (Brittain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ATS, 2012, AM J RESP CRIT CARE, V166, P111; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; BUSH CA, 1977, CIRCULATION, V56, P924, DOI 10.1161/01.CIR.56.6.924; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; DELLITALIA LJ, 1984, J AM COLL CARDIOL, V4, P931, DOI 10.1016/S0735-1097(84)80053-4; Fang JC, 2012, J HEART LUNG TRANSPL, V31, P913, DOI 10.1016/j.healun.2012.06.002; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fujimoto N, 2013, CIRCULATION, V127, P55, DOI 10.1161/CIRCULATIONAHA.112.111302; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Hancock EW, 2009, CIRCULATION, V119, pE251, DOI 10.1161/CIRCULATIONAHA.108.191097; Hemnes AR, 2011, CHEST, V140, P1267, DOI 10.1378/chest.11-0155; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; NAEIJE R, 1994, AM J RESP CRIT CARE, V149, P881, DOI 10.1164/ajrccm.149.4.8143050; Naeije R, 2013, EUR RESPIR J, V41, P217, DOI 10.1183/09031936.00074312; Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654; PACKER M, 2002, C AM COLL CARD LAT B; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Robbins IM, 2009, CHEST, V136, P31, DOI 10.1378/chest.08-2008; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76461	10.1371/journal.pone.0076461	http://dx.doi.org/10.1371/journal.pone.0076461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124561	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100118
J	Chougule, A; Prabhash, K; Noronha, V; Joshi, A; Thavamani, A; Chandrani, P; Upadhyay, P; Utture, S; Desai, S; Jambhekar, N; Dutt, A				Chougule, Anuradha; Prabhash, Kumar; Noronha, Vanita; Joshi, Amit; Thavamani, Abhishek; Chandrani, Pratik; Upadhyay, Pawan; Utture, Sagarika; Desai, Saral; Jambhekar, Nirmala; Dutt, Amit			Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FEMALE NEVER-SMOKERS; CANCER PATIENTS; ACTIVATING MUTATIONS; 1ST-LINE TREATMENT; GEFITINIB THERAPY; CLINICAL-RESPONSE; GENE-MUTATIONS; OPEN-LABEL; ERLOTINIB	Background: During the past decade, the incidence of EGFR mutation has been shown to vary across different ethnicities. It occurs at the rate of 10-15% in North Americans and Europeans, 19% in African-Americans, 20-30% in various East Asian series including Chinese, Koreans, and Japanese. Frequency of EGFR mutations in India however remains sparsely explored. Methodology/Principal Findings: We report 23% incidence of Epidermal growth factor receptor (EGFR) mutations in 907 Non small cell lung cancer (NSCLC) patients of Indian ethnicity, in contrast to 10-15% known in Caucasians and 27-62% among East Asians. In this study, EGFR mutations were found to be more common in never-smokers 29.4% as compared to smokers 15.3%. Consistent with other populations, mutation rates among adenocarcinoma-males were predominantly lower than females with 32% incidence. However unlike Caucasians, EGFR mutation rate among adenocarcinoma-never-smoker females were comparable to males suggesting lack of gender bias among never smokers likely to benefit from EGFR targeted therapy. Conclusions/Significance: This study has an overall implication for establishing relevance for routine EGFR mutation diagnostics for NSCLC patients in clinics and emphasizes effectiveness for adoption of EGFR inhibitors as the first line treatment among Indian population. The intermediate frequency of EGFR mutation among Indian population compared to Caucasians and East Asians is reminiscent of an ancestral admixture of genetic influence from Middle Easterners, Central Asians, and Europeans on modern-Indian population that may confer differential susceptibility to somatic mutations in EGFR.	[Chougule, Anuradha; Prabhash, Kumar; Noronha, Vanita; Joshi, Amit] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Mumbai 400012, Maharashtra, India; [Thavamani, Abhishek; Chandrani, Pratik; Upadhyay, Pawan; Dutt, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Utture, Sagarika; Desai, Saral; Jambhekar, Nirmala] Tata Mem Hosp, Tata Mem Ctr, Dept Pathol, Mumbai 400012, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	Prabhash, K (corresponding author), Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Mumbai 400012, Maharashtra, India.	kprabhash1@gmail.com; adutt@actrec.gov.in	Upadhyay, Pawan/AAM-6668-2020; Dutt, Amit/I-1911-2013; Thavamani, Abhishek/I-3207-2018; Chandrani, Pratik/AAV-9081-2021	Upadhyay, Pawan/0000-0003-4945-5375; Dutt, Amit/0000-0002-1119-4774; Thavamani, Abhishek/0000-0001-7187-9188; Chandrani, Pratik/0000-0003-2572-0189	Wellcome Trust/DBT India Alliance [IA/I/11/2500278]; DBT [BT/PR2372/AGR/36/696/2011];  [Seed-In-Air 2897];  [2712];  [IRB 92]	Wellcome Trust/DBT India Alliance(Wellcome Trust); DBT(Department of Biotechnology (DBT) India); ; ; 	A.D. is supported by an Intermediate Fellowship from the Wellcome Trust/DBT India Alliance (IA/I/11/2500278), by a grant from DBT (BT/PR2372/AGR/36/696/2011), and intramural grants (Seed-In-Air 2897, TMH Plan Project 2712 and IRB 92). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Ferlay J, 2010, IARC CANCERBASE; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Kim HJ, 2013, ONCOL LETT, V5, P271, DOI 10.3892/ol.2012.950; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lee JW, 2005, CLIN CANCER RES, V11, P2879, DOI 10.1158/1078-0432.CCR-04-2029; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Lindeman NI, 2013, J MOL DIAGN; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Noronha V, 2012, INDIAN J CANCER, V49, P74, DOI 10.4103/0019-509X.98925; Noronha V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061561; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan-Chyr Yang YS, 2012, J CLIN ONCOL, V30; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sahoo R, 2011, LUNG CANCER, V73, P316, DOI 10.1016/j.lungcan.2011.01.004; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; ShyamAggarwal S, 2012, J CLIN ONCOL S, V30, P2012; Suda K, 2009, J THORAC ONCOL, V4, P1, DOI 10.1097/JTO.0b013e3181913c9f; Sun Meng-hong, 2011, Chinese Journal of Pathology, V40, P655, DOI 10.3760/cma.j.issn.0529-5807.2011.10.003; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Tomizawa Y, 2005, CLIN CANCER RES, V11, P6816, DOI 10.1158/1078-0432.CCR-05-0441; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	37	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76164	10.1371/journal.pone.0076164	http://dx.doi.org/10.1371/journal.pone.0076164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124538	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100095
J	Pavlidou, K; Savvas, I; Moens, YPS; Vasilakos, D; Raptopoulos, D				Pavlidou, Kiriaki; Savvas, Ioannis; Moens, Yves P. S.; Vasilakos, Dimitrios; Raptopoulos, Dimitrios			The Effect of Four Anaesthetic Protocols for Maintenance of Anaesthesia on Trans-Diaphragmatic Pressure in Dogs	PLOS ONE			English	Article							TRANSDIAPHRAGMATIC PRESSURE; INTRAABDOMINAL PRESSURE; RESPIRATORY MUSCLE; BLOOD-FLOW; PROPOFOL; KETAMINE; HALOTHANE; INFUSION; SEVOFLURANE; FENTANYL	The diaphragm is the main inspiratory muscle and the main indicator of diaphragmatic contractility is the transdiaphragmatic pressure (P-di). The aim of this clinical study was to determine the effect of four different anaesthetic protocols on P-di in anaesthetized healthy dogs. Eighty client-owned dogs were recruited in this clinical study. All the animals received dexmedetomidine and morphine as premedication and propofol for induction. Anaesthesia was maintained with one of four protocols: isoflurane (I), isoflurane with CRI of propofol (IP), isoflurane with CRI of fentanyl (IF), and isoflurane with CRI of ketamine (IK). When the surgical plane of anaesthesia was achieved, two balloon catheters were inserted, one into the stomach and one into the mid-third of the oesophagus for P-di measurement. P-di value was the highest in groups I (14.9 +/- 4.7 mmHg) and IK (15.2 +/- 3.5 mmHg) and the lowest in groups IP (12.2 +/- 3.2 mmHg) and IF (12.0 +/- 5.9 mmHg). There was a statistically significant difference (p = 0.029) between groups IK and IF. PE'CO2 was statistically significantly higher (p<0.0005) in group IF (7.7 +/- 0.8 kPa) than in group IK (6.5 +/- 0.7 kPa). Isoflurane alone or isoflurane with ketamine for the maintenance of anaesthesia seem to better preserve the respiratory function and the diaphragmatic contractility than isoflurane with either propofol or fentanyl in dogs. Therefore, the use of isoflurane or isoflurane with ketamine may be of benefit when animals with respiratory problems have to be anaesthetized.	[Pavlidou, Kiriaki; Savvas, Ioannis; Raptopoulos, Dimitrios] Aristotle Univ Thessaloniki, Fac Vet Med, Compan Anim Clin, Anaesthesiol & Intens Care Unit, GR-54006 Thessaloniki, Greece; [Moens, Yves P. S.] Vet Univ Vienna, A-1030 Vienna, Austria; [Vasilakos, Dimitrios] AHEPA Univ Hosp, Anaesthesiol & ICU Dept, Thessaloniki, Greece	Aristotle University of Thessaloniki; University of Veterinary Medicine Vienna; Aristotle University of Thessaloniki; Ahepa University Hospital	Savvas, I (corresponding author), Aristotle Univ Thessaloniki, Fac Vet Med, Compan Anim Clin, Anaesthesiol & Intens Care Unit, GR-54006 Thessaloniki, Greece.	isavas@vet.auth.gr	Savvas, Ioannis/H-9622-2019	Savvas, Ioannis/0000-0001-5575-7244; Pavlidou, Kiriaki/0000-0002-1771-3811	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1988, J APPL PHYSIOL, V64, P2279, DOI 10.1152/jappl.1988.64.6.2279; ANDREWS CJH, 1983, BRIT J ANAESTH, V55, pS211; AUBIER M, 1981, NEW ENGL J MED, V305, P249, DOI 10.1056/NEJM198107303050503; Benditt Joshua O, 2005, Respir Care, V50, P68; Boriek AM, 2006, J APPL PHYSIOL, V101, P794, DOI 10.1152/japplphysiol.00865.2004; Bufalari A, 2012, SCHWEIZ ARCH TIERH, V154, P105, DOI 10.1024/0036-7281/a000308; CLERGUE F, 1986, ANESTHESIOLOGY, V64, P181, DOI 10.1097/00000542-198602000-00009; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; Dorfelt R, 2012, VET ANAESTH ANALG, V39, P390, DOI 10.1111/j.1467-2995.2012.00710.x; Drummond GB, 1996, BRIT J ANAESTH, V76, P663, DOI 10.1093/bja/76.5.663; Drummond GB, 2002, BRIT J ANAESTH, V88, P384, DOI 10.1093/bja/88.3.384; FARKAS G, 1990, CHEST, V97, pS39; GILBERT R, 1979, J APPL PHYSIOL, V47, P628, DOI 10.1152/jappl.1979.47.3.628; HASKINS SC, 1985, AM J VET RES, V46, P1855; HIGGS BD, 1983, ANESTHESIOLOGY, V59, P340, DOI 10.1097/00000542-198310000-00012; HILLMAN DR, 1990, J APPL PHYSIOL, V68, P2296, DOI 10.1152/jappl.1990.68.6.2296; HUBMAYR RD, 1990, J APPL PHYSIOL, V69, P2050, DOI 10.1152/jappl.1990.69.6.2050; HUSSAIN SNA, 1988, J APPL PHYSIOL, V64, P329, DOI 10.1152/jappl.1988.64.1.329; IDE T, 1992, ANESTH ANALG, V74, P739; IDE T, 1991, CAN J ANAESTH, V38, P116, DOI 10.1007/BF03009174; IDE T, 1993, ACTA ANAESTH SCAND, V37, P253, DOI 10.1111/j.1399-6576.1993.tb03710.x; Kagawa T, 1998, ANESTH ANALG, V86, P392, DOI 10.1097/00000539-199802000-00033; KOCHI T, 1990, ANESTH ANALG, V70, P362; KOCHI T, 1992, BRIT J ANAESTH, V68, P562, DOI 10.1093/bja/68.6.562; Kuusela E, 2003, J VET PHARMACOL THER, V26, P199, DOI 10.1046/j.1365-2885.2003.00465.x; Lambert DM, 2005, OBES SURG, V15, P1225, DOI 10.1381/096089205774512546; Lamont LA, 2007, LUMB JONES VET ANEST, P241; LAPORTA D, 1985, J APPL PHYSIOL, V58, P1469, DOI 10.1152/jappl.1985.58.5.1469; Laredo FG, 2004, VET REC, V155, P667, DOI 10.1136/vr.155.21.667; Lumb A.B., 2010, NUNNS APPL RESP PHYS, P327; MAGDER S, 1985, J APPL PHYSIOL, V58, P1148, DOI 10.1152/jappl.1985.58.4.1148; MANKIKIAN B, 1986, ANESTHESIOLOGY, V65, P492, DOI 10.1097/00000542-198611000-00007; Mannarino R, 2012, VET ANAESTH ANALG, V39, P160, DOI 10.1111/j.1467-2995.2011.00679.x; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McDonell W.N., 2007, LUMB JONES VET ANEST, P117; Moore RL, 1927, J EXP MED, V45, P1065, DOI 10.1084/jem.45.6.1065; Nishina K, 2003, ANESTH ANALG, V96, P1674, DOI 10.1213/01.ANE.0000060455.94684.69; Ora J, 2011, J APPL PHYSIOL, V111, P10, DOI 10.1152/japplphysiol.01131.2010; Pavlidou K, 2014, VET ANAESTH ANALG, V41, P278, DOI 10.1111/vaa.12073; POLKEY MI, 1995, THORAX, V50, P1131, DOI 10.1136/thx.50.11.1131; Sano T, 2006, VET ANAESTH ANALG, V33, P266, DOI 10.1111/j.1467-2995.2005.00266.x; SANTIAGO TV, 1979, J APPL PHYSIOL, V47, P112, DOI 10.1152/jappl.1979.47.1.112; SANTIAGO TV, 1985, J APPL PHYSIOL, V59, P1675, DOI 10.1152/jappl.1985.59.6.1675; Seliskar A, 2007, VET REC, V160, P85, DOI 10.1136/vr.160.3.85; SPRUNG J, 1990, J APPL PHYSIOL, V69, P2296, DOI 10.1152/jappl.1990.69.6.2296; Udeshi A, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.12.014; ULKER S, 1991, INT J EXP PATHOL, V72, P527; WANKE T, 1993, CLIN PHYSIOL, V13, P349, DOI 10.1111/j.1475-097X.1993.tb00335.x; WATERMAN AE, 1991, VET REC, V129, P261, DOI 10.1136/vr.129.12.261; Zakynthinos S., 2005, PHYSL BASIS RESP DIS, P289; Zhang XJ, 2009, BRIT J ANAESTH, V102, P61, DOI 10.1093/bja/aen327; Zin W. A., 2005, PHYSL BASIS RESP DIS, P639	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75341	10.1371/journal.pone.0075341	http://dx.doi.org/10.1371/journal.pone.0075341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124482	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100039
J	York, PH; Gruber, RK; Hill, R; Ralph, PJ; Booth, DJ; Macreadie, PI				York, Paul H.; Gruber, Renee K.; Hill, Ross; Ralph, Peter J.; Booth, David J.; Macreadie, Peter I.			Physiological and Morphological Responses of the Temperate Seagrass Zostera muelleri to Multiple Stressors: Investigating the Interactive Effects of Light and Temperature	PLOS ONE			English	Article							GREAT-BARRIER-REEF; XANTHOPHYLL-CYCLE; PHOTOSYSTEM-II; HETEROZOSTERA-TASMANICA; FLUORESCENCE TRANSIENT; THALASSIA-TESTUDINUM; POPULATION-DYNAMICS; POSIDONIA-OCEANICA; HALOPHILA-OVALIS; CLIMATE-CHANGE	Understanding how multiple environmental stressors interact to affect seagrass health (measured as morphological and physiological responses) is important for responding to global declines in seagrass populations. We investigated the interactive effects of temperature stress (24, 27, 30 and 32 degrees C) and shading stress (75, 50, 25 and 0% shade treatments) on the seagrass Zostera muelleri over a 3-month period in laboratory mesocosms. Z. muelleri is widely distributed throughout the temperate and tropical waters of south and east coasts of Australia, and is regarded as a regionally significant species. Optimal growth was observed at 27 degrees C, whereas rapid loss of living shoots and leaf mass occurred at 32 degrees C. We found no difference in the concentration of photosynthetic pigments among temperature treatments by the end of the experiment; however, up-regulation of photoprotective pigments was observed at 30 degrees C. Greater levels of shade resulting in high photochemical efficiencies, while elevated irradiance suppressed effective quantum yield (Delta F/F-M'). Chlorophyll fluorescence fast induction curves (FIC) revealed that the J step amplitude was significantly higher in the 0% shade treatment after 8 weeks, indicating a closure of PSII reaction centres, which likely contributed to the decline in Delta F/F-M' and photoinhibition under higher irradiance. Effective quantum yield of PSII (Delta F/F-M') declined steadily in 32 degrees C treatments, indicating thermal damage. Higher temperatures (30 degrees C) resulted in reduced above-ground biomass ratio and smaller leaves, while reduced light led to a reduction in leaf and shoot density, above-ground biomass ratio, shoot biomass and an increase in leaf senescence. Surprisingly, light and temperature had few interactive effects on seagrass health, even though these two stressors had strong effects on seagrass health when tested in isolation. In summary, these results demonstrate that populations of Z. muelleri in southeastern Australia are sensitive to small chronic temperature increases and light decreases that are predicted under future climate change scenarios.	[York, Paul H.; Ralph, Peter J.; Booth, David J.; Macreadie, Peter I.] Univ Technol, Sch Environm, Broadway, NSW, Australia; [York, Paul H.] James Cook Univ, Ctr Trop Water, Cairns, Qld, Australia; [York, Paul H.] James Cook Univ, Environm Res Ctr, Cairns, Qld, Australia; [Gruber, Renee K.] Off Environm & Heritage, Sydney, NSW, Australia; [Gruber, Renee K.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hill, Ross; Ralph, Peter J.; Macreadie, Peter I.] Univ Technol, Plant Funct Biol & Climate Change Cluster, Broadway, NSW, Australia; [Hill, Ross] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Hill, Ross] Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia	University of Technology Sydney; James Cook University; James Cook University; Office of Environment & Heritage - New South Wales; University of Western Australia; University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney	York, PH (corresponding author), Univ Technol, Sch Environm, Broadway, NSW, Australia.	Paul.York@jcu.edu.au	Hill, Ross/E-6075-2013; Ralph, Peter/L-1527-2019; York, Paul H./C-4120-2009; Ralph, Peter J/C-5029-2009	Hill, Ross/0000-0002-4623-1563; Ralph, Peter/0000-0002-3103-7346; York, Paul H./0000-0003-3530-4146; Ralph, Peter J/0000-0002-3103-7346; Gruber, Renee/0000-0002-8788-6910; Booth, David/0000-0002-8256-1412	ARC DECRA Fellowship [DE130101084]; University of Technology, Sydney; NSW Office of Environment and the Heritage; NSW Department of Primary Industries; Hornsby Shire Council; Gosford City Council	ARC DECRA Fellowship(Australian Research Council); University of Technology, Sydney; NSW Office of Environment and the Heritage; NSW Department of Primary Industries; Hornsby Shire Council; Gosford City Council	This work was funded by an ARC DECRA Fellowship (DE130101084, to PM) and a partnership Grant involving the University of Technology, Sydney (http://www.uts.edu.au/), NSW Office of Environment and the Heritage (http://www.environment.nsw.gov.au/), NSW Department of Primary Industries (http://www.dpi.nsw.gov.au/fisheries), Hornsby Shire Council (http://www.hornsby.nsw.gov.au/), and Gosford City Council (http://www.gosford.nsw.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAL EG, 1994, J EXP MAR BIOL ECOL, V178, P113, DOI 10.1016/0022-0981(94)90228-3; Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Brouwer B, 2012, PLANT CELL ENVIRON, V35, P1084, DOI 10.1111/j.1365-3040.2011.02474.x; BULTHUIS DA, 1987, AQUAT BOT, V27, P27, DOI 10.1016/0304-3770(87)90084-2; BULTHUIS DA, 1983, AQUAT BOT, V16, P111, DOI 10.1016/0304-3770(83)90088-8; BULTHUIS DA, 1983, MAR BIOL LETT, V4, P47; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Carr JA, 2012, MAR ECOL PROG SER, V448, P289, DOI 10.3354/meps09556; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; CSIRO & BoM, 2007, CLIM CHANG AUSTR TEC; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Fonseca MS, 2007, J EXP MAR BIOL ECOL, V340, P227, DOI 10.1016/j.jembe.2006.09.015; FOURQUREAN JW, 1991, MAR ECOL PROG SER, V69, P161, DOI 10.3354/meps069161; Fourqurean JW, 2003, LIMNOL OCEANOGR, V48, P2070; GORDON DM, 1994, AQUAT BOT, V47, P265, DOI 10.1016/0304-3770(94)90057-4; Gordon JDM, 2002, J MAR BIOL ASSOC UK, V82, P339, DOI 10.1017/S0025315402005532; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Haldimann P, 1999, PHOTOSYNTH RES, V62, P67, DOI 10.1023/A:1006321126009; Havaux M, 1996, PLANTA, V198, P324, DOI 10.1007/BF00620047; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoffle H, 2011, ESTUAR COAST SHELF S, V92, P35, DOI 10.1016/j.ecss.2010.12.017; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Ingleton T, 2012, ESTUAR COAST SHELF S, V99, P132, DOI 10.1016/j.ecss.2011.12.024; IPCC, 2000, SPECIAL REPORT EMISS; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/nclimate1533, 10.1038/NCLIMATE1533]; KERR EA, 1985, AQUAT BOT, V23, P177, DOI 10.1016/0304-3770(85)90063-4; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Lavorel J, 1977, PRIMARY PROCESSES PH, P203; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; MARSH JA, 1986, J EXP MAR BIOL ECOL, V101, P257, DOI 10.1016/0022-0981(86)90267-4; Moore KA, 2008, J COASTAL RES, P135, DOI 10.2112/SI55-014; Nellemann C., 2009, BLUE CARBON RAPID RE; Olesen B, 2002, MAR ECOL PROG SER, V236, P89, DOI 10.3354/meps236089; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Ralph PJ, 2005, AQUAT BOT, V81, P69, DOI 10.1016/j.aquabot.2004.11.003; Ralph PJ, 2002, J EXP MAR BIOL ECOL, V271, P189, DOI 10.1016/S0022-0981(02)00047-3; Ralph PJ, 1999, AQUAT BOT, V65, P83, DOI 10.1016/S0304-3770(99)00033-9; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Robinson KIM, 1987, WETLANDS, V7, P1, DOI 10.1007/BF03160798.; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; Ulstrup KE, 2005, MAR ECOL PROG SER, V286, P125, DOI 10.3354/meps286125; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Waycott M, 2005, MAR POLLUT BULL, V51, P343, DOI 10.1016/j.marpolbul.2005.01.017; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zann LP, 2000, MAR POLLUT BULL, V41, P188, DOI 10.1016/S0025-326X(00)00110-7; Zimmerman RC, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P303	68	76	77	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76377	10.1371/journal.pone.0076377	http://dx.doi.org/10.1371/journal.pone.0076377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124551	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000325489100108
J	de Araujo, RF; Souza, TO; de Moura, LM; Torres, KP; de Souza, LB; Alves, MDCF; Rocha, HO; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Souza, Tatiana Oliveira; de Moura, Ligia Moreno; Torres, Kerginaldo Paulo; de Souza, Lelia Batista; Costa Feitosa Alves, Maria do Socorro; Rocha, Hugo Oliveira; de Araujo, Aurigena Antunes			Atorvastatin Decreases Bone Loss, Inflammation and Oxidative Stress in Experimental Periodontitis	PLOS ONE			English	Article							OSTEOPROTEGERIN; TISSUE; RATS	The aim of this study is to determine the effects of Atorvastatin treatment, an inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase, in periodontal disease. Male Wistar albino rats were randomly divided into five groups of ten rats each: (1) non-ligated treatment (NL), (2) ligature only (L), (3) ligature plus 1 mg/kg Atorvastatin daily for 10 days, (4) ligature plus 5 mg/kg Atorvastatin daily for 10 days, and (5) ligature plus 10 mg/kg Atorvastatin daily for 10 days. Following the treatment course, the periodontal tissue of the animals was analyzed by Measurement of alveolar bone loss, Histopathology and immunohistochemistry to determine of the expression of COX-2, MMP-2, MMP9, and RANKL/RANK/OPG. ELISA assay was used to quantitate the levels of IL-1 beta, IL-10, TNF-alpha, myeloperoxidase, malondialdehyde, and glutathione. The periodontal group treated with 10 mg/kg of Atorvastatin (3.9 +/- 0.9 mm; p<0.05) showed reverse the alveolar bone loss caused Experimental Periodontal Disease compared to (L) (7.02 +/- 0.17 mm). The periodontal group treated with 10 mg/kg of Atorvastatin showed a significant reduction in MPO and MDA (p<0.05) compared to ligature only group (L). Similarly in this group, the levels of the proinflammatory cytokines IL-1 beta and TNF-alpha were significantly decreased (p<0.05). Furthermore, MMP-2, MMP-9, RANKL/RANK, and COX-2 were all downregulated by Atorvastatin treatment, while OPG expression was increased. The findings support a role of Atorvastatin for reducing the bone loss, inflammatory response, oxidative stress, and expression of extracellular matrix proteins, while reducing RANK/RANKL and increase OPG in periodontal disease.	[de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Hlth Sci, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil; [Souza, Tatiana Oliveira] Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil; [de Moura, Ligia Moreno] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, UNP, Dept Dent, Natal, RN, Brazil; [Torres, Kerginaldo Paulo] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [de Souza, Lelia Batista] Univ Fed Rio Grande do Norte, Postgrad Program Oral Pathol, Natal, RN, Brazil; [Costa Feitosa Alves, Maria do Socorro] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Postgrad Program Hlth Sci, Natal, RN, Brazil; [Rocha, Hugo Oliveira] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Potiguar; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil.	aurigena@ufrnet.br	de Araujo, Aurigena/ABI-8455-2020	Araujo, Aurigena/0000-0001-9264-4695				Araujo AA, 2013, NAUNYN SCHMIEDEBERGS; ARAUJO RFD, 2013, PLOS ONE, V0008; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Carvalho RD, 2013, ARCH ORAL BIOL, V58, P50, DOI 10.1016/j.archoralbio.2012.04.020; Chang BC, 2011, PHARMAZIE, V66, P535, DOI 10.1691/ph.2011.0826; Corotti MV, 2009, ARCH ORAL BIOL, V54, P764, DOI 10.1016/j.archoralbio.2009.04.013; Cui JJ, 2012, CELL BIOCHEM BIOPHYS, V62, P87, DOI 10.1007/s12013-011-9264-7; Dalcico R, 2012, J PERIODONTOL; Deng Ping, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P1018; Deo V, 2010, DENT TODAY, V29, P64; Deo V, 2010, DENT TODAY, V29, P68; Deo Vikas, 2010, Dent Today, V29, P60; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Hernandez C, 2011, DIABETES METAB, V37, P124, DOI 10.1016/j.diabet.2010.08.006; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kim JY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4018; Kirkwood KL, 2007, PERIODONTOL 2000, V43, P294, DOI 10.1111/j.1600-0757.2006.00166.x; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Otenio CC, 2012, GENET MOL RES, V11; Pozo P, 2005, J PERIODONTAL RES, V40, P199, DOI 10.1111/j.1600-0765.2005.00786.x; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Shirakabe A, 2012, J CARDIOL, V59, P374, DOI 10.1016/j.jjcc.2012.01.009; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; WAHL SM, 1993, J PERIODONTOL, V64, P450; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; Yen CA, 2008, J PERIODONTOL, V79, P104, DOI [10.1902/jop.2008.070271, 10.1902/jop.2008.070271 ]	32	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75322	10.1371/journal.pone.0075322	http://dx.doi.org/10.1371/journal.pone.0075322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130702	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200010
J	Gu, GM; Wang, TT; Yang, Y; Xu, XH; Wang, JK				Gu, Guangming; Wang, Tingting; Yang, Yang; Xu, Xinhui; Wang, Jinke			An Improved SELEX-Seq Strategy for Characterizing DNA-Binding Specificity of Transcription Factor: NF-kappa B as an Example	PLOS ONE			English	Article							IN-VIVO; CHROMATIN IMMUNOPRECIPITATION; ONLINE DATABASE; MICROARRAY DATA; PROTEIN; SEQUENCE; GENOME; CELLS; EXPRESSION; MOLECULES	SELEX-Seq is now the optimal high-throughput technique for characterizing DNA-binding specificities of transcription factors. In this study, we introduced an improved EMSA-based SELEX-Seq strategy with several advantages. The improvements of this strategy included: (1) using a FAM-labeled probe to track protein-DNA complex in polyacrylamide gel for rapidly recovering the protein-bound dsDNA without relying on traditional radioactive labeling or ethidium bromide staining; (2) monitoring the specificity of SELEX selection by detecting a positive and negative sequence doped into the input DNAs used in each round with PCR amplification; (3) using nested PCR to ensure the specificity of PCR amplification of the selected DNAs after each round; (4) using the nucleotides added at the 59 end of the nested PCR primers as the split barcode to code DNAs from various rounds for multiplexing sequencing samples. The split barcode minimized selection times and thus greatly simplified the current SELEX-Seq procedure. The reliability of the strategy was demonstrated by performing a successful SELEX-Seq of a well-known transcription factor, NF-kappa B. Therefore, this study provided a useful SELEX-Seq strategy for characterizing DNA-binding specificities of transcription factors.	[Gu, Guangming; Wang, Tingting; Yang, Yang; Xu, Xinhui; Wang, Jinke] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, JK (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	wangjinke@seu.edu.cn	wang, tingting/AAK-2640-2020; Wang, Jinke/AAT-7832-2021		National Natural Science Foundation of China [61171030]; Technology Support Program of Jiangsu [BE2012741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Support Program of Jiangsu	This work was supported by the National Natural Science Foundation of China (61171030) and Technology Support Program of Jiangsu (BE2012741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamanova D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-225; ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Celedon A, 2010, J PHYS CHEM B, V114, P16929, DOI 10.1021/jp107541q; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ferraris L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1213; Gao J, 2011, LETT BIOTECHNOL CHIN, V22, P71; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hallikas O, 2006, NAT PROTOC, V1, P215, DOI 10.1038/nprot.2006.33; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Liu JJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni139; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ohmori K, 2005, EUR J CARDIO-THORAC, V27, P23, DOI 10.1016/j.ejcts.2004.09.016; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; PAPOULAS O, 1992, J BIOL CHEM, V267, P10470; Puckett JW, 2007, J AM CHEM SOC, V129, P12310, DOI 10.1021/ja0744899; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Sooter LJ, 2004, J ASS LAB AUTOM, V9, P277; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tantin D, 2008, GENOME RES, V18, P631, DOI 10.1101/gr.072942.107; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JK, 2003, ANAL BIOCHEM, V316, P192, DOI 10.1016/S0003-2697(03)00049-6; Wang XL, 2009, J CLIN IMMUNOL, V29, P387, DOI 10.1007/s10875-009-9274-z; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	51	23	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76109	10.1371/journal.pone.0076109	http://dx.doi.org/10.1371/journal.pone.0076109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130762	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200031
J	Oettler, J; Dijkstra, MB; Heinze, J				Oettler, Jan; Dijkstra, Michiel B.; Heinze, Juergen			Egg-Laying "Intermorphs'' in the Ant Crematogaster smithi neither Affect Sexual Production nor Male Parentage	PLOS ONE			English	Article							FLORIDA HARVESTER ANT; WORKER REPRODUCTION; ALLOCATION RATIOS; RESOURCE AVAILABILITY; INVESTMENT RATIOS; UNFERTILIZED EGGS; INSECT SOCIETIES; QUEEN CONTROL; EVOLUTION; CASTE	We study male parentage and between-colony variation in sex allocation and sexual production in the desert ant Crematogaster smithi, which usually has only one singly-mated queen per nest. Colonies of this species are known to temporarily store nutrients in the large fat body of intermorphs, a specialized female caste intermediate in morphology between queens and workers. Intermorphs repackage at least part of this fat into consumable but viable male-destined eggs. If these eggs sometimes develop instead of being eaten, intermorphs will be reproductive competitors of the queen but-due to relatedness asymmetries-allies of their sister worker. Using genetic markers we found a considerable proportion of non-queen sons in some, but not all, colonies. Even though intermorphs produce similar to 1.7 x more eggs than workers, their share in the parentage of adult males is estimated to be negligible due to their small number compared to workers. Furthermore, neither colony-level sex allocation nor overall sexual production was correlated with intermorph occurrence or number. We conclude that intermorph-laid eggs typically do not survive and that the storage of nutrients and their redistribution as eggs by intermorphs is effectively altruistic.	[Oettler, Jan; Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany; [Dijkstra, Michiel B.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Regensburg; University of Lausanne	Oettler, J (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	jan.oettler@biologie.uni-regensburg.de; michiel.b.dijkstra@gmail.com		Dijkstra, Michiel/0000-0003-1519-4656	German Academic Exchange Service (DAAD); Marie Curie grant [41343-INVICTA2]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie grant(European Commission)	This study was supported by two grants to JO from the German Academic Exchange Service (DAAD) and a Marie Curie grant 41343-INVICTA2 to MBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; BARTZ SH, 1982, BEHAV ECOL SOCIOBIOL, V10, P137, DOI 10.1007/BF00300174; Beekman M, 2003, TRENDS ECOL EVOL, V18, P277, DOI 10.1016/S0169-5347(03)00068-5; Blaimer BB, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.199.2631; Bono JM, 2003, P ROY SOC B-BIOL SCI, V270, P811, DOI 10.1098/rspb.2002.2287; Bono JM, 2002, INSECT SOC, V49, P320, DOI 10.1007/PL00012655; BOOMSMA JJ, 1989, AM NAT, V133, P517, DOI 10.1086/284933; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; BOOMSMA JJ, 1995, FUNCT ECOL, V9, P743, DOI 10.2307/2390247; Boomsma JJ, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P93, DOI 10.1017/CBO9780511542053.005; Borgesen LW, 2000, INSECT SOC, V47, P141, DOI 10.1007/PL00001692; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bourke Andrew F.G., 2005, P1, DOI 10.1079/9780851998121.0001; Brown WD, 2006, BEHAV ECOL SOCIOBIOL, V60, P612, DOI 10.1007/s00265-006-0204-2; Buschmann AH, 2002, AMEISENSCHUTZ AKTUEL, V16, P1; Cahan S, 1999, BEHAV ECOL, V10, P585, DOI 10.1093/beheco/10.5.585; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Crozier R.H., 1996, EVOLUTION SOCIAL INS; de Menten L, 2005, ANIM BEHAV, V69, P1031, DOI 10.1016/j.anbehav.2004.09.005; Desfor KB, 2007, IBIS, V149, P98; DESLIPPE RJ, 1995, ECOLOGY, V76, P375, DOI 10.2307/1941196; Dijkstra MB, 2007, ANIM BEHAV, V74, P519, DOI 10.1016/j.anbehav.2006.11.020; Dijkstra MB, 2008, OIKOS, V117, P1892, DOI 10.1111/j.1600-0706.2008.16822.x; Foitzik S, 2004, BEHAV ECOL SOCIOBIOL, V55, P484, DOI 10.1007/s00265-003-0718-9; Foster KR, 2000, MOL ECOL, V9, P735, DOI 10.1046/j.1365-294x.2000.00920.x; Foster KR, 2001, AM NAT, V158, P615, DOI 10.1086/323588; FRANK SA, 1987, BEHAV ECOL SOCIOBIOL, V20, P195, DOI 10.1007/BF00299733; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; HEINZE J, 1993, P NATL ACAD SCI USA, V90, P8412, DOI 10.1073/pnas.90.18.8412; Heinze J, 1999, NATURWISSENSCHAFTEN, V86, P93, DOI 10.1007/s001140050579; Heinze J., 1997, Psyche (Cambridge), V102, P173, DOI 10.1155/1995/65249; Heinze J, 1998, INSECT SOC, V45, P113, DOI 10.1007/s000400050073; Heinze J, 2000, INSECT SOC, V47, P299, DOI 10.1007/PL00001719; Heinze J, 2001, BEHAV ECOL SOCIOBIOL, V50, P270, DOI 10.1007/s002650100353; Helantera H, 2009, BIOL LETTERS, V5, P700, DOI 10.1098/rsbl.2009.0501; HERBERS JM, 1990, AM NAT, V136, P178, DOI 10.1086/285091; HERBERS JM, 1979, AM NAT, V114, P818, DOI 10.1086/283531; Holldobler B., 1990, pi; KASPARI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P255, DOI 10.1007/s002650050189; Khila A, 2008, P NATL ACAD SCI USA, V105, P17884, DOI 10.1073/pnas.0807351105; Kim JY, 1999, BEHAV ECOL, V10, P552, DOI 10.1093/beheco/10.5.552; Kummerli R, 2009, BIOL LETTERS, V5, P713, DOI 10.1098/rsbl.2009.0295; Longino John T., 2003, Zootaxa, V151, P1; Mehdiabadi NJ, 2003, TRENDS ECOL EVOL, V18, P88, DOI 10.1016/S0169-5347(02)00056-3; Meunier J, 2008, BEHAV ECOL, V19, P382, DOI 10.1093/beheco/arm143; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; NONACS P, 1986, Q REV BIOL, V61, P1, DOI 10.1086/414723; PAMILO P, 1991, AM NAT, V137, P83, DOI 10.1086/285147; PAMILO P, 1993, HEREDITY, V70, P472, DOI 10.1038/hdy.1993.69; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Peeters C, 2013, ARTHROPOD STRUCT DEV, V42, P257, DOI 10.1016/j.asd.2013.02.003; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Rosenheim JA, 1996, AM NAT, V148, P501, DOI 10.1086/285937; Rosset H, 2006, CURR BIOL, V16, P328, DOI 10.1016/j.cub.2005.12.036; SCHMIDHEMPEL P, 1992, J EVOLUTION BIOL, V5, P1, DOI 10.1046/j.1420-9101.1992.5010001.x; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schrempf A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002592; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Smith CR, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_32.1; Smith CR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1479, DOI 10.1007/s00265-007-0380-8; Strohm E, 1997, P ROY SOC B-BIOL SCI, V264, P423, DOI 10.1098/rspb.1997.0060; Suefuji M, 2008, BIOL LETTERS, V4, P670, DOI 10.1098/rsbl.2008.0355; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tsuneoka Y, 2013, ENTOMOL SCI, V16, P259, DOI 10.1111/ens.12001; Wenseleers T, 2005, BIOL LETT-UK, V1, P125, DOI 10.1098/rsbl.2004.0281; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Yamauchi K, 2006, CURR BIOL, V16, P2424, DOI 10.1016/j.cub.2006.10.007; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	73	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75278	10.1371/journal.pone.0075278	http://dx.doi.org/10.1371/journal.pone.0075278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130699	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200007
J	Birke, K; Lipo, E; Birke, MT; Kumar-Singh, R				Birke, Kerstin; Lipo, Erion; Birke, Marco T.; Kumar-Singh, Rajendra			Topical Application of PPADS Inhibits Complement Activation and Choroidal Neovascularization in a Model of Age-Related Macular Degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEMBRANE-ATTACK-COMPLEX; FACTOR-H POLYMORPHISM; RECEPTOR; VEGF; IMMUNOLOGY; EXPRESSION; PAZOPANIB; DISEASE; RETINA	Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly. AMD patients have elevated levels of membrane attack complex (MAC) in their choroidal blood vessels and retinal pigment epithelium (RPE). MAC forms pores in cell membranes. Low levels of MAC result in an elevation of cytokine release such as vascular endothelial growth factor (VEGF) that promotes the formation of choroidal neovascularization (CNV). High levels of MAC result in cell lysis and RPE degeneration is a hallmark of advanced AMD. The current standard of care for CNV associated with wet AMD is intravitreal injection of anti-VEGF molecules every 4 to 12 weeks. Such injections have significant side effects. Recently, it has been found that membrane pore-forming proteins such as a-haemolysin can mediate their toxic effects through auto-and paracrine signaling and that complement-induced lysis is amplified through ATP release followed by P2X receptor activation. We hypothesized that attenuation of P2X receptor activation may lead to a reduction in MAC deposition and consequent formation of CNV. Hence, in this study we investigated topical application of the purinergic P2X antagonist Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) as a potential treatment for AMD. We found that 4.17 mu M PPADS inhibited formation of HUVEC master junctions and master segments by 74.7%. In a human complement mediated cell lysis assay, 104 mM PPADS enabled almost complete protection of Hepa1c1c7 cells from 1% normal human serum mediated cell lysis. Daily topical application of 4.17 mM PPADS for 3 days attenuated the progression of laser induced CNV in mice by 41.8% and attenuated the deposition of MAC at the site of the laser injury by 19.7%. Our data have implications for the future treatment of AMD and potentially other ocular disorders involving CNV such as angioid streaks, choroidal rupture and high myopia.	[Birke, Kerstin; Lipo, Erion; Birke, Marco T.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Kumar-Singh, R (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	Rajendra.Kumar-Singh@tufts.edu		Lipo, Erion/0000-0002-3179-0688; Kumar-Singh, Rajendra/0000-0002-7754-0713	Ellison Foundation; Virginia B Smith Trust; National Institute of Health/National Eye Institute [EY021805, EY013837]; Department of Defense/Telemedicine and Advanced Technology Research Center; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013837, R01EY021805] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Virginia B Smith Trust; National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Defense/Telemedicine and Advanced Technology Research Center(United States Department of Defense); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to R. K. S. from The Ellison Foundation, The Virginia B Smith Trust, The National Institute of Health/National Eye Institute (EY021805 and EY013837), The Department of Defense/Telemedicine and Advanced Technology Research Center and grants to the Department of Ophthalmology at Tufts University School of Medicine from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ament CS, 2006, ARCH OPHTHALMOL-CHIC, V124, P957, DOI 10.1001/archopht.124.7.957; Bee YS, 2010, MOL VIS, V16, P756; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Brand CS, 2012, EYE, V26, pS1, DOI 10.1038/eye.2012.32; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; Casten RJ, 2013, CURR OPIN OPHTHALMOL, V24, P239, DOI 10.1097/ICU.0b013e32835f8e55; Cloutier F, 2012, INVEST OPHTH VIS SCI, V53, P1195, DOI 10.1167/iovs.11-9064; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; DAVIES A, 1993, IMMUNOL RES, V12, P258, DOI 10.1007/BF02918257; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Georgalas Ilias, 2009, Ther Clin Risk Manag, V5, P81; Goldstein JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1028, DOI 10.1001/archophthalmol.2012.1197; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Iwase T, 2013, INVEST OPHTH VIS SCI, V54, P503, DOI 10.1167/iovs.12-10473; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; Kiuchi K, 2008, INVEST OPHTH VIS SCI, V49, P1705, DOI 10.1167/iovs.07-0089; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kunchithapautham K, 2012, ADV EXP MED BIOL, V723, P23, DOI 10.1007/978-1-4614-0631-0_4; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Montero JA, 2010, CURR DRUG TARGETS, V11, P630; Mullins RF, 2011, EXP EYE RES, V93, P565, DOI 10.1016/j.exer.2011.06.015; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Nishiguchi KM, 2012, INVEST OPHTH VIS SCI, V53, P508, DOI 10.1167/iovs.11-8425; Robbie SJ, 2013, INVEST OPHTH VIS SCI, V54, P1490, DOI 10.1167/iovs.12-10169; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sarman S, 2008, CURR EYE RES, V33, P285, DOI 10.1080/02713680701885470; Sheu SJ, 2009, MOL VIS, V15, P1897; Shima C, 2008, ACTA OPHTHALMOL, V86, P372, DOI 10.1111/j.1600-0420.2007.01067.x; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu L, 2008, GRAEF ARCH CLIN EXP, V246, P81, DOI 10.1007/s00417-007-0660-z; Wu T, 2011, AM J PHYSIOL-HEART C, V301, pH69, DOI 10.1152/ajpheart.01035.2010; Yafai Y, 2011, EUR J PHARMACOL, V666, P12, DOI 10.1016/j.ejphar.2011.05.016	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76766	10.1371/journal.pone.0076766	http://dx.doi.org/10.1371/journal.pone.0076766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130789	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900083
J	Castoria, G; Giovannelli, P; Di Donato, M; Hayashi, R; Arra, C; Appella, E; Auricchio, F; Migliaccio, A				Castoria, Gabriella; Giovannelli, Pia; Di Donato, Marzia; Hayashi, Ryo; Arra, Claudio; Appella, Ettore; Auricchio, Ferdinando; Migliaccio, Antimo			Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells	PLOS ONE			English	Article							DEPENDENT NUCLEAR EXPORT; SOFT-TISSUE SARCOMAS; BREAST-CANCER CELLS; ESTRADIOL-RECEPTOR; MATRIX METALLOPROTEINASES; DNA-SYNTHESIS; STEROID-RECEPTORS; GROWTH; SRC; PEPTIDE	Background: Hormones and growth factors influence the proliferation and invasiveness of human mesenchymal tumors. The highly aggressive human fibrosarcoma HT1080 cell line harbors classical androgen receptor (AR) that responds to androgens triggering cell migration in the absence of significant mitogenesis. As occurs in many human cancer cells, HT1080 cells also express epidermal growth factor receptor (EGFR). Experimental: Findings: We report that the pure anti-androgen Casodex inhibits the growth of HT1080 cell xenografts in immune-depressed mice, revealing a novel role of AR in fibrosarcoma progression. In HT1080 cultured cells EGF, but not androgens, robustly increases DNA synthesis. Casodex abolishes the EGF mitogenic effect, implying a crosstalk between EGFR and AR. The mechanism underlying this crosstalk has been analyzed using an AR-derived small peptide, S1, which prevents AR/Src tyrosine kinase association and androgen-dependent Src activation. Present findings show that in HT1080 cells EGF induces AR/Src Association, and the S1 peptide abolishes both the assembly of this complex and Src activation. The S1 peptide inhibits EGF-stimulated DNA synthesis, cell matrix metalloproteinase-9 (MMP-9) secretion and invasiveness of HT1080 cells. Both Casodex and S1 peptide also prevent DNA synthesis and migration triggered by EGF in various human cancer-derived cells (prostate, breast, colon and pancreas) that express AR. Conclusion: This study shows that targeting the AR domain involved in AR/ Src association impairs EGF signaling in human fibrosarcoma HT1080 cells. The EGF-elicited processes inhibited by the peptide (DNA synthesis, MMP-9 secretion and invasiveness) cooperate in increasing the aggressive phenotype of HT1080 cells. Therefore, AR represents a new potential therapeutic target in human fibrosarcoma, as supported by Casodex inhibition of HT1080 cell xenografts. The extension of these findings in various human cancer-derived cell lines highlights the conservation of this process across divergent cancer cells and identifies new potential targets in the therapeutic approach to human cancers.	[Castoria, Gabriella; Giovannelli, Pia; Di Donato, Marzia; Auricchio, Ferdinando; Migliaccio, Antimo] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Arra, Claudio] Ist Diag & Cura Tumori Fdn G Pascale, Naples, Italy; [Hayashi, Ryo; Appella, Ettore] NCI, Cell Biol Lab, Bethesda, MD 20892 USA	Universita della Campania Vanvitelli; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Migliaccio, A (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	antimo.migliaccio@unina2.it	Giovannelli, Pia/J-7931-2019; Migliaccio, Antimo/AAB-3376-2019; Castoria, Gabriella/I-3349-2019; Di Donato, Marzia/M-3114-2018	Castoria, Gabriella/0000-0002-0576-4494; Arra, Claudio/0000-0003-3162-2091; Di Donato, Marzia/0000-0001-7207-826X; Giovannelli, Pia/0000-0002-2488-917X; Migliaccio, Antimo/0000-0002-4197-2055	Italian Association for Cancer Research (A.I.R.C.) [IG 11520]; Italian Ministry for University and Scientific Research (P.R.I.N) [2010NFEB9L_002]; A.I.R.C.	Italian Association for Cancer Research (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research (P.R.I.N)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); A.I.R.C.(Fondazione AIRC per la ricerca sul cancro)	The Italian Association for Cancer Research (A.I.R.C.; grant number IG 11520 to AM), and the Italian Ministry for University and Scientific Research (P.R.I.N 2010-2011; grant number 2010NFEB9L_002 to GC) funded this work. Pia Giovannelli is supported by a fellowship from A.I.R.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogush TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1421, DOI 10.1134/S0006297910120011; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, STEROIDS, V69, P517, DOI 10.1016/j.steroids.2004.05.001; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHAUDHURI PK, 1980, CANCER RES, V40, P861; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; DiDomenico M, 1996, CANCER RES, V56, P4516; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GUSTERSON B, 1985, INT J CANCER, V36, P689; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 2011, METHODS MOL BIOL, V776, P361, DOI 10.1007/978-1-61779-243-4_21; Migliaccio A, 2010, MOL CELL ENDOCRINOL, V327, P19, DOI 10.1016/j.mce.2010.06.014; Okitsu Kohichiroh, 2010, Genes Cancer, V1, P859, DOI 10.1177/1947601910383417; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; Ren WH, 2008, CLIN CANCER RES, V14, P2785, DOI 10.1158/1078-0432.CCR-07-4471; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stabile LP, 2002, CANCER RES, V62, P2141; Vanderschueren D, 2008, CURR OPIN ENDOCRINOL, V15, P250, DOI 10.1097/MED.0b013e3282fe6ca9; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298	28	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76899	10.1371/journal.pone.0076899	http://dx.doi.org/10.1371/journal.pone.0076899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130806	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900100
J	Tompkins, VS; Han, SS; Olivier, A; Syrbu, S; Bair, T; Button, A; Jacobus, L; Wang, ZB; Lifton, S; Raychaudhuri, P; Morse, HC; Weiner, G; Link, B; Smith, BJ; Janz, S				Tompkins, Van S.; Han, Seong-Su; Olivier, Alicia; Syrbu, Sergei; Bair, Thomas; Button, Anna; Jacobus, Laura; Wang, Zebin; Lifton, Samuel; Raychaudhuri, Pradip; Morse, Herbert C., III; Weiner, George; Link, Brian; Smith, Brian J.; Janz, Siegfried			Identification of Candidate B-Lymphoma Genes by Cross-Species Gene Expression Profiling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; PLASMA-CELL NEOPLASMS; C-MYC; BURKITTS-LYMPHOMA; TUMOR-SUPPRESSOR; CANCER; TARGET; PROGRESSION; CYCLE; RESISTANCE	Comparative genome-wide expression profiling of malignant tumor counterparts across the human-mouse species barrier has a successful track record as a gene discovery tool in liver, breast, lung, prostate and other cancers, but has been largely neglected in studies on neoplasms of mature B-lymphocytes such as diffuse large B cell lymphoma (DLBCL) and Burkitt lymphoma (BL). We used global gene expression profiles of DLBCL-like tumors that arose spontaneously in Myc-transgenic C57BL/6 mice as a phylogenetically conserved filter for analyzing the human DLBCL transcriptome. The human and mouse lymphomas were found to have 60 concordantly deregulated genes in common, including 8 genes that Cox hazard regression analysis associated with overall survival in a published landmark dataset of DLBCL. Genetic network analysis of the 60 genes followed by biological validation studies indicate FOXM1 as a candidate DLBCL and BL gene, supporting a number of studies contending that FOXM1 is a therapeutic target in mature B cell tumors. Our findings demonstrate the value of the "mouse filter" for genomic studies of human B-lineage neoplasms for which a vast knowledge base already exists.	[Tompkins, Van S.; Han, Seong-Su; Olivier, Alicia; Syrbu, Sergei; Lifton, Samuel; Janz, Siegfried] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Bair, Thomas] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Button, Anna; Smith, Brian J.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; [Jacobus, Laura; Weiner, George; Link, Brian] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Syrbu, Sergei; Jacobus, Laura; Weiner, George; Link, Brian; Smith, Brian J.; Janz, Siegfried] Univ Iowa, Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA; [Wang, Zebin; Raychaudhuri, Pradip] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA; [Lifton, Samuel] Univ Iowa, Dept Stat & Actuarial Sci, Coll Liberal Arts & Sci, Iowa City, IA 52242 USA; [Morse, Herbert C., III] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Janz, S (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.	siegfried-janz@uiowa.edu	Tompkins, Van/A-5757-2018	Tompkins, Van/0000-0003-1279-8075; weiner, george/0000-0003-3427-0562; Link, Brian/0000-0001-5084-0698; Button, Anna/0000-0002-8540-6047; Morse, Herbert/0000-0002-9331-3705; Han, Seong-Su/0000-0001-9824-6751; Syrbu, Sergei/0000-0003-4620-7923	UI/MC Lymphoma SPORE [5 P50 CA097274]; American Cancer Society [PF0818001L2B]; NIH [T32 HL07734]; Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations; NCI [R01CA151354]; NIH, National institute of Allergy and Infectious Diseases (HCM); NATIONAL CANCER INSTITUTE [R01CA151354, P50CA097274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	UI/MC Lymphoma SPORE; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National institute of Allergy and Infectious Diseases (HCM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Developmental Research Award of the UI/MC Lymphoma SPORE 5 P50 CA097274 to SJ. VST was supported by Postdoctoral Fellowship PF0818001L2B from the American Cancer Society and NIH T32 HL07734. This work was also supported, in part, by research awards from the Multiple Myeloma Research and International Waldenstrom's Macroglobulinemia Foundations (SJ) and R01CA151354 from the NCI (SJ), as well as the Intramural Research Program of the NIH, National institute of Allergy and Infectious Diseases (HCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2010, HUM PATHOL, V41, P1448, DOI 10.1016/j.humpath.2010.04.001; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andreasson U, 2009, AM J HEMATOL, V84, P803, DOI 10.1002/ajh.21549; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Chan MM, 2005, CARCINOGENESIS, V26, P1343, DOI 10.1093/carcin/bgi100; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frontini M, 2012, DEV CELL, V23, P356, DOI 10.1016/j.devcel.2012.06.018; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Green MR, 2011, GENE CHROMOSOME CANC, V50, P313, DOI 10.1002/gcc.20856; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hsu PL, 1998, CANCER RES, V58, P5507; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Janz Siegfried, 2008, P179, DOI 10.1007/978-0-387-69132-9_8; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kass DJ, 2011, CYTOKINE, V55, P325, DOI 10.1016/j.cyto.2011.05.021; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kramer MHH, 1996, J CLIN ONCOL, V14, P2131, DOI 10.1200/JCO.1996.14.7.2131; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mancina RM, 2013, DIABETES-METAB RES, V29, P413, DOI 10.1002/dmrr.2408; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nadler-Holly M, 2012, P NATL ACAD SCI USA, V109, P18833, DOI 10.1073/pnas.1209277109; OFFIT K, 1991, GENE CHROMOSOME CANC, V3, P189, DOI 10.1002/gcc.2870030304; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Rhodes DR, 2004, ANN NY ACAD SCI, V1020, P32, DOI 10.1196/annals.1310.005; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Uddin S, 2012, HAEMATOL-HEMATOL J, V97, P1092, DOI 10.3324/haematol.2011.053421; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Zhao L, 2003, MOL CANCER RES, V1, P195	66	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76889	10.1371/journal.pone.0076889	http://dx.doi.org/10.1371/journal.pone.0076889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130802	Green Published, gold			2022-12-25	WOS:000325810900097
J	Leyton, PA; Beppu, H; Pappas, A; Martyn, TM; Derwall, M; Baron, DM; Galdos, R; Bloch, DB; Bloch, KD				Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Galdos, Rita; Bloch, Donald B.; Bloch, Kenneth D.			Deletion of the Sequence Encoding the Tail Domain of the Bone Morphogenetic Protein type 2 Receptor Reveals a Bone Morphogenetic Protein 7-Specific Gain of Function	PLOS ONE			English	Article							PRIMARY PULMONARY-HYPERTENSION; II RECEPTOR; ARTERIAL-HYPERTENSION; INCREASED SUSCEPTIBILITY; SIGNAL-TRANSDUCTION; MICE; BMPR2; MUTATIONS; GENERATION; CLONING	The bone morphogenetic protein (BMP) type II receptor (BMPR2) has a long cytoplasmic tail domain whose function is incompletely elucidated. Mutations in the tail domain of BMPR2 are found in familial cases of pulmonary arterial hypertension. To investigate the role of the tail domain of BMPR2 in BMP signaling, we generated a mouse carrying a Bmpr2 allele encoding a non-sense mediated decay-resistant mutant receptor lacking the tail domain of Bmpr2. We found that homozygous mutant mice died during gastrulation, whereas heterozygous mice grew normally without developing pulmonary arterial hypertension. Using pulmonary artery smooth muscle cells (PaSMC) from heterozygous mice, we determined that the mutant receptor was expressed and retained its ability to transduce BMP signaling. Heterozygous PaSMCs exhibited a BMP7-specific gain of function, which was transduced via the mutant receptor. Using siRNA knockdown and cells from conditional knockout mice to selectively deplete BMP receptors, we observed that the tail domain of Bmpr2 inhibits Alk2-mediated BMP7 signaling. These findings suggest that the tail domain of Bmpr2 is essential for normal embryogenesis and inhibits Alk2-mediated BMP7 signaling in PaSMCs.	[Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Bloch, Donald B.; Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Leyton, Patricio A.; Beppu, Hideyuki; Pappas, Alexandra; Martyn, Trejeeve M.; Derwall, Matthias; Baron, David M.; Galdos, Rita; Bloch, Donald B.; Bloch, Kenneth D.] Harvard Univ, Sch Med, Boston, MA USA; [Beppu, Hideyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Lab & Mol Pathol, Toyama 930, Japan; [Derwall, Matthias] Rhein Westfal TH Aachen, Uniklin Aachen, Dept Anesthesiol, Aachen, North Rhine Wes, Germany; [Baron, David M.] Med Univ Vienna, Dept Anesthesia Gen Intens Care & Pain Management, Vienna, Austria; [Galdos, Rita; Bloch, Donald B.] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toyama; RWTH Aachen University; RWTH Aachen University Hospital; Medical University of Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Leyton, PA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA.	pleyton@partners.org	Leyton, Patricio/GSM-6747-2022	Bloch, Donald/0000-0002-6828-4754	National Institutes of Health Heart, Lung and Blood Institute [HL074352]; Deutsche Forschungsgemeinschaft [DE-1685-1/1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074352] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from National Institutes of Health Heart, Lung and Blood Institute HL074352, http://www.nhlbi.nih.gov, DE-1685-1/1, Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decisio to publish, or preparation of the manuscript.	Aoki H, 2001, J CELL SCI, V114, P1483; Aramaki T, 2010, DEV CELL, V19, P547, DOI 10.1016/j.devcel.2010.09.001; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Fessel Joshua P, 2011, Pulm Circ, V1, P305, DOI 10.4103/2045-8932.87293; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nasim MT, 2012, HUM MOL GENET, V21, P2548, DOI 10.1093/hmg/dds073; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76947	10.1371/journal.pone.0076947	http://dx.doi.org/10.1371/journal.pone.0076947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116187	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200087
J	Trefz, P; Koehler, H; Klepik, K; Moebius, P; Reinhold, P; Schubert, JK; Miekisch, W				Trefz, Phillip; Koehler, Heike; Klepik, Klaus; Moebius, Petra; Reinhold, Petra; Schubert, Jochen K.; Miekisch, Wolfram			Volatile Emissions from Mycobacterium avium subsp paratuberculosis Mirror Bacterial Growth and Enable Distinction of Different Strains	PLOS ONE			English	Article							RESTRICTION ENDONUCLEASE ANALYSIS; SHORT-SEQUENCE-REPEAT; IN-VITRO; MYCOLIC ACIDS; MOBILITY SPECTROMETRY; ASPERGILLUS-FUMIGATUS; RADIOMETRIC CULTURE; CYTOKINE RESPONSES; DNA HYBRIDIZATION; ORGANIC-COMPOUNDS	Control of paratuberculosis in livestock is hampered by the low sensitivity of established direct and indirect diagnostic methods. Like other bacteria, Mycobacterium avium subsp. paratuberculosis (MAP) emits volatile organic compounds (VOCs). Differences of VOC patterns in breath and feces of infected and not infected animals were described in first pilot experiments but detailed information on potential marker substances is missing. This study was intended to look for characteristic volatile substances in the headspace of cultures of different MAP strains and to find out how the emission of VOCs was affected by density of bacterial growth. One laboratory adapted and four field strains, three of MAP C-type and one MAP S-type were cultivated on Herrold's egg yolk medium in dilutions of 10(-0), 10(-2), 10(-4) and 10(-6). Volatile substances were pre-concentrated from the headspace over the MAP cultures by means of Solid Phase Micro Extraction (SPME), thermally desorbed from the SPME fibers and separated and identified by means of GC-MS. Out of the large number of compounds found in the headspace over MAP cultures, 34 volatile marker substances could be identified as potential biomarkers for growth and metabolic activity. All five MAP strains could clearly be distinguished from blank culture media by means of emission patterns based on these 34 substances. In addition, patterns of volatiles emitted by the reference strain were significantly different from the field strains. Headspace concentrations of 2-ethylfuran, 2-methylfuran, 3-methylfuran, 2-pentylfuran, ethyl acetate, 1-methyl-1-H-pyrrole and dimethyldisulfide varied with density of bacterial growth. Analysis of VOCs emitted from mycobacterial cultures can be used to identify bacterial growth and, in addition, to differentiate between different bacterial strains. VOC emission patterns may be used to approximate bacterial growth density. In a perspective volatile marker substances could be used to diagnose MAP infections in animals and to identify different bacterial strains and origins.	[Trefz, Phillip; Klepik, Klaus; Schubert, Jochen K.; Miekisch, Wolfram] Univ Rostock, Dept Anaesthesia & Intens Care, D-18055 Rostock, Germany; [Koehler, Heike; Moebius, Petra; Reinhold, Petra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	University of Rostock; Friedrich Loeffler Institute	Miekisch, W (corresponding author), Univ Rostock, Dept Anaesthesia & Intens Care, D-18055 Rostock, Germany.	wolfram.miekisch@uni-rostock.de	Miekisch, Wolfram/I-1300-2019; Schubert, Jochen/F-4788-2016	Schubert, Jochen/0000-0002-0956-9506; Trefz, Phillip/0000-0001-6138-6515; Mobius, Petra/0000-0002-5574-2998; Miekisch, Wolfram/0000-0003-1619-0315	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [SCHU 1960/4-1, RE 1098/4-1]	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by German Research Foundation (DFG, Deutsche Forschungsgemeinschaft, SCHU 1960/4-1, RE 1098/4-1) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Biet F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-264; BORJESSON T, 1992, APPL ENVIRON MICROB, V58, P2599; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Bull TJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-11; Chambers ST, 2009, MED MYCOL, V47, P468, DOI 10.1080/13693780802475212; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; COLLINS DM, 1990, J CLIN MICROBIOL, V28, P1591, DOI 10.1128/JCM.28.7.1591-1596.1990; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; Collins MT, 1996, VET CLIN N AM-FOOD A, V12, P357, DOI 10.1016/S0749-0720(15)30411-4; de Juan L, 2006, VET MICROBIOL, V115, P102, DOI 10.1016/j.vetmic.2006.01.008; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; DELISLE GW, 1992, ONDERSTEPOORT J VET, V59, P163; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Farhana A, 2012, ANTIOXID REDOX SIGN, V17, P1232, DOI 10.1089/ars.2012.4613; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Gumber S, 2007, VET MICROBIOL, V119, P42, DOI 10.1016/j.vetmic.2006.08.009; Harris NB, 2005, J VET DIAGN INVEST, V17, P554, DOI 10.1177/104063870501700605; Janagama HK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-268; Janagama HK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-10; Junger M, 2012, APPL MICROBIOL BIOT, V93, P2603, DOI 10.1007/s00253-012-3924-4; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Koehler H, 2008, MAGYAR ALLATORVOSOK, V130, P67; Mobius P, 2008, VET MICROBIOL, V126, P324, DOI 10.1016/j.vetmic.2007.07.016; Pavlou AK, 2004, BIOSENS BIOELECTRON, V20, P538, DOI 10.1016/j.bios.2004.03.002; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295, DOI 10.1128/AEM.62.4.1295-1299.1996; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Rafidinarivo E, 2009, J LIPID RES, V50, P477, DOI 10.1194/jlr.M800384-JLR200; Reddacliff LA, 2003, APPL ENVIRON MICROB, V69, P3510, DOI 10.1128/AEM.69.6.3510-3516.2003; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Shnayderman M, 2005, ANAL CHEM, V77, P5930, DOI 10.1021/ac050348i; Stich RW, 2004, J MICROBIOL METH, V56, P267, DOI 10.1016/j.mimet.2003.10.013; Svistunenko DA, 2012, BIOCHIMIE, V94, P1274, DOI 10.1016/j.biochi.2012.02.021; Syhre M, 2008, MED MYCOL, V46, P209, DOI 10.1080/13693780701753800; Syhre M, 2008, TUBERCULOSIS, V88, P317, DOI 10.1016/j.tube.2008.01.002; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Thibault VC, 2008, J CLIN MICROBIOL, V46, P4091, DOI 10.1128/JCM.01349-08; Whittington RJ, 1999, J CLIN MICROBIOL, V37, P1077, DOI 10.1128/JCM.37.4.1077-1083.1999; Whittington RJ, 1998, J CLIN MICROBIOL, V36, P701, DOI 10.1128/JCM.36.3.701-707.1998; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; Zhou LX, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/193963	53	40	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76868	10.1371/journal.pone.0076868	http://dx.doi.org/10.1371/journal.pone.0076868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116177	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200081
J	Dhingra, S; Lind, AL; Lin, HC; Tang, Y; Rokas, A; Calvo, AM				Dhingra, Sourabh; Lind, Abigail L.; Lin, Hsiao-Ching; Tang, Yi; Rokas, Antonis; Calvo, Ana M.			The Fumagillin Gene Cluster, an Example of Hundreds of Genes under veA Control in Aspergillus fumigatus	PLOS ONE			English	Article							FUNGAL METABOLITE GLIOTOXIN; CELL TRANSPLANT RECIPIENTS; VELVET-LIKE COMPLEX; SECONDARY METABOLISM; INVASIVE ASPERGILLOSIS; SCLEROTIAL PRODUCTION; IMPORTIN-ALPHA; BIOSYNTHESIS; NIDULANS; REGULATOR	Aspergillus fumigatus is the causative agent of invasive aspergillosis, leading to infection-related mortality in immunocompromised patients. We previously showed that the conserved and unique-to-fungi veA gene affects different cell processes such as morphological development, gliotoxin biosynthesis and protease activity, suggesting a global regulatory effect on the genome of this medically relevant fungus. In this study, RNA sequencing analysis revealed that veA controls the expression of hundreds of genes in A. fumigatus, including those comprising more than a dozen known secondary metabolite gene clusters. Chemical analysis confirmed that veA controls the synthesis of other secondary metabolites in this organism in addition to gliotoxin. Among the secondary metabolite gene clusters regulated by veA is the elusive but recently identified gene cluster responsible for the biosynthesis of fumagillin, a meroterpenoid known for its anti-angiogenic activity by binding to human methionine aminopeptidase 2. The fumagillin gene cluster contains a veA-dependent regulatory gene, fumR (Afu8g00420), encoding a putative C6 type transcription factor. Deletion of fumR results in silencing of the gene cluster and elimination of fumagillin biosynthesis. We found expression of fumR to also be dependent on laeA, a gene encoding another component of the fungal velvet complex. The results in this study argue that veA is a global regulator of secondary metabolism in A. fumigatus, and that veA may be a conduit via which chemical development is coupled to morphological development and other cellular processes.	[Dhingra, Sourabh; Calvo, Ana M.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Lind, Abigail L.; Rokas, Antonis] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Lin, Hsiao-Ching; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Northern Illinois University; Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vanderbilt University	Calvo, AM (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	National Institutes of Health (NIH) [R03AI079496]; Northern Illinois University; NLM training grant [2T15LM007450]; Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI079496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106413] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern Illinois University; NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by National Institutes of Health (NIH) R03AI079496 and Northern Illinois University to AMC, a NLM training grant 2T15LM007450 to ALL, and a Vanderbilt Discovery Grant to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; AMITANI R, 1995, INFECT IMMUN, V63, P3266, DOI 10.1128/IAI.63.9.3266-3271.1995; Araujo-Bazan L, 2009, FUNGAL GENET BIOL, V46, P506, DOI 10.1016/j.fgb.2009.03.006; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Cary JW, 2007, APPL MICROBIOL BIOT, V76, P1107, DOI 10.1007/s00253-007-1081-y; Comera C, 2007, MICROBES INFECT, V9, P47, DOI 10.1016/j.micinf.2006.10.009; Coyle CM, 2005, APPL ENVIRON MICROB, V71, P3112, DOI 10.1128/AEM.71.6.3112-3118.2005; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran R. M., 2009, Open Mycology Journal, V3, P27, DOI 10.2174/1874437000903010027; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; FRAME R, 1988, TOXICOL LETT, V40, P269, DOI 10.1016/0378-4274(88)90050-1; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gibbons JG, 2012, CURR BIOL, V22, P1403, DOI 10.1016/j.cub.2012.05.033; Gibbons JG, 2012, EUKARYOT CELL, V11, P68, DOI 10.1128/EC.05102-11; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; KILLOUGH JH, 1952, SCIENCE, V115, P71, DOI 10.1126/science.115.2977.71; Klyasova GA, 2005, TERAPEVT ARKH, V77, P65; Kontoyiannis DP, 2002, EUR J CLIN MICROBIOL, V21, P161, DOI 10.1007/s10096-002-0699-z; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lefkove B, 2007, EXPERT REV ANTI-INFE, V5, P573, DOI 10.1586/14787210.5.4.573; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim FY, 2012, APPL ENVIRON MICROB, V78, P4117, DOI 10.1128/AEM.07710-11; Lin HC, 2013, J AM CHEM SOC, V135, P4616, DOI 10.1021/ja312503y; Lodeiro S, 2009, ORG LETT, V11, P1241, DOI 10.1021/ol802696a; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Molina JM, 2002, NEW ENGL J MED, V346, P1963, DOI 10.1056/NEJMoa012924; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLBACHER A, 1984, P NATL ACAD SCI-BIOL, V81, P3835, DOI 10.1073/pnas.81.12.3835; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Myung K, 2009, J AGR FOOD CHEM, V57, P5089, DOI 10.1021/jf900783u; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oren I, 2002, CURR OPIN PULM MED, V8, P195, DOI 10.1097/00063198-200205000-00008; Pagano L, 2001, HAEMATOLOGICA, V86, P862; Palmer JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003193; Pan XQ, 2007, IN VIVO, V21, P259; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Park HB, 2009, J NAT PROD, V72, P248, DOI 10.1021/np800606e; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PIVA TJ, 1994, BIOCHEM MOL BIOL INT, V33, P411; Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Richard JL, 1996, MYCOPATHOLOGIA, V134, P167, DOI 10.1007/BF00436725; Rokas A, 2012, ANN NY ACAD SCI, V1273, P25, DOI 10.1111/j.1749-6632.2012.06755.x; Ruchel R, 1999, Contrib Microbiol, V2, P21; Sambrook J., 2001, MOL CLONING LAB MANU; Samson R A, 1999, Contrib Microbiol, V2, P5; SCHMITT HJ, 1990, MYCOSES, V33, P539, DOI 10.1111/myc.1990.33.11-12.539; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherif R, 2010, CURR OPIN PULM MED, V16, P242, DOI 10.1097/MCP.0b013e328337d6de; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sprote P, 2007, ARCH MICROBIOL, V188, P69, DOI 10.1007/s00203-007-0224-y; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Suen YK, 2001, FREE RADICAL RES, V35, P1, DOI 10.1080/10715760100300541; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsunawaki S, 2004, INFECT IMMUN, V72, P3373, DOI 10.1128/IAI.72.6.3373-3382.2004; Wallwey C, 2010, ORG BIOMOL CHEM, V8, P3500, DOI 10.1039/c003823g; WARING P, 1990, J BIOL CHEM, V265, P14476; Wiederhold NP, 2003, PHARMACOTHERAPY, V23, P1592, DOI 10.1592/phco.23.15.1592.31965; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Yamada A, 2000, IMMUNOL LETT, V71, P27, DOI 10.1016/S0165-2478(99)00155-8; YAMAZAKI M, 1980, CHEM PHARM BULL, V28, P245, DOI 10.1248/cpb.28.245; Yoshida LS, 2000, BIOCHEM BIOPH RES CO, V268, P716, DOI 10.1006/bbrc.2000.2192; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	89	32	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77147	10.1371/journal.pone.0077147	http://dx.doi.org/10.1371/journal.pone.0077147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116213	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300116
J	Gritsch, K; Laroche, N; Bonnet, JM; Exbrayat, P; Morgon, L; Rabilloud, M; Grosgogeat, B				Gritsch, Kerstin; Laroche, Norbert; Bonnet, Jeanne-Marie; Exbrayat, Patrick; Morgon, Laurent; Rabilloud, Muriel; Grosgogeat, Brigitte			In Vivo Evaluation of Immediately Loaded Stainless Steel and Titanium Orthodontic Screws in a Growing Bone	PLOS ONE			English	Article							MINISCREW IMPLANTS; MINI-IMPLANTS; HISTOLOGICAL-EVALUATION; SKELETAL ANCHORAGE; MINERAL DENSITY; ORAL IMPLANTS; ALVEOLAR BONE; BEAGLE DOG; PIG; ADOLESCENTS	The present work intends to evaluate the use of immediate loaded orthodontic screws in a growing model, and to study the specific bone response. Thirty-two screws (half of stainless steel and half of titanium) were inserted in the alveolar bone of 8 growing pigs. The devices were immediately loaded with a 100 g orthodontic force. Two loading periods were assessed: 4 and 12 weeks. Both systems of screws were clinically assessed. Histological observations and histomorphometric analysis evaluated the percent of "bone-to-implant contact" and static and dynamic bone parameters in the vicinity of the devices (test zone) and in a bone area located 1.5 cm posterior to the devices (control zone). Both systems exhibit similar responses for the survival rate; 87.5% and 81.3% for stainless steel and titanium respectively (p = 0.64; 4-week period), and 62.5% and 50.0% for stainless steel and titanium respectively (p = 0.09; 12-week period). No significant differences between the devices were found regarding the percent of "bone-to-implant contact" (p = 0.1) or the static and dynamic bone parameters. However, the 5% threshold of "bone-to-implant contact" was obtained after 4 weeks with the stainless steel devices, leading to increased survival rate values. Bone in the vicinity of the miniscrew implants showed evidence of a significant increase in bone trabecular thickness when compared to bone in the control zone (p = 0.05). In our study, it is likely that increased trabecular thickness is a way for low density bone to respond to the stress induced by loading.	[Gritsch, Kerstin; Grosgogeat, Brigitte] Univ Lyon, Fac Odontol Lyon, CNRS, Lab Multimat & Interfaces,UMR 5615, Lyon, France; [Gritsch, Kerstin; Exbrayat, Patrick; Morgon, Laurent; Rabilloud, Muriel; Grosgogeat, Brigitte] Hosp Civils Lyon, Lyon, France; [Laroche, Norbert] Univ St Etienne, Fac Med, INSERM, Lab Biol Integrat Tissu Osseux,U890, St Etienne, France; [Bonnet, Jeanne-Marie] Univ Lyon, Agress Vasc & Reponses Tissulaires INSERM ERI22 E, Lyon, France; [Rabilloud, Muriel] Univ Lyon, CNRS, UMR 5558, Lab Biostat Sante, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Gritsch, K (corresponding author), Univ Lyon, Fac Odontol Lyon, CNRS, Lab Multimat & Interfaces,UMR 5615, Lyon, France.	kerstin.gritsch@univ-lyon1.fr	GROSGOGEAT, Brigitte/AAE-2810-2019; Gritsch, Kerstin/ABF-8626-2020	GROSGOGEAT, Brigitte/0000-0003-2194-7300; Gritsch, Kerstin/0000-0001-7027-3731; Bonnet Garin, Jeanne-Marie/0000-0001-5350-338X				Antoszewska J, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.03.031, 10.1016/j.ajodo.2009.03.032]; Bouvier M, 1996, ARCH ORAL BIOL, V41, P941, DOI 10.1016/S0003-9969(96)00047-7; Buchter A, 2006, CLIN ORAL IMPLAN RES, V17, P714, DOI 10.1111/j.1600-0501.2006.01233.x; Carano Aldo, 2005, Prog Orthod, V6, P82; Cha JY, 2010, AM J ORTHOD DENTOFAC, V137, P73, DOI 10.1016/j.ajodo.2008.03.024; CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0; Chen YJ, 2007, CLIN ORAL IMPLAN RES, V18, P768, DOI 10.1111/j.1600-0501.2007.01405.x; Christensen FB, 2000, EUR SPINE J, V9, P97, DOI 10.1007/s005860050218; Chung Kyu-Rhim, 2004, J Clin Orthod, V38, P478; Ciochon RL, 1997, J CRAN GENET DEV BIO, V17, P96; Cope J.B., 2005, SEMIN ORTHOD, V11, P3, DOI [10.1053/j.sodo.2004.11.002, DOI 10.1053/J.SODO.2004.11.002]; Cornelis MA, 2008, CLIN ORAL IMPLAN RES, V19, P1054, DOI 10.1111/j.1600-0501.2008.01553.x; Cornelis MA, 2010, ORTHOD CRANIOFAC RES, V13, P21, DOI 10.1111/j.1601-6343.2009.01468.x; Deguchi T, 2003, J DENT RES, V82, P377, DOI 10.1177/154405910308200510; Eliades T, 2009, AM J ORTHOD DENTOFAC, V135, P10, DOI 10.1016/j.ajodo.2008.09.018; Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x; Florvaag B, 2010, J OROFAC ORTHOP, V71, P53, DOI 10.1007/s00056-010-9933-y; Garfinkle JS, 2008, AM J ORTHOD DENTOFAC, V133, P642, DOI 10.1016/j.ajodo.2006.04.053; Giancotti A, 2004, AM J ORTHOD DENTOFAC, V126, P113, DOI 10.1016/j.ajodo.2003.08.025; Kingsmill VJ, 2010, J DENT RES, V89, P510, DOI 10.1177/0022034510362970; Kuboki T, 1997, J DENT RES, V76, P1760, DOI 10.1177/00220345970760110701; Labanauskaite Birute, 2005, Stomatologija, V7, P128; Lin D, 2009, J MECH BEHAV BIOMED, V2, P410, DOI 10.1016/j.jmbbm.2008.11.007; Luzi C, 2009, EUR J ORTHODONT, V31, P21, DOI 10.1093/ejo/cjn087; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Melsen B, 2000, Clin Orthod Res, V3, P23, DOI 10.1034/j.1600-0544.2000.030105.x; Melsen B, 2001, CLIN ORAL IMPLAN RES, V12, P144, DOI 10.1034/j.1600-0501.2001.012002144.x; Melsen Birte, 2005, J Clin Orthod, V39, P539; MILLAR BG, 1990, BRIT J ORAL MAX SURG, V28, P92, DOI 10.1016/0266-4356(90)90129-9; MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693; Motoyoshi M, 2007, INT J ORAL MAX SURG, V36, P695, DOI 10.1016/j.ijom.2007.03.009; Ohmae M, 2001, AM J ORTHOD DENTOFAC, V119, P489, DOI 10.1067/mod.2001.114300; Ohnishi H, 2005, ANGLE ORTHOD, V75, P444; Oltramari PVP, 2007, VET J, V173, P399, DOI 10.1016/j.tvjl.2005.11.001; Papadopoulos MA, 2011, J DENT RES, V90, P969, DOI 10.1177/0022034511409236; Papadopoulos MA, 2007, ORAL SURG ORAL MED O, V103, pE6, DOI 10.1016/j.tripleo.2006.11.022; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park H S, 2001, J Clin Orthod, V35, P417; Park HS, 2005, ANGLE ORTHOD, V75, P602; POWELL K, 1973, ARCH ORAL BIOL, V18, P171, DOI 10.1016/0003-9969(73)90136-2; Proffit WR, 1993, CONT ORTHODONTICS; ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247; Roth S, 1997, ARCH ORAL BIOL, V42, P63, DOI 10.1016/S0003-9969(97)83718-1; Sarnat BG, 2007, J CRANIOFAC SURG, V18, P917, DOI 10.1097/scs.0b013e31806843d5; Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010; Traini T, 2009, CLIN IMPLANT DENT R, V11, P41, DOI 10.1111/j.1708-8208.2008.00086.x; Vannet BV, 2007, EUR J ORTHODONT, V29, P437, DOI 10.1093/ejo/cjm078; VONWOWERN N, 1980, SCAND J DENT RES, V88, P134; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Wang ZQ, 2010, AM J ORTHOD DENTOFAC, V137, P100, DOI 10.1016/j.ajodo.2008.01.025; Willems NMBK, 2007, J STRUCT BIOL, V158, P421, DOI 10.1016/j.jsb.2006.12.011; Wu JC, 2007, AM J ORTHOD DENTOFAC, V132, P353, DOI 10.1016/j.ajodo.2006.10.021; Zhang LK, 2010, ANGLE ORTHOD, V80, P354, DOI 10.2319/021909-106.1	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76223	10.1371/journal.pone.0076223	http://dx.doi.org/10.1371/journal.pone.0076223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124540	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100097
J	Jang, BG; Choi, BY; Kim, JH; Kim, MJ; Sohn, M; Suh, SW				Jang, Bong Geom; Choi, Bo Young; Kim, Jin Hee; Kim, Min-Ju; Sohn, Min; Suh, Sang Won			Impairment of Autophagic Flux Promotes Glucose Reperfusion-Induced Neuro2A Cell Death after Glucose Deprivation	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; MEDIATED CLEAVAGE; BRAIN INJURY; HYPOGLYCEMIA; APOPTOSIS; RAT; DEGRADATION; LYSOSOMES; DISEASE	Hypoglycemia-induced brain injury is a common and serious complication of intensive insulin therapy experienced by Type 1 diabetic patients. We previously reported that hypoglycemic neuronal death is triggered by glucose reperfusion after hypoglycemia rather than as a simple result of glucose deprivation. However, the precise mechanism of neuronal death initiated by glucose reperfusion is still unclear. Autophagy is a self-degradation process that acts through a lysosome-mediated trafficking pathway to degrade and recycle intracellular components, thereby regulating metabolism and energy production. Recent studies suggest that autophagic and lysosomal dysfunction leads to abnormal protein degradation and deposition that may contribute to neuronal death. Here, we focused on the relationship between autophagy and lysosomal dysfunction in hypoglycemia-induced neuronal death. In neuronal cells, glucose reperfusion after glucose deprivation resulted in inhibition of autophagy, which may promote cell death. This cell death was accompanied with activation of caspase3 and the lysosomal proteases cathepsin B and D, which indicated impairment of autophagic flux. Taken together, these results suggest that interplay of autophagy, caspase3 activation and lysosomal proteases serve as a basis for neuronal death after hypoglycemia. Thus, we provide the molecular mechanism of neuronal death by glucose reperfusion and suggest some clues for therapeutic strategies to prevent hypoglycemia-induced neuronal death.	[Jang, Bong Geom; Choi, Bo Young; Kim, Jin Hee; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon, South Korea; [Kim, Min-Ju] Hallym Univ, Dept Anat & Neurobiol, Coll Med, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea	Hallym University; Hallym University; Inha University	Suh, SW (corresponding author), Hallym Univ, Dept Physiol, Coll Med, Chunchon, South Korea.	swsuh@hallym.ac.kr		SOHN, MIN/0000-0003-4021-2051; Choi, Bo Young/0000-0002-9579-3503	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120202]; Hallym University Specialization Fund [HRF-S-41]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Hallym University Specialization Fund	This work was supported by the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120202) and by a grant from the Hallym University Specialization Fund (HRF-S-41) to S. W. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; CRYER PE, 1989, DIABETES, V38, P1193, DOI 10.2337/diabetes.38.9.1193; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davis EA, 1998, J PEDIATR ENDOCR MET, V11, P177; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; HALLENBECK JM, 1990, ARCH NEUROL-CHICAGO, V47, P1245, DOI 10.1001/archneur.1990.00530110107027; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marambio P, 2010, BBA-MOL BASIS DIS, V1802, P509, DOI 10.1016/j.bbadis.2010.02.002; Martinez-Vicente M, NAT NEUROSCI, V13, P567; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; NIXON RA, 1993, ANN NY ACAD SCI, V679, P87, DOI 10.1111/j.1749-6632.1993.tb18291.x; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sommerfield AJ, 2003, DIABETES CARE, V26, P390, DOI 10.2337/diacare.26.2.390; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2003, J NEUROSCI, V23, P10681; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; WIELOCH T, 1982, PATHOL BIOL, V30, P269; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	53	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76466	10.1371/journal.pone.0076466	http://dx.doi.org/10.1371/journal.pone.0076466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124562	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100119
J	Du, X; Chen, NLH; Wong, A; Craik, CS; Bromme, D				Du, Xin; Chen, Nelson L. H.; Wong, Andre; Craik, Charles S.; Broemme, Dieter			Elastin Degradation by Cathepsin V Requires Two Exosites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Elastin; Extracellular Matrix Proteins; Protein Degradation; Site-directed Mutagenesis; Elastase; Cathepsin V; Exosite; Substrate Specificity	LYSOSOMAL CYSTEINE PROTEASES; MATRIX METALLOPROTEINASE-12; TROPOELASTIN; SPECIFICITY; EXPRESSION; INHIBITOR	Background: Elastin degradation is a key event in various pathologies of the skin, lung, and the vascular system. Results: Elastin degradation by cathepsin V requires two exosites. Conclusion: Cathepsin exosites support the recognition of and binding to insoluble elastin. Significance: Exosites may represent novel target sites for the selective inhibition of the elastase activity of cathepsins. Cathepsin V is a highly effective elastase and has been implicated in physiological and pathological extracellular matrix degradation. However, its mechanism of action remains elusive. Whereas human cathepsin V exhibits a potent elastolytic activity, the structurally homologous cathepsin L, which shares a 78% amino acid sequence, has only a minimal proteolytic activity toward insoluble elastin. This suggests that there are distinct structural domains that play an important role in elastinolysis. In this study, a total of 11 chimeras of cathepsins V and L were generated to identify elastin-binding domains in cathepsin V. Evaluation of these chimeras revealed two exosites contributing to the elastolytic activity of cathepsin V that are distant from the active cleft of the protease and are located in surface loop regions. Replacement of exosite 1 or 2 with analogous residues from cathepsin L led to a 75 and 43% loss in the elastolytic activity, respectively. Replacement of both exosites yielded a non-elastase variant similar to that of cathepsin L. Identification of these exosites may contribute to the design of inhibitors that will only affect the elastolytic activity of cysteine cathepsins without interfering with other physiological protease functions.	[Du, Xin; Chen, Nelson L. H.; Broemme, Dieter] Univ British Columbia, Fac Med, Ctr Blood Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wong, Andre; Broemme, Dieter] Univ British Columbia, Fac Dent, Life Sci Ctr, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Craik, Charles S.] Univ Calif San Francisco, Program Chem & Chem Biol, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Craik, Charles S.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bromme, D (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall,Rm 4558, Vancouver, BC V6T 1Z3, Canada.	dbromme@dentistry.ubc.ca			Canadian Institutes of Health [MOP89974]; National Institutes of Health [R01 CA128765]; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported by Canadian Institutes of Health Research Grant MOP89974 (to D.B.) and National Institutes of Health Grant R01 CA128765 (to C.S.C.).	BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Hornebeck W, 2011, FRONT BIOSCI-LANDMRK, V16, P707, DOI 10.2741/3714; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Brun AP, 2012, BIOMACROMOLECULES, V13, P379, DOI 10.1021/bm201404x; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; Makrantonaki E, 2007, DERMATOLOGY, V214, P352, DOI 10.1159/000100890; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Robert L, 2008, BIOGERONTOLOGY, V9, P119, DOI 10.1007/s10522-007-9122-6; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200	30	33	34	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34871	34881		10.1074/jbc.M113.510008	http://dx.doi.org/10.1074/jbc.M113.510008			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121514	hybrid, Green Published			2022-12-25	WOS:000329812800054
J	Archer, E; Hand, GA; Blair, SN				Archer, Edward; Hand, Gregory A.; Blair, Steven N.			Validity of US Nutritional Surveillance: National Health and Nutrition Examination Survey Caloric Energy Intake Data, 1971-2010	PLOS ONE			English	Article							RESTING METABOLIC-RATE; HABITUAL FOOD-INTAKE; DIETARY-INTAKE; SELF-REPORT; FUNDAMENTAL PRINCIPLES; NUTRIENT; OBESE; FAT; EXPENDITURE; PHYSIOLOGY	Importance: Methodological limitations compromise the validity of U.S. nutritional surveillance data and the empirical foundation for formulating dietary guidelines and public health policies. Objectives: Evaluate the validity of the National Health and Nutrition Examination Survey (NHANES) caloric intake data throughout its history, and examine trends in the validity of caloric intake estimates as the NHANES dietary measurement protocols evolved. Design: Validity of data from 28,993 men and 34,369 women, aged 20 to 74 years from NHANES I (1971-1974) through NHANES 2009-2010 was assessed by: calculating physiologically credible energy intake values as the ratio of reported energy intake (rEI) to estimated basal metabolic rate (BMR), and subtracting estimated total energy expenditure (TEE) from NHANES rEI to create 'disparity values'. Main Outcome Measures: 1) Physiologically credible values expressed as the ratio rEI/BMR and 2) disparity values (rEI-TEE). Results: The historical rEI/BMR values for men and women were 1.31 and 1.19, (95% CI: 1.30-1.32 and 1.18-1.20), respectively. The historical disparity values for men and women were -281 and -365 kilocalorie-per-day, (95% CI: -299, -264 and -378, -351), respectively. These results are indicative of significant under-reporting. The greatest mean disparity values were -716 kcal/day and -856 kcal/day for obese (i.e., >= 30 kg/m2) men and women, respectively. Conclusions: Across the 39-year history of the NHANES, EI data on the majority of respondents (67.3% of women and 58.7% of men) were not physiologically plausible. Improvements in measurement protocols after NHANES II led to small decreases in underreporting, artifactual increases in rEI, but only trivial increases in validity in subsequent surveys. The confluence of these results and other methodological limitations suggest that the ability to estimate population trends in caloric intake and generate empirically supported public policy relevant to diet-health relationships from U. S. nutritional surveillance is extremely limited.	[Archer, Edward; Hand, Gregory A.; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Archer, E (corresponding author), Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	archerec@email.sc.edu	Archer, Edward/J-9567-2017	Archer, Edward/0000-0002-9339-6918	Coca-Cola Company	Coca-Cola Company	This study was funded via an unrestricted research grant from The Coca-Cola Company. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Ahuja JKC, 2008, J FOOD COMPOS ANAL, V21, pS119, DOI 10.1016/j.jfca.2007.05.005; Ahuja JKC, 2009, J FOOD COMPOS ANAL, V22, pS63, DOI 10.1016/j.jfca.2009.02.005; Ahuja JKC, 2006, J FOOD COMPOS ANAL, V19, pS7, DOI 10.1016/j.jfca.2005.12.007; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Becker W, 1999, BRIT J NUTR, V81, pS127, DOI 10.1017/S0007114599000975; BLACK AE, 1991, EUR J CLIN NUTR, V45, P583; Black AE, 2001, J AM DIET ASSOC, V101, P70, DOI 10.1016/S0002-8223(01)00018-9; Blair D, 1992, Vital Health Stat 4, P43; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Briefel RR, 1997, AM J CLIN NUTR, V65, P1203; CDC Ce nter of Disease Control and Prevention, 2012, NAT HLTH EX SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Dwyer J, 2003, J NUTR, V133, p590S; FAO, 2001, FOOD BAL SHEETS HDB; FAO/WHO/UNU, 2004, HUM EN REQ REP JOINT; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Ford ES, 2013, AM J CLIN NUTR; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Freedman LS, 2004, J NUTR, V134, P1836, DOI 10.1093/jn/134.7.1836; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Goris AHC, 1999, J NUTR, V129, P878, DOI 10.1093/jn/129.4.878; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; GUENTHER PM, 1994, J AM DIET ASSOC, V94, P270, DOI 10.1016/0002-8223(94)90367-0; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hebert JR, 2002, ANN EPIDEMIOL, V12, P577, DOI 10.1016/S1047-2797(01)00297-6; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186; Heitmann BL, 2005, PUBLIC HEALTH NUTR, V8, P1322, DOI 10.1079/PHN2005750; Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; IOM, 2005, REP PAN MACR DIET RE; IOM, 2003, DIET REF INT APPL DI, P248; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kelly A, 1991, WHO Reg Publ Eur Ser, V34, P39; Kelly A, 1991, WHO Reg Publ Eur Ser, V34, P15; Kohlmeier L, 1991, WHO Reg Publ Eur Ser, V34, P73; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Lissner L, 2000, BRIT J NUTR, V83, pS21; Livingstone MBE, 2003, MARKERS VALIDITY REP, p895S; McCrory MA, 2002, PUBLIC HEALTH NUTR, V5, P873, DOI 10.1079/PHN2002387; McDowell M, 1994, DIETARY COLLECTION S; McDowell MA, 1994, UPDATE 3 NATL HLTH N; McGowan MJ, 2001, PUBLIC HEALTH NUTR, V4, P1043, DOI 10.1079/PHN2001185; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Muth M. K., 2011, USDA EC RES SERV TEC, V1927; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; O'Neil CE, 2011, MEAT SCI, V87, P250, DOI 10.1016/j.meatsci.2010.10.020; Okubo H, 2004, PUBLIC HEALTH NUTR, V7, P911, DOI 10.1079/PHN2004635; Perloff B, 1998, Public Health Rev, V26, P43; Phillips KM, 2006, ANAL BIOANAL CHEM, V384, P1341, DOI 10.1007/s00216-005-0294-0; RACETTE SB, 1995, AM J CLIN NUTR, V62, P345, DOI 10.1093/ajcn/62.2.345; Scagliusi FB, 2003, J AM DIET ASSOC, V103, P1306, DOI 10.1016/S0002-8223(03)01074-5; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shiely F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054386; Skinner AC, 2012, PEDIATRICS, V130, pE936, DOI 10.1542/peds.2012-0605; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; Smith AM, 2011, MEAT SCI, V89, P228, DOI 10.1016/j.meatsci.2011.04.027; Stewart H, 2004, FOOD POLICY, V29, P643, DOI 10.1016/j.foodpol.2004.10.003; Stewart H, 2012, ELECT REPORT EC RES; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Taber DR, 2009, ANN EPIDEMIOL, V19, P316, DOI 10.1016/j.annepidem.2009.01.001; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891; Urban LE, 2011, JAMA-J AM MED ASSOC, V306, P287, DOI 10.1001/jama.2011.993; USDA, 2011, NUTR DAT SET RET BEE; USDA, 2012, NAT AGR LIB NAT NUTR; Weihrauch JL, 1992, PROBLEMS ENERGY CALC; Yanetz R, 2008, J AM DIET ASSOC, V108, P455, DOI 10.1016/j.jada.2007.12.004	74	243	245	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76632	10.1371/journal.pone.0076632	http://dx.doi.org/10.1371/journal.pone.0076632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130784	Green Published, gold			2022-12-25	WOS:000325810900079
J	Chen, H; Zhou, B; Brecher, M; Banavali, N; Jones, SA; Li, Z; Zhang, J; Nag, D; Kramer, LD; Ghosh, AK; Li, HM				Chen, Hui; Zhou, Bing; Brecher, Matthew; Banavali, Nilesh; Jones, Susan A.; Li, Zhong; Zhang, Jing; Nag, Dilip; Kramer, Laura D.; Ghosh, Arun K.; Li, Hongmin			S-Adenosyl-Homocysteine Is a Weakly Bound Inhibitor for a Flaviviral Methyltransferase	PLOS ONE			English	Article							NILE-VIRUS METHYLTRANSFERASE; GENERAL FORCE-FIELD; RNA CAP; NS5; DENGUE; ADENOSYLHOMOCYSTEINE; CHARMM; MOLECULES; DYNAMICS; ADENOSYLMETHIONINE	The methyltransferase enzyme (MTase), which catalyzes the transfer of a methyl group from S-adenosyl-methionine (AdoMet) to viral RNA, and generates S-adenosyl-homocysteine (AdoHcy) as a by-product, is essential for the life cycle of many significant human pathogen flaviviruses. Here we investigated inhibition of the flavivirus MTase by several AdoHcy-derivatives. Unexpectedly we found that AdoHcy itself barely inhibits the flavivirus MTase activities, even at high concentrations. AdoHcy was also shown to not inhibit virus growth in cell-culture. Binding studies confirmed that AdoHcy has a much lower binding affinity for the MTase than either the AdoMet co-factor, or the natural AdoMet analog inhibitor sinefungin (SIN). While AdoMet is a positively charged molecule, SIN is similar to AdoHcy in being uncharged, and only has an additional amine group that can make extra electrostatic contacts with the MTase. Molecular Mechanics Poisson-Boltzmann Sovation Area analysis on AdoHcy and SIN binding to the MTase suggests that the stronger binding of SIN may not be directly due to interactions of this amine group, but due to distributed differences in SIN binding resulting from its presence. The results suggest that better MTase inhibitors could be designed by using SIN as a scaffold rather than AdoHcy.	[Chen, Hui; Brecher, Matthew; Banavali, Nilesh; Jones, Susan A.; Li, Zhong; Zhang, Jing; Nag, Dilip; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Bing; Ghosh, Arun K.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Zhou, Bing; Ghosh, Arun K.] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA; [Banavali, Nilesh; Kramer, Laura D.; Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	lih@wadsworth.org	Zhou, Bing/J-3281-2015; Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Li, Zhong/0000-0002-1039-7000; Banavali, Nilesh/0000-0003-2206-7049; Brecher, Matthew/0000-0003-1151-2290	National Institute of Health (NIH) [AI 09433501]; NIAID training grant [1T32AI055429]; National Science Foundation [OCI-1053575]; Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094335, T32AI055429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID training grant; National Science Foundation(National Science Foundation (NSF)); Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants (AI 09433501 to LDK, AKG, HL) from the National Institute of Health (NIH). MB was supported by funding from a NIAID training grant (1T32AI055429). The authors would also like to acknowledge computing resources provided by the Wadsworth Center, New York State Department of Health and the Wadsworth Center Tissue Culture Core facility for providing cells and media. This work also used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575, and the Computational Center for Nanotechnology Innovations (CCNI) resources housed at the Rensselaer Polytechnic Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS JB, 1983, J CHROMATOGR, V276, P279, DOI 10.1016/S0378-4347(00)85094-X; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012; Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642; Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Li SH, 2013, J VIROL IN PRESS; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Liu Lihui, 2010, Front Biol (Beijing), V5, P286; Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001; PERNA AF, 1993, J CLIN INVEST, V91, P2497; Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m; Poirier LA, 2001, CANCER EPIDEM BIOMAR, V10, P649; Puig-Basagoiti F, 2009, ANTIVIR RES, V83, P71, DOI 10.1016/j.antiviral.2009.03.005; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0; Stabler SP, 2006, AM J CLIN NUTR, V84, P1422, DOI 10.1093/ajcn/84.6.1422; TERUELLOPEZ E, 1991, INVEST CLIN, V32, P201; Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang PY, 2000, J AM CHEM SOC, V122, P12422, DOI 10.1021/ja001989s; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	51	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76900	10.1371/journal.pone.0076900	http://dx.doi.org/10.1371/journal.pone.0076900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130807	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900101
J	Han, XJ; Wang, YD; Chen, YC; Lin, LY; Wu, QK				Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke			Transcriptome Sequencing and Expression Analysis of Terpenoid Biosynthesis Genes in Litsea cubeba	PLOS ONE			English	Article							ESSENTIAL OILS; CHEMICAL-COMPOSITION; GENOME SEQUENCE; MEDICINAL-PLANT; FAMILY; IDENTIFICATION; ANNOTATION; METABOLISM; GENERATION; TOXICITY	Background: Aromatic essential oils extracted from fresh fruits of Litsea cubeba (Lour.) Pers., have diverse medical and economic values. The dominant components in these essential oils are monoterpenes and sesquiterpenes. Understanding the molecular mechanisms of terpenoid biosynthesis is essential for improving the yield and quality of terpenes. However, the 40 available L. cubeba nucleotide sequences in the public databases are insufficient for studying the molecular mechanisms. Thus, high-throughput transcriptome sequencing of L. cubeba is necessary to generate large quantities of transcript sequences for the purpose of gene discovery, especially terpenoid biosynthesis related genes. Results: Using Illumina paired-end sequencing, approximately 23.5 million high-quality reads were generated. De novo assembly yielded 68,648 unigenes with an average length of 834 bp. A total of 38,439 (56%) unigenes were annotated for their functions, and 35,732 and 25,806 unigenes could be aligned to the GO and COG database, respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 16,130 unigenes were assigned to 297 KEGG pathways, and 61 unigenes, which contained the mevalonate and 2-C-methyl-D-erythritol 4-phosphate pathways, could be related to terpenoid backbone biosynthesis. Of the 12,963 unigenes, 285 were annotated to the terpenoid pathways using the PlantCyc database. Additionally, 14 terpene synthase genes were identified from the transcriptome. The expression patterns of the 16 genes related to terpenoid biosynthesis were analyzed by RT-qPCR to explore their putative functions. Conclusion: RNA sequencing was effective in identifying a large quantity of sequence information. To our knowledge, this study is the first exploration of the L. cubeba transcriptome, and the substantial amount of transcripts obtained will accelerate the understanding of the molecular mechanisms of essential oils biosynthesis. The results may help improve future genetic and genomics studies on the molecular mechanisms behind the chemical composition of essential oils in L. cubeba fruits.	[Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke] Chinese Acad Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China; [Han, Xiao-Jiao; Wang, Yang-Dong; Chen, Yi-Cun; Lin, Li-Yuan; Wu, Qing-Ke] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China	Chinese Academy of Forestry; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wang, YD (corresponding author), Chinese Acad Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China.	wyd11111@126.com		Han, Xiaojiao/0000-0001-6082-7569	Zhejiang Science and Technology Hall [2011R50030]; Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry [61254]	Zhejiang Science and Technology Hall; Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry	The work presented here was supported by Zhejiang Science and Technology Hall (No. 2011R50030) and Basic Scientific Research Project of Nonprofit Central Research Institutions of Chinese Academy of Forestry (No. 61254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chang YT, 2011, TREE GENET GENOMES, V7, P835, DOI 10.1007/s11295-011-0377-3; Chen CJ, 2012, J WOOD SCI, V58, P538, DOI 10.1007/s10086-012-1277-3; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Choi EM, 2004, FITOTERAPIA, V75, P141, DOI 10.1016/j.fitote.2003.11.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Foster AJ, 2013, PLANT PHYSIOL, V161, P1993, DOI 10.1104/pp.112.206383; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ho CL, 2010, NAT PROD COMMUN, V5, P617; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Hwang JK, 2005, FITOTERAPIA, V76, P684, DOI 10.1016/j.fitote.2005.05.007; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang ZL, 2009, J AGR FOOD CHEM, V57, P4833, DOI 10.1021/jf900274r; Julsing MK, 2006, BIOMOL ENG, V23, P265, DOI 10.1016/j.bioeng.2006.08.001; Kamal KJ, 2006, MED AROMATIC PLANTS, P166; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu TT, 2012, INT J FOOD MICROBIOL, V156, P68, DOI 10.1016/j.ijfoodmicro.2012.03.005; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Luo M, 2005, J FOOD PROTECT, V68, P581, DOI 10.4315/0362-028X-68.3.581; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagegowda D.A., 2007, MED PLANTS BIOTECHNO, V2, P469; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Nieuwenhuizen NJ, 2013, PLANT PHYSIOL, V161, P787, DOI 10.1104/pp.112.208249; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sapir-Mir M, 2008, PLANT PHYSIOL, V148, P1219, DOI 10.1104/pp.108.127951; Seo SM, 2009, J AGR FOOD CHEM, V57, P6596, DOI 10.1021/jf9015416; Si LL, 2012, MOLECULES, V17, P7057, DOI 10.3390/molecules17067057; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang HW, 2010, CHEM BIODIVERS, V7, P229, DOI 10.1002/cbdv.200800349; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wouters J, 2003, J AM CHEM SOC, V125, P3198, DOI 10.1021/ja029171p; Wullschleger SD, 2013, TREE PHYSIOL, V33, P357, DOI 10.1093/treephys/tps081; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	58	50	55	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76890	10.1371/journal.pone.0076890	http://dx.doi.org/10.1371/journal.pone.0076890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130803	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900098
J	Leutheuser, H; Schuldhaus, D; Eskofier, BM				Leutheuser, Heike; Schuldhaus, Dominik; Eskofier, Bjoern M.			Hierarchical, Multi-Sensor Based Classification of Daily Life Activities: Comparison with State-of-the-Art Algorithms Using a Benchmark Dataset	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY RECOGNITION; WALKING; PREVENTION; PATTERNS; SENSOR; SPORTS; HEALTH	Insufficient physical activity is the 4th leading risk factor for mortality. Methods for assessing the individual daily life activity (DLA) are of major interest in order to monitor the current health status and to provide feedback about the individual quality of life. The conventional assessment of DLAs with self-reports induces problems like reliability, validity, and sensitivity. The assessment of DLAs with small and light-weight wearable sensors (e. g. inertial measurement units) provides a reliable and objective method. State-of-the-art human physical activity classification systems differ in e. g. the number and kind of sensors, the performed activities, and the sampling rate. Hence, it is difficult to compare newly proposed classification algorithms to existing approaches in literature and no commonly used dataset exists. We generated a publicly available benchmark dataset for the classification of DLAs. Inertial data were recorded with four sensor nodes, each consisting of a triaxial accelerometer and a triaxial gyroscope, placed on wrist, hip, chest, and ankle. Further, we developed a novel, hierarchical, multi-sensor based classification system for the distinction of a large set of DLAs. Our hierarchical classification system reached an overall mean classification rate of 89.6% and was diligently compared to existing state-of-the-art algorithms using our benchmark dataset. For future research, the dataset can be used in the evaluation process of new classification algorithms and could speed up the process of getting the best performing and most appropriate DLA classification system.	[Leutheuser, Heike; Schuldhaus, Dominik; Eskofier, Bjoern M.] Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, Dept Comp Sci, Nurnberg, Germany	University of Erlangen Nuremberg	Leutheuser, H (corresponding author), Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, Dept Comp Sci, Nurnberg, Germany.	heike.leutheuser@cs.fau.de; dominik.schuldhaus@cs.fau.de	Eskofier, Bjoern/ABF-1284-2021; Leutheuser, Heike/GYJ-1186-2022	Eskofier, Bjoern/0000-0002-0417-0336; 	Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology; European fund for regional development [IUK-1103-0012//IUK383/001]; adidas AG; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-University Erlangen-Nuremberg	Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology; European fund for regional development(European Commission); adidas AG; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nuremberg	This work was supported by the Bavarian Ministry for Economic Affairs, Infrastructure, Transport, and Technology and the European fund for regional development (grant number: IUK-1103-0012//IUK383/001; http://www.stmwivt.bayern.de/themen/). Financial and technical support of the study were provided by adidas AG. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-University Erlangen-Nuremberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 1999, CAN FAM PHYSICIAN, V45, P992; Agostini G, 2003, EURASIP J APPL SIG P, V2003, P5, DOI 10.1155/S1110865703210118; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Altun K, 2010, LECT NOTES COMPUT SC, V6219, P38, DOI 10.1007/978-3-642-14715-9_5; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Burns A, 2010, IEEE SENS J, V10, P1527, DOI 10.1109/JSEN.2010.2045498; Duda R.O., 2000, PATTERN CLASSIFICATI; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Koskimaki H, 2009, MED C CONTR AUTOMAT, P401, DOI 10.1109/MED.2009.5164574; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Liu SP, 2012, IEEE T BIO-MED ENG, V59, P687, DOI 10.1109/TBME.2011.2178070; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Nyan MN, 2006, J BIOMECH, V39, P2647, DOI 10.1016/j.jbiomech.2005.08.014; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Schuldhaus D, 2012, INT C PATT RECOG, P2258; Sekine M, 2000, MED ENG PHYS, V22, P285, DOI 10.1016/S1350-4533(00)00041-2; Sekine M, 2002, IEEE T NEUR SYS REH, V10, P188, DOI 10.1109/TNSRE.2002.802879; Seon-Woo Lee, 2002, IEEE Pervasive Computing, V1, P24, DOI 10.1109/MPRV.2002.1037719; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Tamura T, 1997, METHOD INFORM MED, V36, P356; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Wang N, 2007, P ANN INT IEEE EMBS, P4899, DOI 10.1109/IEMBS.2007.4353438; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010; Witten IH, 2011, MOR KAUF D, P1	43	107	109	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75196	10.1371/journal.pone.0075196	http://dx.doi.org/10.1371/journal.pone.0075196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130686	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900019
J	Ording, AG; Garne, JP; Nystrom, PMW; Froslev, T; Sorensen, HT; Lash, TL				Ording, Anne Gulbech; Garne, Jens Peter; Nystrom, Petra Mariann Witt; Froslev, Trine; Sorensen, Henrik Toft; Lash, Timothy L.			Comorbid Diseases Interact with Breast Cancer to Affect Mortality in the First Year after Diagnosis-A Danish Nationwide Matched Cohort Study	PLOS ONE			English	Article							OLDER PATIENTS; SURVIVAL; REGISTRY; RECURRENCE; QUALITY; COLON; DEATH; CARE; AGE	Background: Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been well characterized. The interaction between comorbid diseases and breast cancer, however, has not been well-studied. Methods: From Danish nationwide medical registries, we identified all breast cancer patients between 45 and 85 years of age diagnosed from 1994 to 2008. Women without breast cancer were matched to the breast cancer patients on specific comorbid diseases included in the Charlson comorbidity Index (CCI). Interaction contrasts were calculated as a measure of synergistic effect on mortality between comorbidity and breast cancer. Results: The study included 47,904 breast cancer patients and 237,938 matched comparison women. In the first year, the strongest interaction between comorbidity and breast cancer was observed in breast cancer patients with a CCI score of >= 4, which accounted for 29 deaths per 1000 person-years. Among individual comorbidities, dementia interacted strongly with breast cancer and accounted for 148 deaths per 1000 person-years within one year of follow-up. There was little interaction between comorbidity and breast cancer during one to five years of follow-up. Conclusions: There was substantial interaction between comorbid diseases and breast cancer, affecting mortality. Successful treatment of the comorbid diseases or the breast cancer can delay mortality caused by this interaction in breast cancer patients.	[Ording, Anne Gulbech; Froslev, Trine; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Garne, Jens Peter] Aalborg Univ Hosp, Aalborg Hosp, Breast Clin, Aalborg, Denmark; [Nystrom, Petra Mariann Witt] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden; [Lash, Timothy L.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Aarhus University; Aalborg University; Aalborg University Hospital; Uppsala University; Uppsala University Hospital; Emory University; Rollins School Public Health	Ording, AG (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	ao@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040	Danish Agency for Science, Technology and Innovation; Karen Elise Jensen Foundation; Clinical Epidemiology Research Foundation; Aarhus University; Aalborg Sygehus; Region North Denmark; Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	Danish Agency for Science, Technology and Innovation; Karen Elise Jensen Foundation; Clinical Epidemiology Research Foundation; Aarhus University; Aalborg Sygehus; Region North Denmark; Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	This study was supported by the Danish Agency for Science, Technology and Innovation, Karen Elise Jensen Foundation, the Clinical Epidemiology Research Foundation, Aarhus University, Aalborg Sygehus, Region North Denmark, Arkitekt Holger Hjortenberg og hustru Dagmar Hjortenbergs Foundation, and Inge og Jorgen Larsens Mindelegat Foundation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Baade PD, 2006, CANCER CAUSE CONTROL, V17, P287, DOI 10.1007/s10552-005-0530-0; Bush D, 2011, BREAST CANCER RES TR, V127, P243, DOI 10.1007/s10549-010-1186-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gonzalez EC, 2001, SOUTHERN MED J, V94, P913; Gorin SS, 2005, J AM GERIATR SOC, V53, P1897, DOI 10.1111/j.1532-5415.2005.00467.x; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Greenland S., 2008, MODERN EPIDEMIOLOGY; Gupta SK, 2004, J AM GERIATR SOC, V52, P1681, DOI 10.1111/j.1532-5415.2004.52461.x; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Land LH, 2012, BREAST CANCER RES TR, V131, P1013, DOI 10.1007/s10549-011-1819-1; Lash TL, 2000, CANCER-AM CANCER SOC, V89, P1739, DOI 10.1002/1097-0142(20001015)89:8<1739::AID-CNCR14>3.0.CO;2-F; Launay-Vacher V, 2007, CANCER-AM CANCER SOC, V110, P1376, DOI 10.1002/cncr.22904; Newschaffer CJ, 1998, J GERONTOL A-BIOL, V53, pM372, DOI 10.1093/gerona/53A.5.M372; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Pedersen CB, 2006, DAN MED BULL, V53, P441; Raji MA, 2008, ARCH INTERN MED, V168, P2033, DOI 10.1001/archinte.168.18.2033; Riihimaki M, 2012, ANN ONCOL, V23, P604, DOI 10.1093/annonc/mdr160; Ring A, 2011, J CLIN ONCOL, V29, P4266, DOI 10.1200/JCO.2011.35.5545; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Snyder CF, 2013, J CLIN ONCOL, V31, P1140, DOI 10.1200/JCO.2012.43.0272; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	28	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76013	10.1371/journal.pone.0076013	http://dx.doi.org/10.1371/journal.pone.0076013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130755	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900065
J	Savage, N; Yang, TJW; Chen, CY; Lin, KL; Monk, NAM; Schmidt, W				Savage, Natasha; Yang, Thomas J. W.; Chen, Chung Ying; Lin, Kai-Lan; Monk, Nicholas A. M.; Schmidt, Wolfgang			Positional Signaling and Expression of ENHANCER OF TRY AND CPC1 Are Tuned to Increase Root Hair Density in Response Phosphate Deficiency in Arabidopsis thaliana	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; RECEPTOR-LIKE KINASE; CAPRICE TRANSCRIPTION; FATE SPECIFICATION; ELONGATION; PATTERN; PROTEIN; ORGANIZATION; WEREWOLF; DIVISION	Phosphate (Pi) deficiency induces a multitude of responses aimed at improving the acquisition of Pi, including an increased density of root hairs. To understand the mechanisms involved in Pi deficiency-induced alterations of the root hair phenotype in Arabidopsis (Arabidopsis thaliana), we analyzed the patterning and length of root epidermal cells under control and Pi-deficient conditions in wild-type plants and in four mutants defective in the expression of master regulators of cell fate, CAPRICE (CPC), ENHANCER OF TRY AND CPC 1 (ETC1), WEREWOLF (WER) and SCRAMBLED (SCM). From this analysis we deduced that the longitudinal cell length of root epidermal cells is dependent on the correct perception of a positional signal ('cortical bias') in both control and Pi-deficient plants; mutants defective in the receptor of the signal, SCM, produced short cells characteristic of root hair-forming cells (trichoblasts). Simulating the effect of cortical bias on the time-evolving probability of cell fate supports a scenario in which a compromised positional signal delays the time point at which non-hair cells opt out the default trichoblast pathway, resulting in short, trichoblast-like non-hair cells. Collectively, our data show that Pi-deficient plants increase root hair density by the formation of shorter cells, resulting in a higher frequency of hairs per unit root length, and additional trichoblast cell fate assignment via increased expression of ETC1.	[Savage, Natasha] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Yang, Thomas J. W.; Chen, Chung Ying; Lin, Kai-Lan; Schmidt, Wolfgang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Monk, Nicholas A. M.] Univ Nottingham, Div Appl Math, Sch Math Sci, Nottingham NG7 2RD, England; [Monk, Nicholas A. M.] Univ Nottingham, Ctr Plant Integrat Biol, Sch Biosci, Loughborough, Leics, England; [Schmidt, Wolfgang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Schmidt, Wolfgang] Natl Taiwan Univ, Coll Life Sci, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	University of Liverpool; Academia Sinica - Taiwan; University of Nottingham; University of Nottingham; National Chung Hsing University; National Taiwan University	Schmidt, W (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	wosh@gate.sinica.edu.tw	Schmidt, Wolfgang/AAA-2807-2022; Schmidt, Wolfgang/A-3234-2014	Schmidt, Wolfgang/0000-0002-7850-6832; Monk, Nick/0000-0002-5465-4857	Royal Society UK; National Science Council Taiwan; Royal Society; Wellcome Trust	Royal Society UK(Royal Society of London); National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	This work was supported by a bilateral grant from the Royal Society UK and the National Science Council Taiwan to NAMM and WS. NS was funded by the Royal Society and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Chandrika NNP, 2013, NEW PHYTOL, V198, P709, DOI 10.1111/nph.12194; Clowes FAL, 2000, NEW PHYTOL, V146, P83, DOI 10.1046/j.1469-8137.2000.00614.x; Costa S, 2000, CURR OPIN GENET DEV, V10, P405, DOI 10.1016/S0959-437X(00)00104-0; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Grierson C, 2002, ARABIDOPSIS BOOK, V1, pe0060; Kang YH, 2009, PLANT CELL, V21, P1080, DOI 10.1105/tpc.108.063180; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Leavitt RG, 1904, TRICHOMES ROOT VASCU; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Lin WD, 2011, PLANT PHYSIOL, V155, P1383, DOI 10.1104/pp.110.166520; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Savage NS, 2008, PLOS BIOL, V6, P1899, DOI 10.1371/journal.pbio.0060235; Schiefelbein J, 2009, J EXP BOT, V60, P1515, DOI 10.1093/jxb/ern339; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562	36	36	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75452	10.1371/journal.pone.0075452	http://dx.doi.org/10.1371/journal.pone.0075452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130712	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325810900037
J	Carbon, CC; Gruter, M; Gruter, T				Carbon, Claus-Christian; Grueter, Martina; Grueter, Thomas			Age-Dependent Face Detection and Face Categorization Performance	PLOS ONE			English	Article							MACULAR DEGENERATION; RECOGNITION; STIMULI; PERCEPTION; BRAIN	Empirical studies on the development of face processing skills with age show inconsistent patterns concerning qualitative vs. quantitative changes over time or the age range for peak cognitive performance. In the present study, we tested the proficiency in face detection and face categorization with a large sample of participants (N = 312; age range: 2-88 yrs). As test objects, we used so-called Mooney faces, two-tone (black and white) images of faces lacking critical information of a local, featural and relational nature, reflecting difficult real world face processing conditions. We found that performance in the assessment of gender and age from Mooney faces increases up to about age 15, and decreases from 65 years on. The implications of these findings are discussed in the light of classic and recent findings from face development literature.	[Carbon, Claus-Christian; Grueter, Martina; Grueter, Thomas] Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany; [Grueter, Martina] Grad Sch Affect & Cognit Sci, Bamberg, Germany	Otto Friedrich University Bamberg	Carbon, CC (corresponding author), Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany.	ccc@experimental-psychology.com	Carbon, Claus-Christian/GLQ-6274-2022; Carbon, Claus-Christian/A-7494-2008	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347; Gruter, Martina/0000-0002-2784-0486; Gruter, Thomas/0000-0003-3529-9244	University of Bamberg (FNK); Doktor Robert Pfleger-Stiftung	University of Bamberg (FNK); Doktor Robert Pfleger-Stiftung	This research was supported by a research grant from the University of Bamberg (FNK) and a grant from Doktor Robert Pfleger-Stiftung to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Cattell R. B., 1971, ABILITIES THEIR STRU; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Chaby L, 2003, NEUROSCI LETT, V349, P125, DOI 10.1016/S0304-3940(03)00800-0; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; Doi H, 2009, NEUROSCI RES, V64, P317, DOI 10.1016/j.neures.2009.04.002; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Edelman S, 2001, SCI PSYCH S, P397; FOREMAN N, 1991, J GEN PSYCHOL, V118, P13, DOI 10.1080/00221309.1991.9711129; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; GOREN CC, 1975, PEDIATRICS, V56, P544; Grady CL, 2002, CAN J EXP PSYCHOL, V56, P208, DOI 10.1037/h0087398; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Kadosh KC, 2007, TRENDS COGN SCI, V11, P367, DOI 10.1016/j.tics.2007.06.007; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; KINI MM, 1978, AM J OPHTHALMOL, V85, P28, DOI 10.1016/S0002-9394(14)76661-9; Latinus M, 2005, J COGNITIVE NEUROSCI, V17, P1316, DOI 10.1162/0898929055002490; Leder H, 2006, BRIT J PSYCHOL, V97, P19, DOI 10.1348/000712605X54794; Leo I, 2009, INFANCY, V14, P641, DOI 10.1080/15250000903264047; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; McKeeff TJ, 2007, CEREB CORTEX, V17, P669, DOI 10.1093/cercor/bhk015; Mckone E, 2009, COGNITIVE NEUROSCIEN, V4th, P467; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Rakover SS, 2002, BRIT J PSYCHOL, V93, P1, DOI 10.1348/000712602162427; READ DE, 1988, J CLIN EXP NEUROPSYC, V10, P451, DOI 10.1080/01688638808408252; RITCHIE K, 1993, INT J GERIATR PSYCH, V8, P969, DOI 10.1002/gps.930081203; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; SALTHOUSE TA, 1988, AM J PSYCHOL, V101, P217, DOI 10.2307/1422836; Schwaninger A, 2003, DEVELOPMENT OF FACE PROCESSING, P81; Schwarzer G, 2003, DEVELOPMENT OF FACE PROCESSING, P55; Schwarzer G, 2006, AM J PSYCHOL, V119, P329, DOI 10.2307/20445343; Tejeria L, 2002, BRIT J OPHTHALMOL, V86, P1019, DOI 10.1136/bjo.86.9.1019; Tranel D, 1997, DEV NEUROPSYCHOL, V13, P87, DOI 10.1080/87565649709540669; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Webb SJ, 2006, PSYCHOPHYSIOLOGY, V43, pS105; WIBRAL M, 2010, J NEUROSCI, V30, P8342, DOI DOI 10.1523/JNEUR0SCI.5434-09.2010.PUBMED:20554885; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232	45	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e79164	10.1371/journal.pone.0079164	http://dx.doi.org/10.1371/journal.pone.0079164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116236	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200121
J	Rua, R; Betsem, E; Gessain, A				Rua, Rejane; Betsem, Edouard; Gessain, Antoine			Viral Latency in Blood and Saliva of Simian Foamy Virus-Infected Humans	PLOS ONE			English	Article							TRANSMISSION; REPLICATION; EPIDEMIOLOGY; PRIMATES	Simian foamy viruses (SFV) are widespread retroviruses among non-human primates (NHP). SFV actively replicate in the oral cavity and can be transmitted to humans through NHP bites, giving rise to a persistent infection. We aimed at studying the natural history of SFV infection in human. We have analyzed viral load and gene expression in 14 hunters from Cameroon previously shown to be infected with a gorilla SFV strain. Viral DNA could be detected by quantitative polymerase chain reaction (q-PCR) targeting the pol-in region, in most samples of peripheral blood mononuclear cells (PBMCs) (7.1 +/- 6.0 SFV DNA copies/105 PBMCs) and saliva (2.4 +/- 4.3 SFV DNA copies/105 cells) derived from the hunters. However, quantitative real-time reverse-transcription polymerase chain reaction (RT)-qPCR revealed the absence of SFV viral gene expression in both PBMCs and saliva, suggesting that SFV was latent in the human samples. Our study demonstrates that a latent infection can occur in humans and persist for years, both in PBMCs and saliva. Such a scenario may contribute to the putative lack of secondary human-to-human transmissions of SFV.	[Rua, Rejane; Betsem, Edouard; Gessain, Antoine] Inst Pasteur, Dept Virol, Unit Epidemiol & Physiopathol Oncogen Viruses, Paris, France; [Rua, Rejane; Betsem, Edouard; Gessain, Antoine] Inst Pasteur, CNRS, Paris, France; [Rua, Rejane] Paris Diderot Univ, Paris, France; [Betsem, Edouard] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol, Yaounde, Cameroon	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Yaounde I	Gessain, A (corresponding author), Inst Pasteur, Dept Virol, Unit Epidemiol & Physiopathol Oncogen Viruses, Paris, France.	antoine.gessain@pasteur.fr	Rua, Rejane/GLQ-7139-2022	Rua, Rejane/0000-0002-4289-3498	"Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot"; "Association Virus Cancer Prevention"; Institut National pour le Cancer; Institut Pasteur in Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	"Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot"; "Association Virus Cancer Prevention"; Institut National pour le Cancer; Institut Pasteur in Paris; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	R. Rua was personally supported by the "Bourse de l'Ecole Normale Superieure, Faculte Paris Diderot". E. Betsem was supported by the "Association Virus Cancer Prevention" and the Institut National pour le Cancer. Financial support was also provided by the Institut Pasteur in Paris. This study has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no ANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Boyer PL, 2007, VIROLOGY, V367, P253, DOI 10.1016/j.virol.2007.05.034; Brooks JI, 2007, TRANSFUSION, V47, P162, DOI 10.1111/j.1537-2995.2007.01079.x; Calattini S, 2006, J MED PRIMATOL, V35, P59, DOI 10.1111/j.1600-0684.2006.00149.x; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Calattini S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-23; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Falcone V, 2003, CURR TOP MICROBIOL, V277, P161; Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Khan AS, 2009, EXPERT REV ANTI-INFE, V7, P569, DOI [10.1586/eri.09.39, 10.1586/ERI.09.39]; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Murray SM, 2008, J VIROL, V82, P5981, DOI 10.1128/JVI.00367-08; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Rethwilm A, 2010, MED MICROBIOL IMMUN, V199, P197, DOI 10.1007/s00430-010-0158-x; Rua R, 2012, J VIROL, V86, P13350, DOI 10.1128/JVI.01715-12; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Schweizer M, 1999, J VIROL, V73, P9256, DOI 10.1128/JVI.73.11.9256-9265.1999; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; SCHWEIZER M, 1995, VIROLOGY, V207, P577, DOI 10.1006/viro.1995.1120; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YU SF, 1993, J VIROL, V67, P6618, DOI 10.1128/JVI.67.11.6618-6624.1993	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77072	10.1371/journal.pone.0077072	http://dx.doi.org/10.1371/journal.pone.0077072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116202	gold, Green Submitted, Green Published			2022-12-25	WOS:000325552200098
J	Studer, B; Pedroni, A; Rieskamp, J				Studer, Bettina; Pedroni, Andreas; Rieskamp, Joerg			Predicting Risk-Taking Behavior from Prefrontal Resting-State Activity and Personality	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; DECISION-MAKING; INDIVIDUAL-DIFFERENCES; INHIBITION; ACTIVATION; CORTEX; RELIABILITY; SENSITIVITY; PUNISHMENT; REWARD	Risk-taking is subject to considerable individual differences. In the current study, we tested whether resting-state activity in the prefrontal cortex and trait sensitivity to reward and punishment can help predict risk-taking behavior. Prefrontal activity at rest was assessed in seventy healthy volunteers using electroencephalography, and compared to their choice behavior on an economic risk-taking task. The Behavioral Inhibition System/Behavioral Activation System scale was used to measure participants' trait sensitivity to reward and punishment. Our results confirmed both prefrontal resting-state activity and personality traits as sources of individual differences in risk-taking behavior. Right-left asymmetry in prefrontal activity and scores on the Behavioral Inhibition System scale, reflecting trait sensitivity to punishment, were correlated with the level of risk-taking on the task. We further discovered that scores on the Behavioral Inhibition System scale modulated the relationship between asymmetry in prefrontal resting-state activity and risk-taking. The results of this study demonstrate that heterogeneity in risk-taking behavior can be traced back to differences in the basic physiology of decision-makers' brains, and suggest that baseline prefrontal activity and personality traits might interplay in guiding risk-taking behavior.	[Studer, Bettina; Pedroni, Andreas; Rieskamp, Joerg] Univ Basel, Dept Psychol, Basel, Switzerland; [Studer, Bettina] UCL, Inst Cognit Neurosci, London, England	University of Basel; University of London; University College London	Studer, B (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	b.studer@ucl.ac.uk	Studer, Bettina/AAI-8179-2021; Studer, Bettina/AFV-9290-2022; Rieskamp, Joerg/D-4004-2013; Studer, Bettina/E-6177-2017	Studer, Bettina/0000-0002-9483-385X; Studer, Bettina/0000-0002-9483-385X; Rieskamp, Joerg/0000-0003-2632-8015; Studer, Bettina/0000-0002-9483-385X	University of Basel; Swiss National Science Foundation [CRSII1_136227, PBSKP3_138595]	University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the University of Basel (http://www.unibas.ch). AP and JR acknowledge support of the Swiss National Science Foundation (http://www.snf.ch) [grant number CRSII1_136227]. BS is also supported by the Swiss National Science Foundation [grant number PBSKP3_138595]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelt KC, 2011, JUDGM DECIS MAK, V6, P252; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Brand M, 2008, PERS INDIV DIFFER, V45, P226, DOI 10.1016/j.paid.2008.04.003; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; Corsi-Cabrera M, 2007, CLIN NEUROPHYSIOL, V118, P9, DOI 10.1016/j.clinph.2006.08.013; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Fox CR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00298; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; Gianotti LR, 2009, PSYCHOL SCI, V20, P33, DOI 10.1111/j.1467-9280.2008.02260.x; Goudriaan AE, 2006, DRUG ALCOHOL DEPEN, V84, P231, DOI 10.1016/j.drugalcdep.2006.02.007; Gray J. A., 1972, BIOL BASES INDIVIDUA, P182, DOI [10.1016/0005-7967(70)90069-0, DOI 10.1016/B978-0-12-515350-8.50017-X]; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Gray J. A., 1981, MODEL PERSONALITY, P246, DOI [10.1007/978-3-642-67783-0_8, DOI 10.1007/978-3-642-67783-0_8]; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hewig J, 2006, BIOL PSYCHOL, V71, P42, DOI 10.1016/j.biopsycho.2005.01.006; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kim DY, 2011, PERS INDIV DIFFER, V50, P1131, DOI 10.1016/j.paid.2011.01.041; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Levin IP, 2002, ORGAN BEHAV HUM DEC, V88, P411, DOI 10.1006/obhd.2001.2983; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Massar SAA, 2012, CLIN NEUROPHYSIOL, V123, P1958, DOI 10.1016/j.clinph.2012.03.005; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oakes TR, 2004, HUM BRAIN MAPP, V21, P257, DOI 10.1002/hbm.20004; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schutter DJLG, 2005, COGNITIVE BRAIN RES, V24, P685, DOI 10.1016/j.cogbrainres.2005.04.002; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Suhr JA, 2007, PERS INDIV DIFFER, V43, P27, DOI 10.1016/j.paid.2006.11.004; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Venkatraman V, 2012, EUR J NEUROSCI, V35, P1075, DOI 10.1111/j.1460-9568.2012.08009.x; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475	47	24	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76861	10.1371/journal.pone.0076861	http://dx.doi.org/10.1371/journal.pone.0076861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116176	Green Published, gold			2022-12-25	WOS:000325501300102
J	Bajic, A; Spasic, M; Andjus, PR; Savic, D; Parabucki, A; Nikolic-Kokic, A; Spasojevic, I				Bajic, Aleksandar; Spasic, Mihajlo; Andjus, Pavle R.; Savic, Danijela; Parabucki, Ana; Nikolic-Kokic, Aleksandra; Spasojevic, Ivan			Fluctuating vs. Continuous Exposure to H2O2: The Effects on Mitochondrial Membrane Potential, Intracellular Calcium, and NF-kappa B in Astroglia	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; GENE-EXPRESSION; CELL-CULTURE; REDOX STATE; ASTROCYTES; ACTIVATION; NEURONS; DEATH	The effects of H2O2 are widely studied in cell cultures and other in vitro systems. However, such investigations are performed with the assumption that H2O2 concentration is constant, which may not properly reflect in vivo settings, particularly in redox-turbulent microenvironments such as mitochondria. Here we introduced and tested a novel concept of fluctuating oxidative stress. We treated C6 astroglial cells and primary astrocytes with H2O2, using three regimes of exposure - continuous, as well as fluctuating at low or high rate, and evaluated mitochondrial membrane potential and other parameters of mitochondrial activity - respiration, reducing capacity, and superoxide production, as well as intracellular ATP, intracellular calcium, and NF-kappa B activation. When compared to continuous exposure, fluctuating H2O2 induced a pronounced hyperpolarization in mitochondria, whereas the activity of electron transport chain appears not to be significantly affected. H2O2 provoked a decrease of ATP level and an increase of intracellular calcium concentration, independently of the regime of treatment. However, fluctuating H2O2 induced a specific pattern of large-amplitude fluctuations of calcium concentration. An impact on NF kappa B activation was observed for high rate fluctuations, whereas continuous and low rate fluctuating oxidative stress did not provoke significant effects. Presented results outline the (patho)physiological relevance of redox fluctuations.	[Bajic, Aleksandar; Andjus, Pavle R.] Univ Belgrade, Fac Biol, Ctr Laser Microscopy, Belgrade, Serbia; [Spasic, Mihajlo; Nikolic-Kokic, Aleksandra] Univ Belgrade, Dept Physiol, Inst Biol Res Sinisa Stankov, Belgrade, Serbia; [Savic, Danijela; Parabucki, Ana] Univ Belgrade, Dept Neurobiol, Inst Biol Res Sinisa Stankov, Belgrade, Serbia; [Spasojevic, Ivan] Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Spasojevic, I (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia.	redoxsci@gmail.com	Nikolic-Kokic, Aleksandra/AAD-5591-2022; Savic, Danijela/I-7471-2019; Spasic, Mihajlo/AAE-9381-2020	Savic, Danijela/0000-0001-7411-4527; Spasojevic, Ivan/0000-0002-3150-3087; Nikolic-Kokic, Aleksandra/0000-0002-1116-2035; Bajic, Aleksandar/0000-0002-1255-9835; Spasic, Mihajlo/0000-0001-9046-0139	Ministry of Education and Science of the Republic of Serbia [III41005, OI173014, III41014]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of the Republic of Serbia grant numbers, III41005, OI173014, and III41014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Choi JJ, 2007, FREE RADICAL RES, V41, P555, DOI 10.1080/10715760601173010; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Desagher S, 1996, J NEUROSCI, V16, P2553; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dunn JF, 2003, METHODS, V30, P159, DOI 10.1016/S1046-2023(03)00077-X; GILLE JJP, 1992, MUTAT RES, V275, P405, DOI 10.1016/0921-8734(92)90043-O; Grover D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007580; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Li R, 2011, CURR PROTOC CYTOM, V9, P37; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Makino N, 2008, BBA-GEN SUBJECTS, V1780, P927, DOI 10.1016/j.bbagen.2008.03.010; Miljkovic D, 2013, ANTIOXID REDOX SIGN, V19, P2286, DOI 10.1089/ars.2012.5068; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; Scorrano L, 1999, J BIOL CHEM, V274, P24657, DOI 10.1074/jbc.274.35.24657; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Spasojevic I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/596019; Spasojevic I, 2010, REDOX REP, V15, P29, DOI 10.1179/174329210X12650506623087; Spaspjevic I, 2009, CARBOHYD RES, V344, P1676, DOI 10.1016/j.carres.2009.05.023; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; SWARTZ HM, 1994, MAGN RESON MED, V31, P229, DOI 10.1002/mrm.1910310218; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1379, DOI 10.1089/ars.2010.3645; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xie W, 2008, THESIS IOWA STATE U; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Yoo BK, 2005, NEUROSCI RES, V51, P39, DOI 10.1016/j.neures.2004.09.008; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	46	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76383	10.1371/journal.pone.0076383	http://dx.doi.org/10.1371/journal.pone.0076383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124554	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100111
J	Cornelissen, L; Fabrizi, L; Patten, D; Worley, A; Meek, J; Boyd, S; Slater, R; Fitzgerald, M				Cornelissen, Laura; Fabrizi, Lorenzo; Patten, Deborah; Worley, Alan; Meek, Judith; Boyd, Stewart; Slater, Rebeccah; Fitzgerald, Maria			Postnatal Temporal, Spatial and Modality Tuning of Nociceptive Cutaneous Flexion Reflexes in Human Infants	PLOS ONE			English	Article							SPINAL DORSAL-HORN; SUBSTANTIA-GELATINOSA NEURONS; C-FOS; ELECTRICAL-STIMULATION; CENTRAL SENSITIZATION; WITHDRAWAL REFLEX; RECEPTIVE-FIELDS; EVOKED ALLODYNIA; FLEXOR REFLEX; LOWER-LIMB	Cutaneous flexion reflexes are amongst the first behavioural responses to develop and are essential for the protection and survival of the newborn organism. Despite this, there has been no detailed, quantitative study of their maturation in human neonates. Here we use surface electromyographic (EMG) recording of biceps femoris activity in preterm (<37 weeks gestation, GA) and term (>= 37 weeks GA) human infants, less than 14 days old, in response to tactile, punctate and clinically required skin-breaking lance stimulation of the heel. We show that all infants display a robust and long duration flexion reflex (>4 seconds) to a single noxious skin lance which decreases significantly with gestational age. This reflex is not restricted to the stimulated limb: heel lance evokes equal ipsilateral and contralateral reflexes in preterm and term infants. We further show that infant flexion withdrawal reflexes are not always nociceptive specific: in 29% of preterm infants, tactile stimulation evokes EMG activity that is indistinguishable from noxious stimulation. In 40% of term infants, tactile responses are also present but significantly smaller than nociceptive reflexes. Infant flexion reflexes are also evoked by application of calibrated punctate von Frey hairs (vFh), 0.8-17.2 g, to the heel. Von Frey hair thresholds increase significantly with gestational age and the magnitude of vFh evoked reflexes are significantly greater in preterm than term infants. Furthermore flexion reflexes in both groups are sensitized by repeated vFh stimulation. Thus human infant flexion reflexes differ in temporal, modality and spatial characteristics from those in adults. Reflex magnitude and tactile sensitivity decreases and nociceptive specificity and spatial organisation increases with gestational age. Strong, relatively non-specific, reflex sensitivity in early life may be important for driving postnatal activity dependent maturation of targeted spinal cord sensory circuits.	[Cornelissen, Laura; Fabrizi, Lorenzo; Patten, Deborah; Slater, Rebeccah; Fitzgerald, Maria] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Meek, Judith] Univ Coll Hosp, Elizabeth Garrett Anderson Obstet Wing, London, England; [Worley, Alan; Boyd, Stewart] Great Ormond St Hosp Sick Children, Dept Clin Neurophysiol, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Fitzgerald, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	m.fitzgerald@ucl.ac.uk	Boyd, Stewart/O-3770-2019; Fabrizi, Lorenzo/H-8135-2019	Boyd, Stewart/0000-0001-7363-2453; Fabrizi, Lorenzo/0000-0002-9582-0727; Slater, Rebeccah/0000-0003-1595-4846; Cornelissen, Laura/0000-0001-8579-0870	Wellcome Trust; Medical Research Council; MRC DTA PhD studentship; Medical Research Council [G0502146] Funding Source: researchfish; MRC [G0502146] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC DTA PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the Wellcome Trust and Medical Research Council. LC was funded by an MRC DTA PhD studentship. This research was carried out at the National Institute for Health Research (NIHR) UCLH Clinical Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2004, METH MOLEC MED, P11; ANDREWS K, 1994, PAIN, V56, P95, DOI 10.1016/0304-3959(94)90154-6; Andrews K, 1999, DEV MED CHILD NEUROL, V41, P696, DOI 10.1017/S0012162299001425; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Arendt-Nielsen L, 2000, EUR J APPL PHYSIOL, V81, P165, DOI 10.1007/s004210050026; ARENDTNIELSEN L, 1994, EUR J APPL PHYSIOL O, V68, P266, DOI 10.1007/BF00376776; Baccei ML, 2004, J NEUROSCI, V24, P4749, DOI 10.1523/JNEUROSCI.5211-03.2004; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; Bjerre L, 2011, EUR J PAIN, V15, P816, DOI 10.1016/j.ejpain.2011.01.015; Campbell CM, 2008, PAIN, V134, P91, DOI 10.1016/j.pain.2007.03.035; CHAN CWY, 1989, BRAIN RES, V479, P145, DOI 10.1016/0006-8993(89)91344-9; Daniele CA, 2009, J NEUROSCI, V29, P686, DOI 10.1523/JNEUROSCI.5120-08.2009; Decchi B, 1997, ELECTROMYOGR MOTOR C, V105, P484, DOI 10.1016/S0924-980X(97)00048-9; Ekholm J, 1967, ACTA SOC MED UPS, V1967; Fabrizi L, 2011, CURR BIOL, V21, P1552, DOI 10.1016/j.cub.2011.08.010; Fields HL, 2000, PROG BRAIN RES, V122, P245; Fitzgerald M, 1999, P NATL ACAD SCI USA, V96, P7719, DOI 10.1073/pnas.96.14.7719; FITZGERALD M, 1988, LANCET, V1, P292; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FITZGERALD M, 1984, NEUROSCIENCE, V13, P933, DOI 10.1016/0306-4522(84)90107-6; FITZGERALD M, 1988, DEV MED CHILD NEUROL, V30, P520; FITZGERALD M, 1989, PAIN, V39, P31, DOI 10.1016/0304-3959(89)90172-3; FITZGERALD M, 1985, J PHYSIOL-LONDON, V364, P1; Gaspardo CM, 2008, PAIN, V140, P58, DOI 10.1016/j.pain.2008.07.004; Granmo M, 2008, J NEUROSCI, V28, P5494, DOI 10.1523/JNEUROSCI.0651-08.2008; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hellerud BC, 2002, EARLY HUM DEV, V70, P35, DOI 10.1016/S0378-3782(02)00070-1; Hochman S, 2012, FRONT BIOSCI-LANDMRK, V17, P2158, DOI 10.2741/4043; Jennings E, 1998, J PHYSIOL-LONDON, V509, P859, DOI 10.1111/j.1469-7793.1998.859bm.x; Jennings E, 1996, PAIN, V68, P301, DOI 10.1016/S0304-3959(96)03194-6; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Koch SC, 2013, ANN NY ACAD SCI, V1279, P97, DOI 10.1111/nyas.12033; Koch SC, 2012, P NATL ACAD SCI USA, V109, P12201, DOI 10.1073/pnas.1118960109; KUGELBERG E, 1960, BRAIN, V83, P394, DOI 10.1093/brain/83.3.394; Le Bars D, 2001, PHARMACOL REV, V53, P597; Levinsson A, 1999, J NEUROSCI, V19, P10397; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Miraucourt LS, 2009, J NEUROSCI, V29, P2519, DOI 10.1523/JNEUROSCI.3923-08.2009; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Neziri AY, 2010, PAIN, V151, P798, DOI 10.1016/j.pain.2010.09.017; Park JS, 1999, DEV BRAIN RES, V113, P29, DOI 10.1016/S0165-3806(98)00186-2; PRICE DD, 1972, EXP NEUROL, V37, P371, DOI 10.1016/0014-4886(72)90081-7; Rhudy JL, 2011, J PAIN, V12, P782, DOI 10.1016/j.jpain.2011.01.002; Ririe DG, 2008, ANESTHESIOLOGY, V109, P698, DOI 10.1097/ALN.0b013e3181870a32; Roy M, 2012, EUR J PAIN, V16, P870, DOI 10.1002/j.1532-2149.2011.00030.x; Ruscheweyh R, 2011, PAIN, V152, P2662, DOI 10.1016/j.pain.2011.08.016; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; Sherman SE, 1996, PAIN, V66, P321, DOI 10.1016/0304-3959(96)03063-1; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; SKOGLUND S, 1960, NATURE, V187, P132, DOI 10.1038/187132a0; TODD AJ, 1990, NEUROSCIENCE, V39, P387, DOI 10.1016/0306-4522(90)90275-9; Waldenstrom A, 2003, J NEUROSCI, V23, P7719; Walker SM, 2007, PAIN, V128, P157, DOI 10.1016/j.pain.2006.09.015; WIESENFELDHALLIN Z, 1984, BRAIN RES, V311, P375, DOI 10.1016/0006-8993(84)90104-5; WILLER JC, 1979, PAIN, V7, P15, DOI 10.1016/0304-3959(79)90103-9; WILLIAMS S, 1990, NEUROSCI LETT, V109, P309, DOI 10.1016/0304-3940(90)90013-Y; Woolf CJ, 2007, ANESTHESIOLOGY, V106, P864, DOI 10.1097/01.anes.0000264769.87038.55; Worley A, 2012, J NEUROSCI METH, V205, P252, DOI 10.1016/j.jneumeth.2012.01.009; Wu J, 2012, BRAIN RES, V1448, P11, DOI 10.1016/j.brainres.2012.02.002; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7	68	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76470	10.1371/journal.pone.0076470	http://dx.doi.org/10.1371/journal.pone.0076470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124564	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100121
J	Jiang, ZH; Zhu, S; Ye, R; Xue, Y; Chen, A; An, LZ; Pei, ZM				Jiang, Zhonghao; Zhu, Shan; Ye, Rui; Xue, Yan; Chen, Amelia; An, Lizhe; Pei, Zhen-Ming			Relationship between NaCl- and H2O2-Induced Cytosolic Ca2+ Increases in Response to Stress in Arabidopsis	PLOS ONE			English	Article							OXIDATIVE STRESS; SALT TOLERANCE; ION CHANNELS; CALCIUM; HOMEOSTASIS; THALIANA; DROUGHT; SIGNALS; NADPH; SOS1	Salinity is among the environmental factors that affect plant growth and development and constrain agricultural productivity. Salinity stress triggers increases in cytosolic free Ca2+ concentration ([Ca2+](i)) via Ca2+ influx across the plasma membrane. Salinity stress, as well as other stresses, induces the production of reactive oxygen species (ROS). It is well established that ROS also triggers increases in [Ca2+](i). However, the relationship and interaction between salinity stress-induced [Ca2+](i) increases and ROS-induced [Ca2+](i) increases remain poorly understood. Using an aequorin-based Ca2+ imaging assay we have analyzed [Ca2+](i) changes in response to NaCl and H2O2 treatments in Arabidopsis thaliana. We found that NaCl and H2O2 together induced larger increases in [Ca2+](i) in Arabidopsis seedlings than either NaCl or H2O2 alone, suggesting an additive effect on [Ca2+](i) increases. Following a pretreatment with either NaCl or H2O2, the subsequent elevation of [Ca2+](i) in response to a second treatment with either NaCl or H2O2 was significantly reduced. Furthermore, the NaCl pre-treatment suppressed the elevation of [Ca2+](i) seen with a second NaCl treatment more than that seen with a second treatment of H2O2. A similar response was seen when the initial treatment was with H2O2; subsequent addition of H2O2 led to less of an increase in [Ca2+](i) than did addition of NaCl. These results imply that NaCl-gated Ca2+ channels and H2O2-gated Ca2+ channels may differ, and also suggest that NaCl-and H2O2-evoked [Ca2+](i) may reduce the potency of both NaCl and H2O2 in triggering [Ca2+](i) increases, highlighting a feedback mechanism. Alternatively, NaCl and H2O2 may activate the same Ca2+ permeable channel, which is expressed in different types of cells and/or activated via different signaling pathways.	[Jiang, Zhonghao; An, Lizhe] Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China; [Jiang, Zhonghao; Zhu, Shan; Pei, Zhen-Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Global Change, Ctr Plant Environm Sensing, Hangzhou, Zhejiang, Peoples R China; [Jiang, Zhonghao; Ye, Rui; Xue, Yan; Chen, Amelia; Pei, Zhen-Ming] Duke Univ, Dept Biol, Durham, NC USA	Lanzhou University; Hangzhou Normal University; Duke University	Pei, ZM (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Global Change, Ctr Plant Environm Sensing, Hangzhou, Zhejiang, Peoples R China.	zpei@duke.edu	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921; Jiang, Zhonghao/0000-0002-6675-5997; Pei, Zhen-Ming/0000-0003-1473-696X	China Scholarship Council; Hangzhou Normal University [PD11001008001, PD11002002004002]; Zhejiang NSF [Z3110443]; USDA [CSREES-2006-35100-17304]; NSF [IOS-0848263]	China Scholarship Council(China Scholarship Council); Hangzhou Normal University; Zhejiang NSF; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	ZJ and SZ were supported by fellowships from China Scholarship Council, Pandeng Project funds (PD11001008001; PD11002002004002) from Hangzhou Normal University, and a grant from Zhejiang NSF (Z3110443). This work is supported by grants from USDA (CSREES-2006-35100-17304) and from NSF (IOS-0848263) to ZMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; MA W, 2011, CA2 CONDUCTION PLANT, DOI DOI 10.1111/J.1469-8137.2010.03577.X.PUBMED:21166809; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vaidyanathan H, 2003, PLANT SCI, V165, P1411, DOI 10.1016/j.plantsci.2003.08.005; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Waring P, 2005, ARCH BIOCHEM BIOPHYS, V434, P33, DOI 10.1016/j.abb.2004.08.001; WISE RR, 1987, PLANT PHYSIOL, V83, P272, DOI 10.1104/pp.83.2.272; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	42	25	29	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76130	10.1371/journal.pone.0076130	http://dx.doi.org/10.1371/journal.pone.0076130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124535	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100092
J	Kolozsvari, BL; Berta, A; Petrovski, G; Mihaltz, K; Gogolak, P; Rajnavolgyi, E; Hassan, Z; Szeles, P; Fodor, M				Kolozsvari, Bence Lajos; Berta, Andras; Petrovski, Goran; Mihaltz, Kata; Gogolak, Peter; Rajnavoelgyi, Eva; Hassan, Ziad; Szeles, Peter; Fodor, Mariann			Alterations of Tear Mediators in Patients with Keratoconus after Corneal Crosslinking Associate with Corneal Changes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROGRESSIVE KERATOCONUS; INFLAMMATORY MOLECULES; ULTRAVIOLET-A; MATRIX-METALLOPROTEINASES; COLLAGEN; RIBOFLAVIN; ECTASIA; DEGRADATION; EXPRESSION	Keratoconus (KC) is the most common primary corneal ectatic disease which has considerable importance in public health. Corneal collagen crosslinking (CXL) is a procedure to mitigate progression of KC and reduce demand for corneal transplantation. Although studies have proven the efficacy of CXL regarding corneal shape, none have investigated the effects of CXL on tear biomarkers which are useful tools to understand molecular mechanisms behind CXL. Our purpose was to determine the effect of CXL on tear mediators in patients with KC and analyze associations with corneal changes. Tear samples were collected pre-CXL from 26 eyes of 23 patients and during a 12-month follow-up. The mediators' concentration was measured by Cytometric Bead Array technology. Corneal topography parameters measured by Scheimpflug Camera included: Thinnest-corneal-thickness (ThCT), keratometry values (K1, K2), Radii-Minimum (Rmin), Keratoconus-Index (KI), Center-KI (CKI), Index-of-Height Asymmetry (IHA) and Index-of-Surface Variance (ISV). At baseline, KI was correlated negatively with chemokine (C-C motif) ligand 5 (CCL5) (p=0.015) and matrix metalloproteinase (MMP)-13 (p=0.007). At day 4, interleukin (IL)-6 and IL-8 increased, while IL-13, IL-17A, interferon (IFN)-gamma, CCL5, MMP-13, epidermal growth factor (EGF), nerve growth factor (NGF) and plasminogen activator inhibitor (PAI-1) decreased significantly compared to pre-CXL concentrations (p=0.02). At 6 months tissue plasminogen activator (t-PA) increased (p=0.02), while at 12 months Rmin increased (p=0.004), and IL-6 and CXCL8 (p=0.005 and p=0.047) as well as K1, ISV and KI decreased. After 6 months CKI and ISV showed significant associations with IL-17A; CKI with IL-13 and ThCT with IL-13 (p=0.02), while at 12 months there were reverse associations between ThCT and IL-6, IL-13, INF gamma, CCL5 and PAI-1 (p=0.02). Alterations of mediators in tear fluid after CXL associate with topographic changes highlight the fact that many mediators are involved in the complex mechanisms after CXL. Further studies on biomarkers to investigate the efficacy of CXL are needed.	[Kolozsvari, Bence Lajos; Berta, Andras; Hassan, Ziad; Szeles, Peter; Fodor, Mariann] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Petrovski, Goran] Univ Debrecen, Stem Cells & Eye Res Lab, Dept Biochem & Mol Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Petrovski, Goran] Univ Szeged, Dept Ophthalmol, Fac Med, Szeged, Hungary; [Mihaltz, Kata] Hietzing Hosp, Dept Ophthalmol, Vienna, Austria; [Gogolak, Peter; Rajnavoelgyi, Eva] Univ Debrecen, Dept Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; Szeged University; Hietzing Hospital; University of Debrecen	Fodor, M (corresponding author), Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.	mfodor@med.unideb.hu		Petrovski, Goran/0000-0003-2905-9252; Gogolak, Peter/0000-0001-9411-9587; Fodor, Mariann/0000-0002-1089-3899	Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen [DEOEC Mec-4/2011]	Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen	This work was supported by the Mecenatura Research Grant, Medical and Health Sciences Centre, Faculty of Medicine, University of Debrecen (DEOEC Mec-4/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2000, CORNEA, V19, P474, DOI 10.1097/00003226-200007000-00014; Asri D, 2011, J CATARACT REFR SURG, V37, P2137, DOI 10.1016/j.jcrs.2011.08.026; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Bhogal R, 2008, INT REV IMMUNOL, V27, P472, DOI 10.1080/08830180802430974; Brooks NO, 2012, J CATARACT REFR SURG, V38, P615, DOI 10.1016/j.jcrs.2011.11.029; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Fodor M, 2009, J INTERF CYTOK RES, V29, P375, DOI 10.1089/jir.2008.0116; Greenstein SA, 2012, J CATARACT REFR SURG, V38, P292, DOI 10.1016/j.jcrs.2011.08.041; Greenstein SA, 2011, J CATARACT REFR SURG, V37, P1282, DOI 10.1016/j.jcrs.2011.01.029; Hafezi F, 2009, J CATARACT REFR SURG, V35, P621, DOI 10.1016/j.jcrs.2008.10.060; Hersh PS, 2011, J CATARACT REFR SURG, V37, P149, DOI 10.1016/j.jcrs.2010.07.030; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Koller T, 2009, CORNEA, V28, P510, DOI 10.1097/ICO.0b013e3181915943; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Kranitz K, 2012, J REFRACT SURG, V28, P645, DOI 10.3928/1081597X-20120823-01; Lambiase A, 2012, CURR OPIN OPHTHALMOL, V23, P296, DOI 10.1097/ICU.0b013e3283543b61; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Liu Q, 2009, EYE CONTACT LENS, V35, P232, DOI 10.1097/ICL.0b013e3181b3e87f; Matthews FJ, 2007, EXP EYE RES, V84, P1125, DOI 10.1016/j.exer.2007.02.013; Mazzotta C, 2008, AM J OPHTHALMOL, V146, P527, DOI 10.1016/j.ajo.2008.05.042; Mazzotta C, 2012, ACTA OPHTHALMOL, V90, P259, DOI 10.1111/j.1755-3768.2010.01890.x; McMonnies Charles W, 2007, Eye Contact Lens, V33, P265, DOI 10.1097/ICL.0b013e31814fb64b; Pannebaker C, 2010, MOL VIS, V16, P1949; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; RABINOWITZ YS, 1995, J REFRACT SURG, V11, P371; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Vinciguerra P, 2009, ARCH OPHTHALMOL-CHIC, V127, P1258, DOI 10.1001/archophthalmol.2009.205; Wilson SE, 1999, INVEST OPHTH VIS SCI, V40, P2185; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2007, CORNEA, V26, P600, DOI 10.1097/ICO.0b013e318041f073; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76333	10.1371/journal.pone.0076333	http://dx.doi.org/10.1371/journal.pone.0076333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124547	gold, Green Published			2022-12-25	WOS:000325489100104
J	Nanduri, J; Vaddi, DR; Khan, SA; Wang, N; Makerenko, V; Prabhakar, NR				Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makerenko, Vladislav; Prabhakar, Nanduri R.			Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2 alpha Degradation by Intermittent Hypoxia	PLOS ONE			English	Article							OXIDATIVE STRESS; REPERFUSION INJURY; NADPH OXIDASE; SLEEP-APNEA; FACTOR-I; ACTIVATION; RESPONSES; CELLS; RAT; HOMEOSTASIS	Sleep-disordered breathing with recurrent apnea produces chronic intermittent hypoxia (IH). We previously reported that IH leads to down-regulation of HIF-2 alpha protein via a calpain-dependent signaling pathway resulting in oxidative stress. In the present study, we delineated the signaling pathways associated with calpain-dependent HIF-2 alpha degradation in cell cultures and rats subjected to chronic IH. Reactive oxygen species (ROS) scavengers prevented HIF-2 alpha degradation by IH and ROS mimetic decreased HIF-2 alpha protein levels in rat pheochromocytoma PC12 cell cultures, suggesting that ROS mediate IH-induced HIF-2 alpha degradation. IH activated xanthine oxidase (XO) by increased proteolytic conversion of xanthine dehydrogenase to XO. ROS generated by XO activated calpains, which contributed to HIF-2 alpha degradation by IH. Calpain-induced HIF-2 alpha degradation involves C-terminus but not the N-terminus of the HIF-2 alpha protein. Pharmacological blockade as well as genetic knock down of XO prevented IH induced calpain activation and HIF-2 alpha degradation in PC12 cells. Systemic administration of allopurinol to rats prevented IH-induced hypertension, oxidative stress and XO activation in adrenal medulla. These results demonstrate that ROS generated by XO activation mediates IH-induced HIF-2 alpha degradation via activation of calpains.	[Nanduri, Jayasri] Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA; Univ Chicago, Ctr Syst Biol Sensing O2, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Nanduri, J (corresponding author), Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA.	jnanduri@uchicago.edu	Vaddi, Damodara Reddy/AAU-1398-2020	Vaddi, Damodara Reddy/0000-0002-4441-0859	National Heart, Lung, and Blood Institute [HL-76537, HL-90554]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554, R01HL076537] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute grants HL-76537 and HL-90554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Han Q, 2013, CELL BIOCHEM BIOPHYS, V66, P431, DOI 10.1007/s12013-012-9491-6; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Kumar GK, 2006, J PHYSIOL-LONDON, V575, P229, DOI 10.1113/jphysiol.2006.112524; Lavie Lena, 2012, Front Biosci (Elite Ed), V4, P1391; Makarenko VV, 2012, AM J PHYSL CELL PHYS; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; McCord J M, 1985, Adv Myocardiol, V5, P183; MCCORD JM, 1982, CAN J PHYSIOL PHARM, V60, P1346, DOI 10.1139/y82-201; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; NISHINO T, 1994, J BIOCHEM, V116, P1; PARKS DA, 1985, GASTROENTEROLOGY, V89, P6, DOI 10.1016/0016-5085(85)90738-3; Peng YJ, 2003, ADV EXP MED BIOL, V536, P559; Peng YJ, 2003, J APPL PHYSIOL, V94, P2342, DOI 10.1152/japplphysiol.00613.2002; POETS CF, 1994, BIOL NEONATE, V65, P211; Prabhakar NR, 2012, J APPL PHYSIOL, V113, P1304, DOI 10.1152/japplphysiol.00444.2012; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P156, DOI 10.1016/j.resp.2010.08.021; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Swei A, 1999, MICROCIRCULATION, V6, P179, DOI 10.1038/sj.mn.7300070; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503	39	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75838	10.1371/journal.pone.0075838	http://dx.doi.org/10.1371/journal.pone.0075838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124516	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100073
J	Pagano, B; Jama, A; Martinez, P; Akanho, E; Bui, TTT; Drake, AF; Fraternali, F; Nikolova, PV				Pagano, Bruno; Jama, Abdullah; Martinez, Pierre; Akanho, Ester; Bui, Tam T. T.; Drake, Alex F.; Fraternali, Franca; Nikolova, Penka V.			Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins	PLOS ONE			English	Article							DNA-BINDING DOMAIN; CORE DOMAIN; CRYSTAL-STRUCTURE; THERMODYNAMIC STABILITY; MOLECULAR SIMULATIONS; SECONDARY STRUCTURE; RESPONSE ELEMENTS; RECOGNITION; SEQUENCE; DYNAMICS	The p53 family of genes and their protein products, namely, p53, p63 and p73, have over one billion years of evolutionary history. Advances in computational biology and genomics are enabling studies of the complexities of the molecular evolution of p53 protein family to decipher the underpinnings of key biological conditions spanning from cancer through to various metabolic and developmental disorders and facilitate the design of personalised medicines. However, a complete understanding of the inherent nature of the thermodynamic and structural stability of the p53 protein family is still lacking. This is due, to a degree, to the lack of comprehensive structural information for a large number of homologous proteins and to an incomplete knowledge of the intrinsic factors responsible for their stability and how these might influence function. Here we investigate the thermal stability, secondary structure and folding properties of the DNA-binding domains (DBDs) of a range of proteins from the p53 family using biophysical methods. While the N- and the C-terminal domains of the p53 family show sequence diversity and are normally targets for post-translational modifications and alternative splicing, the central DBD is highly conserved. Together with data obtained from Molecular Dynamics simulations in solution and with structure based homology modelling, our results provide further insights into the molecular properties of evolutionary related p53 proteins. We identify some marked structural differences within the p53 family, which could account for the divergence in biological functions as well as the subtleties manifested in the oligomerization properties of this family.	[Pagano, Bruno; Martinez, Pierre; Fraternali, Franca] Kings Coll London, Sch Biomed Sci, Dept Biochem, London, England; [Pagano, Bruno; Martinez, Pierre; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Pagano, Bruno] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Jama, Abdullah; Akanho, Ester; Bui, Tam T. T.; Drake, Alex F.; Nikolova, Penka V.] Inst Pharmaceut Sci, London, England	University of London; King's College London; University of London; King's College London; University of Naples Federico II	Fraternali, F (corresponding author), Kings Coll London, Sch Biomed Sci, Dept Biochem, New Hunts House, London, England.	franca.fraternali@kcl.ac.uk; penka.nikolova@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011; Pagano, Bruno/F-2931-2012	Fraternali, Franca/0000-0002-3143-6574; Pagano, Bruno/0000-0002-7716-9010; Bui, Tam Thu Thi/0000-0002-8074-4928; Martinez, Pierre/0000-0001-7069-4413	Royal Society; University of London	Royal Society(Royal Society of London); University of London	This work was supported in part by funding from the Royal Society and the University of London Central Research Fund Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Canning P, 2012, J MOL BIOL, V423, P515, DOI 10.1016/j.jmb.2012.08.005; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chen C, 2012, J BIOL CHEM, V287, P7477, DOI 10.1074/jbc.M111.315820; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; HAYWARD S, 1995, ANNU REV PHYS CHEM, V46, P223, DOI 10.1146/annurev.pc.46.100195.001255; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang Q, 2013, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbapap.2013.04.002, DOI 10.1016/J.BBAPAP.2013.04.002.PUBMED:23583620]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huyen Y, 2004, STRUCTURE, V12, P1237, DOI 10.1016/j.str.2004.05.007; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lane DP, 2010, CELL CYCLE, V9, P540, DOI 10.4161/cc.9.3.10516; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Lunardi A, 2010, P NATL ACAD SCI USA, V107, P6322, DOI 10.1073/pnas.1002447107; Madhumalar A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S17; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mintseris J, 2003, PROTEINS, V53, P629, DOI 10.1002/prot.10432; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Patel S, 2008, NUCLEIC ACIDS RES, V36, P5139, DOI 10.1093/nar/gkn490; Patel S, 2008, BIOCHEMISTRY-US, V47, P3235, DOI 10.1021/bi7023207; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Shams I, 2013, J MOL BIOL, V425, P1111, DOI 10.1016/j.jmb.2013.01.007; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhao KH, 2001, J BIOL CHEM, V276, P12120, DOI 10.1074/jbc.M011644200	68	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76014	10.1371/journal.pone.0076014	http://dx.doi.org/10.1371/journal.pone.0076014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124530	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100087
J	Price, LC; Caramori, G; Perros, F; Meng, C; Gambaryan, N; Dorfmuller, P; Montani, D; Casolari, P; Zhu, J; Dimopoulos, K; Shao, DM; Girerd, B; Mumby, S; Proudfoot, A; Griffiths, M; Papi, A; Humbert, M; Adcock, IM; Wort, SJ				Price, Laura C.; Caramori, Gaetano; Perros, Frederic; Meng, Chao; Gambaryan, Natalia; Dorfmuller, Peter; Montani, David; Casolari, Paolo; Zhu, Jie; Dimopoulos, Konstantinos; Shao, Dongmin; Girerd, Barbara; Mumby, Sharon; Proudfoot, Alastair; Griffiths, Mark; Papi, Alberto; Humbert, Marc; Adcock, Ian M.; Wort, S. John			Nuclear Factor kappa-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; PROINFLAMMATORY CYTOKINES; ALVEOLAR MACROPHAGES; INCREASED EXPRESSION; GROWTH-FACTORS; II RECEPTOR; INTERLEUKIN-6; INFLAMMATION; ENDOTHELIN-1	Objectives: To assess activation of the inflammatory transcription factor NF-kappa B (NF-kappa B) in human idiopathic pulmonary arterial hypertension (PAH). Background: Idiopathic PAH is a severe progressive disease characterized by pulmonary vascular remodeling and excessive proliferation of vascular cells. Increasing evidence indicates that inflammation is important in disease pathophysiology. Methods: NF-kappa B-p65 and CD68, CD20 and CD45 were measured by immunohistochemistry and confocal microscopy on lung specimens from patients with idiopathic PAH (n = 12) and controls undergoing lung surgery (n = 14). Clinical data were recorded for all patients including invasive pulmonary hemodynamics for the PAH patients. Immunohistochemical images were analyzed by blinded observers to include standard pulmonary vascular morphometry; absolute macrophage counts/mm 2 and p65-positivity (p65+) using composite images and image-analysis software; and cytoplasmic: nuclear p65+ of individual pulmonary arterial endothelial and smooth muscle cells (PASMC) in 10-20 pulmonary arteries or arterioles per subject. The expression of ET-1 and CCL5 (RANTES) in whole lung was determined by RT-qPCR. Results: Macrophage numbers were increased in idiopathic PAH versus controls (49.0 +/- 4.5 vs. 7.95 +/- 1.9 macrophages/100 mm(2), p<0.0001): these macrophages demonstrated more nuclear p65+ than in macrophages from controls (16.9 +/- 2.49 vs. 3.5 +/- 1.25%, p<0.001). An increase in p65+ was also seen in perivascular lymphocytes in patients with PAH. Furthermore, NF-kappa B activation was increased in pulmonary arterial endothelial cells (62.3 +/- 2.9 vs. 14.4 +/- 3.8, p<0.0001) and PASMC (22.6 +/- 2.3 vs. 11.2 +/- 2.0, p<0.001) in patients with PAH versus controls, with similar findings in arterioles. Gene expression of both ET-1 mRNA ((0.213 +/- 0.069 vs. 1.06 +/- 0.23, p<0.01) and CCL5 (RANTES) (0.16 +/- 0.045 vs. 0.26 +/- 0.039, p<0.05) was increased in whole lung homogenates from patients with PAH. Conclusions: NF-kappa B is activated in pulmonary macrophages, lymphocytes, endothelial and PASMC in patients with end-stage idiopathic PAH. Future research should determine whether NF-kappa B activation is a driver or bystander of pulmonary vascular inflammation and if the former, its potential role as a therapeutic target.	[Price, Laura C.; Meng, Chao; Gambaryan, Natalia; Dimopoulos, Konstantinos; Shao, Dongmin; Mumby, Sharon; Proudfoot, Alastair; Griffiths, Mark; Wort, S. John] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, Unit Crit Care,Fac Med, London, England; [Zhu, Jie] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London, England; [Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England; [Perros, Frederic; Dorfmuller, Peter; Montani, David; Girerd, Barbara; Humbert, Marc] Univ Paris 11, Le Kremlin Bicetre, France; [Perros, Frederic; Dorfmuller, Peter; Montani, David; Girerd, Barbara; Humbert, Marc] Ctr Chirurg Marie Lannelongue, INSERM, LabEx LERMIT, UMR S 999, Le Plessis Robinson, France; [Montani, David; Girerd, Barbara; Humbert, Marc] Hop Bicetre, AP HP, Serv Pneumol, DHU Thorax Innovat, Le Kremlin Bicetre, France; [Dorfmuller, Peter] Ctr Chirurg Marie Lannelongue, Dept Pathol, Le Plessis Robinson, France; [Caramori, Gaetano; Casolari, Paolo; Papi, Alberto] Univ Ferrara, Sect Resp Dis, Ctr Interdipartimentale Studio Malattie Infiammat, I-44100 Ferrara, Italy	Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton Hospital; Imperial College London; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; University of Ferrara	Price, LC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, Unit Crit Care,Fac Med, London, England.	l.price@imperial.ac.uk	Papi, alberto/AAC-1888-2019; Perros, Frédéric/N-6921-2017; Humbert, Marc/ABD-5112-2021; David, Montani/I-6885-2019; Caramori, Gaetano/AAS-8611-2020; Dimopoulos, Konstantinos/AAD-5229-2019; Humbert, Marc/AAC-8459-2019; Adcock, Ian/L-3217-2019; Proudfoot, Alastair/AAG-3235-2021	Perros, Frédéric/0000-0001-7730-2427; David, Montani/0000-0002-9358-6922; Caramori, Gaetano/0000-0002-9807-327X; Dimopoulos, Konstantinos/0000-0003-1300-0504; Humbert, Marc/0000-0003-0703-2892; Griffiths, Mark/0000-0002-1615-1896; Adcock, Ian/0000-0003-2101-8843; PAPI, ALBERTO/0000-0002-6924-4500; Dorfmuller, Peter/0000-0003-2499-6829	British Heart Foundation [F09/043]; Pfizer; Bayer; GSK; Actelion; Wellcome Trust [093080]; Medical Research Council [G0801266]; Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust; Imperial College London; University of Ferrara; British Heart Foundation [FS/09/043/28040] Funding Source: researchfish; MRC [G0801266] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Pfizer(Pfizer); Bayer(Bayer AG); GSK(GlaxoSmithKline); Actelion; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust; Imperial College London(General Electric); University of Ferrara; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a clinical research fellowship grant from the British Heart Foundation number F09/043 (LCP). SJW receives unrestricted educational grants from Pfizer, Bayer, GSK and Actelion. IMA receives project grants from the Wellcome Trust (093080) and Medical Research Council (G0801266). It was also supported by the Department of Health's National Institute Health Research Respiratory Disease Biomedical Research Centre at the Royal Brompton and Harefield National Health Service Foundation Trust, Imperial College London and University of Ferrara (GC and AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bhargava A, 1999, Heart Dis, V1, P126; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Caramori G, 2003, THORAX, V58, P348, DOI 10.1136/thorax.58.4.348; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Djordjevic T, 2004, ANTIOXID REDOX SIGN, V6, P713, DOI 10.1089/1523086041361703; Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x; Dorfmuller P, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-119; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Dorfmuller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Eickelberg O, 1999, CIRCULATION, V99, P2276, DOI 10.1161/01.CIR.99.17.2276; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Graham BB, 2013, AM J RESP CELL MOL B; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; HEATH D, 1991, J CLIN PATHOL, V44, P1003, DOI 10.1136/jcp.44.12.1003; Huang J, 2008, AM J PHYSIOL-LUNG C, V294, pL1250, DOI 10.1152/ajplung.00069.2007; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Kimura S, 2009, HYPERTENSION, V53, P877, DOI 10.1161/HYPERTENSIONAHA.108.121418; Marok R, 1996, ARTHRITIS RHEUM, V39, P583, DOI 10.1002/art.1780390407; MEYRICK B, 1986, LAB INVEST, V55, P164; MIYATA M, 1995, INT ARCH ALLERGY IMM, V108, P287, DOI 10.1159/000237166; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619; Park JES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030075; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706; Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Raychaudhuri B, 2002, CLIN IMMUNOL, V104, P191, DOI 10.1006/clim.2002.5253; Raychaudhuri B, 2002, J BIOL CHEM, V277, P33344, DOI 10.1074/jbc.M203567200; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Savai R, 2012, AM J RESP CRIT CARE; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Sawada H, 2007, CHEST, V132, P1265, DOI 10.1378/chest.06-2243; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; TUDER RM, 1994, AM J PATHOL, V144, P275; Wang WY, 2009, J CLIN IMMUNOL, V29, P705, DOI 10.1007/s10875-009-9322-8; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wilson SH, 2002, ATHEROSCLEROSIS, V160, P147, DOI 10.1016/S0021-9150(01)00546-9; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458	63	58	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75415	10.1371/journal.pone.0075415	http://dx.doi.org/10.1371/journal.pone.0075415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124488	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100045
J	Thompson, JP; Serrano-Gomez, A; McDonald, J; Ladak, N; Bowrey, S; Lambert, DG				Thompson, Jonathan P.; Serrano-Gomez, Alcira; McDonald, John; Ladak, Nadia; Bowrey, Sarah; Lambert, David G.			The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; OPIOID RECEPTORS; SEPTIC SHOCK; STATES; MORPHINE; OUTCOMES; EPIDEMIOLOGY; CHEMOTAXIS; INHIBITION; ACTIVATION	Background And Objectives: Nociceptin/Orphanin FQ (N/OFQ) is a non-classical endogenous opioid peptide that modulates immune function in vitro. Its importance in inflammation and human sepsis is unknown. The objectives of this study were to determine the relationship between N/OFQ, transcripts for its precursor (pre-pro-N/OFQ [ppNOC]) and receptor (NOP), inflammatory markers and clinical outcomes in patients undergoing cardiopulmonary bypass and with sepsis. Methods: A prospective observational cohort study of 82 patients admitted to Intensive Care (ICU) with sepsis and 40 patients undergoing cardiac surgery under cardiopulmonary bypass (as a model of systemic inflammation). Sixty three healthy volunteers, matched by age and sex to the patients with sepsis were also studied. Clinical and laboratory details were recorded. Polymorph ppNOC and NOP receptor mRNA were determined using quantitative PCR. Plasma N/OFQ was determined using ELISA and cytokines (TNF-alpha, IL-8, IL-10) measured using radioimmunoassay. Data from patients undergoing cardiac surgery were recorded before, 3 and 24 hours after cardiopulmonary bypass. ICU patients with sepsis were assessed on Days 1 and 2 of ICU admission, and after clinical recovery. Main Results: Plasma N/OFQ concentrations increased (p<0.0001) on Days 1 and 2 of ICU admission with sepsis compared to matched recovery samples. Polymorph ppNOC (p=0.019) and NOP mRNA (p<0.0001) decreased compared to healthy volunteers. TNF-alpha, IL-8 and IL-10 concentrations increased on Day 1 compared to matched recovery samples and volunteers (p<0.0001). Similar changes (increased plasma N/OFQ, [p=0.0058], decreased ppNOC [p<0.0001], increased IL-8 and IL-10 concentrations [both p<0.0001]) occurred after cardiac surgery but these were comparatively lower and of shorter duration. Conclusions: The N/OFQ system is modulated in ICU patients with sepsis with similar but reduced changes after cardiac surgery under cardiopulmonary bypass. Further studies are required to clarify the role of the N/OFQ system in inflammation and sepsis, and the mechanisms involved.	[Thompson, Jonathan P.; Serrano-Gomez, Alcira; McDonald, John; Ladak, Nadia; Bowrey, Sarah; Lambert, David G.] Univ Leicester, Leicester Royal Infirm, Div Anaesthesia Crit Care & Pain Management, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester	Thompson, JP (corresponding author), Univ Leicester, Leicester Royal Infirm, Div Anaesthesia Crit Care & Pain Management, Dept Cardiovasc Sci, Leicester, Leics, England.	jt23@le.ac.uk		Thompson, Jonathan/0000-0002-8595-5943; Lambert, David/0000-0003-4769-8090	Anaesthesia/AAGBI under National Institue of Academic Anaesthesia	Anaesthesia/AAGBI under National Institue of Academic Anaesthesia	This work has been funded by grants from Anaesthesia/AAGBI Small Project Grants 2008 (13,300) pound and the Anaesthesia/AAGBI Small Project Grants 2009 (13,800) pound, both administrated by and under the auspices of the National Institue of Academic Anaesthesia (http://www.niaa.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Anton B, 2010, J NEUROIMMUNE PHARM, V5, P143, DOI 10.1007/s11481-010-9190-2; Archard C, 1909, B MEM SOC MED HOP P, V28, P958; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brookes ZLS, 2007, AM J PHYSIOL-HEART C, V293, pH2977, DOI 10.1152/ajpheart.00448.2007; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Easten KH, 2009, PEPTIDES, V30, P926, DOI 10.1016/j.peptides.2009.01.021; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Fiset MT, 2003, BIOCHEMISTRY-US, V42, P10498, DOI 10.1021/bi0300635; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Galley HF, 2003, BRIT J ANAESTH, V91, P424, DOI 10.1093/bja/aeg174; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; MANFREDI B, 1993, J NEUROIMMUNOL, V44, P43, DOI 10.1016/0165-5728(93)90266-2; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McDonald J, 2010, BRIT J ANAESTH, V105, P707; Mellon RD, 1998, J NEUROIMMUNOL, V83, P19, DOI 10.1016/S0165-5728(97)00217-8; Morgan EL, 1996, J NEUROIMMUNOL, V65, P21, DOI 10.1016/0165-5728(95)00171-9; Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Peluso J, 1998, J NEUROIMMUNOL, V81, P184, DOI 10.1016/S0165-5728(97)00178-1; Roy S, 2001, SURGERY, V130, P304, DOI 10.1067/msy.2001.116033; Serhan CN, 2001, J IMMUNOL, V166, P3650, DOI 10.4049/jimmunol.166.6.3650; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Stamer UM, 2011, BRIT J ANAESTH, V106, P566, DOI 10.1093/bja/aer007; Trombella S, 2005, PEPTIDES, V26, P1497, DOI 10.1016/j.peptides.2005.03.015; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waits PS, 2004, J NEUROIMMUNOL, V149, P110, DOI 10.1016/j.jneuroim.2003.12.018; Wilhelm W, 2002, SHOCK, V17, P354, DOI 10.1097/00024382-200205000-00002; Williams JP, 2008, BRIT J ANAESTH, V100, P810, DOI 10.1093/bja/aen093; Williams JP, 2008, ANESTH ANALG, V106, P865, DOI 10.1213/ane.0b013e3181617646; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wu ZK, 2008, WORLD J SURG, V32, P2643, DOI 10.1007/s00268-008-9758-7; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zhao HF, 2012, CRIT CARE MED, V40, P1700, DOI 10.1097/CCM.0b013e318246b83a	51	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76682	10.1371/journal.pone.0076682	http://dx.doi.org/10.1371/journal.pone.0076682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124588	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100145
J	Tobin, ED; Grunbaum, D; Patterson, J; Cattolico, RA				Tobin, Elizabeth D.; Gruenbaum, Daniel; Patterson, Johnathan; Cattolico, Rose Ann			Behavioral and Physiological Changes during Benthic-Pelagic Transition in the Harmful Alga, Heterosigma akashiwo: Potential for Rapid Bloom Formation	PLOS ONE			English	Article							VERTICAL MIGRATION BEHAVIOR; POLYUNSATURATED FATTY-ACIDS; POPULATION-DYNAMICS; SPORE DISPERSAL; NEUTRAL LIPIDS; RED TIDE; RAPHIDOPHYCEAE; GROWTH; BAY; TEMPERATURE	Many species of harmful algae transition between a motile, vegetative stage in the water column and a non-motile, resting stage in the sediments. Physiological and behavioral traits expressed during benthic-pelagic transition potentially regulate the timing, location and persistence of blooms. The roles of key physiological and behavioral traits involved in resting cell emergence and bloom formation were examined in two geographically distinct strains of the harmful alga, Heterosigma akashiwo. Physiological measures of cell viability, division and population growth, and cell fatty acid content were made using flow cytometry and gas chromatography - mass spectrometry techniques as cells transitioned between the benthic resting stage and the vegetative pelagic stage. Video-based tracking was used to quantify cell-level swimming behaviors. Data show increased temperature and light triggered rapid emergence from the resting stage and initiated cell swimming. Algal strains varied in important physiological and behavioral traits, including survivorship during life-stage transitions, population growth rates and swimming velocities. Collectively, these traits function as "population growth strategies" that can influence bloom formation. Many resting cells regained the up-swimming capacity necessary to cross an environmentally relevant halocline and the ability to aggregate in near-surface waters within hours after vegetative growth supporting conditions were restored. Using a heuristic model, we illustrate how strain-specific population growth strategies can govern the timescales over which H. akashiwo blooms form. Our findings highlight the need for identification and quantification of strain-specific physiological and behavioral traits to improve mechanistic understanding of bloom formation and successful bloom prediction.	[Tobin, Elizabeth D.; Gruenbaum, Daniel] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Patterson, Johnathan; Cattolico, Rose Ann] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tobin, ED (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	etobin@u.washington.edu			NOAA Washington Sea Grants [NA10OAR-4170057, NA07OAR-4170007]; United States Department of Energy [DE-EE0003046]; NSF IGERT Program on Ocean Change Fellowship	NOAA Washington Sea Grants; United States Department of Energy(United States Department of Energy (DOE)); NSF IGERT Program on Ocean Change Fellowship	Funding for this research was provided by NOAA Washington Sea Grants (NA10OAR-4170057 to D. Grunbaum); the United States Department of Energy (contract DE-EE0003046) awarded to the National Alliance for Advanced Biofuels and Bioproducts and NOAA Washington Sea Grants (NA07OAR-4170007 to R. A. Cattolico); and the NSF IGERT Program on Ocean Change Fellowship to E. Tobin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; ANDERSON DM, 2007, BRUUN MEMORIAL LECT; [Anonymous], 2007, FISH KILLS HARMFUL A; Bearon RN, 2008, J THEOR BIOL, V251, P679, DOI 10.1016/j.jtbi.2008.01.007; Bearon RN, 2006, MAR ECOL PROG SER, V306, P153, DOI 10.3354/meps306153; Bearon RN, 2004, LIMNOL OCEANOGR, V49, P607, DOI 10.4319/lo.2004.49.2.0607; BIGELOW N, 2013, ALGAL RES IN PRESS; Bigelow NW, 2011, J AM OIL CHEM SOC, V88, P1329, DOI 10.1007/s11746-011-1799-7; BRZEZINSKI MA, 1993, J PHYCOL, V29, P16, DOI 10.1111/j.1529-8817.1993.tb00275.x; CATTOLICO RA, 1976, PLANT PHYSIOL, V57, P497, DOI 10.1104/pp.57.4.497; Cembella Allan D., 2005, Oceanography, V18, P158; Clough J, 2005, AQUAT MICROB ECOL, V39, P121, DOI 10.3354/ame039121; Cohen Z, 2000, BIOCHEM SOC T, V28, P740, DOI 10.1042/BST0280740; Cullen J.J., 1985, Contributions in Marine Science, V27, P135; Darzynkiewicz Zbigniew, 2010, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0702s52; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Eltgroth ML, 2005, J PHYCOL, V41, P1000, DOI 10.1111/j.1529-8817.2005.00128.x; Franks PJS, 1997, LIMNOL OCEANOGR, V42, P1297, DOI 10.4319/lo.1997.42.5_part_2.1297; FREDRICKSON KA, 2011, J PHYCOL, V47, P1, DOI DOI 10.1111/J.1529-8817.2011.00970.X; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gaylord B, 2004, J MARINE SYST, V49, P19, DOI 10.1016/j.jmarsys.2003.05.003; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gurarie E, 2011, B MATH BIOL, V73, P1358, DOI 10.1007/s11538-010-9575-7; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Han MS, 2002, J PHYCOL, V38, P304, DOI 10.1046/j.1529-8817.2002.01087.x; Handy SM, 2005, AQUAT MICROB ECOL, V40, P121, DOI 10.3354/ame040121; Haque SM, 2002, BOT MAR, V45, P356, DOI 10.1515/BOT.2002.036; *HARRNESS, 2005, HARMF ALG RES RESP N, P96; Harvey EL, 2011, LIMNOL OCEANOGR, V56, P371, DOI 10.4319/lo.2011.56.1.0371; He RY, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004602; Herndon J, 2007, HARMFUL ALGAE, V6, P260, DOI 10.1016/j.hal.2006.08.006; Hershberger PK, 1997, CAN J FISH AQUAT SCI, V54, P2228, DOI 10.1139/cjfas-54-10-2228; HONJO J, 1990, HARMFUL RED TIDES HE; Imai I, 1999, MAR BIOL, V133, P755, DOI 10.1007/s002270050517; Ishikawa A, 1996, MAR ECOL PROG SER, V140, P169, DOI 10.3354/meps140169; Itakura S, 2001, PHYCOLOGIA, V40, P263, DOI 10.2216/i0031-8884-40-3-263.1; Jeong HJ, 2003, J EUKARYOT MICROBIOL, V50, P274, DOI 10.1111/j.1550-7408.2003.tb00134.x; Kempton J, 2008, HARMFUL ALGAE, V7, P235, DOI 10.1016/j.hal.2007.08.003; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Lawrence JE, 2002, LIMNOL OCEANOGR, V47, P545, DOI 10.4319/lo.2002.47.2.0545; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Martinez R, 2010, J PLANKTON RES, V32, P529, DOI 10.1093/plankt/fbp135; McKay L, 2006, HARMFUL ALGAE, V5, P623, DOI 10.1016/j.hal.2005.12.001; Okuyama H, 2008, APPL ENVIRON MICROB, V74, P570, DOI 10.1128/AEM.02256-07; Olofsson M, 2012, ENERGIES, V5, P1577, DOI 10.3390/en5051577; Ralston DK, 2007, J PLANKTON RES, V29, P803, DOI 10.1093/plankt/fbm061; Reed DC, 1999, MAR BIOL, V133, P737, DOI 10.1007/s002270050515; Rensel JEJ, 2010, HARMFUL ALGAE, V10, P98, DOI 10.1016/j.hal.2010.07.005; Rosman JH, 2010, LIMNOL OCEANOGR, V55, P1145, DOI 10.4319/lo.2010.55.3.1145; SATOH E, 1987, PLANT CELL PHYSIOL, V28, P1093; Shikata T, 2008, LIMNOL OCEANOGR, V53, P2503, DOI 10.4319/lo.2008.53.6.2503; Shikata T, 2007, HARMFUL ALGAE, V6, P700, DOI 10.1016/j.hal.2007.02.008; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; SMAYDA TJ, 1998, PHYSL ECOLOGY HARMFU, P115; Solovchenko AE, 2011, RUSS J PLANT PHYSL+, V58, P674, DOI 10.1134/S1021443711040157; Taylor F.J., 2002, HARMFUL ALGAL BLOOMS; Taylor F.J.R., 1994, CAN TECH REP FISH AQ, V1948, P175; TAYLOR FJR, 1993, DEV MAR BIOL, V1993; Tobin ED, 2011, HARMFUL ALGAE, V10, P619, DOI 10.1016/j.hal.2011.04.014; TOMAS CR, 1978, J PHYCOL, V14, P309, DOI 10.1111/j.1529-8817.1978.tb00303.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; WADA M, 1985, PLANT CELL PHYSIOL, V26, P431, DOI 10.1093/oxfordjournals.pcp.a076926; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457	65	18	19	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76663	10.1371/journal.pone.0076663	http://dx.doi.org/10.1371/journal.pone.0076663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124586	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100143
J	Zhang, XM; Liu, W; Schloter, M; Zhang, GM; Chen, QS; Huang, JH; Li, LH; Elser, JJ; Han, XG				Zhang, Ximei; Liu, Wei; Schloter, Michael; Zhang, Guangming; Chen, Quansheng; Huang, Jianhui; Li, Linghao; Elser, James J.; Han, Xingguo			Response of the Abundance of Key Soil Microbial Nitrogen-Cycling Genes to Multi-Factorial Global Changes	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; DENITRIFYING BACTERIA; TERRESTRIAL ECOSYSTEMS; COMMUNITIES; BIODIVERSITY; DEPOSITION; DIVERSITY; STEPPE; DENITRIFICATION; TRANSFORMATION	Multiple co-occurring environmental changes are affecting soil nitrogen cycling processes, which are mainly mediated by microbes. While it is likely that various nitrogen-cycling functional groups will respond differently to such environmental changes, very little is known about their relative responsiveness. Here we conducted four long-term experiments in a steppe ecosystem by removing plant functional groups, mowing, adding nitrogen, adding phosphorus, watering, warming, and manipulating some of their combinations. We quantified the abundance of seven nitrogen-cycling genes, including those for fixation (nifH), mineralization (chiA), nitrification (amoA of ammonia-oxidizing bacteria (AOB) or archaea (AOA)), and denitrification (nirS, nirK and nosZ). First, for each gene, we compared its sensitivities to different environmental changes and found that the abundances of various genes were sensitive to distinct and different factors. Overall, the abundances of nearly all genes were sensitive to nitrogen enrichment. In addition, the abundances of the chiA and nosZ genes were sensitive to plant functional group removal, the AOB-amoA gene abundance to phosphorus enrichment when nitrogen was added simultaneously, and the nirS and nirK gene abundances responded to watering. Second, for each single-or multifactorial environmental change, we compared the sensitivities of the abundances of different genes and found that different environmental changes primarily affected different gene abundances. Overall, AOB-amoA gene abundance was most responsive, followed by the two denitrifying genes nosZ and nirS, while the other genes were less sensitive. These results provide, for the first time, systematic insights into how the abundance of each type of nitrogen-cycling gene and the equilibrium state of all these nitrogen-cycling gene abundances would shift under each single-or multi-factorial global change.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Zhang, Ximei; Zhang, Guangming; Chen, Quansheng; Huang, Jianhui; Li, Linghao; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Liu, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Schloter, Michael] Helmholtz Ctr Environm Hlth, Oberschleissheim, Germany; [Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe	Elser, JJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	j.elser@asu.edu; xghan@ibcas.ac.cn	Han, Xingguo/K-7552-2016; Elser, James/A-7082-2008; Chen, Quansheng/AGH-8083-2022; Schloter, 1Michael/H-9151-2013; Elser, James J/AAL-6199-2020	Han, Xingguo/0000-0002-1836-975X; Elser, James/0000-0002-1460-2155; Chen, Quansheng/0000-0003-2498-3278; Elser, James J/0000-0002-1460-2155; Zhang, Ximei/0000-0002-0038-5460	National Natural Science Foundation of China [30830026]; State Key Basic Research Development Program of China (973 Program) [2009CB825103]; Postdoctoral Science Foundation of China [2011M500440, 2012T50158]; US National Science Foundation [DEB-0925017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); US National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Natural Science Foundation of China(30830026) and the State Key Basic Research Development Program of China (973 Program) (2009CB825103), Postdoctoral Science Foundation of China (2011M500440, 2012T50158), and the US National Science Foundation (DEB-0925017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Forbes MS, 2009, AUST J SOIL RES, V47, P380, DOI 10.1071/SR08126; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grogan P, 2003, ECOLOGY, V84, P202, DOI 10.1890/0012-9658(2003)084[0202:COANCI]2.0.CO;2; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Houlton BZ, 2009, P NATL ACAD SCI USA, V106, P21713, DOI 10.1073/pnas.0912111106; Kaiser C, 2011, ECOLOGY, V92, P1036, DOI 10.1890/i0012-9658-92-5-1036; Knops JMH, 2002, ECOL LETT, V5, P454, DOI 10.1046/j.1461-0248.2002.00332.x; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; LI B, 1988, RES GRASSLAND ECOSYS, V3, P84; Lindsay EA, 2010, APPL ENVIRON MICROB, V76, P5547, DOI 10.1128/AEM.03054-09; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; McCrackin ML, 2010, ECOLOGY, V91, P528, DOI 10.1890/08-2210.1; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P926, DOI 10.1016/j.soilbio.2010.02.009; Swift MJ, 1998, GLOBAL CHANGE BIOL, V4, P729, DOI 10.1046/j.1365-2486.1998.00207.x; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Towe S, 2010, MICROB ECOL, V60, P762, DOI 10.1007/s00248-010-9695-5; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wakelin SA, 2010, PEDOBIOLOGIA, V53, P391, DOI 10.1016/j.pedobi.2010.08.001; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Wallenstein MD, 2005, PEDOBIOLOGIA, V49, P665, DOI 10.1016/j.pedobi.2005.05.005; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wu Jianguo, 1992, P67; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zhang XM, 2012, J ENVIRON SCI-CHINA, V24, P1483, DOI 10.1016/S1001-0742(11)60900-5; Zhang XM, 2011, MOL ECOL, V20, P429, DOI 10.1111/j.1365-294X.2010.04933.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019	61	40	54	17	324	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76500	10.1371/journal.pone.0076500	http://dx.doi.org/10.1371/journal.pone.0076500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124568	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100125
J	Liu, ZF; Lin, YB; Lu, HF; Ding, MM; Tan, YW; Xu, SJ; Fu, SL				Liu, Zhanfeng; Lin, Yongbiao; Lu, Hongfang; Ding, Mingmao; Tan, Yaowen; Xu, Shejin; Fu, Shenglei			Maintenance of a Living Understory Enhances Soil Carbon Sequestration in Subtropical Orchards	PLOS ONE			English	Article							FLOOR MANAGEMENT; VEGETATION; FERTILITY; IMPACTS; FOREST	Orchard understory represents an important component of the orchards, performing numerous functions related to soil quality, water relations and microclimate, but little attention has been paid on its effect on soil C sequestration. In the face of global climate change, fruit producers also require techniques that increase carbon (C) sequestration in a cost-effective manner. Here we present a case study to compare the effects of understory management (sod culture vs. clean tillage) on soil C sequestration in four subtropical orchards. The results of a 10-year study indicated that the maintenance of sod significantly enhanced the soil C stock in the top 1 m of orchard soils. Relative to clean tillage, sod culture increased annual soil C sequestration by 2.85 t C ha(-1), suggesting that understory management based on sod culture offers promising potential for soil carbon sequestration. Considering that China has the largest area of orchards in the world and that few of these orchards currently have sod understories, the establishment and maintenance of sod in orchards can help China increase C sequestration and greatly contribute to achieving CO2 reduction targets at a regional scale and potentially at a national scale.	[Liu, Zhanfeng; Lin, Yongbiao; Lu, Hongfang; Ding, Mingmao; Fu, Shenglei] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Tan, Yaowen; Xu, Shejin] Guangzhou Fruit Res Inst, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS	Lin, YB (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linyb@scbg.ac.cn; sfu@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021; Fu, Shenglei/B-2729-2012	Liu, Zhanfeng/0000-0002-6602-6196; 	National Science Foundation of China [31100384, 30925010, U1131001]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-J-28]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05070301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Science Foundation of China (31100384, 30925010 and U1131001), the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-J-28), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05070301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5; Balesdent J, 1996, SOIL BIOL BIOCHEM, V28, P1261, DOI 10.1016/0038-0717(96)00112-5; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Goh KM, 2001, BIOL AGRIC HORTIC, V18, P269, DOI 10.1080/01448765.2001.9754889; Granatstein D, 2009, INT J FRUIT SCI, V9, P257, DOI 10.1080/15538360903245212; He Y., 2005, SUBTROPICAL AGR RES, V1, P45; Hoagland L, 2008, BIOL FERT SOILS, V45, P11, DOI 10.1007/s00374-008-0304-4; Huang ZM, 2011, FRUIT CULTIVATION PE; Ingram JSI, 2001, AGR ECOSYST ENVIRON, V87, P111, DOI 10.1016/S0167-8809(01)00145-1; Itoh M, 1997, J JPN SOC HORTIC SCI, V66, P1, DOI 10.2503/jjshs.66.1; [寇建村 Kou Jiancun], 2010, [草业科学, Pratacultural Science], V27, P154; Kumar BM, 2011, ADV AGROFOR, V8, P1, DOI 10.1007/978-94-007-1630-8; LAL R, 2000, ADV SOIL SCI SER, P3; Liu ZF, 2012, APPL SOIL ECOL, V54, P7, DOI 10.1016/j.apsoil.2011.12.002; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Marsh KB, 1996, BIOL AGRIC HORTIC, V13, P161, DOI 10.1080/01448765.1996.9754775; MERWIN IA, 1994, J AM SOC HORTIC SCI, V119, P216, DOI 10.21273/JASHS.119.2.216; Morgan JA, 2010, J SOIL WATER CONSERV, V65, p6A, DOI 10.2489/jswc.65.1.6A; Nieder R, 2003, HANDBOOK OF PROCESSES AND MODELING IN THE SOIL-PLANT SYSTEM, P345; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Shui JG, 2008, PEDOSPHERE, V18, P214, DOI 10.1016/S1002-0160(08)60009-0; SKROCH WA, 1986, HORTSCIENCE, V21, P390; Wang YX, 2010, SUBTROPICAL AGR RES, V6, P189; Wardle DA, 2001, SOIL BIOL BIOCHEM, V33, P893, DOI 10.1016/S0038-0717(00)00235-2; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Winjum JK, 1993, WATER AIR SOIL POLL, V64, P227; Wu JP, 2011, SOIL BIOL BIOCHEM, V43, P2355, DOI 10.1016/j.soilbio.2011.07.011; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057	31	12	18	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76950	10.1371/journal.pone.0076950	http://dx.doi.org/10.1371/journal.pone.0076950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116188	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200088
J	Babujee, L; Balakrishnan, V; Kiley, PJ; Glasner, JD; Perna, NT				Babujee, Lavanya; Balakrishnan, Venkatesh; Kiley, Patricia J.; Glasner, Jeremy D.; Perna, Nicole T.			Transcriptome Changes Associated with Anaerobic Growth in Yersinia intermedia (ATCC29909)	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; BORNE TRANSMISSION; ENTEROCOLITICA; EVOLUTION; VIRULENCE; PSEUDOTUBERCULOSIS; RPOS; IDENTIFICATION; METABOLISM	Background: The yersiniae (Enterobacteriaceae) occupy a variety of niches, including some in human and flea hosts. Metabolic adaptations of the yersiniae, which contribute to their success in these specialized environments, remain largely unknown. We report results of an investigation of the transcriptome under aerobic and anaerobic conditions for Y. intermedia, a non-pathogenic member of the genus that has been used as a research surrogate for Y. pestis. Y. intermedia shares characteristics of pathogenic yersiniae, but is not known to cause disease in humans. Oxygen restriction is an important environmental stimulus experienced by many bacteria during their life-cycles and greatly influences their survival in specific environments. How oxygen availability affects physiology in the yersiniae is of importance in their life cycles but has not been extensively characterized. Methodology/Principal Findings: Tiled oligonucleotide arrays based on a draft genome sequence of Y. intermedia were used in transcript profiling experiments to identify genes that change expression in response to oxygen availability during growth in minimal media with glucose. The expression of more than 400 genes, constituting about 10% of the genome, was significantly altered due to oxygen-limitation in early log phase under these conditions. Broad functional categorization indicated that, in addition to genes involved in central metabolism, genes involved in adaptation to stress and genes likely involved with host interactions were affected by oxygen-availability. Notable among these, were genes encoding functions for motility, chemotaxis and biosynthesis of cobalamin, which were up-regulated and those for iron/heme utilization, methionine metabolism and urease, which were down-regulated. Conclusions/Significance: This is the first transcriptome analysis of a non-pathogenic Yersinia spp. and one of few elucidating the global response to oxygen limitation for any of the yersiniae. Thus this study lays the foundation for further experimental characterization of oxygen-responsive genes and pathways in this ecologically diverse genus.	[Babujee, Lavanya; Balakrishnan, Venkatesh; Glasner, Jeremy D.; Perna, Nicole T.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Kiley, Patricia J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Perna, Nicole T.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Perna, NT (corresponding author), Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA.	ntperna@wisc.edu		Kiley, Patricia/0000-0002-8771-1782; Perna, Nicole/0000-0001-8208-0929	"Molecular Evolution of Microbial Pathogen Genomes", NIH [R01-GM62994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062994] Funding Source: NIH RePORTER	"Molecular Evolution of Microbial Pathogen Genomes", NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LB is supported by the "Molecular Evolution of Microbial Pathogen Genomes", NIH R01-GM62994 (P.I. N.T. Perna; Co-P.I.s J.D. Glasner, P.J. Kiley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Babujee L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-110; BAHRANI FK, 1994, J BACTERIOL, V176, P3412, DOI 10.1128/jb.176.11.3412-3419.1994; Bai GC, 2007, ADV EXP MED BIOL, V603, P131; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BOTTONE EJ, 1977, CRC CR REV MICROBIOL, V5, P211, DOI 10.3109/10408417709102312; Boulette ML, 2007, J BACTERIOL, V189, P6957, DOI 10.1128/JB.00621-07; BRENNER DJ, 1980, CURR MICROBIOL, V4, P207, DOI 10.1007/BF02605858; BUTLER T, 1984, T ROY SOC TROP MED H, V78, P449, DOI 10.1016/0035-9203(84)90057-9; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, INFECT IMMUN, V77, P501, DOI 10.1128/IAI.00850-08; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; Dufour YS, 2010, NUCLEIC ACIDS RES, V38, pW321, DOI 10.1093/nar/gkq517; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FARMER JJ, 1985, J CLIN MICROBIOL, V21, P46, DOI 10.1128/JCM.21.1.46-76.1985; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Forman S, 2007, MICROBIOL-SGM, V153, P2332, DOI 10.1099/mic.0.2006/004275-0; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Foster JW, 1999, NOVART FDN SYMP, V221, P55; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V48, P229, DOI 10.1016/0378-1097(87)90167-4; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Hu YB, 2010, FEBS LETT, V584, P2311, DOI 10.1016/j.febslet.2010.03.045; IRIARTE M, 1995, INFECT IMMUN, V63, P1840, DOI 10.1128/IAI.63.5.1840-1847.1995; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Maier RJ, 2005, BIOCHEM SOC T, V33, P83, DOI 10.1042/BST0330083; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Obi IR, 2011, BIOCHEM J, V439, P321, DOI 10.1042/BJ20110767; OLD DC, 1982, J MED MICROBIOL, V15, P551, DOI 10.1099/00222615-15-4-551; OLD DC, 1984, MICROBIOL IMMUNOL, V28, P1303, DOI 10.1111/j.1348-0421.1984.tb00788.x; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; PEDERSON KJ, 1995, INFECT IMMUN, V63, P4199, DOI 10.1128/IAI.63.10.4199-4201.1995; Perry R D, 1993, Trends Microbiol, V1, P142, DOI 10.1016/0966-842X(93)90129-F; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; PROVENCE DL, 1992, INFECT IMMUN, V60, P4460, DOI 10.1128/IAI.60.11.4460-4467.1992; PUNSALANG A, 1987, J CLIN MICROBIOL, V25, P859, DOI 10.1128/JCM.25.5.859-862.1987; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Stenkova AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020546; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; STUART SJ, 1986, J BACTERIOL, V166, P1131, DOI 10.1128/jb.166.3.1131-1133.1986; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Wang QF, 2006, J BACTERIOL, V188, P7981, DOI 10.1128/JB.00852-06; WARD TFD, 1995, INFECT IMMUN, V63, P3790; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Winans SC, 2002, J BACTERIOL, V184, P873, DOI 10.1128/jb.184.4.873-883.2002; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	88	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76567	10.1371/journal.pone.0076567	http://dx.doi.org/10.1371/journal.pone.0076567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116118	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300065
J	Bon, I; Lembo, D; Rusnati, M; Clo, A; Morini, S; Miserocchi, A; Bugatti, A; Grigolon, S; Musumeci, G; Landolfo, S; Re, MC; Gibellini, D				Bon, Isabella; Lembo, David; Rusnati, Marco; Clo, Alberto; Morini, Silvia; Miserocchi, Anna; Bugatti, Antonella; Grigolon, Sonia; Musumeci, Giuseppina; Landolfo, Santo; Re, Maria Carla; Gibellini, Davide			Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPARAN-SULFATE PROTEOGLYCANS; ENVELOPE GLYCOPROTEIN GP120; PREEXPOSURE PROPHYLAXIS; ENTRY INHIBITORS; ANTIRETROVIRAL THERAPY; QUANTITATIVE DETECTION; TOPICAL MICROBICIDES; VAGINAL TRANSMISSION; ANTIVIRAL ACTIVITY	Peptide dendrimers are a class of molecules that exhibit a large array of biological effects including antiviral activity. In this report, we analyzed the antiviral activity of the peptide-derivatized SB105-A10 dendrimer, which is a tetra-branched dendrimer synthetized on a lysine core, in activated peripheral blood mononuclear cells (PBMCs) that were challenged with reference and wild-type human immunodeficiency virus type 1 (HIV-1) strains. SB105-A10 inhibited infections by HIV-1 X4 and R5 strains, interfering with the early phases of the viral replication cycle. SB105-A10 targets heparan sulfate proteoglycans (HSPGs) and, importantly, the surface plasmon resonance (SPR) assay revealed that SB105-A10 strongly binds gp41 and gp120, most likely preventing HIV-1 attachment/entry through multiple mechanisms. Interestingly, the antiviral activity of SB105-A10 was also detectable in an organ-like structure of human cervicovaginal tissue, in which SB105-A10 inhibited the HIV-1(ada) R5 strain infection without altering the tissue viability. These results demonstrated the strong antiviral activity of SB105-A10 and suggest a potential microbicide use of this dendrimer to prevent the heterosexual transmission of HIV-1.	[Bon, Isabella; Clo, Alberto; Morini, Silvia; Miserocchi, Anna; Musumeci, Giuseppina; Re, Maria Carla; Gibellini, Davide] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Microbiol Sect, Bologna, Italy; [Lembo, David] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Rusnati, Marco; Bugatti, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Grigolon, Sonia] Spider Biotech Srl, Colleretto Giacosa, Turin, Italy; [Landolfo, Santo] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy; [Re, Maria Carla] INBB, Interuniv Consortium, Rome, Italy	University of Bologna; University of Turin; University of Brescia; University of Turin	Gibellini, D (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Microbiol Sect, Bologna, Italy.	davide.gibellini@unibo.it	Gibellini, Davide/K-8725-2016; BON, ISABELLA/HIK-0216-2022; Rusnati, Marco/F-1168-2010	Gibellini, Davide/0000-0003-3688-1252; BON, ISABELLA/0000-0002-9433-5201; Rusnati, Marco/0000-0001-9968-5908; Lembo, David/0000-0002-0969-100X; Re, Maria Carla/0000-0003-1486-9033; MUSUMECI, GIUSEPPINA/0000-0003-0118-4537	Italian Ministry of Health; University of Bologna; MURST; Spider Biotech grant	Italian Ministry of Health(Ministry of Health, Italy); University of Bologna; MURST(Ministry of Education, Universities and Research (MIUR)); Spider Biotech grant	This work was supported by Italian Ministry of Health (AIDS project), University of Bologna (selected topics) and MURST 60%. The authors acknowledge a grant for the Lagrange Project - Crt Foundation. This study was partially funded by Spider Biotech grant to DG for the purchase of reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Abraham BK, 2012, CURR OPIN HIV AIDS, V7, P600, DOI 10.1097/COH.0b013e328358b9ce; Argyris EG, 2003, J VIROL, V77, P12140, DOI 10.1128/JVI.77.22.12140-12151.2003; Asaftei S, 2012, J MED CHEM, V55, P10405, DOI 10.1021/jm301337y; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Borges A. Rosa, 2005, Current Drug Targets - Infectious Disorders, V5, P247, DOI 10.2174/1568005054880127; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chang DK, 2007, ANTIVIR RES, V74, P51, DOI 10.1016/j.antiviral.2006.12.006; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen Myron S, 2004, Top HIV Med, V12, P104; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Cummins Jr JE, 2007, ANTIMICROB AGENTS CH, V5; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Donalisio M, 2012, ANTIMICROB AGENTS CH, V56, P5278, DOI 10.1128/AAC.00771-12; Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Foss AM, 2009, SEX TRANSM INFECT, V85, P276, DOI 10.1136/sti.2008.032458; Gartner S, 1990, HIV TECHNIQUES, P53; Gibellini D, 2004, J CLIN VIROL, V29, P282, DOI 10.1016/S1386-6532(03)00169-0; Gibellini D, 2004, J VIROL METHODS, V115, P183, DOI 10.1016/j.jviromet.2003.09.030; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Grobler A, 2012, AIDS, V26, P2261, DOI 10.1097/QAD.0b013e328355ce08; HANSEN JES, 1989, AIDS, V3, P635, DOI 10.1097/00002030-198910000-00003; Heegaard Peter M H, 2006, Recent Pat Antiinfect Drug Discov, V1, P331; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lalezari JP, 2003, AIDS, V17, P691, DOI 10.1097/00002030-200303280-00007; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Luganini A, 2010, ANTIVIR RES, V85, P532, DOI 10.1016/j.antiviral.2010.01.003; Maldarelli F, 2011, CURR OPIN HIV AIDS, V6, P49, DOI 10.1097/COH.0b013e32834134ea; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; McEnery Regina, 2011, IAVI Rep, V15, P21; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Ohshiro Y, 1996, MICROBIOL IMMUNOL, V40, P827, DOI 10.1111/j.1348-0421.1996.tb01148.x; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sarrazin S., 2011, COLD SPRING HARB PER, V3, P7; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Smith RJ, 2005, AIDS, V19, P413, DOI 10.1097/01.aids.0000161771.44276.92; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Svicher V, 2010, NEW MICROBIOL, V33, P195; Telwatte S, 2011, ANTIVIR RES, V90, P195, DOI 10.1016/j.antiviral.2011.03.186; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Tyssen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012309; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wilson LE, 2009, CLIN INFECT DIS, V48, P214, DOI 10.1086/595701; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995	94	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76482	10.1371/journal.pone.0076482	http://dx.doi.org/10.1371/journal.pone.0076482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116111	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300059
J	Cueno, ME; Imai, K; Tamura, M; Ochiai, K				Cueno, Marni E.; Imai, Kenichi; Tamura, Muneaki; Ochiai, Kuniyasu			Structural Differences between the Avian and Human H7N9 Hemagglutinin Proteins Are Attributable to Modifications in Salt Bridge Formation: A Computational Study with Implications in Viral Evolution	PLOS ONE			English	Article							INFLUENZA-A VIRUS; RECEPTOR-BINDING; ELECTROSTATIC INTERACTIONS; TRANSMISSION; GLYCOPROTEIN; OUTBREAK; GLYCANS; FUSION; MODELS; SERVER	Influenza A hemagglutinin (HA) is a homotrimeric glycoprotein composed of a fibrous globular stem supporting a globular head containing three sialic acid binding sites responsible for infection. The H7N9 strain has consistently infected an avian host, however, the novel 2013 strain is now capable of infecting a human host which would imply that the HA in both strains structurally differ. A better understanding of the structural differences between the avian and human H7N9 strains may shed light into viral evolution and transmissibility. In this study, we elucidated the structural differences between the avian and human H7N9 strains. Throughout the study, we generated HA homology models, verified the quality of each model, superimposed HA homology models to determine structural differences, and, likewise, elucidated the probable cause for these structural differences. We detected two different types of structural differences between the novel H7N9 human and representative avian strains, wherein, one type (Pattern-1) showed three non-overlapping regions while the other type (Pattern-2) showed only one non-overlapping region. In addition, we found that superimposed HA homology models exhibiting Pattern-1 contain three non-overlapping regions designated as: Region-1 (S157(1)-A160(1)); Region-3 (R262(1)-S265(1)); and Region-4 (S270(1)-D281(1)), whereas, superimposed HA homology models showing Pattern-2 only contain one non-overlapping region designated as Region-2 (S137(1)-S145(1)). We attributed the two patterns we observed to either the presence of salt bridges involving the E114(1) residue or absence of the R141(1):D77(1) salt bridge. Interestingly, comparison between the human H7N7 and H7N9 HA homology models showed high structural similarity. We propose that the putative absence of the R141(1):D77(1) salt bridge coupled with the putative presence of the E114(1):R262(1) and E114(1):K264(1) salt bridges found in the 2013 H7N9 HA homology model is associated to human-type receptor binding. This highlights the possible significance of HA salt bridge formation modifications in viral infectivity, immune escape, transmissibility and evolution.	[Cueno, Marni E.; Imai, Kenichi; Tamura, Muneaki; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan	Nihon University	Cueno, ME (corresponding author), Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 101, Japan.	marni.cueno@nihon-u.ac.jp; ochiai.kuniyasu@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1001024, 2479210]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the following grants: Grants-in-Aid for Scientific Research, Grants-in-Aid for Young Scientist (2479210), Nihon University President's Grant for Multidisciplinary Research, Satoh Fund and Dental Research Center-Nihon University School of Dentistry (Tokyo), "Strategic Research Base Development" Program for Private Universities subsidized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) 2010(S1001024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2006, STRUCTURE, V14, P1211, DOI 10.1016/j.str.2006.06.005; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018664; Cherry JL, 2009, PLOS CURR, V1; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SAHAL D, 1986, BIOCHEMISTRY-US, V25, P6004, DOI 10.1021/bi00368a026; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yassine HM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-258	39	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76764	10.1371/journal.pone.0076764	http://dx.doi.org/10.1371/journal.pone.0076764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116152	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300092
J	Hua, KF; Chou, JC; Lam, YL; Tasi, YL; Chen, A; Ka, SM; Fang, ZX; Liu, ML; Yang, FL; Yang, YL; Chiu, YC; Wu, SH				Hua, Kuo-Feng; Chou, Ju-Ching; Lam, Yulin; Tasi, Yu-Ling; Chen, Ann; Ka, Shuk-Man; Fang, Zhanxiong; Liu, May-Lan; Yang, Feng-Ling; Yang, Yu-Liang; Chiu, Yi-Chich; Wu, Shih-Hsiung			Polyenylpyrrole Derivatives Inhibit NLRP3 Inflammasome Activation and Inflammatory Mediator Expression by Reducing Reactive Oxygen Species Production and Mitogen-Activated Protein Kinase Activation	PLOS ONE			English	Article							NF-KAPPA-B; NALP3 INFLAMMASOME; POLYKETIDES; SECRETION; CYTOKINES; CRYSTALS	Two polyenylpyrroles from a soil ascomycete Gymnoascus reessii were previously identified as hit compounds in screening for cytotoxicity against lung cancer cells. These compounds and various analogs, which have been previously synthesized and tested for anti-lung cancer cell activity, were tested for anti-inflammatory activity. After preliminary screening for cytotoxicity for RAW 264.7 murine macrophage cells, the non-toxic compounds were tested for anti-inflammatory activity using lipopolysaccharide (LPS)-activated RAW 264.7 cells. Compounds 1h, 1i, and 1n reduced LPS-induced nitric oxide (NO) production, with respective ED50 values of 15 +/- 2, 16 +/- 2, and 17 +/- 2 mu M. They also reduced expression of inducible NO synthase and interleukin-6 (IL-6) without affecting cyclooxygenase-2 expression. Compound 1h also reduced secretion of IL-6 and tumor necrosis factor-a by LPS-activated J774A. 1 murine macrophage cells, primary mice peritoneal macrophages, and JAWSII murine bone marrow-derived dendritic cells and reduced NLRP3 inflammasome-mediated interleukin-1 beta (IL-1 beta) secretion by LPS + adenosine triphosphate-activated J774A. 1 and JAWSII cells. The underlying mechanisms for the anti-inflammatory activity of compound 1h were found to be a decrease in LPS-induced reactive oxygen species (ROS) production, mitogen-activated protein kinase phosphorylation, and NF-kappa B activation and a decrease in ATP-induced ROS production and PKC-alpha phosphorylation. These results provide promising insights into the anti-inflammatory activity of these conjugated polyenes and a molecular rationale for future therapeutic intervention in inflammation-related diseases. They also show how compound 1h regulates inflammation and suggest it may be a new source for the development of anti-inflammatory agents to ameliorate inflammation-and NLRP3 inflammasome-related diseases.	[Hua, Kuo-Feng; Chou, Ju-Ching] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Lam, Yulin; Fang, Zhanxiong] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Tasi, Yu-Ling] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Ann] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Liu, May-Lan] Toko Univ, Dept Nutr Sci, Chiayi, Taiwan; [Yang, Feng-Ling; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Yang, Yu-Liang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chiu, Yi-Chich] Natl Ilan Univ, Dept Biomechatron Engn, Ilan, Taiwan	National Ilan University; National University of Singapore; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Ilan University	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.	kfhua@niu.edu.tw			National Science Council, Taiwan [NSC 102-2628-B-197-001-MY3]; Ministry of Education, Singapore (Tier 2) [R-143-000-478-112]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Singapore (Tier 2)(Ministry of Education, Singapore)	The authors wish to thank the National Science Council, Taiwan (contract grant number: NSC 102-2628-B-197-001-MY3) and the Ministry of Education, Singapore (Tier 2 Grant: R-143-000-478-112) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chomcheon P, 2010, CHEM-EUR J, V16, P11178, DOI 10.1002/chem.201000652; Clark BR, 2006, ORG LETT, V8, P701, DOI 10.1021/ol052880y; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fang Z, 2010, J MED CHEM, V53, P7967, DOI 10.1021/jm100619x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Molina JM, 2002, NEW ENGL J MED, V346, P1963, DOI 10.1056/NEJMoa012924; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Shim SH, 2011, J NAT PROD, V74, P395, DOI 10.1021/np100791b; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Yang YL, 2007, CHEM-EUR J, V13, P6985, DOI 10.1002/chem.200700038; Yang YL, 2009, CHEM-EUR J, V15, P11573, DOI 10.1002/chem.200901556; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76754	10.1371/journal.pone.0076754	http://dx.doi.org/10.1371/journal.pone.0076754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116148	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300090
J	Lee, HS; Jang, MS; Kim, JH; Hong, CP; Lee, EJ; Jeun, EJ; Kim, C; Kim, EK; Ahn, KS; Yang, BG; Ahn, KS; Jang, YP; Ahn, KS; Kim, YM; Jang, MH				Lee, Han-Sung; Jang, Min Seong; Kim, Jung-Hwan; Hong, Chun-Pyo; Lee, Eun-Jung; Jeun, Eun Ji; Kim, Chan; Kim, Eun-Kyung; Ahn, Kwang-Seong; Yang, Bo-Gie; Ahn, Kwang Seok; Jang, Young Pyo; Ahn, Kyoo-Seok; Kim, You-Me; Jang, Myoung Ho			Ulmus davidiana var. japonica Nakai Upregulates Eosinophils and Suppresses Th1 and Th17 Cells in the Small Intestine	PLOS ONE			English	Article							DENDRITIC CELLS; LAMINA-PROPRIA; T-CELLS; IN-VIVO; IMMUNITY; SIGNALS; IL-17	The bark of Ulmus davidiana var. japonica Nakai (Ulmaceae) has been used in traditional Korean medicine for chronic inflammation in the gastrointestinal tract. Here we investigated the frequency and cytokine profile of the major immune cells in the small intestinal lamina propria (SI LP), spleen, and mesenteric lymph nodes (MLNs) of mice treated orally with Ulmus davidiana var. japonica Nakai bark water extract (UDE) to address the immunomodulatory role of this herb in intestinal homeostasis. B6 mice were given 5g/kg UDE once daily for 14 days. They were then sacrificed, and cells were isolated from the spleen, MLNs, and SI LP. The proportion of B versus T lymphocytes, CD4(+) versus CD8(+) T lymphocytes, Th1 and Th17 cells, and Foxp3(+) regulatory T cells in the spleen, MLNs, and SI LP were analyzed. The frequency of antigen-presenting cells (APCs), including dendritic cells, macrophages, and eosinophils in the SI LP and the expression of costimulatory molecules on APCs were also evaluated. The numbers and frequencies of Th1 and Th17 cells in the SI LP were significantly reduced in the UDE-treated mice compared with PBS controls. In addition, the proportion of IL-4-producing eosinophils in the SI LP was significantly elevated in the UDE-treated mice compared with controls. Taken together, these data indicate that UDE up-regulates the number and frequency of SI LP eosinophils, which can down-regulate the Th1 and Th17 responses via IL-4 secretion and contribute to intestinal homeostasis.	[Lee, Han-Sung; Jang, Min Seong; Kim, Jung-Hwan; Hong, Chun-Pyo; Lee, Eun-Jung; Jeun, Eun Ji; Kim, Chan; Yang, Bo-Gie; Kim, You-Me; Jang, Myoung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Lee, Han-Sung; Ahn, Kwang Seok; Ahn, Kyoo-Seok] Kyung Hee Univ, Coll Korean Med, Dept Pathol, Seoul, South Korea; [Kim, Eun-Kyung; Ahn, Kwang-Seong; Jang, Young Pyo] Kyung Hee Univ, Coll Pharm, Div Pharmacognosy, Seoul, South Korea; [Jang, Myoung Ho] AIM, IBS, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Kyung Hee University; Kyung Hee University; Institute for Basic Science - Korea (IBS)	Jang, MH (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea.	jangmh@ibs.re.kr	Jang, Myoung Ho/D-1714-2009; Kim, You-Me/I-5553-2013; Jang, Young Pyo/AAJ-8782-2020	Jang, Myoung Ho/0000-0001-8909-4725; Kim, You-Me/0000-0001-8780-704X; Jang, Young Pyo/0000-0001-5865-9228; Yang, Bo-Gie/0000-0002-1538-8488	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) [2013030693]; Institute for Basic Science (IBS); World Class Universities Project, NRF, MEST [R31-10105]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Institute for Basic Science (IBS); World Class Universities Project, NRF, MEST(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology of Korea (MEST) (No. 2013030693), the Institute for Basic Science (IBS) and the World Class Universities Project, NRF, MEST (R31-10105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Choi SY, 2010, J MED FOOD, V13, P1019, DOI 10.1089/jmf.2009.1207; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Guo Z, 2008, INT IMMUNOL, V20, P307, DOI 10.1093/intimm/dxm143; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kim YC, 2007, FITOTERAPIA, V78, P196, DOI 10.1016/j.fitote.2006.11.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee EH, 2013, J ETHNOPHARMACOL, V146, P608, DOI 10.1016/j.jep.2013.01.035; Lee SJ, 2007, FOOD CHEM TOXICOL, V45, P990, DOI 10.1016/j.fct.2006.12.006; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Park JW, 2011, ORIENTAL PHARM EXP M, V11, P107, DOI 10.1007/s13596-011-0011-9; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Song IK, 2007, ENVIRON TOXICOL PHAR, V23, P102, DOI 10.1016/j.etap.2006.07.013; Straumann A, 2004, ALLERGY, V59, P15, DOI 10.1046/j.1398-9995.2003.00382.x; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Stumhofer JS, 2007, SEMIN IMMUNOL, V19, P394, DOI 10.1016/j.smim.2007.11.006; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson-Frej M, 2011, J INNATE IMMUN, V3, P565, DOI 10.1159/000328799; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wen T, 2012, J IMMUNOL, V188, P1075, DOI 10.4049/jimmunol.1102222; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	30	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76716	10.1371/journal.pone.0076716	http://dx.doi.org/10.1371/journal.pone.0076716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116141	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300084
J	Marquez, A; Cenit, MC; Cordero-Coma, M; Ortego-Centeno, N; Adan, A; Fonollosa, A; Valle, DD; Pato, E; Blanco, R; Canal, J; Diaz-Llopis, M; de Ramon, E; del Rio, MJ; Serrano, JLG; Artaraz, J; Martin-Villa, JM; Llorenc, V; Gorrono-Echebarria, MB; Martin, J				Marquez, Ana; Carmen Cenit, Maria; Cordero-Coma, Miguel; Ortego-Centeno, Norberto; Adan, Alfredo; Fonollosa, Alejandro; Diaz Valle, David; Pato, Esperanza; Blanco, Ricardo; Canal, Joaquin; Diaz-Llopis, Manuel; de Ramon, Enrique; Jose del Rio, Maria; Garcia Serrano, Jose Luis; Artaraz, Joseba; Manuel Martin-Villa, Jose; Llorenc, Vctor; Begona Gorrono-Echebarria, Marina; Martin, Javier			Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; DISTINCT POPULATIONS; INTERMEDIATE UVEITIS; BEHCETS-DISEASE; GENE; INTERFERON; POLYMORPHISM; RISK; SUSCEPTIBILITY	Objective: Interferon (IFN) signaling plays a crucial role in autoimmunity. Genetic variation in interferon regulatory factor 5 (IRF5), a major regulator of the type I interferon induction, has been associated with risk of developing several autoimmune diseases. In the current study we aimed to evaluate whether three sets of correlated IRF5 genetic variants, independently associated with SLE and with different functional roles, are involved in uveitis susceptibility and its clinical subphenotypes. Methods: Three IRF5 polymorphisms, rs2004640, rs2070197 and rs10954213, representative of each group, were genotyped using TaqMan (R) allelic discrimination assays in a total of 263 non-anterior uveitis patients and 724 healthy controls of Spanish origin. Results: A clear association between two of the three analyzed genetic variants, rs2004640 and rs10954213, and the absence of macular edema was observed in the case/control analysis (P-FDR=5.07E-03, OR= 1.48, CI 95%= 1.14-1.92 and P-FDR= 3.37E-03, OR= 1.54, CI 95%= 1.19-2.01, respectively). Consistently, the subphenotype analysis accordingly with the presence/absence of this clinical condition also reached statistical significance (rs2004640: P= 0.037, OR= 0.69, CI 95%= 0.48-0.98; rs10954213: P= 0.030, OR= 0.67, CI 95%= 0.47-0.96), thus suggesting that both IRF5 genetic variants are specifically associated with the lack of macular edema in uveitis patients. Conclusion: Our results clearly showed for the first time that two functional genetic variants of IRF5 may play a role in the development of macular edema in non-anterior uveitis patients. Identifying genetic markers for macular edema could lead to the possibility of developing novel treatments or preventive therapies.	[Marquez, Ana; Carmen Cenit, Maria; Martin, Javier] CSIC, IPBLN, Granada, Spain; [Cordero-Coma, Miguel] Hosp Leon, Dept Ophthalmol, Leon, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [Adan, Alfredo; Llorenc, Vctor] Hosp Clin Barcelona, Dept Ophthalmol, Barcelona, Spain; [Fonollosa, Alejandro; Artaraz, Joseba] Hosp Cruces, Dept Ophthalmol, Bilbao, Spain; [Diaz Valle, David] Hosp Clin San Carlos, Dept Ophthalmol, Madrid, Spain; [Pato, Esperanza] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Blanco, Ricardo] IFIMAV, Hosp Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Canal, Joaquin] IFIMAV, Hosp Marques de Valdecilla, Dept Ophthalmol, Santander, Spain; [Diaz-Llopis, Manuel] Hosp La Fe, Dept Ophthalmol, E-46009 Valencia, Spain; [de Ramon, Enrique] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Jose del Rio, Maria] Hosp Carlos Haya, Dept Ophthalmol, Malaga, Spain; [Garcia Serrano, Jose Luis] Hosp Clin San Cecilio, Dept Ophthalmol, Granada, Spain; [Manuel Martin-Villa, Jose] Univ Complutense Madrid, Fac Med, Dept Immunol, Madrid, Spain; [Begona Gorrono-Echebarria, Marina] Hosp Principe Asturias, Dept Ophthalmol, Alcala De Henares, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universidad de Leon; Hospital de Leon; Hospital Universitario San Cecilio; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Cruces; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitari i Politecnic La Fe; Hospital Carlos Haya; Hospital Carlos Haya; Hospital Universitario San Cecilio; Complutense University of Madrid; Prince of Asturias University Hospital	Marquez, A (corresponding author), CSIC, IPBLN, Granada, Spain.	anamaort@ipb.csic.es	Martín, María/HDL-9512-2022; Cenit, Maria Carmen MC/E-9538-2017; Martin-Villa, Jose M. M/F-9234-2013; Llorens Bellés, Víctor/V-3892-2019; blanco, ricardo/AAA-1248-2020; Martin, Javier/B-8141-2008; Martin-Villa, Jose M./K-2522-2019; Fonollosa Calduch, Alejandro/E-5381-2012; Centeno, Norberto Ortego/C-4793-2019	Cenit, Maria Carmen MC/0000-0001-8667-5313; Martin-Villa, Jose M. M/0000-0002-2436-8585; Llorens Bellés, Víctor/0000-0002-7375-1564; blanco, ricardo/0000-0003-2344-2285; Martin, Javier/0000-0002-2202-0622; Martin-Villa, Jose M./0000-0002-2436-8585; Centeno, Norberto Ortego/0000-0003-2325-0937; Marquez, Ana/0000-0001-9913-7688; Gorrono Echebarria, Marina Begona/0000-0003-2805-9664; DIAZ VALLE, DAVID/0000-0003-4450-7471; Adan, Alfredo/0000-0002-0849-8814				BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; Caspi Rachel R, 2002, Int Rev Immunol, V21, P197, DOI 10.1080/08830180212063; Commodaro AG, 2011, AUTOIMMUN REV, V10, P205, DOI 10.1016/j.autrev.2010.10.002; Deschenes J, 2008, OCUL IMMUNOL INFLAMM, V16, P1, DOI 10.1080/09273940801899822; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Forooghian F, 2009, ARCH OPHTHALMOL-CHIC, V127, P179, DOI 10.1001/archophthalmol.2008.564; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; LEHOANG P, 1992, AM J OPHTHALMOL, V113, P33, DOI 10.1016/S0002-9394(14)75749-6; Li HJ, 2009, MOL VIS, V15, P2018; Lofgren SE, 2010, J RHEUMATOL, V37, P574, DOI 10.3899/jrheum.090440; Mackensen F, 2013, AM J OPHTHALMOL, V156, P478, DOI 10.1016/j.ajo.2013.05.002; Martin Tammy M., 2005, International Ophthalmology Clinics, V45, P15, DOI 10.1097/01.iio.0000155939.83083.dd; Mattapallil MJ, 2008, J IMMUNOL, V180, P6751, DOI 10.4049/jimmunol.180.10.6751; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Pennesi Giuseppina, 2002, Int Rev Immunol, V21, P67, DOI 10.1080/08830180212059; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Valentincic NV, 2011, MOL VIS, V17, P2003; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76777	10.1371/journal.pone.0076777	http://dx.doi.org/10.1371/journal.pone.0076777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116155	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300094
J	Meredith, JE; Sankaranarayanan, S; Guss, V; Lanzetti, AJ; Berisha, F; Neely, RJ; Slemmon, JR; Portelius, E; Zetterberg, H; Blennow, K; Soares, H; Ahlijanian, M; Albright, CF				Meredith, Jere E., Jr.; Sankaranarayanan, Sethu; Guss, Valerie; Lanzetti, Anthony J.; Berisha, Flora; Neely, Robert J.; Slemmon, J. Randall; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Soares, Holly; Ahlijanian, Michael; Albright, Charles F.			Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID TAU; MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATED-TAU; DIFFERENTIAL-DIAGNOSIS; AFFINITY PURIFICATION; AMYLOID DEPOSITION; SANDWICH ELISA; PROTEIN; QUANTIFICATION; SECRETION	Cerebral spinal fluid (CSF) A beta 42, tau and p181tau are widely accepted biomarkers of Alzheimer's disease (AD). Numerous studies show that CSF tau and p181tau levels are elevated in mild-to-moderate AD compared to age-matched controls. In addition, these increases might predict preclinical AD in cognitively normal elderly. Despite their importance as biomarkers, the molecular nature of CSF tau and ptau is not known. In the current study, reverse-phase high performance liquid chromatography was used to enrich and concentrate tau prior to western-blot analysis. Multiple N-terminal and mid-domain fragments of tau were detected in pooled CSF with apparent sizes ranging from <20 kDa to similar to 40 kDa. The pattern of tau fragments in AD and control samples were similar. In contrast, full-length tau and C-terminal-containing fragments were not detected. To quantify levels, five tau ELISAs and three ptau ELISAs were developed to detect different overlapping regions of the protein. The discriminatory potential of each assay was determined using 20 AD and 20 age-matched control CSF samples. Of the tau ELISAs, the two assays specific for tau containing N-terminal sequences, amino acids 9-198 (numbering based on tau 441) and 9-163, exhibited the most significant differences between AD and control samples. In contrast, CSF tau was not detected with an ELISA specific for a more C-terminal region (amino acids 159-335). Significant discrimination was also observed with ptau assays measuring amino acids 159-p181 and 159-p231. Interestingly, the discriminatory potential of p181 was reduced when measured in the context of tau species containing amino acids 9-p181. Taken together, these results demonstrate that tau in CSF occurs as a series of fragments and that discrimination of AD from control is dependent on the subset of tau species measured. These assays provide novel tools to investigate CSF tau and ptau as biomarkers for other neurodegenerative diseases.	[Meredith, Jere E., Jr.; Sankaranarayanan, Sethu; Guss, Valerie; Lanzetti, Anthony J.; Slemmon, J. Randall; Soares, Holly; Ahlijanian, Michael; Albright, Charles F.] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA; [Berisha, Flora; Neely, Robert J.] Bristol Myers Squibb Co, Res & Dev, Lawrenceville, NJ USA; [Portelius, Erik; Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	Bristol-Myers Squibb; Bristol-Myers Squibb; University of Gothenburg; University of London; University College London	Meredith, JE (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	jere.meredith@bms.com			Bristol-Myers Squibb; Swedish Research Council; Swedish State Support for Clinical Research	Bristol-Myers Squibb(Bristol-Myers Squibb); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State Support for Clinical Research	Funding was provided by Bristol-Myers Squibb and grants to EP, HZ, and KB from the Swedish Research Council and Swedish State Support for Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; Bahl JMC, 2009, NEUROBIOL AGING, V30, P1834, DOI 10.1016/j.neurobiolaging.2008.01.013; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; Borroni B, 2008, NEUROLOGY, V71, P1796, DOI 10.1212/01.wnl.0000335941.68602.39; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Ditto NT, 2009, J NEUROSCI METH, V182, P260, DOI 10.1016/j.jneumeth.2009.05.025; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hanger DP, 2010, BIOCHEM SOC T, V38, P1016, DOI 10.1042/BST0381016; Hanisch K, 2010, J PROTEOME RES, V9, P1476, DOI 10.1021/pr901002t; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Ishiguro K, 1999, NEUROSCI LETT, V270, P91, DOI 10.1016/S0304-3940(99)00476-0; Itoh N, 2001, ANN NEUROL, V50, P150, DOI 10.1002/ana.1054; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Kuiperij HB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.011; Luk C, 2012, J NEUROCHEM, V123, P396, DOI 10.1111/j.1471-4159.2012.07911.x; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MERCKEN M, 1992, J NEUROCHEM, V58, P548, DOI 10.1111/j.1471-4159.1992.tb09754.x; MORI H, 1995, NEUROSCI LETT, V186, P181, DOI 10.1016/0304-3940(95)11291-4; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Singer D, 2009, ANAL BIOANAL CHEM, V395, P2263, DOI 10.1007/s00216-009-3208-8; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Slemmon JR, 2012, J NEUROCHEM, V120, P325, DOI 10.1111/j.1471-4159.2011.07553.x; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; VIGOPELFREY C, 1995, NEUROLOGY, V45, P788, DOI 10.1212/WNL.45.4.788; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2013, J ALZHEIMERS DIS, V33, pS361, DOI 10.3233/JAD-2012-129035	56	71	77	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76523	10.1371/journal.pone.0076523	http://dx.doi.org/10.1371/journal.pone.0076523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116116	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300063
J	Santos, M; Rebelo, S; Van Kleeff, PJM; Kim, CE; Dauer, WT; Fardilha, M; Silva, OADE; Silva, EFDE				Santos, Mariana; Rebelo, Sandra; Van Kleeff, Paula J. M.; Kim, Connie E.; Dauer, William T.; Fardilha, Margarida; da Cruz e Silva, Odete A.; da Cruz e Silva, Edgar F.			The Nuclear Envelope Protein, LAP1B, Is a Novel Protein Phosphatase 1 Substrate	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; B-TYPE LAMINS; SUBCELLULAR-LOCALIZATION; INTERACTING PROTEINS; DOCKING MOTIF; BINDING; TORSINA; IDENTIFICATION; ISOFORMS; RELEVANCE	Protein phosphatase 1 (PP1) binding proteins are quintessential regulators, determining substrate specificity and defining subcellular localization and activity of the latter. Here, we describe a novel PP1 binding protein, the nuclear membrane protein lamina associated polypeptide 1B (LAP1B), which interacts with the DYT1 dystonia protein torsinA. The PP1 binding domain in LAP1B was here identified as the REVRF motif at amino acids 55-59. The LAP1B: PP1 complex can be immunoprecipitated from cells in culture and rat cortex and the complex was further validated by yeast co-transformations and blot overlay assays. PP1, which is enriched in the nucleus, binds to the N-terminal nuclear domain of LAP1B, as shown by immunocolocalization and domain specific binding studies. PP1 dephosphorylates LAP1B, confirming the physiological relevance of this interaction. These findings place PP1 at a key position to participate in the pathogenesis of DYT1 dystonia and related nuclear envelope-based diseases.	[Santos, Mariana; Rebelo, Sandra; da Cruz e Silva, Odete A.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal; [Van Kleeff, Paula J. M.; Fardilha, Margarida; da Cruz e Silva, Edgar F.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Signal Transduct Lab, P-3800 Aveiro, Portugal; [Kim, Connie E.; Dauer, William T.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Kim, Connie E.; Dauer, William T.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	Universidade de Aveiro; Universidade de Aveiro; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rebelo, S (corresponding author), Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal.	srebelo@ua.pt	Santos, Mariana/AAO-2021-2020; da Cruz e Silva, Odete A B/F-4072-2010; Rebelo, S/B-8973-2008; Cruz e Silva, Odete/AAH-5595-2020; Rebelo, Sandra/Q-2215-2019; Fardilha, Margarida/G-3182-2010	Santos, Mariana/0000-0002-2343-2215; da Cruz e Silva, Odete A B/0000-0003-3718-9874; Rebelo, S/0000-0002-5862-5797; Rebelo, Sandra/0000-0002-5862-5797; Fardilha, Margarida/0000-0001-7459-9173; Dauer, William/0000-0003-1775-7504; van Kleeff, Paula/0000-0002-1789-5547	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology; COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional); Centre for Cell Biology, University of Aveiro;  [REEQ/1023/BIO/2005];  [PTDC/QUI-BIQ/101317/2008];  [Pest-OE/SAU/UI0482/2011];  [SFRH/BD/65353/2009];  [SFRH/BPD/45611/2008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077730] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/101317/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology(Portuguese Foundation for Science and Technology); COMPETE program; QREN; European Union (Fundo Europeu de Desenvolvimento Regional); Centre for Cell Biology, University of Aveiro; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology, The COMPETE program, QREN, the European Union (Fundo Europeu de Desenvolvimento Regional), Centre for Cell Biology, University of Aveiro. Funding and scholarships references: REEQ/1023/BIO/2005, PTDC/QUI-BIQ/101317/2008, Pest-OE/SAU/UI0482/2011 and SFRH/BD/65353/2009 and SFRH/BPD/45611/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bordelon JR, 2005, CEREB CORTEX, V15, P1928, DOI 10.1093/cercor/bhi070; BRIDGER JM, 1993, J CELL SCI, V104, P297; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Esteves SLC, 2012, OMICS, V16, P3, DOI 10.1089/omi.2011.0041; Esteves SL, 2012, J MOL NEUROSCI; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Naismith TV, 2009, J BIOL CHEM; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Santos M, 2009, VALIDATION LAP1B NOV; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Silva OABDE, 2004, J MOL NEUROSCI, V23, P123, DOI 10.1385/JMN:23:1-2:123; Steen RL, 2003, J CELL SCI, V116, P2237, DOI 10.1242/jcs.00432; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Steen RL, 2001, J CELL BIOL, V153, P621, DOI 10.1083/jcb.153.3.621; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Tsai KW, 2007, MOL CELL BIOL, V27, P5835, DOI 10.1128/MCB.00363-07; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Watanabe T, 2003, METHOD ENZYMOL, V366, P321	48	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76788	10.1371/journal.pone.0076788	http://dx.doi.org/10.1371/journal.pone.0076788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116158	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300095
J	Sun, YH; Dong, YL; Wang, YT; Zhao, GL; Lu, GJ; Yang, J; Wu, SX; Gu, ZX; Wang, W				Sun, Yong-Hai; Dong, Yu-Lin; Wang, Yu-Tong; Zhao, Guo-Li; Lu, Gui-Jun; Yang, Jing; Wu, Sheng-Xi; Gu, Ze-Xu; Wang, Wen			Synergistic Analgesia of Duloxetine and Celecoxib in the Mouse Formalin Test: A Combination Analysis	PLOS ONE			English	Article							NORADRENERGIC REUPTAKE INHIBITOR; INFLAMMATORY PAIN; RATS; MORPHINE; MODULATION; MANAGEMENT; RECEPTORS; EFFICACY; NEURONS; MODEL	Duloxetine, a serotonin and noradrenaline reuptake inhibitor, and celecoxib, a non-steroidal anti-inflammatory drug, are commonly used analgesics for persistent pain, however with moderate gastrointestinal side effects or analgesia tolerance. One promising analgesic strategy is to give a combined prescription, allowing the maximal or equal efficacy with fewer side effects. In the current study, the efficacy and side effects of combined administration of duloxetine and celecoxib were tested in the mouse formalin pain model. The subcutaneous (s.c.) injection of formalin into the left hindpaw induced significant somatic and emotional pain evaluated by the biphasic spontaneous flinching of the injected hindpaw and interphase ultrasonic vocalizations (USVs) during the 1 h after formalin injection, respectively. Pretreatment with intraperitoneal (i.p.) injection of duloxetine or celecoxib at 1 h before formalin injection induced the dose-dependent inhibition on the second but not first phase pain responses. Combined administration of duloxetine and celecoxib showed significant analgesia for the second phase pain responses. Combination analgesia on the first phase was observed only with higher dose combination. A statistical difference between the theoretical and experimental ED50 for the second phase pain responses was observed, which indicated synergistic interaction of the two drugs. Concerning the emotional pain responses revealed with USVs, we assumed that the antinociceptive effects were almost completely derived from duloxetine, since celecoxib was ineffective when administered alone or reduced the dosage of duloxetine when given in combination. Based on the above findings, acute concomitant administration of duloxetine and celecoxib showed synergism on the somatic pain behavior but not emotional pain behaviors.	[Sun, Yong-Hai; Zhao, Guo-Li; Lu, Gui-Jun; Yang, Jing] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Dept Anesthesiol, Beijing, Peoples R China; [Dong, Yu-Lin; Wu, Sheng-Xi; Wang, Wen] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Preclin Sch Med, Xian 710032, Peoples R China; [Dong, Yu-Lin; Wu, Sheng-Xi; Wang, Wen] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Preclin Sch Med, Xian 710032, Peoples R China; [Wang, Yu-Tong] Fourth Mil Med Univ, Dept Emergency, Xijing Hosp, Xian 710032, Peoples R China; [Gu, Ze-Xu] Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Gu, ZX (corresponding author), Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Peoples R China.	guzexu@fmmu.edu.cn; wangwen@fmmu.edu.cn			Natural Science Foundation of China [81271230, 81171050, 81171052, 30971123, 31010103909]; International Science & Technology Cooperation Program of China [2011DFA32560]; Program for Shaanxi Province Key Research Team of Science and Technology Innovation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Program for Shaanxi Province Key Research Team of Science and Technology Innovation	The study was supported by grants from the Natural Science Foundation of China (Nos 81271230, 81171050, 81171052, 30971123 and 31010103909), International Science & Technology Cooperation Program of China (2011DFA32560) and Program for Shaanxi Province Key Research Team of Science and Technology Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1984, BRAIN RES, V295, P77, DOI 10.1016/0006-8993(84)90817-5; Bai L, 2012, PAIN PHYSICIAN, V15, P311; Bajic D, 1999, J COMP NEUROL, V405, P359; Bardin L, 2010, NEUROSCI RES, V66, P135, DOI 10.1016/j.neures.2009.10.009; Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4; Bovill JG, 1997, EUR J ANAESTH, V14, P9, DOI 10.1097/00003643-199705001-00003; Boyle J, 2012, DIABETES CARE, V35, P2451, DOI 10.2337/dc12-0656; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Buvanendran A, 2009, CURR OPIN ANESTHESIO, V22, P588, DOI 10.1097/ACO.0b013e328330373a; Capuano A, 2009, EUR J PHARMACOL, V605, P57, DOI 10.1016/j.ejphar.2008.12.029; Chen HS, 2003, ANESTHESIOLOGY, V98, P1231, DOI 10.1097/00000542-200305000-00027; CHICHORRO J, 2004, BR J PHARM, V141; DALLEL R, 1995, PAIN, V61, P11, DOI 10.1016/0304-3959(94)00212-W; Deeks JJ, 2002, BRIT MED J, V325, P619, DOI 10.1136/bmj.325.7365.619; Deumens R, 2013, PROG NEUROBIOL, V104, P1, DOI 10.1016/j.pneurobio.2013.01.002; ENGLEMAN EA, 1995, NEUROPSYCHOPHARMACOL, V12, P287, DOI 10.1016/0893-133X(94)00093-F; Fekadu A, 2012, BRIT J PSYCHIAT, V201, P369, DOI 10.1192/bjp.bp.111.102665; Frakes EP, 2011, CURR MED RES OPIN, V27, P2361, DOI 10.1185/03007995.2011.633502; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; HAPPICH M, 2012, DEPRESS RES TREAT, P64854; Huang J, 2006, EXP NEUROL, V200, P124, DOI 10.1016/j.expneurol.2006.01.036; Jones CK, 2007, EUR J PAIN, V11, P208, DOI 10.1016/j.ejpain.2006.02.008; Jones CK, 2005, J PHARMACOL EXP THER, V312, P726, DOI 10.1124/jpet.104.075960; Koch S, 2003, NEUROPHARMACOLOGY, V45, P935, DOI 10.1016/S0028-3908(03)00268-5; Liu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007548; Mallen SR, 2011, CURR MED RES OPIN, V27, P1359, DOI 10.1185/03007995.2011.581274; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miranda HF, 2012, INFLAMMATION, V35, P1132, DOI 10.1007/s10753-011-9420-7; Mixcoatl-Zecuatl T, 2011, BRIT J PHARMACOL, V164, P159, DOI 10.1111/j.1476-5381.2011.01334.x; MOORE PK, 1991, BRIT J PHARMACOL, V102, P198, DOI 10.1111/j.1476-5381.1991.tb12153.x; Muller Norbert, 2008, Expert Rev Neurother, V8, P527, DOI 10.1586/14737175.8.4.527; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Niederberger E, 2001, FASEB J, V15, P1622, DOI 10.1096/fj.00-0716fje; Nishiyama T, 2006, ACTA ANAESTH SCAND, V50, P228, DOI 10.1111/j.1399-6576.2006.00921.x; Nuseir K, 2000, NEUROSCIENCE, V96, P773, DOI 10.1016/S0306-4522(99)00603-X; Oliveira AR, 2006, ANESTH ANALG, V102, P832, DOI 10.1213/01.ane.0000196530.72813.d9; Ormseth MJ, 2011, PATIENT PREFER ADHER, V5, P343, DOI 10.2147/PPA.S16358; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; RAHMAN AFMM, 1994, JPN J PHARMACOL, V65, P313, DOI 10.1254/jjp.65.313; Raskin J, 2006, J PALLIAT MED, V9, P29, DOI 10.1089/jpm.2006.9.29; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezende RM, 2012, PHARMACOLOGY, V89, P127, DOI 10.1159/000336346; Rezende RM, 2010, NEUROPHARMACOLOGY, V59, P551, DOI 10.1016/j.neuropharm.2010.07.022; SAGEN J, 1985, BRAIN RES, V331, P285, DOI 10.1016/0006-8993(85)91554-9; Shi M, 2010, J PAIN, V11, P219, DOI 10.1016/j.jpain.2009.07.002; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P233, DOI 10.1007/s00228-007-0400-7; Shibazaki T, 2009, ANGLE ORTHOD, V79, P1169, DOI 10.2319/121108-629R.1; SKAGERBERG G, 1985, NEUROSCIENCE, V15, P445, DOI 10.1016/0306-4522(85)90225-8; Skljarevski V, 2012, PAIN RES TREAT, V2012; Smith T, 2007, VASC HEALTH RISK MAN, V3, P833; Su YL, 2010, NEUROSCI BULL, V26, P429, DOI 10.1007/s12264-010-0932-1; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tamaddonfard E, 2011, PHARMACOL REP, V63, P423, DOI 10.1016/S1734-1140(11)70508-4; Taylor BK, 2000, J PAIN, V1, P218, DOI 10.1054/jpai.2000.7308; Vellani V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-61; Vos BP, 1998, PAIN, V76, P173, DOI 10.1016/S0304-3959(98)00039-6; VOS BP, 1994, J NEUROSCI, V14, P2708; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107	63	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76603	10.1371/journal.pone.0076603	http://dx.doi.org/10.1371/journal.pone.0076603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116126	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300072
J	Juvin, V; Malek, M; Anderson, KE; Dion, C; Chessa, T; Lecureuil, C; Ferguson, GJ; Cosulich, S; Hawkins, PT; Stephens, LR				Juvin, Veronique; Malek, Mouhannad; Anderson, Karen E.; Dion, Carine; Chessa, Tamara; Lecureuil, Charlotte; Ferguson, G. John; Cosulich, Sabina; Hawkins, Phillip T.; Stephens, Len R.			Signaling via Class IA Phosphoinositide 3-Kinases (PI3K) in Human, Breast-Derived Cell Lines	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; PROTEIN-KINASE B; PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; CANCER-CELLS; BETA P85-ALPHA-P110-BETA; EMBRYONIC LETHALITY; P110-ALPHA ISOFORM; TUMOR-SUPPRESSOR	We have addressed the differential roles of class I Phosphoinositide 3-kinases (PI3K) in human breast-derived MCF10a (and iso-genetic derivatives) and MDA-MB 231 and 468 cells. Class I PI3Ks are heterodimers of p110 catalytic (alpha, beta, delta and gamma) and p50-101 regulatory subunits and make the signaling lipid, phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) that can activate effectors, eg protein kinase B (PKB), and responses, eg migration. The PtdIns(3,4,5) P-3-3-phosphatase and tumour-suppressor, PTEN inhibits this pathway. p110 alpha, but not other p110s, has a number of onco-mutant variants that are commonly found in cancers. mRNA-seq data shows that MCF10a cells express p110 beta>>alpha>delta with undetectable p110 gamma. Despite this, EGF-stimulated phosphorylation of PKB depended upon p110 alpha-, but not beta- or delta- activity. EGF-stimulated chemokinesis, but not chemotaxis, was also dependent upon p110 alpha, but not beta- or delta- activity. In the presence of single, endogenous alleles of onco-mutant p110 alpha (H1047R or E545K), basal, but not EGF-stimulated, phosphorylation of PKB was increased and the effect of EGF was fully reversed by p110 alpha inhibitors. Cells expressing either onco-mutant displayed higher basal motility and EGF-stimulated chemokinesis. This latter effect was, however, only partially-sensitive to PI3K inhibitors. In PTEN-/- cells, basal and EGF-stimulated phosphorylation of PKB was substantially increased, but the p110-dependency was variable between cell types. In MDA-MB 468s phosphorylation of PKB was significantly dependent on p110 beta, but not a-or delta- activity; in PTEN-/- MCF10a it remained, like the parental cells, p110 alpha-dependent. Surprisingly, loss of PTEN suppressed basal motility and EGF-stimulated chemokinesis. These results indicate that; p110a is required for EGF signaling to PKB and chemokinesis, but not chemotaxis; onco-mutant alleles of p110a augment signaling in the absence of EGF and may increase motility, in part, via acutely modulating PI3K-activity-independent mechanisms. Finally, we demonstrate that there is not a universal mechanism that up-regulates p110 beta function in the absence of PTEN.	[Juvin, Veronique; Malek, Mouhannad; Anderson, Karen E.; Dion, Carine; Chessa, Tamara; Lecureuil, Charlotte; Ferguson, G. John; Cosulich, Sabina; Hawkins, Phillip T.; Stephens, Len R.] Babraham Inst, Cambridge, England; [Cosulich, Sabina] Astrazeneca, Macclesfield, Cheshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca	Stephens, LR (corresponding author), Babraham Inst, Cambridge, England.	len.stephens@babraham.ac.uk	Lécureuil, Charlotte/B-4841-2016	Lécureuil, Charlotte/0000-0002-7339-9185; Anderson, Karen/0000-0002-7394-6660; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464	BBSRC [BB/I003916]; AstraZeneca; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/I003916/1, BBS/E/B/0000S239] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/I003916/1, BBS/E/B/0000S239] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work presented here was funded by a BBSRC grant (BB/I003916, funding VJ and MM, http://www.bbsrc.ac.uk/) and AstraZeneca (funding CD, http://www.astrazeneca.co.uk/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Anderson KE, 2000, CURR BIOL, V10, P1403, DOI 10.1016/S0960-9822(00)00794-6; Bastian P, 2006, MOL CANCER RES, V4, P411, DOI 10.1158/1541-7786.MCR-06-0030; Benistant C, 2000, ONCOGENE, V19, P5083, DOI 10.1038/sj.onc.1203871; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Burke John E., 2013, Advances in Biological Regulation, V53, P97, DOI 10.1016/j.jbior.2012.09.005; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dbouk HA, 2010, ONCOTARGET, V1, P729; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Fan QW, 2006, CELL CYCLE, V5, P2301, DOI 10.4161/cc.5.20.3362; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hill K, 2000, J BIOL CHEM, V275, P3741, DOI 10.1074/jbc.275.6.3741; Hill KM, 2010, PROSTATE, V70, P755, DOI 10.1002/pros.21108; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Li HF, 2011, J BIOMOL SCREEN, V16, P383, DOI 10.1177/1087057110397357; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Okkenhaug K, 2002, SCIENCE, V297, P1031; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Philp AJ, 2001, CANCER RES, V61, P7426; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sawyer C, 2003, CANCER RES, V63, P1667; So L, 2012, J BIOL CHEM; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sturge J, 2002, J CELL SCI, V115, P699; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Voigt P, 2006, J BIOL CHEM; Wallin JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036402; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Weng LP, 1999, CANCER RES, V59, P5808; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; YANO H, 1993, J BIOL CHEM, V268, P25846; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	94	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75045	10.1371/journal.pone.0075045	http://dx.doi.org/10.1371/journal.pone.0075045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124465	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100022
J	Pal, HC; Sharma, S; Strickland, LR; Agarwal, J; Athar, M; Elmets, CA; Afaq, F				Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Agarwal, Jyoti; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh			Delphinidin Reduces Cell Proliferation and Induces Apoptosis of Non-Small-Cell Lung Cancer Cells by Targeting EGFR/VEGFR2 Signaling Pathways	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; NECK-CANCER; EGFR; INHIBITION; ACTIVATION; PHOSPHORYLATION; CHEMOTHERAPY; RESISTANCE; THERAPY	Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor 2 (VEGFR2) have emerged as two effective clinical targets for non-small-cell lung cancer (NSCLC). In the present study, we found that delphinidin, an anthocyanidin, present in pigmented fruits and vegetables, is a potent inhibitor of both EGFR and VEGFR2 in NSCLC cells that overexpress EGFR/VEGFR2. Using these cells, we next determined the effects of delphinidin on cell growth and apoptosis in vitro and on tumor growth and angiogenesis in vivo. Delphinidin (5-60 mu M) treatment of NSCLC cells inhibited the activation of PI3K, and phosphorylation of AKT and MAPKs. Additionally, treatment of NSCLC cells with delphinidin resulted in inhibition of cell growth without having significant toxic effects on normal human bronchial epithelial cells. Specifically, treatment of NCI-H441 and SK-MES-1 cells with delphindin (5-60 mu M) resulted in (i) cleavage of PARP protein, (ii) activation of caspase-3 and -9, (iii) downregulation of anti-apoptotic proteins (Bcl2, Bcl-xL and Mcl-1), (iv) upregulation of pro-apoptotic proteins (Bax and Bak), and (v) decreased expression of PCNA and cyclin D1. Furthermore, in athymic nude mice subcutaneously implanted with human NSCLC cells, delphinidin treatment caused a (i) significant inhibition of tumor growth, (ii) decrease in the expression of markers for cell proliferation (Ki67 and PCNA) and angiogenesis (CD31 and VEGF), and (iii) induction of apoptosis, when compared with control mice. Based on these observations, we suggest that delphinidin, alone or as an adjuvant to current therapies, could be used for the management of NSCLC, especially those that overexpress EGFR and VEGFR2.	[Pal, Harish Chandra; Sharma, Samriti; Strickland, Leah Ray; Agarwal, Jyoti; Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Athar, Mohammad; Elmets, Craig A.; Afaq, Farrukh] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Afaq, F (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	fafaq@uab.edu	Pal, Harish C./AAH-9604-2020	Pal, Harish C./0000-0003-3079-7439	NIH [AT004966]; National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program [CA13148-39]; NATIONAL CANCER INSTITUTE [R01CA138998, P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by NIH Grant AT004966 and the National Cancer Institute CA13148-39 UAB Comprehensive Cancer Center Junior Faculty Development Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2008, INT J CANCER, V123, P1508, DOI 10.1002/ijc.23675; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Bin Hafeez B, 2008, CANCER RES, V68, P8564, DOI 10.1158/0008-5472.CAN-08-2232; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Earnshaw WC, 2006, ANNU REV BIOCHEM, V68, P383; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrero JM, 2001, ANN ONCOL, V12, P841, DOI 10.1023/A:1011183421477; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Jimeno A, 2006, BBA-REV CANCER, V1766, P217, DOI 10.1016/j.bbcan.2006.08.008; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; MAZZA G, 1995, CRIT REV FOOD SCI, V35, P341, DOI 10.1080/10408399509527704; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mueller KL, 2010, TRANSL ONCOLOGY, V5, P327; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Noda Y, 2002, J AGR FOOD CHEM, V50, P166, DOI 10.1021/jf0108765; Pennell NA, 2009, ONCOLOGIST, V14, P399, DOI 10.1634/theoncologist.2008-0276; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Seong AR, 2011, BIOCHEM BIOPH RES CO, V410, P581, DOI 10.1016/j.bbrc.2011.06.029; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Siegel R., 2013, CANC FACTS FIGURES 2; Silva SR, 2011, INT J CANCER, V128, P1045, DOI 10.1002/ijc.25441; Syed DN, 2008, TOXICOL APPL PHARM, V231, P52, DOI 10.1016/j.taap.2008.03.023; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yang F, 2011, CANCER RES, V71, P5512, DOI 10.1158/0008-5472.CAN-10-2614; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040178	51	70	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77270	10.1371/journal.pone.0077270	http://dx.doi.org/10.1371/journal.pone.0077270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124611	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100168
J	Qiao, T; Ma, RH; Luo, XB; Yang, LQ; Luo, ZL; Zheng, PM				Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming			The Systematic Classification of Gallbladder Stones	PLOS ONE			English	Article							CALCIUM-CARBONATE GALLSTONES; CHOLESTEROL GALLSTONES; INFRARED-SPECTROSCOPY; BETA-GLUCURONIDASE; FT-IR; PATHOGENESIS; DISEASE; EXPRESSION; LIVER	Background: To develop a method for systematic classification of gallbladder stones, analyze the clinical characteristics of each type of stone and provide a theoretical basis for the study of the formation mechanism of different types of gallbladder stones. Methodology: A total of 807 consecutive patients with gallbladder stones were enrolled and their gallstones were studied. The material composition of gallbladder stones was analyzed using Fourier Transform Infrared spectroscopy and the distribution and microstructure of material components was observed with Scanning Electron Microscopy. The composition and distribution of elements were analyzed by an X-ray energy spectrometer. Gallbladder stones were classified accordingly, and then, gender, age, medical history and BMI of patients with each type of stone were analyzed. Principal Findings: Gallbladder stones were classified into 8 types and more than ten subtypes, including cholesterol stones (297), pigment stones (217), calcium carbonate stones (139), phosphate stones (12), calcium stearate stones (9), protein stones (3), cystine stones (1) and mixed stones (129). Mixed stones were those stones with two or more than two kinds of material components and the content of each component was similar. A total of 11 subtypes of mixed stones were found in this study. Patients with cholesterol stones were mainly female between the ages of 30 and 50, with higher BMI and shorter medical history than patients with pigment stones (P<0.05), however, patients with pigment, calcium carbonate, phosphate stones were mainly male between the ages of 40 and 60. Conclusion: The systematic classification of gallbladder stones indicates that different types of stones have different characteristics in terms of the microstructure, elemental composition and distribution, providing an important basis for the mechanistic study of gallbladder stones.	[Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming] Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China; [Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Yang, Liu-qing; Luo, Zhen-liang; Zheng, Pei-ming] Sixth Peoples Hosp Nansha, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China		Qiao, T (corresponding author), Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China.	fqj1958@163.com						AHLBERG J, 1981, J LIPID RES, V22, P404; [Anonymous], [No title captured]; Cao J, 2006, J CHINESE PHYS, V8, P1111; Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215; Chihara G., 1960, CHEM PHARM BULL, V8, P771; Djessou PS, 2010, ANN BIOL CLIN-PARIS, V68, P39; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; ELEK G, 1982, KLIN WOCHENSCHR, V60, P33, DOI 10.1007/BF01721585; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Fu PB., 1984, CHINESE J SURG, V22, P258; Goto K, 1996, Ryoikibetsu Shokogun Shirizu, P418; Hattori Y, 2000, DIGEST DIS SCI, V45, P1413, DOI 10.1023/A:1005524624411; Jarrar BM, 2011, MALAYS J MED SCI, V18, P47; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; Liu Gang, 2002, Acta Optica Sinica, V22, P441; MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010; MALET PF, 1988, GASTROENTEROLOGY, V94, P1217, DOI 10.1016/0016-5085(88)90015-7; Mittal B, 2002, J Postgrad Med, V48, P149; Nakeeb A, 2002, ANN SURG, V235, P842, DOI 10.1097/00000658-200206000-00012; Paluszkiewicz C, 1998, CELL MOL BIOL, V44, P65; Qiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042471; Qiao T, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-6; Qiao T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3673472; RAVNBORG L, 1990, SCAND J GASTROENTERO, V25, P720, DOI 10.3109/00365529008997598; Sakorafas GH, 2007, DIGEST DIS SCI, V52, P1313, DOI 10.1007/s10620-006-9107-3; Stewart L, 2000, J GASTROINTEST SURG, V4, P547, DOI 10.1016/S1091-255X(00)80100-6; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; Stolk MFJ, 2001, DIGEST DIS SCI, V46, P1328, DOI 10.1023/A:1010635901414; Stringer MD, 2007, J PEDIATR SURG, V42, P1677, DOI 10.1016/j.jpedsurg.2007.05.022; TAYLOR DR, 1995, HEPATOLOGY, V22, P488, DOI 10.1016/0270-9139(95)90570-7; Wang HH, 2008, FRONT BIOSCI-LANDMRK, V13, P401, DOI 10.2741/2688; Wang Z, 2006, CHINESE J CLIN GASTR, V18, P325; Wu J, 1984, ACTA SCI NATUR U PEK, V20, P28; Xiao ZL, 1999, AM J PHYSIOL-GASTR L, V276, pG1401, DOI 10.1152/ajpgi.1999.276.6.G1401; Yoo EH, 2008, CLIN CHEM LAB MED, V46, P376, DOI 10.1515/CCLM.2008.074; Yu JK, 2013, ASIAN J SURG, V36, P26, DOI 10.1016/j.asjsur.2012.06.001; Zeng FQ, 2001, SPECTROSC SPECT ANAL, V21, P314; Zhang W., 2011, J SURG CONCEPTS PR, V16, P408; Zhang Z, 2008, WORLD CHINESE J DIGE, V16, P1200	42	50	56	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74887	10.1371/journal.pone.0074887	http://dx.doi.org/10.1371/journal.pone.0074887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124459	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100016
J	Roberts, BJ; Reddy, R; Wahl, JK				Roberts, Brett J.; Reddy, Roopa; Wahl, James K., III			Stratifin (14-3-3 sigma) Limits Plakophilin-3 Exchange with the Desmosomal Plaque	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-CELLS; E-CADHERIN; IDENTIFICATION; DESMOPLAKIN; DESMOGLEIN; BINDING; PLAKOGLOBIN; PROTEINS; ASSOCIATION	Desmosomes are prominent cell-cell adhesive junctions in stratified squamous epithelia and disruption of desmosomal adhesion has been shown to have dramatic effects on the function and integrity of these tissues. During normal physiologic processes, such as tissue development and wound healing, intercellular adhesion must be modified locally to allow coordinated cell movements. The mechanisms that control junction integrity and adhesive strength under these conditions are poorly understood. We utilized a proteomics approach to identify plakophilin-3 associated proteins and identified the 14-3-3 family member stratifin. Stratifin interacts specifically with plakophilin-3 and not with other plakophilin isoforms and mutation analysis demonstrated the binding site includes serine 285 in the amino terminal head domain of plakophilin-3. Stratifin interacts with a cytoplasmic pool of plakophilin-3 and is not associated with the desmosome in cultured cells. FRAP analysis revealed that decreased stratifin expression leads to an increase in the exchange rate of cytoplasmic plakophilin-3/GFP with the pool of plakophilin-3/GFP in the desmosome resulting in decreased desmosomal adhesion and increased cell migration. We propose a model by which stratifin plays a role in regulating plakophilin-3 incorporation into the desmosomal plaque by forming a plakophilin-3 stratifin complex in the cytosol and thereby affecting desmosome dynamics in squamous epithelial cells.	[Roberts, Brett J.; Reddy, Roopa; Wahl, James K., III] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Wahl, JK (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE USA.	jwahl@unmc.edu			National Institute of General Medical Sciences from the National Institutes of Health [P20GM103489]; Nebraska Department of Health and Human Services; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Nebraska Department of Health and Human Services; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Institute of General Medical Sciences (P20GM103489) from the National Institutes of Health and the Nebraska Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Bornslaeger EA, 2001, J CELL SCI, V114, P727; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Cabral RM, 2012, J CELL SCI, V125, P2853, DOI 10.1242/jcs.084152; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; HAMMOND NL, 2012, J INVEST DERMATOL; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Petrof G, 2012, BRIT J DERMATOL, V166, P36, DOI 10.1111/j.1365-2133.2011.10640.x; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Sobolik-Delmaire T, 2010, J INVEST DERMATOL, V130, P2638, DOI 10.1038/jid.2010.191; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; THOMASON HA, 2012, J PATHOL; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Wahl JK, 2000, J CELL SCI, V113, P1737; Wahl JK, 2002, HYBRIDOMA HYBRIDOM, V21, P37, DOI 10.1089/15368590252917629; Wahl JK, 1996, J CELL SCI, V109, P1143; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Xin Y, 2010, J INVEST DERMATOL, V130, P1934, DOI 10.1038/jid.2010.56; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029554	44	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77012	10.1371/journal.pone.0077012	http://dx.doi.org/10.1371/journal.pone.0077012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124604	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100161
J	Hirsch, BT; Prange, S; Hauver, SA; Gehrt, SD				Hirsch, Ben T.; Prange, Suzanne; Hauver, Stephanie A.; Gehrt, Stanley D.			Raccoon Social Networks and the Potential for Disease Transmission	PLOS ONE			English	Article							PROCYON-LOTOR; CANINE-DISTEMPER; GENETIC RELATEDNESS; SEROLOGIC SURVEY; CONTACT RATES; UNITED-STATES; NEW-JERSEY; RABIES; ONTARIO; USA	Raccoons are an important vector of rabies and other pathogens. The degree to which these pathogens can spread through a raccoon population should be closely linked to association rates between individual raccoons. Most studies of raccoon sociality have found patterns consistent with low levels of social connectivity within populations, thus the likelihood of direct pathogen transmission between raccoons is theoretically low. We used proximity detecting collars and social network metrics to calculate the degree of social connectivity in an urban raccoon population for purposes of estimating potential pathogen spread. In contrast to previous assumptions, raccoon social association networks were highly connected, and all individuals were connected to one large social network during 15 out of 18 months of study. However, these metrics may overestimate the potential for a pathogen to spread through a population, as many of the social connections were based on relatively short contact periods. To more closely reflect varying probabilities of pathogen spread, we censored the raccoon social networks based on the total amount of time spent in close proximity between two individuals per month. As this time criteria for censoring the social networks increased from one to thirty minutes, corresponding measures of network connectivity declined. These findings demonstrate that raccoon populations are much more tightly connected than would have been predicted based on previous studies, but also point out that additional research is needed to calculate more precise transmission probabilities by infected individuals, and determine how disease infection changes normal social behaviors.	[Hirsch, Ben T.; Gehrt, Stanley D.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Hirsch, Ben T.] Smithsonian Trop Res Inst, Balboa, Panama; [Prange, Suzanne] Ohio Div Wildlife, Athens, OH USA; SUNY Binghamton, Sch Educ, Binghamton, NY USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Hirsch, BT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	hirschb@si.edu	Prange, Suzanne/GSE-3990-2022	hirsch, ben/0000-0003-0142-7340	National Science Foundation [0425203]; Cook County Animal and Rabies Control; Max McGraw Wildlife Foundation	National Science Foundation(National Science Foundation (NSF)); Cook County Animal and Rabies Control; Max McGraw Wildlife Foundation	This project was funded in part by the National Science Foundation (ID-0425203), Cook County Animal and Rabies Control and the Max McGraw Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARASH DP, 1974, SCIENCE, V185, P794, DOI 10.1126/science.185.4153.794; Beasley JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058982; BIGLER WJ, 1973, AM J EPIDEMIOL, V98, P326, DOI 10.1093/oxfordjournals.aje.a121562; Blanton JD, 2011, JAVMA-J AM VET MED A, V239, P773, DOI 10.2460/javma.239.6.773; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Chamberlain MJ, 2002, AM MIDL NAT, V148, P297, DOI 10.1674/0003-0031(2002)148[0297:STRAAR]2.0.CO;2; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; CRANFIELD MR, 1984, CAN VET J, V25, P63; Cullingham CI, 2008, MOL ECOL, V17, P4874, DOI 10.1111/j.1365-294X.2008.03956.x; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Dharmarajan G, 2012, BASIC APPL ECOL, V13, P560, DOI 10.1016/j.baae.2012.08.010; Ewer, 1998, CARNIVORES; Gehrt S.D., 2003, WILD MAMMALS N AM BI, V2nd, P611; Gehrt SD, 2001, WILDLIFE SOC B, V29, P833; Gehrt SD, 1998, ANIM BEHAV, V55, P1211, DOI 10.1006/anbe.1997.0657; Gehrt SD, 2004, SOUTHWEST NAT, V49, P116, DOI 10.1894/0038-4909(2004)049<0116:SPADIA>2.0.CO;2; Gompper ME, 2005, J ZOOL, V266, P215, DOI 10.1017/S0952836905006813; Grant JWA, 2002, ANIM BEHAV, V63, P323, DOI 10.1006/anbe.2001.1891; GRAU GA, 1970, J WILDLIFE MANAGE, V34, P364, DOI 10.2307/3799023; Greene GE, 1990, INFECT DIS DOG CAT, P226; Hamede R, 2012, J APPL ECOL, V49, P447, DOI 10.1111/j.1365-2664.2011.02103.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hanlon C.A., 2007, RABIES, P201, DOI DOI 10.1016/B978-012369366-2/50007-5; Hauver S, 2013, ETHOLOGY, V119, P769, DOI 10.1111/eth.12118; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; HOFF G L, 1974, Journal of Wildlife Diseases, V10, P423; HUBBARD DR, 1985, J WILDLIFE DIS, V21, P105, DOI 10.7589/0090-3558-21.2.105; JENKINS SR, 1988, REV INFECT DIS, V10, pS620; JENKINS SR, 1987, AM J EPIDEMIOL, V126, P429, DOI 10.1093/oxfordjournals.aje.a114674; KAPPUS K D, 1970, Journal of Wildlife Diseases, V6, P507; Kaufmann J.H., 1982, P567; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; McLean R.G., 1975, P53; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Mitchell MA, 1999, J WILDLIFE DIS, V35, P347, DOI 10.7589/0090-3558-35.2.347; Moore DA, 1999, PREV VET MED, V40, P19, DOI 10.1016/S0167-5877(99)00005-7; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; NETTLES VF, 1979, AM J PUBLIC HEALTH, V69, P601, DOI 10.2105/AJPH.69.6.601; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pitt JA, 2008, J MAMMAL, V89, P646, DOI 10.1644/07-MAMM-A-224R.1; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Prange S, 2004, J MAMMAL, V85, P483, DOI 10.1644/BOS-121; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Prange S, 2011, J MAMMAL, V92, P1331, DOI 10.1644/10-MAMM-A-416.1; Raizman EA, 2009, J WILDLIFE DIS, V45, P531, DOI 10.7589/0090-3558-45.2.531; Recuenco S, 2008, PREV VET MED, V86, P30, DOI 10.1016/j.prevetmed.2008.03.001; Robert K, 2012, J WILDLIFE MANAGE, V76, P1670, DOI 10.1002/jwmg.435; Rosatte RC, 2009, J WILDLIFE DIS, V45, P772, DOI 10.7589/0090-3558-45.3.772; Rosatte R, 2006, J WILDLIFE DIS, V42, P589, DOI 10.7589/0090-3558-42.3.589; Roscoe DE, 1998, J WILDLIFE DIS, V34, P752, DOI 10.7589/0090-3558-34.4.752; ROSCOE DE, 1993, J WILDLIFE DIS, V29, P390, DOI 10.7589/0090-3558-29.3.390; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Ryder TB, 2012, BIOL LETTERS, V8, P917, DOI 10.1098/rsbl.2012.0536; Sandell M., 1989, P164; SEIDENSTICKER J, 1988, NATL GEOGR RES, V4, P359; SMITH JS, 1990, J WILDLIFE DIS, V26, P473, DOI 10.7589/0090-3558-26.4.473; Tinline R, 2002, PREV VET MED, V56, P89, DOI 10.1016/S0167-5877(02)00126-5; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; Wilson E.O., 1975, P1; Wilson ML, 1997, AM J TROP MED HYG, V57, P457, DOI 10.4269/ajtmh.1997.57.457; Winkler W.G., 1991, P325; Wright AN, 2005, OECOLOGIA, V144, P148, DOI 10.1007/s00442-005-0018-3	65	35	35	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75830	10.1371/journal.pone.0075830	http://dx.doi.org/10.1371/journal.pone.0075830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130746	Green Published, Green Accepted, gold			2022-12-25	WOS:000325814200024
J	Zhang, ZF; Cogswell, ME; Gillespie, C; Fang, J; Loustalot, F; Dai, SF; Carriquiry, AL; Kuklina, EV; Hong, YL; Merritt, R; Yang, QH				Zhang, Zefeng; Cogswell, Mary E.; Gillespie, Cathleen; Fang, Jing; Loustalot, Fleetwood; Dai, Shifan; Carriquiry, Alicia L.; Kuklina, Elena V.; Hong, Yuling; Merritt, Robert; Yang, Quanhe			Association between Usual Sodium and Potassium Intake and Blood Pressure and Hypertension among US Adults: NHANES 2005-2010	PLOS ONE			English	Article							DIETARY-SODIUM; NUTRITIONAL FACTORS; RANDOMIZED-TRIALS; SALT INTAKE; CALCIUM; DISEASE; METAANALYSIS; COLLECTION; REDUCTION; EXCRETION	Objectives: Studies indicate high sodium and low potassium intake can increase blood pressure suggesting the ratio of sodium-to-potassium may be informative. Yet, limited studies examine the association of the sodium-to-potassium ratio with blood pressure and hypertension. Methods: We analyzed data on 10,563 participants aged >= 20 years in the 2005-2010 National Health and Nutrition Examination Survey who were neither taking anti-hypertensive medication nor on a low sodium diet. We used measurement error models to estimate usual intakes, multivariable linear regression to assess their associations with blood pressure, and logistic regression to assess their associations with hypertension. Results: The average usual intakes of sodium, potassium and sodium-to-potassium ratio were 3,569 mg/d, 2,745 mg/d, and 1.41, respectively. All three measures were significantly associated with systolic blood pressure, with an increase of 1.04 mmHg (95% CI, 0.27-1.82) and a decrease of 1.24 mmHg (95% CI, 0.31-2.70) per 1,000 mg/d increase in sodium or potassium intake, respectively, and an increase of 1.05 mmHg (95% CI, 0.12-1.98) per 0.5 unit increase in sodium-to-potassium ratio. The adjusted odds ratios for hypertension were 1.40 (95% CI, 1.07-1.83), 0.72 (95% CI, 0.53-0.97) and 1.30 (95% CI, 1.05-1.61), respectively, comparing the highest and lowest quartiles of usual intake of sodium, potassium or sodium-to-potassium ratio. Conclusions: Our results provide population-based evidence that concurrent higher sodium and lower potassium consumption are associated with hypertension.	[Zhang, Zefeng; Cogswell, Mary E.; Gillespie, Cathleen; Fang, Jing; Loustalot, Fleetwood; Dai, Shifan; Kuklina, Elena V.; Hong, Yuling; Merritt, Robert; Yang, Quanhe] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA; [Carriquiry, Alicia L.] Iowa State Univ, Dept Stat, Ames, IA USA	Centers for Disease Control & Prevention - USA; Iowa State University	Zhang, ZF (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA.	zzhang3@cdc.gov	Kuklina, Elena/AAF-3532-2020	Kuklina, Elena/0000-0002-9686-6495; Gillespie, Cathleen/0000-0003-1878-1055	Office of Dietary Supplements, National Institutes of Health [3R01HL091024-02S1]; NSF-PGRP from the National Science Foundation [114139]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091024] Funding Source: NIH RePORTER	Office of Dietary Supplements, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-PGRP from the National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Carriquiry is currently receiving a grant (#3R01HL091024-02S1) from the Office of Dietary Supplements, National Institutes of Health and A GRANT (NSF-PGRP#114139) from the National Science Foundation. For the remaining authors, no funding was declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto Nancy J, 2013, BMJ, V346, pf1378, DOI 10.1136/bmj.f1378; Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; *AM HEART ASS, 2010, HEART DIS STROK STAT, pE19; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; CUTLER JA, 1991, HYPERTENSION, V17, pI27, DOI 10.1161/01.HYP.17.1_Suppl.I27; ELLIOTT P, 1988, BRIT MED J, V297, P319; ELLIOTT P, 1991, HYPERTENSION S1, V17, P3; Elliott P, 2007, CIRCULATION, V116, P1563, DOI 10.1161/CIRCULATIONAHA.106.675579; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Geleijnse JM, 1996, J HYPERTENS, V14, P737, DOI 10.1097/00004872-199606000-00009; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; GRUCHOW HW, 1988, AM J CLIN NUTR, V48, P1463, DOI 10.1093/ajcn/48.6.1463; Guenther PM, 2013, AM J CLIN NUTR, V97, P842, DOI 10.3945/ajcn.112.047779; Guenther PM, 1997, J NUTR, V127, P1106, DOI 10.1093/jn/127.6.1106; Hajjar IM, 2001, ARCH INTERN MED, V161, P589, DOI 10.1001/archinte.161.4.589; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Hedayati SS, 2012, CLIN J AM SOC NEPHRO, V7, P315, DOI 10.2215/CJN.02060311; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huggins CE, 2011, BRIT J NUTR, V105, P248, DOI 10.1017/S0007114510003223; *I MED, 2005, DIET REF INT WAT POT, P546; Joseph ML, 2010, J NUTR, V140, p2094S, DOI 10.3945/jn.110.123588; KESTELOOT H, 1988, HYPERTENSION, V12, P594, DOI 10.1161/01.HYP.12.6.594; KHAW KT, 1988, CIRCULATION, V77, P53, DOI 10.1161/01.CIR.77.1.53; KOK FJ, 1986, AM J EPIDEMIOL, V123, P1043, DOI 10.1093/oxfordjournals.aje.a114332; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LJ, 2000, HYPERTENS RES, V23, P151, DOI 10.1291/hypres.23.151; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Tunstall-Pedoe H, 1999, SEMIN NEPHROL, V19, P500; WITTEMAN JCM, 1989, CIRCULATION, V80, P1320, DOI 10.1161/01.CIR.80.5.1320	39	89	92	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75289	10.1371/journal.pone.0075289	http://dx.doi.org/10.1371/journal.pone.0075289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130700	Green Submitted, gold, Green Published			2022-12-25	WOS:000325814200008
J	Baran, B; Daniels, D; Spencer, RMC				Baran, Bengi; Daniels, Dasha; Spencer, Rebecca M. C.			Sleep-Dependent Consolidation of Value-Based Learning	PLOS ONE			English	Article							MEMORY REACTIVATION; STRATEGIC CONTROL; OLDER-ADULTS; ATTENTION; CHILDREN	It has been suggested that sleep selectively enhances memories with future relevance. Given that sleep's benefits can vary by item within a learning context, the present study investigated whether the amount of sleep-dependent consolidation may vary across items based on the value of the to-be-learned material. For this purpose, we used a value-based learning paradigm in which participants studied words paired with point values. There were two groups; participants either studied the words in the evening and were tested after a 12 hr interval containing a full night of sleep, or studied the words in the morning and were tested after 12 hr of continuous daytime wake. Free recall (F(1,36) = 19.35, p < .001) and recognition accuracy (F(1,36) = 7.59, p = .01) for words were better following sleep relative to wake. However there was no difference in the linear increase in the probability of delayed recall with increasing word value for sleep and wake groups (p = .74). Thus, while encoding may vary with the value of the to-be-learned item, sleep-dependent consolidation does not.	[Baran, Bengi; Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Daniels, Dasha; Spencer, Rebecca M. C.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Baran, B (corresponding author), Univ Massachusetts, Dept Psychol, Tobin Hall, Amherst, MA 01003 USA.	bbaran@psych.umass.edu		Spencer, Rebecca/0000-0002-8674-2384	Commonwealth College Honors Research Grant; National Institutes of Health [R01 AG040133]; NATIONAL INSTITUTE ON AGING [R01AG040133] Funding Source: NIH RePORTER	Commonwealth College Honors Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by a Commonwealth College Honors Research Grant awarded to D.D. at University of Massachusetts, Amherst. R.M.C.S. and B.B. were supported by National Institutes of Health R01 AG040133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; Castel AD, 2011, NEUROPSYCHOLOGY, V25, P15, DOI 10.1037/a0020298; Castel AD, 2009, NEUROPSYCHOLOGY, V23, P297, DOI 10.1037/a0014888; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Davies M., 2010, FREQUENCY DICT CONT; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Oudiette D, 2013, J NEUROSCI, V33, P6672, DOI 10.1523/JNEUROSCI.5497-12.2013; Oudiette D, 2013, TRENDS COGN SCI, V17, P142, DOI 10.1016/j.tics.2013.01.006; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; R Development Core Team, 2011, R LANG ENV STAT COMP; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Spencer R.M.C., 2013, ISRN PHYSL, V71, P233, DOI [10.1155/2013/619319, DOI 10.1155/2013/619319]; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Wilhelm I, 2012, DEVELOPMENTAL SCI, V15, P506, DOI 10.1111/j.1467-7687.2012.01146.x; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	26	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75326	10.1371/journal.pone.0075326	http://dx.doi.org/10.1371/journal.pone.0075326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130703	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900030
J	Bernardi, C; Soffientini, U; Piacente, F; Tonetti, MG				Bernardi, Cinzia; Soffientini, Ugo; Piacente, Francesco; Tonetti, Michela G.			Effects of MicroRNAs on Fucosyltransferase 8 (FUT8) Expression in Hepatocarcinoma Cells	PLOS ONE			English	Article							CORE FUCOSYLATION; GROWTH; CARCINOMA	Fucosyltransferase 8 (FUT8) catalyzes the transfer of alpha 1,6-linked fucose to the first N-acetylglucosamine in N-linked glycans (core fucosylation). Increased core fucosylation has been reported during hepatocarcinogenesis, in both cell-associated and secreted proteins. Accordingly, increased core fucosylation of alpha-fetoprotein and alpha 1-antitrypsin is currently used as a diagnostic and prognostic indicator. The present study provides new evidences that FUT8 can be regulated also through miRNA-mediated mechanisms. Using microRNA/target prediction programs, we identified miR-122 and miR-34a seed regions in the 3' untranslated region (3'UTR) of FUT8. Then we used human and rodents hepatocarcinoma cell lines to evaluate the impact of transfection of miR-122 and miR-34a mimics on FUT8 mRNA and protein levels. This study demonstrated that forced expression of these miRNAs is able to induce a decrease of FUT8 levels and also to affect core fucosylation of secreted proteins. The ability of miR-122 and miR-34a to specifically interact with and regulate the 3'UTR of FUT8 was demonstrated via a luciferase reporter assay. Since miR-122 and miR-34a downregulation is a common feature in spontaneous human hepatocarcinoma, our finding that these miRNAs are able to target FUT8 3'UTR suggests that, together with transcriptional and other post-transcriptional systems, a miRNA-mediated mechanism could also be involved in the increased core fucosylation observed in liver tumors. Moreover, these findings also point out that miRNAs may be widely involved in the regulation of glycosylation machinery.	[Tonetti, Michela G.] Univ Genoa, Dept Expt Med, Genoa, Italy; Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy	University of Genoa; University of Genoa	Tonetti, MG (corresponding author), Univ Genoa, Dept Expt Med, Genoa, Italy.	tonetti@unige.it	Tonetti, Michela/F-3039-2018; Bernardi, Cinzia/K-3416-2018; TONETTI, MICHELA/AAF-3404-2021; Piacente, Francesco/J-8295-2016	Bernardi, Cinzia/0000-0001-9342-5929; TONETTI, MICHELA/0000-0002-8829-7173; Piacente, Francesco/0000-0001-5470-5987; Soffientini, Ugo/0000-0001-9676-4803	Regione Liguria [Progetto di Ricerca Sanitaria Regionale]; Regione Liguria [P.O. C.R.O. FSE, Asse IV Capitale umano]	Regione Liguria [Progetto di Ricerca Sanitaria Regionale]; Regione Liguria [P.O. C.R.O. FSE, Asse IV Capitale umano]	This work was supported in part by Regione Liguria [Progetto di Ricerca Sanitaria Regionale 2009]. C. B. was supported by a PhD fellowship from Regione Liguria [P.O. C.R.O. FSE 2007-2013, Asse IV Capitale umano]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Cheng J, 2010, PROTEOMICS, V10, P1557, DOI 10.1002/pmic.200900646; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Ito Y, 2003, CANCER LETT, V200, P167, DOI 10.1016/S0304-3835(03)00383-5; Jansson MD, 2010, MOL ONCOL, V30, P1; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Matsumoto K, 2008, CANCER SCI, V99, P1611, DOI 10.1111/j.1349-7006.2008.00847.x; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Sturla L, 2005, GLYCOBIOLOGY, V15, P924, DOI 10.1093/glycob/cwi081; Takahashi M, 1999, CARBOHYD RES, V344, P1387; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200	22	53	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76540	10.1371/journal.pone.0076540	http://dx.doi.org/10.1371/journal.pone.0076540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130780	Green Submitted, gold, Green Published			2022-12-25	WOS:000325810900076
J	Cangi, N; Horak, IG; Apanaskevich, DA; Matthee, S; das Neves, LCBG; Estrada-Pena, A; Matthee, CA				Cangi, Nidia; Horak, Ivan G.; Apanaskevich, Dmitry A.; Matthee, Sonja; das Neves, Luis C. B. G.; Estrada-Pena, Agustin; Matthee, Conrad A.			The Influence of Interspecific Competition and Host Preference on the Phylogeography of Two African Ixodid Tick Species	PLOS ONE			English	Article							GENUS HYALOMMA KOCH; SOUTH-AFRICA; WILD ANIMALS; AMBLYOMMA-HEBRAEUM; LIFE-CYCLE; RICKETTSIA-AFRICAE; POPULATION-GROWTH; GENETIC DIVERSITY; EASTERN TRANSVAAL; ACARI IXODIDAE	A comparative phylogeographic study on two economically important African tick species, Amblyomma hebraeum and Hyalomma rufipes was performed to test the influence of host specificity and host movement on dispersion. Pairwise AMOVA analyses of 277 mtDNA COI sequences supported significant population differentiation among the majority of sampling sites. The geographic mitochondrial structure was not supported by nuclear ITS-2 sequencing, probably attributed to a recent divergence. The three-host generalist, A. hebraeum, showed less mtDNA geographic structure, and a lower level of genetic diversity, while the more host-specific H. rufipes displayed higher levels of population differentiation and two distinct mtDNA assemblages (one predominantly confined to South Africa/Namibia and the other to Mozambique and East Africa). A zone of overlap is present in southern Mozambique. A mechanistic climate model suggests that climate alone cannot be responsible for the disruption in female gene flow. Our findings furthermore suggest that female gene dispersal of ticks is more dependent on the presence of juvenile hosts in the environment than on the ability of adult hosts to disperse across the landscape. Documented interspecific competition between the juvenile stages of H. rufipes and H. truncatum is implicated as a contributing factor towards disrupting gene flow between the two southern African H. rufipes genetic assemblages.	[Cangi, Nidia; Matthee, Conrad A.] Univ Stellenbosch, Evolutionary Genom Grp, Dept Bot & Zool, Matieland, South Africa; [Horak, Ivan G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Apanaskevich, Dmitry A.] Georgia So Univ, US Natl Tick Collect, James H Oliver Jr Inst Coastal Plain Sci, Statesboro, GA 30460 USA; [Matthee, Sonja] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Matieland, South Africa; [das Neves, Luis C. B. G.] Eduardo Mondlane Univ, Ctr Biotecnol UEM, Maputo, Mozambique; [das Neves, Luis C. B. G.] Eduardo Mondlane Univ, Fac Vet, Maputo, Mozambique; [Estrada-Pena, Agustin] Fac Vet, Dept Parasitol, Zaragoza, Zaragoza, Spain	Stellenbosch University; University of Pretoria; University System of Georgia; Georgia Southern University; Stellenbosch University; Eduardo Mondlane University; Eduardo Mondlane University	Matthee, CA (corresponding author), Univ Stellenbosch, Evolutionary Genom Grp, Dept Bot & Zool, Matieland, South Africa.	cam@sun.ac.za	Matthee, Conrad A./B-1620-2012	Matthee, Conrad A./0000-0002-6836-069X; Matthee, Sonja/0000-0001-7289-6262; Neves, Luis/0000-0002-5435-5996; Estrada Pena, Agustin/0000-0001-7483-046X	National Research Foundation (NRF); South African Biosystematics Initiative (SABI); Stellenbosch University; South African National Research Foundation	National Research Foundation (NRF); South African Biosystematics Initiative (SABI); Stellenbosch University; South African National Research Foundation(National Research Foundation - South Africa)	The National Research Foundation (NRF), South African Biosystematics Initiative (SABI) and Stellenbosch University are thanked for financial support. There was a South African National Research Foundation grant to Conrad Matthee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; [Anonymous], GUIDE IDENTIFICATION; Apanaskevich DA, 2006, ONDERSTEPOORT J VET, V73, P1; Apanaskevich DA, 2008, INT J ACAROL, V34, P13, DOI 10.1080/01647950808683704; Barker SC, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P1, DOI 10.1017/CBO9780511551802.002; Barker SC, 2002, EXP APPL ACAROL, V28, P55, DOI 10.1023/A:1025333830086; Berkvens DL, 1998, MED VET ENTOMOL, V12, P234, DOI 10.1046/j.1365-2915.1998.00106.x; BOOMKER J, 1992, ONDERSTEPOORT J VET, V59, P175; BROWN SJ, 1988, VET PARASITOL, V28, P245, DOI 10.1016/0304-4017(88)90112-4; Chen Z, 2012, EXP APPL ACAROL, V56, P85, DOI 10.1007/s10493-011-9490-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cumming GS, 1999, B ENTOMOL RES, V89, P303, DOI 10.1017/S0007485399000450; Cumming GS, 2002, ECOLOGY, V83, P255, DOI 10.1890/0012-9658(2002)083[0255:CCAVAL]2.0.CO;2; de Meeus T, 2002, TRENDS PARASITOL, V18, P247, DOI 10.1016/S1471-4922(02)02269-9; Deem SL, 1998, J ZOO WILDLIFE MED, V29, P109; DEVOS AJ, 1981, ONDERSTEPOORT J VET, V48, P1; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estrada-Pena A, 2008, VET PARASITOL, V151, P256, DOI 10.1016/j.vetpar.2007.11.014; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fielden LJ, 1996, EXP APPL ACAROL, V20, P625, DOI 10.1007/BF00053326; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FOURIE LJ, 1991, J S AFR VET ASSOC, V62, P104; Fu YX, 1997, GENETICS, V147, P915; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Gylfe A, 2001, HEREDITAS, V134, P195, DOI 10.1111/j.1601-5223.2001.00195.x; Hall TA, 2005, BIOEDIT V7 0 5; Hasle G, 2009, ONDERSTEPOORT J VET, V76, P167; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P259; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P125; HORAK IG, 1991, ONDERSTEPOORT J VET, V58, P261; HORAK IG, 1982, ONDERSTEPOORT J VET, V49, P85; Horak IG, 2002, EXP APPL ACAROL, V27, P113, DOI 10.1023/A:1021587001198; HORAK IG, 1987, J S AFR VET ASSOC, V58, P15; HORAK IG, 1995, ONDERSTEPOORT J VET, V62, P123; HORAK IG, 1993, ONDERSTEPOORT J VET, V60, P163; Kain DE, 1999, HEREDITY, V83, P378, DOI 10.1038/sj.hdy.6886110; Kelly PJ, 1996, INT J SYST BACTERIOL, V46, P611, DOI 10.1099/00207713-46-2-611; Kelly PJ, 2001, J S AFR VET ASSOC, V72, P182; Kempf F, 2010, INFECT GENET EVOL, V10, P989, DOI 10.1016/j.meegid.2010.06.003; Kempf F, 2009, MOL ECOL, V18, P4450, DOI 10.1111/j.1365-294X.2009.04356.x; Krakowetz CN, 2010, J VECTOR ECOL, V35, P163, DOI 10.1111/j.1948-7134.2010.00043.x; KUHNERT F, 1995, INT J PARASITOL, V25, P887, DOI 10.1016/0020-7519(95)00009-Q; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; LAWRENCE JA, 1979, J S AFR VET ASSOC, V50, P311; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; McCoy KD, 2003, EVOLUTION, V57, P288, DOI 10.1111/j.0014-3820.2003.tb00263.x; Mitchell M, 1996, TROP ANIM HEALTH PRO, V28, pS53, DOI 10.1007/BF02310700; Mixson Tonya R., 2004, Acta Zoologica Sinica, V50, P176; Mixson TR, 2006, J VECTOR ECOL, V31, P181, DOI 10.3376/1081-1710(2006)31[181:ITPSAD]2.0.CO;2; Morand S., 2010, BIOGEOGRAPHY HOST PA; Mtshali MS, 2007, ZOONOSES PUBLIC HLTH, V54, P23, DOI 10.1111/j.1863-2378.2007.00998.x; Needham G.R., 1986, P100; Norval R. A. I., 2004, Infectious diseases of livestock, Volume One, P3; Norval RAI, 1983, VET J, V23, P1; Norval RAI, 1984, ACAROLOGY; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; Parola P, 2001, EMERG INFECT DIS, V7, P1014, DOI 10.3201/eid0706.010616; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Porretta D, 2013, MOL ECOL, V22, P1666, DOI 10.1111/mec.12203; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Qiu WG, 2002, GENETICS, V160, P833; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; RAHMAN MH, 1984, FOLIA PARASIT, V31, P63; RECHAV Y, 1987, J MED ENTOMOL, V24, P575, DOI 10.1093/jmedent/24.5.575; RECHAV Y, 1987, EXP APPL ACAROL, V3, P219, DOI 10.1007/BF01270458; RECHAV Y, 1990, ONDERSTEPOORT J VET, V57, P7; Rees DJ, 2003, MOL PHYLOGENET EVOL, V27, P131, DOI 10.1016/S1055-7903(02)00374-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Song S, 2011, INT J PARASITOL, V41, P871, DOI 10.1016/j.ijpara.2011.03.008; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Uys AC, 2005, ONDERSTEPOORT J VET, V72, P339; Van Niekerk DJ, 2006, ONDERSTEPOORT J VET, V73, P123; WALKER JB, 1984, ONDERSTEPOORT J VET, V51, P171	88	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76930	10.1371/journal.pone.0076930	http://dx.doi.org/10.1371/journal.pone.0076930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130813	Green Published, gold			2022-12-25	WOS:000325810900107
J	Dean, AS; Fournie, G; Kulo, AE; Boukaya, GA; Schelling, E; Bonfoh, B				Dean, Anna S.; Fournie, Guillaume; Kulo, Abalo E.; Boukaya, G. Aboudou; Schelling, Esther; Bonfoh, Bassirou			Potential Risk of Regional Disease Spread in West Africa through Cross-Border Cattle Trade	PLOS ONE			English	Article							TRANSMISSION; RINDERPEST; MOVEMENTS; DYNAMICS; PATTERNS; NETWORK; MODEL	Background: Transboundary animal movements facilitate the spread of pathogens across large distances. Cross-border cattle trade is of economic and cultural importance in West Africa. This study explores the potential disease risk resulting from large-scale, cross-border cattle trade between Togo, Burkina Faso, Ghana, Benin, and Nigeria for the first time. Methods and Principal Findings: A questionnaire-based survey of livestock movements of 226 cattle traders was conducted in the 9 biggest cattle markets of northern Togo in February-March 2012. More than half of the traders (53.5%) operated in at least one other country. Animal flows were stochastically simulated based on reported movements and the risk of regional disease spread assessed. More than three quarters (79.2%, range: 78.1-80.0%) of cattle flowing into the market system originated from other countries. Through the cattle market system of northern Togo, non-neighbouring countries were connected via potential routes for disease spread. Even for diseases with low transmissibility and low prevalence in a given country, there was a high risk of disease introduction into other countries. Conclusions: By stochastically simulating data collected by interviewing cattle traders in northern Togo, this study identifies potential risks for regional disease spread in West Africa through cross-border cattle trade. The findings highlight that surveillance for emerging infectious diseases as well as control activities targeting endemic diseases in West Africa are likely to be ineffective if only conducted at a national level. A regional approach to disease surveillance, prevention and control is essential.	[Dean, Anna S.; Schelling, Esther] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Dean, Anna S.; Schelling, Esther] Univ Basel, Basel, Switzerland; [Fournie, Guillaume] Univ London, Royal Vet Coll, Dept Vet Clin Sci, London WC1E 7HU, England; [Kulo, Abalo E.] Univ Lome, Ecole Super Agron, Lome, Togo; [Boukaya, G. Aboudou] Minist Agr Elevage & Peche, Direct Elevage, Lome, Togo; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; University of London Royal Veterinary College	Schelling, E (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	esther.schelling@unibas.ch	Schelling, Esther/K-7990-2015	Schelling, Esther/0000-0001-6444-0898; Fournie, Guillaume/0000-0002-6998-1201; Dean, Anna/0000-0002-9539-7164	National Center of Competence in Research North-South (NCCR North-South) in Switzerland	National Center of Competence in Research North-South (NCCR North-South) in Switzerland	This study was funded by the National Center of Competence in Research North-South (NCCR North-South) in Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; de Haan L, 1999, AFR STUD CTR RES SER, V15, P205; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; FAO/OIE, 2012, GLOB FOOT MOUTH DIS; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kerr J, 2010, WORKING TRADERS UNDE, P59; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kulo A, 2011, B ANIMAL HLTH PRODUC, V59; Ly I, 2007, SEMINAIRE FORMATION; Mariner JC, 2006, PREV VET MED, V73, P55, DOI 10.1016/j.prevetmed.2005.09.001; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Perry BD, 2013, P NATL ACAD SCI USA, V110, P20871, DOI 10.1073/pnas.1012953108; R Development Core Team, 2012, R LANG ENV STAT COMP; Schwarzer G., 2012, META METAANALYSIS R; Tempia S, 2010, REV SCI TECH OIE, V29, P497, DOI 10.20506/rst.29.3.1996; The Pirbright Institute, 2012, FOOT AND MOUTH DIS; Tounkara K, 2012, FAO OIE GLOB C FOOT; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Williams T.O., 2006, IMPROVING LIVESTOCK	24	35	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75570	10.1371/journal.pone.0075570	http://dx.doi.org/10.1371/journal.pone.0075570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130721	Green Published, Green Accepted, gold			2022-12-25	WOS:000325810900042
J	Lee, CW; Cheng, TM; Lin, CP; Pan, JP				Lee, Chin-Wei; Cheng, Tsai-Mu; Lin, Chih-Pei; Pan, Ju-Pin			Plasma Haptoglobin Concentrations Are Elevated in Patients with Coronary Artery Disease	PLOS ONE			English	Article							HEART-DISEASE; RISK FACTOR; POLYMORPHISM; INFLAMMATION; PHENOTYPE; GENOTYPE; PURIFICATION; INDIVIDUALS; DETERMINANT; MORTALITY	Inflammation underlies the development and progression of coronary artery plaques. Haptoglobin (Hp) is an acute phase protein, the synthesis of which is increased during inflammation. The aim of this study was to investigate plasma Hp concentrations and phenotype in patients with coronary artery disease (CAD). We recruited 359 patients with fixed luminal stenosis >= 50% in at least one coronary artery (CAD group) and 83 patients with luminal stenosis <= 40%, normal ejection fraction, and normal regional wall motion (control group). Plasma Hp concentrations were measured using a phenotype-specific enzyme-linked immunosorbent assay. Hp phenotype was determined by native polyacrylamide gel electrophoresis. Plasma lipid concentrations were measured. Plasma Hp concentrations were significantly higher in the CAD compared with the control group (262.4 +/- 144.2 vs 176.0 +/- 86.7 ng/mL, P<0.001); however, there was no between group difference in the distribution of Hp phenotype (1-1 = 7.5% vs 7.2%; 2-1 = 40.4% vs 42.2%; 2-2 = 52.1% vs 50.6%). Stepwise multivariate logistic regression revealed that high Hp concentrations (odds ratio [OR] = 5.865), male sex (OR = 3.689), hypertension (OR = 2.632), diabetes mellitus (OR = 3.300), and low-density lipoprotein concentrations (OR = 1.480) were independently associated with CAD (all P<0.05). Hp phenotype was not associated with CAD. Plasma Hp concentrations were significantly correlated with the severity of luminal stenosis (r = 0.236, P<0.001). Our findings suggest that plasma Hp concentrations may be elevated in patients with CAD. There does not appear to be any relationship between Hp phenotype and CAD.	[Lee, Chin-Wei] Taipei Vet Gen Hosp, Tao Yuan Branch, Dept Med, Div Cardiol, Tao Yuan, Taiwan; [Cheng, Tsai-Mu] Taipei Med Univ, Coll Med & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Lin, Chih-Pei] Taipei Vet Gen Hosp, Biochem Sect, Dept Pathol & Lab Med, Taipei, Taiwan; [Lin, Chih-Pei] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Pan, Ju-Pin] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Pan, Ju-Pin] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Pan, JP (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	jppan@vghtpe.gov.tw			Taipei Veterans General Hospital Taiwan, ROC [VGH92-356, VGH94-210]	Taipei Veterans General Hospital Taiwan, ROC(Taipei Veterans General Hospital)	This study was supported by grants from the Taipei Veterans General Hospital (VGH92-356 and VGH94-210, [J.P.P]) Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Austen W G, 1975, Circulation, V51, P5; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Carter K, 2007, INT J LAB HEMATOL, V29, P92, DOI 10.1111/j.1751-553X.2007.00898.x; Cheng TM, 2007, CLIN BIOCHEM, V40, P1045, DOI 10.1016/j.clinbiochem.2007.04.018; De Bacquer D, 2001, ATHEROSCLEROSIS, V157, P161, DOI 10.1016/S0021-9150(00)00690-0; Delanghe J, 1999, ATHEROSCLEROSIS, V145, P287, DOI 10.1016/S0021-9150(99)00079-9; Delanghe JR, 2011, ATHEROSCLEROSIS, V217, P80, DOI 10.1016/j.atherosclerosis.2011.03.031; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Holme I, 2009, ANN MED, V41, P522, DOI 10.1080/07853890903089453; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Levy AP, 2004, ATHEROSCLEROSIS, V172, P361, DOI 10.1016/j.atherosclerosis.2003.10.014; Levy AP, 2002, J AM COLL CARDIOL, V40, P1984, DOI 10.1016/S0735-1097(02)02534-2; Liau CY, 2003, J CHROMATOGR B, V790, P209, DOI 10.1016/S1570-0232(03)00128-4; McPherson R, 2012, CAN J CARDIOL, V28, P662, DOI 10.1016/j.cjca.2012.05.014; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Moreno PR, 2008, J AM COLL CARDIOL, V52, P1049, DOI 10.1016/j.jacc.2008.06.029; MORIMATSU M, 1991, J BIOL CHEM, V266, P11833; Pan JP, 2011, J VASC SURG, V53, P1189, DOI 10.1016/j.jvs.2010.10.122; Roguin A, 2003, DIABETES CARE, V26, P2628, DOI 10.2337/diacare.26.9.2628; Staals J, 2008, CURR NEUROVASC RES, V5, P153, DOI 10.2174/156720208785425675; Suleiman M, 2005, DIABETES, V54, P2802, DOI 10.2337/diabetes.54.9.2802; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; Tseng CF, 2004, PROTEIN EXPRES PURIF, V33, P265, DOI 10.1016/j.pep.2003.09.006; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012	30	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76817	10.1371/journal.pone.0076817	http://dx.doi.org/10.1371/journal.pone.0076817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130793	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900088
J	Sisay, S; Pryce, G; Jackson, SJ; Tanner, C; Ross, RA; Michael, GJ; Selwood, DL; Giovannoni, G; Baker, D				Sisay, Sofia; Pryce, Gareth; Jackson, Samuel J.; Tanner, Carolyn; Ross, Ruth A.; Michael, Gregory J.; Selwood, David L.; Giovannoni, Gavin; Baker, David			Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ACID-AMIDE-HYDROLASE; CANNABINOID RECEPTOR; C57BL/6 MICE; BIOZZI ABH; TNF-ALPHA; 17 CELLS; T-CELLS; SUSCEPTIBILITY	Endocannabinoids and some phytocannabinoids bind to CB1 and CB2 cannabinoid receptors, transient receptor potential vanilloid one (TRPV1) receptor and the orphan G protein receptor fifty-five (GPR55). Studies using C57BL/10 and C57BL/6 (Cnr2(tm1Zim)) CB2 cannabinoid receptor knockout mice have demonstrated an immune-augmenting effect in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis. However, other EAE studies in Biozzi ABH mice often failed to show any treatment effect of either CB2 receptor agonism or antagonism on inhibition of T cell autoimmunity. The influence of genetic background on the induction of EAE in endocannabinoid system-related gene knockout mice was examined. It was found that C57BL/6. GPR55 knockout mice developed less severe disease, notably in female mice, following active induction with myelin oligodendrocyte glycoprotein 35-55 peptide. In contrast C57BL/6. CB2 (Cnr2(Dgen)) receptor knockout mice developed augmented severity of disease consistent with the genetically and pharmacologically-distinct, Cnr2(tm1Zim) mice. However, when the knockout gene was bred into the ABH mouse background and EAE induced with spinal cord autoantigens the immune-enhancing effect of CB2 receptor deletion was lost. Likewise CB1 receptor and transient receptor potential vanilloid one knockout mice on the ABH background demonstrated no alteration in immune-susceptibility, in terms of disease incidence and severity of EAE, in contrast to that reported in some C57BL/6 mouse studies. Furthermore the immune-modulating influence of GPR55 was marginal on the ABH mouse background. Whilst sedative doses of tetrahydrocannabinol could induce immunosuppression, this was associated with a CB1 receptor rather than a CB2 receptor-mediated effect. These data support the fact that non-psychoactive doses of medicinal cannabis have a marginal influence on the immune response in MS. Importantly, it adds a note of caution for the translational value of some transgenic/gene knockout and other studies on low-EAE susceptibility backgrounds with inconsistent disease course and susceptibility.	[Sisay, Sofia; Pryce, Gareth; Jackson, Samuel J.; Michael, Gregory J.; Giovannoni, Gavin; Baker, David] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Tanner, Carolyn; Ross, Ruth A.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Ross, Ruth A.] Univ Toronto, Toronto, ON, Canada; [Selwood, David L.] UCL, Wolfson Inst Biomed Res, London, England	University of London; Queen Mary University London; University of Aberdeen; University of Toronto; University of London; University College London	Baker, D (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England.	david.baker@qmul.ac.uk	Ross, R./AAG-7468-2019	Selwood, David/0000-0002-6817-5064	Multiple Sclerosis Society of Great Britain and Northern Ireland; Wellcome Trust; MRC [MC_PC_13037] Funding Source: UKRI	Multiple Sclerosis Society of Great Britain and Northern Ireland; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Multiple Sclerosis Society of Great Britain and Northern Ireland and The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; AMOR S, 1994, J IMMUNOL, V153, P4349; Amor S, 2005, J NEUROIMMUNOL, V165, P1, DOI 10.1016/j.jneuroim.2005.04.010; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; BAKER D, 1995, J IMMUNOL, V155, P4046; Baker D, 2012, MULT SCLER RELAT DIS, V1, P64, DOI 10.1016/j.msard.2011.11.001; Baker D, 2012, J NEUROIMMUNOL, V242, P78, DOI 10.1016/j.jneuroim.2011.11.003; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; BOLTON C, 2013, INFLAMM RES, P3993; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Croxford JL, 1997, J NEUROIMMUNOL, V74, P205, DOI 10.1016/S0165-5728(96)00219-6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Lago E, 2012, NEUROPHARMACOLOGY, V62, P2299, DOI 10.1016/j.neuropharm.2012.01.030; Delarasse C, 2003, GLIA, P67; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Encinas JA, 1996, J IMMUNOL, V157, P2186; FESTING MFW, 1993, J EXP ANIM SCI, V35, P210; Fillmore PD, 2004, AM J PATHOL, V164, P167, DOI 10.1016/S0002-9440(10)63107-0; Graves RS, 2011, MULT SCLER J, V17, pS431; Hoi PM, 2007, BRIT J PHARMACOL, V152, P751, DOI 10.1038/sj.bjp.0707470; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlsson J, 2003, J IMMUNOL, V170, P1019, DOI 10.4049/jimmunol.170.2.1019; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Katona S, 2005, CLIN EXP IMMUNOL, V140, P580, DOI 10.1111/j.1365-2249.2005.02803.x; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; LEVINE S, 1973, J IMMUNOL, V110, P139; Li K, 2013, PANCREAS, V42, P123, DOI 10.1097/MPA.0b013e318259f6f0; Lou ZY, 2011, MOL IMMUNOL, V49, P453, DOI 10.1016/j.molimm.2011.09.016; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; McHugh Douglas, 2012, J Mol Signal, V7, P10, DOI 10.1186/1750-2187-7-10; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Montero E, 2004, J AUTOIMMUN, V23, P1, DOI 10.1016/j.jaut.2004.05.001; Musumeci G, 2011, NEUROBIOL DIS, V43, P669, DOI 10.1016/j.nbd.2011.05.018; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Okuda Y, 2002, IMMUNOL LETT, V81, P25, DOI 10.1016/S0165-2478(01)00339-X; Olsson LM, 2012, EUR J IMMUNOL, V42, P1969, DOI 10.1002/eji.201242601; ONEILL JK, 1993, J NEUROIMMUNOL, V45, P1, DOI 10.1016/0165-5728(93)90157-T; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; PALTSER G, 2013, MOL MED, DOI DOI 10.2119/M0LMED.2012.00329.PUBMED:23689362; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Shetty A, 2012, NEUROLOGY, V78; Slingsby JH, 1996, IMMUNOGENETICS, V43, P72; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Spach KM, 2009, J IMMUNOL, V182, P1789, DOI 10.4049/jimmunol.0803200; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; TEUSCHER C, 1987, CELL IMMUNOL, V110, P294, DOI 10.1016/0008-8749(87)90124-9; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Webb M, 2008, NEUROSCI LETT, V439, P106, DOI 10.1016/j.neulet.2008.04.090; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wotherspoon G, 2005, NEUROSCIENCE, V135, P235, DOI 10.1016/j.neuroscience.2005.06.009; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Wu FL, 2010, HISTOCHEM CELL BIOL, V133, P313, DOI 10.1007/s00418-009-0673-2; Zajicek JP, 2012, J NEUROL NEUROSUR PS, V83, P1125, DOI 10.1136/jnnp-2012-302468; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8	81	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76907	10.1371/journal.pone.0076907	http://dx.doi.org/10.1371/journal.pone.0076907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130809	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900103
J	Jensen, P; Heimberg, M; Ducray, AD; Widmer, HR; Meyer, M				Jensen, Pia; Heimberg, Michel; Ducray, Angelique D.; Widmer, Hans R.; Meyer, Morten			Expression of Trefoil Factor 1 in the Developing and Adult Rat Ventral Mesencephalon	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; DEVELOPMENTAL CELL-DEATH; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; PS2 GENE; REGULATED PROTEIN; MOUSE ASTROCYTES; TEGMENTAL AREA; 2 PARTS	Trefoil factor 1 (TFF1) belongs to a family of secreted peptides with a characteristic tree-looped trefoil structure. TFFs are mainly expressed in the gastrointestinal tract where they play a critical role in the function of the mucosal barrier. TFF1 has been suggested as a neuropeptide, but not much is known about its expression and function in the central nervous system. We investigated the expression of TFF1 in the developing and adult rat midbrain. In the adult ventral mesencephalon, TFF1-immunoreactive (-ir) cells were predominantly found in the substantia nigra pars compacta (SNc), the ventral tegmental area (VTA) and in periaqueductal areas. While around 90% of the TFF1-ir cells in the SNc co-expressed tyrosine hydroxylase (TH), only a subpopulation of the TH-ir neurons expressed TFF1. Some TFF1-ir cells in the SNc co-expressed the calcium-binding proteins calbindin or calretinin and nearly all were NeuN-ir confirming a neuronal phenotype, which was supported by lack of co-localization with the astroglial marker glial fibrillary acidic protein (GFAP). Interestingly, at postnatal (P) day 7 and P14, a significantly higher proportion of TH-ir neurons in the SNc co-expressed TFF1 as compared to P21. In contrast, the proportion of TFF1-ir cells expressing TH remained unchanged during postnatal development. Furthermore, significantly more TH-ir neurons expressed TFF1 in the SNc, compared to the VTA at all four time-points investigated. Injection of the tracer fluorogold into the striatum of adult rats resulted in retrograde labeling of several TFF1 expressing cells in the SNc showing that a significant fraction of the TFF1-ir cells were projection neurons. This was also reflected by unilateral loss of TFF1-ir cells in SNc of 6-hydroxylase-lesioned hemiparkinsonian rats. In conclusion, we show for the first time that distinct subpopulations of midbrain dopaminergic neurons express TFF1, and that this expression pattern is altered in a rat model of Parkinson's disease.	[Jensen, Pia; Meyer, Morten] Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, Odense, Denmark; [Jensen, Pia; Heimberg, Michel; Ducray, Angelique D.; Widmer, Hans R.] Univ Bern, Dept Neurosurg, Bern, Switzerland	University of Southern Denmark; University of Bern	Meyer, M (corresponding author), Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, Odense, Denmark.	mmeyer@health.sdu.dk	Widmer, Hans Rudolf/O-5172-2017; Widmer, Hans R./AAC-8948-2022	Widmer, Hans Rudolf/0000-0003-3378-8765; 	Danish Parkinson Association; Danish Medical Research Council [271-07-0582]; Danish Centre for Stem Cell Research; Horslev Fonden; IMK Almene Fond; Familien Hede Nielsens Fond; Augustinus Fonden; Fonden til Laegevidenskabens Fremme; Laegeforeningens Forskningsfond; Swiss National Science Foundation [3100A0-112529, 31003A_135565]	Danish Parkinson Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Stem Cell Research; Horslev Fonden; IMK Almene Fond; Familien Hede Nielsens Fond; Augustinus Fonden; Fonden til Laegevidenskabens Fremme; Laegeforeningens Forskningsfond; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Danish Parkinson Association, the Danish Medical Research Council (J. No. 271-07-0582), the Danish Centre for Stem Cell Research (www.dasc.dk), Horslev Fonden, IMK Almene Fond, Familien Hede Nielsens Fond, Augustinus Fonden, Fonden til Laegevidenskabens Fremme, Laegeforeningens Forskningsfond and the Swiss National Science Foundation (Contract No. 3100A0-112529 and 31003A_135565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlfahelKakunda A, 1997, DEV BRAIN RES, V103, P9, DOI 10.1016/S0165-3806(97)00101-6; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Baydyuk M, 2013, J NEUROSCI, V33, P3363, DOI 10.1523/JNEUROSCI.3687-12.2013; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; GERFEN CR, 1987, J NEUROSCI, V7, P3915; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; Hinz M, 2004, PEPTIDES, V25, P827, DOI 10.1016/j.peptides.2004.01.020; HIROTA M, 1994, BIOCHEM MOL BIOL INT, V33, P515; HIROTA M, 1994, NEUROSCI LETT, V171, P49, DOI 10.1016/0304-3940(94)90601-7; HIROTA M, 1995, BIOCHEM MOL BIOL INT, V35, P1079; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Kanai M, 1998, P NATL ACAD SCI USA, V95, P178, DOI 10.1073/pnas.95.1.178; Kim BG, 2000, BRAIN RES, V855, P162, DOI 10.1016/S0006-8993(99)02374-4; Kozicz T, 2011, J COMP NEUROL, V519, P1413, DOI 10.1002/cne.22580; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LAUDER JM, 1974, J COMP NEUROL, V155, P469, DOI 10.1002/cne.901550407; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1; Meyer M, 1999, CELL TRANSPLANT, V8, P25, DOI 10.1177/096368979900800112; Meyer M, 1998, EXP BRAIN RES, V119, P345, DOI 10.1007/s002210050350; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Oo TF, 1997, DEV BRAIN RES, V98, P191, DOI 10.1016/S0165-3806(96)00173-3; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Sautter J, 1997, EXP BRAIN RES, V117, P111, DOI 10.1007/s002210050204; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A	46	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76592	10.1371/journal.pone.0076592	http://dx.doi.org/10.1371/journal.pone.0076592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116124	Green Published, gold			2022-12-25	WOS:000325501300070
J	Friend, SF; Peterson, LK; Treacy, E; Stefanski, AL; Sosinowski, T; Pennock, ND; Berger, AJ; Winn, VD; Dragone, LL				Friend, Samantha F.; Peterson, Lisa K.; Treacy, Eric; Stefanski, Adrianne L.; Sosinowski, Tomasz; Pennock, Nathan D.; Berger, Allison J.; Winn, Virginia D.; Dragone, Leonard L.			The Discovery of a Reciprocal Relationship between Tyrosine-Kinase Signaling and Cullin Neddylation	PLOS ONE			English	Article							UBIQUITIN LIGASE; T-CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; C-CBL; COMPLEX; EXPRESSION; INHIBITOR; NEDD8; TRANSDUCTION	While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood. Using the investigational NEDD8 activating enzyme (NAE) inhibitor, MLN4924, we found that neddylation negatively regulates T cell receptor (TCR) signaling, as its inhibition increases IL-2 production, T cell proliferation and Treg development in vitro. We also discovered that loss of CUL neddylation occurs upon TCR signaling, and CRLs negatively regulate IL-2 production. Additionally, we found that tyrosine kinase signaling leads to CUL deneddylation in multiple cell types. These studies indicate that CUL neddylation is a global regulatory mechanism for tyrosine kinase signaling.	[Friend, Samantha F.; Peterson, Lisa K.; Treacy, Eric; Dragone, Leonard L.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80202 USA; [Friend, Samantha F.; Peterson, Lisa K.; Sosinowski, Tomasz; Pennock, Nathan D.; Dragone, Leonard L.] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO USA; [Friend, Samantha F.; Peterson, Lisa K.; Sosinowski, Tomasz; Pennock, Nathan D.; Dragone, Leonard L.] Natl Jewish Hlth, Denver, CO USA; [Stefanski, Adrianne L.; Winn, Virginia D.] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Sosinowski, Tomasz] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Sch Med, Aurora, CO USA; [Berger, Allison J.] Millennium Pharmaceut Inc, Cambridge, MA USA; [Dragone, Leonard L.] Colorado Childrens Hosp, Div Rheumatol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Children's Hospital Colorado	Dragone, LL (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80202 USA.	dragonel@njhealth.org	Pennock, Nathan/G-2464-2017	Pennock, Nathan/0000-0001-5374-7843; Friend, Samantha/0000-0002-2936-5041; Winn, Virginia/0000-0003-1136-2907	National Institutes of Health (NIH) T32 grant [AI07405]; Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship; NIH R21 grant [AI097572]; Rheumatology Research Foundation from the American College of Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405, R21AI097572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Institutes of Health (NIH) T32 grant; Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship; NIH R21 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation from the American College of Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) T32 grant AI07405 (S.F.F.), an Easton M. Crawford Charitable Lead Unitrust Postdoctoral Fellowship (L.K.P.), an NIH R21 grant AI097572 (L.L.D, S.F.F, E.T.) and a Rheumatology Research Foundation (http://www.rheumatology.org/foundation/) from the American College of Rheumatology (L.L.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Aubrecht J, 2011, DRUG CHEM TOXICOL, V34, P433, DOI 10.3109/01480545.2010.544316; Balachandran P, 2007, J CLIN INVEST, V117, P419, DOI 10.1172/JCI28792; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Dragone LL, 2006, P NATL ACAD SCI USA, V103, P18202, DOI 10.1073/pnas.0608965103; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; GLIMCHER LH, 1985, J IMMUNOL, V135, P3542; Jin H-S, 2012, P NATL ACAD SCI; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kawaida R, 2005, GENES IMMUN, V6, P194, DOI 10.1038/sj.gene.6364177; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Locke NR, 2009, J IMMUNOL, V183, P975, DOI 10.4049/jimmunol.0803749; MacManus CF, 2011, FASEB J; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mikalsen SO, 1998, J BIOL CHEM, V273, P10036, DOI 10.1074/jbc.273.16.10036; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Peterson LK, 2011, J IMMUNOL, V186, P2273, DOI 10.4049/jimmunol.1003601; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2012, IMMUNOL CELL BIOL, V90, P277, DOI 10.1038/icb.2012.4; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; van der Heijden JW, 2009, CLIN EXP RHEUMATOL, V27, P92; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75200	10.1371/journal.pone.0075200	http://dx.doi.org/10.1371/journal.pone.0075200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124476	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100033
J	Gong, XP; Liu, J; Dong, P; Zhang, PD; Li, N; Zhao, XQ; Wang, YJ				Gong, Xiping; Liu, Jia; Dong, Pei; Zhang, Pandeng; Li, Na; Zhao, Xingquan; Wang, Yongjun			Assessment of Dynamic Cerebral Autoregulation in Patients with Basilar Artery Stenosis	PLOS ONE			English	Article							IMPAIRED CEREBROVASCULAR AUTOREGULATION; BLOOD-PRESSURE; TRANSCRANIAL DOPPLER; CAROTID STENOSIS; OCCLUSION; HUMANS; CORTEX; STROKE; RISK	Background and Aims: Previous studies have shown impaired cerebral autoregulation (CA) in carotid and middle cerebral artery (MCA) stenosis/occlusion. Little is known about CA in patients with basilar artery (BA) stenosis. We therefore investigated dynamic CA patterns in BA stenosis using transfer function analysis (TFA). Methods: We measured spontaneous oscillations of blood flow velocity (CBFV) in the right posterior cerebral artery (PCA), and left MCA and mean arterial pressure (ABP) continuously in 25 patients with BA stenosis (moderate n=16 with 50-69% occlusion and severe n=9 with >= 70% occlusion) and 22 healthy volunteers in supine position during 6 circles per minute deep breath. Analysis was based on the 'black-box' model of transfer function deriving phase and gain in both PCA and MCA. Results: Though changes of phase shift and gain between the patients and healthy controls were observed in MCA, the differences are however not significant. Phase shift in PCA was significantly decreased in severe stenosis when comparing with healthy controls and moderate stenosis (4.2 +/- 34.2 degrees VS 41.1 +/- 40.4 degrees, 4.2 +/- 34.2 degrees VS 34.2 +/- 27.2 degrees, both p<0.05), whilst the gain in PCA is increased for moderate BA stenosis and decreased for severe BA stenosis. Furthermore, we found that phase shift were almost abolished in patients with ischemic stroke who developed unfavorable clinical outcome (mRs>2) on the 90 days after stroke onset. Conclusion: Dynamic CA in PCA reduces in patients with severe BA stenosis and those with ischemic stroke who present poor outcome in 90 days after stroke onset. Phase shift might be a sensitive index prompting impaired CA in posterior circulation.	[Gong, Xiping; Dong, Pei; Li, Na; Zhao, Xingquan; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Liu, Jia; Zhang, Pandeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Liu, J (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	Jia.liu@siat.ac.cn; yongjunwang1962@gmail.com			Beijing Municipal Science & Technology Commission [D111107003111007]; National Natural Science Foundation of China [81000644]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by Beijing Municipal Science & Technology Commission (No. D111107003111007) and Dr. Jia Liu's work is supported by National Natural Science Foundation of China (No. 81000644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Blaser T, 2002, STROKE, V33, P1057, DOI 10.1161/01.STR.0000013671.70986.39; BrantZawadzki M, 1997, AM J NEURORADIOL, V18, P1820; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Endo A, 2012, PEDIATR EMERG CARE, V28, P153, DOI 10.1097/PEC.0b013e3182442fe8; Haubrich C, 2004, STROKE, V35, P848, DOI 10.1161/01.STR.0000120729.99039.B6; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Marquardt L, 2009, BRAIN, V132, P982, DOI 10.1093/brain/awp026; Nakagawa K, 2009, STROKE, V40, P2062, DOI 10.1161/STROKEAHA.108.545285; Oehm E, 2006, CEREBROVASC DIS, V22, P204, DOI 10.1159/000093810; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Reinhard M, 2001, NEUROL RES, V23, P55, DOI 10.1179/016164101101198299; Rosengarten B, 2002, CEREBROVASC DIS, V13, P21, DOI 10.1159/000047741; Tang SC, 2008, J VASC SURG, V48, P88, DOI 10.1016/j.jvs.2008.02.025; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	25	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77802	10.1371/journal.pone.0077802	http://dx.doi.org/10.1371/journal.pone.0077802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124620	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100178
J	Jiang, H; Wang, H; Xu, LQ; Hu, GY; Ma, JY; Xiao, P; Fan, WX; Di, DD; Tian, GZ; Fan, MG; Mi, JC; Yu, RP; Song, LT; Zhao, HY; Piao, DR; Cui, BY				Jiang, Hai; Wang, Heng; Xu, Liqing; Hu, Guiying; Ma, Junying; Xiao, Pei; Fan, Weixing; Di, Dongdong; Tian, Guozhong; Fan, Mengguang; Mi, Jingchuan; Yu, Ruiping; Song, Litao; Zhao, Hongyan; Piao, Dongri; Cui, Buyun			MLVA Genotyping of Brucella melitensis and Brucella abortus Isolates from Different Animal Species and Humans and Identification of Brucella suis Vaccine Strain S2 from Cattle in China	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; REV-1 VACCINE; ASSAY; PCR; POLYMORPHISM; DIVERSITY; INFECTION; GOATS; GENE	In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3) is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals were analyzed and compared by multi-locus variable-number tandem-repeat analysis (MLVA). Among the B. melitensis isolates, the majority (74/82) belonged to MLVA8 genotype 42, clustering in the 'East Mediterranean' group. Two B. melitensis biovar 1 genotype 47 isolates, belonging to the 'Americas' group, were recovered; both were from the Himalayan blue sheep (Pseudois nayaur, a wild animal). The majority of B. abortus isolates (51/70) were biovar 3, genotype 36. Ten B. suis biovar 1 field isolates, including seven outbreak isolates recovered from a cattle farm in Inner Mongolia, were genetically indistinguishable from the vaccine strain S2, based on MLVA cluster analysis. MLVA analysis provided important information for epidemiological trace-back. To the best of our knowledge, this is the first report to associate Brucella cross-infection with the vaccine strain S2 based on molecular comparison of recovered isolates to the vaccine strain. MLVA typing could be an essential assay to improve brucellosis surveillance and control programs.	[Jiang, Hai; Xiao, Pei; Tian, Guozhong; Zhao, Hongyan; Piao, Dongri; Cui, Buyun] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Wang, Heng] Hangzhou Ctr Dis Control & Prevent, Lab Endem & Parasit Dis Control & Prevent, Hangzhou, Peoples R China; [Xu, Liqing; Hu, Guiying; Ma, Junying] Qinghai Inst Endem Dis Prevent & Control, Lab Brucellosis, Xining, Peoples R China; [Fan, Weixing; Di, Dongdong] MOA, China Anim Hlth & Epidemiol Ctr, Lab Zoonoses, Qingdao, Peoples R China; [Fan, Mengguang; Mi, Jingchuan; Yu, Ruiping; Song, Litao] Inner Mongolia Ctr Endem Dis Control & Res, Dept Brucellosis, Hohhot, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; China Animal Health & Epidemiology Center	Cui, BY (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	cuibuyun@icdc.cn		Xiao, Pei/0000-0001-9976-7655	National Nature Science Foundation [81271900]; National Key Program for Infectious Diseases of China [2013ZX10004221, 2014ZX10004003]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This study was funded by the National Nature Science Foundation (81271900), National Key Program for Infectious Diseases of China (2013ZX10004221, 2014ZX10004003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton G. G., 1975, Laboratory techniques in brucellosis.; Bardenstein S, 2002, J CLIN MICROBIOL, V40, P1475, DOI 10.1128/JCM.40.2.1475-1480.2002; Berkelman RL, 2003, CLIN INFECT DIS, V37, P407, DOI 10.1086/375595; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Bricker BJ, 2003, J VET DIAGN INVEST, V15, P374, DOI 10.1177/104063870301500413; Cloeckaert A, 2002, VACCINE, V20, P2546, DOI 10.1016/S0264-410X(02)00159-7; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; DAVIS DS, 1991, J WILDLIFE DIS, V27, P258, DOI 10.7589/0090-3558-27.2.258; ELBERG SS, 1957, J BACTERIOL, V73, P211, DOI 10.1128/JB.73.2.211-217.1957; Ferreira AC, 2012, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0042514; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garcia-Yoldi D, 2007, VACCINE, V25, P2858, DOI 10.1016/j.vaccine.2006.09.063; Gopaul KK, 2010, J CLIN MICROBIOL, V48, P1461, DOI 10.1128/JCM.02193-09; GRAVES RR, 1943, J AM VET MED ASSOC, V102, P193; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2012, VET MICROBIOL, V154, P419, DOI 10.1016/j.vetmic.2011.07.014; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kang SI, 2011, J VET MED SCI, V73, P779, DOI 10.1292/jvms.10-0334; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; THOMAS EL, 1981, VET REC, V108, P90, DOI 10.1136/vr.108.5.90; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Van Metre DC, 1999, J AM VET MED ASSOC, V215, P1491; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Zhang WY, 2010, EMERG INFECT DIS, V16, P2001, DOI 10.3201/eid1612.091081	35	32	43	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76332	10.1371/journal.pone.0076332	http://dx.doi.org/10.1371/journal.pone.0076332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124546	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100103
J	Lan, XZ; Chang, K; Zeng, LJ; Liu, XQ; Qiu, F; Zheng, WL; Quan, H; Liao, ZH; Chen, M; Huang, WL; Liu, WH; Wang, Q				Lan, Xiaozhong; Chang, Kai; Zeng, Lingjiang; Liu, Xiaoqiang; Qiu, Fei; Zheng, Weilie; Quan, Hong; Liao, Zhihua; Chen, Min; Huang, Wenlin; Liu, Wanhong; Wang, Qiang			Engineering Salidroside Biosynthetic Pathway in Hairy Root Cultures of Rhodiola crenulata Based on Metabolic Characterization of Tyrosine Decarboxylase	PLOS ONE			English	Article							ATROPA-BELLADONNA; OVEREXPRESSING PMT; GENE-EXPRESSION; PLANTS; ALKALOIDS; JASMONATE; ROSEA	Tyrosine decarboxylase initializes salidroside biosynthesis. Metabolic characterization of tyrosine decarboxylase gene from Rhodiola crenulata (RcTYDC) revealed that it played an important role in salidroside biosynthesis. Recombinant 53 kDa RcTYDC converted tyrosine into tyramine. RcTYDC gene expression was induced coordinately with the expression of RcUDPGT (the last gene involved in salidroside biosynthesis) in SA/MeJA treatment; the expression of RcTYDC and RcUDPGT was dramatically upregulated by SA, respectively 49 folds and 36 folds compared with control. MeJA also significantly increased the expression of RcTYDC and RcUDPGT in hairy root cultures. The tissue profile of RcTYDC and RcUDPGT was highly similar: highest expression levels found in stems, higher expression levels in leaves than in flowers and roots. The gene expressing levels were consistent with the salidroside accumulation levels. This strongly suggested that RcTYDC played an important role in salidroside biosynthesis in R. crenulata. Finally, RcTYDC was used to engineering salidroside biosynthetic pathway in R. crenulata hairy roots via metabolic engineering strategy of overexpression. All the transgenic lines showed much higher expression levels of RcTYDC than non-transgenic one. The transgenic lines produced tyramine, tyrosol and salidroside at higher levels, which were respectively 3.21-6.84, 1.50-2.19 and 1.27-3.47 folds compared with the corresponding compound in non-transgenic lines. In conclusion, RcTYDC overexpression promoted tyramine biosynthesis that facilitated more metabolic flux flowing toward the downstream pathway and as a result, the intermediate tyrosol was accumulated more that led to the increased production of the end-product salidroside.	[Lan, Xiaozhong; Zheng, Weilie; Quan, Hong] Tibet Univ, Agr & Anim Husb Coll, Nyingchi Of Tibet, Peoples R China; [Lan, Xiaozhong; Chang, Kai; Zeng, Lingjiang; Liu, Xiaoqiang; Qiu, Fei; Liao, Zhihua; Huang, Wenlin] Southwest Univ, Chongqing Engn & Technol Res Ctr Sweetpotato, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Chen, Min] Southwest Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China; [Liu, Wanhong] Chongqing Univ Sci & Technol, Sch Chem & Chem Engn, Chongqing, Peoples R China; [Wang, Qiang] Minist Sci & Technol, China Rural Technol Dev Ctr, Beijing, Peoples R China	Tibet University; Southwest University - China; Southwest University - China; Chongqing University of Science & Technology	Liao, ZH (corresponding author), Southwest Univ, Chongqing Engn & Technol Res Ctr Sweetpotato, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.	zhliao@swu.edu.cn; mminchen@163.com			Natural Science Foundation Project of Chongqing [2010BB5296]; NSFC Project [31070266]; National Science & Technology Pillar Program [2011BAI13B06]; Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine) [20120716-540000]; Tibet Science and Technology Funding	Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); NSFC Project(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine); Tibet Science and Technology Funding	The research was financially supported by the Natural Science Foundation Project of Chongqing (2010BB5296), the NSFC Project (31070266), the National Science & Technology Pillar Program (2011BAI13B06), Tibet Medicinal Resources Investigation Project (State Administration of Chinese Traditional Medicine 20120716-540000) and Tibet Science and Technology Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartley GE, 2010, NEW BIOTECHNOL, V27, P308, DOI 10.1016/j.nbt.2010.04.003; Chan SW, 2012, INT J FOOD SCI NUTR, V63, P75, DOI 10.3109/09637486.2011.627840; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; FACCHINI PJ, 1994, J BIOL CHEM, V269, P26684; Gauger KJ, 2010, J MED PLANTS RES, V4, P446; Gyorgy Z, 2009, J PLANT PHYSIOL, V166, P1581, DOI 10.1016/j.jplph.2009.03.016; Imanishi S, 1998, PLANT MOL BIOL, V38, P1101, DOI 10.1023/A:1006058700949; Islas-Flores I, 2002, MOL BIOTECHNOL, V21, P211, DOI 10.1385/MB:21:3:211; Kai GY, 2011, METAB ENG, V13, P319, DOI 10.1016/j.ymben.2011.02.003; Landtag J, 2002, PHYTOCHEMISTRY, V60, P683, DOI 10.1016/S0031-9422(02)00161-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Liu WH, 2012, PLANTA, V236, P239, DOI 10.1007/s00425-012-1608-z; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Mao Y, 2007, J PHARMACEUT BIOMED, V45, P510, DOI 10.1016/j.jpba.2007.05.031; Memelink J, 2001, TRENDS PLANT SCI, V6, P212, DOI 10.1016/S1360-1385(01)01924-0; Pasquali G, 2006, J BIOSCI BIOENG, V101, P287, DOI 10.1263/jbb.101.287; Qu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029641; SIMONSARKADI L, 1994, J FOOD BIOCHEM, V17, P407, DOI 10.1111/j.1745-4514.1993.tb00483.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang XR, 2011, PHYSIOL PLANTARUM, V143, P309, DOI 10.1111/j.1399-3054.2011.01506.x; Yang CX, 2011, PLANT OMICS, V4, P29; Yang YN, 2012, J AGR FOOD CHEM, V60, P964, DOI 10.1021/jf204660c; Yu HS, 2011, PHYTOCHEMISTRY, V72, P862, DOI 10.1016/j.phytochem.2011.03.020; YUN DJ, 1992, P NATL ACAD SCI USA, V89, P11799, DOI 10.1073/pnas.89.24.11799; Zhao Y, 2012, APPL BIOCHEM BIOTECH, V166, P1480, DOI 10.1007/s12010-012-9542-x; Zhou XF, 2007, BIOL PHARM BULL, V30, P439, DOI 10.1248/bpb.30.439	28	39	48	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75459	10.1371/journal.pone.0075459	http://dx.doi.org/10.1371/journal.pone.0075459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124492	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100049
J	Nakamura, T; Otsuka, S; Ichii, O; Sakata, Y; Nagasaki, KI; Hashimoto, Y; Kon, Y				Nakamura, Teppei; Otsuka, Saori; Ichii, Osamu; Sakata, Yuko; Nagasaki, Ken-Ichi; Hashimoto, Yoshiharu; Kon, Yasuhiro			Relationship between Numerous Mast Cells and Early Follicular Development in Neonatal MRL/MpJ Mouse Ovaries	PLOS ONE			English	Article							METAPHASE-SPECIFIC APOPTOSIS; MURINE MODEL; MRL; TISSUE; DEATH; MICE; TNF; EXPRESSION; SPERMATOCYTES; ANGIOGENESIS	In the neonatal mouse ovary, clusters of oocytes called nests break into smaller cysts and subsequently form individual follicles. During this period, we found numerous mast cells in the ovary of MRL/MpJ mice and investigated their appearance and morphology with follicular development. The ovarian mast cells, which were already present at postnatal day 0, tended to localize adjacent to the surface epithelium. Among 11 different mouse strains, MRL/MpJ mice possessed the greatest number of ovarian mast cells. Ovarian mast cells were also found in DBA/1, BALB/c, NZW, and DBA/2 mice but rarely in C57BL/6, NZB, AKR, C3H/He, CBA, and ICR mice. The ovarian mast cells expressed connective tissue mast cell markers, although mast cells around the surface epithelium also expressed a mucosal mast cell marker in MRL/MpJ mice. Some ovarian mast cells migrated into the oocyte nests and directly contacted the compressed and degenerated oocytes. In MRL/MpJ mice, the number of oocytes in the nest was significantly lower than in the other strains, and the number of oocytes showed a positive correlation with the number of ovarian mast cells. The gene expression of a mast cell marker also correlated with the expression of an oocyte nest marker, suggesting a link between the appearance of ovarian ? 4mast cells and early follicular development. Furthermore, the expression of follicle developmental markers was significantly higher in MRL/MpJ mice than in C57BL/6 mice. These results indicate that the appearance of ovarian mast cells is a unique phenotype of neonatal MRL/MpJ mice, and that ovarian mast cells participate in early follicular development, especially nest breakdown.	[Nakamura, Teppei; Otsuka, Saori; Ichii, Osamu; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Nakamura, Teppei; Sakata, Yuko; Nagasaki, Ken-Ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Japan; [Hashimoto, Yoshiharu] Hokkaido Univ, Off Fac Dev & Teaching Enriched Vet Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kon, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp		Kon, Yasuhiro/0000-0002-8859-6122; NAKAMURA, Teppei/0000-0003-3204-0245	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380156]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	These studies were supported by a Grant-in-Aid for Scientific Research B (No. 24380156) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; CAVENDER JL, 1988, BIOL REPROD, V39, P989, DOI 10.1095/biolreprod39.4.989; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; De Felici M, 2008, AUTOPHAGY, V4, P240, DOI 10.4161/auto.5410; De Pol A, 1997, HUM REPROD, V12, P2235, DOI 10.1093/humrep/12.10.2235; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GAYTAN F, 1991, BIOL REPROD, V45, P27, DOI 10.1095/biolreprod45.1.27; Greenfeld CR, 2007, BIOL REPROD, V76, P224, DOI 10.1095/biolreprod.106.055509; Gurish MF, 1997, BLOOD, V90, P382; Heikkilae HM, 2008, ARTERIOSCL THROM VAS, V28, P309, DOI 10.1161/ATVBAHA.107.151340; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Kon Y, 2000, ANAT HISTOL EMBRYOL, V29, P313, DOI 10.1046/j.1439-0264.2000.00279.x; Kon Y, 2007, ANAT HISTOL EMBRYOL, V36, P172, DOI 10.1111/j.1439-0264.2006.00728.x; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2&lt;216::AID-MRD11&gt;3.0.CO;2-C; KRISHNA A, 1989, J ENDOCRINOL, V120, P363, DOI 10.1677/joe.0.1200363; Latti S, 2003, J CELL PHYSIOL, V195, P130, DOI 10.1002/jcp.10235; Lee S, 2010, MAMM GENOME, V21, P162, DOI 10.1007/s00335-010-9254-x; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lobascio AM, 2007, REPRODUCTION, V134, P241, DOI 10.1530/REP-07-0141; Marcinkiewicz JL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1997, DOI 10.2741/marcin; Namiki Y, 2005, MAMM GENOME, V16, P96, DOI 10.1007/s00335-004-2424-y; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; NORMAN RJ, 1994, J ENDOCRINOL, V140, P333, DOI 10.1677/joe.0.1400333; Nose M, 2000, INT J CARDIOL, V75, pS53, DOI 10.1016/S0167-5273(00)00191-1; Otsuka S, 2008, JPN J VET RES, V56, P129; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Otsuka S, 2012, MAMM GENOME, V23, P741, DOI 10.1007/s00335-012-9405-3; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Ramirez RA, 2012, DEV DYNAM, V241, P890, DOI 10.1002/dvdy.23778; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rudolph MI, 2004, BIOCELL, V28, P1; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SKALKO RG, 1968, ANAT REC, V161, P459, DOI 10.1002/ar.1091610407; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yu HR, 2005, MAMM GENOME, V16, P918, DOI 10.1007/s00335-005-0077-0	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77246	10.1371/journal.pone.0077246	http://dx.doi.org/10.1371/journal.pone.0077246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124609	gold, Green Published			2022-12-25	WOS:000325489100166
J	Pereboeva, L; Westin, E; Patel, T; Flaniken, I; Lamb, L; Klingelhutz, A; Goldman, F				Pereboeva, Larisa; Westin, Erik; Patel, Toral; Flaniken, Ian; Lamb, Lawrence; Klingelhutz, Aloysius; Goldman, Frederick			DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; FANCONI-ANEMIA; N-ACETYLCYSTEINE; TELOMERE LENGTH; UNRELATED DONOR; STEM-CELLS; FIBROBLASTS; SENESCENCE; P53; KERATINOCYTES	Dyskeratosis congenita (DC) is an inherited multisystem disorder of premature aging, cancer predisposition, and bone marrow failure caused by selective exhaustion of highly proliferative cell pools. DC patients also have a poor tolerance to chemo/radiotherapy and bone marrow transplantation. Although critically shortened telomeres and defective telomere maintenance contribute to DC pathology, other mechanisms likely exist. We investigate the link between telomere dysfunction and oxidative and DNA damage response pathways and assess the effects of antioxidants. In vitro studies employed T lymphocytes from DC subjects with a hTERC mutation and age-matched controls. Cells were treated with cytotoxic agents, including Paclitaxel, Etoposide, or ionizing radiation. Apoptosis and reactive oxygen species (ROS) were assessed by flow cytometry, and Western blotting was used to measure expression of DNA damage response (DDR) proteins, including total p53, p53S15, and p21(WAF). N-acetyl-cysteine (NAC), an antioxidant, was used to modulate cell growth and ROS. In stimulated culture, DC lymphocytes displayed a stressed phenotype, characterized by elevated levels of ROS, DDR and apoptotic markers as well as a proliferative defect that was more pronounced after exposure to cytotoxic agents. NAC partially ameliorated the growth disadvantage of DC cells and decreased radiation-induced apoptosis and oxidative stress. These findings suggest that oxidative stress may play a role in the pathogenesis of DC and that pharmacologic intervention to correct this pro-oxidant imbalance may prove useful in the clinical setting, potentially alleviating untoward toxicities associated with current cytotoxic treatments.	[Pereboeva, Larisa; Lamb, Lawrence] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Westin, Erik; Patel, Toral; Flaniken, Ian; Goldman, Frederick] Childrens Hosp Alabama, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA; [Klingelhutz, Aloysius] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Alabama System; University of Alabama Birmingham; University of Iowa	Goldman, F (corresponding author), Childrens Hosp Alabama, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA.	fgoldman@peds.uab.edu	Klingelhutz, Aloysius/L-9081-2018	Klingelhutz, Aloysius/0000-0003-4258-5046	National Institutes of Health [AG0227388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially funded by a National Institutes of Health R01 grant (AG0227388 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ayas M, 2013, BONE MARROW TRANSPLA, DOI 10:1038/bmt2013.35; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Buckingham EM, 2012, AGING DIS, V3, P427; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038/bmt.2010.65; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; DOKAL I, 1992, BLOOD, V80, P3090; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Gazit R, 2008, SEMIN HEMATOL, V45, P218, DOI 10.1053/j.seminhematol.2008.07.010; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Gu BW, 2009, CELL CYCLE, V8, P6, DOI 10.4161/cc.8.1.7265; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Kurre P, 2003, J PEDIAT HEMATOL ONC, V25, P581, DOI 10.1097/00043426-200307000-00019; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Pagano G, 2005, EUR J HAEMATOL, V75, P93, DOI 10.1111/j.1600-0609.2005.00507.x; Pagano G., 2011, BIOL CHEM; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thakar MS, 2011, BONE MARROW TRANSPL, V46, P539, DOI 10.1038/bmt.2010.154; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188	41	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76473	10.1371/journal.pone.0076473	http://dx.doi.org/10.1371/journal.pone.0076473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124565	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100122
J	Aihara, E; Hentz, CL; Korman, AM; Perry, NPJ; Prasad, V; Shull, GE; Montrose, MH				Aihara, Eitaro; Hentz, Courtney L.; Korman, Abraham M.; Perry, Nicholas P. J.; Prasad, Vikram; Shull, Gary E.; Montrose, Marshall H.			In Vivo Epithelial Wound Repair Requires Mobilization of Endogenous Intracellular and Extracellular Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Imaging; Calcium Signaling; Cell Migration; Fluorescence Resonance Energy Transfer (FRET); Fura Red; Yellow Cameleon; Photodamage; Two-photon Microscopy	PLASMA-MEMBRANE CA2+-ATPASE; BICARBONATE SECRETION; ACID-SECRETION; ISOFORM 4; CA2+; MOUSE; CELLS; HOMEOSTASIS; DISRUPTION; TRANSPORT	We report that a localized intracellular and extracellular Ca2+ mobilization occurs at the site of microscopic epithelial damage in vivo and is required to mediate tissue repair. Intravital confocal/two-photon microscopy continuously imaged the surgically exposed stomach mucosa of anesthetized mice while photodamage of gastric epithelial surface cells created a microscopic lesion that healed within 15 min. Transgenic mice with an intracellular Ca2+-sensitive protein (yellow cameleon 3.0) report that intracellular Ca2+ selectively increases in restituting gastric epithelial cells adjacent to the damaged cells. Pretreatment with U-73122, indomethacin, 2-aminoethoxydiphenylborane, or verapamil inhibits repair of the damage and also inhibits the intracellular Ca2+ increase. Confocal imaging of Fura-Red dye in luminal superfusate shows a localized extracellular Ca2+ increase at the gastric surface adjacent to the damage that temporally follows intracellular Ca2+ mobilization. Indomethacin and verapamil also inhibit the luminal Ca2+ increase. Intracellular Ca2+ chelation (1,2-bis(o-aminophenoxy)ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester, BAPTA/AM) fully inhibits intracellular and luminal Ca2+ increases, whereas luminal calcium chelation (N-(2-hydroxyetheyl)-ethylendiamin-N,N,N-triacetic acid trisodium, HEDTA) blocks the increase of luminal Ca2+ and unevenly inhibits late-phase intracellular Ca2+ mobilization. Both modes of Ca2+ chelation slow gastric repair. In plasma membrane Ca-ATPase 1(+/-) mice, but not plasma membrane Ca-ATPase 4(-/-) mice, there is slowed epithelial repair and a diminished gastric surface Ca2+ increase. We conclude that endogenous Ca2+, mobilized by signaling pathways and transmembrane Ca2+ transport, causes increased Ca2+ levels at the epithelial damage site that are essential to gastric epithelial cell restitution in vivo.	[Aihara, Eitaro; Hentz, Courtney L.; Korman, Abraham M.; Perry, Nicholas P. J.; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Prasad, Vikram; Shull, Gary E.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Cincinnati; University of Cincinnati	Montrose, MH (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, ML 0576,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	mhm@uc.edu			National Institutes of Health [RO1-DK-54940, R01-DK050594, P30-DK078392]; University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050594, P30DK078392, R01DK054940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK-54940 (to M. H. M.), R01-DK050594 (to G. E. S.), and P30-DK078392. This work was also supported by university research council funding from the University of Cincinnati (to E. A.).	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; Baumgartner HK, 2002, J PHYSIOL-LONDON, V544, P871, DOI 10.1113/jphysiol.2002.024620; Belkacemi L, 2005, CELL CALCIUM, V37, P1, DOI 10.1016/j.ceca.2004.06.010; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Caroppo R, 2004, J CELL BIOL, V166, P111, DOI 10.1083/jcb.200310145; Caroppo R, 2001, EMBO J, V20, P6316, DOI 10.1093/emboj/20.22.6316; Cheng AM, 2001, AM J PHYSIOL-CELL PH, V281, pC430, DOI 10.1152/ajpcell.2001.281.2.C430; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; CRITCHLOW J, 1985, GASTROENTEROLOGY, V88, P236, DOI 10.1016/S0016-5085(85)80177-3; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; DelValle J, 1996, AM J PHYSIOL-GASTR L, V270, pG897, DOI 10.1152/ajpgi.1996.270.6.G897; Demitrack ES, 2012, GUT, V61, P804, DOI 10.1136/gutjnl-2011-300420; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Dong X, 2009, AM J PHYSIOL-GASTR L, V296, pG424, DOI 10.1152/ajpgi.90314.2008; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; KOO MWL, 1994, PHARMACOL RES, V29, P217, DOI 10.1016/1043-6618(94)80045-6; Lindstrom E, 2001, J PHYSIOL-LONDON, V535, P663, DOI 10.1111/j.1469-7793.2001.00663.x; Liu L, 2006, AM J PHYSIOL-CELL PH, V290, pC1239, DOI 10.1152/ajpcell.00440.2005; Liu L, 2007, AM J PHYSIOL-CELL PH, V292, pC423, DOI 10.1152/ajpcell.00313.2006; Lohr C, 2003, CELL CALCIUM, V34, P295, DOI 10.1016/S0143-4160(03)00105-2; Miller TA, 2001, LIFE SCI, V69, P3091, DOI 10.1016/S0024-3205(01)01415-1; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; NEGULESCU PA, 1993, AM J PHYSIOL, V264, pC843, DOI 10.1152/ajpcell.1993.264.4.C843; Nyqvist D, 2005, J ENDOCRINOL, V186, P333, DOI 10.1677/joe.1.06204; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Peng T, 2008, CARDIOVASC RES, V78, P90, DOI 10.1093/cvr/cvm100; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Ranta-Knuuttila T, 2002, DIGEST DIS SCI, V47, P1008, DOI 10.1023/A:1015025704589; Ray JM, 1997, AM J PHYSIOL-GASTR L, V273, pG281, DOI 10.1152/ajpgi.1997.273.2.G281; Shi TJS, 2008, P NATL ACAD SCI USA, V105, P20004, DOI 10.1073/pnas.0810899105; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Takeuchi K, 1997, GASTROENTEROLOGY, V113, P1553, DOI 10.1053/gast.1997.v113.pm9352857; TAKEUCHI K, 1985, DIGEST DIS SCI, V30, P1072, DOI 10.1007/BF01315605; Takeuchi K, 1999, DIGEST DIS SCI, V44, P515, DOI 10.1023/A:1026645004918; Talarico EF, 2010, MOL VIS, V16, P2259; Tsien Roger Y, 2003, Harvey Lect, V99, P77; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Xue L, 2010, GUT, V59, P1184, DOI 10.1136/gut.2009.205625	43	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33585	33597		10.1074/jbc.M113.488098	http://dx.doi.org/10.1074/jbc.M113.488098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121509	Green Published, hybrid			2022-12-25	WOS:000327250200008
J	Yang, FC; Lin, YH; Chen, WH; Huang, JY; Chang, HY; Su, SH; Wang, HT; Chiang, CY; Hsu, PH; Tsai, MD; Tan, BCM; Lee, SC				Yang, Fu-Chia; Lin, Ya-Huei; Chen, Wei-Hao; Huang, Jing-Yi; Chang, Hsin-Yun; Su, Su-Hui; Wang, Hsiao-Ting; Chiang, Chun-Yi; Hsu, Pang-Hung; Tsai, Ming-Daw; Tan, Bertrand Chin-Ming; Lee, Sheng-Chung			Interaction between Salt-inducible Kinase 2 (SIK2) and p97/Valosin-containing Protein (VCP) Regulates Endoplasmic Reticulum (ER)-associated Protein Degradation in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; ER-associated Degradation; ERAD; Protein Degradation; Unfolded Protein Response; SIK2; p97; VCP	VALOSIN-CONTAINING-PROTEIN; ER-ASSOCIATED DEGRADATION; TYROSINE PHOSPHORYLATION; P97-UFD1-NPL4 COMPLEX; INCREASED EXPRESSION; P97; INVOLVEMENT; PROTEASOME; ATPASE; TRANSCRIPTION	Salt-inducible kinase 2 (SIK2) is an important regulator of cAMP response element-binding protein-mediated gene expression in various cell types and is the only AMP-activated protein kinase family member known to interact with the p97/valosin-containing protein (VCP) ATPase. Previously, we have demonstrated that SIK2 can regulate autophagy when proteasomal function is compromised. Here we report that physical and functional interactions between SIK2 and p97/VCP underlie the regulation of endoplasmic reticulum (ER)-associated protein degradation (ERAD). SIK2 co-localizes with p97/VCP in the ER membrane and stimulates its ATPase activity through direct phosphorylation. Although the expression of wild-type recombinant SIK2 accelerated the degradation and removal of ERAD substrates, the kinase-deficient variant conversely had no effect. Furthermore, down-regulation of endogenous SIK2 or mutation of the SIK2 target site on p97/VCP led to impaired degradation of ERAD substrates and disruption of ER homeostasis. Collectively, these findings highlight a mechanism by which the interplay between SIK2 and p97/VCP contributes to the regulation of ERAD in mammalian cells.	[Yang, Fu-Chia; Lin, Ya-Huei; Chen, Wei-Hao; Huang, Jing-Yi; Chang, Hsin-Yun; Su, Su-Hui; Wang, Hsiao-Ting; Chiang, Chun-Yi; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Lee, Sheng-Chung] Natl Taiwan Univ, Inst Clin Med, Taipei 100, Taiwan; [Hsu, Pang-Hung; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Tsai, Ming-Daw; Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Chang Gung University	Lee, SC (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw	Hsu, Pang-Hung/C-5587-2018; Kisker, Caroline/T-1724-2019	Hsu, Pang-Hung/0000-0001-6873-6434; Tan, Bertrand/0000-0002-2218-7115	National Science Council [NSC96-2321-B-002-008, NSC100-2320-B-002-008, NSC99-2632-B-182-011MY3, NSC101-2320-B-182-036-MY3, NSC102-2321-B-182-007]; National Health Research Institute [NHRI-EX102-9923SC]; Academia Sinica; Institute of Biological Chemistry, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Academia Sinica(Academia Sinica - Taiwan); Institute of Biological Chemistry, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2321-B-002-008andNSC100-2320-B-002-008 (to S.-C. L.) and NSC99-2632-B-182-011MY3, NSC101-2320-B-182-036-MY3, and NSC102-2321-B-182-007(to B.C.-M.T.); National Health Research Institute Grant NHRI-EX102-9923SC; Academia Sinica (to M.-D.T.); and the Institute of Biological Chemistry (to S.-C.L.), Academia Sinica, Taiwan.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Qiu Y, 2007, AM J PATHOL, V170, P152, DOI 10.2353/ajpath.2007.060722; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	61	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33861	33872		10.1074/jbc.M113.492199	http://dx.doi.org/10.1074/jbc.M113.492199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129571	Green Published, hybrid			2022-12-25	WOS:000327250200030
J	Bonnan, MF; Wilhite, DR; Masters, SL; Yates, AM; Gardner, CK; Aguiar, A				Bonnan, Matthew F.; Wilhite, D. Ray; Masters, Simon L.; Yates, Adam M.; Gardner, Christine K.; Aguiar, Adam			What Lies Beneath: Sub-Articular Long Bone Shape Scaling in Eutherian Mammals and Saurischian Dinosaurs Suggests Different Locomotor Adaptations for Gigantism	PLOS ONE			English	Article							KNEE-JOINT; ALLIGATOR-MISSISSIPPIENSIS; GEOMETRIC MORPHOMETRICS; SAUROPOD DINOSAURS; SEXUAL-DIMORPHISM; ANIMAL JOINTS; BODY-SIZE; CARTILAGE; EVOLUTION; THICKNESS	Eutherian mammals and saurischian dinosaurs both evolved lineages of huge terrestrial herbivores. Although significantly more saurischian dinosaurs were giants than eutherians, the long bones of both taxa scale similarly and suggest that locomotion was dynamically similar. However, articular cartilage is thin in eutherian mammals but thick in saurischian dinosaurs, differences that could have contributed to, or limited, how frequently gigantism evolved. Therefore, we tested the hypothesis that sub-articular bone, which supports the articular cartilage, changes shape in different ways between terrestrial mammals and dinosaurs with increasing size. Our sample consisted of giant mammal and reptile taxa (i.e., elephants, rhinos, sauropods) plus erect and non-erect outgroups with thin and thick articular cartilage. Our results show that eutherian mammal sub-articular shape becomes narrow with well-defined surface features as size increases. In contrast, this region in saurischian dinosaurs expands and remains gently convex with increasing size. Similar trends were observed in non-erect outgroup taxa (monotremes, alligators), showing that the trends we report are posture-independent. These differences support our hypothesis that sub-articular shape scales differently between eutherian mammals and saurischian dinosaurs. Our results show that articular cartilage thickness and sub-articular shape are correlated. In mammals, joints become ever more congruent and thinner with increasing size, whereas archosaur joints remained both congruent and thick, especially in sauropods. We suggest that gigantism occurs less frequently in mammals, in part, because joints composed of thin articular cartilage can only become so congruent before stress cannot be effectively alleviated. In contrast, frequent gigantism in saurischian dinosaurs may be explained, in part, by joints with thick articular cartilage that can deform across large areas with increasing load.	[Bonnan, Matthew F.; Aguiar, Adam] Richard Stockton Coll New Jersey, Biol Program, Galloway, NJ USA; [Wilhite, D. Ray] Auburn Univ, Sch Vet Med, Auburn, AL 36849 USA; [Masters, Simon L.] Beaumont Sch, Cleveland Hts, OH USA; [Yates, Adam M.] Museum Cent Australia, Alice Springs, NT, Australia; [Gardner, Christine K.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	Auburn University System; Auburn University; Western Illinois University	Bonnan, MF (corresponding author), Richard Stockton Coll New Jersey, Biol Program, Galloway, NJ USA.	Matthew.Bonnan@stockton.edu			College of New Jersey	College of New Jersey	We thank the many institutions and individuals that provided us with access to specimens for this study. Much of the archosaur data was collected for previous studies [14,15,26,31] and the heartfelt thanks and appreciation expressed in those references continues more strongly than ever here. For the present study, we wish to thank the following institutions and staff: AMNH: N. B. Simmons and staff (Mammalogy), J. Meng, J. Galkin, and staff (Fossil Mammals); FMNH: W. Stanley and staff (Mammalogy), K. D. Angielczyk, W. Simpson, and staff (Fossil Mammals); UNMH: R. Irmis, M. Getty, and staff; CLQ: M. Leschin; SAM: A. Chinsamy-Turan and staff; BPI: B. Rubidge and staff. We thank K. Schuenman at WIU for collecting data on felids used in this study. Feedback from G. S. Paul, H. Tsai, and S. Gatesy at the 2012 Society of Vertebrate Paleontology meeting further improved our manuscript. Discussions with J. Shulman at the Richard Stockton College of New Jersey on static physics were helpful. D. Henderson and an anonymous reviewer provided useful comments, critiques, and suggestions on a first draft of this manuscript. We also thank PLoS One editor P. Dodson for shepherding our manuscript through the PLoS system, and his feedback, comments, and suggestions. Finally, we thank the Richard Stockton College of New Jersey for support with publication charges.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Bonnan MF, 2008, J VERTEBR PALEONTOL, V28, P422, DOI 10.1671/0272-4634(2008)28[422:ULAGMT]2.0.CO;2; Bonnan MF, 2007, ANAT REC, V290, P1089, DOI 10.1002/ar.20578; Bonnan MF, 2010, ANAT REC, V293, P2044, DOI 10.1002/ar.21266; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; Carter DR, 2001, SKELETAL FUNCTION FO; Castaneda S, 2011, BIOCHEM PHARMACOL, V83, P315, DOI DOI 10.1016/J.BCP.2011.09.018; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Christiansen Per, 1997, Gaia, V14, P45; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V149, P423; Dilkes DW, 2012, COMPLETE DINOSAUR, V27, P151; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Egger GF, 2008, J MORPHOL, V269, P118, DOI 10.1002/jmor.10600; Farlow J, 1995, ECOLOGY EVOLUTION, V193, P44, DOI [10.1126/science.193.4247.44, DOI 10.1126/SCIENCE.193.4247.44]; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Fortelius M., 2008, ZOOLOGICAL J LINNEAN, V108, P85, DOI [DOI 10.1111/J.1096-3642.1993.TB02560.X, 10.1111/j.1096-3642.1993.tb02560.x.]; Fujiwara S, 2010, J MORPHOL, V271, P883, DOI 10.1002/jmor.10846; FUSS FK, 1994, ANAT REC, V238, P297, DOI 10.1002/ar.1092380303; Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; GRAF J, 1993, INT ORTHOP, V17, P113; Haines RW, 1942, J ANAT, V76, P270; Hassell EMA, 2012, ECOL EVOL, V2, P1738, DOI 10.1002/ece3.278; Hildebrand M., 1995, ANAL VERTEBRATE STRU; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; HOSHINO A, 1987, J BONE JOINT SURG BR, V69, P807, DOI 10.1302/0301-620X.69B5.3680348; JENKINS FA, 1973, AM J ANAT, V137, P281, DOI 10.1002/aja.1001370304; Ji YN, 2011, ACTA GEOL SIN-ENGL, V85, P58, DOI 10.1111/j.1755-6724.2011.00378.x; Kovachev Dimitar, 2006, Geologica Balcanica, V35, P5; Liem KF., 2001, FUNCTIONAL ANATOMY V; Malda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057683; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Neraudeau D, 2012, CRETACEOUS RES, V37, P1, DOI 10.1016/j.cretres.2012.01.006; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Prothero D. R., 2002, HORNS TUSKS FLIPPERS; Prothero D. R., 2013, RHINOCEROS GIANTS PA; PROTHERO DR, 1982, PALEOBIOLOGY, V8, P16, DOI 10.1017/S0094837300004322; Rohlf J, 2012, THIN PLATE SPLINES P; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Shoshani Jeheskel, 1996, P9; SIMON WH, 1973, J BONE JOINT SURG AM, VA 55, P1614, DOI 10.2106/00004623-197355080-00004; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; SIMON WH, 1971, ARTHRITIS RHEUM, V14, P493, DOI 10.1002/art.1780140409; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Snover M.L., 2007, BIOL TURTLES, P17; Tidwell V, 2005, LIFE O PAST, P187; Tsai HP, 2012, J VERTEBR PALEONTOL, V32, P184; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vogel S., 2003, COMP BIOMECHANICS LI; Von Huene F, 1929, ANALES MUSEO PLATA, V2, P1; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	66	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75216	10.1371/journal.pone.0075216	http://dx.doi.org/10.1371/journal.pone.0075216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130690	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900022
J	Martinez-Estevez, L; Balvanera, P; Pacheco, J; Ceballos, G				Martinez-Estevez, Lourdes; Balvanera, Patricia; Pacheco, Jesus; Ceballos, Gerardo			Prairie Dog Decline Reduces the Supply of Ecosystem Services and Leads to Desertification of Semiarid Grasslands	PLOS ONE			English	Article							CYNOMYS-LUDOVICIANUS; HABITAT; HETEROGENEITY; DEGRADATION; SYSTEM	Anthropogenic impacts on North American grasslands, a highly endangered ecosystem, have led to declines of prairie dogs, a keystone species, over 98% of their historical range. While impacts of this loss on maintenance of grassland biodiversity have been widely documented, much less is known about the consequences on the supply of ecosystem services. Here we assessed the effect of prairie dogs in the supply of five ecosystem services by comparing grasslands currently occupied by prairie dogs, grasslands devoid of prairie dogs, and areas that used to be occupied by prairie dogs that are currently dominated by mesquite scrub. Groundwater recharge, regulation of soil erosion, regulation of soil productive potential, soil carbon storage and forage availability were consistently quantitatively or qualitatively higher in prairie dog grasslands relative to grasslands or mesquite scrub. Our findings indicate a severe loss of ecosystem services associated to the absence of prairie dogs. These findings suggest that contrary to a much publicize perception, especially in the US, prairie dogs are fundamental in maintaining grasslands and their decline have strong negative impacts in human well - being through the loss of ecosystem services.	[Martinez-Estevez, Lourdes; Pacheco, Jesus; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Balvanera, Patricia] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Mexico City 04510, DF, Mexico; [Balvanera, Patricia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Balvanera, Patricia] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Stanford University; Columbia University	Martinez-Estevez, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	mariadelourdes_martinez@yahoo.com.mx		Ceballos, Gerardo/0000-0001-8374-2656	National Council of Science and Technology (CONACyT) [83773]; J.M. Kaplan Fund; Whitley Fund for Nature; Fundacion Slim; International and Borderlands Program of the Arizona Game and Fish Department; National Council of Science and Technology (CONACyT)	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); J.M. Kaplan Fund; Whitley Fund for Nature; Fundacion Slim; International and Borderlands Program of the Arizona Game and Fish Department; National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors' work in the Janos region has been supported by many institutions. They are particularly grateful to the National Council of Science and Technology (CONACyT) through the project 83773, the J.M. Kaplan Fund, the Whitley Fund for Nature, the Fundacion Slim, and the International and Borderlands Program of the Arizona Game and Fish Department. LME was supported by a scholarship by the National Council of Science and Technology (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2006, J TORREY BOT SOC, V133, P626, DOI 10.3159/1095-5674(2006)133[626:EAOOTC]2.0.CO;2; [Anonymous], 1996, PRAIRIE CONSERVATION; Archer S., 2000, GLOBAL BIOGEOCHEMICA, P1; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Avila-Flores R., 2009, THESIS U ALBERTA EDM; Bagchi S, 2006, BIOL CONSERV, V127, P438, DOI 10.1016/j.biocon.2005.09.003; BONHAM CD, 1976, J RANGE MANAGE, V29, P221, DOI 10.2307/3897280; Brady N.C., 2004, ELEMENTS NATURE PROP, Vsecond; Cartron J.-L., 2005, BIODIVERSITY ECOSYST; Ceballos G, 1999, J ARID ENVIRON, V41, P161, DOI 10.1006/jare.1998.0479; CEBALLOS G, 1993, BIOL CONSERV, V63, P105, DOI 10.1016/0006-3207(93)90497-O; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Davidson AD, 2008, J ARID ENVIRON, V72, P2142, DOI 10.1016/j.jaridenv.2008.07.006; Davidson AD, 2008, J ARID ENVIRON, V72, P1133, DOI 10.1016/j.jaridenv.2007.12.015; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agriculture Organization of the United Nations, 2010, INTEGRATED CROP MANA, V9; Fredrickson EL, 2006, J ARID ENVIRON, V65, P285, DOI 10.1016/j.jaridenv.2005.10.019; Garcia E, 1981, MODIFICACIONES SISTE, V3rd; Havstad Kris M., 2006, P3; Herrick J. E., 2005, MONITORING MANUAL GR, VI; Herrick J. E, 2005, MONITORING MANUAL GR, VII; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huber-Sannwald E, 2006, HYDROL PROCESS, V20, P3395, DOI 10.1002/hyp.6337; Kay S, 2010, STRAIGHT FURROW; Kotliar Natasha B., 2006, P53; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; Letey J., 1985, Advances in soil science. Volume I, P277; List R, 2010, INT J WILDERNESS, V16, P35; Mc Ginty A, 2005, BRUSH BUSTERS AVOID; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller B, 2000, CONSERV BIOL, V14, P318, DOI 10.1046/j.1523-1739.2000.99201.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Murray S., 2000, PILOT ANAL GLOBAL EC; Ortega-Ochoa C., 2008, RANGELANDS, V30, P2, DOI 10.2111/1551-501X-30.6.2; PELLANT M, 2005, INTERPRETING INDICAT, P1734; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Proctor Jonathan, 2006, P232; Risser P, 2003, BIODIVERSITY, P176; Royo Marquez M. H., 2001, Tecnica Pecuaria en Mexico, V39, P89; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Siebe C., 2006, MANUAL DESCRIPCION E; Snyman HA, 2005, J ARID ENVIRON, V60, P457, DOI 10.1016/j.jaridenv.2004.06.006; Soil Survey Staff, 2010, KEYS SOIL TAX; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; WRIGHT JP, 2006, BIOSCIENCE, P56	53	36	37	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75229	10.1371/journal.pone.0075229	http://dx.doi.org/10.1371/journal.pone.0075229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130691	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900023
J	Takata, H; Hanafusa, T; Mori, T; Shimura, M; Iida, Y; Ishikawa, K; Yoshikawa, K; Yoshikawa, Y; Maeshima, K				Takata, Hideaki; Hanafusa, Tomo; Mori, Toshiaki; Shimura, Mari; Iida, Yutaka; Ishikawa, Kenichi; Yoshikawa, Kenichi; Yoshikawa, Yuko; Maeshima, Kazuhiro			Chromatin Compaction Protects Genomic DNA from Radiation Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SINGLE-MOLECULE OBSERVATION; CHROMOSOME TERRITORIES; MITOTIC CHROMOSOMES; MAMMALIAN-CELLS; NUCLEAR ARCHITECTURE; IONIZING-RADIATION; ANTICANCER DRUGS; GAMMA-RADIATION; LIVING CELLS	Genomic DNA is organized three-dimensionally in the nucleus, and is thought to form compact chromatin domains. Although chromatin compaction is known to be essential for mitosis, whether it confers other advantages, particularly in interphase cells, remains unknown. Here, we report that chromatin compaction protects genomic DNA from radiation damage. Using a newly developed solid-phase system, we found that the frequency of double-strand breaks (DSBs) in compact chromatin after ionizing irradiation was 5-50-fold lower than in decondensed chromatin. Since radical scavengers inhibited DSB induction in decondensed chromatin, condensed chromatin had a lower level of reactive radical generation after ionizing irradiation. We also found that chromatin compaction protects DNA from attack by chemical agents. Our findings suggest that genomic DNA compaction plays an important role in maintaining genomic integrity.	[Takata, Hideaki; Hanafusa, Tomo; Maeshima, Kazuhiro] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan; [Takata, Hideaki] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan; [Mori, Toshiaki] Osaka Prefecture Univ, Ctr Radiat Res, Sakai, Osaka 591, Japan; [Shimura, Mari] Natl Ctr Global Hlth & Med, Dept Intractable Dis, Res Inst, Shinjuku Ku, Tokyo, Japan; [Iida, Yutaka] Toray Res Ctr Ltd, Inorgan Anal Labs, Otsu, Shiga, Japan; [Ishikawa, Kenichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Adv Radiat Biol Res Program, Inage Ku, Chiba 260, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan; [Yoshikawa, Yuko] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Shiga, Japan; [Maeshima, Kazuhiro] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; Osaka Metropolitan University; National Center for Global Health & Medicine - Japan; Toray Research Center, Inc.; National Institutes for Quantum Science & Technology; Kyoto University; Ritsumeikan University; Graduate University for Advanced Studies - Japan	Takata, H (corresponding author), Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan.	htakata@wakate.frc.eng.osaka-u.ac.jp; kmaeshim@lab.nig.ac.jp	Takata, Hideaki/L-6914-2018; Yoshikawa, Kenichi/N-1867-2019	Takata, Hideaki/0000-0001-9436-1517; Yoshikawa, Kenichi/0000-0002-2751-7136; Maeshima, Kazuhiro/0000-0003-3909-0341	JST CREST grant; NIG Collaborative Research (A); Naitoh Science Foundation	JST CREST grant; NIG Collaborative Research (A); Naitoh Science Foundation	JST CREST grant, NIG Collaborative Research (A), Naitoh Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Aker T, 1977, OVARY, V3, P1; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Berezney R, 2005, ADV ENZYME REGUL, V45, P17, DOI 10.1016/j.advenzreg.2005.02.013; Bryant JM, 2012, MOL CELL BIOL, V32, P2771, DOI 10.1128/MCB.00282-12; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cole A., 1967, THEORETICAL BIOPHYSI, V1, P305; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; De Schutter H, 2009, ANTICANCER AGENTS ME, V9, P99; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Douki T, 2000, RADIAT RES, V153, P29, DOI 10.1667/0033-7587(2000)153[0029:PARIDO]2.0.CO;2; ELIA MC, 1992, CANCER RES, V52, P1580; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Gan L, 2013, CHROMOSOMA; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hable V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041943; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Hansen JC, 2012, EMBO J, V31, P1621, DOI 10.1038/emboj.2012.66; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kim MS, 2003, CANCER RES, V63, P7291; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; KRISCH RE, 1991, RADIAT RES, V126, P251, DOI 10.2307/3577826; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Ma H, 1998, J CELL BIOL, V143, P1415, DOI 10.1083/jcb.143.6.1415; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; MILLIGAN JR, 1993, RADIAT RES, V133, P151, DOI 10.2307/3578350; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nozaki T, 2013, NUCLEUS-PHILA, V4, P349, DOI 10.4161/nucl.26053; NYGREN J, 1995, INT J RADIAT BIOL, V68, P11, DOI 10.1080/09553009514550861; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Quenet D, 2012, EMBO REP, V13, P943, DOI 10.1038/embor.2012.143; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Sadler TW., 2010, LANGMANS MED EMBRYOL, V11th; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SPOTHEIMMAURIZOT M, 1995, INT J RADIAT BIOL, V68, P571, DOI 10.1080/09553009514551561; Suzuki M, 2000, INT J RADIAT ONCOL, V48, P241, DOI 10.1016/S0360-3016(00)00568-X; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Valota A, 2003, INT J RADIAT BIOL, V79, P643, DOI 10.1080/09553000310001596977; Vasireddy RS, 2010, CELL MOL LIFE SCI, V67, P291, DOI 10.1007/s00018-009-0181-5; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Ward JF, 1997, FACTORS CONTROLLING; WARTERS RL, 1992, RADIAT RES, V130, P309, DOI 10.2307/3578376; Warters RL, 1999, RADIAT RES, V151, P354, DOI 10.2307/3579948; WOODCOCK CLF, 1976, EXP CELL RES, V97, P101, DOI 10.1016/0014-4827(76)90659-5; Yoshikawa Y, 2006, BIOPHYS J, V90, P993, DOI 10.1529/biophysj.105.069963; Yoshikawa Y, 2008, CHEM PHYS LETT, V456, P80, DOI 10.1016/j.cplett.2008.03.009; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143; Zink D, 1999, EXP CELL RES, V247, P176, DOI 10.1006/excr.1998.4311	70	130	132	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75622	10.1371/journal.pone.0075622	http://dx.doi.org/10.1371/journal.pone.0075622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130727	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900046
J	Bronstein, O; Loya, Y				Bronstein, Omri; Loya, Yossi			The Taxonomy and Phylogeny of Echinometra (Camarodonta: Echinometridae) from the Red Sea and Western Indian Ocean	PLOS ONE			English	Article							GAMETE RECOGNITION; GENUS ECHINOMETRA; SPECIATION; URCHINS; PACIFIC; SPERM; BIOGEOGRAPHY; MORPHOLOGY; EVOLUTION; GENETICS	The number of valid species in the genus Echinometra (Echinodermata, Echinoidea) and their associated identification keys have been debated in the scientific literature for more than 180 years. As the phylogeny and dispersal patterns of these species have been widely used as a prominent model for marine speciation, new insights into their taxonomy have the potential to deepen our understanding of marine speciation processes. In this study we examine Echinometra taxonomy, combining morphology and molecular tools. We present the taxonomy and phylogeny of Red Sea and Western Indian Ocean Echinometra. The currently available morphological keys were found to be limited in their ability to delineate all species within this genus. Nonetheless, morphological similarities between the Red Sea and Western Indian Ocean populations were high, and delimited them from the other species. These latter populations together formed a monophyletic clade, genetically distant from any of the other Echinometra species by more than 3%. Combining both traditional taxonomy and molecular evidence, we found that these populations were neither Echinometra mathaei nor E. oblonga, as previously considered. The morphological discrepancies of these populations, and their genetic divergence from the other Echinometra species, suggest that they should be considered as a new Echinometra species.	[Bronstein, Omri; Loya, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bronstein, O (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	omribronstein@gmail.com	Loya, Joseph/AAJ-9014-2020; Loya, Yossi/J-3039-2012	Loya, Yossi/0000-0001-6870-9444; Bronstein, Omri/0000-0003-2620-3976	Israel Science Foundation (ISF); Raynor Chair for Environmental Conservation Research	Israel Science Foundation (ISF)(Israel Science Foundation); Raynor Chair for Environmental Conservation Research	This research was supported by the Israel Science Foundation (ISF) and the Raynor Chair for Environmental Conservation Research (to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AMY RL, 1983, B MAR SCI, V33, P173; Arakaki Y, 1999, ZOOL SCI, V16, P551, DOI 10.2108/zsj.16.551; Arakaki Y, 1998, ZOOL SCI, V15, P159, DOI 10.2108/zsj.15.159; Berlocher SH, 1998, ENDLESS FORMS, P99; BERMINGHAM E, 1993, P NATL ACAD SCI USA, V90, P2734, DOI 10.1073/pnas.90.7.2734; Blainville H, 1825, DICT SCI NATURELLES; CHIA FS, 1975, AM ZOOL, V15, P553; CLARK AM, 1971, MONOGRAPH SHALLOW WA, P690; FISHELSON L, 1971, MAR BIOL, V10, P113, DOI 10.1007/BF00354828; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Geyer LB, 2003, EVOLUTION, V57, P1049; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KELSO DP, 1970, COMP MORPHOLOGICAL E, P112; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Landry C, 2003, P ROY SOC B-BIOL SCI, V270, P1839, DOI 10.1098/rspb.2003.2395; Lawrence J.M., 1983, Bulletin of the Institute of Oceanography and Fisheries, V9, P141; Lessios HA, 1998, P ROY SOC B-BIOL SCI, V265, P583, DOI 10.1098/rspb.1998.0334; MATSUOKA N, 1991, ZOOL SCI, V8, P121; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MAYR E, 1954, EVOLUTION, V8, P1, DOI 10.2307/2405661; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; MCCLANAHAN T, 2001, EDIBLE SEA URCHINS B, P297; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MICHEL C, 1974, NOTES MARINE BIOL ST, P77230; Mortensen T., 1943, MONOGRAPH ECHINOIDEA; Motokawa T., 1991, BIOL ECHINODERMATA, P89; Palumbi SR, 2005, P NATL ACAD SCI USA, V102, P6566, DOI 10.1073/pnas.0501806102; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; Palumbi SR, 1997, EVOLUTION, V51, P1506, DOI 10.1111/j.1558-5646.1997.tb01474.x; Pochon X, 2001, MAR BIOL, V139, P1069; RAFF RA, 1990, DEV GROWTH DIFFER, V32, P283; Rahman SM, 2004, COMP BIOCHEM PHYS A, V139, P469, DOI 10.1016/j.cbpb.2004.10.005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSO AR, 1977, AUST J MAR FRESH RES, V28, P693; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	40	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77374	10.1371/journal.pone.0077374	http://dx.doi.org/10.1371/journal.pone.0077374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116225	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200116
J	Sukowati, CHC; Anfuso, B; Torre, G; Francalanci, P; Croce, LS; Tiribelli, C				Sukowati, Caecilia Hapsari Ceriapuri; Anfuso, Beatrice; Torre, Giuliano; Francalanci, Paola; Croce, Lory Saveria; Tiribelli, Claudio			The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study	PLOS ONE			English	Article							CANCER STEM-CELLS; PROGENITOR CELLS; DOWN-REGULATION; LIVER; TRANSPORTER; QUANTIFICATION; POPULATION; INHIBITION; THY-1	Although the CD90 (Thy-1) was proposed as biomarker of several tumors and cancer stem cells, the involvement of this molecule in the progression of hepatocellular carcinoma (HCC) and other less frequent hepatic neoplasms is still undefined. The distribution of CD90 was investigated both in in vivo (human tissues samples) and in vitro (human HCC cell line JHH-6). A total of 67 liver tumors were analyzed: 51 HCC, 6 cholangiocarcinoma and 10 hepatoblastoma. In all cases, paired tissue sample of both the tumor and cirrhotic liver was available. Hepatic tissue obtained in 12 healthy livers was used as control. CD90 gene expression was studied by RT-qPCR, protein expression was assessed by quantitative Western Blot, immunofluorescence and flow cytometry. The CD90 expression analysis showed a significant increment in tumor compared to both its paired cirrhotic tissue and normal liver (p<0.05 and p<0.001, respectively). This increase was accompanied by the up-regulation of stromal component in the cancer, as demonstrated by alpha smooth muscle actin staining. In vitro analysis of JHH-6 cell line showed a higher proliferation capacity of CD90(+) compared to CD90-cells (p<0.001), also noticed in 3D clonogenic assay (p<0.05), associated by a significant higher expression of the promoting factors (hepatocyte growth factor, fibroblast associated protein and alpha smooth muscle actin 2). A higher expression of the breast cancer resistance protein was found in CD90+ subpopulation while the multidrug resistance protein 1 showed an opposite behavior. Collectively, these results point to the importance of CD90 in the HCC.	[Sukowati, Caecilia Hapsari Ceriapuri; Anfuso, Beatrice; Croce, Lory Saveria; Tiribelli, Claudio] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy; [Torre, Giuliano] Osped Pediat Bambino Gesu, Dept Surg & Transplantat, Hepatol Unit, Rome, Italy; [Francalanci, Paola] Osped Pediat Bambino Gesu, Dept Labs, Rome, Italy; [Sukowati, Caecilia Hapsari Ceriapuri; Croce, Lory Saveria; Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Trieste	Sukowati, CHC (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy.	caecilia.sukowati@csf.units.it	croce', lory saveria l/E-2565-2011; Francalanci, Paola/AAA-4908-2020; Tiribelli, Claudio/A-4716-2014	croce', lory saveria l/0000-0001-9890-7011; Sukowati, Caecilia/0000-0001-9699-7578; Anfuso, Beatrice/0000-0001-7819-6830; Tiribelli, Claudio/0000-0001-6596-7595	Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia; Fondazione Umberto Veronesi, Milan, Italy; Fondazione Aldo Duca of the University of Trieste, Italy; grant PORFESR [2000/ISTR/2011]; Italian Liver Foundation	Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia; Fondazione Umberto Veronesi, Milan, Italy(Fondazione Umberto Veronesi); Fondazione Aldo Duca of the University of Trieste, Italy; grant PORFESR; Italian Liver Foundation	CHCS was supported by fellowships of the Italian Ministry of Foreign Affairs of the Istituto Italiano di Cultura, Jakarta, Indonesia, Fondazione Umberto Veronesi, Milan, Italy, and Fondazione Aldo Duca of the University of Trieste, Italy; BA fellowship was partially supported by grant PORFESR 2007/2013 (2000/ISTR/2011); This work was supported by a grant from the Italian Liver Foundation. The funders had nor role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts. No additional external funding received for this study.	[Anonymous], 2013, OCTOBER, V8; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cesselli D, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/120925; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Dudas J, 2009, HISTOCHEM CELL BIOL, V131, P115, DOI 10.1007/s00418-008-0503-y; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lu JW, 2011, ACTA HISTOCHEM, V113, P833, DOI 10.1016/j.acthis.2011.01.001; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Murakami Koji, 1999, Neoplasia (New York), V1, P424, DOI 10.1038/sj.neo.7900046; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-317; Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SIMONETTI RG, 1991, DIGEST DIS SCI, V36, P962, DOI 10.1007/BF01297149; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; True LD, 2010, MODERN PATHOL, V23, P1346, DOI 10.1038/modpathol.2010.122; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu XH, 2011, DIGEST DIS SCI, V56, P252, DOI 10.1007/s10620-010-1256-8; Zen Y, 2007, AM J PATHOL, V170, P1750, DOI 10.2353/ajpath.2007.060798; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946	34	66	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76830	10.1371/journal.pone.0076830	http://dx.doi.org/10.1371/journal.pone.0076830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116172	gold, Green Submitted, Green Published			2022-12-25	WOS:000325552200076
J	Crewe, C; Kinter, M; Szweda, LI				Crewe, Clair; Kinter, Michael; Szweda, Luke I.			Rapid Inhibition of Pyruvate Dehydrogenase: An Initiating Event in High Dietary Fat-Induced Loss of Metabolic Flexibility in the Heart	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-OXIDATION; ACID-METABOLISM; EXPRESSION; KINASE-4; STARVATION; ALPHA; CYCLE; DYSFUNCTION; MECHANISMS	Cardiac function depends on the ability to switch between fatty acid and glucose oxidation for energy production in response to changes in substrate availability and energetic stress. In obese and diabetic individuals, increased reliance on fatty acids and reduced metabolic flexibility are thought to contribute to the development of cardiovascular disease. Mechanisms by which cardiac mitochondria contribute to diet-induced metabolic inflexibility were investigated. Mice were fed a high fat or low fat diet for 1 d, 1 wk, and 20 wk. Cardiac mitochondria isolated from mice fed a high fat diet displayed a diminished ability to utilize the glycolytically derived substrate pyruvate. This response was rapid, occurring within the first day on the diet, and persisted for up to 20 wk. A selective increase in the expression of pyruvate dehydrogenase kinase 4 and inhibition of pyruvate dehydrogenase are responsible for the rapid suppression of pyruvate utilization. An important consequence is that pyruvate dehydrogenase is sensitized to inhibition when mitochondria respire in the presence of fatty acids. Additionally, increased expression of pyruvate dehydrogenase kinase 4 preceded any observed diet-induced reductions in the levels of glucose transporter type 4 and glycolytic enzymes and, as judged by Akt phosphorylation, insulin signaling. Importantly, diminished insulin signaling evident at 1 wk on the high fat diet did not occur in pyruvate dehydrogenase kinase 4 knockout mice. Dietary intervention leads to a rapid decline in pyruvate dehydrogenase kinase 4 levels and recovery of pyruvate dehydrogenase activity indicating an additional form of regulation. Finally, an overnight fast elicits a metabolic response similar to that induced by high dietary fat obscuring diet-induced metabolic changes. Thus, our data indicate that diet-induced inhibition of pyruvate dehydrogenase may be an initiating event in decreased oxidation of glucose and increased reliance of the heart on fatty acids for energy production.	[Crewe, Clair; Kinter, Michael; Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Crewe, Clair; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Kinter, Michael; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Reynolds Ctr Aging, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Szweda, LI (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Luke-Szweda@omrf.org		Kinter, Michael/0000-0001-7409-8918	NIA [R01AG016339]; Oklahoma Medical Research Foundation (OMRF.org); Hille Family Foundation (hillefoundation.org); NATIONAL INSTITUTE ON AGING [R01AG016339] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oklahoma Medical Research Foundation (OMRF.org); Hille Family Foundation (hillefoundation.org); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by a Grant (R01AG016339) from the NIA with additional support from the Oklahoma Medical Research Foundation (OMRF.org) and the Hille Family Foundation (hillefoundation.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIA or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Holness MJ, 2002, BIOCHEM J, V364, P687, DOI 10.1042/bj20011841; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; ORFALI KA, 1993, FEBS LETT, V336, P501, DOI 10.1016/0014-5793(93)80864-Q; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; RANDLE PJ, 1963, LANCET, V1, P785; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Rinnankoski-Tuikka R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-53; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Zhang LY, 2012, FEBS LETT, V586, P996, DOI 10.1016/j.febslet.2012.02.027; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	41	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77280	10.1371/journal.pone.0077280	http://dx.doi.org/10.1371/journal.pone.0077280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116221	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300117
J	Hughes, AD; Bathula, R; Park, C; Tillin, T; Wit, N; Thom, SM; Chaturvedi, N				Hughes, Alun D.; Bathula, Raj; Park, Chloe; Tillin, Therese; Wit, Nicholas; Thom, Simon McG; Chaturvedi, Nish			Microcirculatory Rarefaction in South Asians - A Potential Mechanism for Increased Cardiovascular Risk and Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RETINAL MICROVASCULAR STRUCTURE; CAPILLARY RAREFACTION; ARTERIAL STIFFNESS; VASCULAR CALIBER; WHITE EUROPEANS; VESSEL DIAMETER; BLOOD-PRESSURE; INDIAN ASIANS; ATHEROSCLEROSIS	People of South Asian descent have an increased risk of cardiovascular disease (CVD) and diabetes, but little is known about the microcirculation in South Asian people despite evidence that this plays an important role in the aetiology of CVD. We compared the retinal microcirculation in a population-based sample of 287 middle-aged adults (144 European 143 South Asian) matched for age and sex. Retinal photographs were taken and analysed using a validated semi-automated program and microvascular measures were compared. Blood pressure, anthropometry and fasting bloods were also measured. South Asians had significantly fewer arteriolar and venular vessels and bifurcations. Arterioles and venules were longer and venules were also more tortuous in South Asians. These differences were not explained by adjustment for traditional risk factors including blood pressure, body mass index, diabetes or measures of insulin resistance. People of South Asian descent have rarefaction of the retinal microcirculation compared to age-sex matched individuals of European descent. Reduced microvascular density could contribute to the elevated risk of CVD and impaired glucose tolerance in South Asian people.	[Hughes, Alun D.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, NHLI Div, London, England; Imperial Coll Healthcare NHS Trust, London, England	Imperial College London; Imperial College London	Hughes, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, NHLI Div, London, England.	a.hughes@imperial.ac.uk	Hughes, Alun David/N-3781-2013	Hughes, Alun David/0000-0001-5432-5271; Tillin, Therese/0000-0003-1590-9826; Thom, Simon/0000-0002-3020-1351; Park, Chloe/0000-0001-8302-7484	British Heart Foundation NIHR Biomedical Research Centre Scheme; British Heart Foundation [PG/12/29/29497] Funding Source: researchfish	British Heart Foundation NIHR Biomedical Research Centre Scheme; British Heart Foundation(British Heart Foundation)	Funding came from the British Heart Foundation NIHR Biomedical Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathula R, 2010, DIABETOLOGIA; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chambers JC, 1999, HEART, V81, P501, DOI 10.1136/hrt.81.5.501; Chapman N, 2001, BRIT J OPHTHALMOL, V85, P74, DOI 10.1136/bjo.85.1.74; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Cheung N, 2007, INVEST OPHTH VIS SCI, V48, P1018, DOI 10.1167/iovs.06-0978; Dixon Anthony N, 2006, Diab Vasc Dis Res, V3, P22, DOI 10.3132/dvdr.2006.002; Fischbacher CM, 2003, DIABETIC MED, V20, P31, DOI 10.1046/j.1464-5491.2003.00822.x; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Gunarathne A, 2008, J HYPERTENS, V26, P1420, DOI 10.1097/HJH.0b013e3282ffb42a; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; He FJ, 2010, HYPERTENSION, V56, P253, DOI 10.1161/HYPERTENSIONAHA.110.155747; Hughes A, 2009, MICROCIRCULATION, V16, P159, DOI 10.1080/10739680802353868; Jarrett R J, 1979, Diabetes Care, V2, P175, DOI 10.2337/diacare.2.2.175; Jeganathan VSE, 2009, HYPERTENS RES, V32, P975, DOI 10.1038/hr.2009.130; Jeganathan VSE, 2009, MICROCIRCULATION, V16, P534, DOI 10.1080/10739680902975222; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mahal S, 2009, CLIN SCI, V117, P229, DOI 10.1042/CS20080538; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MEYER LC, 1994, DIABETIC MED, V11, P670; Nama V, 2011, J HUM HYPERTENS, V25, P465, DOI 10.1038/jhh.2011.1; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; O'Brien, 1996, Blood Press Monit, V1, P55; Owen CG, 2011, ARTERIOSCL THROM VAS, V31, P1933, DOI 10.1161/ATVBAHA.111.225219; Park C, 2012, ATHEROSCLEROSIS, V221, P503, DOI 10.1016/j.atherosclerosis.2011.11.025; Patel SR, 2011, BRIT J OPHTHALMOL, V95, P1573, DOI 10.1136/bjo.2010.201665; Pradeepa R, 2008, DIABETIC MED, V25, P536, DOI 10.1111/j.1464-5491.2008.02423.x; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; Serne EH, 2001, CARDIOVASC RES, V49, P161, DOI 10.1016/S0008-6363(00)00198-X; Stolk RP, 2008, DIABETES CARE, V31, P708, DOI 10.2337/dc07-1657; Tapp RJ, 2007, PEDIATRICS, V120, pE1225, DOI 10.1542/peds.2006-2951; Tapp RJ, 2013, MICROCIRCULATION, V20, P609, DOI 10.1111/micc.12060; Taylor B, 2007, INT J OBESITY, V31, P1527, DOI 10.1038/sj.ijo.0803674; Tillin T, 2008, DIABETOLOGIA, V51, P1719, DOI 10.1007/s00125-008-1096-7; Tillin T, 2005, J AM SOC NEPHROL, V16, P3702, DOI 10.1681/ASN.2005060584; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2013, DIABETES CARE, V36, P383, DOI 10.2337/dc12-0544; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang L, 2008, HYPERTENSION, V51, P119, DOI 10.1161/HYPERTENSIONAHA.107.098343; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2008, AM J EPIDEMIOL, V167, P51, DOI 10.1093/aje/kwm256; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153	44	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76680	10.1371/journal.pone.0076680	http://dx.doi.org/10.1371/journal.pone.0076680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116136	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300078
J	Middlebrooks, JC; Nick, HS; Subramony, SH; Advincula, J; Rosales, RL; Lee, LV; Ashizawa, T; Waters, MF				Middlebrooks, John C.; Nick, Harry S.; Subramony, S. H.; Advincula, Joel; Rosales, Raymond L.; Lee, Lillian V.; Ashizawa, Tetsuo; Waters, Michael F.			Mutation in the Kv3.3 Voltage-Gated Potassium Channel Causing Spinocerebellar Ataxia 13 Disrupts Sound-Localization Mechanisms	PLOS ONE			English	Article							NEURONAL EXCITABILITY; INTERAURAL PHASE; SUPERIOR OLIVE; MEDIAL NUCLEUS; TRAPEZOID BODY; MOUSE-BRAIN; EXPRESSION; SUBUNITS; SYSTEM; CUES	Normal sound localization requires precise comparisons of sound timing and pressure levels between the two ears. The primary localization cues are interaural time differences, ITD, and interaural level differences, ILD. Voltage-gated potassium channels, including Kv3.3, are highly expressed in the auditory brainstem and are thought to underlie the exquisite temporal precision and rapid spike rates that characterize brainstem binaural pathways. An autosomal dominant mutation in the gene encoding Kv3.3 has been demonstrated in a large Filipino kindred manifesting as spinocerebellar ataxia type 13 (SCA13). This kindred provides a rare opportunity to test in vivo the importance of a specific channel subunit for human hearing. Here, we demonstrate psychophysically that individuals with the mutant allele exhibit profound deficits in both ITD and ILD sensitivity, despite showing no obvious impairment in pure-tone sensitivity with either ear. Surprisingly, several individuals exhibited the auditory deficits even though they were pre-symptomatic for SCA13. We would expect that impairments of binaural processing as great as those observed in this family would result in prominent deficits in localization of sound sources and in loss of the "spatial release from masking" that aids in understanding speech in the presence of competing sounds.	[Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Middlebrooks, John C.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA; [Nick, Harry S.; Subramony, S. H.; Ashizawa, Tetsuo; Waters, Michael F.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Subramony, S. H.] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA; [Advincula, Joel] Western Visayas State Univ Med Ctr, Iloilo, Philippines; [Rosales, Raymond L.] Univ Santo Tomas, Dept Neurol & Psychiat, Manila, Philippines; [Lee, Lillian V.] Philippine Childrens Med Ctr, Child Neurosci Ctr, Quezon City, Philippines	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Santo Tomas	Waters, MF (corresponding author), Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	mwaters@neurology.ufl.edu			NIH NIDCD [RO1 DC000420]; NIH NINDS [K23 NS054715]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS054715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000420] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH NIDCD RO1 DC000420 (to JCM), NIH NINDS K23 NS054715 (to MFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059815; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Cherry CE, 1953, J ACOUST SOC AM, V25, P975, DOI [10.1121/1.1907229, DOI 10.1121/1.1907229]; Grigg JJ, 2000, HEARING RES, V140, P77, DOI 10.1016/S0378-5955(99)00187-2; GUINAN JJ, 1972, INT J NEUROSCI, V4, P147, DOI 10.3109/00207457209164756; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kidd G, 2008, J ACOUST SOC AM, V124, P3793, DOI 10.1121/1.2998980; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Middlebrooks JC, 2012, J ACOUST SOC AM, V132, P3896, DOI 10.1121/1.4764879; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Strutt JW, 1907, PHILOS MAG, V13, P214, DOI DOI 10.1080/14786440709463595; Subramony SH, 2013, CEREBELLUM; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; Tsuchitani C, 1997, HEARING RES, V105, P211, DOI 10.1016/S0378-5955(96)00212-2; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498; YOST WA, 1974, J ACOUST SOC AM, V55, P1299, DOI 10.1121/1.1914701; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	28	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76749	10.1371/journal.pone.0076749	http://dx.doi.org/10.1371/journal.pone.0076749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116147	Green Published, gold			2022-12-25	WOS:000325501300089
J	Rodriguez-Perez, MA; Adeleke, MA; Burkett-Cadena, ND; Garza-Hernandez, JA; Reyes-Villanueva, F; Cupp, EW; Toe, L; Salinas-Carmona, MC; Rodriguez-Ramirez, AD; Katholi, CR; Unnasch, TR				Rodriguez-Perez, Mario A.; Adeleke, Monsuru A.; Burkett-Cadena, Nathan D.; Garza-Hernandez, Javier A.; Reyes-Villanueva, Filiberto; Cupp, Eddie W.; Toe, Laurent; Salinas-Carmona, Mario C.; Rodriguez-Ramirez, Americo D.; Katholi, Charles R.; Unnasch, Thomas R.			Development of a Novel Trap for the Collection of Black Flies of the Simulium ochraceum Complex	PLOS ONE			English	Article							ONCHOCERCA-VOLVULUS TRANSMISSION; DAMNOSUM SL; IVERMECTIN TREATMENT; DIPTERA-SIMULIIDAE; BITING ACTIVITY; ENDEMIC FOCI; 1ST EVIDENCE; ELIMINATION; DISEASE; ATTRACTION	Background: Human landing collections are currently the standard method for collecting onchocerciasis vectors in Africa and Latin America. As part of the efforts to develop a trap to replace human landing collections for the monitoring and surveillance of onchocerciasis transmission, comprehensive evaluations of several trap types were conducted to assess their ability to collect Simulium ochraceum sensu lato, one of the principal vectors of Onchocerca volvulus in Latin America. Methodology/Principal Findings: Diverse trap designs with numerous modifications and bait variations were evaluated for their abilities to collect S. Ochraceum s.l. females. These traps targeted mostly host seeking flies. A novel trap dubbed the "Esperanza window trap" showed particular promise over other designs. When baited with CO2 and BG-lure (a synthetic blend of human odor components) a pair of Esperanza window traps collected numbers of S. Ochraceum s.l. females similar to those collected by a team of vector collectors. Conclusions/Significance: The Esperanza window trap, when baited with chemical lures and CO2 can be used to collect epidemiologically significant numbers of Simulium ochraceum s.l., potentially serving as a replacement for human landing collections for evaluation of the transmission of O. volvulus.	[Rodriguez-Perez, Mario A.; Garza-Hernandez, Javier A.; Reyes-Villanueva, Filiberto] Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa, Tamaulipas, Mexico; [Rodriguez-Perez, Mario A.; Salinas-Carmona, Mario C.] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Nuevo Leon, Mexico; [Adeleke, Monsuru A.] Osun State Univ, Dept Biol Sci, Osogbo, Nigeria; [Burkett-Cadena, Nathan D.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA; [Cupp, Eddie W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Toe, Laurent] World Hlth Org, Multidis Surveillance Ctr, Ouagadougou, Burkina Faso; [Rodriguez-Ramirez, Americo D.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Katholi, Charles R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; State University System of Florida; University of South Florida; Auburn University System; Auburn University; World Health Organization; Instituto Nacional de Salud Publica; University of Alabama System; University of Alabama Birmingham	Unnasch, TR (corresponding author), Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA.	tunnasch@health.usf.edu	Salinas-Carmona, Mario C/Y-2456-2019; Perez, Mario A. Rodriguez/AAH-3572-2020; Rodriguez-Perez, Mario A./P-8814-2014; Garza-Hernandez, Javier A./AAQ-6167-2021	Salinas-Carmona, Mario C/0000-0002-4239-7363; Perez, Mario A. Rodriguez/0000-0002-0905-6073; Rodriguez-Perez, Mario A./0000-0002-0905-6073; Garza-Hernandez, Javier A./0000-0001-9580-2126; Adeleke, Monsuru/0000-0001-7447-3220; Burkett-Cadena, Nathan/0000-0001-6168-1637	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this work was provided by The Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basanez MG, 2007, T ROY SOC TROP MED H, V101, P256, DOI 10.1016/j.trstmh.2006.08.009; Basanez MG, 1998, J MED ENTOMOL, V35, P745, DOI 10.1093/jmedent/35.5.745; BELLEC C, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P209; Bellec C, 1974, METHODES ECHANTILLON; Biogents, 2013, BG LUR MOSQ LUR PROF; Biogents, 2008, MAT SAF DAT SHEET BG; BRADBURY WC, 1974, CAN J ZOOL, V52, P251, DOI 10.1139/z74-030; BRIGHTWELL R, 1991, MED VET ENTOMOL, V5, P153, DOI 10.1111/j.1365-2915.1991.tb00536.x; COLLINS RC, 1981, AM J TROP MED HYG, V30, P728, DOI 10.4269/ajtmh.1981.30.728; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Cupp EW, 2011, ACTA TROP, V120, pS100, DOI 10.1016/j.actatropica.2010.08.009; CUPP EW, 1979, AM J TROP MED HYG, V28, P422, DOI 10.4269/ajtmh.1979.28.422; Dar SC, 1984, MOSQ NEWS, V44, P79; DAVIES JB, 1981, TROPENMED PARASITOL, V32, P17; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DISLICH H, 1979, ANGEW CHEM INT EDIT, V18, P49, DOI 10.1002/anie.197900491; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; GREEN CH, 1988, B ENTOMOL RES, V78, P591, DOI 10.1017/S0007485300015443; GUERENSTEIN PG, 1995, EXPERIENTIA, V51, P834, DOI 10.1007/BF01922439; HRIBAR LJ, 1991, J MED ENTOMOL, V28, P874, DOI 10.1093/jmedent/28.6.874; Jacobi CA, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-53; JONSSON E, 1986, FRESHWATER BIOL, V16, P711, DOI 10.1111/j.1365-2427.1986.tb01012.x; Katabarwa Moses N, 2012, J Parasitol Res, V2012, P748540, DOI 10.1155/2012/748540; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Lindblade KA, 2007, AM J TROP MED HYG, V77, P334, DOI 10.4269/ajtmh.2007.77.334; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; PORTER CH, 1988, AM J TROP MED HYG, V39, P567, DOI 10.4269/ajtmh.1988.39.567; PORTER CH, 1988, AM J TROP MED HYG, V38, P153, DOI 10.4269/ajtmh.1988.38.153; PORTER CH, 1988, AM J TROP MED HYG, V38, P142, DOI 10.4269/ajtmh.1988.38.142; Program Coordinating Comm OEPA Sta, 2012, RES REP TROP MED, V3, P21, DOI 10.2147/RRTM.S30482; PROST A, 1986, T ROY SOC TROP MED H, V80, P525, DOI 10.1016/0035-9203(86)90129-X; Rodriguez-Perez M, 2013, DROSOPHILA INF SERV, V7, pe2133; Rodriguez-Perez MA, 2008, AM J TROP MED HYG, V79, P239, DOI 10.4269/ajtmh.2008.79.239; Rodriguez-Perez MA, 2008, AM J TROP MED HYG, V78, P147, DOI 10.4269/ajtmh.2008.78.147; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; THOMPSON BH, 1977, TROPENMED PARASITOL, V28, P83; THOMPSON BH, 1977, TROPENMED PARASITOL, V28, P226; THOMPSON BH, 1976, TROPENMED PARASITOL, V27, P455; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; WALSH JF, 1980, TROPENMED PARASITOL, V31, P479; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; World Health Organization, 1995, 852 WHO EXP COMM; World Health Organization, 2001, WHOCDSCPECEE200118A, P64	46	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76814	10.1371/journal.pone.0076814	http://dx.doi.org/10.1371/journal.pone.0076814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116169	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300100
J	Boggavarapu, R; Jeckelmann, JM; Harder, D; Schneider, P; Ucurum, Z; Hediger, M; Fotiadis, D				Boggavarapu, Rajendra; Jeckelmann, Jean-Marc; Harder, Daniel; Schneider, Philipp; Ucurum, Zoehre; Hediger, Matthias; Fotiadis, Dimitrios			Expression, Purification and Low-Resolution Structure of Human Vitamin C Transporter SVCT1 (SLC23A1)	PLOS ONE			English	Article							FAMILY	Expression and purification of human membrane proteins for structural studies represent a great challenge. This is because micro-to milligram amounts of pure isolated protein are required. To this aim, we successfully expressed the human vitamin C transporter-1 (hSVCT1; SLC23A1) in Xenopus laevis oocytes and isolated highly pure protein in microgram amounts. Recombinant hSVCT1 was functional when expressed in oocytes and glycosylated. Structural analysis of purified hSVCT1 by transmission electron microscopy and single particle analysis unveiled its shape, dimensions and low-resolution structure as well as the existence of a major monomeric and minor dimeric population. Chemical crosslinking of isolated oocyte membranes containing expressed hSVCT1 indicated similar oligomeric states of hSVCT1 in lipid bilayers. This work reports the first purification and structural analysis of a human SVCT protein and opens the way for future functional and structural studies using purified hSVCT1.	[Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; Univ Bern, Swiss Natl Ctr Competence Res NCCR TransCure, Bern, Switzerland	University of Bern; University of Bern	Fotiadis, D (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	dimitrios.fotiadis@ibmm.unibe.ch		Harder, Daniel/0000-0003-4226-9748; Jeckelmann, Jean-Marc/0000-0001-9973-2700; Hediger, Matthias/0000-0003-1946-027X; Boggavarapu, Venkata/0000-0001-6312-5722	University of Bern; Swiss National Science Foundation [31003A_125150, 31003A_144168]; European Science Foundation [09-EuroSYNBIO-FP-012 NANOCELL]; National Centre of Competence in Research (NCCR) TransCure	University of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); National Centre of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF))	This research has been supported by the University of Bern, the Swiss National Science Foundation (Grants 31003A_125150 and 31003A_144168 to DF), the European Science Foundation (Grant 09-EuroSYNBIO-FP-012 NANOCELL to DF), and the National Centre of Competence in Research (NCCR) TransCure (to DF and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021901; BLOCK G, 1991, AM J CLIN NUTR, V53, pS270, DOI 10.1093/ajcn/53.1.270S; Burzle M, 2013, MOL ASPECTS MED, V34, P436, DOI 10.1016/j.mam.2012.12.002; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Erichsen HC, 2006, AM J EPIDEMIOL, V163, P245, DOI 10.1093/aje/kwj035; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Hong SW, 2013, ONCOGENE, V32, P1508, DOI 10.1038/onc.2012.176; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo SH, 2011, INT J PHARMACEUT, V414, P77, DOI 10.1016/j.ijpharm.2011.05.001; Mackenzie B, 2008, AM J PHYSIOL-CELL PH, V294, pC451, DOI 10.1152/ajpcell.00439.2007; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Patak P, 2004, ENDOCR RES, V30, P871, DOI 10.1081/ERC-200044126; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Verrax J, 2008, BIOCHEM PHARMACOL, V76, P1644, DOI 10.1016/j.bcp.2008.09.024; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76427	10.1371/journal.pone.0076427	http://dx.doi.org/10.1371/journal.pone.0076427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124560	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100117
J	Chatterjee, R; Halder, PK; Datta, S				Chatterjee, Rakesh; Halder, Pranab Kumar; Datta, Saumen			Identification and Molecular Characterization of YsaL (Ye3555): A Novel Negative Regulator of YsaN ATPase in Type Three Secretion System of Enteropathogenic Bacteria Yersinia enterocolitica	PLOS ONE			English	Article							III SECRETION; FLAGELLAR EXPORT; OUTER PROTEINS; SALMONELLA; VIRULENCE; FLIH; COMPONENT; CHAPERONE; COMPLEX; LOCUS	Type Three Secretion (T3S) ATPases are involved in delivery of virulent factors from bacteria to their hosts (through injectisome) in an energy (ATP) dependent manner during pathogenesis. The activities of these ATPases are tightly controlled by their specific regulators. In Yersinia enterocolitica, YsaN was predicted as a putative ATPase of the Ysa-Ysp Type Three Secretion System (T3SS) based on sequence similarity with other T3S ATPases. However detailed study and characterization of YsaN and its regulation remains largely obscure. Here, in this study, we have successfully cloned, over-expressed, purified and characterized the molecular properties of YsaN from Yersinia enterocolitica. YsaN acts as a Mg2+ dependent ATPase and exists in solution as higher order oligomer (dodecamer). The ATPase activity of oligomeric YsaN is several fold higher than the monomeric form. Furthermore, by employing in silico studies we have identified the existence of a negative regulator of YsaN- a hypothetical protein YE3555 (termed 'YsaL'). To verify the functionality of YsaL, we have evaluated the biochemical and biophysical properties of YsaL. Purified YsaL is dimeric in solution and strongly associates with YsaN to form a stable heterotrimeric YsaL-YsaN complex (stoichiometry-2:1). The N terminal 6-20 residues of YsaN are invariably required for stable YsaL-YsaN complex formation. YsaL inhibited the ATPase activity of YsaN with a maximum inhibition at the molar ratio 2:1 (YsaL:YsaN). In short, our studies provide an insight into the presence of YsaN ATPase in Yersinia enterocolitica and its regulator YsaL. Our studies also correlate the functionality of one of the existing protein interaction networks that possibly is indispensable for the energy dependent process of Ysa-Ysp T3SS in pathogenic Yersinia enterocolitica.	[Chatterjee, Rakesh; Halder, Pranab Kumar; Datta, Saumen] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Datta, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.	saumen_datta@iicb.res.in		Chatterjee, Rakesh/0000-0003-0501-4252; Chatterjee, Rakesh/0000-0003-4430-9491	Department of Science and Technology (DST), Government of India; CSIR; UGC	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India)	This project was funded by Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are also thankful to the Council of scientific and Industrial Research (CSIR), Government of India. The authors also are grateful to Prof. Siddhartha Roy, Director, CSIR-Indian Institute of Chemical Biology (CSIR-IICB). CSIR fellowship to Rakesh Chatterjee and UGC fellowship to Pranab Kumar Halder.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Foultier B, 2003, INFECT IMMUN, V71, P242, DOI 10.1128/IAI.71.1.242-253.2003; Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; HUANG HC, 1995, MOL PLANT MICROBE IN, V8, P733, DOI 10.1094/MPMI-8-0733; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Jenks PJ, 1997, FEMS MICROBIOL LETT, V152, P205, DOI 10.1016/S0378-1097(97)00170-5; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Laukkanen R, 2010, J APPL MICROBIOL, V108, P956, DOI 10.1111/j.1365-2672.2009.04494.x; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Okabe M, 2009, FEBS LETT, V583, P743, DOI 10.1016/j.febslet.2009.01.026; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Snellings NJ, 2001, INFECT IMMUN, V69, P4627, DOI 10.1128/IAI.69.7.4627-4638.2001; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trost B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-72; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75028	10.1371/journal.pone.0075028	http://dx.doi.org/10.1371/journal.pone.0075028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124464	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100021
J	Li, XL; Cao, J; Wang, SP; Geng, ZR; Song, XL; Hu, X; Wang, ZL				Li, Xiangli; Cao, Jing; Wang, Shuping; Geng, Zhirong; Song, Xiaoli; Hu, Xin; Wang, Zhilin			Residues in Human Arsenic (+3 Oxidation State) Methyltransferase Forming Potential Hydrogen Bond Network around S-adenosylmethionine	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SITE-DIRECTED MUTAGENESIS; CIRCULAR-DICHROISM; DIMETHYLARSINOUS ACID; CYSTEINE RESIDUES; INFRARED-SPECTRA; METHYLATION; RAT; BINDING; HAS3MT	Residues Tyr59, Gly78, Ser79, Met103, Gln107, Ile136 and Glu137 in human arsenic (+3 oxidation state) methyltransferase (hAS3MT) were deduced to form a potential hydrogen bond network around S-adenosylmethionine (SAM) from the sequence alignment between Cyanidioschyzon merolae arsenite S-adenosylmethyltransferase (CmArsM) and hAS3MT. Herein, seven mutants Y59A, G78A, S79A, M103A, Q107A, I136A and E137A were obtained. Their catalytic activities and conformations were characterized and models were built. Y59A and G78A were completely inactive. Only 7.0%, 10.6% and 13.8% inorganic arsenic (iAs) was transformed to monomethylated arsenicals (MMA) when M103A, Q107A and I136A were used as the enzyme. The V-max (the maximal velocity of the reaction) values of M103A, Q107A, I136A and E137A were decreased to 8%, 22%, 15% and 50% of that of WT-hAS3MT, respectively. The K-M(SAM) (the Michaelis constant for SAM) values of mutants M103A, I136A and E137A were 15.7, 8.9 and 5.1 fold higher than that of WT-hAS3MT, respectively, indicating that their affinities for SAM were weakened. The altered microenvironment of SAM and the reduced capacity of binding arsenic deduced from K-M(As) (the Michaelis constant for iAs) value probably synergetically reduced the catalytic activity of Q107A. The catalytic activity of S79A was higher than that of WT despite of the higher K-M(SAM), suggesting that Ser79 did not impact the catalytic activity of hAS3MT. In short, residues Tyr59 and Gly78 significantly influenced the catalytic activity of hAS3MT as well as Met103, Ile136 and Glu137 because they were closely associated with SAM-binding, while residue Gln107 did not affect SAM-binding regardless of affecting the catalytic activity of hAS3MT. Modeling and our experimental results suggest that the adenine ring of SAM is sandwiched between Ile136 and Met103, the amide group of SAM is hydrogen bonded to Gly78 in hAS3MT and SAM is bonded to Tyr59 with van der Waals, cation-pi and hydrogen bonding contacts.	[Li, Xiangli; Cao, Jing; Wang, Shuping; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Yangzhou University; Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Basic Research Program of China (2013CB922102) and the National Natural Science Foundation of China (21075064, 21027013, 21021062, 21275072 and 21201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Aposhian HV, 1997, ANNU REV PHARMACOL, V37, P397, DOI 10.1146/annurev.pharmtox.37.1.397; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; Chen YC, 2003, J OCCUP ENVIRON MED, V45, P241, DOI 10.1097/01.jom.0000058336.05741.e8; Cleland W. W, 1970, ENZYMES, V2, P1; Delano W. L., 2004, PYMOL USERS GUIDE; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; DONG A, 1992, BIOCHEMISTRY-US, V31, P182, DOI 10.1021/bi00116a027; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Francesconi KA, 2004, ANALYST, V129, P373, DOI 10.1039/b401321m; Gailer J, 1999, APPL ORGANOMET CHEM, V13, P837, DOI 10.1002/(SICI)1099-0739(199911)13:11<837::AID-AOC924>3.0.CO;2-Z; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kedderis GL, 2006, CHEM-BIOL INTERACT, V161, P139, DOI 10.1016/j.cbi.2006.04.001; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; KUROKI T, 1987, MUTAGENESIS, V2, P33, DOI 10.1093/mutage/2.1.33; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lu XF, 2003, ANAL CHEM, V75, P6463, DOI 10.1021/ac034868u; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; MCCURDY A, 1992, J AM CHEM SOC, V114, P10314, DOI 10.1021/ja00052a031; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y; Saxena D, 1998, APPL ENVIRON MICROB, V64, P2831; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Sun GF, 2007, ENVIRON HEALTH PERSP, V115, P648, DOI 10.1289/ehp.9271; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Tseng CH, 2005, TOXICOL APPL PHARM, V206, P299, DOI 10.1016/j.taap.2004.11.022; Waddell TG, 2000, ORIGINS LIFE EVOL B, V30, P539, DOI 10.1023/A:1026523222285; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; Wang SP, 2012, J BIOL CHEM, V287, P38790, DOI 10.1074/jbc.M112.368050; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563; Xu YY, 2008, TOXICOL APPL PHARM, V232, P142, DOI 10.1016/j.taap.2008.06.010; YANG JT, 1986, METHOD ENZYMOL, V130, P208	52	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76709	10.1371/journal.pone.0076709	http://dx.doi.org/10.1371/journal.pone.0076709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124590	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100147
J	Preuss, S; Stein, W				Preuss, Stephanie; Stein, Wolfgang			Comparison of Two Voltage-Sensitive Dyes and Their Suitability for Long-Term Imaging of Neuronal Activity	PLOS ONE			English	Article							OPTICAL MEASUREMENT; FUNCTIONAL-ORGANIZATION; STOMATOGASTRIC GANGLION; PYLORIC PATTERN; NEURAL ACTIVITY; NERVOUS-SYSTEM; LOBSTER; RESOLUTION; SIGNALS; NETWORK	One of the key approaches for studying neural network function is the simultaneous measurement of the activity of many neurons. Voltage-sensitive dyes (VSDs) simultaneously report the membrane potential of multiple neurons, but often have pharmacological and phototoxic effects on neuronal cells. Yet, to study the homeostatic processes that regulate neural network function long-term recordings of neuronal activities are required. This study aims to test the suitability of the VSDs RH795 and Di-4-ANEPPS for optically recording pattern generating neurons in the stomatogastric nervous system of crustaceans with an emphasis on long-term recordings of the pyloric central pattern generator. We demonstrate that both dyes stain pyloric neurons and determined an optimal concentration and light intensity for optical imaging. Although both dyes provided sufficient signal-to-noise ratio for measuring membrane potentials, Di-4-ANEPPS displayed a higher signal quality indicating an advantage of this dye over RH795 when small neuronal signals need to be recorded. For Di-4-ANEPPS, higher dye concentrations resulted in faster and brighter staining. Signal quality, however, only depended on excitation light strength, but not on dye concentration. RH795 showed weak and slowly developing phototoxic effects on the pyloric motor pattern as well as slow bleaching of the staining and is thus the better choice for long-term experiments. Low concentrations and low excitation intensities can be used as, in contrast to Di-4-ANEPPS, the signal-to-noise ratio was independent of excitation light strength. In summary, RH795 and Di-4-ANEPPS are suitable for optical imaging in the stomatogastric nervous system of crustaceans. They allow simultaneous recording of the membrane potential of multiple neurons with high signal quality. While Di-4-ANEPPS is better suited for short-term experiments that require high signal quality, RH795 is a better candidate for long-term experiments since it has only minor effects on the motor pattern.	[Preuss, Stephanie] Univ Ulm, Inst Neurobiol, D-89069 Ulm, Germany; [Stein, Wolfgang] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Ulm University; Illinois State University	Stein, W (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	wstein@neurobiologie.de		Preuss, Stephanie/0000-0003-3318-8284	Illinois State University; DFG [STE 937/8-1]	Illinois State University; DFG(German Research Foundation (DFG))	This work was supported by a startup grant from Illinois State University and DFG grant STE 937/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.005.2009; ANTIC S, 1995, J NEUROSCI, V15, P1392; Antic S, 1999, FASEB J, V13, pS271, DOI 10.1096/fasebj.13.9002.S271; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35, DOI 10.1007/3-540-08907-1_2; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dumas JH, 2005, ANN BIOMED ENG, V33, P1802, DOI 10.1007/s10439-005-8466-9; EBNER TJ, 1995, PROG NEUROBIOL, V46, P463, DOI 10.1016/0301-0082(95)00010-S; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1; GRINVALD A, 1985, ANNU REV NEUROSCI, V8, P263; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GUPTA RK, 1981, J MEMBRANE BIOL, V58, P123, DOI 10.1007/BF01870975; Gutierrez Gabrielle J, 2009, J Vis Exp, DOI 10.3791/1207; Harris-Warrick RM, 1992, DYNAMIC BIOIL NETWOR; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P566, DOI 10.1152/jn.1988.59.2.566; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P207, DOI 10.1023/A:1008867702131; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Karlson P, 1980, KURZES LEHRBUCH BIOC; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; LOEW LM, 1981, BIOPHYS J, V34, P353, DOI 10.1016/S0006-3495(81)84854-0; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder Eve, 1992, Pergamon Studies in Neuroscience, V4, P3; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Obaid AL, 1999, J NEUROSCI, V19, P3073; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; ORBACH HS, 1983, J NEUROSCI, V3, P2251; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; POOLER J, 1972, J GEN PHYSIOL, V60, P367, DOI 10.1085/jgp.60.4.367; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; ROSS WN, 1977, J MEMBRANE BIOL, V33, P141, DOI 10.1007/BF01869514; ROSS WN, 1989, P NATL ACAD SCI USA, V86, P1679, DOI 10.1073/pnas.86.5.1679; ROSS WN, 1979, J MEMBRANE BIOL, V48, P343, DOI 10.1007/BF01869445; Sacconi L, 2006, P NATL ACAD SCI USA, V103, P3124, DOI 10.1073/pnas.0511338103; SALZBERG BM, 1993, JPN J PHYSIOL, V43, pS37; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; SCHAFFER P, 1994, PFLUG ARCH EUR J PHY, V426, P548, DOI 10.1007/BF00378533; SENSEMAN DM, 1980, SCIENCE, V208, P1269, DOI 10.1126/science.7375937; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Stadele C, 2012, J NEUROSCI METH, V203, P78, DOI 10.1016/j.jneumeth.2011.09.015; Stein W, 2007, EUR J NEUROSCI, V26, P1148, DOI 10.1111/j.1460-9568.2007.05744.x; Stein W, 2010, J NEUROSCI METH, V188, P290, DOI 10.1016/j.jneumeth.2010.03.003; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuart GJ, 2006, PFLUG ARCH EUR J PHY, V453, P403, DOI 10.1007/s00424-006-0149-3; Swensen AM, 2000, J EXP BIOL, V203, P2075; Tabor R, 2008, EUR J NEUROSCI, V28, P117, DOI 10.1111/j.1460-9568.2008.06316.x; Tsau Y, 1996, J NEUROSCI METH, V70, P121, DOI 10.1016/S0165-0270(96)00109-4; Tsytsarev Vassiliy, 2009, Front Neuroeng, V2, P2, DOI 10.3389/neuro.16.002.2009; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	68	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75678	10.1371/journal.pone.0075678	http://dx.doi.org/10.1371/journal.pone.0075678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124505	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100062
J	Banerjee, S; Sangwan, V; McGinn, O; Chugh, R; Dudeja, V; Vickers, SM; Saluja, AK				Banerjee, Sulagna; Sangwan, Veena; McGinn, Olivia; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok K.			Triptolide-induced Cell Death in Pancreatic Cancer Is Mediated by O-GlcNAc Modification of Transcription Factor Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein; O-GlcNAc; Pancreas; Pancreatic Cancer; Sp1; Minnelide; Triptolide	N-ACETYLGLUCOSAMINE TRANSFERASE; IN-VITRO; KAPPA-B; TUMOR-GROWTH; APOPTOSIS; INHIBITION; EXPRESSION; GENE; ACTIVATION; PATHWAYS	Pancreatic cancer, the fourth most prevalent cancer-related cause of death in the United States, is a disease with a dismal survival rate of 5% 5 years after diagnosis. One of the survival proteins responsible for its extraordinary ability to evade cell death is HSP70. A naturally derived compound, triptolide, and its water-soluble prodrug, Minnelide, down-regulate the expression of this protein in pancreatic cancer cells, thereby causing cell death. However, the mechanism of action of triptolide has not been elucidated. Our study shows that triptolide-induced down-regulation of HSP70 expression is associated with a decrease in glycosylation of the transcription factor Sp1. We further show that triptolide inhibits glycosylation of Sp1, inhibiting the hexosamine biosynthesis pathway, particularly the enzyme O-GlcNAc transferase. Inhibition of O-GlcNAc transferase prevents nuclear localization of Sp1 and affects its DNA binding activity. This in turn down-regulates prosurvival pathways like NF-B, leading to inhibition of HSF1 and HSP70 and eventually to cell death. In this study, we evaluated the mechanism by which triptolide affects glycosylation of Sp1, which in turn affects downstream pathways controlling survival of pancreatic cancer cells.	[Banerjee, Sulagna; Sangwan, Veena; McGinn, Olivia; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Div Basic & Translat Res, Dept Surg, Minneapolis, MN 55455 USA; [Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saluja, AK (corresponding author), Univ Minnesota, Div Basic & Translat Res, Dept Surg, 515 Delaware St SE, Minneapolis, MN 55455 USA.	asaluja@umn.edu	McGinn, Olivia/J-8337-2015	McGinn, Olivia/0000-0003-0769-5581	National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant from NCI [P50 CA101955];  [T32CA132715];  [R01 CA170946];  [CA124723]; NATIONAL CANCER INSTITUTE [P50CA101955, R01CA170946, R01CA124723, T32CA132715] Funding Source: NIH RePORTER	National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant P50 CA101955 from NCI (to S. M. V.), Training Grant T32CA132715 (to R. C.), and Grants R01 CA170946 and CA124723 (to A. K. S.). University of Minnesota has filed a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. A. K. S. and S. M. V. have financial interests in this company. A. K. S., S. M. V., and R. C. are inventors on this patent.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Banerjee S., 2012, PLOS ONE, V7; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Blasco F, 2004, ONCOLOGY-BASEL, V67, P277, DOI 10.1159/000081329; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Krosch TCK, 2013, AM J SURG, V205, P387, DOI 10.1016/j.amjsurg.2013.01.008; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sclabas GM, 2005, CANCER-AM CANCER SOC, V103, P2485, DOI 10.1002/cncr.21075; Shi Q, 2001, CANCER RES, V61, P4143; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tengchaisri T, 1998, CANCER LETT, V133, P169, DOI 10.1016/S0304-3835(98)00222-5; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yang M, 2008, INT J MOL MED, V22, P489, DOI 10.3892/ijmm_00000047; Yang SM, 2003, MOL CANCER THER, V2, P65; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	39	86	89	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33927	33938		10.1074/jbc.M113.500983	http://dx.doi.org/10.1074/jbc.M113.500983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129563	Green Published, hybrid			2022-12-25	WOS:000327250200035
J	Burke, TL; Miller, JL; Grant, PA				Burke, Tara L.; Miller, Jaime L.; Grant, Patrick A.			Direct Inhibition of Gcn5 Protein Catalytic Activity by Polyglutamine-expanded Ataxin-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Histone Acetylase; Histone Modification; Neurodegeneration; Polyglutamine Disease; Protein Complexes; Spinocerebellar Ataxia Type 7	HISTONE ACETYLTRANSFERASE ACTIVITY; IN-VIVO; RETINAL DEGENERATION; REPEAT EXPANSION; HAT COMPLEXES; SAGA; ACETYLATION; RECRUITMENT; DEUBIQUITINATION; IDENTIFICATION	Background: Polyglutamine expansion of the ataxin-7 protein, a subunit of the SAGA (Spt-Ada-Gcn5-acetyltransferase) complex, causes spinocerebellar ataxia type 7. Results: Polyglutamine-expanded ataxin-7 aberrantly binds to SAGA, affecting Gcn5 acetyltransferase activity at SAGA-regulated genes. Conclusion: Ataxin-7 exhibits a dominant-negative effect on Gcn5 catalytic activity in vivo. Significance: We show a direct dominant effect of polyglutamine-expanded ataxin-7 on SAGA acetyltransferase function. Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disease caused by polyglutamine (polyQ) expansion within the N-terminal region of the ataxin-7 protein, a known subunit of the SAGA complex. Although the mechanisms of SCA7 pathogenesis remain poorly understood, previous studies have shown perturbations in SAGA histone acetyltransferase function and transcriptional alterations. We sought to determine whether and how polyQ-expanded ataxin-7 affects SAGA catalytic activity. Here, we determined that polyQ-expanded ataxin-7 directly bound the Gcn5 catalytic core of SAGA while in association with its regulatory proteins, Ada2 and Ada3. This caused a significant decrease in Gcn5 histone acetyltransferase activity in vitro and in vivo at two SAGA-regulated galactose genes, GAL1 and GAL7. However, Gcn5 occupancy at the GAL1 and GAL7 promoters was increased in these cells, revealing a dominant-negative phenotype of the polyQ-expanded ataxin-7-incorporated, catalytically inactive SAGA. These findings suggest a dominant mechanism of polyQ-mediated SAGA inhibition that potentially contributes to SCA7 disease pathogenesis.	[Burke, Tara L.; Miller, Jaime L.; Grant, Patrick A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	pag9n@virginia.edu		Miller, Jaime/0000-0001-8589-9892	National Institutes of Health [R01 NS049065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS049065 (to P.A.G.).	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Burke T. L., 2011, REGULATION ORGANELLE, P109; Chen YC, 2012, HUM MOL GENET, V21, P394, DOI 10.1093/hmg/ddr474; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; McCullough SD, 2012, P NATL ACAD SCI USA, V109, P21319, DOI 10.1073/pnas.1218331110; McCullough SD, 2010, ADV PROTEIN CHEM STR, V79, P165, DOI 10.1016/S1876-1623(10)79005-2; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; McMahon SJ, 2004, METHOD ENZYMOL, V377, P154; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108	32	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34266	34275		10.1074/jbc.M113.487538	http://dx.doi.org/10.1074/jbc.M113.487538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129567	Green Published, hybrid			2022-12-25	WOS:000327250200069
J	Li, X; Nooh, MM; Bahouth, SW				Li, Xin; Nooh, Mohammed M.; Bahouth, Suleiman W.			Role of AKAP79/150 Protein in beta(1)-Adrenergic Receptor Trafficking and Signaling in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; AKAP; Cyclic AMP (cAMP); Fluorescence Resonance Energy Transfer (FRET); G-protein-coupled Receptors (GPCR); Protein Kinase A (PKA); Receptor Recycling; Trafficking	KINASE-ANCHORING PROTEINS; GLUTAMATE RECEPTORS; IN-VIVO; PKA; CARDIOMYOCYTES; CALCINEURIN; ASSOCIATION; MEMBRANE; SCAFFOLD; BETA(1)	Protein kinase A-anchoring proteins (AKAPs) participate in the formation of macromolecular signaling complexes that include protein kinases, ion channels, effector enzymes, and G-protein-coupled receptors. We examined the role of AKAP79/150 (AKAP5) in trafficking and signaling of the (1)-adrenergic receptor ((1)-AR). shRNA-mediated down-regulation of AKAP5 in HEK-293 cells inhibited the recycling of the (1)-AR. Recycling of the (1)-AR in AKAP5 knockdown cells was rescued by shRNA-resistant AKAP5. However, truncated mutants of AKAP5 with deletions in the domains involved in membrane targeting or in binding to calcineurin or PKA failed to restore the recycling of the (1)-AR, indicating that full-length AKAP5 was required. Furthermore, recycling of the (1)-AR in rat neonatal cardiac myocytes was dependent on targeting the AKAP5-PKA complex to the C-terminal tail of the (1)-AR. To analyze the role of AKAP5 more directly, recycling of the (1)-AR was determined in ventricular myocytes from AKAP5(-/-) mice. In AKAP5(-/-) myocytes, the agonist-internalized (1)-AR did not recycle, except when full-length AKAP5 was reintroduced. These data indicate that AKAP5 exerted specific and profound effects on (1)-AR recycling in mammalian cells. Biochemical or real time FRET-based imaging of cyclic AMP revealed that deletion of AKAP5 sensitized the cardiac (1)-AR signaling pathway to isoproterenol. Moreover, isoproterenol-mediated increase in contraction rate, surface area, or expression of -myosin heavy chains was significantly greater in AKAP5(-/-) myocytes than in AKAP5(+/+) myocytes. These results indicate a significant role for the AKAP5 scaffold in signaling and trafficking of the (1)-AR in cardiac myocytes and mammalian cells.	[Li, Xin; Nooh, Mohammed M.; Bahouth, Suleiman W.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Bahouth, SW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@uthsc.edu		Nooh, Mohammed/0000-0001-9794-4099	National Institutes of Health [HL-085848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-085848 (to S. W. B.).	Bahouth SW, 1997, J MOL CELL CARDIOL, V29, P3223, DOI 10.1006/jmcc.1997.0549; Baker JG, 2011, FASEB J, V25, P4486, DOI 10.1096/fj.11-192435; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHN JN, 1989, AM J HYPERTENS, V2, pS353; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Devic E, 2001, MOL PHARMACOL, V60, P577; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gooch JL, 2006, J CELL SCI, V119, P2468, DOI 10.1242/jcs.02971; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Horvat SJ, 2012, FASEB J, V26, P3670, DOI 10.1096/fj.11-201020; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jo IH, 2001, AM J PHYSIOL-RENAL, V281, pF958; Jones BW, 2012, P NATL ACAD SCI USA, V109, P17099, DOI 10.1073/pnas.1215219109; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOWALSKI MT, 1990, BRIT J PHARMACOL, V99, P27, DOI 10.1111/j.1476-5381.1990.tb14648.x; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schafer M, 2000, AM J PHYSIOL-CELL PH, V279, pC495, DOI 10.1152/ajpcell.2000.279.2.C495; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; YU SS, 1993, J BIOL CHEM, V268, P337	56	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33797	33812		10.1074/jbc.M113.470559	http://dx.doi.org/10.1074/jbc.M113.470559			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121510	Green Published, hybrid			2022-12-25	WOS:000327250200025
J	Yan, YL; Shapiro, AP; Haller, S; Katragadda, V; Liu, LJ; Tian, J; Basrur, V; Malhotra, D; Xie, ZJ; Abraham, NG; Shapiro, JI; Liu, J				Yan, Yanling; Shapiro, Anna P.; Haller, Steven; Katragadda, Vinai; Liu, Lijun; Tian, Jiang; Basrur, Venkatesha; Malhotra, Deepak; Xie, Zi-jian; Abraham, Nader G.; Shapiro, Joseph I.; Liu, Jiang			Involvement of Reactive Oxygen Species in a Feed-forward Mechanism of Na/K-ATPase-mediated Signaling Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypertension; NAK-ATPase; Reactive Oxygen Species (ROS); Signal Transduction; Sodium Transport; Na; K-ATPase Signaling	ENDOGENOUS CARDIOTONIC STEROIDS; SALT-SENSITIVE RATS; NA+/K+-ATPASE; STATISTICAL-MODEL; OXIDATIVE STRESS; LLC-PK1 CELLS; SODIUM-PUMP; K+-ATPASE; OUABAIN; SRC	Background: Na/K-ATPase signaling regulates sodium reabsorption in renal proximal tubules. Results: Carbonylation modification of the Na/K-ATPase 1 subunit regulates Na/K-ATPase signaling and subsequent transepithelial sodium transport. Conclusion: ROS is involved in the Na/K-ATPase signaling transduction in a feed-forward mechanism. Significance: ROS regulates Na/K-ATPase signaling and sodium transport in LLC-PK1 cells. Cardiotonic steroids (such as ouabain) signaling through Na/K-ATPase regulate sodium reabsorption in the renal proximal tubule. We report here that reactive oxygen species are required to initiate ouabain-stimulated Na/K-ATPasec-Src signaling. Pretreatment with the antioxidant N-acetyl-l-cysteine prevented ouabain-stimulated Na/K-ATPasec-Src signaling, protein carbonylation, redistribution of Na/K-ATPase and sodium/proton exchanger isoform 3, and inhibition of active transepithelial Na-22(+) transport. Disruption of the Na/K-ATPasec-Src signaling complex attenuated ouabain-stimulated protein carbonylation. Ouabain-stimulated protein carbonylation is reversed after removal of ouabain, and this reversibility is largely independent of de novo protein synthesis and degradation by either the lysosome or the proteasome pathways. Furthermore, ouabain stimulated direct carbonylation of two amino acid residues in the actuator domain of the Na/K-ATPase 1 subunit. Taken together, the data indicate that carbonylation modification of the Na/K-ATPase 1 subunit is involved in a feed-forward mechanism of regulation of ouabain-mediated renal proximal tubule Na/K-ATPase signal transduction and subsequent sodium transport.	[Yan, Yanling; Abraham, Nader G.; Shapiro, Joseph I.; Liu, Jiang] Marshall Univ, JCE Sch Med, Dept Pharmacol Physiol & Toxicol, Huntington, WV 25755 USA; [Shapiro, Anna P.; Haller, Steven; Katragadda, Vinai; Tian, Jiang; Malhotra, Deepak; Xie, Zi-jian; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA; [Liu, Lijun; Tian, Jiang; Xie, Zi-jian] Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; [Yan, Yanling] Yanshan Univ, Inst Biomed Engn, Qinhuangdao 066004, Peoples R China; [Basrur, Venkatesha] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Marshall University; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Yanshan University; University of Michigan System; University of Michigan	Liu, J (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Pharmacol Physiol & Toxicol, 1 John Marshall Dr, Huntington, WV 25755 USA.	liuj@marshall.edu	Liu, Jiang/AAF-2742-2021; Yan, Yanling/AAX-1691-2020; Yan, Yanling/AAE-8460-2021	Yan, Yanling/0000-0001-6549-3393; 	National Institutes of Health [RO1 HL-109015, RO1 HL-105649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105649, R01HL109015, P01HL034300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-109015 (to Z.X. and J.I.S.) and RO1 HL-105649 (to J.T.).	Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bizzozero OA, 2006, J NEUROSCI RES, V83, P656, DOI 10.1002/jnr.20771; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; Dasgupta A, 2012, ASN NEURO, V4, DOI 10.1042/AN20110064; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; Fedorova OV, 2000, CIRCULATION, V102, P3009; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GROSS CL, 1993, CELL BIOL TOXICOL, V9, P259, DOI 10.1007/BF00755604; Han HJ, 2005, AM J PHYSIOL-RENAL, V288, pF988, DOI 10.1152/ajprenal.00327.2004; HUANG WH, 1992, INT J BIOCHEM, V24, P621; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy DJ, 2006, AM J PHYSIOL-HEART C, V291, pH3003, DOI 10.1152/ajpheart.00603.2006; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; Liu J, 2000, J BIOL CHEM, V275, P27838; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu J, 2011, J BIOL CHEM, V286, P22806, DOI 10.1074/jbc.M111.246249; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2006, FREE RADICAL BIO MED, V41, P1548, DOI 10.1016/j.freeradbiomed.2006.08.018; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Mokry M, 2008, HYPERTENSION, V51, P922, DOI 10.1161/HYPERTENSIONAHA.107.108415; Nesher M, 2009, AM J PHYSIOL-HEART C, V297, pH2026, DOI 10.1152/ajpheart.00734.2009; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NISHI A, 1993, ACTA PHYSIOL SCAND, V149, P377, DOI 10.1111/j.1748-1716.1993.tb09633.x; Panico C, 2009, HYPERTENSION, V54, P1291, DOI 10.1161/HYPERTENSIONAHA.109.134783; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Periyasamy SM, 2005, KIDNEY INT, V67, P1868, DOI 10.1111/j.1523-1755.2005.00285.x; Petrushanko IY, 2012, J BIOL CHEM, V287, P32195, DOI 10.1074/jbc.M112.391094; Qiang W, 1999, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V21, P175; Schoner W, 2008, NEPHROL DIAL TRANSPL, V23, P2723, DOI 10.1093/ndt/gfn325; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zanetti M, 2005, METH MOLEC MED, V108, P65; Zhang CJ, 2002, NITRIC OXIDE-BIOL CH, V7, P30, DOI 10.1016/S1089-8603(02)00003-4; Zheng J, 2010, FREE RADICAL RES, V44, P258, DOI 10.3109/10715760903456092	50	68	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34249	34258		10.1074/jbc.M113.461020	http://dx.doi.org/10.1074/jbc.M113.461020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121502	Green Published, hybrid			2022-12-25	WOS:000327250200067
J	Voet, A; Berenger, F; Zhang, KYJ				Voet, Arnout; Berenger, Francois; Zhang, Kam Y. J.			Electrostatic Similarities between Protein and Small Molecule Ligands Facilitate the Design of Protein-Protein Interaction Inhibitors	PLOS ONE			English	Article							DISCOVERY; SHAPE; IDENTIFICATION; BENCHMARKING; RECOGNITION; POTENTIALS; INTERFACES; LESSONS; DOCKING; BINDING	One of the underlying principles in drug discovery is that a biologically active compound is complimentary in shape and molecular recognition features to its receptor. This principle infers that molecules binding to the same receptor may share some common features. Here, we have investigated whether the electrostatic similarity can be used for the discovery of small molecule protein-protein interaction inhibitors (SMPPIIs). We have developed a method that can be used to evaluate the similarity of electrostatic potentials between small molecules and known protein ligands. This method was implemented in a software called EleKit. Analyses of all available (at the time of research) SMPPII structures indicate that SMPPIIs bear some similarities of electrostatic potential with the ligand proteins of the same receptor. This is especially true for the more polar SMPPIIs. Retrospective analysis of several successful SMPPIIs has shown the applicability of EleKit in the design of new SMPPIIs.	[Voet, Arnout; Berenger, Francois; Zhang, Kam Y. J.] RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan	RIKEN	Zhang, KYJ (corresponding author), RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan.	kamzhang@riken.jp	Zhang, Kam Y. J./B-3552-2012; Berenger, Francois/ABH-8997-2020; voet, arnout/O-5248-2014	Zhang, Kam Y. J./0000-0002-9282-8045; Berenger, Francois/0000-0003-1377-944X; voet, arnout/0000-0002-3329-2703	JSPS; Initiative Research Unit program from RIKEN, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Initiative Research Unit program from RIKEN, Japan	This work was supported by the JSPS and the Initiative Research Unit program from RIKEN, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Armstrong MS, 2010, J COMPUT AID MOL DES, V24, P789, DOI 10.1007/s10822-010-9374-0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; Cavalluzzo C, 2012, RSC ADV, V2, P974, DOI 10.1039/c1ra00582k; Chau PL, 1994, J COMPUT AID MOL DES, V8, P51325; Chemical Computing Group Inc, 2011, MOL OP ENV MOE; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Danelutto M, 2012, PROCEDIA COMPUT SCI, V9, P1837, DOI 10.1016/j.procs.2012.04.202; Dias R, 2008, CURR DRUG TARGETS, V9, P1040, DOI 10.2174/138945008786949432; Dlugosz M, 2012, J PHYS CHEM B, V116, P5437, DOI 10.1021/jp301265y; Dlugosz M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2948414; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fry DC, 2008, CURR PROTEIN PEPT SC, V9, P240, DOI 10.2174/138920308784533989; Fry DC, 2012, CURR PHARM DESIGN, V18, P4679; Gorham RD, 2011, ANN BIOMED ENG, V39, P1252, DOI 10.1007/s10439-010-0226-9; Hartman G, 1992, J MED CHEM, V35, P46402; HODGKIN EE, 1987, INT J QUANTUM CHEM, V14, P105; Horvath D, 2011, METHODS MOL BIOL, V672, P261, DOI 10.1007/978-1-60761-839-3_11; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Kieslich CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002840; Kieslich CA, 2011, BIOTECHNOL PROGR, V27, P316, DOI 10.1002/btpr.541; Leroy X, 2011, OCAML SYSTEM RELEASE; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Muchmore SW, 2006, CHEM BIOL DRUG DES, V67, P174, DOI 10.1111/j.1747-0285.2006.00341.x; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Neudert G, 2011, BIOINFORMATICS, V27, P1021, DOI 10.1093/bioinformatics/btr055; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nray-Szab G, 1993, J MOL RECOGNIT, V6, P205; OpenEye Scientific Software Inc, 2010, OECHEM 1 7 4; PETKE JD, 1993, J COMPUT CHEM, V14, P928, DOI 10.1002/jcc.540140808; Press W.H., 2007, NUMERICAL RECIPES AR; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Ullmann GM, 1997, BIOCHEMISTRY-US, V36, P16187, DOI 10.1021/bi971241v; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Villoutreix BO, 2012, CURR PHARM DESIGN, V18, P4648; Voet A, 2013, CURR TOP MED CHEM, V13, P989, DOI 10.2174/1568026611313090003; Voet A, 2012, CURR PHARM DESIGN, V18, P4586, DOI 10.2174/138161212802651616; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	49	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75762	10.1371/journal.pone.0075762	http://dx.doi.org/10.1371/journal.pone.0075762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130741	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200022
J	Perry, C; Pick, M; Bdolach, N; Hazan-Halevi, I; Kay, S; Berr, I; Reches, A; Harishanu, Y; Grisaru, D				Perry, Chava; Pick, Marjorie; Bdolach, Nir; Hazan-Halevi, Inbal; Kay, Sigi; Berr, Idit; Reches, Adi; Harishanu, Yair; Grisaru, Dan			Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TGF-BETA; IMMUNE FUNCTION; PHYSICAL-ACTIVITY; ASTHMA; INFLAMMATION; MECHANISMS; CYTOKINE; RESPONSES; MARATHON	Endurance, marathon-type exertion is known to induce adverse changes in the immune system. Increased airway hyper-responsiveness and airway inflammation are well documented in endurance athletes and endurance exercise is considered a major risk factor for asthma in elite athletes. Yet, the mechanisms underlying this phenomenon are still to be deduced. We studied the effect of strenuous endurance exercise (marathon and half-ironman triathlon) on CD4+ lymphocyte sub-populations and on the balance between effector and regulatory CD4+ lymphocytes in the peripheral blood of trained athletes, Endurance exercise induced a significant increase in Th17 cells and a sustained decrease in peripheral blood regulatory T cells (Tregs). While interleukin (IL)-2 levels remained undetectable, post-race serum IL-6 and transforming growth factor (TGF) beta levels were significantly elevated. Treg levels in sedentary controls' decreased in vitro after incubation with athletes' post-exercise serum, an effect that was attenuated by supplements of IL-2 or anti IL-6 neutralizing antibodies. Our data suggest that exercise-induced changes in serum cytokine levels promote alterations in Tregs and Th17 cell populations, which may divert the subtle balance in the immune system towards inflammation. This may explain allergic and autoimmune phenomena previously reported in endurance athletes and contribute to our understanding of exercise-related asthma.	[Perry, Chava; Hazan-Halevi, Inbal; Kay, Sigi; Berr, Idit; Harishanu, Yair] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel; [Pick, Marjorie] Hebrew Univ Jerusalem, Dept Hematol, Hadassah Univ Hosp, Jerusalem, Israel; [Bdolach, Nir; Reches, Adi; Grisaru, Dan] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol Unit,Lis Matern Hosp, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Perry, C (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-69978 Tel Aviv, Israel.	chavap@tlvmc.gov.il			Department of Hematology, Tel Aviv Medical Center	Department of Hematology, Tel Aviv Medical Center	The work was funded by Department of Hematology, Tel Aviv Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaranta A, 2004, MED SCI SPORT EXER, V36, P919, DOI 10.1249/01.MSS.0000128250.17793.47; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Balen S, 2008, COLLEGIUM ANTROPOL, V32, P285; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Das UN, 2004, NUTRITION, V20, P323, DOI 10.1016/j.nut.2003.11.017; Das UN, 2006, EUR HEART J, V27, P1385, DOI 10.1093/eurheartj/ehi867; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Haahtela T, 2008, ALLERGY, V63, P685, DOI 10.1111/j.1398-9995.2008.01686.x; Helenius I, 2002, J ALLERGY CLIN IMMUN, V109, P962, DOI 10.1067/mai.2002.124769; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nicklas BJ, 2008, J AM GERIATR SOC, V56, P2045, DOI 10.1111/j.1532-5415.2008.01994.x; Nieman DC, 1999, SPORTS MED, V27, P73, DOI 10.2165/00007256-199927020-00001; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; Nystad W, 2000, MED SCI SPORT EXER, V32, P266, DOI 10.1097/00005768-200002000-00003; Robson-Ansley P, 2012, MED SCI SPORT EXER, V44, P999, DOI 10.1249/MSS.0b013e318243253d; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Suzuki K, 2002, EXERC IMMUNOL REV, V8, P6; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Xu QY, 2007, J IMMUNOL, V178, P3983, DOI 10.4049/jimmunol.178.6.3983; Yegutkin GG, 2007, J PHYSIOL-LONDON, V579, P553, DOI 10.1113/jphysiol.2006.119453; Yeh SH, 2006, BRIT J SPORT MED, V40, P239, DOI 10.1136/bjsm.2005.022095; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	37	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74722	10.1371/journal.pone.0074722	http://dx.doi.org/10.1371/journal.pone.0074722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130669	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900005
J	Salih, MA; Mundwiller, E; Khan, AO; AlDrees, A; Elmalik, SA; Hassan, HH; Al-Owain, M; Alkhalidi, HMS; Katona, I; Kabiraj, MM; Chrast, R; Kentab, AY; Alzaidan, H; Rodenburg, RJ; Bosley, TM; Weis, J; Koenig, M; Stevanin, G; Azzedine, H				Salih, Mustafa A.; Mundwiller, Emeline; Khan, Arif O.; AlDrees, Abdulmajeed; Elmalik, Salah A.; Hassan, Hamdy H.; Al-Owain, Mohammed; Alkhalidi, Hisham M. S.; Katona, Istvan; Kabiraj, Mohammad M.; Chrast, Roman; Kentab, Amal Y.; Alzaidan, Hamad; Rodenburg, Richard J.; Bosley, Thomas M.; Weis, Joachim; Koenig, Michel; Stevanin, Giovanni; Azzedine, Hamid			New Findings in a Global Approach to Dissect the Whole Phenotype of PLA2G6 Gene Mutations	PLOS ONE			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; PHOSPHOLIPASE A(2); PARKINSONISM; DEFICIENCY; SPECTRUM	Mutations in PLA2G6 gene have variable phenotypic outcome including infantile neuroaxonal dystrophy, atypical neuroaxonal dystrophy, idiopathic neurodegeneration with brain iron accumulation and Karak syndrome. The cause of this phenotypic variation is so far unknown which impairs both genetic diagnosis and appropriate family counseling. We report detailed clinical, electrophysiological, neuroimaging, histologic, biochemical and genetic characterization of 11 patients, from 6 consanguineous families, who were followed for a period of up to 17 years. Cerebellar atrophy was constant and the earliest feature of the disease preceding brain iron accumulation, leading to the provisional diagnosis of a recessive progressive ataxia in these patients. Ultrastructural characterization of patients' muscle biopsies revealed focal accumulation of granular and membranous material possibly resulting from defective membrane homeostasis caused by disrupted PLA2G6 function. Enzyme studies in one of these muscle biopsies provided evidence for a relatively low mitochondrial content, which is compatible with the structural mitochondrial alterations seen by electron microscopy. Genetic characterization of 11 patients led to the identification of six underlying PLA2G6 gene mutations, five of which are novel. Importantly, by combining clinical and genetic data we have observed that while the phenotype of neurodegeneration associated with PLA2G6 mutations is variable in this cohort of patients belonging to the same ethnic background, it is partially influenced by the genotype, considering the age at onset and the functional disability criteria. Molecular testing for PLA2G6 mutations is, therefore, indicated in childhood-onset ataxia syndromes, if neuroimaging shows cerebellar atrophy with or without evidence of iron accumulation.	[Salih, Mustafa A.; Kentab, Amal Y.] King Saud Univ, Coll Med, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; [Mundwiller, Emeline; Stevanin, Giovanni] Grp Hosp Pitie Salpetriere, Genotyping & Sequencing Facil, Inst Cerveau & Moelle Epiniere ICM, F-75634 Paris, France; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Div Paediat Ophthalmol, Riyadh, Saudi Arabia; [AlDrees, Abdulmajeed; Elmalik, Salah A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11461, Saudi Arabia; [Hassan, Hamdy H.] King Saud Univ, Coll Med, Dept Radiol, Riyadh 11461, Saudi Arabia; [Al-Owain, Mohammed; Alzaidan, Hamad] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Alkhalidi, Hisham M. S.] King Saud Univ, Coll Med, Dept Pathol, Riyadh 11461, Saudi Arabia; [Katona, Istvan; Weis, Joachim] Univ Klinikum RWTH, Inst Neuropathol, Aachen, Germany; [Kabiraj, Mohammad M.] Armed Forces Hosp, Dept Neurosci, Riyadh, Saudi Arabia; [Chrast, Roman; Azzedine, Hamid] Univ Lausanne, Dept Med Genet, Fac Biol & Med, Lausanne, Switzerland; [Rodenburg, Richard J.] Radboud Univ Nijmegen, Lab Genet Endocrine & Metab disorders LGEM 774, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat,Dept Lab Med,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Bosley, Thomas M.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Bosley, Thomas M.] Cooper Univ Hosp, Div Neurol, Camden, NJ USA; [Koenig, Michel] Univ Strasbourg, INSERM, CNRS, IGBMC, Illkirch Graffenstaden, France; [Koenig, Michel] Coll France, Illkirch Graffenstaden, France; [Stevanin, Giovanni] EPHE, F-75006 Paris, France; [Stevanin, Giovanni] INSERM, U975, Paris, France; [Stevanin, Giovanni] CNRS, UMR 7225, Paris, France; [Stevanin, Giovanni] Univ Paris 06, UMR S 975, Ctr Rech, Inst Cerveau & Moelle Epiniere,GHPS, Paris, France; [Stevanin, Giovanni] GPHS, AP HP, Dept Genet & Cytogenet, Paris, France	King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; King Khaled Eye Specialist Hospital; King Saud University; King Saud University; King Faisal Specialist Hospital & Research Center; King Saud University; RWTH Aachen University; RWTH Aachen University Hospital; Prince Sultan Military Medical City; University of Lausanne; Radboud University Nijmegen; King Saud University; Cooper University Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Azzedine, H (corresponding author), Univ Lausanne, Dept Med Genet, Fac Biol & Med, Lausanne, Switzerland.	Hamid.Azzeddine@yahoo.fr	Stevanin, Giovanni/E-5038-2016; AL-DREES, ABDULMAJEED A/N-9534-2016; Rodenburg, Richard/N-3579-2014; Salih, Mustafa/C-1222-2014; Katona, Istvan/I-6704-2016; Weis, Joachim/G-1984-2014	Stevanin, Giovanni/0000-0001-9368-8657; AL-DREES, ABDULMAJEED A/0000-0002-3125-050X; Rodenburg, Richard/0000-0001-5227-3527; Salih, Mustafa/0000-0002-4379-2111; Katona, Istvan/0000-0002-0955-8911; Weis, Joachim/0000-0003-3280-6773; Chrast, Roman/0000-0003-4189-3514; Kentab, Amal/0000-0002-3627-4973	King Saud University, Riyadh, Saudi Arabia [RGP-VPP]; Gebert Ruf Foundation [GRS-046/09]; French National Agency for Research(ANR); Association Contre les Syndromes Cerebelleux, France; Verum Foundation; European Union (Omics call, "Neuromics"); Fondation Roger de Spoelberch; program "Investissements d'avenir" [ANR-10-IAIHU-06]; Association Francaise contre les Myopathies (AFM), France	King Saud University, Riyadh, Saudi Arabia(King Saud University); Gebert Ruf Foundation; French National Agency for Research(ANR)(French National Research Agency (ANR)); Association Contre les Syndromes Cerebelleux, France; Verum Foundation; European Union (Omics call, "Neuromics"); Fondation Roger de Spoelberch; program "Investissements d'avenir"(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM), France(Association Francaise contre les Myopathies)	MAM and co-authors are thankful to the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, for supporting the work through the research group project number RGP-VPP. RC was supported by the Gebert Ruf Foundation (grant number GRS-046/09). GS was supported by the French National Agency for Research(ANR), Association Contre les Syndromes Cerebelleux, France, The Verum Foundation, the European Union (Omics call, "Neuromics"), The Fondation Roger de Spoelberch and the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute). HA was supported by Association Francaise contre les Myopathies (AFM), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoum M, 2013, CEREBELLUM; Assoum M, 2010, BRAIN, V133, P2439, DOI 10.1093/brain/awq181; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Biancheri R, 2007, EUR J PAEDIATR NEURO, V11, P175, DOI 10.1016/j.ejpn.2006.11.013; Bower MA, 2011, MOVEMENT DISORD, V26, P1768, DOI 10.1002/mds.23617; Carrilho I, 2008, EUR J PAEDIATR NEURO, V12, P491, DOI 10.1016/j.ejpn.2008.01.005; FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735; Garcia A, 2000, CLIN NEUROPHYSIOL, V111, P513, DOI 10.1016/S1388-2457(99)00279-5; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Grosser HR, 2007, EUR RESPIR J, V1, P73; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kimura J, 2001, ELECTRODIAGNOSIS DIS, P109; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lu CS, 2012, AM J MED GENET B, V159B, P183, DOI 10.1002/ajmg.b.32012; Mehler MF, 2009, BRAIN RES REV, V59, P388, DOI 10.1016/j.brainresrev.2008.11.001; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mubaidin A, 2003, J MED GENET, V40, P543, DOI 10.1136/jmg.40.7.543; Oh SJ, 2003, CLIN ELECTROMYOGRAPH, V3rd; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Preston DC, 2005, ELECTROMYOGRAPHY NEU, P628; SALIH MAM, 1990, J CHILD NEUROL, V5, P321, DOI 10.1177/088307389000500410; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; SPERL W, 1990, EUR J PEDIATR, V149, P487, DOI 10.1007/BF01959401; Tonelli A, 2010, CLIN GENET, V78, P432, DOI 10.1111/j.1399-0004.2010.01417.x; WEIS J, 1995, MUSCLE NERVE, V18, P175, DOI 10.1002/mus.880180205; Wu Y, 2009, EUR J NEUROL, V16, P240, DOI 10.1111/j.1468-1331.2008.02397.x; Yoshino H, 2010, NEUROLOGY, V75, P1356, DOI 10.1212/WNL.0b013e3181f73649; Zhao ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026991; Zhao ZS, 2011, ENDOCRINOLOGY, V152, P336; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	36	31	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76831	10.1371/journal.pone.0076831	http://dx.doi.org/10.1371/journal.pone.0076831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130795	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900090
J	Smith, HC; Pollock, K; Waples, K; Bradley, S; Bejder, L				Smith, Holly C.; Pollock, Ken; Waples, Kelly; Bradley, Stuart; Bejder, Lars			Use of the Robust Design to Estimate Seasonal Abundance and Demographic Parameters of a Coastal Bottlenose Dolphin (Tursiops aduncus) Population	PLOS ONE			English	Article							CAPTURE-RECAPTURE; TEMPORARY EMIGRATION; PHOTOGRAPHIC IDENTIFICATION; SITE FIDELITY; GROUP-SIZE; SHARK BAY; TRUNCATUS; PATTERNS; SURVIVAL; HABITAT	As delphinid populations become increasingly exposed to human activities we rely on our capacity to produce accurate abundance estimates upon which to base management decisions. This study applied mark-recapture methods following the Robust Design to estimate abundance, demographic parameters, and temporary emigration rates of an Indo-Pacific bottlenose dolphin (Tursiops aduncus) population off Bunbury, Western Australia. Boat-based photo-identification surveys were conducted year-round over three consecutive years along pre-determined transect lines to create a consistent sampling effort throughout the study period and area. The best fitting capture-recapture model showed a population with a seasonal Markovian temporary emigration with time varying survival and capture probabilities. Abundance estimates were seasonally dependent with consistently lower numbers obtained during winter and higher during summer and autumn across the three-year study period. Specifically, abundance estimates for all adults and juveniles (combined) varied from a low of 63 (95% CI 59 to 73) in winter of 2007 to a high of 139 (95% CI 134 to148) in autumn of 2009. Temporary emigration rates (gamma') for animals absent in the previous period ranged from 0.34 to 0.97 (mean = 0.54; +/- SE 0.11) with a peak during spring. Temporary emigration rates for animals present during the previous period (gamma '') were lower, ranging from 0.00 to 0.29, with a mean of 0.16 (+/- SE 0.04). This model yielded a mean apparent survival estimate for juveniles and adults (combined) of 0.95 (+/- SE 0.02) and a capture probability from 0.07 to 0.51 with a mean of 0.30 (+/- SE 0.04). This study demonstrates the importance of incorporating temporary emigration to accurately estimate abundance of coastal delphinids. Temporary emigration rates were high in this study, despite the large area surveyed, indicating the challenges of sampling highly mobile animals which range over large spatial areas.	[Smith, Holly C.; Pollock, Ken; Waples, Kelly; Bradley, Stuart; Bejder, Lars] Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, Perth, WA, Australia; [Smith, Holly C.; Waples, Kelly] Dept Environm & Conservat, Nat Conservat Div, Marine Sci Program, Perth, WA, Australia; [Pollock, Ken] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	Murdoch University; University of North Carolina; North Carolina State University	Smith, HC (corresponding author), Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Sch Vet & Life Sci, Perth, WA, Australia.	h.smith@murdoch.edu.au	Bejder, Lars/D-1772-2017	Bejder, Lars/0000-0001-8138-8606; Raudino, Holly/0000-0002-2661-6431	South West Marine Research Program; Bemax Cable Sands; BHP Billiton Worsley Alumina Pty Ltd; Bunbury Dolphin Discovery Centre; Bunbury Port Authority; City of Bunbury; Cristal Global; Department of Environment and Conservation; Iluka; Millard Marine; Naturaliste Charters; Newmont Boddington Gold; South West Development Commission; WA Plantation Resources; Murdoch University	South West Marine Research Program; Bemax Cable Sands; BHP Billiton Worsley Alumina Pty Ltd; Bunbury Dolphin Discovery Centre; Bunbury Port Authority; City of Bunbury; Cristal Global; Department of Environment and Conservation; Iluka; Millard Marine; Naturaliste Charters; Newmont Boddington Gold; South West Development Commission; WA Plantation Resources; Murdoch University	This project was financially and logistically supported by the partners of the South West Marine Research Program. These include Bemax Cable Sands, BHP Billiton Worsley Alumina Pty Ltd, Bunbury Dolphin Discovery Centre, Bunbury Port Authority, the City of Bunbury, Cristal Global, Department of Environment and Conservation, Iluka, Millard Marine, Naturaliste Charters, Newmont Boddington Gold, South West Development Commission and WA Plantation Resources. HS was supported by a Murdoch University scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Beasley I, 2013, MAR MAMMAL SCI, V29, pE226, DOI 10.1111/j.1748-7692.2012.00614.x; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; Currey RJC, 2008, NEW ZEAL J MAR FRESH, V42, P439, DOI 10.1080/00288330809509972; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Genov Tilen, 2008, Annales Series Historia Naturalis, V18, P227; Gowans S, 2001, MAR MAMMAL SCI, V17, P76, DOI 10.1111/j.1748-7692.2001.tb00981.x; Gubbins C, 2002, J MAMMAL, V83, P178, DOI 10.1644/1545-1542(2002)083<0178:UOHRBR>2.0.CO;2; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kendall W. L., 2004, Animal Biodiversity and Conservation, V27, P97; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Krebs, 2001, ECOLOGY; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Reynolds J. R. I., 2000, BOTTLENOSE DOLPHIN B; Rosel PE, 2011, NMFSSEFSC621 NOAA, P38; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Straley JM, 2009, J BIOGEOGR, V36, P427, DOI 10.1111/j.1365-2699.2008.01906.x; Toth JL, 2012, MAR MAMMAL SCI, V28, P461, DOI 10.1111/j.1748-7692.2011.00497.x; Urian K., 1999, 425 NMFSSEFSC NAT OC, P22; Urian KW, 2009, MAR MAMMAL SCI, V25, P619, DOI 10.1111/j.1748-7692.2009.00284.x; Verborgh P, 2009, MAR MAMMAL SCI, V25, P523, DOI 10.1111/j.1748-7692.2008.00280.x; Vermeulen Els, 2009, Aquatic Mammals, V35, P378, DOI 10.1578/AM.35.3.2009.378; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Watson-Capps JJ, 2005, BIOL CONSERV, V124, P519, DOI 10.1016/j.biocon.2005.03.001; Wells R.S., 1991, P199; Wells RS, 2008, MAR MAMMAL SCI, V24, P774, DOI 10.1111/j.1748-7692.2008.00212.x; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams K. B., 2002, ANAL MANAGEMENT ANIM, P3; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	53	67	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76574	10.1371/journal.pone.0076574	http://dx.doi.org/10.1371/journal.pone.0076574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130781	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900077
J	Watanabe, M; Nakano, K; Matsunari, H; Matsuda, T; Maehara, M; Kanai, T; Kobayashi, M; Matsumura, Y; Sakai, R; Kuramoto, M; Hayashida, G; Asano, Y; Takayanagi, S; Arai, Y; Umeyama, K; Nagaya, M; Hanazono, Y; Nagashima, H				Watanabe, Masahito; Nakano, Kazuaki; Matsunari, Hitomi; Matsuda, Taisuke; Maehara, Miki; Kanai, Takahiro; Kobayashi, Mirina; Matsumura, Yukina; Sakai, Rieko; Kuramoto, Momoko; Hayashida, Gota; Asano, Yoshinori; Takayanagi, Shuko; Arai, Yoshikazu; Umeyama, Kazuhiro; Nagaya, Masaki; Hanazono, Yutaka; Nagashima, Hiroshi			Generation of Interleukin-2 Receptor Gamma Gene Knockout Pigs from Somatic Cells Genetically Modified by Zinc Finger Nuclease-Encoding mRNA	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; EMBRYO MICROINJECTION; LYMPHOID DEVELOPMENT; CLONED PIGS; MICE; DISRUPTION; CLONING; MODEL; CHAIN; RATS	Zinc finger nuclease (ZFN) is a powerful tool for genome editing. ZFN-encoding plasmid DNA expression systems have been recently employed for the generation of gene knockout (KO) pigs, although one major limitation of this technology is the use of potentially harmful genome-integrating plasmid DNAs. Here we describe a simple, non-integrating strategy for generating KO pigs using ZFN-encoding mRNA. The interleukin-2 receptor gamma (IL2RG) gene was knocked out in porcine fetal fibroblasts using ZFN-encoding mRNAs, and IL2RG KO pigs were subsequently generated using these KO cells through somatic cell nuclear transfer (SCNT). The resulting IL2RG KO pigs completely lacked a thymus and were deficient in T and NK cells, similar to human X-linked SCID patients. Our findings demonstrate that the combination of ZFN-encoding mRNAs and SCNT provides a simple robust method for producing KO pigs without genomic integration.	[Watanabe, Masahito; Nakano, Kazuaki; Matsunari, Hitomi; Matsuda, Taisuke; Maehara, Miki; Kanai, Takahiro; Kobayashi, Mirina; Matsumura, Yukina; Sakai, Rieko; Kuramoto, Momoko; Hayashida, Gota; Asano, Yoshinori; Takayanagi, Shuko; Arai, Yoshikazu; Umeyama, Kazuhiro; Nagashima, Hiroshi] Meiji Univ, Lab Dev Engn, Dept Life Sci, Sch Agr, Kawasaki, Kanagawa, Japan; [Watanabe, Masahito; Matsunari, Hitomi; Umeyama, Kazuhiro; Nagaya, Masaki; Nagashima, Hiroshi] MUIIBR, Kawasaki, Kanagawa, Japan; [Hanazono, Yutaka] Jichi Med Univ, Div Regenerat Med, Ctr Mol Med, Shimotsuke, Tochigi, Japan; [Hanazono, Yutaka; Nagashima, Hiroshi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Meiji University; Jichi Medical University; Japan Science & Technology Agency (JST)	Nagashima, H (corresponding author), Meiji Univ, Lab Dev Engn, Dept Life Sci, Sch Agr, Kawasaki, Kanagawa, Japan.	hnagas@isc.meiji.ac.jp		Nagashima, Hiroshi/0000-0001-9940-8783	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Meiji University International Institute for Bio-Resource Research (MUIIBR)	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Meiji University International Institute for Bio-Resource Research (MUIIBR)	This work was supported by the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency and by the Meiji University International Institute for Bio-Resource Research (MUIIBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Forsberg EJ, 2002, BIOL REPROD, V67, P327, DOI 10.1095/biolreprod67.1.327; Fujimura T, 2008, J REPROD DEVELOP, V54, P58, DOI 10.1262/jrd.19110; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Honma D, 2003, J INTERF CYTOK RES, V23, P101, DOI 10.1089/107999003321455499; Iguma LT, 2005, GENET MOL RES, V4, P55; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MATSUNARI H, 2012, XENOTRANSPLANTATION, P37; Matsunari H, 2008, CLONING STEM CELLS, V10, P313, DOI 10.1089/clo.2008.0024; Matsunari H, 2009, J REPROD DEVELOP, V55, P225, DOI 10.1262/jrd.20164; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PORTER ACG, 1993, EUR J BIOCHEM, V218, P273, DOI 10.1111/j.1432-1033.1993.tb18375.x; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Vajta G, 2006, ANIM REPROD SCI, V92, P211, DOI 10.1016/j.anireprosci.2005.12.001; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098	47	64	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76478	10.1371/journal.pone.0076478	http://dx.doi.org/10.1371/journal.pone.0076478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130776	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900073
J	McGrath, J; Mortensen, PB; Pedersen, CB; Ehrenstein, V; Petersen, L				McGrath, John; Mortensen, Preben Bo; Pedersen, Carsten Bocker; Ehrenstein, Vera; Petersen, Liselotte			Paternal Age and General Cognitive Ability-A Cross Sectional Study of Danish Male Conscripts	PLOS ONE			English	Article							DE-NOVO MUTATIONS; BIRTH-ORDER; MATERNAL AGE; PARENTAL AGE; RISK-FACTORS; INTELLIGENCE; OVERADJUSTMENT; SCHIZOPHRENIA; ASSOCIATION; OUTCOMES	Objectives: Offspring of older men have impaired cognitive ability as children, but it is unclear if this impairment persists into adulthood. The main objective of this study was to explore the association between paternal age at offspring birth and general cognitive ability as young adults. Design: Population-based cross-sectional study with prospectively collected data on obstetric factors and parental education. Setting: Nationwide Danish sample. Participants: Male conscripts (n = 169,009). Primary and secondary outcome measures: General cognitive ability as assessed by the Borge Priens test score, an intelligence test with components related to logical, verbal, numerical and spatial reasoning. Results: We observed an inverse U-shaped association between paternal age and general cognitive ability (slightly lower test scores in the offspring of fathers aged less than 25 years and older than 40 years, compared with fathers aged 25 to 29 years). However, after adjustment for maternal age, parental education and birth order the shape of the association changed. Offspring of fathers younger than 20 still showed slightly lower cognitive ability (-1.11 (95% CI -1.68 to -0.54)), but no significant impairments were identified in the men whose fathers were older than 29 years at the time of their birth (e. g. the mean difference in test score in the offspring of fathers aged 40 to 44 years were -0.03 [95% CI (-0.27 to 0.20)] compared with fathers aged 25 to 29 years). Conclusions: We did not find that the offspring of older fathers had impaired cognitive ability as young adults. Whereas, we found a tendency that the offspring of teen fathers have lower cognitive ability. Thus, our results suggest that any potentially deleterious effects of older fathers on general cognitive ability as young adults may be counter-balanced by other potentially beneficial factors.	[McGrath, John] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Australia; [Mortensen, Preben Bo; Pedersen, Carsten Bocker; Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Mortensen, Preben Bo; Pedersen, Carsten Bocker; Petersen, Liselotte] Lundbeck Fdn Initiat Integrat Psychiat Res, IPSYCH, Aarhus, Denmark; [Mortensen, Preben Bo; Pedersen, Carsten Bocker] Aarhus Univ, CIRRAU, Aarhus, Denmark; [Ehrenstein, Vera] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	University of Queensland; Queensland Centre for Mental Health Research; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University	Petersen, L (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark.	llp@ncrr.dk	McGrath, John Joseph/G-5493-2010; Mortensen, Preben B/D-2358-2015; Pedersen, Carsten Bøcker/B-8441-2013	McGrath, John Joseph/0000-0002-4792-6068; Mortensen, Preben B/0000-0002-5230-9865; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Ehrenstein, Vera/0000-0002-3415-3254	Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark	Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark	This study was funded by the Lundbeck Foundation, Denmark: The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark. This funder had no involvement in any aspect of the study.	Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Crow JF, 2003, SCIENCE, V301, P606, DOI 10.1126/science.1088552; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; Fergusson D M, 1993, Paediatr Perinat Epidemiol, V7, P77, DOI 10.1111/j.1365-3016.1993.tb00604.x; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Green A, 1996, DAN MED BULL, V43, P464; Hamlyn J, 2013, NEUROBIOL DIS, V53, P3, DOI 10.1016/j.nbd.2012.10.023; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina Dolores, 2002, CNS Spectr, V7, P26; Miller B, 2011, SCHIZOPHRENIA BULL, V37, P1039, DOI 10.1093/schbul/sbq011; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Myrskyla M, 2013, AM J EPIDEMIOL, V177, P649, DOI 10.1093/aje/kws237; Nahum GG, 2003, J REPROD MED, V48, P963; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Osler M, 2007, SCHIZOPHR RES, V92, P132, DOI 10.1016/j.schres.2007.01.009; Pedersen CB, 2014, MOL PSYCHIATR, V19, P530, DOI 10.1038/mp.2013.69; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Rodgers JL, 2000, AM PSYCHOL, V55, P599, DOI 10.1037//0003-066X.55.6.599; Rose G., 2008, ROSES STRATEGY PREVE; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; *STAT DANM, 1991, IDA INT DAT ARB; Sulloway FJ, 2007, SCIENCE, V316, P1711, DOI 10.1126/science.1144749; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Svensson AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024771; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P496, DOI 10.1097/EDE.0b013e3181a82f12; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241	43	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77444	10.1371/journal.pone.0077444	http://dx.doi.org/10.1371/journal.pone.0077444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116230	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200117
J	Raborn, J; Fu, T; Wu, X; Xiu, ZL; Li, GH; Luo, BH				Raborn, Joel; Fu, Ting; Wu, Xue; Xiu, Zhilong; Li, Guohui; Luo, Bing-Hao			Variation in One Residue Associated with the Metal Ion-Dependent Adhesion Site Regulates alpha IIb beta 3 Integrin Ligand Binding Affinity	PLOS ONE			English	Article							I-LIKE DOMAIN; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; BETA(3) INTEGRIN; FIRM ADHESION; OUTSIDE-IN; ALPHA-I; X-RAY; SUBUNIT	The Asp of the RGD motif of the ligand coordinates with the beta I domain metal ion dependent adhesion site (MIDAS) divalent cation, emphasizing the importance of the MIDAS in ligand binding. There appears to be two distinct groups of integrins that differ in their ligand binding affinity and adhesion ability. These differences may be due to a specific residue associated with the MIDAS, particularly the beta 3 residue Ala(252) and corresponding Ala in the beta 1 integrin compared to the analogous Asp residue in the beta 2 and beta 7 integrins. Interestingly, mutations in the adjacent to MIDAS (ADMIDAS) of integrins alpha 4 beta 7 and alpha L beta 2 increased the binding and adhesion abilities compared to the wild-type, while the same mutations in the alpha 2 beta 1, alpha 5 beta 1, alpha V beta 3, and alpha IIb beta 3 integrins demonstrated decreased ligand binding and adhesion. We introduced a mutation in the alpha IIb beta 3 to convert this MIDAS associated Ala252 to Asp. By combination of this mutant with mutations of one or two ADMIDAS residues, we studied the effects of this residue on ligand binding and adhesion. Then, we performed molecular dynamics simulations on the wild-type and mutant alpha IIb beta 3 integrin beta I domains, and investigated the dynamics of metal ion binding sites in different integrin-RGD complexes. We found that the tendency of calculated binding free energies was in excellent agreement with the experimental results, suggesting that the variation in this MIDAS associated residue accounts for the differences in ligand binding and adhesion among different integrins, and it accounts for the conflicting results of ADMIDAS mutations within different integrins. This study sheds more light on the role of the MIDAS associated residue pertaining to ligand binding and adhesion and suggests that this residue may play a pivotal role in integrin-mediated cell rolling and firm adhesion.	[Raborn, Joel; Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fu, Ting; Wu, Xue; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Peoples R China; [Fu, Ting; Wu, Xue; Xiu, Zhilong] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China; [Fu, Ting] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Raborn, Joel] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA	Louisiana State University System; Louisiana State University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alabama System; University of Alabama Birmingham	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian, Peoples R China.	ghli@dicp.ac.cn; luo@lsu.edu			American Heart Association [10GRNT3960011]; Louisiana Board of Regents [LEQSF(2009-12)-RD-A07]	American Heart Association(American Heart Association); Louisiana Board of Regents	The research is supported by the American Heart Association (#10GRNT3960011) and the Louisiana Board of Regents (LEQSF(2009-12)-RD-A07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Case D.A., 2008, AMBER10; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen JS, 2006, AM J RESP CRIT CARE, V174, P103; Cierniewska-Cieslak A, 2002, J BIOL CHEM, V277, P11126, DOI 10.1074/jbc.M112388200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goodman TG, 1996, J BIOL CHEM, V271, P23729, DOI 10.1074/jbc.271.39.23729; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata T, 2002, J IMMUNOL, V168, P2296, DOI 10.4049/jimmunol.168.5.2296; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lin ECK, 1997, J BIOL CHEM, V272, P14236, DOI 10.1074/jbc.272.22.14236; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Raborn J, 2012, J CELL BIOCHEM, V113, P1190, DOI 10.1002/jcb.23448; Raborn J, 2011, BIOCHEMISTRY-US, V50, P2084, DOI 10.1021/bi2000092; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Wang JN, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624401; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wu J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651626; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052460; Xu BS, 2011, J COMPUT CHEM, V32, P3188, DOI 10.1002/jcc.21900; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zhang YX, 2013, J PHYS CHEM B, V117, P982, DOI 10.1021/jp309682t; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	51	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76793	10.1371/journal.pone.0076793	http://dx.doi.org/10.1371/journal.pone.0076793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116162	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200071
J	Crooks, N; Babey, L; Haddon, WJ; Love, AC; Waring, CP				Crooks, Neil; Babey, Lucy; Haddon, William J.; Love, Adrian C.; Waring, Colin P.			Sexual Dimorphisms in the Dermal Denticles of the Lesser-Spotted Catshark, Scyliorhinus canicula (Linnaeus, 1758)	PLOS ONE			English	Article							MATING-BEHAVIOR; REPRODUCTIVE-BIOLOGY; SHARK SKIN; SIMULTANEOUS HERMAPHRODITE; NURSE SHARK; BLUE SHARK; BODY-SIZE; STRATEGIES; COURTSHIP; STINGRAY	The dermal layers of several elasmobranch species have been shown to be sexually dimorphic. Generally, when this occurs the females have thicker dermal layers compared to those of males. This sexual dimorphism has been suggested to occur as a response to male biting during mating. Although male biting as a copulatory behaviour in Scyliorhinus canicula has been widely speculated to occur, only relatively recently has this behaviour been observed. Male S. canicula use their mouths to bite the female's pectoral and caudal fins as part of their pre-copulatory behaviour and to grasp females during copulation. Previous work has shown that female S. canicula have a thicker epidermis compared to that of males. The structure of the dermal denticles in females may also differ from that of males in order to protect against male biting or to provide a greater degree of friction in order to allow the male more purchase. This study reveals that the length, width and density of the dermal denticles of mature male and female S. canicula are sexually dimorphic across the integument in areas where males have been observed to bite and wrap themselves around females (pectoral fin, area posterior to the pectoral fin, caudal fin, and pelvic girdle). No significant differences in the dermal denticle dimensions were found in other body areas examined (head, dorsal skin and caudal peduncle). Sexually dimorphic dermal denticles in mature S. canicula could be a response to male biting/wrapping as part of the copulatory process.	[Crooks, Neil; Babey, Lucy; Haddon, William J.; Love, Adrian C.] Sparsholt Coll, Winchester, Hants, England; [Waring, Colin P.] Univ Portsmouth, Inst Marine Sci, Portsmouth, Hants, England	University of Portsmouth	Crooks, N (corresponding author), Sparsholt Coll, Winchester, Hants, England.	neil.crooks@sparsholt.ac.uk		Crooks, Neil/0000-0003-3904-3879				Angeloni L, 2003, ANIM BEHAV, V66, P417, DOI 10.1006/anbe.2003.2255; Arnqvist Goran, 2005, pUnpaginated; Ball P, 1999, NATURE, V400, P507, DOI 10.1038/22883; Bechert D.W., 1986, ICAS, P1044; Bolau H, 1881, Z WISS ZOOL, V35, P321; Bone Q., 1975, P493; Brunnschweiler J.M., 2008, OPEN FISH SCI J, V1, P23; Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854; CARRIER JC, 1994, COPEIA, P646; Carrier JC, 2004, CRC MAR BIOL SER, P269; CASTRO JI, 1988, COPEIA, P740; Chapman DD, 2003, ENVIRON BIOL FISH, V68, P241, DOI 10.1023/A:1027332113894; Chapman T, 2006, CURR BIOL, V16, pR744, DOI 10.1016/j.cub.2006.08.020; CLARK E, 1975, NATL GEOGR, V148, P338; Compagno L.J.V., 1984, CARCHARHINIFORMES; Crooks N, 2013, ACTA ZOOL-STOCKHOLM, V94, P331, DOI 10.1111/j.1463-6395.2012.00560.x; DEMPSTER ROBERT P., 1961, OCCAS PAPERS CALIFORNIA ACAD SCI, V33, P1; DODD JM, 1983, FISH PHYSIOL, V9, P31; Domi N, 2000, 3RD MEETING OF THE EUROPEAN ELASMOBRANCH ASSOCIATION, PROCEEDINGS, P67; ELLIS JR, 1995, J FISH BIOL, V47, P155, DOI 10.1111/j.1095-8649.1995.tb01881.x; Ellis JR, 1997, J FISH BIOL, V51, P361; Gianguzza P, 2004, FUNCT ECOL, V18, P899, DOI 10.1111/j.0269-8463.2004.00911.x; Griffiths AM, 2012, J HERED, V103, P166, DOI 10.1093/jhered/esr112; Houziaux Jean-Sebastien, 1997, Revue Francaise d'Aquariologie Herpetologie, V24, P15; Ivory P, 2004, J NORTHWEST ATL FISH, V35, P89, DOI [10.2960/J.v35.m504, DOI 10.2960/J.V35.M504]; Kajiura SM, 1996, J EXP BIOL, V199, P2297; Kajiura SM, 2000, ENVIRON BIOL FISH, V58, P23, DOI 10.1023/A:1007667108362; Kapoor B.G., 2004, ICHTHYOLOGY HDB; KLIMLEY AP, 1980, COPEIA, P878; Lang A., 2012, ENCY NANOTECHNOLOGY, P2394, DOI DOI 10.1007/978-90-481-9751-4_266; McCauley DJ, 2010, PAC SCI, V64, P349, DOI 10.2984/64.2.349; MCCOURT RM, 1980, COPEIA, P900, DOI 10.2307/1444479; Mello WC, 2011, ACTA ZOOLOGICA, V94, P147; Mok EYM, 1997, J NAT HIST, V31, P739, DOI 10.1080/00222939700770371; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Motta P, 2012, J MORPHOL, V273, P1096, DOI 10.1002/jmor.20047; NORDELL SE, 1994, ENVIRON BIOL FISH, V39, P219, DOI 10.1007/BF00005124; Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; Orvig T., 1977, Linnean Soc Symp Ser, VNo. 4, P53; Pierce SJ, 2009, J FISH BIOL, V74, P1291, DOI 10.1111/j.1095-8649.2009.02202.x; Powter DM, 2008, J FISH BIOL, V72, P2615, DOI 10.1111/j.1095-8649.2008.01878.x; Pratt Harold L. Jr, 1995, National Geographic Magazine, V187, P44; PRATT HL, 1979, FISH B-NOAA, V77, P445; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; RASCHI W, 1992, AUST J MAR FRESH RES, V43, P123, DOI 10.1071/MF9920123; Raschi WG, 1986, 3963 JASA, P1; Reif W.-E., 1985, Courier Forschungsinstitut Senckenberg, V78, P1; Reif W.-E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V157, P133; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P172; Reif W.-E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P184; Rodriguez-Cabello C, 2007, J FISH BIOL, V70, P1568, DOI 10.1111/j.1095-8649.2007.01444.x; Rodriguez-Cabello C, 2004, FISH RES, V69, P57, DOI 10.1016/j.fishres.2004.04.002; Schensky F, 1914, TIER UND PFLANZENLEB; Schlegel H, 1869, VISSCHEN; Schumacher JF, 2007, BIOFOULING, V23, P307, DOI 10.1080/08927010701393276; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Southall EJ, 2003, P ROY SOC B-BIOL SCI, V270, pS47, DOI 10.1098/rsbl.2003.0006; STEVENS JD, 1974, J MAR BIOL ASSOC UK, V54, P373, DOI 10.1017/S0025315400058604; Sullivan T, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046001; TRICAS TC, 1980, COPEIA, P553, DOI 10.2307/1444540; TRICAS TC, 1985, MAR BIOL, V84, P233, DOI 10.1007/BF00392492; UCHIDA S, 1990, NOAA Technical Report NMFS, P211; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Whitney NM, 2004, ANIM BEHAV, V68, P1435, DOI 10.1016/j.anbehav.2004.02.018; Yano K, 1999, ICHTHYOL RES, V46, P289, DOI 10.1007/BF02678515	66	21	21	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76887	10.1371/journal.pone.0076887	http://dx.doi.org/10.1371/journal.pone.0076887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116179	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300103
J	Bostanci, N; Thurnheer, T; Aduse-Opoku, J; Curtis, MA; Zinkernagel, AS; Belibasakis, GN				Bostanci, Nagihan; Thurnheer, Thomas; Aduse-Opoku, Joseph; Curtis, Michael A.; Zinkernagel, Annelies S.; Belibasakis, Georgios N.			Porphyromonas gingivalis Regulates TREM-1 in Human Polymorphonuclear Neutrophils via Its Gingipains	PLOS ONE			English	Article							MYELOID CELLS-1; INFLAMMATORY RESPONSES; PERIODONTAL-DISEASE; IN-VITRO; EPITHELIAL-CELLS; APOPTOTIC CELLS; RECEPTOR; LIPOPOLYSACCHARIDE; PATHOGEN; ACTIVATION	The Triggering Receptor Expressed on Myeloid cells 1 (TREM-1) is a cell surface receptor of the immunoglobulin superfamily, with the capacity to amplify pro-inflammatory cytokine production and regulate apoptosis. Polymorphonuclear neutrophils (PMNs) are the first line of defence against infection, and a major source of TREM-1. Porphyromonas gingivalis is a Gram-negative anaerobe highly implicated in the inflammatory processes governing periodontal disease, which is characterized by the destruction of the tooth-supporting tissues. It expresses a number of virulence factors, including the cysteine proteinases (or gingipains). The aim of this in vitro study was to investigate the effect of P. gingivalis on TREM-1 expression and production by primary human PMNs, and to evaluate the role of its gingipains in this process. After 4 h of challenge, P. gingivalis enhanced TREM-1 expression as identified by quantitative real-time PCR. This was followed by an increase in soluble (s)TREM-1 secretion over a period of 18 h, as determined by ELISA. At this time-point, the P. gingivalis-challenged PMNs exhibited diminished TREM-1 cell-membrane staining, as identified by flow cytometry and confocal laser scanning microscopy. Furthermore engagement of TREM-1, by means of anti-TREM-1 antibodies, enhanced the capacity of P. gingivalis to stimulate interleukin (IL)-8 production. Conversely, antagonism of TREM-1 using a synthetic peptide resulted in reduction of IL-8 secretion. Using isogenic P. gingivalis mutant strains, we identified the Arg-gingipain to be responsible for shedding of sTREM-1 from the PMN surface, whereas the Lys-gingipain had the capacity to degrade TREM-1. In conclusion, the differential regulation of TREM-1 by the P. gingivalis gingipains may present a novel mechanism by which P. gingivalis manipulates the host innate immune response helping to establish chronic periodontal inflammation.	[Bostanci, Nagihan; Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Aduse-Opoku, Joseph; Curtis, Michael A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Immunol & Infect Dis, London, England; [Zinkernagel, Annelies S.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University of London; Queen Mary University London; University of Zurich; University Zurich Hospital	Bostanci, N (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	nagihan.bostanci@zzm.uzh.ch	Zinkernagel, Annelies S/F-1780-2017; Bostanci, Nagihan/ABD-5524-2020; Belibasakis, Georgios/AAL-3159-2020; Aduse-Opoku, Joseph/CAF-0056-2022	Zinkernagel, Annelies S/0000-0003-4700-1118; Bostanci, Nagihan/0000-0002-6742-3556; Belibasakis, Georgios/0000-0002-8164-0653; opoku, anita/0000-0001-7243-8157; Thurnheer, Thomas/0000-0002-8615-8209; Curtis, Mike A/0000-0002-1563-9953				Aduse-Opoku J, 2000, MICROBIOL-UK, V146, P1933, DOI 10.1099/00221287-146-8-1933; Belibasakis GN, 2013, INT ENDOD J, V46, P99, DOI 10.1111/j.1365-2591.2012.02105.x; Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Berker E, 2005, J PERIODONTOL, V76, P964, DOI 10.1902/jop.2005.76.6.964; Bisson C, 2012, J CLIN PERIODONTOL, V39, P1141, DOI 10.1111/jcpe.12008; Bondy-Carey JL, 2013, MOL ORAL MICROBIOL, V28, P102, DOI 10.1111/omi.12008; Bostanci N, 2013, J DENT RES, V92, P161, DOI 10.1177/0022034512470691; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Bostanci N, 2012, FEMS IMMUNOL MED MIC, V66, P37, DOI 10.1111/j.1574-695X.2012.00982.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bostanci N, 2011, MOL IMMUNOL, V49, P387, DOI 10.1016/j.molimm.2011.09.012; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cai MT, 2013, ANESTHESIOLOGY, V118, P1140, DOI 10.1097/ALN.0b013e31828744a5; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DeCarlo AA, 1997, J DENT RES, V76, P1260, DOI 10.1177/00220345970760060501; Galicia JC, 2009, J LEUKOCYTE BIOL, V86, P181, DOI [10.1189/JLB.0109003, 10.1189/jlb.0109003]; Gamonal J, 2003, J CLIN PERIODONTOL, V30, P616, DOI 10.1034/j.1600-051X.2003.00350.x; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot Sebastien, 2004, Clin Med Res, V2, P181; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hiroi M, 1998, ANTICANCER RES, V18, P3475; Jagels MA, 1996, ADV EXP MED BIOL, V389, P155; Kantarci A, 2003, J PERIODONTOL, V74, P66, DOI 10.1902/jop.2003.74.1.66; Kantarci Alpdogan, 2002, J Int Acad Periodontol, V4, P119; Kishimoto M, 2006, MICROBIOL IMMUNOL, V50, P315, DOI 10.1111/j.1348-0421.2006.tb03799.x; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Murray DA, 2003, INFECT IMMUN, V71, P7232, DOI 10.1128/IAI.71.12.7232-7235.2003; Preshaw PM, 1999, J PERIODONTAL RES, V34, P197, DOI 10.1111/j.1600-0765.1999.tb02242.x; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	51	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75784	10.1371/journal.pone.0075784	http://dx.doi.org/10.1371/journal.pone.0075784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124513	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000325489100070
J	Guo, ZG; Wang, XR; Li, HH; Gao, YH				Guo, Zhengguang; Wang, Xiaorong; Li, Huihua; Gao, Youhe			Screening E3 Substrates Using a Live Phage Display Library	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; MDM2 PROMOTES; NEGATIVE REGULATOR; PROTEIN; DEGRADATION; UBIQUITINATION; P53; IDENTIFICATION; SPECIFICITY; GENE	Ubiquitin ligases (E3s) determine specificity of ubiquitination by recognizing target substrates. However, most of their substrates are unknown. Most known substrates have been identified using distinct approaches in different laboratories. We developed a high-throughput strategy using a live phage display library as E3 substrates in in vitro screening. His-ubiquitinated phage, enriched with Ni-beads, could effectively infect E. coli for amplification. Sixteen natural potential substrates and many unnatural potential substrates of E3 MDM2 were identified through 4 independent screenings. Some substrates were identified in different independent experiments. Additionally, 10 of 12 selected candidates were ubiquitinated by MDM2 in vitro, and 3 novel substrates, DDX42, TP53RK and RPL36a were confirmed ex vivo. The whole strategy is rather simple and efficient. Non-degradation substrates can be discovered. This strategy can be extended to any E3s as long as the E3 does not ubiquitinate the empty phage.	[Guo, Zhengguang; Wang, Xiaorong; Gao, Youhe] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Sch Basic Med, Dept Physiol & Pathophysiol,Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Zhengguang] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Core Instrument Facil,Peking Union Med Coll, Beijing 100730, Peoples R China; [Li, Huihua] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Dept Pathol,Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Gao, YH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Sch Basic Med, Dept Physiol & Pathophysiol,Peking Union Med Coll, Beijing 100730, Peoples R China.	gaoyouhe@pumc.edu.cn			National Basic Research Program of China [2012CB517606, 2013CB530805, 2011CB964901]; National High Technology Research and Development Program of China [2011AA020116]; Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT [IRT0909]; 111 Project [B08007]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB517606, 2013CB530805, 2011CB964901), the National High Technology Research and Development Program of China (2011AA020116), Program for Changjiang Scholars and Innovative Research Team in University-PCSIRT (IRT0909), and 111 Project (B08007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Abu Shadat NM, 2010, CANCER INVEST, V28, P806, DOI 10.3109/07357907.2010.494323; Andrews PS, 2010, ASSAY DRUG DEV TECHN, V8, P471, DOI 10.1089/adt.2009.0264; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Benhar I, 2001, BIOTECHNOL ADV, V19, P1, DOI 10.1016/S0734-9750(00)00054-9; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Buyse IM, 1997, J VIROL, V71, P6200, DOI 10.1128/JVI.71.8.6200-6203.1997; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; CORDONCARDO C, 1994, CANCER RES, V54, P794; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hitomi K, 2009, AMINO ACIDS, V36, P619, DOI 10.1007/s00726-008-0126-6; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hwang YC, 2009, AM J PATHOL, V175, P342, DOI 10.2353/ajpath.2009.080931; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Miwa S, 2006, BIOCHEM BIOPH RES CO, V340, P54, DOI 10.1016/j.bbrc.2005.11.148; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; *RIZ, P NATL ACAD SCI USA, V92, P4467, DOI DOI 10.1073/PNAS.92.10.4467.PUBMED:7538672; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wyszomierski SL, 2005, CANCER CELL, V8, P437, DOI 10.1016/j.ccr.2005.11.006; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	76	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76622	10.1371/journal.pone.0076622	http://dx.doi.org/10.1371/journal.pone.0076622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124579	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100136
J	Koreissi-Dembele, Y; Fanou-Fogny, N; Moretti, D; Schuth, S; Dossa, RAM; Egli, I; Zimmermann, MB; Brouwer, ID				Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Moretti, Diego; Schuth, Stephan; Dossa, Romain A. M.; Egli, Ines; Zimmermann, Michael B.; Brouwer, Inge D.			Dephytinisation with Intrinsic Wheat Phytase and Iron Fortification Significantly Increase Iron Absorption from Fonio (Digitaria exilis) Meals in West African Women	PLOS ONE			English	Article							PHYTIC ACID; INOSITOL PHOSPHATES; HUMANS; BIOAVAILABILITY; ZINC; FOODS; PURIFICATION; DEGRADATION; CEREALS; PROTEIN	Low iron and high phytic acid content make fonio based meals a poor source of bioavailable iron. Phytic acid degradation in fonio porridge using whole grain cereals as phytase source and effect on iron bioavailability when added to iron fortified fonio meals were investigated. Grains, nuts and seeds collected in Mali markets were screened for phytic acid and phytase activity. We performed an iron absorption study in Beninese women (n = 16), using non-dephytinised fonio porridge (FFP) and dephytinised fonio porridge (FWFP; 75% fonio-25% wheat), each fortified with Fe-57 or Fe-58 labeled FeSO4. Iron absorption was quantified by measuring the erythrocyte incorporation of stable iron isotopes. Phytic acid varied from 0.39 (bambara nut) to 4.26 g/100 g DM (pumpkin seed), with oilseeds values higher than grains and nuts. Phytase activity ranged from 0.17 +/- 1.61 (fonio) to 2.9 +/- 1.3 phytase unit (PU) per g (whole wheat). Phytic acid was almost completely degraded in FWFP after 60 min of incubation (pH approximate to 5.0, 50 degrees C). Phytate: iron molar ratios decreased from 23.7:1 in FFP to 2.7:1 in FWFP. Iron fortification further reduced phytate: iron molar ratio to 1.9:1 in FFP and 0.3:1 in FWFP, respectively. Geometric mean (95% CI) iron absorption significantly increased from 2.6% (0.8-7.8) in FFP to 8.3% (3.8-17.9) in FWFP (P<0.0001). Dephytinisation of fonio porridge with intrinsic wheat phytase increased fractional iron absorption 3.2 times, suggesting it could be a possible strategy to decrease PA in cereal-based porridges.	[Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Zimmermann, Michael B.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Dept Food Sci, NL-6700 AP Wageningen, Netherlands; [Koreissi-Dembele, Yara; Fanou-Fogny, Nadia; Zimmermann, Michael B.; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Moretti, Diego; Egli, Ines; Zimmermann, Michael B.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [Koreissi-Dembele, Yara] Reg Agron Res Ctr CRRA Sotuba, Inst Rural Econ IER, Food Technol Lab LTA, Bamako, Mali; [Fanou-Fogny, Nadia; Dossa, Romain A. M.] Univ Abomey Calavi, FSA, Dept Nutr & Food Sci, Cotonou, Benin; [Schuth, Stephan] Univ Bonn, Steinmann Inst Geol Mineral & Petrol, Bonn, Germany	Wageningen University & Research; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Abomey Calavi; University of Bonn	Koreissi-Dembele, Y (corresponding author), Wageningen Univ, Div Human Nutr, Dept Food Sci, NL-6700 AP Wageningen, Netherlands.	ykoreissidemb@gmail.com; nadiafanou.fogny@gmail.com	Moretti, Diego/AAC-9028-2019; Moretti, Diego/G-5212-2013; Zimmermann, Michael B/C-3062-2016; Brouwer, Inge D/K-8455-2013	Moretti, Diego/0000-0002-7366-2182; Moretti, Diego/0000-0002-7366-2182; Brouwer, Inge/0000-0002-2554-7227	Netherlands Fellowships Program NUFFIC; International Foundation for Science, (IFS Stockholm, Sweden) [IFS-E-4491]; European Union [INCO CT-2005-015403]	Netherlands Fellowships Program NUFFIC; International Foundation for Science, (IFS Stockholm, Sweden)(International Foundation for Science); European Union(European Commission)	Financial support was provided by the Netherlands Fellowships Program NUFFIC. Part of fieldwork activities and equipment purchase was funded by the International Foundation for Science, (IFS Stockholm, Sweden), under the project reference IFS-E-4491. Another part of the field work such as the fonio treatement and porridge degradation test was funded by the European Union funded project FP6/EU/INCO FONIO project No. INCO CT-2005-015403 through a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adubiaro H. O., 2011, Advance Journal of Food Science & Technology, V3, P228; Allen L, 2006, GUIDELINES FOOD FORT; BROWN E, 1962, J CLIN INVEST, V41, P2182, DOI 10.1172/JCI104677; COOK JD, 1991, AM J CLIN NUTR, V54, P717, DOI 10.1093/ajcn/54.4.717; Cook JD, 1997, AM J CLIN NUTR, V65, P964, DOI 10.1093/ajcn/65.4.964; Coulibaly A., 2011, American Journal of Plant Nutrition and Fertilization Technology, V1, P1, DOI 10.3923/ajpnft.2011.1.22; Drame D., 2011, FONIO AFRICAN CEREAL, DOI DOI 10.1186/s12864-015-2255-0; Egli I, 2004, J NUTR, V134, P1077, DOI 10.1093/jn/134.5.1077; Egli I, 2003, J FOOD SCI, V68, P1855, DOI 10.1111/j.1365-2621.2003.tb12342.x; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; Egli I, 2001, THESIS SWISS FEDERAL; Elemo G. N., 2011, African Journal of Plant Science, V5, P291; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; FAO/WHO, 1998, VIT MIN REQ HUM NUTR; Fogny-Fanou N., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1927; GIBSON DM, 1988, ARCH BIOCHEM BIOPHYS, V260, P503, DOI 10.1016/0003-9861(88)90475-4; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GILLOOLY M, 1984, BRIT J NUTR, V51, P37, DOI 10.1079/BJN19840007; Greiner R, 1999, J SCI FOOD AGR, V79, P1453, DOI [10.1002/(SICI)1097-0010(199908)79:11<1453::AID-JSFA386>3.0.CO;2-R, 10.1002/(SICI)1097-0010(199908)79:11&lt;1453::AID-JSFA386&gt;3.0.CO;2-R]; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; HOSAIN F, 1967, J CLIN INVEST, V46, P1, DOI 10.1172/JCI105501; Hurrell RF, 2003, AM J CLIN NUTR, V77, P1213, DOI 10.1093/ajcn/77.5.1213; Hurrell RF, 1997, EUR J CLIN NUTR, V51, pS4; HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Ip H, 2007, EUR J CLIN NUTR, V63, P165; KASTENMAYER P, 1994, BRIT J NUTR, V71, P411, DOI 10.1079/BJN19940148; Kayode APP, 2006, J AGR FOOD CHEM, V54, P256, DOI 10.1021/jf0521404; Koreissi-Dembele Y, 2013, J FOOD COMPOS ANAL, V29, P134, DOI 10.1016/j.jfca.2012.07.010; Lei XG, 2000, J APPL ANIM RES, V17, P97, DOI 10.1080/09712119.2000.9706294; MAKOWER RU, 1970, CEREAL CHEM, V47, P288; Mansfeldt T, 2012, J SOIL SEDIMENT, V12, P97, DOI 10.1007/s11368-011-0402-z; Moretti D, 2006, AM J CLIN NUTR, V83, P632, DOI 10.1093/ajcn.83.3.632; Porres JM, 2001, J FOOD SCI, V66, P614, DOI 10.1111/j.1365-2621.2001.tb04610.x; Ravindran V., 1995, Poultry and Avian Biology Reviews, V6, P125; RICKARD ES, 1997, ANTINUTRIENTS PHYTOC; Sandberg AS, 1999, AM J CLIN NUTR, V70, P240; Sandberg AS, 1996, J NUTR, V126, P476, DOI 10.1093/jn/126.2.476; SANDSTROM B, 1992, J TRACE ELEM ELECT H, V6, P99; Schoenberg R, 2005, INT J MASS SPECTROM, V242, P257, DOI 10.1016/j.ijms.2004.11.025; Teutsch N, 2009, EARTH PLANET SC LETT, V285, P52, DOI 10.1016/j.epsl.2009.05.044; Troesch B, AM J CLIN NUTR, V89, P539; Vall E, 2011, CAH AGRIC, V20, P294, DOI 10.1684/agr.2011.0499; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Vietmeyer N., 1996, LOST CROPS AFRICA, V1, P59, DOI DOI 10.17226/2305; Walczyk T, 1997, FRESEN J ANAL CHEM, V359, P445, DOI 10.1007/s002160050608; Weyer S, 2003, INT J MASS SPECTROM, V226, P355, DOI 10.1016/S1387-3806(03)00078-2; World Health Organization, 2001, IR DEF AN ASS PREV C; World Health Organization, 2008, METH MAN PROD TEST M; World Health Organization, 1995, PHYS STAT US INT ANT; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	52	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e70613	10.1371/journal.pone.0070613	http://dx.doi.org/10.1371/journal.pone.0070613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124445	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100002
J	Milano, G; Abruzzo, PM; Bolotta, A; Marini, M; Terraneo, L; Ravara, B; Gorza, L; Vitadello, M; Burattini, S; Curzi, D; Falcieri, E; von Segesser, LK; Samaja, M				Milano, Giuseppina; Abruzzo, Provvidenza Maria; Bolotta, Alessandra; Marini, Marina; Terraneo, Laura; Ravara, Barbara; Gorza, Luisa; Vitadello, Maurizio; Burattini, Sabrina; Curzi, Davide; Falcieri, Elisabetta; von Segesser, Ludwig K.; Samaja, Michele			Impact of the Phosphatidylinositide 3-Kinase Signaling Pathway on the Cardioprotection Induced by Intermittent Hypoxia	PLOS ONE			English	Article							IMPROVES POSTISCHEMIC RECOVERY; RAT CAROTID-BODY; UP-REGULATION; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; MYOCARDIAL INJURY; ACTIVATION; KINASE; AKT; SURVIVAL	Background: Exposure to intermittent hypoxia (IH) may enhance cardiac function and protects heart against ischemia-reperfusion (I/R) injury. To elucidate the underlying mechanisms, we developed a cardioprotective IH model that was characterized at hemodynamic, biochemical and molecular levels. Methods: Mice were exposed to 4 daily IH cycles (each composed of 2-min at 6-8% O-2 followed by 3-min reoxygenation for 5 times) for 14 days, with normoxic mice as controls. Mice were then anesthetized and subdivided in various subgroups for analysis of contractility (pressure-volume loop), morphology, biochemistry or resistance to I/R (30-min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion and measurement of the area at risk and infarct size). In some mice, the phosphatidylinositide 3-kinase (PI3K) inhibitor wortmannin was administered (24 mu g/kg ip) 15 min before LAD. Results: We found that IH did not induce myocardial hypertrophy; rather both contractility and cardiac function improved with greater number of capillaries per unit volume and greater expression of VEGF-R2, but not of VEGF. Besides increasing the phosphorylation of protein kinase B (Akt) and the endothelial isoform of NO synthase with respect to control, IH reduced the infarct size and post-LAD proteins carbonylation, index of oxidative damage. Administration of wortmannin reduced the level of Akt phosphorylation and worsened the infarct size. Conclusion: We conclude that the PI3K/Akt pathway is crucial for IH-induced cardioprotection and may represent a viable target to reduce myocardial I/R injury.	[Milano, Giuseppina; von Segesser, Ludwig K.] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Milano, Giuseppina] IRCSS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Regenerat, Milan, Italy; [Abruzzo, Provvidenza Maria; Bolotta, Alessandra; Marini, Marina] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Terraneo, Laura; Samaja, Michele] Univ Milan, Dept Hlth Sci, Milan, Italy; [Ravara, Barbara; Gorza, Luisa] Univ Padua, Dipartimento Sci Biomed, Padua, Italy; [Vitadello, Maurizio] CNR, Inst Neurosci, Padova Sect, Padua, Italy; [Burattini, Sabrina; Curzi, Davide; Falcieri, Elisabetta] Univ Urbino Carlo Bo, DiSTeVA, Urbino, Italy	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Centro Cardiologico Monzino; University of Bologna; University of Milan; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Urbino	Milano, G (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.	giuseppina.milano@chuv.ch	Samaja, Michele/N-3499-2013; Abruzzo, Provvidenza Maria/G-7009-2015; Marini, Marina/B-1490-2012; Marini, Marina/Y-6191-2019	Samaja, Michele/0000-0002-0705-340X; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; Marini, Marina/0000-0003-1932-7380; Marini, Marina/0000-0003-1932-7380; Terraneo, Laura/0000-0003-2991-1898; GORZA, LUISA/0000-0003-4897-400X; Milano, Giuseppina/0000-0002-5560-4667; Falcieri, Elisabetta/0000-0002-0006-9871	Italian Ministry of Education (MIUR-PRIN); Lausanne CardioMet Foundation	Italian Ministry of Education (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Lausanne CardioMet Foundation	This study was supported by grants from The Italian Ministry of Education (MIUR-PRIN) and from Lausanne CardioMet Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; AHLUWALIA A, 2013, BIOCH BIOPHYS RES CO; Beguin PC, 2007, J MOL CELL CARDIOL, V42, P343, DOI 10.1016/j.yjmcc.2006.11.008; Belaidi E, 2008, AM J PHYSIOL-HEART C, V294, pH901, DOI 10.1152/ajpheart.00715.2007; Belaidi E, 2012, FUND CLIN PHARMACOL, V26, P454, DOI 10.1111/j.1472-8206.2011.00940.x; Bianciardi P, 2006, BIOCHEM BIOPH RES CO, V342, P875, DOI 10.1016/j.bbrc.2006.02.042; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; Burtscher M, 2004, INT J CARDIOL, V96, P247, DOI 10.1016/j.ijcard.2003.07.021; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Caretti A, 2008, EXP BIOL MED, V233, P1222, DOI 10.3181/0802-RM-73; Chong KY, 2013, BIOCHEM BIOPH RES CO, V430, P774, DOI 10.1016/j.bbrc.2012.11.072; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; Del Rio R, 2011, BRAIN RES, V1395, P74, DOI 10.1016/j.brainres.2011.04.028; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Esposito F, 2011, EUR J APPL PHYSIOL, V111, P859, DOI 10.1007/s00421-010-1707-0; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kolar F, 2007, AM J PHYSIOL-HEART C, V292, pH224, DOI 10.1152/ajpheart.00689.2006; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee SD, 2007, INT J CARDIOL, V116, P348, DOI 10.1016/j.ijcard.2006.03.064; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Manukhina EB, 2011, EXP BIOL MED, V236, P867, DOI 10.1258/ebm.2011.011023; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marini M, 2008, HISTOCHEM CELL BIOL, V129, P479, DOI 10.1007/s00418-007-0373-8; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Milano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027910; Milano G, 2010, EUR J CARDIO-THORAC, V37, P942, DOI 10.1016/j.ejcts.2009.10.030; Milano G, 2010, EXP BIOL MED, V235, P401, DOI 10.1258/ebm.2009.009153; Naghshin J, 2012, J APPL PHYSIOL, V113, P791, DOI 10.1152/japplphysiol.00185.2012; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Natarajan R, 2009, VASC PHARMACOL, V51, P110, DOI 10.1016/j.vph.2009.05.007; Paris S, 2005, FEBS LETT, V579, P105, DOI 10.1016/j.febslet.2004.11.055; Park AM, 2007, ANTIOXID REDOX SIGN, V9, P723, DOI 10.1089/ars.2007.1460; Park AM, 2007, AM J PHYSIOL-HEART C, V292, pH751, DOI 10.1152/ajpheart.01016.2006; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Qian YZ, 1999, AM J PHYSIOL-HEART C, V276, pH224, DOI 10.1152/ajpheart.1999.276.1.H224; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; REIMER KA, 1990, CIRCULATION, V82, P2266, DOI 10.1161/01.CIR.82.6.2266; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Seng S, 2010, J BIOL CHEM, V285, P26190, DOI 10.1074/jbc.M109.095786; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tagliavacca L, 2012, BBA-GEN SUBJECTS, V1820, P900, DOI 10.1016/j.bbagen.2012.02.016; Tarricone E, 2008, CELL STRESS CHAPERON, V13, P483, DOI 10.1007/s12192-008-0048-y; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Valle MD, 2006, J NUCL CARDIOL, V13, P69, DOI 10.1016/j.nuclcard.2005.11.008; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wang ZH, 2012, EXP PHYSIOL, V97, P1105, DOI 10.1113/expphysiol.2012.065102; Wang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1695, DOI 10.1152/ajpheart.00276.2011; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Yang CH, 2013, J ATHEROSCLER THROMB, V20, P9, DOI 10.5551/jat.14316; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200	65	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76659	10.1371/journal.pone.0076659	http://dx.doi.org/10.1371/journal.pone.0076659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124584	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100141
J	Sparks, A; Dayal, S; Das, J; Robertson, P; Menendez, S; Saville, MK				Sparks, A.; Dayal, S.; Das, J.; Robertson, P.; Menendez, S.; Saville, M. K.			The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a	ONCOGENE			English	Article						p53; Mdm2; S5a; Rpn10; proteasome; proteasomal recognition	CONJUGATING ENZYMES; PROTEIN-DEGRADATION; 26S PROTEASOME; TUMOR-CELLS; SUBUNIT; ACTIVATION; BINDING; ONCOPROTEIN; RECOGNITION; SUBSTRATE	p53 and its major E3 ligase Mdm2 are both ubiquitinated and targeted to the proteasome for degradation. Despite the importance of this in regulating the p53 pathway, little is known about the mechanisms of proteasomal recognition of ubiquitinated p53 and Mdm2. In this study, we show that knockdown of the proteasomal ubiquitin receptor S5a/PSMD4/Rpn10 inhibits p53 protein degradation and results in the accumulation of ubiquitinated p53. Overexpression of a dominant-negative deletion of S5a lacking its ubiquitin-interacting motifs (UIM)s, but which can be incorporated into the proteasome, also causes the stabilization of p53. Furthermore, small-interferring RNA (siRNA) rescue experiments confirm that the UIMs of S5a are required for the maintenance of low p53 levels. These observations indicate that S5a participates in the recognition of ubiquitinated p53 by the proteasome. In contrast, targeting S5a has no effect on the rate of degradation of Mdm2, indicating that proteasomal recognition of Mdm2 can be mediated by an S5a-independent pathway. S5a knockdown results in an increase in the transcriptional activity of p53. The selective stabilization of p53 and not Mdm2 provides a mechanism for p53 activation. Depletion of S5a causes a p53-dependent decrease in cell proliferation, demonstrating that p53 can have a dominant role in the response to targeting S5a. This study provides evidence for alternative pathways of proteasomal recognition of p53 and Mdm2. Differences in recognition by the proteasome could provide a means to modulate the relative stability of p53 and Mdm2 in response to cellular signals. In addition, they could be exploited for p53-activating therapies. This work shows that the degradation of proteins by the proteasome can be selectively dependent on S5a in human cells, and that this selectivity can extend to an E3 ubiquitin ligase and its substrate.	[Sparks, A.; Dayal, S.; Das, J.; Saville, M. K.] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, Dundee DD1 9SY, Scotland; [Robertson, P.] Univ Dundee, Coll Life Sci, Div Mol Med, Dundee DD1 9SY, Scotland; [Menendez, S.] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of Dundee; University of Dundee; University of Edinburgh	Saville, MK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, James Arrott Dr, Dundee DD1 9SY, Scotland.	m.k.saville@dundee.ac.uk		Menendez, Sergio/0000-0002-7929-8641; Das, Joyutpal/0000-0002-9166-4624	Wellcome Trust [094208/Z/10/Z]; European Research Council; Cancer Research UK	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was funded by the Wellcome Trust (grant no. 094208/Z/10/Z), the European Research Council and Cancer Research UK.	Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Allende-Vega N, 2010, SEMIN CANCER BIOL, V20, P29, DOI 10.1016/j.semcancer.2009.10.004; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bousquet-Dubouch MP, 2011, EXPERT REV PROTEOMIC, V8, P459, DOI 10.1586/EPR.11.41; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Elangovan M, 2010, BIOCHEM BIOPH RES CO, V396, P425, DOI 10.1016/j.bbrc.2010.04.108; Elangovan M, 2009, BIOCHEM BIOPH RES CO, V388, P723, DOI 10.1016/j.bbrc.2009.08.078; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 2010, TRENDS PLANT SCI, V15, P375, DOI 10.1016/j.tplants.2010.03.004; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Haririnia A, 2008, J MOL BIOL, V375, P979, DOI 10.1016/j.jmb.2007.11.016; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hock AK, 2013, BIOCHIM BIOPHYS ACTA; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Inuzuka H, 2010, ONCOTARGET, V1, P685; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kaur M, 2007, ONCOGENE, V26, P1231, DOI 10.1038/sj.onc.1209865; Kawahara H, 2000, EMBO J, V19, P4144, DOI 10.1093/emboj/19.15.4144; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Lipinszki Z, 2012, BIOCHEMISTRY-US, V51, P2461, DOI 10.1021/bi3001006; Lipinszki Z, 2009, J CELL SCI, V122, P3083, DOI 10.1242/jcs.049049; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; Midorikawa Y, 2002, JPN J CANCER RES, V93, P636, DOI 10.1111/j.1349-7006.2002.tb01301.x; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pei DS, 2012, ONCOTARGET, V3, P228; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Shen YH, 2011, TOXICOL LETT, V205, P341, DOI 10.1016/j.toxlet.2011.06.028; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-208; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wei SJ, 2008, J MOL BIOL, V383, P693, DOI 10.1016/j.jmb.2008.08.044; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Xu Q, 2004, MOL CANCER THER, V3, P1263; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	88	25	25	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4685	4696		10.1038/onc.2013.413	http://dx.doi.org/10.1038/onc.2013.413			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24121268	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000342007200007
J	El Osta, M; Liu, ML; Adada, M; Senkal, CE; Idkowiak-Baldys, J; Obeid, LM; Clarke, CJ; Hannun, YA				El Osta, Mohamad; Liu, Mengling; Adada, Mohamad; Senkal, Can E.; Idkowiak-Baldys, Jolanta; Obeid, Lina M.; Clarke, Christopher J.; Hannun, Yusuf A.			Sustained PKC beta II activity confers oncogenic properties in a phospholipase D-and mTOR-dependent manner	FASEB JOURNAL			English	Article						protein kinase C; proliferation; migration	PROTEIN-KINASE-C; P70 S6 KINASE; BREAST-CANCER CELLS; RECYCLING ENDOSOMES; PERINUCLEAR REGION; PLASMA-MEMBRANE; SEQUESTRATION; PHOSPHORYLATION; ENZASTAURIN; MECHANISMS	Protein kinase C (PKC) is a family of serine/threonine kinases implicated in a variety of physiological processes. We have shown previously that sustained activation of the classical PKC and PKCII induces their phospholipase D (PLD)-dependent internalization and translocation to a subset of the recycling endosomes defined by the presence of PKC and PLD (the pericentrion), which results in significant differences in phosphorylation of PKC substrates. Here, we have investigated the biological consequences of sustained PKC activity and the involvement of PLD in this process. We find that sustained activation of PKC results in activation of the mammalian target of rapamycin (mTOR)/S6 kinase pathway in a PLD- and endocytosis-dependent manner, with both pharmacologic inhibitors and siRNA implicating the PLD2 isoform. Notably, dysregulated overexpression of PKCII in A549 lung cancer cells was necessary for the enhanced proliferation and migration of these cancer cells. Inhibition of PKCII with enzastaurin reduced A549 cell proliferation by >60% (48 h) and migration by >50%. These biological effects also required both PLD activity and mTOR function, with both the PLD inhibitor FIPI and rapamycin reducing cell growth by >50%. Reciprocally, forced overexpression of wild-type PKCII, but not an F666D mutant that cannot interact with PLD, was sufficient to enhance cell growth and increase migration of noncancerous HEK cells; indeed, both properties were almost doubled when compared to vector control and PKC-F666D-overexpressing cells. Notably, this condition was also dependent on both PLD and mTOR activity. In summary, these data define a PKC-driven oncogenic signaling pathway that requires both PLD and mTOR, and suggest that inhibitors of PLD or mTOR would be beneficial in cancers where PKC overexpression is a contributing or driving factor.El Osta, M., Liu, M. Adada, M., Senkal, C. E., Idkowiak-Baldys, J., Obeid, L. M., Clarke, C. J., Hannun, Y. A. Sustained PKCII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.	[El Osta, Mohamad; Idkowiak-Baldys, Jolanta] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Liu, Mengling; Adada, Mohamad; Senkal, Can E.; Obeid, Lina M.; Clarke, Christopher J.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, 100 Nicolls Rd, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrook.edu		obeid, lina/0000-0002-0734-0847; Adada, Mohamad/0000-0002-2988-2081; Liu, Mengling/0000-0003-1309-0087	U.S. National Institutes of Health [HL43707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grant HL43707.	Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Blobe GC, 1996, CANCER SURV, V27, P213; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chen YB, 2008, EXPERT OPIN INV DRUG, V17, P939, DOI 10.1517/13543784.17.6.939 ; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Courage C, 1997, INT J CANCER, V73, P763, DOI 10.1002/(SICI)1097-0215(19971127)73:5<763::AID-IJC25>3.0.CO;2-5; El-Osta MA, 2011, J BIOL CHEM, V286, P19340, DOI 10.1074/jbc.M110.152330; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fasolo A, 2012, CURR PHARM DESIGN, V18, P2766, DOI 10.2174/138161212800626210; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Ghobrial IM, 2011, AM J HEMATOL, V86, P573, DOI 10.1002/ajh.22048; Gomez-Cambronero J, 2012, SCI WORLD J, V10, P1356; Gullberg M, 2003, CURR OPIN BIOTECH, V14, P82, DOI 10.1016/S0958-1669(02)00011-3; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hu TH, 2005, BIOCHEM BIOPH RES CO, V333, P750, DOI 10.1016/j.bbrc.2005.05.184; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; Hu TH, 2003, J BIOL CHEM, V278, P2348, DOI 10.1074/jbc.M210093200; Husseinzadeh HD, 2011, CURR CLIN PHARMACOL, V6, P214, DOI 10.2174/157488411797189433; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Morse-Gaudio M, 1998, INT J ONCOL, V12, P1349; Nazarewicz R. R., 2011, J BIOL CHEM, V286, P2866; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Proud CG, 1997, BIOCHEM J, V328, P329; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vansteenkiste J, 2012, ONCOLOGY-BASEL, V82, P25, DOI 10.1159/000335268; Wells A, 2000, ADV CANCER RES, V78, P31; Winter JN, 2010, AM J PHYSIOL-CELL PH, V299, pC335, DOI 10.1152/ajpcell.00039.2010; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30	50	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					495	505		10.1096/fj.13-230557	http://dx.doi.org/10.1096/fj.13-230557			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24121461	Green Published			2022-12-25	WOS:000333526100046
J	Stavrum, AK; Heiland, I; Schuster, S; Puntervoll, P; Ziegler, M				Stavrum, Anne-Kristin; Heiland, Ines; Schuster, Stefan; Puntervoll, Pal; Ziegler, Mathias			Model of Tryptophan Metabolism, Readily Scalable Using Tissue-specific Gene Expression Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Metabolism; Liver Metabolism; Mathematical Modeling; Neurodegenerative Diseases; Tryptophan; Tumor Metabolism	INDOLEAMINE 2,3-DIOXYGENASE; KYNURENINE; PATHWAY; BRAIN; FLUX; SEROTONIN; NEURODEGENERATION; QUANTIFICATION; COMPETITION; INHIBITION	Background: Changes in tryptophan metabolism are associated with various diseases. Results: A comprehensive model of human tryptophan metabolism was constructed and verified with existing experimental data. Conclusion: The subtle balance of tryptophan derivatives required for proper brain function is sensitive to alterations in peripheral tissues. Significance: The model is applicable as a diagnostic tool to study disease related changes in tryptophan metabolism. Tryptophan is utilized in various metabolic routes including protein synthesis, serotonin, and melatonin synthesis and the kynurenine pathway. Perturbations in these pathways have been associated with neurodegenerative diseases and cancer. Here we present a comprehensive kinetic model of the complex network of human tryptophan metabolism based upon existing kinetic data for all enzymatic conversions and transporters. By integrating tissue-specific expression data, modeling tryptophan metabolism in liver and brain returned intermediate metabolite concentrations in the physiological range. Sensitivity and metabolic control analyses identified expected key enzymes to govern fluxes in the branches of the network. Combining tissue-specific models revealed a considerable impact of the kynurenine pathway in liver on the concentrations of neuroactive derivatives in the brain. Moreover, using expression data from a cancer study predicted metabolite changes that resembled the experimental observations. We conclude that the combination of the kinetic model with expression data represents a powerful diagnostic tool to predict alterations in tryptophan metabolism. The model is readily scalable to include more tissues, thereby enabling assessment of organismal tryptophan metabolism in health and disease.	[Stavrum, Anne-Kristin] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Heiland, Ines] Arctic Univ Norway, Dept Arctic & Marine Biol, UiT, N-9037 Tromso, Norway; [Schuster, Stefan] Univ Jena, Dept Bioinformat, D-07743 Jena, Germany; [Puntervoll, Pal] Uni Res, Computat Biol Unit, Uni Comp, N-5008 Bergen, Norway; [Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway	University of Bergen; UiT The Arctic University of Tromso; Friedrich Schiller University of Jena; University of Bergen	Heiland, I (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Dramsveien 201, N-9037 Tromso, Norway.	ines.heiland@uit.no	Heiland, Ines/B-9212-2014	Heiland, Ines/0000-0002-9124-5112; Ziegler, Mathias/0000-0001-6961-2396	German Federal Ministry of Education and Research (BMBF) within the Research Initiative in Systems Biology of Aging (GerontoSys) [0315591D, 0315890C]; German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme; Norwegian Cancer Society; Research Council of Norway [178885, 191721]	German Federal Ministry of Education and Research (BMBF) within the Research Initiative in Systems Biology of Aging (GerontoSys)(Federal Ministry of Education & Research (BMBF)); German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme(Deutscher Akademischer Austausch Dienst (DAAD)); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by German Federal Ministry of Education and Research (BMBF) Projects 0315591D and 0315890C within the Research Initiative in Systems Biology of Aging (GerontoSys), the German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme, the Norwegian Cancer Society, and Research Council of Norway Grants 178885 and 191721.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carretti N, 2005, HUM REPROD, V20, P1548, DOI 10.1093/humrep/deh795; Chen YG, 2009, INT J COMPUT INT SYS, V2, P1, DOI 10.2991/jnmp.2009.2.1.1; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Dolusic E, 2011, J MED CHEM, V54, P5320, DOI 10.1021/jm2006782; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fell DA, 1998, BIOTECHNOL BIOENG, V58, P121, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<121::AID-BIT2>3.3.CO;2-F; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Heinmets F, 1974, Comput Biol Med, V1, P323; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kincses ZT, 2010, J CELL MOL MED, V14, P2045, DOI 10.1111/j.1582-4934.2010.01123.x; Klipp E, 1999, BIOSYSTEMS, V54, P1, DOI 10.1016/S0303-2647(99)00059-3; Klipp Edda, 2004, Genome Inform, V15, P125; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pawlak D, 2001, J PHYSIOL PHARMACOL, V52, P755; Sahle S, 2008, PHILOS T R SOC A, V366, P3619, DOI 10.1098/rsta.2008.0108; SALTER M, 1986, BIOCHEM J, V234, P635, DOI 10.1042/bj2340635; Schauble S, 2013, FEBS LETT, V587, P2818, DOI 10.1016/j.febslet.2013.06.025; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schuster S., 1996, REGULATION CELLULAR, P138; Schuster S., 2006, BIOINFORMATICS GENOM, P755; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; SPECIALE C, 1989, J NEUROSCI, V9, P2066; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Stavrum A. K., 2008, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi0703s21; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vogt AM, 2002, FEBS LETT, V517, P245, DOI 10.1016/S0014-5793(02)02632-7; Zadori D, 2012, J NEURAL TRANSM, V119, P275, DOI 10.1007/s00702-011-0697-3; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	46	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34555	34566		10.1074/jbc.M113.474908	http://dx.doi.org/10.1074/jbc.M113.474908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129579	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000329812800024
J	Suhanovsky, MM; Teschke, CM				Suhanovsky, Margaret M.; Teschke, Carolyn M.			An Intramolecular Chaperone Inserted in Bacteriophage P22 Coat Protein Mediates Its Chaperonin-independent Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Protein Folding; Protein Self-assembly; Protein Stability; Virus Assembly	CIRCULAR-DICHROISM; UNFOLDING KINETICS; POLYHEAD FORMATION; PULSE PROTEOLYSIS; RIBONUCLEASE-A; PHAGE-P22; MECHANISM; MUTANTS; MATURATION; STABILITY	The bacteriophage P22 coat protein has the common HK97-like fold but with a genetically inserted domain (I-domain). The role of the I-domain, positioned at the outermost surface of the capsid, is unknown. We hypothesize that the I-domain may act as an intramolecular chaperone because the coat protein folds independently, and many folding mutants are localized to the I-domain. The function of the I-domain was investigated by generating the coat protein core without its I-domain and the isolated I-domain. The core coat protein shows a pronounced folding defect. The isolated I-domain folds autonomously and has a high thermodynamic stability and fast folding kinetics in the presence of a peptidyl prolyl isomerase. Thus, the I-domain provides thermodynamic stability to the full-length coat protein so that it can fold reasonably efficiently while still allowing the HK97-like core to retain the flexibility required for conformational switching during procapsid assembly and maturation.	[Suhanovsky, Margaret M.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	teschke@uconn.edu			National Institutes of Health [GMS 076661]; IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health [8P20GM103449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449, R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMS 076661 (to C. M. T.) and the IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health Grant 8P20GM103449 (to the Vermont Genetics Network).	Aksyuk AA, 2012, P NATL ACAD SCI USA, V109, P14001, DOI 10.1073/pnas.1207730109; Anderson E, 2003, VIROLOGY, V313, P184, DOI 10.1016/S0042-6822(03)00240-X; Aramli LA, 1999, J BIOL CHEM, V274, P22217, DOI 10.1074/jbc.274.32.22217; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Creighton T. E., 1992, PROTEINS STRUCTURES, P5; Dodge RW, 1996, BIOCHEMISTRY-US, V35, P1548, DOI 10.1021/bi952348q; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Gloss LM, 1998, BIOCHEMISTRY-US, V37, P15990, DOI 10.1021/bi981511p; GORDON CL, 1993, J BIOL CHEM, V268, P9358; GORDON CL, 1994, GENETICS, V136, P427; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Inouye K, 1998, BBA-PROTEIN STRUCT M, V1388, P209, DOI 10.1016/S0167-4838(98)00189-7; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kang SB, 2005, J MOL BIOL, V347, P935, DOI 10.1016/j.jmb.2005.02.021; Kang S, 2010, BIOMACROMOLECULES, V11, P2804, DOI 10.1021/bm100877q; KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9; KING J, 1976, PHILOS T ROY SOC B, V276, P37, DOI 10.1098/rstb.1976.0096; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498; MAYR LM, 1994, J MOL BIOL, V240, P288, DOI 10.1006/jmbi.1994.1446; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Na YR, 2009, PROTEIN SCI, V18, P268, DOI 10.1002/pro.29; Nakonechny WS, 1998, J BIOL CHEM, V273, P27236, DOI 10.1074/jbc.273.42.27236; OCHMAN H, 1988, GENETICS, V120, P621; Parent KN, 2007, MOL MICROBIOL, V65, P1300, DOI 10.1111/j.1365-2958.2007.05868.x; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Pierre B, 2011, BIOTECHNOL BIOENG, V108, P1011, DOI 10.1002/bit.23039; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rizzo AA, 2013, BIOMOL NMR ASSIGN, V7, P257, DOI 10.1007/s12104-012-9422-x; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suhanovsky MM, 2010, MOL MICROBIOL, V77, P1568, DOI 10.1111/j.1365-2958.2010.07311.x; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	59	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33772	33783		10.1074/jbc.M113.515312	http://dx.doi.org/10.1074/jbc.M113.515312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126914	Green Published, hybrid			2022-12-25	WOS:000327250200023
J	Liu, Y; Luo, DJ; Zhao, H; Zhu, ZY; Hu, W; Cheng, CHK				Liu, Yun; Luo, Daji; Zhao, Hui; Zhu, Zuoyan; Hu, Wei; Cheng, Christopher H. K.			Inheritable and Precise Large Genomic Deletions of Non-Coding RNA Genes in Zebrafish Using TALENs	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; CHROMOSOMAL DELETIONS; EFFECTOR NUCLEASES; EMBRYONIC-DEVELOPMENT; MICRORNA EXPRESSION; TRANSCRIPTION; CELLS; KNOCKOUT; ORGANIZATION; RECOGNITION	Transcription activator-like effector nucleases (TALENs) have so far been applied to disrupt protein-coding genes which constitute only 2-3% of the genome in animals. The majority (70-90%) of the animal genome is actually transcribed as non-coding RNAs (ncRNAs), yet the lack of efficient tools to knockout ncRNA genes hinders studies on their in vivo functions. Here we have developed novel strategies using TALENs to achieve precise and inheritable large genomic deletions and knockout of ncRNA genes in zebrafish. We have demonstrated that individual miRNA genes could be disrupted using one pair of TALENs, whereas large microRNA (miRNA) gene clusters and long non-coding RNA (lncRNA) genes could be precisely deleted using two pairs of TALENs. We have generated large genomic deletions of two miRNA clusters (the 1.2 kb miR-17-92 cluster and the 79.8 kb miR-430 cluster) and one long non-coding RNA (lncRNA) gene (the 9.0 kb malat1), and the deletions are transmitted through the germline. Taken together, our results establish TALENs as a robust tool to engineer large genomic deletions and knockout of ncRNA genes, thus opening up new avenues in the application of TALENs to study the genome in vivo.	[Liu, Yun; Zhao, Hui; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Luo, Daji; Zhu, Zuoyan; Hu, Wei] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Luo, Daji] Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Peoples R China; [Liu, Yun; Zhao, Hui; Cheng, Christopher H. K.] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci, Core Lab, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Wuhan University; Chinese University of Hong Kong, Shenzhen	Hu, W (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	huwei@ihb.ac.cn; chkcheng@cuhk.edu.hk	Luo, Daji/AAQ-3065-2021; Zhao, Hui/B-8429-2016; CHENG, Ki Christopher/R-9641-2018	Zhao, Hui/0000-0001-8160-6415; CHENG, Ki Christopher/0000-0001-8970-9048	Research Grant Council of Hong Kong [462312]; National Natural Science Foundation of China [31172394, 30900853, 30930069]; Chinese Academy of Sciences [KSCX2-EW-N-004]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Research Grant Council of Hong Kong (462312 to CHKC), the National Natural Science Foundation of China (31172394 to CHKC, 30900853 to DL and 30930069 to WH) and the Chinese Academy of Sciences (KSCX2-EW-N-004 to WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ansai S, 2013, GENETICS IN PRESS; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Huarte M, 2013, CELL RES, V23, P449, DOI 10.1038/cr.2012.169; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koprunner M, 2001, GENE DEV, V15, P2877; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lim SM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r69; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	50	13	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76387	10.1371/journal.pone.0076387	http://dx.doi.org/10.1371/journal.pone.0076387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130773	Green Submitted, gold, Green Published			2022-12-25	WOS:000325814200038
J	Wan, H; Hu, JP; Li, KS; Tian, XH; Chang, S				Wan, Hua; Hu, Jian-ping; Li, Kang-shun; Tian, Xu-hong; Chang, Shan			Molecular Dynamics Simulations of DNA-Free and DNA-Bound TAL Effectors	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; BINDING SPECIFICITY; CRYSTAL-STRUCTURE; III EFFECTORS; RECOGNITION; PROTEIN; COMPLEXES; PATHOGEN; RICE; GENE	TAL (transcriptional activator-like) effectors (TALEs) are DNA-binding proteins, containing a modular central domain that recognizes specific DNA sequences. Recently, the crystallographic studies of TALEs revealed the structure of DNA-recognition domain. In this article, molecular dynamics (MD) simulations are employed to study two crystal structures of an 11.5-repeat TALE, in the presence and absence of DNA, respectively. The simulated results indicate that the specific binding of RVDs (repeat-variable diresidues) with DNA leads to the markedly reduced fluctuations of tandem repeats, especially at the two ends. In the DNA-bound TALE system, the base-specific interaction is formed mainly by the residue at position 13 within a TAL repeat. Tandem repeats with weak RVDs are unfavorable for the TALE-DNA binding. These observations are consistent with experimental studies. By using principal component analysis (PCA), the dominant motions are open-close movements between the two ends of the superhelical structure in both DNA-free and DNA-bound TALE systems. The open-close movements are found to be critical for the recognition and binding of TALE-DNA based on the analysis of free energy landscape (FEL). The conformational analysis of DNA indicates that the 59 end of DNA target sequence has more remarkable structural deformability than the other sites. Meanwhile, the conformational change of DNA is likely associated with the specific interaction of TALE-DNA. We further suggest that the arrangement of N-terminal repeats with strong RVDs may help in the design of efficient TALEs. This study provides some new insights into the understanding of the TALE-DNA recognition mechanism.	[Wan, Hua; Li, Kang-shun; Tian, Xu-hong; Chang, Shan] South China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China; [Hu, Jian-ping] Leshan Normal Univ, Coll Chem, Leshan, Peoples R China	South China Agricultural University; Leshan Normal University	Chang, S (corresponding author), South China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China.	schang@scau.edu.cn		Chang, Shan/0000-0001-7169-9398	National Natural Science Foundation of China [31200990, 31372116, 11247018, 31071837, 70971043]; Guangdong Province Science and Technology Plan Project [2012B010100029, 2010B080701070]; key Project of Chinese Ministry of Education [211159]; Science and Technology Bureau Foundation of Sichuan Province [2011JYZ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Plan Project; key Project of Chinese Ministry of Education(Ministry of Education, China); Science and Technology Bureau Foundation of Sichuan Province	This work was supported by the National Natural Science Foundation of China (31200990, 31372116, 11247018, 31071837, 70971043), Guangdong Province Science and Technology Plan Project (2012B010100029, 2010B080701070), the key Project of Chinese Ministry of Education (211159) and the Science and Technology Bureau Foundation of Sichuan Province (2011JYZ007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bradley P, 2012, PROTEIN SCI, V21, P471, DOI 10.1002/pro.2034; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Hu JP, 2008, ACTA PHYS-CHIM SIN, V24, P1803, DOI 10.3866/PKU.WHXB20081012; Hu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054929; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jalili S, 2012, EUR BIOPHYS J BIOPHY, V41, P329, DOI 10.1007/s00249-012-0790-z; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Maisuradze GG, 2010, J CHEM THEORY COMPUT, V6, P583, DOI 10.1021/ct9005745; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Negureanu L, 2012, J BIOMOL STRUCT DYN, V29, P757, DOI 10.1080/07391102.2012.10507412; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prabakaran P, 2006, STRUCTURE, V14, P1355, DOI 10.1016/j.str.2006.06.018; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wan H, 2013, PHYS CHEM CHEM PHYS, V15, P1241, DOI 10.1039/c2cp41388d; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	59	37	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76045	10.1371/journal.pone.0076045	http://dx.doi.org/10.1371/journal.pone.0076045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130757	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200028
J	Cohen-Or, I; Katz, C; Ron, EZ				Cohen-Or, Ifat; Katz, Chen; Ron, Eliora Z.			Metabolism of AGEs - Bacterial AGEs Are Degraded by Metallo-Proteases	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INVOLVEMENT; DEGRADATION; INHIBITION; COMPLICATIONS; PATHOGENESIS; MECHANISM; PROTEINS	Advanced Glycation End Products (AGEs) are the final products of non-enzymatic protein glycation that results in loss of protein structure and function. We have previously shown that in E. coli AGEs are continually formed as high-molecular weight protein complexes. Moreover, we showed that AGEs are removed from the cells by an active, ATP-dependent secretion and that these secreted molecules have low molecular weight. Taken together, these results indicate that E. coli contains a fraction of low molecular weight AGEs, in addition to the high-molecular weight AGEs. Here we show that the low-molecular weight AGEs originate from high-molecular weight AGEs by proteolytic degradation. Results of in-vitro and in vivo experiments indicated that this degradation is carried out not by the major ATP-dependent proteases that are responsible for the main part of bacterial protein quality control but by an alternative metal-dependent proteolysis. This proteolytic reaction is essential for the further secretion of AGEs from the cells. As the biochemical reactions involving AGEs are not yet understood, the implication of a metalloprotease in breakdown of high molecular weight AGEs and their secretion constitutes an important step in the understanding of AGEs metabolism.	[Cohen-Or, Ifat; Ron, Eliora Z.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Katz, Chen] MIGAL Galilee Res Ctr, Kiriat Shmone, Israel	Tel Aviv University	Ron, EZ (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	eliora@post.tau.ac.il						Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Cohen-Or I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017974; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Kankova K, 2008, P NUTR SOC, V67, P60, DOI 10.1017/S0029665108006034; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; MAZUS B, 1986, BIOCHEMISTRY-US, V25, P2941, DOI 10.1021/bi00358a031; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Njoroge F G, 1989, Prog Clin Biol Res, V304, P85; Petrillo TM, 2000, NEW ENGL J MED, V342, P1250, DOI 10.1056/NEJM200004273421704; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Stolzing A, 2006, FREE RADICAL BIO MED, V40, P1017, DOI 10.1016/j.freeradbiomed.2005.10.061; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; TAYLOR ES, 1947, J GEN MICROBIOL, V1, P86, DOI 10.1099/00221287-1-1-86; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Turlin E, 1996, BIOCHIMIE, V78, P822, DOI 10.1016/S0300-9084(97)84334-9; Van Nguyen C, 2006, MOL NUTR FOOD RES, V50, P1140, DOI 10.1002/mnfr.200600144; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Zhu BZ, 2000, CHEM-BIOL INTERACT, V129, P249, DOI 10.1016/S0009-2797(00)00208-8	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74970	10.1371/journal.pone.0074970	http://dx.doi.org/10.1371/journal.pone.0074970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130678	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900013
J	Ebsen, H; Schroder, A; Kabelitz, D; Janssen, O				Ebsen, Henriette; Schroeder, Alexandra; Kabelitz, Dieter; Janssen, Ottmar			Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; REGULATED INTRAMEMBRANE PROTEOLYSIS; TRANS-GOLGI NETWORK; SECRETORY LYSOSOMES; TNF-ALPHA; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; GAMMA-SECRETASE; CALCIUM INFLUX	A disintegrin and metalloproteases (ADAMs) have been implicated in many processes controlling organismic development and integrity. Important substrates of ADAM proteases include growth factors, cytokines and their receptors and adhesion proteins. The inducible but irreversible cleavage of their substrates alters cell-cell communication and signaling. The crucial role of ADAM proteases (e. g. ADAM10 and 17) for mammalian development became evident from respective knockout mice, that displayed pre- or perinatal lethality with severe defects in many organs and tissues. Although many substrates for these two ADAM proteases were identified over the last decade, the regulation of their surface appearance, their enzymatic activity and their substrate specificity are still not well understood. We therefore analyzed the constitutive and inducible surface expression of ADAM10 and ADAM17 on a variety of human T cell and tumor cell lines. We demonstrate that ADAM10 is constitutively present at comparably high levels on the majority of the tested cell types. Stimulation with phorbol ester and calcium ionophore does not significantly alter the amount of surface ADAM10, except for a slight down-regulation from T cell blasts. Using FasL shedding as a readout for ADAM10 activity, we show that PKC activation and calcium mobilization are both prerequisite for activation of ADAM10 resulting in a production of soluble FasL. In contrast to ADAM10, the close relative ADAM17 is detected at only low levels on unstimulated cells. ADAM17 surface expression on T cell blasts is rapidly induced by stimulation. Since this inducible mobilization of ADAM17 is sensitive to inhibitors of actin filament formation, we propose that ADAM17 but not ADAM10 is prestored in a subcellular compartment that is transported to the cell surface in an activation-and actin-dependent manner.	[Ebsen, Henriette; Schroeder, Alexandra; Kabelitz, Dieter; Janssen, Ottmar] Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein Campus Kiel, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Janssen, O (corresponding author), Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein Campus Kiel, Kiel, Germany.	ojanssen@email.uni-kiel.de	Kabelitz, Dieter/A-2757-2010; Janssen, Ottmar/E-9735-2010; Kabelitz, Dieter/AAB-4199-2021; Janssen, Ottmar/N-8769-2019; Ebsen, Henriette/B-1886-2015	Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; 	Deutsche Forschungsgemeinschaft Bonn, Germany (DFG) [SFB877]	Deutsche Forschungsgemeinschaft Bonn, Germany (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft Bonn, Germany (SFB877, projects B4, A7) (DFG: http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Annaert WG, 2009, SEMIN CELL DEV BIOL, V20, P125, DOI 10.1016/j.semcdb.2009.03.005; Bell HL, 2010, AM J MED SCI, V339, P105, DOI 10.1097/MAJ.0b013e3181cb4487; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Guo Sha, 2012, Chinese Medical Sciences Journal, V27, P73; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Holback S, 2008, BIOCHEM BIOPH RES CO, V365, P298, DOI 10.1016/j.bbrc.2007.10.167; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; LETTAU M, 2004, SIGNAL TRANSDUCT, V4, P206, DOI DOI 10.1002/SITA.200400037; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schmidt H, 2008, PROTEOMICS, V8, P2911, DOI 10.1002/pmic.200800170; Schmidt H, 2011, J PROTEOME RES, V10, P1603, DOI 10.1021/pr100967v; Schmidt H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-4; Schmidt H, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-41; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Trad A, 2011, J IMMUNOL METHODS, V371, P91, DOI 10.1016/j.jim.2011.06.015; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Voss Matthias, 2008, Cell Commun Signal, V6, P11, DOI 10.1186/1478-811X-6-11; Walev I, 1996, P NATL ACAD SCI USA, V93, P7882, DOI 10.1073/pnas.93.15.7882; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391	70	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76853	10.1371/journal.pone.0076853	http://dx.doi.org/10.1371/journal.pone.0076853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130797	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900092
J	Chaves-Kirsten, GP; Mazucanti, CHY; Real, CC; Souza, BM; Britto, LRG; Torrao, AS				Chaves-Kirsten, Gabriela P.; Mazucanti, Caio H. Y.; Real, Caroline C.; Souza, Bruna M.; Britto, Luiz R. G.; Torrao, Andrea S.			Temporal Changes of CB1 Cannabinoid Receptor in the Basal Ganglia as a Possible Structure-Specific Plasticity Process in 6-OHDA Lesioned Rats	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ENDOCANNABINOID SYSTEM; MESSENGER-RNA; ENDOGENOUS CANNABINOIDS; GLOBUS-PALLIDUS; IN-VIVO; MODEL; EXPRESSION; MPTP	The endocannabinoid system has been implicated in several neurobiological processes, including neurodegeneration, neuroprotection and neuronal plasticity. The CB1 cannabinoid receptors are abundantly expressed in the basal ganglia, the circuitry that is mostly affected in Parkinson's Disease (PD). Some studies show variation of CB1 expression in basal ganglia in different animal models of PD, however the results are quite controversial, due to the differences in the procedures employed to induce the parkinsonism and the periods analyzed after the lesion. The present study evaluated the CB1 expression in four basal ganglia structures, namely striatum, external globus pallidus (EGP), internal globus pallidus (IGP) and substantia nigra pars reticulata (SNpr) of rats 1, 5, 10, 20, and 60 days after unilateral intrastriatal 6-hydroxydopamine injections, that causes retrograde dopaminergic degeneration. We also investigated tyrosine hydroxylase (TH), parvalbumin, calbindin and glutamic acid decarboxylase (GAD) expression to verify the status of dopaminergic and GABAergic systems. We observed a structure-specific modulation of CB1 expression at different periods after lesions. In general, there were no changes in the striatum, decreased CB1 in IGP and SNpr and increased CB1 in EGP, but this increase was not sustained over time. No changes in GAD and parvalbumin expression were observed in basal ganglia, whereas TH levels were decreased and the calbindin increased in striatum in short periods after lesion. We believe that the structure-specific variation of CB1 in basal ganglia in the 6-hydroxydopamine PD model could be related to a compensatory process involving the GABAergic transmission, which is impaired due to the lack of dopamine. Our data, therefore, suggest that the changes of CB1 and calbindin expression may represent a plasticity process in this PD model.	[Chaves-Kirsten, Gabriela P.; Souza, Bruna M.; Torrao, Andrea S.] Univ Sao Paulo, Dept Physiol & Biophys, Lab Neuronal Commun, Sao Paulo, Brazil; [Mazucanti, Caio H. Y.] Univ Sao Paulo, Dept Pharmacol, Lab Mol Neuropharmacol, Sao Paulo, Brazil; [Real, Caroline C.; Britto, Luiz R. G.] Univ Sao Paulo, Dept Physiol & Biophys, Lab Cellular Neurobiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Chaves-Kirsten, GP (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Lab Neuronal Commun, Sao Paulo, Brazil.	gabipc@icb.usp.br	Mazucanti, Caio/AAI-4704-2021; Torrao, Andrea S/C-2353-2012; Real, Caroline C/N-1674-2013	Mazucanti, Caio/0000-0001-9144-4886; Torrao, Andrea S/0000-0001-6301-3448; Real, Caroline C/0000-0001-6096-3341	FAPESP CNPq University of Sao Paulo - NAPNA	FAPESP CNPq University of Sao Paulo - NAPNA	FAPESP CNPq University of Sao Paulo - NAPNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, EUR J NEUROSCI, V9, P120, DOI 10.1111/j.1460-9568.1997.tb01360.x; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Allen KL, 2009, J CHEM NEUROANAT, V37, P266, DOI 10.1016/j.jchemneu.2009.02.001; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Baek JH, 2011, NEUROSCI LETT, V487, P330, DOI 10.1016/j.neulet.2010.10.050; Benarroch E, 2007, NEUROLOGY, V69, P306, DOI 10.1212/01.wnl.0000267407.79757.75; Blandini F, 2007, EUR J NEUROSCI, V25, P397, DOI 10.1111/j.1460-9568.2006.05285.x; Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brotchie JM, 2003, CURR OPIN PHARMACOL, V3, P54, DOI 10.1016/S1471-4892(02)00011-5; Cabranes A, 2005, NEUROBIOL DIS, V20, P207, DOI 10.1016/j.nbd.2005.03.002; Casteels C, 2011, EXP NEUROL, V229, P440, DOI 10.1016/j.expneurol.2011.03.014; Casteels C, 2010, BRAIN RES, V1316, P153, DOI 10.1016/j.brainres.2009.12.026; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chung YC, 2011, J IMMUNOL, V187, P6508, DOI 10.4049/jimmunol.1102435; de Lago Eva, 2007, CNS & Neurological Disorders-Drug Targets, V6, P377; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dowie MJ, 2009, NEUROSCIENCE, V163, P456, DOI 10.1016/j.neuroscience.2009.06.014; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Garcia-Arencibia M, 2007, BRAIN RES, V1134, P162, DOI 10.1016/j.brainres.2006.11.063; Garcia-Arencibia M, 2009, J NEURAL TRANSM-SUPP, P269, DOI 10.1007/978-3-211-92660-4_22; Garcia-Arencibia M, 2009, CNS NEUROL DISORD-DR, V8, P432, DOI 10.2174/187152709789824642; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gonzalez S, 2006, BRAIN RES, V1073, P209, DOI 10.1016/j.brainres.2005.12.014; Gubellini P, 2002, J NEUROSCI, V22, P6900; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Hontanilla B, 1998, BRAIN RES BULL, V47, P107, DOI 10.1016/S0361-9230(98)00035-5; Hu H, 2012, NEUROSCIENCE, V227, P211, DOI 10.1016/j.neuroscience.2012.09.067; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Hurley MJ, 2003, J NEURAL TRANSM, V110, P1279, DOI 10.1007/s00702-003-0033-7; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; KITA H, 1994, BRAIN RES, V657, P31, DOI 10.1016/0006-8993(94)90950-4; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Lastres-Becker I, 2001, EUR J NEUROSCI, V14, P1827, DOI 10.1046/j.0953-816x.2001.01812.x; Leonelli M, 2005, DEV BRAIN RES, V156, P176, DOI 10.1016/j.devbrainres.2005.02.009; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Morera-Herreras T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00110; Ng MC, 1996, MOL BRAIN RES, V36, P329, DOI 10.1016/0169-328X(95)00266-U; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Papa SM, 2008, EXP NEUROL, V211, P334, DOI 10.1016/j.expneurol.2008.03.009; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Romero J, 2000, LIFE SCI, V66, P485, DOI 10.1016/S0024-3205(99)00618-9; Sanchez AJ, 2012, CLIN IMMUNOL, V142, P57, DOI 10.1016/j.clim.2011.02.010; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Silverdale MA, 2001, EXP NEUROL, V169, P400, DOI 10.1006/exnr.2001.7649; Tanaka KI, 2006, NEUROSCI LETT, V410, P85, DOI 10.1016/j.neulet.2006.08.021; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Van Laere K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.009; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Venderova K, 2005, EXP NEUROL, V194, P284, DOI 10.1016/j.expneurol.2005.02.012; Walsh S, 2010, BRAIN RES BULL, V81, P543, DOI 10.1016/j.brainresbull.2010.01.009; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z	60	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76874	10.1371/journal.pone.0076874	http://dx.doi.org/10.1371/journal.pone.0076874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116178	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200082
J	Woody, S; Stall, R; Ramos, J; Patel, YM				Woody, Shelly; Stall, Richard; Ramos, Joseph; Patel, Yashomati M.			Regulation of Myosin Light Chain Kinase during Insulin-Stimulated Glucose Uptake in 3T3-L1 Adipocytes	PLOS ONE			English	Article							GLUT4 VESICLE TRANSLOCATION; DEPENDENT PROTEIN-KINASE; ADIPOSE CELL; MUSCLE-CELLS; PHOSPHORYLATION; TRANSPORT; MEMBRANE; EXOCYTOSIS; FUSION; MYO1C	Myosin II (MyoII) is required for insulin-responsive glucose transporter 4 (GLUT4)-mediated glucose uptake in 3T3-L1 adipocytes. Our previous studies have shown that insulin signaling stimulates phosphorylation of the regulatory light chain (RLC) of MyoIIA via myosin light chain kinase (MLCK). The experiments described here delineate upstream regulators of MLCK during insulin-stimulated glucose uptake. Since 3T3-L1 adipocytes express two MyoII isoforms, we wanted to determine which isoform was required for insulin-stimulated glucose uptake. Using a siRNA approach, we demonstrate that a 60% decrease in MyoIIA protein expression resulted in a 40% inhibition of insulin-stimulated glucose uptake. We also show that insulin signaling stimulates the phosphorylation of MLCK. We further show that MLCK can be activated by calcium as well as signaling pathways. We demonstrate that adipocytes treated with the calcium chelating agent, 1,2-b (iso-aminophenoxy) ethane-N,N,N',N'-tetra acetic acid, (BAPTA) (in the presence of insulin) impaired the insulin-induced phosphorylation of MLCK by 52% and the RLC of MyoIIA by 45% as well as impairing the recruitment of MyoIIA to the plasma membrane when compared to cells treated with insulin alone. We further show that the calcium ionophore, A23187 alone stimulated the phosphorylation of MLCK and the RLC associated with MyoIIA to the same extent as insulin. To identify signaling pathways that might regulate MLCK, we examined ERK and CaMKII. Inhibition of ERK2 impaired phosphorylation of MLCK and insulin-stimulated glucose uptake. In contrast, while inhibition of CaMKII did inhibit phosphorylation of the RLC associated with MyoIIA, inhibition of CAMKIId did not impair MLCK phosphorylation or translocation to the plasma membrane or glucose uptake. Collectively, our results are the first to delineate a role for calcium and ERK in the activation of MLCK and thus MyoIIA during insulin-stimulated glucose uptake in 3T3-L1 adipocytes.	[Woody, Shelly; Stall, Richard; Ramos, Joseph; Patel, Yashomati M.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Patel, YM (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	ympatel@uncg.edu			National Institutes of Health [2R15DK073180-02A1]; National Science Foundation [DBI-0319021]; North Carolina Biotechnology Center [003-IDG-1011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK073180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an National Institutes of Health grant to Y.M.P. (2R15DK073180-02A1). Microscopy studies were supported in part by grants from the National Science Foundation (DBI-0319021) and the North Carolina Biotechnology Center (003-IDG-1011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Bessard A, 2006, HEPATOLOGY, V44, P152, DOI 10.1002/hep.21222; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brozinick JT, 1999, BIOCHEM J, V339, P533, DOI 10.1042/0264-6021:3390533; Choi YO, 2006, EXP MOL MED, V38, P180, DOI 10.1038/emm.2006.22; Chung LTK, 2010, BIOCHEM BIOPH RES CO, V391, P995, DOI 10.1016/j.bbrc.2009.12.004; CONTI MA, 1981, J BIOL CHEM, V256, P3178; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Harmon AW, 2004, AM J PHYSIOL-ENDOC M, V287, pE758, DOI 10.1152/ajpendo.00581.2003; Hartshorne DJ, 1998, ACTA PHYSIOL SCAND, V164, P483; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; IKEBE M, 1990, J BIOL CHEM, V265, P8975; Illario M, 2009, CELL SIGNAL, V21, P786, DOI 10.1016/j.cellsig.2009.01.022; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Konstantopoulos N, 2007, ENDOCRINOLOGY, V148, P374, DOI 10.1210/en.2006-0446; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Steimle PA, 2005, BIOCHEM BIOPH RES CO, V331, P1560, DOI 10.1016/j.bbrc.2005.04.082; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Worrall DS, 2002, MOL ENDOCRINOL, V16, P378, DOI 10.1210/me.16.2.378; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Zhang JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045976	47	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77248	10.1371/journal.pone.0077248	http://dx.doi.org/10.1371/journal.pone.0077248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116218	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200110
J	Allan, G; Ouadid-Ahidouch, H; Sanchez-Fernandez, EM; Risquez-Cuadro, R; Fernandez, JMG; Ortiz-Mellet, C; Ahidouch, A				Allan, Ghada; Ouadid-Ahidouch, Halima; Sanchez-Fernandez, Elena M.; Risquez-Cuadro, Rocio; Garcia Fernandez, Jose M.; Ortiz-Mellet, Carmen; Ahidouch, Ahmed			New Castanospermine Glycoside Analogues Inhibit Breast Cancer Cell Proliferation and Induce Apoptosis without Affecting Normal Cells	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; HUMAN HEPATOCELLULAR-CARCINOMA; N-LINKED OLIGOSACCHARIDES; CYCLIN-DEPENDENT KINASES; ENDOPLASMIC-RETICULUM; PROGNOSTIC MARKER; IN-VITRO; PHARMACOLOGICAL CHAPERONES; GM(1) GANGLIOSIDOSIS; TUMOR-GROWTH	sp(2)-Iminosugar-type castanospermine analogues have been shown to exhibit anti-tumor activity. However, their effects on cell proliferation and apoptosis and the molecular mechanism at play are not fully understood. Here, we investigated the effect of two representatives, namely the pseudo-S-and C-octyl glycoside 2-oxa-3-oxocastanospermine derivatives SO-OCS and CO-OCS, on MCF-7 and MDA-MB-231 breast cancer and MCF-10A mammary normal cell lines. We found that SO-OCS and CO-OCS inhibited breast cancer cell viability in a concentration-and time-dependent manner. This effect is specific to breast cancer cells as both molecules had no impact on normal MCF-10A cell proliferation. Both drugs induced a cell cycle arrest. CO-OCS arrested cell cycle at G1 and G2/M in MCF-7 and MDA-MB-231cells respectively. In MCF-7 cells, the G1 arrest is associated with a reduction of CDK4 (cyclin-dependent kinase 4), cyclin D1 and cyclin E expression, pRb phosphorylation, and an overexpression of p21(Waf1/Cip1). In MDA-MB-231 cells, CO-OCS reduced CDK1 but not cyclin B1 expression. SO-OCS accumulated cells in G2/M in both cell lines and this blockade was accompanied by a decrease of CDK1, but not cyclin B1 expression. Furthermore, both drugs induced apoptosis as demonstrated by the increased percentage of annexin V positive cells and Bax/Bcl-2 ratio. Interestingly, in normal MCF-10A cells the two drugs failed to modify cell proliferation, cell cycle progression, cyclins, or CDKs expression. These results demonstrate that the effect of CO-OCS and SO-OCS is triggered by both cell cycle arrest and apoptosis, suggesting that these castanospermine analogues may constitute potential anti-cancer agents against breast cancer.	[Allan, Ghada; Ouadid-Ahidouch, Halima; Ahidouch, Ahmed] UPJV, Lab Cellular & Mol Physiol EA 4667, SFR CAP SANTE FED 4132, UFR Sci, Amiens, France; [Sanchez-Fernandez, Elena M.; Risquez-Cuadro, Rocio; Ortiz-Mellet, Carmen] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain; [Garcia Fernandez, Jose M.] Univ Seville, CSIC, IIQ, Seville, Spain; [Ahidouch, Ahmed] Univ Ibn Zohr, Dept Biol, Fac Sci, Agadir, Morocco	Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Ibn Zohr University of Agadir	Ouadid-Ahidouch, H (corresponding author), UPJV, Lab Cellular & Mol Physiol EA 4667, SFR CAP SANTE FED 4132, UFR Sci, Amiens, France.	ha-sciences@u-picardie.fr; aa-lbv@u-picardie.fr	Cuadro, Rísquez/M-3977-2013; Mellet, Carmen Ortiz/C-7993-2011; Sánchez-Fernández, Elena/C-4594-2013; Fernandez, Jose M Garcia/D-8105-2011	Mellet, Carmen Ortiz/0000-0002-7676-7721; Sánchez-Fernández, Elena/0000-0002-8617-8234; Fernandez, Jose M Garcia/0000-0002-6827-0387	"Region Picardie"; "Ministere de la Recherche et de l'Enseignement Superieur"; Syrian Ministry of Higher Education; Ministry of Health; Spanish Ministerio de Economia y Competitividad [SAF2010-15670, CTQ2010-15848]; European Comission; Fondo Europeo de Desarrollo Regional (FEDER); Fondo Social Europeo (FSE); Fundacion Ramon Areces; Junta de Andalucia; FPU; Marie Curie Career Integration Grant	"Region Picardie"(Region Hauts-de-France); "Ministere de la Recherche et de l'Enseignement Superieur"; Syrian Ministry of Higher Education; Ministry of Health; Spanish Ministerio de Economia y Competitividad(Spanish Government); European Comission(European CommissionEuropean Commission Joint Research Centre); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission); Fundacion Ramon Areces; Junta de Andalucia(Junta de Andalucia); FPU(Spanish Government); Marie Curie Career Integration Grant	This work was supported by the "Region Picardie", and the "Ministere de la Recherche et de l'Enseignement Superieur". The authors greatly acknowledge the Syrian Ministry of Higher Education and Ministry of Health for funding the PhD thesis of GA. The Spanish Ministerio de Economia y Competitividad (contract numbers SAF2010-15670 and CTQ2010-15848), the European Comission, the Fondo Europeo de Desarrollo Regional (FEDER), the Fondo Social Europeo (FSE), the Fundacion Ramon Areces and the Junta de Andalucia are gratefully acknowledged for funding. RRC is recipient of a FPU grant. EMSF is recipient of a Marie Curie Career Integration Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Aguilar-Moncayo M, 2012, CHEM COMMUN, V48, P6514, DOI 10.1039/c2cc32065g; Aguilar-Moncayo M, 2009, ORG BIOMOL CHEM, V7, P2738, DOI 10.1039/b906968b; Alfonso P, 2013, CHEMBIOCHEM, V14, P943, DOI 10.1002/cbic.201200708; Alle KM, 1998, CLIN CANCER RES, V4, P847; Bobrovnikova-Marjon E, 2007, DEV CELL, V13, P322, DOI 10.1016/j.devcel.2007.08.006; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; CARLBERG M, 1993, ANTICANCER RES, V13, P167; Chiang PC, 2008, N-S ARCH PHARMACOL, V377, P167, DOI 10.1007/s00210-007-0249-4; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Faouzi M, 2013, BBA-MOL CELL RES, V1833, P752, DOI 10.1016/j.bbamcr.2012.12.009; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; HADWIGER A, 1986, EMBO J, V5, P689, DOI 10.1002/j.1460-2075.1986.tb04268.x; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017; Hsu JL, 2009, N-S ARCH PHARMACOL, V380, P373, DOI 10.1007/s00210-009-0453-5; HUMPHRIES MJ, 1986, CANCER RES, V46, P5215; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jimenez JB, 1997, REV CLIN ESP, V197, P299; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kaufman R. J., 1999, BIOCHIM BIOPHYS ACTA, V1423, P13; KEYOMARSI K, 1994, CANCER RES, V54, P380; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li ZC, 2012, J BIOSCIENCES, V37, P1005, DOI 10.1007/s12038-012-9265-8; Malumbres M, 2000, BIOL CHEM, V381, P827, DOI 10.1515/BC.2000.105; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MELERO JA, 1978, J CELL PHYSIOL, V95, P295, DOI 10.1002/jcp.1040950307; Nadler Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1998; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OSTRANDER GK, 1988, CANCER RES, V48, P1091; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PILI R, 1995, CANCER RES, V55, P2920; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rudolph P, 2003, INT J CANCER, V105, P674, DOI 10.1002/ijc.11132; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Russo A, 2006, ANN ONCOLOGY OFFI S7, V17; Sanchez-Fernandez EM, 2010, CHEM COMMUN, V46, P5328, DOI 10.1039/c0cc00446d; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Sun JY, 2007, PHYTOMEDICINE, V14, P353, DOI 10.1016/j.phymed.2006.08.003; Sun JY, 2009, PHYTOMEDICINE, V16, P1070, DOI 10.1016/j.phymed.2009.02.012; Takai T, 2013, MOL THER, V21, P526, DOI 10.1038/mt.2012.263; Tiscornia G, 2013, HUM MOL GENET, V22, P633, DOI 10.1093/hmg/dds471; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Tsai Yien Che, 2010, Genes Cancer, V1, P764; vanSlooten HJ, 1996, BRIT J CANCER, V74, P78, DOI 10.1038/bjc.1996.319; Veronese S, 1998, INT J CANCER, V79, P13, DOI 10.1002/(SICI)1097-0215(19980220)79:1<13::AID-IJC3>3.0.CO;2-Z; Wang L, 2006, CANCER INVEST, V24, P581, DOI 10.1080/07357900600894799; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wrodnigg TM, 2008, ANTI-CANCER AGENT ME, V8, P77, DOI 10.2174/187152008783330851; Zhao YX, 2008, BIOORGAN MED CHEM, V16, P6333, DOI 10.1016/j.bmc.2008.05.012; Zhao YX, 2010, CHEM BIOL DRUG DES, V75, P570, DOI 10.1111/j.1747-0285.2010.00968.x; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560	72	40	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76411	10.1371/journal.pone.0076411	http://dx.doi.org/10.1371/journal.pone.0076411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124558	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100115
J	Arya, T; Kishor, C; Saddanapu, V; Reddi, R; Addlagatta, A				Arya, Tarun; Kishor, Chandan; Saddanapu, Venkateshwarlu; Reddi, Ravikumar; Addlagatta, Anthony			Discovery of a New Genetic Variant of Methionine Aminopeptidase from Streptococci with Possible Post-Translational Modifications: Biochemical and Structural Characterization	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; RIBOSOME; ALIGNMENT	Protein N-terminal methionine excision is an essential co-translational process that occurs in the cytoplasm of all organisms. About 60-70% of the newly synthesized proteins undergo this modification. Enzyme responsible for the removal of initiator methionine is methionine aminopeptidase (MetAP), which is a dinuclear metalloprotease. This protein is conserved through all forms of life from bacteria to human except viruses. MetAP is classified into two isoforms, Type I and II. Removal of the map gene or chemical inhibition is lethal to bacteria and to human cell lines, suggesting that MetAP could be a good drug target. In the present study we describe the discovery of a new genetic variant of the Type I MetAP that is present predominantly in the streptococci bacteria. There are two inserts (insert one: 27 amino acids and insert two: four residues) within the catalytic domain. Possible glycosylation and phosphorylation posttranslational modification sites are identified in the 'insert one'. Biochemical characterization suggests that this enzyme behaves similar to other MetAPs in terms of substrate specificity. Crystal structure Type Ia MetAP from Streptococcus pneumoniae (SpMetAP1a) revealed that it contains two molecules in the asymmetric unit and well ordered inserts with structural features that corroborate the possible posttranslational modification. Both the new inserts found in the SpMetAP1a structurally align with the P-X-X-P motif found in the M. tuberculosis and human Type I MetAPs as well as the 60 amino acid insert in the human Type II enzyme suggesting possible common function. In addition, one of the beta-hairpins within in the catalytic domain undergoes a flip placing a residue which is essential for enzyme activity away from the active site and the beta-hairpin loop of this secondary structure in the active site obstructing substrate binding. This is the first example of a MetAP crystallizing in the inactive form.	[Arya, Tarun; Kishor, Chandan; Saddanapu, Venkateshwarlu; Reddi, Ravikumar; Addlagatta, Anthony] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Addlagatta, A (corresponding author), CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India.	anthony@iict.res.in	Reddi, Ravikumar/AAM-6814-2021; Addlagatta, Anthony/B-1101-2010; Addlagatta, Anthony/AAW-2675-2020	Reddi, Ravikumar/0000-0002-7657-4727; Kishor, Chandan/0000-0002-6328-1116	University Grants commission (UGC); Council of Scientific and Industrial Research (CSIR), New Delhi	University Grants commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Thanks to University Grants commission (UGC), Council of Scientific and Industrial Research (CSIR), New Delhi, for research fellowships to CK and TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P14741, DOI 10.1021/bi051691k; Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P7166, DOI 10.1021/bi0501176; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano WL, 2002, HE PYMOL MOL GRAPHIC; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Imperiali B, 1997, ACCOUNTS CHEM RES, V30, P452, DOI 10.1021/ar950226k; Kishor C, 2012, MEDCHEMCOMM, V3, P1406, DOI 10.1039/c2md20096a; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100	21	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75207	10.1371/journal.pone.0075207	http://dx.doi.org/10.1371/journal.pone.0075207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124477	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100034
J	Hou, YL; Wang, YC; Lu, XM; Zhang, X; Zhao, Q; Todhunter, RJ; Zhang, ZW				Hou, Yali; Wang, Yachun; Lu, Xuemei; Zhang, Xu; Zhao, Qian; Todhunter, Rory J.; Zhang, Zhiwu			Monitoring Hip and Elbow Dysplasia Achieved Modest Genetic Improvement of 74 Dog Breeds over 40 Years in USA	PLOS ONE			English	Article							UK LABRADOR RETRIEVERS; CANINE HIP; DORSOLATERAL SUBLUXATION; SELECTION; PEDIGREE; TRAITS; SCORES; TRENDS	Hip (HD) and Elbow Dysplasia (ED) are two common complex developmental disorders of dogs. In order to decrease their prevalence and severity, the Orthopedic Foundation for Animals (OFA) has a voluntary registry of canine hip and elbow conformation certified by boarded radiologists. However, the voluntarily reports have been severely biased against exposing dogs with problems, especially at beginning period. Fluctuated by additional influential factors such as age, the published raw scores barely showed trends of improvement. In this study, we used multiple-trait mixed model to simultaneously adjust these factors and incorporate pedigree to derive Estimated Breeding Values (EBV). A total of 1,264,422 dogs from 74 breeds were evaluated for EBVs from 760,455 hip scores and 135,409 elbow scores. These EBVs have substantially recovered the reporting bias and the other influences. Clear and steady trends of genetic improvement were observed over the 40 years since 1970. The total genetic improvements were 16.4% and 1.1% of the phenotypic standard deviation for HD and ED, respectively. The incidences of dysplasia were 0.83% and 2.08%, and the heritabilities were estimated as 0.22 and 0.17 for hip and elbow scores, respectively. The genetic correlation between them was 0.12. We conclude that EBV is more effective than reporting raw phenotype. The weak genetic correlation suggested that selection based on hip scores would also slightly improve elbow scores but it is necessary to allocate effort toward improvement of elbow scores alone.	[Hou, Yali; Wang, Yachun; Zhang, Xu] China Agr Univ, Key Lab Agr Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Hou, Yali; Lu, Xuemei] Chinese Acad Sci, Lab Dis Genom & Individualized Med, Beijing Inst Genom, Beijing, Peoples R China; [Zhao, Qian; Zhang, Zhiwu] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Northeast Agricultural University - China; Cornell University; Cornell University	Todhunter, RJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	rjt2@cornell.edu; zz19@cornell.edu	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016	Zhang, Zhiwu/0000-0002-5784-9684	National Institutes of Health [1R21AR055228-01A1]; National Science Foundation [0606461]; Chinese National Key Technologies RD Program [2011BAD28B02]; China Agriculture Research System [CARS-37]; National Natural Science Foundation of China [31172191]; Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chinese National Key Technologies RD Program(National Key Technology R&D Program); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), National Science Foundation (#0606461), Chinese National Key Technologies R&D Program (No. 2011BAD28B02), China Agriculture Research System (CARS-37), National Natural Science Foundation of China (No. 31172191), and the Department of Clinical Sciences in the College of Veterinary Medicine, Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Farese JP, 1999, AM J VET RES, V60, P1571; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Gibbs C, 1997, VET REC, V141, P275; Ginja MMD, 2010, VET J, V184, P269, DOI 10.1016/j.tvjl.2009.04.009; Guo G, 2011, OSTEOARTHR CARTILAGE, V19, P420, DOI 10.1016/j.joca.2010.12.011; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hedhammar AA, 2011, VET J, V189, P141, DOI [10.1016/j.tvjl.2011.06.011, 10.1016/j.tvjl.2011.06.018]; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Keller GG, 2011, VET J, V189, P197, DOI 10.1016/j.tvjl.2011.06.019; Lavrijsen ICM, 2012, VET J, V193, P486, DOI 10.1016/j.tvjl.2012.01.001; Lewis TW, 2011, VET J, V189, P227, DOI 10.1016/j.tvjl.2011.06.024; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; Madsen P, 2006, P 8 WORLD C GEN APPL, P13; Madsen P, 2007, USERS GUIDE DMU VERS; Maki K, 2000, J ANIM SCI, V78, P1141; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Murdoch BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026819; Ogden DM, 2011, VET SURG, V00, P1; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Robinson GK., 1991, STAT SCI, V6, P18, DOI DOI 10.1214/SS/1177011926; Samoy Y, 2006, VET COMP ORTHOPAED, V19, P1; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Sorensen DA., 2002, STAT BIOL HEALTH; Sun C, 2010, J ANIM SCI, V88, P871, DOI 10.2527/jas.2009-1912; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; Todhunter RJ, 2012, GENETICS ORTHOPEDIC; Vernau KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057195; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Woolliams JA, 2011, VET J, V189, P169, DOI 10.1016/j.tvjl.2011.06.015; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	36	26	26	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76390	10.1371/journal.pone.0076390	http://dx.doi.org/10.1371/journal.pone.0076390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124555	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100112
J	Wu, MQ; Huang, F; Jiang, XM; Fan, ZP; Zhou, HS; Liu, C; Jiang, QL; Zhang, Y; Zhao, K; Xuan, L; Zhai, X; Zhang, FH; Yin, CX; Sun, J; Feng, R; Liu, QF				Wu, Meiqing; Huang, Fen; Jiang, Xinmiao; Fan, Zhiping; Zhou, Hongsheng; Liu, Can; Jiang, Qianli; Zhang, Yu; Zhao, Ke; Xuan, Li; Zhai, Xiao; Zhang, Fuhua; Yin, Changxin; Sun, Jing; Feng, Ru; Liu, Qifa			Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SOLID-ORGAN TRANSPLANTATION; VIRAL ENCEPHALITIS; LYMPHOPROLIFERATIVE DISORDERS; HEMATOLOGICAL MALIGNANCIES; INFECTIONS; GUIDELINES; MANAGEMENT; ADULTS; CNS	Herpesvirus infections of the central nervous system (CNS) are associated with encephalitis/myelitis and lymphoproliferative diseases in immunocompromised individuals. As of now, data of herpesvirus-associated CNS diseases in transplant recipients is limited. Hence, in this prospective study, we investigated the incidence of herpesvirus-associated CNS diseases and explored the diagnosis of these diseases in 281 allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Herpesvirus-DNA and cerebrospinal fluid (CSF) cells were sampled from 58 recipients with herpesvirus-associated diseases or with unexplainable CNS manifestations. Results showed that 23 patients were diagnosed as herpesvirus-associated CNS diseases, including 15 Epstein-Barr virus (EBV)-associated diseases (4 encephalitis and 11 lymphoproliferative diseases), 5 herpes simplex virus type 1 encephalitis, 2 cytomegalovirus encephalitis/myelitis and 1 varicella zoster virus encephalitis. The median time of diseases onset was 65 (range 22-542) days post-transplantation. The 3-year cumulative incidence of herpesvirus-associated encephalitis/myelitis and post-transplant lymphoproliferative disorder (PTLD) was 6.3% +/- 1.9% and 4.1% +/- 1.2%, respectively. Of the evaluable cases, CSF cells mainly consisted of CD19(+)CD20(+) B cells (7/11) and had clonal rearrangement of immunoglobulin genes (3/11) in patients with CNS-PTLD. On the contrary, in patients with encephalitis/myelitis, CSF cells were comprised of different cell populations and none of the gene rearrangement was detected. Herpesvirus-associated CNS diseases are common in the early stages of allo-HSCT, wherein EBV is the most frequent causative virus. The immunophenotypic and clonal analysis of CSF cells might be helpful in the differential diagnosis between encephalitis and lymphoproliferative diseases.	[Wu, Meiqing; Huang, Fen; Jiang, Xinmiao; Fan, Zhiping; Zhou, Hongsheng; Liu, Can; Jiang, Qianli; Zhang, Yu; Zhao, Ke; Xuan, Li; Zhai, Xiao; Zhang, Fuhua; Yin, Changxin; Sun, Jing; Feng, Ru; Liu, Qifa] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Liu, QF (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	liuqifa628@163.com			National Natural Science Foundation of China [81000231, 30971300, 81270647]; National Public Health Grand Research Foundation [201202017]; Research Fund for the Doctoral Program of Higher Education of China [20104433110003]; Science and Technology Project of Guangdong Province of China [2009A030200007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Project of Guangdong Province of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81000231, No. 30971300, No. 81270647); the National Public Health Grand Research Foundation (Grant No. 201202017); the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20104433110003); and the Science and Technology Project of Guangdong Province of China (Grant No. 2009A030200007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-13; Anduze-Faris BM, 2000, AIDS, V14, P517, DOI 10.1097/00002030-200003310-00007; Boivin Guy, 2004, Herpes, V11 Suppl 2, p48A; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; Brion A, 1995, NOUV REV FR HEMATOL, V37, P289; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; De Broucker T, 2012, CLIN MICROBIOL INFEC, V18, P808, DOI 10.1111/j.1469-0691.2011.03705.x; Denes E, 2004, EMERG INFECT DIS, V10, P729, DOI 10.3201/eid1004.030587; Evens AM, 2010, J CLIN ONCOL, V28, P1038, DOI 10.1200/JCO.2009.25.4961; Jagadeesh D, 2012, CURR TREAT OPTION ON, V13, P122, DOI 10.1007/s11864-011-0177-x; Kalita J, 2011, NEUROL INDIA, V59, P116, DOI 10.4103/0028-3886.84347; Kittan NA, 2011, TRANSPL INFECT DIS, V13, P524, DOI 10.1111/j.1399-3062.2011.00621.x; Korfel A, 2013, HAEMATOLOGICA, V98, P364, DOI 10.3324/haematol.2012.077917; Koskiniemi M, 2001, J NEUROVIROL, V7, P400, DOI 10.1080/135502801753170255; Liu QF, 2010, TRANSPL INFECT DIS, V12, P284, DOI 10.1111/j.1399-3062.2010.00502.x; Maecker B, 2007, J CLIN ONCOL, V25, P4902, DOI 10.1200/JCO.2006.10.2392; Martelius T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-281; Reddy N, 2011, BIOL BLOOD MARROW TR, V17, P591, DOI 10.1016/j.bbmt.2010.08.007; Sawada A, 2011, PEDIATR INT, V53, P1010, DOI 10.1111/j.1442-200X.2011.03437.x; Schmidt-Hieber M, 2011, HAEMATOL-HEMATOL J, V96, P142, DOI 10.3324/haematol.2010.029876; Shimizu H, 2011, INT J HEMATOL, V94, P495, DOI 10.1007/s12185-011-0951-3; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Steiner I, 2005, EUR J NEUROL, V12, P331, DOI 10.1111/j.1468-1331.2005.01126.x; Studahl M, 1998, SCAND J INFECT DIS, V30, P215, DOI 10.1080/00365549850160828; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343; Tsao SY, 2011, ANN HEMATOL, V90, P113, DOI 10.1007/s00277-010-0947-8; Weinberg A, 2002, ANN NEUROL, V52, P543, DOI 10.1002/ana.10321; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Xu B, 1999, J 1 MILITARY MED U, V19; Xuan L, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-46	31	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77805	10.1371/journal.pone.0077805	http://dx.doi.org/10.1371/journal.pone.0077805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124621	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100179
J	Zhang, M; Liu, JY; Li, K; Yu, DY				Zhang, Man; Liu, Jianyu; Li, Kai; Yu, Deyue			Identification and Characterization of a Novel Monoterpene Synthase from Soybean Restricted to Neryl Diphosphate Precursor	PLOS ONE			English	Article							TERPENE SYNTHASES; (E)-BETA-OCIMENE SYNTHASE; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; GENE-EXPRESSION; FLORAL SCENT; PLANTS; PYROPHOSPHATE; METABOLISM	Terpenes are important defensive compounds against herbivores and pathogens. Here, we report the identification of a new monoterpene synthase gene, GmNES, from soybean. The transcription of GmNES was up-regulated in soybean plants that were infested with cotton leafworm (Prodenia litura), mechanically wounded or treated with salicylic acid (SA). Gas chromatography-mass spectrometry (GC-MS) analysis revealed that recombinant GmNES enzyme exclusively produced nerol, generated from a newly identified substrate for monoterpene synthase: neryl diphosphate (NPP). This finding indicates that GmNES is a nerol synthase gene in soybean. Subcellular localization using GFP fusions showed that GmNES localized to the chloroplasts. Transgenic tobacco overexpressing GmNES was generated. In dual-choice assays, the GmNES-expressing tobacco lines significantly repelled cotton leafworm. In feeding tests with transgenic plants, the growth and development of cotton leafworm were significantly retarded. This study confirms the ecological role of terpenoids and provides new insights into their metabolic engineering in transgenic plants.	[Zhang, Man; Liu, Jianyu; Li, Kai; Yu, Deyue] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Man] Jiangsu Acad Agr Sci, Inst Vegetable Crops, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Yu, DY (corresponding author), Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	dyyu@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB125906, 2009CB118400]; National Natural Science Foundation of China [30800692, 31000718]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program) (2010CB125906, 2009CB118400) and National Natural Science Foundation of China (30800692, 31000718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bohlmann J, 2009, P NATL ACAD SCI USA, V106, P10402, DOI 10.1073/pnas.0905226106; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chorianopoulos N, 2004, J AGR FOOD CHEM, V52, P8261, DOI 10.1021/jf049113i; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROTEAU R, 1976, ARCH BIOCHEM BIOPHYS, V176, P734, DOI 10.1016/0003-9861(76)90217-4; CROTEAU R, 1981, ARCH BIOCHEM BIOPHYS, V207, P460, DOI 10.1016/0003-9861(81)90054-0; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2003, CURR OPIN BIOTECH, V14, P169, DOI 10.1016/S0958-1669(03)00025-9; Demissie ZA, 2011, PLANTA, V233, P685, DOI 10.1007/s00425-010-1332-5; Dobson H, 2006, RELATIONSHIP FLORAL; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Gomez SK, 2005, ARCH INSECT BIOCHEM, V58, P114, DOI 10.1002/arch.20037; Hori M, 1998, J CHEM ECOL, V24, P1425, DOI 10.1023/A:1020947414051; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Navia-Gine WG, 2009, PLANT PHYSIOL BIOCH, V47, P416, DOI 10.1016/j.plaphy.2009.01.008; Nieuwenhuizen NJ, 2009, J EXP BOT, V60, P3203, DOI 10.1093/jxb/erp162; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; RAFFA KF, 1985, ENVIRON ENTOMOL, V14, P552, DOI 10.1093/ee/14.5.552; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Terzi V, 2007, LETT APPL MICROBIOL, V44, P613, DOI 10.1111/j.1472-765X.2007.02128.x; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Zhang M, 2012, PLANT BIOTECHNOL REP, V6, P363, DOI 10.1007/s11816-012-0233-4; Zhang M, 2009, MOL BIOL REP, V36, P879, DOI 10.1007/s11033-008-9258-8	35	22	24	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75972	10.1371/journal.pone.0075972	http://dx.doi.org/10.1371/journal.pone.0075972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124526	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100083
J	Shnitsar, V; Li, J; Li, XY; Calmettes, C; Basu, A; Casey, JR; Moraes, TF; Reithmeier, RAF				Shnitsar, Volodymyr; Li, Jing; Li, Xuyao; Calmettes, Charles; Basu, Arghya; Casey, Joseph R.; Moraes, Trevor F.; Reithmeier, Reinhart A. F.			A Substrate Access Tunnel in the Cytosolic Domain Is Not an Essential Feature of the Solute Carrier 4 (SLC4) Family of Bicarbonate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Membrane Proteins; Protein Folding; Site-directed Mutagenesis; Trafficking; Transporters; X-ray Crystallography; Anion Exchanger 1 (AE1); Band 3; SLC4	RENAL TUBULAR-ACIDOSIS; HEREDITARY SPHEROCYTOSIS MUTANTS; REVERSIBLE CONFORMATIONAL EQUILIBRIUM; ERYTHROCYTE ANION-EXCHANGER; REACTIVE SULFHYDRYL-GROUPS; CYTOPLASMIC DOMAIN; STRUCTURAL-CHARACTERIZATION; KIDNEY ANION-EXCHANGER-1; TRAFFICKING DEFECTS; BAND-3 POLYPEPTIDE	Anion exchanger 1 (AE1; Band 3; SLC4A1) is the founding member of the solute carrier 4 (SLC4) family of bicarbonate transporters that includes chloride/bicarbonate AEs and Na+-bicarbonate co-transporters (NBCs). These membrane proteins consist of an amino-terminal cytosolic domain involved in protein interactions and a carboxyl-terminal membrane domain that carries out the transport function. Mutation of a conserved arginine residue (R298S) in the cytosolic domain of NBCe1 (SLC4A4) is linked to proximal renal tubular acidosis and results in impaired transport function, suggesting that the cytosolic domain plays a role in substrate permeation. Introduction of single and double mutations at the equivalent arginine (Arg(283)) and at an interacting glutamate (Glu(85)) in the cytosolic domain of human AE1 (cdAE1) had no effect on the cell surface expression or the transport activity of AE1 expressed in HEK-293 cells. In addition, the membrane domain of AE1 (mdAE1) efficiently mediated anion transport. A 2.1- resolution crystal structure of cd54AE1 (residues 55-356 of cdAE1) lacking the amino-terminal and carboxyl-terminal disordered regions, produced at physiological pH, revealed an extensive hydrogen-bonded network involving Arg(283) and Glu(85). Mutations at these residues affected the pH-dependent conformational changes and stability of cd54AE1. As these structural alterations did not impair functional expression of AE1, the cytosolic and membrane domains operate independently. A substrate access tunnel within the cytosolic domain is not present in AE1 and therefore is not an essential feature of the SLC4 family of bicarbonate transporters.	[Shnitsar, Volodymyr; Li, Jing; Li, Xuyao; Calmettes, Charles; Moraes, Trevor F.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Basu, Arghya; Casey, Joseph R.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Basu, Arghya; Casey, Joseph R.] Univ Alberta, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Alberta; University of Alberta	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca		calmettes, charles/0000-0002-2542-4382; Basu, Arghya/0000-0002-0826-5359; Casey, Joseph/0000-0002-9890-5056	National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Michael Jennings (Arkansas) for providing the IVF-12 monoclonal anti-AE1 antibody. This work is based upon research conducted at the Northeastern Collaborative Access Team beam lines of the Advanced Photon Source, which is supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alper S L, 2001, JOP, V2, P171; ALPER SL, 1988, J BIOL CHEM, V263, P17092; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Alper SL, 2002, J NEPHROL, V15, pS41; Alper SL, 2002, CELL BIOCHEM BIOPHYS, V36, P123, DOI 10.1385/CBB:36:2-3:123; APPELL KC, 1981, J BIOL CHEM, V256, P1104; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; BRUCE LJ, 1993, BIOCHEM J, V293, P317, DOI 10.1042/bj2930317; BRUCE LJ, 1994, BLOOD, V84, P916; Bruce LJ, 1999, BEST PRACT RES CL HA, V12, P637, DOI 10.1053/beha.1999.0046; Bustos SP, 2006, BIOCHEMISTRY-US, V45, P1026, DOI 10.1021/bi051692c; Bustos SP, 2011, BIOCHEM J, V433, P313, DOI 10.1042/BJ20101375; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CASEY JR, 1995, J BIOL CHEM, V270, P8521, DOI 10.1074/jbc.270.15.8521; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Chernova MN, 2008, AM J PHYSIOL-CELL PH, V295, pC302, DOI 10.1152/ajpcell.00109.2008; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; GROVES JD, 1994, J MEMBRANE BIOL, V140, P81; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; JENNINGS ML, 1986, J BIOL CHEM, V261, P9002; JENNINGS ML, 1987, J BIOL CHEM, V262, P1691; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Johnson DE, 2011, J PHYSIOL-LONDON, V589, P1551, DOI 10.1113/jphysiol.2010.201483; KAY MMB, 1988, P NATL ACAD SCI USA, V85, P492, DOI 10.1073/pnas.85.2.492; KIYATKIN AB, 1995, PROTEINS, V22, P293, DOI 10.1002/prot.340220312; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; Loiselle Frederick B, 2003, Methods Mol Biol, V227, P259, DOI 10.1385/1-59259-387-9:259; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LOW PS, 1984, J BIOL CHEM, V259, P3070; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; RAO A, 1979, J BIOL CHEM, V254, P6144; REITHMEIER RAF, 1979, J BIOL CHEM, V254, P6151; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; STECK TL, 1972, J MOL BIOL, V66, P295, DOI 10.1016/0022-2836(72)90481-0; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 2004, J BIOL CHEM, V279, P52664, DOI 10.1074/jbc.M408108200; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; THEVENIN BJM, 1989, J BIOL CHEM, V264, P15886; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; WALDER JA, 1984, J BIOL CHEM, V259, P238; WANG CC, 1992, PROTEIN SCI, V1, P1206, DOI 10.1002/pro.5560010913; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Zhang DC, 2000, BLOOD, V96, P2925; Zhou JZ, 2001, J BIOL CHEM, V276, P38147	70	25	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33848	33860		10.1074/jbc.M113.511865	http://dx.doi.org/10.1074/jbc.M113.511865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121512	hybrid, Green Published			2022-12-25	WOS:000327250200029
J	Rooker, JR; Kitchens, LL; Dance, MA; Wells, RJD; Falterman, B; Cornic, M				Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.; Wells, R. J. David; Falterman, Brett; Cornic, Maelle			Spatial, Temporal, and Habitat-Related Variation in Abundance of Pelagic Fishes in the Gulf of Mexico: Potential Implications of the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							CRUDE-OIL; ENVIRONMENTAL-CONTROL; IMPROVING LIGHT; LARVAL; RECRUITMENT; PACIFIC; IMPACTS; IDENTIFICATION; GEOLOCATION; TOXICITY	Time-series data collected over a four-year period were used to characterize patterns of abundance for pelagic fishes in the northern Gulf of Mexico (GoM) before (2007-2009) and after (2010) the Deepwater Horizon oil spill. Four numerically dominant pelagic species (blackfin tuna, blue marlin, dolphinfish, and sailfish) were included in our assessment, and larval density of each species was lower in 2010 than any of the three years prior to the oil spill, although larval abundance in 2010 was often statistically similar to other years surveyed. To assess potential overlap between suitable habitat of pelagic fish larvae and surface oil, generalized additive models (GAMs) were developed to evaluate the influence of ocean conditions on the abundance of larvae from 2007-2009. Explanatory variables from GAMs were then linked to environmental data from 2010 to predict the probability of occurrence for each species. The spatial extent of surface oil overlapped with early life habitat of each species, possibly indicating that the availability of high quality habitat was affected by the DH oil spill. Shifts in the distribution of spawning adults is another factor known to influence the abundance of larvae, and the spatial occurrence of a model pelagic predator (blue marlin) was characterized over the same four-year period using electronic tags. The spatial extent of oil coincided with areas used by adult blue marlin from 2007-2009, and the occurrence of blue marlin in areas impacted by the DH oil spill was lower in 2010 relative to pre-spill years.	[Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.; Wells, R. J. David; Cornic, Maelle] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.; Kitchens, Larissa L.; Dance, Michael A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Falterman, Brett] McDaniel Charitable Fdn, Texas City, TX USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	rookerj@tamug.edu	Rooker, Jay/M-3197-2013	Rooker, Jay/0000-0002-5934-7688	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	This work was supported by the National Marine Fisheries Service (Southeast Fisheries Science Center) and the McDaniel Charitable Foundation. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019735; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Carr JP, 2009, BIOL CONSERV, V142, P477, DOI 10.1016/j.biocon.2008.10.004; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; de Soysa TY, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-40; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fauchald P, 2006, ECOLOGY, V87, P2915, DOI 10.1890/0012-9658(2006)87[2915:DMWITM]2.0.CO;2; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Hemmer MJ, 2011, ENVIRON TOXICOL CHEM, V30, P2244, DOI 10.1002/etc.619; Hernandez FJ, 2010, FISH B-NOAA, V108, P193; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Kraus RT, 2011, MAR BIOL, V158, P699, DOI 10.1007/s00227-010-1593-3; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Le Henaff M, 2012, ENVIRON SCI TECHNOL, V46, P7267, DOI 10.1021/es301570w; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Machu E, 2009, FISH OCEANOGR, V18, P287, DOI 10.1111/j.1365-2419.2009.00511.x; Muhling BA, 2012, MAR ECOL PROG SER, V450, P37, DOI 10.3354/meps09540; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Nunn AD, 2012, REV FISH BIOL FISHER, V22, P377, DOI 10.1007/s11160-011-9240-8; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Polovina JJ, 2009, FISH B-NOAA, V107, P523; R Development Core Team, 2010, R LANG ENV STAT COMP; Richards W. J., 2005, EARLY STAGES ATLANTI; Rocha-Olivares A, 2008, ICHTHYOL RES, V55, P389, DOI 10.1007/s10228-008-0040-7; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Sandman A, 2008, J MARINE SYST, V74, pS86, DOI 10.1016/j.jmarsys.2008.03.028; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x; Smultea Mari Ann, 1995, Aquatic Mammals, V21, P171; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Velando A, 2011, BIOL CONSERV, V144, P1167, DOI 10.1016/j.biocon.2011.01.004; Villamor B, 2011, FISH OCEANOGR, V20, P397, DOI 10.1111/j.1365-2419.2011.00592.x; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; WEISS J, 1991, PHYSICA D, V48, P273, DOI 10.1016/0167-2789(91)90088-Q; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	50	81	82	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76080	10.1371/journal.pone.0076080	http://dx.doi.org/10.1371/journal.pone.0076080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130759	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200029
J	Yabuki, C; Komatsu, H; Tsujihata, Y; Maeda, R; Ito, R; Matsuda-Nagasumi, K; Sakuma, K; Miyawaki, K; Kikuchi, N; Takeuchi, K; Habata, Y; Mori, M				Yabuki, Chiori; Komatsu, Hidetoshi; Tsujihata, Yoshiyuki; Maeda, Risa; Ito, Ryo; Matsuda-Nagasumi, Kae; Sakuma, Kensuke; Miyawaki, Kazumasa; Kikuchi, Naoya; Takeuchi, Koji; Habata, Yugo; Mori, Masaaki			A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1	PLOS ONE			English	Article							FREE FATTY-ACID; STIMULATED INSULIN-SECRETION; PANCREATIC BETA-CELLS; RECEPTOR 1 AGONIST; GPR40 AGONIST; DOUBLE-BLIND; GLUCOSE; TAK-875; IDENTIFICATION; DISCOVERY	Selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist fasiglifam (TAK-875), an antidiabetic drug under phase 3 development, potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed in pancreatic b cells. Although fasiglifam significantly improved glycemic control in type 2 diabetes patients with a minimum risk of hypoglycemia in a phase 2 study, the precise mechanisms of its potent pharmacological effects are not fully understood. Here we demonstrate that fasiglifam acts as an ago-allosteric modulator with a partial agonistic activity for FFAR1. In both Ca2+ influx and insulin secretion assays using cell lines and mouse islets, fasiglifam showed positive cooperativity with the FFAR1 ligand c-linolenic acid (gamma-LA). Augmentation of glucose-induced insulin secretion by fasiglifam, gamma-LA, or their combination was completely abolished in pancreatic islets of FFAR1-knockout mice. In diabetic rats, the insulinotropic effect of fasiglifam was suppressed by pharmacological reduction of plasma free fatty acid (FFA) levels using a lipolysis inhibitor, suggesting that fasiglifam potentiates insulin release in conjunction with plasma FFAs in vivo. Point mutations of FFAR1 differentially affected Ca2+ influx activities of fasiglifam and c-LA, further indicating that these agonists may bind to distinct binding sites. Our results strongly suggest that fasiglifam is an ago-allosteric modulator of FFAR1 that exerts its effects by acting cooperatively with endogenous plasma FFAs in human patients as well as diabetic animals. These findings contribute to our understanding of fasiglifam as an attractive antidiabetic drug with a novel mechanism of action.	[Yabuki, Chiori; Tsujihata, Yoshiyuki; Ito, Ryo; Matsuda-Nagasumi, Kae; Sakuma, Kensuke; Miyawaki, Kazumasa; Takeuchi, Koji; Habata, Yugo; Mori, Masaaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Komatsu, Hidetoshi; Maeda, Risa; Kikuchi, Naoya] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Yabuki, C (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	chiori.yabuki@takeda.com		Komatsu, Hidetoshi/0000-0003-1630-0537	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kaku K, 2013, DIABETES CARE, V36, P245, DOI 10.2337/dc12-0872; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Lin DCH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027270; Lu SY, 2010, J MOL GRAPH MODEL, V28, P766, DOI 10.1016/j.jmgm.2010.02.001; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsuda-Nagasumi K, 2013, DIABETES OBES METAB, V15, P538, DOI 10.1111/dom.12065; Meijssen S, 2001, J CLIN ENDOCR METAB, V86, P4193, DOI 10.1210/jc.86.9.4193; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan NG, 2009, CURR OPIN CLIN NUTR, V12, P117, DOI 10.1097/MCO.0b013e328321e423; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Sasaki S, 2011, J MED CHEM, V54, P1365, DOI 10.1021/jm101405t; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Takeuchi M, 2012, BRIT J PHARMACOL, V168, P1570; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; VAAG A, 1991, J CLIN INVEST, V88, P1282, DOI 10.1172/JCI115432; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708	43	72	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76280	10.1371/journal.pone.0076280	http://dx.doi.org/10.1371/journal.pone.0076280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130766	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200032
J	Silva, MA; Prieto, R; Jonsen, I; Baumgartner, MF; Santos, RS				Silva, Monica A.; Prieto, Rui; Jonsen, Ian; Baumgartner, Mark F.; Santos, Ricardo S.			North Atlantic Blue and Fin Whales Suspend Their Spring Migration to Forage in Middle Latitudes: Building up Energy Reserves for the Journey?	PLOS ONE			English	Article							VERTICAL MIGRATION; BALEEN WHALES; SATELLITE; MOVEMENTS; ZOOPLANKTON; BEHAVIOR; AZORES; RIDGE; TEMPERATURE; ENERGETICS	The need to balance energy reserves during migration is a critical factor for most long-distance migrants and an important determinant of migratory strategies in birds, insects and land mammals. Large baleen whales migrate annually between foraging and breeding sites, crossing vast ocean areas where food is seldom abundant. How whales respond to the demands and constraints of such long migrations remains unknown. We applied a behaviour discriminating hierarchical state-space model to the satellite tracking data of 12 fin whales and 3 blue whales tagged off the Azores, to investigate their movements, behaviour (transiting and area-restricted search, ARS) and daily activity cycles during the spring migration. Fin and blue whales remained at middle latitudes for prolonged periods, spending most of their time there in ARS behaviour. While near the Azores, fin whale ARS behaviour occurred within a restricted area, with a high degree of overlap among whales. There were noticeable behavioural differences along the migratory pathway of fin whales tracked to higher latitudes: ARS occurred only in the Azores and north of 56 degrees N, whereas in between these areas whales travelled at higher overall speeds while maintaining a nearly direct trajectory. This suggests fin whales may alternate periods of active migration with periods of extended use of specific habitats along the migratory route. ARS behaviour in blue whales occurred over a much wider area as whales slowly progressed northwards. The tracks of these whales terminated still at middle latitudes, before any behavioural switch was detected. Fin whales exhibited behavioural-specific diel rhythms in swimming speed but these varied significantly between geographic areas, possibly due to differences in the day-night cycle across areas. Finally, we show a link between fin whales seen in the Azores and those summering in eastern Greenland-western Iceland along a migratory corridor located in central Atlantic waters.	[Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Univ Azores, Ctr Inst Marine Res IMAR, Horta, Azores, Portugal; [Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Univ Azores, Dept Oceanog & Fisheries, Horta, Azores, Portugal; [Silva, Monica A.; Prieto, Rui; Santos, Ricardo S.] Lab Robot & Syst Engn & Sci LARSyS, Lisbon, Portugal; [Silva, Monica A.; Baumgartner, Mark F.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jonsen, Ian] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution; Dalhousie University	Silva, MA (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, Horta, Azores, Portugal.	monica@uac.pt	Santos, Ricardo/B-3960-2008; Silva, Mónica/D-1893-2012; Prieto, Rui/G-8286-2011	Santos, Ricardo/0000-0002-2536-1369; Silva, Mónica/0000-0002-2683-309X; Prieto, Rui/0000-0002-0354-2572; Jonsen, Ian/0000-0001-5423-6076	Fundacao para a Ciencia e a Tecnologia (FCT); Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC); FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores Program [PTDC/MAR/74071/2006, M2.1.2/F/012/2011]; FCT; DRCTC -Government of the Azores pluriannual funding; LARSyS Associated Laboratory through FCT/MCE project [PEst-OE/EEI/LA0009/2011-2013]; FCT [SFRH/BPD/29841/2006, SFRH/BD/41192/2007]; Azores Regional Fund for Science and Technology [M3.1.5/F/115/2012]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC); FEDER(European Commission); Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores Program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DRCTC -Government of the Azores pluriannual funding; LARSyS Associated Laboratory through FCT/MCE project; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Azores Regional Fund for Science and Technology	This research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCTC), FEDER, the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, and Proconvergencia Acores Program through research projects PTDC/MAR/74071/2006 and M2.1.2/F/012/2011. The authors acknowledge funds provided by FCT to LARSyS Associated Laboratory & IMAR-University of the Azores/the Thematic Area E of the Strategic Project (OE & Compete) and by the DRCTC -Government of the Azores pluriannual funding. Publication fees for this open access publication were supported by LARSyS Associated Laboratory through FCT/MCE project PEst-OE/EEI/LA0009/2011-2013. MAS was supported by an FCT postdoctoral grant (SFRH/BPD/29841/2006) and RP was supported by an FCT doctoral grant (SFRH/BD/41192/2007) and by the research grant from the Azores Regional Fund for Science and Technology (M3.1.5/F/115/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2012, MAR BIOL, V159, P2441, DOI 10.1007/s00227-012-1947-0; Acevedo-Gutierrez A, 2002, J EXP BIOL, V205, P1747; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Anonymous, 2009, Journal of Cetacean Research and Management, V11, P425; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baumgartner Mark F., 2007, P138; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Burtenshaw JC, 2004, DEEP-SEA RES PT II, V51, P967, DOI 10.1016/j.dsr2.2004.06.020; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Clark DR, 2001, J PLANKTON RES, V23, P365, DOI 10.1093/plankt/23.4.365; Cohen EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041818; Connor RC, 2001, MAR MAMMAL SCI, V17, P436, DOI 10.1111/j.1748-7692.2001.tb01290.x; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Dale T, 2000, ICES J MAR SCI, V57, P1800, DOI 10.1006/jmsc.2000.0961; De Robertis A, 2003, ICES J MAR SCI, V60, P885, DOI 10.1016/S1054-3139(03)00070-5; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FASHAM MJR, 1985, PROG OCEANOGR, V14, P129, DOI 10.1016/0079-6611(85)90009-6; Gales N, 2011, 61 M SCI COMM INT WH, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A., 2003, BAYESIAN DATA ANAL; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Gordon J, 1995, LIFE MARINE SCI A, V13A, P79; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Heger A, 2008, DEEP-SEA RES PT II, V55, P126, DOI 10.1016/j.dsr2.2007.09.014; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Huskin I, 2001, J PLANKTON RES, V23, P671, DOI 10.1093/plankt/23.7.671; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kaartvedt S, 2010, ADV MAR BIOL, V57, P255, DOI 10.1016/S0065-2881(10)57009-3; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Klevjer TA, 2011, LIMNOL OCEANOGR, V56, P765, DOI 10.4319/lo.2011.56.3.0765; Letessier TB, 2011, J PLANKTON RES, V33, P1510, DOI 10.1093/plankt/fbr056; Lockyer C., 1984, Reports of the International Whaling Commission Special Issue, P27; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lockyer C.H., 1987, APPROACHES MARINE MA, P183; Lopez R., 2011, CLSDTMEMO1165; Machin F, 2009, DEEP-SEA RES PT II, V56, P2606, DOI 10.1016/j.dsr2.2008.12.038; Martins A, 2011, ESA SOLAS EGU JOINT; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; Mauritzen C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001114; Opdal A.F., 2009, Journal of Northwest Atlantic Fishery Science, V41, P13; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Saenko OA, 2005, J PHYS OCEANOGR, V35, P826, DOI 10.1175/JPO2722.1; Sigurjonsson J, 1995, WHALES SEALS FISH MA, P720; Silva IF, 2011, 63 M SCI COMM INT WH, P1; Silva MA, MARINE BIOL IN PRESS; TINBERGEN N, 1967, BEHAVIOUR, V28, P307, DOI 10.1163/156853967X00064; TURCHIN P, 1991, ECOLOGY, V72, P1253, DOI 10.2307/1941099; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; Villa E, 2011, 25 ANN C EUR CET SOC; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Wall Dave, 2009, Marine Biodiversity Records, V2, pe128, DOI 10.1017/S1755267209990443; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Waring Gordon T., 2008, Journal of Cetacean Research and Management, V10, P137; WATKINS W A, 1984, Rit Fiskideildar, V8, P1; Watkins WA, 1996, MAR MAMMAL SCI, V12, P564; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; White M., 2007, BLACKWELL FISHERIES, V12, P65; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Zerbini A.N., 2011, INT WHAL COMM M SCI, P1; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	74	111	119	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76507	10.1371/journal.pone.0076507	http://dx.doi.org/10.1371/journal.pone.0076507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116112	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200057
J	Hammerle, B; Yanez, Y; Palanca, S; Canete, A; Burks, DJ; Castel, V; de Mora, JF				Haemmerle, Barbara; Yanez, Yania; Palanca, Sarai; Canete, Adela; Burks, Deborah J.; Castel, Victoria; Font de Mora, Jaime			Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; FACTOR-KAPPA-B; MYELOID-LEUKEMIA CELLS; INDUCED DIFFERENTIATION; BORTEZOMIB STABILIZES; 13-CIS-RETINOIC ACID; COLORECTAL-CARCINOMA; MULTIPLE-MYELOMA; CANCER-CELLS; APOPTOSIS	Background: Neuroblastma cell lines contain a side-population of cells which express stemness markers. These stem-like cells may represent the potential underlying mechanism for resistance to conventional therapy and recurrence of neuroblastoma in patients. Methodology/Principal Findings: To develop novel strategies for targeting the side-population of neurobastomas, we analyzed the effects of 13-cis-retinoic acid (RA) combined with the proteasome inhibitor MG132. The short-term action of the treatment was compared with effects after a 5-day recovery period during which both chemicals were withdrawn. RA induced growth arrest and differentiation of SH-SY5Y and SK-N-BE(2) neuroblastoma cell lines. Inhibition of the proteasome caused apoptosis in both cell lines, thus, revealing the critical role of this pathway in the regulated degradation of proteins involved in neuroblastoma proliferation and survival. The combination of RA with MG132 induced apoptosis in a dose-dependent manner, in addition to promoting G2/M arrest in treated cultures. Interestingly, expression of stem cell markers such as Nestin, Sox2, and Oct4 were reduced after the recovery period of combined treatment as compared with untreated cells or treated cells with either compound alone. Consistent with this, neurosphere formation was significantly impaired by the combined treatment of RA and MG132. Conclusions: Given that stem-like cells are associated with resistant to conventional therapy and are thought to be responsible for relapse, our results suggest that dual therapy of RA and proteasome inhibitor might be beneficial for targeting the side-population of cells associated residual disease in high-risk neuroblastoma.	[Haemmerle, Barbara; Burks, Deborah J.] Ctr Invest Principe Felipe, Mol Endocrinol Lab, Valencia, Spain; [Yanez, Yania; Canete, Adela; Castel, Victoria] Hosp La Fe, Paediat Oncol Unit, E-46009 Valencia, Spain; [Palanca, Sarai] Hosp La Fe, Mol Biol Lab, E-46009 Valencia, Spain; [Burks, Deborah J.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Font de Mora, Jaime] Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain; [Font de Mora, Jaime] Hosp La Fe, Fdn Invest, Lab Cellular & Mol Biol, E-46009 Valencia, Spain	Prince Felipe Research Center; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universidad Catolica de Valencia San Vicente Martir; Hospital Universitari i Politecnic La Fe	de Mora, JF (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Inst Valenciano Patol, Valencia, Spain.	jaime.fontdemora@gmail.com	de Mora, Jaime Font/H-6304-2015; Yañez, Yania/ABH-2960-2020; canete, adela/G-5903-2016; de Mora, Jaime Font/AAK-7591-2021; Cañete, Adela/ABG-7558-2020	de Mora, Jaime Font/0000-0002-6816-2095; Yañez, Yania/0000-0001-8392-4978; canete, adela/0000-0002-5669-5097; de Mora, Jaime Font/0000-0002-6816-2095; Castel, Victoria/0000-0002-3792-0615	Spanish Ministry of Economy and Competitivity [SAF2009-08334, SAF2012-37330]; NeuroblastoVal from Gent per Gent; Regenerative Medicine program of the Valencian Community (ISCIII); Bancaixa Foundation	Spanish Ministry of Economy and Competitivity(Spanish Government); NeuroblastoVal from Gent per Gent; Regenerative Medicine program of the Valencian Community (ISCIII); Bancaixa Foundation	This work was supported by SAF2009-08334 and SAF2012-37330 grants from Spanish Ministry of Economy and Competitivity and NeuroblastoVal from Gent per Gent. A part of this work was also funded by the Regenerative Medicine program of the Valencian Community (ISCIII). BH was supported by a post-doctoral fellowship from Bancaixa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bavi P, 2011, AM J PATHOL, V178, P2109, DOI 10.1016/j.ajpath.2011.01.034; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Brown RE, 2007, ANN CLIN LAB SCI, V37, P141; Canete A, 2009, J CLIN ONCOL, V27, P1014, DOI 10.1200/JCO.2007.14.5839; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Combaret V, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-50; Cusack JC, 2001, CANCER RES, V61, P3535; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Fang YF, 2011, MOL CARCINOGEN, V50, P24, DOI 10.1002/mc.20687; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Hutter G, 2012, ANN HEMATOL, V91, P847, DOI 10.1007/s00277-011-1377-y; Kim OH, 2004, INT J ONCOL, V24, P935; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lavelin I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008503; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Lorenzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046928; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; MacLaren AP, 2001, CELL DEATH DIFFER, V8, P210, DOI 10.1038/sj.cdd.4400801; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Moon Ki-Young, 2007, Cancer Res Treat, V39, P82, DOI 10.4143/crt.2007.39.2.82; Nakaso K, 2004, NEUROSCI LETT, V354, P213, DOI 10.1016/j.neulet.2003.10.048; Newton TC, 2010, TRANSL ONCOL, V3, P246, DOI 10.1593/tlo.09301; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Pagnan G, 2009, CLIN CANCER RES, V15, P1199, DOI 10.1158/1078-0432.CCR-08-2477; Pickering BM, 2007, ONCOGENE, V26, P1166, DOI 10.1038/sj.onc.1209897; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Reynolds CP, 2000, MED PEDIATR ONCOL, V35, P597, DOI 10.1002/1096-911X(20001201)35:6<597::AID-MPO23>3.0.CO;2-B; Richardson Paul G, 2003, Cancer Control, V10, P361; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Suzuki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027996; Tanturli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017008; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Tweddle DA, 2001, CANCER RES, V61, P8; Uttenweiler-Joseph S, 2013, PROTEOMICS, V13, P37, DOI 10.1002/pmic.201200233; Veal GJ, 2007, BRIT J CANCER, V96, P424, DOI 10.1038/sj.bjc.6603554; Wang XL, 2012, BIOCHEM J, V443, P821, DOI 10.1042/BJ20111491; Williams SA, 2003, CANCER RES, V63, P7338; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Ying MD, 2013, MOL CANCER THER, V12, P195, DOI 10.1158/1535-7163.MCT-12-0433	51	45	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76761	10.1371/journal.pone.0076761	http://dx.doi.org/10.1371/journal.pone.0076761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116151	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300091
J	Wu, JK; Li, MF; Li, TZ				Wu, Junkai; Li, Maofu; Li, Tianzhong			Genetic Features of the Spontaneous Self-Compatible Mutant, 'Jin Zhui' (Pyrus bretschneideri Rehd.)	PLOS ONE			English	Article							F-BOX GENE; INCOMPATIBILITY S-LOCUS; SKP1-LIKE PROTEIN; NICOTIANA-ALATA; PRUNUS-AVIUM; POLLEN; RNASE; IDENTIFICATION; MULTIPLE; RECOGNITION	'Jin Zhui' is a spontaneous self-compatible mutant of 'Ya Li' (Pyrus bretschneideri Rehd. S21S34), the latter displaying a typical S-RNase-based gametophytic self-incompatibility (GSI). The pollen-part mutation (PPM) of 'Jin Zhui' might be due to a natural mutation in the pollen-S gene (S-34 haplotype). However, the molecular mechanisms behind these phenotypic changes are still unclear. In this study, we identified five SLF (S-Locus F-box) genes in 'Ya Li', while no nucleotide differences were found in the SLF genes of 'Jin Zhui'. Further genetic analysis by S-RNase PCR-typing of selfed progeny of 'Jin Zhui' and 'Ya Li' x 'Jin Zhui' progeny showed three progeny classes (S21S21, S21S34 and S34S34) as opposed to the two classes reported previously (S21S34 and S34S34), indicating that the pollen gametes of 'Jin Zhui', bearing either the S-21- or S-34-haplotype, were able to overcome self-incompatibility (SI) barriers. Moreover, no evidence of pollen-S duplication was found. These findings support the hypothesis that loss of function of S-locus unlinked PPM expressed in pollen leads to SI breakdown in 'Jin Zhui', rather than natural mutation in the pollen-S gene (S-34 haplotype). Furthermore, abnormal meiosis was observed in a number of pollen mother cells (PMCs) in 'Jin Zhui', but not in 'Ya Li'. These and other interesting findings are discussed.	[Wu, Junkai; Li, Tianzhong] China Agr Univ, Lab Fruit Tree Cell & Mol Breeding, Beijing 100094, Peoples R China; [Li, Maofu] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, MF (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	maofuli@ibcas.ac.cn; litianzhong1535@163.com			Beijing Natural Science Foundation [6102017]; National Science Foundation for Young Scholars of China [31201606]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Natural Science Foundation (6102017) and National Science Foundation for Young Scholars of China (31201606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2009, J JPN SOC HORTIC SCI, V78, P402, DOI 10.2503/jjshs1.78.402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; Chen G, 2012, J GENET GENOMICS, V39, P93, DOI 10.1016/j.jgg.2012.01.001; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Cheng JianHong, 2006, Acta Horticulturae Sinica, V33, P470; Crane MB, 1942, J GENET, V43, P31, DOI 10.1007/BF02982745; De Franceschi P, 2011, TREE GENET GENOMES, V7, P231, DOI 10.1007/s11295-010-0327-5; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Entani T, 1999, THEOR APPL GENET, V99, P391, DOI 10.1007/s001220051249; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Li MF, 2009, PLANT BIOLOGY, V11, P774, DOI 10.1111/j.1438-8677.2008.00180.x; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; Okada K, 2008, PLANT MOL BIOL, V66, P389, DOI 10.1007/s11103-007-9277-1; Qi YJ, 2011, TREE GENET GENOMES, V7, P685, DOI 10.1007/s11295-011-0366-6; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Sanzol J, 2009, PLANT CELL REP, V28, P457, DOI 10.1007/s00299-008-0645-3; SASSA H, 1992, PLANT CELL PHYSIOL, V33, P811; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Wu J, 2011, SEX PLANT REPROD, V24, P23, DOI 10.1007/s00497-010-0148-6; Xu C, 2013, PLANT MOL BIOL, V81, P245, DOI 10.1007/s11103-012-9995-x; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, PLANT CELL PHYSIOL, V44, P764, DOI 10.1093/pcp/pcg088; Yang M, 1999, P NATL ACAD SCI USA, V96, P11416, DOI 10.1073/pnas.96.20.11416; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zuriaga E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053947; Zuriaga E, 2012, PLANT MOL BIOL, V79, P229, DOI 10.1007/s11103-012-9908-z	45	12	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76509	10.1371/journal.pone.0076509	http://dx.doi.org/10.1371/journal.pone.0076509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116113	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300060
J	Beyene, T; Woldeamanuel, Y; Asrat, D; Ayana, G; Boulware, DR				Beyene, Tafese; Woldeamanuel, Yimtubezinash; Asrat, Daniel; Ayana, Gonfa; Boulware, David R.			Comparison of Cryptococcal Antigenemia between Antiretroviral Naive and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia	PLOS ONE			English	Article							PRIMARY PROPHYLAXIS; INFECTED PATIENTS; MENINGITIS; SERUM; THERAPY; PREVALENCE; MORTALITY; UGANDA; ADULTS; DIAGNOSIS	Background: Cryptococcal meningitis is a major cause of HIV/AIDS-related deaths in Africa. Cryptococcosis is a neglected killer. However, meningitis can be prevented by early cryptococcal antigen (CrAg) screening and preemptive antifungal treatment during a prolonged period of detectable, subclinical infection. We determined the prevalence of cryptococcal antigenemia in comparison to CD4 count and clinical symptoms. Methods: We surveyed 254 consenting HIV-infected participants to obtain demographic information and clinical history. Serum CrAg was measured by latex agglutination at two sites in the Oromia region of Ethiopia among all persons receiving a CD4 count. Results: Of the 254 participants, 127(50.0%) were ART-naive, 121(47.6%) were ART-experienced, and 6(2.4%) were ART-defaulters. The prevalence of cryptococcal antigenemia was 10.2% overall being 14.2% among ART-naive, 4.1% among ART-experienced, and 50% (3/6) among ART-defaulters, irrespective of CD4 count. Cryptococcal antigenemia was more frequently detected from ART-naive patients (p = 0.012) and ART-defaulters (p = 0.001) compared with ART-experienced. Serum CrAg positivity was 20.9% in persons with CD4 <= 150 cells/mu L, 12.2% in 151-200 cells/mu L, 5.8% among 201-350 CD4/mu L, and none above 350 cells/mu L. Potential meningitis symptoms were common in the outpatient cohort irrespective of CrAg-status, with only fever and altered mental status statistically more common in CrAg-positive compared to CrAg-negative persons (P<0.05), yet no symptom had a positive predictive value >33%. Conclusion: We report a 20.9% cryptococcal antigenemia prevalence among those with CD4+ T cells count <= 150 cells/mu L, irrespective of ART status, with even higher CrAg prevalence in ART-naives and ART-defaulters. These groups are target populations for CrAg screening at entry into HIV care.	[Beyene, Tafese] Adama Sci & Technol Univ, Asella Sch Hlth Sci, Dept Biomed Sci, Asella, Ethiopia; [Woldeamanuel, Yimtubezinash; Asrat, Daniel] Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Ayana, Gonfa] EHNRI, Reg Labs Capac Bldg Directorate, Addis Ababa, Ethiopia; [Boulware, David R.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA	Adama Science & Technology University; Addis Ababa University; Ethiopian Health & Nutrition Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Beyene, T (corresponding author), Adama Sci & Technol Univ, Asella Sch Hlth Sci, Dept Biomed Sci, Asella, Ethiopia.	tafeseb.tufa@yahoo.com	Boulware, David R/AAF-7124-2021; Woldeamanuel, YImtubezinash/AAX-9402-2020; Boulware, David R/GRS-0999-2022	Woldeamanuel, YImtubezinash/0000-0001-6606-8903; Boulware, David R/0000-0002-4715-0060	Addis Ababa University; Oromia Health bureau	Addis Ababa University; Oromia Health bureau	Addis Ababa University has supported stationary's fee, Oromia Health bureau has supported some laboratory reagents, and Pharma share and Oxiod company donated Remal Cryptococcal antigen Test kit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Cachay ER, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-29; Chariyalertsak S, 2002, CLIN INFECT DIS, V34, P277, DOI 10.1086/338154; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; DESMET P, 1989, AIDS, V3, P77, DOI 10.1097/00002030-198902000-00004; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Hakim JG, 2000, AIDS, V14, P1401, DOI 10.1097/00002030-200007070-00013; Harris JR, 2012, CLIN INFECT DIS, V54, pe43, DOI 10.1093/cid/cir903; Jarvis J, 2011, SAMJ S AFR MED J, V101, P244, DOI 10.7196/SAMJ.4795; Jarvis Joseph N, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P374, DOI 10.1177/1545109712459077; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2011, SAMJ S AFR MED J, V101, P232, DOI 10.7196/SAMJ.4752; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Katwere M, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-21; Kisenge PR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-39; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Mamoojee Y, 2011, TROP MED INT HEALTH, V16, P53, DOI 10.1111/j.1365-3156.2010.02683.x; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Osazuwa Oghomwen Favour, 2012, Acta Med Iran, V50, P344; Oyella J, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-15; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parkes-Ratanshi R, 2011, LANCET INFECT DIS, V11, P933, DOI 10.1016/S1473-3099(11)70245-6; PEPFAR, 2013, PRES EM PLAN AIDS RE; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, CLIN INFECT DIS, V55, P1742, DOI 10.1093/cid/cis725; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Rolfes MAR, 2012, CROI SEATTL; Ryan KJ, 2004, SHERIS MED MICROBIOL, P669; Seboxa Teshale, 2010, Ethiop Med J, V48, P237; Smith RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062213; Tassie JM, 2003, JAIDS-J ACQ IMM DEF, V33, P411, DOI 10.1097/00126334-200307010-00019; Trachtenberg JD, 2007, INT J INFECT DIS, V11, P524, DOI 10.1016/j.ijid.2007.01.014; Wajanga BMK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-48; Woldemanuel Y, 2001, Ethiop Med J, V39, P185; World Health Organization, 2011, RAP ADV DIAGN PREV M	47	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75585	10.1371/journal.pone.0075585	http://dx.doi.org/10.1371/journal.pone.0075585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124498	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100055
J	Lan, MY; Liu, CP; Huang, HH; Lee, SW				Lan, Ming-Ying; Liu, Chia-Pei; Huang, Her-Hsiung; Lee, Sheng-Wei			Both Enhanced Biocompatibility and Antibacterial Activity in Ag-Decorated TiO2 Nanotubes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SILVER NANOPARTICLES; ESCHERICHIA-COLI; SURFACE; TITANIUM; ADSORPTION; ATTACHMENT; COATINGS; FACES	In this study, Ag is electron-beam evaporated to modify the topography of anodic TiO2 nanotubes of different diameters to obtain an implant with enhanced antibacterial activity and biocompatibility. We found that highly hydrophilic as-grown TiO2 nanotubes became poorly hydrophilic with Ag incorporation; however they could effectively recover their wettability to some extent under ultraviolet light irradiation. The results obtained from antibacterial tests suggested that the Ag-decorated TiO2 nanotubes could greatly inhibit the growth of Staphylococcus aureus. In vitro biocompatibility evaluation indicated that fibroblast cells exhibited an obvious diameter-dependent behavior on both as-grown and Ag-decorated TiO2 nanotubes. Most importantly, of all samples, the smallest diameter (25-nm-diameter) Ag-decorated nanotubes exhibited the most obvious biological activity in promoting adhesion and proliferation of human fibroblasts, and this activity could be attributed to the highly irregular topography on a nanometric scale of the Ag-decorated nanotube surface. These experimental results demonstrate that by properly controlling the structural parameters of Ag-decorated TiO2 nanotubes, an implant surface can be produced that enhances biocompatibility and simultaneously boosts antibacterial activity.	[Lan, Ming-Ying] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lan, Ming-Ying] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Pei; Lee, Sheng-Wei] Natl Cent Univ, Inst Mat Sci & Engn, Jhongli, Taiwan; [Huang, Her-Hsiung] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Yang Ming Chiao Tung University	Lee, SW (corresponding author), Natl Cent Univ, Inst Mat Sci & Engn, Jhongli, Taiwan.	swlee@ncu.edu.tw			Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST101-G4-3-1, VGHUST101-G4-3-2]; National Science Council of Taiwan [NSC-100-2221-E-008-016-MY3]	Veterans General Hospitals University System of Taiwan Joint Research Program; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The research is supported by the Veterans General Hospitals University System of Taiwan Joint Research Program under Contract nos. VGHUST101-G4-3-1 and VGHUST101-G4-3-2 and by the National Science Council of Taiwan under Contract no. NSC-100-2221-E-008-016-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092; Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004; Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h; Cabal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042393; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; Chun AL, 2005, BIOMATERIALS, V26, P7304, DOI 10.1016/j.biomaterials.2005.05.080; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1; Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125; Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003; de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8; Dong W, 2007, CHEM MATER, V19, P4454, DOI 10.1021/cm070845a; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gibbins B., 2005, MED DEVICE DIAGN IND, V8, P2; Hatchett DW, 1996, J PHYS CHEM-US, V100, P9854, DOI 10.1021/jp953757z; Hiramatsu H, 2004, CHEM MATER, V16, P2509, DOI 10.1021/cm049532v; Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031; Jin M, 2007, J PHYS CHEM C, V111, P658, DOI 10.1021/jp065590n; KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1; Lan MY, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-150; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Meng FM, 2009, APPL SURF SCI, V255, P6715, DOI 10.1016/j.apsusc.2009.02.076; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020; Rottman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052883; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; VITANOV T, 1983, J ELECTROANAL CHEM, V159, P437, DOI 10.1016/S0022-0728(83)80639-1; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098; Yang WE, 2009, J ALLOY COMPD, V479, P642, DOI 10.1016/j.jallcom.2009.01.021; Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102; Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s; Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040	44	49	50	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75364	10.1371/journal.pone.0075364	http://dx.doi.org/10.1371/journal.pone.0075364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124484	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100041
J	Lee, EJ; Kang, G; Kang, SW; Jang, KT; Lee, J; Park, JO; Park, CK; Sohn, TS; Kim, S; Kim, KM				Lee, Eui Jin; Kang, Guhyun; Kang, Shin Woo; Jang, Kee-Taek; Lee, Jeeyun; Park, Joon Oh; Park, Cheol Keun; Sohn, Tae Sung; Kim, Sung; Kim, Kyoung-Mee			GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; GENE-EXPRESSION SIGNATURES; WILD-TYPE; KIT; MUTATIONS; ABERRATIONS	Oncogenic mutations in gastrointestinal stromal tumors (GISTs) predict prognosis and therapeutic responses to imatinib. In wild-type GISTs, the tumor-initiating events are still unknown, and wild-type GISTs are resistant to imatinib therapy. We performed an association study between copy number alterations (CNAs) identified from array CGH and gene expression analyses results for four wild-type GISTs and an imatinib-resistant PDGFRA D842V mutant GIST, and compared the results to those obtained from 27 GISTs with KIT mutations. All wild-type GISTs had multiple CNAs, and CNAs in 1p and 22q that harbor the SDHB and GSTT1 genes, respectively, correlated well with expression levels of these genes. mRNA expression levels of all SDH gene subunits were significantly lower (P=0.041), whereas mRNA expression levels of VEGF (P=0.025), IGF1R (P=0.026), and ZNFs (P<0.05) were significantly higher in GISTs with wild-type/PDGFRA D842V mutations than GISTs with KIT mutations. qRT-PCR validation of the GSTT1 results in this cohort and 11 additional malignant GISTs showed a significant increase in the frequency of GSTT1 CN gain and increased mRNA expression of GSTT1 in wild-type/PDGFRA D842V GISTs than KIT-mutant GISTs (P=0.033). Surprisingly, all four malignant GISTs with KIT exon 11 deletion mutations with primary resistance to imatinib had an increased GSTT1 CN and mRNA expression level of GSTT1. Increased mRNA expression of GSTT1 and ZNF could be predictors of a poor response to imatinib. Our integrative approach reveals that for patients with wild-type (or imatinib-resistant) GISTs, attempts to target VEGFRs and IGF1R may be reasonable options.	[Lee, Eui Jin; Kang, Guhyun; Kang, Shin Woo; Jang, Kee-Taek; Park, Cheol Keun; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Jeeyun; Park, Joon Oh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Sohn, Tae Sung; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Kang, Guhyun] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pathol, Seoul, South Korea; [Kang, Shin Woo] Korea Univ, Dept Math, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Korea University	Kim, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	kkmkys@skku.ed	Lee, Jee Yun/C-9646-2011; Kim, Sung/G-4114-2014; Lee, Jeeyun/I-7171-2015		National Research Foundation of Korea [S-2010-0503-000-1]; Samsung Biomedical Research Institute [C-A9-203-1]	National Research Foundation of Korea(National Research Foundation of Korea); Samsung Biomedical Research Institute(Samsung)	This study was supported by grants from the National Research Foundation of Korea (http://www.nrf.re.kr)(S-2010-0503-000-1) and Samsung Biomedical Research Institute (http://www.sbri.or.kr)(C-A9-203-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; Antonescu CR, 2004, CLIN CANCER RES, V10, P3282, DOI 10.1158/1078-0432.CCR-03-0715; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760; Belinsky MG, 2009, GENE CHROMOSOME CANC, V48, P886, DOI 10.1002/gcc.20689; Chen Y, 2004, J BIOMED SCI, V11, P65, DOI 10.1159/000075290; Chung YJ, 2006, LEUKEMIA, V20, P1542, DOI 10.1038/sj.leu.2404310; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Gunawan B, 2007, J PATHOL, V211, P463, DOI 10.1002/path.2128; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Janeway KA, 2007, CANCER RES, V67, P9084, DOI 10.1158/0008-5472.CAN-07-1938; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2009, PEDIATR BLOOD CANCER, V52, P767, DOI 10.1002/pbc.21909; Kang DY, 2007, AM J SURG PATHOL, V31, P224, DOI 10.1097/01.pas.0000213318.66800.94; Kang HJ, 2006, PROTEOMICS, V6, P1151, DOI 10.1002/pmic.200500372; Koh Y, 2010, CANCER GENET CYTOGEN, V203, P215, DOI 10.1016/j.cancergencyto.2010.08.022; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pierotti MA, 2011, NAT REV CLIN ONCOL, V8, P161, DOI 10.1038/nrclinonc.2011.3; Rink L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054477; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Wardelmann E, 2007, VIRCHOWS ARCH, V451, P743, DOI 10.1007/s00428-007-0473-9; Wozniak A, 2007, GENE CHROMOSOME CANC, V46, P261, DOI 10.1002/gcc.20408; Yang JL, 2008, CANCER, V113, P1532, DOI 10.1002/cncr.23778	35	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77219	10.1371/journal.pone.0077219	http://dx.doi.org/10.1371/journal.pone.0077219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124608	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100165
J	Ling, ZX; Liu, X; Luo, YQ; Wu, XX; Yuan, L; Tong, XJ; Li, LJ; Xiang, C				Ling, Zongxin; Liu, Xia; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie			Associations between Vaginal Pathogenic Community and Bacterial Vaginosis in Chinese Reproductive-Age Women	PLOS ONE			English	Article							PYROSEQUENCING ANALYSIS; ATOPOBIUM-VAGINAE; MICROBIOTA; PH; METRONIDAZOLE; LACTOBACILLI; DIVERSITY; HEALTH	Background: Bacterial vaginosis (BV) is one of the most common urogenital infections among women of reproductive age that represents shifts in microbiota from Lactobacillus spp. to diverse anaerobes. The aim of our study was to evalute the diagnostic values of Gardnerella, Atopobium, Eggerthella, Megasphaera typeI, Leptotrichia/Sneathia and Prevotella, defined as a vaginal pathogenic community for BV and their associations with vaginal pH and Nugent scores. Methods and Findings: We investigated the vaginal pathogenic bacteria and Lactobacillus spp. with species-specific real-time quantitative PCR (qPCR) in 50 BV-positive and 50 BV-negative Chinese women of reproductive age. Relative to BV-negative subjects, a siginificant decline in Lactobacillus and an obvious increase in bacteria in the vaginal pathogenic community were observed in BV-postive subjects (P<0.05). With the exception of Megasphaera typeI, other vaginal pathogenic bacteria were highly predictable for BV with a better sensitivity and specificity. The vaginal pathogenic community was positively associated with vaginal pH and Nugent scores, while Lactobacillus spp., such as L. iners and L. crispatus was negatively associated with them (P<0.05). Conclusions: Our data implied that the prevalance of vaginal pathogenic bacteria as well as the depletion of Lactobacillus was highly accurate for BV diagnosis. Vaginal microbiota shifts, especially the overgrowth of the vaginal pathogenic community, showed well diagnostic values in predicting BV. Postive correlations between those vaginal pathogenic bacteria and vaginal pH, Nugent score indicated the vaginal pathogenic community rather than a single vaginal microorganism, was participated in the onset of BV directly.	[Ling, Zongxin; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Ling, Zongxin; Luo, Yueqiu; Wu, Xiaoxing; Yuan, Li; Tong, Xiaojuan; Li, Lanjuan; Xiang, Charlie] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Liu, Xia] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China; [Xiang, Charlie] J Craig Venter Inst, Rockville, MD USA	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; J. Craig Venter Institute	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cxiang@zju.edu.cn	Ling, Zongxin/AAM-4059-2021; Ling, Zongxin/M-1657-2018	Ling, Zongxin/0000-0001-9662-099X; Liu, Xia/0000-0002-9987-3332	National Basic Research Program of China (973 program) [2013CB531404]; Zhejiang University	National Basic Research Program of China (973 program)(National Basic Research Program of China); Zhejiang University	This present work was funded by the grants of the National Basic Research Program of China (973 program) Grant 2013CB531404 and partly supported by a Qiu-Shi Scholarship from Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; Caillouette JC, 1997, AM J OBSTET GYNECOL, V176, P1270, DOI 10.1016/S0002-9378(97)70345-4; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; Garcia-Closas M, 1999, AM J OBSTET GYNECOL, V180, P1060, DOI 10.1016/S0002-9378(99)70595-8; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Kalra Apoorv, 2007, Curr Infect Dis Rep, V9, P485, DOI 10.1007/s11908-007-0074-4; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390; Ling ZX, 2013, MICROB ECOL, V65, P773, DOI 10.1007/s00248-012-0154-3; Ling ZX, 2013, MICROB ECOL, V65, P487, DOI 10.1007/s00248-012-0123-x; Ling ZX, 2011, MICROB ECOL, V61, P704, DOI 10.1007/s00248-011-9813-z; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Zhang R, 2012, J MED MICROBIOL, V61, P729, DOI 10.1099/jmm.0.038687-0	28	20	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76589	10.1371/journal.pone.0076589	http://dx.doi.org/10.1371/journal.pone.0076589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124575	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100132
J	Piazza, R; Magistroni, V; Pirola, A; Redaelli, S; Spinelli, R; Redaelli, S; Galbiati, M; Valletta, S; Giudici, G; Cazzaniga, G; Gambacorti-Passerini, C				Piazza, Rocco; Magistroni, Vera; Pirola, Alessandra; Redaelli, Sara; Spinelli, Roberta; Redaelli, Serena; Galbiati, Marta; Valletta, Simona; Giudici, Giovanni; Cazzaniga, Giovanni; Gambacorti-Passerini, Carlo			CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data	PLOS ONE			English	Article							CANCER	Copy number alterations (CNA) are common events occurring in leukaemias and solid tumors. Comparative Genome Hybridization (CGH) is actually the gold standard technique to analyze CNAs; however, CGH analysis requires dedicated instruments and is able to perform only low resolution Loss of Heterozygosity (LOH) analyses. Here we present CEQer (Comparative Exome Quantification analyzer), a new graphical, event-driven tool for CNA/allelic-imbalance (AI) coupled analysis of exome sequencing data. By using case-control matched exome data, CEQer performs a comparative digital exonic quantification to generate CNA data and couples this information with exome-wide LOH and allelic imbalance detection. This data is used to build mixed statistical/heuristic models allowing the identification of CNA/AI events. To test our tool, we initially used in silico generated data, then we performed whole-exome sequencing from 20 leukemic specimens and corresponding matched controls and we analyzed the results using CEQer. Taken globally, these analyses showed that the combined use of comparative digital exon quantification and LOH/AI allows generating very accurate CNA data. Therefore, we propose CEQer as an efficient, robust and user-friendly graphical tool for the identification of CNA/AI in the context of whole-exome sequencing data.	[Piazza, Rocco; Magistroni, Vera; Pirola, Alessandra; Redaelli, Sara; Spinelli, Roberta; Valletta, Simona; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Redaelli, Serena] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy; [Galbiati, Marta; Giudici, Giovanni; Cazzaniga, Giovanni] Univ Milano Bicocca, San Gerardo Hosp, Tettamanti Res Ctr, Monza, Italy	University of Milano-Bicocca; University of Milano-Bicocca; San Gerardo Hospital; University of Milano-Bicocca	Piazza, R (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	rocco.piazza@unimib.it	Magistroni, Vera/AAA-5582-2020; redaelli, sara/I-5146-2012; Cazzaniga, Giovanni/K-6338-2016	Magistroni, Vera/0000-0002-7334-9401; redaelli, sara/0000-0003-0166-1188; Rocco, Piazza/0000-0003-4198-9620; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Valletta, Simona/0000-0002-3524-4991; Cazzaniga, Giovanni/0000-0003-2955-4528	Progetti di Ricerca di Interesse Nazionale [20084XBENM_004]; Italian Ministry of Health [RFPS-2006-333974]; Italian Association for Cancer Research (AIRC) [IG-10092]; CARIPLO Foundation [2009-2667]; Regione Lombardia [ID-16871, ID-14546A]; Regione Lombardia -Dote Ricercatori FSE - 16-AR	Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); Regione Lombardia -Dote Ricercatori FSE - 16-AR(Regione Lombardia)	This work was supported by the Progetti di Ricerca di Interesse Nazionale (PRIN: http://prin.miur.it/) (20084XBENM_004); Italian Ministry of Health (RFPS-2006-333974); the Italian Association for Cancer Research (AIRC: http://www.airc.it/) (IG-10092); CARIPLO Foundation (http://www.fondazionecariplo.it/) (2009-2667); Regione Lombardia (ID-16871 and ID-14546A); Regione Lombardia -Dote Ricercatori FSE - 16-AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Haimovich Adrian D., 2011, Yale Journal of Biology and Medicine, V84, P439; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Love MI, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1732; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Piazza R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks394; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Popp HD, 2010, GENE CHROMOSOME CANC, V49, P1071, DOI 10.1002/gcc.20823; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308	16	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74825	10.1371/journal.pone.0074825	http://dx.doi.org/10.1371/journal.pone.0074825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124457	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100014
J	Warner, D; Ferreira, LMM; Breuer, MJH; Dijkstra, J; Pellikaan, WF				Warner, Daniel; Ferreira, Luis M. M.; Breuer, Michel J. H.; Dijkstra, Jan; Pellikaan, Wilbert F.			Stable Isotope Labeled n-Alkanes to Assess Digesta Passage Kinetics through the Digestive Tract of Ruminants	PLOS ONE			English	Article							MARKER EXCRETION PATTERNS; ENRICHMENTS DELTA-C-13; BOTANICAL COMPOSITION; DAIRY-COWS; IN-VIVO; CARBON; RUMEN; METABOLISM; CATTLE; SHEEP	We describe the use of carbon stable isotope (C-13) labeled n-alkanes as a potential internal tracer to assess passage kinetics of ingested nutrients in ruminants. Plant cuticular n-alkanes originating from intrinsically v labeled ryegrass plants were pulse dosed intraruminally in four rumen-cannulated lactating dairy cows receiving four contrasting ryegrass silage treatments that differed in nitrogen fertilization level (45 or 90 kg nitrogen ha(-1)) and maturity (early or late). Passage kinetics through the gastrointestinal tract were derived from the delta C-13 (i.e. the ratio C-13:C-12) in apparently undigested fecal material. Isotopic enrichment was observed in a wide range of long-chain n-alkanes (C-27-C-36) and passage kinetics were determined for the most abundant C-29, C-31 and C-33 n-alkanes, for which a sufficiently high response signal was detected by combustion isotope ratio mass spectrometry. Basal diet treatment and carbon chain length of n-alkanes did not affect fractional passage rates from the rumen (K-1) among individual n-alkanes (3.71-3.95%/h). Peak concentration time and transit time showed a quantitatively small, significant (p <= 0.002) increase with carbon chain length. K-1 estimates were comparable to those of the C-13 labeled digestible dry matter fraction (3.38%/h; r = 0.61 to 0.71; p <= 0.012). A literature review has shown that n-alkanes are not fermented by microorganisms in the rumen and affirms no preferential depletion of C-13 versus C-12. Our results suggest that C-13 labeled n-alkanes can be used as nutrient passage tracers and support the reliability of the delta C-13 signature of digestible feed nutrients as a tool to measure nutrient-specific passage kinetics.	[Warner, Daniel; Breuer, Michel J. H.; Dijkstra, Jan; Pellikaan, Wilbert F.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Ferreira, Luis M. M.] Univ Tras Os Montes & Alto Douro, Ctr Ciencia Anim & Vet, Vila Real, Portugal	Wageningen University & Research; University of Tras-os-Montes & Alto Douro	Warner, D (corresponding author), Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands.	daniel.warner@wur.nl	Ferreira, Luis M.M./C-6868-2009; DIJKSTRA, Jan/G-7680-2011	Ferreira, Luis M.M./0000-0002-3341-861X; DIJKSTRA, Jan/0000-0003-3728-6885	Product Board Animal Feed (Den Haag, The Netherlands)	Product Board Animal Feed (Den Haag, The Netherlands)	This work was co-financed by the Product Board Animal Feed (Den Haag, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahamse PA, 2008, J DAIRY SCI, V91, P2033, DOI 10.3168/jds.2007-0579; Abrahamse PA, 2008, J DAIRY SCI, V91, P4778, DOI 10.3168/jds.2008-1350; ALEXANDER CL, 1969, J ANIM SCI, V29, P948, DOI 10.2527/jas1969.296948x; Ali HAM, 2005, J AGR SCI-CAMBRIDGE, V143, P85, DOI 10.1017/S0021859605004958; BARTLEY EE, 1971, J ANIM SCI, V33, P1351; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Bezabih M, 2011, LIVEST SCI, V142, P298, DOI 10.1016/j.livsci.2011.08.009; Bezabih M, 2011, ANIMAL, V5, P57, DOI 10.1017/S1751731110001515; Bibby J., 1977, PREDICTION IMPROVED; BOSCH MW, 1995, BRIT J NUTR, V73, P41, DOI 10.1079/BJN19950007; BRUINING M, 1992, ANIM FEED SCI TECH, V37, P193, DOI 10.1016/0377-8401(92)90003-O; Bulang M, 2008, LIVEST SCI, V115, P42, DOI 10.1016/j.livsci.2007.06.007; Cannas A., 2000, Modelling nutrient utilization in farm animals, P49, DOI 10.1079/9780851994499.0049; Clauss M, 2001, OECOLOGIA, V129, P321, DOI 10.1007/s004420100735; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; COLUCCI PE, 1990, J DAIRY SCI, V73, P2143, DOI 10.3168/jds.S0022-0302(90)78895-9; DHANOA MS, 1985, BRIT J NUTR, V53, P663, DOI 10.1079/BJN19850076; Dijkstra J, 2007, ANIMAL, V1, P99, DOI 10.1017/S1751731107657760; Dijkstra J., 2000, Modelling nutrient utilization in farm animals, P25, DOI 10.1079/9780851994499.0025; DOVE H, 1991, AUST J AGR RES, V42, P913, DOI 10.1071/AR9910913; Dove H, 1996, AUST J AGR RES, V47, P1333, DOI 10.1071/AR9961333; Dove H, 2006, NAT PROTOC, V1, P1680, DOI 10.1038/nprot.2006.225; EHLE FR, 1984, J DAIRY SCI, V67, P2910, DOI 10.3168/jds.S0022-0302(84)81654-9; Ferreira LMM, 2009, J ANIM SCI, V87, P2732, DOI 10.2527/jas.2008-1718; Ferreira LMM, 2009, ANIM FEED SCI TECH, V151, P128, DOI 10.1016/j.anifeedsci.2008.11.003; Firkins JL, 1998, J DAIRY SCI, V81, P3350, DOI 10.3168/jds.S0022-0302(98)75901-6; FRANCE J, 1993, BRIT J NUTR, V70, P369, DOI 10.1079/BJN19930129; Giraldez FJ, 2006, LIVEST SCI, V100, P195, DOI 10.1016/j.livprodsci.2005.08.009; Gorissen A, 1996, PLANT SOIL, V179, P81, DOI 10.1007/BF00011645; Hatt JM, 1998, ZOO BIOL, V17, P295, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;295::AID-ZOO4&gt;3.0.CO;2-4; Huhtanen P, 2001, ANIM FEED SCI TECH, V94, P29, DOI 10.1016/S0377-8401(01)00297-8; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Ippel JH, 2004, PROTEOMICS, V4, P226, DOI 10.1002/pmic.200300506; Kebreab E, 2004, ANIM FEED SCI TECH, V112, P131, DOI 10.1016/j.anifeedsci.2003.10.009; Keli A, 2008, ANIMAL, V2, P1748, DOI 10.1017/S1751731108003108; LECHNERDOLL M, 1989, J ANIM PHYSIOL AN N, V61, P120, DOI 10.1111/j.1439-0396.1989.tb00091.x; Mayes R. W., 1988, Proceedings of the 12th General Meeting of the European Grassland Federation, Dublin, Ireland, July 4-7, 1988., P159; Mayes R. W., 1997, Proceedings of the Nutrition Society, V56, p187A; MAYES RW, 1986, J AGR SCI, V107, P161, DOI 10.1017/S0021859600066910; MCCARTHY RD, 1964, BIOCHIM BIOPHYS ACTA, V84, P74, DOI 10.1016/0926-6542(64)90102-7; OHAJURUKA OA, 1991, J ANIM SCI, V69, P1726; Olivan M, 1999, J AGR SCI, V132, P305, DOI 10.1017/S0021859699006358; Owens F. N., 1986, CONTROL DIGESTION ME, P196; OWENS FN, 1992, J DAIRY SCI, V75, P2605, DOI 10.3168/jds.S0022-0302(92)78023-0; Pellikaan WF, 2013, ANIMAL, V7, P754, DOI 10.1017/S1751731112002303; POPPI DP, 1980, J AGR SCI-CAMBRIDGE, V94, P275, DOI 10.1017/S0021859600028859; Scott MP, 1999, PHYTOCHEMISTRY, V52, P555, DOI 10.1016/S0031-9422(99)00271-X; SICILIANOJONES J, 1986, J DAIRY SCI, V69, P2304, DOI 10.3168/jds.S0022-0302(86)80669-5; Sponheimer M, 2003, SMALL RUMINANT RES, V48, P149, DOI 10.1016/S0921-4488(03)00002-6; Sudekum KH, 1995, ISOT ENVIRON HEALT S, V31, P219, DOI 10.1080/10256019508234020; Sutherland T. M., 1988, Aspects of digestive physiology in ruminants. Proceedings of a Satellite Symposium of the 30th International Congress of the International Union of Physiological Sciences, July 21-23, 1986. Ithaca, New York, P43; UDEN P, 1980, J SCI FOOD AGR, V31, P625, DOI 10.1002/jsfa.2740310702; Warner D, 2013, J DAIRY SCI, V96, P5844, DOI 10.3168/jds.2013-6694; [No title captured]	54	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75496	10.1371/journal.pone.0075496	http://dx.doi.org/10.1371/journal.pone.0075496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124493	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100050
J	Lim, D; Gold, DA; Julien, L; Rosowski, EE; Niedelman, W; Yaffe, MB; Saeij, JPJ				Lim, Daniel; Gold, Daniel A.; Julien, Lindsay; Rosowski, Emily E.; Niedelman, Wendy; Yaffe, Michael B.; Saeij, Jeroen P. J.			Structure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Protein Kinases; Protein Phosphorylation; Protozoan; Signal Transduction; Toxoplasma Gondii; Rhoptry Protein	AUTOMATED STRUCTURE SOLUTION; WIDE PREDICTION; PROTEIN; PHOSPHORYLATION; INFECTION; SUBUNIT; CRYSTALLOGRAPHY; THREONINE; IMMUNITY; XTALVIEW	Background: ROP18 is a Toxoplasma secreted Ser/Thr protein kinase important for acute virulence. Results: The crystal structure of the unphosphorylated ROP18 kinase domain was determined in complex with an ATP analog. Conclusion: The structure is inconsistent with a previously proposed model of autoinhibition and identifies an additional ligand binding site important for virulence. Significance: Structure-function studies of ROP18 will aid development of novel drugs against toxoplasmosis. At least a third of the human population is infected with the intracellular parasite Toxoplasma gondii, which contributes significantly to the disease burden in immunocompromised and neutropenic hosts and causes serious congenital complications when vertically transmitted to the fetus. Genetic analyses have identified the Toxoplasma ROP18 Ser/Thr protein kinase as a major factor mediating acute virulence in mice. ROP18 is secreted into the host cell during the invasion process, and its catalytic activity is required for the acute virulence phenotype. However, its precise molecular function and regulation are not fully understood. We have determined the crystal structure of the ROP18 kinase domain, which is inconsistent with a previously proposed autoinhibitory mechanism of regulation. Furthermore, a sucrose molecule bound to our structure identifies an additional ligand-binding pocket outside of the active site cleft. Mutational analysis confirms an important role for this pocket in virulence.	[Lim, Daniel; Gold, Daniel A.; Julien, Lindsay; Rosowski, Emily E.; Niedelman, Wendy; Yaffe, Michael B.; Saeij, Jeroen P. J.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lim, Daniel; Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), 77 Massachusetts Ave,Bldg 76-353, Cambridge, MA 02139 USA.	myaffe@mit.edu; jsaeij@mit.edu	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098; Saeij, Jeroen/0000-0003-0289-7109	National Institutes of Health [R01-A1080621, R01-GM52981, P50GM68762, R01-GM104047]; Massachusetts Life Sciences Center New Investigator Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104047, T32GM007287, P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Sciences Center New Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-A1080621 (to J.P.J.S.) and R01-GM52981, P50GM68762, and R01-GM104047 (to M.B.Y.) and a Massachusetts Life Sciences Center New Investigator Award (to J.P.J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dar A.C., 2005, EUKARYOTIC PROTEIN K, DOI 10. 1002/3527603611. ch9; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fentress SJ, 2012, CELL MICROBIOL, V14, P1921, DOI 10.1111/cmi.12022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; JOINER KA, 1993, INFECT IMMUN, V61, P1169, DOI 10.1128/IAI.61.4.1169-1172.1993; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ku SY, 2007, ACTA CRYSTALLOGR D, V63, P493, DOI 10.1107/S0907444907006592; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Laudet B, 2008, MOL CELL BIOCHEM, V316, P63, DOI 10.1007/s11010-008-9821-6; Lim DC, 2012, INT J PARASITOL, V42, P21, DOI 10.1016/j.ijpara.2011.11.007; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mcree DE, 2008, J STRUCT BIOL, V163, P208, DOI 10.1016/j.jsb.2008.02.004; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; Raaf J, 2009, J MOL BIOL, V386, P1212, DOI 10.1016/j.jmb.2009.01.033; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660	67	12	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34968	34980		10.1074/jbc.M113.523266	http://dx.doi.org/10.1074/jbc.M113.523266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129568	Green Published, hybrid			2022-12-25	WOS:000329812800062
J	MacLean, JA; Hu, ZY; Welborn, JP; Song, HW; Rao, MK; Wayne, CM; Wilkinson, MF				MacLean, James A., II; Hu, Zhiying; Welborn, Joshua P.; Song, Hye-Won; Rao, Manjeet K.; Wayne, Chad M.; Wilkinson, Miles F.			The RHOX Homeodomain Proteins Regulate the Expression of Insulin and Other Metabolic Regulators in the Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Homeobox; Insulin; Spermatogenesis; Testis; Sertoli Cells	PEM HOMEOBOX GENE; TRANSCRIPTION FACTOR PDX-1; AKITA DIABETIC MICE; HUMAN SERTOLI-CELLS; MALE GERM-CELLS; IN-VITRO; ANDROGEN RECEPTOR; RAPID EVOLUTION; RAT TESTIS; SPERMATOGENIC CELLS	Background: RHOX5 is a transcription factor important for spermatogenesis. Results: Using Rhox5-null mice, we demonstrate that RHOX5 regulates key metabolism genes, including insulin (Ins), resistin (Retn), and adiponectin (Adipoq) in specific cell types and developmental stages in the testis. Conclusion: RHOX5 is a crucial regulator of metabolism genes in the testis. Significance: This work provides a framework for understanding why metabolism defects cause male infertility. Defects in cellular metabolism have been widely implicated in causing male infertility, but there has been little progress in understanding the underlying mechanism. Here we report that several key metabolism genes are regulated in the testis by Rhox5, the founding member of a large X-linked homeobox gene cluster. Among these Rhox5-regulated genes are insulin 2 (Ins2), resistin (Retn), and adiponectin (Adipoq), all of which encode secreted proteins that have profound and wide-ranging effects on cellular metabolism. The ability of Rhox5 to regulate their levels in the testis has the potential to dictate metabolism locally in this organ, given the existence of the blood-testes barrier. We demonstrate that Ins2 is a direct target of Rhox5 in Sertoli cells, and we show that this regulation is physiologically significant, because Rhox5-null mice fail to up-regulate Ins2 expression during the first wave of spermatogenesis and have insulin-signaling defects. We identify other Rhox family members that induce Ins2 transcription, define protein domains and homeodomain amino acid residues crucial for this property, and demonstrate that this regulation is conserved. Rhox5-null mice also exhibit altered expression of other metabolism genes, including those encoding the master transcriptional regulators of metabolism, PPARG and PPARGC1A, as well as SCD1, the rate-limiting enzyme for fatty acid metabolism. These results, coupled with the known roles of RHOX5 and its target metabolism genes in spermatogenesis in vivo, lead us to propose a model in which RHOX5 is a central transcription factor that promotes the survival of male germ cells via its effects on cellular metabolism.	[MacLean, James A., II; Welborn, Joshua P.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Wayne, Chad M.] Univ Houston, Dept Biol, Houston, TX 77004 USA; [Song, Hye-Won; Wilkinson, Miles F.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [MacLean, James A., II; Hu, Zhiying; Song, Hye-Won; Rao, Manjeet K.; Wayne, Chad M.; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Song, Hye-Won; Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; University of Texas Health San Antonio; University of Houston System; University of Houston; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Wilkinson, MF (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	mfwilkinson@ucsd.edu			National Institutes of Health [R01 HD045595, HD053808, R03 HD55268, R15 HD65584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053808, R03HD055268, R15HD065584] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD045595 and HD053808 (to M. F. W.) and R03 HD55268 and R15 HD65584 (to J. A. M.).	ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Ahuja HS, 2001, MOL PHARMACOL, V59, P765, DOI 10.1124/mol.59.4.765; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Alves MG, 2012, BBA-MOL CELL RES, V1823, P1389, DOI 10.1016/j.bbamcr.2012.06.002; Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Bhardwaj A, 2012, MOL ENDOCRINOL, V26, P538, DOI 10.1210/me.2011-1059; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Bobes RJ, 2001, POULTRY SCI, V80, P637, DOI 10.1093/ps/80.5.637; Bouma GJ, 2010, BIOL REPROD, V82, P380, DOI 10.1095/biolreprod.109.079822; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Caminos JE, 2008, ENDOCRINOLOGY, V149, P3390, DOI 10.1210/en.2007-1582; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DUBOULE D, 1994, GUIDEBOOK HOMEBOX GE; Fleenor DE, 2001, ENDOCRINOLOGY, V142, P2805, DOI 10.1210/en.142.7.2805; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Geyer CB, 2008, GENE, V423, P194, DOI 10.1016/j.gene.2008.06.031; Goulis DG, 2008, GYNECOL ENDOCRINOL, V24, P33, DOI 10.1080/09513590701582273; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; HALES DB, 1987, J BIOL CHEM, V262, P11200; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Hu ZY, 2007, ANN NY ACAD SCI, V1120, P72, DOI 10.1196/annals.1411.011; Hu ZY, 2010, MOL ENDOCRINOL, V24, P60, DOI 10.1210/me.2009-0303; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kim ST, 2008, REPRODUCTION, V136, P313, DOI 10.1530/REP-08-0167; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; LIN TP, 1994, DEV BIOL, V166, P170, DOI 10.1006/dbio.1994.1305; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; MacLean JA, 2005, BIOL REPROD, V73, P1126, DOI 10.1095/biolreprod.105.042747; MacLean JA, 2013, FRONT BIOSCI-LANDMRK, V18, P474, DOI 10.2741/4115; MacLean JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099184; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Maiti S, 1996, GENOMICS, V34, P304, DOI 10.1006/geno.1996.0291; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nakayama Y, 1999, INT J DEV BIOL, V43, P343; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Niu AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-298; Nogueiras R, 2004, J CELL SCI, V117, P3247, DOI 10.1242/jcs.01196; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oliveira PF, 2012, BBA-GEN SUBJECTS, V1820, P84, DOI 10.1016/j.bbagen.2011.11.006; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Rao MK, 2002, J BIOL CHEM, V277, P48771, DOI 10.1074/jbc.M209417200; Reul BA, 1997, BIOCHEM J, V324, P605, DOI 10.1042/bj3240605; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Saether T, 2007, REPRODUCTION, V133, P467, DOI 10.1530/REP-06-00294; SAEZ JM, 1988, REPROD NUTR DEV, V28, P989, DOI 10.1051/rnd:19880701; SAKKAS D, 1993, BIOL REPROD, V49, P1288, DOI 10.1095/biolreprod49.6.1288; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schoeller EL, 2012, CELL TISSUE RES, V349, P839, DOI 10.1007/s00441-012-1387-7; Schoeller EL, 2012, DIABETES, V61, P1869, DOI 10.2337/db11-1527; Song HW, 2013, HUM REPROD, V28, P1635, DOI 10.1093/humrep/det043; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Su LL, 2009, INT J BIOCHEM CELL B, V41, P2578, DOI 10.1016/j.biocel.2009.08.015; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; VITALE R, 1973, ANAT REC, V176, P333, DOI 10.1002/ar.1091760309; Wang J, 2000, BIOTECHNIQUES, V29, P976, DOI 10.2144/00295bm09; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wayne CM, 2002, ENDOCRINOLOGY, V143, P4875, DOI 10.1210/en.2002-220558; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Wiecek A, 2002, NEPHROL DIAL TRANSPL, V17, P191, DOI 10.1093/ndt/17.2.191; WILKINSON M, 2000, ESSENTIAL MOL BIOL, P69; Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008; Woods SC, 2001, INT J OBESITY, V25, pS35, DOI 10.1038/sj.ijo.0801909; Wu HT, 2003, REPROD DOMEST ANIM, V38, P470, DOI 10.1046/j.0936-6768.2003.00465.x; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	100	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34809	34825		10.1074/jbc.M113.486340	http://dx.doi.org/10.1074/jbc.M113.486340			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121513	Green Published, hybrid			2022-12-25	WOS:000329812800049
J	Moller-Hackbarth, K; Dewitz, C; Schweigert, O; Trad, A; Garbers, C; Rose-John, S; Scheller, J				Moeller-Hackbarth, Katja; Dewitz, Christin; Schweigert, Olga; Trad, Ahmad; Garbers, Christoph; Rose-John, Stefan; Scheller, Juergen			A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Cell Culture; Cell Surface; Shedding; Signaling	KIDNEY INJURY MOLECULE-1; CHRONIC VIRAL-INFECTION; EPIDERMAL-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; L-SELECTIN; IL-6 RECEPTOR; ANTITUMOR IMMUNITY; EXPRESSION; TACE; PROTEINS	Background: Membrane-bound Tim-3 regulates immune responses. Results: Soluble Tim-3 is generated by A disintegrin and metalloprotease (ADAM) 10 and ADAM17. Conclusion: ADAM proteases are involved in Tim-3 processing. Significance: Shedding of Tim-3 influences immune cell activation. T cell immunoglobulin and mucin domain 3 (Tim-3) dampens the response of CD4(+) and CD8(+) effector T cells via induction of cell death and/or T cell exhaustion and enhances the ability of macrophages to clear pathogens via binding to galectin 9. Here we provide evidence that human Tim-3 is a target of A disintegrin and metalloprotease (ADAM)-mediated ectodomain shedding resulting in a soluble form of Tim-3. We identified ADAM10 and ADAM17 as major sheddases of Tim-3 as shown by ADAM-specific inhibitors and the ADAM10 pro-domain in HEK293 cells and ADAM10/ADAM17-deficient murine embryonic fibroblasts. PMA-induced shedding of Tim-3 was abrogated by deletion of amino acids Glu(181)-Asp(190) of the stalk region and Tim-3 lacking the intracellular domain was not efficiently cleaved after PMA stimulation. Surprisingly, a single lysine residue within the intracellular domain rescues shedding of Tim-3. Shedding of endogenous Tim-3 was found in primary human CD14(+) monocytes after PMA and ionomycin stimulation. Importantly, the recently described down-regulation of Tim-3 from Toll-like receptor-activated CD14(+) monocytes was caused by ADAM10- and ADAM17-mediated shedding. Inhibition of Tim-3 shedding from lipopolysaccharide-induced monocytes did not influence lipopolysaccharide-induced TNF and IL-6 but increases IL-12 expression. In summary, we describe Tim-3 as novel target for ADAM-mediated ectodomain shedding and suggest a role of Tim-3 shedding in TLR-mediated immune responses of CD14(+) monocytes.	[Moeller-Hackbarth, Katja; Dewitz, Christin; Schweigert, Olga; Trad, Ahmad; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-24098 Kiel, Germany; [Garbers, Christoph; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany	University of Kiel; Heinrich Heine University Dusseldorf	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279	Deutsche Forschungsgemeinschaft [DFG SCHE 907/2-1, SFB654, C8, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported in part by Deutsche Forschungsgemeinschaft Grant DFG SCHE 907/2-1, SFB654, C8, and SFB877 projects A1 and Z3, and the Cluster of Excellence "Inflammation at Interfaces."	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Canobbio I, 2011, BBA-MOL CELL RES, V1813, P500, DOI 10.1016/j.bbamcr.2010.12.002; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gonzales PE, 2008, BIOCHEMISTRY-US, V47, P9911, DOI 10.1021/bi801049v; Guo LY, 2012, J BIOCHEM, V152, P425, DOI 10.1093/jb/mvs082; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kenny PA, 2007, DIFFERENTIATION, V75, P800, DOI 10.1111/j.1432-0436.2007.00198.x; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Lim AI, 2012, INT J BIOCHEM CELL B, V44, P1040, DOI 10.1016/j.biocel.2012.03.015; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Yoshiyama K, 1997, GENOMICS, V41, P56, DOI 10.1006/geno.1997.4607; Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	53	74	80	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34529	34544		10.1074/jbc.M113.488478	http://dx.doi.org/10.1074/jbc.M113.488478			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121505	Green Published, hybrid			2022-12-25	WOS:000329812800022
J	Patel, N; Exell, JC; Jardine, E; Ombler, B; Finger, LD; Ciani, B; Grasby, JA				Patel, Nikesh; Exell, Jack C.; Jardine, Emma; Ombler, Ben; Finger, L. David; Ciani, Barbara; Grasby, Jane A.			Proline Scanning Mutagenesis Reveals a Role for the Flap Endonuclease-1 Helical Cap in Substrate Unpairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circular Dichroism (CD); DNA Physical Chemistry; DNA Repair; DNA Replication; DNA-Protein Interaction; Enzyme Catalysis; Enzyme Mechanisms; Fluorescence; Fluorescence Correlation Spectroscopy; Nucleic Acid Enzymology	METAL-IONS; DNA; MECHANISM; CATALYSIS; NUCLEASE; RECOGNITION; SUPERFAMILY; SPECIFICITY; PROTEINS; CLEAVAGE	Background: Human flap endonuclease-1, the prototypical 5-nuclease, removes 5-flaps by incising one nucleotide into duplex DNA using a double nucleotide unpairing mechanism. Results: Alteration of the hFEN1 helical cap structure, but not removal of conserved basic residues, prevents substrate unpairing. Conclusion: The hFEN1 helical cap is required for substrate rearrangement. Significance: Mechanistic details of 5-nuclease catalysis are crucial for understanding DNA replication and repair. The prototypical 5-nuclease, flap endonuclease-1 (FEN1), catalyzes the essential removal of single-stranded flaps during DNA replication and repair. FEN1 hydrolyzes a specific phosphodiester bond one nucleotide into double-stranded DNA. This specificity arises from double nucleotide unpairing that places the scissile phosphate diester on active site divalent metal ions. Also related to FEN1 specificity is the helical arch, through which 5-flaps, but not continuous DNAs, can thread. The arch contains basic residues (Lys-93 and Arg-100 in human FEN1 (hFEN1)) that are conserved by all 5-nucleases and a cap region only present in enzymes that process DNAs with 5 termini. Proline mutations (L97P, L111P, L130P) were introduced into the hFEN1 helical arch. Each mutation was severely detrimental to reaction. However, all proteins were at least as stable as wild-type (WT) hFEN1 and bound substrate with comparable affinity. Moreover, all mutants produced complexes with 5-biotinylated substrate that, when captured with streptavidin, were resistant to challenge with competitor DNA. Removal of both conserved basic residues (K93A/R100A) was no more detrimental to reaction than the single mutation R100A, but much less severe than L97P. The ability of protein-Ca2+ to rearrange 2-aminopurine-containing substrates was monitored by low energy CD. Although L97P and K93A/R100A retained the ability to unpair substrates, the cap mutants L111P and L130P did not. Taken together, these data challenge current assumptions related to 5-nuclease family mechanism. Conserved basic amino acids are not required for double nucleotide unpairing and appear to act cooperatively, whereas the helical cap plays an unexpected role in hFEN1-substrate rearrangement.	[Patel, Nikesh; Exell, Jack C.; Jardine, Emma; Ombler, Ben; Finger, L. David; Ciani, Barbara; Grasby, Jane A.] Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England	University of Sheffield	Finger, LD (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.	d.finger@sheffield.ac.uk; b.ciani@sheffield.ac.uk; j.a.grasby@sheffield.ac.uk	Ciani, Barbara/A-1679-2012	Ciani, Barbara/0000-0001-7223-4154; Finger, L. David/0000-0002-2342-9569; Patel, Nikesh/0000-0001-6098-3633	Biotechnology and Biological Sciences Research Council [BB/J00300X, BB/K009079/1]; Biotechnology and Biological Sciences Research Council [BB/J00300X/1] Funding Source: researchfish; BBSRC [BB/K009079/1, BB/J00300X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council grants BB/J00300X (to J.A.G. and B.C.) and BB/K009079/1 (to J.A.G. and L.D.F.).	Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063	27	13	13	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34239	34248		10.1074/jbc.M113.509489	http://dx.doi.org/10.1074/jbc.M113.509489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126913	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000327250200066
J	Borthakur, A; Bhattacharyya, S; Kumar, A; Anbazhagan, AN; Tobacman, JK; Dudeja, PK				Borthakur, Alip; Bhattacharyya, Sumit; Kumar, Anoop; Anbazhagan, Arivarasu Natarajan; Tobacman, Joanne K.; Dudeja, Pradeep K.			Lactobacillus acidophilus Alleviates Platelet-Activating Factor-Induced Inflammatory Responses in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROTIZING ENTEROCOLITIS; CROHNS-DISEASE; COLONIC-MUCOSA; PROBIOTICS; EXPRESSION; MICROBIOTA; PATHWAY; PHOSPHORYLATION; INTERLEUKIN-8	Probiotics have been used as alternative prevention and therapy modalities in intestinal inflammatory disorders including inflammatory bowel diseases (IBD) and necrotizing enterocolitis (NEC). Pathophysiology of IBD and NEC includes the production of diverse lipid mediators, including platelet-activating factor (PAF) that mediate inflammatory responses in the disease. PAF is known to activate NF-kappa B, however, the mechanisms of PAF-induced inflammation are not fully defined. We have recently described a novel PAF-triggered pathway of NF-kappa B activation and IL-8 production in intestinal epithelial cells (IECs), requiring the pivotal role of the adaptor protein Bcl10 and its interactions with CARMA3 and MALT1. The current studies examined the potential role of the probiotic Lactobacillus acidophilus in reversing the PAF-induced, Bcl10-dependent NF-kappa B activation and IL-8 production in IECs. PAF treatment (5 mu Mx24 h) of NCM460 and Caco-2 cells significantly increased nuclear p65 NF-kappa B levels and IL-8 secretion (2-3-fold, P < 0.05), compared to control, which were blocked by pretreatment of the cells for 6 h with L. acidophilus (LA) or its culture supernatant (CS), followed by continued treatments with PAF for 24 h. LA-CS also attenuated PAF-induced increase in Bcl10 mRNA and protein levels and Bcl10 promoter activity. LA-CS did not alter PAF-induced interaction of Bcl10 with CARMA3, but attenuated Bcl10 interaction with MALT1 and also PAF-induced ubiquitination of IKK gamma. Efficacy of bacteria-free CS of LA in counteracting PAF-induced inflammatory cascade suggests that soluble factor(s) in the CS of LA mediate these effects. These results define a novel mechanism by which probiotics counteract PAF-induced inflammation in IECs.	[Borthakur, Alip; Bhattacharyya, Sumit; Kumar, Anoop; Anbazhagan, Arivarasu Natarajan; Tobacman, Joanne K.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA; [Dudeja, Pradeep K.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Borthakur, A (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60607 USA.	alipb@uic.edu			National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [DK-54016, DK-81858, DK-92441]; Bill & Melinda Gates Foundation [OPP1058288]; Department of Veteran Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092441, R01DK054016, R01DK081858] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK): DK-54016 (PKD), DK-81858 (PKD), DK-92441 (PKD); Bill & Melinda Gates Foundation: OPP1058288 (AB) and Department of Veteran Affairs (PKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borman RA, 1998, BRIT J PHARMACOL, V123, P231, DOI 10.1038/sj.bjp.0701602; Borthakur A, 2008, J NUTR, V138, P1355, DOI 10.1093/jn/138.7.1355; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; CHAO W, 1992, J BIOL CHEM, V267, P6725; Choi JH, 2001, J IMMUNOL, V166, P5139, DOI 10.4049/jimmunol.166.8.5139; Claud EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1191, DOI 10.1152/ajpgi.00318.2007; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; De Plaen IG, 1998, BBA-LIPID LIPID MET, V1392, P185, DOI 10.1016/S0005-2760(98)00024-1; Egea L, 2008, BBA-MOL CELL BIOL L, V1781, P270, DOI 10.1016/j.bbalip.2008.03.009; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Frost BL, 2013, SEMIN PEDIATR SURG, V22, P88, DOI 10.1053/j.sempedsurg.2013.01.005; Ganguli K, 2012, GASTROENTEROL CLIN N, V41, P733, DOI 10.1016/j.gtc.2012.08.004; Gautheron J, 2010, CELL MOL LIFE SCI, V67, P3101, DOI 10.1007/s00018-010-0404-9; Grishin A, 2013, SEMIN PEDIATR SURG, V22, P69, DOI 10.1053/j.sempedsurg.2013.01.002; Han SJ, 1999, EUR J IMMUNOL, V29, P1334, DOI 10.1002/(SICI)1521-4141(199904)29:04<1334::AID-IMMU1334>3.0.CO;2-0; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Howarth GS, 2013, NUTRIENTS, V5, P58, DOI 10.3390/nu5010058; HSUEH W, 1994, ACTA PAEDIATR, V83, P11, DOI 10.1111/j.1651-2227.1994.tb13234.x; Im SY, 1997, EUR J IMMUNOL, V27, P2800, DOI 10.1002/eji.1830271109; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; KALD B, 1990, DIGESTION, V46, P199, DOI 10.1159/000200346; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Lu J, 2008, AM J PHYSIOL-GASTR L, V294, pG1181, DOI 10.1152/ajpgi.00343.2007; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Magrone T, 2013, CURR PHARM DESIGN, V19, P1329; Merendino N, 1999, AM J PHYSIOL-GASTR L, V277, pG810, DOI 10.1152/ajpgi.1999.277.4.G810; Nasu K, 1999, MOL HUM REPROD, V5, P548, DOI 10.1093/molehr/5.6.548; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Rosebeck S, 2011, CELL CYCLE, V10, P2485, DOI 10.4161/cc.10.15.16923; Roth M, 1996, J EXP MED, V184, P191, DOI 10.1084/jem.184.1.191; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; SOBHANI I, 1992, GUT, V33, P1220, DOI 10.1136/gut.33.9.1220; Sun Jiyuan, 2010, World J Biol Chem, V1, P353, DOI 10.4331/wjbc.v1.i12.353; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Veerappan Ganesh R, 2012, Curr Gastroenterol Rep, V14, P324, DOI 10.1007/s11894-012-0265-5; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Whelan K, 2013, CURR OPIN GASTROEN, V29, P184, DOI 10.1097/MOG.0b013e32835d7bba; Wu GD, 2013, ANAEROBE; Xu LF, 2012, INFLAMMATION, V35, P308, DOI 10.1007/s10753-011-9320-x; Yang YJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-38; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	50	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75664	10.1371/journal.pone.0075664	http://dx.doi.org/10.1371/journal.pone.0075664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130731	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900050
J	Wiens, GD; Vallejo, RL; Leeds, TD; Palti, Y; Hadidi, S; Liu, SX; Evenhuis, JP; Welch, TJ; Rexroad, CE				Wiens, Gregory D.; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Hadidi, Sima; Liu, Sixin; Evenhuis, Jason P.; Welch, Timothy J.; Rexroad, Caird E., III			Assessment of Genetic Correlation between Bacterial Cold Water Disease Resistance and Spleen Index in a Domesticated Population of Rainbow Trout: Identification of QTL on Chromosome Omy19	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; QUANTITATIVE TRAIT LOCI; SALMON SALMO-SALAR; AMEBIC GILL DISEASE; ATLANTIC SALMON; FLAVOBACTERIUM-PSYCHROPHILUM; INCREASE RESISTANCE; INTEGRATED MAP; MAJOR QTL; MYKISS	Selective breeding of animals for increased disease resistance is an effective strategy to reduce mortality in aquaculture. However, implementation of selective breeding programs is limited by an incomplete understanding of host resistance traits. We previously reported results of a rainbow trout selection program that demonstrated increased survival following challenge with Flavobacterium psychrophilum, the causative agent of bacterial cold water disease (BCWD). Mechanistic study of disease resistance identified a positive phenotypic correlation between post-challenge survival and spleen somatic-index (SI). Herein, we investigated the hypothesis of a genetic correlation between the two traits influenced by colocalizing QTL. We evaluated the inheritance and calculated the genetic correlation in five year-classes of odd-and even-year breeding lines. A total of 322 pedigreed families (n = 25,369 fish) were measured for disease resistance, and 251 families (n = 5,645 fish) were evaluated for SI. Spleen index was moderately heritable in both even-year (h(2) = 0.56 +/- 0.18) and odd-year (h(2) = 0.60 +/- 0.15) lines. A significant genetic correlation between SI and BCWD resistance was observed in the even-year line (r(g) = 0.45 +/- 0.20, P = 0.03) but not in the odd-year line (r(g) = 0.16 +/- 0.12, P = 0.19). Complex segregation analyses of the even-year line provided evidence of genes with major effect on SI, and a genome scan of a single family, 2008132, detected three significant QTL on chromosomes Omy19, 16 and 5, in addition to ten suggestive QTL. A separate chromosome scan for disease resistance in family 2008132 identified a significant BCWD QTL on Omy19 that was associated with time to death and percent survival. In family 2008132, Omy19 microsatellite alleles that associated with higher disease resistance also associated with increased spleen size raising the hypothesis that closely linked QTL contribute to the correlation between these traits. To our knowledge, this is the first estimation of spleen size heritability and evidence for genetic linkage with specific disease resistance in a teleost fish.	[Wiens, Gregory D.; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Hadidi, Sima; Liu, Sixin; Evenhuis, Jason P.; Welch, Timothy J.; Rexroad, Caird E., III] ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV USA	United States Department of Agriculture (USDA)	Wiens, GD (corresponding author), ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV USA.	greg.wiens@ars.usda.gov	Vallejo, Roger/AAE-7591-2020	Vallejo, Roger/0000-0002-5399-3531; Wiens, Gregory/0000-0002-5478-7780; Welch, Tim/0000-0003-1096-3006; Leeds, Timothy/0000-0002-9872-1134	Agricultural Research Service CRIS project [1930-32000-005]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by Agricultural Research Service CRIS project 1930-32000-005 "Integrated Approaches for Improving Aquatic Animal Health in Cool and Cold Water Aquaculture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GENETICS ANAL QUANTI; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Barnes M. E., 2011, The Open Fish Science Journal, V4, P40, DOI 10.2174/1874401X01104010040; BOLDMAN KG, 1995, MANUAL USE IN PRESS; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Brown LL, 1997, DIS AQUAT ORGAN, V29, P213, DOI 10.3354/dao029213; Cipriano RC, 2005, J AQUAT ANIM HEALTH, V17, P275, DOI 10.1577/H05-003.1; Crump EM, 2001, APPL ENVIRON MICROB, V67, P750, DOI 10.1128/AEM.67.2.750-759.2001; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Falconer D. S, 1996, INTRO QUANTITATIVE G; FANGE R, 1985, EXPERIENTIA, V41, P152, DOI 10.1007/BF02002607; Fawcett GL, 2008, OBESITY, V16, P1861, DOI 10.1038/oby.2008.300; Figenschou L, 2012, BEHAV ECOL, P1; Groff Joseph M., 2000, Journal of Applied Aquaculture, V10, P17, DOI 10.1300/J028v10n04_02; Hadidi S, 2008, J IMMUNOL, V180, P4156, DOI 10.4049/jimmunol.180.6.4156; Henryon M, 2005, AQUACULTURE, V250, P621, DOI 10.1016/j.aquaculture.2004.12.022; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; Houston RD, 2008, DEV BIOLOGICALS, V132, P199, DOI 10.1159/000317160; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; JANSS LLG, 2008, IBAY MANUAL VERSION; Kenney-Hunt JP, 2006, MAMM GENOME, V17, P526, DOI 10.1007/s00335-005-0160-6; Kjoglum S, 2008, AQUAC RES, V39, P498, DOI 10.1111/j.1365-2109.2008.01904.x; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kube PD, 2012, AQUACULTURE, V364, P165, DOI 10.1016/j.aquaculture.2012.08.026; LaFrentz BR, 2004, DIS AQUAT ORGAN, V59, P17, DOI 10.3354/dao059017; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Langevin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039126; Leach RJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-107; Leeds TD, 2010, J ANIM SCI, V88, P1936, DOI 10.2527/jas.2009-2538; Moen T, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-53; Moen T, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P166, DOI 10.1079/9781845935559.0166; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Palti Y, 2006, ANIM GENET, V37, P597, DOI 10.1111/j.1365-2052.2006.01527.x; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Phillips RB, 2013, ANIM GENET, V44, P107, DOI 10.1111/j.1365-2052.2011.02314.x; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Quillet E, 2007, DIS AQUAT ORGAN, V76, P7, DOI 10.3354/dao076007; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; SAS Institute Inc, 2007, SAS 9 1 3 HELP DOC; Seaton G, 2006, GRIDQTL GRID PORTAL; Silverstein JT, 2009, J ANIM SCI, V87, P860, DOI 10.2527/jas.2008-1157; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Stear M.J., 2012, CAB REV PERSPECTIVES, V7; Taylor RS, 2009, AQUACULTURE, V294, P172, DOI 10.1016/j.aquaculture.2009.06.007; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; Vallejo RL, 2009, J ANIM SCI, V87, P3490, DOI 10.2527/jas.2008-1616; VANMUISWINKEL WB, 1991, RES IMMUNOL, V142, P362, DOI 10.1016/0923-2494(91)90093-X; Vatsos IN, 2006, J FISH DIS, V29, P441, DOI 10.1111/j.1365-2761.2006.00735.x; Verrier ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055302; Verrier ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033935; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wiens GD, 2013, AQUACULTURE, V388, P128, DOI 10.1016/j.aquaculture.2013.01.018; Wiens GD, 2010, FISH SHELLFISH IMMUN, V29, P639, DOI 10.1016/j.fsi.2010.06.010; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	60	47	49	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75749	10.1371/journal.pone.0075749	http://dx.doi.org/10.1371/journal.pone.0075749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130739	gold, Green Published			2022-12-25	WOS:000325810900056
J	Charbonneau, DM; Beauregard, M				Charbonneau, David M.; Beauregard, Marc			Role of Key Salt Bridges in Thermostability of G. thermodenitrificans EstGtA2: Distinctive Patterns within the New Bacterial Lipolytic Enzyme Family XV	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; MONOACYLGLYCEROL LIPASE; PROTEIN STABILITY; CRYSTAL-STRUCTURE; FOLDING PATHWAY; CARBOXYLESTERASE; SURFACE; CLASSIFICATION; STABILIZATION; EXPRESSION	Bacterial lipolytic enzymes were originally classified into eight different families defined by Arpigny and Jaeger (families I-VIII). Recently, the discovery of new lipolytic enzymes allowed for extending the original classification to fourteen families (I-XIV). We previously reported that G. thermodenitrificans EstGtA2 (access no. AEN92268) belonged to a novel group of bacterial lipolytic enzymes. Here we propose a 15th family (family XV) and suggest criteria for the assignation of protein sequences to the N' subfamily. Five selected salt bridges, hallmarks of the N' subfamily (E3/R54, E12/R37, E66/R140, D124/K178 and D205/R220) were disrupted in EstGtA2 using a combinatorial alanine-scanning approach. A set of 14 (R/K -> A) mutants was produced, including five single, three double, three triple and three quadruple mutants. Despite a high tolerance to non-conservative mutations for folding, all the alanine substitutions were destabilizing (decreasing T-m by 5 to 14 degrees C). A particular combination of four substitutions exceeded this tolerance and prevents the correct folding of EstGtA2, leading to enzyme inactivation. Although other mutants remain active at low temperatures, the accumulation of more than two mutations had a dramatic impact on EstGtA2 activity at high temperatures suggesting an important role of these conserved salt bridge-forming residues in thermostability of lipolytic enzymes from the N' subfamily. We also identified a particular interloop salt bridge in EstGtA2 (D194/H222), located at position i-2 and i-4 residues from the catalytic Asp and His respectively which is conserved in other related bacterial lipolytic enzymes (families IV and XIII) with high tolerance to mutations and charge reversal. We investigated the role of residue identity at position 222 in controlling stability-pH dependence in EstGtA2. The introduction of a His to Arg mutation led to increase thermostability under alkaline pH. Our results suggest primary targets for optimization of EstGtA2 for specific biotechnological purposes.	[Charbonneau, David M.; Beauregard, Marc] Univ Quebec Trois Rivieres, Dept Chim Phys, Ctr Rech Mat Lignocellulos, Trois Rivieres, PQ GA9 5H7, Canada; [Charbonneau, David M.; Beauregard, Marc] Univ Laval, PROTEO Quebec Network Res Prot Struct Funct & Eng, Quebec City, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; Laval University	Beauregard, M (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Phys, Ctr Rech Mat Lignocellulos, Trois Rivieres, PQ GA9 5H7, Canada.	marc.beauregard@uqtr.ca			National Sciences and Engineering Research Council of Canada (NSERC); NSERC [138654]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	DMC was supported by a fellowship from the National Sciences and Engineering Research Council of Canada (NSERC) and a NSERC grant 138654 award to MB (www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; BENSON AD, 2013, ENBANK, P41, DOI DOI 10.1093/NAR/GKS1195; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Brown BM, 1999, P NATL ACAD SCI USA, V96, P1983, DOI 10.1073/pnas.96.5.1983; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Charbonneau DM, 2010, J BIOCHEM, V148, P299, DOI 10.1093/jb/mvq064; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dadarlat VM, 2008, J PHYS CHEM B, V112, P6159, DOI 10.1021/jp077024d; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kitaura S, 2001, J BIOCHEM-TOKYO, V129, P397, DOI 10.1093/oxfordjournals.jbchem.a002870; Knochel T, 2002, J BIOL CHEM, V277, P8626, DOI 10.1074/jbc.M109517200; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; MULKERRIN MG, 1989, BIOCHEMISTRY-US, V28, P6556, DOI 10.1021/bi00442a005; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P6795, DOI 10.1021/bi9529317; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; Rao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060645; Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006; Reyes-Duarte D, 2005, ANGEW CHEM INT EDIT, V44, P7553, DOI 10.1002/anie.200502461; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer RT, 1996, FASEB J, V10, P42, DOI 10.1096/fasebj.10.1.8566546; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yennamalli RM, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-10	56	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76675	10.1371/journal.pone.0076675	http://dx.doi.org/10.1371/journal.pone.0076675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116134	gold, Green Published			2022-12-25	WOS:000325552200062
J	Selva, L; Benmessaoud, R; Lanaspa, M; Jroundi, I; Moraleda, C; Acacio, S; Inigo, M; Bastiani, A; Monsonis, M; Pallares, R; Bassat, Q; Munoz-Almagro, C				Selva, Laura; Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Acacio, Sozinho; Inigo, Melania; Bastiani, Alien; Monsonis, Manuel; Pallares, Roman; Bassat, Quique; Munoz-Almagro, Carmen			Detection of Streptococcus pneumoniae and Haemophilus influenzae Type B by Real-Time PCR from Dried Blood Spot Samples among Children with Pneumonia: A Useful Approach for Developing Countries	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; CONJUGATE VACCINE; STRAINS; DISEASE; IMPACT	Background: Dried blood spot (DBS) is a reliable blood collection method for storing samples at room temperature and easily transporting them. We have previously validated a Real-Time PCR for detection of Streptococcus pneumoniae in DBS. The objective of this study was to apply this methodology for the diagnosis of S. pneumoniae and Haemophilus influenzae b (Hib) in DBS samples of children with pneumonia admitted to two hospitals in Mozambique and Morocco. Methods: Ply and wzg genes of S. pneumoniae and bexA gene of Hib, were used as targets of Real-Time PCR. 329 DBS samples of children hospitalized with clinical diagnosis of pneumonia were tested. Results: Real-Time PCR in DBS allowed for a significant increase in microbiological diagnosis of S. pneumoniae and Hib. When performing blood bacterial culture, only ten isolates of S. pneumoniae and none of Hib were detected (3.0% positivity rate, IC95% 1.4-5.5%). Real-Time PCR from DBS samples increased the detection yield by 4x fold, as 30 S. pneumoniae and 11 Hib cases were detected (12.4% positivity rate, IC95% 9.0-16.5%; P< 0.001). Conclusion: Real-Time PCR applied in DBS may be a valuable tool for improving diagnosis and surveillance of pneumonia caused by S. pneumoniae or Hib in developing countries.	[Selva, Laura; Inigo, Melania; Bastiani, Alien; Monsonis, Manuel; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Barcelona, Spain; [Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Bassat, Quique] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Lanaspa, Miguel; Acacio, Sozinho; Bassat, Quique] CISM, Maputo, Mozambique; [Benmessaoud, Rachid; Moraleda, Cinta] Fdn Clin Recerca Biomed, Rabat, Morocco; [Jroundi, Imane] Minist Sante, INAS, Rabat, Morocco; [Pallares, Roman] Bellvitge Hosp, Idibell, Ciberes, Barcelona, Spain; [Pallares, Roman] Univ Barcelona, Barcelona, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Munoz-Almagro, C (corresponding author), Univ Hosp St Joan de Deu, Barcelona, Spain.	cma@hsjdbcn.org	PALLARES, Roman/B-5710-2008; Munoz-Almagro, Carmen/B-4308-2015; Bassat, Quique/P-2341-2016; Lanaspa, Miguel/AAO-4971-2020; Muñoz-Almagro, Carmen/N-7248-2015	PALLARES, Roman/0000-0003-3262-8508; Munoz-Almagro, Carmen/0000-0001-5586-404X; Bassat, Quique/0000-0003-0875-7596; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Moraleda, Cinta/0000-0002-8335-903X; Lanaspa, Miguel/0000-0002-9310-177X	Fondo de Investigaciones Sanitarias [PI10/02058]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR00136, FI-ICIP 2012]; Fundacio Sant Joan de Deu	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacio Sant Joan de Deu	This work was supported in part by Fondo de Investigaciones Sanitarias [PI10/02058 and a Research Grant to QB], Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR00136 and FI-ICIP 2012 to LS] and Fundacio Sant Joan de Deu [Research Grant to LS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydogan H, 2006, MICROBIOL RES, V161, P55, DOI 10.1016/j.micres.2005.06.004; Benninger MS, 2010, CURR ALLERGY ASTHM R, V10, P411, DOI 10.1007/s11882-010-0139-6; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Braikat M, 2012, VACCINE, V30, P2594, DOI 10.1016/j.vaccine.2012.01.041; Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; de Almeida AECC, 2005, BRAZ J MED BIOL RES, V38, P777, DOI 10.1590/S0100-879X2005000500016; De Crignis E, 2010, J VIROL METHODS, V165, P51, DOI 10.1016/j.jviromet.2009.12.017; Diez-Padrisa N, 2012, TROP MED INT HEALTH, V17, P1100, DOI 10.1111/j.1365-3156.2012.03035.x; El Mdaghri N., 2012, Eastern Mediterranean Health Journal, V18, P1097; Gessner BD, 2009, EXPERT REV VACCINES, V8, P91, DOI 10.1586/14760584.8.1.91; Hernandez-Bou S, 2009, PEDIATR PULM, V44, P1192, DOI 10.1002/ppul.21114; Ladhani SN, 2012, CLIN THER, V34, P385, DOI 10.1016/j.clinthera.2011.11.027; Lakshmi V, 2011, INDIAN J MICROBIOL, V51, P147, DOI 10.1007/s12088-011-0135-0; Munoz-Almagro C, 2011, EUR J CLIN MICROBIOL, V30, P327, DOI 10.1007/s10096-010-1086-9; Roca A, 2008, TROP MED INT HEALTH, V13, P818, DOI 10.1111/j.1365-3156.2008.02061.x; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Selva L, 2011, EMERG INFECT DIS, V17, P1125, DOI [10.3201/eid1706.100997, 10.3201/eid/1706.100997]; Siberry G, 2001, B WORLD HEALTH ORGAN, V79, P43; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; UNICEF/WHO, 2006, NEUM FORG KILL CHILD; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Wasas AD, 1999, J CLIN MICROBIOL, V37, P2045, DOI 10.1128/JCM.37.6.2045-2046.1999; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; World Health Organization (WHO), 1991, LANCET, V338, P1453, DOI [10.1016/0140-6736(91)92751-M, DOI 10.1016/0140-6736(91)92751-M.PUBMED:1683434]; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76970	10.1371/journal.pone.0076970	http://dx.doi.org/10.1371/journal.pone.0076970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116190	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200090
J	Ko, JY; Kim, YD; Hong, YJ; Lee, HJ; Hur, J; Choi, BW; Heo, JH; Kim, YJ				Ko, Ji Young; Kim, Young Dae; Hong, Yoo Jin; Lee, Hye-Jeong; Hur, Jin; Choi, Byoung Wook; Heo, Ji Hoe; Kim, Young Jin			Lack of Association between Stroke and Left Atrial Out-Pouching Structures: Results of a Case-Control Study	PLOS ONE			English	Article							CORONARY CT ANGIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RADIOFREQUENCY ABLATION; ACCESSORY APPENDAGES; MULTIDETECTOR CT; CARDIAC CT; DIVERTICULUM; FIBRILLATION; THROMBUS	Background and Purpose: Clinical significance of out-pouching structures of the left atrium (LA) as potential embolic sources remains unclear. We sought to evaluate the association between stroke and LA out-pouching structures. Methods: A case-control study was conducted to assess the prevalence of LA out-pouching structures in subjects with and without stroke. Case subjects were 270 stroke patients who had undergone cardiac CT. Control subjects were 270 age-and sex-matched patients without a history of stroke and who had undergone cardiac CT. Presence of LA out-pouching structures was determined by ECG-gated cardiac CT. The location of out-pouching structures was categorized as near Bachmann bundle, anterior, inferoseptal, inferior, and lateral. The prevalence, number and location of out-pouching structures and clinical characteristics were compared between the two groups. Results: One hundred sixty eight out-pouching structures were identified in 139 stroke patients (51%), while a total of 169 out-pouching structures were found in 155 control patients (57%) (p=0.1949). The prevalence of LA out-pouching structures with different locations was not significantly different between the stroke group and control group. In the stroke group, the prevalence of out-pouching structures was not significantly different by subtypes of ischemic stroke and the prevalence of LA out-pouching structures was not different between patients with atrial fibrillation (AF) and without AF. Conclusion: The left atrial out-pouching structures are commonly seen in a population with and without stroke with similar prevalence. Our study suggests that LA out-pouching structures are not significant risk factors of stroke.	[Ko, Ji Young; Hong, Yoo Jin; Lee, Hye-Jeong; Hur, Jin; Choi, Byoung Wook; Kim, Young Jin] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea; [Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Dept Neurol, Severance Hosp, Seoul, South Korea; [Choi, Byoung Wook] Yonsei Univ, Coll Med, Div Cardiovasc Radiol, Severance Cardiovasc Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol,Severance Hosp, Seoul, South Korea.	dryj@yuhs.ac		Choi, Byoung Wook/0000-0002-8873-5444; Hur, Jin/0000-0002-8651-6571; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Young Jin/0000-0002-6235-6550; Lee, Hye-Jeong/0000-0003-4349-9174; Hong, Yoojin/0000-0002-7276-0944; Kim, Young Dae/0000-0001-5750-2616				Abbara S, 2009, AM J ROENTGENOL, V193, P807, DOI 10.2214/AJR.08.2229; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Balli O, 2012, EUR J RADIOL, V81, pE37, DOI 10.1016/j.ejrad.2010.11.017; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Duerinckx AJ, 2008, INT J CARDIOVAS IMAG, V24, P215, DOI 10.1007/s10554-007-9240-x; Hur J, 2011, STROKE, V42, P2471, DOI 10.1161/STROKEAHA.110.611293; Hur J, 2009, STROKE, V40, P2073, DOI 10.1161/STROKEAHA.108.537928; Killeen RP, 2010, INT J CARDIOVAS IMAG, V26, P241, DOI 10.1007/s10554-009-9511-9; Killeen RP, 2009, CIRCULATION, V120, pE60, DOI 10.1161/CIRCULATIONAHA.109.855569; Kim HY, 2012, INT J CARDIOVAS IMAG, V28, P101, DOI 10.1007/s10554-012-0142-1; Kim YJ, 2009, RADIOLOGY, V250, P61, DOI 10.1148/radiol.2501080559; Lazoura O, 2012, J CARDIOVASC COMPUT, V6, P268, DOI 10.1016/j.jcct.2012.02.004; Lee BI, 2001, CEREBROVASC DIS, V12, P145, DOI 10.1159/000047697; Lee WJ, 2008, CIRCULATION, V117, P1351, DOI 10.1161/CIRCULATIONAHA.107.744706; McGuinness J, 2007, J THORAC CARDIOV SUR, V133, P820, DOI 10.1016/j.jtcvs.2006.09.084; Nagai T, 2011, CIRCULATION, V124, P1086, DOI 10.1161/CIRCULATIONAHA.110.000315; Naqvi TZ, 2004, J AM SOC ECHOCARDIOG, V17, P1077, DOI 10.1016/j.echo.2004.05.008; Peng LQ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P345, DOI 10.1161/CIRCEP.111.965665; SRINIVASAN V, 1980, CARDIOVASC DIS, V7, P405; Troupis J, 2012, INT J CARDIOVAS IMAG, V28, P375, DOI 10.1007/s10554-011-9815-4; Wan YD, 2009, SURG RADIOL ANAT, V31, P191, DOI 10.1007/s00276-008-0427-1	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76617	10.1371/journal.pone.0076617	http://dx.doi.org/10.1371/journal.pone.0076617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116128	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300074
J	Lennon, JT; Hamilton, SK; Muscarella, ME; Grandy, AS; Wickings, K; Jones, SE				Lennon, Jay T.; Hamilton, Stephen K.; Muscarella, Mario E.; Grandy, A. Stuart; Wickings, Kyle; Jones, Stuart E.			A Source of Terrestrial Organic Carbon to Investigate the Browning of Aquatic Ecosystems	PLOS ONE			English	Article							LAKE FOOD WEBS; FLUORESCENCE SPECTROSCOPY; HUMIC MATERIALS; MATTER; WATER; POTASSIUM; PHOSPHORUS; SUBSIDIES; DAPHNIA; GROWTH	There is growing evidence that terrestrial ecosystems are exporting more dissolved organic carbon (DOC) to aquatic ecosystems than they did just a few decades ago. This "browning" phenomenon will alter the chemistry, physics, and biology of inland water bodies in complex and difficult-to-predict ways. Experiments provide an opportunity to elucidate how browning will affect the stability and functioning of aquatic ecosystems. However, it is challenging to obtain sources of DOC that can be used for manipulations at ecologically relevant scales. In this study, we evaluated a commercially available source of humic substances ("Super Hume") as an analog for natural sources of terrestrial DOC. Based on chemical characterizations, comparative surveys, and whole-ecosystem manipulations, we found that the physical and chemical properties of Super Hume are similar to those of natural DOC in aquatic and terrestrial ecosystems. For example, Super Hume attenuated solar radiation in ways that will not only influence the physiology of aquatic taxa but also the metabolism of entire ecosystems. Based on its chemical properties (high lignin content, high quinone content, and low C:N and C: P ratios), Super Hume is a fairly recalcitrant, low-quality resource for aquatic consumers. Nevertheless, we demonstrate that Super Hume can subsidize aquatic food webs through 1) the uptake of dissolved organic constituents by microorganisms, and 2) the consumption of particulate fractions by larger organisms (i.e., Daphnia). After discussing some of the caveats of Super Hume, we conclude that commercial sources of humic substances can be used to help address pressing ecological questions concerning the increased export of terrestrial DOC to aquatic ecosystems.	[Lennon, Jay T.; Muscarella, Mario E.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Hamilton, Stephen K.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Hamilton, Stephen K.] Michigan State Univ, Dept Zool, Hickory Corners, MI USA; [Grandy, A. Stuart] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Wickings, Kyle] Cornell Univ, Dept Entomol, Geneva, NY USA; [Jones, Stuart E.] Univ Notre Dame, Dept Biol Sci, South Bend, IN USA	Indiana University System; Indiana University Bloomington; Michigan State University; Michigan State University; University System Of New Hampshire; University of New Hampshire; Cornell University; University of Notre Dame	Lennon, JT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lennonj@indiana.edu	Hamilton, Stephen K/N-2979-2014; Jones, Stuart/ABD-5264-2021; Muscarella, Mario E/G-7595-2017; Lennon, Jay T./ABE-6120-2020	Hamilton, Stephen K/0000-0002-4702-9017; Jones, Stuart/0000-0003-4740-6721; Muscarella, Mario E/0000-0001-6183-6037; Lennon, Jay T./0000-0003-3126-6111	National Science Foundation [DEB-0842441, DEB-0743402]; Center for Water Sciences at Michigan State University; Huron Mountains Wildlife Foundation	National Science Foundation(National Science Foundation (NSF)); Center for Water Sciences at Michigan State University; Huron Mountains Wildlife Foundation	This research was supported with funding from the National Science Foundation (DEB-0842441 to JTL an SEJ and DEB-0743402 to SKH and JTL), the Center for Water Sciences at Michigan State University, and the Huron Mountains Wildlife Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; APHA, 2005, STANDARD METHODS EXA, V21st; Arvola L, 1996, CAN J FISH AQUAT SCI, V53, P1646, DOI 10.1139/cjfas-53-7-1646; Ask J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003951; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Briand E, 2004, LIMNOL OCEANOGR-METH, V2, P406, DOI 10.4319/lom.2004.2.406; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; CARPENTER SR, 1990, ECOLOGY, V71, P2038, DOI 10.2307/1938617; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Christensen DL, 1996, LIMNOL OCEANOGR, V41, P553, DOI 10.4319/lo.1996.41.3.0553; Civitello DJ, 2013, ECOLOGY, V94, P380, DOI 10.1890/12-0883.1; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Curtis PJ, 1997, BIOGEOCHEMISTRY, V36, P125, DOI 10.1023/A:1005787913638; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Evans C, 2008, BIOGEOCHEMISTRY, V91, P13, DOI 10.1007/s10533-008-9256-x; Fellman JB, 2009, ENVIRON SCI TECHNOL, V43, P6228, DOI 10.1021/es900143g; Findlay SEG, 2005, FRONT ECOL ENVIRON, V3, P133, DOI 10.1890/1540-9295(2005)003[0133:ICTITH]2.0.CO;2; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Geddes P, 2009, HYDROBIOLOGIA, V628, P47, DOI 10.1007/s10750-009-9745-5; Grandy AS, 2009, GEODERMA, V150, P278, DOI 10.1016/j.geoderma.2009.02.007; GRASSO D, 1990, CHEMOSPHERE, V21, P1181, DOI 10.1016/0045-6535(90)90139-K; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hamilton SK, 2001, BIOGEOCHEMISTRY, V54, P297, DOI 10.1023/A:1010635524108; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; Hamilton SK, 2009, CAN J FISH AQUAT SCI, V66, P343, DOI 10.1139/F09-003; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hood E, 2005, BIOGEOCHEMISTRY, V74, P231, DOI 10.1007/s10533-004-4322-5; Jaworski GHM, 2003, FRESHWATER BIOL, V48, P833, DOI 10.1046/j.1365-2427.2003.01051.x; JONES RI, 1988, FRESHWATER BIOL, V19, P357, DOI 10.1111/j.1365-2427.1988.tb00357.x; Jones SE, TIPPING POI IN PRESS; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; KASPRZAK P, 1993, PROC INT ASSOC THEOR, V25, P652; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kirchman D. L., 1993, HDB METHODS AQUATIC, P509, DOI [10.1201/9780203752746, DOI 10.1201/9780203752746]; Klug JL, 2005, CAN J FISH AQUAT SCI, V62, P472, DOI 10.1139/F04-229; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P646, DOI 10.4319/lo.1976.21.5.0646; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Lennon JT, 2008, ECOLOGY, V89, P1001, DOI 10.1890/07-1380.1; Lennon JT, 2006, LIMNOL OCEANOGR, V51, P1602, DOI 10.4319/lo.2006.51.4.1602; Lennon JT, 2004, OECOLOGIA, V138, P584, DOI 10.1007/s00442-003-1459-1; Lennon JT, 2001, J PLANKTON RES, V23, P425, DOI 10.1093/plankt/23.4.425; MALCOLM RL, 1986, ENVIRON SCI TECHNOL, V20, P904, DOI 10.1021/es00151a009; Maranger RJ, 2003, AQUATIC ECOSYSTEMS I, P26; McCallister SL, 2004, LIMNOL OCEANOGR, V49, P1687, DOI 10.4319/lo.2004.49.5.1687; McKnight DM, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000269; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mulholland PJ, 2003, AQUATIC ECOSYSTEMS I, P26; Neter J., 1996, APPL LINEAR STAT MOD; NIELSEN MV, 1989, LIMNOL OCEANOGR, V34, P1311, DOI 10.4319/lo.1989.34.7.1311; Oksanen J., 2017, R PACKAGE VERSION 26; Ozdoba DM, 2001, ROY SOC CH, P309, DOI 10.1039/9781847551085-00309; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Parn J, 2012, BIOGEOCHEMISTRY, V108, P351, DOI 10.1007/s10533-011-9604-0; Parker DL, 1997, APPL ENVIRON MICROB, V63, P2324, DOI 10.1128/AEM.63.6.2324-2329.1997; Quilty JR, 2011, SOIL RES, V49, P1, DOI 10.1071/SR10059; RICHEY JE, 1978, SCIENCE, V202, P1183, DOI 10.1126/science.202.4373.1183; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; Sandgren C.D., 1988, P9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stanley EH, 2012, FRESHWATER BIOL, V57, P26, DOI 10.1111/j.1365-2427.2011.02613.x; Steiner CF, 2003, ECOLOGY, V84, P982, DOI 10.1890/0012-9658(2003)084[0982:VDIPCA]2.0.CO;2; STEMBERGER RS, 1981, CAN J FISH AQUAT SCI, V38, P721, DOI 10.1139/f81-095; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Stomp M, 2007, ISME J, V1, P271, DOI 10.1038/ismej.2007.59; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Talling J. F., 2010, Freshwater Reviews, V3, P97, DOI 10.1608/FRJ-3.2.1; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tranvik LJ, 2009, ENCY INLAND WATERS, P754; Vinebrooke RD, 1998, LIMNOL OCEANOGR, V43, P1065, DOI 10.4319/lo.1998.43.6.1065; von Wachenfeldt E, 2009, LIMNOL OCEANOGR, V54, P1811, DOI 10.4319/lo.2009.54.5.1811; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Wetzel R.G., 2000, LIMNOLOGICAL ANAL	88	27	27	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75771	10.1371/journal.pone.0075771	http://dx.doi.org/10.1371/journal.pone.0075771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124511	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100068
J	Markosyan, RM; Cohen, FS				Markosyan, Ruben M.; Cohen, Fredric S.			The Transmembrane Domain and Acidic Lipid Flip-Flop Regulates Voltage-Dependent Fusion Mediated by Class II and III Viral Proteins	PLOS ONE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; MEMBRANE-FUSION; CELL-LINE; CYTOPLASMIC DOMAINS; HEMIFUSION; ENTRY; ACTIVATION; RECEPTOR; SUPPORT; PEPTIDE	Voltage dependence of fusion induced by class II and class III viral fusion proteins was investigated. Class II proteins from Ross River and Sindbus virus and a mutant class III protein from Epstein Barr virus were found to induce cell-cell fusion that is voltage dependent. Combined with previous studies, in all, four class II and two class III protein have now been shown to exhibit voltage-dependent fusion, demonstrating that this is probably a general phenomenon for these two classes of viral fusion proteins. In the present study, monitoring fusion of pseudovirus expressing Vesicular Stomatitis virus (VSV) G within endosomes shows that here, too, fusion is voltage dependent. This supports the claim that voltage dependence of fusion is biologically relevant and that cell-cell fusion reliably models the voltage dependence. Fusion induced by class I viral proteins is independent of voltage; chimeras expressing the ectodomain of a class I fusion protein and the transmembrane domain of VSV G could therefore be used to explore the location within the protein responsible for voltage dependence. Results showed that the transmembrane domain is the region associated with voltage dependence. Experiments in which cells were enriched with acidic lipids led to the conclusion that it is the flip-flop of acidic lipids that carries the charge responsible for the observed voltage dependence of fusion. This flip-flop occurred downstream of hemifusion, in accord with previous findings that the voltage dependent steps of fusion occur at a stage subsequent to hemifusion.	[Markosyan, Ruben M.; Cohen, Fredric S.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	Cohen, FS (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	Fredric_Cohen@rush.edu			National Institutes of Health [R01 GM066837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101539, R01GM066837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding by: National Institutes of Health R01 GM066837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; DeMartini JC, 2001, J VIROL, V75, P4239, DOI 10.1128/JVI.75.9.4239-4246.2001; DOMS RW, 1985, J BIOL CHEM, V260, P2973; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Gibbons DL, 2004, J VIROL, V78, P3312, DOI 10.1128/JVI.78.7.3312-3318.2004; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; JONAK ZL, 1993, AIDS RES HUM RETROV, V9, P23, DOI 10.1089/aid.1993.9.23; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Kunzelmann K, 2013, PFLUGERS ARCH; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359; Lin G, 2003, J VIROL, V77, P931, DOI 10.1128/JVI.77.2.931-942.2003; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Markosyan RM, 2007, J VIROL, V81, P11218, DOI 10.1128/JVI.01256-07; Markosyan RM, 2010, MOL BIOL CELL, V21, P2001, DOI 10.1091/mbc.E09-10-0904; Markovic I, 2001, J CELL BIOL, V155, P833, DOI 10.1083/jcb.200103005; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Odell D, 1997, J VIROL, V71, P7996, DOI 10.1128/JVI.71.10.7996-8000.1997; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Roth SL, 2011, FEBS LETT, V585, P865, DOI 10.1016/j.febslet.2011.02.015; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; SchrothDiez B, 1998, J VIROL, V72, P133, DOI 10.1128/JVI.72.1.133-141.1998; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wilk T, 1996, VIROLOGY, V218, P269, DOI 10.1006/viro.1996.0190; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	45	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76174	10.1371/journal.pone.0076174	http://dx.doi.org/10.1371/journal.pone.0076174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124539	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100096
J	Sung, KE; Su, XJ; Berthier, E; Pehlke, C; Friedl, A; Beebe, DJ				Sung, Kyung Eun; Su, Xiaojing; Berthier, Erwin; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.			Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MICROFLUIDIC DEVICES; TUMOR-GROWTH; CELL-INTERACTIONS; MAMMARY-GLAND; MATRIX; COLLAGEN; MICROENVIRONMENTS; PROGRESSION; BIOLOGY	The utilization of 3D, physiologically relevant in vitro cancer models to investigate complex interactions between tumor and stroma has been increasing. Prior work has generally focused on the cancer cells and, the role of fibroblast culture conditions on tumor-stromal cell interactions is still largely unknown. Here, we focus on the stroma by comparing functional behaviors of human mammary fibroblasts (HMFs) cultured in 2D and 3D and their effects on the invasive progression of breast cancer cells (MCF10DCIS.com). We identified increased levels of several paracrine factors from HMFs cultured in 3D conditions that drive the invasive transition. Using a microscale co-culture model with improved compartmentalization and sensitivity, we demonstrated that HMFs cultured in 3D intensify the promotion of the invasive progression through the HGF/c-Met interaction. This study highlights the importance of the 3D stromal microenvironment in the development of multiple cell type in vitro cancer models.	[Sung, Kyung Eun; Su, Xiaojing; Pehlke, Carolyn; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Berthier, Erwin] Univ Wisconsin, Dept Med Microbiol, Madison, WI USA; [Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Sung, Kyung Eun; Su, Xiaojing; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Sung, Kyung Eun; Pehlke, Carolyn; Friedl, Andreas; Beebe, David J.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Beebe, DJ (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	djbeebe@wisc.edu		Sung, Kyung/0000-0001-9664-6399; Berthier, Erwin/0000-0002-4421-9034	National Institutes of Health [K25-CA104162, R01CA107012, 1R33CA137673-01, R01EB010039BRG]; National Science Foundation [EFRI-1136903]; Wisconsin Partnership Program; DARPA Micro/nano Fluidics Fundamentals Focus Center; Department of Defense breast cancer research grant [DOD BCRP W81XWH-10-BCRP-CA]; Korea Research Foundation [KRF-2008-220-D00133]; NLM training grant [NLM 5T15LM007359]; NATIONAL CANCER INSTITUTE [R33CA137673, K25CA104162, R01CA107012] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wisconsin Partnership Program; DARPA Micro/nano Fluidics Fundamentals Focus Center; Department of Defense breast cancer research grant(United States Department of Defense); Korea Research Foundation(National Research Foundation of Korea); NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by National Institutes of Health grants (K25-CA104162, R01CA107012, 1R33CA137673-01, and R01EB010039BRG), National Science Foundation award (EFRI-1136903), the Wisconsin Partnership Program, the DARPA Micro/nano Fluidics Fundamentals Focus Center, the Department of Defense breast cancer research grant (DOD BCRP W81XWH-10-BCRP-CA), the Korea Research Foundation grant (KRF-2008-220-D00133), and NLM training grant (NLM 5T15LM007359). D.J. Beebe has equity in Bellbrook Labs which has licensed technology reported in this manuscript. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Berthier E, 2008, LAB CHIP, V8, P860, DOI 10.1039/b717423c; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blobel CP, 2010, BLOOD, V115, P5128, DOI 10.1182/blood-2010-03-275271; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dawson PJ, 1996, AM J PATHOL, V148, P313; Domenech M, 2009, INTEGR BIOL-UK, V1, P267, DOI 10.1039/b823059e; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Elliott BE, 2002, CAN J PHYSIOL PHARM, V80, P91, DOI 10.1139/y02-010; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Espina V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010240; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Gao CF, 2009, MOL CANCER THER, V8, P2803, DOI 10.1158/1535-7163.MCT-09-0125; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Goda S, 2006, AM J PATHOL, V169, P445, DOI 10.2353/ajpath.2006.050676; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grinnell F, 2008, J BODYW MOV THER, V12, P191, DOI 10.1016/j.jbmt.2008.03.005; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Han X, 2008, OPT EXPRESS, V16, P1846, DOI 10.1364/OE.16.001846; Haslam SZ, 2003, BREAST CANCER RES, V5, P208, DOI 10.1186/bcr615; Hompland T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983664; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Montanez-Sauri SI, 2013, INTEGR BIOL-UK, V5, P631, DOI 10.1039/c3ib20225a; Montanez-Sauri SI, 2011, JALA-J LAB AUTOM, V16, P171, DOI 10.1016/j.jala.2011.02.003; Morales J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-462; Nakamura T, 1997, CANCER RES, V57, P3305; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Puccinelli JP, 2010, JALA-J LAB AUTOM, V15, P25, DOI 10.1016/j.jala.2009.10.002; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Sharma M, 2010, BREAST CANCER RES TR, V123, P397, DOI 10.1007/s10549-009-0654-0; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Yang WT, 2010, BREAST CANCER RES TR, V119, P305, DOI 10.1007/s10549-009-0350-0; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zhao XS, 2008, CANCER RES, V68, P467, DOI 10.1158/0008-5472.CAN-07-0782; Zhuo SM, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088029	62	110	113	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76373	10.1371/journal.pone.0076373	http://dx.doi.org/10.1371/journal.pone.0076373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124550	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100107
J	Zulueta, A; Caretti, A; Signorelli, P; Dall'Olio, F; Trinchera, M				Zulueta, Aida; Caretti, Anna; Signorelli, Paola; Dall'Olio, Fabio; Trinchera, Marco			Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements	FASEB JOURNAL			English	Article						hepatocyte nuclear factor 1; colon cancer; type 1 chain carbohydrates; transposon	SIALYL-LEWIS-X; DNA METHYLATION; BETA-1,3-GALACTOSYLTRANSFERASE BETA-3GAL-T5; CELL-ADHESION; CANCER; EXPRESSION; ANTIGEN; ENHANCERS; CHAIN; CDX2	We focused on transcription factors and epigenetic marks that regulate the B3GALT5 gene through its retroviral long terminal repeat (LTR) promoter. We compared the expression levels of the B3GALT5 LTR transcript, quantitated by competitive RT-PCR, with those of the candidate transcription factors HNF1/ and Cdx1/2, determined by Western blot analysis, in colon cancer biopsies, various cell lines, and cell models serving as controls. We found that HNF1/ were easily detected, irrespective of the amount of LTR transcript expressed by the source, whereas Cdx1/2 were undetectable, and no sample lacking HNF1/ expressed the LTR transcript. On transfection in proper host cells, both HNF1 and HNF1 provided detectable LTR transcript, whereas shRNA-mediated silencing of HNF1 impaired transcription. Treating cells with 5-aza-2-deoxycytidine (5AZA) strongly reduced expression, without affecting HNF1/, despite the lack of CpG islands in the LTR and proximal sequences. By electrophoresis mobility shift and luciferase reporter assays, the LTR promoter binding and activity did not correlate with the amounts of LTR transcript expressed in the cells and depended on the levels of the transcription factors. We conclude that HNF1/ are necessary but insufficient to activate and regulate B3GALT5 LTR transcription, which depends on unknown regulatory elements that are active when methylated and located outside of and far from the LTR promoter.Zulueta, A., Caretti, A., Signorelli, P., Dall'Olio, F., Trinchera, M. Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements.	[Zulueta, Aida; Caretti, Anna; Signorelli, Paola] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Milan, Italy; [Dall'Olio, Fabio] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Trinchera, Marco] Univ Insubria, Dept Med Clin & Expt DMCS, I-21100 Varese, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; University of Bologna; University of Insubria	Trinchera, M (corresponding author), Univ Insubria, Via JH Dunant 5, I-21100 Varese, Italy.	marco.trinchera@uninsubria.it	CARETTI, ANNA/L-3557-2019; Caretti, Anna/O-8958-2017; Zulueta, Aida/AHH-9389-2022	CARETTI, ANNA/0000-0001-6140-6969; Caretti, Anna/0000-0001-6140-6969; Zulueta, Aida/0000-0001-8295-6847; signorelli, paola/0000-0003-2368-2393	Ph.D. Program in Molecular Medicine of the University of Milan	Ph.D. Program in Molecular Medicine of the University of Milan	A.Z. was supported by the Ph.D. Program in Molecular Medicine of the University of Milan.	Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Aran D, 2013, CELL, V154, P11, DOI 10.1016/j.cell.2013.06.018; Caretti A, 2012, INT J BIOCHEM CELL B, V44, P84, DOI 10.1016/j.biocel.2011.09.010; Caretti A, 2010, CELL PHYSIOL BIOCHEM, V26, P831, DOI 10.1159/000323992; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Duffy MJ, 2010, ANN ONCOL, V21, P441, DOI 10.1093/annonc/mdp332; Dunn CA, 2005, GENE, V364, P2, DOI 10.1016/j.gene.2005.05.045; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Isshiki S, 2003, J BIOL CHEM, V278, P36611, DOI 10.1074/jbc.M302681200; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; Kulis M, 2013, BIOCH BIOPHYS ACTA; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Mare L, 2004, EUR J BIOCHEM, V271, P186, DOI 10.1046/j.1432-1033.2003.03919.x; Mare L, 2007, J BIOL CHEM, V282, P49, DOI 10.1074/jbc.M606666200; Mare L, 2013, INT J BIOCHEM CELL B, V45, P792, DOI 10.1016/j.biocel.2013.01.004; Pilozzi E, 2004, J PATHOL, V204, P289, DOI 10.1002/path.1641; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Trinchera M, 2011, INT J BIOCHEM CELL B, V43, P130, DOI 10.1016/j.biocel.2010.10.004; Wicking C, 1998, ONCOGENE, V17, P657, DOI 10.1038/sj.onc.1201971; WU GD, 1994, J BIOL CHEM, V269, P17080	32	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					946	955		10.1096/fj.13-236273	http://dx.doi.org/10.1096/fj.13-236273			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24128890	Green Submitted			2022-12-25	WOS:000331072200039
J	Bharathi, SS; Zhang, YX; Mohsen, AW; Uppala, R; Balasubramani, M; Schreiber, E; Uechi, G; Beck, ME; Rardin, MJ; Vockley, J; Verdin, E; Gibson, BW; Hirschey, MD; Goetzman, ES				Bharathi, Sivakama S.; Zhang, Yuxun; Mohsen, Al-Walid; Uppala, Radha; Balasubramani, Manimalha; Schreiber, Emanuel; Uechi, Guy; Beck, Megan E.; Rardin, Matthew J.; Vockley, Jerry; Verdin, Eric; Gibson, Bradford W.; Hirschey, Matthew D.; Goetzman, Eric S.			Sirtuin 3 (SIRT3) Protein Regulates Long-chain Acyl-CoA Dehydrogenase by Deacetylating Conserved Lysines Near the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Transfer; Enzyme Catalysis; FAD; Fatty Acid Oxidation; Mitochondria; Posttranslational Modification; Sirtuins; Acyl-CoA Dehydrogenase; Lysine Acetylation	CALORIE RESTRICTION; ACETYLATION; METABOLISM; PROTEOMICS; ACETYLOME; MECHANISM; OXIDATION; ACYLATION; ENZYMES; PLAYS	Long-chain acyl-CoA dehydrogenase (LCAD) is a key mitochondrial fatty acid oxidation enzyme. We previously demonstrated increased LCAD lysine acetylation in SIRT3 knockout mice concomitant with reduced LCAD activity and reduced fatty acid oxidation. To study the effects of acetylation on LCAD and determine sirtuin 3 (SIRT3) target sites, we chemically acetylated recombinant LCAD. Acetylation impeded substrate binding and reduced catalytic efficiency. Deacetylation with recombinant SIRT3 partially restored activity. Residues Lys-318 and Lys-322 were identified as SIRT3-targeted lysines. Arginine substitutions at Lys-318 and Lys-322 prevented the acetylation-induced activity loss. Lys-318 and Lys-322 flank residues Arg-317 and Phe-320, which are conserved among all acyl-CoA dehydrogenases and coordinate the enzyme-bound FAD cofactor in the active site. We propose that acetylation at Lys-318/Lys-322 causes a conformational change which reduces hydride transfer from substrate to FAD. Medium-chain acyl-CoA dehydrogenase and acyl-CoA dehydrogenase 9, two related enzymes with lysines at positions equivalent to Lys-318/Lys-322, were also efficiently deacetylated by SIRT3 following chemical acetylation. These results suggest that acetylation/deacetylation at Lys-318/Lys-322 is a mode of regulating fatty acid oxidation. The same mechanism may regulate other acyl-CoA dehydrogenases.	[Bharathi, Sivakama S.; Zhang, Yuxun; Mohsen, Al-Walid; Uppala, Radha; Vockley, Jerry; Goetzman, Eric S.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Balasubramani, Manimalha; Schreiber, Emanuel; Uechi, Guy] Univ Pittsburgh, Genom & Prote Core Facil, Pittsburgh, PA 15224 USA; [Beck, Megan E.; Vockley, Jerry; Goetzman, Eric S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15224 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Verdin, Eric] Gladstone Inst, San Francisco, CA 94158 USA; [Verdin, Eric] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University	Goetzman, ES (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.	eric.goetzman@chp.edu	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016; Verdin, Eric/AAB-7999-2019; Mohsen, Al-Walid/D-6577-2018	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Mohsen, Al-Walid/0000-0002-0096-5959; Hirschey, Matthew/0000-0003-4541-5376; Verdin, Eric/0000-0003-3703-3183	National Institutes of Health [R01 DK090242, R03 DK88870]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R01DK078775, R03DK088870, P30DK026743, R01DK090242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health Grants R01 DK090242 and R03 DK88870. To whom correspondence should be addressed. E-mail: eric.goetzman@chp.edu.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Goetzman ES, 2009, OBESITY, V17, P196, DOI 10.1038/oby.2008.467; Goetzman ES, 2005, J BIOL CHEM, V280, P4873, DOI 10.1074/jbc.M412640200; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hirschey MD, 2009, METHOD ENZYMOL, V457, P137, DOI 10.1016/S0076-6879(09)05008-3; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kormanik K, 2012, MOL GENET METAB, V107, P684, DOI 10.1016/j.ymgme.2012.10.009; Landry J, 2003, METHODS, V31, P33, DOI 10.1016/S1046-2023(03)00085-9; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Volchenboum SL, 2001, MOL GENET METAB, V74, P226, DOI 10.1006/mgme.2001.3234; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511	38	121	127	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33837	33847		10.1074/jbc.M113.510354	http://dx.doi.org/10.1074/jbc.M113.510354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121500	Green Published, hybrid			2022-12-25	WOS:000327250200028
J	Huang, SB; Okamoto, K; Yu, CR; Sinicrope, FA				Huang, Shengbing; Okamoto, Koichi; Yu, Chunrong; Sinicrope, Frank A.			p62/Sequestosome-1 Up-regulation Promotes ABT-263-induced Caspase-8 Aggregation/Activation on the Autophagosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Bcl-2 Family Proteins; Cancer Therapy; Caspase; BH3 Mimetic; p62; Sequestosome 1	INDUCED CELL-DEATH; PANCREATIC-CANCER CELLS; INDUCED APOPTOSIS; TARGETING AUTOPHAGY; MIMETIC ABT-737; TUMOR-CELLS; ACTIVATION; PROTEIN; INHIBITION; DEGRADATION	Autophagy and apoptosis regulate cancer cell viability in response to cytotoxic stress; however, their functional relationship remains unclear. p62/sequestosome 1 is a multifunctional protein and a signaling hub that shuttles ubiquitinated proteins to the lysosome during autophagy. Autophagy inhibition up-regulates p62, and prior data suggest that p62 may mediate apoptosis. Here, we demonstrate that p62 can regulate a caspase-8-dependent apoptosis in response to the BH3 mimetic agent, ABT-263. Up-regulation of p62 was shown to enhance ABT-263-induced caspase-8 activation that was Bax-dependent and resulted from mitochondrial amplification. Dependence upon caspase-8 was confirmed using caspase-8-deficient cells and by caspase-8 siRNA. Ectopic wild-type p62, but not p62 mutants with loss of ability to promote apoptosis, was shown to co-localize with caspase-8 and to promote its self-aggregation in ABT-263-treated cells, shown using a bimolecular fluorescence complementation assay. Endogenous p62 co-localized with caspase-8 in the presence of ABT-263 plus an autophagy inhibitor. Caspase-8 was shown to interact and co-localize with the autophagosome marker, LC3II. Knockdown of p62 attenuated binding between caspase-8 and LC3II, whereas p62 overexpression enhanced the co-localization of caspase-8 aggregates with LC3. LC3 knockdown did not affect interaction between caspase-8 and p62, suggesting that p62 may facilitate caspase-8 translocation to the autophagosomal membrane. A direct activator of caspase-8, i.e., TRAIL, alone or combined with ABT-263, induced caspase-8 aggregation and co-localization with p62 that was associated with a synergistic drug interaction. Together, these results demonstrate that up-regulation of p62 can mediate apoptosis via caspase-8 in the setting of autophagy inhibition.	[Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Canc Ctr, Rochester, MN 55905 USA; [Yu, Chunrong] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute	Sinicrope, FA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol & Med Oncol, 200 1st St SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu			National Institutes of Health [K05CA142885, R01CA132991, R01CA113681]; Mayo Cancer Center [CA15083]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL CANCER INSTITUTE [K05CA142885, P30CA015083, R01CA113681, R01CA132991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Cancer Center; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K05CA142885, R01CA132991, and R01CA113681 (to F. A. S.). This work was also supported by Mayo Cancer Center Core Grant CA15083 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mutlu A, 2012, BRIT J HAEMATOL, V159, P565, DOI 10.1111/bjh.12066; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Periyasamy-Thandavan S, 2010, AUTOPHAGY, V6, P19, DOI 10.4161/auto.6.1.10323; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Williams J. A., 2012, PLOS ONE, V7; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104	44	79	80	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33654	33666		10.1074/jbc.M113.518134	http://dx.doi.org/10.1074/jbc.M113.518134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121507	Green Published, hybrid			2022-12-25	WOS:000327250200014
J	Kalleda, N; Naorem, A; Manchikatla, RV				Kalleda, Natarajaswamy; Naorem, Aruna; Manchikatla, Rajam V.			Targeting Fungal Genes by Diced siRNAs: A Rapid Tool to Decipher Gene Function in Aspergillus nidulans	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; DOUBLE-STRANDED-RNA; INSERTIONAL MUTAGENESIS; MAMMALIAN-CELLS; CANCER-THERAPY; EFFICIENT TOOL; INTERFERENCE; EXPRESSION; FUMIGATUS; MECHANISMS	Background: Gene silencing triggered by chemically synthesized small interfering RNAs (siRNAs) has become a powerful tool for deciphering gene function in many eukaryotes. However, prediction and validation of a single siRNA duplex specific to a target gene is often ineffective. RNA interference (RNAi) with synthetic siRNA suffers from lower silencing efficacy, off-target effects and is cost-intensive, especially for functional genomic studies. With the explosion of fungal genomic information, there is an increasing need to analyze gene function in a rapid manner. Therefore, studies were performed in order to investigate the efficacy of gene silencing induced by RNase III-diced-siRNAs (d-siRNA) in model filamentous fungus, Aspergillus nidulans. Methodology/Principal Findings: Stable expression of heterologous reporter gene in A. nidulans eases the examination of a new RNAi-induction route. Hence, we have optimized Agrobacterium tumefaciens-mediated transformation (AMT) of A. nidulans for stable expression of sGFP gene. This study demonstrates that the reporter GFP gene stably introduced into A. nidulans can be effectively silenced by treatment of GFP-d-siRNAs. We have shown the down-regulation of two endogenous genes, AnrasA and AnrasB of A. nidulans by d-siRNAs. We have also elucidated the function of an uncharacterized Ras homolog, rasB gene, which was found to be involved in hyphal growth and development. Further, silencing potency of d-siRNA was higher as compared to synthetic siRNA duplex, targeting AnrasA. Silencing was shown to be sequence-specific, since expression profiles of other closely related Ras family genes in d-siRNA treated AnrasA and AnrasB silenced lines exhibited no change in gene expression. Conclusions/Significance: We have developed and applied a fast, specific and efficient gene silencing approach for elucidating gene function in A. nidulans using d-siRNAs. We have also optimized an efficient AMT in A. nidulans, which is useful for stable integration of transgenes.	[Kalleda, Natarajaswamy; Naorem, Aruna; Manchikatla, Rajam V.] Univ Delhi South Campus, Dept Genet, New Delhi, India	University of Delhi	Manchikatla, RV (corresponding author), Univ Delhi South Campus, Dept Genet, New Delhi, India.	rajam.mv@gmail.com		Tripp, Ralph/0000-0002-2924-9956	Department of Science and Technology (DST), New Delhi, India [SR/SO/BB-29/2008]; Indian Council of Medical Research, New Delhi	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was funded by the Department of Science and Technology (DST) (Grant No: SR/SO/BB-29/2008), New Delhi, India. NK is grateful to the Indian Council of Medical Research, New Delhi for the award of a senior research fellowship. The authors are also indebted to the Department of Science and Technology for the FIST program and the University Grants Commission for the special assistance program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRATT RW, 1965, GENETICS, V52, P233; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; dos Santos ACC, 2009, FUNGAL GENET BIOL, V46, P825, DOI 10.1016/j.fgb.2009.06.012; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Costa AMSB, 2008, J MICROBIOL METH, V75, P205, DOI 10.1016/j.mimet.2008.06.006; de Jong JF, 2006, APPL ENVIRON MICROB, V72, P1267, DOI 10.1128/AEM.72.2.1267-1269.2006; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fitzgerald A, 2004, FUNGAL GENET BIOL, V41, P963, DOI 10.1016/j.fgb.2004.06.006; Fortwendel JR, 2005, EUKARYOT CELL, V4, P1982, DOI 10.1128/EC.4.12.1982-1989.2005; Fortwendel JR, 2004, FUNGAL GENET BIOL, V41, P129, DOI 10.1016/j.fgb.2003.10.004; Gomase VS, 2008, CURR DRUG METAB, V9, P241, DOI 10.2174/138920008783884777; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond TM, 2008, EUKARYOT CELL, V7, P339, DOI 10.1128/EC.00355-07; Hammond TM, 2005, GENETICS, V169, P607, DOI 10.1534/genetics.104.035964; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Henriet SSV, 2012, J INFECT DIS, V206, P1128, DOI 10.1093/infdis/jis473; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jochl C, 2009, RNA BIOL, V6, P179; Kadotani N, 2003, MOL PLANT MICROBE IN, V16, P769, DOI 10.1094/MPMI.2003.16.9.769; Khatri M, 2007, MED MYCOL, V45, P211, DOI 10.1080/13693780601158779; Kim VN, 2003, J KOREAN MED SCI, V18, P309, DOI 10.3346/jkms.2003.18.3.309; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Krappmann S, 2006, TRENDS MICROBIOL, V14, P356, DOI 10.1016/j.tim.2006.06.005; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Michielse CB, 2008, NAT PROTOC, V3, P1671, DOI 10.1038/nprot.2008.154; Morlighem JE, 2007, BIOTECHNIQUES, V42, P599, DOI 10.2144/000112444; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Osherov N, 2000, GENETICS, V155, P647; Osmani SA, 2004, FUNGAL GENET BIOL, V41, P401, DOI 10.1016/j.fgb.2003.11.009; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Sambrook J., 2002, MOL CLONING LAB MANU; Schumann U., 2010, FRONT BIOL, V5, P478, DOI DOI 10.1007/S11515-010-0550-3; Semizarov D, 2004, NUCLEIC ACIDS RES, V32, P3836, DOI 10.1093/nar/gkh714; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SOM T, 1994, MOL CELL BIOL, V14, P5333, DOI 10.1128/MCB.14.8.5333; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	55	31	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75443	10.1371/journal.pone.0075443	http://dx.doi.org/10.1371/journal.pone.0075443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130711	gold, Green Published			2022-12-25	WOS:000325814200012
J	da Gama, PAMD; Slama, H; Caspar, EA; Gevers, W; Cleeremans, A				da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel			Placebo-Suggestion Modulates Conflict Resolution in the Stroop Task	PLOS ONE			English	Article							HYPNOTIC SUGGESTION; IMAGINATIVE SUGGESTIBILITY; HYPNOSIS; VARIABILITY; EXPECTANCY; MEMORY; INTERFERENCE; EXPECTATIONS; EXPERIENCE; ANALGESIA	Here, we ask whether placebo-suggestion (without any form of hypnotic induction) can modulate the resolution of cognitive conflict. Nave participants performed a Stroop Task while wearing an EEG cap described as a "brain wave" machine. In Experiment 1, participants were made to believe that the EEG cap would either enhance or decrease their color perception and performance on the Stroop task. In Experiment 2, participants were explicitly asked to imagine that their color perception and performance would be enhanced or decreased (non-hypnotic imaginative suggestion). We observed effects of placebo-suggestion on Stroop interference on accuracy: interference was decreased with positive suggestion and increased with negative suggestion compared to baseline. Intra-individual variability was also increased under negative suggestion compared to baseline. Compliance with the instruction to imagine a modulation of performance, on the other hand, did not influence accuracy and only had a negative impact on response latencies and on intra-individual variability, especially in the congruent condition of the Stroop Task. Taken together, these results demonstrate that expectations induced by a placebo-suggestion can modulate our ability to resolve cognitive conflict, either facilitating or impairing response accuracy depending on the suggestion's contents. Our results also demonstrate a dissociation between placebo-suggestion and non-hypnotic imaginative suggestion.	[da Gama, Pedro A. Magalhaes De Saldanha; Caspar, Emilie A.; Cleeremans, Axel] Univ Libre Bruxelles, Consciousness Cognit & Computat Grp CO3, Brussels, Belgium; [Slama, Hichem; Gevers, Wim] Univ Libre Bruxelles, UNESCOG Res Unit Cognit Neurosci, Brussels, Belgium; [Slama, Hichem] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit UR2NF, Brussels, Belgium; [Slama, Hichem] Univ Libre Bruxelles, Erasme Hosp, Dept Clin & Cognit Neuropsychol, Brussels, Belgium; [da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel] Univ Libre Bruxelles, CRCN, Brussels, Belgium; [da Gama, Pedro A. Magalhaes De Saldanha; Slama, Hichem; Caspar, Emilie A.; Gevers, Wim; Cleeremans, Axel] Univ Libre Bruxelles, UNI, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	da Gama, PAMD (corresponding author), Univ Libre Bruxelles, Consciousness Cognit & Computat Grp CO3, Brussels, Belgium.	pmagalha@ulb.ac.be	da Gama, Pedro Magalhaes De Saldanha/AAP-8856-2021; Slama, Hichem/HGA-3213-2022; Caspar, Emilie/AAC-6322-2022	da Gama, Pedro Magalhaes De Saldanha/0000-0002-8546-4482; Slama, Hichem/0000-0003-3856-4488; Caspar, Emilie/0000-0003-1415-2032	Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation) [SFRH / BD / 44723 / 2008]	Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation)	This work was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) (Science and Technology Foundation), Grant #SFRH / BD / 44723 / 2008. http://www.fct.pt/. A. C. is a Research Director for the National Fund for Scientific Research (FRS - FNRS Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CN, 1977, PERS SOC PSYCHOL B, V3, P455; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Assefi SL, 2003, PSYCHOL SCI, V14, P77, DOI 10.1111/1467-9280.01422; Augustinova M, 2012, PSYCHON B REV, V19, P521, DOI 10.3758/s13423-012-0217-y; Baker S.L., 1993, CONT HYPNOSIS, V10, P117; Benedetti F, 2007, NEUROSCIENCE, V147, P260, DOI 10.1016/j.neuroscience.2007.02.020; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 2002, EVAL HEALTH PROF, V25, P369, DOI 10.1177/0163278702238051; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Benham G, 1998, J PERS SOC PSYCHOL, V75, P1604, DOI 10.1037/0022-3514.75.6.1604; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Braffman W., 2001, CONT HYPNOSIS, V18, P107, DOI DOI 10.1002/CH.224; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2011, CURR OPIN PSYCHIATR, V24, P149, DOI 10.1097/YCO.0b013e328343803b; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Di Blasi Z, 2003, EVAL HEALTH PROF, V26, P166, DOI 10.1177/0163278703026002003; Dienes Z., 2008, UNDERSTANDING PSYCHO; DIENES Z, 2006, HYPNOSIS CONSCIOUS S, P293; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Eitam B, 2008, PSYCHOL SCI, V19, P261, DOI 10.1111/j.1467-9280.2008.02078.x; Elsenbruch S, 2012, Neurogastroenterol Motil, V24, P914, DOI 10.1111/j.1365-2982.2012.01950.x; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fields HL, 1997, PLACEBO EFFECT INTER, P93; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Iani C, 2006, PSYCHOL SCI, V17, P721, DOI 10.1111/j.1467-9280.2006.01772.x; Iani C, 2009, CONSCIOUS COGN, V18, P856, DOI 10.1016/j.concog.2009.07.002; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Jones R.A., 1977, SELF FULFILLING PROP; Kirsch I, 1997, INT J CLIN EXP HYP, V45, P212, DOI 10.1080/00207149708416124; Kirsch I, 1997, APPL PREV PSYCHOL, V6, P69, DOI 10.1016/S0962-1849(05)80012-5; Kirsch I, 1999, AM PSYCHOL, V54, P504, DOI 10.1037/0003-066X.54.7.504; Kirsch I, 1999, INT J CLIN EXP HYP, V47, P40, DOI 10.1080/00207149908410021; Kirsch I, 2001, CURR DIR PSYCHOL SCI, V10, P57, DOI 10.1111/1467-8721.00115; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Kirsch I., 1999, ANALES PSICOLOGIA, V15, P99; Kirsch I., 2011, CONT HYPNOSIS, V28, P107; Lifshitz M, 2013, CORTEX, V49, P463, DOI 10.1016/j.cortex.2012.08.007; MacDonald SWS, 2008, J COGNITIVE NEUROSCI, V20, P779, DOI 10.1162/jocn.2008.20502; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McClung M, 2007, J SPORT EXERCISE PSY, V29, P382, DOI 10.1123/jsep.29.3.382; Michael RB, 2012, CURR DIR PSYCHOL SCI, V21, P151, DOI 10.1177/0963721412446369; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; Milling LS, 2005, ANN BEHAV MED, V29, P116, DOI 10.1207/s15324796abm2902_6; MORSE CK, 1993, PSYCHOL AGING, V8, P156, DOI 10.1037/0882-7974.8.2.156; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; ORNE MT, 1969, RRR ROSNOW ARTIFACT, P143; Parker S, 2011, MEMORY, V19, P606, DOI 10.1080/09658211.2011.592500; PARRIS BA, HYPNOTIC SU IN PRESS; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raz A, 2006, PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-9280.2006.01669.x; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2003, CONSCIOUS COGN, V12, P332, DOI 10.1016/S1053-8100(03)00024-2; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P1155, DOI 10.1001/archpsyc.59.12.1155; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P85, DOI 10.1001/archpsyc.59.1.85; Raz A, 2007, AM J CLIN HYPN, V50, P29, DOI 10.1080/00029157.2007.10401595; Raz A, 2007, CONSCIOUS COGN, V16, P331, DOI 10.1016/j.concog.2006.04.004; Rosenthal R., 1968, PYGMALION CLASSROOM; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Staats P, 1998, J PAIN SYMPTOM MANAG, V15, P235, DOI 10.1016/S0885-3924(97)00363-1; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van Oorsouw K, 2007, AM J PSYCHOL, V120, P287, DOI 10.2307/20445399; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEST R, 1999, J GERONTOL B-PSYCHOL, V54, P34; WICKLESS C, 1989, J PERS SOC PSYCHOL, V57, P762, DOI 10.1037/0022-3514.57.5.762	78	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75701	10.1371/journal.pone.0075701	http://dx.doi.org/10.1371/journal.pone.0075701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130735	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900053
J	Reza, LW; Satyanarayna, S; Enarson, DA; Kumar, AMV; Sagili, K; Kumar, S; Prabhakar, LA; Devendrappa, NM; Pandey, A; Wilson, N; Chadha, S; Thapa, B; Sachdeva, KS; Kohli, MP				Reza, Lord Wasim; Satyanarayna, Srinath; Enarson, Donald A.; Kumar, Ajay M. V.; Sagili, Karuna; Kumar, Sujeet; Prabhakar, Levi Anand; Devendrappa, N. M.; Pandey, Ashish; Wilson, Nevin; Chadha, Sarabjit; Thapa, Badri; Sachdeva, Kuldeep Singh; Kohli, Mohan P.			LED-Fluorescence Microscopy for Diagnosis of Pulmonary Tuberculosis under Programmatic Conditions in India	PLOS ONE			English	Article							ZIEHL-NEELSEN MICROSCOPY; ACID-FAST BACILLI; SPUTUM	Background: Light-emitting diode fluorescence microscopy (LED-FM) has been shown to be more sensitive than conventional bright field microscopy using Ziehl-Neelsen (ZN) stain in detecting sputum smear positive tuberculosis in controlled laboratory conditions. In 2012, Auramine O staining based LED-FM replaced conventional ZN microscopy in 200 designated microscopy centres (DMC) of medical colleges operating in collaboration with India's Revised National Tuberculosis Control Programme. We aimed to assess the impact of introduction of LED-FM services on sputum smear positive case detection under program conditions. Methods: This was a before and after comparison study. In 15 randomly selected medical college DMCs, all presumptive TB patients who underwent sputum smear examination in the years 2011 (before LED-FM) and 2012 (after LED-FM) were compared. An additional 15 comparable DMCs that implemented conventional ZN sputum smear microscopy were also selected for comparison between 2011 and 2012. Results: The proportion of presumptive TB patients (PTP) found sputum smear positive increased by 30%- from 13.6% (3432/25159) in 2011 to 17.8% (4706/26426) in 2012 (P value < 0.01) in the sites that implemented LED-FM microscopy, whereas in DMCs where the ZN staining procedure is followed the proportion of sputum smear positive had remained unchanged (13.0% versus 12.6%; P value0.31). Conclusion: Use of LED-FM significantly increased the proportion of smear positive cases among presumptive TB patients under routine program conditions in high workload laboratories. The study provides operational evidence needed to scale-up the use of LED-FM in similar settings in India and beyond.	[Reza, Lord Wasim; Satyanarayna, Srinath; Kumar, Ajay M. V.; Sagili, Karuna; Kumar, Sujeet; Prabhakar, Levi Anand; Devendrappa, N. M.; Pandey, Ashish; Wilson, Nevin; Chadha, Sarabjit; Thapa, Badri; Kohli, Mohan P.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Sachdeva, Kuldeep Singh; Kohli, Mohan P.] Minist Hlth & Family Welf, Cent TB Div, Directorate Gen Hlth Serv, New Delhi, India		Reza, LW (corresponding author), Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India.	lwreza@theunion.org		Wilson, Nevin/0000-0002-0191-8855; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551	TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,) [T9-370-114]; American People through the United States Agency for International Development (USAID)	TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,); American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This project was supported by TB REACH Initiative of Stop TB Partnership (through a grant from the Canadian International Development Agency,) grant no T9-370-114. This study was a part of Operational Research course. Funding for the operational research course was made possible from by the support of the American People through the United States Agency for International Development (USAID). Funders had no role in study design, data collection, analysis or interpretation of data. The donor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The contents of this paper do not necessarily reflect the views of USAID or the United States Government or The Union.	Agarwal S, 2005, TUBERCULOSIS CONTROL, P127; Ba F, 1999, INT J TUBERC LUNG D, V3, P1101; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020175; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2005, TECHN OP GUID TUB CO; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2005, MOD LAB TECHN; Central TB Division Directorate of health services Ministry of Health & Family Welfare, 2009, DIAGN SMEAR POS PULM; Central TB Division Directorate of health services Ministry of Health & Family Welfare I, 2012, RNTCP ANN STAT REP 2; Central TB Division Directorate of health services Ministry of Health & Family Welfare I, 2005, MOD SEN TUB LAB SUP; Chaidir L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061727; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Das D, 2012, INT J TUBERC LUNG D, V16, P1558, DOI 10.5588/ijtld.12.0407; Foundation for Innovative New Diagnostics, 2007, FEAS STUD PROT ILED; Gordon C, 2009, INT J TUBERC LUNG D, V13, P130; Kline E. K, 1941, J BACTERIOL, P275; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; RICHARDS OSCAR W., 1941, SCIENCE, V93, P190, DOI 10.1126/science.93.2408.190; RICHARDS OSCAR W., 1941, AMER REV TUBERC, V44, P255; Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1558, DOI 10.5588/ijtld.12.0407-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, FLUOR LIGHT EM DIOD; Xia H, 2013, INT J TUBERC LUNG D, V17, P107, DOI 10.5588/ijtld.12.0184	22	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75566	10.1371/journal.pone.0075566	http://dx.doi.org/10.1371/journal.pone.0075566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130719	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900041
J	Kohli, S; Chhabra, A; Jaiswal, A; Rustagi, Y; Sharma, M; Rani, V				Kohli, Shrey; Chhabra, Aastha; Jaiswal, Astha; Rustagi, Yashika; Sharma, Manish; Rani, Vibha			Curcumin Suppresses Gelatinase B Mediated Norepinephrine Induced Stress in H9c2 Cardiomyocytes	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MYOCARDIAL EXTRACELLULAR-MATRIX; GENE-EXPRESSION; HEART-FAILURE; TRANSGENIC MOUSE; DISEASE; CARDIOTOXICITY; NORADRENALINE; PROTEINASES; HYPERTROPHY	Background: Extracellular matrix (ECM) remodeling facilitates biomechanical signals in response to abnormal physiological conditions. This process is witnessed as one of the major effects of the stress imposed by catecholamines, such as epinephrine and norepinephrine (NE), on cardiac muscle cells. Matrix metalloproteinases (MMPs) are the key proteases involved in degradation of the ECM in heart. Objectives: The present study focuses on studying the effect of curcumin on Gelatinase B (MMP-9), an ECM remodeling regulatory enzyme, in NE-induced cardiac stress. Curcumin, a bioactive polyphenol found in the spice turmeric, has been studied for its multi-fold beneficial properties. This study focuses on investigating the role of curcumin as a cardio-protectant. Methods: H9c2 cardiomyocytes were subjected to NE and curcumin treatments to study the response in stress conditions. Effect on total collagen content was studied using Picrosirus red staining. Gelatinase B activity was assessed through Gel-Diffusion Assay and Zymographic techniques. RT-PCR, Western Blotting and Immunocytochemistry were performed to study effect on expression of gelatinase B. Further, the effect of curcumin on the localization of NF-kappa B, known to regulate gelatinase B, was also examined. Results: Curcumin suppressed the increase in the total collagen content under hypertrophic stress and was found to inhibit the in-gel and in-situ gelatinolytic activity of gelatinase B. Moreover, it was found to suppress the mRNA and protein expression of gelatinase B. Conclusions: The study provides an evidence for an overall inhibitory effect of curcumin on Gelatinase B in NE-induced hypertrophic stress in H9c2 cardiomyocytes which may contribute in the prevention of ECM remodeling.	[Kohli, Shrey; Chhabra, Aastha; Jaiswal, Astha; Rustagi, Yashika; Rani, Vibha] Jaypee Inst Informat Technol, Dept Biotechnol, Noida, Uttar Pradesh, India; [Sharma, Manish] DRDO, DIPAS, Peptide & Prote Div, Delhi, India	Jaypee Institute of Information Technology (JIIT); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Rani, V (corresponding author), Jaypee Inst Informat Technol, Dept Biotechnol, Noida, Uttar Pradesh, India.	vibha.rani@jiit.ac.in		RUSTAGI, YASHIKA/0000-0003-1122-941X	Department of Biotechnology, Government of India [BT/PR3978/17/766/2011]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the research grant awarded to Dr. Vibha Rani by the Department of Biotechnology, Government of India (BT/PR3978/17/766/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2011, J PHARM PHARMACOL, V63, P1604, DOI 10.1111/j.2042-7158.2011.01363.x; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BISHOP JE, 1994, CARDIOVASC RES, V28, P1581, DOI 10.1093/cvr/28.10.1581; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Brown PD, 2000, EXPERT OPIN INV DRUG, V9, P2167, DOI 10.1517/13543784.9.9.2167; Carvalho RF, 2006, INT J EXP PATHOL, V87, P437, DOI 10.1111/j.1365-2613.2006.00497.x; CAWSTON TE, 1995, BRIT MED BULL, V51, P385, DOI 10.1093/oxfordjournals.bmb.a072968; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Deschamps AM, 2006, CARDIOVASC RES, V69, P666, DOI 10.1016/j.cardiores.2005.10.004; Epstein JA, 2008, J CLIN INVEST, V118, P850, DOI 10.1172/JCI34650; Hong DS, 2010, PHARMACOL RES, V61, P142, DOI 10.1016/j.phrs.2009.08.009; Jaiswal A, 2011, BIOINFORMATION, V6, P23, DOI 10.6026/97320630006023; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; Kang YJ, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434844; Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522; Kizaki K, 2006, PHARMACOL RES, V53, P341, DOI 10.1016/j.phrs.2006.01.001; Li YY, 2002, AM J PHYSIOL-HEART C, V282, pH983, DOI 10.1152/ajpheart.00233.2001; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lindsey ML, 2010, J MOL CELL CARDIOL, V48, P431, DOI 10.1016/j.yjmcc.2009.09.007; Liu P, 2006, CAN J CARDIOL, V22, p25B, DOI 10.1016/S0828-282X(06)70983-7; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Menon B, 2005, AM J PHYSIOL-CELL PH, V289, pC168, DOI 10.1152/ajpcell.00606.2004; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Rump AFE, 2002, ARZNEIMITTEL-FORSCH, V52, P543; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Spinale FG, 2000, CARDIOVASC RES, V46, P225, DOI 10.1016/S0008-6363(99)00431-9; Tyagi SC, 1997, MOL CELL BIOCHEM, V168, P1, DOI 10.1023/A:1006850903242; Vanden Berghe W, 2012, PHARMACOL RES, V65, P565, DOI 10.1016/j.phrs.2012.03.007; Wang NP, 2012, BRIT J PHARMACOL, V167, P1550, DOI 10.1111/j.1476-5381.2012.02109.x; Wang XY, 2010, J CELL COMMUN SIGNAL, V4, P15, DOI 10.1007/s12079-009-0083-1; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	36	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76519	10.1371/journal.pone.0076519	http://dx.doi.org/10.1371/journal.pone.0076519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116115	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300062
J	Chiapponi, C; Piras, F; Piras, F; Fagioli, S; Caltagirone, C; Spalletta, G				Chiapponi, Chiara; Piras, Fabrizio; Piras, Federica; Fagioli, Sabrina; Caltagirone, Carlo; Spalletta, Gianfranco			Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; FOLLOW-UP MRI; 1ST-EPISODE SCHIZOPHRENIA; ALZHEIMERS-DISEASE; VOXELWISE ANALYSIS; CORPUS-CALLOSUM; CEREBRAL-CORTEX; AREA VOLUMES; INTEGRITY; ABNORMALITIES	It is still unknown whether the structural brain impairments that characterize schizophrenia (SZ) worsen during the lifetime. Here, we aimed to describe age-related microstructural brain changes in cortical grey matter and subcortical white matter of patients affected by SZ. In this diffusion tensor imaging study, we included 69 patients diagnosed with SZ and 69 healthy control (HC) subjects, age and gender matched. We carried out analyses of covariance, with diagnosis as fixed factor and brain diffusion-related parameters as dependent variables, and controlled for the effect of education. White matter fractional anisotropy decreased in the entire age range spanned (18-65 years) in both SZ and HC and was significantly lower in younger patients with SZ, with no interaction (age by diagnosis) effect in fiber tracts including corpus callosum, corona radiata, thalamic radiations and external capsule. Also, grey matter mean diffusivity increased in the entire age range in both SZ and HC and was significantly higher in younger patients, with no age by diagnosis interaction in the left frontal operculum cortex, left insula and left planum polare and in the right temporal pole and right intracalcarine cortex. In individuals with SZ we found that localized brain cortical and white matter subcortical microstructural impairments appear early in life but do not worsen in the 18-65 year age range.	[Chiapponi, Chiara; Piras, Fabrizio; Piras, Federica; Fagioli, Sabrina; Caltagirone, Carlo; Spalletta, Gianfranco] IRCCS Santa Lucia Fdn, Lab Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Spalletta, G (corresponding author), IRCCS Santa Lucia Fdn, Lab Clin & Behav Neurol, Rome, Italy.	g.spalletta@hsantalucia.it	Piras, Federica/AAC-4768-2022; Piras, Fabrizio/M-7902-2016; Fagioli, Sabrina/I-4512-2017; Spalletta, Gianfranco/K-3828-2018	Piras, Federica/0000-0002-9546-7038; Piras, Fabrizio/0000-0003-3566-5494; Fagioli, Sabrina/0000-0002-6381-0989; Spalletta, Gianfranco/0000-0002-7432-4249; Chiapponi, Chiara/0000-0002-5264-492X	Italian Ministry of Health [RC07-08-09-10-11-12/A]; ERANET NEUCONNECT grant from the European Community	Italian Ministry of Health(Ministry of Health, Italy); ERANET NEUCONNECT grant from the European Community	This work was supported by RC07-08-09-10-11-12/A grants from the Italian Ministry of Health and by the ERANET NEUCONNECT grant from the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; ANDREASEN NC, 1986, SCHIZOPHRENIA BULL, V12, P348, DOI 10.1093/schbul/12.3.348; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bersani G, 2010, PSYCHIAT RES-NEUROIM, V183, P119, DOI 10.1016/j.pscychresns.2010.04.011; Bose SK, 2009, SCHIZOPHR RES, V112, P7, DOI 10.1016/j.schres.2009.04.023; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Bronge L, 2002, DEMENT GERIATR COGN, V13, P205, DOI 10.1159/000057698; Cacciari C, 2010, J ALZHEIMERS DIS, V20, P501, DOI 10.3233/JAD-2010-1384; Carlesimo GA, 2012, NEUROLOGY, V78, P1939, DOI 10.1212/WNL.0b013e318259e1c5; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Chew LJ, 2013, DEV NEUROSCI-BASEL, V35, P102, DOI 10.1159/000346157; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Coleman MJ, 2009, SCHIZOPHRENIA BULL, V35, P1108, DOI 10.1093/schbul/sbp090; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Covington MA, 2005, SCHIZOPHR RES, V77, P85, DOI 10.1016/j.schres.2005.01.016; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman JI, 2008, AM J PSYCHIAT, V165, P1024, DOI 10.1176/appi.ajp.2008.07101640; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2012, CURR OPIN NEUROL, V25, P727, DOI 10.1097/WCO.0b013e32835a26b3; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griego JA, 2008, BRAIN LANG, V107, P158, DOI 10.1016/j.bandl.2008.04.001; Ho BC, 2003, ARCH GEN PSYCHIAT, V60, P585, DOI 10.1001/archpsyc.60.6.585; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Jang DP, 2006, NEUROIMAGE, V32, P220, DOI 10.1016/j.neuroimage.2006.01.032; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jeon T, 2012, NEUROIMAGE, V62, P1705, DOI 10.1016/j.neuroimage.2012.05.082; John JP, 2009, SCHIZOPHR RES, V109, P148, DOI 10.1016/j.schres.2008.12.019; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kantrowitz JT, 2009, SCHIZOPHRENIA BULL, V35, P1085, DOI 10.1093/schbul/sbp100; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kochunov P, 2013, BIOL PSYCHIAT, V73, P482, DOI 10.1016/j.biopsych.2012.10.002; Konrad A, 2012, J COGNITIVE NEUROSCI, V24, P888, DOI 10.1162/jocn_a_00187; Koo MS, 2008, ARCH GEN PSYCHIAT, V65, P746, DOI 10.1001/archpsyc.65.7.746; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kubota M, 2011, SCHIZOPHR RES, V125, P21, DOI 10.1016/j.schres.2010.10.004; Lam M, 2012, SCHIZOPHR RES, V134, P125, DOI 10.1016/j.schres.2011.10.020; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Mason O, 2013, INT PSYCHOGERIATR, V25, P320, DOI 10.1017/S1041610212001731; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Mitelman SA, 2005, NEUROIMAGE, V27, P753, DOI 10.1016/j.neuroimage.2005.05.024; Mitelman SA, 2005, SCHIZOPHR RES, V76, P207, DOI 10.1016/j.schres.2005.01.010; Mitelman SA, 2009, SCHIZOPHR RES, V113, P241, DOI 10.1016/j.schres.2009.06.022; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mori T, 2007, PSYCHIAT RES-NEUROIM, V154, P133, DOI 10.1016/j.pscychresns.2006.09.004; Nakamura M, 2007, BIOL PSYCHIAT, V62, P773, DOI 10.1016/j.biopsych.2007.03.030; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oquendo MA, 2003, J CLIN PSYCHIAT, V64, P825, DOI 10.4088/JCP.v64n0714; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Peran P, 2009, HUM BRAIN MAPP, V30, P2667, DOI 10.1002/hbm.20698; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pfefferbaum A, 2010, NEUROBIOL AGING, V31, P482, DOI 10.1016/j.neurobiolaging.2008.04.013; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Piras F, 2011, HUM BRAIN MAPP, V32, P282, DOI 10.1002/hbm.21018; Puri BK, 2010, EXPERT REV NEUROTHER, V10, P33, DOI [10.1586/ern.09.142, 10.1586/ERN.09.142]; Rosenberger G, 2008, SCHIZOPHR RES, V102, P181, DOI 10.1016/j.schres.2008.04.019; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schneiderman JS, 2011, SCHIZOPHR RES, V130, P57, DOI 10.1016/j.schres.2011.04.027; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shergill SS, 2001, J NEUROL NEUROSUR PS, V71, P688, DOI 10.1136/jnnp.71.5.688; Shi YD, 2013, CEREB CORTEX, V23, P36, DOI 10.1093/cercor/bhr372; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Simons JS, 2006, NEUROIMAGE, V32, P696, DOI 10.1016/j.neuroimage.2006.04.209; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spalletta G, 2003, SCHIZOPHR RES, V64, P15, DOI 10.1016/S0920-9964(03)00010-0; Spalletta G, 2010, PSYCHIAT RES-NEUROIM, V182, P77, DOI 10.1016/j.pscychresns.2009.11.001; Spoletini I, 2009, SCHIZOPHR RES, V108, P57, DOI 10.1016/j.schres.2008.11.011; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Takahashi T, 2011, PROG NEURO-PSYCHOPH, V35, P1957, DOI 10.1016/j.pnpbp.2011.07.009; Takahashi T, 2010, SCHIZOPHR RES, V119, P65, DOI 10.1016/j.schres.2009.12.006; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Weiss EM, 2004, SCHIZOPHR RES, V70, P287, DOI 10.1016/j.schres.2004.01.010; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yoshida T, 2009, SCHIZOPHR RES, V113, P84, DOI 10.1016/j.schres.2009.05.004; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	124	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75115	10.1371/journal.pone.0075115	http://dx.doi.org/10.1371/journal.pone.0075115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124469	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100026
J	Cooper, P; Walker, AW; Reyes, J; Chico, M; Salter, SJ; Vaca, M; Parkhill, J				Cooper, Philip; Walker, Alan W.; Reyes, Jorge; Chico, Martha; Salter, Susannah J.; Vaca, Maritza; Parkhill, Julian			Patent Human Infections with the Whipworm, Trichuris trichiura, Are Not Associated with Alterations in the Faecal Microbiota	PLOS ONE			English	Article							HELMINTH INFECTIONS; GUT MICROBIOME; SUIS THERAPY; ASCARIASIS; MICROFLORA; CHILDREN; IMPACT; TRACT; COLON	Background: The soil-transmitted helminth (STH), Trichuris trichiura colonises the human large intestine where it may modify inflammatory responses, an effect possibly mediated through alterations in the intestinal microbiota. We hypothesised that patent T. trichiura infections would be associated with altered faecal microbiota and that anthelmintic treatment would induce a microbiota resembling more closely that observed in uninfected individuals. Materials and Methods: School children in Ecuador were screened for STH infections and allocated to 3 groups: uninfected, T. trichiura only, and mixed infections with T. trichiura and Ascaris lumbricoides. A sample of uninfected children and those with T. trichiura infections only were given anthelmintic treatment. Bacterial community profiles in faecal samples were studied by 454 pyrosequencing of 16 S rRNA genes. Results: Microbiota analyses of faeces were done for 97 children: 30 were uninfected, 17 were infected with T. trichiura, and 50 with T. trichiura and A. lumbricoides. Post-treatment samples were analyzed for 14 children initially infected with T. trichiura alone and for 21 uninfected children. Treatment resulted in 100% cure of STH infections. Comparisons of the microbiota at different taxonomic levels showed no statistically significant differences in composition between uninfected children and those with T. trichiura infections. We observed a decreased proportional abundance of a few bacterial genera from the Clostridia class of Firmicutes and a reduced bacterial diversity among children with mixed infections compared to the other two groups, indicating a possible specific effect of A. lumbricoides infection. Anthelmintic treatment of children with T. trichiura did not alter faecal microbiota composition. Discussion: Our data indicate that patent human infections with T. trichiura may have no effect on faecal microbiota but that A. lumbricoides colonisation might be associated with a disturbed microbiota. Our results also catalogue the microbiota of rural Ecuadorians and indicate differences with individuals from more urban industrialised societies.	[Cooper, Philip; Chico, Martha; Vaca, Maritza] Fdn Ecuatoriana Invest Salud, Quito, Ecuador; [Cooper, Philip; Reyes, Jorge] Univ San Francisco Quito, Quito, Ecuador; [Cooper, Philip] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Walker, Alan W.; Salter, Susannah J.; Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, England	Liverpool School of Tropical Medicine; University of Liverpool; Wellcome Trust Sanger Institute	Cooper, P (corresponding author), Fdn Ecuatoriana Invest Salud, Quito, Ecuador.	P.J.Cooper@liv.ac.uk	Parkhill, Julian/G-4703-2011; Walker, Alan W./AAE-8102-2019	Parkhill, Julian/0000-0002-7069-5958; Walker, Alan W./0000-0001-5099-8495; Cooper, Philip/0000-0002-6770-6871; Reyes, Jorge A/0000-0002-5215-164X; Salter, Susannah/0000-0003-3898-8504	Wellcome Trust [088862/Z/09/Z, WT076964]	Wellcome Trust(Wellcome Trust)	The collection of samples in Ecuador was supported by the Wellcome Trust (grant number, 088862/Z/09/Z) and the Foundation for the National Institutes of Health (Grand Challenges in Global Health). Funding for AWW, SJS, JP and sequencing was provided by the Wellcome Trust (grant number, WT076964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; BRYANT MP, 1956, J BACTERIOL, V72, P22, DOI 10.1128/JB.72.1.22-26.1956; BUNDY DAP, 1987, EPIDEMIOL INFECT, V98, P65, DOI 10.1017/S0950268800061719; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; CROWTHER JS, 1971, J MED MICROBIOL, V4, P343, DOI 10.1099/00222615-4-3-343; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Moncayo AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000293; MACDONALD TT, 1991, J CLIN PATHOL, V44, P194, DOI 10.1136/jcp.44.3.194; Mansfield LS, 2003, AM J TROP MED HYG, V68, P70; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; Montresor A, 1988, GUIDELINES EVALUATIO; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ortiz MR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001157; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Suputtamongkol Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001044; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WHO, 1985, DIAGN TECHN INT PAR; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	43	120	124	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76573	10.1371/journal.pone.0076573	http://dx.doi.org/10.1371/journal.pone.0076573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124574	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100131
J	Harbour, VL; Weigl, Y; Robinson, B; Amir, S				Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon			Comprehensive Mapping of Regional Expression of the Clock Protein PERIOD2 in Rat Forebrain across the 24-h Day	PLOS ONE			English	Article							AGRANULAR INSULAR CORTEX; CA1 AXONAL PROJECTIONS; STRIA TERMINALIS; BED NUCLEUS; SUPRACHIASMATIC NUCLEUS; HIPPOCAMPAL-FORMATION; CIRCADIAN-RHYTHM; CORTICAL AFFERENTS; EXTENDED AMYGDALA; LIMBIC FOREBRAIN	In mammals, a light-entrainable clock located in the suprachiasmatic nucleus (SCN) regulates circadian rhythms by synchronizing oscillators throughout the brain and body. Notably, the nature of the relation between the SCN clock and subordinate oscillators in the rest of the brain is not well defined. We performed a high temporal resolution analysis of the expression of the circadian clock protein PERIOD2 (PER2) in the rat forebrain to characterize the distribution, amplitude and phase of PER2 rhythms across different regions. Eighty-four LEW/Crl male rats were entrained to a 12-h: 12-h light/dark cycle, and subsequently perfused every 30 min across the 24-h day for a total of 48 time-points. PER2 expression was assessed with immunohistochemistry and analyzed using automated cell counts. We report the presence of PER2 expression in 20 forebrain areas important for a wide range of motivated and appetitive behaviors including the SCN, bed nucleus, and several regions of the amygdala, hippocampus, striatum, and cortex. Eighteen areas displayed significant PER2 rhythms, which peaked at different times of day. Our data demonstrate a previously uncharacterized regional distribution of rhythms of a clock protein expression in the brain that provides a sound basis for future studies of circadian clock function in animal models of disease.	[Harbour, Valerie L.; Weigl, Yuval; Robinson, Barry; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada.	shimon.amir@concordia.ca	Amir, Shimon/AAE-4635-2022		Canadian Institutes of Health Research [MOP 13625]; Fonds de la recherche en sante Quebec; Concordia University Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante Quebec(Fonds de la Recherche en Sante du Quebec); Concordia University Research Chair Program	Supported by grants from the Canadian Institutes of Health Research (Grant # MOP 13625), le Fonds de la recherche en sante Quebec, and the Concordia University Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Alheid GF, 2003, ANN NY ACAD SCI, V985, P185; Amir S, 2006, NEUROSCI LETT, V399, P147, DOI 10.1016/j.neulet.2006.01.041; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Amir S, 2009, PROG NEURO-PSYCHOPH, V33, P1321, DOI 10.1016/j.pnpbp.2009.04.003; Amir S, 2009, BIOL PSYCHIAT, V65, P829, DOI 10.1016/j.biopsych.2008.12.019; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; [Anonymous], 1993, NEUROBIOLOGY CINGULA; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Beaule C, 2003, J MOL NEUROSCIENCE; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CASSONE VM, 1993, J BIOL RHYTHM, V8, pS73; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Day HEW, 1999, J COMP NEUROL, V413, P113; Day HEW, 2001, J NEUROSCI, V21, P732, DOI 10.1523/JNEUROSCI.21-02-00732.2001; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Erb S, 2001, PSYCHOPHARMACOLOGY, V158, P360, DOI 10.1007/s002130000642; Erb S, 2001, Stress, V4, P289; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; Haberly LB, 1990, SYNAPTIC ORG BRAIN, P317; Harbour VL, 2011, J MOL NEUROSCI, V45, P154, DOI 10.1007/s12031-010-9469-z; Hood S, 2010, THESIS CONCORDIA U M; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Kobayashi M, 2011, INT REV NEUROBIOL, V97, P285, DOI 10.1016/B978-0-12-385198-7.00011-4; KOHLER C, 1988, J COMP NEUROL, V271, P208, DOI 10.1002/cne.902710204; Kowianski P, 1999, Folia Morphol (Warsz), V58, P9; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lee YL, 1997, J NEUROSCI, V17, P6434; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Pantazopoulos H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020658; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrin JS, 2006, P NATL ACAD SCI USA, V103, P5591, DOI 10.1073/pnas.0601310103; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Petrovich GD, 2003, ANN NY ACAD SCI, V985, P251; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ramanathan C, 2010, NEUROSCI LETT, V473, P220, DOI 10.1016/j.neulet.2010.02.051; REEP RL, 1982, NEUROSCIENCE, V7, P1265, DOI 10.1016/0306-4522(82)91133-2; REEP RL, 1982, NEUROSCIENCE, V7, P2609, DOI 10.1016/0306-4522(82)90087-2; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Willuhn I, 2003, EUR J NEUROSCI, V17, P1053, DOI 10.1046/j.1460-9568.2003.02525.x; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Yamamoto S, 2001, J COMP NEUROL, V430, P518; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	91	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76391	10.1371/journal.pone.0076391	http://dx.doi.org/10.1371/journal.pone.0076391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124556	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000325489100113
J	Ma, NN; Wang, Y; Qiu, SC; Kang, ZH; Che, SG; Wang, GX; Huang, JL				Ma, Nana; Wang, Ying; Qiu, Shichun; Kang, Zhenhui; Che, Shugang; Wang, Guixue; Huang, Junli			Overexpression of OsEXPA8, a Root-Specific Gene, Improves Rice Growth and Root System Architecture by Facilitating Cell Extension	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; FT-IR SPECTROSCOPY; MECHANICAL-PROPERTIES; WALL POLYSACCHARIDES; ARABIDOPSIS-THALIANA; HAIR DEVELOPMENT; PETUNIA-HYBRIDA; PLANT-GROWTH; EXPRESSION; WOOD	Expansins are unique plant cell wall proteins that are involved in cell wall modifications underlying many plant developmental processes. In this work, we investigated the possible biological role of the root-specific a-expansin gene OsEXPA8 in rice growth and development by generating transgenic plants. Overexpression of OsEXPA8 in rice plants yielded pleiotropic phenotypes of improved root system architecture (longer primary roots, more lateral roots and root hairs), increased plant height, enhanced leaf number and enlarged leaf size. Further study indicated that the average cell length in both leaf and root vascular bundles was enhanced, and the cell growth in suspension cultures was increased, which revealed the cellular basis for OsEXPA8-mediated rice plant growth acceleration. Expansins are thought to be a key factor required for cell enlargement and wall loosening. Atomic force microscopy (AFM) technology revealed that average wall stiffness values for 35S::OsEXPA8 transgenic suspension-cultured cells decreased over six-fold compared to wild-type counterparts during different growth phases. Moreover, a prominent change in the wall polymer composition of suspension cells was observed, and Fourier-transform infrared (FTIR) spectra revealed a relative increase in the ratios of the polysaccharide/lignin content in cell wall compositions of OsEXPA8 overexpressors. These results support a role for expansins in cell expansion and plant growth.	[Ma, Nana; Wang, Ying; Qiu, Shichun; Kang, Zhenhui; Che, Shugang; Wang, Guixue; Huang, Junli] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China	Chongqing University	Huang, JL (corresponding author), Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China.	huangjunli@cqu.edu.cn	Kang, Zhenhui/CAE-9105-2022	Wang, Guixue/0000-0002-9192-8757	National Natural Science Foundation of China [31271685]; Fundamental Research Funds for the Central Universities [CQDXWL-2012-114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant no. 31271685) and Fundamental Research Funds for the Central Universities (grant no. CQDXWL-2012-114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerholm M, 2001, POLYMER, V42, P963, DOI 10.1016/S0032-3861(00)00434-1; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081; Chen MH, 2000, PHYTOCHEM ANALYSIS, V11, P153, DOI 10.1002/(SICI)1099-1565(200005/06)11:3&lt;153::AID-PCA502&gt;3.0.CO;2-Z; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Damanik RI, 2012, PLANT GROWTH REGUL, V67, P83, DOI 10.1007/s10725-012-9668-4; Ding WN, 2009, CELL RES, V19, P1309, DOI 10.1038/cr.2009.109; FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21; Gray-Mitsumune M, 2008, PLANT BIOTECHNOL J, V6, P62, DOI 10.1111/j.1467-7652.2007.00295.x; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Hepworth DG, 1998, ANN BOT-LONDON, V81, P729, DOI 10.1006/anbo.1998.0619; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kalamaki MS, 2003, J AGR FOOD CHEM, V51, P7456, DOI 10.1021/jf034164l; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Kohler L, 2002, PLANTA, V215, P33, DOI 10.1007/s00425-001-0718-9; LEPPARD GG, 1971, J CELL BIOL, V50, P63, DOI 10.1083/jcb.50.1.63; Lesniewska E, 2004, ULTRAMICROSCOPY, V100, P171, DOI 10.1016/j.ultramic.2003.11.004; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; Rodrigues J, 1998, HOLZFORSCHUNG, V52, P46, DOI 10.1515/hfsg.1998.52.1.46; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; Shin JH, 2005, MOL CELLS, V20, P210; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; STRACK D, 1989, PHYTOCHEMISTRY, V28, P2071, DOI 10.1016/S0031-9422(00)97922-6; TAKEUCHI Y, 1978, PHYSIOL PLANTARUM, V42, P21, DOI 10.1111/j.1399-3054.1978.tb01532.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang CX, 2004, ANN BOT-LONDON, V93, P443, DOI 10.1093/aob/mch062; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wilson RH, 2000, PLANT PHYSIOL, V124, P397, DOI 10.1104/pp.124.1.397; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang XQ, 2011, PLANT CELL REP, V30, P27, DOI 10.1007/s00299-010-0937-2	46	76	83	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75997	10.1371/journal.pone.0075997	http://dx.doi.org/10.1371/journal.pone.0075997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124527	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100084
J	Okada, N; Shimizu, N				Okada, Naoya; Shimizu, Noriaki			Dissection of the Beta-Globin Replication-Initiation Region Reveals Specific Requirements for Replicator Elements during Gene Amplification	PLOS ONE			English	Article							EXTRACHROMOSOMAL DOUBLE MINUTES; DNA-REPLICATION; NUCLEAR-MATRIX; SEQUENCE MODULES; SITES; EXPRESSION; PLASMIDS; BEARING; PROTEIN; ORIGIN	Gene amplification plays a pivotal role in malignant transformation of human cells. A plasmid with both a mammalian replication-initiation region (IR)/origin/replicator and a nuclear matrix-attachment region (MAR) is spontaneously amplified in transfected cells by a mechanism that involves amplification at the extrachromosomal site, followed by amplification at the chromosomal arm, ultimately generating a long homogeneously staining region (HSR). Several observations suggest that replication initiation from IR sequences might mediate amplification. To test this idea, we previously dissected c-myc and DHFR IRs to identify the minimum sequence required to support amplification. In this study, we applied an improved analysis that discriminates between two amplification steps to the beta-globin RepP IR, which contains separate elements already known to be essential for initiation on the chromosome arm. The IR sequence was required at least for the extrachromosomal amplification step. In addition to the vector-encoded MAR, amplification also required an AT-rich region and a MAR-like element, consistent with the results regarding replicator activity on the chromosome. However, amplification did not require the AG-rich tract necessary for replicator activity, but instead required a novel sequence containing another AG-rich tract. The differential sequence requirement might be a consequence of extrachromosomal replication.	[Okada, Naoya; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (grant number 23380203) and a Grant-in-Aid for Challenging Exploratory Research (grant number 24658290), both from Japan Society for the Promotion of Science to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Altman AL, 2004, MOL CELL BIOL, V24, P4138, DOI 10.1128/MCB.24.10.4138-4150.2004; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BOULIKAS T, 1993, J CELL BIOCHEM, V52, P23, DOI 10.1002/jcb.240520105; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; Demczuk A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001360; Djeliova V, 2001, NUCLEIC ACIDS RES, V29, P3181, DOI 10.1093/nar/29.15.3181; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Huang L, 2011, MOL CELL BIOL, V31, P3472, DOI 10.1128/MCB.05587-11; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Paixao S, 2004, MOL CELL BIOL, V24, P2958, DOI 10.1128/MCB.24.7.2958-2967.2004; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Soultanas P, 2011, TRANSCR-AUSTIN, V2, P140, DOI 10.4161/trns.2.3.15908; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; Wang LX, 2006, HUM MOL GENET, V15, P2613, DOI 10.1093/hmg/ddl187; Wang LX, 2004, MOL CELL BIOL, V24, P3373, DOI 10.1128/MCB.24.8.3373-3386.2004; Wilson RHC, 2013, GENES CELLS, V18, P17, DOI 10.1111/gtc.12010; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009	32	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77350	10.1371/journal.pone.0077350	http://dx.doi.org/10.1371/journal.pone.0077350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124615	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100172
J	Sahu, SN; Anriany, Y; Grim, CJ; Kim, S; Chang, Z; Joseph, SW; Cinar, HN				Sahu, Surasri N.; Anriany, Yuda; Grim, Christopher J.; Kim, Sungji; Chang, Zenas; Joseph, Sam W.; Cinar, Hediye N.			Identification of Virulence Properties in Salmonella Typhimurium DT104 Using Caenorhabditis elegans	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MULTIDRUG-RESISTANCE REGION; UNFOLDED PROTEIN RESPONSE; INNATE IMMUNE-RESPONSE; C-ELEGANS; ANTIMICROBIAL PEPTIDES; MODEL HOST; INTESTINE; PATHOGEN; PATHWAY	Salmonella enterica serover Typhimurium definitive phage type DT104, resistant to multiple antibiotics, is one of the most widespread Salmonella species in human infection worldwide. Although several cohort studies indicate that DT104 carrying the multidrug resistance (MDR) locus on salmonella genomic island 1 is a possible hyper-virulent strain compared to DT104 strains without MDR, or other Salmonella enterica serotypes, existing experimental evidence regarding virulence properties associated with the MDR region is controversial. To address this question, we constructed an isogenic MDR deletion (Delta MDR) mutant strain of DT104, SNS12, by allelic exchange and used Caenorhabditis elegans as a host model to assess differences in virulence between these two strains. SNS12 exhibited decreased virulence in C. elegans, and we observed increased colonization and proliferation of the intestine of C. elegans by DT104. The immune response against MDR-carrying DT104 appears to function through a non-canonical Unfolded Protein Response (UPR) pathway, namely prion-like-(QN-rich)-domain-bearing protein pathway (PQN), in a ced-1 dependent manner in C. elegans. Further, we also demonstrate that genes of the PQN pathway and antimicrobial peptide gene abf-2, are expressed at higher transcriptional levels in worms immediately following exposure to DT104, in comparison with worms exposed to SNS12. Altogether, our results suggest that the MDR region of Salmonella Typhimurium DT104 has a direct role in virulence against Caenorhabditis elegans.	[Sahu, Surasri N.; Grim, Christopher J.; Cinar, Hediye N.] US FDA, Div Virulence Assessment, Laurel, MD USA; [Sahu, Surasri N.; Grim, Christopher J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Anriany, Yuda] Prince Georges Community Coll, Dept Biol Sci, Laurel, MD USA; [Kim, Sungji; Joseph, Sam W.] Kyungpook Natl Univ KNU, Taegu, South Korea; [Chang, Zenas] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kyungpook National University; University System of Maryland; University of Maryland College Park	Sahu, SN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	surasri.sahu@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This study was funded by Food and Drug Administration intramural funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alegado RA, 2003, CELL MICROBIOL, V5, P435, DOI 10.1046/j.1462-5822.2003.00287.x; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Allen CA, 2001, INFECT IMMUN, V69, P4673, DOI 10.1128/IAI.69.7.4673-4677.2001; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Arcangioli MA, 1999, FEMS MICROBIOL LETT, V174, P327, DOI 10.1016/S0378-1097(99)00161-5; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Briggs CE, 1999, ANTIMICROB AGENTS CH, V43, P846, DOI 10.1128/AAC.43.4.846; Carlson SA, 2000, MICROB PATHOGENESIS, V28, P373, DOI 10.1006/mpat.2000.0355; Carlson SA, 2005, MICROB PATHOGENESIS, V38, P181, DOI 10.1016/j.micpath.2005.01.004; Carlson SA, 2000, MICROB PATHOGENESIS, V28, P37, DOI 10.1006/mpat.1999.0322; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Randall LP, 2001, J MED MICROBIOL, V50, P770, DOI 10.1099/0022-1317-50-9-770; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Slutsker L, 1998, INFECT DIS CLIN N AM, V12, P199, DOI 10.1016/S0891-5520(05)70418-9; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; Wu MT, 2002, MICROB PATHOGENESIS, V33, P279, DOI 10.1006/mpat.2002.0535; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	44	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76673	10.1371/journal.pone.0076673	http://dx.doi.org/10.1371/journal.pone.0076673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124587	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100144
J	Santha, P; Pakaski, M; Fodor, EK; Fazekas, OC; Kalman, S; Kalman, J; Janka, Z; Szabo, G; Kalman, J				Santha, Petra; Pakaski, Magdolna; Fodor, Eszter K.; Fazekas, Orsike Cs; Kalman, Sara; Kalman, Janos, Jr.; Janka, Zoltan; Szabo, Gyula; Kalman, Janos			Cytoskeletal Protein Translation and Expression in the Rat Brain Are Stressor-Dependent and Region-Specific	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; SYNAPTIC PLASTICITY; ACTIN CYTOSKELETON; RESTRAINT STRESS; CELL-PROLIFERATION; FOOTSHOCK STRESS; HIPPOCAMPUS; RECEPTORS; ADF/COFILIN; DISORDERS	Stress is an integral component of life that can sometimes cause a critical overload, depending on the qualitative and quantitative natures of the stressors. The involvement of actin, the predominant component of dendritic integrity, is a plausible candidate factor in stress-induced neuronal cytoskeletal changes. The major aim of this study was to compare the effects of three different stress conditions on the transcription and translation of actin-related cytoskeletal genes in the rat brain. Male Wistar rats were exposed to one or other of the frequently used models of physical stress, i.e. electric foot shock stress (EFSS), forced swimming stress (FSS), or psychosocial stress (PSS) for periods of 3, 7, 14, or 21 days. The relative mRNA and protein expressions of beta-actin, cofilin and mitogen-activated protein kinase 1 (MAPK-1) were determined by qRT-PCR and western blotting from hippocampus and frontal cortex samples. Stressor-specific alterations in both beta-actin and cofilin expression levels were seen after stress. These alterations were most pronounced in response to EFSS, and exhibited a U-shaped time course. FSS led to a significant beta-actin mRNA expression elevation in the hippocampus and the frontal cortex after 3 and 7 days, respectively, without any subsequent change. PSS did not cause any change in beta-actin or cofilin mRNA or protein expression in the examined brain regions. EFSS, FSS and PSS had no effect on the expression of MAPK-1 mRNA at any tested time point. These findings indicate a very delicate, stress type-dependent regulation of neuronal cytoskeletal components in the rat hippocampus and frontal cortex.	[Santha, Petra; Pakaski, Magdolna; Fodor, Eszter K.; Fazekas, Orsike Cs; Kalman, Sara; Kalman, Janos, Jr.; Kalman, Janos] Univ Szeged, Dept Psychiat, Alzheimers Dis Res Ctr, Szeged, Hungary; [Janka, Zoltan] Univ Szeged, Dept Psychiat, Szeged, Hungary; [Szabo, Gyula] Univ Szeged, Dept Pathophysiol, Szeged, Hungary	Szeged University; Szeged University; Szeged University	Santha, P (corresponding author), Univ Szeged, Dept Psychiat, Alzheimers Dis Res Ctr, Szeged, Hungary.	santha.petra@gmail.com	Szabó, Gyula/E-3602-2012	Szabó, Gyula/0000-0002-3409-5357; Kalman, Janos/0000-0003-0930-4214	OTKA [83667]; Hungarian Ministry of Education and Culture [TAMOP 4.2.2.A-11/16KONV-2012-0052, 4.2.2/B, TAMOP-4.2.2.A-11/1/KONV-2012-0052]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Education and Culture	This study was supported by OTKA (grant no. 83667) and by The Hungarian Ministry of Education and Culture (grant nos. TAMOP 4.2.2.A-11/16KONV-2012-0052, 4.2.2/B and TAMOP-4.2.2.A-11/1/KONV-2012-0052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa AM, 2006, NEUROBIOL DIS, V22, P453, DOI 10.1016/j.nbd.2005.12.005; Alkadhi KA, 2005, NEUROBIOL DIS, V20, P849, DOI 10.1016/j.nbd.2005.05.020; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bianchi M, 2003, SYNAPSE, V49, P188, DOI 10.1002/syn.10230; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; Carboni L, 2006, EUR NEUROPSYCHOPHARM, V16, P521, DOI 10.1016/j.euroneuro.2006.01.007; Carvalho-Netto EF, 2011, PHYSIOL BEHAV, V104, P242, DOI 10.1016/j.physbeh.2011.01.024; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Fuchs E, 1998, NEUROSCI BIOBEHAV R, V23, P295, DOI 10.1016/S0149-7634(98)00031-1; Gerges NZ, 2001, BRAIN RES, V922, P250, DOI 10.1016/S0006-8993(01)03181-X; Huang HC, 2009, J ALZHEIMERS DIS, V16, P15, DOI 10.3233/JAD-2009-0960; Jafari M, 2012, MOL NEUROBIOL, V46, P304, DOI 10.1007/s12035-012-8288-3; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Lahmame A, 1997, BRAIN RES, V750, P285, DOI 10.1016/S0006-8993(96)01368-6; Lamprecht R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Munsie Lise N, 2012, Bioarchitecture, V2, P204, DOI 10.4161/bioa.22549; Piubelli C, 2011, NEUROSCIENCE, V176, P349, DOI 10.1016/j.neuroscience.2010.12.043; Piubelli C, 2011, EUR NEUROPSYCHOPHARM, V21, P545, DOI 10.1016/j.euroneuro.2010.11.003; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Robbins MT, 2008, J PAIN, V9, P991, DOI 10.1016/j.jpain.2008.05.006; Rosenbrock H, 2005, BRAIN RES, V1040, P55, DOI 10.1016/j.brainres.2005.01.065; Santha P, 2012, NEUROCHEM RES, V37, P958, DOI 10.1007/s11064-011-0688-7; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sousa N, 2012, TRENDS NEUROSCI, V35, P742, DOI 10.1016/j.tins.2012.08.006; Szucs Szabina, 2010, Neuropsychopharmacol Hung, V12, P301; Takao K, 1995, EUR J PHARMACOL, V294, P721, DOI 10.1016/0014-2999(95)00620-6; Trentani A, 2003, NEUROBIOL DIS, V14, P602, DOI 10.1016/j.nbd.2003.08.006; Tsukada F, 2003, BIOL PHARM BULL, V26, P368; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010	43	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e73504	10.1371/journal.pone.0073504	http://dx.doi.org/10.1371/journal.pone.0073504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124448	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100005
J	Santin, JR; Machado, ID; Rodrigues, SFP; Teixeira, S; Muscara, MN; Galdino, SL; Pitta, ID; Farsky, SHP				Santin, Jose Roberto; Machado, Isabel Daufenback; Rodrigues, Stephen F. P.; Teixeira, Simone; Muscara, Marcelo N.; Galdino, Suely Lins; Pitta, Ivan da Rocha; Farsky, Sandra H. P.			Role of an Indole-Thiazolidine Molecule PPAR Pan-Agonist and COX Inhibitor on Inflammation and Microcirculatory Damage in Acute Gastric Lesions	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION; PROLIFERATOR; PIOGLITAZONE; EXPRESSION; CELLS; ROSIGLITAZONE; NEUTROPHILS; ULCERS	The present study aimed to show the in vivo mechanisms of action of an indole-thiazolidine molecule peroxisome-proliferator activated receptor pan-agonist (PPAR pan) and cyclooxygenase (COX) inhibitor, LYSO-7, in an ethanol/HCl-induced (Et/HCl) gastric lesion model. Swiss male mice were treated with vehicle, LYSO-7 or Bezafibrate (p.o.) 1 hour before oral administration of Et/HCl (60%/0.03M). In another set of assays, animals were injected i.p. with an anti-granulocyte antibody, GW9962 or L-NG-nitroarginine methyl ester (L-NAME) before treatment. One hour after Et/HCl administration, neutrophils were quantified in the blood and bone marrow and the gastric microcirculatory network was studied in situ. The gastric tissue was used to quantify the percentage of damaged area, as well as myeloperoxidase (MPO), inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS) protein and PPAR. protein and gene expression. Acid secretion was evaluated by the pylorus ligation model. LYSO-7 or Bezafibrate treatment reduced the necrotic area. LYSO-7 treatment enhanced PPAR. gene and protein expression in the stomach, and impaired local neutrophil influx and stasis of the microcirculatory network caused by Et/HCl administration. The effect seemed to be due to PPAR. agonist activity, as the LYSO-7 effect was abolished in GW9962 pre-treated mice. The reversal of microcirculatory stasis, but not neutrophil influx, was mediated by nitric oxide (NO), as L-NAME pre-treatment abolished the LYSO-7-mediated reestablishment of microcirculatory blood flow. This effect may depend on enhanced eNOS protein expression in injured gastric tissue. The pH and concentration of H+ in the stomach were not modified by LYSO-7 treatment. In addition, LYSO-7 may induce less toxicity, as 28 days of oral treatment did not induce weight loss, as detected in pioglitazone treated mice. Thus, we show that LYSO-7 may be an effective treatment for gastric lesions by controlling neutrophil influx and microcirculatory blood flow mediated by NO.	[Santin, Jose Roberto; Machado, Isabel Daufenback; Rodrigues, Stephen F. P.; Farsky, Sandra H. P.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil; [Teixeira, Simone; Muscara, Marcelo N.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Galdino, Suely Lins; Pitta, Ivan da Rocha] Univ Fed Pernambuco, Dept Chem, Recife, PE, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Pernambuco	Farsky, SHP (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Lab Expt Toxicol, Sao Paulo, Brazil.	sfarsky@usp.br	Machado, Isabel D/B-8913-2014; Rodrigues, Stephen Fernandes/F-7073-2012; Farsky, Sandra HP/C-4044-2012; Muscará, Marcelo N/F-3250-2012; Pitta, Ivan/C-9265-2014; Machado, Isabel/AAE-3418-2020; Santin, José Roberto/E-6951-2013; Teixeira, Simone/K-3991-2016	Rodrigues, Stephen Fernandes/0000-0002-6818-0365; Muscará, Marcelo N/0000-0002-8342-5586; Pitta, Ivan/0000-0002-2899-4049; Machado, Isabel/0000-0003-0724-5150; Santin, José Roberto/0000-0002-8805-8818; Teixeira, Simone/0000-0002-8515-5030	FAPESP [2010/17175-0, 2011/01848-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank FAPESP for financial support (Grants No. 2010/17175-0 and 2011/01848-8). MN Muscara, SL Galdino, IR Pitta and SHP Farsky are fellow of the Conselho Nacional de Pesquisa e Tecnologia (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; Bayir Y, 2006, PHYTOMEDICINE, V13, P584, DOI 10.1016/j.phymed.2005.07.002; Betz B, 2012, PPAR RES, V2012, DOI 10.1155/2012/219319; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brzozowski Tomasz, 2005, Inflammopharmacology, V13, P317, DOI 10.1163/156856005774423908; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dembinski A, 2011, GASTROENTEROLOGY, V140, pS; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; El-Demerdash E, 2010, DRUG DISCOV THER, V4, P276; Fajas L, 2001, NUTR METAB CARDIOVAS, V11, P64; Farnesi-de-Assuncao TS, 2012, CELL IMMUNOL, V273, P23, DOI 10.1016/j.cellimm.2011.11.010; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; Friedland SN, 2012, AM J MED, V125, P126, DOI 10.1016/j.amjmed.2011.08.025; Goso Y, 2007, ALCOHOL CLIN EXP RES, V31, P390, DOI 10.1111/j.1530-0277.2006.00319.x; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; Guha P, 2009, J PHARMACOL EXP THER, V328, P829, DOI 10.1124/jpet.108.145334; Guo JS, 2006, EUR J PHARMACOL, V536, P301, DOI 10.1016/j.ejphar.2005.12.088; GUSLANDI M, 1987, Digestive Diseases, V5, P21, DOI 10.1159/000171159; Imamoto E, 2004, BIOFACTORS, V20, P37, DOI 10.1002/biof.5520200104; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kato S, 2009, J PHYSIOL PHARMACOL, V60, P147; Konturek PC, 2010, J PHYSIOL PHARMACOL, V61, P429; Konturek PC, 2003, EUR J PHARMACOL, V472, P213, DOI 10.1016/S0014-2999(03)01932-0; Krznaric Z, 2011, DIGEST DIS, V29, P469, DOI 10.1159/000331515; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lahiri S, 2009, EUR J PHARMACOL, V609, P118, DOI 10.1016/j.ejphar.2009.03.005; Lakshmi V, 2010, PHYTOMEDICINE, V17, P569, DOI 10.1016/j.phymed.2009.10.016; Lee JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-34; Lemos M, 2011, J ETHNOPHARMACOL, V138, P503, DOI 10.1016/j.jep.2011.09.046; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Liang YJ, 2010, DIABETES-METAB RES, V26, P406, DOI 10.1002/dmrr.1100; Lim HA, 2012, BIOGERONTOLOGY, V13, P133, DOI 10.1007/s10522-011-9361-4; Long EM, 2011, P NATL ACAD SCI USA, V108, P16357, DOI 10.1073/pnas.1100702108; Ma L, 2000, AM J PHYSIOL-GASTR L, V279, pG341, DOI 10.1152/ajpgi.2000.279.2.G341; Martin HL, 2012, EXP NEUROL, V235, P528, DOI 10.1016/j.expneurol.2012.02.017; Medeiros JVR, 2008, BRIT J PHARMACOL, V153, P721, DOI 10.1038/sj.bjp.0707605; Meissner M, 2010, J BIOL CHEM, V285, P33797, DOI 10.1074/jbc.M110.137943; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; MIZUI T, 1983, JPN J PHARMACOL, V33, P939, DOI 10.1254/jjp.33.939; Morsy MA, 2010, CLIN EXP PHARMACOL P, V37, P173, DOI 10.1111/j.1440-1681.2009.05250.x; Rocha NFM, 2011, EUR J PHARM SCI, V44, P455, DOI 10.1016/j.ejps.2011.08.020; Muscara MN, 1999, AM J PHYSIOL-GASTR L, V276, pG1313, DOI 10.1152/ajpgi.1999.276.6.G1313; Naito Yuji, 2010, Nihon Rinsho, V68, P341; Ning JW, 2012, WORLD J GASTROENTERO, V18, P2262, DOI 10.3748/wjg.v18.i18.2262; OHNO T, 1995, J GASTROENTEROL, V30, P557, DOI 10.1007/BF02367779; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Reilly CM, 2000, J IMMUNOL, V164, P1498, DOI 10.4049/jimmunol.164.3.1498; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sadaghiani MS, 2011, BEHAV BRAIN RES, V224, P336, DOI 10.1016/j.bbr.2011.06.011; Santin JR, 2013, EUR J PHARM SCI, V48, P689, DOI 10.1016/j.ejps.2012.12.029; Beserra AMSES, 2011, J AGR FOOD CHEM, V59, P6957, DOI 10.1021/jf2003267; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Sung NY, 2007, BRIT J CANCER, V97, P700, DOI 10.1038/sj.bjc.6603893; SZABO S, 1990, GASTROENTEROL CLIN N, V19, P67; Takagi T, 2004, REDOX REP, V9, P376, DOI 10.1179/135100004225006911; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Villegas I, 2004, EUR J PHARMACOL, V505, P195, DOI 10.1016/j.ejphar.2004.10.020; WALLACE JL, 1995, AM J PHYSIOL-GASTR L, V268, pG134, DOI 10.1152/ajpgi.1995.268.1.G134; Wang ACC, 2001, AM J RESP CELL MOL, V24, P688, DOI 10.1165/ajrcmb.24.6.4376; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; YANG X, 2011, PLOS ONE, V6, P1516, DOI DOI 10.1371/J0URNAL.P0NE.0025271.PUBMED:21966476; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhang LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048453	67	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76894	10.1371/journal.pone.0076894	http://dx.doi.org/10.1371/journal.pone.0076894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124600	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100157
J	Mantuano, E; Lam, MS; Gonias, SL				Mantuano, Elisabetta; Lam, Michael S.; Gonias, Steven L.			LRP1 Assembles Unique Co-receptor Systems to Initiate Cell Signaling in Response to Tissue-type Plasminogen Activator and Myelin-associated Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; ERK; Lipoprotein-like Receptor (LRP); Protease Inhibitor; Tissue-type Plasminogen Activator (tPA)	RECEPTOR-RELATED PROTEIN; METHYL-D-ASPARTATE; BLOOD-BRAIN-BARRIER; LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR DISSECTION; MEDIATED ACTIVATION; CALCIUM RESPONSES	In addition to functioning as an activator of fibrinolysis, tissue-type plasminogen activator (tPA) interacts with neurons and regulates multiple aspects of neuronal cell physiology. In this study, we examined the mechanism by which tPA initiates cell signaling in PC12 and N2a neuron-like cells. We demonstrate that enzymatically active and inactive tPA (EI-tPA) activate ERK1/2 in a biphasic manner. Rapid ERK1/2 activation is dependent on LDL receptor-related protein-1 (LRP1). In the second phase, ERK1/2 is activated by tPA independently of LRP1. The length of the LRP1-dependent phase varied inversely with the tPA concentration. Rapid ERK1/2 activation in response to EI-tPA and activated (2)-macroglobulin (M-2*) required the NMDA receptor and Trk receptors, which assemble with LRP1 into a single pathway. Assembly of this signaling system may have been facilitated by the bifunctional adapter protein, PSD-95, which associated with LRP1 selectively in cells treated with EI-tPA or M-2*. Myelin-associated glycoprotein binds to LRP1 with high affinity but failed to induce phosphorylation of TrkA or ERK1/2. Instead, myelin-associated glycoprotein recruited p75 neurotrophin receptor (p75NTR) into a complex with LRP1 and activated RhoA. p75NTR was not recruited by other LRP1 ligands, including EI-tPA and M-2*. Lactoferrin functioned as an LRP1 signaling antagonist, inhibiting Trk receptor phosphorylation and ERK1/2 activation in response to EI-tPA. These results demonstrate that LRP1-initiated cell signaling is ligand-dependent. Proteins that activate cell signaling by binding to LRP1 assemble different co-receptor systems. Ligand-specific co-receptor recruitment provides a mechanism by which one receptor, LRP1, may trigger different signaling responses.	[Mantuano, Elisabetta; Lam, Michael S.; Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, Biomed Sci Bldg,9500 Gilman Dr,0612, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261; Lam, Michael/0000-0001-9670-0025	National Institutes of Health [HL-060551, NS-054671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL-060551 and NS-054671.	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Baron A, 2010, BIOL CELL, V102, P539, DOI 10.1042/BC20100072; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; BU GJ, 1994, BLOOD, V83, P3427; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; COLLEN D, 1987, J CELL BIOCHEM, V33, P77, DOI 10.1002/jcb.240330202; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Domeniconi M, 2010, HISTOL HISTOPATHOL, V25, P1207, DOI 10.14670/HH-25.1207; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fernandez-Castaneda A, 2013, J BIOL CHEM, V288, P4538, DOI 10.1074/jbc.M112.384693; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; HUSSAINI IM, 1990, J BIOL CHEM, V265, P19441; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; NEY KA, 1985, BIOCHEMISTRY-US, V24, P4586, DOI 10.1021/bi00338a016; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Rebeck GW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pe28; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Vazhappilly R, 2010, NEUROCHEM INT, V56, P569, DOI 10.1016/j.neuint.2009.12.020; Webb DJ, 1995, EUR J BIOCHEM, V234, P714, DOI 10.1111/j.1432-1033.1995.714_a.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	56	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34009	34018		10.1074/jbc.M113.509133	http://dx.doi.org/10.1074/jbc.M113.509133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129569	Green Published, hybrid			2022-12-25	WOS:000327250200042
J	Sun, J; Lin, Y; Wu, J				Sun, Jin; Lin, Yi; Wu, Ji			Long Non-Coding RNA Expression Profiling of Mouse Testis during Postnatal Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; SPERMATOGONIAL STEM-CELLS; H19 METHYLATION IMPRINT; ANTISENSE RNA; TRANSCRIPTIONAL NOISE; MOLECULAR-MECHANISMS; ANALYSIS UNCOVERS; PARENTAL ALLELES; DNA METHYLATION; GENE-EXPRESSION	Mammalian testis development and spermatogenesis play critical roles in male fertility and continuation of a species. Previous research into the molecular mechanisms of testis development and spermatogenesis has largely focused on the role of protein-coding genes and small non-coding RNAs, such as microRNAs and piRNAs. Recently, it has become apparent that large numbers of long (>200 nt) non-coding RNAs (lncRNAs) are transcribed from mammalian genomes and that lncRNAs perform important regulatory functions in various developmental processes. However, the expression of lncRNAs and their biological functions in post-natal testis development remain unknown. In this study, we employed microarray technology to examine lncRNA expression profiles of neonatal (6-day-old) and adult (8-week-old) mouse testes. We found that 8,265 lncRNAs were expressed above background levels during post-natal testis development, of which 3,025 were differentially expressed. Candidate lncRNAs were identified for further characterization by an integrated examination of genomic context, gene ontology (GO) enrichment of their associated protein-coding genes, promoter analysis for epigenetic modification, and evolutionary conservation of elements. Many lncRNAs overlapped or were adjacent to key transcription factors and other genes involved in spermatogenesis, such as Ovol1, Ovol2, Lhx1, Sox3, Sox9, Plzf, c-Kit, Wt1, Sycp2, Prm1 and Prm2. Most differentially expressed lncRNAs exhibited epigenetic modification marks similar to protein-coding genes and tend to be expressed in a tissue-specific manner. In addition, the majority of differentially expressed lncRNAs harbored evolutionary conserved elements. Taken together, our findings represent the first systematic investigation of lncRNA expression in the mammalian testis and provide a solid foundation for further research into the molecular mechanisms of lncRNAs function in mammalian testis development and spermatogenesis.	[Sun, Jin; Wu, Ji] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Inst, Minist Educ, Shanghai 200030, Peoples R China; [Wu, Ji] Ningxia Med Univ, Minist Educ, Key Lab Fertil Preservat & Maintenance, Ningxia, Peoples R China; [Lin, Yi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ningxia Medical University; Shanghai Jiao Tong University	Wu, J (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Inst, Minist Educ, Shanghai 200030, Peoples R China.	jiwu@sjtu.edu.cn			National Basic Research Program of China [2013CB967401, 2010CB945001]; National Nature Science Foundation of China [81121001]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (grant numbers 2013CB967401 and 2010CB945001; http://www.most.gov.cn) and the National Nature Science Foundation of China (grant number 81121001; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Deng Y, 2005, ACTA BIOCH BIOPH SIN, V37, P159, DOI 10.1093/abbs/37.3.159; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lee JY, 2012, MOL CELLS, V33, P111, DOI 10.1007/s10059-012-2164-x; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lee TL, 2011, SPERM CHROMATIN: BIOLOGICAL AND CLINICAL APPLICATIONS IN MALE INFERTILITY AND ASSISTED REPRODUCTION, P107, DOI 10.1007/978-1-4419-6857-9_8; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mattick JS, 2011, SEMIN CELL DEV BIOL, V22, P327, DOI 10.1016/j.semcdb.2011.05.002; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Nie DS, 2013, MOL BIOL REP, V40, P1905, DOI 10.1007/s11033-012-2246-z; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Pang ALY, 2003, J ANDROL, V24, P899; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; Reis EM, 2005, OMICS, V9, P2, DOI 10.1089/omi.2005.9.2; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Roberts KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029495; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt JA, 2009, BIOL REPROD, V81, P56, DOI 10.1095/biolreprod.108.075358; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Sha JH, 2002, MOL HUM REPROD, V8, P511, DOI 10.1093/molehr/8.6.511; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spiess AN, 2003, BIOL REPROD, V68, P2044, DOI 10.1095/biolreprod.102.011593; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Takeuchi A, 2003, NAT GENET, V33, P172, DOI 10.1038/ng1072; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vemuganti SA, 2007, DEV BIOL, V309, P18, DOI 10.1016/j.ydbio.2007.06.010; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	97	108	114	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75750	10.1371/journal.pone.0075750	http://dx.doi.org/10.1371/journal.pone.0075750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130740	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200021
J	Mochida, K; Uehara-Yamaguchi, Y; Takahashi, F; Yoshida, T; Sakurai, T; Shinozaki, K				Mochida, Keiichi; Uehara-Yamaguchi, Yukiko; Takahashi, Fuminori; Yoshida, Takuhiro; Sakurai, Tetsuya; Shinozaki, Kazuo			Large-Scale Collection and Analysis of Full-Length cDNAs from Brachypodium distachyon and Integration with Pooideae Sequence Resources	PLOS ONE			English	Article							DATABASE RAP-DB; FOX HUNTING SYSTEM; MESSENGER-RNA; DRAFT GENOME; ARABIDOPSIS; ANNOTATION; RICE; PROJECT; STRESS; MODEL	A comprehensive collection of full-length cDNAs is essential for correct structural gene annotation and functional analyses of genes. We constructed a mixed full-length cDNA library from 21 different tissues of Brachypodium distachyon Bd21, and obtained 78,163 high quality expressed sequence tags (ESTs) from both ends of ca. 40,000 clones (including 16,079 contigs). We updated gene structure annotations of Brachypodium genes based on full-length cDNA sequences in comparison with the latest publicly available annotations. About 10,000 non-redundant gene models were supported by full-length cDNAs; ca. 6,000 showed some transcription unit modifications. We also found ca. 580 novel gene models, including 362 newly identified in Bd21. Using the updated transcription start sites, we searched a total of 580 plant cis-motifs in the -3 kb promoter regions and determined a genome-wide Brachypodium promoter architecture. Furthermore, we integrated the Brachypodium full-length cDNAs and updated gene structures with available sequence resources in wheat and barley in a web-accessible database, the RIKEN Brachypodium FL cDNA database. The database represents a "one-stop'' information resource for all genomic information in the Pooideae, facilitating functional analysis of genes in this model grass plant and seamless knowledge transfer to the Triticeae crops.	[Mochida, Keiichi; Uehara-Yamaguchi, Yukiko; Takahashi, Fuminori; Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div,Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yoshida, Takuhiro; Sakurai, Tetsuya] RIKEN Ctr Sustainable Resource Sci, Integrated Genome Informat Res Unit, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Mochida, Keiichi] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan	RIKEN; RIKEN; Yokohama City University	Mochida, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div,Tsurumi Ku, Yokohama, Kanagawa, Japan.	keiichi.mochida@riken.jp	Mochida, Keiichi/T-2866-2019; Mochida, Keiichi/N-9052-2014; Sakurai, Tetsuya/B-2690-2010; Takahashi, Fuminori/D-6200-2017	Mochida, Keiichi/0000-0003-1299-0024; Mochida, Keiichi/0000-0003-1299-0024; Sakurai, Tetsuya/0000-0003-2046-8973; Takahashi, Fuminori/0000-0001-8817-8652	strategic research project in RIKEN Biomass engineering program	strategic research project in RIKEN Biomass engineering program	This work was supported by a grant from a strategic research project in RIKEN Biomass engineering program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hayashizaki Y, 2003, COLD SPRING HARB SYM, V68, P195, DOI 10.1101/sqb.2003.68.195; Higuchi M, 2011, METHODS MOL BIOL, V678, P77, DOI 10.1007/978-1-60761-682-5_7; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kawaura K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-271; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu XH, 2011, P NATL ACAD SCI USA, V108, P12533, DOI 10.1073/pnas.1019732108; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435	41	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75265	10.1371/journal.pone.0075265	http://dx.doi.org/10.1371/journal.pone.0075265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130698	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900029
J	Radman, I; Greiss, S; Chin, JW				Radman, Inja; Greiss, Sebastian; Chin, Jason W.			Efficient and Rapid C. elegans Transgenesis by Bombardment and Hygromycin B Selection	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENETIC-CODE; ANTIBIOTIC SELECTION; TRANSFORMATION; RESISTANCE; EXPRESSION	We report a simple, cost-effective, scalable and efficient method for creating transgenic Caenorhabditis elegans that requires minimal hands-on time. The method combines biolistic bombardment with selection for transgenics that bear a hygromycin B resistance gene on agar plates supplemented with hygromycin B, taking advantage of our observation that hygromycin B is sufficient to kill wild-type C. elegans at very low concentrations. Crucially, the method provides substantial improvements in the success of bombardments for isolating transmitting strains, the isolation of multiple independent strains, and the isolation of integrated strains: 100% of bombardments in a large data set yielded transgenics; 10 or more independent strains were isolated from 84% of bombardments, and up to 28 independent strains were isolated from a single bombardment; 82% of bombardments yielded stably transmitting integrated lines with most yielding multiple integrated lines. We anticipate that the selection will be widely adopted for C. elegans transgenesis via bombardment, and that hygromycin B resistance will be adopted as a marker in other approaches for manipulating, introducing or deleting DNA in C. elegans.	[Radman, Inja; Greiss, Sebastian; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Greiss, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sgreiss@mrc-lmb.cam.ac.uk; chin@mrc-lmb.cam.ac.uk	Greiss, Sebastian/B-2395-2015	Greiss, Sebastian/0000-0001-9130-0831	UK Medical Research Council (MRC) [U105181009, UD99999908]; Louis-Jeantet Foundation Young Investigator Career Award; Herchel Smith Foundation studentship; MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis-Jeantet Foundation Young Investigator Career Award; Herchel Smith Foundation studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC; http://www.mrc.ac.uk/) (grant numbers U105181009, UD99999908) to J.W.C.; the Louis-Jeantet Foundation Young Investigator Career Award to J.W.C. (http://www.jeantet.ch/); Herchel Smith Foundation studentship to I. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; BRENNER S, 1974, GENETICS, V77, P71; Chen C, 2013, NUCL ACIDS IN PRESS; Chin JW, 2012, SCIENCE, V336, P428, DOI 10.1126/science.1221761; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Praitis V, 2001, GENETICS, V157, P1217; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Semple JI, 2012, NAT METHODS, V9, P118, DOI 10.1038/nmeth.1864; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495	16	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76019	10.1371/journal.pone.0076019	http://dx.doi.org/10.1371/journal.pone.0076019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130756	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900066
J	Sanchez-Puig, JM; Lorenzo, MM; Blasco, R				Sanchez-Puig, Juana M.; Lorenzo, Maria M.; Blasco, Rafael			A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles	PLOS ONE			English	Article							DEFECTIVE RETROVIRAL PARTICLES; ALLOW CYTOPLASMIC PRODUCTION; INTRON-CONTAINING GENES; IN-VIVO; CHIMERIC VECTORS; HELPER RNAS; TRANSDUCTION; SYSTEM; CELLS; GENERATION	Poxviruses and Alphaviruses constitute two promising viral vectors that have been used extensively as expression systems, or as vehicles for vaccine purposes. Poxviruses, like vaccinia virus (VV) are well-established vaccine vectors having large insertion capacity, excellent stability, and ease of administration. In turn, replicons derived from Alphaviruses like Semliki Forest virus (SFV) are potent protein expression and immunization vectors but stocks are difficult to produce and maintain. In an attempt to demonstrate the use of a Poxvirus as a means for the delivery of small vaccine vectors, we have constructed and characterized VV/SFV hybrid vectors. A SFV replicon cDNA was inserted in the VV genome and placed under the control of a VV early promoter. The replicon, transcribed from the VV genome as an early transcript, was functional, and thus capable of initiating its own replication and transcription. Further, we constructed a VV recombinant additionally expressing the SFV structural proteins under the control of a vaccinia synthetic early/late promoter. Infection with this recombinant produced concurrent transcription of the replicon and expression of SFV structural proteins, and led to the generation of replicon-containing SFV particles that were released to the medium and were able to infect additional cells. This combined VV/SFV system in a single virus allows the use of VV as a SFV delivery vehicle in vivo. The combination of two vectors, and the possibility of generating in vivo single-cycle, replicon containing alphavirus particles, may open new strategies in vaccine development or in the design of oncolytic viruses.	[Sanchez-Puig, Juana M.; Lorenzo, Maria M.; Blasco, Rafael] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Blasco, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	blasco@inia.es	Eyré, Juana Sánchez-Puig/ABF-8080-2020; Lorenzo, Maria M./ABH-4437-2020; Blasco, Rafael/B-5829-2016	Sanchez-Puig Eyre, Juana/0000-0002-3966-3499; Lorenzo, Maria M./0000-0001-7588-673X; Blasco, Rafael/0000-0002-8819-5767	European Commission [QLK2-CT2002-01867, CT2006-037536]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [BFU2005-05124, BIO2008-03713]; Comunidad Autonoma de Madrid [S2009/TIC-1476]	European Commission(European CommissionEuropean Commission Joint Research Centre); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by contracts QLK2-CT2002-01867 and CT2006-037536 from the European Commission, and grants BFU2005-05124 and BIO2008-03713 from Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and by grant S2009/TIC-1476 from Comunidad Autonoma de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins Gregory J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000859; Barcena J, 2000, J GEN VIROL, V81, P1073, DOI 10.1099/0022-1317-81-4-1073; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; BERGLUND P, 1993, BIO-TECHNOL, V11, P916, DOI 10.1038/nbt0893-916; Bilbao G, 1997, FASEB J, V11, P624, DOI 10.1096/fasebj.11.8.9240964; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BLASCO R, 1992, J VIROL, V66, P4170, DOI 10.1128/JVI.66.7.4170-4179.1992; Caplen NJ, 1999, GENE THER, V6, P454, DOI 10.1038/sj.gt.3300835; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Dominguez J, 1998, J IMMUNOL METHODS, V220, P115, DOI 10.1016/S0022-1759(98)00156-2; Falkner FG, 2004, CURR GENE THER, V4, P417; Feng MZ, 1997, NAT BIOTECHNOL, V15, P866, DOI 10.1038/nbt0997-866; GLAUERT AM, 1974, J CELL BIOL, V63, P717, DOI 10.1083/jcb.63.3.717; Holzer Georg W, 2003, Methods Mol Med, V76, P565; Holzer GW, 1999, VIROLOGY, V253, P107, DOI 10.1006/viro.1998.9496; Kamrud KI, 2010, J GEN VIROL, V91, P1723, DOI 10.1099/vir.0.020081-0; Kamrud KI, 2010, J VIROL, V84, P7713, DOI 10.1128/JVI.00310-10; Kohno A, 1998, GENE THER, V5, P415, DOI 10.1038/sj.gt.3300589; Konetschny C, 2003, J VIROL, V77, P7017, DOI 10.1128/JVI.77.12.7017-7025.2003; Konetschny C, 2002, J VIROL, V76, P1236, DOI 10.1128/JVI.76.3.1236-1243.2002; Li KJ, 1998, P NATL ACAD SCI USA, V95, P3650, DOI 10.1073/pnas.95.7.3650; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Liljestrom P, 1994, CURRENT POTOCOLS MOL; Lorenzo Maria M, 2004, Methods Mol Biol, V269, P15; Lorenzo MD, 1998, BIOTECHNIQUES, V24, P308, DOI 10.2144/98242rr03; Lorenzo MM, 2000, J VIROL, V74, P10535, DOI 10.1128/JVI.74.22.10535-10550.2000; Lundstrom K, 2002, CURR OPIN MOL THER, V4, P28; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Okada T, 2004, J GENE MED, V6, P288, DOI 10.1002/jgm.490; Pan YF, 2009, J GENE MED, V11, P1030, DOI 10.1002/jgm.1390; Perdiguero B, 2006, J VIROL, V80, P8763, DOI 10.1128/JVI.00598-06; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quetglas JI, 2010, VIRUS RES, V153, P179, DOI 10.1016/j.virusres.2010.07.027; Ramsey WJ, 1998, BIOCHEM BIOPH RES CO, V246, P912, DOI 10.1006/bbrc.1998.8726; Sanchez-Puig Juana M, 2012, Methods Mol Biol, V890, P93, DOI 10.1007/978-1-61779-876-4_5; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; USDIN TB, 1993, BIOTECHNIQUES, V14, P222; Vasilakis N, 2003, NAT BIOTECHNOL, V21, P932, DOI 10.1038/nbt845; Wahlfors JJ, 1997, HUM GENE THER, V8, P2031, DOI 10.1089/hum.1997.8.17-2031; Wahlfors JJ, 1999, HUM GENE THER, V10, P1197, DOI 10.1089/10430349950018184	41	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75574	10.1371/journal.pone.0075574	http://dx.doi.org/10.1371/journal.pone.0075574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130722	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900043
J	Santarcangelo, EL; Paoletti, G; Chiavacci, I; Palombo, C; Carli, G; Varanini, M				Santarcangelo, Enrica L.; Paoletti, Giulia; Chiavacci, Iacopo; Palombo, Carlo; Carli, Giancarlo; Varanini, Maurizio			Cognitive Modulation of Psychophysical, Respiratory and Autonomic Responses to Cold Pressor Test	PLOS ONE			English	Article							HEART-RATE; HYPNOTIC ANALGESIA; PAIN PERCEPTION; BLOOD-PRESSURE; HYPNOSIS; SUGGESTIONS; HYPNOTIZABILITY; SUGGESTIBILITY; SUSCEPTIBILITY; RELAXATION	In healthy subjects with high hypnotisability (highs) under hypnosis, subjectively effective suggestions for analgesia abolish the increases in blood pressure associated with cold pressor test (cpt) by reducing the peripheral vascular resistance. The aim of the present study was to investigate the effects of the suggestions of analgesia on the responses to cpt in healthy highs (n = 22) and in low hypnotisable participants (lows, n = 22) out of hypnosis. Cpt was administered without (CPT) and with suggestions for analgesia (CPT+AN). Psychophysical (pain intensity, pain threshold, cpt duration (time of immersion) and pain tolerance, defined as the difference between cpt duration and pain threshold), respiratory (amplitude and frequency) and autonomic variables (tonic skin conductance, mean RR interval (RR = 1/heart rate), blood pressure, skin blood flow) were studied. The suggestions for analgesia increased cpt duration and RR in both groups, but decreased pain intensity and enhanced pain threshold only in highs; in both groups they did not modulate systolic blood pressure, tonic skin conductance and skin blood flow; thus, increased parasympathetic activity appears responsible for the heart rate reduction induced by suggestions in both groups. In conclusion, our findings show that suggestions modulate pain experience differentially in highs and lows, and are partially effective also in lows. We hypothesize that the mechanisms responsible for the efficacy of suggestions in healthy lows may be involved also in their efficacy in chronic pain patients with low hypnotisability.	[Santarcangelo, Enrica L.; Paoletti, Giulia; Chiavacci, Iacopo] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Palombo, Carlo] Univ Pisa, Dept Surg, Pisa, Italy; [Carli, Giancarlo] Univ Siena, Dept Physiol, I-53100 Siena, Italy; [Varanini, Maurizio] CNR, Inst Clin Physiol, Pisa, Italy	University of Pisa; University of Pisa; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Santarcangelo, EL (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	enricals@dfb.unipi.it	Varanini, Maurizio/B-7945-2015; SANTARCANGELO, ENRICA Laura/AAM-7275-2021	Varanini, Maurizio/0000-0001-8489-3560; santarcangelo, enrica laura/0000-0003-2519-1491	Pisa University; Fondazione ARPA (Pisa)	Pisa University; Fondazione ARPA (Pisa)	The study was funded by Pisa University and Fondazione ARPA (Pisa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SL, 1991, J PERS SOC PSYCHOL, V61, P504, DOI 10.1037/0022-3514.61.3.504; BALTHAZARD CG, 1989, INT J CLIN EXP HYP, V37, P70, DOI 10.1080/00207148908410534; Carli G, 2008, ARCH ITAL BIOL, V146, P75; Carvalho C, 2008, INT J CLIN EXP HYP, V56, P295, DOI 10.1080/00207140802041850; Casiglia E, 2007, AM J CLIN HYPN, V49, P255, DOI 10.1080/00029157.2007.10524503; CHEN ACN, 1989, PAIN, V37, P143, DOI 10.1016/0304-3959(89)90126-7; de la Fuente-Fernandez R, 2009, PARKINSONISM RELAT D, V15, pS72, DOI 10.1016/S1353-8020(09)70785-0; De Pascalis V, 1999, PAIN, V83, P499, DOI 10.1016/S0304-3959(99)00157-8; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; DEBENEDITTIS G, 1989, INT J CLIN EXP HYP, V37, P55, DOI 10.1080/00207148908410533; DePascalis V, 1996, INT J PSYCHOPHYSIOL, V21, P163, DOI 10.1016/0167-8760(95)00050-X; DEPASCALIS V, 2000, INT J CLIN EXP HYP, V48, P15; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Fillingim Roger B, 2005, Curr Rheumatol Rep, V7, P342, DOI 10.1007/s11926-005-0018-7; GOLDSTEIN B, 1994, PEDIATR RES, V36, P358, DOI 10.1203/00006450-199409000-00016; HILGARD ER, 1975, ACTA NEUROBIOL EXP, V35, P741; Hodges GJ, 2009, APPL PHYSIOL NUTR ME, V34, P829, DOI 10.1139/H09-076; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Jambrik Z, 2005, PAIN, V116, P181, DOI 10.1016/j.pain.2005.03.041; Jensen M, 2006, J BEHAV MED, V29, P95, DOI 10.1007/s10865-005-9031-6; Mekjavic IB, 2008, EUR J APPL PHYSIOL, V104, P193, DOI 10.1007/s00421-008-0727-5; MILLER MF, 1991, J ABNORM PSYCHOL, V100, P223, DOI 10.1037/0021-843X.100.2.223; Milling LS, 2008, CURR PAIN HEADACHE R, V12, P98, DOI 10.1007/s11916-008-0019-0; Milling LS, 2010, J CONSULT CLIN PSYCH, V78, P126, DOI 10.1037/a0017388; Milling LS, 2005, ANN BEHAV MED, V29, P116, DOI 10.1207/s15324796abm2902_6; Montgomery GH, 2000, INT J CLIN EXP HYP, V48, P138, DOI 10.1080/00207140008410045; Mourot L, 2009, PHYSIOL RES, V58, P83, DOI 10.33549/physiolres.931360; Oosterman JM, 2010, EUR J PAIN, V14, P1046, DOI 10.1016/j.ejpain.2010.04.004; Paoletti G, 2010, BRAIN RES BULL, V82, P65, DOI 10.1016/j.brainresbull.2010.03.003; Payne RA, 2006, J APPL PHYSIOL, V100, P136, DOI 10.1152/japplphysiol.00657.2005; PECKERMAN A, 1991, PSYCHOPHYSIOLOGY, V28, P485, DOI 10.1111/j.1469-8986.1991.tb01985.x; Pollatos O, 2012, PAIN, V153, P1680, DOI 10.1016/j.pain.2012.04.030; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Ray WJ, 2000, INT J CLIN EXP HYP, V48, P22, DOI 10.1080/00207140008410358; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Santarcangelo EL, 2008, INT J CLIN EXP HYP, V56, P255, DOI 10.1080/00207140802039649; Scattina E, 2012, EXP BRAIN RES, V216, P341, DOI 10.1007/s00221-011-2935-1; Sebastiani L, 2007, INT J PSYCHOPHYSIOL, V63, P125, DOI 10.1016/j.ijpsycho.2006.10.001; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Shea SA, 1996, EXP PHYSIOL, V81, P1; SPANOS NP, 1989, J ABNORM PSYCHOL, V98, P285, DOI 10.1037/0021-843X.98.3.285; TENENBAUM SJ, 1990, AM J CLIN HYPN, V33, P40, DOI 10.1080/00029157.1990.10402899; Tousignant-Laflamme Y, 2010, J PAIN, V11, P983, DOI 10.1016/j.jpain.2010.01.266; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Weise F, 1993, Clin Auton Res, V3, P303, DOI 10.1007/BF01827331	47	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75023	10.1371/journal.pone.0075023	http://dx.doi.org/10.1371/journal.pone.0075023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130680	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900015
J	Taillebois, L; Castelin, M; Ovenden, JR; Bonillo, C; Keith, P				Taillebois, Laura; Castelin, Magalie; Ovenden, Jennifer R.; Bonillo, Celine; Keith, Philippe			Contrasting Genetic Structure among Populations of Two Amphidromous Fish Species (Sicydiinae) in the Central West Pacific	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; INDO-PACIFIC; TELEOSTEI GOBIOIDEI; RANGE EXPANSION; REEF FISHES; PATTERNS; DISPERSAL; CONNECTIVITY; ISLAND; PHYLOGEOGRAPHY	Both present-day and past processes can shape connectivity of populations. Pleistocene vicariant events and dispersal have shaped the present distribution and connectivity patterns of aquatic species in the Indo-Pacific region. In particular, the processes that have shaped distribution of amphidromous goby species still remain unknown. Previous studies show that phylogeographic breaks are observed between populations in the Indian and Pacific Oceans where the shallow Sunda shelf constituted a geographical barrier to dispersal, or that the large spans of open ocean that isolate the Hawaiian or Polynesian Islands are also barriers for amphidromous species even though they have great dispersal capacity. Here we assess past and present genetic structure of populations of two amphidromous fish (gobies of the Sicydiinae) that are widely distributed in the Central West Pacific and which have similar pelagic larval durations. We analysed sections of mitochondrial COI, Cytb and nuclear Rhodospine genes in individuals sampled from different locations across their entire known range. Similar to other Sicydiinae fish, intraspecific mtDNA genetic diversity was high for all species (haplotype diversity between 0.9-0.96). Spatial analyses of genetic variation in Sicyopus zosterophorum demonstrated strong isolation across the Torres Strait, which was a geologically intermittent land barrier linking Australia to Papua New Guinea. There was a clear genetic break between the northwestern and the southwestern clusters in Si. zosterophorum (phi(ST) = 0.67502 for COI) and coalescent analyses revealed that the two populations split at 306 Kyr BP (95% HPD 79-625 Kyr BP), which is consistent with a Pleistocene separation caused by the Torres Strait barrier. However, this geographical barrier did not seem to affect Sm. fehlmanni. Historical and demographic hypotheses are raised to explain the different patterns of population structure and distribution between these species. Strategies aiming to conserve amphidromous fish should consider the presence of cryptic evolutionary lineages to prevent stock depletion.	[Taillebois, Laura; Castelin, Magalie; Keith, Philippe] UPMC, MNHN, CNRS, IRD,Milieux & Peuplements Aquat UMR 7208, Paris, France; [Taillebois, Laura] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Castelin, Magalie] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9R 5K6, Canada; [Ovenden, Jennifer R.] Univ Queensland, Mol Fisheries Lab, Brisbane, Qld, Australia; [Bonillo, Celine] Museum Natl Hist Nat, Serv Systemat Mol UMR 7138, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Charles Darwin University; Fisheries & Oceans Canada; University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN)	Taillebois, L (corresponding author), UPMC, MNHN, CNRS, IRD,Milieux & Peuplements Aquat UMR 7208, Paris, France.	laura.taillebois@cdu.edu.au	Ovenden, Jennifer/A-3717-2010	Ovenden, Jennifer/0000-0001-7538-1504	New Caledonian Government; Museum national d'Histoire naturelle of Paris; BIONEOCAL ANR; French Ichtyological Society (SFI); UMR BOREA [UMR7208]; AIMARA association	New Caledonian Government; Museum national d'Histoire naturelle of Paris; BIONEOCAL ANR(French National Research Agency (ANR)); French Ichtyological Society (SFI); UMR BOREA; AIMARA association	This study was supported by the New Caledonian Government, the Museum national d'Histoire naturelle of Paris (www.mnhn.fr/le-museum/), the BIONEOCAL ANR, the French Ichtyological Society (SFI), the UMR BOREA 7208 (www.mnhn.fr/mnhn/UMR7208/), and the AIMARA association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Brasher AM, 1996, TECHNICAL REPORT; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; BROTHERS EB, 1983, MAR BIOL, V76, P319, DOI 10.1007/BF00393035; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chenoweth SF, 1998, P ROY SOC B-BIOL SCI, V265, P415, DOI 10.1098/rspb.1998.0310; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Cook BD, 2008, MOL ECOL, V17, P1066, DOI 10.1111/j.1365-294X.2007.03637.x; Covich AP, 2006, POL J ECOL, V54, P523; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; Dettai A, 2011, DEEP-SEA RES PT II, V58, P250, DOI 10.1016/j.dsr2.2010.05.021; Dexter KG, 2010, J BIOGEOGR, V37, P2137, DOI 10.1111/j.1365-2699.2010.02362.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzsimons J. Michael, 1993, Ichthyological Exploration of Freshwaters, V4, P1; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Hantoro WS, 1997, QUATERN INT, V37, P73, DOI 10.1016/1040-6182(96)00010-9; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasegawa T, 2009, J OCEANOGR, V65, P817, DOI 10.1007/s10872-009-0068-y; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hodges Marc H., 1998, Pacific Science, V52, P237; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Iida M, 2008, ENVIRON BIOL FISH, V83, P331, DOI 10.1007/s10641-008-9345-7; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Jennings JN, 1972, SOME ATTRIBUTES TORR, P29; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Keith P., 2010, POISSONS CRUSTACES E; KINZIE RA, 1988, ENVIRON BIOL FISH, V22, P179, DOI 10.1007/BF00005380; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leis JM, 2002, ENVIRON BIOL FISH, V65, P199, DOI 10.1023/A:1020096720543; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindstrom DP, 2012, COPEIA, P293, DOI 10.1643/CI-11-027; Lord C, 2012, MAR ECOL PROG SER, V455, P269, DOI 10.3354/meps09617; Lord C, 2010, ECOL FRESHW FISH, V19, P26, DOI 10.1111/j.1600-0633.2009.00386.x; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lukoschek V, 2007, MOL ECOL, V16, P3406, DOI 10.1111/j.1365-294X.2007.03392.x; Luton Corene D., 2005, Micronesica, V38, P1; Maeda K, 2010, PAC SCI, V64, P161, DOI 10.2984/64.2.161; Marquet G., 2003, ATLAS POISSONS CRUST; McDowall RM, 2007, FISH FISH, V8, P1, DOI 10.1111/j.1467-2979.2007.00232.x; Mirams AGK, 2011, CORAL REEFS, V30, P937, DOI 10.1007/s00338-011-0767-x; Monti D, 2009, CAN J FISH AQUAT SCI, V66, P1282, DOI 10.1139/F09-075; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; MYERS GS, 1949, COPEIA, P89; Myers MJ, 2000, FRESHWATER BIOL, V44, P535, DOI 10.1046/j.1365-2427.2000.00599.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishimoto RT, 1991, NEW DIRECTIONS RES M, P77; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaud A., 2007, TRACER VERSION 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; Roughgarden J., 1989, P403; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Schultz JK, 2007, MAR BIOL, V151, P167, DOI 10.1007/s00227-006-0471-5; SLATKIN M, 1991, GENETICS, V129, P555; Smith GC, 2003, BIOSCIENCE, V53, P1048, DOI 10.1641/0006-3568(2003)053[1048:AEPOTB]2.0.CO;2; Taillebois L, 2011, GEN COMP ENDOCR, V173, P281, DOI 10.1016/j.ygcen.2011.06.008; Taillebois L, 2012, THESIS MUSEUM NATL H; Taillebois L, 2012, ECOL FRESHW FISH, V21, P552, DOI 10.1111/j.1600-0633.2012.00575.x; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Tillett BJ, 2012, CONSERV GENET, V13, P99, DOI 10.1007/s10592-011-0268-z; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WALLACE C C, 1991, Australian Systematic Botany, V4, P199, DOI 10.1071/SB9910199; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe Shun, 2006, Coastal Marine Science, V30, P473; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 2000, MOL ECOL, V9, P1815, DOI 10.1046/j.1365-294x.2000.01082.x; Watson RE, 2001, CYBIUM, V25, P41; Watson Ronald E., 1999, Aqua (Graffignana), V3, P113; Watson Ronald E., 1999, Aqua (Graffignana), V3, P93; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Winters KL, 2010, MAR BIOL, V157, P1679, DOI 10.1007/s00227-010-1442-4; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	95	23	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75465	10.1371/journal.pone.0075465	http://dx.doi.org/10.1371/journal.pone.0075465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130714	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900038
J	Zou, JH; Storm, DR; Xia, ZG				Zou, Junhui; Storm, Daniel R.; Xia, Zhengui			Conditional Deletion of ERK5 MAP Kinase in the Nervous System Impairs Pheromone Information Processing and Pheromone-Evoked Behaviors	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; TARGETED DELETION; VOMERONASAL ORGAN; SEXUAL-BEHAVIOR; MALE-MICE; MAIN; DISCRIMINATION; NEUROGENESIS; PREFERENCE; INPUT	ERK5 MAP kinase is highly expressed in the developing nervous system but absent in most regions of the adult brain. It has been implicated in regulating the development of the main olfactory bulb and in odor discrimination. However, whether it plays an essential role in pheromone-based behavior has not been established. Here we report that conditional deletion of the Mapk7 gene which encodes ERK5 in mice in neural stem cells impairs several pheromone-mediated behaviors including aggression and mating in male mice. These deficits were not caused by a reduction in the level of testosterone, by physical immobility, by heightened fear or anxiety, or by depression. Using mouse urine as a natural pheromone-containing solution, we provide evidence that the behavior impairment was associated with defects in the detection of closely related pheromones as well as with changes in their innate preference for pheromones related to sexual and reproductive activities. We conclude that expression of ERK5 during development is critical for pheromone response and associated animal behavior in adult mice.	[Zou, Junhui; Xia, Zhengui] Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Storm, Daniel R.; Xia, Zhengui] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xia, ZG (corresponding author), Univ Washington, Toxicol Program, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	zxia@u.washington.edu			National Institutes of Health [R01 MH95840, R01 DC004156]; National Institute of Child Health and Human Development [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants (R01 MH95840 to Z X and R01 DC004156 to DRS) and facilitated by grant P30 HD02274 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MJ, 2009, ANNU REV PHYSIOL, V71, P141, DOI 10.1146/annurev.physiol.010908.163137; BRENNAN PA, 2010, PHEROMONES MAMMALIAN; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Giammanco M, 2005, MED SCI MONITOR, V11, pRA136; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Jakupovic J, 2008, PHYSIOL BEHAV, V93, P467, DOI 10.1016/j.physbeh.2007.10.005; Keller M, 2006, CHEM SENSES, V31, P753, DOI 10.1093/chemse/bjl018; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; LI T, 2013, PLOS ONE; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; RAISMAN G, 1972, EXP BRAIN RES, V14, P395; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Slotnick B, 2010, EUR J NEUROSCI, V31, P1108, DOI 10.1111/j.1460-9568.2010.07141.x; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Wang Z, 2007, MOL NEUROBIOL, V35, P317, DOI 10.1007/s12035-007-0014-1; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; WINANS SS, 1970, SCIENCE, V170, P330, DOI 10.1126/science.170.3955.330; WYSOCKI CJ, 1979, NEUROSCI BIOBEHAV R, V3, P301, DOI 10.1016/0149-7634(79)90015-0; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76901	10.1371/journal.pone.0076901	http://dx.doi.org/10.1371/journal.pone.0076901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130808	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900102
J	Maudet, C; Sourisce, A; Dragin, L; Lahouassa, H; Rain, JC; Bouaziz, S; Ramirez, BC; Margottin-Goguet, F				Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Rain, Jean-Christophe; Bouaziz, Serge; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence			HIV-1 Vpr Induces the Degradation of ZIP and sZIP, Adaptors of the NuRD Chromatin Remodeling Complex, by Hijacking DCAF1/VprBP	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; CUL4-DDB1 UBIQUITIN LIGASE; VIRAL PROTEIN-R; NF-KAPPA-B; MACROPHAGE INFECTION; MI-2/NURD COMPLEX; ENZYME APOBEC3G; IN-VIVO; TRANSCRIPTION	The Vpr protein from type 1 and type 2 Human Immunodeficiency Viruses (HIV-1 and HIV-2) is thought to inactivate several host proteins through the hijacking of the DCAF1 adaptor of the Cul4A ubiquitin ligase. Here, we identified two transcriptional regulators, ZIP and sZIP, as Vpr-binding proteins degraded in the presence of Vpr. ZIP and sZIP have been shown to act through the recruitment of the NuRD chromatin remodeling complex. Strikingly, chromatin is the only cellular fraction where Vpr is present together with Cul4A ubiquitin ligase subunits. Components of the NuRD complex and exogenous ZIP and sZIP were also associated with this fraction. Several lines of evidence indicate that Vpr induces ZIP and sZIP degradation by hijacking DCAF1: (i) Vpr induced a drastic decrease of exogenously expressed ZIP and sZIP in a dose-dependent manner, (ii) this decrease relied on the proteasome activity, (iii) ZIP or sZIP degradation was impaired in the presence of a DCAF1-binding deficient Vpr mutant or when DCAF1 expression was silenced. Vpr-mediated ZIP and sZIP degradation did not correlate with the growth-related Vpr activities, namely G2 arrest and G2 arrest-independent cytotoxicity. Nonetheless, infection with HIV-1 viruses expressing Vpr led to the degradation of the two proteins. Altogether our results highlight the existence of two host transcription factors inactivated by Vpr. The role of Vpr-mediated ZIP and sZIP degradation in the HIV-1 replication cycle remains to be deciphered.	[Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] Inst Cochin, INSERM, U1016, Paris, France; [Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] CNRS, UMR8104, Paris, France; [Maudet, Claire; Sourisce, Adele; Dragin, Loic; Lahouassa, Hichem; Bouaziz, Serge; Ramirez, Bertha Cecilia; Margottin-Goguet, Florence] Univ Paris 05, Paris, France; [Maudet, Claire] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Rain, Jean-Christophe] HYBRIGEN Serv SAS, Paris, France; [Bouaziz, Serge] CNRS, UMR8015, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Margottin-Goguet, F (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	florence.margottin-goguet@inserm.fr	Margottin-Goguet, Florence/F-9272-2013; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Maudet, Claire/AAH-1728-2019; RAMIREZ, Cecilia/O-6100-2017	Margottin-Goguet, Florence/0000-0002-3124-6690; Bouaziz, Serge/0000-0001-7792-8307; Maudet, Claire/0000-0001-8856-0819; RAMIREZ, Cecilia/0000-0002-6670-9827; RAIN, Jean-Christophe/0000-0001-8110-0641	"Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS); "Sidaction"; "Fondation de France"; University Paris Diderot; University Paris Descartes; ANRS	"Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); "Sidaction"; "Fondation de France"(Fondation de France); University Paris Diderot; University Paris Descartes; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the "Agence Nationale de la Recherche sur le SIDA et les hepatites virales" (ANRS), "Sidaction" and "Fondation de France". CM and LD received support from the University Paris Diderot and University Paris Descartes respectively; AS and LH received support from "Sidaction" and ANRS respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 1996, J MOL BIOL, V261, P599, DOI 10.1006/jmbi.1996.0485; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Amini S, 2004, DNA CELL BIOL, V23, P249, DOI 10.1089/104454904773819833; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cui JQ, 2006, CELL CYCLE, V5, P2626, DOI 10.4161/cc.5.22.3442; de Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035385; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Deshmane SL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-477; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Janket ML, 2004, BIOCHEM BIOPH RES CO, V314, P1126, DOI 10.1016/j.bbrc.2004.01.008; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P621, DOI 10.1038/ni0612-621c; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Maudet C, 2011, J BIOL CHEM, V286, P23742, DOI 10.1074/jbc.M111.220780; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Planelles V, 2010, MOL ASPECTS MED, V31, P398, DOI 10.1016/j.mam.2010.05.002; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Roux P, 2000, J VIROL, V74, P4658, DOI 10.1128/JVI.74.10.4658-4665.2000; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Taneichi D, 2011, J NEUROIMMUNE PHARM, V6, P177, DOI 10.1007/s11481-011-9276-5; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yu WH, 2010, J BIOL CHEM, V285, P14301, DOI 10.1074/jbc.M110.107508; Zhu Y, 2003, APOPTOSIS, V8, P71, DOI 10.1023/A:1021653119934; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	63	18	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77320	10.1371/journal.pone.0077320	http://dx.doi.org/10.1371/journal.pone.0077320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116224	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200115
J	Cai, H; Cong, WN; Daimon, CM; Wang, R; Tschop, MH; Sevigny, J; Martin, B; Maudsley, S				Cai, Huan; Cong, Wei-na; Daimon, Caitlin M.; Wang, Rui; Tschoep, Matthias H.; Sevigny, Jean; Martin, Bronwen; Maudsley, Stuart			Altered Lipid and Salt Taste Responsivity in Ghrelin and GOAT Null Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EPITHELIAL NA+ CHANNEL; CHAIN FATTY-ACIDS; INSULIN SENSITIVITY; DIETARY LIPIDS; MOLECULAR-MECHANISMS; ALPHA-GUSTDUCIN; KNOCKOUT MICE; FOOD-INTAKE; CELLS	Taste perception plays an important role in regulating food preference, eating behavior and energy homeostasis. Taste perception is modulated by a variety of factors, including gastric hormones such as ghrelin. Ghrelin can regulate growth hormone release, food intake, adiposity, and energy metabolism. Octanoylation of ghrelin by ghrelin O-acyltransferase (GOAT) is a specific post-translational modification which is essential for many biological activities of ghrelin. Ghrelin and GOAT are both widely expressed in many organs including the gustatory system. In the current study, overall metabolic profiles were assessed in wild-type (WT), ghrelin knockout (ghrelin(-/-)), and GOAT knockout (GOAT(-/-)) mice. Ghrelin(-/-) mice exhibited decreased food intake, increased plasma triglycerides and increased ketone bodies compared to WT mice while demonstrating WT-like body weight, fat composition and glucose control. In contrast GOAT(-/-) mice exhibited reduced body weight, adiposity, resting glucose and insulin levels compared to WT mice. Brief access taste behavioral tests were performed to determine taste responsivity in WT, ghrelin(-/-) and GOAT(-/-) mice. Ghrelin and GOAT null mice possessed reduced lipid taste responsivity. Furthermore, we found that salty taste responsivity was attenuated in ghrelin(-/-) mice, yet potentiated in GOAT(-/-) mice compared to WT mice. Expression of the potential lipid taste regulators Cd36 and Gpr120 were reduced in the taste buds of ghrelin and GOAT null mice, while the salt-sensitive ENaC subunit was increased in GOAT(-/-) mice compared with WT mice. The altered expression of Cd36, Gpr120 and ENaC may be responsible for the altered lipid and salt taste perception in ghrelin(-/-) and GOAT(-/-) mice. The data presented in the current study potentially implicates ghrelin signaling activity in the modulation of both lipid and salt taste modalities.	[Cai, Huan; Cong, Wei-na; Daimon, Caitlin M.; Wang, Rui; Martin, Bronwen] NIA, Metab Unit, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Tschoep, Matthias H.] Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany; [Sevigny, Jean] Ctr Rech CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Lab Neurosci, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Laval University; Laval University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012; Tschoep, Matthias H/I-5443-2014; Wang, Rui/I-5643-2019; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Cai, Huan/B-6578-2016	Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Wang, Rui/0000-0001-7015-0272; Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Tschoep, Matthias/0000-0002-4744-371X; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging, National Institutes of Health	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Massadi O, 2011, PEPTIDES, V32, P2301, DOI 10.1016/j.peptides.2011.08.020; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Bigiani A, 2001, J NEUROPHYSIOL, V85, P1552, DOI 10.1152/jn.2001.85.4.1552; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; DESIMONE JA, 1985, AM J PHYSIOL, V249, pR52, DOI 10.1152/ajpregu.1985.249.1.R52; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; FARBMAN AI, 1965, J ULTRA MOL STRUCT R, V12, P328, DOI 10.1016/S0022-5320(65)80103-4; Gaillard D, 2008, ANN NY ACAD SCI, V1141, P163, DOI 10.1196/annals.1441.028; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Granata R, 2012, FASEB J, V26, P3393, DOI 10.1096/fj.11-201343; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; HAMILTON CL, 1964, J COMP PHYSIOL PSYCH, V58, P459, DOI 10.1037/h0047142; Hashimoto H, 2007, ENDOCRINOLOGY, V148, P1638, DOI 10.1210/en.2006-0993; Hashimoto H, 2011, CURR PROTEIN PEPT SC, V12, P280, DOI 10.2174/138920311795906727; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Heppner KM, 2012, METHOD ENZYMOL, V514, P249, DOI 10.1016/B978-0-12-381272-8.00015-5; Hiraoka T, 2003, PHYSIOL BEHAV, V79, P713, DOI 10.1016/S0031-9384(03)00201-4; Hummler E, 2000, J AM SOC NEPHROL, V11, pS129; Kang K, 2011, PEPTIDES, V32, P2236, DOI 10.1016/j.peptides.2011.04.028; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Laugerette F, 2007, BIOCHIMIE, V89, P265, DOI 10.1016/j.biochi.2006.10.011; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Liu P, 2011, J NEUROSCI, V31, P8634, DOI 10.1523/JNEUROSCI.6273-10.2011; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Matsumura S, 2007, BIOMED RES-TOKYO, V28, P49, DOI 10.2220/biomedres.28.49; MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rice HB, 2000, PHYSIOL BEHAV, V68, P755, DOI 10.1016/S0031-9384(99)00255-3; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Sclafani A, 2007, AM J PHYSIOL-REG I, V292, pR1828, DOI 10.1152/ajpregu.00826.2006; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; St-Pierre DH, 2007, J CLIN ENDOCR METAB, V92, P264, DOI 10.1210/jc.2006-1603; Stranahan AM, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/732975; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Takeda M, 2001, NUTRITION, V17, P117, DOI 10.1016/S0899-9007(00)00513-X; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; Tsuruta M, 1999, PHYSIOL BEHAV, V66, P285, DOI 10.1016/S0031-9384(98)00299-6; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Verhulst PJ, 2012, WORLD J GASTROENTERO, V18, P3183, DOI 10.3748/wjg.v18.i25.3183; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052	81	42	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76553	10.1371/journal.pone.0076553	http://dx.doi.org/10.1371/journal.pone.0076553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124572	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100129
J	Horikiri, Y; Shimo, T; Kurio, N; Okui, T; Matsumoto, K; Iwamoto, M; Sasaki, A				Horikiri, Yuu; Shimo, Tsuyoshi; Kurio, Naito; Okui, Tatsuo; Matsumoto, Kenichi; Iwamoto, Masahiro; Sasaki, Akira			Sonic Hedgehog Regulates Osteoblast Function by Focal Adhesion Kinase Signaling in the Process of Fracture Healing	PLOS ONE			English	Article							KAPPA-B LIGAND; BREAST-CANCER CELLS; RECEPTOR ACTIVATOR; BONE-FORMATION; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; INDIAN HEDGEHOG; EXPRESSION; PATHWAY	Several biological studies have indicated that hedgehog signaling plays an important role in osteoblast proliferation and differentiation, and sonic hedgehog (SHH) expression is positively correlated with phosphorylated focal adhesion kinase (FAK) Tyr(397). However, the relationship between them and their role in the process of normal fracture repair has not been clarified yet. Immunohistochemical analysis revealed that SHH and pFAK Tyr(397) were expressed in bone marrow cells and that pFAK Tyr(397) was also detected in ALP-positive osteoblasts near the TRAP-positive osteoclasts in the fracture site in the ribs of mice on day 5 after fracture. SHH and pFAK Tyr(397) were detectable in osteoblasts near the hypertrophic chondrocytes on day 14. In vitro analysis showed that SHH up-regulated the expression of FAK mRNA and pFAK Tyr(397) time dependently in osteoblastic MC3T3-E1 cells. Functional analysis revealed that 5 lentivirus encoding short hairpin FAK RNAs (shFAK)-infected MC3T3-E1 cell groups displayed a round morphology and decreased proliferation, adhesion, migration, and differentiation. SHH stimulated the proliferation and differentiation of MC3T3-E1 cells, but had no effect on the shFAK-infected cells. SHH also stimulated osteoclast formation in a co-culture system containing MC3T3-E1 and murine CD11b(+) bone marrow cells, but did not affect the shFAK-infected MC3T3-E1 co-culture group. These data suggest that SHH signaling was activated in osteoblasts at the dynamic remodeling site of a bone fracture and regulated their proliferation and differentiation, as well as osteoclast formation, via FAK signaling.	[Horikiri, Yuu; Shimo, Tsuyoshi; Kurio, Naito; Okui, Tatsuo; Matsumoto, Kenichi; Sasaki, Akira] Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Iwamoto, Masahiro] Childrens Hosp Philadelphia, Res Inst, Div Orthoped Surg, Philadelphia, PA 19104 USA	Okayama University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shimo, T (corresponding author), Okayama Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	shimotsu@md.okayama-u.ac.jp	Shimo, Tsuyoshi/AAT-8358-2020	Shimo, Tsuyoshi/0000-0002-7811-2366	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by the programs Grants-in-Aid for Young Scientists (A) [to T. S.] and Grants-in-Aid for Exploratory Research (to T. S. and A. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Blaess S, 2004, J NEUROSCI, V24, P3402, DOI 10.1523/JNEUROSCI.5241-03.2004; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Fournier-Thibault C, 2009, J NEUROSCI, V29, P12506, DOI 10.1523/JNEUROSCI.2003-09.2009; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Honami T, 2012, ORAL ONCOL, V48, P49, DOI 10.1016/j.oraloncology.2011.08.026; Huang CH, 2009, J CELL BIOCHEM, V108, P1263, DOI 10.1002/jcb.22356; ILLC D, 1995, NATURE, V377, P539; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Kurio N, 2011, EXP CELL RES, V317, P1134, DOI 10.1016/j.yexcr.2011.02.008; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Miyaji T, 2003, HISTOCHEM CELL BIOL, V119, P233, DOI 10.1007/s00418-003-0501-z; Mundy GR, 2008, DEV CELL, V14, P637, DOI 10.1016/j.devcel.2008.04.010; Nakamura M, 2010, J BIOMED MATER RES A, V92A, P783, DOI 10.1002/jbm.a.32404; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Plaisant M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016798; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sotobori T, 2006, EXP CELL RES, V312, P3927, DOI 10.1016/j.yexcr.2006.08.024; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Tian Y, 2012, CELL BIOCHEM BIOPHYS, V64, P169, DOI 10.1007/s12013-012-9369-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wary KK, 2012, MICROVASC RES, V83, P64, DOI 10.1016/j.mvr.2011.05.002; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811	45	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76785	10.1371/journal.pone.0076785	http://dx.doi.org/10.1371/journal.pone.0076785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124594	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100151
J	Lin, G; Field, JJ; Yu, JC; Ken, R; Neuberg, D; Nathan, DG; Linden, J				Lin, Gene; Field, Joshua J.; Yu, Jennifer C.; Ken, Ruey; Neuberg, Donna; Nathan, David G.; Linden, Joel			NF-kappa B Is Activated in CD4(+) iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A(2A) Receptors	PLOS ONE			English	Article							KILLER T-CELLS; ISCHEMIA-REPERFUSION INJURY; IFN-GAMMA PRODUCTION; NKT CELLS; INVARIANT NKT; VASCULAR INFLAMMATION; MURINE; MICE; VASOOCCLUSION; LOCALIZATION	Reperfusion injury following tissue ischemia occurs as a consequence of vaso-occlusion that is initiated by activation of invariant natural killer T (iNKT) cells. Sickle cell disease (SDC) results in widely disseminated microvascular ischemia and reperfusion injury as a result of vaso-occlusion by rigid and adhesive sickle red blood cells. In mice, iNKT cell activation requires NF-kappa B signaling and can be inhibited by the activation of anti-inflammatory adenosine A(2A) receptors (A(2A)Rs). Human iNKT cells are divided into subsets of CD4+ and CD4- cells. In this study we found that human CD4+ iNKT cells, but not CD4- cells undergo rapid NF-kappa B activation (phosphorylation of NF-kappa B on p65) and induction of A(2A)Rs (detected with a monoclonal antibody 7F6-G5-A2) during SCD painful vaso-occlusive crises. These findings indicate that SCD primarily activates the CD4+ subset of iNKT cells. Activation of NF-kappa B and induction of A(2A)Rs is concordant, i.e. only CD4+ iNKT cells with activated NF-kappa B expressed high levels of A(2A)Rs. iNKT cells that are not activated during pVOC express low levels of A(2A)R immunoreactivity. These finding suggest that A(2A)R transcription may be induced in CD4+ iNKT cells as a result of NFkB activation in SCD. In order to test this hypothesis further we examined cultured human iNKT cells. In cultured cells, blockade of NF-kappa B with Bay 11-7082 or IKK inhibitor VII prevented rapid induction of A(2A)R mRNA and protein upon iNKT activation. In conclusion, NF-kappa B-mediated induction of A(2A)Rs in iNKT cells may serve as a counter-regulatory mechanism to limit the extent and duration of inflammatory immune responses. As activated iNKT cells express high levels of A(2A)Rs following their activation, they may become highly sensitive to inhibition by A(2A)R agonists.	[Lin, Gene; Yu, Jennifer C.; Ken, Ruey; Linden, Joel] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Field, Joshua J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Neuberg, Donna; Nathan, David G.] Dana Farber Canc Inst, Boston, MA 02115 USA	La Jolla Institute for Immunology; Medical College of Wisconsin; Harvard University; Dana-Farber Cancer Institute	Linden, J (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA.	jlinden@liai.org	Linden, Joel/AAH-5690-2020; Linden, Joel/J-9259-2014	Linden, Joel/0000-0002-0689-1647	National Institutes of Health [RC2 HL101367, R34 HL108757, R01HL095704]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111969, RC2HL101367, R34HL108757, R01HL095704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants RC2 HL101367, R34 HL108757 and R01HL095704 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Bessoles S, 2008, J LEUKOCYTE BIOL, V84, P224, DOI 10.1189/jlb.1007669; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brittain JE, 2004, J BIOL CHEM, V279, P42393, DOI 10.1074/jbc.M407631200; Cao ZX, 2009, AM J PHYSIOL-GASTR L, V297, pG249, DOI 10.1152/ajpgi.00041.2009; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Field JJ, 2013, BLOOD; Field JJ, 2011, CHEST, V139, P563, DOI 10.1378/chest.10-1243; Glover DK, 2007, AM J PHYSIOL-HEART C, V292, pH3164, DOI 10.1152/ajpheart.00743.2005; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HEBBEL RP, 1981, BLOOD, V58, P947; Hettinger BD, 2001, J COMP NEUROL, V431, P331, DOI 10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Kollander R, 2010, TRANSL RES, V155, P170, DOI 10.1016/j.trsl.2009.10.004; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Li L, 2007, J IMMUNOL, V178, P5899, DOI 10.4049/jimmunol.178.9.5899; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P843, DOI 10.1161/ATVBAHA.112.247874; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; O'Reilly V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028648; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Polanowska-Grabowska R, 2010, ARTERIOSCL THROM VAS, V30, P2392, DOI 10.1161/ATVBAHA.110.211615; Pritchard KA, 2012, AM J RESP CELL MOL, V46, P389, DOI 10.1165/rcmb.2011-0097OC; Rosin DL, 1998, J COMP NEUROL, V401, P163; Shryock JC, 1998, CIRCULATION, V98, P711, DOI 10.1161/01.CIR.98.7.711; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Thedrez A, 2007, BLOOD, V110, P251, DOI 10.1182/blood-2007-01-066217; Wallace K.L., 2010, BLOOD; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646	43	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74664	10.1371/journal.pone.0074664	http://dx.doi.org/10.1371/journal.pone.0074664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124453	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100010
J	Matsuzaki, S; Darcha, C				Matsuzaki, Sachiko; Darcha, Claude			Involvement of the Wnt/beta-Catenin Signaling Pathway in the Cellular and Molecular Mechanisms of Fibrosis in Endometriosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELLS; PERITONEAL ENDOMETRIOSIS; MESENCHYMAL TRANSITION; RNA INTEGRITY; BETA; ACTIVATION; EXPRESSION; DISEASE; NODULES	Background: During the development and progression of endometriotic lesions, excess fibrosis may lead to scarring, chronic pain, and altered tissue function. However, the cellular and molecular mechanisms of fibrosis in endometriosis remain to be clarified. Objectives: The objective of the present study was to investigate whether the Wnt/beta-catenin signaling pathway was involved in regulating the cellular and molecular mechanisms of fibrosis in endometriosis in vitro and to evaluate whether fibrosis could be prevented by targeting the Wnt/beta-catenin pathway in a xenograft model of endometriosis in immunodeficient nude mice. Methods: Seventy patients (40 with and 30 without endometriosis) with normal menstrual cycles were recruited. In vitro effects of small-molecule antagonists of the Tcf/beta-catenin complex (PKF 115-584 and CGP049090) on fibrotic markers (alpha smooth muscle actin, type I collagen, connective tissue growth factor, fibronectin) and collagen gel contraction were evaluated in endometrial and endometriotic stromal cells from patients with endometriosis. In vitro effects of activation of the Wnt/beta-catenin signaling pathway by treatment with recombinant Wnt3a on profibrotic responses were evaluated in endometrial stromal cells of patients without endometriosis. The effects of CGP049090 treatment on the fibrosis of endometriotic implants were evaluated in a xenograft model of endometriosis in immunodeficient nude mice. Results: Treatment with PKF 115-584 and CGP049090 significantly decreased the expression of alpha smooth muscle actin, type I collagen, connective tissue growth factor and fibronectin mRNAs in both endometriotic and endometrial stromal cells with or without transforming growth factor-beta 1 stimulation. Both endometriotic and endometrial stromal cell-mediated contraction of collagen gels was significantly decreased by treatment with PKF 115-584 and CGP049090 as compared to that of untreated cells. The animal experiments showed that CGP049090 prevented the progression of fibrosis and reversed established fibrosis in endometriosis. Conclusion: Aberrant activation of the Wnt/beta-catenin pathway may be involved in mediating fibrogenesis in endometriosis.	[Matsuzaki, Sachiko] CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France; [Matsuzaki, Sachiko] Univ Auvergne, Clermont Univ, ISIT UMR6284, Clermont Ferrand, France; [Matsuzaki, Sachiko] Univ Clermont Ferrand, Photochim Mol & Macromol Lab, CNRS, ISIT UMR6284, F-63177 Clermont Ferrand, France; [Darcha, Claude] CHU Clermont Ferrand, Serv Anat & Cytol Pathol, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Matsuzaki, S (corresponding author), CHU Clermont Ferrand, CHU Estaing, Clermont Ferrand, France.	sachikoma@aol.com			Karl Storz Endoscopy; GmbH (Tuttlingen, Germany)	Karl Storz Endoscopy; GmbH (Tuttlingen, Germany)	This study was supported in part by Karl Storz Endoscopy & GmbH (Tuttlingen, Germany). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ewan KBR, 2008, CURR DRUG TARGETS, V9, P532, DOI 10.2174/138945008784911787; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koninckx PR, 2012, FERTIL STERIL, V98, P564, DOI 10.1016/j.fertnstert.2012.07.1061; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Matsuzaki S, 1999, GYNECOL OBSTET INVES, V47, P197, DOI 10.1159/000010094; Matsuzaki S, 2013, PLOS ONE, V28; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; Matsuzaki S, 2010, J CLIN ENDOCR METAB, V95, P3437, DOI 10.1210/jc.2009-2713; Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Solovyan VT, 2006, J CELL PHYSIOL, V207, P445, DOI 10.1002/jcp.20607; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	29	86	103	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76808	10.1371/journal.pone.0076808	http://dx.doi.org/10.1371/journal.pone.0076808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124596	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100153
J	Santana, S; Sastre, I; Recuero, M; Bullido, MJ; Aldudo, J				Santana, Soraya; Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus			Oxidative Stress Enhances Neurodegeneration Markers Induced by Herpes Simplex Virus Type 1 Infection in Human Neuroblastoma Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; VIRAL-INFECTIONS; APOLIPOPROTEIN-E; PROTEIN; ACCUMULATION; INVOLVEMENT; PATHOGENESIS; DEGRADATION; GLUTATHIONE	Mounting evidence suggests that Herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of Alzheimer's disease (AD). Previous work from our laboratory has shown HSV-1 infection to induce the most important pathological hallmarks of AD brains. Oxidative damage is one of the earliest events of AD and is thought to play a crucial role in the onset and development of the disease. Indeed, many studies show the biomarkers of oxidative stress to be elevated in AD brains. In the present work the combined effects of HSV-1 infection and oxidative stress on Ab levels and autophagy (neurodegeneration markers characteristic of AD) were investigated. Oxidative stress significantly potentiated the accumulation of intracellular Ab mediated by HSV-1 infection, and further inhibited its secretion to the extracellular medium. It also triggered the accumulation of autophagic compartments without increasing the degradation of long-lived proteins, and enhanced the inhibition of the autophagic flux induced by HSV-1. These effects of oxidative stress were not due to enhanced virus replication. Together, these results suggest that HSV-1 infection and oxidative damage interact to promote the neurodegeneration events seen in AD.	[Santana, Soraya; Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus] UAM, CSIC, CBMSO, Madrid, Spain; [Sastre, Isabel; Recuero, Maria; Bullido, Maria J.; Aldudo, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Bullido, MJ (corresponding author), UAM, CSIC, CBMSO, Madrid, Spain.	mjbullido@cbm.uam.es; jaldudo@cbm.uam.es	Bullido, maria j/C-8509-2014	Bullido, maria j/0000-0002-6477-1117; Aldudo, Jesus/0000-0002-7098-4709	Ministerio de Economia y Competitividad [SAF2010-15558]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED [PI2010/09-8]	Ministerio de Economia y Competitividad(Spanish Government); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED	This work was supported by grants from the Ministerio de Economia y Competitividad (SAF2010-15558; URL: http://www.mineco.gob.es/portal/site/mineco) and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas CIBERNED (PI2010/09-8; URL: http://www.ciberned.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 2012, J NEUROSCI RES, V90, P1020, DOI 10.1002/jnr.23003; Arimoto E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-62; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Burgos JS, 2006, J VIROL, V80, P5383, DOI 10.1128/JVI.00006-06; Burgos JS, 2002, J VIROL, V76, P12394, DOI 10.1128/JVI.76.23.12394-12398.2002; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Clausen A, 2012, J ALZHEIMERS DIS, V30, P183, DOI 10.3233/JAD-2012-111298; De Chiara G, 2012, MOL NEUROBIOL, V46, P614, DOI 10.1007/s12035-012-8320-7; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Fatokun AA, 2007, NEUROSCI LETT, V416, P34, DOI 10.1016/j.neulet.2007.01.078; Ferrer I, 2004, NEUROTOX RES, V6, P469, DOI 10.1007/BF03033283; Gobeil PAM, 2012, MBIO, V3, DOI 10.1128/mBio.00267-12; GRONOSTAJSKI RM, 1984, J CELL PHYSIOL, V119, P127, DOI 10.1002/jcp.1041190120; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lerchundi R, 2011, J ALZHEIMERS DIS, V23, P513, DOI 10.3233/JAD-2010-101386; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lussignol M, 2013, J VIROL, V87, P859, DOI 10.1128/JVI.01158-12; Mathew SS, 2010, FREE RADICAL BIO MED, V49, P383, DOI 10.1016/j.freeradbiomed.2010.04.026; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Newcomb WW, 2012, J VIROL, V86, P11931, DOI 10.1128/JVI.01349-12; Nucci C, 2000, EXP EYE RES, V70, P215, DOI 10.1006/exer.1999.0782; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paola D, 2000, BIOCHEM BIOPH RES CO, V268, P642, DOI 10.1006/bbrc.2000.2164; Piacentini R, 2010, NEUROBIOL AGING; Porcellini Elisa, 2010, Immun Ageing, V7, P16, DOI 10.1186/1742-4933-7-16; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Recuero M, 2004, FEBS LETT, V570, P114, DOI 10.1016/j.febslet.2004.06.025; Recuero M, 2013, J ALZHEIMERS DIS, V34, P637, DOI 10.3233/JAD-121510; Recuero M, 2010, FEBS LETT, V584, P4611, DOI 10.1016/j.febslet.2010.10.028; Recuero M, 2009, AGING CELL, V8, P128, DOI 10.1111/j.1474-9726.2009.00457.x; Santana S, 2012, J ALZHEIMERS DIS, V30, P815, DOI 10.3233/JAD-2012-112000; Santana S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.010; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2009, J ALZHEIMERS DIS, V16, P341, DOI 10.3233/JAD-2009-0963; Zambrano A, 2008, J ALZHEIMERS DIS, V14, P259	46	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75842	10.1371/journal.pone.0075842	http://dx.doi.org/10.1371/journal.pone.0075842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124518	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100075
J	Basova, P; Pospisil, V; Savvulidi, F; Burda, P; Vargova, K; Stanek, L; Dluhosova, M; Kuzmova, E; Jonasova, A; Steidl, U; Laslo, P; Stopka, T				Basova, P.; Pospisil, V.; Savvulidi, F.; Burda, P.; Vargova, K.; Stanek, L.; Dluhosova, M.; Kuzmova, E.; Jonasova, A.; Steidl, U.; Laslo, P.; Stopka, T.			Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice	ONCOGENE			English	Article						PU.1; leukemia; differentiation; microRNA; p53; AML	HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; MYELODYSPLASTIC SYNDROMES; MICRORNA EXPRESSION; P53 MUTATIONS; MYB; DIFFERENTIATION; GENE; TUMORS		[Basova, P.; Pospisil, V.; Savvulidi, F.; Burda, P.; Vargova, K.; Stanek, L.; Dluhosova, M.; Kuzmova, E.; Jonasova, A.; Stopka, T.] Charles Univ Prague, Dept Pathophysiol, Fac Med 1, Prague 12853 2, Czech Republic; [Basova, P.] Charles Univ Prague, Dept Expt Biomodels, Fac Med 1, Prague 12853 2, Czech Republic; [Stanek, L.] Charles Univ Prague, Dept Pathol, Fac Med 1, Prague 12853 2, Czech Republic; [Jonasova, A.; Stopka, T.] Charles Univ Prague, Dept Med Hematol, Fac Med 1, Prague 12853 2, Czech Republic; [Steidl, U.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; [Laslo, P.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Sect Expt Haematol, Leeds, W Yorkshire, England	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Yeshiva University; Albert Einstein College of Medicine; Saint James's University Hospital; University of Leeds	Stopka, T (corresponding author), Charles Univ Prague, Dept Pathophysiol, Fac Med 1, U Nemocnice 5, Prague 12853 2, Czech Republic.	tstopka@lf1.cuni.cz	Anna, Jonasona/U-6166-2017; Dluhošová, Martina/AAQ-7694-2021; Vargova, Karina/G-9642-2017; Burda, Pavel/K-8219-2017; Savvulidi Vargova, Karina/ABE-7513-2021; Pospisil, Vit/M-9429-2017; Basova, Petra/I-8930-2017; Kužmová, Erika/H-1520-2014	Anna, Jonasona/0000-0003-0246-1524; Vargova, Karina/0000-0002-4969-4133; Burda, Pavel/0000-0002-2841-792X; Savvulidi Vargova, Karina/0000-0002-4969-4133; Pospisil, Vit/0000-0003-2144-0438; Basova, Petra/0000-0003-0587-4471; Savvulidi, Filipp Georgijevic/0000-0002-4889-837X; Kuzmova, Erika/0000-0002-0728-9578	BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences [GACR P305/12/1033, UNCE 204021, PRVOUK-P24/LF1/3, SVV-2013-266509]; Charles University, from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Leukemia and Lymphoma Research grant;  [GAUK 251135 82210];  [GACR P301/12/P380];  [GAUK 251070 45410];  [GACR 305 13-12449P]	BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University, from the European Regional Development Fund; Leukemia and Lymphoma Research grant; ; ; ; 	Primary support: GACR P305/12/1033 Institutional: UNCE 204021, PRVOUK-P24/LF1/3, SVV-2013-266509, BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. Other: PB: GAUK 251135 82210, GACR P301/12/P380; MD: GAUK 251070 45410; VP: GACR 305 13-12449P; PL: Leukemia and Lymphoma Research grant.	Abbas HA, 2011, CELL CYCLE, V10, P3257, DOI 10.4161/cc.10.19.17721; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Burda P, 2009, MOL CANCER RES, V7, P1693, DOI 10.1158/1541-7786.MCR-09-0031; Curik N, 2012, LEUKEMIA, V26, P1804, DOI 10.1038/leu.2012.47; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Epstein CB, 1998, ONCOGENE, V16, P2115, DOI 10.1038/sj.onc.1201734; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; Nakano Y, 2000, EUR J HAEMATOL, V65, P23, DOI 10.1034/j.1600-0609.2000.90138.x; Neiman PE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000132; Noel G, 2012, J IMMUNOL METHODS, V382, P81, DOI 10.1016/j.jim.2012.05.008; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Pattabiraman DR, 2013, LEUKEMIA, V27, P269, DOI 10.1038/leu.2012.225; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	29	22	23	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4735	4745		10.1038/onc.2013.414	http://dx.doi.org/10.1038/onc.2013.414			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24121269				2022-12-25	WOS:000343239500004
J	Cook, I; Wang, T; Falany, CN; Leyh, TS				Cook, Ian; Wang, Ting; Falany, Charles N.; Leyh, Thomas S.			High Accuracy in Silico Sulfotransferase Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; Metabolism; Molecular Dynamics; Sulfotransferase; Binding; In Silico; Phase II Metabolism; Reactivity	ORAL-CONTRACEPTIVE STEROIDS; PHENOL SULFOTRANSFERASE; SULFURYL TRANSFER; CRYSTAL-STRUCTURE; SULFATION; MECHANISM; DEHYDROEPIANDROSTERONE; INHIBITION; METABOLISM; EXPRESSION	Background: Human sulfotransferases (SULTs) regulate the bioactivities of hundreds of compounds in vivo. Results: The in silico models of SULTs developed here proved remarkably accurate in identifying SULT substrates in a 1,455-compound library containing all FDA-approved drugs. Conclusion: Highly accurate in silico SULT models are now available. Significance: The elision of mechanism and modeling can produce remarkably accurate in silico tools for the study of biology. Predicting enzymatic behavior in silico is an integral part of our efforts to understand biology. Hundreds of millions of compounds lie in targeted in silico libraries waiting for their metabolic potential to be discovered. In silico enzymes capable of accurately determining whether compounds can inhibit or react is often the missing piece in this endeavor. This problem has now been solved for the cytosolic sulfotransferases (SULTs). SULTs regulate the bioactivities of thousands of compoundsendogenous metabolites, drugs and other xenobioticsby transferring the sulfuryl moiety (SO3) from 3-phosphoadenosine 5-phosphosulfate to the hydroxyls and primary amines of these acceptors. SULT1A1 and 2A1 catalyze the majority of sulfation that occurs during human Phase II metabolism. Here, recent insights into the structure and dynamics of SULT binding and reactivity are incorporated into in silico models of 1A1 and 2A1 that are used to identify substrates and inhibitors in a structurally diverse set of 1,455 high value compounds: the FDA-approved small molecule drugs. The SULT1A1 models predict 76 substrates. Of these, 53 were known substrates. Of the remaining 23, 21 were tested, and all were sulfated. The SULT2A1 models predict 22 substrates, 14 of which are known substrates. Of the remaining 8, 4 were tested, and all are substrates. The models proved to be 100% accurate in identifying substrates and made no false predictions at K-d thresholds of 100 m. In total, 23 new drug substrates were identified, and new linkages to drug inhibitors are predicted. It now appears to be possible to accurately predict Phase II sulfonation in silico.	[Cook, Ian; Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Falany, Charles N.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Sch Med Birmingham, Birmingham, AL 35294 USA	Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tsleyh@gmail.com	Wang, Ting/J-7577-2015		National Institutes of Health [GM54469, GM38953]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R29GM038953, R01GM038953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54469 and GM38953.	[Anonymous], 2011, NAT REV DRUG DISCOV; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; BAMFORTH KJ, 1992, EUR J PHARM-ENVIRON, V228, P15, DOI 10.1016/0926-6917(92)90006-X; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; BENSON GA, 1980, CHEM REV, V80, P151, DOI 10.1021/cr60324a002; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bode JW, 2004, J AM CHEM SOC, V126, P15317, DOI 10.1021/ja040968l; Cleland W W, 1979, Methods Enzymol, V63, P103; COMER KA, 1993, BIOCHEM J, V289, P233, DOI 10.1042/bj2890233; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Durrant JD, 2013, J MOL GRAPH MODEL, V44, P104, DOI 10.1016/j.jmgm.2013.05.006; Edavana VK, 2011, PHARMACOGN PERS MED, V4, P137, DOI 10.2147/PGPM.S25418; Ekins Sean, 2005, Expert Opin Drug Metab Toxicol, V1, P303, DOI 10.1517/17425255.1.2.303; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Falany JL, 2007, J STEROID BIOCHEM, V107, P202, DOI 10.1016/j.jsbmb.2007.03.046; FORADADA M, 1995, INT J PHARM, V124, P261, DOI 10.1016/0378-5173(95)00097-3; Ginsberg G, 2009, ENVIRON HEALTH PERSP, V117, P1639, DOI 10.1289/ehp.0901010; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang J, 2010, XENOBIOTICA, V40, P184, DOI 10.3109/00498250903514607; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kotov A, 1999, J STEROID BIOCHEM, V68, P137, DOI 10.1016/S0960-0760(99)00022-9; Kumari S, 2011, ANAL CHEM, V83, P5895, DOI 10.1021/ac2006137; Meloche CA, 2001, J STEROID BIOCHEM, V77, P261, DOI 10.1016/S0960-0760(01)00064-4; MITCHELL MC, 1983, CLIN PHARMACOL THER, V34, P48, DOI 10.1038/clpt.1983.127; Mitchell P B, 1994, Aust Fam Physician, V23, P1771; Mitchell PB, 1994, AUST FAM PHYSICIAN, V23, P1776; Nishimuta H, 2005, PHARM RES-DORDR, V22, P1406, DOI 10.1007/s11095-005-5263-y; Nishiyama Takahito, 2002, Drug Metab Pharmacokinet, V17, P221, DOI 10.2133/dmpk.17.221; Nowell S, 2006, ONCOGENE, V25, P1673, DOI 10.1038/sj.onc.1209376; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; ROGERS SM, 1987, BRIT J CLIN PHARMACO, V23, P721, DOI 10.1111/j.1365-2125.1987.tb03107.x; Rohn KJ, 2012, DRUG METAB DISPOS, V40, P1588, DOI 10.1124/dmd.112.045583; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Sorich MJ, 2008, CURR DRUG METAB, V9, P60, DOI 10.2174/138920008783331167; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Tang QX, 2010, J PHYS CHEM B, V114, P16131, DOI 10.1021/jp1055528; Thomas NL, 2003, XENOBIOTICA, V33, P1139, DOI 10.1080/00498250310001609192; Tyapochkin E, 2008, BIOCHEMISTRY-US, V47, P11894, DOI 10.1021/bi801211t; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weger BD, 2012, ACS CHEM BIOL, V7, P1178, DOI 10.1021/cb3000474; Weise AM, 2009, ANN PHARMACOTHER, V43, P761, DOI 10.1345/aph.1L528; WHITTEMORE RM, 1985, BIOCHEMISTRY-US, V24, P2477, DOI 10.1021/bi00331a013; Yang CH, 2011, J PHARM PHARMACOL, V63, P967, DOI 10.1111/j.2042-7158.2011.01298.x; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	59	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34494	34501		10.1074/jbc.M113.510974	http://dx.doi.org/10.1074/jbc.M113.510974			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129576	Green Published, hybrid			2022-12-25	WOS:000329812800019
J	Sa-Moura, B; Funakoshi, M; Tomko, RJ; Dohmen, RJ; Wu, ZP; Peng, JM; Hochstrasser, M				Sa-Moura, Bebiana; Funakoshi, Minoru; Tomko, Robert J., Jr.; Dohmen, R. Juergen; Wu, Zhiping; Peng, Junmin; Hochstrasser, Mark			A Conserved Protein with AN1 Zinc Finger and Ubiquitin-like Domains Modulates Cdc48 (p97) Function in the Ubiquitin-Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; ER-associated Degradation; Proteasome; Ubiquitin; Yeast; Zinc Finger; Cdc48; Cuz1	AAA ATPASE P97/VCP; TRANSCRIPTION FACTOR; GLOBAL ANALYSIS; ER; DEGRADATION; COMPLEX; STRESS; LINKS; UBX2; CDC48(UFD1/NPL4)	Regulated protein degradation mediated by the ubiquitin-proteasome system (UPS) is critical to eukaryotic protein homeostasis. Often vital to degradation of protein substrates is their disassembly, unfolding, or extraction from membranes. These processes are catalyzed by the conserved AAA-ATPase Cdc48 (also known as p97). Here we characterize the Cuz1 protein (Cdc48-associated UBL/zinc finger protein-1), encoded by a previously uncharacterized arsenite-inducible gene in budding yeast. Cuz1, like its human ortholog ZFAND1, has both an AN1-type zinc finger (Zf_AN1) and a divergent ubiquitin-like domain (UBL). We show that Cuz1 modulates Cdc48 function in the UPS. The two proteins directly interact, and the Cuz1 UBL, but not Zf_AN1, is necessary for binding to the Cdc48 N-terminal domain. Cuz1 also associates, albeit more weakly, with the proteasome, and the UBL is dispensable for this interaction. Cuz1-proteasome interaction is strongly enhanced by exposure of cells to the environmental toxin arsenite, and in a proteasome mutant, loss of Cuz1 enhances arsenite sensitivity. Whereas loss of Cuz1 alone causes only minor UPS degradation defects, its combination with mutations in the Cdc48(Npl4-Ufd1) complex leads to much greater impairment. Cuz1 helps limit the accumulation of ubiquitin conjugates on both the proteasome and Cdc48, suggesting a possible role in the transfer of ubiquitylated substrates from Cdc48 to the proteasome or in their release from these complexes.	[Sa-Moura, Bebiana; Funakoshi, Minoru; Tomko, Robert J., Jr.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sa-Moura, Bebiana] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099002 Oporto, Portugal; [Dohmen, R. Juergen] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Dept Dev Neurobiol, Memphis, TN 38105 USA	Yale University; Universidade do Porto; University of Cologne; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hochstrasser, M (corresponding author), 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu	Dohmen, R. Jürgen/AAD-6649-2022; Peng, Junmin/N-2614-2018	Dohmen, R. Jürgen/0000-0002-5756-6780; Peng, Junmin/0000-0003-0472-7648; Hochstrasser, Mark/0000-0002-1131-5484; Tomko Jr., Robert/0000-0003-2515-1078; Sa-Moura, Bebiana/0000-0003-2943-8818	National Institutes of Health [GM083050, GM046904]; American Cancer Society; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083050, R01GM046904, R37GM046904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083050 and GM046904 (to M. H.).; Supported in part by an American Cancer Society postdoctoral fellowship.; Supported by the American Lebanese Syrian Associated Charities.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; [Anonymous], 1991, Methods Enzymol, V194, P1; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Barthelme D, 2013, P NATL ACAD SCI USA, V110, P3327, DOI 10.1073/pnas.1300408110; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chia WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050490; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hochstrasser M, 2012, METHODS MOL BIOL, V832, P349, DOI 10.1007/978-1-61779-474-2_24; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PETERS JM, 1994, J BIOL CHEM, V269, P7709; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij S, 2008, FUNCT INTEGR GENOMIC, V8, P301, DOI 10.1007/s10142-008-0078-7; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	73	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33682	33696		10.1074/jbc.M113.521088	http://dx.doi.org/10.1074/jbc.M113.521088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121501	Green Published, hybrid			2022-12-25	WOS:000327250200016
J	Lin, H; Chen, W; Ding, H				Lin, Hao; Chen, Wei; Ding, Hui			AcalPred: A Sequence-Based Tool for Discriminating between Acidic and Alkaline Enzymes	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; FEATURE-SELECTION; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; PREDICTION; OVEREXPRESSION; INFORMATION; PROPENSITY; FORM	The structure and activity of enzymes are influenced by pH value of their surroundings. Although many enzymes work well in the pH range from 6 to 8, some specific enzymes have good efficiencies only in acidic (pH, 5) or alkaline (pH. 9) solution. Studies have demonstrated that the activities of enzymes correlate with their primary sequences. It is crucial to judge enzyme adaptation to acidic or alkaline environment from its amino acid sequence in molecular mechanism clarification and the design of high efficient enzymes. In this study, we developed a sequence-based method to discriminate acidic enzymes from alkaline enzymes. The analysis of variance was used to choose the optimized discriminating features derived from g-gap dipeptide compositions. And support vector machine was utilized to establish the prediction model. In the rigorous jackknife cross-validation, the overall accuracy of 96.7% was achieved. The method can correctly predict 96.3% acidic and 97.1% alkaline enzymes. Through the comparison between the proposed method and previous methods, it is demonstrated that the proposed method is more accurate. On the basis of this proposed method, we have built an online web-server called AcalPred which can be freely accessed from the website (http://lin.uestc.edu.cn/server/AcalPred). We believe that the AcalPred will become a powerful tool to study enzyme adaptation to acidic or alkaline environment.	[Lin, Hao; Ding, Hui] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Key Lab NeuroInformat,Minist Educ, Chengdu 610054, Peoples R China; [Chen, Wei] Hebei United Univ, Ctr Genom & Computat Biol, Sch Sci, Dept Phys, Tangshan, Peoples R China	University of Electronic Science & Technology of China; North China University of Science & Technology	Lin, H (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Key Lab NeuroInformat,Minist Educ, Chengdu 610054, Peoples R China.	hlin@uestc.edu.cn; greatchen@heuu.edu.cn	Ding, Hui/A-8160-2016; Lin, Hao/B-2066-2012; Chen, Wei/W-8311-2019; Chen, Wei/O-6774-2017	Lin, Hao/0000-0001-6265-2862; Chen, Wei/0000-0002-6857-7696	National Natural Science Foundation of China [61202256, 61100092]; Fundamental Research Funds for the Central Universities [ZYGX2012J113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (61202256, 61100092) and the Fundamental Research Funds for the Central Universities (ZYGX2012J113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Ding H, 2013, CHEMOMETR INTELL LAB, V124, P9, DOI 10.1016/j.chemolab.2013.03.005; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Fan GL, 2013, PROCESS BIOCHEM, V48, P1048, DOI 10.1016/j.procbio.2013.05.012; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Gromiha MM, 2005, BIOINFORMATICS, V21, P961, DOI 10.1093/bioinformatics/bti126; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Ma JW, 2010, BMB REP, V43, P670, DOI [10.3858/BMBRep.2010.43.10.670, 10.5483/BMBRep.2010.43.10.670]; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; Nair NU, 2010, CURR ORG CHEM, V14, P1870; Nakariyakul S, 2012, AMINO ACIDS, V42, P1947, DOI 10.1007/s00726-011-0923-1; Settembre EC, 2004, ACTA CRYSTALLOGR D, V60, P1753, DOI 10.1107/S090744490401858X; Smialowski P, 2007, BIOINFORMATICS, V23, P2536, DOI 10.1093/bioinformatics/btl623; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Taylor TJ, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S5; Vapnik V., 1998, STAT LEARNING THEORY; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang D, 2011, PROTEIN PEPTIDE LETT, V18, P684, DOI 10.2174/092986611795446085; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Yin JB, 2011, CURR PROTEIN PEPT SC, V12, P580, DOI 10.2174/138920311796957702; Zhang GY, 2006, PROTEIN PEPTIDE LETT, V13, P965, DOI 10.2174/092986606778777560; Zhang Guangya, 2013, Int J Bioinform Res Appl, V9, P41, DOI 10.1504/IJBRA.2013.050744; Zhang GY, 2009, PROCESS BIOCHEM, V44, P654, DOI 10.1016/j.procbio.2009.02.007	37	68	69	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75726	10.1371/journal.pone.0075726	http://dx.doi.org/10.1371/journal.pone.0075726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130738	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900055
J	Liu, P; Chen, BJ; Altun, ZF; Gross, MJ; Shan, A; Schuman, B; Hall, DH; Wang, ZW				Liu, Ping; Chen, Bojun; Altun, Zeynep F.; Gross, Maegan J.; Shan, Alan; Schuman, Benjamin; Hall, David H.; Wang, Zhao-Wen			Six Innexins Contribute to Electrical Coupling of C. elegans Body-Wall Muscle	PLOS ONE			English	Article							GAP-JUNCTIONS; PANNEXIN 1; GENE; MUTATIONS; CONNEXIN; FAMILY; CHANNELS; RELEASE; ORGANIZATION; EXPRESSION	C. elegans body-wall muscle cells are electrically coupled through gap junctions. Previous studies suggest that UNC-9 is an important, but not the only, innexin mediating the electrical coupling. Here we analyzed junctional current (I-j) for mutants of additional innexins to identify the remaining innexin(s) important to the coupling. The results suggest that a total of six innexins contribute to the coupling, including UNC-9, INX-1, INX-10, INX-11, INX-16, and INX-18. The I-j deficiency in each mutant was rescued completely by expressing the corresponding wild-type innexin specifically in muscle, suggesting that the innexins function cell-autonomously. Comparisons of I-j between various single, double, and triple mutants suggest that the six innexins probably form two distinct populations of gap junctions with one population consisting of UNC-9 and INX-18 and the other consisting of the remaining four innexins. Consistent with their roles in muscle electrical coupling, five of the six innexins showed punctate localization at muscle intercellular junctions when expressed as GFP- or epitope-tagged proteins, and muscle expression was detected for four of them when assessed by expressing GFP under the control of innexin promoters. The results may serve as a solid foundation for further explorations of structural and functional properties of gap junctions in C. elegans body-wall muscle.	[Liu, Ping; Chen, Bojun; Gross, Maegan J.; Wang, Zhao-Wen] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06032 USA; [Altun, Zeynep F.; Hall, David H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Shan, Alan; Schuman, Benjamin] Univ Connecticut, Ctr Hlth, Undergrad Summer Res Internship Program, Farmington, CT USA	University of Connecticut; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut	Wang, ZW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06032 USA.	zwwang@uchc.edu	Liu, Ping/B-1509-2014		National Institute of Health [5R01GM083049, 1R01MH085927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (5R01GM083049 and 1R01MH085927, ZWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; AVERY L, 1993, GENETICS, V133, P897; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barnes TM, 1997, J NEUROCHEM, V69, P2251; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Edmonds JW, 2011, DEV BIOL, V359, P47, DOI 10.1016/j.ydbio.2011.08.014; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; FERGUSON EL, 1985, GENETICS, V110, P17; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kemp BJ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm857; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Lehmann C, 2006, MOL BIOL CELL, V17, P1676, DOI 10.1091/mbc.E05-11-1059; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; Liu P, 2011, J BIOL CHEM, V286, P44285, DOI 10.1074/jbc.M111.292078; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OKKEMA PG, 1993, GENETICS, V135, P385; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-16; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Thompson RJ, 2008, CHANNELS, V2, P81, DOI 10.4161/chan.2.2.6003; Wang ZW, 1999, ANN NY ACAD SCI, V868, P286, DOI 10.1111/j.1749-6632.1999.tb11294.x; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Zhan HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039489	46	11	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76877	10.1371/journal.pone.0076877	http://dx.doi.org/10.1371/journal.pone.0076877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130800	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900095
J	Oettl, SK; Gerstmeier, J; Khan, SY; Wiechmann, K; Bauer, J; Atanasov, AG; Malainer, C; Awad, EM; Uhrin, P; Heiss, EH; Waltenberger, B; Remias, D; Breuss, JM; Boustie, J; Dirsch, VM; Stuppner, H; Werz, O; Rollinger, JM				Oettl, Sarah K.; Gerstmeier, Jana; Khan, Shafaat Y.; Wiechmann, Katja; Bauer, Julia; Atanasov, Atanas G.; Malainer, Clemens; Awad, Ezzat M.; Uhrin, Pavel; Heiss, Elke H.; Waltenberger, Birgit; Remias, Daniel; Breuss, Johannes M.; Boustie, Joel; Dirsch, Verena M.; Stuppner, Hermann; Werz, Oliver; Rollinger, Judith M.			Imbricaric Acid and Perlatolic Acid: Multi-Targeting Anti-Inflammatory Depsides from Cetrelia monachorum	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE-1; THIOGLYCOLATE PERITONITIS; INHIBITORY-ACTIVITY; KIDNEY-CELLS; 5-LIPOXYGENASE; LICHEN; DERIVATIVES; COMPONENTS; DRUGS	In vitro screening of 17 Alpine lichen species for their inhibitory activity against 5-lipoxygenase, microsomal prostaglandin E-2 synthase-1 and nuclear factor kappa B revealed Cetrelia monachorum (Zahlbr.) W.L. Culb. & C.F. Culb. As conceivable source for novel anti-inflammatory compounds. Phytochemical investigation of the ethanolic crude extract resulted in the isolation and identification of 11 constituents, belonging to depsides and derivatives of orsellinic acid, olivetolic acid and olivetol. The two depsides imbricaric acid (4) and perlatolic acid (5) approved dual inhibitory activities on microsomal prostaglandin E-2 synthase-1 (IC50 = 1.9 and 0.4 mu M, resp.) and on 5-lipoxygenase tested in a cell-based assay (IC50 = 5.3 and 1.8 mu M, resp.) and on purified enzyme (IC50 = 3.5 and 0.4 mu M, resp.). Additionally, these two main constituents quantified in the extract with 15.22% (4) and 9.10% (5) showed significant inhibition of tumor necrosis factor alpha-induced nuclear factor kappa B activation in luciferase reporter cells with IC50 values of 2.0 and 7.0 mu M, respectively. In a murine in vivo model of inflammation, 5 impaired the inflammatory, thioglycollate-induced recruitment of leukocytes to the peritoneum. The potent inhibitory effects on the three identified targets attest 4 and 5 a pronounced multi-target anti-inflammatory profile which warrants further investigation on their pharmacokinetics and in vivo efficacy.	[Oettl, Sarah K.; Waltenberger, Birgit; Remias, Daniel; Stuppner, Hermann; Rollinger, Judith M.] Leopold Franzens Univ Innsbruck, Inst Pharm Pharmacognosy, Ctr Mol Biosci Innsbruck, Innsbruck, Austria; [Gerstmeier, Jana; Wiechmann, Katja; Werz, Oliver] Univ Jena, Chair Pharmaceut Med Chem, Inst Pharm, Jena, Germany; [Khan, Shafaat Y.; Awad, Ezzat M.; Uhrin, Pavel; Breuss, Johannes M.] Med Univ Vienna, Inst Vasc Biol & Thrombosis Res, Ctr Biomol Med & Pharmacol, Vienna, Austria; [Bauer, Julia] Univ Tubingen, Dept Pharmaceut Analyt, Inst Pharmaceut, Tubingen, Germany; [Atanasov, Atanas G.; Malainer, Clemens; Heiss, Elke H.; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, Vienna, Austria; [Boustie, Joel] Univ Rennes 1, Inst Chem Sci Rennes, Team PNSCM, Rennes, France	University of Innsbruck; Friedrich Schiller University of Jena; Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Vienna; Universite de Rennes	Werz, O (corresponding author), Univ Jena, Chair Pharmaceut Med Chem, Inst Pharm, Jena, Germany.	Oliver.Werz@uni-jena.de; Judith.Rollinger@uibk.ac.at	Khan, Shafaat Yar/K-8006-2019; Heiss, Elke/B-6086-2015; Khan, Shafaat Yar/GRO-3887-2022; Rollinger, Judith/Q-5996-2019; Atanasov, Atanas G./C-5535-2013	Heiss, Elke/0000-0001-7618-5505; Atanasov, Atanas G./0000-0003-2545-0967; Dirsch, Verena/0000-0002-9261-5293; Uhrin, Pavel/0000-0002-9792-3420; Remias, Daniel/0000-0003-0896-435X; Rollinger, Judith/0000-0001-6581-0774; breuss, johannes/0000-0003-1312-3387	National Research Network "Drugs from Nature Targeting Inflammation" [S10703, S10704, S10713]; Austrian Science Fund (FWF)	National Research Network "Drugs from Nature Targeting Inflammation"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the National Research Network "Drugs from Nature Targeting Inflammation" (subprojects S10703, S10704, and S10713) granted by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JQ, 2008, PHYTOTHER RES, V22, P1605, DOI 10.1002/ptr.2531; Bauer J, 2012, CHEMMEDCHEM, V7, P2077, DOI 10.1002/cmdc.201200345; Boustie J, 2011, PHYTOCHEM REV, V10, P287, DOI 10.1007/s11101-010-9201-1; Bucar F, 2004, PHYTOMEDICINE, V11, P602, DOI 10.1016/j.phymed.2004.03.004; Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Fischer L, 2003, FASEB J, V17, P949, DOI 10.1096/fj.02-0815fje; Brandao LFG, 2013, CHEM PHARM BULL, V61, P176, DOI 10.1248/cpb.c12-00739; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 1997, PHYTOMEDICINE, V4, P125, DOI 10.1016/S0944-7113(97)80056-6; Ingolfsdottir K, 1996, PHYTOMEDICINE, V2, P243, DOI 10.1016/S0944-7113(96)80049-3; Johnson-Lyles DN, 2010, TOXICOL APPL PHARM, V248, P249, DOI 10.1016/j.taap.2010.08.008; Koeberle A, 2009, CURR MED CHEM, V16, P4274, DOI 10.2174/092986709789578178; Koeberle A, 2008, J MED CHEM, V51, P8068, DOI 10.1021/jm801085s; Li L., 2012, PLOS ONE, V7; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Markasz L, 2007, MOL CANCER THER, V6, P644, DOI 10.1158/1535-7163.MCT-06-0358; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Noha SM, 2011, BIOORG MED CHEM LETT, V21, P577, DOI 10.1016/j.bmcl.2010.10.051; Obermayer W, 2007, PHYTON-ANN REI BOT A, V47, P231; OKUYAMA E, 1995, PLANTA MED, V61, P113, DOI 10.1055/s-2006-958027; Radmark O, 2010, J INTERN MED, V268, P5, DOI 10.1111/j.1365-2796.2010.02246.x; Rozema E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/983023; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; Schneider I, 2005, PHYTOTHER RES, V19, P81, DOI 10.1002/ptr.1603; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Seidman MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004316; Sokolov DN, 2012, BIOORG MED CHEM LETT, V22, P7060, DOI 10.1016/j.bmcl.2012.09.084; Stern ST, 2008, TOXICOL SCI, V106, P140, DOI 10.1093/toxsci/kfn137; Vogl S, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/395316; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Wirth V., 1995, Flechtenflora: Bestimmung und okologische Kennzeichnung der Flechten Sudwestdeutschlands und angrenzender Gebiete: 2. Neubearbeitete und erganzte Auflage.	35	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76929	10.1371/journal.pone.0076929	http://dx.doi.org/10.1371/journal.pone.0076929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130812	Green Published, gold			2022-12-25	WOS:000325810900106
J	Seo, JA; Eun, CR; Cho, H; Lee, SK; Yoo, HJ; Kim, SG; Choi, KM; Baik, SH; Choi, DS; Yim, HJ; Shin, C; Kim, NH				Seo, Ji A.; Eun, Chai Ryoung; Cho, Hyunjoo; Lee, Seung Ku; Yoo, Hye Jin; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Yim, Hyung Joon; Shin, Chol; Kim, Nan Hee			Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-19; D-RECEPTOR POLYMORPHISMS; INSULIN-RESISTANCE; 25-HYDROXYVITAMIN D; METABOLIC SYNDROME; HEPATIC STEATOSIS; SERUM 25-HYDROXYVITAMIN-D; APPARENTLY HEALTHY; D SUPPLEMENTATION; RISK-FACTORS	Objective: To investigate the association between serum 25-hydroxyvitamin D [25(OH)D] levels and nonalcoholic fatty liver disease (NAFLD) independent of visceral obesity in Koreans and to examine whether the associations differ according to the presence of diabetes or insulin resistance. Research Design and Methods: A total of 1081 adults were enrolled from a population-based cohort in Ansan city. Serum 25(OH)D concentrations were measured in all subjects. Insulin resistance was measured by homeostasis model assessment of insulin resistance (HOMA-IR). Using computed tomography, NAFLD was diagnosed if the liver attenuation index (LAI, the difference between the mean hepatic and splenic attenuation) was <5 Hounsfield Units. Results: In subjects with diabetes (n = 282), 25(OH)D levels were negatively associated with waist circumference, fasting insulin, HOMA-IR, triglyceride levels, and visceral abdominal fat, and were positively associated with LAI after adjusting for age, sex, season, exercise, and vitamin supplementation. In subjects without diabetes, only triglyceride level was negatively associated with 25(OH)D. The adjusted odds ratio (OR) for NAFLD increased sequentially across decreasing quartiles of 25(OH)D in subjects with diabetes even after adjusting for visceral fat [Q1 vs. Q4; OR for NAFLD 2.5 (95% CI: 1.0-6.2)]. In contrast, no significant difference in OR was observed in subjects without diabetes. When we classified non-diabetic subjects by HOMA-IR, an increase in the OR for NAFLD across decreasing quartiles of 25(OH)D was observed in the high HOMA-IR (>= 2.5) group [n = 207, Q1 vs. Q4; OR 3.8(1.4-10.3)], but not in the low HOMA-IR (<2.5) group [n = 592, OR 0.8 (0.3-1.9)]. Conclusions: Low vitamin D status is closely associated with NAFLD, independent of visceral obesity in subjects with diabetes or insulin resistance.	[Seo, Ji A.; Eun, Chai Ryoung; Cho, Hyunjoo; Yoo, Hye Jin; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Kim, Nan Hee] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 136705, South Korea; [Lee, Seung Ku; Shin, Chol] Korea Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 136705, South Korea; [Yim, Hyung Joon] Korea Univ, Coll Med, Dept Internal Med, Div Hepatol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, NH (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol, Seoul 136705, South Korea.	nhkendo@gmail.com	SEO, JI A/AAU-7968-2020; Kim, Nan Hee/T-8627-2019; Choi, Kyung Mook/C-4195-2018; Lee, SeungKu/GSN-5012-2022	SEO, JI A/0000-0002-1927-2618; Choi, Kyung Mook/0000-0001-6175-0225; Lee, SeungKu/0000-0001-5120-5557; Yoo, Hye Jin/0000-0003-0600-0266; Kim, Nan Hee/0000-0003-4378-520X; Kim, Sin Gon/0000-0002-7430-3675	Korea Centers for Disease Control and Prevention [2009-E71002-00, 2010-E71001-00]; Korea University; Korean Diabetes Association	Korea Centers for Disease Control and Prevention; Korea University; Korean Diabetes Association	This research was supported by a fund (2009-E71002-00, 2010-E71001-00) by research of Korea Centers for Disease Control and Prevention, by a Korea University grant, and by a grant (N.H.K., 2009) from the Korean Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Al-Daghri NM, 2013, J ENDOCRINOL INVEST, V36, P1, DOI 10.3275/8183; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Baik I, 2008, ARCH INTERN MED, V168, P167, DOI 10.1001/archinternmed.2007.8; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Beydoun MA, 2010, J CLIN ENDOCR METAB, V95, P3814, DOI 10.1210/jc.2010-0410; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Breslavsky A, 2013, CLIN NUTR IN PRESS; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Choi HS, 2011, J NUTR, V141, P1524, DOI 10.3945/jn.111.139121; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Engeli S, 2003, INT J BIOCHEM CELL B, V35, P807, DOI 10.1016/S1357-2725(02)00311-4; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Fliser D, 1997, EUR J CLIN INVEST, V27, P629, DOI 10.1046/j.1365-2362.1997.1520699.x; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gannage-Yared MH, 2003, J ENDOCRINOL INVEST, V26, P748, DOI 10.1007/BF03347358; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Lee S, 2006, J KOREAN MED SCI, V21, P695; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nakano T, 2011, J HEPATOL, V55, P415, DOI 10.1016/j.jhep.2010.11.028; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Park SH, 2005, CLIN SCI, V108, P553, DOI 10.1042/CS20040331; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Pickhardt PJ, 2012, EUR RADIOL, V22, P1075, DOI 10.1007/s00330-011-2349-2; Pinelli NR, 2010, DIABETES CARE, V33, P1373, DOI 10.2337/dc09-2199; Rhee EJ, 2013, ENDOCR J IN PRESS; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shin C, 2005, AM J RESP CRIT CARE, V171, P287, DOI 10.1164/rccm.200407-906OC; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	52	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75197	10.1371/journal.pone.0075197	http://dx.doi.org/10.1371/journal.pone.0075197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130687	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900020
J	Deng, JJ; He, MX; Chen, LZ; Chen, C; Zheng, JM; Cai, ZL				Deng, Jingjing; He, Miaoxia; Chen, Lizao; Chen, Chao; Zheng, Jianming; Cai, Zailong			The Loss of miR-26a-Mediated Post-Transcriptional Regulation of Cyclin E2 in Pancreatic Cancer Cell Proliferation and Decreased Patient Survival	PLOS ONE			English	Article							MICRORNA EXPRESSION; BREAST-CANCER; STATISTICS; MIR-26A; EZH2; CARCINOGENESIS; CARCINOMA; GROWTH	Background: miR-26a plays a critical role in tumorigenesis, either as a tumor suppressor or as an oncogenic miRNA, depending on different tumor types. However, the function of miR-26a in pancreatic cancer has not been clearly elucidated. The present study was designed to determine the roles of miR-26a in pancreatic cancer and its association with the survival of patients with pancreatic cancer. Methods: The expression of miR-26a was examined in 15 pairs of pancreatic duct adenocarcinoma (PDAC) and their adjacent benign pancreatic tissues (ABPT), by qRT-PCR. The results were confirmed by in situ hybridization using two panels of 106 PDACs and their ABPT microarray. The association of miR-26a expression with overall survival was determined. The proliferation and cell cycle distribution of Capan-2, SW-1990, and Panc-1 cells, transfected with miR-26a mimics or a miR-26a inhibitor, were assessed using the Cell Counting Kit-8 assay and flow cytometry, respectively. The cell tumorigenicity was evaluated via murine xenograft experiments. Cyclin D2, E2, EZH2, and PCNA levels were analyzed by Western blot and immunohistochemistry. Results: miR-26a was expressed in the cytoplasm of pancreatic ductal epithelial cells, whereas its expression was significantly downregulated in PDAC tissues compared with that of ABPT. Patients with low miR-26a expression had a significantly shorter survival than those with high miR-26a expression. The in vitro and in vivo assays showed that overexpression of miR-26a resulted in cell cycle arrest, inhibited cell proliferation, and decreased tumor growth, which was associated with cyclin E2 downregulation. Conclusions: miR-26a is an important suppressor of pancreatic ductal carcinoma, and can prove to be a novel prognostic factor and therapeutic target for pancreatic cancer treatment.	[Deng, Jingjing; He, Miaoxia; Zheng, Jianming; Cai, Zailong] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Chen, Lizao; Chen, Chao] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Zheng, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China.	jmzheng1962@163.com; czl8003@163.com			National Natural Science Foundation of China [81172077]; Shanghai biobank network of common human tumor tissue fund [12DZ2295102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai biobank network of common human tumor tissue fund	This study was supported by National Natural Science Foundation of China (Project No. 81172077) and Shanghai biobank network of common human tumor tissue fund (Project No. 12DZ2295102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avan A, 2012, MOL CANCER THER, V11, P1735, DOI 10.1158/1535-7163.MCT-12-0037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen S, 2010, J HEPATOL, V52, P864, DOI 10.1016/j.jhep.2009.12.040; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ikenaga N, 2010, ANN SURG ONCOL, V17, P3120, DOI 10.1245/s10434-010-1188-8; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kota J, 2009, CELL, V137, P1065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Moelans CB, 2011, CELL ONCOL, V34, P89, DOI 10.1007/s13402-011-0021-0; Rachagani S, 2010, CANCER LETT, V292, P8, DOI 10.1016/j.canlet.2009.11.010; Ryu JK, 2011, PANCREATOLOGY, V11, P343, DOI 10.1159/000329183; Sahin F, 2003, MODERN PATHOL, V16, P686, DOI 10.1097/01.MP.0000075645.97329.86; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033577	33	45	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76450	10.1371/journal.pone.0076450	http://dx.doi.org/10.1371/journal.pone.0076450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116110	gold, Green Submitted, Green Published			2022-12-25	WOS:000325552200056
J	Lai, JS; Yang, B; Lin, DM; Kerkhoff, AJ; Ma, KP				Lai, Jiangshan; Yang, Bo; Lin, Dunmei; Kerkhoff, Andrew J.; Ma, Keping			The Allometry of Coarse Root Biomass: Log-Transformed Linear Regression or Nonlinear Regression?	PLOS ONE			English	Article							BREAST-HEIGHT DIAMETERS; NET PRIMARY PRODUCTION; PREDICTING BODY-MASS; FAGUS-SYLVATICA L.; LOGARITHMIC TRANSFORMATIONS; ABOVEGROUND BIOMASS; FOREST ECOSYSTEMS; TROPICAL FORESTS; METABOLIC-RATES; SYSTEM BIOMASS	Precise estimation of root biomass is important for understanding carbon stocks and dynamics in forests. Traditionally, biomass estimates are based on allometric scaling relationships between stem diameter and coarse root biomass calculated using linear regression (LR) on log-transformed data. Recently, it has been suggested that nonlinear regression (NLR) is a preferable fitting method for scaling relationships. But while this claim has been contested on both theoretical and empirical grounds, and statistical methods have been developed to aid in choosing between the two methods in particular cases, few studies have examined the ramifications of erroneously applying NLR. Here, we use direct measurements of 159 trees belonging to three locally dominant species in east China to compare the LR and NLR models of diameter-root biomass allometry. We then contrast model predictions by estimating stand coarse root biomass based on census data from the nearby 24-ha Gutianshan forest plot and by testing the ability of the models to predict known root biomass values measured on multiple tropical species at the Pasoh Forest Reserve in Malaysia. Based on likelihood estimates for model error distributions, as well as the accuracy of extrapolative predictions, we find that LR on log-transformed data is superior to NLR for fitting diameter-root biomass scaling models. More importantly, inappropriately using NLR leads to grossly inaccurate stand biomass estimates, especially for stands dominated by smaller trees.	[Lai, Jiangshan; Yang, Bo; Lin, Dunmei; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yang, Bo; Lin, Dunmei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Math & Stat, Gambier, OH 43022 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kenyon College; Kenyon College	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn		Lin, Dunmei/0000-0001-6112-7783; Yang, Bo/0000-0002-6288-445X; Kerkhoff, Andrew/0000-0001-9617-8687	National Natural Science Foundation of China [31200403, 31270496]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050204]; Kenyon College; NSF Research Opportunity Award [EF-1214332, EF-1065861]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Kenyon College; NSF Research Opportunity Award(National Science Foundation (NSF))	This work was financially supported by the National Natural Science Foundation of China (31200403 and 31270496) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05050204). AJK was supported by sabbatical funding from Kenyon College and by NSF Research Opportunity Award EF-1214332 supplemental to NSF grant EF-1065861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne F, 2013, J THEOR BIOL, V317, P418, DOI 10.1016/j.jtbi.2012.09.035; BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Bolte A, 2004, PLANT SOIL, V264, P1, DOI 10.1023/B:PLSO.0000047777.23344.a3; Brassard BW, 2011, BIOMASS BIOENERG, V35, P4189, DOI 10.1016/j.biombioe.2011.06.045; Brassard BW, 2009, CRIT REV PLANT SCI, V28, P179, DOI 10.1080/07352680902776572; BROWN S, 1989, FOREST SCI, V35, P881; Burnham KP, 2002, MULTIMODEL INFERENCE; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Drexhage M, 1999, SCAND J FOREST RES, V14, P328, DOI 10.1080/02827589950152647; Drexhage M, 2001, FORESTRY, V74, P491, DOI 10.1093/forestry/74.5.491; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; Glass NR, 1969, J FISH RES BOARD CAN, V26, P2543; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; Hui DF, 2007, J THEOR BIOL, V249, P168, DOI 10.1016/j.jtbi.2007.07.003; JANSSON M, 1985, GEOGR ANN A, V67, P61, DOI 10.2307/520466; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Le Goff N, 2001, ANN FOREST SCI, V58, P1, DOI 10.1051/forest:2001104; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Litton CM, 2006, FOREST ECOL MANAG, V231, P105, DOI 10.1016/j.foreco.2006.05.008; Lubowski RN, 2013, REV ENV ECON POLICY, V7, P67, DOI 10.1093/reep/res024; Mascaro J, 2011, BIOTROPICA, V43, P649, DOI 10.1111/j.1744-7429.2011.00798.x; MCCUEN RH, 1990, J HYDRAUL ENG-ASCE, V116, P414, DOI 10.1061/(ASCE)0733-9429(1990)116:3(414); Miller AT, 2006, CAN J FOREST RES, V36, P12, DOI 10.1139/X05-229; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Packard GC, 2010, J ZOOL, V282, P221, DOI 10.1111/j.1469-7998.2010.00737.x; Packard GC, 2008, J EXP BIOL, V211, P3581, DOI 10.1242/jeb.023317; Packard GC, 2011, BIOL REV, V86, P549, DOI 10.1111/j.1469-185X.2010.00160.x; Packard GC, 2011, COMP BIOCHEM PHYS A, V159, P392, DOI 10.1016/j.cbpa.2011.04.005; Packard GC, 2009, J THEOR BIOL, V257, P515, DOI 10.1016/j.jtbi.2008.10.016; Packard G, 2009, J COMP PHYSIOL B, V179, P175, DOI 10.1007/s00360-008-0300-x; Pandey GR, 1999, J HYDROL, V225, P92, DOI 10.1016/S0022-1694(99)00135-3; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, LANG ENV STAT COMP; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Wang CK, 2001, GLOBAL CHANGE BIOL, V7, P719, DOI 10.1046/j.1354-1013.2001.00441.x; Wang XK, 2001, FOREST ECOL MANAG, V148, P117, DOI 10.1016/S0378-1127(00)00482-5; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; ZAR JH, 1968, BIOSCIENCE, V18, P1118, DOI 10.2307/1294589	57	33	42	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77007	10.1371/journal.pone.0077007	http://dx.doi.org/10.1371/journal.pone.0077007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116197	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200094
J	Moriel, DG; Beatson, SA; Wurpel, DJ; Lipman, J; Nimmo, GR; Paterson, DL; Schembri, MA				Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Nimmo, Graeme R.; Paterson, David L.; Schembri, Mark A.			Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; TRIMERIC AUTOTRANSPORTER; NEISSERIA-MENINGITIDIS; BIOFILM FORMATION; ABIOTIC SURFACES; SIGNAL PEPTIDES; PREDICTION; INFECTION; PROTECTION; RESPONSES	Acinetobacter baumannii is an emerging opportunistic bacterium associated with nosocomial infections in intensive care units. The alarming increase in infections caused by A. baumannii is strongly associated with enhanced resistance to antibiotics, in particular carbapenems. This, together with the lack of a licensed vaccine, has translated into significant economic, logistic and health impacts to health care facilities. In this study, we combined reverse vaccinology and proteomics to identify surface-exposed and secreted antigens from A. baumannii. Using in silico prediction tools and comparative genome analysis in combination with in vitro proteomic approaches, we identified 42 antigens that could be used as potential vaccine targets. Considering the paucity of effective antibiotics available to treat multidrug-resistant A. baumannii infections, these vaccine targets may serve as a framework for the development of a broadly protective multi-component vaccine, an outcome that would have a major impact on the burden of A. baumannii infections in intensive care units across the globe.	[Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Nimmo, Graeme R.; Paterson, David L.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Moriel, Danilo G.; Beatson, Scott A.; Wurpel, Daniel J.; Lipman, Jeffrey; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Nimmo, Graeme R.] Pathol Queensland Cent Lab, Brisbane, Qld, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp Campus, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.schembri@uq.edu.au	Nimmo, Graeme/AAG-5426-2019; Beatson, Scott/B-6985-2013; Schembri, Mark A/C-7262-2009; Moriel, Danilo G/I-2885-2013	Beatson, Scott/0000-0002-1806-3283; Schembri, Mark A/0000-0003-4863-9260; Moriel, Danilo G/0000-0002-1421-8129; Lipman, Jeffrey/0000-0002-5965-9876; Paterson, David/0000-0003-2079-4437	Australian National Health and Medical Research Council; University of Queensland; Royal Brisbane and Women's Hospital; Royal Brisbane and Women's Hospital Foundation; Australian Research Council (ARC) Future Fellowship [FT100100662]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Royal Brisbane and Women's Hospital; Royal Brisbane and Women's Hospital Foundation; Australian Research Council (ARC) Future Fellowship(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council, The University of Queensland, the Royal Brisbane and Women's Hospital, and the Royal Brisbane and Women's Hospital Foundation. MAS is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; DiTommaso A, 1997, VACCINE, V15, P1218, DOI 10.1016/S0264-410X(97)00023-6; Donati C, 2013, ANN NY ACAD SCI, V1285, P115, DOI 10.1111/nyas.12046; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Ishikawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048830; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King LB, 2013, J INFECT DIS, V207, P1128, DOI 10.1093/infdis/jis939; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Poirel L, 2003, J CLIN MICROBIOL, V41, P3542, DOI 10.1128/JCM.41.8.3542-3547.2003; Roberts JA, 2004, J UROLOGY, V171, P1682, DOI 10.1097/01.ju.0000116123.05160.43; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	48	65	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77631	10.1371/journal.pone.0077631	http://dx.doi.org/10.1371/journal.pone.0077631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116234	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200120
J	Jones, AMP; Saxena, PK				Jones, Andrew Maxwell Phineas; Saxena, Praveen Kumar			Inhibition of Phenylpropanoid Biosynthesis in Artemisia annua L.: A Novel Approach to Reduce Oxidative Browning in Plant Tissue Culture	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; UV-B TOLERANCE; 2-AMINOINDAN-2-PHOSPHONIC ACID; SECONDARY METABOLISM; SALICYLIC-ACID; DISEASE RESISTANCE; ACTIVATED-CHARCOAL; CELL-DEATH; REGENERATION; SEEDLINGS	Oxidative browning is a common and often severe problem in plant tissue culture systems caused by the accumulation and oxidation of phenolic compounds. The current study was conducted to investigate a novel preventative approach to address this problem by inhibiting the activity of the phenylalanine ammonia lyase enzyme (PAL), thereby reducing the biosynthesis of phenolic compounds. This was accomplished by incorporating 2-aminoindane-2- phosphonic acid (AIP), a competitive PAL inhibitor, into culture media of Artemisia annua as a model system. Addition of AIP into culture media resulted in significant reductions in visual tissue browning, a reduction in total phenol content, as well as absorbance and autoflourescence of tissue extracts. Reduced tissue browning was accompanied with a significant increase in growth on cytokinin based medium. Microscopic observations demonstrated that phenolic compounds accumulated in discrete cells and that these cells were more prevalent in brown tissue. These cells were highly plasmolyzed and often ruptured during examination, demonstrating a mechanism in which phenolics are released into media in this system. These data indicate that inhibiting phenylpropanoid biosynthesis with AIP is an effective approach to reduce tissue browning in A. annua. Additional experiments with Ulmus americana and Acer saccharum indicate this approach is effective in many species and it could have a wide application in systems where oxidative browning restricts the development of biotechnologies.	[Jones, Andrew Maxwell Phineas; Saxena, Praveen Kumar] Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Saxena, PK (corresponding author), Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	psaxena@uoguelph.ca			National Science and Engineering Research Council of Canada; Gosling Foundation	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gosling Foundation	This work was funded by the National Science and Engineering Research Council of Canada and the Gosling Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Aliyu OM, 2005, AFR J BIOTECHNOL, V4, P1485; Appert C, 2003, PHYTOCHEMISTRY, V62, P415, DOI 10.1016/S0031-9422(02)00561-7; Bagheri A, 2011, PLANTS TISSUE CULTUR, V21; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; BHAT SR, 1991, PLANT CELL REP, V10, P358, DOI 10.1007/BF00193159; BROWN GD, 1994, J NAT PROD, V57, P975, DOI 10.1021/np50109a015; Chen MH, 2000, PHYTOCHEMISTRY, V53, P365, DOI 10.1016/S0031-9422(99)00531-2; Cvikrova M, 2003, PLANT PHYSIOL BIOCH, V41, P251, DOI 10.1016/S0981-9428(03)00016-0; DALAL MA, 1992, SCI HORTIC-AMSTERDAM, V51, P35, DOI 10.1016/0304-4238(92)90101-H; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; Folin O, 1927, J BIOL CHEM, V73, P627; FULZELE DP, 1991, PHYTOTHER RES, V5, P149, DOI 10.1002/ptr.2650050402; Gitz DC, 1998, PHYTOCHEMISTRY, V49, P377, DOI 10.1016/S0031-9422(98)00011-9; Gitz DC, 2004, J EXP BOT, V55, P919, DOI 10.1093/jxb/erh092; GRABBER JH, 1995, PHYTOCHEMISTRY, V40, P1077, DOI 10.1016/0031-9422(95)00413-2; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Hu W-J, 1999, REPRESSION LIGNIN BI; Janas KM, 1998, J PLANT GROWTH REGUL, V17, P169, DOI 10.1007/PL00007031; Jones AMP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-75; Krishna H, 2008, SCI HORTIC-AMSTERDAM, V118, P132, DOI 10.1016/j.scienta.2008.05.040; LAINE E, 1994, PLANT CELL REP, V13, P473, DOI 10.1007/BF00231970; Laukkanen H, 2000, TREE PHYSIOL, V20, P467; Lester GE, 2012, J FOOD COMPOSIT ANAL; Madhusudhanan K, 2000, BIOL PLANTARUM, V43, P297, DOI 10.1023/A:1002729032527; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; Medina MB, 2011, J AGR FOOD CHEM, V59, P1565, DOI 10.1021/jf103711c; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAIR MSR, 1986, J NAT PROD, V49, P504, DOI 10.1021/np50045a021; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Nybakken L, 2007, TREES-STRUCT FUNCT, V21, P273, DOI 10.1007/s00468-006-0120-0; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; Oh MM, 2009, J PLANT PHYSIOL, V166, P180, DOI 10.1016/j.jplph.2008.04.015; Panaia M, 2000, PLANT CELL TISS ORG, V63, P23, DOI 10.1023/A:1006457624282; PANIEGO NB, 1994, PLANT CELL TISS ORG, V36, P163, DOI 10.1007/BF00037715; Parthasarathy V. A., 2007, Recent trends in horticultural biotechnology, Vol. I and II. ICAE national symposium on biotechnological interventions for improvement of horticultural crops: issues and strategies, Vellanikkara, Kerala, India, 10-12 January, 2005, P85; Peiser G, 1998, POSTHARVEST BIOL TEC, V14, P171, DOI 10.1016/S0925-5214(98)00048-9; Shukla MR, 2012, CAN J FOREST RES, V42, P686, DOI [10.1139/X2012-022, 10.1139/x2012-022]; Solecka D, 2003, PHYSIOL PLANTARUM, V119, P253, DOI 10.1034/j.1399-3054.2003.00181.x; Tabiyeh DT, 2006, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.2006.726.31; Tamagnone L, 1998, PLANT CELL, V10, P1801, DOI 10.1105/tpc.10.11.1801; Tang W, 2004, PHYSIOL PLANTARUM, V122, P386, DOI 10.1111/j.1399-3054.2004.00406.x; Tang W, 2004, PLANT CELL REP, V22, P871, DOI 10.1007/s00299-004-0781-3; Teklemariam TA, 2004, PHYSIOL PLANTARUM, V122, P244, DOI 10.1111/j.0031-9317.2004.00396.x; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; TOTH K, 1994, BIOL PLANTARUM, V36, P511, DOI 10.1007/BF02921170; Uchendu EE, 2011, IN VITRO CELL DEV-PL, V47, P710, DOI 10.1007/s11627-011-9379-y; WOERDENBAG HJ, 1993, PLANT CELL TISS ORG, V32, P247, DOI 10.1007/BF00029850; ZON J, 1992, LIEBIGS ANN CHEM, P625, DOI 10.1002/jlac.1992199201107	50	83	91	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76802	10.1371/journal.pone.0076802	http://dx.doi.org/10.1371/journal.pone.0076802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116165	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300097
J	Yan, X; Que, YW; Wang, H; Wang, CC; Li, Y; Yue, XF; Ma, ZH; Talbot, NJ; Wang, ZY				Yan, Xia; Que, Yawei; Wang, Hong; Wang, Congcong; Li, Ya; Yue, Xiaofeng; Ma, Zhonghua; Talbot, Nicholas J.; Wang, Zhengyi			The MET13 Methylenetetrahydrofolate Reductase Gene Is Essential for Infection-Related Morphogenesis in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							PLANT INFECTION; PATHOGENICITY; IDENTIFICATION; BIOSYNTHESIS; PENETRATION; EXPRESSION; VIRULENCE; INVASION; SYNTHASE; BIOLOGY	Methylenetetrahydrofolate reductases (MTHFRs) play a key role in the biosynthesis of methionine in both prokaryotic and eukaryotic organisms. In this study, we report the identification of a novel T-DNA-tagged mutant WH672 in the rice blast fungus Magnaporthe oryzae, which was defective in vegetative growth, conidiation and pathogenicity. Analysis of the mutation confirmed a single T-DNA insertion upstream of MET13, which encodes a 626-amino-acid protein encoding a MTHFR. Targeted gene deletion of MET13 resulted in mutants that were non-pathogenic and significantly impaired in aerial growth and melanin pigmentation. All phenotypes associated with Delta met13 mutants could be overcome by addition of exogenous methionine. The M. oryzae genome contains a second predicted MTHFR-encoding gene, MET12. The deduced amino acid sequences of Met13 and Met12 share 32% identity. Interestingly, Delta met12 mutants produced significantly less conidia compared with the isogenic wild-type strain and grew very poorly in the absence of methionine, but were fully pathogenic. Deletion of both genes resulted in Delta met13 Delta met12 mutants that showed similar phenotypes to single Delta met13 mutants. Taken together, we conclude that the MTHFR gene, MET13, is essential for infection-related morphogenesis by the rice blast fungus M. oryzae.	[Yan, Xia; Que, Yawei; Wang, Hong; Wang, Congcong; Li, Ya; Yue, Xiaofeng; Ma, Zhonghua; Wang, Zhengyi] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Zhejiang University; University of Exeter	Wang, ZY (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	zhywang@zju.edu.cn	Ma, Zhonghua/J-6972-2014; Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Ma, Zhonghua/0000-0002-5426-0997; Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	National Key Basic Research and Development Program of China [2012CB114002]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; Natural Science Foundation of China [31071648]; Doctoral Fund of Ministry of Education of China [20100101110097]	National Key Basic Research and Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Key Basic Research and Development Program of China (2012CB114002), by Program for Changjiang Scholars and Innovative Research Team in University (IRT0943), by the Natural Science Foundation of China (Grant No. 31071648) and the Doctoral Fund of Ministry of Education of China (20100101110097) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; Caracuel-Rios Z, 2007, CURR OPIN MICROBIOL, V10, P339, DOI 10.1016/j.mib.2007.05.019; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Frandsen RJN, 2010, EUKARYOT CELL, V9, P1225, DOI 10.1128/EC.00031-10; Fu J, 2013, FUNGAL BIOL-UK, V117, P13, DOI 10.1016/j.funbio.2012.11.001; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; LEUNG H, 1988, PHYTOPATHOLOGY, V78, P1227, DOI 10.1094/Phyto-78-1227; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Li Y, 2010, MOL PLANT MICROBE IN, V23, P1260, DOI 10.1094/MPMI-03-10-0052; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SCC, 2002, EUKARYOT CELL, V1, P311, DOI 10.1128/EC.1.2.311-314.2002; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Malz S, 2005, FUNGAL GENET BIOL, V42, P420, DOI 10.1016/j.fgb.2005.01.010; Naula N, 2002, YEAST, V19, P841, DOI 10.1002/yea.877; Ou SH, 1985, RICE DIS; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Shan XY, 1999, J BIOL CHEM, V274, P32613, DOI 10.1074/jbc.274.46.32613; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; Sienko M, 2007, FUNGAL GENET BIOL, V44, P691, DOI 10.1016/j.fgb.2006.12.002; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot Nicholas J., 1995, Trends in Microbiology, V3, P9, DOI 10.1016/S0966-842X(00)88862-9; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yan X, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002385; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988	48	29	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76914	10.1371/journal.pone.0076914	http://dx.doi.org/10.1371/journal.pone.0076914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116181	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300106
J	Choi, Y; Dienes, HP; Krawczynski, K				Choi, Youkyung; Dienes, Hans-Peter; Krawczynski, Kris			Kinetics of miR-122 Expression in the Liver during Acute HCV Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RT-PCR; MICRORNA MIR-122; RNA; IDENTIFICATION; NORMALIZATION; TRANSLATION; INTERFERON; CANCER; STABILIZATION	The relationships among micro RNA-122 (miR-122) expression in the liver, hepatitis C virus (HCV) replication and hepatic damage were analyzed in three chimpanzees observed for 180 days after inoculation with HCV genotype 1a. Levels of miR-122 in the liver and serum were measured by real-time RT PCR in serial liver biopsies and serum samples. Hepatic miR-122 levels were normalized separately for each of three chimpanzees with small RNAs and microRNAs that are endogenous to the liver and are stably expressed. Two-to 4-fold rise in hepatic miR-122 levels was observed at the onset of HCV infection (the first 4 weeks) when HCV titers in the liver and serum increased rapidly in all three chimpanzees in concordance with in vitro data indicating the miR-122 significance for HCV replication. Between 10 to 14 weeks after inoculation, when hepatic and serum HCV RNA titers exceeded 3 logs and alanine aminotransferase (ALT) activity was elevated, hepatic miR-122 levels were in decline. Cumulative data derived from all three chimpanzees from 180 days of observation documented an inverse (negative) correlation between hepatic miR-122 and HCV RNA in the liver and serum and positive correlation between level of serum miR-122 and HCV replication. Subsequent rise of miR-122 level during HCV clearance and ALT normalization suggested a tri-phasic occurrence of the relationship among hepatic miR-122 expression, HCV replication and hepatic destruction, which was the most apparent in one chimpanzee but less evident in two other animals. In vivo kinetics of hepatic and serum miR-122, HCV replication and hepatic destruction reflects complexities of the virus-host interaction during the acute phase of HCV infection.	[Choi, Youkyung; Krawczynski, Kris] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA; [Dienes, Hans-Peter] Univ Cologne, Inst Pathol, Cologne, Germany	Centers for Disease Control & Prevention - USA; University of Cologne	Krawczynski, K (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA.	kzk1@cdc.gov			Centers for Disease Control budget	Centers for Disease Control budget	The study was funded from Centers for Disease Control budget. Financial Management Office of CDC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li Y, 2012, P NATL ACAD SCI US; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; Shimakami T, 2012, J VIROL, V86, P7372, DOI 10.1128/JVI.00513-12; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	32	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76501	10.1371/journal.pone.0076501	http://dx.doi.org/10.1371/journal.pone.0076501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124569	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100126
J	Chong, HQ; Yeow, J; Wang, I; Song, H; Jiang, RR				Chong, Huiqing; Yeow, Jianwei; Wang, Ivy; Song, Hao; Jiang, Rongrong			Improving Acetate Tolerance of Escherichia coli by Rewiring Its Global Regulator cAMP Receptor Protein (CRP)	PLOS ONE			English	Article							ACETIC-ACID TOLERANCE; TRANSCRIPTION MACHINERY; PHENOTYPIC ALTERATION; ETHANOL TOLERANCE; EXPRESSION; GROWTH; ACCUMULATION; INHIBITION; EVOLUTION; IDENTIFICATION	The presence of acetate exceeding 5 g/L is a major concern during E. coli fermentation due to its inhibitory effect on cell growth, thereby limiting high-density cell culture and recombinant protein production. Hence, engineered E. coli strains with enhanced acetate tolerance would be valuable for these bioprocesses. In this work, the acetate tolerance of E. coli was much improved by rewiring its global regulator cAMP receptor protein (CRP), which is reported to regulate 444 genes. Error-prone PCR method was employed to modify crp and the mutagenesis libraries (similar to 3x10(6)) were subjected to M9 minimal medium supplemented with 5-10 g/L sodium acetate for selection. Mutant A2 (D138Y) was isolated and its growth rate in 15 g/L sodium acetate was found to be 0.083 h(-1), much higher than that of the control (0.016 h(-1)). Real-time PCR analysis via OpenArray (R) system revealed that over 400 CRP-regulated genes were differentially expressed in A2 with or without acetate stress, including those involved in the TCA cycle, phosphotransferase system, etc. Eight genes were chosen for overexpression and the overexpression of uxaB was found to lead to E. coli acetate sensitivity.	[Chong, Huiqing; Song, Hao; Jiang, Rongrong] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Yeow, Jianwei; Wang, Ivy] Life Technol R&D, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Thermo Fisher Scientific	Jiang, RR (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	rrjiang@ntu.edu.sg	Jiang, Rongrong/G-6217-2010		Ministry of Education, Singapore [RG27/11]; Life Technologies CRC program	Ministry of Education, Singapore(Ministry of Education, Singapore); Life Technologies CRC program	This project is supported by Ministry of Education, Singapore (RG27/11) and Life Technologies CRC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; ARISTIDOU AA, 1994, BIOTECHNOL BIOENG, V44, P944, DOI 10.1002/bit.260440810; Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Basak S, 2012, PROCESS BIOCHEM, V47, P2152, DOI 10.1016/j.procbio.2012.08.006; Basak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051179; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Chong HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057628; CHOU CH, 1994, BIOTECHNOL BIOENG, V44, P952, DOI 10.1002/bit.260440811; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Geddes CC, 2011, CURR OPIN BIOTECH, V22, P312, DOI 10.1016/j.copbio.2011.04.012; Gilbert A, 2009, BIOTECHNOL BIOENG, V103, P500, DOI 10.1002/bit.22272; Gonzalez R, 2003, BIOTECHNOL PROGR, V19, P612, DOI 10.1021/bp025658q; HAN K, 1993, BIOTECHNOL BIOENG, V41, P316, DOI 10.1002/bit.260410305; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Huang L, 2008, PROTEIN EXPRES PURIF, V61, P168, DOI 10.1016/j.pep.2008.05.016; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Liu WS, 2012, TOP CATAL, V55, P1146, DOI 10.1007/s11244-012-9893-0; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Polen T, 2003, APPL ENVIRON MICROB, V69, P1759, DOI 10.1128/AEM.69.3.1759-1774.2003; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; PORTALIER RC, 1972, EUR J BIOCHEM, V30, P211, DOI 10.1111/j.1432-1033.1972.tb02089.x; REED WM, 1987, ENZYME MICROB TECH, V9, P117, DOI 10.1016/0141-0229(87)90154-2; Roe AJ, 1998, J BACTERIOL, V180, P767, DOI 10.1128/JB.180.4.767-772.1998; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Tomar A, 2003, APPL MICROBIOL BIOT, V62, P76, DOI 10.1007/s00253-003-1234-6; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Wang L, 2012, APPL MICROBIOL BIOT, V96, P1265, DOI 10.1007/s00253-012-3919-1; Wang L, 2012, APPL MICROBIOL BIOT, V94, P1233, DOI 10.1007/s00253-011-3699-z; Wang L, 2012, J MOL CATAL B-ENZYM, V76, P9, DOI 10.1016/j.molcatb.2011.11.016; Wang LA, 2011, J MOL CATAL B-ENZYM, V69, P120, DOI 10.1016/j.molcatb.2011.01.005; Wei P, 2008, BIOTECHNOL APPL BIOC, V49, P113, DOI 10.1042/BA20070072; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wong MS, 2008, METAB ENG, V10, P97, DOI 10.1016/j.ymben.2007.10.003; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166; Zhang HF, 2012, APPL MICROBIOL BIOT, V94, P1107, DOI 10.1007/s00253-012-4012-5; Zhang HF, 2012, BIOTECHNOL BIOENG, V109, P1165, DOI 10.1002/bit.24411; Zhang HF, 2010, APPL MICROBIOL BIOT, V88, P117, DOI 10.1007/s00253-010-2735-8	54	28	32	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77422	10.1371/journal.pone.0077422	http://dx.doi.org/10.1371/journal.pone.0077422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124618	gold, Green Published			2022-12-25	WOS:000325489100175
J	Free, CL; Baxter, GS; Dickman, CR; Leung, LKP				Free, Carissa L.; Baxter, Greg S.; Dickman, Christopher R.; Leung, Luke K. P.			Resource Pulses in Desert River Habitats: Productivity-Biodiversity Hotspots, or Mirages?	PLOS ONE			English	Article							DASYURID MARSUPIALS; ARID AUSTRALIA; AGAMID LIZARDS; SIMPSON DESERT; VEGETATION; RAINFALL; DYNAMICS; ECOLOGY; WATER; STRATEGIES	Resource pulses in the world's hot deserts are driven largely by rainfall and are highly variable in both time and space. However, run-on areas and drainage lines in arid regions receive more water more often than adjacent habitats, and frequently sustain relatively high levels of primary productivity. These landscape features therefore may support higher biotic diversity than other habitats, and potentially act as refuges for desert vertebrates and other biota during droughts. We used the ephemeral Field River in the Simpson Desert, central Australia, as a case study to quantify how resources and habitat characteristics vary spatially and temporally along the riparian corridor. Levels of moisture and nutrients were greater in the clay-dominated soils of the riverine corridor than in the surrounding sand dunes, as were cover values of trees, annual grasses, other annual plants and litter; these resources and habitat features were also greater near the main catchment area than in the distal reaches where the river channel runs out into extensive dune fields. These observations confirm that the riverine corridor is more productive than the surrounding desert, and support the idea that it may act as a refuge or as a channel for the ingress of peri-desert species. However, the work also demonstrates that species diversity of invertebrates and plants is not higher within the river corridor; rather, it is driven by rainfall and the accompanying increase in annual plants following a rain event. Further research is required to identify the biota that depend upon these resource pulses.	[Free, Carissa L.; Leung, Luke K. P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Baxter, Greg S.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Sydney	Free, CL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia.	carissa.free@uqconnect.edu.au	Baxter, Greg/AAQ-5364-2021; Dickman, Christopher/Q-4662-2019	Baxter, Greg/0000-0003-1816-4970; Dickman, Christopher/0000-0002-1067-3730; Leung, Luke/0000-0002-8829-4925				ABENSPERGTRAUN M, 1993, AUST J ECOL, V18, P317, DOI 10.1111/j.1442-9993.1993.tb00459.x; Arthington A. H., 2012, ENV FLOWS SAVING RIV; BRAITHWAITE RW, 1988, AUST J ECOL, V13, P375, DOI 10.1111/j.1442-9993.1988.tb00986.x; BUCKLEY RC, 1982, AUST J ECOL, V7, P187, DOI 10.1111/j.1442-9993.1982.tb01592.x; Charley J.L., 1968, P ECOL SOC AUST, V3, P28; Cole GA., 1968, DESERT BIOL, P423; Collins N. M., 1983, Nitrogen as an ecological factor, P381; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Daly BG, 2007, AUSTRAL ECOL, V32, P825, DOI 10.1111/j.1442-9993.2007.01768.x; Datry T, 2011, AQUAT SCI, V73, P453, DOI 10.1007/s00027-011-0236-1; Department of Environment and Water Resources, 2007, AUSTR BIOG REG; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Dubbin W, 2001, SOILS; Duguid A, 2002, WETLANDS ARID NO TER; Esteban J, 2006, ECOL COMPLEX, V3, P109, DOI 10.1016/j.ecocom.2005.10.001; Fensham RJ, 2010, ECOLOGY, V91, P681, DOI 10.1890/08-2356.1; FRANK A. S. K., 2010, THESIS U SYDNEY SYDN; Frank ASK, 2012, RANGELAND J, V34, P319, DOI 10.1071/RJ12032; Gibson D. F., 1992, AUST MAMMAL, V15, P105; Gordon CE, 2010, AUSTRAL ECOL, V35, P41, DOI 10.1111/j.1442-9993.2009.02010.x; Graf W. L., 1988, FLUVIAL PROCESSES DR; Greenaway P., 1984, P145; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Greenville AC, 2009, BIOL J LINN SOC, V97, P531, DOI 10.1111/j.1095-8312.2009.01241.x; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Gynther I, 2009, CRAVENS PEAK SCI STU, P199; Hamilton SK, 2005, LIMNOL OCEANOGR, V50, P743, DOI 10.4319/lo.2005.50.3.0743; Haythornthwaite AS, 2006, ECOGRAPHY, V29, P285, DOI 10.1111/j.2006.0906-7590.04307.x; Haythornthwaite AS, 2000, AUSTRAL ECOL, V25, P193; Jacobson PJ, 2000, J ARID ENVIRON, V45, P21, DOI 10.1006/jare.1999.0619; Jones H. A., 2007, P132; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2003, WILDLIFE RES, V30, P547, DOI 10.1071/WR02093; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; LUNDIEJENKINS G, 1993, WILDLIFE RES, V20, P495, DOI 10.1071/WR9930495; Mahon PS, 1999, THESIS U SYDNEY SYDN; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; McDonald R.I.R., 1998, AUSTR SOIL LAND SURV; McIntyre RES, 2009, J ARID ENVIRON, V73, P48, DOI 10.1016/j.jaridenv.2008.09.011; Moore P., 2005, GUIDE PLANTS INLAND; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Morton S.R., 1995, REFUGIA BIOL DIVERSI; MORTON SR, 1985, ECOLOGY, V66, P1859, DOI 10.2307/2937381; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Murrell B, 1984, ARID AUSTR, P327; Noy-Mein I., 1974, Annual Rev Ecol Syst, V5, P195, DOI 10.1146/annurev.es.05.110174.001211; Predavec M, 1997, J ARID ENVIRON, V36, P327, DOI 10.1006/jare.1996.0156; PRIMER-E, 2007, PRIMER 6 6 1 10; Prinsloo GL, 1990, NAMIB ECOLOGY 25 YEA, P67; Purdie R., 1984, LAND SYSTEMS SIMPSON; R Development Core Team, 2005, R LANG ENV STAT COMP; RICE BL, 1994, AUST J BOT, V42, P687, DOI 10.1071/BT9940687; SAS Institute Inc, 2003, SAS VERS 9 1; Sharma R.C., 2005, P149; Sheldon F., 2004, The Darling, P280; Shephard M., 1992, SIMPSON DESERT NATUR; Ponder Winston, 2007, P1; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Stromberg JC, 2009, BIODIVERS CONSERV, V18, P663, DOI 10.1007/s10531-008-9532-z; Tongway D.J., 2001, BANDED VEGETATION PA; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Unmack PJ, 2001, J ARID ENVIRON, V49, P653, DOI 10.1006/jare.2001.0813; Urban A, 1990, Wildflowers and plants of inland Australia; Van Etten EJB, 2009, AUST GEOGR, V40, P109, DOI 10.1080/00049180802657075; Webster R, 1988, EUROP J SOIL SCI, V40, P493; Whitford W., 2002, ECOLOGY DESERT SYSTE; Williams O.B., 1985, P269	72	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e72690	10.1371/journal.pone.0072690	http://dx.doi.org/10.1371/journal.pone.0072690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124446	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100003
J	Sheridan, H; Reingold, EM				Sheridan, Heather; Reingold, Eyal M.			The Mechanisms and Boundary Conditions of the Einstellung Effect in Chess: Evidence from Eye Movements	PLOS ONE			English	Article							SATISFACTION; SEARCH; SET; EXPERTISE; PLAYERS	In a wide range of problem-solving settings, the presence of a familiar solution can block the discovery of better solutions (i.e., the Einstellung effect). To investigate this effect, we monitored the eye movements of expert and novice chess players while they solved chess problems that contained a familiar move (i.e., the Einstellung move), as well as an optimal move that was located in a different region of the board. When the Einstellung move was an advantageous (but suboptimal) move, both the expert and novice chess players who chose the Einstellung move continued to look at this move throughout the trial, whereas the subset of expert players who chose the optimal move were able to gradually disengage their attention from the Einstellung move. However, when the Einstellung move was a blunder, all of the experts and the majority of the novices were able to avoid selecting the Einstellung move, and both the experts and novices gradually disengaged their attention from the Einstellung move. These findings shed light on the boundary conditions of the Einstellung effect, and provide convergent evidence for Bilalic, McLeod, & Gobet (2008)'s conclusion that the Einstellung effect operates by biasing attention towards problem features that are associated with the familiar solution rather than the optimal solution.	[Sheridan, Heather] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Reingold, Eyal M.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Southampton; University of Toronto; University Toronto Mississauga	Sheridan, H (corresponding author), Univ Southampton, Sch Psychol, Southampton, Hants, England.	H.Sheridan@soton.ca.uk			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grant by an NSERC Grant to Eyal Reingold. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; [Anonymous], 1996, PERCEPTION MEMORY CH; Berbaum K.S., 2010, HDB MED IMAGE PERCEP, P107; Berbaum KS, 2000, ACAD RADIOL, V7, P945, DOI 10.1016/S1076-6332(00)80176-2; BERBAUM KS, 1990, INVEST RADIOL, V25, P133, DOI 10.1097/00004424-199002000-00006; Berbaum KS, 1996, ACAD RADIOL, V3, P815, DOI 10.1016/S1076-6332(96)80271-6; Bilalic M, 2008, COGNITION, V108, P652, DOI 10.1016/j.cognition.2008.05.005; Bilalic M, 2008, COGNITIVE PSYCHOL, V56, P73, DOI 10.1016/j.cogpsych.2007.02.001; Bilalic M, 2010, CURR DIR PSYCHOL SCI, V19, P111, DOI 10.1177/0963721410363571; BROWN J, 1968, PSYCHON SCI, V10, P41; Charness N, 2001, MEM COGNITION, V29, P1146, DOI 10.3758/BF03206384; Chesney DL, 2013, MEM COGNITION, V41, P1079, DOI 10.3758/s13421-013-0315-8; Elo A., 1986, RATING CHESSPLAYERS; ELO AE, 1965, J GERONTOL, V20, P289; Frensch Peter A., 1989, ADV PSYCHOL HUMAN IN, V5, P157; Gould Stephen J., 1996, MISMEASURE MAN REVIS; Greenberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036206; HECHT H, 1995, PSYCHOL SCI, V6, P90, DOI 10.1111/j.1467-9280.1995.tb00312.x; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Luchins A. S., 1942, PSYCHOL MONOGRAPHS, V54, P248; Piaget J., 1956, CHILDS CONCEPTION SP; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Reingold EM, 2001, PSYCHON B REV, V8, P504, DOI 10.3758/BF03196185; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Reingold EM, 2005, COGNITIVE PROCESS, P325, DOI DOI 10.1093/ACPR0F:0S0/9780198566816.003.0014; Saariluoma P., 1990, LINES THOUGHT REFLEC, V2, P41; SAMUEL S, 1995, RADIOLOGY, V194, P895, DOI 10.1148/radiology.194.3.7862998; Schultz PW, 2002, GENET SOC GEN PSYCH, V128, P165; SIMON HA, 1973, AM SCI, V61, P394; SWELLER J, 1978, J EXP PSYCHOL-HUM L, V4, P513, DOI 10.1037/0278-7393.4.5.513; Tetlock PE, 2005, EXPERT POLITICAL JUDGMENT: HOW GOOD IS IT, HOW CAN WE KNOW, P1; Vallee-Tourangeau F, 2011, Q J EXP PSYCHOL, V64, P1889, DOI 10.1080/17470218.2011.605151; Wiley J, 1998, MEM COGNITION, V26, P716, DOI 10.3758/BF03211392	34	17	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75796	10.1371/journal.pone.0075796	http://dx.doi.org/10.1371/journal.pone.0075796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124515	Green Published, Green Accepted, gold			2022-12-25	WOS:000325489100072
J	Umschweif, G; Alexandrovich, AG; Trembovler, V; Horowitz, M; Shohami, E				Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria; Horowitz, Michal; Shohami, Esther			The Role and Dynamics of beta-Catenin in Precondition Induced Neuroprotection after Traumatic Brain Injury	PLOS ONE			English	Article							CLOSED-HEAD INJURY; GLYCOGEN-SYNTHASE KINASE-3; ACCLIMATION-INDUCED NEUROPROTECTION; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CELL-DEATH; CADHERIN; PATHWAY; MICE; ACTIVATION; INCREASES	Preconditioning via heat acclimation (34 degrees C 30 d) results in neuroprotection from traumatic brain injury due to constitutive as well as dynamic changes triggered by the trauma. Among these changes is Akt phosphorylation, which decreases apoptosis and induces HIF1 alpha. In the present study we investigated the Akt downstream GSK3 beta/beta -catenin pathway and focused on post injury alternations of beta catenin and its impact on the cellular response in preconditioned heat acclimated mice. We found that the reduction in motor disability is accompanied with attenuation of depressive like behavior in heat acclimated mice that correlates with the GSK3 beta phosphorylation state. Concomitantly, a robust beta catenin phosphorylation is not followed by its degradation, or by reduced nuclear accumulation. Enhanced tyrosine phosphorylation of beta catenin in the injured area weakens the beta catenin-N cadherin complex. Membrane beta catenin is transiently reduced in heat acclimated mice and its recovery 7 days post TBI is accompanied by induction of the synaptic marker synaptophysin. We suggest a set of cellular events following traumatic brain injury in heat acclimated mice that causes beta catenin to participate in cell-cell adhesion alternations rather than in Wnt signaling. These events may contribute to synaptogenesis and the improved motor and cognitive abilities seen heat acclimated mice after traumatic brain injury.	[Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria] Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel; [Umschweif, Gali; Horowitz, Michal; Shohami, Esther] Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Horowitz, M (corresponding author), Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel.	m.horowitz@mail.huji.ac.il; esty@cc.huji.ac.il			Yissum Research Development Company of the Hebrew University of Jerusalem [0334185]	Yissum Research Development Company of the Hebrew University of Jerusalem	This study was supported by Yissum Research Development Company of the Hebrew University of Jerusalem, budget number 0334185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bhuiyan MIH, 2011, ARCH PHARM RES, V34, P1023, DOI 10.1007/s12272-011-0620-3; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Eynan M, 2012, J APPL PHYSIOL, V113, P595, DOI 10.1152/japplphysiol.00228.2012; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hillion JA, 2006, J CEREBR BLOOD F MET, V26, P1323, DOI 10.1038/sj.jcbfm.9600286; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI 10.1089/neu.2008-0743; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schwimmer H, 2004, MOL BRAIN RES, V130, P95, DOI 10.1016/j.molbrainres.2004.07.011; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76129	10.1371/journal.pone.0076129	http://dx.doi.org/10.1371/journal.pone.0076129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124534	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100091
J	Bramham, K; Poli-de-Figueiredo, CE; Seed, PT; Briley, AL; Poston, L; Shennan, AH; Chappell, LC				Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.			Association of Proteinuria Threshold in Pre-Eclampsia with Maternal and Perinatal Outcomes: A Nested Case Control Cohort of High Risk Women	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; PROTEIN/CREATININE RATIO; PREGNANCY; GUIDELINES; MANAGEMENT; DIAGNOSIS	Objectives: To evaluate occurrence of adverse maternal and perinatal outcomes with different thresholds of proteinuria (300-499mg and >= 500mg/24 hours) in pre-eclamptic women, comparing outcomes against women with chronic and gestational hypertension. Design: Secondary analysis of the Vitamins in Pre-Eclampsia Trial. Setting: 25 UK hospitals in ten geographical areas. Population: 946 women with pre-existing risk factors for pre-eclampsia. Methods: Women with pre-eclampsia and proteinuria 300-499mg/24h (PE300, referent group, n=60) or proteinuria >= 500 mg/24h (PE500, n= 161) were compared with two groups of non-proteinuric women with chronic hypertension (CHT, n= 615) or gestational hypertension (GH, n= 110). Main Outcome Measures: Maternal: progression to severe hypertension. Perinatal: small for gestational age (SGA) <5th centile, gestation at delivery. Results: Severe hypertension occurred more frequently in PE500 (35%) and PE300 (27%) than CHT (5.9%; P <= 0.01) and GH (10%; p <= 0.001). Gestation at delivery was earlier in PE500 (33.2w) than PE300 (37.3w; P <= 0.001), and later in CHT (38.3w; P <= 0.05) and GH (39.1w; P <= 0.001). SGA infants were more frequent in PE300 (32%) than in CHT (13.3%; P <= 0.001) and GH (16.5%; P <= 0.05). Women in PE500 were more likely to have a caesarean section than PE300 (78% vs. 48%; P= 0.001), and to receive magnesium sulphate (17% vs. 1.7%, P= 0.05). Conclusion: Women with PE300 have complication rates above those of women managed as out-patients (GH and CHT), meriting closer surveillance and confirming 300 mg/d as an appropriate threshold for determining in-patient management. Adverse perinatal outcomes are higher still in women with PE500.	[Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England; [Bramham, Kate; Poli-de-Figueiredo, Carlos E.; Seed, Paul T.; Briley, Annette L.; Poston, Lucilla; Shennan, Andrew H.; Chappell, Lucy C.] Kings Hlth Partners, London, England; [Poli-de-Figueiredo, Carlos E.] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Rio De Janeiro, Brazil	University of London; King's College London; University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England.	lucy.chappell@kcl.ac.uk	Briley, Annette/N-1704-2019; Seed, Paul T/C-4435-2008; Briley, Annette/AAZ-5305-2020; Poli=de-Figueiredo, Carlos Eduardo/A-2027-2013	Seed, Paul T/0000-0001-7904-7933; Briley, Annette/0000-0002-4266-920X; Poli=de-Figueiredo, Carlos Eduardo/0000-0002-7333-8884; Bramham, Kate/0000-0002-6272-7921; Shennan, Andrew/0000-0001-5273-3132; Poston, Lucilla/0000-0003-1100-2821	Wellcome Trust; Tommy's Charity; National Institute for Health Research [DRF-2009-02-18] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Tommy's Charity; National Institute for Health Research(National Institute for Health Research (NIHR))	The original trial was funded by the Wellcome Trust (registered charity number 210183) with additional support from Tommy's Charity (registered charity number 1060508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis C, 1998, CLIN PHYSL OBSTET, P263; Bramham K, 2011, REPROD SCI, V18, P623, DOI 10.1177/1933719110395403; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Caetano ERSP, 2001, HYPERTENSION, V38, P171, DOI 10.1161/01.HYP.38.2.171; Chan P, 2005, BJOG-INT J OBSTET GY, V112, P280, DOI 10.1111/j.1471-0528.2004.00395.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Goodwin AA, 2005, AM J OBSTET GYNECOL, V193, P973, DOI 10.1016/j.ajog.2005.05.047; *GYN ACOOA, 2002, OBSTET GYNECOL, V33, P159; Harlow FH, 2001, HYPERTENS PREGNANCY, V20, P57, DOI 10.1081/PRG-100104172; HIGBY K, 1994, AM J OBSTET GYNECOL, V171, P984, DOI 10.1016/S0002-9378(13)90019-3; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; McClellan WM, 2011, J AM SOC NEPHROL, V22, P1721, DOI 10.1681/ASN.2010101085; Milne F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3129; National Institute for Clinical Excellence, 2010, HYP PREGN MAN HYP DI; NORTH R, 2007, CLASSIFICATION DIAGN; Pahwa MB, 2007, CLIN CHIM ACTA, V382, P145, DOI 10.1016/j.cca.2007.03.022; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Ramos JGL, 1999, HYPERTENS PREGNANCY, V18, P209, DOI 10.3109/10641959909016194; SIBAI BM, 1991, AM J OBSTET GYNECOL, V165, P1408; Suzuki S, 1997, NEPHROL DIAL TRANSPL, V12, P2488, DOI 10.1093/ndt/12.12.2488; Thangaratinam S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-10; Thornton CE, 2010, CLIN EXP PHARMACOL P, V37, P466, DOI 10.1111/j.1440-1681.2009.05334.x; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Waugh J, 2005, HYPERTENS PREGNANCY, V24, P291, DOI 10.1080/10641950500281019; Waugh J, 2004, AM J OBSTET GYNECOL, V191, P1049, DOI 10.1016/j.ajog.2004.05.040	29	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76083	10.1371/journal.pone.0076083	http://dx.doi.org/10.1371/journal.pone.0076083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130760	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200030
J	Manfrino, C; Jacoby, CA; Camp, E; Frazer, TK				Manfrino, Carrie; Jacoby, Charles A.; Camp, Emma; Frazer, Thomas K.			A Positive Trajectory for Corals at Little Cayman Island	PLOS ONE			English	Article							MARINE PROTECTED AREAS; LONG-TERM DECLINE; BLEACHING EVENT; JUVENILE CORALS; CARIBBEAN CORAL; CLIMATE-CHANGE; ST-JOHN; REEF; RECOVERY; RECRUITMENT	Coral reefs are damaged by natural disturbances and local and global anthropogenic stresses. As stresses intensify, so do debates about whether reefs will recover after significant damage. True headway in this debate requires documented temporal trajectories for coral assemblages subjected to various combinations of stresses; therefore, we report relevant changes in coral assemblages at Little Cayman Island. Between 1999 and 2012, spatiotemporal patterns in cover, densities of juveniles and size structure of assemblages were documented inside and outside marine protected areas using transects, quadrats and measurements of maximum diameters. Over five years, bleaching and disease caused live cover to decrease from 26% to 14%, with full recovery seven years later. Juvenile densities varied, reaching a maximum in 2010. Both patterns were consistent within and outside protected areas. In addition, dominant coral species persisted within and outside protected areas although their size frequency distributions varied temporally and spatially. The health of the coral assemblage and the similarity of responses across levels of protection suggested that negligible anthropogenic disturbance at the local scale was a key factor underlying the observed resilience.	[Manfrino, Carrie] Kean Univ, Union, NJ USA; [Manfrino, Carrie] Cent Caribbean Marine Inst, Princeton, NJ USA; [Jacoby, Charles A.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL USA; [Camp, Emma] Little Cayman Res Ctr, Cent Caribbean Marine Inst, Little Cayman, Cayman Islands, Jamaica; [Frazer, Thomas K.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Frazer, Thomas K.] Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Manfrino, C (corresponding author), Kean Univ, Union, NJ USA.	manfrino@reefresearch.org	Camp, Emma/W-3335-2017; Jacoby, Charles A/D-5608-2013; Manfrino, Carrie/AAZ-9126-2021	Camp, Emma/0000-0003-1962-1336; Jacoby, Charles A/0000-0002-5948-3241; Manfrino, Carrie/0000-0002-3129-9629	Div Of Biological Infrastructure [1227093] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Anderson J. M., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Aronson RB, 2012, ECOLOGY, V93, P303, DOI 10.1890/11-1037.1; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bruckner A.W., 2002, P CAR ACR WORKSH POT; Burke L., 2011, REEFS RISK REVISITED; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Coelho VR, 2007, AQUAT CONSERV, V17, P666, DOI 10.1002/aqc.822; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Edmunds PJ, 1998, B MAR SCI, V62, P937; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GHIOLD J, 1990, Caribbean Journal of Science, V26, P52; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lang JC, 2010, AGRRA PROTOCOLS VERS, P31; McField MD, 1999, B MAR SCI, V64, P155; McGrath TA, 2003, REV BIOL TROP, V51, P67; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; van Hooidonk RJ, 2012, ESTUAR COAST SHELF S, V106, P80, DOI 10.1016/j.ecss.2012.04.021; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Villamizar E, 2008, REV BIOL TROP, V56, P255; Whelan KRT, 2007, CORAL REEFS, V26, P689, DOI 10.1007/s00338-007-0241-y; Wilkinson C, 2008, STATUS CORAL REEFS W	53	12	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75432	10.1371/journal.pone.0075432	http://dx.doi.org/10.1371/journal.pone.0075432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130710	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900036
J	Cuenca, J; Aleza, P; Vicent, A; Brunel, D; Ollitrault, P; Navarro, L				Cuenca, Jose; Aleza, Pablo; Vicent, Antonio; Brunel, Dominique; Ollitrault, Patrick; Navarro, Luis			Genetically Based Location from Triploid Populations and Gene Ontology of a 3.3-Mb Genome Region Linked to Alternaria Brown Spot Resistance in Citrus Reveal Clusters of Resistance Genes	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; HALF-TETRAD ANALYSIS; POWDERY MILDEW RESISTANCE; HOST-SPECIFIC TOXINS; ALLELIC CONFIGURATION; PONCIRUS-TRIFOLIATA; TANGERINE PATHOTYPE; BREEDING PARENTS; MINNEOLA TANGELO; FORTUNE MANDARIN	Genetic analysis of phenotypical traits and marker-trait association in polyploid species is generally considered as a challenge. In the present work, different approaches were combined taking advantage of the particular genetic structures of 2n gametes resulting from second division restitution (SDR) to map a genome region linked to Alternaria brown spot (ABS) resistance in triploid citrus progeny. ABS in citrus is a serious disease caused by the tangerine pathotype of the fungus Alternaria alternata. This pathogen produces ACT-toxin, which induces necrotic lesions on fruit and young leaves, defoliation and fruit drop in susceptible genotypes. It is a strong concern for triploid breeding programs aiming to produce seedless mandarin cultivars. The monolocus dominant inheritance of susceptibility, proposed on the basis of diploid population studies, was corroborated in triploid progeny. Bulk segregant analysis coupled with genome scan using a large set of genetically mapped SNP markers and targeted genetic mapping by half tetrad analysis, using SSR and SNP markers, allowed locating a 3.3 Mb genomic region linked to ABS resistance near the centromere of chromosome III. Clusters of resistance genes were identified by gene ontology analysis of this genomic region. Some of these genes are good candidates to control the dominant susceptibility to the ACT-toxin. SSR and SNP markers were developed for efficient early marker-assisted selection of ABS resistant hybrids.	[Cuenca, Jose; Aleza, Pablo; Vicent, Antonio; Ollitrault, Patrick; Navarro, Luis] Inst Valenciano Invest Agr Moncada, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain; [Brunel, Dominique; Ollitrault, Patrick] INRA, Etud Polymorphisme Genomes Vegetaux, Evry, France; [Ollitrault, Patrick] Coopeerat Int Rech Agron Dev, Ameliorat Genet Especes Multiplicat Vegetat Ctr, BIOS Dept, Montpellier, France	INRAE; CIRAD	Ollitrault, P (corresponding author), Inst Valenciano Invest Agr Moncada, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	ollitrault@cirad.fr; lnavarro@ivia.es	Antonio, Vicent/W-6375-2019; Aleza, Pablo/ABF-4339-2020; Cuenca, Jose/N-7047-2014; Vicent, Antonio/D-1306-2014; Navarro, Luis/D-1001-2012; Aleza, Pablo/M-3710-2014	Antonio, Vicent/0000-0002-3848-0631; Aleza, Pablo/0000-0003-3554-5337; Vicent, Antonio/0000-0002-3848-0631; Navarro, Luis/0000-0001-5163-5960; Aleza, Pablo/0000-0002-8936-1448; Ollitrault, Patrick/0000-0002-9456-5517; CUENCA, JOSE/0000-0002-3094-9933	Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER) [AGL2011-26490]; INIA [RTA2010-00105-00-00]; DOC-INIA	Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER); INIA(Instituto de Investigacion Agropecuaria (INIA)); DOC-INIA	This research was jointly financed by the grant AGL2011-26490-Ministry of "Economia y Competividad"-Fondo Europeo de Desarrollo Regional (FEDER) and INIA RTA2010-00105-00-00 and DOC-INIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero J, 2013, MOL PLANT PATHOL, V14, P610, DOI 10.1111/mpp.12031; Ajiro N, 2010, PHYTOPATHOLOGY, V100, P120, DOI 10.1094/PHYTO-100-2-0120; AKHUNOV E, 2009, THEOR APPL GENET, V119, P507, DOI DOI 10.1007/s00122-009-1059-5; Akimitsu KA, 2003, MOL PLANT PATHOL, V4, P435, DOI 10.1046/j.1364-3703.2003.00189.X; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Aleza P, 2012, TREE GENET GENOMES, V8, P1293, DOI 10.1007/s11295-012-0515-6; Aleza P, 2012, PLANT CELL REP, V31, P1723, DOI 10.1007/s00299-012-1286-0; Aleza P, 2012, 12 INT CITR C 19 23; Aleza P, 2011, ANN BOT-LONDON, V108, P37, DOI 10.1093/aob/mcr099; Aleza P, 2010, HORTSCIENCE, V45, P139, DOI 10.21273/HORTSCI.45.1.139; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bhatia A, 2003, PLANT DIS, V87, P1089, DOI 10.1094/PDIS.2003.87.9.1089; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Canihos Y, 1999, PLANT DIS, V83, P429, DOI 10.1094/PDIS.1999.83.5.429; Cervera M, 2005, METH MOL B, V286, P177; Chen CX, 2008, PLANT SCI, V174, P1, DOI 10.1016/j.plantsci.2007.08.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuenca J, 2011, HEREDITY, V107, P462, DOI 10.1038/hdy.2011.33; Cuenca J, 2013, ANN BOT-LONDON, V111, P731, DOI 10.1093/aob/mct032; Cuenca J, 2010, HORTSCIENCE, V45, P977, DOI 10.21273/HORTSCI.45.6.977; Cuppen Edwin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4841; Dalkilic Z, 2005, J AM SOC HORTIC SCI, V130, P191, DOI 10.21273/JASHS.130.2.191; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DASILVA JAG, 1996, METHODS GENOME ANAL, P211; de Souza MC, 2009, SCI HORTIC-AMSTERDAM, V123, P1, DOI 10.1016/j.scienta.2009.07.005; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; DOUCHES DS, 1988, EUPHYTICA, V38, P247, DOI 10.1007/BF00023528; DOUCHES DS, 1987, GENOME, V29, P519, DOI 10.1139/g87-089; Elena K, 2006, EUR J PLANT PATHOL, V115, P259, DOI 10.1007/s10658-006-9005-8; ESEN A, 1973, J HERED, V64, P147, DOI 10.1093/oxfordjournals.jhered.a108373; ESEN A, 1971, J HERED, V62, P329, DOI 10.1093/oxfordjournals.jhered.a108186; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Everts KL, 1996, PLANT DIS, V80, P276, DOI 10.1094/PD-80-0276; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fang DQ, 1998, GENETICS, V150, P883; Folimonov AS, 2007, VIROLOGY, V368, P205, DOI 10.1016/j.virol.2007.06.038; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Froelicher Y, 2012, 12 INT CITR C; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; Gmitter FG, 2012, 12 INT CITR C 19 23; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; GOES A, 2001, FITOPATOL BRAS, V26, P386; Golmohammadi M, 2006, PLANT PATHOL, V55, P578, DOI 10.1111/j.1365-3059.2006.01427.x; Grosser JW, 2010, HORTSCIENCE, V45, P1160, DOI 10.21273/HORTSCI.45.8.1160; Guest D, 1997, PLANT PATHOGENS PLAN, P242; Gulsen O, 2010, EUPHYTICA, V173, P265, DOI 10.1007/s10681-010-0146-7; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Guo M, 1996, GENETICS, V142, P1349; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; HUTTON D G, 1988, Australasian Plant Pathology, V17, P69, DOI 10.1071/APP9880069; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; JOHNSON SL, 1995, GENETICS, V139, P1727; JORGENSEN JH, 1977, EUPHYTICA, V26, P55, DOI 10.1007/BF00032068; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; Kamiri M, 2011, PLANT CELL REP, V30, P1415, DOI 10.1007/s00299-011-1050-x; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; KOHMOTO K, 1991, PHYTOPATHOLOGY, V81, P719, DOI 10.1094/Phyto-81-719; Lindner KR, 2000, GENOME, V43, P538, DOI 10.1139/gen-43-3-538; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Luro F, 2004, ACTA HORTIC, P841, DOI 10.17660/ActaHortic.2004.663.152; MARSDEN JE, 1987, GENETICS, V116, P299; Mccollum TG, 2007, PROC FL STATE HORTIC, V120, P285; MENDIBURU AO, 1979, THEOR APPL GENET, V54, P177, DOI 10.1007/BF00263048; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Ming R, 2001, GENOME RES, V11, P2075, DOI 10.1101/gr.198801; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mourao FAA, 1996, FRUIT VARIETIES J, V50, P76; Nagy ED, 2007, THEOR APPL GENET, V114, P961, DOI 10.1007/s00122-006-0481-1; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Navarro L., 2005, PHYTOMA, V170, P36; Navarro L, 2012, 12 INT CITR C 19 23; Ollitrault P, 2008, PL BRED RE, V30, P323; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; OTANI H, 1995, CAN J BOT, V73, pS453, DOI 10.1139/b95-282; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Peever TL, 1999, PHYTOPATHOLOGY, V89, P851, DOI 10.1094/PHYTO.1999.89.10.851; PEGG K. G., 1966, QUEENSLAND J AGR ANM SCI, V23, P15; Peres NA, 2006, CROP PROT, V25, P454, DOI 10.1016/j.cropro.2005.07.010; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; REINISCH AJ, 1994, GENETICS, V138, P829; Reis RF, 2007, SCI HORTIC-AMSTERDAM, V113, P336, DOI 10.1016/j.scienta.2007.04.005; Ricci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016912; SOLEL Z, 1991, PLANT PATHOL, V40, P145, DOI 10.1111/j.1365-3059.1991.tb02303.x; Solel Z, 1997, J PHYTOPATHOL, V145, P389, DOI 10.1111/j.1439-0434.1997.tb00420.x; Starrantino A., 1992, P INT SOC CITRIC, V1, P117; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Szelinger S, 2011, METHODS MOL BIOL, V700, P49, DOI 10.1007/978-1-61737-954-3_4; Tavoletti S, 1996, P NATL ACAD SCI USA, V93, P10918, DOI 10.1073/pnas.93.20.10918; Terol J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-31; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Timmer Lavern W., 2003, Phytopathologia Mediterranea, V42, P99; Toyoda K, 2002, TRANSGENIC RES, V11, P567, DOI 10.1023/A:1021182111770; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Vicent A, 2009, CROP PROT, V28, P1, DOI 10.1016/j.cropro.2008.07.004; Vicent A, 2007, PLANT DIS, V91, P393, DOI 10.1094/PDIS-91-4-0393; Vicent A, 2004, EUR J PLANT PATHOL, V110, P245, DOI 10.1023/B:EJPP.0000019794.00000.02; Vicent A., 2000, Plant Disease, V84, P1044, DOI 10.1094/PDIS.2000.84.9.1044B; Wang XF, 2010, PLANT DIS, V94, P375, DOI 10.1094/PDIS-94-3-0375C; XU WW, 1995, THEOR APPL GENET, V91, P947, DOI 10.1007/BF00223905; Yan WY, 2010, J GENET GENOMICS, V37, P47, DOI 10.1016/S1673-8527(09)60024-2; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; Yang ZN, 2003, PLANT PHYSIOL, V131, P482, DOI 10.1104/pp.011262; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Zhao HY, 1998, GENETICS, V150, P473	116	22	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e767553	10.1371/journal.pone.0076755	http://dx.doi.org/10.1371/journal.pone.0076755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116149	Green Published, gold			2022-12-25	WOS:000325552200064
J	Kauwe, JSK; Ridge, PG; Foster, NL; Cannon-Albright, LA				Kauwe, John S. K.; Ridge, Perry G.; Foster, Norman L.; Cannon-Albright, Lisa A.			Strong Evidence for a Genetic Contribution to Late-Onset Alzheimer's Disease Mortality: A Population-Based Study	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY GENE; GENOME-WIDE ASSOCIATION; INHERITED PREDISPOSITION; HERITABLE PREDISPOSITION; IDENTIFIES VARIANTS; DEATH CERTIFICATES; VASCULAR DEMENTIA; COMMON VARIANTS; UTAH MORMONS; RISK	Background: Alzheimer's disease (AD) is an international health concern that has a devastating effect on patients and families. While several genetic risk factors for AD have been identified much of the genetic variance in AD remains unexplained. There are limited published assessments of the familiality of Alzheimer's disease. Here we present the largest genealogy-based analysis of AD to date. Methods: We assessed the familiality of AD in The Utah Population Database (UPDB), a population-based resource linking electronic health data repositories for the state with the computerized genealogy of the Utah settlers and their descendants. We searched UPDB for significant familial clustering of AD to evaluate the genetic contribution to disease. We compared the Genealogical Index of Familiality (GIF) between AD individuals and randomly selected controls and estimated the Relative Risk (RR) for a range of family relationships. Finally, we identified pedigrees with a significant excess of AD deaths. Results: The GIF analysis showed that pairs of individuals dying from AD were significantly more related than expected. This excess of relatedness was observed for both close and distant relationships. RRs for death from AD among relatives of individuals dying from AD were significantly increased for both close and more distant relatives. Multiple pedigrees had a significant excess of AD deaths. Conclusions: These data strongly support a genetic contribution to the observed clustering of individuals dying from AD. This report is the first large population-based assessment of the familiality of AD mortality and provides the only reported estimates of relative risk of AD mortality in extended relatives to date. The high-risk pedigrees identified show a true excess of AD mortality (not just multiple cases) and are greater in depth and width than published AD pedigrees. The presence of these high-risk pedigrees strongly supports the possibility of rare predisposition variants not yet identified.	[Kauwe, John S. K.; Ridge, Perry G.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Foster, Norman L.] Univ Utah, Dept Neurol, Ctr Alzheimers Care Imaging & Res, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA	Brigham Young University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	Kauwe@byu.edu	Kauwe, John/AAC-6646-2021	Kauwe, John/0000-0001-8641-2468; albright, lisa/0000-0003-2602-3668	Huntsman Cancer Foundation; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NIH [R01AG042611]; Alzheimer's Association [MNIRG-11-205386]; Charleston Conference on Alzheimer's Disease; BYU Gerontology Program; Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute [P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042611] Funding Source: NIH RePORTER	Huntsman Cancer Foundation; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Charleston Conference on Alzheimer's Disease; BYU Gerontology Program; Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	LACA acknowledges support from the Huntsman Cancer Foundation; and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. JSKK acknowledges support from NIH (R01AG042611), the Alzheimer's Association (MNIRG-11-205386), the Charleston Conference on Alzheimer's Disease and the BYU Gerontology Program. Partial support for all data sets within the Utah Population Database (UPDB) was provided by Huntsman Cancer Institute, University of Utah and the Huntsman Cancer Institute's Cancer Center Support grant, P30 CA42014 from National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CAMERON HM, 1981, J PATHOL, V133, P273, DOI 10.1002/path.1711330402; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DOLLEAR W, 1992, NEUROEPIDEMIOLOGY, V11, P53, DOI 10.1159/000110912; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1989, ANN NEUROL, V25, P485, DOI 10.1002/ana.410250511; Frecker MF, 1995, NEUROLOGY, V45, P2298, DOI 10.1212/WNL.45.12.2298; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Gatz M, 2001, J Gerontol B Psychol Sci Soc Sci, V56, pP292; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hoyert D L, 1996, Vital Health Stat 20, P1; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; JORDE LB, 1989, ANN HUM GENET, V53, P339, DOI 10.1111/j.1469-1809.1989.tb01803.x; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; MARTYN CN, 1988, J EPIDEMIOL COMMUN H, V42, P134, DOI 10.1136/jech.42.2.134; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; NEWENS AJ, 1993, J EPIDEMIOL COMMUN H, V47, P293, DOI 10.1136/jech.47.4.293; Norton MC, 2011, AM J GERIAT PSYCHIAT, V19, P814, DOI 10.1097/JGP.0b013e3182011b38; Ostbye T, 2008, HEALTH SERV RES, V43, P313, DOI 10.1111/j.1475-6773.2007.00748.x; Patel AA, 2011, J BONE JOINT SURG AM, V93A, P225, DOI 10.2106/JBJS.J.00276; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; RAIFORD K, 1994, NEUROLOGY, V44, P2208, DOI 10.1212/WNL.44.11.2208-a; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Shirts BH, 2010, CLIN GASTROENTEROL H, V8, P812, DOI 10.1016/j.cgh.2010.05.012; Tashjian RZ, 2009, J BONE JOINT SURG AM, V91A, P1136, DOI 10.2106/JBJS.H.00831; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Teerlink CC, 2007, AM J RESP CRIT CARE, V176, P865, DOI 10.1164/rccm.200703-448OC; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1948, MATH HEREDITE; 1990, CATEGORICAL DATA ANA	49	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77087	10.1371/journal.pone.0077087	http://dx.doi.org/10.1371/journal.pone.0077087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116205	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200100
J	Singh, AP; Prabha, V; Rishi, P				Singh, Aman Preet; Prabha, Vijay; Rishi, Praveen			Value Addition in the Efficacy of Conventional Antibiotics by Nisin against Salmonella	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; DRUG-RESISTANT SALMONELLA; ESCHERICHIA-COLI O157-H7; GRAM-NEGATIVE BACTERIA; CELL-FREE-EXTRACT; ANTIMICROBIAL PEPTIDES; REFRIGERATED STORAGE; POSSIBLE ADJUNCT; ESSENTIAL OIL; L. PLANTARUM	Frequent and indiscriminate use of existing battery of antibiotics has led to the development of multi drug resistant (MDR) strains of pathogens. As decreasing the concentration of the antibiotic required to treat Salmonellosis might help in combating the development of resistant strains, the present study was designed to assess the synergistic effects, if any, of nisin, in combination with conventional anti-Salmonella antibiotics against Salmonella enterica serovar Typhimurium. Minimum inhibitory concentrations (MICs) of the selected antimicrobial agents were determined by micro and macro broth dilution assays. In-vitro synergy between the agents was evaluated by radial diffusion assay, fractional inhibitory concentration (FIC) index (checkerboard test) and time-kill assay. Scanning electron microscopy (SEM) was also performed to substantiate the effect of the combinations. In-vivo synergistic efficacy of the combinations selected on the basis of in-vitro results was also evaluated in the murine model, in terms of reduction in the number of Salmonellae in liver, spleen and intestine. Nisin-ampicillin and nisin-EDTA combinations were observed to have additive effects, whereas the combinations of nisin-ceftriaxone and nisin-cefotaxime were found to be highly synergistic against serovar Typhimurium as evident by checkerboard test and time-kill assay. SEM results revealed marked changes on the outer membrane of the bacterial cells treated with various combinations. In-vivo synergy was evident from the larger log unit decreases in all the target organs of mice treated with the combinations than in those treated with drugs alone. This study thus highlights that nisin has the potential to act in conjunction with conventional antibiotics at much lower MICs. These observations seem to be significant, as reducing the therapeutic concentrations of antibiotics may be a valuable strategy for avoiding/reducing the development of emerging antibiotic resistance. Value added potential of nisin in the efficacy of conventional antibiotics may thus be exploited not only against Salmonella but against other Gram-negative infections as well.	[Singh, Aman Preet; Prabha, Vijay; Rishi, Praveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Rishi, P (corresponding author), Panjab Univ, Dept Microbiol, Basic Med Sci Block, Chandigarh 160014, India.	rishipraveen@yahoo.com		Rishi, Praveen/0000-0001-5425-8064; Prabha, Vijay/0000-0002-7654-2215; Singh, Aman Preet/0000-0002-0261-2428	CSIR [09/135(0584)/2009-EMR-I]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Financial support to carry out this study was provided by CSIR funded Junior Research Fellowship, under the fellowship grant no. 09/135(0584)/2009-EMR-I to Mr. Aman Preet Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birosova L, 2009, J MED MICROBIOL, V58, P436, DOI 10.1099/jmm.0.003657-0; Boziaris IS, 1999, INT J FOOD MICROBIOL, V53, P105, DOI 10.1016/S0168-1605(99)00139-7; Chalon MC, 2012, FOOD RES INT, V45, P735, DOI 10.1016/j.foodres.2011.08.024; Chaudhary U, 2004, Indian J Med Microbiol, V22, P75; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUS S; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; CUTTER CN, 1995, J FOOD PROTECT, V58, P977, DOI 10.4315/0362-028X-58.9.977; De Melo AMSC, 1998, J FOOD PROTECT, V61, P839, DOI 10.4315/0362-028X-61.7.839; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Govaris A, 2010, INT J FOOD MICROBIOL, V137, P175, DOI 10.1016/j.ijfoodmicro.2009.12.017; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Jay J M, 2000, MODERN FOOD MICROBIO, V2nd; Ji HF, 2005, BIOCHEM BIOPH RES CO, V333, P661, DOI 10.1016/j.bbrc.2005.05.014; Joerger RD, 2003, POULTRY SCI, V82, P640, DOI 10.1093/ps/82.4.640; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Lin CH, 2012, PEPTIDES, V36, P114, DOI 10.1016/j.peptides.2012.03.002; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Molbak K, 2005, CLIN INFECT DIS, V41, P1613, DOI 10.1086/497599; Murdock CA, 2007, LETT APPL MICROBIOL, V44, P255, DOI 10.1111/j.1472-765X.2006.02076.x; Paul D, 2013, NAT REV MICROBIOL, V11, P95; Preet S, 2010, J ANTIMICROB CHEMOTH, V65, P991, DOI 10.1093/jac/dkq066; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rishi P, 2011, ANTIMICROB AGENTS CH, V55, P4176, DOI 10.1128/AAC.00273-11; Rishi P, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-9; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; Rybak JM, 1996, DRUGS, V52, P390; SERRA P, 1977, ARCH INTERN MED, V137, P1562, DOI 10.1001/archinte.137.11.1562; Singh AP, 2011, J ANTIBIOT, V64, P795, DOI 10.1038/ja.2011.92; Solomakos N, 2008, MEAT SCI, V80, P159, DOI 10.1016/j.meatsci.2007.11.014; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613, DOI 10.1128/AEM.57.12.3613-3615.1991; Ulvatne H, 2001, J ANTIMICROB CHEMOTH, V48, P203, DOI 10.1093/jac/48.2.203; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Yenugu S, 2010, J PEPT SCI, V16, P337, DOI 10.1002/psc.1246	38	34	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76844	10.1371/journal.pone.0076844	http://dx.doi.org/10.1371/journal.pone.0076844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116175	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200079
J	Danielsen, EM; Hansen, GH				Danielsen, E. Michael; Hansen, Gert H.			Generation of Stable Lipid Raft Microdomains in the Enterocyte Brush Border by Selective Endocytic Removal of Non-Raft Membrane	PLOS ONE			English	Article							EPITHELIAL-CELLS; MICROVILLAR ENZYMES; ABSORPTIVE CELLS; PROTEINS; TRANSPORT; ORGANIZATION; TRAFFICKING; POLARITY; BIOSYNTHESIS; MECHANISM	The small intestinal brush border has an unusually high proportion of glycolipids which promote the formation of lipid raft microdomains, stabilized by various cross-linking lectins. This unique membrane organization acts to provide physical and chemical stability to the membrane that faces multiple deleterious agents present in the gut lumen, such as bile salts, digestive enzymes of the pancreas, and a plethora of pathogens. In the present work, we studied the constitutive endocytosis from the brush border of cultured jejunal explants of the pig, and the results indicate that this process functions to enrich the contents of lipid raft components in the brush border. The lipophilic fluorescent marker FM, taken up into early endosomes in the terminal web region (TWEEs), was absent from detergent resistant membranes (DRMs), implying an association with non-raft membrane. Furthermore, neither major lipid raft-associated brush border enzymes nor glycolipids were detected by immunofluorescence microscopy in subapical punctae resembling TWEEs. Finally, two model raft lipids, BODIPY-lactosylceramide and BODIPY-GM(1), were not endocytosed except when cholera toxin subunit B (CTB) was present. In conclusion, we propose that constitutive, selective endocytic removal of non-raft membrane acts as a sorting mechanism to enrich the brush border contents of lipid raft components, such as glycolipids and the major digestive enzymes. This sorting may be energetically driven by changes in membrane curvature when molecules move from a microvillar surface to an endocytic invagination.	[Danielsen, E. Michael; Hansen, Gert H.] Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	University of Copenhagen	Danielsen, EM (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, Fac Hlth Sci, DK-1168 Copenhagen, Denmark.	midan@sund.ku.dk			Augustinus Fonden; Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Fonden til Laegevidenskabens Fremme; Horslev Fonden	Augustinus Fonden; Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Fonden til Laegevidenskabens Fremme; Horslev Fonden	The study was supported by grants from Augustinus Fonden, Aase og Ejnar Danielsens Fond, Brodrene Hartmanns Fond, Fonden til Laegevidenskabens Fremme, and Horslev Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; BLOK J, 1981, CELL TISSUE RES, V216, P1; Booth A G, 1974, Biochem J, V142, P575; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Carmosino M, 2010, BIOL CELL, V102, P75, DOI 10.1042/BC20090134; CHRISTIANSEN K, 1981, BIOCHIM BIOPHYS ACTA, V647, P188, DOI 10.1016/0005-2736(81)90245-5; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; Danielsen EM, 2012, BBA-BIOMEMBRANES, V1818, P530, DOI 10.1016/j.bbamem.2011.11.011; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; DANIELSEN EM, 1995, BIOCHEMISTRY-US, V34, P1596, DOI 10.1021/bi00005a016; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; DANIELSEN EM, 1993, J CELL BIOL, V120, P1347, DOI 10.1083/jcb.120.6.1347; DANIELSEN EM, 1982, BIOCHEM J, V202, P647, DOI 10.1042/bj2020647; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Fujita M, 2007, MED MOL MORPHOL, V40, P1, DOI 10.1007/s00795-006-0346-3; Glenn GM, 2009, INFECT IMMUN, V77, P5206, DOI 10.1128/IAI.00712-09; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Hagerstrand H, 2006, MOL MEMBR BIOL, V23, P277, DOI 10.1080/09687860600682536; Hanani M, 2012, J CELL MOL MED, V16, P22, DOI 10.1111/j.1582-4934.2011.01378.x; Hansen GH, 2009, AM J PHYSIOL-GASTR L, V297, pG708, DOI 10.1152/ajpgi.00192.2009; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hansen GH, 2003, BIOCHEM J, V373, P125, DOI 10.1042/BJ20030235; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kraehenbuhl J P, 1992, Trends Cell Biol, V2, P170, DOI 10.1016/0962-8924(92)90036-M; Kunding AH, 2010, MOL MEMBR BIOL, V27, P170, DOI 10.3109/09687688.2010.494625; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; MOOSEKER MS, 1983, CIBA F SYMP, V95, P195; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; PALAY SL, 1959, J BIOPHYS BIOCHEM CY, V5, P363, DOI 10.1083/jcb.5.3.363; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SJOSTROM H, 1983, CIBA F SYMP, V95, P50; SKOVBJERG H, 1978, SCAND J CLIN LAB INV, V38, P723, DOI 10.3109/00365517809104879; SKOVBJERG H, 1982, BIOCHIM BIOPHYS ACTA, V707, P89, DOI 10.1016/0167-4838(82)90400-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615	53	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76661	10.1371/journal.pone.0076661	http://dx.doi.org/10.1371/journal.pone.0076661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124585	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100142
J	Dasgupta, N; Xu, YH; Oh, S; Sun, Y; Jia, L; Keddache, M; Grabowski, GA				Dasgupta, Nupur; Xu, You-Hai; Oh, Sunghee; Sun, Ying; Jia, Li; Keddache, Mehdi; Grabowski, Gregory A.			Gaucher Disease: Transcriptome Analyses Using Microarray or mRNA Sequencing in a Gba1 Mutant Mouse Model Treated with Velaglucerase alfa or Imiglucerase	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; LINKED SIDEROBLASTIC ANEMIA; ENZYME REPLACEMENT THERAPY; GLOBAL GENE-EXPRESSION; ACID-BETA-GLUCOSIDASE; MEGAKARYOCYTIC DIFFERENTIATION; MITOCHONDRIAL DYSFUNCTION; PARKINSONS-DISEASE; FACTOR GATA-1; GLUCOCEREBROSIDASE	Gaucher disease type 1, an inherited lysosomal storage disorder, is caused by mutations in GBA1 leading to defective glucocerebrosidase (GCase) function and consequent excess accumulation of glucosylceramide/glucosylsphingosine in visceral organs. Enzyme replacement therapy (ERT) with the biosimilars, imiglucerase (imig) or velaglucerase alfa (vela) improves/reverses the visceral disease. Comparative transcriptomic effects (microarray and mRNA-Seq) of no ERT and ERT (imig or vela) were done with liver, lung, and spleen from mice having Gba1 mutant alleles, termed D409V/null. Disease-related molecular effects, dynamic ranges, and sensitivities were compared between mRNA-Seq and microarrays and their respective analytic tools, i.e. Mixed Model ANOVA (microarray), and DESeq and edgeR (mRNA-Seq). While similar gene expression patterns were observed with both platforms, mRNA-Seq identified more differentially expressed genes (DEGs) (similar to 3-fold) than the microarrays. Among the three analytic tools, DESeq identified the maximum number of DEGs for all tissues and treatments. DESeq and edgeR comparisons revealed differences in DEGs identified. In 9V/null liver, spleen and lung, post-therapy transcriptomes approximated WT, were partially reverted, and had little change, respectively, and were concordant with the corresponding histological and biochemical findings. DEG overlaps were only 8-20% between mRNA-Seq and microarray, but the biological pathways were similar. Cell growth and proliferation, cell cycle, heme metabolism, and mitochondrial dysfunction were most altered with the Gaucher disease process. Imig and vela differentially affected specific disease pathways. Differential molecular responses were observed in direct transcriptome comparisons from imig- and vela-treated tissues. These results provide cross-validation for the mRNA-Seq and microarray platforms, and show differences between the molecular effects of two highly structurally similar ERT biopharmaceuticals.	[Dasgupta, Nupur; Xu, You-Hai; Oh, Sunghee; Sun, Ying; Keddache, Mehdi; Grabowski, Gregory A.] Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA; [Xu, You-Hai; Oh, Sunghee; Sun, Ying; Keddache, Mehdi; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Jia, Li] NIH, CCR Bioinformat Core, Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA	Grabowski, GA (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA.	greg.grabowski@cchmc.org			National Institutes of Health [DK 36729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is supported by a grant by from the National Institutes of Health (DK 36729).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cardoso SM, 2010, EXP NEUROL, V223, P294, DOI 10.1016/j.expneurol.2009.06.008; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; CHIBA T, 1993, P NATL ACAD SCI USA, V90, P11593, DOI 10.1073/pnas.90.24.11593; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Friedman BA, 1999, BLOOD, V93, P2807; Grabowski G. A., 2010, METABOLIC MOL BASES; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Guggenbuhl P, 2008, JOINT BONE SPINE, V75, P116, DOI 10.1016/j.jbspin.2007.06.006; Gutierrez L, 2004, DEVELOPMENT, V131, P3183, DOI 10.1242/dev.01198; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hollak CEM, 1997, BLOOD CELL MOL DIS, V23, P201, DOI 10.1006/bcmd.1997.0137; Hong YB, 2004, J HUM GENET, V49, P349, DOI 10.1007/s10038-004-0155-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Lahiry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025400; Lalle M, 2011, J BIOL CHEM, V286, P1227, DOI 10.1074/jbc.M110.194613; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Michelakakis H, 1996, BBA-MOL BASIS DIS, V1317, P219, DOI 10.1016/S0925-4439(96)00056-7; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myerowitz R, 2004, MOL GENET METAB, V83, P288, DOI 10.1016/j.ymgme.2004.06.020; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; PASTORES GM, 1993, BLOOD, V82, P408; Patel-Hett S, 2011, BLOOD, V118, P1641, DOI 10.1182/blood-2011-01-330688; PEVNY L, 1995, DEVELOPMENT, V121, P163; Ponka P, 1997, BLOOD, V89, P1; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roukos DH, 2010, EXPERT REV MED DEVIC, V7, P723, DOI [10.1586/erd.10.68, 10.1586/ERD.10.68]; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRITSCHLER HJ, 1994, BIOCHEM MOL BIOL INT, V34, P169; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; van den Akker E, 2004, BLOOD, V103, P4457, DOI 10.1182/blood-2003-08-2713; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-20; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yamaguchi Y, 1998, BLOOD, V91, P3447, DOI 10.1182/blood.V91.9.3447.3447_3447_3458	84	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74912	10.1371/journal.pone.0074912	http://dx.doi.org/10.1371/journal.pone.0074912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124461	Green Submitted, gold, Green Published			2022-12-25	WOS:000325489100018
J	Hauke, J; Schild, A; Neugebauer, A; Lappa, A; Fricke, J; Fauser, S; Rosler, S; Pannes, A; Zarrinnam, D; Altmuller, J; Motameny, S; Nurnberg, G; Nurnberg, P; Hahnen, E; Beck, BB				Hauke, Jan; Schild, Andrea; Neugebauer, Antje; Lappa, Alexandra; Fricke, Julia; Fauser, Sascha; Roesler, Stefanie; Pannes, Andrea; Zarrinnam, Dirk; Altmueller, Janine; Motameny, Susanne; Nuernberg, Gudrun; Nuernberg, Peter; Hahnen, Eric; Beck, Bodo B.			A Novel Large In-Frame Deletion within the CACNA1F Gene Associates with a Cone-Rod Dystrophy 3-Like Phenotype	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; LINKED RETINAL DISORDER; PROGRESSIVE CONE; CALCIUM-CHANNEL; CLINICAL-FEATURES; RIBBON SYNAPSES; EYE DISEASE; HIGH MYOPIA; MUTATIONS; FAMILIES	Cone-rod dystrophies (CORDs) represent a heterogeneous group of monogenic diseases leading to early impairment of vision. The majority of CORD entities show autosomal modes of inheritance and X-linked traits are comparably rare. So far, three X-chromosomal entities were reported (CORDX1, -X2 and -X3). In this study, we analysed a large family of German origin with solely affected males over three generations showing a CORDX-like phenotype. Due to the heterogeneity of cone-rod dystrophies, we performed a combined linkage and X-exome sequencing approach and identified a novel large intragenic in-frame deletion encompassing exons 18 to 26 within the CACNA1F gene. CACNA1F is described causative for CORDX3 in a single family originating from Finland and alterations in this gene have not yet been reported in other CORDX pedigrees. Our data independently confirm CACNA1F as the causative gene for CORDX3-like phenotypes and detailed clinical characterization of the family expands the knowledge about the phenotypic spectrum of deleterious CACNA1F alterations.	[Hauke, Jan; Roesler, Stefanie; Pannes, Andrea; Beck, Bodo B.] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hauke, Jan; Roesler, Stefanie; Nuernberg, Peter; Hahnen, Eric] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Hauke, Jan; Hahnen, Eric] Univ Cologne, Ctr Familial Breast & Ovarian Canc, D-50931 Cologne, Germany; [Schild, Andrea; Neugebauer, Antje; Lappa, Alexandra; Fricke, Julia; Fauser, Sascha] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany; [Altmueller, Janine; Motameny, Susanne; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Hahnen, E (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.	eric.hahnen@uk-koeln.de		Hauke, Jan/0000-0001-8236-4075; Altmuller, Janine/0000-0003-4372-1521	'Gertrud Kusen-Stiftung'; 'Ernst und Berta Grimmke-Stiftung' [5/10]; 'Koln Fortune Programm' [46/2010]; 'Imhoff Stiftung'	'Gertrud Kusen-Stiftung'; 'Ernst und Berta Grimmke-Stiftung'; 'Koln Fortune Programm'; 'Imhoff Stiftung'	This study was kindly supported by the 'Gertrud Kusen-Stiftung' (to EH, BB, AS, and AN). JH was supported by the 'Ernst und Berta Grimmke-Stiftung' (grant 5/10), the 'Koln Fortune Programm' (grant 46/2010) and the 'Imhoff Stiftung'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bergen AAB, 1996, J MED GENET, V33, P869, DOI 10.1136/jmg.33.10.869; Bergen AAB, 1997, AM J HUM GENET, V60, P1468, DOI 10.1086/515458; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Doering CJ, 2007, CHANNELS, V1; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; FORSIUS H, 1964, Klin Monbl Augenheilkd, V144, P447; Goldschmidt E, 2011, ACTA OPHTHALMOL, V89, P97, DOI 10.1111/j.1755-3768.2010.02104.x; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2003, J MED GENET, V40, P418, DOI 10.1136/jmg.40.6.418; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Lorenz B, 1996, Ther Umsch, V53, P7; MANTYJARVI M, 1989, ACTA OPHTHALMOL, V67, P234; Mantyjarvi M, 2001, ACTA OPHTHALMOL SCAN, V79, P359, DOI 10.1034/j.1600-0420.2001.079004359.x; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2000, IMMUNOL CELL BIOL, V78, P442, DOI 10.1046/j.1440-1711.2000.00923.x; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2000, MICROSC RES TECHNIQ, V50, P141, DOI 10.1002/1097-0029(20000715)50:2<141::AID-JEMT6>3.0.CO;2-B; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; RABB M F, 1981, International Ophthalmology Clinics, V21, P51, DOI 10.1097/00004397-198102130-00006; Ruether K, 1993, Ger J Ophthalmol, V2, P429; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; VANDORP DB, 1985, CLIN GENET, V28, P526; Vincent A, 2011, MOL VIS, V17, P3262; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zito I, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9106	50	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76414	10.1371/journal.pone.0076414	http://dx.doi.org/10.1371/journal.pone.0076414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124559	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100116
J	Pryce, G; Visintin, C; Ramagopalan, SV; Al-Izki, S; De Faveri, LE; Nuamah, RA; Mein, CA; Montpetit, A; Hardcastle, AJ; Kooij, G; de Vries, HE; Amor, S; Thomas, SA; Ledent, C; Marsicano, G; Lutz, B; Thompson, AJ; Selwood, DL; Giovannoni, G; Baker, D				Pryce, Gareth; Visintin, Cristina; Ramagopalan, Sreeram V.; Al-Izki, Sarah; De Faveri, Lia E.; Nuamah, Rosamond A.; Mein, Charles A.; Montpetit, Alexandre; Hardcastle, Alison J.; Kooij, Gijs; de Vries, Helga E.; Amor, Sandra; Thomas, Sarah A.; Ledent, Catherine; Marsicano, Giovanni; Lutz, Beat; Thompson, Alan J.; Selwood, David L.; Giovannoni, Gavin; Baker, David			Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists	FASEB JOURNAL			English	Article						drug transporters; experimental autoimmune encephalomyelitis; genomics; multidrug resistance transporters; therapeutics	ANTIHYPERALGESIC PROPERTIES; CANNABIMIMETIC PROPERTIES; SMOKED CANNABIS; MICE DEFICIENT; EXPRESSION; NEURODEGENERATION; SUBPOPULATION; TRANSPORT; NEURONS	The purpose of this study was the generation of central nervous system (CNS)-excluded cannabinoid receptor agonists to test the hypothesis that inhibition of spasticity, due to CNS autoimmunity, could be controlled by affecting neurotransmission within the periphery. Procedures included identification of chemicals and modeling to predict the mode of exclusion; induction and control of spasticity in the ABH mouse model of multiple sclerosis; conditional deletion of CB1 receptor in peripheral nerves; side-effect profiling to demonstrate the mechanism of CNS-exclusion via drug pumps; genome-wide association study in N2(129xABH) backcross to map polymorphic cannabinoid drug pump; and sequencing and detection of cannabinoid drug-pump activity in human brain endothelial cell lines. Three drugs (CT3, SAB378 and SAD448) were identified that control spasticity via action on the peripheral nerve CB1 receptor. These were peripherally restricted via drug pumps that limit the CNS side effects (hypothermia) of cannabinoids to increase the therapeutic window. A cannabinoid drug pump is polymorphic and functionally lacking in many laboratory (C57BL/6, 129, CD-1) mice used for transgenesis, pharmacology, and toxicology studies. This phenotype was mapped and controlled by 1-3 genetic loci. ABCC1 within a cluster showing linkage is a cannabinoid CNS-drug pump. Global and conditional CB1 receptor-knockout mice were used as controls. In summary, CNS-excluded CB1 receptor agonists are a novel class of therapeutic agent for spasticity.Pryce, G., Visintin, C., Ramagopalan, S. V., Al-Izki, S., De Faveri, L. E., Nuamah, R. A., Mein, C. A., Montpetit, A., Hardcastle, A. J., Kooij, G., de Vries, H. E., Amor, S., Thomas, S. A., Ledent, C., Marsicano, G., Lutz, B., Thompson, A. J., Selwood, D. L., Giovannoni, G., Baker, D. Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.	[Pryce, Gareth; Ramagopalan, Sreeram V.; Al-Izki, Sarah; Amor, Sandra; Giovannoni, Gavin; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [De Faveri, Lia E.; Nuamah, Rosamond A.; Mein, Charles A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Genome Ctr, London E1 2AT, England; [Pryce, Gareth; Visintin, Cristina; Thompson, Alan J.; Giovannoni, Gavin; Baker, David] UCL, Inst Neurol, London, England; [Visintin, Cristina; Selwood, David L.] UCL, Wolfson Inst Biomed Res, London, England; [Hardcastle, Alison J.] UCL, Inst Ophthalmol, London, England; [Montpetit, Alexandre] McGill Univ, Montreal, PQ, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Kooij, Gijs; de Vries, Helga E.; Amor, Sandra] Free Univ Amsterdam, Vrije Univ Med Ctr, Amsterdam, Netherlands; [Thomas, Sarah A.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Ledent, Catherine] Free Univ Brussels, Inst Interdisciplinary Res Human & Mol Biol, Brussels, Belgium; [Marsicano, Giovanni] Univ Bordeaux, Neuroctr Magendie, INSERM, Bordeaux, France; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55122 Mainz, Germany	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of London; University College London; McGill University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; King's College London; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johannes Gutenberg University of Mainz	Baker, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England.	david.baker@qmul.ac.uk	Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; Kooij, Gijs/AAA-4268-2020; Thompson, Alan J/C-2654-2008; Lutz, Beat/AAG-4538-2022; Thomas, Sarah/C-6796-2009	Thompson, Alan J/0000-0002-4333-8496; Thomas, Sarah/0000-0002-0053-0154; De Faveri, Lia/0000-0002-6685-8806; Mein, Charles/0000-0003-0811-9658; Marsicano, Giovanni/0000-0003-3804-1951; Hardcastle, Alison/0000-0002-0038-6770; Selwood, David/0000-0002-6817-5064; Kooij, Gijs/0000-0002-9488-2918	Atlantic Ventures Inc.; MRC [MC_PC_13037] Funding Source: UKRI	Atlantic Ventures Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Multiple Sclerosis Society of Great Britain and Northern Ireland, Aims2Cure, the Brain Research Trust, and the Barts and the London Charity. Atlantic Ventures Inc. in part funded spasticity studies involving CT3. Some authors (D. B., G. P., A.J.T., and G. G.) are named inventors on a patent relating to the use of CT3, but receive no financial reward from this.	AdamWorrall J., 2007, Patent, Patent No. [WO2007006732, 2007006732]; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Baker D, 2012, MULT SCLER RELAT DIS, V1, P64, DOI 10.1016/j.msard.2011.11.001; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bonhomme-Faivre L, 2008, ADDICT BIOL, V13, P295, DOI 10.1111/j.1369-1600.2008.00096.x; Brain C. T., 2003, Patent, Patent No. [03066603, WO03066603]; Burstein SH, 2004, LIFE SCI, V75, P1513, DOI 10.1016/j.lfs.2004.04.010; Carl SM, 2010, MOL PHARMACEUT, V7, P1057, DOI 10.1021/mp900178j; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Dyson A, 2005, PAIN, V116, P129, DOI 10.1016/j.pain.2005.03.037; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Hendrikse NH, 1998, BRIT J PHARMACOL, V124, P1413, DOI 10.1038/sj.bjp.0701979; Hiragata S, 2007, UROLOGY, V70, P202, DOI 10.1016/j.urology.2007.02.069; Holland ML, 2007, BRIT J PHARMACOL, V152, P815, DOI 10.1038/sj.bjp.0707467; Holland ML, 2008, EUR J PHARMACOL, V591, P128, DOI 10.1016/j.ejphar.2008.06.079; Holland ML, 2006, BIOCHEM PHARMACOL, V71, P1146, DOI 10.1016/j.bcp.2005.12.033; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Huestis MA, 2007, PSYCHOPHARMACOLOGY, V194, P505, DOI 10.1007/s00213-007-0861-5; Karst M, 2007, J PHARMACOL EXP THER, V322, P420, DOI 10.1124/jpet.107.124214; Katona I., 2006, ANNU REV NEUROSCI, V35, P529; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kheder Ammar, 2012, Pract Neurol, V12, P289, DOI 10.1136/practneurol-2011-000155; Kooij G, 2010, J AUTOIMMUN, V34, P416, DOI 10.1016/j.jaut.2009.10.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lankas GR, 1997, TOXICOL APPL PHARM, V143, P357, DOI 10.1006/taap.1996.8086; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Martin BR, 2006, J PHARMACOL EXP THER, V318, P1230, DOI 10.1124/jpet.106.104109; Musumeci G, 2011, NEUROBIOL DIS, V43, P669, DOI 10.1016/j.nbd.2011.05.018; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; Novotna A, 2011, EUR J NEUROL, V18, P1122, DOI 10.1111/j.1468-1331.2010.03328.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Pawarode A, 2007, CANCER CHEMOTH PHARM, V60, P179, DOI 10.1007/s00280-006-0357-8; Pippert TR, 2001, J BIOCHEM MOL TOXIC, V15, P83, DOI 10.1002/jbt.3; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Rishton GM, 2006, CURR OPIN DRUG DISC, V9, P303; Vann RE, 2007, J PHARMACOL EXP THER, V320, P678, DOI 10.1124/jpet.106.111625; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Wilkinson JD, 2003, J PHARM PHARMACOL, V55, P1687, DOI 10.1211/0022357022304; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zajicek J. P., 2012, J NEUROL NEUROSUR PS, V83, P1125; Zhou L, 2002, FEBS LETT, V523, P68, DOI 10.1016/S0014-5793(02)02936-8	50	23	23	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					117	130		10.1096/fj.13-239442	http://dx.doi.org/10.1096/fj.13-239442			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24121462				2022-12-25	WOS:000333526100014
J	Loch, D; Heidel, C; Breer, H; Strotmann, J				Loch, Diana; Heidel, Christian; Breer, Heinz; Strotmann, Joerg			Adiponectin Enhances the Responsiveness of the Olfactory System	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS NEURONS; CIRCULATING ADIPONECTIN; CALORIC RESTRICTION; ADIPOSE-TISSUE; RECEPTORS; INCREASES; INSULIN; NEUROENDOCRINE; MODULATION; EXPRESSION	The peptide hormone adiponectin is secreted by adipose tissue and the circulating concentration is reversely correlated with body fat mass; it is considered as starvation signal. The observation that mature sensory neurons of the main olfactory epithelium express the adiponectin receptor 1 has led to the concept that adiponectin may affect the responsiveness of the olfactory system. In fact, electroolfactogram recordings from olfactory epithelium incubated with exogenous adiponectin resulted in large amplitudes upon odor stimulation. To determine whether the responsiveness of the olfactory sensory neurons was enhanced, we have monitored the odorant-induced expression of the immediate early gene Egr1. It was found that in an olfactory epithelium incubated with nasally applied adiponectin the number of Egr1 positive cells was significantly higher compared to controls, suggesting that adiponectin rendered the olfactory neurons more responsive to an odorant stimulus. To analyze whether the augmented responsiveness of sensory neurons was strong enough to elicit a higher neuronal activity in the olfactory bulb, the number of activated periglomerular cells of a distinct glomerulus was determined by monitoring the stimulus-induced expression of c-fos. The studies were performed using the transgenic mOR256-17-IRES-tauGFP mice which allowed to visualize the corresponding glomerulus and to stimulate with a known ligand. The data indicate that upon exposure to 2,3-hexanedione in adiponectin-treated mice the number of activated periglomerular neurons was significantly increased compared to controls. The results of this study indicate that adiponectin increases the responsiveness of the olfactory system, probably due to a higher responsiveness of olfactory sensory neurons.	[Loch, Diana; Heidel, Christian; Breer, Heinz; Strotmann, Joerg] Univ Hohenheim, Inst Physiol, Stuttgart, Germany	University Hohenheim	Strotmann, J (corresponding author), Univ Hohenheim, Inst Physiol, Stuttgart, Germany.	strotman@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [BR712/25-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (grant #BR712/25-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; Baly C, 2007, BRAIN RES, V1129, P130, DOI 10.1016/j.brainres.2006.10.030; Bautze V, 2012, CHEM SENSES, V37, P479, DOI 10.1093/chemse/bjr130; Caillol M, 2003, BRAIN RES, V960, P48, DOI 10.1016/S0006-8993(02)03755-1; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011; Guthoff M, 2011, INT J OBESITY, V35, P873, DOI 10.1038/ijo.2010.211; Hass N, 2008, CELL TISSUE RES, V334, P187, DOI 10.1007/s00441-008-0677-6; Henry BA, 2008, J NEUROENDOCRINOL, V20, P842, DOI 10.1111/j.1365-2826.2008.1730.x; Hoyda TD, 2007, J PHYSIOL-LONDON, V585, P805, DOI 10.1113/jphysiol.2007.144519; Hoyda TD, 2010, ENDOCRINOLOGY, V151, P3154, DOI 10.1210/en.2009-1390; Hoyda TD, 2009, ENDOCRINOLOGY, V150, P832, DOI 10.1210/en.2008-1179; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Luxenhofer G, 2008, J COMP NEUROL, V509, P580, DOI 10.1002/cne.21766; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Ricci R, 2012, VET J, V191, P292, DOI 10.1016/j.tvjl.2011.04.009; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Strotmann J, 2011, HISTOCHEM CELL BIOL, V136, P357, DOI 10.1007/s00418-011-0850-y; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Trellakis S, 2011, REGUL PEPTIDES, V167, P112, DOI 10.1016/j.regpep.2010.12.005; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	28	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75716	10.1371/journal.pone.0075716	http://dx.doi.org/10.1371/journal.pone.0075716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130737	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200020
J	Shi, YY; Sun, LX; Huang, ZY; Wu, XB; Zhu, YQ; Zheng, HJ; Zeng, ZJ				Shi, Yuan Yuan; Sun, Liang Xian; Huang, Zachary Y.; Wu, Xiao Bo; Zhu, Yong Qiang; Zheng, Hua Jun; Zeng, Zhi Jiang			A SNP Based High-Density Linkage Map of Apis cerana Reveals a High Recombination Rate Similar to Apis mellifera	PLOS ONE			English	Article							HONEY-BEE; DROSOPHILA-MELANOGASTER; READ ALIGNMENT; SOCIAL INSECTS; GENETIC-MAP; EVOLUTION; GENOME; MARKERS; REPRODUCTION; ELEGANS	Background: The Eastern honey bee, Apis cerana Fabricius, is distributed in southern and eastern Asia, from India and China to Korea and Japan and southeast to the Moluccas. This species is also widely kept for honey production besides Apis mellifera. Apis cerana is also a model organism for studying social behavior, caste determination, mating biology, sexual selection, and host-parasite interactions. Few resources are available for molecular research in this species, and a linkage map was never constructed. A linkage map is a prerequisite for quantitative trait loci mapping and for analyzing genome structure. We used the Chinese honey bee, Apis cerana cerana to construct the first linkage map in the Eastern honey bee. Results: F2 workers (N = 103) were genotyped for 126,990 single nucleotide polymorphisms (SNPs). After filtering low quality and those not passing the Mendel test, we obtained 3,000 SNPs, 1,535 of these were informative and used to construct a linkage map. The preliminary map contains 19 linkage groups, we then mapped the 19 linkage groups to 16 chromosomes by comparing the markers to the genome of A. mellfiera. The final map contains 16 linkage groups with a total of 1,535 markers. The total genetic distance is 3,942.7 centimorgans (cM) with the largest linkage group (180 loci) measuring 574.5 cM. Average marker interval for all markers across the 16 linkage groups is 2.6 cM. Conclusion: We constructed a high density linkage map for A. c. cerana with 1,535 markers. Because the map is based on SNP markers, it will enable easier and faster genotyping assays than randomly amplified polymorphic DNA or microsatellite based maps used in A. mellifera.	[Shi, Yuan Yuan; Wu, Xiao Bo; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Sun, Liang Xian] Quanzhou Normal Univ, Mol Biol & Pharmacol Key Lab Fujian Adv Educ, Quanzhou, Fujian, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Zhu, Yong Qiang; Zheng, Hua Jun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Jiangxi Agricultural University; Quanzhou Normal University; Michigan State University	Zheng, HJ (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	zhenghj@chgc.sh.cn; bees1965@sina.com	Zheng, Huajun/AAN-4973-2020; Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ12]; Special Fund for Agro-scientific Research in the Public Interest [200903006]; National Natural Science Foundation of China [31260524]	Earmarked Fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ12), Special Fund for Agro-scientific Research in the Public Interest (No. 200903006) and the National Natural Science Foundation of China (No. 31260524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Aslam ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-647; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Cheng S L, 2001, APICULTURAL SCI CHIN, P488; *CHIN NAT COMM AN, 2011, AN GEN RES CHIN BEES; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimopoulos G, 1996, GENETICS, V143, P953; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Green P, 1990, DOCUMENTATION CRI MA; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Hoskins RA, 2001, GENOME RES, V11, P1100, DOI 10.1101/gr.GR-1780R; HUNT GJ, 1995, GENETICS, V139, P1371; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZG, 2012, APIDOLOGIE, V43, P487, DOI 10.1007/s13592-012-0119-z; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Oldroyd BP, 2001, BEHAV ECOL SOCIOBIOL, V50, P371, DOI 10.1007/s002650100376; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; RATH W, 1992, AM BEE J, V132, P329; Roethele JB, 2001, ANN ENTOMOL SOC AM, V94, P936, DOI 10.1603/0013-8746(2001)094[0936:EFBSCO]2.0.CO;2; Schmid-Hempel P, 2002, AM NAT, V160, P403, DOI 10.1086/341517; Sobel E, 1996, AM J HUM GENET, V58, P1323; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Stolle E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-48; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; WILLIAMS BD, 1992, GENETICS, V131, P609; Wu R., 2007, STAT GENETICS QUANTI; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239; XU Y, 1994, MOL QUANTITATIVE GEN; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Zeng ZJ, 2010, BIOL HONEY BEE; Zeng ZJ, 2009, APICULTURE	48	12	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76459	10.1371/journal.pone.0076459	http://dx.doi.org/10.1371/journal.pone.0076459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130775	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200040
J	Zhu, WN; Drewes, J; Gegenfurtner, KR				Zhu, Weina; Drewes, Jan; Gegenfurtner, Karl R.			Animal Detection in Natural Images: Effects of Color and Image Database	PLOS ONE			English	Article							HUMAN FACE PERCEPTION; RAPID VISUAL CATEGORIZATION; SACCADIC EYE-MOVEMENTS; SELECTIVE ATTENTION; PROCESSING SPEED; TIME-COURSE; RECOGNITION; POTENTIALS; CONTEXT; CORTEX	The visual system has a remarkable ability to extract categorical information from complex natural scenes. In order to elucidate the role of low-level image features for the recognition of objects in natural scenes, we recorded saccadic eye movements and event-related potentials (ERPs) in two experiments, in which human subjects had to detect animals in previously unseen natural images. We used a new natural image database (ANID) that is free of some of the potential artifacts that have plagued the widely used COREL images. Color and grayscale images picked from the ANID and COREL databases were used. In all experiments, color images induced a greater N1 EEG component at earlier time points than grayscale images. We suggest that this influence of color in animal detection may be masked by later processes when measuring reation times. The ERP results of go/nogo and forced choice tasks were similar to those reported earlier. The non-animal stimuli induced bigger N1 than animal stimuli both in the COREL and ANID databases. This result indicates ultra-fast processing of animal images is possible irrespective of the particular database. With the ANID images, the difference between color and grayscale images is more pronounced than with the COREL images. The earlier use of the COREL images might have led to an underestimation of the contribution of color. Therefore, we conclude that the ANID image database is better suited for the investigation of the processing of natural scenes than other databases commonly used.	[Zhu, Weina] Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China; [Zhu, Weina; Gegenfurtner, Karl R.] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany; [Zhu, Weina] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Drewes, Jan] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada	Yunnan University; Justus Liebig University Giessen; Chinese Academy of Sciences; Kunming Institute of Zoology; York University - Canada	Zhu, WN (corresponding author), Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China.	zhuweina.cn@gmail.com		Gegenfurtner, Karl/0000-0001-5390-0684	National Natural Science Foundation of China [61005087, 61263042]; Science and Technology Project of Yunnan Province, China [2009CD018]; Key Science and Technology Project of Department of Education, Yunnan Province, China [2010Z067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Yunnan Province, China; Key Science and Technology Project of Department of Education, Yunnan Province, China	This work was supported by the National Natural Science Foundation of China (61005087, 61263042), Science and Technology Project of Yunnan Province, China (2009CD018), Key Science and Technology Project of Department of Education, Yunnan Province, China (2010Z067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Bacon-Mace N, 2005, VISION RES, V45, P1459, DOI 10.1016/j.visres.2005.01.004; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Crouzet SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051471; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00342; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Doherty LM, 1999, SPATIAL VISION, V12, P485, DOI 10.1163/156856899X00274; Drewes J, 2011, J VISION, V11, DOI 10.1167/11.2.20; Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Foster DH, 2000, VISION RES, V40, P65, DOI 10.1016/S0042-6989(99)00164-9; Gaspar CM, 2009, VISION RES, V49, P3001, DOI 10.1016/j.visres.2009.09.021; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Goffaux V, 2005, VIS COGN, V12, P878, DOI 10.1080/13506280444000562; Harter M.R., 1984, VARIETIES ATTENTION, P293; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Li FF, 2005, VIS COGN, V12, P893, DOI 10.1080/13506280444000571; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Moller P, 1996, P NATL ACAD SCI USA, V93, P7421, DOI 10.1073/pnas.93.14.7421; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Pinto N., 2008, ECCV, P1; Ponce J, 2006, LECT NOTES COMPUT SC, P1; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Rieger JW, 2008, J EXP PSYCHOL HUMAN, V34, P56, DOI 10.1037/0096-1523.34.1.56; Rousselet GA, 2007, J COGNITIVE NEUROSCI, V19, P1241, DOI 10.1162/jocn.2007.19.8.1241; Tanaka JW, 1999, PERCEPT PSYCHOPHYS, V61, P1140, DOI 10.3758/BF03207619; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2006, PERCEPTION, V35, P128; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vogel J, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1278387.1278393; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; Wichmann FA, 2010, J VISION, V10, DOI 10.1167/10.4.6; WIJERS AA, 1989, BIOL PSYCHOL, V29, P213, DOI 10.1016/0301-0511(89)90021-5	52	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75816	10.1371/journal.pone.0075816	http://dx.doi.org/10.1371/journal.pone.0075816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130744	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200023
J	Jiang, XJ; Chen, YY; Wei, HM; Sun, R; Tian, ZG				Jiang, Xiaojun; Chen, Yongyan; Wei, Haiming; Sun, Rui; Tian, Zhigang			Characterizing the Lymphopoietic Kinetics and Features of Hematopoietic Progenitors Contained in the Adult Murine Liver In Vivo	PLOS ONE			English	Article							STEM-CELLS; TRANSPLANTED LIVERS; YOLK-SAC; NK CELLS; CHIMERISM; RECIPIENT; EMBRYO; DIFFERENTIATION; POPULATION; FREQUENCY	The appearance of donor-derived lymphocytes in liver transplant patients suggests that adult livers may contain cells capable of lymphopoiesis. However, only a few published studies have addressed the lymphopoietic capacity of adult liver cells, and its kinetics and features remain unclear. Herein, we investigated the lymphopoietic capacity of adult liver mononuclear cells (MNCs) and purified liver hematopoietic progenitor cells (HPCs) in vivo. Similar to bone-marrow transplantation (BMT), transplantation of liver MNCs alone was able to rescue survival of lethally irradiated mice. In terms of kinetics, liver MNC-derived myeloid lineage cells reconstituted more slowly than those from BMT. Liver MNC-derived lymphocyte lineage cells in the blood, spleen and BM also reconstituted more slowly than BMT, but lymphocytes in the liver recovered at a similar rate. Interestingly, liver MNCs predominantly gave rise to CD3(+)CD19(-) T cells in both irradiated WT and non-irradiated lymphocyte-deficient Rag-1(-/-)Il2rg(-/-) recipients. To define the lymphopoietic potential of various cell populations within liver MNCs, we transplanted purified lineage-negative (Lin(-)) liver HPCs into recipient mice. Unlike total liver MNCs, liver HPCs reconstituted T and B cells in similar frequencies to BMT. We further determined that the predominance of T cells observed after transplanting total liver MNCs likely originated from mature T cells, as purified donor liver T cells proliferated in the recipients and gave rise to CD8(+) T cells. Thus, the capacity of donor adult liver cells to reconstitute lymphocytes in recipients derives from both HPCs and mature T cells contained in the liver MNC population.	[Jiang, Xiaojun; Chen, Yongyan; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China; [Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013		Ministry of Science & Technology of China [2013CB944902]; Natural Science Foundation of China [31021061]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (973 Basic Science Project 2013CB944902) and the Natural Science Foundation of China (#31021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Bilezikci B, 2006, TRANSPL P, V38, P598, DOI 10.1016/j.transproceed.2005.12.059; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Crosbie OM, 1999, HEPATOLOGY, V29, P1193, DOI 10.1002/hep.510290402; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Laurenti E, 2012, ANN NY ACAD SCI, V1266, P68, DOI 10.1111/j.1749-6632.2012.06577.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Moroso V, 2011, EUR J IMMUNOL, V41, P3340, DOI 10.1002/eji.201141760; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Ng IOL, 2003, HEPATOLOGY, V38, P989, DOI 10.1053/jhep.2003.50395; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shi X, 2012, HEPATOLOGY; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Uchida N, 2002, EXP HEMATOL, V30, P862, DOI 10.1016/S0301-472X(02)00879-2; Wang XQ, 2012, HEPATOLOGY, V56, P1557, DOI 10.1002/hep.25820	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76762	10.1371/journal.pone.0076762	http://dx.doi.org/10.1371/journal.pone.0076762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130788	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900082
J	Johnson, N; Hassdenteufel, S; Theis, M; Paton, AW; Paton, JC; Zimmermann, R; High, S				Johnson, Nicholas; Hassdenteufel, Sarah; Theis, Melanie; Paton, Adrienne W.; Paton, James C.; Zimmermann, Richard; High, Stephen			The Signal Sequence Influences Post-Translational ER Translocation at Distinct Stages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; CELL-ADHESION MOLECULE-1; PREPRO-ALPHA-FACTOR; PRESECRETORY PROTEINS; MAMMALIAN MICROSOMES; COTRANSLATIONAL TRANSLOCATION; SECRETORY PROTEINS; DOCKING PROTEIN; TRANSPORT; YEAST	The metazoan Sec61 translocon transports polypeptides into and across the membrane of the endoplasmic reticulum via two major routes, a well-established co-translational pathway and a post-translational alternative. We have used two model substrates to explore the elements of a secretory protein precursor that preferentially direct it towards a co- or post-translational pathway for ER translocation. Having first determined the capacity of precursors to enter ER derived microsomes post-translationally, we then exploited semi-permeabilized mammalian cells specifically depleted of key membrane components using siRNA to address their contribution to the membrane translocation process. These studies suggest precursor chain length is a key factor in the post-translational translocation at the mammalian ER, and identify Sec62 and Sec63 as important components acting on this route. This role for Sec62 and Sec63 is independent of the signal sequence that delivers the precursor to the ER. However, the signal sequence can influence the subsequent membrane translocation process, conferring sensitivity to a small molecule inhibitor and dictating reliance on the molecular chaperone BiP. Our data support a model where secretory protein precursors that fail to engage the signal recognition particle, for example because they are short, are delivered to the ER membrane via a distinct route that is dependent upon both Sec62 and Sec63. Although this requirement for Sec62 and Sec63 is unaffected by the specific signal sequence that delivers a precursor to the ER, this region can influence subsequent events, including both Sec61 mediated transport and the importance of BiP for membrane translocation. Taken together, our data suggest that an ER signal sequence can regulate specific aspects of Sec61 mediated membrane translocation at a stage following Sec62/Sec63 dependent ER delivery.	[Johnson, Nicholas; High, Stephen] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Hassdenteufel, Sarah; Theis, Melanie; Zimmermann, Richard] Univ Saarland, Homburg, Germany; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Adelaide, SA, Australia; [Johnson, Nicholas] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Manchester; Saarland University; University of Adelaide; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	High, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	stephen.high@manchester.ac.uk	Johnson, Nicholas/G-5930-2014; Hassdenteufel, Sarah/AAE-8915-2022	Hassdenteufel, Sarah/0000-0001-7243-6602; Johnson, Nicholas/0000-0002-8247-2874; High, Stephen/0000-0002-4532-8152	PhD studentship from the Biotechnology and Biological Sciences Research Council; Deutsche Forschungemeinschaft [IRTG1830]	PhD studentship from the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungemeinschaft(German Research Foundation (DFG))	This work was supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council (N. Johnson) and a grant from the Deutsche Forschungemeinschaft (IRTG1830) (S. Hassdenteufel and R. Zimmermann). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; GARCIA PD, 1988, J CELL BIOL, V106, P1043, DOI 10.1083/jcb.106.4.1043; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; High S, 1997, TRENDS CELL BIOL, V7, P206; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KLAPPA P, 1991, EMBO J, V10, P2795, DOI 10.1002/j.1460-2075.1991.tb07828.x; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; MULLER G, 1987, EMBO J, V6, P2099, DOI 10.1002/j.1460-2075.1987.tb02476.x; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; ZIMMERMANN R, 1990, J BIOENERG BIOMEMBR, V22, P711; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	40	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75394	10.1371/journal.pone.0075394	http://dx.doi.org/10.1371/journal.pone.0075394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130708	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900034
J	Lu, JW; Yang, WY; Tsai, SM; Lin, YM; Chang, PH; Chen, JR; Wang, HD; Wu, JL; Jin, SLC; Yuh, CH				Lu, Jeng-Wei; Yang, Wan-Yu; Tsai, Su-Mei; Lin, Yueh-Min; Chang, Pen-Heng; Chen, Jim-Ray; Wang, Horng-Dar; Wu, Jen-Leih; Jin, Shiow-Lian Catherine; Yuh, Chiou-Hwa			Liver-Specific Expressions of HBx and src in the p53 Mutant Trigger Hepatocarcinogenesis in Zebrafish	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; TRANSGENIC ZEBRAFISH; TUMOR PROGRESSION; TP53 MUTATIONS; FAMILY KINASES; HUMAN CANCER; MOUSE MODEL; GENE	Hepatocarcinogenesis is a multistep process that starts from fatty liver and transitions to fibrosis and, finally, into cancer. Many etiological factors, including hepatitis B virus X antigen (HBx) and p53 mutations, have been implicated in hepatocarcinogenesis. However, potential synergistic effects between these two factors and the underlying mechanisms by which they promote hepatocarcinogenesis are still unclear. In this report, we show that the synergistic action of HBx and p53 mutation triggers progressive hepatocellular carcinoma (HCC) formation via src activation in zebrafish. Liver-specific expression of HBx in wild-type zebrafish caused steatosis, fibrosis and glycogen accumulation. However, the induction of tumorigenesis by HBx was only observed in p53 mutant fish and occurred in association with the up-regulation and activation of the src tyrosine kinase pathway. Furthermore, the overexpression of src in p53 mutant zebrafish also caused hyperplasia, HCC, and sarcomatoid HCC, which were accompanied by increased levels of the signaling proteins p-erk, p-akt, myc, jnk1 and vegf. Increased expression levels of lipogenic factors and the genes involved in lipid metabolism and glycogen storage were detected during the early stages of hepatocarcinogenesis in the HBx and src transgenic zebrafish. The up-regulation of genes involved in cell cycle regulation, tumor progression and other molecular hallmarks of human liver cancer were found at later stages in both HBx and src transgenic, p53 mutant zebrafish. Together, our study demonstrates that HBx and src overexpression induced hepatocarcinogenesis in p53 mutant zebrafish. This phenomenon mimics human HCC formation and provides potential in vivo platforms for drug screening for therapies for human liver cancer.	[Lu, Jeng-Wei; Yang, Wan-Yu; Tsai, Su-Mei; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Lu, Jeng-Wei; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Changhua County, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Hou Loung Town, Miaoli County, Taiwan; [Chang, Pen-Heng] Natl Taiwan Univ, Dept Vet Med, Taipei 10764, Taiwan; [Chen, Jim-Ray] Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan; [Chen, Jim-Ray] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Central University; Changhua Christian Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University	Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan.	chyuh@nhri.org.tw	Yuh, Chiou-Hwa/E-3972-2010; Yuh, Chiou-Hwa/AAL-3531-2020; Yuh, Chiou-Hwa/AAL-2938-2020	Wang, Horng-Dar/0000-0001-9570-3611; Lu, Jeng-Wei/0000-0003-2128-2046; CHANG, PEN-HENG/0000-0002-8676-8760	NRPGM [NSC 99-3112-B-400-010]; NSC [NSC 101-2321-B-400-017, NSC 102-2321-B-400 -016]; National Health Research Institute; Liver Disease Prevention & Treatment Research Foundation, Taiwan; National Science Council (NSC) [101-2321-B-400-014]	NRPGM; NSC(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan; National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This research was supported by NRPGM (NSC 99-3112-B-400-010) and NSC grants (NSC 101-2321-B-400-017 and NSC 102-2321-B-400 -016) provided to CHY. Funding support from the National Health Research Institute provided to CHY is gratefully acknowledged. The fellowship to JWL and the funding support to CHY from the Liver Disease Prevention & Treatment Research Foundation, Taiwan is gratefully acknowledged. We also would like to thank the Taiwan Zebrafish Core Facility at the NTHU-NHRI site (TZeTH) for providing the fish lines and resources. The TZeTH is supported by grant 101-2321-B-400-014 from the National Science Council (NSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chan C, 2013, MOL CELL BIOL, V33, P485, DOI 10.1128/MCB.01189-12; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen J, 2007, J VIROL, V81, P6757, DOI 10.1128/JVI.00172-07; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Goessling W, 2007, NAT METHODS, V4, P551, DOI 10.1038/NMETH1059; Gouas DA, 2012, CARCINOGENESIS, V33, P1219, DOI [10.1093/carcin/bgs135, 10.1093/carcin/bgs068]; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Guerrieri F, 2013, SEMIN LIVER DIS, V33, P147, DOI 10.1055/s-0033-1345721; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Hobbie KR, 2012, VET PATHOL, V49, P372, DOI 10.1177/0300985811409443; HSIA CC, 1992, J NATL CANCER I, V84, P1638, DOI 10.1093/jnci/84.21.1638; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Knoll S, 2011, CELL CYCLE, V10, P3554, DOI 10.4161/cc.10.20.17856; Koo JS, 2005, INTERVIROLOGY, V48, P16, DOI 10.1159/000082090; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lara-Pezzi E, 2001, ONCOGENE, V20, P3323, DOI 10.1038/sj.onc.1204451; Lau GM, 2009, DIGEST DIS SCI, V54, P1465, DOI 10.1007/s10620-008-0519-0; Li D, 2012, LIFE SCI, V91, P440, DOI 10.1016/j.lfs.2012.08.015; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu W, 2012, HEPATOLOGY; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Lu JW, 2013, ACTA HISTOCHEM, V115, P728, DOI 10.1016/j.acthis.2013.02.012; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Lu JW, 2011, BIRTH DEFECTS RES C, V93, P157, DOI 10.1002/bdrc.20205; Ma J, 2013, CLIN RES HEPATOL GAS; Marrero CR, 2007, ARCH MED RES, V38, P612, DOI 10.1016/j.arcmed.2006.09.004; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Muntane J, 2013, CURR CANCER DRUG TAR, V13, P300, DOI 10.2174/15680096113139990075; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Ortiz-Cuaran S, 2013, CANCER LETT, V331, P46, DOI 10.1016/j.canlet.2012.11.012; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Park SG, 2009, CANCER LETT, V282, P229, DOI 10.1016/j.canlet.2009.03.019; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Puisieux A, 1997, PATHOL BIOL, V45, P864; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; SEIFER M, 1991, J HEPATOL, V13, pS61, DOI 10.1016/0168-8278(91)90026-8; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Soussi T, 2003, HUM MUTAT, V21, P192, DOI 10.1002/humu.10189; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P705, DOI 10.1177/019262330002800511; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thompson KJ, 2011, HPB, V13, P225, DOI 10.1111/j.1477-2574.2010.00259.x; Tsai SM, 2013, TRANSGENIC RES, V22, P301, DOI 10.1007/s11248-012-9636-9; Tseng WF, 2011, DEV BIOL, V357, P541, DOI 10.1016/j.ydbio.2011.06.040; UEDA H, 1995, INT J ONCOL, V7, P735; Wang CM, 2013, CELL CYCLE, V12, P1999, DOI 10.4161/cc.25099; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Xian LL, 2010, MOL BIOL REP, V37, P2935, DOI 10.1007/s11033-009-9855-1; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	72	46	47	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76951	10.1371/journal.pone.0076951	http://dx.doi.org/10.1371/journal.pone.0076951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130815	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900109
J	Ouattara, JPN; Louwagie, J; Pigeon, O; Spanoghe, P				Ouattara, Jean Pierre Nableni; Louwagie, Johanna; Pigeon, Olivier; Spanoghe, Pieter			Comparison of the Laboratory Standard Washing Using CIPAC Washing Agent and the Domestic Washing on Three Recommended Types of Long-Lasting Insecticidal Mosquito Nets	PLOS ONE			English	Article							BED NETS; ANOPHELES-CULICIFACIES; ALPHA-CYPERMETHRIN; TREATED NETS; RESISTANCE; DELTAMETHRIN; EFFICACY; INTERCEPTOR(R); BIOEFFICACY; BEDNETS	Background: One of the best ways to prevent malaria is the use of insecticide-treated bed nets. Manufacturers pursue easier, safer and more efficient nets. Hence, many studies on the efficacy and wash resistance using World Health Organization standards have been reported. The commonly used detergent is "Savon de Marseille", because it closely resembles actually used soaps. At the 54th Collaborative International Pesticides Analytical Council (CIPAC) Technical Meeting in 2010, it was suggested to replace it by a standardized "CIPAC washing agent". The aim of this study was to investigate the difference between a laboratory hand washing simulation using the CIPAC washing agent (method-1) and a domestic washing (method-2) on different bed nets, as well as the effect of the drying process on the release of active ingredient. Methods: Interceptor (R), Permanet (R) 2.0 and Netprotect (R) nets were used in three treatments, each repeated 20 times. The first treatment included method-1 washing and indoor drying. The second treatment included method-2 washing and indoor drying. The third treatment used method-2 washing and UV-drying. The residual insecticide contents were determined using gas chromatography. Results: The washing procedure and the number of washes have a significant effect on the release of active ingredient. Statistically, the two washing methods have the same effect on removing the active ingredient from the Interceptor (R) and Permanet (R) 2.0 net, but a significantly different influence on the Netprotect (R) nets. The drying process has no significant effect on the insecticide. Conclusion: Both washing procedures affected the amount of insecticide remaining on nets independently of the impregnation technology. The active ingredient decreases with the number of washing cycles following an exponential or logarithmic model for coated nets. The laboratory hand washing simulation had more impact on the decrease of active ingredient content of the Netprotect (R) nets. All net types seemed to be effectively protected against UV-light.	[Ouattara, Jean Pierre Nableni; Spanoghe, Pieter] Univ Ghent, Lab Crop Protect Chem, Dept Crop Protect, B-9000 Ghent, Belgium; [Louwagie, Johanna] Univ Ghent, Dept Text, Zwijnaarde, Belgium; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Agr & Nat Environm Dept, Plant Protect Prod & Biocides Physicochem & Resid, Gembloux, Belgium	Ghent University; Ghent University	Ouattara, JPN (corresponding author), Univ Ghent, Lab Crop Protect Chem, Dept Crop Protect, B-9000 Ghent, Belgium.	JeanPierreNableni.Ouattara@Ugent.be	Spanoghe, Pieter/B-9440-2015	Spanoghe, Pieter/0000-0002-8158-4401	Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia	Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia	The work was performed under research scholarship funded by the Islamic Development Bank Merit Scholarship Program, Jeddah - Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDELINES LAB FIELD; Atieli FK, 2010, MALARIA J, V9; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; CIPAC - Collaborative International Pesticides Analytical Council, 2010, 7 JOINT CIPAC FAO WH; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; FAO, 2010, FATS FATT AC HUM NUT, P1; Faulde M, 2012, PARASITOL RES, V110, P2341, DOI 10.1007/s00436-011-2769-6; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; Hassan V, 2010, ASIAN PAC J TROP MED, V3, P642, DOI 10.1016/S1995-7645(10)60155-1; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; ISO (International Organization for Standardization), 2007, 213482007 ISO; ISO - International Standard Organization, 2012, 63302012 ISO BSI; Jiang Y, 2009, BIOPHYS J, V96, P1151, DOI 10.1016/j.bpj.2008.10.030; Kayedi MH, 2008, T ROY SOC TROP MED H, V102, P811, DOI 10.1016/j.trstmh.2008.05.025; Kayedi MH, 2009, ANN TROP MED PARASIT, V103, P85, DOI 10.1179/136485909X385018; Kayedi MH, 2009, ACTA TROP, V111, P192, DOI 10.1016/j.actatropica.2009.04.002; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Koudou BG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-172; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lee AJ, 2008, FIBER POLYM, V9, P101, DOI 10.1007/s12221-008-0017-1; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Liu PY, 2010, J ENVIRON SCI-CHINA, V22, P1123, DOI 10.1016/S1001-0742(09)60227-8; Mac Namara C, 2012, CHEM ENG SCI, V75, P14, DOI 10.1016/j.ces.2012.03.009; Morris SE, 2006, IND CROP PROD, V23, P9, DOI 10.1016/j.indcrop.2005.01.007; Msangi S, 2008, ACTA TROP, V107, P43, DOI 10.1016/j.actatropica.2008.03.014; Muller M, 2010, CIPAC WASH METHOD LN; NAJERA JA, 2002, MALARIA VECTOR CONTR, P1; Ouattara JPN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-77; Pigeon O, 2011, 8 JOINT CIPAC FAO WH, P1; Pigeon O, 2011, 55 CIPAC TECHN M BEI, P1; Rafinejad J., 2008, Journal of Vector Borne Diseases, V45, P143; Rodler M, 2011, CIPAC M BEIJ, P1; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Skovmand O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-114; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P647, DOI 10.1016/0035-9203(88)90547-0; Sreehari U, 2009, TROP MED INT HEALTH, V14, P597, DOI 10.1111/j.1365-3156.2009.02252.x; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Vanlerberghe V, 2010, TROPICAL MED INT HLT, V15; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, 11 WHOPES WORK GROUP; WHO - World Health Organization, 2003, CURR STAT PROGR ISS; WHO - World Health Organization, 1993, B WORLD HEALTH ORGAN, P281; WHO - World Health Organization, VECT CONTR MAL; WHO - World Health Organization, 2001, SPEC NETT MAT REP IN; WHOPES - World Health Organization Pesticide Evaluation Scheme, 2006, REP WHOPES WORK GROU; World Health Organization, 2005, MULT STUD WOM HLTH D, P1; World Health Organization, 2008, 12 WHOPES WORK GROUP; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	51	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74824	10.1371/journal.pone.0074824	http://dx.doi.org/10.1371/journal.pone.0074824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130671	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900006
J	Poudyal, D; Cui, XL; Le, PM; Hofseth, AB; Windust, A; Nagarkatti, M; Nagarkatti, PS; Schetter, AJ; Harris, CC; Hofseth, LJ				Poudyal, Deepak; Cui, Xiangli; Le, Phuong Mai; Hofseth, Anne B.; Windust, Anthony; Nagarkatti, Mitzi; Nagarkatti, Prakash S.; Schetter, Aaron J.; Harris, Curtis C.; Hofseth, Lorne J.			A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GENE-EXPRESSION; COLORECTAL-CANCER; TUMOR INVASION; LUNG-CANCER; METASTASIS; MMP-9; MATRIX-METALLOPROTEINASE-7; GINSENOSIDE-RB2; PROLIFERATION	Metastasis of colon cancer cells increases the risk of colon cancer mortality. We have recently shown that American ginseng prevents colon cancer, and a Hexane extract of American Ginseng (HAG) has particularly potent anti-inflammatory and anticancer properties. Dysregulated microRNA (miR) expression has been observed in several disease conditions including colon cancer. Using global miR expression profiling, we observed increased miR-29b in colon cancer cells following exposure to HAG. Since miR-29b plays a role in regulating the migration of cancer cells, we hypothesized that HAG induces miR-29b expression to target matrix metalloproteinase-2 (MMP-2) thereby suppressing the migration of colon cancer cells. Results are consistent with this hypothesis. Our study supports the understanding that targeting MMP-2 by miR-29b is a mechanism by which HAG suppresses the migration of colon cancer cells.	[Poudyal, Deepak; Cui, Xiangli; Hofseth, Anne B.; Hofseth, Lorne J.] Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Cui, Xiangli] Shanxi Med Univ, Taiyuan, Shanxi, Peoples R China; [Le, Phuong Mai; Windust, Anthony] Natl Res Council Canada, Inst Natl Measurement Stand, Ottawa, ON K1A 0R6, Canada; [Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ S Carolina, Sch Med, Columbia, SC USA; [Schetter, Aaron J.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Shanxi Medical University; National Research Council Canada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hofseth, LJ (corresponding author), Univ S Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA.	hofseth@cop.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Nagarkatti, Mitzi/0000-0002-5977-5615	Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH [1P01AT003961-01A1]; COBRE [P20RR17698-01]; NATIONAL CANCER INSTITUTE [ZIABC011492] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Center for CAM Research on Autoimmune and Inflammatory Diseases, NIH grant 1P01AT003961-01A1 (PN, LJH, MN), and the COBRE funded University of South Carolina Center for Colon Cancer Research, NIH grant P20RR17698-01 (Franklin Berger, Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Ara T, 1998, J PEDIATR SURG, V33, P1272, DOI 10.1016/S0022-3468(98)90167-1; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Cheng CC, 2005, CANCER CHEMOTH PHARM, V55, P531, DOI 10.1007/s00280-004-0919-6; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Cui XL, 2010, CARCINOGENESIS, V31, P1734, DOI 10.1093/carcin/bgq163; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Fujimoto J, 2001, EUR J GYNAECOL ONCOL, V22, P339; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jin Y, 2008, CARCINOGENESIS, V29, P2351, DOI 10.1093/carcin/bgn211; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung JS, 2010, BIOCHEM BIOPH RES CO, V397, P323, DOI 10.1016/j.bbrc.2010.05.117; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JY, 2002, PLANTA MED, V68, P119, DOI 10.1055/s-2002-20240; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Lee SD, 2010, J MED FOOD, V13, P1, DOI 10.1089/jmf.2009.1142; Lee SD, 2009, J AM OIL CHEM SOC, V86, P1065, DOI 10.1007/s11746-009-1460-x; Liabakk NB, 1996, CANCER RES, V56, P190; Liu WK, 2000, LIFE SCI, V67, P1297, DOI 10.1016/S0024-3205(00)00720-7; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Lu MC, 2009, CELL BIOCHEM FUNCT, V27, P186, DOI 10.1002/cbf.1554; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MATSUNAGA H, 1990, CHEM PHARM BULL, V38, P3480, DOI 10.1248/cpb.38.3480; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Melo SA, 2013, NAT CELL BIOL, V15, P139, DOI 10.1038/ncb2684; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Ogawa M, 2005, HEPATO-GASTROENTEROL, V52, P875; Park MT, 1999, MOL CELLS, V9, P476; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pesta M, 2005, ANTICANCER RES, V25, P3387; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Poudyal D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/785739; Poudyal D, 2012, CANCER PREV RES, V5, P685, DOI 10.1158/1940-6207.CAPR-11-0421; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steele Robert, 2010, Genes Cancer, V1, P381; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang CZ, 2007, PLANTA MED, V73, P669, DOI 10.1055/s-2007-981524; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041586; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358; Yoon JH, 2012, PHYTOMEDICINE, V19, P284, DOI 10.1016/j.phymed.2011.08.069; Yue Patrick Y. K., 2005, Angiogenesis, V8, P205, DOI 10.1007/s10456-005-9000-2; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	74	37	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75034	10.1371/journal.pone.0075034	http://dx.doi.org/10.1371/journal.pone.0075034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130681	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900016
J	Wilson, CB; McLaughlin, LD; Nair, A; Ebenezer, PJ; Dange, R; Francis, J				Wilson, C. Brad; McLaughlin, Leslie D.; Nair, Anand; Ebenezer, Philip J.; Dange, Rahul; Francis, Joseph			Inflammation and Oxidative Stress Are Elevated in the Brain, Blood, and Adrenal Glands during the Progression of Post-Traumatic Stress Disorder in a Predator Exposure Animal Model	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PLASMA-CORTISOL; COMBAT VETERANS; PLUS-MAZE; CYTOKINES; ANXIETY; RAT; MECHANISM; MITOCHONDRIAL; STIMULATION	This study sought to analyze specific pathophysiological mechanisms involved in the progression of post-traumatic stress disorder (PTSD) by utilizing an animal model. To examine PTSD pathophysiology, we measured damaging reactive oxygen species and inflammatory cytokines to determine if oxidative stress and inflammation in the brain, adrenal glands, and systemic circulation were upregulated in response to constant stress. Pre-clinical PTSD was induced in naive, male Sprague-Dawley rats via a predator exposure/psychosocial stress regimen. PTSD group rats were secured in Plexiglas cylinders and placed in a cage with a cat for one hour on days 1 and 11 of a 31-day stress regimen. In addition, PTSD group rats were subjected to psychosocial stress whereby their cage cohort was changed daily. This model has been shown to cause heightened anxiety, exaggerated startle response, impaired cognition, and increased cardiovascular reactivity, all of which are common symptoms seen in humans with PTSD. At the conclusion of the predator exposure/psychosocial stress regimen, the rats were euthanized and their brains were dissected to remove the hippocampus, amygdala, and pre-frontal cortex (PFC), the three areas commonly associated with PTSD development. The adrenal glands and whole blood were also collected to assess systemic oxidative stress. Analysis of the whole blood, adrenal glands, and brain regions revealed oxidative stress increased during PTSD progression. In addition, examination of pro-inflammatory cytokine (PIC) mRNA and protein demonstrated neurological inflammatory molecules were significantly upregulated in the PTSD group vs. controls. These results indicate oxidative stress and inflammation in the brain, adrenal glands, and systemic circulation may play a critical role in the development and further exacerbation of PTSD. Thus, PTSD may not be solely a neurological pathology but may progress as a systemic condition involving multiple organ systems.	[Wilson, C. Brad; Nair, Anand; Ebenezer, Philip J.; Dange, Rahul; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [McLaughlin, Leslie D.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Wilson, CB (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@vetmed.lsu.edu			Louisiana State University School of Veterinary Medicine corps grant	Louisiana State University School of Veterinary Medicine corps grant	This work was funded by the Louisiana State University School of Veterinary Medicine corps grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Alexopoulos G.S., 2012, J AFFECT DISORD; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Baker DG, 1999, AM J PSYCHIAT, V156, P585; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; BLANCHARD RJ, 1975, J COMP PHYSIOL PSYCH, V88, P81, DOI 10.1037/h0076213; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Dansie EJ, 2012, PSYCHOSOMATICS, V53, P250, DOI 10.1016/j.psym.2011.08.007; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Edmondson D, 2013, PROG CARDIOVASC DIS, V55, P548, DOI 10.1016/j.pcad.2013.03.004; Elks CM, 2010, CURR HYPERTENS REP, V12, P99, DOI 10.1007/s11906-010-0096-4; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Hu SX, 1998, BIOCHEM PHARMACOL, V56, P285, DOI 10.1016/S0006-2952(98)00162-2; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; KRAHN DD, 1990, BIOL PSYCHIAT, V27, P1094, DOI 10.1016/0006-3223(90)90046-5; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Mazjoub JA, 2006, EUROPEAN J ENDOCRINO, V155, pS71; McCann SM, 2000, ANN NY ACAD SCI, V917, P4, DOI 10.1111/j.1749-6632.2000.tb05368.x; MOKUNO K, 1994, J NEUROCHEM, V63, P612; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Pall ML, 2001, ANN NY ACAD SCI, V933, P323; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rohleder N, 2004, BIOL PSYCHIAT, V55, P745, DOI 10.1016/j.biopsych.2003.11.018; Salgo MG, 1996, ARCH BIOCHEM BIOPHYS, V333, P482, DOI 10.1006/abbi.1996.0418; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Sondergaard HP, 2004, CLIN CHIM ACTA, V342, P93, DOI 10.1016/j.cccn.2003.12.019; Stein MB, 1997, BIOL PSYCHIAT, V42, P680, DOI 10.1016/S0006-3223(96)00489-1; SUTHERLAND SM, 1994, PSYCHIAT CLIN N AM, V17, P409; Turnbull AV, 1998, ANN NY ACAD SCI, V840, P434, DOI 10.1111/j.1749-6632.1998.tb09582.x; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; Vidovic A, 2011, PSYCHONEUROENDOCRINO, V36, P161, DOI 10.1016/j.psyneuen.2010.08.005; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007	49	127	130	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76146	10.1371/journal.pone.0076146	http://dx.doi.org/10.1371/journal.pone.0076146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130763	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900069
J	Osmundson, J; Dewell, S; Darst, SA				Osmundson, Joseph; Dewell, Scott; Darst, Seth A.			RNA-Seq Reveals Differential Gene Expression in Staphylococcus aureus with Single-Nucleotide Resolution	PLOS ONE			English	Article							LABORATORY STRAINS; CELL-WALL; TRANSCRIPTION; AGR; REGULATOR; GENOMES; SARA; IDENTIFICATION; RESISTANCE; INHIBITION	Staphylococcus aureus is a gram-positive cocci and an important human commensal bacteria and pathogen. S. aureus infections are increasingly difficult to treat because of the emergence of highly resistant MRSA (methicillin-resistant S. aureus) strains. Here we present a method to study differential gene expression in S. aureus using high-throughput RNA-sequencing (RNA-seq). We used RNA-seq to examine gene expression in S. aureus RN4220 cells containing an exogenously expressed transcription factor and between two S. aureus strains (RN4220 and NCTC8325-4). We investigated the sequence and gene expression differences between RN4220 and NCTC8325-4 and used the RNA-seq data to identify S. aureus promoters suitable for in vitro analysis. We used RNA-seq to describe, on a genome wide scale, genes positively and negatively regulated by the phage encoded transcription factor gp67. RNA-seq offers the ability to study differential gene expression with single-nucleotide resolution, and is a considerable improvement over the predominant genome-wide transcriptome technologies used in S. aureus.	[Osmundson, Joseph; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Osmundson, J (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	josmundson@rockefeller.edu			National Institutes of Health [RO1 GM053759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by the National Institutes of Health Grant RO1 GM053759 to S. A. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hubscher J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-307; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; MENDOZAVARGAS A, 2009, PLOS ONE, V4, pNI158; Montero-Diez C, 2013, J BACTERIOL; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; O'Neill AJ, 2009, ANTIMICROB AGENTS CH, V53, P1701, DOI 10.1128/AAC.01309-08; Ohta T, 2004, DNA RES, V11, P51, DOI 10.1093/dnares/11.1.51; Osmundson J., 2013, BACTERIOPHAGE, V3, pe24767, DOI 10.4161/bact.24767; Osmundson J, 2012, CELL, V151, P1005, DOI 10.1016/j.cell.2012.10.034; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truong-Bolduc QC, 2011, J BACTERIOL, V193, P6207, DOI 10.1128/JB.05847-11; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Vvedenskaya IO, 2012, GENE DEV, V26, P1498, DOI 10.1101/gad.192732.112; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10	50	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76572	10.1371/journal.pone.0076572	http://dx.doi.org/10.1371/journal.pone.0076572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116120	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300067
J	Pang, PF; Wu, C; Shen, M; Gong, FM; Zhu, KS; Jiang, ZB; Guan, SH; Shan, H; Shuai, XT				Pang, Pengfei; Wu, Chun; Shen, Min; Gong, Faming; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong; Shuai, Xintao			An MRI-Visible Non-Viral Vector Bearing GD2 Single Chain Antibody for Targeted Gene Delivery to Human Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							NEURAL GANGLIOSIDE GD2; STROMAL CELLS; UMBILICAL-CORD; DNA; CYTOTOXICITY; EXPRESS; DISEASE; CULTURE; TRAIL; PEI	The neural ganglioside GD2 has recently been reported to be a novel surface marker that is only expressed on human bone marrow mesenchymal stem cells within normal marrow. In this study, an MRI-visible, targeted, non-viral vector for effective gene delivery to human bone marrow mesenchymal stem cells was first synthesized by attaching a targeting ligand, the GD2 single chain antibody (scAb(GD2)), to the distal ends of PEG-g-PEI-SPION. The targeted vector was then used to condense plasmid DNA to form nanoparticles showing stable small size, low cytotoxicity, and good biocompatibility. Based on a reporter gene assay, the transfection efficiency of targeting complex reached the highest value at 59.6% +/- 4.5% in human bone marrow mesenchymal stem cells, which was higher than those obtained using nontargeting complex and lipofectamine/pDNA (17.7% +/- 2.9% and 34.9% +/- 3.6%, respectively) (P<0.01). Consequently, compared with the nontargeting group, more in vivo gene expression was observed in the fibrotic rat livers of the targeting group. Furthermore, the targeting capacity of scAb(GD2)-PEG-g-PEI-SPION was successfully verified in vitro by confocal laser scanning microscopy, Prussian blue staining, and magnetic resonance imaging. Our results indicate that scAb(GD2)-PEG-g-PEI-SPION is a promising MRI-visible non-viral vector for targeted gene delivery to human bone marrow mesenchymal stem cells.	[Pang, Pengfei; Wu, Chun; Shen, Min; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Mol Imaging Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Faming; Shuai, Xintao] Sun Yat Sen Univ, PCFM Lab, Minist Educ, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Pengfei; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Intervent Radiol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Pengfei; Zhu, Kangshun; Jiang, Zaibo; Guan, Shouhai; Shan, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shan, H (corresponding author), Sun Yat Sen Univ, Mol Imaging Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	Shanhong@mail.sysu.edu.cn; shuaixt@mail.sysu.edu.cn	Shuai, Xintao/C-5819-2008	Shuai, Xintao/0000-0003-4271-0310; Jiang, Zaibo/0000-0003-0523-6488	NSFC-Guangdong Joint Foundation Key Project [U1032002]; National Natural Science Foundation of China [81071206, 81172193, 81201090, 81070349, 50830107]; Ministry of Public Health of China [164]; Science and Technology Plannig Project of Guangdong Province [2008A 030201004]; National Science Foundation for Distinguished Young Scholars of China [51225305]	NSFC-Guangdong Joint Foundation Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public Health of China; Science and Technology Plannig Project of Guangdong Province; National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the NSFC-Guangdong Joint Foundation Key Project (Grant No. U1032002), the National Natural Science Foundation of China (Grant Nos. 81071206, 81172193, 81201090, 81070349, and 50830107), the 2010-2012 Clinical Key Program of Ministry of Public Health of China (Grant No. 164), the Science and Technology Plannig Project of Guangdong Province (Grant No. 2008A 030201004), and the National Science Foundation for Distinguished Young Scholars of China (Grant No. 51225305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006; Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Bosch P, 2006, MOL REPROD DEV, V73, P1393, DOI 10.1002/mrd.20593; Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026; Chen GH, 2009, BIOMATERIALS, V30, P1962, DOI 10.1016/j.biomaterials.2008.12.043; Dai LJ, 2009, STEM CELL RES, V2, P16, DOI 10.1016/j.scr.2008.07.005; Dutta T, 2010, NANOMED-NANOTECHNOL, V6, P25, DOI 10.1016/j.nano.2009.05.005; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Farrell LL, 2007, EUR J PHARM BIOPHARM, V65, P388, DOI 10.1016/j.ejpb.2006.11.026; Fischer D, 2002, BIOCONJUGATE CHEM, V13, P1124, DOI 10.1021/bc025550w; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kim SW, 2004, J BIOMED MATER RES A, V71A, P308, DOI 10.1002/jbm.a.30160; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686; Meyerrose TE, 2008, STEM CELLS, V26, P1713, DOI 10.1634/stemcells.2008-0008; Nemeth K, 2012, STEM CELLS, V30, P222, DOI 10.1002/stem.771; Pandita D, 2011, BIOMACROMOLECULES, V12, P472, DOI 10.1021/bm1012647; Ricks DM, 2008, STEM CELLS DEV, V17, P441, DOI 10.1089/scd.2007.0194; Shan YB, 2012, BIOMATERIALS, V33, P3025, DOI 10.1016/j.biomaterials.2011.12.045; Shen M, 2012, INT J NANOMED, V7, P3319, DOI 10.2147/IJN.S32900; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xu J, 2009, CELL PHYSIOL BIOCHEM, V23, P415, DOI 10.1159/000218188; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	27	15	17	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76612	10.1371/journal.pone.0076612	http://dx.doi.org/10.1371/journal.pone.0076612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116127	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300073
J	Anderson, P; Carrillo-Galvez, AB; Garcia-Perez, A; Cobo, M; Martin, F				Anderson, Per; Belen Carrillo-Galvez, Ana; Garcia-Perez, Angelica; Cobo, Marien; Martin, Francisco			CD105 (Endoglin)-Negative Murine Mesenchymal Stromal Cells Define a New Multipotent Subpopulation with Distinct Differentiation and Immunomodulatory Capacities	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; ADULT STEM-CELLS; BONE-MARROW; TGF-BETA; EXPERIMENTAL COLITIS; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; DENDRITIC CELLS; IN-VITRO; ENDOGLIN	Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo-and xenogeneic settings. However, MSC preparations are heterogeneous which impairs their therapeutic efficacy and endorses variability between experiments. This heterogeneity has also been a main hurdle in translating experimental MSC data from mouse models to human patients. The objective of the present manuscript has been to further characterize murine MSCs (mMSCs) with the aim of designing more efficient and specific MSC-based therapies. We have found that mMSCs are heterogeneous for endoglin (CD105) expression and that this heterogeneity is not due to different stages of MSC differentiation. CD105 is induced on a subpopulation of mMSCs early upon in vitro culture giving rise to CD105(+) and CD105(-) MSCs. CD105(+) and CD105(-) mMSCs represent independent subpopulations that maintain their properties upon several passages. CD105 expression on CD105(+) mMSCs was affected by passage number and cell confluency while CD105(-) mMSCs remained negative. The CD105(+) and CD105(-) mMSC subpopulations had similar growth potential and expressed almost identical mMSC markers (CD29(+)CD44(+)Sca1 (+) MHC-I+ and CD45(-)CD11b(-)CD31(-)) but varied in their differentiation and immunoregulatory properties. Interestingly, CD105-mMSCs were more prone to differentiate into adipocytes and osteocytes and suppressed the proliferation of CD4(+) T cells more efficiently compared to CD105+ mMSCs. Based on these studies we propose to redefine the phenotype of mMSCs based on CD105 expression.	[Anderson, Per; Belen Carrillo-Galvez, Ana; Garcia-Perez, Angelica; Cobo, Marien; Martin, Francisco] Univ Granada, Dept Human DNA Variabil, Ctr Genom & Oncol Res, GENYO,Pfizer,Andalusian Reg Govt,PTS Granada, Granada, Spain	Pfizer; University of Granada	Anderson, P (corresponding author), Univ Granada, Dept Human DNA Variabil, Ctr Genom & Oncol Res, GENYO,Pfizer,Andalusian Reg Govt,PTS Granada, Granada, Spain.	per.anderson@genyo.es	Martin, Francisco/K-8763-2014	Martin, Francisco/0000-0003-1961-8612; Anderson, Per/0000-0002-0958-7990	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI12/01390, PS09/00340]; Consejer a de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejer a de Salud from the Junta de Andalucia [PI0001/2009]; FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Miguel Servet Contract [CP09/00228]; Fondo Europeo de Desarollo Regional (FEDER) from the European Union); Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andalucia)	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Consejer a de Innovacion Ciencia y Empresa(Junta de Andalucia); Consejer a de Salud from the Junta de Andalucia(Junta de Andalucia); FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Miguel Servet Contract; Fondo Europeo de Desarollo Regional (FEDER) from the European Union); Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andalucia)(Junta de Andalucia)	This work has been financed by Fondo de Investigaciones Sanitarias ISCIII (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union, through the research grants No PI12/01390 (P. A) and No PS09/00340 (F. M), by the Consejer a de Innovacion Ciencia y Empresa (grants No P09-CTS-04532 and PAIDI-Bio-326) and Consejer a de Salud (grant No PI0001/2009) from the Junta de Andalucia and FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia 2007-2013 to F. M. P. A. has a Miguel Servet Contract (CP09/00228) cofinanced by the Fondo Europeo de Desarollo Regional (FEDER) from the European Union). M. C. and F. M. are funded by Fundacion Progreso y Salud (Consejer a de Salud - Junta de Andaluc a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2013, GUT, V62, P1131, DOI 10.1136/gutjnl-2012-302152; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bernardo ME, 2012, ANN NY ACAD SCI, V1266, P107, DOI 10.1111/j.1749-6632.2012.06667.x; Blanco FJ, 2008, CIRC RES, V103, P1383, DOI 10.1161/CIRCRESAHA.108.176552; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chang CB, 2013, OSTEOARTHR CARTILAGE, V21, P190, DOI 10.1016/j.joca.2012.10.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cobo M, 2012, CELL TRANSPLANT; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Connick P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-62; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Divya MS, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt148; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Herreros MD, 2012, DIS COLON RECTUM, V55, P762, DOI 10.1097/DCR.0b013e318255364a; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishimura D, 2008, TOHOKU J EXP MED, V216, P149, DOI 10.1620/tjem.216.149; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118; KAWASHIMA I, 1991, FEBS LETT, V283, P199, DOI 10.1016/0014-5793(91)80587-S; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Levi B, 2011, J BIOL CHEM, V286, P39497, DOI 10.1074/jbc.M111.256529; Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359; Li CG, 2003, ANTICANCER RES, V23, P1189; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rosu-Myles M, 2010, CYTOTHERAPY, V12, P818, DOI 10.3109/14653249.2010.501785; Russell K. C., 2013, TISSUE ENG A; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Spiropoulos A, 2011, J CELL MOL MED, V15, P1983, DOI 10.1111/j.1582-4934.2010.01157.x; Sugiyama Y, 2012, INT IMMUNOL, V24, P253, DOI 10.1093/intimm/dxr126; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Wall ME, 2007, TISSUE ENG, V13, P1291, DOI 10.1089/ten.2006.0275; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	63	90	95	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76979	10.1371/journal.pone.0076979	http://dx.doi.org/10.1371/journal.pone.0076979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124603	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100160
J	Bellay, S; de Oliveira, EF; Almeida-Neto, M; Lima, DP; Takemoto, RM; Luque, JL				Bellay, Sybelle; de Oliveira, Edson Fontes; Almeida-Neto, Mario; Lima Junior, Dilermando Pereira; Takemoto, Ricardo Massato; Luque, Jose Luis			Developmental Stage of Parasites Influences the Structure of Fish-Parasite Networks	PLOS ONE			English	Article							HOST-SPECIFICITY; NESTEDNESS; CARTOGRAPHY; MODULARITY; EVOLUTION	Specialized interactions tend to be more common in systems that require strong reciprocal adaptation between species, such as those observed between parasites and hosts. Parasites exhibit a high diversity of species and life history strategies, presenting host specificity which increases the complexity of these antagonistic systems. However, most studies are limited to the description of interactions between a few parasite and host species, which restricts our understanding of these systems as a whole. We investigated the effect of the developmental stage of the parasite on the structure of 30 metazoan fish-parasite networks, with an emphasis on the specificity of the interactions, connectance and modularity. We assessed the functional role of each species in modular networks and its interactions within and among the modules according to the developmental stage (larval and adult) and taxonomic group of the parasites. We observed that most parasite and host species perform a few interactions but that parasites at the larval stage tended to be generalists, increasing the network connectivity within and among modules. The parasite groups did not differ among each other in the number of interactions within and among the modules when considering only species at the larval stage. However, the same groups of adult individuals differed from each other in their interaction patterns, which were related to variations in the degree of host specificity at this stage. Our results show that the interaction pattern of fishes with parasites, such as acanthocephalans, cestodes, digeneans and nematodes, is more closely associated with their developmental stage than their phylogenetic history. This finding corroborates the hypothesis that the life history of parasites results in adaptations that cross phylogenetic boundaries.	[Bellay, Sybelle; Takemoto, Ricardo Massato] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Programa Posgrad Ecol Ambientes Aquat Continentai, Dept Ciencias Biol, Maringa, Parana, Brazil; [Bellay, Sybelle] Univ Estadual Norte Parana, Ctr Ciencias Humanas & Educ, Grp Estudos & Pesquisa Recursos Hidr & Ecol Aplic, Jacarezinho, Parana, Brazil; [de Oliveira, Edson Fontes] Univ Tecnol Fed Parana, Dept Engn Ambiental, Programa Posgrad Engn Ambiental, Londrina, Parana, Brazil; [Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Lima Junior, Dilermando Pereira] Univ Fed Mato Grosso, Dept Ciencias Biol & Saude, Pontal Do Araguaia, MG, Brazil; [Luque, Jose Luis] Univ Fed Rio de Janeiro, Dept Parasitol Anim, Rio De Janeiro, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Norte do Parana (UENP); Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal de Goias; Universidade Federal de Mato Grosso; Universidade Federal do Rio de Janeiro	Bellay, S (corresponding author), Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Programa Posgrad Ecol Ambientes Aquat Continentai, Dept Ciencias Biol, Maringa, Parana, Brazil.	sybellebellay@yahoo.com.br	Luque, Jose L/C-9767-2014; de Oliveira, Edson Fontes/AAO-2107-2020; Almeida-Neto, M./A-6389-2009; de Oliveira, Edson Fontes/AGY-4950-2022; Takemoto, Ricardo M/F-7010-2012; Lima-Junior, Dilermando/AAT-6144-2020	de Oliveira, Edson Fontes/0000-0002-4224-6565; Almeida-Neto, M./0000-0002-2161-2968; de Oliveira, Edson Fontes/0000-0002-4224-6565; Takemoto, Ricardo M/0000-0001-7592-2083; Lima-Junior, Dilermando/0000-0001-5071-3314; Bellay, Sybelle/0000-0002-2242-9735; Luque, Jose/0000-0003-3515-1127	PEA/CAPES/PROEX; DIRPPG/UTFPR- Campus Londrina; CNPq	PEA/CAPES/PROEX; DIRPPG/UTFPR- Campus Londrina; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Manuscript funded by PEA/CAPES/PROEX, DIRPPG/UTFPR- Campus Londrina and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BARKER SC, 1991, INT J PARASITOL, V21, P497, DOI 10.1016/0020-7519(91)90053-A; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bellay S, 2011, PARASITOLOGY, V138, P1945, DOI 10.1017/S0031182011001314; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bozza AN, 2010, BIOTA NEOTROP, V10, P217, DOI 10.1590/S1676-06032010000300025; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Fernandez J.C, 1993, FUNCTIONAL BIOL PARA; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Jordano P, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P173; Khan R A, 2012, J Parasitol Res, V2012, P237280, DOI 10.1155/2012/237280; Krasnov BR, 2012, AM NAT, V179, P501, DOI 10.1086/664612; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lima DP, 2012, J ANIM ECOL, V81, P905, DOI 10.1111/j.1365-2656.2012.01967.x; Luque JL, 2004, ACTA PARASITOL, V49, P353; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0021326, 10.1371/journal.pone.0018318]; Mouillot D, 2008, ECOGRAPHY, V31, P16, DOI 10.1111/j.2007.0906-7590.05231.x; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Palm HW, 2008, INT J PARASITOL, V38, P381, DOI 10.1016/j.ijpara.2007.08.011; PIMM SL, 1982, FOOD WEBS; Podani J, 2012, ECOGRAPHY, V35, P889, DOI 10.1111/j.1600-0587.2011.07319.x; POULIN R, 1992, INT J PARASITOL, V22, P753, DOI 10.1016/0020-7519(92)90124-4; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; POULIN R, 1998, EVOLUTIONARY ECOLOGY; Poulin R, 2013, J ANIM ECOL, V82, P1265, DOI 10.1111/1365-2656.12101; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; Price P. W., 1980, EVOLUTIONARY BIOL PA; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core Team, 2016, R FDN STAT COMP; StatSoft Inc., 2005, STAT DAT AN SOFTW SY; Thatcher V. E., 2006, AQUATIC BIODIVERSITY, V1; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Whittington ID, 2011, INTEGR COMP BIOL, V51, P91, DOI 10.1093/icb/icr003; Woo P. T. K., 2006, FISH DIS DISORDERS P, V1	42	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75710	10.1371/journal.pone.0075710	http://dx.doi.org/10.1371/journal.pone.0075710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124506	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100063
J	Camilli, R; Daprai, L; Cavrini, F; Lombardo, D; D'Ambrosio, F; Del Grosso, M; Vescio, MF; Landini, MP; Pascucci, MG; Torresani, E; Garlaschi, ML; Sambri, V; Pantosti, A				Camilli, Romina; Daprai, Laura; Cavrini, Francesca; Lombardo, Donatella; D'Ambrosio, Fabio; Del Grosso, Maria; Vescio, Maria Fenicia; Landini, Maria Paola; Pascucci, Maria Grazia; Torresani, Erminio; Garlaschi, Maria Laura; Sambri, Vittorio; Pantosti, Annalisa			Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy	PLOS ONE			English	Article							PNEUMONIAE NASOPHARYNGEAL CARRIAGE; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE 19A; GENETIC-STRUCTURE; HEALTHY-CHILDREN; UNITED-STATES; DISEASE; PREVALENCE; ERA; 6C	Background: In mid 2010, the 7-valent pneumococcal conjugate vaccine (PCV7) was replaced by the 13-valent conjugate vaccine (PCV13) for childhood immunization in Italy. Our objective in this study was to obtain a snapshot of pneumococcal carriage frequency, colonizing serotypes, and antibiotic resistance in healthy children in two Italian cities one year after PCV13 was introduced. Methods: Nasopharyngeal swabs were obtained from 571 children aged 0-5 years from November 2011-April 2012. Pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. Penicillin and/or erythromycin nonsusceptible isolates were analyzed by Multi Locus Sequence Typing (MLST). Results: Among the children examined, 81.2% had received at least one dose of PCV7 or PCV13 and 74.9% had completed the recommended vaccination schedule for their age. Among the latter, 57.3% of children had received PCV7, 27.1% PCV13, and 15.6% a combination of the two vaccines. The overall carriage rate was 32.9%, with children aged 6-35 months the most prone to pneumococcal colonization (6-23 months OR: 3.75; 95% CI: 2.19-6.43 and 24-35 months OR: 3.15, 95% CI: 2.36-4.22). A total of 184 pneumococcal isolates were serotyped and divided into PCV7 (5.4%), PCV13 (18.0%), and non-PCV13 (82.0%) serotypes. Serotypes 6C, 24F, and 19A were the most prevalent (10.3%, 8.6%, and 8.1%, respectively). The proportion of penicillin non-susceptible (MIC >0.6 mg/L) isolates was 30.9%, while 42.3% were erythromycin resistant. Non-PCV13 serotypes accounted for 75.4% and 70.8% of the penicillin and erythromycin non-susceptible isolates, respectively. Conclusions: Our results revealed low rates of PCV7 and PCV13 serotypes in Italian children, potentially due to the effects of vaccination. As the use of PCV13 continues, its potential impact on vaccine serotypes such as 19A and cross-reactive serotypes such as 6C will be assessed, with this study providing a baseline for further analysis of surveillance isolates.	[Camilli, Romina; D'Ambrosio, Fabio; Del Grosso, Maria; Vescio, Maria Fenicia; Pantosti, Annalisa] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Daprai, Laura; Torresani, Erminio; Garlaschi, Maria Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Microbiol Unit, Milan, Italy; [Cavrini, Francesca; Lombardo, Donatella; Landini, Maria Paola; Sambri, Vittorio] Univ Bologna, S Orsola M Malpighi Hosp, Microbiol Unit, Bologna, Italy; [Pascucci, Maria Grazia] Direz Gen Sanita & Polit Sociali, Serv Sanita Pubbl, Bologna, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Pantosti, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	annalisa.pantosti@iss.it	Pantosti, Annalisa/A-7291-2013; CAMILLI, ROMINA/C-8811-2016; Sambri, Vittorio/H-5372-2019; Del Grosso, Maria/C-8815-2016; Lombardo, Donatella/GZL-5851-2022; Vescio, Fenicia/N-5776-2017	Pantosti, Annalisa/0000-0002-8409-4731; CAMILLI, ROMINA/0000-0003-1309-5670; Sambri, Vittorio/0000-0002-5012-7355; Del Grosso, Maria/0000-0002-2663-9764; Lombardo, Donatella/0000-0003-0730-742X; Vescio, Fenicia/0000-0002-3285-919X; D'Ambrosio, Fabio/0000-0003-4101-7186	Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM)	Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM)	This study was supported by the Italian Ministry of Health, Centro Nazionale per la prevenzione e il controllo delle malattie (CCM, http://www.ccm-network.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Alfonsi V, 2011, HEALTH POLICY, V103, P176, DOI 10.1016/j.healthpol.2011.10.002; Ansaldi F, 2012, VACCINE, V30, P2288, DOI 10.1016/j.vaccine.2012.01.067; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Boccalini S, 2011, VACCINE, V29, P9521, DOI 10.1016/j.vaccine.2011.10.013; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020; Cardozo DM, 2008, J MED MICROBIOL, V57, P185, DOI 10.1099/jmm.0.47470-0; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Del Grosso M, 2013, J MED MICROBIOL, V62, P1220, DOI 10.1099/jmm.0.061242-0; Dunais B, 2011, EUR J CLIN MICROBIOL, V30, P837, DOI 10.1007/s10096-011-1154-9; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in europe, 2012, ANN REP EUR ANT RES; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Green MC, 2011, J CLIN MICROBIOL, V49, P2097, DOI 10.1128/JCM.02207-10; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Grivea IN, 2011, VACCINE, V29, P8882, DOI 10.1016/j.vaccine.2011.09.074; Hermans PWM, 2008, VACCINE, V26, P449, DOI 10.1016/j.vaccine.2007.11.026; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; ICONA Working Group, 2009, 0929 ISTISAN; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Marchisio P, 2002, EMERG INFECT DIS, V8, P479; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moschioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061003; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pantosti A, 2002, CLIN INFECT DIS, V35, P205, DOI 10.1086/341250; Petrosillo N, 2002, EUR J CLIN MICROBIOL, V21, P181, DOI 10.1007/s10096-001-0689-6; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Rodrigues F, 2009, MICROB DRUG RESIST, V15, P269, DOI 10.1089/mdr.2009.0043; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Valente C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030235; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weil-Olivier C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-207; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac	51	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76309	10.1371/journal.pone.0076309	http://dx.doi.org/10.1371/journal.pone.0076309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124543	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100100
J	Dunne, MR; Elliott, L; Hussey, S; Mahmud, N; Kelly, J; Doherty, DG; Feighery, CF				Dunne, Margaret R.; Elliott, Louise; Hussey, Seamus; Mahmud, Nasir; Kelly, Jacinta; Doherty, Derek G.; Feighery, Conleth F.			Persistent Changes in Circulating and Intestinal gamma delta T Cell Subsets, Invariant Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Children and Adults with Coeliac Disease	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; PERIPHERAL-BLOOD; INTRAEPITHELIAL LYMPHOCYTES; AUTOIMMUNE DISORDERS; CYTOKINE SECRETION; GENE-EXPRESSION; ALPHA-BETA; NKT CELLS; TCR; INFECTION	Coeliac disease is a chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed individuals. The only current therapy is a lifelong gluten free diet. While much work has focused on the gliadin-specific adaptive immune response in coeliac disease, little is understood about the involvement of the innate immune system. Here we used multi-colour flow cytometry to determine the number and frequency of gamma delta T cells (V delta 1, V delta 2 and V delta 3 subsets), natural killer cells, CD56(+) T cells, invariant NKT cells, and mucosal associated invariant T cells, in blood and duodenum from adults and children with coeliac disease and healthy matched controls. All circulating innate lymphocyte populations were significantly decreased in adult, but not paediatric coeliac donors, when compared with healthy controls. Within the normal small intestine, we noted that V delta 3 cells were the most abundant gamma delta T cell type in the adult epithelium and lamina propria, and in the paediatric lamina propria. In contrast, patients with coeliac disease showed skewing toward a predominant V delta 1 profile, observed for both adult and paediatric coeliac disease cohorts, particularly within the gut epithelium. This was concurrent with decreases in all other gut lymphocyte subsets, suggesting a specific involvement of V delta 1 cells in coeliac disease pathogenesis. Further analysis showed that gamma delta T cells isolated from the coeliac gut display an activated, effector memory phenotype, and retain the ability to rapidly respond to in vitro stimulation. A profound loss of CD56 expression in all lymphocyte populations was noted in the coeliac gut. These findings demonstrate a sustained aberrant innate lymphocyte profile in coeliac disease patients of all ages, persisting even after elimination of gluten from the diet. This may lead to impaired immunity, and could potentially account for the increased incidence of autoimmune co-morbidity.	[Dunne, Margaret R.; Elliott, Louise; Mahmud, Nasir; Doherty, Derek G.; Feighery, Conleth F.] St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland; [Dunne, Margaret R.; Elliott, Louise; Mahmud, Nasir; Doherty, Derek G.; Feighery, Conleth F.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Dunne, Margaret R.; Hussey, Seamus; Kelly, Jacinta] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Hussey, Seamus] Our Ladys Childrens Hosp, Natl Ctr Paediat Gastroenterol Hepatol & Nutr, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Dunne, MR (corresponding author), St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland.	dunnem12@tcd.ie	Hussey, Séamus/F-8810-2015; Dunne, Margaret/AAE-9152-2020	Hussey, Séamus/0000-0002-9362-0465; Dunne, Margaret/0000-0002-2816-5064; Doherty, Derek/0000-0002-4394-658X	Children's Medical Research Foundation; Our Lady's Children's Hospital Crumlin; St. James's Hospital	Children's Medical Research Foundation; Our Lady's Children's Hospital Crumlin; St. James's Hospital	Sources of funding: The Children's Medical Research Foundation, Our Lady's Children's Hospital Crumlin and St. James's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BUCHT A, 1995, CLIN EXP IMMUNOL, V99, P57; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; Cianci R, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.22; Cohavy O, 2007, J IMMUNOL, V178, P5524, DOI 10.4049/jimmunol.178.9.5524; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; De Rosa SC, 2001, J LEUKOCYTE BIOL, V70, P518; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; DELIBERO G, 1993, EUR J IMMUNOL, V23, P499, DOI 10.1002/eji.1830230230; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Ellis HJ, 2003, GUT, V52, P212, DOI 10.1136/gut.52.2.212; FALK MC, 1994, CLIN EXP IMMUNOL, V98, P78; FARSTAD IN, 1993, SCAND J IMMUNOL, V38, P451, DOI 10.1111/j.1365-3083.1993.tb02587.x; Fasano A, 2006, CURR OPIN GASTROEN, V22, P674, DOI 10.1097/01.mog.0000245543.72537.9e; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; GIACOMELLI R, 1994, CLIN EXP IMMUNOL, V98, P83; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Grose RH, 2007, GUT, V56, P790, DOI 10.1136/gut.2006.095307; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; HALSTENSEN TS, 1995, ADV EXP MED BIOL, V371, P1333; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kerttula TO, 1998, CLIN EXP IMMUNOL, V111, P536; KERTTULA TO, 1995, IMMUNOLOGY, V86, P104; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kress E, 2006, MOL IMMUNOL, V43, P2002, DOI 10.1016/j.molimm.2005.11.011; Kuhl AA, 2009, IMMUNOLOGY, V128, P580, DOI 10.1111/j.1365-2567.2009.03162.x; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Li JQ, 2005, CELL MOL IMMUNOL, V2, P253; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; Mangan BA, 2013, J IMMUNOL, V191, P30, DOI 10.4049/jimmunol.1300121; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; PEYRAT MA, 1995, J IMMUNOL, V155, P3060; RUST C, 1992, SCAND J IMMUNOL, V35, P459, DOI 10.1111/j.1365-3083.1992.tb02881.x; SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005; Soderstrom K, 1996, J IMMUNOL, V156, P2331; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; TREJDOSIEWICZ LK, 1991, CLIN EXP IMMUNOL, V84, P440; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verbeek WHM, 2008, AM J GASTROENTEROL, V103, P3152, DOI 10.1111/j.1572-0241.2008.02213.x; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zeissig S, 2007, AM J PHYSIOL-GASTR L, V293, pG1101, DOI 10.1152/ajpgi.00342.2007	53	83	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76008	10.1371/journal.pone.0076008	http://dx.doi.org/10.1371/journal.pone.0076008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124528	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100085
J	Farkas, I; Vastagh, C; Sarvari, M; Liposits, Z				Farkas, Imre; Vastagh, Csaba; Sarvari, Miklos; Liposits, Zsolt			Ghrelin Decreases Firing Activity of Gonadotropin-Releasing Hormone (GnRH) Neurons in an Estrous Cycle and Endocannabinoid Signaling Dependent Manner	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA EXPRESSION; GAMMA-AMINOBUTYRIC-ACID; LUTEINIZING-HORMONE; GROWTH-HORMONE; ACYLATED PEPTIDE; GABAERGIC TRANSMISSION; UNACYLATED GHRELIN; MULTIUNIT ACTIVITY; PULSE-GENERATOR	The orexigenic peptide, ghrelin is known to influence function of GnRH neurons, however, the direct effects of the hormone upon these neurons have not been explored, yet. The present study was undertaken to reveal expression of growth hormone secretagogue receptor (GHS-R) in GnRH neurons and elucidate the mechanisms of ghrelin actions upon them. Ca2+-imaging revealed a ghrelin-triggered increase of the Ca2+-content in GT1-7 neurons kept in a steroid-free medium, which was abolished by GHS-R-antagonist JMV2959 (10 mu M) suggesting direct action of ghrelin. Estradiol (1nM) eliminated the ghrelin-evoked rise of Ca2+-content, indicating the estradiol dependency of the process. Expression of GHS-R mRNA was then confirmed in GnRH-GFP neurons of transgenic mice by single cell RT-PCR. Firing rate and burst frequency of GnRH-GFP neurons were lower in metestrous than proestrous mice. Ghrelin (40nM-4 mu M) administration resulted in a decreased firing rate and burst frequency of GnRH neurons in metestrous, but not in proestrous mice. Ghrelin also decreased the firing rate of GnRH neurons in males. The ghrelin-evoked alterations of the firing parameters were prevented by JMV2959, supporting the receptor-specific actions of ghrelin on GnRH neurons. In metestrous mice, ghrelin decreased the frequency of GABAergic mPSCs in GnRH neurons. Effects of ghrelin were abolished by the cannabinoid receptor type-1 (CB1) antagonist AM251 (1 mu M) and the intracellularly applied DAG-lipase inhibitor THL (10 mu M), indicating the involvement of retrograde endocannabinoid signaling. These findings demonstrate that ghrelin exerts direct regulatory effects on GnRH neurons via GHS-R, and modulates the firing of GnRH neurons in an ovarian-cycle and endocannabinoid dependent manner.	[Farkas, Imre; Vastagh, Csaba; Sarvari, Miklos; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Farkas, I (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	farkas.imre@koki.mta.hu	Liposits, Zsolt/K-8145-2019	Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K100722]; National Development Agency of Hungary [NFU-BONUS-HU08/2-2011-0006]; European Community [245009]	National Science Foundation of Hungary; National Development Agency of Hungary; European Community(European Commission)	This research was supported by the National Science Foundation of Hungary (OTKA K100722) and the National Development Agency of Hungary (NFU-BONUS-HU08/2-2011-0006). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Banks WA, 2012, ANN NY ACAD SCI, V1264, P13, DOI 10.1111/j.1749-6632.2012.06568.x; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bosch MA, 2013, MOL CELL ENDOCRINOL, V367, P85, DOI 10.1016/j.mce.2012.12.021; Bramley JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022721; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Castellano JM, 2010, BRAIN RES, V1364, P129, DOI 10.1016/j.brainres.2010.08.057; Chen PL, 2009, J NEUROSCI, V29, P9809, DOI 10.1523/JNEUROSCI.2509-09.2009; Christian CA, 2005, P NATL ACAD SCI USA, V102, P15682, DOI 10.1073/pnas.0504270102; Christian CA, 2007, J NEUROSCI, V27, P1913, DOI 10.1523/JNEUROSCI.4738-06.2007; Chu Z, 2012, J NEUROENDOCRINOL, V24, P1065, DOI 10.1111/j.1365-2826.2012.02313.x; Chu ZG, 2005, J NEUROSCI, V25, P5740, DOI 10.1523/JNEUROSCI.0913-05.2005; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Constantin S, 2012, ENDOCRINOLOGY, V153, P3758, DOI 10.1210/en.2012-1126; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Farkas I, 2010, ENDOCRINOLOGY, V151, P5818, DOI 10.1210/en.2010-0638; Fernandez-Fernandez R, 2007, REPRODUCTION, V133, P1223, DOI 10.1530/REP-06-0227; Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753; Forbes S, 2009, NEUROSCI LETT, V460, P143, DOI 10.1016/j.neulet.2009.05.060; Garcia-Galiano D, 2012, AM J PHYSIOL-ENDOC M, V303, pE1252, DOI 10.1152/ajpendo.00250.2012; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Glanowska KM, 2011, J NEUROPHYSIOL, V106, P3073, DOI 10.1152/jn.00046.2011; Halem HA, 2005, NEUROENDOCRINOLOGY, V81, P339, DOI 10.1159/000088796; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; Herbison AE, 2009, J PHYSIOL-LONDON, V587, P5025, DOI 10.1113/jphysiol.2009.179838; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Himmerich H, 2010, J PSYCHIATR PRACT, V16, P82, DOI 10.1097/01.pra.0000369969.87779.1c; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hrabovszky E, 2000, ENDOCRINOLOGY, V141, P3506, DOI 10.1210/en.141.9.3506; Hrabovszky E, 2001, ENDOCRINOLOGY, V142, P3261, DOI 10.1210/en.142.7.3261; Jasoni CL, 2007, J NEUROSCI, V27, P860, DOI 10.1523/JNEUROSCI.3579-06.2007; Jasoni CL, 2005, NEUROENDOCRINOLOGY, V82, P320, DOI 10.1159/000093155; KIMURA F, 1991, NEUROENDOCRINOLOGY, V53, P97, DOI 10.1159/000125704; Kluge M, 2007, J CLIN ENDOCR METAB, V92, P3202, DOI 10.1210/jc.2007-0593; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Lanfranco F, 2008, J CLIN ENDOCR METAB, V93, P3633, DOI 10.1210/jc.2008-0049; Lanfranco F, 2010, FRONT HORM RES, V38, P206, DOI 10.1159/000318512; Lebrethon MC, 2007, J NEUROENDOCRINOL, V19, P181, DOI 10.1111/j.1365-2826.2006.01518.x; Lee K, 2012, J NEUROENDOCRINOL, V24, P1476, DOI 10.1111/j.1365-2826.2012.02360.x; Lim CT, 2013, MOL CELL ENDOCRINOL, V365, P303, DOI 10.1016/j.mce.2012.11.007; Maletinska L, 2011, MOL CELL ENDOCRINOL, V343, P55, DOI 10.1016/j.mce.2011.06.006; MARTIN GB, 1987, EXP BRAIN RES, V67, P469; Martini AC, 2006, ENDOCRINOLOGY, V147, P2374, DOI 10.1210/en.2005-1422; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Mircea CN, 2007, J OBSTET GYNAECOL CA, V29, P887, DOI 10.1016/S1701-2163(16)32661-5; Moenter SM, 2005, ENDOCRINOLOGY, V146, P5374, DOI 10.1210/en.2005-0788; Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X; Moenter SM, 2010, BRAIN RES, V1364, P10, DOI 10.1016/j.brainres.2010.09.066; MORI Y, 1991, NEUROENDOCRINOLOGY, V53, P392, DOI 10.1159/000125746; Murakami N, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740283; Nakahara T, 2007, J PSYCHIATR RES, V41, P814, DOI 10.1016/j.jpsychires.2006.07.021; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Nunemaker CS, 2003, ENDOCRINOLOGY, V144, P823, DOI 10.1210/en.2002-220585; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Repaci A, 2011, MOL CELL ENDOCRINOL, V340, P70, DOI 10.1016/j.mce.2011.02.022; Romano N, 2008, ENDOCRINOLOGY, V149, P5335, DOI 10.1210/en.2008-0424; Romano N, 2012, J NEUROENDOCRINOL, V24, P1296, DOI 10.1111/j.1365-2826.2012.02342.x; Ronnekleiv OK, 2012, J NEUROENDOCRINOL, V24, P122, DOI 10.1111/j.1365-2826.2011.02160.x; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Sullivan SD, 2003, J NEUROSCI, V23, P8578; Suter KJ, 2000, ENDOCRINOLOGY, V141, P3731, DOI 10.1210/en.141.10.3731; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; TASKER JG, 1993, J PHYSIOL-LONDON, V469, P179, DOI 10.1113/jphysiol.1993.sp019810; Tena-Sempere M, 2008, VITAM HORM, V77, P285, DOI 10.1016/S0083-6729(06)77012-1; Terasawa E, 2012, FRONT NEUROENDOCRIN, V33, P364, DOI 10.1016/j.yfrne.2012.08.001; THIERY JC, 1981, NEUROENDOCRINOLOGY, V32, P217, DOI 10.1159/000123162; Usdan Lisa S, 2008, Endocr Pract, V14, P1055; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; Watterson KR, 2013, NEUROSIGNALS, V21, P28, DOI 10.1159/000334144; WILSON RC, 1984, NEUROENDOCRINOLOGY, V39, P256, DOI 10.1159/000123988; Yin C, 2008, J NEUROENDOCRINOL, V20, P566, DOI 10.1111/j.1365-2826.2008.01697.x; Zhang C, 2007, J NEUROSCI, V27, P10153, DOI 10.1523/JNEUROSCI.1657-07.2007; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	92	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e78178	10.1371/journal.pone.0078178	http://dx.doi.org/10.1371/journal.pone.0078178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124622	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325489100180
J	Kroezen, M; van Dijk, L; Groenewegen, PP; Francke, AL				Kroezen, Marieke; van Dijk, Liset; Groenewegen, Peter P.; Francke, Anneke L.			Knowledge Claims, Jurisdictional Control and Professional Status: The Case of Nurse Prescribing	PLOS ONE			English	Article							ANGLO-SAXON COUNTRIES; HEALTH-CARE WORKFORCE; LEGITIMACY CLAIMS; WORKPLACE; PERSPECTIVES; MEDICINES; ORDER; POWER	Over the past decades, professional boundaries in health care have come under pressure, and the expansion of prescriptive authority to include nurses touches on issues of professional domains and interprofessional competition. Knowledge claims play an important role in achieving jurisdictional control. Knowledge can take on multiple forms, ranging from indeterminate to technical (I/T ratio) and from everyday to exclusive knowledge. To investigate the interrelatedness of jurisdiction, knowledge claims and professional status, we examine which knowledge claims were made by the medical and nursing professions in the Netherlands to secure or obtain, respectively, jurisdictional control over prescribing, and which form this knowledge took. The study is based on thirteen semi-structured stakeholder interviews and an extensive document analysis. We found that the nursing profession in its knowledge claims strongly emphasized the technicality and everyday knowledge character of the prescribing task, by asserting that nurses were already prescribing medicines, albeit on an illegal basis. Their second claim focused on the indeterminate knowledge skills of nurses and stated that nurse prescribing would do justice to nurses' skills and expertise. This is a strong claim in a quest for (higher) professional status. Results showed that the medical profession initially proclaimed that prescribing should be reserved for doctors as it is a task requiring medical knowledge, i.e. indeterminate knowledge. Gradually, however, the medical profession adjusted its claims and tried to reduce nurse prescribing to a task almost exclusively based on technicality knowledge, among others by stating that nurses could prescribe in routine cases, which would generate little professional status. By investigating the form that professional knowledge claims took, this study was able to show the interconnectedness of jurisdictional control, knowledge claims and professional status. Knowledge claims are not mere rhetoric, but actively influence the everyday realities of professional status, interprofessional competition and jurisdictional division between professions.	[Kroezen, Marieke; van Dijk, Liset; Groenewegen, Peter P.; Francke, Anneke L.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Groenewegen, Peter P.] Univ Utrecht, Dept Sociol, Utrecht, Netherlands; [Groenewegen, Peter P.] Univ Utrecht, Dept Human Geog, Utrecht, Netherlands; [Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res EMGO, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Utrecht University; Utrecht University; Vrije Universiteit Amsterdam	Kroezen, M (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	M.Kroezen@nivel.nl		Groenewegen, Peter/0000-0003-2127-8442	Dutch Ministry of Education, Culture and Science	Dutch Ministry of Education, Culture and Science	This study was funded by a grant to NIVEL from the Dutch Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts J, 2009, HEALTH AFFAIR, V28, P404, DOI 10.1377/hlthaff.28.2.404; Abbott A., 1988, SYSTEM PROFESSIONS E; ADAMSON BJ, 1995, J ADV NURS, V21, P172, DOI 10.1046/j.1365-2648.1995.21010172.x; Allen D, 1997, SOCIOL HEALTH ILL, V19, P498; [Anonymous], 2009, REACT KNMG EV WET BI; Apesoa-Varano EC, 2011, QUAL HEALTH RES, V21, P1469, DOI 10.1177/1049732311412788; Associatie van Eerste, 2007, EADV MAGAZINE, V22, P27; Associatie van Eerste, 2006, EADV MAGAZINE, V2, P94; Ball J., 2009, IMPLEMENTING NURSE P; Bechky BA, 2003, AM J SOCIOL, V109, P720, DOI 10.1086/379527; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; BUCKLEY P, 2006, PHARM J, V277, P394; Cooper R, 2008, J AMBUL CARE MANAG, V31, P244, DOI 10.1097/01.JAC.0000324670.91153.b4; Drennan J., 2009, NATL INDEPENDENT EVA; Fisher R, 2010, INT J NURS PRACT, V16, P579, DOI 10.1111/j.1440-172X.2010.01884.x; Freidson E., 1988, PROFESSION MED STUDY; Gerrish Kate, 2003, Nurs Inq, V10, P103, DOI 10.1046/j.1440-1800.2003.00168.x; Glucksmann MA, 2009, SOCIOLOGY, V43, P878, DOI 10.1177/0038038509340727; Goundrey-Smith S., 2008, PRINCIPLES ELECT PRE, P119; Green J., 2018, QUALITATIVE METHODS, VFourth; Hendriks AC, 2011, MEDISCH CONTACT, V66, P555; Hirschkorn KA, 2006, SOCIOL HEALTH ILL, V28, P533, DOI 10.1111/j.1467-9566.2006.00506.x; Huisartsen Vereniging Landelijke, 2010, LHV BEZW TEG VOORSCH, P8; Implementatie Commissie Opleidingscontinuum en Taakherschikking, 2003, ZORG MORG FLEX SAM C; Jamous H., 1970, PROFESSIONS PROFESSI; Kaljouw M, 2010, NRC HANDELSBLAD; Kennedy J, 2002, WELOVERWOGEN DOOD; Koninklijke, 2011, NED MAATSCH BEV GEN; Koninklijke, 2006, MEDISCH CONTACT, V18, P728; Koninklijke, 2006, MEDISCH CONTACT, V18, P761; Kroezen M, 2012, INT J NURS STUD, V49, P1002, DOI 10.1016/j.ijnurstu.2012.02.002; Kroezen M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-127; Lewis R, 2001, NURSE LED PRIMARY CA; MAXQDA, 2007, VERBI SOFTW; McCann T V, 2002, J Psychiatr Ment Health Nurs, V9, P175, DOI 10.1046/j.1365-2850.2002.00454.x; Mclaughlin J, 1998, SOCIOL REV, V46, P781, DOI 10.1111/1467-954X.00140; Nancarrow SA, 2005, SOCIOL HEALTH ILL, V27, P897, DOI 10.1111/j.1467-9566.2005.00463.x; NILSSON M, 1994, LANCET, V344, P1077; Pickard S, 2009, SOCIOLOGY, V43, P250, DOI 10.1177/0038038508101164; Plonczynski D, 2003, NURSE PRESCRIBING, V1, P170; PORTER S, 1992, J ADV NURS, V17, P720, DOI 10.1111/j.1365-2648.1992.tb01970.x; Raadvoor de Volksgezondheid en Zorg, 2002, TAAKH GEZ; Reed MI, 1996, ORGAN STUD, V17, P573, DOI 10.1177/017084069601700402; Sanders T, 2008, SOCIOL HEALTH ILL, V30, P289, DOI 10.1111/j.1467-9566.2007.01052.x; Snelgrove S, 2000, J ADV NURS, V31, P661, DOI 10.1046/j.1365-2648.2000.01321.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Traynor M, 2010, SOC SCI MED, V71, P1506, DOI 10.1016/j.socscimed.2010.07.029; Van der Peet R, 2010, TIJDSCHRIFT VERPLEEG, V120, P45; Van der Peet R., 2010, TIJDSCHRIFT VERPLEEG, V120, P50; Van Meersbergen W., 2011, WORLD MED J, V57, P126; van Volksgezondheid Ministerie WeS, 2012, MEVABOA3109304 VOLKS; Verpleegkundigen Verzorgenden. Nederland, 2013, VOORSCHR VERPL JAN 2	52	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77279	10.1371/journal.pone.0077279	http://dx.doi.org/10.1371/journal.pone.0077279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124613	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100170
J	Sapoznikov, D; Elhalel, MD; Rubinger, D				Sapoznikov, Dan; Elhalel, Michal Dranitzki; Rubinger, Dvora			Heart Rate Response to Blood Pressure Variations: Sympathetic Activation versus Baroreflex Response in Patients with End-Stage Renal Disease	PLOS ONE			English	Article							FEEDFORWARD NEURAL REGULATION; SPONTANEOUS ARTERIAL-PRESSURE; NERVE ACTIVITY; TRANSPLANT PATIENTS; RATE FLUCTUATIONS; CONSCIOUS RATS; SENSITIVITY; HUMANS; HYPERTENSION; CALCINEURIN	Background: Continuous systolic blood pressure (SBP) and interbeat intervals (IBI) recordings reveal sequences of consecutive beats in which SBP and heart rate change in opposite direction, representing negative feedback baroreflex mechanisms, as well as sequences in which SBP and heart rate change in the same direction (non-baroreflex), believed to represent feedforward control mechanisms. The present study was undertaken to assess the relationship between baroreflex and non-baroreflex sequences in end stage renal insufficiency. Methodology/Principal Findings: Continuous beat-to-beat SBP and IBI monitoring was performed in patients on chronic hemodialysis (HD, n=72), in age-matched patients after renal transplantation (TX, n=41) and healthy (control) individuals (C, n=34). The proportion of baroreflex and nonbaroreflex episodes and the b coefficients (the regression line slope of SBP-IBI correlation) were determined using a newly developed 1 minute sliding window method, the classical sequence technique and the "Z" coefficient method. Analysis using the 1 minute sliding window showed an increased proportion of baroreflex episodes in controls and HD, and predominance of nonbaroreflex episodes in TX. An increased proportion of nonbaroreflex episodes in TX patients relative to HD was also revealed by the "Z" method. Baroreflex and nonbaroreflex b coefficients obtained by all methods were markedly decreased in HD. This alteration was reversed at least partly in TX. In HD, both baroreflex and nonbaroreflex b coefficients were inversely correlated to age and CRP levels; in TX, the nonbaroreflex b coefficient was influenced by the type of calcineurin inhibitor. Conclusion/Significance: Renal status affects the contribution of baroreflex and nonbaroreflex mechanisms and the strength of SBP-IBI relationship. The predominant contribution of nonbaroreflex mechanisms in TX may be suggestive of enhanced central sympathetic control. Our data may be relevant for understanding of the pathogenesis and selection of appropriate treatment of post-transplant hypertension.	[Rubinger, Dvora] Hadassah Hebrew Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Dept Med, Hypertens Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rubinger, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel.	rdvora@hadassah.org.il						Castiglioni P, 2011, J ELECTROCARDIOL, V44, P391, DOI 10.1016/j.jelectrocard.2011.01.006; CHAPLEAU MW, 1987, CIRC RES, V61, P648, DOI 10.1161/01.RES.61.5.648; Dampney RAL, 2002, CLIN EXP PHARMACOL P, V29, P261, DOI 10.1046/j.1440-1681.2002.03640.x; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; DUCHER M, 1995, CLIN SCI, V88, P651, DOI 10.1042/cs0880651; DUCHER M, 1994, MED BIOL ENG COMPUT, V32, P649, DOI 10.1007/BF02524241; GUZZETTI S, 1988, J HYPERTENS, V6, P711, DOI 10.1097/00004872-198809000-00004; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; Hausberg M, 2006, J HYPERTENS, V24, P957, DOI 10.1097/01.hjh.0000222767.15100.e4; Iellamo F, 1996, J HYPERTENS, V14, P1099; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kamiya A, 2011, J PHYSIOL-LONDON, V589, P1769, DOI 10.1113/jphysiol.2011.203455; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P425, DOI 10.1097/01.ASN.0000045049.72965.B7; Klein IHHT, 2010, J HYPERTENS, V28, P1928, DOI 10.1097/HJH.0b013e32833c20eb; Kosch M, 2002, J HYPERTENS, V20, P501, DOI 10.1097/00004872-200203000-00026; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Legramante JM, 2009, AM J PHYSIOL-HEART C, V296, pH202, DOI 10.1152/ajpheart.00358.2008; Legramante JM, 1999, CIRCULATION, V99, P1760, DOI 10.1161/01.CIR.99.13.1760; Legramante JM, 2001, CIRCULATION, V103, P1250; Luft FC, 2012, NEPHROL DIAL TRANSPL, V27, P473, DOI 10.1093/ndt/gfr679; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Nollo G, 2005, AM J PHYSIOL-HEART C, V288, pH1777, DOI 10.1152/ajpheart.00594.2004; PAGANI M, 1982, CIRC RES, V50, P125, DOI 10.1161/01.RES.50.1.125; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Penaz, 1973, P 10 INT C MED BIOL; Persson PB, 2001, J HYPERTENS, V19, P1699, DOI 10.1097/00004872-200110000-00001; Reyes-Bahamonde J, 2013, SEMIN DIALYSIS, V26, P31, DOI 10.1111/sdi.12024; Rubinger D, 2012, ASN KIDNEY WEEK; Rubinger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036943; Rubinger D, 2009, NEPHROL DIAL TRANSPL, V24, P1305, DOI 10.1093/ndt/gfn732; Schlaich MP, 2010, J HYPERTENS, V28, P1809, DOI 10.1097/HJH.0b013e32833e0e74; Silvani A, 2008, AM J PHYSIOL-REG I, V294, pR1686, DOI 10.1152/ajpregu.00756.2007; Silvani A, 2011, AUTON NEUROSCI-BASIC, V162, P66, DOI 10.1016/j.autneu.2011.04.003; Velez-Roa S, 2004, NEPHROL DIAL TRANSPL, V19, P1606, DOI 10.1093/ndt/gfh124; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; WESSELING KH, 1995, HOMEOSTASIS HLTH DIS, V36, P67; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	38	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e78338	10.1371/journal.pone.0078338	http://dx.doi.org/10.1371/journal.pone.0078338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124623	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100181
J	Sehr, P; Rubio, I; Seitz, H; Putzker, K; Ribeiro-Muller, L; Pawlita, M; Muller, M				Sehr, Peter; Rubio, Ivonne; Seitz, Hanna; Putzker, Kerstin; Ribeiro-Mueller, Lis; Pawlita, Michael; Mueller, Martin			High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CERVICAL INTRAEPITHELIAL NEOPLASIA; POPULATION-BASED COHORT; VIRUS-LIKE PARTICLES; SENSITIVE MEASURE; COSTA-RICA; HPV; L1; CANCER; WOMEN	A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assay (HT-PBNA) with excellent repeatability and run-to-run reproducibility was developed for human papillomavirus types (HPV) 16, 18, 31, 45, 52, 58 and bovine papillomavirus type 1. Preparation of 384 well assay plates with serially diluted sera and the actual cell-based assay are separated in time, therefore batches of up to one hundred assay plates can be processed sequentially. A mean coefficient of variation (CV) of 13% was obtained for anti-HPV 16 and HPV 18 titers for a standard serum tested in a total of 58 repeats on individual plates in seven independent runs. Natural antibody response was analyzed in 35 sera from patients with HPV 16 DNA positive cervical intraepithelial neoplasia grade 2+ lesions. The new HT-PBNA is based on Gaussia luciferase with increased sensitivity compared to the previously described manual PBNA (manPBNA) based on secreted alkaline phosphatase as reporter. Titers obtained with HT-PBNA were generally higher than titers obtained with the manPBNA. A good linear correlation (R-2 = 0.7) was found between HT-PBNA titers and anti-HPV 16 L1 antibody-levels determined by a Luminex bead-based GST-capture assay for these 35 sera and a Kappa-value of 0.72, with only 3 discordant sera in the low titer range. In addition to natural low titer antibody responses the high sensitivity of the HT-PBNA also allows detection of cross-neutralizing antibodies induced by commercial HPV L1-vaccines and experimental L2-vaccines. When analyzing the WHO international standards for HPV 16 and 18 we determined an analytical sensitivity of 0.864 and 1.105 mIU, respectively.	[Sehr, Peter; Putzker, Kerstin] European Mol Biol Lab, EMBL DKFZ Chem Biol Core Facil, D-69012 Heidelberg, Germany; [Rubio, Ivonne; Seitz, Hanna; Ribeiro-Mueller, Lis; Pawlita, Michael; Mueller, Martin] German Canc Res Ctr, Infect & Canc Program, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Muller, M (corresponding author), German Canc Res Ctr, Infect & Canc Program, Heidelberg, Germany.	Martin.mueller@dkfz.de	Waterboer, Tim/G-1252-2010	Putzker, Kerstin/0000-0001-8375-5908; Sehr, Peter/0000-0002-4348-5066; Pawlita, Michael/0000-0002-4720-8306	German Cancer Research Center	German Cancer Research Center(Helmholtz Association)	Funding from the German Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2007, CURR PROTOC CELL BIO; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; CHRISTENSEN ND, 1990, J VIROL, V64, P3151, DOI 10.1128/JVI.64.7.3151-3156.1990; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dianna E., 2012, COLLABORATIVE STUDY, V18; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Ferguson M, 2011, VACCINE, V29, P6520, DOI 10.1016/j.vaccine.2011.07.007; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Gissmann L, 2009, ARCH MED RES, V40, P466, DOI 10.1016/j.arcmed.2009.07.002; IARC Biological Agents, 2011, IARC MON EV CARC RIS, V100B, P255; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kaufmann AM, 2007, INT J CANCER, V121, P2794, DOI 10.1002/ijc.23022; Kawana K, 1998, J VIROL, V72, P10298, DOI 10.1128/JVI.72.12.10298-10300.1998; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; RODEN RBS, 1995, J VIROL, V69, P5147, DOI 10.1128/JVI.69.8.5147-5151.1995; RODEN RBS, 1994, J VIROL, V68, P7570, DOI 10.1128/JVI.68.11.7570-7574.1994; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Schiller JT, 2010, ANNU REV MICROBIOL, V64, P23, DOI 10.1146/annurev.micro.112408.134019; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Wang Qing-yong, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P584; Wang SS, 2004, BRIT J CANCER, V91, P1269, DOI 10.1038/sj.bjc.6602088; Wang SS, 2003, BRIT J CANCER, V89, P1248, DOI 10.1038/sj.bjc.6601272; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; Yeager MD, 2000, VIROLOGY, V278, P570, DOI 10.1006/viro.2000.0674; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	42	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75677	10.1371/journal.pone.0075677	http://dx.doi.org/10.1371/journal.pone.0075677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124504	gold, Green Published, Green Submitted			2022-12-25	WOS:000325489100061
J	Sun, ZJ; Zhang, L; Zhang, W; Hall, B; Bian, YS; Kulkarni, AB				Sun, Zhi-jun; Zhang, Lu; Zhang, Wei; Hall, Bradford; Bian, Yansong; Kulkarni, Ashok B.			Inhibition of mTOR Reduces Anal Carcinogenesis in Transgenic Mouse Model	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TGF-BETA; CANCER; HEAD; NECK; GROWTH; PATHWAY; PTEN; INFLAMMATION; ACTIVATION	The molecular mechanism of human anal squamous cell carcinoma (ASCC) is unclear, and the accumulating evidence indicate association of ASCC with the activation of the Akt/mTOR pathway. Here we describe a mouse model with spontaneous anal squamous cell cancer, wherein a combined deletion of Tgfbr1 and Pten in stratified squamous epithelia was induced using inducible K14-Cre. Histopathologic analyses confirmed that 33.3% of the mice showed increased susceptibility to ASCC and precancerous lesions. Biomarker analyses demonstrated that the activation of the Akt pathway in ASCC of the Tgfbr1 and Pten double knockout (2cKO) mouse was similar to that observed in human anal cancer. Chemopreventive experiments using mTOR inhibitor-rapamycin treatment significantly delayed the onset of the ASCC tumors and reduced the tumor burden in 2cKO mice by decreasing the phosphorylation of Akt and S6. This is the first conditional knockout mouse model used for investigating the contributions of viral and cellular factors in anal carcinogenesis without carcinogen-mediated induction, and it would provide a platform for assessing new therapeutic modalities for treating and/or preventing this type of cancer.	[Sun, Zhi-jun; Zhang, Lu; Zhang, Wei] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Sun, Zhi-jun; Zhang, Lu; Zhang, Wei] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Sun, Zhi-jun; Zhang, Lu; Hall, Bradford; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Bian, Yansong] Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, NIH, Bethesda, MD USA	Wuhan University; Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Sun, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	zhijundejia@163.com; ak40m@nih.gov	Sun, Zhi-Jun/AAD-8791-2022	Sun, Zhi-Jun/0000-0003-0932-8013	National Institute of Dental and Craniofacial Research, NIH [ZIA-DE-000698]; National Natural Science Foundation of China [81072203, 81272963, 81371106]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000723, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000698] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Intramural Research Programs ZIA-DE-000698 (ABK) of the National Institute of Dental and Craniofacial Research, NIH, and National Natural Science Foundation of China 81072203, 81272963 (ZJS) and 81371106 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Cress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diaz-Chavez J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-3; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Honjo Y, 2007, CELL CYCLE, V6, P1360, DOI 10.4161/cc.6.11.4268; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Lee JH, 2012, EUR J IMMUNOL, V42, P2683, DOI 10.1002/eji.201142317; Liang CH, 2012, CANCER RES, V72, P5004, DOI 10.1158/0008-5472.CAN-11-3277; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mitsuishi T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-118; Patel H, 2007, INT J CANCER, V121, P2668, DOI 10.1002/ijc.23028; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Snietura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033396; Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228; Stelzer MK, 2010, CANCER PREV RES, V3, P1534, DOI 10.1158/1940-6207.CAPR-10-0086; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Szmulowicz UM, 2012, SEX HEALTH, V9, P593, DOI 10.1071/SH12010; Thomas MK, 2011, VIROLOGY, V421, P114, DOI 10.1016/j.virol.2011.09.018; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74888	10.1371/journal.pone.0074888	http://dx.doi.org/10.1371/journal.pone.0074888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124460	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100017
J	Witkiewicz, AK; Cox, DW; Rivadeneira, D; Ertel, AE; Fortina, P; Schwartz, GF; Knudsen, ES				Witkiewicz, A. K.; Cox, D. W.; Rivadeneira, D.; Ertel, A. E.; Fortina, P.; Schwartz, G. F.; Knudsen, E. S.			The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer	ONCOGENE			English	Article						tumor suppressor; epithelial-to-mesenchymal transition; cyclin-dependent kinase; cell cycle; E2F; CDK4/6; PD-0332991	CARCINOMA IN-SITU; GENE AMPLIFICATION; BASAL-LIKE; LUMINAL-B; HER-2 NEU; EXPRESSION; RB; MORPHOGENESIS; PROGRESSION; INHIBITION	The processes that control the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer remain poorly understood. Epidermal growth factor receptor 2 (ErbB2) overexpression is common in DCIS, as is disruption of the retinoblastoma tumor suppressor (RB) pathway. Here, we examined the cooperative impact of ErbB2 and RB deregulation on facets of disease progression. Our studies demonstrate that RB deficiency altered the expression of key molecules needed for proper cellular organization and epithelial cell-cell adhesion as part of a program related to the epithelial-to-mesenchymal transition (EMT). An increase in the invasive potential of ErbB2-overexpressing cells was observed upon RB depletion. Further, stable knockdown of RB resulted in invasive lesions in orthotopic xenograft assays, compared with DCIS-like lesions developing from RB-proficient cells. Conversely, the invasive phenotype observed in ErbB2-positive cancer models was inhibited through CDK4/6 inhibition in an RB-dependent manner. Finally, in a cohort of DCIS cases, we show that, although elevated levels of ErbB2 are associated with increased risk of a subsequent DCIS recurrence, it is not associated with progression to invasive disease. In contrast, RB loss in ErbB2-positive DCIS cases was associated with increased risk for invasive breast cancer. Taken together, these data demonstrate a key role for the RB pathway in invasion associated with breast tumor progression, and shed light on the key molecular events that promote the progression of DCIS to invasive disease.	[Witkiewicz, A. K.; Cox, D. W.; Knudsen, E. S.] UT Southwest Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Witkiewicz, A. K.; Knudsen, E. S.] UT Southwest Med Ctr, Simmons Canc Ctr, Dallas, TX USA; [Rivadeneira, D.; Ertel, A. E.; Fortina, P.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA USA; [Schwartz, G. F.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA USA	Jefferson University; Jefferson University	Witkiewicz, AK (corresponding author), UT Southwest Med Ctr, Dept Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	agnes.witkiewicz@utsouthwestern.edu	Fortina, Paolo/ABE-8350-2020	Fortina, Paolo/0000-0002-5898-2081	NIH [RO1-CA129134, RO1-CA137494, RO1-CA163863]; NATIONAL CANCER INSTITUTE [R01CA129134, R01CA137494, R01CA163863, P30CA142543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all of our colleagues who contributed to this study. This work was supported by NIH grants to ESK (RO1-CA129134 and RO1-CA137494) and AKW (RO1-CA163863).	Allegra CJ, 2010, J NATL CANCER I, V102, P161, DOI 10.1093/jnci/djp485; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Correa C, 2010, J NATL CANC I MONOGR, V2010, P162, DOI [DOI 10.1093/JNCIMONOGRAPHS/LGQ039, DOI 10.1093/JNCIM0N0GRAPHS/LGQ039]; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hoque A, 2002, CANCER EPIDEM BIOMAR, V11, P587; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Jones JL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1397; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Kim YS, 2008, J KOREAN MED SCI, V23, P414, DOI 10.3346/jkms.2008.23.3.414; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2012, JNCI-J NATL CANCER I, V104, P1825, DOI 10.1093/jnci/djs446; Knudsen ES, 2012, BREAST CANCER RES TR, V133, P1009, DOI 10.1007/s10549-011-1894-3; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; McClendon AK, 2011, GASTROENTEROLOGY, V141, P1439, DOI 10.1053/j.gastro.2011.06.046; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Rakovitch E, 2012, BRIT J CANCER, V106, P1160, DOI 10.1038/bjc.2012.41; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Romero L, 2004, AM J SURG, V188, P371, DOI 10.1016/j.amjsurg.2004.06.034; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Schnitt Stuart J., 2010, Journal of the National Cancer Institute Monographs, P158, DOI 10.1093/jncimonographs/lgq031; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Witkiewicz AK, 2011, AM J PATHOL, V179, P1171, DOI 10.1016/j.ajpath.2011.05.043; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhurinsky J, 2000, J CELL SCI, V113, P3127	55	18	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3980	3991		10.1038/onc.2013.367	http://dx.doi.org/10.1038/onc.2013.367			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24121271	Green Accepted			2022-12-25	WOS:000339394700010
J	Deyev, IE; Mitrofanova, AV; Zhevlenev, ES; Radionov, N; Berchatova, AA; Popova, NV; Serova, OV; Petrenko, AG				Deyev, Igor E.; Mitrofanova, Alla V.; Zhevlenev, Egor S.; Radionov, Nikita; Berchatova, Anastasiya A.; Popova, Nadezhda V.; Serova, Oxana V.; Petrenko, Alexander G.			Structural Determinants of the Insulin Receptor-related Receptor Activation by Alkali	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Insulin; Membrane Proteins; Phosphorylation; Receptor Tyrosine Kinase; Site-directed Mutagenesis; Alkaline pH	ALANINE SCANNING MUTAGENESIS; EPIDERMAL-GROWTH-FACTOR; LIGAND-BINDING-SITE; TYROSINE KINASES; SPECIFICITY; FAMILY; SENSOR	IRR is a member of the insulin receptor (IR) family that does not have any known agonist of a peptide nature but can be activated by mildly alkaline medium and was thus proposed to function as an extracellular pH sensor. IRR activation by alkali is defined by its N-terminal extracellular region. To reveal key structural elements involved in alkali sensing, we developed an in vitro method to quantify activity of IRR and its mutants. Replacing the IRR L1C domains (residues 1-333) or L2 domain (residues 334-462) or both with the homologous fragments of IR reduced the receptor activity to 35, 64, and 7% percent, respectively. Within L1C domains, five amino acid residues (Leu-135, Gly-188, Arg-244, and vicinal His-318 and Lys-319) were identified as IRR-specific by species conservation analysis of the IR family. These residues are exposed and located in junctions between secondary structure folds. The quintuple mutation of these residues to alanine had the same negative effect as the entire L1C domain replacement, whereas none of the single mutations was as effective. Separate mutations of these five residues and of L2 produced partial negative effects that were additive. The pH dependence of cell-expressed mutants (L1C and L2 swap, L2 plus triple LGR mutation, and L2 plus quintuple LGRHK mutation) was shifted toward alkalinity and, in contrast with IRR, did not show significant positive cooperativity. Our data suggest that IRR activation is not based on a single residue deprotonation in the IRR ectodomain but rather involves synergistic conformational changes at multiple points.	[Deyev, Igor E.; Mitrofanova, Alla V.; Zhevlenev, Egor S.; Radionov, Nikita; Berchatova, Anastasiya A.; Popova, Nadezhda V.; Serova, Oxana V.; Petrenko, Alexander G.] Russian Acad Sci, Lab Receptor Cell Biol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Deyev, IE (corresponding author), Inst Bioorgan Chem, Lab Receptor Cell Biol, GSP-7,Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	deyevie@ibch.ru	Mitrofanova, Alla/L-1590-2019; Popova, Nadezhda/ABD-7185-2021; Popova, Nadezhda/AAJ-8312-2020; Deyev, Igor E/L-5841-2016; Deyev, Igor E/CAJ-5868-2022	Mitrofanova, Alla/0000-0001-5065-9522; Popova, Nadezhda/0000-0002-6761-589X; Popova, Nadezhda/0000-0002-6761-589X; Deyev, Igor E/0000-0002-2041-808X; Deyev, Igor E/0000-0002-2041-808X; Petrenko, Alexander/0000-0002-6689-6546; Serova, Oxana/0000-0002-4941-8913	Russian Foundation for Basic Research [10-04-01794-a, 11-04-12151-ofi-m-2011, 12-04-01817-a, 12-04-33190, 12-04-32099]; Basic Sciences to Medicine Program of the Russian Academy of Sciences; Russian Federation [MK-127.2012.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Basic Sciences to Medicine Program of the Russian Academy of Sciences; Russian Federation(Russian Federation)	This work was supported by the Russian Foundation for Basic Research (Grants 10-04-01794-a, 11-04-12151-ofi-m-2011, 12-04-01817-a, 12-04-33190, and 12-04-32099), Basic Sciences to Medicine Program of the Russian Academy of Sciences, and by the President of the Russian Federation (Grant MK-127.2012.4).	BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Deev I E, 2006, Dokl Biochem Biophys, V408, P184, DOI 10.1134/S1607672906030203; Deyev IE, 2011, ACTA NATURAE, V3, P114, DOI 10.32607/20758251-2011-3-4-114-117; Deyev IE, 2011, CELL METAB, V13, P679, DOI 10.1016/j.cmet.2011.03.022; Deyev IE, 2010, BIOCHIMIE, V92, P418, DOI 10.1016/j.biochi.2010.01.015; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; GRIGORESCU F, 1983, J BIOL CHEM, V258, P3708; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Klammt J, 2005, BIOCHEM BIOPH RES CO, V327, P557, DOI 10.1016/j.bbrc.2004.12.039; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mynarcik DC, 1997, J BIOL CHEM, V272, P2077; NAKAE J, 1995, J BIOL CHEM, V270, P22017, DOI 10.1074/jbc.270.37.22017; Petrenko AG, 2013, BBA-PROTEINS PROTEOM, V1834, P2170, DOI 10.1016/j.bbapap.2012.11.011; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; Rouard M, 1999, J BIOL CHEM, V274, P18487, DOI 10.1074/jbc.274.26.18487; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SHIER P, 1989, J BIOL CHEM, V264, P14605; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012	28	21	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33884	33893		10.1074/jbc.M113.483172	http://dx.doi.org/10.1074/jbc.M113.483172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121506	hybrid, Green Published			2022-12-25	WOS:000327250200032
J	Popovic, M; Zaja, R; Fent, K; Smital, T				Popovic, Marta; Zaja, Roko; Fent, Karl; Smital, Tvrtko			Molecular Characterization of Zebrafish Oatp1d1 (Slco1d1), a Novel Organic Anion-transporting Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Membrane Proteins; Membrane Transport; Organic Anion Channels; Zebrafish; New Slco Transporter in zebrafish; New Slco Transporter in Zebrafish; Molecular Characterization	THYROID-HORMONE TRANSPORTERS; CHOLESTEROL IN-VITRO; XENOBIOTIC TRANSPORTERS; OATP/SLCO SUPERFAMILY; IDENTIFICATION; PROTEIN; MEMBRANE; SUBSTRATE; FAMILY; CELLS	The organic anion-transporting polypeptide (OATP/Oatp) superfamily includes a group of polyspecific transporters that mediate transport of large amphipathic, mostly anionic molecules across cell membranes of eukaryotes. OATPs/Oatps are involved in the disposition and elimination of numerous physiological and foreign compounds. However, in non-mammalian species, the functional properties of Oatps remain unknown. We aimed to elucidate the role of Oatp1d1 in zebrafish to gain insights into the functional and structural evolution of the OATP1/Oatp1 superfamily. We show that diversification of the OATP1/Oatp1 family occurs after the emergence of jawed fish and that the OATP1A/Oatp1a and OATP1B/Oatp1b subfamilies appeared at the root of tetrapods. The Oatp1d subfamily emerged in teleosts and is absent in tetrapods. The zebrafish Oatp1d1 is similar to mammalian OATP1A/Oatp1a and OATP1B/Oatp1b members, with the main physiological role in transport and balance of steroid hormones. Oatp1d1 activity is dependent upon pH gradient, which could indicate bicarbonate exchange as a mode of transport. Our analysis of evolutionary conservation and structural properties revealed that (i) His-79 in intracellular loop 3 is conserved within OATP1/Oatp1 family and is crucial for the transport activity; (ii) N-glycosylation impacts membrane targeting and is conserved within the OATP1/Oatp1 family with Asn-122, Asn-133, Asn-499, and Asn-512 residues involved; (iii) the evolutionarily conserved cholesterol recognition interaction amino acid consensus motif is important for membrane localization; and (iv) Oatp1d1 is present in dimeric and possibly oligomeric form in the cell membrane. In conclusion, we describe the first detailed characterization of a new Oatp transporter in zebrafish, offering important insights into the functional evolution of the OATP1/Oatp1 family and the physiological role of Oatp1d1.	[Popovic, Marta; Zaja, Roko; Smital, Tvrtko] Rudjer Boskovic Inst, Div Marine & Environm Res, Lab Mol Ecotoxicol, Zagreb 10000, Croatia; [Fent, Karl] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland; [Fent, Karl] Swiss Fed Inst Technol ETHZ, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	Rudjer Boskovic Institute; FHNW University of Applied Sciences & Arts Northwestern Switzerland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Smital, T (corresponding author), Rudjer Boskovic Inst, Div Marine & Environm Res, Lab Mol Ecotoxicol, Bijenicka 54, Zagreb 10000, Croatia.	smital@irb.hr		Zaja, Roko/0000-0003-3944-0153; Popovic, Marta/0000-0002-9464-5824	Ministry for Science, Technology, and Sports of the Republic of Croatia [098-0982934-2745]; Swiss National Science Foundation (SNSF) [SCOPES-IZ73ZO_128025/1]	Ministry for Science, Technology, and Sports of the Republic of Croatia; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by Ministry for Science, Technology, and Sports of the Republic of Croatia Project 098-0982934-2745 and by Swiss National Science Foundation (SNSF) Grant SCOPES-IZ73ZO_128025/1.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Badagnani I, 2006, J PHARMACOL EXP THER, V318, P521, DOI 10.1124/jpet.106.104364; BENDAYAN R, 1994, J AM SOC NEPHROL, V5, P75; Boyarsky G, 1996, FASEB J, V10, P1205, DOI 10.1096/fasebj.10.10.8751723; Cai SY, 2002, AM J PHYSIOL-GASTR L, V282, pG702, DOI 10.1152/ajpgi.00458.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gui CS, 2009, PHARMACOL RES, V60, P50, DOI 10.1016/j.phrs.2009.03.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanggi E, 2006, MOL PHARMACOL, V70, P806, DOI 10.1124/mol.105.019547; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hagey LR, 2010, ZOOL SCI, V27, P565, DOI 10.2108/zsj.27.565; Hirano M, 2006, DRUG METAB DISPOS, V34, P1229, DOI 10.1124/dmd.106.009290; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; Hong M, 2001, J PHARMACOL EXP THER, V296, P141; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; Huber RD, 2007, AM J PHYSIOL-CELL PH, V292, pC795, DOI 10.1152/ajpcell.00597.2005; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; James MO, 2011, J STEROID BIOCHEM, V127, P167, DOI 10.1016/j.jsbmb.2010.10.003; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Kindla J, 2011, DRUG METAB DISPOS, V39, P1047, DOI 10.1124/dmd.110.037622; Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martinez-Becerra P, 2011, MOL PHARMACOL, V79, P596, DOI 10.1124/mol.110.069971; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Meier-Abt F, 2007, TOXICOL APPL PHARM, V218, P274, DOI 10.1016/j.taap.2006.11.015; Molina H, 2008, BBA-BIOMEMBRANES, V1778, P1283, DOI 10.1016/j.bbamem.2008.01.020; Nakao N, 2006, ENDOCRINOLOGY, V147, P1067, DOI 10.1210/en.2005-1090; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Pippal JB, 2011, MOL CELL ENDOCRINOL, V332, P58, DOI 10.1016/j.mce.2010.09.014; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Popovic M, 2010, COMP BIOCHEM PHYS A, V155, P327, DOI 10.1016/j.cbpa.2009.11.011; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Roth M, 2011, J PHARMACOL EXP THER, V339, P624, DOI 10.1124/jpet.111.184564; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tom R., 2008, CSH PROTOC; Tschantz WR, 2008, PROTEIN EXPRES PURIF, V57, P163, DOI 10.1016/j.pep.2007.10.007; van der Deure WM, 2010, J MOL ENDOCRINOL, V44, P1, DOI 10.1677/JME-09-0042; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007; Westholm DE, 2009, ENDOCRINOLOGY, V150, P5153, DOI 10.1210/en.2009-0769; Xiao YH, 2007, BIOTECHNOL LETT, V29, P925, DOI 10.1007/s10529-007-9327-4; Yamazaki M, 2005, XENOBIOTICA, V35, P737, DOI 10.1080/00498250500136676; Yao J., 2012, PLOS ONE, V7	56	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33894	33911		10.1074/jbc.M113.518506	http://dx.doi.org/10.1074/jbc.M113.518506			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126916	Green Published, hybrid			2022-12-25	WOS:000327250200033
J	Chiu, HW; Yeh, YL; Wang, YC; Huang, WJ; Chen, YA; Chiou, YS; Ho, SY; Lin, PP; Wang, YJ				Chiu, Hui-Wen; Yeh, Ya-Ling; Wang, Yi-Ching; Huang, Wei-Jan; Chen, Yi-An; Chiou, Yi-Shiou; Ho, Sheng-Yow; Lin, Pinpin; Wang, Ying-Jan			Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; DNA-DAMAGE; CELL-DEATH; COMBINATION TREATMENT; RADIATION RESPONSE; PANCREATIC-CANCER; ARSENIC TRIOXIDE; AUTOPHAGY; VORINOSTAT; EXPRESSION	Triple-negative breast cancer (TNBC), defined by the absence of an estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression, is associated with an early recurrence of disease and poor outcome. Furthermore, the majority of deaths in breast cancer patients are from metastases instead of from primary tumors. In this study, MCF-7 (an estrogen receptor-positive human breast cancer cell line), MDA-MB-231 (a human TNBC cell line) and 4T1 (a mouse TNBC cell line) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with suberoylanilide hydroxamic acid (SAHA, an inhibitor of histone deacetylase (HDAC)) and to determine the underlying mechanisms of these effects in vitro and in vivo. We also evaluated the ability of SAHA to inhibit the metastasis of 4T1 cells. We found that IR combined with SAHA showed increased therapeutic efficacy when compared with either treatment alone in MCF-7, MDA-MB-231 and 4T1 cells. Moreover, the combined treatment enhanced DNA damage through the inhibition of DNA repair proteins. The combined treatment was induced primarily through autophagy and ER stress. In an orthotopic breast cancer mouse model, the combination treatment showed a greater inhibition of tumor growth. In addition, SAHA inhibited the migration and invasion abilities of 4T1 cells and inhibited breast cancer cell migration by inhibiting the activity of MMP-9. In an in vivo experimental metastasis mouse model, SAHA significantly inhibited lung metastasis. SAHA not only enhances radiosensitivity but also suppresses lung metastasis in breast cancer. These novel findings suggest that SAHA alone or combined with IR could serve as a potential therapeutic strategy for breast cancer.	[Chiu, Hui-Wen; Yeh, Ya-Ling; Chen, Yi-An; Chiou, Yi-Shiou; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Huang, Wei-Jan] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Chiou, Yi-Shiou] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Ho, Sheng-Yow] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Kaohsiung University of Science & Technology; Chi Mei Hospital; National Health Research Institutes - Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019; Lin, Pinpin/B-2668-2010; Lin, PinPin/A-2006-2019	Wang, Yi-Ching/0000-0002-7694-2067; Lin, Pinpin/0000-0001-5459-907X; Lin, PinPin/0000-0001-5459-907X	National Science Council, Taiwan [NSC101-2314-B-006-050, NSC100-2325-B-400-012]; Sinlau Christian Hospital, Tainan, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan	This study was supported by the National Science Council, Taiwan (NSC101-2314-B-006-050 and NSC100-2325-B-400-012) and the Sinlau Christian Hospital, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Baschnagel A, 2009, MOL CANCER THER, V8, P1589, DOI 10.1158/1535-7163.MCT-09-0038; Blattmann C, 2010, INT J RADIAT ONCOL, V78, P237, DOI 10.1016/j.ijrobp.2010.03.010; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brem GJ, 2013, GYNECOL ONCOL, V128, P383, DOI 10.1016/j.ygyno.2012.10.021; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chinnaiyan P, 2005, INT J RADIAT ONCOL, V62, P223, DOI 10.1016/j.ijrobp.2004.12.088; Chiu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040462; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cupic DF, 2011, COLLEGIUM ANTROPOL, V35, P7; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flatmark K, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-25; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Groselj B, 2013, BR J CANC; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; He L, 2009, FEBS LETT, V583, P903, DOI 10.1016/j.febslet.2009.02.002; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Marcilla-Etxenike A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048235; McArt DG, 2010, MUTAGENESIS, V25, P299, DOI 10.1093/mutage/geq006; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moretti L, 2007, CELL CYCLE, V6, P793, DOI 10.4161/cc.6.7.4036; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Paglin S, 2001, CANCER RES, V61, P439; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Rieber M, 2008, CANCER BIOL THER, V7, P1561, DOI 10.4161/cbt.7.10.6540; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shieh JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030240; Shubassi G, 2012, CANCER RES, V72, P1332, DOI 10.1158/0008-5472.CAN-11-3172; Sun Y, 2009, POSTGRAD MED J, V85, P134, DOI 10.1136/pgmj.2008.072629; Tang FY, 2008, J NUTR BIOCHEM, V19, P287, DOI 10.1016/j.jnutbio.2007.03.003; UCKUN FM, 1991, BLOOD, V78, P2945; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455	57	58	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76340	10.1371/journal.pone.0076340	http://dx.doi.org/10.1371/journal.pone.0076340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130769	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200034
J	Dam, B; Dam, S; Blom, J; Liesack, W				Dam, Bomba; Dam, Somasri; Blom, Jochen; Liesack, Werner			Genome Analysis Coupled with Physiological Studies Reveals a Diverse Nitrogen Metabolism in Methylocystis sp Strain SC2	PLOS ONE			English	Article							PARTICULATE METHANE MONOOXYGENASE; METHYLOCOCCUS-CAPSULATUS BATH; 16S RIBOSOMAL-RNA; ACTIVE METHANOTROPHIC COMMUNITY; POLY-BETA-HYDROXYBUTYRATE; LANDFILL COVER SOIL; ESCHERICHIA-COLI; OXIDIZING BACTERIA; SP NOV.; OBLIGATE METHANOTROPH	Background: Methylocystis sp. strain SC2 can adapt to a wide range of methane concentrations. This is due to the presence of two isozymes of particulate methane monooxygenase exhibiting different methane oxidation kinetics. To gain insight into the underlying genetic information, its genome was sequenced and found to comprise a 3.77 Mb chromosome and two large plasmids. Principal Findings: We report important features of the strain SC2 genome. Its sequence is compared with those of seven other methanotroph genomes, comprising members of the Alphaproteobacteria, Gammaproteobacteria, and Verrucomicrobia. While the pan-genome of all eight methanotroph genomes totals 19,358 CDS, only 154 CDS are shared. The number of core genes increased with phylogenetic relatedness: 328 CDS for proteobacterial methanotrophs and 1,853 CDS for the three alphaproteobacterial Methylocystaceae members, Methylocystis sp. strain SC2 and strain Rockwell, and Methylosinus trichosporium OB3b. The comparative study was coupled with physiological experiments to verify that strain SC2 has diverse nitrogen metabolism capabilities. In correspondence to a full complement of 34 genes involved in N-2 fixation, strain SC2 was found to grow with atmospheric N-2 as the sole nitrogen source, preferably at low oxygen concentrations. Denitrification-mediated accumulation of 0.7 nmol N-30(2)/hr/mg dry weight of cells under anoxic conditions was detected by tracer analysis. N-2 production is related to the activities of plasmid-borne nitric oxide and nitrous oxide reductases. Conclusions/Perspectives: Presence of a complete denitrification pathway in strain SC2, including the plasmid-encoded nosRZDFYX operon, is unique among known methanotrophs. However, the exact ecophysiological role of this pathway still needs to be elucidated. Detoxification of toxic nitrogen compounds and energy conservation under oxygen-limiting conditions are among the possible roles. Relevant features that may stimulate further research are, for example, absence of CRISPR/Cas systems in strain SC2, high number of iron acquisition systems in strain OB3b, and large number of transposases in strain Rockwell.	[Dam, Bomba; Dam, Somasri; Liesack, Werner] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Dam, Bomba; Dam, Somasri; Liesack, Werner] Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Blom, Jochen] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany	Max Planck Society; Philipps University Marburg; University of Bielefeld	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de	DAM, BOMBA/AAT-6036-2020	DAM, BOMBA/0000-0003-2417-2088; Liesack, Werner/0000-0002-9533-1552	LOEWE Research Center for Synthetic Microbiology (SYNMIKRO); Alexander von Humboldt Foundation; German Federal Ministry of Education and Research [0315599A, 0315599B]	LOEWE Research Center for Synthetic Microbiology (SYNMIKRO); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded by the LOEWE Research Center for Synthetic Microbiology (SYNMIKRO). BD is grateful to the Alexander von Humboldt Foundation for his fellowship. JB acknowledges funding by the German Federal Ministry of Education and Research (grants 0315599A & 0315599B "GenoMik-Transfer''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Arp DJ, 2003, CRIT REV BIOCHEM MOL, V38, P471, DOI 10.1080/10409230390267446; Auman AJ, 2001, APPL ENVIRON MICROB, V67, P4009, DOI 10.1128/AEM.67.9.4009-4016.2001; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; BEDARD C, 1989, MICROBIOL REV, V53, P68; Belova SE, 2011, ENV MICROBIOL REP, V3, P36, DOI 10.1111/j.1758-2229.2010.00180.x; Bergmann DJ, 1998, J BACTERIOL, V180, P6440, DOI 10.1128/JB.180.24.6440-6445.1998; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; Braker G, 2010, FEMS MICROBIOL ECOL, V73, P134, DOI 10.1111/j.1574-6941.2010.00884.x; BUURMAN ET, 1991, ARCH MICROBIOL, V155, P391; Campbell MA, 2011, FEMS MICROBIOL LETT, V322, P82, DOI 10.1111/j.1574-6968.2011.02340.x; Cebron A, 2007, FEMS MICROBIOL ECOL, V62, P12, DOI 10.1111/j.1574-6941.2007.00368.x; Chen Y, 2008, ENVIRON MICROBIOL, V10, P446, DOI 10.1111/j.1462-2920.2007.01466.x; Chen Y, 2007, ENVIRON MICROBIOL, V9, P2855, DOI 10.1111/j.1462-2920.2007.01401.x; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; DALTON H, 1976, ARCH MICROBIOL, V109, P147, DOI 10.1007/BF00425127; Dam B, 2012, J BACTERIOL, V194, P6008, DOI 10.1128/JB.01446-12; Dam B, 2012, APPL ENVIRON MICROB, V78, P4373, DOI 10.1128/AEM.00628-12; DEBONT JAM, 1974, J GEN MICROBIOL, V83, P113, DOI 10.1099/00221287-83-1-113; Dedysh SN, 2004, MICROBIOL-SGM, V150, P1301, DOI 10.1099/mic.0.26585-0; Dedysh SN, 2003, FEMS MICROBIOL ECOL, V43, P299, DOI 10.1111/j.1574-6941.2003.tb01070.x; Dedysh SN, 2002, INT J SYST EVOL MICR, V52, P251, DOI 10.1099/00207713-52-1-251; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; del Cerro C, 2012, J BACTERIOL, V194, P5709, DOI 10.1128/JB.01346-12; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dunfield PF, 2002, FEMS MICROBIOL ECOL, V41, P17, DOI 10.1111/j.1574-6941.2002.tb00962.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eller G, 2001, APPL ENVIRON MICROB, V67, P2395, DOI 10.1128/AEM.67.6.2395-2403.2001; Elmore BO, 2007, FEBS LETT, V581, P911, DOI 10.1016/j.febslet.2007.01.068; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Garcia-Martinez J, 2001, NUCLEIC ACIDS RES, V29, P178, DOI 10.1093/nar/29.1.178; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Helling RB, 1998, J BACTERIOL, V180, P4571, DOI 10.1128/JB.180.17.4571-4575.1998; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Horz HP, 2001, APPL ENVIRON MICROB, V67, P4177, DOI 10.1128/AEM.67.9.4177-4185.2001; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Im J, 2011, ENV MICROBIOL REP, V3, P174, DOI 10.1111/j.1758-2229.2010.00204.x; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Khadem AF, 2012, J BACTERIOL, V194, P3729, DOI 10.1128/JB.00501-12; Khadem AF, 2010, MICROBIOL-SGM, V156, P1052, DOI 10.1099/mic.0.036061-0; Kits KD, 2013, GENOME ANNOUNC, V1; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Knief C, 2003, APPL ENVIRON MICROB, V69, P6703, DOI 10.1128/AEM.69.11.6703-6714.2003; Knief C, 2006, ENVIRON MICROBIOL, V8, P321, DOI 10.1111/j.1462-2920.2005.00898.x; KOHLER T, 1989, J BACTERIOL, V171, P4326; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolsto AB, 1997, MOL MICROBIOL, V24, P241, DOI 10.1046/j.1365-2958.1997.3501715.x; Kono N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-19; Lapidus A, 2011, J BACTERIOL, V193, P3757, DOI 10.1128/JB.00404-11; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Lindner AS, 2007, INT J SYST EVOL MICR, V57, P1891, DOI 10.1099/ijs.0.64541-0; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Matsugi J, 2004, BBA-GENE STRUCT EXPR, V1676, P23, DOI 10.1016/j.bbaexp.2003.10.003; McDonald IR, 1997, FEMS MICROBIOL LETT, V156, P205, DOI 10.1016/S0378-1097(97)00425-4; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MURRELL JC, 1983, J GEN MICROBIOL, V129, P3481; Nauer PA, 2012, BIOGEOSCIENCES, V9, P2259, DOI 10.5194/bg-9-2259-2012; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Nyerges G, 2010, APPL ENVIRON MICROB, V76, P5648, DOI 10.1128/AEM.00747-10; Nyerges G, 2009, FEMS MICROBIOL LETT, V297, P131, DOI 10.1111/j.1574-6968.2009.01674.x; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Pieja AJ, 2011, MICROB ECOL, V62, P564, DOI 10.1007/s00248-011-9873-0; Pieja AJ, 2011, APPL ENVIRON MICROB, V77, P6012, DOI 10.1128/AEM.00509-11; Poret-Peterson AT, 2008, ISME J, V2, P1213, DOI 10.1038/ismej.2008.71; Qin L, 2005, WATER RES, V39, P1503, DOI 10.1016/j.watres.2005.01.025; Radajewski S, 2002, MICROBIOL-SGM, V148, P2331, DOI 10.1099/00221287-148-8-2331; Ren T, 2000, APPL ENVIRON MICROB, V66, P3891, DOI 10.1128/AEM.66.9.3891-3897.2000; Ricke P, 2004, APPL ENVIRON MICROB, V70, P3055, DOI 10.1128/AEM.70.5.3055-3063.2004; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas.1211238109, 10.1073/pnas.]; SEMRAU JD, 1995, J BACTERIOL, V177, P3071, DOI 10.1128/jb.177.11.3071-3079.1995; Sernova NV, 2008, BRIEF BIOINFORM, V9, P376, DOI 10.1093/bib/bbn031; SHONNARD DR, 1992, APPL ENVIRON MICROB, V58, P2737, DOI 10.1128/AEM.58.9.2737-2743.1992; Stein LY, 2011, BIOCHEM SOC T, V39, P1826, DOI 10.1042/BST20110712; Stein LY, 2011, J BACTERIOL, V193, P2668, DOI 10.1128/JB.00278-11; Stein LY, 2011, METHOD ENZYMOL, V486, P131, DOI [10.1016/B978-0-12-381294-0.00006-7, 10.1016/S0076-6879(11)86006-4]; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Steingruber SM, 2001, APPL ENVIRON MICROB, V67, P3771, DOI 10.1128/AEM.67.9.3771-3778.2001; Strobel T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-465; Sutka RL, 2003, RAPID COMMUN MASS SP, V17, P738, DOI 10.1002/RCM.968; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Svenning MM, 2011, J BACTERIOL, V193, P6418, DOI 10.1128/JB.05380-11; TAKEDA K, 1988, A VAN LEEUW J MICROB, V54, P521, DOI 10.1007/BF00588388; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TOUKDARIAN AE, 1984, J GEN MICROBIOL, V130, P1827; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; Vuilleumier S, 2012, J BACTERIOL, V194, P551, DOI 10.1128/JB.06392-11; Waibel AE, 1999, SCIENCE, V283, P2064, DOI 10.1126/science.283.5410.2064; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P541, DOI 10.1099/ijs.0.63912-0; Weiss V, 2002, J MOL MICROB BIOTECH, V4, P229; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yoon S, 2011, METHOD ENZYMOL, P247, DOI 10.1016/B978-0-12-386905-0.00016-4; YOSHINARI T, 1976, BIOCHEM BIOPH RES CO, V69, P705, DOI 10.1016/0006-291X(76)90932-3; ZAHN JA, 1994, J BACTERIOL, V176, P5879, DOI 10.1128/jb.176.19.5879-5887.1994; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; ZHIVOTCHENKO AG, 1995, BIOPROCESS ENG, V14, P9, DOI 10.1007/s004490050177; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	119	42	45	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e74767	10.1371/journal.pone.0074767	http://dx.doi.org/10.1371/journal.pone.0074767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130670	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200002
J	Ferracci, J; Ueno, H; Numayama-Tsuruta, K; Imai, Y; Yamaguchi, T; Ishikawa, T				Ferracci, Jonathan; Ueno, Hironori; Numayama-Tsuruta, Keiko; Imai, Yohsuke; Yamaguchi, Takami; Ishikawa, Takuji			Entrapment of Ciliates at the Water-Air Interface	PLOS ONE			English	Article							BACTERIA; MODEL	The importance of water-air interfaces (WAI) on microorganism activities has been recognized by many researchers. In this paper, we report a novel phenomenon: the entrapment of ciliates Tetrahymena at the WAI. We first characterized the behavior of cells at the interface and showed that the cells' swimming velocity was considerably reduced at the WAI. To verify the possible causes of the entrapment, we investigated the effects of positive chemotaxis for oxygen, negative geotaxis and surface properties. Even though the taxes were still effective, the entrapment phenomenon was not dependent on the physiological conditions, but was instead affected by the physical properties at the interface. This knowledge is useful for a better understanding of the physiology of microorganisms at interfaces in nature and in industry.	[Ferracci, Jonathan] Tohoku Univ, Dept Engn, Sendai, Miyagi 980, Japan; [Numayama-Tsuruta, Keiko; Yamaguchi, Takami] Tohoku Univ, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Imai, Yohsuke; Ishikawa, Takuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Ferracci, J (corresponding author), Tohoku Univ, Dept Engn, Sendai, Miyagi 980, Japan.	jferracci@pfsl.mech.tohoku.ac.jp; ishikawa@pfsl.mech.tohoku.ac.jp	Imai, Yohsuke/D-9977-2017	Imai, Yohsuke/0000-0002-4856-3799; Numayama-Tsuruta, Keiko/0000-0001-6969-6489; Ishikawa, Takuji/0000-0002-3573-8414	NEXT program from JSPS; Grants-in-Aid for Scientific Research [24680048] Funding Source: KAKEN	NEXT program from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the NEXT program from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038102; Blawzdziewicz J, 1999, PHYS FLUIDS, V11, P251, DOI 10.1063/1.869875; Crowdy D, 2011, J FLUID MECH, V681, P24, DOI 10.1017/jfm.2011.223; Drescher K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168101; Edwards D.A., 1991, INTERFACIAL TRANSPOR; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Giacche D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056309; GLASSMAN HN, 1948, BACTERIOL REV, V12, P105, DOI 10.1128/MMBR.12.2.105-148.1948; Ishikawa T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.028102; Ishikawa T, 2006, J FLUID MECH, V568, P119, DOI 10.1017/S0022112006002631; Kristiansen TB, 1996, J CELL PHYSIOL, V169, P139, DOI 10.1002/(SICI)1097-4652(199610)169:1<139::AID-JCP14>3.0.CO;2-8; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LEICK V, 1983, ANAL BIOCHEM, V135, P466, DOI 10.1016/0003-2697(83)90713-3; Llopis I, 2010, J NON-NEWTON FLUID, V165, P946, DOI 10.1016/j.jnnfm.2010.01.023; Marcos, 2011, P NATL ACAD SCI USA, V108, P3860, DOI 10.1073/pnas.1014576108; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; NOEVER DA, 1994, BIOPHYS J, V67, P2090, DOI 10.1016/S0006-3495(94)80692-7; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Samanta S, 2011, CHEM ENG RES DES, V89, P2344, DOI 10.1016/j.cherd.2011.04.006; Schafer A, 1998, ENVIRON SCI TECHNOL, V32, P3704, DOI 10.1021/es980191u; Spagnolie SE, 2012, J FLUID MECH, V700, P105, DOI 10.1017/jfm.2012.101	22	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75238	10.1371/journal.pone.0075238	http://dx.doi.org/10.1371/journal.pone.0075238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130692	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200006
J	Kinoshita, SM; Kogure, A; Taguchi, S; Nolan, GP				Kinoshita, Shigemi M.; Kogure, Amane; Taguchi, Shizuka; Nolan, Garry P.			Snapin, Positive Regulator of Stimulation- Induced Ca2+ Release through RyR, Is Necessary for HIV-1 Replication in T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CALCIUM-RELEASE; ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; ACTIVATION; PROTEIN; LYMPHOCYTES; MECHANISMS; EXPRESSION; RECEPTORS	To identify critical host factors necessary for human immunodeficiency virus 1 (HIV-1) replication, large libraries of short-peptide-aptamers were expressed retrovirally. The target of one inhibitor peptide, Pep80, identified in this screen was determined to be Snapin, a protein associated with the soluble N-ethyl maleimide sensitive factor adaptor protein receptor (SNARE) complex that is critical for calcium-dependent exocytosis during neurotransmission. Pep80 inhibited Ca2+ release from intracellular stores and blocked downstream signaling by direct interruption of the association between Snapin and an intracellular calcium release channel, the ryanodine receptor (RyR). NFAT signaling was preferentially abolished by Pep80. Expression of Snapin overcame Pep80-mediated inhibition of Ca2+/NFAT signaling and HIV-1 replication. Furthermore, Snapin induced HIV-1 replication in primary CD4+ T cells. Thus, through its interaction with RyR, Snapin is a critical regulator of Ca2+ signaling and T cell activation. Use of the genetically selected intracellular aptamer inhibitors allowed us to define unique mechanisms important to HIV-1 replication and T cell biology.	[Kinoshita, Shigemi M.; Kogure, Amane] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kinoshita, Shigemi M.; Taguchi, Shizuka] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Suita, Osaka, Japan; [Nolan, Garry P.] Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA; [Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Jefferson University; Osaka University; Stanford University; Stanford University	Kinoshita, SM (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	shigemi.kinoshita@jefferson.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	National Institute of Health [AI56920]; Sankyo Foundation of Life Science; Chugai-Roche Pharmaceutical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI056920] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sankyo Foundation of Life Science; Chugai-Roche Pharmaceutical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was supported by National Institute of Health grant AI56920, Sankyo Foundation of Life Science, and Chugai-Roche Pharmaceutical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Brini M, 2004, BIOCHEM BIOPH RES CO, V322, P1245, DOI 10.1016/j.bbrc.2004.08.029; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kinoshita SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041725; Kinoshita SM, 2008, P NATL ACAD SCI USA, V105, P15022, DOI 10.1073/pnas.0807269105; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Ogawa Y, 2008, BIOCHEM BIOPH RES CO, V369, P208, DOI 10.1016/j.bbrc.2007.11.139; Shirokova N, 2008, METHODS, V46, P183, DOI 10.1016/j.ymeth.2008.09.017; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Suzuki F, 2007, J BIOL CHEM, V282, P29563, DOI 10.1074/jbc.M702063200; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Wang SC, 2009, NEUROSIGNALS, V17, P169, DOI 10.1159/000200076; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502; Zissimopoulos S, 2006, J CELL SCI, V119, P2386, DOI 10.1242/jcs.02936	40	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75297	10.1371/journal.pone.0075297	http://dx.doi.org/10.1371/journal.pone.0075297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130701	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200009
J	Deng, XD; Tian, YX; Niu, QH; Xu, XE; Shi, H; Zhang, HB; Liang, LM; Zhang, KQ; Huang, XW				Deng, Xidan; Tian, Yunxia; Niu, Qiuhong; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei			The ComP-ComA Quorum System Is Essential For "Trojan horse" Like Pathogenesis in Bacillus nematocida	PLOS ONE			English	Article							TO-CELL COMMUNICATION; VIRULENCE REGULATION; GENOME ANALYSIS; SENSING SYSTEM; CEREUS GROUP; GENE; SUBTILIS; DEGU; PLCR; CONSERVATION	Bacillus nematocida B16 has been shown to use "Trojan horse" mechanism in pathogenesis that has characteristics of "social" behavior. The ComP-ComA system, a conserved quorum sensing system in the genus Bacillus, functions in many physiological processes including competence development, lipopeptide antibiotic surfactin production, degradative enzyme production and even some unknown functions. Here we investigated the requirement of ComP-ComA system in B. nematocida B16 for its pathogenicity against nematodes. The Delta comP mutant displayed deficiencies in attracting and killing nematodes, due to the absence of attractive signal molecules and the decreased expressions of virulence factors, respectively. Contrarily, a complemented comP mutant at least partially resumed its pathogenicity. Our data from transcriptional analysis further confirmed that this signaling system directly or indirectly regulated the expressions of two major virulence proteases in the infection of B. nematocida B16. Bioinformatics analyses from comparative genomics also suggested that the potential target genes of transcription factor ComA were involved in the processes such as the synthesis of attractants, production of extracellular degradative enzymes and sortase, secondary metabolites biosynthesis, regulation of transcription factors, mobility, as well as transporters, most of which were different from a saprophytic relative B. subtilis 168. Therefore, our investigation firstly revealed that the participation and necessity of ComP-ComA signaling system in bacterial pathogenesis.	[Deng, Xidan; Tian, Yunxia; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Yunnan, Peoples R China; [Deng, Xidan; Tian, Yunxia; Xu, Xiao'e; Shi, Hui; Zhang, Hanbo; Liang, Lianming; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Yunnan, Peoples R China; [Deng, Xidan] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Niu, Qiuhong] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Henan, Peoples R China	Yunnan University; Yunnan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Nanyang Normal College	Zhang, KQ (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Yunnan, Peoples R China.	kqzhang@ynu.edu.cn; xwhuang@ynu.edu.cn	zhang, ke/AAH-8217-2019; Liang, Lian-Ming/AAL-3861-2021		National Basic Research Program of China [2013CB127500, 2011AA10A203]; National Natural Science Foundation Program of China [30970065, U1036602]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province, China	This work is supported by the National Basic Research Program of China (grant no. 2013CB127500 and no. 2011AA10A203), the National Natural Science Foundation Program of China (grant no. 30970065 and no. U1036602), the Department of Science and Technology of Yunnan Province, China (grant No. 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Chan WC, 2004, J MED CHEM, V47, P4633, DOI 10.1021/jm0400754; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; GARZA AG, 1995, P NATL ACAD SCI USA, V92, P1970, DOI 10.1073/pnas.92.6.1970; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Huang XW, 2005, SYST APPL MICROBIOL, V28, P323, DOI 10.1016/j.syapm.2005.01.008; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; Mylonakis E, 2002, INFECT IMMUN, V70, P4678, DOI 10.1128/IAI.70.8.4678-4681.2002; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Slamti L, 2004, J BACTERIOL, V186, P3531, DOI 10.1128/JB.186.11.3531-3538.2004; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Tortosa P, 1999, CURR OPIN MICROBIOL, V2, P588, DOI 10.1016/S1369-5274(99)00026-0; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224; Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Withers H, 2001, CURR OPIN MICROBIOL, V4, P186, DOI 10.1016/S1369-5274(00)00187-9	39	5	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76920	10.1371/journal.pone.0076920	http://dx.doi.org/10.1371/journal.pone.0076920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130811	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900105
J	dos Santos, CG; Silva, AL; Souza, FL; Lanfredi, AJC; Di Mascio, P; Nascimento, OR; Rodrigues, T; Nantes, IL				dos Santos, Carolina G.; Silva, Andre L.; Souza, Flavio L.; Lanfredi, Alexandre J. C.; Di Mascio, Paolo; Nascimento, Otaciro R.; Rodrigues, Tiago; Nantes, Iseli L.			UV-Light Effects on Cytochrome C Modulated by the Aggregation State of Phenothiazines	PLOS ONE			English	Article							SPIN-STATE; SINGLET OXYGEN; HEME IRON; MITOCHONDRIAL; MECHANISMS; RELEASE; PHOTOSENSITIZERS; INTERFACES; ABILITY	The present study shows the factors that modulate the photodamage promoted by phenothiazines. Cytochrome c was irradiated with UV light for 120 min, over a pH range from 4.0 to 8.0, in the absence and in the presence of different concentrations of thioridazine (TR) and fluphenazine (FP). In the absence of phenothiazines, the maximal rate of a Soret band blue shift (nm/min) from 409 to 406 nm was obtained at pH 4.0 (0.028 nm/min). The presence of phenothiazines at the concentration range 10-25 mu mol/L amplified and accelerated a cytochrome c blue shift (409 to 405 nm, at a rate = 0.041 nm/min). Above 25 mu mol/L, crescent concentrations of phenothiazines contributed to cytochrome c protection with (maximal at 2500 mu mol/L). Scanning electronic microscopy revealed the formation of nanostructures. The pH also influenced the effect of low phenothiazine concentrations on cytochrome c. Thus, the predominance of phenothiazine-promoted cytochrome c damage or protection depends on a balance of the following factors: the yield of photo-generated drug cation radicals, which is favored by acidic pH; the stability of the cation radicals, which is favored by the drug aggregation; and the cytochrome c structure, modulated by the pH.	[dos Santos, Carolina G.; Silva, Andre L.; Souza, Flavio L.; Rodrigues, Tiago; Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, NanoBioMAv, Santo Andre, SP, Brazil; [dos Santos, Carolina G.] Univ Mogi das Cruzes UMC, Mogi Das Cruzes, SP, Brazil; [Lanfredi, Alexandre J. C.] Univ Fed ABC, Ctr Engn & Ciencias Sociais Aplicadas, Santo Andre, SP, Brazil; [Di Mascio, Paolo] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Nascimento, Otaciro R.] Univ Sao Paulo USP Sao Carlos, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Carlos, SP, Brazil	Universidade Federal do ABC (UFABC); Universidade de Mogi das Cruzes; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Nantes, IL (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, NanoBioMAv, Santo Andre, SP, Brazil.	ilnantes@gmail.com	Souza, Flavio Leandro/C-3128-2012; Santos, Carolina G dos/A-7032-2018; Rodrigues, Tiago/AAG-1121-2020; Lanfredi, Alexandre JC/C-5721-2013; Di Mascio, Paolo/D-1264-2014; Rodrigues, Tiago/B-8459-2012; Nantes, Iseli Lourenço/B-9517-2012	Souza, Flavio Leandro/0000-0003-2036-9123; Santos, Carolina G dos/0000-0003-0684-2463; Rodrigues, Tiago/0000-0003-1277-0224; Di Mascio, Paolo/0000-0003-4125-8350; Rodrigues, Tiago/0000-0003-1277-0224; Nantes, Iseli Lourenço/0000-0003-1434-3154; de Castro Lanfredi, Alexandre Jose/0000-0002-8530-8826	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC); NanoBioMed Brazil Network (CAPES); Guggenheim Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC); NanoBioMed Brazil Network (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Guggenheim Foundation	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa da UMC (FAEP-UMC), NanoBioMed Brazil Network (CAPES) and the Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron JJ, 2009, TOP HETEROCYCL CHEM, V16, P153, DOI 10.1007/7081_2008_125; Abu-Abdoun II, 1997, EUR POLYM J, V33, P1671, DOI 10.1016/S0014-3057(97)00044-X; ALKAITIS SA, 1975, J AM CHEM SOC, V97, P5723, DOI 10.1021/ja00853a015; Amaral L, 2001, INT J ANTIMICROB AG, V18, P411, DOI 10.1016/S0924-8579(01)00432-0; Babul J, 1972, BIOCHEMISTRY-US, V11, P7; Borges MBD, 2010, FREE RADICAL RES, V44, P1054, DOI 10.3109/10715762.2010.498826; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; Cruz TS, 2010, BIOCHEM PHARMACOL, V80, P1284, DOI 10.1016/j.bcp.2010.06.052; Dasgupta A, 2008, TOP HETEROCYCL CHEM, V15, P67, DOI 10.1007/7081_2007_108; dos Santos CG, 2010, FREE RADICAL BIO MED, V49, pS180, DOI 10.1016/j.freeradbiomed.2010.10.513; EberleinKonig B, 1997, DERMATOLOGY, V194, P131, DOI 10.1159/000246080; Elisei F, 2002, PHOTOCHEM PHOTOBIOL, V75, P11, DOI 10.1562/0031-8655(2002)075<0011:ESPAIV>2.0.CO;2; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; FORD JM, 1989, MOL PHARMACOL, V35, P105; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gomurashvili Z, 2001, J POLYM SCI POL CHEM, V39, P1187, DOI 10.1002/pola.1096; Guo QX, 1996, J PHOTOCH PHOTOBIO A, V93, P27, DOI 10.1016/1010-6030(95)04148-6; Hendrich AB, 2003, MOL MEMBR BIOL, V20, P53, DOI 10.1080/0968768031000045815; KAMEN MD, 1973, P NATL ACAD SCI USA, V70, P1851, DOI 10.1073/pnas.70.6.1851; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOCHEVAR IE, 1981, J INVEST DERMATOL, V77, P59, DOI 10.1111/1523-1747.ep12479244; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Michalak K, 2006, CURR DRUG TARGETS, V7, P1095, DOI 10.2174/138945006778226570; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2000, FREE RADICAL BIO MED, V28, P786, DOI 10.1016/S0891-5849(00)00170-2; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Ordway D, 2002, INT J ANTIMICROB AG, V20, P34, DOI 10.1016/S0924-8579(02)00110-3; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; RAMOS GR, 1986, MIKROCHIM ACTA, V1, P115; Rinaldi TA, 2004, FREE RADICAL BIO MED, V36, P802, DOI 10.1016/j.freeradbiomed.2003.12.002; Rodrigues T., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P19; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Rodrigues T, 2006, J PHYS CHEM B, V110, P12257, DOI 10.1021/jp0605404; Severino D, 2003, PHOTOCHEM PHOTOBIOL, V77, P459, DOI 10.1562/0031-8655(2003)077<0459:IONCIO>2.0.CO;2; Sharonov GV, 2005, APOPTOSIS, V10, P797, DOI 10.1007/s10495-005-0366-9; Simon M, 2013, J BIOL INORG CHEM, V18, P27, DOI 10.1007/s00775-012-0946-4; Sudeshna G, 2010, EUR J PHARMACOL, V648, P6, DOI 10.1016/j.ejphar.2010.08.045; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; Viola G, 2003, CHEM RES TOXICOL, V16, P644, DOI 10.1021/tx025680t; Wainwright M, 1999, DYES PIGMENTS, V42, P45, DOI 10.1016/S0143-7208(99)00008-X; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76857	10.1371/journal.pone.0076857	http://dx.doi.org/10.1371/journal.pone.0076857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130798	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900093
J	Marongiu, L; Donini, M; Toffali, L; Zenaro, E; Dusi, S				Marongiu, Laura; Donini, Marta; Toffali, Lara; Zenaro, Elena; Dusi, Stefano			ESAT-6 and HspX Improve the Effectiveness of BCG to Induce Human Dendritic Cells-Dependent Th1 and NK Cells Activation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; BACILLUS-CALMETTE-GUERIN; ANTIMYCOBACTERIAL T-CELL; SECRETED ANTIGEN ESAT-6; IFN-GAMMA; DC-SIGN; VACCINE; RESPONSES; IMMUNITY; INNATE	The limited efficacy of the BCG vaccine against tuberculosis is partly due to the missing expression of immunogenic proteins. We analyzed whether the addition to BCG of ESAT-6 and HspX, two Mycobacterium tuberculosis (Mtb) antigens, could enhance its capacity to activate human dendritic cells (DCs). BCG showed a weak ability to induce DC maturation, cytokine release, and CD4(+) lymphocytes and NK cells activation. The addition of ESAT-6 or HspX alone to BCG-stimulated DC did not improve these processes, whereas their simultaneous addition enhanced BCG-dependent DC maturation and cytokine release, as well as the ability of BCG-treated DCs to stimulate IFN-gamma release and CD69 expression by CD4(+) lymphocytes and NK cells. Addition of TLR2-blocking antibody decreased IL-12 release by BCG-stimulated DCs incubated with ESAT-6 and HspX, as well as IFN-gamma secretion by CD4+ lymphocytes co-cultured with these cells. Moreover, HspX and ESAT-6 improved the capacity of BCG-treated DCs to induce the expression of memory phenotype marker CD45RO in naive CD4(+) T cells. Our results indicate that ESAT-6 and HspX cooperation enables BCG-treated human DCs to induce T lymphocyte and NK cell-mediated immune responses through TLR2-dependent IL-12 secretion. Therefore ESAT-6 and HspX represent good candidates for improving the effectiveness of BCG vaccination.	[Marongiu, Laura; Donini, Marta; Toffali, Lara; Zenaro, Elena; Dusi, Stefano] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy	University of Verona	Dusi, S (corresponding author), Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy.	stefano.dusi@univr.it		Zenaro, Elena/0000-0003-3928-6272; Donini, Marta/0000-0003-3101-0183	Fondazione Cariverona (Bando)	Fondazione Cariverona (Bando)(Fondazione Cariverona)	This work was supported by grants from Fondazione Cariverona (Bando 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Andoniou CE, 2008, EUR J IMMUNOL, V38, P2938, DOI 10.1002/eji.200838882; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2010, EUR J IMMUNOL, V40, P3312, DOI 10.1002/eji.201041145; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Hespel C, 2012, EUR J IMMUNOL, V42, P2535, DOI 10.1002/eji.201242480; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Ize B, 2006, SCIENCE, V313, P1583, DOI 10.1126/science.1132537; Jacobs B, 2008, HORM METAB RES, V40, P99, DOI 10.1055/s-2007-1022561; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kong CU, 2011, VACCINE, V29, P1374, DOI 10.1016/j.vaccine.2010.12.070; Li Q, 2011, SCAND J IMMUNOL, V73, P568, DOI 10.1111/j.1365-3083.2011.02531.x; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mariotti S, 2004, INFECT IMMUN, V72, P4385, DOI 10.1128/IAI.72.8.4385-4392.2004; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Presky DH, 1998, J IMMUNOL, V160, P2174; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Siddiqui KF, 2011, CRIT REV MICROBIOL, V37, P349, DOI 10.3109/1040841X.2011.606425; Taylor JL, 2012, IMMUNOL CELL BIOL; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Xu J, 2008, VACCINE, V26, P4519, DOI 10.1016/j.vaccine.2008.06.044; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	55	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75684	10.1371/journal.pone.0075684	http://dx.doi.org/10.1371/journal.pone.0075684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130733	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900052
J	Meyer, JB; Cartier, LE; Pinto-Figueroa, EA; Krzemnicki, MS; Hanni, HA; McDonald, BA				Meyer, Joana B.; Cartier, Laurent E.; Pinto-Figueroa, Eric A.; Krzemnicki, Michael S.; Haenni, Henry A.; McDonald, Bruce A.			DNA Fingerprinting of Pearls to Determine Their Origins	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NACREOUS LAYER; PINCTADA-MARGARITIFERA; CULTURED PEARLS; NATURAL PEARLS; RIBOSOMAL DNA; OYSTER; EXTRACTION; BIVALVIA; PROTEINS	We report the first successful extraction of oyster DNA from a pearl and use it to identify the source oyster species for the three major pearl-producing oyster species Pinctada margaritifera, P. maxima and P. radiata. Both mitochondrial and nuclear gene fragments could be PCR-amplified and sequenced. A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay in the internal transcribed spacer (ITS) region was developed and used to identify 18 pearls of unknown origin. A micro-drilling technique was developed to obtain small amounts of DNA while maintaining the commercial value of the pearls. This DNA fingerprinting method could be used to document the source of historic pearls and will provide more transparency for traders and consumers within the pearl industry.	[Meyer, Joana B.; McDonald, Bruce A.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Meyer, Joana B.; Cartier, Laurent E.; Krzemnicki, Michael S.] Swiss Gemmol Inst SSEF, Basel, Switzerland; [Cartier, Laurent E.] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Pinto-Figueroa, Eric A.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Haenni, Henry A.] GemExpert, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Lausanne	Meyer, JB (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	joana.meyer82@gmail.com; gemlab@ssef.ch	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172; Krzemnicki, Michael/0000-0003-3757-8781	Swiss Gemmological Institute (SSEF)	Swiss Gemmological Institute (SSEF)	This study was supported by the Swiss Gemmological Institute (SSEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud Sophie, 2000, Conservation Genetics, V1, P299, DOI 10.1023/A:1011575722481; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Arnaud-Haond S, 2003, J EVOLUTION BIOL, V16, P388, DOI 10.1046/j.1420-9101.2003.00549.x; Bari H, 2010, PEARLS; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Bowen RL, 1951, MIDDLE E J, V5, P161; Carter Robert, 2005, J ECON SOC HIST ORIE, V48, P139, DOI [10.1163/1568520054127149, DOI 10.1163/1568520054127149]; Cartier LE, 2012, GEMS GEMOL, V48, P108, DOI 10.5741/GEMS.48.2.108; Charpentier V, 2012, ARAB ARCHAEOL EPIGR, V23, P1, DOI 10.1111/j.1600-0471.2011.00351.x; Checa AG, 2006, P R SOC B, V273, P1329, DOI 10.1098/rspb.2005.3460; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Comps M, 2000, AQUAT LIVING RESOUR, V13, P49, DOI 10.1016/S0990-7440(00)00134-0; Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022; Cunha RL, 2011, MAR BIOTECHNOL, V13, P181, DOI 10.1007/s10126-010-9278-y; Doherty S, 2007, AQUAT BIOL, V1, P161, DOI 10.3354/ab00020; Domard J, 1962, COMM PAC SUD C TECH, V1, P13; Donkin Robin A., 1998, PRICE PEARLS PEARL F; Elen S, 2002, G G, V38, P66, DOI [DOI 10.5741/GEMS.38.1.66, 10.5741/GEMS.38.1.66]; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; Forsman ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015021; Geist J, 2008, J MOLLUS STUD, V74, P337, DOI 10.1093/mollus/eyn025; Goebel M., 1989, GEMS GEMOL, V25, P130, DOI [DOI 10.5741/GEMS.25.3.130, 10.5741/GEMS.25.3.130]; Guthrie JN, 2000, J MICROBIOL METH, V43, P73, DOI 10.1016/S0167-7012(00)00207-4; Gwak WS, 2011, AQUACULT INT, V19, P585, DOI 10.1007/s10499-010-9385-9; Hanni HA, 2010, J GEMMOL, V32, P31; Hanni HA, 2007, J GEMMOL, V30, P357; He MX, 2005, MAR BIOTECHNOL, V7, P40, DOI 10.1007/s10126-004-0003-6; Karampelas S, 2011, GEMS GEMOL, V47, P31, DOI 10.5741/GEMS.47.1.31; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Krzemnicki MS, 2010, GEMS GEMOL, V46, P128, DOI 10.5741/GEMS.46.2.128; Krzemnicki MS, 2013, RADIOCARBON IN PRESS; Krzemnicki MS, 2010, KESHI CULTURED PEARL; Kunz GF, 1908, BOOK PEARL HIST ART, DOI [10.1184/OCLC/00838185, DOI 10.1184/0CLC/00838185]; Landman Neil H., 2001, PEARLS NATURAL HIST; Lind CE, 2012, BIOL J LINN SOC, V107, P632, DOI 10.1111/j.1095-8312.2012.01960.x; Liping L., 2001, J GEMMOL, V27, P449, DOI [DOI 10.15506/JOG.2001.278.449, 10.15506/JoG.2001.27.8.449]; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Loreille OM, 2007, FORENSIC SCI INT-GEN, V1, P191, DOI 10.1016/j.fsigen.2007.02.006; Macpherson C., 2000, PACIFIC STUDIES, V23, P33; Marie B, 2012, AMINO ACIDS, V42, P2009, DOI 10.1007/s00726-011-0932-0; MARTINSON HG, 1973, BIOCHEMISTRY-US, V12, P2737, DOI 10.1021/bi00738a029; Masaoka T, 2005, FISH GENET BREED SCI, V35, P49, DOI [10.1111/j.1444-2906.2005.01035.x, DOI 10.1111/J.1444-2906.2005.01035.X]; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; MIYOSHI T, 1987, JPN J APPL PHYS 1, V26, P1069, DOI 10.1143/JJAP.26.1069; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Safar A, 2012, PEARLS TREATED IMITA; Scarratt K, 2012, GEMS GEMOL, V48, P236, DOI 10.5741/GEMS.48.4.236; Shor R, 2007, GEMS GEMOL, V43, P200, DOI 10.5741/GEMS.43.3.200; SIMKISS K, 1980, ENDEAVOUR, V4, P32, DOI 10.1016/0160-9327(80)90107-6; Sims NA., 1992, BIOL CULTURE PEARL O; Southgate P, 2008, PEARL OYSTER, pVII; Strack Elisabeth, 2006, PEARLS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Temkin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-342; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Yang SC, 2011, AFR J BIOTECHNOL, V10, P19203, DOI 10.5897/AJB11.2780; Yu DH, 2006, FISHERIES SCI, V72, P1183, DOI 10.1111/j.1444-2906.2006.01275.x; Yu DH, 2006, BIOCHEM SYST ECOL, V34, P240, DOI 10.1016/j.bse.2005.09.004	63	13	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75606	10.1371/journal.pone.0075606	http://dx.doi.org/10.1371/journal.pone.0075606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130725	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900045
J	Yang, LY; Jia, XB; Li, NW; Chen, C; Liu, Y; Wang, HJ				Yang, LingYun; Jia, XiBiao; Li, NingWei; Chen, Cen; Liu, Yi; Wang, HongJing			Comprehensive Clinic-Pathological Characteristics of Cervical Cancer in Southwestern China and the Clinical Significance of Histological Type and Lymph Node Metastases in Young Patients	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; CARCINOMA; WOMEN; AGE; CHEMORADIATION; ADENOCARCINOMA; MORTALITY; NEOPLASIA	Objective: To analyze the clinic-pathological characteristics of women with cervical cancers in southwestern China and discuss the features and prognosis of young patients. Methods: A retrospective study was performed, which consisted of 1,543 patients diagnosed with cervical cancer and underwent treatment at West China Second University Hospital between November 2005 and December 2010. Among them, 154 young patients with surgical procedures between November 2005 and December 2008 were selected for a 5-year follow-up and prognostic analysis. Results: The proportion of advanced FIGO stage in patients aged over 35 years was higher than in patients aged 35 years or younger (55.1% vs 38.8%, P<0.001), and strong correlation was found between FIGO stages and the postoperative pathological risk factors (P<0.05). 312 patients (20.2%) were under 35 years old in the last 5 years. The proportion of cervical adenocarcinoma remained high in young patients (13.6%), and young women with adenocarcinoma had a higher rate of LN metastases, comparing with those with squamous cell carcinoma (42.9% vs 15.8%, P = 0.004). Young patients with adenocarcinoma had shorter progression-free survival than those who had squamous cell carcinoma (P = 0.024). Patients aged 35 years or younger with positive postoperative pathological risk factors had shorter progression-free survival, comparing with those with negative factors (P<0.01). Conclusion: Patients over 35 years were preliminarily diagnosed as advanced FIGO stage and they were more likely to have deep stromal invasion, LVSI, LN metastases, parametrial and surgical margin involvement. Regarding to young patients, cervical adenocarcinoma increased the risk of LN metastases and positive postoperative pathological risk factors could apparently worsen the prognosis. Histological type and LN metastases were independent prognostic factors for young patients in southwestern China. We re-emphasize the importance of health education and regular smear screening for elder women, and more attention should be paid to young patients with adenocarcinoma or LN metastases.	[Yang, LingYun; Jia, XiBiao; Li, NingWei; Chen, Cen; Liu, Yi; Wang, HongJing] Sichuan Univ, Dept Gynecol & Obstet, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China	Sichuan University	Wang, HJ (corresponding author), Sichuan Univ, Dept Gynecol & Obstet, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China.	whjscdx@163.com						Adamopoulou M, 2009, ANTICANCER RES, V29, P3401; Barnholtz-Sloan J, 2009, CANCER CAUSE CONTROL, V20, P1129, DOI 10.1007/s10552-009-9317-z; Bulk S, 2003, BRIT J CANCER, V89, P834, DOI 10.1038/sj.bjc.6601157; Cao ZY, 2010, CHINA OBSTETRICS GYN; CARMICHAEL JA, 1986, AM J OBSTET GYNECOL, V154, P264, DOI 10.1016/0002-9378(86)90652-6; CLARK MA, 1991, AM J CLIN ONCOL-CANC, V14, P352, DOI 10.1097/00000421-199108000-00016; Delaloye JF, 1996, EUR J OBSTET GYN R B, V64, P201, DOI 10.1016/0301-2115(95)02290-2; ELLIOTT PM, 1989, BRIT MED J, V298, P288, DOI 10.1136/bmj.298.6669.288; Frega A, 2003, CANCER LETT, V196, P127, DOI 10.1016/S0304-3835(03)00218-0; Gold MA, 2008, CANCER, V112, P1954, DOI 10.1002/cncr.23400; Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO;2-1; Ho CM, 2004, GYNECOL ONCOL, V93, P458, DOI 10.1016/j.ygyno.2004.01.026; Hoque ME, 2013, J CANCER RES THER, V9, P25, DOI 10.4103/0973-1482.110350; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JUNOR EJ, 1989, BRIT J OBSTET GYNAEC, V96, P522, DOI 10.1111/j.1471-0528.1989.tb03250.x; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KODAMA S, 1991, CANCER, V68, P2481, DOI 10.1002/1097-0142(19911201)68:11<2481::AID-CNCR2820681127>3.0.CO;2-K; Lau HY, 2009, INT J GYNECOL OBSTET, V107, P220, DOI 10.1016/j.ijgo.2009.07.029; [刘兰芳 LIU Lanfang], 2008, [中国癌症杂志, China Oncology], V18, P298; Marchiole P, 2005, GYNECOL ONCOL, V97, P727, DOI 10.1016/j.ygyno.2005.01.004; Masumoto N, 2004, GYNECOL ONCOL, V94, P509, DOI 10.1016/j.ygyno.2004.05.011; McMullin JM, 2005, ETHNIC HEALTH, V10, P3, DOI 10.1080/1355785052000323001; MEANWELL CA, 1988, BRIT MED J, V296, P386, DOI 10.1136/bmj.296.6619.386; Moore DH, 2008, CANCER, V112, P1874, DOI 10.1002/cncr.23386; Moscicki Anna-Barbara, 2010, Adolesc Med State Art Rev, V21, P347; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; PIVER MS, 1974, OBSTET GYNECOL, V44, P265; Robertson D., 1993, European Journal of Gynaecological Oncology, V14, P283; RUTLEDGE FN, 1992, GYNECOL ONCOL, V44, P123, DOI 10.1016/0090-8258(92)90027-G; Sasieni P, 2009, INT J CANCER, V125, P525, DOI 10.1002/ijc.24410; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Shi JF, 2008, VACCINE, V26, pM53, DOI 10.1016/j.vaccine.2008.05.009; SPANOS WJ, 1989, GYNECOL ONCOL, V35, P66, DOI 10.1016/0090-8258(89)90013-9; Touboul C, 2010, ONCOLOGIST, V15, P405, DOI 10.1634/theoncologist.2009-0295; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Vinh-Hung V, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-164; Wang SS, 2010, CANCER-AM CANCER SOC, V116, P949, DOI 10.1002/cncr.24843	39	9	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75849	10.1371/journal.pone.0075849	http://dx.doi.org/10.1371/journal.pone.0075849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130747	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900060
J	Baksi, S; Jana, NR; Bhattacharyya, NP; Mukhopadhyay, D				Baksi, Shounak; Jana, Nihar R.; Bhattacharyya, Nitai Pada; Mukhopadhyay, Debashis			Grb2 Is Regulated by Foxd3 and Has Roles in Preventing Accumulation and Aggregation of Mutant Huntingtin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN STRIATAL CELLS; CAG REPEAT; DISEASE; PROTEIN; TRANSCRIPTION; DOMAIN; MICE; GENE; EXPRESSION	Growth factor receptor protein binding protein 2 (Grb2) is known to be associated with intracellular growth and proliferation related signaling cascades. Huntingtin (Htt), a ubiquitously expressed protein, when mutated, forms toxic intracellular aggregates - the hallmark of Huntington's disease (HD). We observed an elevated expression of Grb2 in neuronal cells in animal and cell models of HD. Grb2 overexpression was predominantly regulated by the transcription factor Forkhead Box D3 (Foxd3). Exogenous expression of Grb2 also reduced aggregation of mutant Htt in Neuro2A cells. Grb2 is also known to interact with Htt, depending on epidermal growth factor receptor (EGFR) activation. Grb2- mutant Htt interaction in the contrary, took place in vesicular structures, independent of EGFR activation that eventually merged with autophagosomes and activated the autophagy machinery helping in autophagosome and lysosome fusion. Grb2, with its emerging dual role, holds promise for a survival mechanism for HD.	[Baksi, Shounak; Mukhopadhyay, Debashis] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, India; [Jana, Nihar R.] Natl Brain Res Ctr, Div Cellular & Mol Neurosci, Manesar, Haryana, India; [Bhattacharyya, Nitai Pada] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Saha Institute of Nuclear Physics	Mukhopadhyay, D (corresponding author), Saha Inst Nucl Phys, Struct Genom Div, Kolkata, India.	debashis.mukhopadhyay@saha.ac.in		Baksi, Shounak/0000-0001-7225-5377; Jana, Nihar/0000-0002-6549-4211	IBOP, DAE, Govt. of India	IBOP, DAE, Govt. of India	This work is funded by IBOP, DAE, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Banerjee M, 2010, NUCLEIC ACIDS RES, V38, P878, DOI 10.1093/nar/gkp1011; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Choudhury KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051415; Datta M, 2011, J BIOL CHEM, V286, P33759, DOI 10.1074/jbc.M111.265173; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P221; Heng MY, 2010, AUTOPHAGY, V6, P1206, DOI 10.4161/auto.6.8.13617; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Maheshwari M, 2012, J BIOL CHEM, V287, P29949, DOI 10.1074/jbc.M112.371724; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Raychaudhuri M, 2010, J ALZHEIMERS DIS, V20, P275, DOI 10.3233/JAD-2010-1371; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; Sinha M, 2010, BIOCHEM BIOPH RES CO, V396, P742, DOI 10.1016/j.bbrc.2010.05.007; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tari AM, 2001, SEMIN ONCOL, V28, P142, DOI 10.1053/sonc.2001.28555; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76792	10.1371/journal.pone.0076792	http://dx.doi.org/10.1371/journal.pone.0076792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116161	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200070
J	Bol, K; Haeck, JC; Groen, HC; Niessen, WJ; Bernsen, MR; de Jong, M; Veenland, JF				Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Niessen, Wiro J.; Bernsen, Monique R.; de Jong, Marion; Veenland, Jifke F.			Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; RADIOLABELED SOMATOSTATIN ANALOG; INDIUM-111-PENTETREOTIDE; PARAMETERS; PERFUSION; TRACER	Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled peptides can be visualized in a neuroendocrine tumor model overexpressing somatostatin receptors. A heterogeneous peptide uptake is often observed in these tumors. We hypothesized that peptide distribution in the tumor is spatially related to tumor perfusion, vessel density and permeability, as imaged and quantified by DCE-MRI in a neuroendocrine tumor model. Four subcutaneous CA20948 tumor-bearing Lewis rats were injected with the somatostatin-analog In-111-DTPA-Octreotide (50 MBq). SPECT-CT and MRI scans were acquired and MRI was spatially registered to SPECT-CT. DCE-MRI was analyzed using semi-quantitative and quantitative methods. Correlation between SPECT and DCE-MRI was investigated with 1) Spearman's rank correlation coefficient; 2) SPECT uptake values grouped into deciles with corresponding median DCE-MRI parametric values and vice versa; and 3) linear regression analysis for median parameter values in combined datasets. In all tumors, areas with low peptide uptake correlated with low perfusion/density//permeability for all DCE-MRI-derived parameters. Combining all datasets, highest linear regression was found between peptide uptake and semi-quantitative parameters (R-2>0.7). The average correlation coefficient between SPECT and DCE-MRI-derived parameters ranged from 0.52-0.56 (p<0.05) for parameters primarily associated with exchange between blood and extracellular extravascular space. For these parameters a linear relation with peptide uptake was observed. In conclusion, the 'exchange-related' DCE-MRI-derived parameters seemed to predict peptide uptake better than the 'contrast amount-related' parameters. Consequently, fast and efficient diffusion through the vessel wall into tissue is an important factor for peptide delivery. DCE-MRI helps to elucidate the relation between vascular characteristics, peptide delivery and treatment efficacy, and may form a basis to predict targeting efficiency.	[Bol, Karin; Haeck, Joost C.; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Niessen, Wiro J.; Veenland, Jifke F.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Niessen, Wiro J.; Bernsen, Monique R.; de Jong, Marion; Veenland, Jifke F.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Bol, Karin; Haeck, Joost C.; Groen, Harald C.; Bernsen, Monique R.; de Jong, Marion] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Bol, K (corresponding author), Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands.	k.bol@erasmusmc.nl		Niessen, Wiro/0000-0002-5822-1995; Veenland, Jifke/0000-0003-0456-6143; Bernsen, Monique/0000-0002-5203-5083	Dutch Cancer Society - KWF [2008-4037]	Dutch Cancer Society - KWF(KWF Kankerbestrijding)	This work was funded by the Dutch Cancer Society - KWF (grant no. 2008-4037) - http://www.kwfkankerbestrijding.nl/Pages/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PHYS MED BIOL, V56, P1601, DOI 10.1088/0031-9155/56/6/006; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Bodei L, 2010, EUR REV MED PHARMACO, V14, P347; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Capello A, 2005, EUR J NUCL MED MOL I, V32, P1288, DOI 10.1007/s00259-005-1877-x; de Herder Wouter W, 2006, Pituitary, V9, P243, DOI 10.1007/s11102-006-0270-5; de Jong M, 1999, EUR J NUCL MED, V26, P693, DOI 10.1007/s002590050439; Delaunoit T, 2005, MAYO CLIN PROC, V80, P502, DOI 10.4065/80.4.502; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Forrer F, 2007, BEST PRACT RES CL EN, V21, P111, DOI 10.1016/j.beem.2007.01.007; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Hansen AE, 2012, RADIOTHER ONCOL, V102, P424, DOI 10.1016/j.radonc.2011.10.021; Heisen M, 2010, MAGN RESON MED, V63, P811, DOI 10.1002/mrm.22171; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Jong M, 2003, EUR J NUCL MED MOL I, V30, P463, DOI 10.1007/s00259-002-1107-8; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; KRENNING EP, 1993, EUR J NUCL MED, V20, P716, DOI 10.1007/BF00181765; Kwekkeboom DJ, 2008, J CLIN ONCOL, V26, P2124, DOI 10.1200/JCO.2007.15.2553; Kwekkeboom DJ, 2005, J NUCL MED, V46, p62S; LEE JD, 1995, J NUCL MED, V36, P537; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Melancon MP, 2011, J CONTROL RELEASE, V156, P265, DOI 10.1016/j.jconrel.2011.06.030; Metz S, 2010, J NUCL MED, V51, P1691, DOI 10.2967/jnumed.110.077719; Miyazaki K, 2012, RADIOLOGY, V263, P139, DOI 10.1148/radiol.12110770; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; Parker GJM, 1997, JMRI-J MAGN RESON IM, V7, P564, DOI 10.1002/jmri.1880070318; PATEL YC, 1990, NEW ENGL J MED, V323, P1274, DOI 10.1056/NEJM199011013231811; Reubi JC, 2005, J NUCL MED, V46, p67S; Rufini V, 2006, SEMIN NUCL MED, V36, P228, DOI 10.1053/j.semnuclmed.2006.03.007; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Van Essen M, 2007, ACTA ONCOL, V46, P723, DOI 10.1080/02841860701441848	32	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77076	10.1371/journal.pone.0077076	http://dx.doi.org/10.1371/journal.pone.0077076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116203	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200099
J	Rougeron, V; Woods, CM; Tiedje, KE; Bodeau-Livinec, F; Migot-Nabias, F; Deloron, P; Luty, AJF; Fowkes, FJI; Day, KP				Rougeron, Virginie; Woods, Caira M.; Tiedje, Kathryn E.; Bodeau-Livinec, Florence; Migot-Nabias, Florence; Deloron, Philippe; Luty, Adrian J. F.; Fowkes, Freya J. I.; Day, Karen P.			Epistatic Interactions between Apolipoprotein E and Hemoglobin S Genes in Regulation of Malaria Parasitemia	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; ALZHEIMERS-DISEASE; HAPTOGLOBIN GENOTYPE; CLINICAL MALARIA; E POLYMORPHISM; ENDEMIC AREA; RECEPTOR; ALLELE	Apolipoprotein E is a monomeric protein secreted by the liver and responsible for the transport of plasma cholesterol and triglycerides. The APOE gene encodes 3 isoforms epsilon 4, epsilon 3 and epsilon 2 with APOE epsilon 4 associated with higher plasma cholesterol levels and increased pathogenesis in several infectious diseases (HIV, HSV). Given that cholesterol is an important nutrient for malaria parasites, we examined whether APOE epsilon 4 was a risk factor for Plasmodium infection, in terms of prevalence or parasite density. A cross sectional survey was performed in 508 children aged 1 to 12 years in Gabon during the wet season. Children were screened for Plasmodium spp. infection, APOE and hemoglobin S (HbS) polymorphisms. Median parasite densities were significantly higher in APOE epsilon 4 children for Plasmodium spp. densities compared to non-APOE epsilon 4 children. When stratified for HbS polymorphisms, median Plasmodium spp. densities were significantly higher in HbAA children if they had an APOE epsilon 4 allele compared to those without an APOE epsilon 4 allele. When considering non-APOE epsilon 4 children, there was no quantitative reduction of Plasmodium spp. parasite densities for HbAS compared to HbAA phenotypes. No influence of APOE epsilon 4 on successful Plasmodium liver cell invasion was detected by multiplicity of infection. These results show that the APOE epsilon 4 allele is associated with higher median malaria parasite densities in children likely due to the importance of cholesterol availability to parasite growth and replication. Results suggest an epistatic interaction between APOE and HbS genes such that sickle cell trait only had an effect on parasite density in APOE epsilon 4 children. This suggests a linked pathway of regulation of parasite density involving expression of these genes. These findings have significance for understanding host determinants of regulation of malaria parasite density, the design of clinical trials as well as studies of co-infection with Plasmodium and other pathogens.	[Rougeron, Virginie; Woods, Caira M.; Tiedje, Kathryn E.; Bodeau-Livinec, Florence; Fowkes, Freya J. I.; Day, Karen P.] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Bodeau-Livinec, Florence; Migot-Nabias, Florence; Deloron, Philippe; Luty, Adrian J. F.] Inst Rech Dev, UMR216, Paris, France; [Deloron, Philippe] Univ Paris 05, Paris Sorbonne Cite, PRES, Paris, France; [Fowkes, Freya J. I.] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Populat Hlth, Melbourne, Vic, Australia	New York University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Burnet Institute	Day, KP (corresponding author), NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA.	karen.day@nyumc.org	Rougeron, Virginie/AAH-7447-2020; Deloron, Philippe/G-6305-2010; Day, Karen/F-3697-2015; Luty, Adrian/CAH-2547-2022; Bodeau-Livinec, Florence/U-9053-2017	Deloron, Philippe/0000-0003-4705-2484; Day, Karen/0000-0002-6115-6135; Bodeau-Livinec, Florence/0000-0002-4266-6287; Fowkes, Freya/0000-0001-5832-9464; Migot-Nabias, Florence/0000-0001-9982-594X; Luty, Adrian John Frederick/0000-0001-8830-3425; Rougeron, Virginie/0000-0001-5873-5681; Tiedje, Kathryn E/0000-0003-3305-0533	Wellcome Trust Programme [041354]; European Union INCO Programme [IC18-CT98-0359]; NIH/National Institute of Allergy and Infectious Disease [R01-AI-084156]; NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship [F31-GM-86134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086134] Funding Source: NIH RePORTER	Wellcome Trust Programme(Wellcome Trust); European Union INCO Programme; NIH/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FJIF and KPD received financial support from the Wellcome Trust Programme (grant No. 041354) and FMN, PD, AJFL and KPD received support from the European Union INCO Programme (contract no. IC18-CT98-0359). VR, KET and KPD were supported by a grant from NIH/National Institute of Allergy and Infectious Disease grant (R01-AI-084156). CMW was a recipient of a NIH Ruth L. Kirschstein National Research Service Award Individual Fellowship (F31-GM-86134). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucan C, 2004, J MED GENET, V41, P21, DOI 10.1136/jmg.2003.011981; Bansal Devendra, 2005, Lipids Health Dis, V4, P10, DOI 10.1186/1476-511X-4-10; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corder EH, 2008, REJUV RES, V11, P667, DOI 10.1089/rej.2008.0742; Corder EH, 2008, P NATL ACAD SCI USA, V105, pE87, DOI 10.1073/pnas.0808164105; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Fairhurst RM, 2006, CURR OPIN HEMATOL, V13, P124, DOI 10.1097/01.moh.0000219655.73162.42; Falk N, 2006, AM J TROP MED HYG, V74, P944, DOI 10.4269/ajtmh.2006.74.944; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Fowkes FJI, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-1; Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2002, STAT APROGRAM ESTIMA; Gregg R E, 1986, Methods Enzymol, V129, P482; GREGG RE, 1988, CLIN CHEM, V34, pB28; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Jayabalasingham B, 2010, BIOL REPROD, V2; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Katzman Robert, 1994, Current Opinion in Neurobiology, V4, P703, DOI 10.1016/0959-4388(94)90013-2; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Labaied M, 2011, CELL MICROBIOL, V13, P569, DOI 10.1111/j.1462-5822.2010.01555.x; Lucotte G, 1997, HUM BIOL, V69, P253; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Migot-Nabias F, 2000, GENES IMMUN, V1, P435, DOI 10.1038/sj.gene.6363703; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Parquet V, 2009, ANTIMICROB AGENTS CH, V53, P2248, DOI 10.1128/AAC.01462-08; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rathore D, 2001, MOL BIOCHEM PARASIT, V118, P75, DOI 10.1016/S0166-6851(01)00369-3; Ribalta J, 2003, CURR OPIN CLIN NUTR, V6, P177, DOI 10.1097/00075197-200303000-00006; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 2000, Bull Mem Acad R Med Belg, V155, P218; Shakibaei M, 1996, J EXP MED, V184, P1699, DOI 10.1084/jem.184.5.1699; SIEST G, 1995, CLIN CHEM, V41, P1068; Sinnis P, 1996, J EXP MED, V184, P945, DOI 10.1084/jem.184.3.945; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; Vignali M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-211; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	60	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76924	10.1371/journal.pone.0076924	http://dx.doi.org/10.1371/journal.pone.0076924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116184	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200084
J	Stames, EM; O'Toole, JF				Stames, Erine M.; O'Toole, John F.			Mitochondrial Aminopeptidase Deletion Increases Chronological Lifespan and Oxidative Stress Resistance while Decreasing Respiratory Metabolism in S. cerevisiae	PLOS ONE			English	Article							MAMMALIAN TARGET; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; GLOBAL ANALYSIS; YEAST; PROTEIN; RAPAMYCIN; MTOR; ACTIVATION; PATHWAY	Recessive mutations in XPNPEP3, encoding a mitochondrial x-prolyl aminopeptidase, have been identified in families with a rare hereditary tubulointerstitial kidney disease. The yeast ortholog of XPNPEP3, Icp55p, participates in the proteolytic processing and stabilization of mitochondrial proteins and its deletion accelerates the degradation of its protein targets. We used icp55 deletion strains of S. cerevisiae to model loss of XPNPEP3 enzymatic function and study its phenotypic consequences on mitochondrial function. We found that Icp55p is not required for respiratory competence; however, compared to controls deletion strains had reduced mitochondrial oxygen consumption when grown in glucose containing media. The reduced mitochondrial respiration of icp55 deletion strains in glucose media requires the mitochondrial peptide transporter, Mdl1p, and was corrected by Tor1p inhibition with rapamycin. Under similar growth conditions the abundance of the mitochondrial ATP synthase complex was decreased in the icp55 deletion strain and was corrected by concurrent deletion of tor1. The icp55 deletion strain demonstrated an increased chronological lifespan and decreased reactive oxygen species. These changes were additive to similar changes known to occur in tor1 deletion strains suggesting independent mechanisms. Together, these results demonstrate that loss of Icp55p function reduces mitochondrial oxygen consumption and ATP synthase complex assembly in glucose media, while also promoting stress resistance, decreasing reactive oxygen species and increasing chronological lifespan through mechanisms that are distinct from decreased Tor1p activity.	[O'Toole, John F.] MetroHealth Med Syst, Div Nephrol, Dept Med, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA	MetroHealth System; Case Western Reserve University	O'Toole, JF (corresponding author), MetroHealth Med Syst, Div Nephrol, Dept Med, Cleveland, OH USA.	jxo69@case.edu			National Institutes of Health [K08DK071108, RO1DK091597]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071108, R01DK091597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JFO has received support through the National Institutes of Health (K08DK071108 and RO1DK091597) and this publication was made possible by the Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF180, DOI 10.1152/ajprenal.00015.2012; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Varshavsky A, 2011, PROTEIN SCI, V10; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YOSHIMOTO T, 1988, J BIOCHEM, V104, P93, DOI 10.1093/oxfordjournals.jbchem.a122430; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77234	10.1371/journal.pone.0077234	http://dx.doi.org/10.1371/journal.pone.0077234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116217	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200109
J	Wang, HX; Wu, XR; Yang, H; Yin, CL; Shi, LJ; Wang, XJ				Wang, Hong-Xia; Wu, Xin-Rui; Yang, Hui; Yin, Chun-Lin; Shi, Li-Jin; Wang, Xue-Jiang			Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase Pathway	PLOS ONE			English	Article							INSULIN-RESISTANCE; EXPRESSION; MOUSE; PROLIFERATION; ACTIVATION; MODEL; GENE	Our previous studies have demonstrated that the urotensin (UII) and its receptor are up-regulated in the skeletal muscle of mice with type II diabetes mellitus (T2DM), but the significance of UII in skeletal muscle insulin resistance remains unknown. The purpose of this study was to investigate the effect of UII on NADPH oxidase and glucose transport signaling pathways in the skeletal muscle of mice with T2DM and in C2C12 mouse myotube cells. KK/upj-AY/J mice (KK) mice were divided into the following groups: KK group, with saline treatment for 2 weeks; KK+urantide group, with daily 30 mu g/kg body weight injections over the same time period of urantide, a potent urotensin II antagonist peptide; Non-diabetic C57BL/6J mice were used as normal controls. After urantide treatment, mice were subjected to an intraperitoneal glucose tolerance test, in addition to measurements of the levels of ROS, NADPH oxidase and the phosphorylated AKT, PKC and ERK. C2C12 cells were incubated with serum-free DMEM for 24 hours before conducting the experiments, and then administrated with 100 nM UII for 2 hours or 24 hours. Urantide treatment improved glucose tolerance, decreased the translocation of the NADPH subunits p40-phox and p47-phox, and increased levels of the phosphorylated PKC, AKT and ERK. In contrast, UII treatment increased ROS production and p47-phox and p67-phox translocation, and decreased the phosphorylated AKT, ERK1/2 and p38MAPK; Apocynin abrogated this effect. In conclusion, UII increased ROS production by NADPH oxidase, leading to the inhibition of signaling pathways involving glucose transport, such as AKT/PKC/ERK. Our data imply a role for UII at the molecular level in glucose homeostasis, and possibly in skeletal muscle insulin resistance in T2DM.	[Wang, Hong-Xia; Wu, Xin-Rui; Yang, Hui; Wang, Xue-Jiang] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yin, Chun-Lin] Capital Med Univ, Xuan Wu Hosp, Dept Cardiol, Beijing, Peoples R China; [Shi, Li-Jin] Xinxiang Med Coll, Affiliated Hosp 1, Dept Neurol, Xinxiang, Peoples R China	Capital Medical University; Capital Medical University; Xinxiang Medical University	Wang, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	whxdy@sina.com			National Natural Science Foundation of China [81000343]; Beijing Natural Science Foundation [7112013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (no. 81000343, http://www.nsfc.gov.cn/Portal0/default152.htm) and Beijing Natural Science Foundation (no. 7112013, http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165; Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533; CASTLE CK, 1993, ARTERIOSCLER THROMB, V13, P302, DOI 10.1161/01.ATV.13.2.302; Chen YL, 2008, EUR J PHARMACOL, V593, P24, DOI 10.1016/j.ejphar.2008.07.025; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; Samocha-Bonet D, 2010, TRENDS ENDOCRIN MET, V21, P83, DOI 10.1016/j.tem.2009.09.008; Sullivan-Gunn MJ, 2011, J CACHEXIA SARCOPENI, V2, P181, DOI 10.1007/s13539-011-0037-3; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Wang HX, 2009, REGUL PEPTIDES, V154, P85, DOI 10.1016/j.regpep.2009.01.004; Wang HX, 2012, CYTOKINE, V60, P360, DOI 10.1016/j.cyto.2012.04.029; Wang XW, 2012, TOXICOL APPL PHARM, V259, P346, DOI 10.1016/j.taap.2012.01.013; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Watson AMD, 2013, DIABETOLOGIA, V56, P1155, DOI 10.1007/s00125-013-2837-9; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Woods Yvonne L., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P187	24	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76796	10.1371/journal.pone.0076796	http://dx.doi.org/10.1371/journal.pone.0076796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116164	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200073
J	Wong, G; Barlow, CK; Weir, JM; Jowett, JBM; Magliano, DJ; Zimmet, P; Shaw, J; Meikle, PJ				Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Jowett, Jeremy B. M.; Magliano, Dianna J.; Zimmet, Paul; Shaw, Jonathan; Meikle, Peter J.			Inclusion of Plasma Lipid Species Improves Classification of Individuals at Risk of Type 2 Diabetes	PLOS ONE			English	Article							INFLAMMATION; CERAMIDES; OBESITY	Background: A significant proportion of individuals with diabetes or impaired glucose tolerance have fasting plasma glucose less than 6.1 mmol/L and so are not identified with fasting plasma glucose measurements. In this study, we sought to evaluate the utility of plasma lipids to improve on fasting plasma glucose and other standard risk factors for the identification of type 2 diabetes or those at increased risk (impaired glucose tolerance). Methods and Findings: Our diabetes risk classification model was trained and cross-validated on a cohort 76 individuals with undiagnosed diabetes or impaired glucose tolerance and 170 gender and body mass index matched individuals with normal glucose tolerance, all with fasting plasma glucose less than 6.1 mmol/L. The inclusion of 21 individual plasma lipid species to triglycerides and HbA1c as predictors in the diabetes risk classification model resulted in a statistically significant gain in area under the receiver operator characteristic curve of 0.049 (p<0.001) and a net reclassification improvement of 10.5% (p<0.001). The gain in area under the curve and net reclassification improvement were subsequently validated on a separate cohort of 485 subjects. Conclusions: Plasma lipid species can improve the performance of classification models based on standard lipid and non-lipid risk factors.	[Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Jowett, Jeremy B. M.; Magliano, Dianna J.; Zimmet, Paul; Shaw, Jonathan; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute	Meikle, PJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	peter.meikle@bakeridi.edu.au	Shaw, Jonathan/E-7388-2010; Zimmet, Paul/O-8486-2019; Meikle, Peter J/B-4023-2009	Shaw, Jonathan/0000-0002-6187-2203; Zimmet, Paul/0000-0003-0627-0776; Barlow, Christopher/0000-0001-9309-2829; Meikle, Peter/0000-0002-2593-4665; Magliano, Dianna/0000-0002-9507-6096	NHMRC; Victorian Cancer Agency Public Health Fellowship; Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia; OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA [1R01DK088972-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088972] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency Public Health Fellowship; Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PJM and JS are supported by an NHMRC senior research fellowship. DJM is supported by a Victorian Cancer Agency Public Health Fellowship. This work was supported by funding from the Dairy Health and Nutrition Consortium, Australia, The National Health and Medical Research Council of Australia, the OIS Program of the Victorian Government, Australia and by Award Number 1R01DK088972-01 from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the aforementioned funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Barr ELM., 2006, AUSDIAB 2005 AUSTR D; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Cefalu WT, 2009, DIABETES, V58, P307, DOI 10.2337/db08-1656; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5; Magliano DJ, 2009, AUST NZ J PUBL HEAL, V33, P540, DOI 10.1111/j.1753-6405.2009.00450.x; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rizza S, 2012, ATHEROSCLEROSIS; Rizza S, 2010, ATHEROSCLEROSIS, V212, P316, DOI 10.1016/j.atherosclerosis.2010.05.017; Shaw J., 2012, DIABETES SILENT PAND; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stahlman M, 2012, DIABETOLOGIA, V55, P1156, DOI 10.1007/s00125-011-2444-6; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76577	10.1371/journal.pone.0076577	http://dx.doi.org/10.1371/journal.pone.0076577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116121	gold, Green Published			2022-12-25	WOS:000325552200058
J	Mills, KT; Hamm, LL; Alper, AB; Miller, C; Hudaihed, A; Balamuthusamy, S; Chen, CS; Liu, YX; Tarsia, J; Rifai, N; Kleinpeter, M; He, J; Chen, J				Mills, Katherine T.; Hamm, L. Lee; Alper, A. Brent; Miller, Chad; Hudaihed, Alhakam; Balamuthusamy, Saravanan; Chen, Chung-Shiuan; Liu, Yanxi; Tarsia, Joseph; Rifai, Nader; Kleinpeter, Myra; He, Jiang; Chen, Jing			Circulating Adipocytokines and Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; PLASMA-PROTEIN; ADIPONECTIN; LEPTIN; ASSOCIATION; ALBUMINURIA; PROGRESSION; POPULATION	Background: Adipokines have been associated with atherosclerotic heart disease, which shares many common risk factors with chronic kidney disease (CKD), but their relationship with CKD has not been well characterized. Methods: We investigated the association of plasma leptin, resistin and adiponectin with CKD in 201 patients with CKD and 201 controls without. CKD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2) or presence of albuminuria. Quantile regression and logistic regression models were used to examine the association between adipokines and CKD adjusting for multiple confounding factors. Results: Compared to controls, adjusted median leptin (38.2 vs. 17.2 ng/mL, p<0.0001) and adjusted mean resistin (16.2 vs 9.0 ng/mL, p<0.0001) were significantly higher in CKD cases. The multiple-adjusted odds ratio (95% confidence interval) of CKD comparing the highest tertile to the lower two tertiles was 2.3 (1.1, 4.9) for leptin and 12.7 (6.5, 24.6) for resistin. Median adiponectin was not significantly different in cases and controls, but the odds ratio comparing the highest tertile to the lower two tertiles was significant (1.9; 95% CI, 1.1, 3.6). In addition, higher leptin, resistin, and adiponectin were independently associated with lower eGFR and higher urinary albumin levels. Conclusions: These findings suggest that adipocytokines are independently and significantly associated with the risk and severity of CKD. Longitudinal studies are warranted to evaluate the prospective relationship of adipocytokines to the development and progression of CKD.	[Mills, Katherine T.; Chen, Chung-Shiuan; Liu, Yanxi; He, Jiang; Chen, Jing] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Hamm, L. Lee; Alper, A. Brent; Miller, Chad; Hudaihed, Alhakam; Balamuthusamy, Saravanan; Tarsia, Joseph; Kleinpeter, Myra; He, Jiang; Chen, Jing] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Hamm, L. Lee; Alper, A. Brent; Kleinpeter, Myra; Chen, Jing] Tulane Univ, Sch Med, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Rifai, Nader] Children Hosp, Dept Lab Med, Boston, MA USA; [Rifai, Nader] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Tulane University; Tulane University; Tulane University; Harvard University; Boston Children's Hospital; King Abdulaziz University	Chen, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	jchen@tulane.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652	National Center for Research Resources, National Institutes of Health, Bethesda, Maryland [P20-RR017659, P30-GM103337]; Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P30GM103337] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants (P20-RR017659 and P30-GM103337) from the National Center for Research Resources, National Institutes of Health, Bethesda, Maryland (http://www.nih.gov/about/almanac/organization/NCRR.htm) and partially supported by a Clinical and Translational Clinical Research Center grant from the Louisiana Board of Regents RC/EEP Fund (http://web.laregents.org/programs/rceep/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fruehwald-Schultes B, 1999, METABOLISM, V48, P1290, DOI 10.1016/S0026-0495(99)90270-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsieh C C, 1991, Epidemiology, V2, P137, DOI 10.1097/00001648-199103000-00008; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Nanayakkara PWB, 2009, CLIN NEPHROL, V72, P21; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Nordfors L, 1998, KIDNEY INT, V54, P1267, DOI 10.1046/j.1523-1755.1998.00088.x; Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Sarnak MJ, 2002, KIDNEY INT, V62, P2208, DOI 10.1046/j.1523-1755.2002.00677.x; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Shankar A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/269532; Sharma K, 1997, KIDNEY INT, V51, P1980, DOI 10.1038/ki.1997.269; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yaturu S, 2007, CYTOKINE, V37, P1, DOI 10.1016/j.cyto.2007.02.003; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	31	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76902	10.1371/journal.pone.0076902	http://dx.doi.org/10.1371/journal.pone.0076902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116180	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300104
J	Park, E; Nebenfuhr, A				Park, Eunsook; Nebenfuehr, Andreas			Myosin XIK of Arabidopsis thaliana Accumulates at the Root Hair Tip and Is Required for Fast Root Hair Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MOTILITY; EXPRESSED SEQUENCE TAGS; F-ACTIN ORGANIZATION; PLANT-CELLS; PHYSCOMITRELLA-PATENS; POLARIZED GROWTH; GTPASE CONTROLS; TAIL FUSIONS; GENE FAMILY; ROP2 GTPASE	Myosin motor proteins are thought to carry out important functions in the establishment and maintenance of cell polarity by moving cellular components such as organelles, vesicles, or protein complexes along the actin cytoskeleton. In Arabidopsis thaliana, disruption of the myosin XIK gene leads to reduced elongation of the highly polar root hairs, suggesting that the encoded motor protein is involved in this cell growth. Detailed live-cell observations in this study revealed that xik root hairs elongated more slowly and stopped growth sooner than those in wild type. Overall cellular organization including the actin cytoskeleton appeared normal, but actin filament dynamics were reduced in the mutant. Accumulation of RabA4b-containing vesicles, on the other hand, was not significantly different from wild type. A functional YFP-XIK fusion protein that could complement the mutant phenotype accumulated at the tip of growing root hairs in an actin-dependent manner. The distribution of YFP-XIK at the tip, however, did not match that of the ER or several tip-enriched markers including CFP-RabA4b. We conclude that the myosin XIK is required for normal actin dynamics and plays a role in the subapical region of growing root hairs to facilitate optimal growth.	[Park, Eunsook; Nebenfuehr, Andreas] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Nebenfuhr, A (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	nebenfuehr@utk.edu		Nebenfuhr, Andreas/0000-0002-4997-2180; Park, Eunsook/0000-0003-2984-3039	National Science Foundation [MCB-0822111]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (grant MCB-0822111 to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Furt F, 2013, PLANT J, V73, P417, DOI 10.1111/tpj.12039; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Grierson CS, 2002, ARABIODPSIS BOOK; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Hoffmann A, 2004, PROTOPLASMA, V224, P201, DOI 10.1007/s00709-004-0068-0; Houtman D, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/18001; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Jiang SY, 2004, PLANT CELL PHYSIOL, V45, P590, DOI 10.1093/pcp/pch061; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kang BH, 2011, TRAFFIC, V12, P313, DOI 10.1111/j.1600-0854.2010.01146.x; Kawamura E, 2006, PLANT PHYSIOL, V140, P102, DOI 10.1104/pp.105.069989; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; KINKEMA M, 1994, J MOL BIOL, V239, P591, DOI 10.1006/jmbi.1994.1400; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Lee YJ, 2008, J CELL BIOL, V181, P1155, DOI 10.1083/jcb.200801086; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; Lo Presti L, 2012, MOL BIOL CELL, V23, P4579, DOI 10.1091/mbc.E12-07-0499; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Natesan SKA, 2009, MOL PLANT, V2, P1262, DOI 10.1093/mp/ssp078; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Ojangu EL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-81; Park E, 2011, ADVAN PL BIO, V2, P259, DOI 10.1007/978-1-4419-0987-9_12; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Peremyslov VV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00184; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Sparkes IA, 2010, BIOCHEM SOC T, V38, P833, DOI 10.1042/BST0380833; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; Sun C, 2009, J MICROSC-OXFORD, V234, P147, DOI 10.1111/j.1365-2818.2009.03156.x; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Thole JM, 2008, PLANT CELL, V20, P381, DOI 10.1105/tpc.107.054304; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Vidali L, 2010, PLANT CELL, V22, P1868, DOI 10.1105/tpc.109.073288; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang GF, 2012, PLANT CELL, V24, P3447, DOI 10.1105/tpc.112.101360; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	64	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76745	10.1371/journal.pone.0076745	http://dx.doi.org/10.1371/journal.pone.0076745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116145	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300087
J	Chirino, B; Strahsburger, E; Agullo, L; Gonzalez, M; Seeger, M				Chirino, Bernardita; Strahsburger, Erwin; Agullo, Loreine; Gonzalez, Myriam; Seeger, Michael			Genomic and Functional Analyses of the 2-Aminophenol Catabolic Pathway and Partial Conversion of Its Substrate into Picolinic Acid in Burkholderia xenovorans LB400	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PSEUDOMONAS-PUTIDA; DEGRADATION; SEQUENCE; NITROBENZENE; METABOLITES; BIPHENYL; 1,6-DIOXYGENASE; BIODEGRADATION; PROTOANEMONIN	2-aminophenol (2-AP) is a toxic nitrogen-containing aromatic pollutant. Burkholderia xenovorans LB400 possess an amn gene cluster that encodes the 2-AP catabolic pathway. In this report, the functionality of the 2-aminophenol pathway of B. xenovorans strain LB400 was analyzed. The amnRJBACDFEHG cluster located at chromosome 1 encodes the enzymes for the degradation of 2-aminophenol. The absence of habA and habB genes in LB400 genome correlates with its no growth on nitrobenzene. RT-PCR analyses in strain LB400 showed the co-expression of amnJB, amnBAC, amnACD, amnDFE and amnEHG genes, suggesting that the amn cluster is an operon. RT-qPCR showed that the amnB gene expression was highly induced by 2-AP, whereas a basal constitutive expression was observed in glucose, indicating that these amn genes are regulated. We propose that the predicted MarR-type transcriptional regulator encoded by the amnR gene acts as repressor of the amn gene cluster using a MarR-type regulatory binding sequence. This report showed that LB400 resting cells degrade completely 2-AP. The amn gene cluster from strain LB400 is highly identical to the amn gene cluster from P. knackmussi strain B13, which could not grow on 2-AP. However, we demonstrate that B. xenovorans LB400 is able to grow using 2-AP as sole nitrogen source and glucose as sole carbon source. An amnBA 2 mutant of strain LB400 was unable to grow with 2-AP as nitrogen source and glucose as carbon source and to degrade 2-AP. This study showed that during LB400 growth on 2-AP this substrate was partially converted into picolinic acid (PA), a well-known antibiotic. The addition of PA at lag or mid-exponential phase inhibited LB400 growth. The MIC of PA for strain LB400 is 2 mM. Overall, these results demonstrate that B. xenovorans strain LB400 posses a functional 2-AP catabolic central pathway, which could lead to the production of picolinic acid.	[Seeger, Michael] Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.	michael.seeger@usm.cl	Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Strahsburger, Erwin/0000-0001-8829-5859; Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1020221, 1070507]; Center for Nanotechnology and Systems Biology; USM [131109, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for Nanotechnology and Systems Biology; USM	M.S. gratefully acknowledges financial support from FONDECYT (1020221 and 1070507) (http://www.fondecyt.cl), Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (131109, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aoki K, 1997, MICROBIOL RES, V152, P33; Beltrametti F, 2001, MICROBIOL-SGM, V147, P2169, DOI 10.1099/00221287-147-8-2169; BLASCO R, 1995, J BIOL CHEM, V270, P29229, DOI 10.1074/jbc.270.49.29229; Blasco R, 1997, APPL ENVIRON MICROB, V63, P427, DOI 10.1128/AEM.63.2.427-434.1997; Borawska Maria H., 2008, Polish Journal of Food and Nutrition Sciences, V58, P415; Brennan RJ, 1997, MUTAGENESIS, V12, P215, DOI 10.1093/mutage/12.4.215; BRUHN C, 1987, APPL ENVIRON MICROB, V53, P208, DOI 10.1128/AEM.53.1.208-210.1987; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Cai S, 2006, J ANTIMICROB CHEMOTH, V57, P85, DOI 10.1093/jac/dki418; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Clinical and Laboratory Standards Institute, 2008, METH DIL ANT SUSC TE; Davis JK, 1999, ARCH MICROBIOL, V172, P330, DOI 10.1007/s002030050787; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; FERNANDEZPOL JA, 1977, P NATL ACAD SCI USA, V74, P2889, DOI 10.1073/pnas.74.7.2889; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; He Z, 2000, J IND MICROBIOL BIOT, V25, P25, DOI 10.1038/sj.jim.7000018; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Lai QL, 2012, J BACTERIOL, V194, P6674, DOI 10.1128/JB.01813-12; Le Roes-Hill M, 2009, TRENDS BIOTECHNOL, V27, P248, DOI 10.1016/j.tibtech.2009.01.001; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; MELILLO G, 1994, J BIOL CHEM, V269, P8128; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Musk DJ, 2008, J APPL MICROBIOL, V105, P380, DOI 10.1111/j.1365-2672.2008.03751.x; NISHINO SF, 1993, APPL ENVIRON MICROB, V59, P2520, DOI 10.1128/AEM.59.8.2520-2525.1993; Ohkuma Y, 2001, ARCH BIOCHEM BIOPHYS, V389, P49, DOI 10.1006/abbi.2001.2302; Park HS, 1999, APPL ENVIRON MICROB, V65, P1083; Park HS, 2000, J BACTERIOL, V182, P573, DOI 10.1128/JB.182.3.573-580.2000; Park HS, 2001, J BACTERIOL, V183, P5074, DOI 10.1128/JB.183.17.5074-5081.2001; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; Seeger M, 2009, MICROBIOLOGY HYDROCA, P1179; Spain JC, 2003, APPL ENVIRON MICROB, V69, P4037, DOI 10.1128/AEM.69.7.4037-4042.2003; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; Takenaka S, 2005, BIOSCI BIOTECH BIOCH, V69, P1033, DOI 10.1271/bbb.69.1033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vincent JB, 2003, SPORTS MED, V33, P213, DOI 10.2165/00007256-200333030-00004; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Ye J, 2004, WORLD J MICROB BIOT, V20, P117, DOI 10.1023/B:WIBI.0000021720.03712.12	44	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75746	10.1371/journal.pone.0075746	http://dx.doi.org/10.1371/journal.pone.0075746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124510	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100067
J	He, YX; Du, M; Gao, Y; Liu, HS; Wang, HW; Wu, XJ; Wang, ZT				He, Yixin; Du, Min; Gao, Yan; Liu, Hongshuai; Wang, Hongwei; Wu, Xiaojun; Wang, Zhengtao			Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EMERGING THERAPIES; CELL-DEATH; IN-VITRO; SCLEROSIS; INHIBITION; ACID; TAU; BAX; P53	Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory disease found mostly in young adults in the western world. Oxidative stress induced neuronal apoptosis plays an important role in the pathogenesis of MS. In current study, astragaloside IV (ASI), a natural saponin molecule isolated from Astragalus membranceus, given at 20 mg/kg daily attenuated the severity of experimental autoimmune encephalomyelitis (EAE) in mice significantly. Further studies disclosed that ASI treatment inhibited the increase of ROS and pro-inflammatory cytokine levels, down-regulation of SOD and GSH-Px activities, and elevation of iNOS, p53 and phosphorylated tau in central nervous system (CNS) as well as the leakage of BBB of EAE mice. Meanwhile, the decreased ratio of Bcl-2/Bax was reversed by ASI. Moreover, ASI regulated T-cell differentiation and infiltration into CNS. In neuroblast SH-SY5Y cells, ASI dose-dependently reduced cellular ROS level and phosphorylation of tau in response to hydrogen peroxide challenge by modulation of Bcl-2/Bax ratio. ASI also inhibited activation of microglia both in vivo and in vitro. iNOS up-regulation induced by IFN gamma stimulation was abolished by ASI dose-dependently in BV-2 cells. In summary, ASI prevented the severity of EAE progression possibly by counterbalancing oxidative stress and its effects via reduction of cellular ROS level, enhancement of antioxidant defense system, increase of anti-apoptotic and anti-inflammatory pathways, as well as modulation of T-cell differentiation and infiltration into CNS. The study suggested ASI may be effective for clinical therapy/prevention of MS.	[He, Yixin; Gao, Yan; Liu, Hongshuai; Wang, Hongwei; Wu, Xiaojun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China; [He, Yixin] China Pharmaceut Univ, Dept Pharmacognosy, Nanjing, Jiangsu, Peoples R China; [Du, Min] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Immune Signaling & Regulat, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; China Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wu, XJ (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai, Peoples R China.	xiaojunwu320@126.com; wangzht@hotmail.com	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Program of Shanghai Pujiang Talent Plan [11PJ1408800]; National Natural Science Foundation of China [31270917]; Program of Shanghai Talent Developmental Plan [2010009, 2011012]; Key Research Innovation Project [13ZZ099]; Key Project from Department of Education of China [20123107130002]	Program of Shanghai Pujiang Talent Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Talent Developmental Plan; Key Research Innovation Project; Key Project from Department of Education of China	This work was supported by Program of Shanghai Pujiang Talent Plan (11PJ1408800), National Natural Science Foundation of China (31270917), Program of Shanghai Talent Developmental Plan (2010009, 2011012), Key Research Innovation Project (13ZZ099) and Key Project from Department of Education of China (20123107130002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar A, 2012, ACTA NEUROL BELG, V112, P275, DOI 10.1007/s13760-012-0059-4; Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Amorini AM, 2009, CLIN BIOCHEM, V42, P1001, DOI 10.1016/j.clinbiochem.2009.03.020; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; Chan W, 2006, NEUROCHEM INT, V55, P414; Chen LQ, 2005, ANAT REC PART A, V287A, P1236, DOI 10.1002/ar.a.20241; Cheng CY, 2006, J BIOMED MATER RES A, V76A, P463, DOI 10.1002/jbm.a.30249; Cohen JA, 2009, ARCH NEUROL-CHICAGO, V66, P821, DOI 10.1001/archneurol.2009.104; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Frigo M, 2012, CURR MED CHEM, V19, P1295, DOI 10.2174/092986712799462559; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Huang LF, 2012, FITOTERAPIA, V83, P1514, DOI 10.1016/j.fitote.2012.08.019; Ko JKS, 2005, WORLD J GASTROENTERO, V11, P5787, DOI 10.3748/wjg.v11.i37.5787; Koch M, 2006, J NEUROL, V253, P483, DOI 10.1007/s00415-005-0037-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lagrange P, 1999, FREE RADICAL BIO MED, V27, P667, DOI 10.1016/S0891-5849(99)00112-4; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Li ZP, 2002, ACTA PHARMACOL SIN, V23, P898; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; MESSMER UK, 1994, FEBS LETT, V355, P23; Miller SA, 2009, IMMUNOLOGY, V126, P306, DOI 10.1111/j.1365-2567.2008.03040.x; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Peiris M, 2007, J NEUROSCI METH, V163, P245, DOI 10.1016/j.jneumeth.2007.03.013; Qiu LH, 2010, BIOL PHARM BULL, V33, P641, DOI 10.1248/bpb.33.641; Schneider A, 2004, J BIOL CHEM, V279, P55833, DOI 10.1074/jbc.M409954200; Schreibelt G, 2008, FREE RADICAL BIO MED, V45, P256, DOI 10.1016/j.freeradbiomed.2008.03.024; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Shaw PH, 1996, PATHOL RES PRACT, V192, P669, DOI 10.1016/S0344-0338(96)80088-4; Spencer JPE, 2012, MOL ASPECTS MED, V33, P83, DOI 10.1016/j.mam.2011.10.016; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tanaka K, 2004, NEUROCHEM RES, V29, P1529, DOI 10.1023/B:NERE.0000029565.92587.25; Tasset I, 2012, CLIN BIOCHEM, V45, P440, DOI 10.1016/j.clinbiochem.2012.01.023; Uzar E, 2006, MOL CELL BIOCHEM, V291, P63, DOI 10.1007/s11010-006-9196-5; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wang Shi-bo, 2011, Chinese Pharmacological Bulletin, V27, P1603, DOI 10.3969/j.issn.1001-1978.2011.11.031; Wang Yuan-yuan, 2011, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V27, P363; Witherick J, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/164608; Wu XJ, 2010, J NEUROIMMUNOL, V223, P65, DOI 10.1016/j.jneuroim.2010.04.001; Xiang H, 1998, J NEUROSCI, V18, P1363; Zargari M, 2007, NEUROSCI LETT, V412, P24, DOI 10.1016/j.neulet.2006.08.033; Zhang WD, 2006, PLANTA MED, V72, P621, DOI 10.1055/s-2006-931572; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhu SQ, 2008, ACTA PHARMACOL SIN, V29, P57, DOI 10.1111/j.1745-7254.2008.00712.x; 江清林, 2003, [中国老年学杂志, Chinese Journal of Gerontology], V23, P52	59	117	124	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76495	10.1371/journal.pone.0076495	http://dx.doi.org/10.1371/journal.pone.0076495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124567	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100124
J	Hellen, EH; Dana, SK; Kurths, J; Kehler, E; Sinha, S				Hellen, Edward H.; Dana, Syamal K.; Kurths, Juergen; Kehler, Elizabeth; Sinha, Sudeshna			Noise-Aided Logic in an Electronic Analog of Synthetic Genetic Networks	PLOS ONE			English	Article							STOCHASTIC RESONANCE; TOGGLE SWITCH; GATES; SYSTEMS	We report the experimental verification of noise-enhanced logic behaviour in an electronic analog of a synthetic genetic network, composed of two repressors and two constitutive promoters. We observe good agreement between circuit measurements and numerical prediction, with the circuit allowing for robust logic operations in an optimal window of noise. Namely, the input-output characteristics of a logic gate is reproduced faithfully under moderate noise, which is a manifestation of the phenomenon known as Logical Stochastic Resonance. The two dynamical variables in the system yield complementary logic behaviour simultaneously. The system is easily morphed from AND/NAND to OR/NOR logic.	[Hellen, Edward H.; Kehler, Elizabeth] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Dana, Syamal K.] Indian Inst Chem Biol, CSIR, Kolkata, India; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Sinha, Sudeshna] Indian Inst Sci Educ & Res Mohali, Mohali, Punjab, India	University of North Carolina; University of North Carolina Greensboro; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Potsdam Institut fur Klimafolgenforschung; Indian Institute of Science Education & Research (IISER) - Mohali	Hellen, EH (corresponding author), Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA.	ehhellen@uncg.edu	Hellen, Edward/AAN-7714-2021	Hellen, Edward/0000-0001-5060-7220; Sinha, Sudeshna/0000-0002-1364-5276	Council of Scientific and Industrial Research (CSIR) Network project GENESIS [BC0123]; CSIR Emeritus Scientist scheme	Council of Scientific and Industrial Research (CSIR) Network project GENESIS; CSIR Emeritus Scientist scheme	SKD acknowledges support by the Council of Scientific and Industrial Research (CSIR) Network project GENESIS (BC0123) and the CSIR Emeritus Scientist scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/50001; Bartee T, 1991, COMPUTER SCI SERIES; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; BULSARA A, 1991, J THEOR BIOL, V152, P531, DOI 10.1016/S0022-5193(05)80396-0; Dari A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041909; Dari A, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/18001; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Fierens PI, 2010, PHYS LETT A, V374, P2207, DOI 10.1016/j.physleta.2010.03.026; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guerra DN, 2010, NANO LETT, V10, P1168, DOI 10.1021/nl9034175; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hellen EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062997; Hellen EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023286; Mano MM, 1993, COMPUTER SYSTEM ARCH, P1; Murali K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3245318; Murali K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.104101; Perrone S, 2012, OPT EXPRESS, V20, P22692, DOI 10.1364/OE.20.022692; Sharma PR, 2013, PHYS LETT A, V377, P367, DOI 10.1016/j.physleta.2012.12.002; Singh KP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046219; Sinha S, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/60003; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; Worschech L, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3302457	26	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76032	10.1371/journal.pone.0076032	http://dx.doi.org/10.1371/journal.pone.0076032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124531	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100088
J	Li, SQ; Cheuk, AT; Shern, JF; Song, YK; Hurd, L; Liao, HL; Wei, JS; Khan, J				Li, Samuel Q.; Cheuk, Adam T.; Shern, Jack F.; Song, Young K.; Hurd, Laura; Liao, Hongling; Wei, Jun S.; Khan, Javed			Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; EMBRYONAL RHABDOMYOSARCOMA; IN-VIVO; ALVEOLAR RHABDOMYOSARCOMA; MYELOID-LEUKEMIA; CANCER MODELS; POTENT; IDENTIFICATION; GENE; NEUROBLASTOMA	Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. Despite advances in modern therapy, patients with relapsed or metastatic disease have a very poor clinical prognosis. Fibroblast Growth Factor Receptor 4 (FGFR4) is a cell surface tyrosine kinase receptor that is involved in normal myogenesis and muscle regeneration, but not commonly expressed in differentiated muscle tissues. Amplification and mutational activation of FGFR4 has been reported in RMS and promotes tumor progression. Therefore, FGFR4 is a tractable therapeutic target for patients with RMS. In this study, we used a chimeric Ba/F3 TEL-FGFR4 construct to test five tyrosine kinase inhibitors reported to specifically inhibit FGFRs in the nanomolar range. We found ponatinib (AP24534) to be the most potent FGFR4 inhibitor with an IC50 in the nanomolar range. Ponatinib inhibited the growth of RMS cells expressing wild-type or mutated FGFR4 through increased apoptosis. Phosphorylation of wild-type and mutated FGFR4 as well as its downstream target STAT3 was also suppressed by ponatinib. Finally, ponatinib treatment inhibited tumor growth in a RMS mouse model expressing mutated FGFR4. Therefore, our data suggests that ponatinib is a potentially effective therapeutic agent for RMS tumors that are driven by a dysregulated FGFR4 signaling pathway.	[Li, Samuel Q.; Cheuk, Adam T.; Shern, Jack F.; Song, Young K.; Hurd, Laura; Liao, Hongling; Wei, Jun S.; Khan, Javed] NCI, Oncogen Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khan, J (corresponding author), NCI, Oncogen Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	khanjav@mail.nih.gov	Shern, Jack/V-4002-2019; Khan, Javed/P-9157-2014		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010806, ZIABC010999, ZIABC010998] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Cao L, CANC RES, V70, P6497; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Christensen JG, 2003, CANCER RES, V63, P7345; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gozgit JM, 2011, MOL CANCER THER, V10, P1028, DOI 10.1158/1535-7163.MCT-10-1044; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Hu KJ, 2009, MOL CANCER THER, V8, P3024, DOI 10.1158/1535-7163.MCT-09-0365; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Klint Peter, 1999, Frontiers in Bioscience, V4, pD165, DOI 10.2741/Klint; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Marics I, 2002, DEVELOPMENT, V129, P4559; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stauffer JK, 2012, CANCER INVEST, V30, P343, DOI 10.3109/07357907.2012.664670; STRATTON MR, 1989, CANCER RES, V49, P6324; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Thuault S, 2012, ONCOGENE; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	32	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76551	10.1371/journal.pone.0076551	http://dx.doi.org/10.1371/journal.pone.0076551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124571	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100128
J	Park, MK; Ngo, V; Kwon, YM; Lee, YT; Yoo, S; Cho, YH; Hong, SM; Hwang, HS; Ko, EJ; Jung, YJ; Moon, DW; Jeong, EJ; Kim, MC; Lee, YN; Jang, JH; Oh, JS; Kim, CH; Kang, SM				Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Cho, Young-Hee; Hong, Sung-Moon; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Moon, Dae-Won; Jeong, Eun-Ji; Kim, Min-Chul; Lee, Yu-Na; Jang, Ji-Hun; Oh, Joon-Suk; Kim, Cheol-Hyun; Kang, Sang-Moo			Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SSP BULGARICUS OLL1073R-1; IMPROVED CROSS-PROTECTION; CASEI STRAIN SHIROTA; DENDRITIC CELLS; ALVEOLAR MACROPHAGES; HUMAN HEALTH; MICE; INFECTION; RESPONSES	Lactobacillus plantarum DK119 (DK119) isolated from the fermented Korean cabbage food was used as a probiotic to determine its antiviral effects on influenza virus. DK119 intranasal or oral administration conferred 100% protection against subsequent lethal infection with influenza A viruses, prevented significant weight loss, and lowered lung viral loads in a mouse model. The antiviral protective efficacy was observed in a dose and route dependent manner of DK119 administration. Mice that were treated with DK119 showed high levels of cytokines IL-12 and IFN-gamma in bronchoalveolar lavage fluids, and a low degree of inflammation upon infection with influenza virus. Depletion of alveolar macrophage cells in lungs and bronchoalveolar lavages completely abrogated the DK119-mediated protection. Modulating host innate immunity of dendritic and macrophage cells, and cytokine production pattern appeared to be possible mechanisms by which DK119 exhibited antiviral effects on influenza virus infection. These results indicate that DK119 can be developed as a beneficial antiviral probiotic microorganism.	[Park, Min-Kyung] Chungwoon Univ, Dept Human Nutr & Food Sci, Hongsung Kun, Chungnam, South Korea; [Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Park, Min-Kyung; Vu Ngo; Kwon, Young-Man; Lee, Young-Tae; Yoo, Sieun; Hwang, Hye Suk; Ko, Eun-Ju; Jung, Yu-Jin; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Cho, Young-Hee; Hong, Sung-Moon; Kim, Cheol-Hyun] Dankook Univ, Dept Anim Resource Sci, Cheonan Si, Chungnam, South Korea; [Moon, Dae-Won; Jeong, Eun-Ji; Jang, Ji-Hun; Oh, Joon-Suk] Tobico Inc, Cheonan Si, Chungnam, South Korea; [Kim, Min-Chul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Dankook University; Emory University	Kang, SM (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	skang24@gsu.edu	Ngo, Vu/GON-5915-2022	Ngo, Vu L./0000-0002-9820-0443	Tobico Inc.; NIH/NIAID [AI093772, AI087782, AI105170]; faculty sabbatical training grant from Chungwoon University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R56AI087782, R01AI093772] Funding Source: NIH RePORTER	Tobico Inc.; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); faculty sabbatical training grant from Chungwoon University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the research grant from Tobico Inc. (SMK), and NIH/NIAID grants AI093772 (SMK), AI087782 (SMK), and AI105170 (SMK). MKP was a recipient of the faculty sabbatical training grant from Chungwoon University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Cho YH, 2013, KOREAN J FOOD SCI AN, V33, P75, DOI 10.5851/kosfa.2013.33.1.75; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Drouault S, 2001, VET RES, V32, P101, DOI 10.1051/vetres:2001115; Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; GORBACH SL, 1990, ANN MED, V22, P37, DOI 10.3109/07853899009147239; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanniffy S, 2004, ADV APPL MICROBIOL, V56, P1, DOI 10.1016/S0065-2164(04)56001-X; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001; Ishida Y, 2005, J DAIRY SCI, V88, P527, DOI 10.3168/jds.S0022-0302(05)72714-4; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; Joo Hong-Gu, 2003, J Vet Sci, V4, P229; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kawashima T, 2011, INT IMMUNOPHARMACOL, V11, P2017, DOI 10.1016/j.intimp.2011.08.013; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Kim MH, 2009, KOREAN J PHYSIOL PHA, V13, P169, DOI 10.4196/kjpp.2009.13.3.169; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Long JK, 2000, CLEV CLIN J MED, V67, P92; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; Makino S, 2010, BRIT J NUTR, V104, P998, DOI 10.1017/S000711451000173X; Masuda S, 2008, INT J FOOD MICROBIOL, V121, P245, DOI 10.1016/j.ijfoodmicro.2007.10.011; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mok H, 2007, J VIROL, V81, P13710, DOI 10.1128/JVI.01351-07; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Nagai T, 2011, INT IMMUNOPHARMACOL, V11, P2246, DOI 10.1016/j.intimp.2011.09.012; Nagao F, 2000, BIOSCI BIOTECH BIOCH, V64, P2706, DOI 10.1271/bbb.64.2706; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Oxford JS, 2007, INFLUENZA OTHER RESP, V1, P27, DOI 10.1111/j.1750-2659.2006.00006.x; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; THEPEN T, 1991, EUR J IMMUNOL, V21, P2845, DOI 10.1002/eji.1830211128; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; WEN HS, 1959, J INFECT DIS, V105, P9, DOI 10.1093/infdis/105.1.9; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Youn HN, 2012, POULTRY SCI, V91, P2517, DOI 10.3382/ps.2012-02334; Youn HN, 2012, ANTIVIR RES, V93, P138, DOI 10.1016/j.antiviral.2011.11.004	54	93	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75368	10.1371/journal.pone.0075368	http://dx.doi.org/10.1371/journal.pone.0075368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124485	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100042
J	Sutcliffe, B; Forero, MG; Zhu, BF; Robinson, IM; Hidalgo, A				Sutcliffe, Ben; Forero, Manuel G.; Zhu, Bangfu; Robinson, Iain M.; Hidalgo, Alicia			Neuron-Type Specific Functions of DNT1, DNT2 and Spz at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							CYSTINE-KNOT PROTEIN; SYNAPTIC DEVELOPMENT; GENETIC DISSECTION; RETROGRADE SIGNAL; SPATZLE PROTEIN; NERVOUS-SYSTEM; GROWTH CONE; TOLL GENE; NEUROTROPHIN; RECEPTOR	Retrograde growth factors regulating synaptic plasticity at the neuromuscular junction (NMJ) in Drosophila have long been predicted but their discovery has been scarce. In vertebrates, such retrograde factors produced by the muscle include GDNF and the neurotrophins (NT: NGF, BDNF, NT3 and NT4). NT superfamily members have been identified throughout the invertebrates, but so far no functional in vivo analysis has been carried out at the NMJ in invertebrates. The NT family of proteins in Drosophila is formed of DNT1, DNT2 and Spatzle (Spz), with sequence, structural and functional conservation relative to mammalian NTs. Here, we investigate the functions of Drosophila NTs (DNTs) at the larval NMJ. All three DNTs are expressed in larval body wall muscles, targets for motor-neurons. Over-expression of DNTs in neurons, or the activated form of the Spz receptor, Toll(10b), in neurons only, rescued the semi-lethality of spz(2) and DNT1(41), DNT2(e03444) double mutants, indicating retrograde functions in neurons. In spz2 mutants, DNT1(41), DNT2(e03444) double mutants, and upon over-expression of the DNTs, NMJ size and bouton number increased. Boutons were morphologically abnormal. Mutations in spz and DNT1, DNT2 resulted in decreased number of active zones per bouton and decreased active zone density per terminal. Alterations in DNT function induced ghost boutons and synaptic debris. Evoked junction potentials were normal in spz(2) mutants and DNT1(41), DNT2(e03444) double mutants, but frequency and amplitude of spontaneous events were reduced in spz(2) mutants suggesting defective neurotransmission. Our data indicate that DNTs are produced in muscle and are required in neurons for synaptogenesis. Most likely alterations in DNT function and synapse formation induce NMJ plasticity leading to homeostatic adjustments that increase terminal size restoring overall synaptic transmission. Data suggest that Spz functions with neuron-type specificity at the muscle 4 NMJ, and DNT1 and DNT2 function together at the muscles 6,7 NMJ.	[Sutcliffe, Ben; Forero, Manuel G.; Zhu, Bangfu; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sutcliffe, Ben; Robinson, Iain M.] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL4 8AA, Devon, England	University of Birmingham; University of Plymouth	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Sutcliffe, Ben/R-3655-2019; Hidalgo, Alicia/F-5930-2015	Sutcliffe, Ben/0000-0003-3264-1649; Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	MRC [G0200140, G0802208]; Wellcome Trust Equipment [073228, 088583]; MRC PhD studentship; Medical Research Council [G0802208, G0200140] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Equipment(Wellcome Trust); MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by MRC Career Establishment Grant G0200140, Wellcome Trust Equipment 073228 and Project 088583 Grants to A. H., MRC Project Grant G0802208 to I. R. and MRC PhD studentship to B. S. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARNOT CJ, 2010, J BIOL CHEM; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GERTTULA S, 1988, GENETICS, V119, P123; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; Hallbook F, 2006, BRAIN BEHAV EVOLUT, V68, P133, DOI 10.1159/000094083; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kassabov SR, 2013, CELL REP, V3, P1213, DOI 10.1016/j.celrep.2013.03.008; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Morisato D, 2001, DEVELOPMENT, V128, P2309; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Rose D, 1999, J NEUROSCI, V19, P4899; Rose D, 1997, DEVELOPMENT, V124, P1561; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schwenkert I, 2008, MECH DEVELOP, V125, P700, DOI 10.1016/j.mod.2008.04.004; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Wilson KHS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-243; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	44	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75902	10.1371/journal.pone.0075902	http://dx.doi.org/10.1371/journal.pone.0075902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124519	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100076
J	Taniguchi, M; Kajioka, S; Shozib, HB; Sawamura, K; Nakayama, S				Taniguchi, Mizuki; Kajioka, Shunichi; Shozib, Habibul B.; Sawamura, Kenta; Nakayama, Shinsuke			Spatial Analysis of Slowly Oscillating Electric Activity in the Gut of Mice Using Low Impedance Arrayed Microelectrodes	PLOS ONE			English	Article							MOUSE SMALL-INTESTINE; GUINEA-PIG STOMACH; INTERSTITIAL-CELLS; PACEMAKER ACTIVITY; SMOOTH-MUSCLE; GASTROINTESTINAL-TRACT; WAVE PROPAGATION; GASTRIC ANTRUM; CAJAL; MECHANISMS	Smooth and elaborate gut motility is based on cellular cooperation, including smooth muscle, enteric neurons and special interstitial cells acting as pacemaker cells. Therefore, spatial characterization of electric activity in tissues containing these electric excitable cells is required for a precise understanding of gut motility. Furthermore, tools to evaluate spatial electric activity in a small area would be useful for the investigation of model animals. We thus employed a microelectrode array (MEA) system to simultaneously measure a set of 8x8 field potentials in a square area of similar to 1 mm(2). The size of each recording electrode was 50650 mm(2), however the surface area was increased by fixing platinum black particles. The impedance of microelectrode was sufficiently low to apply a high-pass filter of 0.1 Hz. Mapping of spectral power, and auto-correlation and cross-correlation parameters characterized the spatial properties of spontaneous electric activity in the ileum of wild-type (WT) and W/W-v mice, the latter serving as a model of impaired network of pacemaking interstitial cells. Namely, electric activities measured varied in both size and cooperativity in W/W-v mice, despite the small area. In the ileum of WT mice, procedures suppressing the excitability of smooth muscle and neurons altered the propagation of spontaneous electric activity, but had little change in the period of oscillations. In conclusion, MEA with low impedance electrodes enables to measure slowly oscillating electric activity, and is useful to evaluate both histological and functional changes in the spatio-temporal property of gut electric activity.	[Taniguchi, Mizuki; Shozib, Habibul B.; Sawamura, Kenta; Nakayama, Shinsuke] Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kajioka, Shunichi] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan	Nagoya University; Kyushu University	Nakayama, S (corresponding author), Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	h44673a@nucc.cc.nagoya-u.ac.jp			Japan Society for the Promotion Science; Japan Gut Club	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Gut Club	This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion Science, and the Japan Gut Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarali HI, 2010, NEUROGASTROENT MOTIL, V22, P1045, DOI 10.1111/j.1365-2982.2010.01560.x; Bayguinov O, 2011, NEUROGASTROENT MOTIL, V23, P1029, DOI 10.1111/j.1365-2982.2011.01784.x; Brading AF, 2005, NAT CLIN PRACT UROL, V2, P546, DOI 10.1038/ncpuro0340; Bramich NJ, 1996, J PHYSIOL-LONDON, V492, P185, DOI 10.1113/jphysiol.1996.sp021300; Buist ML, 2010, ANN BIOMED ENG, V38, P3022, DOI 10.1007/s10439-010-0051-1; Camilleri Michael, 2002, Rev Gastroenterol Disord, V2, P47; Dickens EJ, 1999, J PHYSIOL-LONDON, V514, P515, DOI 10.1111/j.1469-7793.1999.515ae.x; Du P, 2009, ANN BIOMED ENG, V37, P839, DOI 10.1007/s10439-009-9654-9; Faussone-Pellegrini MS, 1999, MICROSC RES TECHNIQ, V47, P248, DOI 10.1002/(SICI)1097-0029(19991115)47:4<248::AID-JEMT4>3.0.CO;2-W; Faville RA, 2009, BIOPHYS J, V96, P4834, DOI 10.1016/j.bpj.2009.03.058; Furness JB, 2006, ENTERIC NERVOUS SYSTEM, P1; Harhun MI, 2005, J CELL MOL MED, V9, P232, DOI 10.1111/j.1582-4934.2005.tb00352.x; Hirst GDS, 2006, J PHYSIOL-LONDON, V571, P165, DOI 10.1113/jphysiol.2005.100735; Hotta Aya, 2005, Journal of Smooth Muscle Research, V41, P207, DOI 10.1540/jsmr.41.207; Huang SM, 1999, AM J PHYSIOL-GASTR L, V276, pG518, DOI 10.1152/ajpgi.1999.276.2.G518; Huizinga JD, 1998, J PHYSIOL-LONDON, V506, P843, DOI 10.1111/j.1469-7793.1998.843bv.x; Huizinga JD, 2005, J CELL MOL MED, V9, P468, DOI 10.1111/j.1582-4934.2005.tb00372.x; Iino S, 2007, ARCH HISTOL CYTOL, V70, P163, DOI 10.1679/aohc.70.163; Imtiaz MS, 2006, BIOPHYS J, V90, P1, DOI 10.1529/biophysj.104.058743; Ishikawa T, 2004, AM J PHYSIOL-CELL PH, V286, pC1344, DOI 10.1152/ajpcell.00392.2003; Kinoshita K, 2007, HISTOCHEM CELL BIOL, V127, P41, DOI 10.1007/s00418-006-0223-0; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Lammers WJEP, 2008, GASTROENTEROLOGY, V135, P1601, DOI 10.1053/j.gastro.2008.07.020; Lang RJ, 2006, J PHYSIOL-LONDON, V576, P695, DOI 10.1113/jphysiol.2006.116855; MAEDA H, 1992, DEVELOPMENT, V116, P369; Means SA, 2010, J THEOR BIOL, V267, P137, DOI 10.1016/j.jtbi.2010.08.008; Nakayama S, 2012, NEUROGASTROENT MOTIL, V24, P397, DOI 10.1111/j.1365-2982.2012.01882.x; Nakayama S, 2006, J PHYSIOL-LONDON, V576, P727, DOI 10.1113/jphysiol.2006.118893; Nakayama S, 2011, BIOSENS BIOELECTRON, V27, P34, DOI 10.1016/j.bios.2011.05.041; Nakayama S, 2009, BIOSENS BIOELECTRON, V25, P61, DOI 10.1016/j.bios.2009.06.006; O'Grady G, 2012, NEUROGASTROENT MOTIL, V24, pe299, DOI 10.1111/j.1365-2982.2012.01932.x; O'Grady G, 2012, NEUROGASTROENT MOTIL, V24, P1, DOI 10.1111/j.1365-2982.2011.01815.x; O'Grady G, 2012, J PHYSIOL-LONDON, V590, P1299, DOI 10.1113/jphysiol.2011.224014; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Rhee PL, 2011, J PHYSIOL-LONDON, V589, P6105, DOI 10.1113/jphysiol.2011.217497; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Seerden TC, 2005, AM J PHYSIOL-GASTR L, V289, pG1043, DOI 10.1152/ajpgi.00205.2005; Szurszewski JH, 1987, PHYSL GASTROINTESTIN, P383; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; TOMITA T, 1981, SMOOTH MUSCLE ASSESS, P127; Tsutsui H, 2010, J PHYSIOL-LONDON, V588, P2017, DOI 10.1113/jphysiol.2010.189126; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; van Helden DF, 2010, CLIN EXP PHARMACOL P, V37, P516, DOI 10.1111/j.1440-1681.2009.05331.x; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Vogt KE, 2011, J PHYSIOL-LONDON, V589, P489, DOI 10.1113/jphysiol.2010.200220; Wang XY, 2002, AM J PATHOL, V160, P1529, DOI 10.1016/S0002-9440(10)62579-5; Wood JD, 2006, PHYSL GASTROINTESTIN, V2, P665; Yagati AK, 2009, BIOSENS BIOELECTRON, V24, P1503, DOI 10.1016/j.bios.2008.07.080; Youm JB, 2006, PHILOS T R SOC A, V364, P1135, DOI 10.1098/rsta.2006.1759	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75235	10.1371/journal.pone.0075235	http://dx.doi.org/10.1371/journal.pone.0075235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124480	Green Submitted, Green Published, gold			2022-12-25	WOS:000325489100037
J	Wang, ZQ; Keita, M; Bachvarova, M; Gobeil, S; Morin, C; Plante, M; Gregoire, J; Renaud, MC; Sebastianelli, A; Trinh, XB; Bachvarov, D				Wang, Zhi-Qiang; Keita, Mamadou; Bachvarova, Magdalena; Gobeil, Stephane; Morin, Chantale; Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra; Trinh, Xuan Bich; Bachvarov, Dimcho			Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; DOWN-REGULATION; EXPRESSION; TARGET; APOPTOSIS; BETA; HEMATOPOIESIS; METHYLATION	Previously, we have identified the RUNX2 gene as hypomethylated and overexpressed in post-chemotherapy (CT) primary cultures derived from serous epithelial ovarian cancer (EOC) patients, when compared to primary cultures derived from matched primary (prior to CT) tumors. However, we found no differences in the RUNX2 methylation in primary EOC tumors and EOC omental metastases, suggesting that DNA methylation-based epigenetic mechanisms have no impact on RUNX2 expression in advanced (metastatic) stage of the disease. Moreover, RUNX2 displayed significantly higher expression not only in metastatic tissue, but also in high-grade primary tumors and even in low malignant potential tumors. Knockdown of the RUNX2 expression in EOC cells led to a sharp decrease of cell proliferation and significantly inhibited EOC cell migration and invasion. Gene expression profiling and consecutive network and pathway analyses confirmed these findings, as various genes and pathways known previously to be implicated in ovarian tumorigenesis, including EOC tumor invasion and metastasis, were found to be downregulated upon RUNX2 suppression, while a number of pro-apoptotic genes and some EOC tumor suppressor genes were induced. Taken together, our data are indicative for a strong oncogenic potential of the RUNX2 gene in serous EOC progression and suggest that RUNX2 might be a novel EOC therapeutic target. Further studies are needed to more completely elucidate the functional implications of RUNX2 and other members of the RUNX gene family in ovarian tumorigenesis.	[Wang, Zhi-Qiang; Keita, Mamadou; Gobeil, Stephane; Bachvarov, Dimcho] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Wang, Zhi-Qiang; Keita, Mamadou; Bachvarova, Magdalena; Morin, Chantale; Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra; Trinh, Xuan Bich; Bachvarov, Dimcho] Hop Hotel Dieu, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Gobeil, Stephane] CHUL, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Plante, Marie; Gregoire, Jean; Renaud, Marie-Claude; Sebastianelli, Alexandra] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ, Canada; [Trinh, Xuan Bich] Univ Antwerp Hosp, Dept Gynecol Oncol, Antwerp, Belgium	Laval University; Laval University; Laval University; University of Antwerp	Bachvarov, D (corresponding author), Univ Laval, Dept Mol Med, Quebec City, PQ, Canada.	dimtcho.batchvarov@crhdq.ulaval.ca		Bachvarov, Dimcho/0000-0001-6509-9599	Cancer Research Society of Canada	Cancer Research Society of Canada	This study was sustained by a grant to D. B. from the Cancer Research Society of Canada. Clinical specimens were provided by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de recherche du Quebec - Sante which is affiliated with the Canadian Tumor Repository Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Alouini S, 2012, GYNECOL ONCOL, V126, P313, DOI 10.1016/j.ygyno.2012.04.044; Alper O, 2001, MOL CELL BIOCHEM, V218, P55, DOI 10.1023/A:1007205205131; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Barnholtz-Sloan JS, 2003, AM J OBSTET GYNECOL, V189, P1120, DOI 10.1067/S0002-9378(03)00579-9; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Bock AJ, 2010, INT J GYNECOL CANCER, V20, P1448, DOI 10.1111/IGC.0b013e3181f7d6be; Brard L, 2011, GYNECOL ONCOL, V123, P370, DOI 10.1016/j.ygyno.2011.07.002; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Casaburi I, 2012, CELL CYCLE, V11, P2699, DOI 10.4161/cc.21029; Daikoku T, 2005, CANCER RES, V65, P3735, DOI 10.1158/0008-5472.CAN-04-3814; Daikoku T, 2007, CANCER RES, V67, P5285, DOI 10.1158/0008-5472.CAN-07-0828; Duprez E, 2004, CELL CYCLE, V3, P389; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fridman JS, 1998, ONCOGENE, V17, P2981, DOI 10.1038/sj.onc.1202224; Hantke B, 2003, BIOL CHEM, V384, P1247, DOI 10.1515/BC.2003.137; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanamori Y, 1999, CANCER RES, V59, P4225; Karnezis T, 2012, ONCOTARGET, V3, P893, DOI 10.18632/oncotarget.593; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Keita M, 2013, CELL CYCLE, V12, P972, DOI 10.4161/cc.23963; Keita M, 2013, GYNECOL ONCOL, V128, P356, DOI 10.1016/j.ygyno.2012.11.036; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kinjo K, 2005, CELL CYCLE, V4, P1134, DOI 10.4161/cc.4.9.1991; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lecomte C, 2005, CELL CYCLE, V4, P1862, DOI 10.4161/cc.4.12.2300; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Lehtinen L, 2013, ONCOTARGET, V4, P48, DOI 10.18632/oncotarget.756; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li H, 2013, TUMOUR BIOL; Li H, 2012, CANCER PREV RES, V5, P484, DOI 10.1158/1940-6207.CAPR-11-0414; Li W, 2010, CELL CYCLE, V9, P4433, DOI 10.4161/cc.9.22.13838; Li WP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/456534; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Madsen CV, 2012, ANTICANCER RES, V32, P3817; Maier S, 2005, AM J PHARMACOGENOMIC, V5, P223, DOI 10.2165/00129785-200505040-00003; Mann AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013050; Mansour M, 2011, J VIROL, V85, P6015, DOI 10.1128/JVI.01537-10; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Morrow KA, 2011, J BIOL CHEM, V286, P40376, DOI 10.1074/jbc.M111.250035; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Okada-Ban M, 1999, ONCOGENE, V18, P6719, DOI 10.1038/sj.onc.1203092; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papacleovoulou G, 2011, J ENDOCRINOL, V211, P273, DOI 10.1530/JOE-11-0081; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Robinson HM, 2003, LEUKEMIA, V17, P2249, DOI 10.1038/sj.leu.2403140; Sandi MJ, 2011, J CELL PHYSIOL, V226, P3442, DOI 10.1002/jcp.22702; Sasaki H, 2000, CANCER RES, V60, P5659; Scheitz CJ, 2012, J CELL BIOCH; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stone B, 2003, INT J CANCER, V104, P73, DOI 10.1002/ijc.10900; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Taraboletti G, 2010, ONCOTARGET, V1, P662; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wotton S, 2002, CANCER RES, V62, P7181; Yamaoka T, 2011, J DERMATOL SCI, V64, P99, DOI 10.1016/j.jdermsci.2011.07.005; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yang MH, 2012, ONCOGENE, V31, P2401, DOI 10.1038/onc.2011.423; Zhang SQ, 2009, OMICS, V13, P307, DOI 10.1089/omi.2009.0030; Zhao HX, 2012, EXP MOL MED, V44, P633, DOI 10.3858/emm.2012.44.11.072	82	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e74384	10.1371/journal.pone.0074384	http://dx.doi.org/10.1371/journal.pone.0074384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124450	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100007
J	Xu, Y; Ma, LL; Zhou, C; Zhang, FJ; Kong, FJ; Wang, WN; Qian, LB; Wang, CC; Liu, XB; Yan, M; Wang, JA				Xu, Yong; Ma, Lei-Lei; Zhou, Chen; Zhang, Fei-Jiang; Kong, Fei-Juan; Wang, Wen-Na; Qian, Ling-Bo; Wang, Can-Can; Liu, Xian-Bao; Yan, Min; Wang, Jian-An			Hypercholesterolemic Myocardium Is Vulnerable to Ischemia-Reperfusion Injury and Refractory to Sevoflurane-Induced Protection	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; INFARCT SIZE; DIETARY-CHOLESTEROL; CARDIOPROTECTION; RAT; APOPTOSIS; HYPERLIPIDEMIA; SIMVASTATIN; INHIBITION; BCL-2	Recent studies have demonstrated that volatile anesthetic postconditioning confers myocardial protection against ischemia-reperfusion (IR) injury through activation of the reperfusion injury salvage kinase (RISK) pathway. As RISK has been shown to be impaired in hypercholesterolemia. Therefore, we investigate whether anesthetic-induced cardiac protection was maintained in hypercholesterolemic rats. In the present study, normocholesteolemic or hypercholesterolemic rat hearts were subjected to 30 min of ischemia and 2 h of reperfusion. Animals received 2.4% sevoflurane for 5 min or 3 cycles of 10-s ischemia/10-s reperfusion. The hemodynamic parameters, including left ventricular developed pressure, left ventricular end-diastolic pressure and heart rate, were continuously monitored. The infarct size, apoptosis, p-Akt, p-ERK1/2, p-GSK3 beta were determined. We found that both sevoflurane and ischemic postconditioning significantly improved heart pump function, reduced infarct size and increased the phosphorylation of Akt, ERK1/2 and their downstream target of GSK3 beta in the healthy rats. In the hypercholesterolemic rats, neither sevoflurane nor ischemic postconditioning improved left ventricular hemodynamics, reduced infarct size and increased the phosphorylated Akt, ERK1/2 and GSK3 beta. In contrast, GSK inhibitor SB216763 conferred cardioprotection against IR injury in healthy and hypercholesterolemic hearts. In conclusions, hyperchoesterolemia abrogated sevoflurane-induced cardioprotection against IR injury by alteration of upstream signaling of GSK3 beta and acute GSK inhibition may provide a novel therapeutic strategy to protect hypercholesterolemic hearts against IR injury.	[Xu, Yong; Ma, Lei-Lei; Zhou, Chen; Zhang, Fei-Jiang; Wang, Wen-Na; Yan, Min] Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China; [Kong, Fei-Juan] Nanjing Med Univ, Dept Anesthesiol, Hangzhou Peoples Hosp 1, Hangzhou, Zhejaing, Peoples R China; [Qian, Ling-Bo; Wang, Can-Can] Zhejiang Med Coll, Dept Physiol, Hangzhou, Zhejaing, Peoples R China; [Liu, Xian-Bao; Wang, Jian-An] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China	Zhejiang University; Nanjing Medical University; Zhejiang University	Yan, M (corresponding author), Zhejiang Univ, Dept Anesthesiol, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Zhejaing, Peoples R China.	yanminnia@hotmail.com; wang_jian_an@tom.com			Natural Science Foundation of China [81170118, 81201496]; Natural Science Foundation of Zhejiang Province [R2090259]; Medicine Administration Bureau of Zhejiang Province [2011ZZ009]; Foundation from Science and Technology Department of Zhejiang Province [2009C13G2010218, 2012C33088]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medicine Administration Bureau of Zhejiang Province; Foundation from Science and Technology Department of Zhejiang Province	This work was supported by the Natural Science Foundation of China (numbers 81170118 and 81201496), the Natural Science Foundation of Zhejiang Province (number R2090259), Medicine Administration Bureau of Zhejiang Province (number 2011ZZ009), and the Foundation from Science and Technology Department of Zhejiang Province (numbers 2009C13G2010218 and 2012C33088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Corti R, 2001, ANN NY ACAD SCI, V947, P181; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Gorbe A, 2011, AM J PHYSIOL-HEART C, V300, pH1907, DOI 10.1152/ajpheart.01242.2010; Gross ER, 2004, CIRC RES, V94, P960, DOI 10.1161/01.RES.0000122392.33172.09; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; HORTON JD, 1995, J BIOL CHEM, V270, P5381, DOI 10.1074/jbc.270.10.5381; Iliodromitis EK, 2006, ATHEROSCLEROSIS, V188, P356, DOI 10.1016/j.atherosclerosis.2005.11.023; Iliodromitis EK, 2010, BASIC RES CARDIOL, V105, P193, DOI 10.1007/s00395-009-0078-3; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kupai K, 2009, AM J PHYSIOL-HEART C, V297, pH1729, DOI 10.1152/ajpheart.00484.2009; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Mykytenko J, 2007, BASIC RES CARDIOL, V102, P90, DOI 10.1007/s00395-006-0625-0; Okamura T, 2000, CARDIOVASC RES, V45, P642, DOI 10.1016/S0008-6363(99)00271-0; Osipov RM, 2009, CIRCULATION, V120, pS22, DOI 10.1161/CIRCULATIONAHA.108.842724; Pagel PS, 2008, J CARDIOTHOR VASC AN, V22, P753, DOI 10.1053/j.jvca.2008.03.005; Penumathsa SV, 2007, J MOL CELL CARDIOL, V42, P508, DOI 10.1016/j.yjmcc.2006.10.018; ROACH PD, 1993, BIOCHIM BIOPHYS ACTA, V1170, P165, DOI 10.1016/0005-2760(93)90067-J; Sack MN, 2011, J CARDIOVASC PHARM T, V16, P267, DOI 10.1177/1074248411408313; Wang TD, 2002, LIPIDS, V37, P385, DOI 10.1007/s1145-002-0906-2; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Yu CK, 2007, BRIT J ANAESTH, V99, P632, DOI 10.1093/bja/aem261; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zhao HX, 2009, ACTA BIOCH BIOPH SIN, V41, P745, DOI 10.1093/abbs/gmp063; Zheng ZP, 2011, J SURG RES, V170, pE3, DOI 10.1016/j.jss.2011.04.035	30	21	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76652	10.1371/journal.pone.0076652	http://dx.doi.org/10.1371/journal.pone.0076652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124583	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100140
J	Shan, Z; Han, QL; Nie, J; Cao, XZ; Chen, ZJ; Yin, SY; Gao, YY; Lin, F; Zhou, XH; Xu, K; Fan, HM; Qian, ZK; Sun, B; Zhong, J; Li, B; Tsun, A				Shan, Zhao; Han, Qinglin; Nie, Jia; Cao, Xuezhi; Chen, Zuojia; Yin, Shuying; Gao, Yayi; Lin, Fang; Zhou, Xiaohui; Xu, Ke; Fan, Huimin; Qian, Zhikang; Sun, Bing; Zhong, Jin; Li, Bin; Tsun, Andy			Negative Regulation of Interferon-induced Transmembrane Protein 3 by SET7-mediated Lysine Monomethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Host Defense; Host-pathogen Interactions; Post-translational Modification; Protein Methylation; Antiviral Host Restriction Factors; IFITM3; Lysine Methylation; SET7	INFLUENZA-A VIRUS; WEST NILE VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; METHYLATION; IFITM3; METHYLTRANSFERASE; RESISTANCE	Background: IFITM3 is a general antiviral host restriction factor against RNA viruses. Results: SET7-mediated monomethylation of IFITM3 at Lys-88 negatively affected its antiviral activity toward vesicular stomatitis virus (VSV) and influenza A virus (IAV) infection. Conclusion: The monomethylation of antiviral host restriction factors may perturb their function. Significance: Targeting the SET7 pathway could provide new antiviral therapeutic strategies. Although lysine methylation is classically known to regulate histone function, its role in modulating antiviral restriction factor activity remains uncharacterized. Interferon-induced transmembrane protein 3 (IFITM3) was found monomethylated on its lysine 88 residue (IFITM3-K88me1) to reduce its antiviral activity, mediated by the lysine methyltransferase SET7. Vesicular stomatitis virus and influenza A virus infection increased IFITM3-K88me1 levels by promoting the interaction between IFITM3 and SET7, suggesting that this pathway could be hijacked to support infection; conversely, IFN- reduced IFITM3-K88me1 levels. These findings may have important implications in the design of therapeutics targeting protein methylation against infectious diseases.	[Shan, Zhao; Nie, Jia; Chen, Zuojia; Yin, Shuying; Gao, Yayi; Lin, Fang; Li, Bin; Tsun, Andy] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Mol Immunol,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Cao, Xuezhi; Zhong, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Viral Hepatitis,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Han, Qinglin; Xu, Ke; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Mol Virol,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Qian, Zhikang] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Herpesvirus & Mol Virol Res,Inst Pasteur Sh, Shanghai 200031, Peoples R China; [Zhou, Xiaohui; Fan, Huimin] Tongji Univ, Sch Med, Shanghai East Hosp, Shanghai 200120, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Li, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Life Sci Res Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.	binli@sibs.ac.cn; andy@sibs.ac.cn	Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021; Zhong, Jin/M-6859-2018	lI, Bin/0000-0002-7640-8884; Zhong, Jin/0000-0002-3554-1275; Cao, Xuezhi/0000-0002-3602-4560	National Natural Science Foundation of China [30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, 81271835]; National Institutes of Health NSFC Collaborative [81161120417]; Shanghai "Rising Star" Program [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; National Science and Technology Major Project [2012ZX10002007-003, 2013ZX10003009-002]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health NSFC Collaborative; Shanghai "Rising Star" Program; Novo Nordisk-Chinese Academy of Sciences Foundation; National Science and Technology Major Project; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, and 81271835; National Institutes of Health NSFC Collaborative Grant 81161120417;Shanghai "Rising Star" Program Grant 10QA1407900;the Novo Nordisk-Chinese Academy of Sciences Foundation; and National Science and Technology Major Project Grants 2012ZX10002007-003 and 2013ZX10003009-002. This work was also supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences and Chinese Academy of Sciences Grants 2010KIP205 and 2012KIP204.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; He YL, 2012, ACTA BIOCH BIOPH SIN, V44, P70, DOI 10.1093/abbs/gmr109; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kitao Hiroyuki, 2006, Subcell Biochem, V40, P409; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	32	31	33	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35093	35103		10.1074/jbc.M113.511949	http://dx.doi.org/10.1074/jbc.M113.511949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129573	hybrid, Green Published			2022-12-25	WOS:000329867600011
J	Lobysheva, II; Biller, P; Gallez, B; Beauloye, C; Balligand, JL				Lobysheva, Irina I.; Biller, Pauline; Gallez, Bernard; Beauloye, Christophe; Balligand, Jean-Luc			Nitrosylated Hemoglobin Levels in Human Venous Erythrocytes Correlate with Vascular Endothelial Function Measured by Digital Reactive Hyperemia	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; IN-VIVO; NO; DYSFUNCTION; TRANSPORT	Impaired nitric oxide (NO)-dependent endothelial function is associated with the development of cardiovascular diseases. We hypothesized that erythrocyte levels of nitrosylated hemoglobin (HbNO-heme) may reflect vascular endothelial function in vivo. We developed a modified subtraction method using Electron Paramagnetic Resonance (EPR) spectroscopy to identify the 5-coordinate alpha-HbNO (HbNO) concentration in human erythrocytes and examined its correlation with endothelial function assessed by peripheral arterial tonometry (PAT). Changes in digital pulse amplitude were measured by PAT during reactive hyperemia following brachial arterial occlusion in a group of healthy volunteers (50 subjects). Erythrocyte HbNO levels were measured at baseline and at the peak of hyperemia. We digitally subtracted an individual model EPR signal of erythrocyte free radicals from the whole EPR spectrum to unmask and quantitate the HbNO EPR signals. Results: Mean erythrocyte HbNO concentration at baseline was 219+/212 nmol/L (n = 50). HbNO levels and reactive hyperemia (RH) indexes were higher in female (free of contraceptive pills) than male subjects. We observed a dynamic increase of HbNO levels in erythrocytes isolated at 1-2 min of post-occlusion hyperemia (120+/28% of basal levels); post-occlusion HbNO levels were correlated with basal levels. Both basal and post-occlusion HbNO levels were significantly correlated with reactive hyperemia (RH) indexes (r = 0.58; P, 0.0001 for basal HbNO). Conclusion: The study demonstrates quantitative measurements of 5-coordinate a-HbNO in human venous erythrocytes, its dynamic physiologic regulation and correlation with endothelial function measured by tonometry during hyperemia. This opens the way to further understanding of in vivo determinants of NO bioavailability in human circulation.	[Lobysheva, Irina I.; Biller, Pauline; Balligand, Jean-Luc] UCL, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium; [Gallez, Bernard] UCL, Louvain Drug Res Inst, Biomed Magnet Resonance Unit, Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Pole Cardiovasc Res CARD, B-1200 Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Dept Internal Med, B-1200 Brussels, Belgium; [Beauloye, Christophe] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiovasc Dis, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Lobysheva, II (corresponding author), UCL, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium.	Irina.lobysheva@uclouvain.be; jl.balligand@uclouvain.be	Balligand, Jean-Luc J/D-7543-2012	Lobysheva, Irina/0000-0002-4290-3625; BALLIGAND, Jean-Luc/0000-0002-0522-4156	Federation Wallonie Bruxelles [ARC11-16/035]; Region Wallonne; Fonds Special de Recherche-UCL; Fondation Roger Havaux	Federation Wallonie Bruxelles; Region Wallonne; Fonds Special de Recherche-UCL; Fondation Roger Havaux	This work was supported by grant ARC11-16/035 of the Federation Wallonie Bruxelles (to JLB), a PPP "NOHEMIE" from the Region Wallonne (to JLB), the Fonds Special de Recherche-UCL and Fondation Roger Havaux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Carr A, 1999, FASEB J, V13, P1007, DOI 10.1096/fasebj.13.9.1007; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Fink Bruno, 2006, Pharmacol Rep, V58 Suppl, P8; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Glover RE, 1999, MOL PHARMACOL, V55, P1006, DOI 10.1124/mol.55.6.1006; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Henry Y, 1997, NITRIC OXIDE RES CHE, P61; Hogg N, 2010, FREE RADICAL BIO MED, V49, P122, DOI 10.1016/j.freeradbiomed.2010.03.009; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Kirima K, 2003, AM J PHYSIOL-HEART C, V285, pH589, DOI 10.1152/ajpheart.01010.2002; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; MAXWELL JC, 1976, BIOCHEMISTRY-US, V15, P388, DOI 10.1021/bi00647a023; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Paniagua OA, 2001, CIRCULATION, V103, P1752, DOI 10.1161/01.CIR.103.13.1752; Paolini M, 1999, LIFE SCI, V64, pPL273, DOI 10.1016/S0024-3205(99)00167-8; Piknova B, 2005, J BIOL CHEM, V280, P40583, DOI 10.1074/jbc.M506292200; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; SUNDE RA, 1980, NUTR REV, V38, P265, DOI 10.1111/j.1753-4887.1980.tb05957.x; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wood KC, 2013, ARTERIOSCLE IN PRESS	35	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76457	10.1371/journal.pone.0076457	http://dx.doi.org/10.1371/journal.pone.0076457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130774	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200039
J	Davis, JT; Mengersen, K; Abram, NK; Ancrenaz, M; Wells, JA; Meijaard, E				Davis, Jacqueline T.; Mengersen, Kerrie; Abram, Nicola K.; Ancrenaz, Marc; Wells, Jessie A.; Meijaard, Erik			It's Not Just Conflict That Motivates Killing of Orangutans	PLOS ONE			English	Article							PRIMATES; FORESTS; CONSERVATION; WILDLIFE; SUMATRA	We investigated why orangutans are being killed in Kalimantan, Indonesia, and the role of conflict in these killings. Based on an analysis of interview data from over 5,000 respondents in over 450 villages, we also assessed the socio-ecological factors associated with conflict and non-conflict killings. Most respondents never kill orangutans. Those who reported having personally killed an orangutan primarily did so for non-conflict reasons; for example, 56% of these respondents said that the reason they had killed an orangutan was to eat it. Of the conflict-related reasons for killing, the most common reasons orangutans were killed was fear of orangutans or in self-defence. A similar pattern was evident among reports of orangutan killing by other people in the villages. Regression analyses indicated that religion and the percentage of intact forest around villages were the strongest socio-ecological predictors of whether orangutans were killed for conflict or non-conflict related reasons. Our data indicate that between 44,170 and 66,570 orangutans were killed in Kalimantan within the respondents' active hunting lifetimes: between 12,690 and 29,024 for conflict reasons (95% CI) and between 26,361 and 41,688 for non-conflict reasons (95% CI). These findings confirm that habitat protection alone will not ensure the survival of orangutans in Indonesian Borneo, and that effective reduction of orangutan killings is urgently needed.	[Davis, Jacqueline T.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Abram, Nicola K.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc] HUTAN Kinabatangan Orang Utan Conservat Programme, Sandakan, Sabah, Malaysia; [Abram, Nicola K.; Ancrenaz, Marc; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Wells, Jessie A.; Meijaard, Erik] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia	Queensland University of Technology (QUT); University of Kent; People & Nature Consulting International; University of Queensland; Australian National University	Meijaard, E (corresponding author), People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia.	emeijaard@gmail.com	Mengersen, Kerrie/AHC-4096-2022; Wells, Jessie A/F-7318-2010; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Wells, Jessie A/0000-0002-3555-5108; Meijaard, Erik/0000-0001-8685-3685; Mengersen, Kerrie/0000-0001-8625-9168; Abram, Nicola/0000-0003-1886-7297; Davis, Jac/0000-0001-6700-5648	The Adopt-an-Acre program; United States Agency for International Development (USAID)	The Adopt-an-Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The Adopt-an-Acre program and the United States Agency for International Development (USAID) provided funding and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; [Anonymous], 2011, JAKARTA POST; Ave J., 1986, PEOPLE WEEPING FORES; BODMER RE, 1994, BIOL CONSERV, V67, P29, DOI 10.1016/0006-3207(94)90005-1; Bowen-Jones E, 1999, ORYX, V33, P233, DOI 10.1046/j.1365-3008.1999.00066.x; Caldecott J. O., 1988, HUNTING WILDLIFE MAN; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Davies L, 2011, OBSERVER; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2000, CONSERV BIOL, V14, P1602, DOI [10.1111/j.1523-1739.2000.99067.x, 10.1046/j.1523-1739.2000.99067.x]; Fisher RJ, 2000, PSYCHOL MARKET, V17, P105, DOI 10.1002/(SICI)1520-6793(200002)17:2<105::AID-MAR3>3.0.CO;2-9; Gates J. F., 2006, AUSTR J ECOLOGY, V21, P1; Gonzalez-Kirchner J.P., 1998, Human Evolution, V13, P15, DOI 10.1007/BF02439364; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; Hicks Thurston C., 2010, African Primates, V7, P1; Holbrook AL, 2003, PUBLIC OPIN QUART, V67, P79, DOI 10.1086/346010; Marshall Andrew J., 2009, P311; Meijaard E, PLOS ONE IN PRESS; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, BIOTROPICA, V43, P524, DOI 10.1111/j.1744-7429.2011.00802.x; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Mitchell AH, 1968, SEL P 10 C INT PRIM, P249; Mitlermeier R.A., 1987, Monographs in Primatology, V9, P109; Mittermeier, 2012, PRIMATES PERIL WORLD; Nijman V., 2005, HANGING BALANCE ASSE; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Piper PJ, 2009, INT J OSTEOARCHAEOL, V19, P551, DOI 10.1002/oa.1046; Presser S, 1998, AM SOCIOL REV, V63, P137, DOI 10.2307/2657486; Puri RK, 1997, THESIS U HAWAII INDO; Rijksen HD, 1999, OUR VANISHING RELATI; Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049429; Sheil D, 2010, BIOTROPICA, V42, P566, DOI 10.1111/j.1744-7429.2010.00687.x; Singleton I., 2004, ORANGUTAN POPULATION; Soehartono T., 2007, STRATEGI RENCANA AKS; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Wadley RL, 1997, HUM ECOL, V25, P243, DOI 10.1023/A:1021926206649; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wilkie DS, 1998, ORYX, V32, P131, DOI 10.1017/S0030605300029872	47	39	41	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75373	10.1371/journal.pone.0075373	http://dx.doi.org/10.1371/journal.pone.0075373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236PJ	24130707	Green Submitted, gold, Green Published			2022-12-25	WOS:000325810900033
J	de Oliveira, RR; Martins, CS; Rocha, YR; Braga, ABR; Mattos, RM; Hecht, F; Brito, GAC; Nasciutti, LE				de Oliveira, Rodrigo R.; Martins, Conceicao S.; Rocha, Yuri R.; Braga, Allysson B. R.; Mattos, Romulo M.; Hecht, Fabio; Brito, Gerly A. C.; Nasciutti, Luiz E.			Experimental Diabetes Induces Structural, Inflammatory and Vascular Changes of Achilles Tendons	PLOS ONE			English	Article							POWER DOPPLER ULTRASONOGRAPHY; VIVO TENDINOPATHY MODEL; PATELLAR TENDINOSIS; MAST-CELL; MELLITUS; NEOVASCULARIZATION; RATS; FOOT; ANGIOGENESIS; ACTIVATION	This study aims to demonstrate how the state of chronic hyperglycemia from experimental Diabetes Mellitus can influence the homeostatic imbalance of tendons and, consequently, lead to the characteristics of tendinopathy. Twenty animals were randomly divided into two experimental groups: control group, consisting of healthy rats and diabetic group constituted by rats induced to Diabetes Mellitus I. After twenty-four days of the induction of Diabetes type I, the Achilles tendon were removed for morphological evaluation, cellularity, number and cross-sectional area of blood vessel, immunohistochemistry for Collagen type I, VEGF and NF-kappa B nuclear localization sequence (NLS) and nitrate and nitrite level. The Achilles tendon thickness (mu m/100g) of diabetic animals was significantly increased and, similarly, an increase was observed in the density of fibrocytes and mast cells in the tendons of the diabetic group. The average number of blood vessels per field, in peritendinous tissue, was statistically higher in the diabetic group 3.39 (2.98) vessels/field when compared to the control group 0.89 (1.68) vessels/field p = 0.001 and in the intratendinous region, it was observed that blood vessels were extremely rare in the control group 0.035 (0.18) vessels/field and were often present in the tendons of the diabetic group 0.89 (0.99) vessels/field. The immunohistochemistry analysis identified higher density of type 1 collagen and increased expression of VEGF as well as increased immunostaining for NF kappa B p50 NLS in the nucleus in Achilles tendon of the diabetic group when compared to the control group. Higher levels of nitrite/nitrate were observed in the experimental group induced to diabetes. We conclude that experimental DM induces notable structural, inflammatory and vascular changes in the Achilles tendon which are compatible with the process of chronic tendinopathy.	[de Oliveira, Rodrigo R.] Univ Fed Ceara, Fac Med, Dept Phys Therapy, Fortaleza, Ceara, Brazil; [Martins, Conceicao S.; Rocha, Yuri R.; Braga, Allysson B. R.; Brito, Gerly A. C.] Univ Fed Ceara, Fac Med, Dept Morphol, Fortaleza, Ceara, Brazil; [Mattos, Romulo M.; Nasciutti, Luiz E.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Hecht, Fabio] Univ Fed Rio de Janeiro, Dept Endocrinol, Rio De Janeiro, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Oliveira, RR (corresponding author), Univ Fed Ceara, Fac Med, Dept Phys Therapy, Fortaleza, Ceara, Brazil.	rodrigo@ufc.br	de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; de Oliveira, Rodrigo Ribeiro/N-9892-2013; Hecht, Fabio/R-9004-2017	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; de Oliveira, Rodrigo Ribeiro/0000-0002-5810-3737; Hecht, Fabio/0000-0001-9110-2587; Martins, Conceicao/0000-0001-8710-1856	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477692/2011-7]; CAPES [23038044935/2009-12]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The financial support provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Universal no 477692/2011-7) and fellowship from the CAPES for Inter-institutional Doctorate Program in Morphological Sciences - Federal University of Ceara - UFC/Federal University of Rio de Janeiro - UFRJ - Brazil (No23038044935/2009-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2012, INT J IMMUNOPATH PH, V25, P757, DOI 10.1177/039463201202500322; Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; Akturk M, 2002, DIABETES CARE, V25, P408, DOI 10.2337/diacare.25.2.408; Alfredson H, 2005, KNEE SURG SPORT TR A, V13, P74, DOI 10.1007/s00167-004-0549-x; Alfredson H, 2003, KNEE SURG SPORT TR A, V11, P334, DOI 10.1007/s00167-003-0391-6; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498; Berglund ME, 2010, J HAND SURG-AM, V35A, P1842, DOI 10.1016/j.jhsa.2010.06.031; Bolton NRM, 2005, CLIN BIOMECH, V20, P540; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Cook JL, 2004, J ORTHOP RES, V22, P334, DOI 10.1016/j.orthres.2003.08.005; Cook JL, 2004, CLIN J SPORT MED, V14, P296, DOI 10.1097/00042752-200409000-00008; Dall'Ago P, 2002, BRAZ J MED BIOL RES, V35, P843, DOI 10.1590/S0100-879X2002000700013; de Oliveira RR, 2011, DIABETIC MED, V28, P886, DOI 10.1111/j.1464-5491.2010.03197.x; de Oliveira RR, 2012, J DIABETES COMPLICAT, V26, P163, DOI 10.1016/j.jdiacomp.2012.03.017; de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z; de Oliveira RR, 2011, ANN BIOMED ENG; de Vos RJ, 2007, AM J SPORT MED, V35, P1696, DOI 10.1177/0363546507303116; DiDomenico LA, 2008, J FOOT ANKLE SURG, V47, P463, DOI 10.1053/j.jfas.2008.05.007; Fox AJS, 2011, J ORTHOPAEDIC RES; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Karsten K, 2008, J ORTHOPAEDIC SURG R, V3; Knoblock K, 2007, J ORTHOP SPORT PHYS, V37, P269, DOI 10.2519/jospt.2007.2296; Kubota S, 2011, INVESTIGATIVE OPHTHA; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; Nakama LH, 2005, J ORTHOP RES, V23, P1199, DOI 10.1016/j.orthres.2005.03.006; Papanas N, 2009, EXP CLIN ENDOCR DIAB, V117, P645, DOI 10.1055/s-0029-1224121; Peers KHE, 2003, INT ORTHOP, V27, P180, DOI 10.1007/s00264-002-0426-5; Ramirez LC, 1998, J DIABETES COMPLICAT, V12, P337, DOI 10.1016/S1056-8727(98)00024-5; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Scott A, 2008, BRIT J SPORT MED, V42, P753, DOI 10.1136/bjsm.2007.040212; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; Scott A, 2008, CLIN ORTHOP RELAT R, V466, P1598, DOI 10.1007/s11999-008-0272-x; Stein V, 2000, ACTA ORTHOP SCAND, V71, P60, DOI 10.1080/00016470052943919; Szomor ZL, 2006, J ORTHOP RES, V24, P80, DOI 10.1002/jor.20009; Tang JB, 2004, PLAST RECONSTR SURG, V113, P1703, DOI 10.1097/01.PRS.0000117365.48381.42; Unlu Z, 2003, J RHEUMATOL, V30, P352; Walsh DA, 2001, ARTHRITIS RES, V3, P147, DOI 10.1186/ar292; WOO SLY, 2007, TENDINOPATHY ATHLETE; Zanetti M, 2003, RADIOLOGY, V227, P556, DOI 10.1148/radiol.2272012069	46	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e74942	10.1371/journal.pone.0074942	http://dx.doi.org/10.1371/journal.pone.0074942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130676	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900011
J	Han, S; Tie, XX; Meng, LX; Wang, YJ; Wu, AH				Han, Sheng; Tie, Xinxin; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua			PMA and Ionomycin Induce Glioblastoma Cell Death: Activation-Induced Cell-Death-Like Phenomena Occur in Glioma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; T-CELLS; EXPRESSION; NFAT; APOPTOSIS; PATHWAY; FAS; RADIOTHERAPY; TEMOZOLOMIDE; ASTROCYTES	Phorbol myristate acetate (PMA) and ionomycin (Io) can induce T cell activation and proliferation. Furthermore, they stimulate activation-induced cell death (AICD) in mature lymphocytes via Fas/Fas ligand (FasL) up-regulation. In this study, we explored the influence of PMA/Io treatment on glioblastoma cells, and found that AICD-like phenomena may also occur in glioma. Using the MTT assay and cell counting, we demonstrated that treatment of PMA/Io significantly inhibited the proliferation of glioma cell lines, U87 and U251. TUNEL assays and transmission electron microscopy revealed that PMA/Io markedly induced U87 and U251 cell apoptosis. Propidium iodide staining and flow cytometry showed that treatment with PMA/Io resulted in an arrestment of cell cycle and an increase in cell death. Using real-time PCR and western blot, we found that PMA/Io up-regulated the expression of Fas and FasL at both mRNA and protein level, which confirmed that PMA/Io induced glioma cell death. Specific knockdown of NFAT1 expression by small hairpin RNA greatly reduced the PMA/Io induced cell death and apoptosis by inhibition of FasL expression. Microarray analysis showed that the expression of NFAT1 significantly correlated with the expression of Fas. The coexistence of Fas with NFAT1 in vivo provides the background for AICD-like phenomena to occur in glioma. These findings demonstrate that PMA/Io can induce glioblastoma cell death through the NFAT1-Fas/FasL pathway. Glioma-related AICD-like phenomena may provide a novel avenue for glioma treatment.	[Han, Sheng; Tie, Xinxin; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua] China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Dept Neurosurg, Hosp 1, Shenyang, Liaoning, Peoples R China.	cmuwuanhua1@yahoo.com			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No. 2012AA02A508), National Natural Science Foundation of China (No. 81172409) and Science and Technology Department of Liaoning Province (No. 2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Austin JW, 2008, J NEUROTRAUM, V25, P411, DOI 10.1089/neu.2007.0436; Bloch O, 2013, CLIN CANCER RES, V19, P3165, DOI 10.1158/1078-0432.CCR-12-3314; Catala-Rabasa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028591; Pedrosa AMD, 2010, J IMMUNOL, V184, P3487, DOI 10.4049/jimmunol.0902961; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Faget DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047868; Gopinath S, 2009, CELL MOL LIFE SCI, V66, P3967, DOI 10.1007/s00018-009-0157-5; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Greeneltch KM, 2005, J IMMUNOL, V175, P4999, DOI 10.4049/jimmunol.175.8.4999; Hamad A R, 2001, Int Rev Immunol, V20, P535, DOI 10.3109/08830180109045577; Hughes MA, 2005, INT J RADIAT ONCOL, V62, P1423, DOI 10.1016/j.ijrobp.2004.12.085; Ju S T, 1999, Int Rev Immunol, V18, P485, DOI 10.3109/08830189909088495; Konig A, 2010, PANCREATOLOGY, V10, P416, DOI 10.1159/000315035; Kwon D, 2001, J NEUROIMMUNOL, V113, P1, DOI 10.1016/S0165-5728(00)00321-0; Ladjemi MZ, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00158; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Lo CA, 2011, INT J ONCOL, V39, P1353; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Meehan AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060144; Mueller K, 2013, NUCLEIC ACIDS RES, V41, P2138, DOI 10.1093/nar/gks1349; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Pan Q, 2012, CELL BIOCHEM BIOPHYS, V62, P185, DOI 10.1007/s12013-011-9280-7; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Robbs BK, 2013, BBA-MOL CELL RES, V1833, P2016, DOI 10.1016/j.bbamcr.2013.04.003; Roth P, 2013, BRAIN, V136, P564, DOI 10.1093/brain/aws351; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Stankov K, 2012, J BUON, V17, P369; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tie XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066008; van der Most Robbert G, 2005, Discov Med, V5, P265; VANDUUREN BL, 1978, CANCER RES, V38, P865; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Wingett D, 1996, J IMMUNOL, V156, P549; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; Wu AH, 2010, CELL ONCOL, V32, P313, DOI 10.3233/CLO-2010-0524; Yahata T, 1999, EUR J IMMUNOL, V29, P727, DOI 10.1002/(SICI)1521-4141(199903)29:03<727::AID-IMMU727>3.0.CO;2-0; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P279, DOI 10.1093/neuonc/nos306; Zhang YY, 2008, J IMMUNOL, V181, P190, DOI 10.4049/jimmunol.181.1.190	47	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76717	10.1371/journal.pone.0076717	http://dx.doi.org/10.1371/journal.pone.0076717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130787	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900081
J	Nalbandian, A; Nguyen, C; Katheria, V; Llewellyn, KJ; Badadani, M; Caiozzo, V; Kimonis, VE				Nalbandian, Angele; Nguyen, Christopher; Katheria, Veeral; Llewellyn, Katrina J.; Badadani, Mallikarjun; Caiozzo, Vincent; Kimonis, Virginia E.			Exercise Training Reverses Skeletal Muscle Atrophy in an Experimental Model of VCP Disease	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; MUSCULAR-DYSTROPHY; BONE; MUTATIONS; GENE; MICE; REVEALS	Background: The therapeutic effects of exercise resistance and endurance training in the alleviation of muscle hypertrophy/atrophy should be considered in the management of patients with advanced neuromuscular diseases. Patients with progressive neuromuscular diseases often experience muscle weakness, which negatively impact independence and quality of life levels. Mutations in the valosin containing protein (VCP) gene lead to Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD) and more recently affect 2% of amyotrophic lateral sclerosis (ALS)-diagnosed cases. Methods/Principle Findings: The present investigation was undertaken to examine the effects of uphill and downhill exercise training on muscle histopathology and the autophagy cascade in an experimental VCP mouse model carrying the R155H mutation. Progressive uphill exercise in VCPR155H/+ mice revealed significant improvement in muscle strength and performance by grip strength and Rotarod analyses when compared to the sedentary mice. In contrast, mice exercised to run downhill did not show any significant improvement. Histologically, the uphill exercised VCPR155H/+ mice displayed an improvement in muscle atrophy, and decreased expression levels of ubiquitin, P62/SQSTM1, LC3I/II, and TDP-43 autophagy markers, suggesting an alleviation of disease-induced myopathy phenotypes. There was also an improvement in the Paget-like phenotype. Conclusions: Collectively, our data highlights that uphill exercise training in VCPR155H/+ mice did not have any detrimental value to the function of muscle, and may offer effective therapeutic options for patients with VCP-associated diseases.	[Nalbandian, Angele; Nguyen, Christopher; Katheria, Veeral; Llewellyn, Katrina J.; Badadani, Mallikarjun; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kimonis, VE (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA.	vkimonis@uci.edu			Muscular Dystrophy Association (MDA) [175682]	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	Funding for this study was provided by the Muscular Dystrophy Association (MDA) 175682 to VEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badadani M, 2010, PLOS ONE, V5; Benatar M, 2013, NEUROLOGY, V80, P1874, DOI 10.1212/WNL.0b013e3182929fc3; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Biondi O, 2012, J PHYSIOL-LONDON, V590, P5907, DOI 10.1113/jphysiol.2012.238196; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Kim JS, 2005, J APPL PHYSIOL, V98, P334, DOI 10.1152/japplphysiol.00172.2003; Kimonis V, 2012, NEW VISTAS UNDERSTAN; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lim JH, 2004, MUSCLE NERVE, V30, P456, DOI 10.1002/mus.20139; Lima LO, 2013, J PHYSIOTHER, V59, P7, DOI 10.1016/S1836-9553(13)70141-3; Mallinson JE, 2013, NUTRITION, V29, P22, DOI 10.1016/j.nut.2012.04.012; Mangner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052274; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Mortensen B, 2013, AM J PHYSL ENDOCRINO; Mortensen SP, 2013, HYPERTENSION, V61, P1126, DOI 10.1161/HYPERTENSIONAHA.111.00328; Nalbandian A, 2012, MUSCLE NERVE; Nalbandian A, 2011, J MOL NEUROSCI; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2012, CTS-CLIN TRANSL SCI, V5, P226, DOI 10.1111/j.1752-8062.2012.00407.x; Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, pS172, DOI 10.1016/j.nmd.2012.10.005; Spina S, 2008, FASEB J, V22, P584; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Sveen ML, 2013, MUSCLE NERVE, V47, P163, DOI 10.1002/mus.23491; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Viassolo V, 2008, CLIN GENET; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008	46	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76187	10.1371/journal.pone.0076187	http://dx.doi.org/10.1371/journal.pone.0076187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130765	Green Published, gold			2022-12-25	WOS:000325810900071
J	Upadrasta, A; O'Sullivan, L; O'Sullivan, O; Sexton, N; Lawlor, PG; Hill, C; Fitzgerald, GF; Stanton, C; Ross, RP				Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Sexton, Noel; Lawlor, Peadar G.; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul			The Effect of Dietary Supplementation with Spent Cider Yeast on the Swine Distal Gut Microbiome	PLOS ONE			English	Article							PORCINE GASTROINTESTINAL-TRACT; WEANLING PIGS; NUTRIENT DIGESTIBILITY; HIGH-THROUGHPUT; LIVE YEAST; SP NOV.; PERFORMANCE; SALMONELLA; BACTERIA; CULTURE	Background: There is an increasing need for alternatives to antibiotics for promoting animal health, given the increasing problems associated with antibiotic resistance. In this regard, we evaluated spent cider yeast as a potential probiotic for modifying the gut microbiota in weanling pigs using pyrosequencing of 16S rRNA gene libraries. Methodology and Principal Findings: Piglets aged 24-26 days were assigned to one of two study groups; control (n = 12) and treatment (n = 12). The control animals were fed with a basal diet and the treatment animals were fed with basal diet in combination with cider yeast supplement (500 ml cider yeast containing similar to 7.6 log CFU/ml) for 21 days. Faecal samples were collected for 16s rRNA gene compositional analysis. 16S rRNA compositional sequencing analysis of the faecal samples collected from day 0 and day 21 revealed marked differences in microbial diversity at both the phylum and genus levels between the control and treatment groups. This analysis confirmed that levels of Salmonella and Escherichia were significantly decreased in the treatment group, compared with the control (P<0.001). This data suggest a positive influence of dietary supplementation with live cider yeast on the microbial diversity of the pig distal gut. Conclusions/Significance: The effect of dietary cider yeast on porcine gut microbial communities was characterized for the first time using 16S rRNA gene compositional sequencing. Dietary cider yeast can potentially alter the gut microbiota, however such changes depend on their endogenous microbiota that causes a divergence in relative response to that given diet.	[Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Stanton, Catherine; Ross, R. Paul] TEAGASC, Food Res Programme, Fermoy, Cork, Ireland; [Lawlor, Peadar G.] TEAGASC, Pig Prod Dev Unit, Moorepk Res Ctr, Fermoy, Cork, Ireland; [Upadrasta, Aditya; Hill, Colin; Fitzgerald, Gerald F.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Upadrasta, Aditya; O'Sullivan, Lisa; O'Sullivan, Orla; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Sexton, Noel] Food Ingredients Co, Cybercolors Ltd, Cork, Ireland	Teagasc; Teagasc; University College Cork; University College Cork	Ross, RP (corresponding author), TEAGASC, Food Res Programme, Moorepk, Fermoy, Cork, Ireland.	paul.ross@teagasc.ie	Upadrasta, Aditya/B-2977-2008; Ross, Paul/A-7584-2015; Hill, Colin/A-5611-2012; O'Sullivan, Orla/ABE-5980-2020; Stanton, Catherine/A-9549-2015	Upadrasta, Aditya/0000-0002-7788-9894; Ross, Paul/0000-0003-4876-8839; Hill, Colin/0000-0002-8527-1445; O'Sullivan, Orla/0000-0002-4332-1109; Stanton, Catherine/0000-0002-6724-7011	Enterprise Ireland, under the Commercialisation Fund [CFTD/05/117]; Irish Government under the National Development Plan; European Research and Development Fund; Science Foundation Ireland (SFI)	Enterprise Ireland, under the Commercialisation Fund; Irish Government under the National Development Plan; European Research and Development Fund; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was funded by Enterprise Ireland, under the Commercialisation Fund (Contract No: CFTD/05/117), the Irish Government under the National Development Plan, 2000-2006, the European Research and Development Fund and Science Foundation Ireland (SFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benus RFJ, 2010, BRIT J NUTR, V104, P693, DOI 10.1017/S0007114510001030; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Casey PG, 2004, LETT APPL MICROBIOL, V39, P431, DOI 10.1111/j.1472-765X.2004.01603.x; Cavitte JC, 2001, PRESENT FUTURE CONTR, P46; Chapman JD, 1988, PROBIOTICS ACIDIFIER, P219; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO/WHO, 2001, FAO WHO EV HLTH NUTR; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GIONGO A, 2010, ISME J; Giongo A, 2010, DIVERSITY-BASEL, V2, P1015, DOI DOI 10.3390/d2071015; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Jabari L, 2012, INT J SYST EVOL MICR, V62, P2522, DOI 10.1099/ijs.0.032508-0; Kogan G, 2007, LIVEST SCI, V109, P161, DOI 10.1016/j.livsci.2007.01.134; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li JY, 2006, ARCH ANIM NUTR, V60, P277, DOI 10.1080/17450390600785343; Line JE, 1998, POULTRY SCI, V77, P405, DOI 10.1093/ps/77.3.405; Martin FP, 2008, MOL SYSTEMS BIOL, P4; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; Mathew AG, 1998, J ANIM SCI, V76, P2138; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Oli MW, 1998, DIGEST DIS SCI, V43, P138, DOI 10.1023/A:1018892524790; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PEARSON V, 1978, J ANIM SCI, V47, P488, DOI 10.2527/jas1978.472488x; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rambaut A, 2009, FIG TREE V1 3 1; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rozeboom DW, 2005, J ANIM SCI, V83, P2637; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sokol H, 2008, P NATL ACAD SCI; Spring P, 1998, MANNANOLIGOSACCHARID, P553; Stein H, 2007, FEEDING PIGS IMMUNE, P61801; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; Van der Peet-Schwering CMC, 2007, J ANIM SCI; van Heugten E, 2003, J ANIM SCI, V81, P1004; VEUM TL, 1973, J ANIM SCI, V37, P67, DOI 10.2527/jas1973.37167x; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; White LA, 2002, J ANIM SCI, V80, P2619; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	29	35	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75714	10.1371/journal.pone.0075714	http://dx.doi.org/10.1371/journal.pone.0075714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130736	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900054
J	Dueholm, MS; Otzen, D; Nielsen, PH				Dueholm, Morten S.; Otzen, Daniel; Nielsen, Per Halkjaer			Evolutionary Insight into the Functional Amyloids of the Pseudomonads	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERIA; BURKHOLDERIA; AGGREGATION; AERUGINOSA; PATHOGENS; ADHESINS	Functional bacterial amyloids (FuBA) are important components in many environmental biofilms where they provide structural integrity to the biofilm, mediate bacterial aggregation and may function as virulence factor by binding specifically to host cell molecules. A novel FuBA system, the Fap system, was previously characterized in the genus Pseudomonas, however, very little is known about the phylogenetic diversity of bacteria with the genetic capacity to apply this system. Studies of genomes and public metagenomes from a diverse range of habitats showed that the Fap system is restricted to only three classes in the phylum Proteobacteria, the Beta-, Gamma- and Deltaproteobacteria. The structural organization of the fap genes into a single fapABCDEF operon is well conserved with minor variations such as a frequent deletion of fapA. A high degree of variation was seen within the primary structure of the major Fap fibril monomers, FapC, whereas the minor monomers, FapB, showed less sequence variation. Comparison of phylogenetic trees based on Fap proteins and the 16S rRNA gene of the corresponding bacteria showed remarkably similar overall topology. This indicates, that horizontal gene transfer is an infrequent event in the evolution of the Fap system.	[Dueholm, Morten S.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aarhus, Denmark; [Otzen, Daniel] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Prot Struct inSPIN, Dept Mol Biol & Genet, Aarhus, Denmark	Aalborg University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aarhus, Denmark.	phn@bio.aau.dk	Dueholm, Morten Simonsen/T-6718-2018; Nielsen, Per Halkjær/T-6796-2018	Dueholm, Morten Simonsen/0000-0003-4135-2670; Nielsen, Per Halkjær/0000-0002-6402-1877; Otzen, Daniel/0000-0002-2918-8989	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation; Aalborg University	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation(Lundbeckfonden); Aalborg University	The authors are grateful to funding from the Villum Kann Rasmussen Foundation (BioNET), the Lundbeck Foundation and Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attaway HH, 2002, CURR MICROBIOL, V45, P30, DOI 10.1007/s00284-001-0053-1; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Beatson SA, 2011, J BACTERIOL, V193, P1286, DOI 10.1128/JB.01337-10; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Nielsen PH, 2011, SPRINGER SER BIOFILM, V5, P41, DOI 10.1007/978-3-642-19940-0_3; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Segonds C, 2009, J CLIN MICROBIOL, V47, P1510, DOI 10.1128/JCM.02489-08; SENEVIRATNE G, 2011, MICROBIOLOGY MONOGRA, P81; Shankar M, 2013, J BACTERIOL, V195, P39, DOI 10.1128/JB.01236-12; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Woo PCY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000416; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013	37	43	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76630	10.1371/journal.pone.0076630	http://dx.doi.org/10.1371/journal.pone.0076630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116129	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300075
J	Hayashi, Y; Asuzu, DT; Gibbons, SJ; Aarsvold, KH; Bardsley, MR; Lomberk, GA; Mathison, AJ; Kendrick, ML; Shen, KR; Taguchi, T; Gupta, A; Rubin, BP; Fletcher, JA; Farrugia, G; Urrutia, RA; Ordog, T				Hayashi, Yujiro; Asuzu, David T.; Gibbons, Simon J.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Lomberk, Gwen A.; Mathison, Angela J.; Kendrick, Michael L.; Shen, K. Robert; Taguchi, Takahiro; Gupta, Anu; Rubin, Brian P.; Fletcher, Jonathan A.; Farrugia, Gianrico; Urrutia, Raul A.; Ordog, Tamas			Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1-and Stem Cell Factor-Activated Pathways	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; OF-FUNCTION MUTATIONS; SMOOTH-MUSCLE-CELLS; INTERSTITIAL-CELLS; KIT-LIGAND; C-KIT; INHIBITOR; IDENTIFICATION; EXPRESSION; CHROMATIN	Stem cell factor (mouse: Kitl, human: KITLG) and insulin-like growth factor-1 (IGF1), acting via KIT and IGF1 receptor (IGF1R), respectively, are critical for the development and integrity of several tissues. Autocrine/paracrine KITLG-KIT and IGF1-IGF1R signaling are also activated in several cancers including gastrointestinal stromal tumors (GIST), the most common sarcoma. In murine gastric muscles, IGF1 promotes Kitl-dependent development of interstitial cells of Cajal (ICC), the non-neoplastic counterpart of GIST, suggesting cooperation between these pathways. Here, we report a novel mechanism linking IGF1-IGF1R and KITLG-KIT signaling in both normal and neoplastic cells. In murine gastric muscles, the microenvironment for ICC and GIST, human hepatic stellate cells (LX-2), a model for cancer niches, and GIST cells, IGF1 stimulated Kitl/KITLG protein and mRNA expression and promoter activity by activating several signaling pathways including AKT-mediated glycogen synthase kinase-3 beta inhibition (GSK3i). GSK3i alone also stimulated Kitl/KITLG expression without activating mitogenic pathways. Both IGF1 and GSK3i induced chromatin-level changes favoring transcriptional activation at the Kitl promoter including increased histone H3/H4 acetylation and H3 lysine (K) 4 methylation, reduced H3K9 and H3K27 methylation and reduced occupancy by the H3K27 methyltransferase EZH2. By pharmacological or RNA interference-mediated inhibition of chromatin modifiers we demonstrated that these changes have the predicted impact on KITLG expression. KITLG knock-down and immunoneutralization inhibited the proliferation of GIST cells expressing wild-type KIT, signifying oncogenic autocrine/paracrine KITLG-KIT signaling. We conclude that membrane-to-nucleus signaling involving GSK3i establishes a previously unrecognized link between the IGF1-IGF1R and KITLG-KIT pathways, which is active in both physiologic and oncogenic contexts and can be exploited for therapeutic purposes.	[Hayashi, Yujiro; Asuzu, David T.; Gibbons, Simon J.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Farrugia, Gianrico; Ordog, Tamas] Mayo Clin, Enter Neurosci Program, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Hayashi, Yujiro; Asuzu, David T.; Aarsvold, Kirsten H.; Bardsley, Michael R.; Lomberk, Gwen A.; Mathison, Angela J.; Urrutia, Raul A.; Ordog, Tamas] Mayo Clin, Gastroenterol Res Unit, Div Gastroenterol & Hepatol, Rochester, MN USA; [Kendrick, Michael L.; Shen, K. Robert] Mayo Clin, Dept Surg, Rochester, MN USA; [Taguchi, Takahiro] Kochi Univ, Div Human Hlth & Med Sci, Grad Sch Kuroshio Sci, Nanko Ku, Kochi 780, Japan; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Dept Anat Pathol, Lerner Res Inst, Cleveland, OH 44106 USA; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA; [Gupta, Anu; Rubin, Brian P.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fletcher, Jonathan A.] Harvard Univ, Sch Med, Boston, MA USA; [Farrugia, Gianrico; Urrutia, Raul A.; Ordog, Tamas] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Kochi University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mayo Clinic	Ordog, T (corresponding author), Mayo Clin, Enter Neurosci Program, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	ordog.tamas@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X; Mathison, Angela/0000-0002-6763-2710; Harrington, Jon/0000-0003-1293-5201; Gibbons, Simon/0000-0001-5311-5993	National Institutes of Health [R01 DK058185, P01 DK068055, P30 DK084567, P30 CA015083, P50 CA127003]; GIST Cancer Research Fund; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK058185, P01DK068055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIST Cancer Research Fund; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institutes of Health (http://www.nih.gov/) grants R01 DK058185, P01 DK068055 (Project 2), P30 DK084567, P30 CA015083, P50 CA127003, as well as by the GIST Cancer Research Fund (http://www.gistinfo.org/) and the Mayo Clinic Center for Individualized Medicine http://mayoresearch.mayo.edu/center-for-individualized-medicine/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2011, J PATHOL, V223, P251, DOI 10.1002/path.2798; Asuzu DT, 2011, NEUROGASTROENT MOTIL, V23, pE309, DOI 10.1111/j.1365-2982.2011.01730.x; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Baumann U, 1999, HEPATOLOGY, V30, P112, DOI 10.1002/hep.510300140; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bono P, 2004, BLOOD, V103, P2929, DOI 10.1182/blood-2003-10-3443; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Edris B, 2013, P NATL ACAD SCI USA, V110, P3501, DOI 10.1073/pnas.1222893110; Flynn RS, 2009, AM J PHYSIOL-GASTR L, V297, pG1232, DOI 10.1152/ajpgi.00323.2009; Gaca MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Grover M, 2011, GASTROENTEROLOGY, V140, P1575, DOI 10.1053/j.gastro.2011.01.046; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirano K, 2008, PATHOL RES PRACT, V204, P799, DOI 10.1016/j.prp.2008.05.002; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2010, INT J CANCER, V127, P2718, DOI 10.1002/ijc.25247; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuemmerle JF, 2005, AM J PHYSIOL-GASTR L, V288, pG101, DOI 10.1152/ajpgi.00032.2004; Kuemmerle JF, 1998, AM J PHYSIOL-GASTR L, V275, pG151, DOI 10.1152/ajpgi.1998.275.1.G151; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; MAJUMDAR MK, 1994, J BIOL CHEM, V269, P1237; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Negri T, 2009, J PATHOL, V217, P103, DOI 10.1002/path.2450; ORDBG T, 2004, AM J PHYSIOL-GASTR L, V286, pG351, DOI DOI 10.1152/AJPGI.00281.2003.PUBMED:14563669; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Sokolovic A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-3; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Theou-Anton N, 2006, BRIT J CANCER, V94, P1180, DOI 10.1038/sj.bjc.6603063; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Williams KL, 2002, AM J PHYSIOL-GASTR L, V283, pG875, DOI 10.1152/ajpgi.00089.2002; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yakar S, 2012, ENDOCRIN METAB CLIN, V41, P231, DOI 10.1016/j.ecl.2012.04.008; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	63	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76822	10.1371/journal.pone.0076822	http://dx.doi.org/10.1371/journal.pone.0076822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116170	Green Published, gold			2022-12-25	WOS:000325501300101
J	Kelmo, F; Bell, JJ; Attrill, MJ				Kelmo, Francisco; Bell, James J.; Attrill, Martin J.			Tolerance of Sponge Assemblages to Temperature Anomalies: Resilience and Proliferation of Sponges following the 1997-8 El-Nino Southern Oscillation	PLOS ONE			English	Article							CORAL-REEF SPONGES; GREAT-BARRIER-REEF; NORTHERN BAHIA; CLIMATE-CHANGE; CNIDARIAN COMMUNITY; CARIBBEAN REEFS; MARINE SPONGES; BRAZIL; PATTERNS; PACIFIC	Coral reefs across the world are under threat from a range of stressors, and while there has been considerable focus on the impacts of these stressors on corals, far less is known about their effect on other reef organisms. The 1997-8 El-Nino Southern Oscillation (ENSO) had notable and severe impacts on coral reefs worldwide, but not all reef organisms were negatively impacted by this large-scale event. Here we describe how the sponge fauna at Bahia, Brazil was influenced by the 1997-8 ENSO event. Sponge assemblages from three contrasting reef habitats (reef tops, walls and shallow banks) at four sites were assessed annually from 1995 to 2011. The within-habitat sponge diversity did not vary significantly across the study period; however, there was a significant increase in density in all habitats. Multivariate analyses revealed no significant difference in sponge assemblage composition (ANOSIM) between pre- and post-ENSO years for any of the habitats, suggesting that neither the 1997-8 nor any subsequent smaller ENSO events have had any measurable impact on the reef sponge assemblage. Importantly, this is in marked contrast to the results previously reported for a suite of other taxa (including corals, echinoderms, bryozoans, and ascidians), which all suffered mass mortalities as a result of the ENSO event. Our results suggest that of all reef taxa, sponges have the potential to be resilient to large-scale thermal stress events and we hypothesize that sponges might be less affected by projected increases in sea surface temperature compared to other major groups of reef organisms.	[Kelmo, Francisco] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	Universidade Federal da Bahia; Victoria University Wellington; University of Plymouth	Kelmo, F (corresponding author), Univ Fed Bahia, Inst Biol, Campus Univ Ondina, Salvador, BA, Brazil.	kelmo@ufba.br		Attrill, Martin/0000-0002-4039-031X; Bell, James/0000-0001-9996-945X	Plymouth University Marine Institute	Plymouth University Marine Institute	This work is funded by the corresponding author, Francisco Kelmo, with additional support from the Plymouth University Marine Institute to FK. The funder coordinated the overall research objectives and organised the sampling, identification of organisms and data collation throughout the survey, developed sampling methodology, input information on species biology and wrote the paper.	Aerts LAM, 2000, MAR ECOL-P S Z N I, V21, P191, DOI 10.1046/j.1439-0485.2000.00685.x; Alcolado Pedro M., 2007, V28, P3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Antonius A, 1998, REV BIOL TROP, V46, P145; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Attrill MJ, 2007, ESTUAR COAST SHELF S, V73, P243, DOI 10.1016/j.ecss.2007.01.007; Attrill MJ, 2004, CLIM RES, V26, P151, DOI 10.3354/cr026151; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Bell JJ, 2008, MAR BIOL, V155, P563, DOI 10.1007/s00227-008-1036-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Bittencourt ACDP, 2000, AN ACAD BRAS CIENC, V72, P271, DOI 10.1590/S0001-37652000000200012; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carballo JL, 2006, ECOSCIENCE, V13, P119, DOI 10.2980/1195-6860(2006)13[119:EONSOT]2.0.CO;2; Carballo JL, 2008, MAR ECOL-EVOL PERSP, V29, P216, DOI 10.1111/j.1439-0485.2008.00228.x; Carballo JL, 2007, ECOSCIENCE, V14, P92, DOI 10.2980/1195-6860(2007)14[92:ACOSAP]2.0.CO;2; Cebrian E, 2006, MAR ECOL PROG SER, V323, P83, DOI 10.3354/meps323083; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; CORTES J, 1984, REV BIOL TROP, V32, P227; Cuet P., 1988, P 6 INT COR REEF S T, V2, P207; Custodio MR, 2007, MUSEU NACL SERIE LIV, V28; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz MC, 2001, B MAR SCI, V69, P535; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; Duckworth AR, 2012, MAR ECOL PROG SER, V462, P67, DOI 10.3354/meps09853; Dunlap M, 1998, MAR ECOL-P S Z N I, V19, P325, DOI 10.1111/j.1439-0485.1998.tb00471.x; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Eakin CM, 2001, B MAR SCI, V69, P171; Feingold JS, 2001, B MAR SCI, V69, P61; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Hajdu E., 2011, MUSEU NACL SERIE LIV; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jimenez CE, 2003, MAR ECOL-P S Z N I, V24, P179, DOI 10.1046/j.1439-0485.2003.03814.x; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kelmo F, 2006, HYDROBIOLOGIA, V555, P231, DOI 10.1007/s10750-005-1119-z; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kelmo F, 2004, BIOL CONSERV, V118, P609, DOI 10.1016/j.biocon.2003.10.010; Kelmo F, 2001, B MAR SCI, V69, P547; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Kumar A, 2001, J CLIMATE, V14, P345, DOI 10.1175/1520-0442(2001)014<0345:TSNAWO>2.0.CO;2; Leao Z.M.A.N., 1997, P583; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lopez-Victoria M, 2005, MAR ECOL-EVOL PERSP, V26, P33, DOI 10.1111/j.1439-0485.2005.00036.x; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; Mo KC, 2001, GEOPHYS RES LETT, V28, P2065, DOI 10.1029/2000GL012448; Moraes FC, 2011, MUSEU NACL SERIE LIV, V44; MURICY G, 1991, Vie et Milieu, V41, P205; Muricy G, 2006, MUSEU NACL SERIE LIV, V17, P104; Muricy G, 2011, MUSEU NACL SERIE LIV, V46; Nolasco MC, 1986, QUATERNARY S AM ANTA, P159; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Peso-Aguiar M.C., 2000, Aquatic Ecosystem Health & Management, V3, P459, DOI 10.1016/S1463-4988(00)00051-8; Pile A.J., 1997, P1403; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Schils T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046639; Schoenberg Christine H. L., 2007, V28, P569; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Wilkinson C, 1999, NATURE RESOUR, V35, P16; Wilkinson C, 1999, AMBIO, V28, P188; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007	85	29	29	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76441	10.1371/journal.pone.0076441	http://dx.doi.org/10.1371/journal.pone.0076441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116109	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300058
J	Wickstrum, J; Sammons, LR; Restivo, KN; Hefty, PS				Wickstrum, Jason; Sammons, Lindsay R.; Restivo, Keasha N.; Hefty, P. Scott			Conditional Gene Expression in Chlamydia trachomatis Using the Tet System	PLOS ONE			English	Article							TETRACYCLINE ANALOGS; REGULATORY ELEMENTS; ESCHERICHIA-COLI; REPRESSOR; ASSAY; MECHANISMS; PROMOTER; VECTOR	Chlamydia trachomatis is maintained through a complex bi-phasic developmental cycle that incorporates numerous processes that are poorly understood. This is reflective of the previous paucity of genetic tools available. The recent advent of a method for transforming Chlamydia has enabled the development of essential molecular tools to better study these medically important bacteria. Critical for the study of Chlamydia biology and pathogenesis, is a system for tightly controlled inducible gene expression. To accomplish this, a new shuttle vector was generated with gene expression controlled by the Tetracycline repressor and anhydryotetracycline. Evaluation of GFP expression by this system demonstrated tightly controlled gene regulation with rapid protein expression upon induction and restoration of transcription repression following inducer removal. Additionally, induction of expression could be detected relatively early during the developmental cycle and concomitant with conversion into the metabolically active form of Chlamydia. Uniform and strong GFP induction was observed during middle stages of the developmental cycle. Interestingly, variable induced GFP expression by individual organisms within shared inclusions during later stages of development suggesting metabolic diversity is affecting induction and/or expression. These observations support the strong potential of this molecular tool to enable numerous experimental analyses for a better understanding of the biology and pathogenesis of Chlamydia.	[Wickstrum, Jason; Sammons, Lindsay R.; Restivo, Keasha N.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	pshefty@ku.edu			National Institutes of Health NIH [AI103711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103711] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from National Institutes of Health NIH AI103711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; DEGENKOLB J, 1991, ANTIMICROB AGENTS CH, V35, P1591, DOI 10.1128/AAC.35.8.1591; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kamionka A, 2004, NUCLEIC ACIDS RES, V32, P842, DOI 10.1093/nar/gkh200; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; OLIVA B, 1992, ANTIMICROB AGENTS CH, V36, P913, DOI 10.1128/AAC.36.5.913; Osaka I, 2013, ANTIMICROB AGENTS CH, V57, P2838, DOI 10.1128/AAC.00056-13; Osaka I, 2012, ANTIMICROB AGENTS CH, V56, P4184, DOI 10.1128/AAC.00427-12; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaumburg CS, 2003, NUCLEIC ACIDS RES, V31, P551, DOI 10.1093/nar/gkg150; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wang YB, 2013, PATHOG DIS, V67, P100, DOI 10.1111/2049-632X.12024; Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059195; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; Wilson DP, 2004, B MATH BIOL, V66, P523, DOI 10.1016/j.bulm.2003.09.001	33	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76743	10.1371/journal.pone.0076743	http://dx.doi.org/10.1371/journal.pone.0076743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116144	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300086
J	Arakawa, T; Kamiya, N; Nakamura, H; Fukuda, I				Arakawa, Takamasa; Kamiya, Narutoshi; Nakamura, Haruki; Fukuda, Ikuo			Molecular Dynamics Simulations of Double-Stranded DNA in an Explicit Solvent Model with the Zero-Dipole Summation Method	PLOS ONE			English	Article							PARTICLE-MESH EWALD; RANGE ELECTROSTATIC INTERACTIONS; NUCLEIC-ACIDS; B-DNA; ENERGY FUNCTION; REACTION FIELD; LIMITING LAWS; A-DNA; WATER; TRANSITION	Molecular dynamics MD) simulations of a double-stranded DNA with explicit water and small ions were performed with the zero-dipole summation (ZD) method, which was recently developed as one of the non-Ewald methods. Double-stranded DNA is highly charged and polar, with phosphate groups in its backbone and their counterions, and thus precise treatment for the long-range electrostatic interactions is always required to maintain the stable and native double-stranded form. A simple truncation method deforms it profoundly. On the contrary, the ZD method, which considers the neutralities of charges and dipoles in a truncated subset, well reproduced the electrostatic energies of the DNA system calculated by the Ewald method. The MD simulations using the ZD method provided a stable DNA system, with similar structures and dynamic properties to those produced by the conventional Particle mesh Ewald method.	[Arakawa, Takamasa; Kamiya, Narutoshi; Nakamura, Haruki; Fukuda, Ikuo] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kamiya, N (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	nkamiya@protein.osaka-u.ac.jp	Kamiya, Narutoshi/C-4548-2016	Kamiya, Narutoshi/0000-0002-0527-6968	JSPS KAKENHI [23370071, 24118008]; JSPS [25440070, 25390156]; Grants-in-Aid for Scientific Research [25440070] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 23370071 and 24118008. NK and IF are grateful for a Grant-in-Aid for Scientific Research (C) (25440070 and 25390156, respectively) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER JA, 1973, MOL PHYS, V26, P789, DOI 10.1080/00268977300102101; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; BROOKS CL, 1985, J CHEM PHYS, V83, P5897, DOI 10.1063/1.449621; Cheatham TE, 1996, J MOL BIOL, V259, P434; Cheatham TE, 2000, ANNU REV PHYS CHEM, V51, P435, DOI 10.1146/annurev.physchem.51.1.435; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Fennell CJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206581; Fukuda Ikuo, 2012, Biophys Rev, V4, P161, DOI 10.1007/s12551-012-0089-4; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Fukuda I, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114301; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; Heddi B, 2008, J MOL BIOL, V382, P956, DOI 10.1016/j.jmb.2008.07.047; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamiya N, 2013, CHEM PHYS LETT, V568, P26, DOI 10.1016/j.cplett.2013.03.014; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; MacKerell AD, 1997, J PHYS CHEM B, V101, P646, DOI 10.1021/jp9622795; MacKerell AD, 2008, CURR OPIN STRUC BIOL, V18, P194, DOI 10.1016/j.sbi.2007.12.012; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; MANNING GS, 1972, BIOPOLYMERS, V11, P937, DOI 10.1002/bip.1972.360110502; Mashimo T, 2013, HIGH PERF COMP S 201, P70; MIASKIEWICZ K, 1993, J AM CHEM SOC, V115, P1526, DOI 10.1021/ja00057a045; Nakamura H, 1996, Q REV BIOPHYS, V29, P1, DOI 10.1017/S0033583500005746; Ni B, 2011, J MOL MODEL, V17, P2883, DOI 10.1007/s00894-011-0975-x; Nina M, 2002, J PHYS CHEM B, V106, P3696, DOI 10.1021/jp013855m; Norberg J, 2002, ACCOUNTS CHEM RES, V35, P465, DOI 10.1021/ar010026a; Noy A, 2007, NUCLEIC ACIDS RES, V35, P3330, DOI 10.1093/nar/gkl1135; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Pan YP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000448; Pande V, 2008, NUCLEIC ACIDS RES, V36, P1508, DOI 10.1093/nar/gkm1182; Pastor N, 2005, BIOPHYS J, V88, P3262, DOI 10.1529/biophysj.104.058339; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Roy S, 2010, J BIOMOL STRUCT DYN, V27, P443, DOI 10.1080/07391102.2010.10507329; Saenger W., 1984, PRINCIPLES NUCL ACID; SAITO M, 1994, J CHEM PHYS, V101, P4055, DOI 10.1063/1.468411; Sen S, 2001, J AM CHEM SOC, V123, P7414, DOI 10.1021/ja0032632; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Wang YL, 2007, BIOPHYS J, V92, P3063, DOI 10.1529/biophysj.106.092106; Wang ZL, 2011, J NANOSCI NANOTECHNO, V11, P8457, DOI 10.1166/jnn.2011.4994; Wolf D, 1999, J CHEM PHYS, V110, P8254, DOI 10.1063/1.478738; YORK DM, 1995, J AM CHEM SOC, V117, P5001, DOI 10.1021/ja00122a034	52	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76606	10.1371/journal.pone.0076606	http://dx.doi.org/10.1371/journal.pone.0076606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124577	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100134
J	Evans, C; Cook, SJ; Coleman, MP; Gilley, J				Evans, Catherine; Cook, Simon J.; Coleman, Michael P.; Gilley, Jonathan			MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK-ERK Signaling	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; NEURONAL SURVIVAL; SELF-DESTRUCTION; IN-VIVO; PATHWAY; WLD(S); IDENTIFICATION; ERK5/BMK1; SYNAPSES; REVEALS	Wallerian degeneration is delayed when sufficient levels of proteins with NMNAT activity are maintained within axons after injury. This has been proposed to form the basis of 'slow Wallerian degeneration' (Wld(S)), a neuroprotective phenotype conferred by an aberrant fusion protein, Wld(S). Proteasome inhibition also delays Wallerian degeneration, although much less robustly, with stabilization of NMNAT2 likely to play a key role in this mechanism. The pan-MEK inhibitor U0126 has previously been shown to reverse the axon-protective effects of proteasome inhibition, suggesting that MEK-ERK signaling plays a role in delayed Wallerian degeneration, in addition to its established role in promoting neuronal survival. Here we show that whilst U0126 can also reverse Wld(S)-mediated axon protection, more specific inhibitors of MEK1/2 and MEK5, PD184352 and BIX02189, have no significant effect on the delay to Wallerian degeneration in either situation, whether used alone or in combination. This suggests that an off-target effect of U0126 is responsible for reversion of the axon protective effects of Wld(S) expression or proteasome inhibition, rather than inhibition of MEK1/2-ERK1/2 or MEK5-ERK5 signaling. Importantly, this off-target effect does not appear to result in alterations in the stabilities of either Wld(S) or NMNAT2.	[Evans, Catherine; Cook, Simon J.; Coleman, Michael P.; Gilley, Jonathan] Babraham Inst, Signalling Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Gilley, J (corresponding author), Babraham Inst, Signalling Programme, Cambridge, England.	jon.gilley@babraham.ac.uk		Cook, Simon/0000-0001-9087-1616	Synergy grant; Science Policy Committee of the Babraham Institute; BBSRC [BBS/E/B/000C0417, BBS/E/B/000C0419] Funding Source: UKRI; MRC [G1000702] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0417, BBS/E/B/0000C199, BBS/E/B/000C0419] Funding Source: researchfish; Medical Research Council [G1000702] Funding Source: researchfish	Synergy grant; Science Policy Committee of the Babraham Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Synergy grant awarded by the Science Policy Committee of the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; Choi K, 2008, MOL PHARMACOL, V74, P527, DOI 10.1124/mol.107.044628; Cohen MS, 2012, CHEM BIOL, V19, P179, DOI 10.1016/j.chembiol.2012.01.012; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Gerdts J, 2011, J BIOL CHEM, V286, P28011, DOI 10.1074/jbc.M111.250472; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gilley R, 2012, CELL SIGNAL, V24, P170, DOI 10.1016/j.cellsig.2011.08.018; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Ikegami K, 2004, BRAIN RES, V1030, P81, DOI 10.1016/j.brainres.2004.09.050; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McCaw BJ, 2005, GENE, V345, P183, DOI 10.1016/j.gene.2004.11.011; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Xiong X, 2012, PLOS BIOL IN PRESS; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yung HW, 2004, BIOCHEM PHARMACOL, V68, P351, DOI 10.1016/j.bcp.2004.03.030; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76505	10.1371/journal.pone.0076505	http://dx.doi.org/10.1371/journal.pone.0076505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124570	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100127
J	Jamison, RA; Samarage, CR; Bryson-Richardson, RJ; Fouras, A				Jamison, R. Aidan; Samarage, Chaminda R.; Bryson-Richardson, Robert J.; Fouras, Andreas			In Vivo Wall Shear Measurements within the Developing Zebrafish Heart	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; BLOOD-FLOW; VERTEBRATE HEART; CHICKEN EMBRYOS; VELOCITY-FIELD; STRESS; PIV; ACCURACY	Physical forces can influence the embryonic development of many tissues. Within the cardiovascular system shear forces resulting from blood flow are known to be one of the regulatory signals that shape the developing heart. A key challenge in investigating the role of shear forces in cardiac development is the ability to obtain shear force measurements in vivo. Utilising the zebrafish model system we have developed a methodology that allows the shear force within the developing embryonic heart to be determined. Accurate wall shear measurement requires two essential pieces of information; high-resolution velocity measurements near the heart wall and the location and orientation of the heart wall itself. We have applied high-speed brightfield imaging to capture time-lapse series of blood flow within the beating heart between 3 and 6 days post-fertilization. Cardiac-phase filtering is applied to these time-lapse images to remove the heart wall and other slow moving structures leaving only the red blood cell movement. Using particle image velocimetry to calculate the velocity of red blood cells in different regions within the heart, and using the signal-to-noise ratio of the cardiac-phase filtered images to determine the boundary of blood flow, and therefore the position of the heart wall, we have been able to generate the necessary information to measure wall shear in vivo. We describe the methodology required to measure shear in vivo and the application of this technique to the developing zebrafish heart. We identify a reduction in shear at the ventricular-bulbar valve between 3 and 6 days post-fertilization and demonstrate that the shear environment of the ventricle during systole is constantly developing towards a more uniform level.	[Jamison, R. Aidan; Samarage, Chaminda R.; Fouras, Andreas] Monash Univ, Lab Dynam Imaging, Melbourne, Vic 3004, Australia; [Jamison, R. Aidan; Samarage, Chaminda R.; Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Jamison, RA (corresponding author), Monash Univ, Lab Dynam Imaging, Melbourne, Vic 3004, Australia.	aidan.jamison@monash.edu	Fouras, Andreas/A-9410-2008; Bryson-Richardson, Robert/B-7556-2008	Fouras, Andreas/0000-0002-8933-1759; Bryson-Richardson, Robert/0000-0002-9501-8208	Australian Research Council Discovery Project [130100294]; NHMRC Career Development Fellowship [1022721]	Australian Research Council Discovery Project(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported under Australian Research Council Discovery Project number 130100294. A. F. is supported by NHMRC Career Development Fellowship (1022721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Bulwer B, 2009, ECHOCARDIOGRAPHY POC, P45; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Fouras A, 1998, EXP FLUIDS, V25, P409, DOI 10.1007/s003480050248; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Fouras A, 2007, EXP FLUIDS, V42, P799, DOI 10.1007/s00348-007-0293-3; Fouras A, 2009, EXP FLUIDS, V47, P569, DOI 10.1007/s00348-009-0616-7; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Jamison RA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036007; Ku JP, 2002, ANN BIOMED ENG, V30, P743, DOI 10.1114/1.1496086; Lee JY, 2007, PHYSIOL MEAS, V28, P1149, DOI 10.1088/0967-3334/28/10/002; Lu J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830824; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Rosencranz R., 2006, PATHOL PATTERNS REV, V125, pS78; Sugii Y, 2002, PHYSIOL MEAS, V23, P403, DOI 10.1088/0967-3334/23/2/315; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246	23	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75722	10.1371/journal.pone.0075722	http://dx.doi.org/10.1371/journal.pone.0075722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124507	Green Published, Green Submitted, gold			2022-12-25	WOS:000325489100064
J	Lourhmati, A; Buniatian, GH; Paul, C; Verleysdonk, S; Buecheler, R; Buadze, M; Proksch, B; Schwab, M; Gleiter, CH; Danielyan, L				Lourhmati, Ali; Buniatian, Gayane H.; Paul, Christina; Verleysdonk, Stephan; Buecheler, Reinhild; Buadze, Marine; Proksch, Barbara; Schwab, Matthias; Gleiter, Christoph H.; Danielyan, Lusine			Age-Dependent Astroglial Vulnerability to Hypoxia and Glutamate: The Role for Erythropoietin	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; SYNTHETASE ACTIVITY; RAT HIPPOCAMPAL; IN-VITRO; ASTROCYTES; METALLOTHIONEIN; EXPRESSION; RECEPTOR; INJURY	Extracellular accumulation of toxic concentrations of glutamate (Glu) is a hallmark of many neurodegenerative diseases, often accompanied by hypoxia and impaired metabolism of this neuromediator. To address the question whether the multifunctional neuroprotective action of erythropoietin (EPO) extends to the regulation of extracellular Glu-level and is age-related, young and culture-aged rat astroglial primary cells (APC) were simultaneously treated with 1mM Glu and/or human recombinant EPO under normoxic and hypoxic conditions (NC and HC). EPO increased the Glu uptake by astrocytes under both NC and especially upon HC in culture-aged APC (by 60%). Moreover, treatment with EPO up-regulated the activity of glutamine synthetase (GS), the expression of glutamate-aspartate transporter (GLAST) and the level of EPO mRNA. EPO alleviated the Glu- and hypoxia-induced LDH release from astrocytes. These protective EPO effects were concentration-dependent and they were strongly intensified with age in culture. More than a 4-fold increase in apoptosis and a 2-fold decrease in GS enzyme activity was observed in APC transfected with EPO receptor (EPOR)-siRNA. Our in vivo data show decreased expression of EPO and a strong increase of EPOR in brain homogenates of APP/PS1 mice and their wild type controls during aging. Comparison of APP/PS1 and age-matched WT control mice revealed a stronger expression of EPOR but a weaker one of EPO in the Alzheimer's disease (AD) model mice. Here we show for the first time the direct correlation between the extent of differentiation (age) of astrocytes and the efficacy of EPO in balancing extracellular glutamate clearance and metabolism in an in-vitro model of hypoxia and Glu-induced astroglial injury. The clinical relevance of EPO and EPOR as markers of brain cells vulnerability during aging and neurodegeneration is evidenced by remarkable changes in their expression levels in a transgenic model of AD and their WT controls.	[Lourhmati, Ali; Buniatian, Gayane H.; Paul, Christina; Buecheler, Reinhild; Buadze, Marine; Proksch, Barbara; Schwab, Matthias; Gleiter, Christoph H.; Danielyan, Lusine] Univ Hosp Tuebingen, Inst Clin & Expt Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany; [Buniatian, Gayane H.] Natl Acad Sci, H Buniatyan Inst Biochem, Yerevan, Armenia; [Verleysdonk, Stephan] German Univ Cairo, Cairo, Egypt; [Schwab, Matthias] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institute of Biochemistry after H. Buniatyan - NAS RA; National Academy of Sciences of Armenia; Egyptian Knowledge Bank (EKB); German University in Cairo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Buniatian, GH (corresponding author), Univ Hosp Tuebingen, Inst Clin & Expt Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany.	buniatian@web.de; lusine.danielyan@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020	Danielyan, Lusine/0000-0003-4130-8477; Buadze, Marine/0000-0002-4175-0065	University of Tubingen [F124410]	University of Tubingen	This work was supported by University of Tubingen Fortune Grant F124410 (to LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 2003, EXP BIOL MED, V228, P1033, DOI 10.1177/153537020322800908; Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Almeida A, 1998, BRAIN RES, V790, P209, DOI 10.1016/S0006-8993(98)00064-X; Arabpoor Zohreh, 2012, Adv Biomed Res, V1, P50, DOI 10.4103/2277-9175.100157; Assaraf MI, 2007, J NEUROPATH EXP NEUR, V66, P389, DOI 10.1097/nen.0b013e3180517b28; Brettschneider J, 2006, NEUROSCI LETT, V404, P347, DOI 10.1016/j.neulet.2006.06.011; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Buniatian GH, 2001, NEUROCHEM INT, V38, P373, DOI 10.1016/S0197-0186(00)00116-9; Byts N, 2009, EXPT TRANSLATIONAL S, V21, P1; Castegna A, 2011, NEUROSCIENCE, V185, P97, DOI 10.1016/j.neuroscience.2011.04.041; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Danielyan L, 2005, EUR J CELL BIOL, V84, P567, DOI 10.1016/j.ejcb.2004.12.030; Danielyan L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004416; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; IQBAL K, 1970, BIOCHEM J, V119, P145, DOI 10.1042/bj1190145; Juul S, 2002, ACTA PAEDIATR, V91, P36, DOI 10.1080/080352502320764184; Kannurpatti SS, 2004, NEUROCHEM INT, V44, P361, DOI 10.1016/S0197-0186(03)00164-5; Kobayashi S, 2001, J NEUROCHEM, V76, P1935, DOI 10.1046/j.1471-4159.2001.00214.x; Kumar R, 2010, KOREAN J PHYSIOL PHA, V14, P345, DOI 10.4196/kjpp.2010.14.5.345; Lehmann C, 2009, BRAIN RES, V1297, P1, DOI 10.1016/j.brainres.2009.08.070; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Mawatari C, 1996, NEUROSCIENCE, V73, P201, DOI 10.1016/0306-4522(96)00025-5; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V2, P4; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Ndubuizu OI, 2009, AM J PHYSIOL-REG I, V297, pR158, DOI 10.1152/ajpregu.90829.2008; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Parihar MS, 2007, J NEUROSCI RES, V85, P1018, DOI 10.1002/jnr.21218; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Santos SS, 2011, NEUROCHEM INT, V58, P665, DOI 10.1016/j.neuint.2011.02.005; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; SHER PK, 1990, GLIA, V3, P350, DOI 10.1002/glia.440030506; Takeda A, 2010, INT J ALZHEIMERS DIS, V2011; THOLEY G, 1991, NEUROCHEM RES, V16, P423, DOI 10.1007/BF00965561; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wang V., 2010, FRONT AGING NEUROSCI, V30, P2; YU ACH, 1989, J CEREBR BLOOD F MET, V9, P20, DOI 10.1038/jcbfm.1989.3; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	52	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77182	10.1371/journal.pone.0077182	http://dx.doi.org/10.1371/journal.pone.0077182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124607	gold, Green Submitted, Green Published			2022-12-25	WOS:000325489100164
J	Zhang, WL; Muck-Hausl, M; Wang, JC; Sun, CB; Gebbing, M; Miskey, C; Ivics, Z; Izsvak, Z; Ehrhardt, A				Zhang, Wenli; Muck-Hausl, Martin; Wang, Jichang; Sun, Chuanbo; Gebbing, Maren; Miskey, Csaba; Ivics, Zoltan; Izsvak, Zsuzsanna; Ehrhardt, Anja			Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic Integration	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; GENOMES IN-VITRO; GENE-THERAPY; HUMAN-CELLS; TRANSGENE EXPRESSION; MOUSE-LIVER; CHROMOSOMAL INTEGRATION; PHENOTYPIC CORRECTION; STABLE CORRECTION; MAMMALIAN-CELLS	We recently developed adenovirus/transposase hybrid-vectors utilizing the previously described hyperactive Sleeping Beauty (SB) transposase HSB5 for somatic integration and we could show stabilized transgene expression in mice and a canine model for hemophilia B. However, the safety profile of these hybrid-vectors with respect to vector dose and genotoxicity remains to be investigated. Herein, we evaluated this hybrid-vector system in C57Bl/6 mice with escalating vector dose settings. We found that in all mice which received the hyperactive SB transposase, transgene expression levels were stabilized in a dose-dependent manner and that the highest vector dose was accompanied by fatalities in mice. To analyze potential genotoxic side-effects due to somatic integration into host chromosomes, we performed a genome-wide integration site analysis using linker-mediated PCR (LM-PCR) and linear amplification-mediated PCR (LAM-PCR). Analysis of genomic DNA samples obtained from HSB5 treated female and male mice revealed a total of 1327 unique transposition events. Overall the chromosomal distribution pattern was close-to-random and we observed a random integration profile with respect to integration into gene and non-gene areas. Notably, when using the LM-PCR protocol, 27 extra-chromosomal integration events were identified, most likely caused by transposon excision and subsequent transposition into the delivered adenoviral vector genome. In total, this study provides a careful evaluation of the safety profile of adenovirus/Sleeping Beauty transposase hybrid-vectors. The obtained information will be useful when designing future preclinical studies utilizing hybrid-vectors in small and large animal models.	[Zhang, Wenli; Muck-Hausl, Martin; Ehrhardt, Anja] Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany; [Zhang, Wenli] Northwest Agr & Forestry Univ, Yangling, Peoples R China; [Wang, Jichang; Sun, Chuanbo; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany; [Gebbing, Maren] Ruhr Univ Bochum, Bochum, Germany; [Miskey, Csaba; Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany; [Ehrhardt, Anja] Univ Witten Herdecke, Fac Hlth, Dept Human Med, Inst Virol & Microbiol,Ctr Biomed Educ & Res, Witten, Germany	University of Munich; Northwest A&F University - China; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruhr University Bochum; Paul Ehrlich Institute; Witten Herdecke University	Ehrhardt, A (corresponding author), Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany.	anja.ehrhardt@uni-wh.de	Miskey, Csaba/U-3473-2017	Izsvak, Zsuzsanna/0000-0002-2053-2384; Wang, Jichang/0000-0002-7027-0298; Schiwon, Maren/0000-0001-6570-1105; zhang, wenli/0000-0002-6243-6286	DFG [SPP 1230]; Wilhelm Sander-Foundation; EU Framework Programme 7 (Persistent Transgenesis); Friedrich-Baur-Foundation; Chinese Scholarship Council (CSC); Northwest A&F University, Yangling, China	DFG(German Research Foundation (DFG)); Wilhelm Sander-Foundation; EU Framework Programme 7 (Persistent Transgenesis); Friedrich-Baur-Foundation; Chinese Scholarship Council (CSC)(China Scholarship Council); Northwest A&F University, Yangling, China	This work was supported in part by DFG grant SPP 1230, the Wilhelm Sander-Foundation, EU Framework Programme 7 (Persistent Transgenesis), and the Friedrich-Baur-Foundation (A.E.). W.Z. was supported by a fellowship from the Chinese Scholarship Council (CSC) in cooperation with Northwest A&F University, Yangling, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Brunetti-Pierri N, 2008, GENE THER, V15, P553, DOI 10.1038/gt.2008.14; Brunetti-Pierri N, 2005, HUM GENE THER, V16, P811, DOI 10.1089/hum.2005.16.811; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Chuah MKL, 2004, SEMIN THROMB HEMOST, V30, P249, DOI 10.1055/s-2004-825638; Das RK, 2007, J APPL TOXICOL, V27, P527, DOI 10.1002/jat.1230; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Galla M, 2011, NUCLEIC ACIDS RES, V39, P7147, DOI 10.1093/nar/gkr384; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hausl M, 2011, CURR GENE THER, V11, P363; Hausl MA, 2010, MOL THER, V18, P1896, DOI 10.1038/mt.2010.169; Hillgenberg M, 2001, J VIROL, V75, P9896, DOI 10.1128/JVI.75.20.9896-9908.2001; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huang X, 2010, HUM GENE THER, V21, P1577, DOI 10.1089/hum.2009.138; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jager L, 2007, CURR GENE THER, V7, P272; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Jager L, 2009, HUM GENE THER, V20, P883, DOI 10.1089/hum.2009.020; Jiang ZL, 2004, MOL THER, V10, P688, DOI 10.1016/j.ymthe.2004.07.020; Kato K, 2005, NUCLEIC ACIDS RES, V33, pD533; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kubo S, 2011, MOL THER, V19, P76, DOI 10.1038/mt.2010.182; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Nakai H, 2005, J VIROL, V79, P3606, DOI 10.1128/JVI.79.6.3606-3614.2005; Oka K, 2001, CIRCULATION, V103, P1274; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Puntel M, 2006, HUM GENE THER, V17, P531, DOI 10.1089/hum.2006.17.531; Recchia A, 2004, MOL THER, V10, P660, DOI 10.1016/j.ymthe.2004.07.003; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Schiedner G, 2003, HUM GENE THER, V14, P1631, DOI 10.1089/104303403322542275; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Soifer H, 2002, MOL THER, V5, P599, DOI 10.1006/mthe.2002.0586; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Stephen SL, 2008, J GENE MED, V10, P1176, DOI 10.1002/jgm.1246; Toietta G, 2003, MOL THER, V7, P649, DOI 10.1016/S1525-0016(03)00059-5; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wang HJ, 2006, J VIROL, V80, P11699, DOI 10.1128/JVI.00779-06; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.9239-9247.2004; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yant SR, 2003, MOL CELL BIOL, V23, P8505, DOI 10.1128/MCB.23.23.8505-8518.2003; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75344	10.1371/journal.pone.0075344	http://dx.doi.org/10.1371/journal.pone.0075344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124483	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000325489100040
J	Zhao, JF; Chen, HH; Ojcius, DM; Zhao, X; Sun, D; Ge, YM; Zheng, LL; Lin, XA; Li, LJ; Yan, J				Zhao, Jing-Fang; Chen, Hong-Hu; Ojcius, David M.; Zhao, Xin; Sun, Dexter; Ge, Yu-Mei; Zheng, Lin-Li; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie			Identification of Leptospira interrogans Phospholipase C as a Novel Virulence Factor Responsible for Intracellular Free Calcium Ion Elevation during Macrophage Death	PLOS ONE			English	Article							CELL-DEATH; APOPTOSIS; ACTIVATION; INFECTION; PROTEIN; ENTRY; PATHOGENESIS; EXPRESSION; IMMUNITY; SUBTYPES	Background: Leptospira-induced macrophage death has been confirmed to play a crucial role in pathogenesis of leptospirosis, a worldwide zoonotic infectious disease. Intracellular free Ca2+ concentration ([Ca2+](i)) elevation induced by infection can cause cell death, but [Ca2+](i) changes and high [Ca2+](i)-induced death of macrophages due to infection of Leptospira have not been previously reported. Methodology/Principal Findings: We first used a Ca2+-specific fluorescence probe to confirm that the infection of L. interrogans strain Lai triggered a significant increase of [Ca2+](i) in mouse J774A.1 or human THP-1 macrophages. Laser confocal microscopic examination showed that the [Ca2+](i) elevation was caused by both extracellular Ca2+ influx through the purinergic receptor, P2X7, and Ca2+ release from the endoplasmic reticulum, as seen by suppression of [Ca2+](i) elevation when receptor-gated calcium channels were blocked or P2X7 was depleted. The LB361 gene product of the spirochete exhibited phosphatidylinositol phospholipase C (L-PI-PLC) activity to hydrolyze phosphatidylinositol-4,5-bisphosphate (PIP2) into inositol-1,4,5-trisphosphate (IP3), which in turn induces intracellular Ca2+ release from endoplasmic reticulum, with the Km of 199 mu M and Kcat of 8.566E-5 S-1. Secretion of L-PI-PLC from the spirochete into supernatants of leptospire-macrophage co-cultures and cytosol of infected macrophages was also observed by Western Blot assay. Lower [Ca2+](i) elevation was induced by infection with a LB361-deficient leptospiral mutant, whereas transfection of the LB361 gene caused a mild increase in [Ca2+](i). Moreover, PI-PLCs (PI-PLC-beta 3 and PI-PLC-gamma 1) of the two macrophages were activated by phosphorylation during infection. Flow cytometric detection demonstrated that high [Ca2+](i) increases induced apoptosis and necrosis of macrophages, while mild [Ca2+](i) elevation only caused apoptosis. Conclusions/Significance: This study demonstrated that L. interrogans infection induced [Ca2+](i) elevation through extracellular Ca2+ influx and intracellular Ca2+ release cause macrophage apoptosis and necrosis, and the LB361 gene product was shown to be a novel PI-PLC of L. interrogans responsible for the [Ca2+](i) elevation.	[Zhao, Jing-Fang; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing-Fang; Chen, Hong-Hu; Zhao, Xin; Ge, Yu-Mei; Zheng, Lin-Li; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing-Fang] Zhejiang Prov Hosp Tradit Chinese Med, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurol, New York, NY 10021 USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurosci, New York, NY 10021 USA; [Sun, Dexter] Cornell Univ, Weill Med Coll, Hosp Special Surg, New York, NY 10021 USA	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; University of California System; University of California Merced; University of California System; University of California Merced; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81171534, 81261160321]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [2010ZZ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China	This work was supported by grants (81171534 and 81261160321) from the National Natural Science Foundation of China and a grant (2010ZZ09) from the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; Cerella Claudia, 2010, Int J Cell Biol, V2010, P546163, DOI 10.1155/2010/546163; Chen W, 2009, BIOCHEMISTRY-US, V48, P3578, DOI 10.1021/bi802312d; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223; Durban MA, 2007, EUR J LIPID SCI TECH, V109, P469, DOI 10.1002/ejlt.200700027; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hotez PJ, 2011, INT J INFECT DIS, V15, pE611, DOI 10.1016/j.ijid.2011.05.006; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Kim DH, 2012, J INFECT DIS, V205, P445, DOI 10.1093/infdis/jir765; Lemos JR, 2012, CELL CALCIUM, V51, P284, DOI 10.1016/j.ceca.2012.01.008; Lennartz MR, 1999, INT J BIOCHEM CELL B, V31, P415, DOI 10.1016/S1357-2725(98)00108-3; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Liu YY, 2007, MED MICROBIOL IMMUN, V196, P233, DOI 10.1007/s00430-007-0047-0; Lo YC, 2011, EMERG INFECT DIS, V17, P1145, DOI [10.3201/eid1706.100980, 10.3201/eid/1706.100980]; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; Meites E, 2004, EMERG INFECT DIS, V10, P406, DOI 10.3201/eid1003.030431; Meng HW, 2007, INT J DEV NEUROSCI, V25, P509, DOI 10.1016/j.ijdevneu.2007.09.010; Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997; Nakano T, 2006, CARDIOVASC RES, V69, P908, DOI 10.1016/j.cardiores.2005.11.023; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Nomikos M, 2011, J CELL SCI, V124, P2582, DOI 10.1242/jcs.083485; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Putney JW, 2001, J CELL SCI, V114, P2223; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002; Saha S, 2005, TOXICON, V45, P361, DOI 10.1016/j.toxicon.2004.11.007; Schreier S, 2009, BIOL RES, V42, P5, DOI [10.4067/S0716-97602009000100001, /S0716-97602009000100001]; Smaili SS, 2000, J BIOENERG BIOMEMBR, V32, P35, DOI 10.1023/A:1005508311495; Strege PR, 2005, AM J PHYSIOL-GASTR L, V289, pG249, DOI 10.1152/ajpgi.00022.2005; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025432; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042266; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yang T, 2007, J BIOL CHEM, V282, P37471, DOI 10.1074/jbc.M701379200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007; Zhang L, 2012, MOL MICROBIOL, V83, P1006, DOI 10.1111/j.1365-2958.2012.07985.x	63	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75652	10.1371/journal.pone.0075652	http://dx.doi.org/10.1371/journal.pone.0075652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124502	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100059
J	Ngo, B; Hu, CM; Guo, XE; Ngo, B; Wei, R; Zhu, JW; Lee, WH				Ngo, Bryan; Hu, Chun-Mei; Guo, Xuning Emily; Ngo, Brittany; Wei, Randy; Zhu, Jiewen; Lee, Wen-Hwa			Complementary Interhelical Interactions between Three Buried Glu-Lys Pairs within Three Heptad Repeats Are Essential for Hec1-Nuf2 Heterodimerization and Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetochore; Mitosis; Protein-Protein Interactions; Site-directed Mutagenesis; Western Blotting; Coiled-Coil; Hec1; Heptad Repeat; NDC80; Nuf2	KINETOCHORE-MICROTUBULE ATTACHMENT; FAITHFUL CHROMOSOME SEGREGATION; COILED-COIL FORMATION; NDC80 COMPLEX; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; POLAR RESIDUES; STRUCTURAL SPECIFICITY; CORTEXILLIN I; SALT-BRIDGES	Background: Hec1 and Nuf2 are components of the NDC80 complex essential for faithful chromosome segregation. Results: Three contiguous heptad repeats with buried interhelical Glu-Lys pairs are required for Hec1-Nuf2 dimerization, NDC80 complex formation, and mitotic progression. Conclusion: Interhelical electrostatic and hydrophobic interactions define specificity and stability requirements for Hec1-Nuf2 dimerization. Significance: The results elucidate how Hec1-Nuf2 dimerize and provide insight into NDC80 complex formation. Hec1 and Nuf2, core components of the NDC80 complex, are essential for kinetochore-microtubule attachment and chromosome segregation. It has been shown that both Hec1 and Nuf2 utilize their coiled-coil domains to form a functional dimer; however, details of the consequential significance and structural requirements to form the dimerization interface have yet to be elucidated. Here, we showed that Hec1 required three contiguous heptad repeats from Leu-324 to Leu-352, but not the entire first coiled-coil domain, to ensure overall stability of the NDC80 complex through direct interaction with Nuf2. Substituting the hydrophobic core residues, Leu-331, Val-338, and Ile-345, of Hec1 with alanine completely eliminated Nuf2 binding and blocked mitotic progression. Moreover, unlike most coiled-coil proteins, where the buried positions are composed of hydrophobic residues, Hec1 possessed an unusual distribution of glutamic acid residues, Glu-334, Glu-341, and Glu-348, buried within the interior dimerization interface, which complement with three Nuf2 lysine residues: Lys-227, Lys-234, and Lys-241. Substituting these corresponding residues with alanine diminished the binding affinity between Hec1 and Nuf2, compromised NDC80 complex formation, and adversely affected mitotic progression. Taken together, these findings demonstrated that three buried glutamic acid-lysine pairs, in concert with hydrophobic interactions of core residues, provide the major specificity and stability requirements for Hec1-Nuf2 dimerization and NDC80 complex formation.	[Ngo, Bryan; Hu, Chun-Mei; Guo, Xuning Emily; Ngo, Brittany; Wei, Randy; Zhu, Jiewen; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 240D Med Sci Bldg, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014; Zhu, Jiewen/P-8220-2018; Zhu, Jiewen/D-8487-2013	Zhu, Jiewen/0000-0002-6742-8138; Zhu, Jiewen/0000-0002-6742-8138; Ngo, Bryan/0000-0002-7733-2658	National Institutes of Health [CA107568]; NATIONAL CANCER INSTITUTE [R01CA107568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107568 (to W. H. L).	Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P7169, DOI 10.1021/bi025559l; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P4866, DOI 10.1021/bi0159276; Chen Y, 1997, J BIOL CHEM, V272, P24081, DOI 10.1074/jbc.272.38.24081; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McClain DL, 2002, J MOL BIOL, V324, P257, DOI 10.1016/S0022-2836(02)01072-0; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	44	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34403	34413		10.1074/jbc.M113.490524	http://dx.doi.org/10.1074/jbc.M113.490524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129578	Green Published, hybrid			2022-12-25	WOS:000329812800012
J	Rastogi, R; Jiang, ZL; Ahmad, N; Rosati, R; Liu, YS; Beuret, L; Monks, R; Charron, J; Birnbaum, MJ; Samavati, L				Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Liu, Yusen; Beuret, Laurent; Monks, Robert; Charron, Jean; Birnbaum, Morris J.; Samavati, Lobelia			Rapamycin Induces Mitogen-activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Expression through Activation of Protein Kinase B and Mitogen-activated Protein Kinase Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Dual Specificity Phosphoprotein Phosphatase; MAP Kinases (MAPKs); mTOR Complex (mTORC); Signal Transduction	DUAL-SPECIFICITY PHOSPHATASE-1; MAMMALIAN TARGET; INFLAMMATORY RESPONSE; IMMUNE-RESPONSES; CROSS-TALK; T-CELLS; PHOSPHORYLATION; MTOR; AKT; MACROPHAGES	Mitogen-activated protein kinase phosphatase-1 (MKP-1), also known as dual specificity phosphatase-1 (DUSP-1), plays a crucial role in the deactivation of MAPKs. Several drugs with immune-suppressive properties modulate MKP-1 expression as part of their mechanism of action. We investigated the effect of mTOR inhibition through rapamycin and a dual mTOR inhibitor (AZD2014) on MKP-1 expression. Low dose rapamycin led to a rapid activation of both AKT and ERK pathways with a subsequent increase in MKP-1 expression. Rapamycin treatment led to phosphorylation of CREB, transcription factor 1 (ATF1), and ATF2, three transcription factors that bind to the cyclic AMP-responsive elements on the Mkp-1 promoter. Inhibition of either the MEK/ERK or the AKT pathway attenuated rapamycin-mediated MKP-1 induction. AZD2014 did not activate AKT but activated the ERK pathway, leading to a moderate MKP-1 induction. Using bone marrow-derived macrophages (BMDMs) derived from wild-type (WT) mice or mice deficient in AKT1 and AKT2 isoforms or BMDM from targeted deficiency in MEK1 and MEK2, we show that rapamycin treatment led to an increased MKP1 expression in BMDM from WT but failed to do so in BMDMs lacking the AKT1 isoform or MEK1 and MEK2. Importantly, rapamycin pretreatment inhibited LPS-mediated p38 activation and decreased nitric oxide and IL-6 production. Our work provides a conceptual framework for the observed immune modulatory effect of mTOR inhibition.	[Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Samavati, Lobelia] Wayne State Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Sch Med, Detroit, MI 48201 USA; [Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Samavati, Lobelia] Detroit Med Ctr, Detroit, MI 48201 USA; [Liu, Yusen] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Beuret, Laurent; Charron, Jean] Univ Laval, Ctr Rech Canc, CRCHU Q, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; [Monks, Robert; Birnbaum, Morris J.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA; [Samavati, Lobelia] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA	Wayne State University; Detroit Medical Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Laval University; University of Pennsylvania; Wayne State University	Samavati, L (corresponding author), Wayne State Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Sch Med, 3990 John R,3 Hudson, Detroit, MI 48201 USA.	lsamavat@med.wayne.edu	Charron, Jean/A-9792-2013	Charron, Jean/0000-0002-5133-0056; Liu, Yusen/0000-0002-0994-0109; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [R01 HL113508, R01 DK56886]; Department of Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL113508(to L. S.) and R01 DK56886(to M. J. B.). This work was also supported by the Department of Medicine and the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine (to L. S.).	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chaturvedi D, 2009, ONCOGENE, V28, P1187, DOI 10.1038/onc.2008.490; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Huang J, 2011, J CHEMOTHERAPY, V23, P221, DOI 10.1179/joc.2011.23.4.221; Janes MR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe25; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Moua T, 2012, AM J RESP CRIT CARE, V186, P389, DOI 10.1164/ajrccm.186.4.389; Mushaben EM, 2011, J IMMUNOL, V187, P5756, DOI 10.4049/jimmunol.1102133; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Rastogi R, 2011, AM J RESP CRIT CARE, V183, P500, DOI 10.1164/rccm.201005-0792OC; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Sanchez-Tillo E, 2006, J IMMUNOL, V176, P6594, DOI 10.4049/jimmunol.176.11.6594; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Staples CJ, 2010, J BIOL CHEM, V285, P25928, DOI 10.1074/jbc.M110.117911; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	58	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33966	33977		10.1074/jbc.M113.492702	http://dx.doi.org/10.1074/jbc.M113.492702			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126911	Green Published, hybrid			2022-12-25	WOS:000327250200038
J	Gonin, J; Carlotti, A; Dietrich, C; Audebourg, A; Radenen-Bussiere, B; Caignard, A; Avril, MF; Vacher-Lavenu, MC; Larousserie, F; Devergne, O				Gonin, Julie; Carlotti, Agnes; Dietrich, Celine; Audebourg, Anne; Radenen-Bussiere, Brigitte; Caignard, Anne; Avril, Marie-Francoise; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique; Devergne, Odile			Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; COMPLETE REGRESSION; IL-17 PRODUCTION; INDUCED GENE-3; INTERLEUKIN-27; ANTITUMOR; CYTOKINE; INFLAMMATION; INDUCTION; ANTIBODY	Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immunosuppressive functions depending on the context. In various murine tumor models including melanoma models, ectopic expression of IL-27 has been shown to play an anti-tumoral role and to favor tumor regression. In this study, we investigated whether IL-27 might play a role in the development of melanoma in humans. We analyzed the in situ expression of IL-27 in melanocytic lesions (n=82) representative of different stages of tumor progression. IL-27 expression was not observed in nevus (n=8) nor in in situ melanoma (n=9), but was detected in 28/46 (61%) cases of invasive cutaneous melanoma, notably in advanced stages (19/23 cases of stages 3 and 4). In most cases, the main source of IL-27 was tumor cells. Of note, when IL-27 was detected in primary cutaneous melanomas, its expression was maintained in metastatic lesions. These in situ data suggested that the immunosuppressive functions of IL-27 may dominate in human melanoma. Consistent with this hypothesis, we found that IL-27 could induce suppressive molecules such as PD-L1, and to a lesser extent IL-10, in melanoma cells, and that the in situ expression of IL-27 in melanoma correlated with those of PD-L1 and IL-10.	[Gonin, Julie; Dietrich, Celine; Larousserie, Frederique; Devergne, Odile] Univ Paris 05, CNRS, Unite Mixte Rech 8147, Sorbonne Paris Cite, Paris, France; [Gonin, Julie; Carlotti, Agnes; Audebourg, Anne; Radenen-Bussiere, Brigitte; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique] Hop Cochin, Assistance Publ Hop Paris, Serv Anat Pathol, F-75674 Paris, France; [Gonin, Julie; Carlotti, Agnes; Audebourg, Anne; Radenen-Bussiere, Brigitte; Vacher-Lavenu, Marie-Cecile; Larousserie, Frederique] Hop Cochin, Assistance Publ Hop Paris, Univ Paris Descartes, F-75674 Paris, France; [Caignard, Anne] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016,Unite Mixte Rech 8104, Paris, France; [Avril, Marie-Francoise] Hop Cochin, Assistance Publ Hop Paris, Serv Dermatol, F-75674 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Devergne, O (corresponding author), Univ Paris 05, CNRS, Unite Mixte Rech 8147, Sorbonne Paris Cite, Paris, France.	odile.devergne@inserm.fr	Devergne, Odile/M-6633-2017; Caignard, Anne/F-8159-2013	Caignard, Anne/0000-0001-9923-6045; Devergne, Odile/0000-0002-2838-7564	CNRS; Universite Paris Descartes; Ligue Contre le Cancer (Comite de Paris); Academie Nationale de Medecine	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); Academie Nationale de Medecine	This work was supported by institutional funds from the CNRS and Universite Paris Descartes, and by a grant from the Ligue Contre le Cancer (Comite de Paris). JG was supported by a fellowship from the Academie Nationale de Medecine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Dummer W, 1996, INT J CANCER, V66, P607, DOI 10.1002/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.3.CO;2-B; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fregni G, 2011, CLIN CANCER RES, V17, P2628, DOI 10.1158/1078-0432.CCR-10-2084; Gadiot J, 2011, CANCER-AM CANCER SOC, V117, P2192, DOI 10.1002/cncr.25747; Gonin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024617; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Itakura E, 2011, MODERN PATHOL, V24, P801, DOI 10.1038/modpathol.2011.5; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Larousserie F, 2006, J PATHOL, V209, P360, DOI 10.1002/path.1995; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Matsui M, 2004, J VIROL, V78, P9093, DOI 10.1128/JVI.78.17.9093-9104.2004; Mohr P, 2009, ANN ONCOL, V20, P14, DOI 10.1093/annonc/mdp256; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nagai H, 2010, IMMUNOTHERAPY-UK, V2, P697, DOI 10.2217/IMT.10.46; Niedobitek G, 2002, J PATHOL, V198, P310, DOI 10.1002/path.1217; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Tanida S, 2011, CYTOKINE, V55, P237, DOI 10.1016/j.cyto.2011.04.020; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75694	10.1371/journal.pone.0075694	http://dx.doi.org/10.1371/journal.pone.0075694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130734	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200019
J	Wang, L; Pan, JS; Wang, TL; Song, M; Chen, WT				Wang, Li; Pan, Jinsong; Wang, Tingle; Song, Meng; Chen, Wantao			Pathological Cyclic Strain-Induced Apoptosis in Human Periodontal Ligament Cells through the RhoGDI alpha/Caspase-3/PARP Pathway	PLOS ONE			English	Article							MECHANICAL FORCES; TOOTH MOVEMENT; SHEAR-STRESS; STRETCH; INHIBITOR; CASPASE; DEATH; EXPRESSION; CULTURE; TISSUES	Aim: Human periodontal ligament (PDL) cells incur changes in morphology and express proteins in response to cyclic strain. However, it is not clear whether cyclic strain, especially excessive cyclic strain, induces PDL cell apoptosis and if so, what mechanism(s) are responsible. The aim of the present study was to elucidate the molecular mechanisms by which pathological levels of cyclic strain induce human PDL cell apoptosis. Materials and Methods: Human PDL cells were obtained from healthy premolar tissue. After three to five passages in culture, the cells were subjected to 20% cyclic strain at a frequency of 0.1 Hz for 6 or 24 h using an FX-5000T system. Morphological changes of the cells were assessed by inverted phase-contrast microscopy, and apoptosis was detected by fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide staining followed by flow cytometry. Protein expression was evaluated by Western blot analysis. Results: The number of apoptotic human PDL cells increased in a time-dependent manner in response to pathological cyclic strain. The stretched cells were oriented parallel to each another with their long axes perpendicular to the strain force vector. Cleaved caspase-3 and poly-ADP-ribose polymerase (PARP) protein levels increased in response to pathological cyclic strain over time, while Rho GDP dissociation inhibitor alpha (RhoGDI alpha) decreased. Furthermore, knock-down of RhoGDIa by targeted siRNA transfection increased stretch-induced apoptosis and upregulated cleaved caspase-3 and PARP protein levels. Inhibition of caspase-3 prevented stretch-induced apoptosis, but did not change RhoGDIa protein levels. Conclusion: The overall results suggest that pathological-level cyclic strain not only influenced morphology but also induced apoptosis in human PDL cells through the RhoGDI alpha/caspase-3/PARP pathway. Our findings provide novel insight into the mechanism of apoptosis induced by pathological cyclic strain in human PDL cells.	[Wang, Li; Pan, Jinsong; Song, Meng] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Wang, Tingle] Cent Hosp Minhang Dist, Dept Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Song, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China.	smgjzh160@sohu.com; chenwantao2002@hotmail.com			National Natural Science Foundation of China [11172177, 30973343]; Shanghai Science and Technology Committee [11DZ2291800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by grants from the National Natural Science Foundation of China (No. 11172177 and 30973343) and projects of the Shanghai Science and Technology Committee (Grant No. 11DZ2291800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD LF, 1972, J DENT RES, V51, P953, DOI 10.1177/00220345720510043801; BRUNETTE DM, 1976, ARCH ORAL BIOL, V21, P393, DOI 10.1016/0003-9969(76)90001-7; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; Fukui T, 2003, EUR J ORTHODONT, V25, P167, DOI 10.1093/ejo/25.2.167; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Hatai T, 2001, ORAL DIS, V7, P287, DOI 10.1034/j.1601-0825.2001.00663.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Howard PS, 1998, J PERIODONTAL RES, V33, P500; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Liu JQ, 2010, INT J BIOCHEM CELL B, V42, P2004, DOI 10.1016/j.biocel.2010.08.013; Liu JQ, 2009, J CELL BIOCHEM, V107, P834, DOI 10.1002/jcb.22182; LOCKSHIN RICHARD A., 1965, J INSECT PHYSIOL, V11, P123, DOI 10.1016/0022-1910(65)90099-5; MAJNO G, 1995, AM J PATHOL, V146, P3; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33; Pan Jin-song, 2010, Zhonghua Kou Qiang Yi Xue Za Zhi, V45, P80; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401; Pini M, 2004, J BIOMECH, V37, P111, DOI 10.1016/S0021-9290(03)00234-3; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Reitan F., 1994, ORTHODONTICS CURRENT, V2, P96; Rennier Keith, 2013, BMC Res Notes, V6, P10, DOI 10.1186/1756-0500-6-10; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006; Xu C, 2011, J PERIODONTAL RES, V46, P742, DOI 10.1111/j.1600-0765.2011.01397.x; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yamaguchi M, 2005, ARCH IMMUNOL THER EX, V53, P388; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	34	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e75973	10.1371/journal.pone.0075973	http://dx.doi.org/10.1371/journal.pone.0075973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130754	gold, Green Submitted, Green Published			2022-12-25	WOS:000325814200027
J	Mowry, EM; Carey, RF; Blasco, MR; Pelletier, J; Duquette, P; Villoslada, P; Malikova, I; Roger, E; Kinkel, RP; McDonald, J; Bacchetti, P; Waubant, E				Mowry, Ellen M.; Carey, Robert F.; Blasco, Maria R.; Pelletier, Jean; Duquette, Pierre; Villoslada, Pablo; Malikova, Irina; Roger, Elaine; Kinkel, R. Phillip; McDonald, Jamie; Bacchetti, Peter; Waubant, Emmanuelle			Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; GENOME-WIDE ASSOCIATION; 1ST DEMYELINATING EVENT; CONTROLLED-TRIAL; OPTIC NEURITIS; LOCI; RISK; REPLICATION; DISABILITY; ALLELES	Objective: Patients with early multiple sclerosis (MS) have stereotyped attack severity and recovery. We sought to determine if polymorphisms in MS susceptibility genes are associated with these attack features or with the risk of a second attack. Methods: 503 white subjects evaluated within a year of MS onset were included in the study. The severity of and recovery from the first two attacks were determined based on published definitions. Seventeen MS susceptibility genes were genotyped at the UCSF MS Genetics laboratory. Each polymorphism was evaluated in multivariate ordinal models, adjusted for the other polymorphisms, for its association with attack severity and recovery. We also assessed if these polymorphisms were associated with increased risk of a second attack. Results: The MPHOSPH9 polymorphism was associated with greater attack severity (odds ratios [OR] = 1.47, 95% CI [1.11, 1.94], p = 0.008), while the RGS1 and TNFRSF1A polymorphisms tended to be associated with reduced attack severity. The CD6 polymorphism tended to be associated with increased odds of worse attack recovery (OR = 1.25, 95% CI [0.93, 1.68], p = 0.13). In those who were HLA-DRB1-negative, the EVI5 polymorphism was associated with attacks of less severity; in HLA-DRB1 positive patients, EVI5 was associated with attacks of greater severity and worse recovery. The IL7R, TNFRSF1A, and GPC5 polymorphisms tended to be associated with having a second event within a year. Conclusions: Some MS susceptibility polymorphisms may be associated with attack severity, recovery, or frequency. Further characterization of these genes may lead to a better understanding of MS pathogenesis and to a more individualized treatment approach.	[Mowry, Ellen M.] Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA; [Carey, Robert F.; McDonald, Jamie; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Blasco, Maria R.] Hosp Univ Puerta de Hierro, Dept Neurol, Madrid, Spain; [Pelletier, Jean; Malikova, Irina] Aix Marseille Univ, CHU Timone, Ctr Resonance Magnet Biol & Med, Pole Neurosci Clin,Serv Neurol, Marseille, France; [Duquette, Pierre; Roger, Elaine] Ctr Hosp Univ Montreal, Multiple Sclerosis Clin, Montreal, PQ, Canada; [Villoslada, Pablo] August Pi Sunyer Hosp Clin, Inst Biomed Res, Ctr Neuroimmunol, Barcelona, Spain; [Kinkel, R. Phillip] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; University of California System; University of California San Francisco; Hospital Puerta de Hierro-Majadahonda; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Mowry, EM (corresponding author), Johns Hopkins Univ, Dept Neurol, Multiple Sclerosis Ctr, Baltimore, MD 21218 USA.	emowry1@jhmi.edu	Villoslada, Pablo/AAF-9547-2019	Mowry, Ellen/0000-0003-0623-5188; Villoslada, Pablo/0000-0002-8735-6119; Blasco Quilez, Maria Rosario/0000-0003-2719-4629	National Multiple Sclerosis Society research grant [RG-3692A]	National Multiple Sclerosis Society research grant	This study was supported by a National Multiple Sclerosis Society research grant (www.nmss.org; RG-3692A; PI E. Waubant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; CONFAVREUX C, 1994, ANN NEUROL, V36, pS136, DOI 10.1002/ana.410360733; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Habek M, 2010, EXPERT REV MOL DIAGN, V10, P857, DOI 10.1586/ERM.10.77; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hobart J, 2004, MULT SCLER J, V10, P41, DOI 10.1191/1352458504ms983oa; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Kalincik T, 2013, GENES IMMUN, V14, P244, DOI 10.1038/gene.2013.17; Kinkel RP, 2006, NEUROLOGY, V66, P678; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Marcus JF, 2010, MULT SCLER J, V16, P1004; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Mowry EM, 2009, J NEUROL, V256, P1061, DOI 10.1007/s00415-009-5063-0; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sharrack B, 1999, BRAIN, V122, P141, DOI 10.1093/brain/122.1.141; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Tran T, 2010, INT J CELL BIOL, V2010; Waldron-Perrine B, 2009, CLIN NEUROPSYCHOL, V23, P462, DOI 10.1080/13854040802279683; Waubant E, 2012, NEUROLOGY, V78, P1171, DOI 10.1212/WNL.0b013e31824f7fdd	31	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e75416	10.1371/journal.pone.0075416	http://dx.doi.org/10.1371/journal.pone.0075416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130709	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900035
J	Sayeed, A; Fedele, C; Trerotola, M; Ganguly, KK; Languino, LR				Sayeed, Aejaz; Fedele, Carmine; Trerotola, Marco; Ganguly, Kirat K.; Languino, Lucia R.			IGF-IR Promotes Prostate Cancer Growth by Stabilizing alpha(5)beta(1) Integrin Protein Levels	PLOS ONE			English	Article							LYSOSOMAL DEGRADATION; BETA(1C) INTEGRIN; RECEPTOR IGF1R; CELL-ADHESION; CROSS-TALK; E-CADHERIN; EXPRESSION; UBIQUITINATION; FIBRONECTIN; MIGRATION	Dynamic crosstalk between growth factor receptors, cell adhesion molecules and extracellular matrix is essential for cancer cell migration and invasion. Integrins are transmembrane receptors that bind extracellular matrix proteins and enable cell adhesion and cytoskeletal organization. They also mediate signal transduction to regulate cell proliferation and survival. The type 1 insulin-like growth factor receptor (IGF-IR) mediates tumor cell growth, adhesion and inhibition of apoptosis in several types of cancer. We have previously demonstrated that beta(1) integrins regulate anchorage-independent growth of prostate cancer (PrCa) cells by regulating IGF-IR expression and androgen receptor-mediated transcriptional functions. Furthermore, we have recently reported that IGF-IR regulates the expression of beta(1) integrins in PrCa cells. We have dissected the mechanism through which IGF-IR regulates beta(1) integrin expression in PrCa. Here we report that IGF-IR is crucial for PrCa cell growth and that beta(1) integrins contribute to the regulation of proliferation by IGF-IR. We demonstrate that beta(1) integrin regulation by IGF-IR does not occur at the mRNA level. Exogenous expression of a CD4 - beta(1) integrin cytoplasmic domain chimera does not interfere with such regulation and fails to stabilize beta(1) integrin expression in the absence of IGF-IR. This appears to be due to the lack of interaction between the beta(1) cytoplasmic domain and IGF-IR. We demonstrate that IGF-IR stabilizes the beta(1) subunit by protecting it from proteasomal degradation. The alpha(5) subunit, one of the binding partners of beta(1), is also downregulated along with beta(1) upon IGF-IR knockdown while no change is observed in the expression of the alpha(2), alpha(3), alpha(4), alpha(6) and alpha(7) subunits. Our results reveal a crucial mechanistic role for the alpha(5)beta(1) integrin, downstream of IGF-IR, in regulating cancer growth.	[Sayeed, Aejaz; Fedele, Carmine; Trerotola, Marco; Ganguly, Kirat K.; Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA	Jefferson University	Languino, LR (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA.	lucia.languino@jefferson.edu	Trerotola, Marco/J-9015-2016	Trerotola, Marco/0000-0003-1855-7002; Languino, Lucia/0000-0001-9011-7031	NIH [R01 CA-89720, CA-109874, P01 CA-140043]; American Cancer Society [(ACS)-IRG-08-060-04]; Pennsylvania Department of Health; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health (H.R.); NATIONAL CANCER INSTITUTE [R01CA089720, P01CA140043, R01CA109874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pennsylvania Department of Health; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health (H.R.); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Contract grant sponsor: NIH; Contract grant number: R01 CA-89720 and CA-109874 (to LRL), P01 CA-140043 (to LRL); American Cancer Society (ACS)-IRG-08-060-04 (to AS); Contract grant sponsor: Pennsylvania Department of Health. This project is also funded, in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health (H.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Arnaldez FI, 2012, HEMATOL ONCOL CLIN N, V26, P527, DOI 10.1016/j.hoc.2012.01.004; BASERGA R, 1995, CANCER RES, V55, P249; Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002; Damsky C, 2002, ANN NY ACAD SCI, V961, P154, DOI 10.1111/j.1749-6632.2002.tb03069.x; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fornaro M, 1999, J CLIN INVEST, V103, P321, DOI 10.1172/JCI4585; FORNARO M, 1995, J BIOL CHEM, V270, P24666, DOI 10.1074/jbc.270.42.24666; Fornaro M, 1998, AM J PATHOL, V153, P1079, DOI 10.1016/S0002-9440(10)65652-0; Fornaro M, 1997, MATRIX BIOL, V16, P185, DOI 10.1016/S0945-053X(97)90007-X; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Goel H, 2013, J CELL PHYSL; Goel HL, 2010, J CELL PHYSIOL, V224, P210, DOI 10.1002/jcp.22116; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huang P, 2012, CANCER RES, V72, P1428, DOI 10.1158/0008-5472.CAN-11-2621; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; KNOX JD, 1994, AM J PATHOL, V145, P167; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Liu J, 2011, MOL CELL BIOL, V31, P3366, DOI 10.1128/MCB.01403-10; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; Marelli MM, 2006, INT J ONCOL, V28, P723; McKenzie JA, 2013, CARCINOGENESIS; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Morozevich GE, 2012, AGING-US, V4, P368, DOI 10.18632/aging.100457; Murant SJ, 1997, EUR J CANCER, V33, P263, DOI 10.1016/S0959-8049(96)00418-2; Ohyagi-Hara C, 2013, AM J PATHOL, V182, P1876, DOI 10.1016/j.ajpath.2013.01.039; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Quaranta V, 1997, KIDNEY INT, V51, P1441, DOI 10.1038/ki.1997.197; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Salani B, 2009, BIOCHEM BIOPH RES CO, V380, P489, DOI 10.1016/j.bbrc.2009.01.102; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Tai YT, 2003, CANCER RES, V63, P5850; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wu CM, 2011, J CELL PHYSIOL, V226, P3270, DOI 10.1002/jcp.22688; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	55	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76513	10.1371/journal.pone.0076513	http://dx.doi.org/10.1371/journal.pone.0076513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130778	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900074
J	Xu, Q; Chen, ZY; Cheng, X; Xu, L; Jin, H				Xu, Qi; Chen, Zhongying; Cheng, Xing; Xu, Lucy; Jin, Hong			Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HEMAGGLUTININ; SPECIFICITY; H2; REPLICATION; PROTECTION; ANTIBODY; MICE; AMINO-ACID-226; PATHOGENICITY	Live attenuated influenza vaccine (LAIV) candidates of the H7 subtype, A/Netherlands/219/03 (H7N7, NL03 ca) and A/chicken/British Columbia/CN-6/2004 (H7N3, BC04 ca), were evaluated for their receptor binding specificity and immunogenicity in ferrets. The BC04 ca virus exhibited alpha 2,3-SA and alpha 2,6-SA dual receptor binding preference while the NL03 ca virus preferentially bound to alpha 2,3-SA. Substitution of the Q226 and G228 (Q-G) by the L226 and S228 (L-S) residues in the HA improved binding to alpha 2,6-SA for NL03 ca. The vaccine viruses with L-S retained the attenuation phenotype. NL03 L-S ca replicated more efficiently than the original NL03 ca virus in the upper respiratory tract of ferrets, and induced higher levels of humoral and cellular immune responses. Prior vaccination with seasonal LAIV reduced H7-specific antibody responses, but did not reduce the H7N7 vaccine mediated protection against a heterologous H7N3 BC04 wt virus infection in ferrets. In addition, the H7N3 and H7N7 vaccine immunized ferret sera cross reacted with the newly emerged H7N9 virus. These data, in combination with the safety data from previously conducted Phase 1 studies, suggest that these vaccines may have a role in responding to the threat posed by the H7N9 virus.	[Xu, Qi; Chen, Zhongying; Cheng, Xing; Xu, Lucy; Jin, Hong] MedImmune LLC, Mountain View, CA USA	AstraZeneca; Medimmune	Jin, H (corresponding author), MedImmune LLC, Mountain View, CA USA.	jinh@medimmune.com		Xu, Lucy/0000-0001-6765-463X				Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Chen ZY, 2012, J VIROL, V86, P2780, DOI 10.1128/JVI.06219-11; Chen ZY, 2010, VACCINE, V28, P4079, DOI 10.1016/j.vaccine.2010.03.078; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Cherukuri A, 2012, VACCINE, V30, P237, DOI 10.1016/j.vaccine.2011.11.001; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Min JY, 2010, J VIROL, V84, P11950, DOI 10.1128/JVI.01305-10; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Wu H, 2013, N ENGL J MED; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081	35	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76884	10.1371/journal.pone.0076884	http://dx.doi.org/10.1371/journal.pone.0076884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130801	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900096
J	Bernhard, W; Barreto, K; Raithatha, S; Sadowski, I				Bernhard, Wendy; Barreto, Kris; Raithatha, Sheetal; Sadowski, Ivan			An Upstream YY1 Binding Site on the HIV-1 LTR Contributes to Latent Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; TRANSCRIPTION FACTOR YY1; CD4(+) T-CELLS; INTEGRATED HIV-1; REGULATES INDUCTION; FOLLOW-UP; TFII-I; PROMOTER; ESTABLISHMENT	During HIV-1 infection a population of latently infected cells is established. This population is the major obstacle preventing total eradication of the virus from AIDS patients. HIV-1 latency is thought to arise by various mechanisms including repressive chromatin modifications. Transcription factors such as YY1 have been shown to facilitate repressive chromatin modifications by the recruitment of histone deacetylases. In this study, we identified a novel binding site for YY1 on the HIV-1 LTR, 120 nucleotides upstream of the transcription start site. We show that YY1 can bind to this site in vitro and in vivo and that binding to the LTR is dissociated upon T cell activation. Overexpression of YY1 causes an increase in the proportion of cells that produce latent infections. These observations, in combination with previous results, demonstrate that YY1 plays a prominent role in controlling the establishment and maintenance of latent HIV-1 provirus in unstimulated cells.	[Bernhard, Wendy; Barreto, Kris; Raithatha, Sheetal; Sadowski, Ivan] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Sadowski, I (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ijs.ubc@gmail.com			Canadian Institutes for Health Research Operating Grant [HOP-120237]	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes for Health Research Operating Grant HOP-120237 (to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; Bell B, 1996, ONCOGENE, V13, P2687; Bernhard W, 2011, FEBS LETT, V585, P3549, DOI 10.1016/j.febslet.2011.10.018; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Dahabieh MS, 2011, VIROLOGY, V418, P57, DOI 10.1016/j.virol.2011.07.002; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Donahue DA, 2012, J VIROL, V86, P3253, DOI 10.1128/JVI.06648-11; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Guerrero MLF, 2005, CLIN INFECT DIS, V41, P390, DOI 10.1086/431487; HAHN S, 1992, Current Biology, V2, P152, DOI 10.1016/0960-9822(92)90268-F; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; Kolesnitchenko V, 1997, J VIROL, V71, P9753, DOI 10.1128/JVI.71.12.9753-9763.1997; Li XD, 1996, VIROLOGY, V225, P196, DOI 10.1006/viro.1996.0588; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Malcolm T, 2007, VIRUS GENES, V35, P215, DOI 10.1007/s11262-007-0109-9; Malcolm T, 2008, FEBS LETT, V582, P3903, DOI 10.1016/j.febslet.2008.10.032; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; Matalon S, 2011, MOL MED, V17, P466, DOI 10.2119/molmed.2011.00076; MOMOEDA M, 1994, J VIROL, V68, P7159, DOI 10.1128/JVI.68.11.7159-7168.1994; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Romerio F, 1997, J VIROL, V71, P9375, DOI 10.1128/JVI.71.12.9375-9382.1997; Sadowski I, 2008, CURR HIV RES, V6, P286, DOI 10.2174/157016208785132563; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shishido T, 2012, J VIROL, V86, P9055, DOI 10.1128/JVI.00793-12; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Song SK, 1996, VIROLOGY, V225, P377, DOI 10.1006/viro.1996.0612; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zalani S, 1997, J VIROL, V71, P3268, DOI 10.1128/JVI.71.4.3268-3274.1997	46	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77052	10.1371/journal.pone.0077052	http://dx.doi.org/10.1371/journal.pone.0077052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116200	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200096
J	Jiang, WD; Huang, RC; Duan, CH; Fu, LW; Xi, Y; Yang, YB; Yang, WM; Yang, DZ; Yang, DH; Huang, RP				Jiang, Weidong; Huang, Ruochun; Duan, Chaohui; Fu, Liwu; Xi, Yun; Yang, Yuebo; Yang, Wei-Min; Yang, Dongzi; Yang, Dong-Hua; Huang, Ruo-Pan			Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; BREAST-CANCER; OSTEOPROTEGERIN OPG; EXPRESSION; GROWTH; CELLS; BETA; BIOMARKERS; RECEPTOR; TUMOR	Background: Protein and antibody arrays have emerged as a promising technology to study protein expression and protein function in a high-throughput manner. These arrays also represent a new opportunity to profile protein expression levels in cancer patients' samples and to identify useful biosignatures for clinical diagnosis, disease classification, prediction, drug development and patient care. We applied antibody arrays to discover a panel of proteins which may serve as biomarkers to distinguish between patients with ovarian cancer and normal controls. Methodology/Principal Findings: Using a case-control study design of 34 ovarian cancer patients and 53 age-matched healthy controls, we profiled the expression levels of 174 proteins using antibody array technology and determined the CA125 level using ELISA. The expression levels of those proteins were analyzed using 3 discriminant methods, including artificial neural network, classification tree and split-point score analysis. A panel of 5 serum protein markers (MSP-alpha, TIMP-4, PDGF-R alpha, and OPG and CA125) was identified, which could effectively detect ovarian cancer with high specificity (95%) and high sensitivity (100%), with AUC = 0.98, while CA125 alone had an AUC of 0.87. Conclusions/Significance: Our pilot study has shown the promising set of 5 serum markers for ovarian cancer detection.	[Jiang, Weidong; Huang, Ruochun; Huang, Ruo-Pan] RayBiotech Inc, Norcross, GA USA; [Huang, Ruochun; Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Duan, Chaohui] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Fu, Liwu] Sun Yat Sen Univ, Affiliated Canc Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Xi, Yun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yuebo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Wei-Min] Wuxi Maternal & Child Hlth Hosp, Dept Gynecol, Wuxi, Peoples R China; [Yang, Dongzi] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Dong-Hua] Fox Chase Canc Ctr, Biosample Repository, Philadelphia, PA 19111 USA; [Huang, Ruo-Pan] South China Biochip Res Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Fox Chase Cancer Center	Huang, RP (corresponding author), RayBiotech Inc, Norcross, GA USA.	rhuang@raybiotech.com	Yang, Wei/GWV-4107-2022; Fu, Liwu/AAE-8835-2020; Yang, Wei/HIA-0360-2022		RayBiotech Biomarker Discovery Pilot Grant; leading scientist project for Guangzhou economic development district [2009L-P180]; Program of hundred leading innovators and entrepreneurs [LCY201111]; Guangdong innovative research team program [201001s0104659419]; Guangzhou economic development district [2010Q-P450]	RayBiotech Biomarker Discovery Pilot Grant; leading scientist project for Guangzhou economic development district; Program of hundred leading innovators and entrepreneurs; Guangdong innovative research team program; Guangzhou economic development district	The work was in part supported by RayBiotech Biomarker Discovery Pilot Grant. The authors would like to express their thanks for the support of the leading scientist project for Guangzhou economic development district (2009L-P180); Program of hundred leading innovators and entrepreneurs (LCY201111); Guangdong innovative research team program (201001s0104659419), and research grants from the Guangzhou economic development district (2010Q-P450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; Bandera CA, 2003, CURR OPIN OBSTET GYN, V15, P51, DOI 10.1097/00001703-200302000-00008; CARLSON KJ, 1994, ANN INTERN MED, V121, P124, DOI 10.7326/0003-4819-121-2-199407150-00009; Chen L, 2011, INT J BIOL MARKER, V26, P108, DOI 10.5301/JBM.2011.8322; Corey E, 2005, CANCER RES, V65, P1710, DOI 10.1158/0008-5472.CAN-04-2033; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Fjallskog ML, 2007, ACTA ONCOL, V46, P741, DOI 10.1080/02841860601048388; Fu OY, 2009, ANTICANCER RES, V29, P3131; Gentry-Maharaj A, 2012, BEST PRACT RES CL OB, V26, P243, DOI 10.1016/j.bpobgyn.2011.11.006; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Holen I, 2002, CANCER RES, V62, P1619; Huang RP, 2001, J IMMUNOL METHODS, V255, P1, DOI 10.1016/S0022-1759(01)00394-5; Huang RP, 2003, COMB CHEM HIGH T SCR, V6, P769; Huang Ruochun, 2010, Cancer Genomics & Proteomics, V7, P129; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kobayashi E, 2012, CANCER EPIDEM BIOMAR, V21, P1902, DOI 10.1158/1055-9965.EPI-12-0646; Lane D, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-34; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Madsen Christine Vestergaard, 2012, Patholog Res Int, V2012, P851432, DOI 10.1155/2012/851432; MARKOWSKA J, 1992, European Journal of Gynaecological Oncology, V13, P360; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Neville-Webbe HL, 2004, BREAST CANCER RES TR, V86, P269; Ripley D, 2006, INT J GYNECOL CANCER, V16, P1794, DOI 10.1111/j.1525-1438.2006.00714.x; SCHWARTZ PE, 1995, ANN MED, V27, P519, DOI 10.3109/07853899509002463; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	30	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76795	10.1371/journal.pone.0076795	http://dx.doi.org/10.1371/journal.pone.0076795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116163	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200072
J	Ou, CQ; Song, YF; Yang, J; Chau, PYK; Yang, L; Chen, PY; Wong, CM				Ou, Chun-Quan; Song, Yun-Feng; Yang, Jun; Chau, Patsy Yuen-Kwan; Yang, Lin; Chen, Ping-Yan; Wong, Chit-Ming			Excess Winter Mortality and Cold Temperatures in a Subtropical City, Guangzhou, China	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; AMBIENT-TEMPERATURE; SEASONAL-VARIATIONS; RISK; DEATHS; CITIES; DEPRIVATION; POPULATION; WEATHER; BRITAIN	Background: A significant increase in mortality was observed during cold winters in many temperate regions. However, there is a lack of evidence from tropical and subtropical regions, and the influence of ambient temperatures on seasonal variation of mortality was not well documented. Methods: This study included 213,737 registered deaths from January 2003 to December 2011 in Guangzhou, a subtropical city in Southern China. Excess winter mortality was calculated by the excess percentage of monthly mortality in winters over that of non-winter months. A generalized linear model with a quasi-Poisson distribution was applied to analyze the association between monthly mean temperature and mortality, after controlling for other meteorological measures and air pollution. Results: The mortality rate in the winter was 26% higher than the average rate in other seasons. On average, there were 1,848 excess winter deaths annually, with around half (52%) from cardiovascular diseases and a quarter (24%) from respiratory diseases. Excess winter mortality was higher in the elderly, females and those with low education level than the young, males and those with high education level, respectively. A much larger winter increase was observed in out-of-hospital mortality compared to in-hospital mortality (45% vs. 17%). We found a significant negative correlation of annual excess winter mortality with average winter temperature (r(s)=-0.738, P=0.037), but not with air pollution levels. A 1 C decrease in monthly mean temperature was associated with an increase of 1.38% (95% CI: 0.34%-2.40%) and 0.88% (95% CI: 0.11%-1.64%) in monthly mortality at lags of 0-1 month, respectively. Conclusion: Similar to temperate regions, a subtropical city Guangzhou showed a clear seasonal pattern in mortality, with a sharper spike in winter. Our results highlight the role of cold temperature on the winter mortality even in warm climate. Precautionary measures should be strengthened to mitigate cold-related mortality for people living in warm climate.	[Ou, Chun-Quan; Yang, Jun; Chen, Ping-Yan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Song, Yun-Feng] Guangdong 2 Prov Peoples Hosp, Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Chau, Patsy Yuen-Kwan; Yang, Lin; Wong, Chit-Ming] Univ Hong Kong, Dept Community Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chau, Patsy Yuen-Kwan] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong	Chen, PY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China.	chenpy99@smu.edu.cn	YANG, Lin/F-9601-2014; Yang, Jun/Q-3037-2019	YANG, Lin/0000-0002-5964-3233; Ou, Chun-Quan/0000-0001-6866-7213	National Nature Science Foundation of China [81102207]; Guangdong Nature Science Foundation [S2011040005355]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Nature Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Foundation of China [81102207] and Guangdong Nature Science Foundation [S2011040005355]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x; Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Blagojevic LM, 2012, CENT EUR J PUBL HEAL, V20, P135, DOI 10.21101/cejph.a3711; Chang CL, 2004, J CLIN EPIDEMIOL, V57, P749, DOI 10.1016/j.jclinepi.2003.10.016; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davie GS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-263; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; De Lorenzo F, 1999, ARCH INTERN MED, V159, P1954, DOI 10.1001/archinte.159.16.1954; Egondi T, 2012, GLOBAL HEALTH ACTION, V5, P23, DOI 10.3402/gha.v5i0.19065; Eng H, 1998, J Cardiovasc Risk, V5, P89, DOI 10.1097/00043798-199804000-00004; Guangzhou Statistic Bureau, 2011, GUANGHZ STAT B; Guo YM, 2013, HEART, V99, P195, DOI 10.1136/heartjnl-2012-302518; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Iniguez C, 2010, INT J ENV RES PUB HE, V7, P3196, DOI 10.3390/ijerph7083196; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.1289/ehp.9710584; Keatinge W R, 2000, Int J Circumpolar Health, V59, P154; Keatinge W R, 2002, Int J Circumpolar Health, V61, P292; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Kynast-Wolf G, 2010, TROP MED INT HLTH; Maheswaran R, 2004, PUBLIC HEALTH, V118, P167, DOI 10.1016/j.puhe.2003.09.004; Marmot M, 2011, HLTH IMPACTS COLD HO; McCormack GR, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.092841; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; Mrema S, 2012, GLOBAL HEALTH ACTION, V5, P33, DOI 10.3402/gha.v5i0.19068; Nayha Simo, 2002, Int J Circumpolar Health, V61, P373; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; Peachey M, 2010, EXCESS WINTER DEATHS; Pin SP, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.005; Rau R, 2004, BRIT MED J, V329, P976, DOI 10.1136/bmj.329.7472.976-b; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Shahar DR, 1999, EUR J CLIN NUTR, V53, P395, DOI 10.1038/sj.ejcn.1600761; Shahar DR, 2001, EUR J EPIDEMIOL, V17, P129, DOI 10.1023/A:1017542928978; Smolkova B, 2004, MUTAT RES-FUND MOL M, V551, P135, DOI 10.1016/j.mrfmmm.2004.02.021; Tian ZX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-56; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Yang J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-63	43	43	45	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e77150	10.1371/journal.pone.0077150	http://dx.doi.org/10.1371/journal.pone.0077150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116214	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200106
J	Borowiec, AS; Delcourt, P; Dewailly, E; Bidaux, G				Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel			Optimal Differentiation of In Vitro Keratinocytes Requires Multifactorial External Control	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; EXTRACELLULAR CALCIUM; TERMINAL DIFFERENTIATION; CELL-CYCLE; GROWTH; CULTURE; SERUM; EXPRESSION; PROTEIN; RECEPTORS	For almost 30 years, keratinocyte differentiation has been studied in numerous cell models including keratinocyte primary culture with various supplemented culture media. In this respect, it has become quite difficult to draw comparisons between studies using such a variety of culture conditions. Serum-free condition with low calcium has been used to culture basal proliferating cells, though differentiation is induced by various procedures. These latter include the addition of calcium at mM concentration and a concomitant addition of serum and calcium. Lowering the incubation temperature of cells has also been reported to induce a premature differentiation of keratinocytes in organotypic skin culture. This effect of temperature on keratinocyte differentiation has been poorly depicted, although average human skin temperature has been shown to be about 32 degrees C. However, studying differentiation and quantifying shifts in the differentiation rate of a cell population implies to precisely know i) the proportion of differentiated cells in the whole population, and ii) to which extent and to which level of expression, the induction of a gene or a protein might be considered as a marker of differentiation. This lack has rarely been taken into consideration and has surely led to over-interpretations of single protein induction and to consequent extrapolations to real differentiation processes. By means of paralleled analyses with immunocytofluorescence, flow cytometry, and with multiple differentiation markers quantify by qPCR and western-blot, we studied the paradoxical connection between calcium, serum, multilayer culture and incubation temperature on the differentiation of in vitro keratinocytes. Conversely to previous reports, we have shown that calcium switch is indeed a potent model for inducing calcium-dependent genes, but is not an efficient procedure when one wishes to assess the keratinocyte differentiation rate. Moreover, we have demonstrated that a synergic stimulation by calcium, serum, confluence and lower incubation temperature amplified the differentiation rate.	[Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel] Univ Lille 1, INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Borowiec, Anne-Sophie; Delcourt, Philippe; Dewailly, Etienne; Bidaux, Gabriel] Univ Lille 1, Lab Excellence Ion Channels Sci & Therapeut, F-59655 Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Bidaux, G (corresponding author), CNRS, Lab Biophoton Cellulaire Fonct, Inst Rech Interdisciplinaire, USR3078, Parc Sci Haute Borne, Villeneuve Dascq, France.	gabriel.bidaux@gmail.com	Bidaux, Gabriel/F-1294-2016	Bidaux, Gabriel/0000-0002-6162-3223	INSERM (France)	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was funded by INSERM (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; BERGHARD A, 1990, J BIOL CHEM, V265, P21086; BERTOLERO F, 1986, IN VITRO CELL DEV B, V22, P423; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Gibbs S, 1997, ARCH DERMATOL RES, V289, P585, DOI 10.1007/s004030050244; Gifford JR, 2012, J PHYSIOL-LONDON, V590, P6403, DOI 10.1113/jphysiol.2012.240523; Greig AVH, 2003, J INVEST DERMATOL, V121, P1145, DOI 10.1046/j.1523-1747.2003.12567.x; Hennings H, 1980, Curr Probl Dermatol, V10, P3; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; JONES JCR, 1985, J CELL BIOL, V101, P506, DOI 10.1083/jcb.101.2.506; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; Leinonen PT, 2009, J INVEST DERMATOL, V129, P1379, DOI 10.1038/jid.2008.381; Li LW, 1996, J INVEST DERMATOL, V106, P254, DOI 10.1111/1523-1747.ep12340654; MALMQVIST KG, 1983, SCAN ELECTRON MICROS, P1815; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; MOORE EW, 1970, J CLIN INVEST, V49, pA67; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; PITTELKOW MR, 1986, MAYO CLIN PROC, V61, P771, DOI 10.1016/S0025-6196(12)64815-0; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; SMITH EL, 1986, J INVEST DERMATOL, V86, P709, DOI 10.1111/1523-1747.ep12276343; STEWART CA, 1992, IN VITRO CELL DEV-AN, V28A, P211, DOI 10.1007/BF02631094; Sugiura K, 2009, J INVEST DERMATOL, V129, P2126, DOI 10.1038/jid.2009.51; Takagi R, 2011, BIOCHEM BIOPH RES CO, V412, P226, DOI 10.1016/j.bbrc.2011.07.069; Thiele JJ, 1999, J INVEST DERMATOL, V113, P335, DOI 10.1046/j.1523-1747.1999.00693.x; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	40	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e77507	10.1371/journal.pone.0077507	http://dx.doi.org/10.1371/journal.pone.0077507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116231	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300122
J	Dalrymple, SA; Ko, J; Sheoran, I; Kaminskyj, SGW; Sanders, DAR				Dalrymple, Sean A.; Ko, John; Sheoran, Inder; Kaminskyj, Susan G. W.; Sanders, David A. R.			Elucidation of Substrate Specificity in Aspergillus nidulans UDP-Galactose-4-Epimerase	PLOS ONE			English	Article							UDP-GALACTOSE 4-EPIMERASE; N-ACETYLGLUCOSAMINE 4-EPIMERASE; FUMIGATUS CELL-WALL; GALACTOPYRANOSE MUTASE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; GLUCOSE 4-EPIMERASE; FUNGAL-INFECTIONS; ESCHERICHIA-COLI; POTENTIAL TARGET	The frequency of invasive fungal infections has rapidly increased in recent years. Current clinical treatments are experiencing decreased potency due to severe host toxicity and the emergence of fungal drug resistance. As such, new targets and their corresponding synthetic pathways need to be explored for drug development purposes. In this context, galactofuranose residues, which are employed in fungal cell wall construction, but are notably absent in animals, represent an appealing target. Herein we present the structural and biochemical characterization of UDP-galactose-4-epimerase from Aspergillus nidulans which produces the precursor UDP-galactopyranose required for galactofuranose synthesis. Examination of the structural model revealed both NAD(+) and UDP-glucopyranose were bound within the active site cleft in a near identical fashion to that found in the Human epimerase. Mutational studies on the conserved catalytic motif support a similar mechanism to that established for the Human counterpart is likely operational within the A. nidulans epimerase. While the K-m and k(cat) for the enzyme were determined to be 0.11 mM and 12.8 s(-1), respectively, a single point mutation, namely L320C, activated the enzyme towards larger N-acetylated substrates. Docking studies designed to probe active site affinity corroborate the experimentally determined activity profiles and support the kinetic inhibition results.	[Dalrymple, Sean A.; Ko, John; Sheoran, Inder; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada; [Kaminskyj, Susan G. W.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Sanders, DAR (corresponding author), Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 0W0, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016		CIHR; SHRF	CIHR(Canadian Institutes of Health Research (CIHR)); SHRF	This work was supported by a CIHR-Regional Partnership Program grant to DARS and SGWK. Additionally, SAD would like to acknowledge funding from SHRF through a Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alphey MS, 2006, ACTA CRYSTALLOGR F, V62, P829, DOI 10.1107/S1744309106028740; BAKER ME, 1992, FEBS LETT, V301, P89, DOI 10.1016/0014-5793(92)80216-4; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369; Dalrymple SA, 2011, ACTA CRYSTALLOGR F, V67, P885, DOI 10.1107/S1744309111020914; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FUKASAWA T, 1980, J BIOL CHEM, V255, P2705; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gullo A, 2009, DRUGS, V69, P65, DOI 10.2165/11315530-000000000-00000; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; HOLM L, 1994, NAT STRUCT BIOL, V1, P146, DOI 10.1038/nsb0394-146; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Klis FM, 2007, MYCOTA, P95; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, ASPERGILLUS FUMIGATU; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MALEY F, 1959, BIOCHIM BIOPHYS ACTA, V31, P577, DOI 10.1016/0006-3002(59)90047-2; Maor BP, 2004, BIOCHEM J, V381, P131, DOI 10.1042/BJ20031075; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Momany M, 2004, MICROBIOL-SGM, V150, P3261, DOI 10.1099/mic.0.27318-0; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Moyrand F, 2008, EUKARYOT CELL, V7, P2069, DOI 10.1128/EC.00189-08; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILLER F, 1983, J BIOL CHEM, V258, P774; Poulin MB, 2010, J BIOL CHEM, V285, P493, DOI 10.1074/jbc.M109.072157; RAY M, 1975, J BIOL CHEM, V250, P4373; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schrodinger L., 2020, PYMOL; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Scott A, 2007, FEMS YEAST RES, V7, P366, DOI 10.1111/j.1567-1364.2006.00204.x; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8; TEIPEL JW, 1968, J BIOL CHEM, V243, P5684; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Thoden JB, 2005, J BIOL CHEM, V280, P21900, DOI 10.1074/jbc.M502411200; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P10685, DOI 10.1021/bi9704313; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Timson DJ, 2005, FEBS J, V272, P6170, DOI 10.1111/j.1742-4658.2005.05017.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wallis GLF, 2001, FEMS MICROBIOL LETT, V201, P21, DOI 10.1016/S0378-1097(01)00219-1; WILSON DB, 1964, J BIOL CHEM, V239, P2469; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784	76	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76803	10.1371/journal.pone.0076803	http://dx.doi.org/10.1371/journal.pone.0076803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116166	Green Published, gold			2022-12-25	WOS:000325501300098
J	Palepu, A; Gadermann, A; Hubley, AM; Farrell, S; Gogosis, E; Aubry, T; Hwang, SW				Palepu, Anita; Gadermann, Anne; Hubley, Anita M.; Farrell, Susan; Gogosis, Evie; Aubry, Tim; Hwang, Stephen W.			Substance Use and Access to Health Care and Addiction Treatment among Homeless and Vulnerably Housed Persons in Three Canadian Cities	PLOS ONE			English	Article							INJECTION-DRUG USERS; ABUSE SCREENING-TEST; USE DISORDERS; FOLLOW-UP; EMERGENCY-DEPARTMENT; MENTAL-ILLNESS; HIGH-RATES; ADULTS; POPULATION; MORTALITY	Introduction: We examined the prevalence of substance use disorders among homeless and vulnerably housed persons in three Canadian cities and its association with unmet health care needs and access to addiction treatment using baseline data from the Health and Housing in Transition Study. Methods: In 2009, 1191 homeless and vulnerably housed persons were recruited in Vancouver, Toronto, and Ottawa, Canada. Interviewer administered questionnaires collected data on socio-demographics, housing history, chronic health conditions, mental health diagnoses, problematic drug use (DAST-10 >= 6), problematic alcohol use (AUDIT >= 20), unmet physical and mental health care needs, addiction treatment in the past 12 months. Three multiple logistic regression models were fit to examine the independent association of substance use with unmet physical health care need, unmet mental health care need, and addiction treatment. Results: Substance use was highly prevalent, with over half (53%) screening positive for the DAST-10 and 38% screening positive for the AUDIT. Problematic drug use was 29%, problematic alcohol use was lower at 16% and 7% had both problematic drug and alcohol use. In multiple regression models for unmet need, we found that problematic drug use was independently associated with unmet physical (adjusted odds ratio [AOR] 1.95; 95% confidence interval [CI] 1.43-2.64) and unmet mental (AOR 3.06; 95% CI 2.17-4.30) health care needs. Problematic alcohol use was not associated with unmet health care needs. Among those with problematic substance use, problematic drug use was associated with a greater likelihood of accessing addiction treatment compared to those with problematic alcohol use alone (AOR 2.32; 95% CI 1.18-4.54). Conclusions: Problematic drug use among homeless and vulnerably housed individuals was associated with having unmet health care needs and accessing addiction treatment. Strategies to provide comprehensive health services including addiction treatment should be developed and integrated within community supported models of care.	[Palepu, Anita; Gadermann, Anne] Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Hubley, Anita M.] Univ British Columbia, Dept Educ & Counseling Psychol & Special Educ, Vancouver, BC V5Z 1M9, Canada; [Farrell, Susan] Univ Ottawa, Dept Psychiat, Royal Ottawa Hlth Care Grp, Ottawa, ON K1N 6N5, Canada; [Gogosis, Evie; Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Aubry, Tim] Univ Ottawa, Sch Psychol, Ctr Res Educ & Community Serv, Ottawa, ON K1N 6N5, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of British Columbia; University of British Columbia; University of Ottawa; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; University of Toronto	Palepu, A (corresponding author), Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	apalepu@hivnet.ubc.ca	Hwang, Stephen W./GVR-7773-2022; Aubry, Tim/ABB-9932-2021; Hwang, Stephen W./D-2297-2011	Aubry, Tim/0000-0002-6204-3773; Hwang, Stephen W./0000-0002-1276-1101	operating grant from the Canadian Institutes of Health Research [MOP-86765]; Michael Smith Foundation for Health Research	operating grant from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This project was supported by an operating grant (MOP-86765) from the Canadian Institutes of Health Research. Dr Anne Gadermann was supported by a post-doctoral fellowship award from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance to End Homelessness, 2012, REP CARD END HOM OTT; Ardilly P, 2001, SURVEY METHODOL, V27, P109; Aubry T, 2012, AM J COMMUN PSYCHOL, V49, P142, DOI 10.1007/s10464-011-9444-z; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Barbor T., 1992, AUDIT ALCOHOL USE DI; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Coumans M, 2003, SUBST USE MISUSE, V38, P311, DOI 10.1081/JA-120017376; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; Donovan DM, 2006, ADDICTION, V101, P1696, DOI 10.1111/j.1360-0443.2006.01606.x; Edens EL, 2011, WOMEN HEALTH ISS, V21, P383, DOI 10.1016/j.whi.2011.03.004; Farrell SJ, 2005, COMMUNITY MENT HLT J, V41, P737, DOI 10.1007/s10597-005-6430-7; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; French MT, 2001, SUBST USE MISUSE, V36, P927, DOI 10.1081/JA-100104096; Glasser I, 2003, SUBST USE MISUSE, V38, P551, DOI 10.1081/JA-120017385; Gossop M, 2005, DRUG ALCOHOL DEPEN, V79, P295, DOI 10.1016/j.drugalcdep.2005.01.023; Grinman MN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-94; Hodgetts D, 2007, J HEALTH PSYCHOL, V12, P709, DOI 10.1177/1359105307080593; Hwang SW, 2011, INT J PUBLIC HEALTH, V56, P609, DOI 10.1007/s00038-011-0283-3; Hwang SW, 2010, AM J PUBLIC HEALTH, V100, P1454, DOI 10.2105/AJPH.2009.182022; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2003, CAN J PUBLIC HEALTH, V94, P436, DOI 10.1007/BF03405081; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Kertesz SG, 2009, JAMA-J AM MED ASSOC, V301, P1822, DOI 10.1001/jama.2009.596; Kertesz SG, 2009, J GEN INTERN MED, V24, P841, DOI 10.1007/s11606-009-0990-0; Khandor Erika, 2011, Open Med, V5, pe94; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Maisto SA, 2000, PSYCHOL ASSESSMENT, V12, P186, DOI 10.1037/1040-3590.12.2.186; Marshall EG, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-46; Moniruzzaman, 2012, MENTAL HLTH SUBSTANC, V5, P85, DOI [10.1080/17523281.2011.618143, DOI 10.1080/17523281.2011.618143]; North CS, 2010, SOC PSYCH PSYCH EPID, V45, P1055, DOI 10.1007/s00127-009-0144-z; O'Connell MJ, 2012, PSYCHIAT SERV, V63, P1195, DOI 10.1176/appi.ps.201000229; Palepu A, 1999, J URBAN HEALTH, V76, P409, DOI 10.1007/BF02351499; Palepu A, 2001, AIDS, V15, P423, DOI 10.1097/00002030-200102160-00021; Palepu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011697; Robertson MJ, 1997, AM J PUBLIC HEALTH, V87, P221, DOI 10.2105/AJPH.87.2.221; Sanmartin Claudia, 2002, Health Rep, V13, P15; Strehlau V, 2012, J PSYCHIATR PRACT, V18, P349, DOI 10.1097/01.pra.0000419819.60505.dc; SUSSER E, 1989, ARCH GEN PSYCHIAT, V46, P845; The Metro Vancouver Regional Steering Committee on Homelessness, 2012, ON STEP FORW RES 201; Toronto Shelter Support and Housing Administration, 2009, STREET NEEDS ASS RES; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Velasquez MM, 2000, J SUBST ABUSE TREAT, V19, P395, DOI 10.1016/S0740-5472(00)00133-1; Vuchinich R, 2009, EXP CLIN PSYCHOPHARM, V17, P165, DOI 10.1037/a0015296; Winn JL, 2013, PSYCHOL SERV, V10, P233, DOI 10.1037/a0031051; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	49	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75133	10.1371/journal.pone.0075133	http://dx.doi.org/10.1371/journal.pone.0075133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232JF	24124470	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100027
J	Adhikari, D; Risal, S; Liu, K; Shen, Y				Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan			Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling	PLOS ONE			English	Article							OVARIAN TOXICITY; MOUSE OVARY; OOCYTES; CHEMOTHERAPY; OVOTOXICITY; SURVIVAL; PATHWAY; GROWTH	The majority of ovarian primordial follicles must be preserved in a quiescent state to allow for the regular production of gametes over the female reproductive lifespan. However, the molecular mechanism that maintains the long quiescence of primordial follicles is poorly understood. Under certain pathological conditions, the entire pool of primordial follicles matures simultaneously leading to an accelerated loss of primordial follicles and to premature ovarian failure (POF). We have previously shown that loss of Pten (phosphatase and tensin homolog deleted on chromosome ten) in mouse oocytes leads to premature activation of the entire pool of primordial follicles, subsequent follicular depletion in early adulthood, and the onset of POF. Lack of PTEN leads to increased phosphatidylinositol 3-kinase (PI3K)-Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling in the oocytes. To study the functional and pathological roles of elevated mTORC1 signaling in the oocytes, we treated the Pten-mutant mice with the specific mTORC1 inhibitor rapamycin. When administered to Pten-deficient mice prior to the activation of the primordial follicles, rapamycin effectively prevented global follicular activation and preserved the ovarian reserve. These results provide a rationale for exploring the possible use of rapamycin as a drug for the preservation of the primordial follicle pool, and the possible prevention of POF.	[Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Adhikari, D (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	deepak.adhikari@medchem.umu.se; yan.shen@vgregion.se	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609				Adhikari D, 2010, CELL CYCLE, V9, P1673, DOI 10.4161/cc.9.9.11626; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Ben-Aharon I, 2012, REPRODUCTION, V144, P153, DOI 10.1530/REP-12-0121; Braun M, 2012, NEW ENGL J MED, V366, P1062, DOI 10.1056/NEJMc1113145; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jagarlamudi K, 2010, MOL CELL ENDOCRINOL, V315, P1, DOI 10.1016/j.mce.2009.07.016; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	28	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53810	10.1371/journal.pone.0053810	http://dx.doi.org/10.1371/journal.pone.0053810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24124466	Green Submitted, Green Published, gold			2022-12-25	WOS:000314705800077
J	Zhang, JX; Guo, LY; Feng, L; Jiang, WD; Kuang, SY; Liu, Y; Hu, K; Jiang, J; Li, SH; Tang, L; Zhou, XQ				Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Kuang, Sheng-Yao; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Zhou, Xiao-Qiu			Soybean beta-Conglycinin Induces Inflammation and Oxidation and Causes Dysfunction of Intestinal Digestion and Absorption in Fish	PLOS ONE			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MORHUA FED STANDARD; FED GRADED-LEVELS; JUVENILE JIAN; ENZYME-ACTIVITIES; ATLANTIC SALMON; BODY-COMPOSITION; RAINBOW-TROUT; GLUTAMINE SUPPLEMENTATION	beta-conglycinin has been identified as one of the major feed allergens. However, studies of beta-conglycinin on fish are scarce. This study investigated the effects of b-conglycinin on the growth, digestive and absorptive ability, inflammatory response, oxidative status and gene expression of juvenile Jian carp (Cyprinus carpio var. Jian) in vivo and their enterocytes in vitro. The results indicated that the specific growth rate (SGR), feed intake, and feed efficiency were reduced by beta-conglycinin. In addition, activities of trypsin, chymotrypsin, lipase, creatine kinase, Na+, K+-ATPase and alkaline phosphatase in the intestine showed similar tendencies. The protein content of the hepatopancreas and intestines, and the weight and length of the intestines were all reduced by beta-conglycinin. beta-conglycinin increased lipid and protein oxidation in the detected tissues and cells. However, beta-conglycinin decreased superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione peroxidase (GPx) and glutathione reductase (GR) activities and glutathione (GSH) content in the intestine and enterocytes. Similar antioxidant activity in the hepatopancreas was observed, except for GST. The expression of target of rapamycin (TOR) gene was reduced by beta-conglycinin. Furthermore, mRNA levels of interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta) genes were increased by beta-conglycinin. However, beta-conglycinin increased CuZnSOD, MnSOD, CAT, and GPx1b gene expression. In conclusion, this study indicates that beta-conglycinin induces inflammation and oxidation, and causes dysfunction of intestinal digestion and absorption in fish, and finally reduces fish growth. The results of this study provide some information to the mechanism of beta-conglycinin-induced negative effects.	[Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Science Foundation of China [3087192]; National Department Public Benefit Research Foundation (Agriculture) of China [2010003020]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-08-0905]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture) of China; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by the National Science Foundation of China (3087192), National Department Public Benefit Research Foundation (Agriculture) of China (2010003020) and Project supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-08-0905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHUSSAINI AH, 1949, Q J MICROSC SCI, V90, P323; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Baudry N, 1996, FEBS LETT, V396, P223, DOI 10.1016/0014-5793(96)01107-6; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Bicho A, 1999, J EXP BIOL, V202, P39; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttle LG, 2001, VET IMMUNOL IMMUNOP, V80, P237, DOI 10.1016/S0165-2427(01)00269-0; Cao YH, 1998, JPEN-PARENTER ENTER, V22, P224, DOI 10.1177/0148607198022004224; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; DALY JG, 1995, FISH SHELLFISH IMMUN, V5, P265, DOI 10.1006/fsim.1995.0026; Feng L, 2009, THESIS SICHUAN AGR U; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Gamboa-Delgado J, 2009, AQUACULTURE, V291, P115, DOI 10.1016/j.aquaculture.2009.03.012; Guillaume J., 2001, NUTR FEEDING FISH CR, P35; Guo PF, 2008, INT ARCH ALLERGY IMM, V145, P102, DOI 10.1159/000108135; Han PF, 2010, ARCH ANIM NUTR, V64, P254, DOI 10.1080/17450391003625003; Hao Y, 2009, ARCH ANIM NUTR, V63, P188, DOI 10.1080/17450390902860026; He W, 2009, AQUACULT NUTR, V15, P402, DOI 10.1111/j.1365-2095.2008.00604.x; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang HH, 2011, AQUACULT NUTR, V17, pE233, DOI 10.1111/j.1365-2095.2010.00756.x; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; ILENCHUK TT, 1982, INSECT BIOCHEM, V12, P675, DOI 10.1016/0020-1790(82)90056-7; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang J., 2005, THESIS SICHUAN AGR U; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnson AT, 2003, J SURG RES, V115, P242, DOI 10.1016/j.jss.2003.07.003; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; LI DF, 1990, J ANIM SCI, V68, P1790; Li W, 2010, AQUACULT NUTR, V16, P137, DOI 10.1111/j.1365-2095.2008.00645.x; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lin SM, 2011, ANIM FEED SCI TECH, V168, P80, DOI 10.1016/j.anifeedsci.2011.03.012; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x; Liu ZQ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1105, DOI 10.1152/ajpendo.00337.2002; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Moellering D, 1999, FEBS LETT, V448, P292, DOI 10.1016/S0014-5793(99)00371-3; Mulier B, 1998, EUR RESPIR J, V11, P384, DOI 10.1183/09031936.98.11020384; National Research Council, 1993, NUTR REQ FISH; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Ostaszewska T, 2005, AQUACULTURE, V245, P273, DOI 10.1016/j.aquaculture.2004.12.005; Refstie S, 2006, AQUACULTURE, V261, P269, DOI 10.1016/j.aquaculture.2006.07.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; Satoh J, 2003, J GASTROEN HEPATOL, V18, P719, DOI 10.1046/j.1440-1746.2003.03042.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sun P, 2008, J NUTR BIOCHEM, V19, P627, DOI 10.1016/j.jnutbio.2007.08.007; Tan LN, 2011, AQUACULT NUTR, V17, P338, DOI 10.1111/j.1365-2095.2010.00793.x; Tang L, 2009, AQUACULT NUTR, V15, P477, DOI 10.1111/j.1365-2095.2008.00613.x; Turan A, 2007, DIGEST DIS SCI, V52, P1840, DOI 10.1007/s10620-006-9633-z; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Utsumi S., 1997, FOOD PROTEINS THEIR, P257; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Wasa M, 2005, J SURG RES, V123, P75, DOI 10.1016/j.jss.2004.07.018; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Xiao WW, 2011, AQUACULT NUTR, V17, P408, DOI 10.1111/j.1365-2095.2010.00818.x; Xu J, 2010, J ANIM PLANT SCI, V20, P170; Zhang J-X, 2007, AQUACULT SCI, V2, P315; Zhang J-X, 2003, THESIS SICHUAN AGR U; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhao Y, 2010, FOOD AGR IMMUNOL, V21, P209, DOI 10.1080/09540101003596644; Zhou XQ, 2008, AQUACULT NUTR, V14, P381, DOI 10.1111/j.1365-2095.2007.00535.x; Zhu Q, 2012, J APPL ICHTHYOL, DOI [10.1111/j.1439-0426.2011.011676.x, DOI 10.1111/J.1439-0426.2011.011676.X]	76	265	280	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58115	10.1371/journal.pone.0058115	http://dx.doi.org/10.1371/journal.pone.0058115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	24124552	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900047
J	Adhikari, BN; Hamilton, JP; Zerillo, MM; Tisserat, N; Levesque, CA; Buell, CR				Adhikari, Bishwo N.; Hamilton, John P.; Zerillo, Marcelo M.; Tisserat, Ned; Levesque, C. Andre; Buell, C. Robin			Comparative Genomics Reveals Insight into Virulence Strategies of Plant Pathogenic Oomycetes	PLOS ONE			English	Article							PYTHIUM-OLIGANDRUM; BIOLOGICAL-CONTROL; EFFECTOR PROTEINS; PHYLOGENETIC-RELATIONSHIPS; PHYTOPHTHORA-INFESTANS; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; DISEASE; WHEAT	The kingdom Stramenopile includes diatoms, brown algae, and oomycetes. Plant pathogenic oomycetes, including Phytophthora, Pythium and downy mildew species, cause devastating diseases on a wide range of host species and have a significant impact on agriculture. Here, we report comparative analyses on the genomes of thirteen straminipilous species, including eleven plant pathogenic oomycetes, to explore common features linked to their pathogenic lifestyle. We report the sequencing, assembly, and annotation of six Pythium genomes and comparison with other stramenopiles including photosynthetic diatoms, and other plant pathogenic oomycetes such as Phytophthora species, Hyaloperonospora arabidopsidis, and Pythium ultimum var. ultimum. Novel features of the oomycete genomes include an expansion of genes encoding secreted effectors and plant cell wall degrading enzymes in Phytophthora species and an over-representation of genes involved in proteolytic degradation and signal transduction in Pythium species. A complete lack of classical RxLR effectors was observed in the seven surveyed Pythium genomes along with an overall reduction of pathogenesis-related gene families in H. arabidopsidis. Comparative analyses revealed fewer genes encoding enzymes involved in carbohydrate metabolism in Pythium species and H. arabidopsidis as compared to Phytophthora species, suggesting variation in virulence mechanisms within plant pathogenic oomycete species. Shared features between the oomycetes and diatoms revealed common mechanisms of intracellular signaling and transportation. Our analyses demonstrate the value of comparative genome analyses for exploring the evolution of pathogenesis and survival mechanisms in the oomycetes. The comparative analyses of seven Pythium species with the closely related oomycetes, Phytophthora species and H. arabidopsidis, and distantly related diatoms provide insight into genes that underlie virulence.	[Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Levesque, C. Andre] Agr & Agri Food Canada, Ottawa, ON, Canada; [Levesque, C. Andre] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Michigan State University; Colorado State University; Agriculture & Agri Food Canada; Carleton University	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program [2007-35600-17774, 2007-35600-18886]	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program	Funding for the work was provided by the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program to CRB and NT (2007-35600-17774 and 2007-35600-18886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley A, 2007, REF USER SERV Q, V47, P133; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P173, DOI 10.1146/annurev.py.30.090192.001133; Bridge PD, 2008, PLANT PATHOL, V57, P1066, DOI 10.1111/j.1365-3059.2008.01868.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra John A, 2010, Genome Biol, V11, P306, DOI 10.1186/gb-2010-11-6-306; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1987, PHYTOPATHOLOGY, V77, P1192, DOI 10.1094/Phyto-77-1192; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dick MW, 2001, STRAMINIPILOUS FUNGI; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; GOLD SE, 1985, PHYTOPATHOLOGY, V75, P333, DOI 10.1094/Phyto-75-333; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harvey P., 2008, Outlooks on Pest Management, V19, P127, DOI 10.1564/19jun09; Harvey PR, 2000, PLANT PATHOL, V49, P619, DOI 10.1046/j.1365-3059.2000.00493.x; Harvey PR, 2001, MYCOL RES, V105, P85, DOI 10.1017/S0953756200002902; Horner NR, 2012, FUNGAL BIOL-UK, V116, P24, DOI 10.1016/j.funbio.2011.09.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwayama S, 1933, NEW SNOW ROT DIS CER; Kale SD, 2012, NEW PHYTOL, V193, P874, DOI 10.1111/j.1469-8137.2011.03968.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koike S.T., 2006, VEGETABLE DIS COLOR; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P430, DOI 10.1094/Phyto-85-430; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin F.N., 2009, OOMYCETE GENETICS GE, P574; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5; MARTIN FN, 1987, PHYTOPATHOLOGY, V77, P1013, DOI 10.1094/Phyto-77-1013; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Mendoza L, 1996, J MYCOL MED, V6, P151; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mulder Nicola, 2007, V396, P59; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Paulitz TC, 2003, PHYTOPATHOLOGY, V93, P867, DOI 10.1094/PHYTO.2003.93.7.867; Quinn E, 2012, RESOLVING PYTHIUM UL; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUNDERS GA, 1988, J INVERTEBR PATHOL, V52, P360, DOI 10.1016/0022-2011(88)90148-6; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Snowdon A. L., 1990, COLOUR ATLAS POSTHAR, V1; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P1210, DOI 10.1016/j.funbio.2011.08.006; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P157, DOI 10.1016/j.funbio.2010.11.005; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; SUMNER DR, 1990, PLANT DIS, V74, P704, DOI 10.1094/PD-74-0704; TAKAHASHI M, 1977, T MYCOL SOC JPN, V18, P279; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2011, EFFECTORS PLANT MICR, P101; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Vawdrey LL, 2005, AUSTRALAS PLANT PATH, V34, P127, DOI 10.1071/AP04093; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng HC, 2005, MYCOPATHOLOGIA, V159, P601, DOI 10.1007/s11046-005-5258-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	107	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75072	10.1371/journal.pone.0075072	http://dx.doi.org/10.1371/journal.pone.0075072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124466	Green Published, gold, Green Submitted			2022-12-25	WOS:000325489100023
J	Fan, JB; Park, H; Tan, S; Lee, M				Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min			Enhanced Osteogenesis of Adipose Derived Stem Cells with Noggin Suppression and Delivery of BMP-2	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; COMBINATORIAL GENE-THERAPY; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; EXPRESSION; COMPLICATIONS; OSTEOBLAST; INDUCE; MATRIX	Bone morphogenetic proteins (BMPs) are believed to be the most potent osteoinductive factors. However, BMPs are highly pleiotropic molecules and their supra-physiological high dose requirement leads to adverse side effects and inefficient bone formation. Thus, there is a need to develop alternative osteoinductive growth factor strategies that can effectively complement BMP activity. In this study, we intrinsically stimulated BMP signaling in adipose derived stem cells (ASCs) by downregulating noggin, a potent BMP antagonist, using an RNAi strategy. ASCs transduced with noggin shRNA significantly enhanced osteogenic differentiation of cells. The potency of endogenous BMPs was subsequently enhanced by stimulating ASCs with exogenous BMPs at a significantly reduced dose. The level of mineralization in noggin shRNA treated ASCs when treated with BMP-2 was comparable to that of control shRNA treated cell treated with 10-fold more BMP-2. The complementary strategy of noggin suppression + BMP-2 to enhance osteogenesis was further confirmed in 3D in vitro environments using scaffolds consisting of chitosan (CH), chondroitin sulfate (CS), and apatite layer on their surfaces designed to slowly release BMP-2. This finding supports the novel therapeutic potential of this complementary strategy in bone regeneration.	[Fan, Jiabing; Park, Hyejin; Tan, Steven; Lee, Min] Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA; [Lee, Min] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, M (corresponding author), Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90024 USA.	leemin@ucla.edu	Fan, Jiabing/J-6581-2015; Fan, Jinjiang/C-2010-2009	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568	National Institutes of Health [R01 AR060213, R21 DE021819]; International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Association for Dental Research; Academy of Osseointegration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants R01 AR060213 and R21 DE021819, the International Association for Dental Research, and the Academy of Osseointegration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Aghaloo T, 2007, MOL THER, V15, P1872, DOI 10.1038/sj.mt.6300270; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Carlisle Elliot, 2005, Spine J, V5, p240S, DOI 10.1016/j.spinee.2005.02.014; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fan JB, 2010, ACTA BIOMATER, V6, P1178, DOI 10.1016/j.actbio.2009.08.042; Gazzerro E, 2003, BONE, V32, P111, DOI 10.1016/S8756-3282(02)00948-1; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu JL, 2012, J BIOMED MATER RES A, V100A, P1680, DOI 10.1002/jbm.a.34115; James AW, 2011, STEM CELLS DEV, V20, P427, DOI 10.1089/scd.2010.0082; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Kilgore ML, 2009, J BONE MINER RES, V24, P2050, DOI [10.1359/jbmr.090523, 10.1359/JBMR.090523]; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Kuwahara K, 2011, TISSUE ENG PT A, V17, P2955, DOI 10.1089/ten.tea.2011.0290; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/00007632-200208151-00014; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Park H, 2013, CARBOHYD POLYM, DOI DOI 10.1016/J.CARBP0L.2013.05.023; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Stafford DA, 2011, DEVELOPMENT, V138, P1005, DOI 10.1242/dev.051938; Sun Yubo, 2012, Open Rheumatol J, V6, P24, DOI 10.2174/1874312901206010024; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	41	60	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72474	10.1371/journal.pone.0072474	http://dx.doi.org/10.1371/journal.pone.0072474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24124589	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000098
